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Introduction: The Chelsea Critical Care Physical Assessment tool 
(CPAx) is a performance-based measurement instrument to evalu-
ate respiratory function, functional mobility and grip strength in 
critically ill adults [1]. The CPAx has established construct valid-
ity and high interrater reliability in a general ICU population [2], 
but little is known about its validity to measure change over time 
(cross-sectional-validity).
Objectives: The current study investigated cross-sectional validity at 
three relevant, pre-specified timepoints across the ICU and hospital 
stay in critically ill adults on prolonged mechanical ventilation.
Methods: This prospective, longitudinal, clinimetric study was con-
ducted in a mixed ICU of a Swiss academic hospital. Participants were 
assessed by certified physiotherapists at three predefined timepoints: 
ICU baseline (between 72-144 h after the onset of mechanical ventila-
tion), ICU discharge and hospital discharge. We hypothesized that the 
relationship of the CPAx with other measurement tools would differ 
between these timepoints due to temporal changes in the measured 
characteristics. Based on this theoretical model we determined 22 
a-priori defined hypotheses about the relationship of the CPAx-GE 
with other instruments such as the Medical Research Council sum 
score (MRC-SS), ICU Mobility Scale (IMS) or Sequential Organ Failure 
Assessment (SOFA)
Results: CPAx data of 58 participants (70.7% male) with a median age 
of 68 years (IQR 56-73), APACHE II score of 32 (28-36) and ICU stay of 
7.97 days (6.69-12.85) were analysed. Cross-sectional validity was 
excellent with 86% (6 out of 7), 89% (8 out of 9) and 83% (5 out of 6) 
of the a-priori hypotheses accepted at ICU baseline, ICU discharge and 
hospital discharge, respectively. Floor (10%) and ceiling effects (6%) 
were likewise highly acceptable.
Conclusion: The CPAx demonstrated cross-sectional validity as an 
indicator of change over time. Floor and ceiling effects were low ena-
bling therapists to detect change across the ICU and hospital stay. 
The CPAx can therefore be recommended to assess physical function 
and activity in critically ill adults from ICU baseline to ICU and hospital 
discharge.
Reference(s) and grant ackowledgment(s)
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Introduction: Imipenem/cilastatin/relebactam (IMI/REL) is a fixed-
dose combination of imipenem, a carbapenem antibacterial agent, 
cilastatin, a renal dehydropeptidase inhibitor, and relebactam, a novel 
β-lactamase inhibitor.
Objectives: To analyze the efficacy and safety of IMI/REL and pipera-
cillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacte-
rial pneumonia (HABP) and ventilator-associated bacterial pneumonia 
(VABP) from the phase 3 RESTORE-IMI 2 trial (NCT02493764) grouped 
by geographic region.
Methods: Randomized patients received IMI/REL (500 mg/500 
mg/250 mg) or PIP/TAZ (4000 mg/500 mg) intravenously every 6 
hours for 7–14 days; dosing was adjusted for renal impairment. Effi-
cacy endpoints included all-cause mortality (ACM) through day 28, 
clinical response at early follow-up (EFU) in the modified intention-
to-treat population (MITT), and microbiological response at end of 
treatment (EOT) in the microbiological MITT population (mMITT). The 
MITT included patients who received ≥  1 dose of study treatment 
and did not have only gram-positive cocci on the baseline respiratory 
specimen Gram stain; the mMITT comprised patients from the MITT 
with ≥ 1 baseline pathogen, excluding monomicrobial infection with 
organisms known to be intrinsically resistant to IMI/REL (methicillin-
resistant Staphylococcus aureus, Enterococcus faecium, Legionella spp., 
Stenotrophomonas spp., or Burkholderia spp.). Differences in efficacy 
endpoints and 95% CIs were adjusted by the Miettinen & Nurminen 
method. The safety population included patients who received ≥  1 
dose of study treatment. Adverse events (AEs) were collected for 14 
days posttreatment. Efficacy and safety were analyzed by geographic 
region; patients were not randomized based on geographic blocks.
Results: Of 531 MITT patients, 264 received IMI/REL and 267 received 
PIP/TAZ. Most patients were from Eastern Europe (52%), followed 
by Asia (14%), South America (13%), North/Central America (11%), 
and Western Europe (9%). Mean age ranged from 47–71  years, and 
57–80% were male. At baseline, 39–72% had APACHE II scores ≥  15, 
44–80% had Clinical Pulmonary Infection Scores ≥ 6, and 13–47% had 
moderate to severe renal impairment (creatinine clearance < 60 to 
≥ 15 mL/min). Across all regions, day 28 ACM was lower withIMI/REL 
vs PIP/TAZ and clinical response at EFU and microbiological response 
at EOT was higher with IMI/REL vs PIP/TAZ (Table). IMI/REL and PIP/
TAZ had a comparable safety profile; ≥ 85% of patients reported ≥ 1 
AE, and serious AEs ranged from 20–59%. No regional differences in 
AE incidence were noted.
Conclusion: In clinically complex patients, the efficacy and safety of 
IMI/REL were comparable across treatment groups and regions, sup-
porting the use of IMI/REL as an effective treatment for HABP/VABP 
in all regions. The incidence of AEs was typical of patients with HABP/
VABP who receive antibacterials.
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Introduction: Septic shock (SS) is usually responsible of a dysauto-
nomic syndrome including an impairment of cardiovascular vari-
ability, the onset of inappropriate tachycardia, an immunosuppression 
and an increased mortality.  In experimental  SS,  β1-adrenergic block-
ade  is associated with cardiovascular benefits and possibly immune 
modulations.
Objectives: The main goal of this study was to investigate the effect 
of  β1-adrenergic modulation on lymphocyte subpopulations in a 
rodent experimental model of SS.
Methods: SS was induced by cecal ligation and puncture (CLP) in wild 
type (WT) mice with or without esmolol (ultra-selective  β1-blocker) 
and in β1-AR knock out mice (β1KO). Assessment 18 hours after sur-
gery included  in vivocardiac function assessed by echocardiography. 
Blood was collected for cytokine measurements. Splenocytes were 
isolated to assess lymphocyte subpopulations by flow cytometry and 
cultured 72h with a cell trace to measure cell proliferation capacities.
Results: SS was characterized in WT CLP compared to WT sham ani-
mals by a decrease in heart rate (HR) (318 ±  31 in CLP vs. 360 ±  48 
bpm in sham animals, p = 0.01) and in mean arterial pressure (MAP) 
(mean ±  SD) (62.2 ±  11.8 vs. 84.8 ±  6.9 mmHg, p < 0.0001). Com-
pared to WT sham, WT CLP animals showed an increase in both pro- 
and anti-inflammatory cytokines (IL6: 10.58 ±  15.01 vs. 0.05 ±  0.03 
ng/ml, p = 0.004, IL10: 2.28 ± 1.22 vs. 0.04 ± 0.01 ng/ml, p = 0.004), 
a decrease  in Th4 lymphocytes  (10.7 ± 3.1 vs. 16.1 ± 1.8 % of T lym-
phocytes, p = 0.0001) and an increase in regulatory T cell percentage 
(12.49 ± 2.74 vs. 7.55 ± 1.75 % of T helper, p < 0.0001). Compared to 
WT sham, WT CLP animals showed a decrease of lymphocytes prolif-
eration (66.7 ± 9.5 vs. 78.6 ± 7.1 % of proliferative lymphocytes, p = 
0.025).
Compared to WT CLP,  HR  in  WT CLP + esmolol,  was decreased 
(273 ± 45 in WT CLP + esmolol vs. 318 ± 31 bpm in WT CLP animals, p 
= 0.005). There was no difference in MAP between WT CLP + esmolol 
and WT CLP(67.4 ± 17.3 vs. 62.2 ± 11.8 mmHg, p = 0.20). In WT CLP 
+ esmolol, pro- and anti-inflammatory cytokinesdecreased compared 
to WT CLP (IL6: 0.64 ± 0.52 vs. 10.58 ± 15.01 ng/ml, p = 0.004, IL10: 
0.41 ±  0.28 vs. 2.28 ±  1.22 ng/ml, p = 0.002). The T  helper  lympho-
cytes percentage in the spleen increase in  WT CLP + esmolol com-
pared to WT CLP (14.7 ± 2.9 vs. 10.7 ± 3.1 % of T helper, p = 0.007). 
The regulatory T lymphocytes percentage was decreased in WT CLP 
+ esmolol compared to WT CLP (10.09 ± 3.03 vs. 12.49 ± 2.74 % of T 
helper, p = 0.03). There is a trend increase in splenocyte proliferation 
percentage for WT CLP + esmolol animals (72.0 ± 4.2 vs. 66.7 ± 9.5 % 
of proliferative lymphocytes, p = 0,72). Hemodynamic and immune 
pattern results were similar in β1KO septic animals compared to β1KO 
sham animals.
Conclusion: β1-adrenergic modulation by esmolol reduce septic 
shock-related immunosuppression by decreasing regulatory T lym-
phocyte percentage, increasing lymphocyte counts and trend to 
increase proliferation.
Reference(s) and grant ackowledgment(s)
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Introduction: Restrictive use of antibiotics is required to prevent the 
rapid emergence and spread of multidrug-resistant pathogens but 
practice is challenging for critically ill patients.  Gram staining should 
provide immediate information for predicting pathogenic bacteria, 
however, the effectiveness of Gram staining for initial antibiotic choice 
on clinical outcomes is not investigated in intensive care units (ICUs).
Objectives: To compare the clinical response between initial anti-
biotics selection based on Gram staining information and guidelines 
recommendation in patients with ventilator-associated pneumonia 
(VAP), which is one of the most common hospital-acquired infection 
in ICUs.
Methods: The GRam stain-guided Antibiotics ChoicE for Ventilator-
Associated Pneumonia (GRACE-VAP) trial was  a multicenter, rand-
omized, open-label non-inferiority clinical trial conducted in 12 ICUs in 
Japan from April 2018 to April  2020. Eligibility criteria was aged > = 
15 years, with mechanical ventilation for at least 48 hours and diag-
nosed as VAP with a modified clinical pulmonary infection score > = 
5. Patients were randomly assigned to receive Gram stain-guided ini-
tial antibiotic treatment (Gram-stain group) or guidelines-based treat-
ment (standard group).  The primary endpoint  was  clinical response 
rate which was defined as that fulfilling all four of the following com-
ponents: completion of antibiotic therapy within 14 days, improve-
ment or lack of progression of baseline radiographic findings at the 
end of therapy, resolution of signs and symptoms of pneumonia 7 
days after the end of therapy, lack of antibiotic agent re-administration 
due to pneumonia within 7 days. We set non-inferiority margin at 20% 
for primary endpoint with one-sided alpha level of 0.025. Secondary 
endpoints included  the coverage rates of initial antibiotic therapies, 
the selected rates of anti-pseudomonal agents and anti-MRSA agents 
as initial antibiotic therapies, 28-day all-cause mortality, ICU-free days, 
ventilator-free days, and adverse events.
Results: A total of 206 patients underwent randomization (103 
patients to the Gram-stain group and 103 patients to the stand-
ard group). The median age was 69 (range: 16-93)years, and men 
accounted for 68.4%. The median hospital stay from ICU admission 
to enrollment was 4 (range: 3-34) days. The backgrounds were similar 
between groups. In a per-protocol analysis,  the clinical response was 
observed in 79/103 patients (76.2%) with the Gram-stain group and 
74/103 (71.7%) with the standard group (risk difference, 0.049 95% 
confidence interval, − 0.07 to 0.17; p < 0.001 for non-inferiority). Both 
anti-pseudomonal agents and anti-MRSA agents were significantly 
less administered in Gram-stain group than standard group (72 cases 
vs. 103 cases,  p < 0.001; 63 cases vs. 103 cases,  p < 0.001, respec-
tively).  The coverage rates of initial antibiotic therapies and  28-day 
all-cause mortality were similar (86.4% vs. 92.2%;  p = 0.18, 13.6% vs. 
17.5%, p = 0.39, respectively), and all other secondary outcomes were 
also similar between groups.
Conclusion: The  GRACE-VAP  trial showed Gram stain-guided treat-
ment significantly restricted the use of broad-spectrum antibiotics 
than guidelines-based treatment with similar clinical responses in 
patients with VAP in ICU. This reinforced the utility of Gram staining in 
the setting of critical care to ameliorate the spread of multidrug-resist-
ant pathogens. (Trial Registration; Clinicaltrials.gov NCT03506113)
Reference(s) and grant ackowledgment(s)
1. Funding was provided by Public Trust Foundation of Marumo ER Medicine 
& Research Institute. However, the funding source had no role in 1) study 
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Introduction: Sepsis is a life-threatening pathological host response 
to an infection often leading to significant vascular leakage. The ele-
mentary molecular mechanisms remain incompletely understood and 
specially the role of the micro RNAs (MIR) has not been investigated 
further in detail. We hypothesized that specific MIRs might be up-
regulated in the septic endothelium thereby contributing to vascular 
barrier breakdown.
Objectives: To identify MIRs, regulated in the septic endothelium and 
to elucidate their role in endothelial permeability.
Methods: Possible regulated MIRs were screened by an unbiased MIR 
array approach from murine lung endothelial cells (CD146 + mag-
netic isolation). In vivo, the effect of specific MIRs on permeability was 
assessed in a transgenic zebrafish larvae (flk:mCherry) and a murine 
knockout (KO B6.Cg-Mir155tm1.1Rsky/J) model. Both Lipopolysac-
charides (LPS) and cecal ligation and puncture (CLP) were used for 
the induction of systemic inflammation. Readouts were pulmonary 
permeability (Evans Blue, Wet-to-Dry), activity scoring and survival. 
Mechanistic studies were done in human umbilical vein endothelial 
cells (HUVECs) using standard molecular biology tools (RT-PCR, Immu-
noblots) and functional real-time permeability measurements (ECIS-
TER). Furthermore, immediate post mortem kidney biopsies (n = 16) 
were performed to evaluate the expression of MIRs in a septic human 
organism.
Results: MIR155 was significantly upregulated in the array (25×). 
Transgenic overexpression of MIR155 in zebrafish - as a screening 
tool - led to a extensive induction of vascular permeability (eye assay, 
p < 0.01). The same was observed when MIR155 was experimentally 
overexpressed in human ECs in vitro and permeability was measured 
(p < 0,04). Moreover, MIR155 inhibition protects against classical per-
meability mediators (i.e. thrombin, p < 0,03). We identified Claudin-1 
(a tight junction protein) both on protein and mRNA level as putative 
MIR155 target both by overexpression and inhibition. Interestingly, in 
vivo the heterozygote MIR155 knockout mouse showed a protected 
phenotype with regard to capillary leakage and survival (40% benefit, 
p < 0.01). MIR155 was also increased in septic human renal tissue com-
pared to kidney biopsies from non-septic patients (p = 0.01).
Conclusion: Using an unbiased MIR-array approach, we found that 
MIR155 is upregulated in septic endothelium in mouse and men. It 
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might contribute to the pathophysiology of vascular leakage in a 
Claudin-1 dependent manner. Future studies have to clarify if MIR155 
could be a potential therapeutic target.
Reference(s) and grant ackowledgment(s)
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Introduction: Between 2012-2015, the PEPaNIC randomized con-
trolled trial, which included 1440 critically ill infants and children, 
showed that withholding parenteral nutrition during the first week in 
the paediatric intensive care unit (PICU) (late-PN), as compared with 
initiating supplemental PN early (early-PN), improved PICU outcomes 
(1) and improved neurocognitive development assessed 2 years later 
(2). The latter was explained by avoiding early-PN induced adversely 
altered DNA-methylation of 37 CpG sites (3). As a large number of 
patients were younger than 1 year of age at randomization and given 
that assessment of most neurocognitive domains is only possible from 
4 years of age onwards, we performed a 4-year follow-up to determine 
the impact of late-PN versus early-PN on physical, neurocognitive, 
and emotional/behavioural development. This pre-planned, 4-year 
follow-up study of the 1440 PEPaNIC patients and of 369 matched 
healthy children was blinded for treatment allocation (ClinicalTrials.
gov-NCT01536275).
Methods: Studied clinical outcomes included anthropometrics, health 
status, parent/caregiver-reported executive functions, and emotional/
behavioural problems, and clinical tests for intelligence, visual-motor 
integration, alertness,motor coordination and memory. Univariable 
and multivariable linear and logistic regression analyses adjusted for 
risk factors assessed the impact of late-PN versus early-PN on the out-
comes and investigated a potential mediation role of the adversely 
altered DNA-methylation of 37 CpG sites previously shown to be 
evoked by late-PN as compared with early-PN (3).
Results: Overall, at 4 years follow-up, patients (356 late-PN patients, 
328 early-PN patients) could be tested neurocognitively. They 
revealed worse anthropometric, health status, neurocognitive and 
emotional/behavioural developmental outcomes than the healthy 
control children. Outcomes of late-PN patients were never worse than 
those of early-PN patients. In contrast, late-PN patients had fewer 
internalizing (P = 0.042) and externalizing problems (P = 0.046), and 
fewer total emotional/behavioural problems (P = 0.007) than early-
PN patients, which were normalized by late-PN. Avoiding the early-PN 
induced adversely altered DNA-methylation status of the 37 CpG sites 
statistically explained its impact on the behavioural outcomes.
Conclusion: Four years after randomization to late-PN or early-PN in 
the PICU, late-PN did not show harm, and was found to protect against 
emotional/behavioural problems, with altered DNA-methylation as a 
potential biological mediator hereof. These data further support de-
implementation of PN-use early during critical illness in infants and 
children.
Reference(s) and grant ackowledgment(s)
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Introduction: The mortality rate of ARDS is high (35–46% from mild 
to severe) [1]. The acute phase is usually accompanied with moder-
ate to severe hypoxemia. Positive end-expiratory pressure (PEEP) may 
improve oxygenation but at the same time may induce barotraumas. 
The best PEEP selection method is still under debate.
Objectives: The aim of the study was to compare PEEP titration with 
electrical impedance tomography (EIT) and with ventilator-embedded 
pressure–volume (PV) loop in moderate to severe ARDS.
Methods: This randomized control trials study was conducted from 
April 2017 to February  2019 in the ICU of FEMH. Patients with mod-
erate to severe ARDS according to Berlin criteria were included. Total 
eighty-seven ARDS patients were randomized to either EIT group (n = 
42) or PV group (n = 45). The exclusion criteria were clinical contrain-
dications applying EIT or high PEEP level.
All patients were total sedated to prevent any spontaneous breath-
ing and ventilated under volume-control mode (IBW/6ml/kg) and  FiO2 
100%. The PV group used Hamilton G5 to measure the PV loop. The 
lungs were inflated with an increase pressure of 3  cmH2O/sec from 
5  cmH2O to 40  cmH2O. The pressure was kept constant at 40  cmH2O 
for 1 second. Subsequantly, the lungs were passively deflated down 
to 5  cmH2O. PEEP with maximal hysteresis (volume difference in the 
PV loop) was defined as optimal. In the EIT group, optimal PEEP was 
defined according to the regional compliance method published else-
where [2]. The methods are illustrated in Fig. 1.
Parameters including optimal PEEP, airway pressures, compliance (Crs), 
and APACHE II,  PaO2/FiO2, ICU day, resistance of the respiratory system 
(R) were measured and recorded.
Results: After optimization, PEEP was significantly higher in the PV 
group (17.4 ± 1.7 vs. 16.2 ± 2.6  cmH2O, PV vs. EIT groups, p = 0.02). 
After 48 hours, driving pressure was significantly higher in the PV 
group (12.4 ± 3.6 vs. 10.9 ± 2.5  cmH2O, p = 0.04). Lung mechanics and 
oxygenation did not differ between the groups. The survival rate was 
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lower in the PV group(44.4% vs. 69.0%, p = 0.02; hazard ratio 2.1, con-
fidence interval 1.1 to 3.9).
Conclusion: In moderate to severe ARDS, PEEP titration guided with 
EIT, compared with PV curve, was associated with improved driving 
pressure and survival rate. These findings support the use of EIT-based 
PEEP titration in ARDS.
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Introduction: Trauma remains a leading cause of mortality. The lead-
ing cause of preventable deaths in trauma patients is uncontrollable 
hemorrhage. During recent years’ Damage Control Resuscitation 
(DCR) and Damage Control Surgery (DCS) has been the main strat-
egy in the management of major hemorrhage in trauma patients. 
One aspect of DCR is permissive hypotension. However, the duration 
of hypotension that can be tolerated without affecting the brain is 
unknown. The authors have in a previously publishedexperimental 
study shown that prolonged (90 minutes) and severe hypotension 
(mean arterial pressure (MAP) of 40 mmHg) results in irreversible met-
abolic perturbation evaluated by a marked and lasting increase in the 
lactate to pyruvate ratio (LP ratio) measured by intracerebral micro-
dialysis (MD). Furthermore, the same study showed that the cerebral 
biochemical changes in response to severe hypotension was reflected 
in the cerebral venous outflow.
Objectives: In the present study we investigate the effect of 60 min 
severe hypotension (MAP equal 40 mmHg) on the brain’s energy 
metabolism and seek to verify earlier findings that venous cerebral 
blood can be used as a marker of global cerebral energy state. The 
hypothesis is that hemorrhagic shock for 60 min results in less severe 
metabolic changes evaluated as a temporarily increase in the hemi-
sphere LP ratio.
Methods: The study was approved by the Danish Animal Experi-
ments Inspectorate. 10 pigs were anaesthetized, and vital parameters 
recorded. Probes for monitoring brain tissue oxygenation  (PbtO2) 
and intracranial pressure was placed in the right and left hemisphere 
respectively. Microdialysis catheters were placed in the left parietal 
lobe, femoral artery and superior sagittal sinus for analysis of lactate, 
pyruvate, glucose, glycerol and glutamate. The superior sagittal sinus 
was chosen for analysis of cerebral venous blood due to the anatomic 
characteristics of the pig. In the pig, most of the cerebral blood is 
drained via paraspinal venous plexa and only a minor part passes into 
the internal jugular vein. Hemorrhagic shock was induced by bleeding 
the animal until MAP of 40 mmHg was achieved. The MAP was kept 
around 40 mmHg by further withdrawing or infusing shed blood. After 
60 min the pigs was resuscitated with autologous blood and observed 
for 3 hours.
Results: The volume of shed blood was (median (interquartile range)) 
1469 mL (1378.4-1583.44 mL) and median blood loss per kilogram was 
35 mL/Kg (31.9-36.8 mL/Kg).
During the period of hemorrhagic shock, MAP decreased to a median 
value of 39mmHg (35-42). Accordingly, CPP decreased to low levels of 
33 mmHg (28-39). Similarly,  PbtO2 decreased to near critical levels of 
19 mmHg (8-23). After resuscitation with shed blood MAP increased to 
near baseline levels (p < 0.05). The CPP showed a similar response, nor-
malizing, but not reaching baseline levels (p < 0.05). In contrast,  PbtO2 
increased to levels exceeding baseline values and stayed at that level 
during the rest of the observation period (p < 0.05)
At baseline the lactate to pyruvate ratio (LP ratio) in the hemisphere, 
artery and sagittal sinus were 13 (8-16), 21 (18-24) and 9 (6-22), respec-
tively. After induction of hemorrhagic shock, the LP ratio from the left 
hemisphere in 9 pigs increased to levels indicating a reversible pertur-
bation of cerebral energy metabolism 19 (12-30). The same pattern 
was seen in LP measurements from the femoral artery 28 (20-35) and 
sagittal sinus 22 (19-26). At the end of the experiment hemisphere, 
artery and sinus LP ratios were 16 (10-23), 17 (15-25), and 17 (10-27), 
respectively. Although hemisphere and sinus LP ratios decreased, they 
did not reach baseline levels (p < 0.05). In one pig hemisphere LP ratio 
increased to a level indicating irreversible metabolic perturbation (LP 
ratio > 200)
Conclusion: During 60 min of severe hemorrhagic shock intracerebral 
microdialysis shows signs of perturbations of cerebral energy metabo-
lism, and these changes trends towards baseline values after resusci-
tation. Since time apparently is an important factor in the prevention 
of irreversible brain damage future studies should focus on methods 
(e.g. vasoactive drugs) to prolong the period in which permissive 
hypotension is safe for the brain. Sagittal sinus microdialysis values fol-
lowed hemisphere values but were not distinguishable from systemic 
arterial values. Venous (jugular bulb) microdialysis might have a place 
in monitoring conditions were global cerebral ischemia is a risk, but 
further studies are required.
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Introduction: Oral chlorhexidine is used widely for mechanically 
ventilated patients to prevent ventilator-associated pneumonia but 
recent studies show an association with excess mortality [1,2].
Objectives: The primary objective of this study was to determine 
whether de-adoption of oral chlorhexidine and parallel implementa-
tion of a standardized oral care bundle reduces mortality in mechani-
cally ventilated patients. Secondary outcomes were infection-related 
ventilator-associated complications (IVACs), oral health dysfunction 
and oral procedural pain.
Methods: A stepped wedge cluster randomized controlled trial with-
integrated process evaluation conducted December 2017 to January 
2019 in 6 academic intensive care units (ICUs) in Toronto, Canada [3]. 
Clusters were randomized to de-adopt oral chlorhexidine and imple-
ment a standardized 5-part oral care bundle comprising oral assess-
ment, tooth brushing, mouth moisturization, lip moisturization and 
secretion removal every two months. We used an integrated knowl-
edge translation strategy including point-of-care education, audit and 
feedback, and reminders to facilitate change in oral care [4]. Analyses 
were adjusted for patient characteristics, clustering within sites and 
secular trends. Trained observers conducted random evaluation of 
fidelity to the oral care bundle.
Results: A total of 3260 patients were enrolled; 1560 baseline (con-
trol), 1700 intervention phase. We found no difference in crude 
ICU mortality, 332 (21.2%) (control) and 400 (23.5%) (intervention) 
(adjusted odds ratio [aOR], 1.13; 95% confidence interval [CI], 0.82-
1.54; P = 0.46) or the time to IVACs (adjusted hazard ratio, 1.06; 95% CI, 
0.44–2.57; P = 0.90). Oral procedural pain was not significantly differ-
ent (aOR, 0.62; 95% CI, 0.34–1.10; P = 0.10), however, oral health dys-
function scores significantly improved in the intervention phase (-0.96; 
95% CI, −  1.75 to −  0.17;  P = 0.02). Among 348 randomly observed 
oral care encounters, we identified 100% compliance with oral chlo-
rhexidine de-adoption between control and intervention periods 
(P < 0.0001) and delivery of 4 out 5 elements of the oral care bundle 
increased (P < 0.0001) in the intervention phase.
Conclusion: Among patients receiving mechanical ventilation, de-
adoption of oral chlorhexidine and implementation of a standardized 
oral care bundle was not associated with lower mortality, IVACs or oral 
procedural pain, but did improve oral care. Our results indicate active 
de-adoption of oral chlorhexidine for IVAC prevention from clinical 
practice is needed due to lack of benefit and a standardized oral care 
bundle results in clinically important improvements in oral health and 
should be adopted into practice.
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Introduction: High Flow Nasal Cannula (HFNC) provides heated and 
humidified high gas flow (30 to 60 L/min) that reduces the inspiratory 
effort in hypoxemic patients [1]. No study showed the effects of HFNC 
in patients with increased respiratory drive from systemic inflamma-
tion and acidosis.
Objectives: HFNC might decrease effort measured by esophageal 
pressure swing (ΔPes) in non-intubated patients with diagnosis of 
extra-pulmonary sepsis and septic shock.
Methods: We performed a prospective, multicentric physiological 
study in non-intubated sepsis and septic shock patients admitted to 
the Intensive Care Units of Maggiore Policlinico Hospital in Milan and 
of Sant’Anna Hospital in Ferrara. Exclusion criteria were: diagnosis 
of pneumonia, GCS < 12 and contraindication to the positioning of 
the esophageal catheter. Study protocol consisted of 3 consecutive 
phases of 20 minutes: first low flow oxygen (LFO), then HFNC and 
lastly LFO.  FiO2 was titrated to maintain  SpO2 of 92-96%. During all 
phases, esophageal pressure and electrical impedance tomography 
waveforms were continuously recorded.
Results: We present preliminary results on 22 patients (68 ±  14 yo), 
11 (50%) with diagnosis of septic shock, with median serum lactate 
level of 2.30 [1.20-3.37] mmol/L and SOFA score 5 [4-9]. During HFNC, 
spontaneous effort measured as ΔPes (see Figure  1) and as esopha-
geal Pressure-Time Product (PTP) decreased, together with respiratory 
rate (RR), in comparison to LFO. Positive airway pressure generated by 
HFNC is showed by increased End Expiratory Lung Impedance (ΔEELI) 
(see Table). Interestingly these effects were maintained, in part, also 
when patients were switched back to LFO.
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Conclusion: HFNC reduces the inspiratory effort and provides positive 
airway pressure in patients with sepsis and septic shock.
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Introduction: Septic shock associated with cardiovascular failure is 
one ofthe most important reasons of death in Intensive Care Units. 
The mechanisms of the heart failure associated to sepsis remain 
unclear. Some ex-vivo data suggested a hypothetical mitochondrial 
failure inducted by the pro-inflammatory mediators released during 
septic shock. However, those anomalies were not confirmed in vivo.
Objectives: This experiment aims at exploring the cardiac oxidative 
metabolism and its relation with perfusion and work through positron 
emission tomodensitometry (PET) imaging with [11C] acetate tracer, 
during an endotoxic shock in a pig model.
Methods: Forty anesthetized and mechanically ventilated pigs (mean 
weight = 25kg) were randomized into two groups: controls and those 
challenged with intravenous lipopolysaccharid (LPS-150  µg/kg/min 
during 30 min) to achieve a status of profound hypodynamic shock. 
No vasopressors were used. Animals were exclusively cristalloid fluid 
resuscitated as needed, following standard hemodynamic parameters.
Heart rate (HR) and arterial blood pressure were continuously moni-
tored throughout the study period. As a direct myocardial work reflec-
tion, the rate pressure product (RPP, in mmHg*bpm) was calculated as 
the product between HR and systolic blood pressure (SBP).
Subjects were submitted to PET-scan at three different time frames: 
before LPS infusion, during the early stage of the endotoxic shock 
(T = 60 minutes after infusion) and at a late time (T = 450 min from 
the beginning of the experiment). After the second PET-scan, animals 
in both groups were randomized to receive an infusion of ESMO-
LOL (dosed enough to lower the HR of 20%) in order to evaluate the 
impact of beta-blockers in the endotoxic shock. For each PET-scan, 
[11C] acetate was used as tracer for the combined assessment of myo-
cardial mean blood flow (F, in mL/min/g) and oxidative metabolism 
(k2, acetate clearance rate, a measure of MVO2 rate, in mL/min). Defi-
nition of myocardial regions of interests (ROIs) and kinetic modeling 
were performed using PMOD software (Pmod 3.4).
Results: In the LPS group (n = 20), the RPP increased respectively 
from 11708 to 14473 mmHg*bpm (p = 0,03) between the baseline (T 
= 0  min) and the LPS early stage (T = 60  min after infusion). In the 
same time, quantification of PET images performed before and after 
the endotoxic shock does not reveal significant changes in values of 
microcirculation or oxidative metabolism. These results show a dis-
sociation during LPS challenge between the myocardial work that 
increased and the cardiac oxydative metabolism and the cardiac 
microcirculation which remained stable.
As expected, the adjunction of beta-blockers reduced the RPP (18097 
vs 13613 mmHg*bpm; p = 0,02) and increased the microcirculation 
(1,408 vs 2,101 mL/min/g; p = 0,02) between the second and the last 
PET. No impact on the oxidative metabolism has been identified.
Conclusion: (1) These results suggest that despite the increased myo-
cardial work caused by the LPS challenge, no significant changes in 
myocardial flow nor oxidative metabolism were found. These sug-
gest a decoupling between work and PET results. The disregulation of 
these adaptive phenomena may participate in the onset of myocardial 
involvement in sepsis. (2) The beta-blockers increased the microcircu-
lation but had no effects on the oxidative metabolism.
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Introduction: Biological subphenotypes have been identified in 
acute respiratory distress syndrome (ARDS) [1, 2], which have shown 
to provide prognostic- and possibly predictive enrichment [2–4]. Dif-
ferentiation of biological subphenotypes in ARDS is mainly driven by 
inflammatory parameters measured in plasma. Considering that this 
inflammatory response can also be observed in other types of acute 
respiratory failure and patients admitted to the ICU for other reasons 
[5], the question arises whether these subphenotypes are limited to 
ARDS.
Objectives: To determine whether these biological subphenotypes 
and their prognostic- and predictive enrichment could be extended 
to a general ICU population, irrespective of fulfilling the definition of 
ARDS.
Methods: This was a secondary analysis of the Molecular Diagnosis 
and Risk Stratification of Sepsis (MARS) study (ClinicalTrials.gov identi-
fier NCT01905033), a prospective observational study of adult patients 
admitted to the ICU. Two previously proven parsimonious models 
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were used to determine the biological subphenotype of each patient. 
First, a cluster based model distinguishing an uninflamed and reac-
tive subphenotype based on plasma levels of interleukin-6, interferon 
gamma, angiopoietin 1/2, and plasminogen activator inhibitor-1 [2]. 
Second, a latent class analysis (LCA) model revealing a hypo-inflam-
matory and hyper-inflammatory subphenotype using plasma levels 
of interleukin-8, protein C, and bicarbonate [4]. The prognostic enrich-
ment was assessed with logistic regression analysis (30-day mortality) 
while correcting for the mediating effect of ARDS and with Cox regres-
sion analysis (ICU-mortality and ventilor-free days), for both biological 
phenotyping models. As part of predictive enrichment, blood leuko-
cyte gene expression profiles in biological subphenotypes were ana-
lyzed by principal component analysis.
Results: We analyzed the data of 2500 patients (674 with ARDS and 
1826 without ARDS). Here, we only report the results of patients 
without ARDS. The cluster-derived reactive subphenotype was, inde-
pendently of ARDS, associated with (1) a higher 30-day mortality (OR 
1.48, CI 1.16-1.89), (2) a higher probability of ICU mortality (HR 2.43, CI 
1.90-3.11), and (3) a lower probability of successful extubation while 
alive (HR 0.66, CI 0.59-0.74; Figure 1) compared to the uninflamed sub-
phenotype. The blood leukocyte gene expression profiles of each indi-
vidual subphenotype were similar for patients with and without ARDS 
(all p > 0.05; Figure  2). LCA-derived subphenotypes showed similar 
profiles (data not shown).
Conclusion: The prognostic- and predictive enrichment of biological 
ARDS subphenotypes can be extended to a general ICU population. 
Using the concept of biologicalsubphenotypes for splitting cohorts 
of critically ill patients could add to improving future precision-based 
trial strategies and lead to identifying treatable traits for all critically ill.
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Introduction: Biomarkers can be of help in understanding critical ill-
ness and to identifying and stratifying sepsis. Adrenomedullin is a 
peptide hormone with vasoactive properties, with reported prognos-
tic and potentially therapeutic value in sepsis.
Objectives: The aim of this study was to investigate how levels of 
circulating bioactive adrenomedullin (bio-ADM) at admission to the 
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intensive care unit (ICU) correspond to morbidity and mortality in sep-
sis patients as well as in a general ICU population.
Methods: Admission blood samples from all patients admitted to four 
ICUs during 2016 were batch-analysed. Patients fulfilling the sepsis-3 
criteria were identified. Primary outcomes were the predictive capac-
ity of bio-ADM to identify sepsis patients and the association of bio-
ADM with 30-day mortality in the ICU. Secondary outcomes were the 
need for circulatory and renal support. A commonly used bio-ADM 
cutoff of 70 pg/mL was validated.
RESULTS. Bio-ADM in 1867 consecutive adult patients were analysed, 
and 632 patients fulfilled the sepsis criteria of whom 267 had septic 
shock. The median bio-ADM in the entire ICU population was 40 pg/
mL, compared to 74 pg/mL in sepsis patients, 107 pg/mL in septic 
shock and 29 pg/mL in the non-septic patients.  Sepsis was identified 
with an odds ratio (OR) of 1.64 for log2-transformed bio-ADM, after 
adjusting for severity of the disease. The association of elevated bio-
ADM and 30-day mortality was equally strong in sepsis patients and 
the ICU population with an adjusted OR of 1.23 and 1.22, respectively. 
Higher levels of bio-ADM were associated with an increased need 
of renal replacement therapy with adjusted ORs of 2.28 and 1.97 for 
the ICU-population and the sepsis patients respectively, and with an 
increased need of vasopressors with adjusted OR of 1.33 for both popu-
lations. In the sepsis cohort, bio-ADM provided additional information 
to lactate on 30-day mortality. The cutoff of 70 pg/mL of bio-ADM was 
able to differentiate between survivors and non-survivors, but a thresh-
old of 108 pg/mL performed better in the sepsis cohort.
Conclusion: Admission bio-ADM is an independent sepsis biomarker. 
In addition, bio-ADM levels are associated with 30-day mortality and 
organ failure in sepsis patients as well as in a general ICU-population.
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Introduction: Critically ill patients have an increased risk of dyspha-
gia after prolonged oro-tracheal intubation (OTI)  [1, 2]. COVID-19 is a 
multisystem disease caused by SARS-COV-2, characterized by acute 
respiratory failure; severe forms usually need mechanical ventilation 
(MV) support and required OTI; for prolonged courses tracheostomy 
is mandatory [3, 4].
Objectives: The purpose of this study was to evaluate dysphagia in criti-
cally ill COVID-19 patients, analyzing relations with clinical and biologi-
cal data concerning MV during the ICU stay. Moreover, an analysis about 
recovery rate from dysphagia and its characteristics were reported.
Methods: This was a retrospective study on COVID-19 cohort patients 
admitted to intensive care unit (ICU);  patients died before the first 
evaluation were excluded from the analysis. Dysphagia score has been 
reported in agreement with  Gugging Swallowing Screen  (GUSS)  [5]. 
GUSS stratified the severity of dysphagia into severe (0–9), moderate 
(10–14), mild (15–19) or no dysphagia (20 points), according to clinical 
evaluation made by speech and language therapist (SLT). Data related 
to MV days, ICU length of stay (LOS) and other clinically relevant vari-
ables were analyzed.
Results: Forty-two consecutive patients were admitted to ICU, with an 
average age of 61 years (SD 12); according to exclusion criteria, 31 (74%) 
were evaluated by the nurse and the SLT. Twenty-five of them were 
mechanically ventilated; 19 (76%) patients were treated with OTI, and 
6 (24%) of them were tracheostomized; median MV days were 11 (7.5 - 
16). At first SLT evaluation, 14 (45.2%) patients showed no dysphagia, 5 
(16.1%) a mild degree of dysphagia, 6 (19.4%) a moderate level of dys-
phagia and 6 (19.4%) patients had a severe dysphagia. Mean first GUSS 
evaluation was 15.1 (SD 6.5), with a median of 19 (IQR = 12-20).
A correlation was found between distribution of GUSS score at first 
evaluation and ICU LOS (p < 0.001), MV days (p < 0.001), age (p = 0.03) 
and tracheostomy (p = 0.04). No correlation was found with BMI, SAPS, 
SOFA, NEMS at admission, sex, comorbidities (COPD, OSA, diabetes, 
Hypertension and IHD), pronation maneuvers and initial PEEP setting.
After 7 days from the first SLT evaluation, GUSS stratification showed 2 
(6.5%) patients with severe form of dysphagia, 2 (6.5%) with moderate 
dysphagia, 4 (12.9%) with mild dysphagia and finally 23 (74.2%) with-
out dysphagia. This 7-days evolution resulted significantly different 
from baseline (p < 0.001). Severe, moderate, mild and none dyspha-
gia significantly evolved on day 14 (p = 0.01) with a prevalence of 0%, 
3.2%, 9.7%, 87.1% respectively. Intriguingly, severe forms of dysphagia 
were no longer found at 12 days.
Conclusion: In COVID-19 patients, dysphagia disorders were related 
to the length of the MV, to ICU LOS and to tracheostomy placement. 
The GUSS temporal evolution could suggest that a multidisciplinary 
synergic approach to dysphagia management, which consist of a 
nurse and a SLT, would seems to improve the outcome of this symp-
tom in critically ill COVID-19 patients. Futures analysis are necessary to 
confirm the hypothesis that the SLT treatment could have a positive 
predictive role in dysphagia recovery.
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Introduction: Over the past two decades, high-flow nasal cannula 
oxygenation (HFNCO) devices that deliver heated and humidified oxy-
gen at flows up to 60 L/min, were developed as an alternative to low/
intermediate-flow devices. HFNCO has emerged as a safe and useful 
supportive therapy in many clinical situations and is considered a valu-
able tool in enhancing patients’ comfort and oxygenation1.
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The simplicity and potential benefit of HFNCO has led to its wide-
spread use in and out of the Intensive Care Unit (ICU), even in situa-
tions where the evidence is sparse. Patients with established ceilings 
of treatment that prohibit intubation, who develop worsening respira-
tory failure is such an example. These patients are often treated with 
some form of non-invasive ventilation (NIV). However, discomfort 
and complications associated with NIV may outweigh potential ben-
efits, and its use may extend the dying process without providing an 
acceptable quality of life in survivors or an acceptable quality of death 
in non survivors 2,3. The use of HFNCO is seen as a potential alterna-
tive to NIV, however the impact of HFNCO around end of life (EoL) has 
not been extensively investigated.
Objectives: The aim of this study was to assess the number of patients 
receiving HFNCO initiated by an outreach team near the EoL, the indi-
cations for its use, as well as any beneficial and/or unintended effects.
Methods: We conducted a retrospective observational study of all 
ward patients that were initiated on HFNCO within 10 days of death, 
over 2 years (January 2017 to January 2019), in a 950 bedded, tertiary 
London hospital, with a dedicated outreach service. All HFNCO initia-
tion decisions and implementation are made by the outreach service. 
We reviewed electronic patient records and collected patient demo-
graphics, reasons for HFNCO initiation, initial HFNCO flow and oxy-
gen settings, patients’ response and adverse events, as well as EoL 
decision-making.
Results: During the study period, 736 patients received HFNCO with 
95 (12.9%) receiving it within 10 days prior to death. Sixty-five of them 
(68.4%) were more than 70 years old and 44.2% were female. The com-
monest reason for hospital admission was respiratory failure (51.6%) 
and the commonest reason for HFNCO initiation was hypoxia (67.4%). 
Twenty-six patients (27.4%) were recognised as EoL before initiation of 
HFNCO, and 6 (6.3%) after the HFNCO failed to improve their condition. 
Details on EoL decision-making are shown in table 1. Palliative care refer-
ral was made in 82.1% of EoL patients. When HFNCO continued, 27/32 
(87.1%) diedwithin 7 days; of those in whom HFNCO was discontinued, 
32/61 (52.4%) died within 7 days. In the majority of the cases (61.1%), 
there were no adverse events associated with HFNCO. In the remaining 
patients, the most frequently documented adverse event was general 
discomfort, mainly due to nasal administration of high flow gas.
Conclusion: Approximately 13% of HFNCO use initiated by the out-
reach service in our hospital is for ward patients that are approaching 
EoL. This rescue therapy is primarily used in hypoxic respiratory failure, 
aiming to improve comfort. However, treatment related discomfort 
in almost 40% of patients highlights the importance of palliative care 
involvement and optimisation of traditional EoL comfort measures. 
Whether HFNCO actually extends the dying period in such patients 
requires further investigation.
Reference(s) and grant ackowledgment(s)
1. 3. Wilson ME, Majzoub MA, Dobler CC, et al. Noninvasive Ventilation in 
Patients With Do‑Not‑Intubate and Comfort‑Measures‑Only Orders: A 
Systematic Review and Meta‑Analysis. Crit Care Med 2018; 46:1209‑16
2. 2. Kacmarek RM. Should noninvasive ventilation be used with the do‑not‑
intubate patient? Respir Care 2009;54(2):223‑9
3. 1. Papazian L, Corley A, Hess D,et al. Use of high‑flow nasal cannula 




(1,3)‑β‑D‑glucan‑based diagnosis of invasive Candida infection 
versus culture‑ based diagnosis in patients with sepsis 
and with an increased risk of invasive Candida infection 
(CandiSep)
F. Bloos1; J. Held2; S. Kluge3; P. Simon4; K. Kogelmann5; G. De  Heer3; 
SO. Kuhn6; D. Jarczak3; J. Motsch7; G. Hempel4; N. Weiler8; A. Weyland9; 
M. Drüner5; P. Meybohm10; U. Jaschinski11; O. Moerer12; R. Weiss13; 
C. Putensen14; M. Bauer1; D. Thomas‑Rüddel1
1Dept. of Anesthesiology and Intensive Care Medicine, Jena University 
Hospital, Jena, Germany; 2Institute of microbiology, University Hospi‑
tal Erlangen, Erlangen, Germany; 3Department of intensive care medi‑
cine, University Medical Center Hamburg‑Eppendorf, Hamburg, Germany; 
4Dept. of anesthesiology and intensive care medicine, University Hospital 
Leipzig, Leipzig, Germany; 5Klinik für anästhesiologie und intensivmedi‑
zin, Klinikum Emden ‑ Hans‑Susemihl‑Krankenhaus, Emden, Germany; 
6Dept. of anesthesiology and intensive care medicine, Greifswald Univer‑
sity Hospital, Greifswald, Germany; 7Dept. of anesthesiology, University 
Hospital Heidelberg, Heidelberg, Germany; 8Klinik für anästhesiologie 
und operative intensivmedizin, Universitätsklinikum Schleswig‑Holstein, 
Campus Kiel, Kiel, Germany; 9Research center neurosensory science, Uni‑
versity of Oldenburg, Oldenburg, Germany; 10Department of anaesthesi‑
ology, University Hospital Würzburg, Würzburg, Germany; 11Anesthesiol‑
ogy and intensive care, University Hospital Augsburg, Augbsurg, France; 
12Department of anesthesiology, emergency and intensive care medi‑
cine, University Hospital Göttingen ‑ University Medical Center Göttin‑
gen, Göttingen, Germany; 13Dept. of anesthesiology and intensive care 
medicine, Universitätsklinikum Münster, Münster, Germany; 14Department 
of anaesthesiology and critical care medicine, University of Bonn, Bonn, 
Germany 
Correspondence: F. Bloos
Intensive Care Medicine Experimental 2020, 8(2): 000790
Introduction: Invasive candida infection in sepsis patients is associ-
ated with a high mortality. Long time to positivity in culture-based 
pathogen detection further increases the risk of death by delaying 
antifungal therapy (1). Serum (1,3)-β-D-glucan (BDG) has a high diag-
nostic accuracy for detecting ICI (2) and is available within few hours. 
However, the clinical significance of BDG is unclear and current guide-
lines hesitate in recommending this diagnostic tool.
Objectives: To investigate whether guidance by serum-BDG concen-
trations results in an earlier antifungal therapy in sepsis patients with 
high risk of ICI and therefore reduces mortality.
Methods: CandiSep was a prospective multicenter randomized trial 
conducted in 18 ICUs in Germany (4). Patients within 24 hrs after onset 
of severe sepsis or septic shock and high risk for ICI were included. Risk 
factors for ICI were total-parenteral nutrition, recent abdominal sur-
gery, preexisting antimicrobial therapy, or renal replacement therapy. 
Exclusion criteria included a diagnosed ICI or anticipated antifungal 
therapy. Patients were randomized into a control or a BDG-group. 
Patients of the control group received targeted antifungal therapy 
according to current guidelines (3). In the BDG group, treating physi-
cians received BDG-results taken at and 24 hours after enrollment. 
Antifungals were started when at least one BDG serum concentration 
was ≥ 80 pg/ml. Primary endpoint was 28 day all-cause mortality.
Results: Of 2324 eligible patients, 339 patients were included in an 
intention-to-treat analysis comparing the BDG-group (n = 172) with 
standard of care (n = 167). Of those, 99 patients received antifungals 
in the BGD group and 46 patients in the control group. Time from 
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randomization to antifungal therapy was 1.1 (IQR 1.0-2.2) days in the 
BDG group and 4.4 (IQR 2.0-9.1 days, P < 0.01) in the control group. 
The 28-day mortality rate was 33.7% in the BDG group and 30.5% in 
the control group (P = 0.53; relative risk of death: 1.1, 95% CI 0.8-1.5, 
see figure for Kaplan-Meier-curve).
Conclusion: BDG guidance was associated with early initiation of anti-
fungal therapy but did not reduce mortality. These results do not sup-
port BDG-guided preemptive antifungal therapy in sepsis patients.
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Introduction: Patients with obesity are at higher risk for commu-
nity-acquired and ICU-acquired infections. However, no study has 
evaluated the relationship between obesity and ventilator-associated 
pneumonia (VAP).
Objectives: The aim of our study was to determine the impact of obe-
sity on the incidence of VAP.
Methods: Planned ancillary study of the NUTRIREA-2 open-label RCT, 
performed in 44 French ICUs. Adults (18 years or older) receiving inva-
sive mechanical ventilation and vasopressor support for shock were 
randomly assigned (1:1) to either parenteral nutrition or enteral nutri-
tion, both targeting normocaloric goals (20-25 kcal/kg per day), within 
24 h after intubation.
Obesity was defined as body mass index (BMI) ≥ 30 kg/m2 at ICU 
admission. VAP diagnosis was adjudicated by an independent blinded 
committee, based on all available clinical, radiological, and bacterio-
logical data. Only first VAP episodes were taken into account.
Incidence of VAP was analyzed using a competing risk approach, 
with extubation, death and ICU discharge alive as competing risks. 
An adjusted analysis was performed including variables collected at 
ICU admission with p  <  0.2 in the univariate analysis. The choice of 
adjustment variables was based on scientific knowledge, and poten-
tial collinearity.
In a subgroup of patients (n = 151), we also evaluated the impact 
of obesity on abundant microaspiration of gastric contents and 
oropharyngeal secretions (defined as the presence of significant levels 
of pepsin ( > 200 ng/ml) and salivary amylase ( > 1685 UI/ml) in > 30% 
of tracheal aspirates, collected during the 48h following intubation).
Results: Among the 2410 patients included in the NUTRIREA-2 trial, 85 
(4%) were excluded because of missing data on BMI. 699 of the 2325 
(30%) included patients had obesity. Female gender (36% vs 32%), age 
(67 ± 11 vs 65 ± 15 years), Sofa score at ICU admission (med (IR) 11 
(8, 13) vs 10 (8, 13), and comorbidities significantly (p < 0.05) differed 
between obese and non-obese patients. No significant difference 
was found in percentage of patients who received enteral nutrition 
between obese and non-obese patients (51% vs 50%).
224 VAP were diagnosed (60 in the obese group and, 164 in the non-
obese group). The incidence of VAP at day 28 was 8.6% vs 10.1% in 
obese and non-obese patients, respectively; HR: 0.845, 95% CI: [0.63; 
1.14], p = 0.26. After adjustment on gender, age and Knaus score, 
no significant difference was found in VAP incidence between obese 
and non-obese patients (ajusted HR: 0.914, 95% CI: [0.675; 1.238], p = 
0.56). Vomiting at day 7 was more frequent in obese than in non obese 
patients (24% vs 19%, p = 0.008).
No significant difference was found in percentage of patients with 
abundant microaspiration of gastric contents (31% vs 19%, p = 0.13), 
or oropharyngeal secretions (63% vs 65%, p = 0.86) between obese 
and non-obese patients.
Conclusion: Our results suggest that obesity has no significant impact 
on the incidence of VAP.
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Introduction: Previous studies reported a various incidence of deep 
vein thrombosis (DVT) after decannulation from Extracorporeal mem-
brane oxygenation (ECMO), ranging from 18 to 85% depending on 
screening method. The actual incidence of ECMO associated DVT is 
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therefore unclear and the role of anticoagulation and potential risk 
factors is undetermined. Furthermore, it is unclear if cannula-associ-
ated DVT is more common in ECMO patients compared to critically ill 
patients without ECMO.
Objectives: To determine incidence and risk factors of DVT follow-
ing decannulation from ECMO, to assess the relationship with level of 
anticoagulation and to compare the cannula-associated DVT rate in 
patients with and without ECMO.
Methods: We conducted a prospective cohort study in a 30-bed, 
closed format mixed medical-surgical ICU from a Dutch tertiary referral 
hospital. All consecutive adult patients who were successfully weaned 
from ECMO and underwent a routine venous duplex ultrasound of the 
large vessels following decannulation to assess the presence of DVT 
between January 2018 and March 2020 were included. We performed 
three multivariable logistic regression analysis to determine the asso-
ciation between anticoagulation with heparin and the occurrence of 
DVT after ECMO treatment: 1), mean aPTT per 10 seconds increase; 2), 
time weighted average aPTT under 50 seconds; and 3), time weighted 
average aPTT under 60 seconds, adjusted for sex, age, ECMO-mode 
and duration of ECMO treatment. Multivariable stepwise backward 
logistic regression was performed to assess risk factors for DVT. We 
compared cannula-associated DVT rate in ECMO patients with a pro-
spective composed cohort of 53 critically ill adult patients without 
ECMO support receiving a central venous catheter (CVC) for at least 
48 hours in which the inserted vein was screened for DVT after CVC 
removal with duplex ultrasound.
Results: During the study period 95 patients received ECMO of which 
38 were successfully weaned from ECMO. Eight patients had no ultra-
sound of the large vessels after decannulation leaving 30 patients 
eligible for analyses. Of these 30 patients 14 (47%) received veno-arte-
rial ECMO. DVT was found in 15 patients (50%) of which 10 patients 
(33%) had a DVT in a cannulated vein (cannula-associated DVT). 
Overall, patients with DVT had a longer duration of ECMO treatment 
(4.7 days ± 2.4 vs 6.9 days ± 3.4, p = 0.047) and were more often on 
veno-venous (VV) ECMO (33% vs 73%, p = 0.07). Multivariable logis-
tic regression analysis showed no correlation between level of anti-
coagulation and the occurrence of DVT. With the stepwise backward 
logistic regression analysis, we found VV-ECMO mode to be the only 
independent risk factor for DVT after ECMO (OR 5.5; 95%CI 1.16-26.41). 
We found no difference between the ECMO and CVC cohort regarding 
cannula-associated DVT rate (33% vs 32.1%).
Conclusion: DVT following ECMO is frequent with half the patients 
showed DVT after decannulation, although pure cannula-associated 
DVT was not higher compared to CVC-associated DVT in a non-ECMO 
cohort of critically ill patients. We identified VV-ECMO as an independ-
ent risk-factor for DVT after ECMO. The level of anticoagulation based 
on aPTT values is not associated with the occurrence of DVT following 
ECMO. Administration of a higher dose of heparin seems therefore not 
justified to prevent DVT during ECMO treatment.
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Introduction: Continuous administration of vasoactive drugs rep-
resents cornerstone of hemodynamic management in septic shock. 
Standard care of patients with vasodilatory shock includes infusions of 
catecholamines, vasopressin agonists and, newly, angiotensin II. Sin-
gle dose of intravenous vanilloids – capsaicin and its analogue noniva-
mide – substances responsible for pungent taste of some eggplants, 
caused increase of blood pressure in anesthetized mice. We designed 
proof-of-concept study in a large porcine model of progressive peri-
toneal sepsis to analyze the hemodynamic effects of capsaicin and 
nonivamide.
Methods: 28 anesthetized, mechanically ventilated and instrumented 
pigs were assigned into six groups: control groups receiving either 
capsaicin (CC, n = 3) or nonivamide (CN, n = 3); sepsis groups treated 
either with (SNa, n = 3) or without norepinephrine (S, n = 3), and sep-
sis groups treated with capsaicin (SC, n = 6) or nonivamide (SN, n = 
6). Sepsis was induced by autologous feces (2  g/kg) inoculation into 
peritoneal cavity. Continuous infusion of vasopressors was adminis-
tered if the mean arterial pressure (MAP) dropped below 65 mmHg 
and no further positive hemodynamic response was elicited via fluid 
resuscitation. Vasopressors were titrated to maintain MAP between 65 
and 70 mmHg. Before, 6, 12, 18 and 24 h after the induction of perito-
nitis (fixed timepoints) we measured, in addition to systemic, regional 
(renal, portal and femoral) and microvascular (gut mucosal) hemody-
namics, oxygen kinetics (DO2/VO2), organ function (lung, kidney, liver, 
heart), and energy metabolism (lactate kinetics, acid base balance).
Results: Administration of both vanilloids to non-septic animals did 
not induce significant changes in measured variables, although MAP 
and systemic vascular resistance tended to increase. Septic animals 
developed classical hemodynamic alterations with increased cardiac 
output and reduced systemic vascular resistance. Systemic hemo-
dynamic effect of capsaicin and nonivamide administration was 
comparable to that observed in norepinephrine group. Nonivamide 
significantly increased blood flow through the portal vein at 6 and 9 
hour after infusion initiation when compared to norepinephrine. Nei-
ther of tested vasopressors affected progressive sepsis-induced distur-
bances in energy metabolism and multiorgan functions.
Conclusion: To the best of our knowledge, this is the first report of 
intravenous administration of the vanilloids in the established por-
cine model of progressive pertioneal sepsis. We demonstrated their 
therapeutic potential in reversal of sepsis-induced vasodilatory shock. 
While promising, further investigation into the mechanisms of action 
is necessary.
Reference(s) and grant ackowledgment(s)
1. This work was supported by the Charles University Research Fund (Progres 
Q39) and by project No. CZ.02.1.01/0.0/0.0/16_019/0000787 “Fighting INfec‑
tious Diseases”, awarded by the MEYS CR, financed from EFRR.
001170 
Validation of a novel non‑invasive continuous method to monitor 
end expiratory lung volume based on CO2 kinetics
JA. Sanchez  Giralt1; B. Abad Santamaría1; M. Wallin2; M. Hallbäck3; 
M. Trigueros  Genao1; J. Lázaro  Gonzalez1; B. Muñoz  Molina1; G. Tusman4; 
F. Suarez  Sipmann1
1Intensive care medicine, Hospital de La Princesa, Madrid, Spain; 2Physi‑
ology and pharmacology, Karolinska Institute, Solna, Sweden; 3Critical 
care, MAQUET Critical Care, Solna, Sweden; 4Anesthesiology, Community 
Private Hospital, Mar del Plata, Argentina 
Page 13 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Correspondence: J.A. Sanchez Giralt
Intensive Care Medicine Experimental 2020, 8(2): 001170
Introduction: The functionally respiratory monitoring is essential in 
the clinical management of patients under mechanical ventilation. 
Clinical monitoring is a field in constant evolution aiming at devel-
oping less-invasive, continuous, safer and inexpensive methods that 
provide accurate, and relevant data to aid in better clinical decision 
making.
Objectives: Validation of a novel, non-invasive and continuous 
method to monitor end expiratory lung volume based on expired 
CO2 kinetics (EELVCO2) by comparison with computer tomography 
measured volume in mechanically ventilated patients. Being a func-
tional lung volume we specifically compared EELVCO2 with normally 
aerated end-expiratory lung volume measured by computed tomog-
raphy (EELVCT-NA).
Methods: We included patients under passive mechanical ventilation. 
EELVCO2 was measured by the capnodynamic method, which com-
bines the Fick principle for CO2, measured CO2 elimination obtained 
from volumetric capnography and the mole balance equation for CO2 
across the lungs. Expired CO2 was synchronized with flow and volume 
measured by the ventilator´s spirometer (Servo-I, Maquet Critical Care) 
to reconstruct a breath-by-breath volumetric capnogram. A modified 
repetitive breathing pattern adding brief expiratory holds in 3 con-
secutive breaths of the measuring cycle of 9 breaths, changed alveolar 
CO2 concentration to solve the capnodynamic equation. The resulting 
EELVCO2 values were continuously displayed on the computer screen. 
EELVCT-NA was measured during a 8-10 seconds expiratory hold. Lung 
EELVCT-NA was afterwards determined by manually segmenting all 
lung CT slices using OsiriX™ (Pixmeo, Geneva, Switzerland) summing 
all CT compartments with a density between -900 to -500 Hounsfield 
Units. Pearson`s correlation coefficient was used to assess correlation 
between methods and the Bland-Altman method was used to assess 
accuracy and precision.
Results: Presented data correspond to 19 patients. Median(min-
max)  PaO2/FiO2 was 201(95-430). In 3 patients  PaO2/FiO2 was < 100 
and in 7 patients between 100-200. Median (min-max) lung volumes 
were 1445  ml (564-2544  ml) for EELVCO2 and 1305  ml (252-2361ml) 
for EELVCT-NA. Correlation between EELVCO2 and EELVCT-NA was 
r2 = 0.78(p < 0.001). Bias(limits of agreement) of EELVCO2 were 
− 139 ml(− 771 ml to 493 ml).
Conclusion: The new non-invasive and continuous EELVCO2 method 
presented a high correlation and good agreement with normally aer-
ated CT lung volume performing with clinically relevant accuracy and 
precision.
Reference(s) and grant ackowledgment(s)
1. Albu G, Petak F, Zand T, Hallbäck M, Wallin M, Habre W. Lung volume 
assessments in normal and surfactant depleted lungs: agreement between 
bedside techniques and CT imaging. BMC Anesthesiol. 2014 Aug 5;14:64.
001215 
Where did all the women go? The underrepresentation of women 
in educational resources during COVID‑19
T. Hall1; C. Dangoisse2; V. Metaxa3
1Anaesthesia, Brighton and Sussex NHS Trust, Brighton, United King‑
dom; 2Critical care, Ysbyty Gwynedd, Bangor, United Kingdom; 3Critical 
care, King’s College Hospital, London, United Kingdom 
Correspondence: T. Hall
Intensive Care Medicine Experimental 2020, 8(2):001215
Introduction: Intensive care medicine (ICM) is a growing specialty. 
The Centre for workforce intelligence has predicted an expansion 
which would require anywhere between a 25 to 125% increase in 
the medical ICU workforce by 2033 [1]. This will require a substantial 
increase in recruitment to the specialty.
We know that women are currently underrepresented in ICM at con-
sultant level and in leadership positions. According to General Medi-
cal Council (GMC) and Faculty of Intensive Care Medicine (FICM) data, 
55% of UK medical graduates are women but only 20% of ICU consult-
ants are women. These trends are similar in Europe and the rest of 
the world [2] and form part of a wider picture – less than 25% of the 
most influential healthcare leadership positions worldwide are held by 
women [3].
This gender gap within ICM means that the specialty is excluding half 
of Medicine’s talent pool and therefore not producing a workforce that 
is diverse and representative of the population it serves. The world 
economic forum showed in its’ 2014 report that there is a correlation 
between a country’s global competitiveness index and its’ gender gap 
index [4]. If we extrapolate this to the field of Medicine, it suggests that 
a gender balanced ICU medical workforce could lead to improvements 
in the field of ICM and subsequently patient outcomes [5].
An important factor in career choice within medicine is the availabil-
ity of role models and mentorship. Both male and female doctors are 
more likely to choose a specialty when they identify a positive role 
model [6]. For female trainees, having a female role seems to be par-
ticularly important [7].
Objectives: Covid-19 brought ICM into the spotlight. Whereas pre-
viously many trainees may not have had exposure to ICM, the pan-
demic changed this situation. Critical care societies from around the 
world produced excellent free online resources to educate and inform 
doctors who were now treating the surge of ICU patients in various 
settings.
We wanted to ascertain the percentage of female speakers at webi-
nars, to see if intensive care societies are fostering female trainees’ and 
consultants’ careers by providing female role models. Most societies 
have issued statements regarding gender parity; we wanted to see 
whether they demonstrate inclusive leadership and are true advocates 
of gender equity [8].
Methods: We reviewed webinars produced in response to Covid-19 
during a 3 month period (March, April and May 2020) by a few of the 
most prominent Intensive Care Medicine and Anaesthesia societies 
to which we were personally exposed. The choice was subjective but 
felt to represent webinars which were widely available and to which a 
significant proportion of doctors would have been exposed in Europe. 
The speakers were not approached individually and asked as to how 
they identify their gender. We therefore ascertained the gender of the 
speakers subjectively.
Results:
These preliminary results show that women are grossly underrepre-
sented in these webinars.
Conclusion: This lack of representation at a higher level within ICM 
will do little to encourage women into an already male dominated 
specialty. The ESICM equality goal which states “ESICM should aim for 
gender representation according to the gender proportion in the criti-
cal care medicine workforce” [9] does not go far enough to address 
this problem. To tackle the issue of gender inequality within ICM and 
build a diverse and sustainable workforce, we must provide role mod-
els and mentors to help attract female doctors to this specialty. It is 
time we start putting our theoretical aspiration for equal gender rep-
resentation into practice.
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Introduction: Mechanical ventilation (MV), while lifesaving, can lead 
to ventilator-induced diaphragm dysfunction (VIDD) and be associ-
ated difficulty in weaning and prolongation of MV. Mitigating VIDD 
may thus improve respiratory function and reduce duration of MV.
Objectives: We assessed the effects of temporary transvenous dia-
phragm neurostimulation (TTDN) using bilateral phrenic stimulation 
with a multi-electrode central venous catheter (Lungpacer Diaphragm 
Pacing Therapy System) on clinical outcomes and respiratory function 
in a multicenter, open label, randomized controlled trial. In contrast to 
inspiratory muscle strength training, this therapy does not depend on 
patients’ cooperation.
Methods: Patients on invasive MV for > 96 hours who failed at least 
two spontaneous breathing trials and satisfied readiness to wean 
criteria were randomized (1:1) to TTDN, consisting of up to 120stim-
ulations per day for up to 30 days, or standard of care (SoC). Clinical 
outcome measures included the proportion of successfully weaned 
subjects, mean days on MV and 30-day survival. The maximal inspira-
tory pressure (MIP) and rapid shallow breathing index (RSBI) were also 
determined. The diaphragm thickening fraction was assessed with 
M-mode ultrasound in a subset of patients and assessed by an ultra-
sound corelab blinded to group assignment.
Results: A total of 112 patients were randomly assigned to groups (57 
TTDN and 55 SoC). The stimulation catheter was successfully placed in 
43 (75%) subjects and  at least 50% of the protocol-required stimula-
tions were successfully delivered in 34 (60%) subjects. In this per-pro-
tocol subset, the incidence of successful weaning was 84% and 74% 
(p = 0.436), duration of MV to successful weaning/study completion 
was 12.4  ±  9.1 and 14.1  ±  10.8 days (p = 0.438); survival through 
Day 30 was 91% and 85% (p = 0.414) for the TTDN and SoC groups, 
respectively. Change in MIP from baseline was significantly different: 
20 ± 3 (TTDN) and 5 ± 2  cmH2O (SoC) [difference 15 ± 4  cmH2O, p = 
0.0002]; change in RSBI from baseline was also significantly different: 
-48 ± 13 (TTDN) and -18 ± 9 (SoC) [difference -30 ± 15, p = 0.049], 
with both variables showing a stimulation dose-response relationship 
in TTDN subjects. Compared to baseline, diaphragm thickening frac-
tion changed by 60% (TTDN) vs -39.5% (SoC) (p = 0.03) and 34.8% 
(TTDN) vs. −  34.2% (SoC) (p = 0.334) for the right and left hemidi-
aphragms, respectively. There were no unanticipated adverse device 
effects noted in the study.
Conclusion: TTDN increased the diaphragm thickening fraction and 
improved MIP and RSBI. While this study was not powered to show 
clinical efficacy, the results will contribute to defining the patient pop-
ulation and effect size to appropriately power future studies for clini-
cal outcomes.
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Introduction: Community-acquired pneumonia (CAP) is the most 
common cause of sepsis in the developed world. Identifying factors 
associated with mortality is one of the main research issues with the 
aim to describe high-risk subsets (1). Different combinations of clinical 
data and host-response features may naturally cluster into previously 
undescribed subsets or subphenotypes  (2)  that may have different 
risks for a poor outcome and may respond to different etiologies. 
Similar studies have been made in sepsis (3)and ARDS (4) patients, but 
information in CAP is lacking.
Objectives: To derive CAP subphenotypes from clinical data and rea-
lationship with host-response inflammation, organ damage, etiology 
and clinical outcomes
Methods: Retrospective analysis of data sets using statistical, machine 
learning methods. Phenotypes were derived among 6963 patients (16 
552 unique patients) who were evaluated in the emergency depart-
ment (ED) from Spain and were diagnosed with pneumonia. Candi-
dates variables were selected on clinical relevance and based on their 
association of CAP onset, availability during the first clinical examina-
tion, outcomes, missingness and correlations. The TRIPOD statement 
were followed (5). Missing data above 35% were excluded from anal-
ysis and the Little’s test was used to assess the distribution and pat-
tern of those included. Highly correlated variables were excluded (r 
> 0.85). Multiple imputation with chained equations (MICE) was used 
to account for missing data. Ordering points to identify the cluster-
ing structure (OPTICS) plots were used to determine the optimal 
clustering strategy, and K-means clustering was the most appropri-
ate method and therefore used. Robustness and internal validation 
were assessed trough Dunn’s test and cluster silhouettes. We studied 
the frequency and clinical characteristics of the predicted phenotype 
groups. All analysis were performed with R version 3.6.1.
Results: Twenty-three variable were selected. These clusters were 
identified with different size, laboratory and clinical characteristics. 
Members of Cluster 1 (33.5%) were the youngest [age: 45 (SD = 13.8)], 
less comorbid [Charlson Index: 0.7 (1)] 62.6% were male, 54.4% were 
current smoker and 4.9% used inhaled steroids. Individuals from 
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Cluster 2 (39.5%) were the eldest [age: 79.8 (8.6)], the most comor-
bid [Charlson Index: 4.6 (1.6)], gender was equally distributed (male 
49.8%), the lesser smokers (9.7%), with a 15.4% of inhaled steroids 
usage. Patients from Cluster 3 (27%) were old [age: 71.6 (13.1)], pre-
dominantly male (78.5%), with comorbidities [Charlson Index: 3.8 (1.8)] 
and smokers (58.9%), and were those ones who used inhaled steroids 
the most (33.2%). Signs and symptoms in cluster 1, 2 and 3 respec-
tively were: respiratory rate: 22,8 (5.6), 24,8 (5.9) and 31.7 (7.8); heart 
rate: 98 (14.4), 92 (17) and 106 (21); SpO2: 96% (IQR = 94-97), 94% 
(92-96) and 90% (85-93); systolic blood pressure: 121 (20), 139 (25), 
and 126 (29). Fever was more common in Cluster 1 (90.4%). Inflamma-
tory biomarkers as: C-reactive protein and white blood cells in Clus-
ter 1, 2 and 3 respectively were: 16.8 (8.3-26.7), 14 (6.4-23.1) and 20.4 
(10.4-29); and: 11.405 (7.600-16.200), 11.520 (8.200-15.900) and 14.500 
(10.200-19.800). Organ damage were more common in Cluster 3 with 
higher respiratory, hemodynamic and renal SOFA score system. Hos-
pital admission occurred in 74.2% of Cluster 1, 94.7% of Cluster 2 and 
99% of Cluster 3’s patients. Critical care admission was more common 
in Cluster 3 (36.5%) that Cluster 2 (8.8%) and Cluster 1 (14.6) respec-
tively. Thirty-day and 1-yr mortality was higher in Cluster 3 (4.4% and 
18.2%, respectively) compared to Cluster 1 (0.2% and 1.9%) and Clus-
ter 2 (0.3 and 10.1%) respectively.
Pneumococcal pneumonia was the most frequent etiology [Cluster 1 
(21.7%), Cluster 2 (15.7%) and Cluster 3 (25.4%)]. Atypical pneumonia 
(Legionella, Mycoplasma and Chlamydia) was more frequent in Cluster 
1 (3.6%, 2.6% and 1.2% respectively).
Conclusion: In this retrospective analysis of data sets from patients 
evaluated in the ED with CAP, 3 clinical subphenotypes were identi-
fied that were related with host-response patterns, etiology and clini-
cal outcomes. External validation and further research are needed to 
determine the utility of these subphenotypes in clinical care.
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Introduction: During the COVID-19 pandemic, restrictions on hospi-
tal visitations created an unprecedented emotional stress on isolated 
patients and grieving families, leading to significant communication 
challenges [1-4]. Junior Doctors (JDs) have had to broach sensitive 
topics of life and death over the phone. Although there is a paucity 
of data on interventions to support effective communication, written 
and structured conversation guides are amongst the most validated 
[5-8].
Methods: We developed a framework in collaboration with our pallia-
tive care team to guide JDs through telephone communication with 
relatives of ICU patients; this outlined common events such as admis-
sion, daily updates, deterioration and bereavement.
We supported the roll out of a nurse-led video-calling service to facili-
tate sensitive communication, by creating a standard operating proce-
dure (SOP) to outline instructions and define clinical governance limits 
[3, 6, 7].
We distributed a questionnaire to JDs working in ICU during the pan-
demic, to evaluate whether our tools improved their confidence in 
effectively communicating with relatives (using a Likert scale 1 to 5 = 
not at all confident to very confident) and their perception of whether 
the video-calling service improved communication with families.
Results: We received 21 responses from JDs, 57% of whom had been 
redeployed from other departments. Pre COVID-19, only 10% of JDs 
had experienced difficult conversations with relatives about criti-
cally unwell patients once a week or more. During the pandemic, this 
increased to 100% of them having difficult conversations at least three 
times a week.
75% of JDs scored their initial confidence in telephone communication 
with relatives as neutral/not confident/not at all confident; following 
the introduction of our framework, 76% felt confident/very confident. 
71% of JDs found example conversations for different scenarios out-
lined in the framework helpful. Many commented that the framework 
was useful as point of reference and in providing phrases.
81% of JDs were able to arrange a video-call post introduction of the 
SOP and felt that a nurse led video-calling service was helpful. All JDs 
felt that video-calls improved communication with patients’ fami-
lies. The main challenges identified with video-calling were concerns 
about confidentiality, time-burden and technical issues.
The difficulties faced by JDs in telephone discussions were the lack of 
non-verbal cues, technology issues, interruptions, and difficulty align-
ing perception of illness severity with reality. JDs commented on the 
emotional toll these conversations had taken on their mental health 
particularly when breaking bad news, describing these as “very sad”, 
“stressful”, and “traumatic”.
Conclusion: The introduction of our framework for telephone com-
munication has improved the confidence of JDs in their ability to 
interact with patient’s relatives over the phone during the COVID-19 
pandemic. The roll out of a nurse led video-calling service was felt to 
improve communication and was successfully facilitated by the intro-
duction of a SOP.
Our work helps recognise the need to develop structured tools to sup-
port communication. It has been an opportunity to appreciate the 
emotional burden placed on JDs which is reflected in the experience 
of many filling this role throughout the country [9-10].
Future quality improvement interventions include assessing the fami-
lies’ experience of communication, providing relatives with written 
information about ICU and organising debriefing for JDs.
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Introduction: Coronavirus disease 2019 (COVID-19) causes a respira-
tory failure that may require Intensive Care Unit (ICU) admission and 
mechanical ventilation (MV). Ventilator associated pneumonia (VAP) is 
a frequent complication in mechanically ventilated patients. However, 
there is no data about prevalence and risk factors for VAP in patients 
with COVID-19.
Objectives: To analyse the prevalence and risk factors for VAP in 
COVID-19 patients.
Methods: Retrospective observational study including all invasive 
mechanically ventilated COVID-19 patients admitted in the ICU in Vall 
d’Hebron University Hospital between March and April 2020. VAP was 
defined according to ATS/IDSA guidelines (1). Results were described 
using mean (standard deviation), median (interquartile range) or fre-
quency (percentage). Differences between continuous variables were 
analysed using Student T-test or Mann-Withney U-test, as appropriate. 
Differences between categorical variables were assessed using Chi2 
test or Fisher exact test.
To account for imbalances of baseline characteristics between both 
groups a propensity score matching was performed using the R® 
package “matchit” with a nearest neighbour algorithm and a 1:1 
matching ratio (2). Differences in variables in the matched cohort were 
assessed as previously described. To determine which variables were 
independently associated with VAP development, a logistic regres-
sion analysis was also performed in both non-matched and matched 
cohort using variables with p < 0.1 in the univariate analysis. P-value < 
0.05 was considered statistically significant.
Results: A total of 353 patients were admitted on the study period 
and 250 required invasive MV. Median age was 59 (51-67), 69.2% 
(173) were male. Median APACHE was 11 (8-13) and SOFA 4 (3-5). 100 
patients (40%) developed VAP. Patients who developed VAP were 
more frequently male, had a higher APACHE and SOFA score, were 
more frequently admitted to a newly open unit, and received more 
frequently treatment with corticosteroids and tocilizumab. These 
variables were included in the propensity score matching. The results 
of the multivariate logistic regression analysis for the risk of VAP are 
shown in table  1. Treatment with corticosteroids was independently 
associated with a higher risk of VAP in both non-matched (OR 3.364; 
95% CI 1.829-6.185; p < 0.001) and matched cohort (OR 2.071; 95% CI 
1.141-3.758; p = 0.017).
Conclusion: VAP is a prevalent complication among COVID-19 
patients. Those mechanically ventilated COVID-19 patients who 
received treatment with corticosteroids may present a higher risk of 
developing VAP.
Reference(s) and grant ackowledgment(s)
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Introduction: It is unclear whether patients with Severe Acute Res-
piratory Syndrome Coronavirus 2 (SARS-CoV-2) ARDS present with 
an atypical form of pulmonary illness, characterised by preserved 
lung compliance and low lung weight - termed L-subphenotype, or 
whether they reflect ‘traditional’ ARDS characterised by low lung com-
pliance and high lung weight - H-subphenotype [1].
Objectives: To calculate the prevalence of H and L-subphenotypes in 
ARDS patients with and without SARS-CoV-2 admitted to a single cen-
tre ICU.
Methods: This is a single-centre, retrospective study from the Queen 
Elizabeth Hospital Birmingham, UK. Two cohorts of ICU patients that 
received invasive mechanical ventilation were analysed: SARS-CoV-2 
patients admitted between 11th March and 21st  April 2020 and all 
patients with community acquired-pneumonia (CAP) that developed 
ARDS between 4th April 2016 and 5th July 2019. Patients were classi-
fied into putative H- and L-subphenotypes based on their admission 
dynamic compliance (Cdyn) and severity of opacification on chest 
radiography (graded by two independent reviewers using a validated, 
semi-quantitative opacification score ranging from 0 to 16 [2]). Cdyn is 
assumed to be 65% of static compliance in severe lung disease [3]. 
Patients with average semi-quantitative radiography scores ≤8 and 
a Cdyn > 26 ml/cmH2O were classified as the L-subphenotype whilst 
patients with average semi-quantitative radiography scores ≥ 8 and a 
Cdyn ≤26 ml/cmH2O were classified as the H-subphenotype. Patients 
who did not meet these criteria were placed in discordant 1 and 2 (D1, 
D2) groups. Statistical analysis was performed using GraphPad Prism 
v.8.0. Continuous data is presented as median (IQR) and analysed 
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using a Mann-Whitney-U test. Categorical data is presented as number 
(%) and analysed using a chi-squared test.
Results: 112 patients with SARS-CoV-2 ARDS and 121 patients with 
CAP ARDS met the inclusion criteria. The prevalence of H and L-sub-
phenotypes were similar between SARS-CoV-2 and CAP ARDS cohorts. 
ICU mortality was lower in patients classified as L-subphenotype and 
higher in patients classified as H-subphenotype (Figure 1).
Table 1: Clinical characteristics of SARS-CoV-2 and
CAP ARDS cohorts
Conclusion: The prevalence of H and L-subphenotypes was similar in 
ARDS cohorts with and without and SARS-CoV-2, indicating that SARS-
CoV-2 respiratory failure is not an atypical form of ARDS requiring an 
alternative ventilation strategy. Given the lower mortality of patients 
classified as L-subphenotype, the heterogeneity in compliance and 
lung weight and the presence of these subphenotypes may simply 
reflect different patterns of disease severity.
Reference(s) and grant ackowledgment(s)
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Introduction: Acute kidney injury (AKI) is commonly observed in 
intensive care unit (ICU) and affects more than 50% of these patients. 
The consequences of AKI are well described (increased mortality, 
length of hospital stay, risk of chronic kidney disease (CKD)). Acute 
kidney disease (AKD) has been recently proposed to define the dis-
ease process after AKI and before CKD among patients in which renal 
pathophysiologic processes are in progress. We know that patients 
who suffered from AKI may have different clinical trajectories and 
outcomes (early, late or absence of recovery, early or late relapse, 
AKD or CKD), but to date, no cohort study has been able to accurately 
describe them.
Objectives: The main objective of this study was to assess the differ-
ent clinical trajectories and evaluate risk and timing of AKD and CKD 
after AKI in ICU. Secondary objectives were to evaluate the long-term 
incidence of CKD after AKI in critically ill patients and to propose the 
ideal timing for post-intensive care clinics.
Methods: We conducted a prospective 5-years follow-up cohort study 
in a medical ICU in Bordeaux University Hospital (France). Our center 
participated in the Artificial Kidney Initiation in Kidney Injury (AKIKI) 
study, during which all patients with AKI from stage 1 of the KDIGO 
classification were prospectively screened from September  2013 
to May 2015. Patients were included if they were ≥  18 years of age, 
received invasive mechanical ventilation, catecholamine infusion, or 
both, and developed AKI. We excluded patients with estimated glo-
merular filtration rate (eGFR) < 90 mL/min/1.73 m2 (CKD-EPI) prior to 
ICU admission. AKI was classified according to the KDIGO classifica-
tion. AKD was defined as a condition wherein criteria for AKI stage 1 or 
greater persists ≥ 7 days after an exposure. CKD was defined by eGFR 
< 60 ml/min/1.73 m2 (CKD-EPI) at least 90 days after AKI. Renal recov-
ery was defined by the absence of KDIGO criteria. Early recovery was 
kidney recovery within 7 days and late recovery was renal recovery 
from 7 to 90 days after AKI.
Results: 304 patients suffered from AKI. Among them, 72/304 (24%) 
had prior CKD and were excluded and 232 patients were enrolled: 
AKI stage 1, 62/232 (27%), AKI stage 2, 50/232 (21%) and AKI stage 3, 
120/232 (52%). Age was 62 ± 16 years, 142/232 (63%) were men. Basal 
serum creatinine (SCr) was 78 ± 18 μmol/l and no patients had miss-
ing baseline creatinine value. Mechanical ventilation was required for 
192/232 (83%) and 191/232 (82%) required catecholamine use. Length 
of mechanical ventilation and catecholamine use were respectively 
4  [2-8]  days and 2.5  [1-5] days. SOFA score was 11.2 ±  3.4 and SAPS 
II was 62 ±  19. Among patients with AKI, 61/232 (26%) died, 65/232 
(28%) recovered early and among them 3/65 (5%) recovered early 
but secondary suffered from AKD resulting in 109/232 (47%) who had 
been progressing to AKD (figure). Among AKD patients, 41/109 (38%) 
died, 21/109 (19%) had late recovery and 47/109 (43%) developed 
CKD. CKD also developed in patients who recovered early and late, in 
respectively, 11/65 (17%) and 5/21 (24%) for a total of 63 out of 232 
(27%) patients included in the study. At the end of 5 years follow-up, 
CKD prevalence was 31%. Among CKD patients, 16/65 (17%) patients 
had already recovered and had developed a secondary relapse. A 
post-intensive care clinic from 30 to 90 days after ICU discharge could 
have failed to detect CKD in 16/63 (25%) patients.
Conclusion: Because of many different clinical trajectories, a simple 
SCr dosage, within 3 months of ICU discharge in patients who had suf-
fered from AKI was not sufficient to detect and prevent CKD. Assess-
ment of progressive markers (hypertension, proteinuria) appears to be 
essential.
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Introduction: Critically ill patients may have considerable and sus-
tained loss of muscle mass. This loss may amount to more than 1% 
per day in ICU patients. It has been shown that urinary creatinine 
excretion (UCE) is a useful marker of muscle mass in non-ICU and ICU 
patients [1]. Recently we found that ICU patients display a negative 
potassium balance immediately after ICU admission, compatible with 
loss of intracellular volume, such as muscle mass.
Objectives: In the current study we compared UCE with urinary potas-
sium excretion (UPE), where UCE served as marker of absolute mus-
cle mass and UPE was hypothesized to indicate loss of muscle mass. 
We analyzed the time course of UCE with UPE in patients admitted for 
up to 30 days to our ICU and analyzed if there was a difference in UPE 
between males and females.
Methods: Patients for whom 24  h UCE and UPE were available 
between ICU day 1 and 30 were analyzed. Our computerized potas-
sium regulation system regulated potassium administration in all 
patients. This system does not distinguish between males and females 
in their recommended potassium dose.
Results: 17,000 patients, aged 60 ± 16 year, 62% male, with a hospital 
mortality of 18% and 61,000 UCE and 45,000 UPE measurements were 
analyzed. UCE on ICU admission was 49% higher in males compared 
to females (P < 0.001) and decreased by 1.2%/d (P < 0.001). Mean UPE 
showed a bimodal time course with a near stable excretion between 
ICU day 7 to 30 (88 ±59 and 79 ±54 mmol/d in males and females 
respectively; P < 0.001). This difference between males and females in 
UPE of 9 mmol/d corresponds to the expected difference on the basis 
of muscle intracellular potassium concentration and observed muscle 
loss as reflected by UCE.
Conclusion: During prolonged ICU stay, there is a sustained difference 
in potassium excretion between males and females that is consistent 
with the muscle mass loss derived from creatinine excretion. Future 
balance studies could establish if creatinine and potassium excretion 
are suitable markers for direct monitoring of muscle mass loss.
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Introduction: Prone positioning in patients with acute respiratory 
distress syndrome (ARDS) has variable effects on cardiac index. It 
has been reported that prone positioning increases cardiac preload 
and cardiac index in patients with preload responsiveness. We made 
the hypothesis that the increase in cardiac preload was related to an 
increased mean systemic filling pressure (Pms), the forward pressure 
of venous return.
Objectives: To examine the effects of prone positioning on venous 
return and its determinants such as Pms and venous return resistance 
(Rvr) in patients with ARDS.
Methods: We included 22 patients with moderate to severe ARDS in 
whom prone positioning was decided. Preload responsiveness was 
assessed at baseline using an end-expiratory occlusion test. Hemo-
dynamic measurements, including cardiac index, central venous 
pressure (CVP), Pms and Rvr (the latter two estimated through the 
heart-lung interactions method) were measured in semi-recumbent, 
supine horizontal (in 15 patients) and after pronepositioning.
Results: Prone positioning significantly increased Pms (from 24 (19-
34) to 35 (32-46) mmHg). This was partly due to the trunk lowering 
performed before prone positioning. In seven patients, prone posi-
tioning increased cardiac index ≥ 15%. All were preload responsive. In 
these patients, prone positioning increased Pms by 82 (76-95)%, CVP 
by 33 (21-59)%, (Pms – CVP) by 144 (83-215)%, while it increased Rvr 
by 71 (60-154)%. In 15 patients, prone positioning did not increase car-
diac index ≥ 15%. In these patients, prone positioning increased Pms 
by 28 (18-56)% (p < 0.05 vs. patients with significant increase in cardiac 
index), CVP by 21 (7-54)%, (Pms – CVP) by 28 (23-86)%, and Rvr by 37 
(17-77)%. Eleven of these 15 patients were preload unresponsive.
Conclusion: Prone positioning increased Pms, CVP and Rvr. The result-
ing change in cardiac index depended on the extent of increase in 
(Pms-CVP), of preload responsiveness and of the increase in Rvr. Car-
diac index increased only in preload responsive patients if the increase 
in Rvr was lower than the increase in the (Pms – CVP) difference.
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Introduction: The Sequential Organ Failure Assessment (SOFA) score 
is being used to predict mortality in patients admitted to intensive 
care units (ICUs). The extent of organ failure in the SOFA is quantified 
using a point score with equal weights of abnormalities in different 
systems.
Objectives: To determine the relative contribution of alterations in 
different systems to the risk of ICU mortality in a population of very old 
intensive care unit patients (VIPs).
Methods: We used data from the Prognostic Score in the Very Old ICU 
Patients (VIP2) prospective, multicentre study (NCT03370692) which 
recruited consecutive patients ≥ 80 years old between May 2018 and 
May 2019. Worst SOFA scores within 24 hours from admission to the 
ICU was reported overall and in categories (i.e. respiratory, cardiovas-
cular, hepatic, coagulation, renal and neurological systems). Logistic 
regression was used to study the association between the SOFA score 
and mortality.
Results: We included 3898/3919 (99.5%) patients who had complete 
data on all components of the SOFA score in the analysis. The median 
age in the sample was equal to 84 years (IQR: 81-87), 2078 (53.3%) 
patients were male. The median SOFA score was equal to 6 points 
(IQR: 4-9) and 1022/3898 (26.2%) patients died in the ICU. Odds ratios 
for ICU mortality associated with the number of points in a given 
system (1, 2, 3, or 4 points respectively) with 0 points set as the ref-
erence category were as follows (95% confidence intervals shown in 
brackets):
• respiratory: 1.21 (0.91-1.61), 1.67 (1.29-2.15), 1.63 (1.24-2.14), 
3.51 (2.53-4.86),
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• cardiovascular: 1.15 (0.90-1.45), 0.62 (0.36-1.07), 0.98 (0.77-1.25), 
1.83 (1.48-2.26),
• neurologic: 1.49 (1.20-1.85), 2.33 (1.76-3.09), 2.57 (1.95-3.39), 
5.12 (4.11-6.37),
• renal: 1.57 (1.29-1.91), 1.78 (1.42-2.23), 2.59 (1.90-3.53), 2.21 
(1.56-3.12),
• coagulation: 1.13 (0.91-1.39), 1.33 (0.99-1.79), 2.71 (1.54-4.76), 
0.78 (0.18-3.36),
• hepatic: 1.23 (0.98-1.55), 1.54 (1.14-2.06), 1.80 (0.85-3.81), 1.91 
(0.68-5.30).
Conclusion: Our results suggest that the current SOFA score may be 
too simplistic to capture the relative contribution of individual organs’ 
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Introduction: Erythromycin is a potent prokinetic agent and has a 
shorter onset of action time. The combination of prokinetic medica-
tions is increasingly used as they accelerate the prokinetic action and 
at the same time decrease the adverse effects.
Objectives: Aim of our study was to know the effective prokinetic 
dose, duration of usage, response and safety of erythromycin in 
patients already on metoclopramide.
Methods: All patients in surgical and trauma intensive care unit hav-
ing enteral feed intolerance and already on metoclopramide for 
24  hours were enrolled in the study prospectively. Patient’s demo-
graphic data, diagnosis, surgical intervention, disease severity scores, 
erythromycin dose, duration, any adverse effects, factors affecting 
erythromycin response and outcome were recoded. All these patients 
received 125 mg syrup erythromycin twice daily through nasogastric 
tube and nasogastric tube was clamped for 2 hours and half amount 
of previous enteral feeds were resumed. If patient did not tolerate 
the feeds, the erythromycin dose was increased every 24 hours in the 
increment of 250, 500 and 1000 mgs.
Results: Total of 313 patients were included in the study. Males were 
higher in number (77.6%) and majority (48.2%) of patients with feed 
intolerance were post laparotomy. Ninety percent patients responded 
to prokinetic erythromycin therapy, 54% received lower dose (125 mg 
twice daily) and 14% had diarrhoea. Mean duration of erythromycin 
therapy was 4.98 days. The most effective dose of erythromycin was 
125mg twice daily (P = 0.001). It was significantly effective in patients 
with multiple organ dysfunction and shock (P = 0.001 and 0.003 
respectively). Patients not responding to erythromycin therapy had a 
significant higher mortality (p = 0.001).
Conclusion: Post-laparotomy patients had higher enteral feed intoler-
ance. Erythromycin was effective in 125 mgs dose and minimal dura-
tion. Patients who did not tolerate feeds despite increasing dose of 
erythromycin had higher mortality.
Reference(s) and grant ackowledgment(s)
1. 8. Ritz MA, Chapman MJ, Fraser RJ et al. Erythromycin dose of 70 mg 
accelerates gastric emptying as effective as 200mgs in critically ill patients. 
Intensive Care Med 2005; 31:949‑54
2. 4. Catherine V. Hawkyard, Roland J. Koerner, The use of erythromycin as a 
gastrointestinal prokinetic agent in adult critical care: benefits versus risks, 




Methotrexate carried in lipid core nanoparticles prevents 
cardiac dysfunction by increasing angiogenesis and availability 
of intracellular adenosine in the left ventricle of sepsis‑induced 
rats
NM. Lopes1; MC. Guido1; CI. Albuquerque1; L. Jensen2; RC. Maranhão1
1Lipids and Metabolism Laboratory, Heart Institute of the State of Sao 
Paulo (InCor), Sao Paulo, Brazil; 2Experimental biology laboratory, Heart 
Institute of the State of Sao Paulo (InCor), Sao Paulo, Brazil 
Correspondence: N.M. Lopes
Intensive Care Medicine Experimental 2020, 8(2): 000015
Introduction: In sepsis, besides the dysregulation of the immune 
system and disturbances of several vital organs, life-threatening car-
diac dysfunction often occurs. We showed in previous studies that 
LDE, a non-protein lipid core nanoparticle, is able to concentrate in 
inflammatory sites. When carried in LDE, the cellular uptake of meth-
otrexate (MTX) increased several-fold compared to the uptake of the 
commercial version. LDE-MTX formulation was shown to modulate 
the immune response in rats with myocardial infarction, reduce the 
inflammation and improve the post-infarction cardiac function by 
increasing angiogenesis, thereby improving hypoxia.
Objectives: To test whether LDE-MTX can improve the cardiac status 
in septic rats.
Methods: Sepsis was induced in Wistar rats by two I.P. injections of 
lipopolysaccharide (LPS, 10  mg/kg) administered with a 24  h inter-
val. Rats were allocated in a Control group (CT, without sepsis) and 3 
groups with sepsis: LDE, treated with LDE only; MTX, with commercial 
MTX (1 mg/kg); and LDE-MTX, with LDE-MTX (1 mg/kg). Echocardiog-
raphy was performed 72 h after sepsis induction. Animals were eutha-
nized for morphometric analysis of the LV and protein expression 
analysis of inflammatory, apoptotic, angiogenesis, hypoxia and adeno-
sine bioavailability markers in the LV.
Results: Septic rats treated with LDE developed diastolic dysfunc-
tion and presented decreased diastolic volume and diameter of the 
LV. LDE-MTX group had the appearance of diastolic dysfunction and 
alterations in LV dilation totally prevented. Also, LDE-MTX treatment 
elicited cardiac hypertrophy through the increase of the thickness of 
septum and of the LV posterior wall. LDE-MTX increased LV mass and 
relative heart weight, as compared to the other groups. Morphomet-
ric analysis showed increased myocyte diameter in LDE-MTX when 
compared to other groups. All groups showed no differences in the 
protein expression of inflammatory (lymphocytes, tumor necrosis fac-
tor, interleukins) and apoptotic (caspases and B-cell lymphoma fam-
ily) markers, although LDE-MTX showed higher expression of CD68 
(macrophage marker). In LDE, hypoxia was remarkably higher while 
LDE-MTX showed higher angiogenesis and lower cellular hypoxia, 
respectively represented by vascular endothelial growth factor (VEGF) 
and hypoxia-inducible factor 1 alpha. MTX showed no effects in angio-
genesis or hypoxia. The intracellular adenosine bioavailability was 
increased in LDE-MTX-treated animals, promoted by higher expres-
sion of the A1 receptor, as compared to CT. Myocyte diameter was 
positively correlated with VEGF (r2 = 0.52; p < 0.0001).
Conclusion: The appearance of cardiac dysfunction associated to 
sepsis, was successfully avoided by the treatment with LDE-MTX. This 
outcome is conceivably associated to different effects observed in this 
group, such as the development of an adaptive hypertrophy as result 
of the modulation of different pathways, such as the activation of 
angiogenesis mechanisms, increase of adenosine bioavailability and 
immune recruitment to the LV.
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Introduction: As an alternative to stress ulcer prophylaxis (SUP), 
enteral nutrition (EN) alone may provide prophylaxis against stress-
related gastrointestinal bleeding. In animal studies, EN increased gas-
trointestinal blood flow and luminal pH, contributing to the protection 
of the gastric mucosa [1]. Similarly, a previous prospective study of 
Intensive care unit (ICU) patients showed that both continuous EN and 
SUP independently increased gastric pH and gastric colonization [2]. 
However, the effects and safety of SUP in ICU patients receiving EN are 
poorly understood.
Objectives: To evaluate whether EN alone provides prophylaxis 
against stress-related gastrointestinal bleeding and reduces drug 
complications compared with concomitant pharmacological SUP and 
EN.
Methods: Using data for July 2010 to March 2018 from the Japanese 
Diagnosis Procedure Combination inpatient database, we identified 
adults with at least one risk factor for gastrointestinal bleeding and 
who had received EN within 2 days of intensive care unit admission. 
We allocated patients who had received intravenous or enteral SUP 
(proton-pump inhibitor and/or histamine-2 receptor antagonists) 
within 2 days of receiving EN as the SUP group, and patients who had 
received EN alone as the control group.
Results: We identified 50,663 eligible patients, and 4615 patients (9%) 
constituted the SUP group. After propensity score matching, there 
was no significant difference in in-hospital mortality and endoscopic 
hemostasis for gastrointestinal bleeding between the two groups. 
The SUP group was more likely to have hospital-acquired pneumonia 
(odds ratio, 1.25; 95% confidence interval, 1.06–1.46) than the control 
group. Patients who had received proton-pump inhibitors were more 
likely to receive percutaneous coronary intervention for acute myo-
cardial infarction (odds ratio, 1.51; 95% confidence interval, 1.04–2.18) 
than patients without SUP.
Conclusion: Our results suggest that among patients at risk for gastroin-
testinal bleeding who had received EN, SUP may not reduce in-hospital 
mortality or gastrointestinal bleeding but may increase complications 
of hospital-acquired pneumonia or acute myocardial infarction. Future 
randomized control trials are warranted to confirm our findings.
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Introduction: Hypoxic ischemic brain injury (HIBI) is the leading cause 
of morbidity and mortality in patients who survive cardiac arrest. The 
goal of HIBI management is to augment cerebral oxygen delivery by 
optimizing mean arterial pressure in these patients. Real-time cer-
ebral autoregulation monitoring provides a method of identifying 
the patient specific optimal mean arterial pressure (MAPOPT) but 
while this method has been well established in traumatic brain injury 
patients, similar studies are lacking in HIBI patients.
Objectives: Our systematic review aims to determine (a) the average 
MAPOPT in post-cardiac arrest HIBI patients, (b) the feasibility of iden-
tifying MAPOPT, (c) the brain tissue oxygenation levels when within 
proximity to the MAPOPT, and (d) the relationship between neurologi-
cal outcome and MAPOPT.
Methods: We carried out this review in accordance with the PRISMA 
guidelines. We searched MEDLINE (Ovid), Embase (Ovid), EBM Reviews 
(Ovid), CINAHL (EBSCO), the Cochrane Database of Systematic Reviews 
and the WHO Global Health Library from inception to October 31 
2019. We also searched the Cochrane Central Register of Controlled 
Trials (CENTRAL), BioMed Central, ClinicalTrials.gov, WHO International 
Clinical Trials Registry Platform (ICTRP) and Thomson Center Watch for 
unpublished works and ongoing clinical trials.
We included all studies that used cerebral autoregulation to deter-
mine MAPOPT in adult patients (> 16 years old) who achieved return 
of spontaneous circulation (ROSC) post-cardiac arrest. Patients had to 
be intubated and ventilated while undergoing invasive cardiovascular 
and neurovascular monitoring in an Intensive Care Unit. We excluded 
studies where patients had any history of traumatic brain injury, 
ischemic stroke or intracranial hemorrhage.
Results: We identified six studies with 181 patients. There was wide 
variability in cerebral autoregulation monitoring methods, length of 
monitoring, calculation and reporting of MAPOPT. Amongst all studies, 
the median or mean MAPOPT was consistently above 65 mmHg (range: 
70-114  mmHg). Definitions of feasibility varied amongst studies and 
was difficult to summarize. Some studies defined feasibility as the abil-
ity to calculate one MAPOPT value during the monitoring period while 
others defined it as the duration of monitoring time for which MAPOPT 
could be calculated. Only one study noted that brain tissue oxygenation 
increased as patients’ MAP approached MAPOPT. However, this effect 
disappeared when the MAP exceeded MAPOPT. Finally, there was no 
consistent association between MAPOPT and neurological outcome.
Conclusion: There is considerable heterogeneity in determining 
MAPOPT due to differences in autoregulation monitoring. Further 
standardized randomized controlled trials and prospective studies are 
needed to assess the clinical utility of MAPOPT guided strategies on 
improving neurological outcomes after ROSC.
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Introduction: Intensive Care Units (ICUs) treat patients with high mor-
tality risk. Early and accurate mortality estimation is crucial for guid-
ing care and resource allocation. Identification of patients with poor 
trajectories is difficult and often wrought with biases. Machine Learn-
ing (ML) with quality data is a means of accurate mortality prediction. 
Several studies compared machine learning models to severity illness 
scores in predicting mortality. To our knowledge, no study has com-
pared ML and clinician feature importances.
Objectives: We compared important features for mortality chosen by 
ML models and clinicians.
Methods: We extracted data from the eICU Collaborative Research 
Database. The dataset included 27 variables (26 independent and 1 
dependent) and 147,233 values. Mortality was the dependent vari-
able for our prediction models. Exploratory data analysis performed 
in Python. Missing data imputed with Sklearn Iterative Imputer. Fea-
ture selection performed using Pearson correlation and Sklearn Select 
From Model library. Top ten features for the ML group chosen by the 
frequency in the top ten for Pearson Correlation and four ML model 
feature selection methods. ICU clinicians filled out a survey to choose 
the top ten features that predict mortality. Fifty-one surveys filled out, 
and the most common features compiled to create a top ten list. The 
mortality outcome of death was rare (136,451 alive versus 8,184 died). 
Given the imbalanced dataset, we employed an oversampling tech-
nique (SMOTE). The top features in both groups were passed through 
Logistic Regression (LR) and Naive Bayes (NB) algorithms. Area Under 
Receiver Operator Characteristic (AUROC) was chosen as our metric.
Results: White blood count (WBC), Prothrombin Time (PT), Lactate, Hypo-
glycemia, and  PaO2:FiO2 ratio were the top features for the ML group. Clini-
cians chose hepatic failure, advanced age, immunosuppressed status, and 
history of metastatic cancer. The AUROC for the ML group in predicting 
mortality was 0.865 (LR); 0.840 (NB), as compared to 0.737 (LR); 0.744 (NB) 
for clinicians. As a benchmark, we compared our feature inputs to SAPS II 
and APACHE IV scores input into LR and NB. SAPS II and APACHE IV per-
formance were 0.842 (LR);0.844 (NB) and 0.855 (LR);0.855 (NB) respectively.
Conclusion: ML models can identify important features for accurate 
ICU mortality prediction. ML predictive models can be important 
adjuncts to augment clinical decision making.
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Introduction: The hippocampus is part of the limbic system known 
as an emotional neuro-circuit, and its activity is coupled with the 
breathing cycle.1Ventilation-Induced Brain Injury (VIBI) was recently 
identified preclinically, 2  where VIBI was characterized by hippocam-
pal neuroinflammation and apoptosis. However, these studies used 
high-tidal-volume mechanical ventilation for short durations (for up 
to 3½ hours), and the effect on the hippocampus of long-term lung-
protective (i.e. gold standard) mechanical ventilation (MV) is not 
known. We hypothesize that lung-protective MV for 50 hours in a non-
injured preclinical model shifts the behavior of hippocampal microglia 
towards inflammation, contributing to local apoptosis. The interaction 
between the apoptotic process and microglia cells has been described 
in other conditions, such as epilepsy and traumatic brain injury. 
3–5  Characterizing changes in the behavior of hippocampal micro-
glia might assist in a better understanding of the neuro-inflammatory 
process happening during VIBI. This data might also contribute to the 
design of future studies into cognitive dysfunction after MV.
Objectives: To investigate whether lung-protective mechanical ven-
tilation in a porcine model for 50 hours modifies  microglia behavior, 
and to analyze the level of hippocampal apoptosis after 50 hours of 
lung-protective mechanical ventilation.
Methods: We ventilated eight human-size pigs (MV group) using 
lung-protective MV for 50 hours in a mock ICU, and compared them 
with six never-ventilated pigs (NV group). Ventilation settings were 
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adjusted to achieve and maintain a tidal volume of 6-8  ml/kg, with 
a PEEP of 5  cm  H2O. The pigs’ hippocampi were harvested, and 
machine-learning software was used to count and classify cells. Per-
centages of cells stained by the TUNEL and IBA1 markers were then 
determined. Microglia behavior was determined, and quantified fol-
lowing biometric cellular characteristics based on pre-established cri-
teria in the literature.
Results: The hippocampal apoptotic percentage was 38% 
(44,797/117,886) in the MV group and 1% (338/33,805) in the NV 
group (p < 0.01). Total microglia population as a percentage of total 
cell population, including those displaying pro- and anti-inflammatory 
characteristics, was 36% (74,212/205,006) in the MV group and 10% 
(58,398/589,888) in the NV group (p < 0.01). Analysis of MV group 
microglia identified 81% (60,111/74,212) with anti-inflammatory 
characteristics and 19% (14,101/74,212) with pro-inflammatory char-
acteristics (p < 0.01). Analysis of the NV group microglia identified 
84% (49,288/58,398) with anti-inflammatory characteristics and 16% 
(9,110/58,398) with pro-inflammatory characteristics (p < 0.01). The 
percentage of microglia with pro-inflammatory characteristics was 
slightly, but significantly higher in the MV group (19%) than in the NV 
group (16%, p < 0.05). The percentage of microglia with anti-inflam-
matory characteristics was also significantly different; 81% in the MV 
group, compared to 84% in the NV group (p < 0.05).
Conclusion: Lung-protective MV for 50 hours in a non-injured preclin-
ical model is associated with VIBI, characterized by high hippocampal 
apoptotic percentage and also a shift in the behavior and number of 
hippocampal microglia from anti-inflammatory to pro-inflammatory.
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Introduction: The approach to limit therapy in very old intensive care 
unit patients (VIPs) significantly differs between regions. The focus of 
this multicenter analysis is to illuminate, whether the Clinical Frailty 
Scale (CFS) is a suitable tool for risk stratification in VIPs admitted to 
intensive care units (ICUs) in Germany. Furthermore, this investigation 
elucidates the impact of therapeutic limitation on the length of stay 
and mortality in this setting.
Methods: German cohorts’ data from two multinational studies (VIP-1, 
VIP-2) were combined. Univariate and multivariate logistic regression 
were used to evaluate associations with mortality.
Results: 415 acute VIPs were included. Frail VIPs (CFS > 4) were older 
(85 [IQR 82-88] vs. 83 [IQR 81-86] years; p < 0.001) and suffered from an 
increased 30-day-mortality (43.4% versus 23.9%, p < 0.0001). CFS was 
an independent predictor of 30-day-mortality in a multivariate logistic 
regression model (aOR 1.23 95%CI 1.04-1.46; p = 0.02). Patients with 
any limitation of life-sustaining therapy had a significantly increased 
30-day mortality (86% versus 16%, p < 0.001) and length of stay (144 
[IQR 72-293] versus 96 [IQR 47.25-231.5] hours, p = 0.026).
Conclusion: In German ICUs, any limitation of life-sustaining therapy 
in VIPs is associated with a significantly increased ICU length of stay 
and mortality. CFS reliably predicts outcome.
Reference(s) and grant ackowledgment(s)
1. Guidet B, de Lange DW, Boumendil A, Leaver S, Watson X, Boulanger C, et al. 
The contribution of frailty, cognition, activity of daily life and comorbidities 
on outcome in acutely admitted patients over 80 years in European ICUs: 
the VIP2 study. Intensive Care Med 2019.
2. Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, 
et al. The impact of frailty on ICU and 30‑day mortality and the level of care 
in very elderly patients ( > = 80 years). Intens Care Med 2017;43(12):1820‑8.
3. The authors thank the steering committee of the VIP‑1 and VIP‑2 study 
for their support: Hans Flaatten, principal Investigator (Norway), Bertrand 
Guidet (France), Dylan de Lange (The Netherlands), Antonio Artigas (Spain), 
Finn Andersen (Norway), Carol Boulanger (UK), Ariane Boumendil (France), 
Maurizio Cecconi (Italy), Jesper Fjølner (Denmark), Brian Marsh (Ireland), 
Alessandro Morandi (Italy), Rui Moreno (Portugal), Sandra Oyen (Belgium), 
Joerg Schefold (Switzerland), Ivo Soliman (The Netherlands), Wojciech Szc‑
zeklik (Poland), Michael Joannidis (Austria), Sten Walther (Sweden), Ximena 
Watson (UK), Tilemachos Zafeiridis (Greece), Yuriy Nalapko (Ukranian).
000144 
Management and outcomes in critically ill nonagenarian 
versus octogenarian patients
RR. Bruno1; B. Wernly2; M. Kelm1; FH. Andersen3; A. Artigas4; M. Cecconi5; 
S. Christensen6; M. Lichtenauer7; B. Marsh8; RP. Moreno9; S. Oeyen10; 
B. Bollen  Pinto11; W. Szczeklik12; S. Leaver13; M. Joannidis14; J. Fjølner15; 
D. De  Lange16; B. Guidet17; H. Flaaten18; C. Jung1
1Cardiology, Pulmonary Diseases, Vascular Medicine, Universität Düs‑
seldorf, Düsseldorf, Germany; 2Cardiology, Paracelsus Medical Univer‑
sity, Salzburg, Austria; 3Dep of circulation and medical imaging, Alesund 
Hospital, Alesund, Norway; 4Department of intensive care medicine, Cor‑
poracion Sanitaria Universitaria Parc Tauli, Barcelona, Spain; 5Anesthesia 
and intensive care, Humanitas Research Hospital, Milan, Italy; 6Depart‑
ment of anaesthesia and intensive care medicine, Aarhus University Hos‑
pital, Aarhus, Denmark; 7Department of cardiology, Paracelsus Medical 
University, Salzburg, Austria; 8Intensive care unit, The Mater Misericordiae 
University Hospital, Dublin, Ireland; 9Unidade de cuidados intensivos neu‑
rocríticos, Hospital de São José, Centro Hospitalar de Lisboa Central, Nova 
Page 23 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Médical School, Lisbon, Portugal; 10Department of intensive care, Ghent 
University Hospital, Gent, Belgium; 11Anesthesiology, Hôpitaux Universi‑
taires de Genève (HUG), Genève, Switzerland; 12Intensive care and periop‑
erative medicine, Jagiellonian University Medical College, Kraków, Poland; 
13Research lead critical care directorate, St George’s Hospital, London, 
United Kingdom; 14Division of intensive care and emergency medi‑
cine, Medizinische Universität Innsbruck, Innsbruck, Austria; 15Department 
of intensive care, Aarhus University Hospital, Aarhus, Denmark; 16Depart‑
ment of intensive care medicine, Utrecht University, Utrecht, Netherlands; 
17Réanimation Médicale, Hôpital Saint‑Antoine, Paris, France; 18Depart‑
ment of anaestesia and intensive care, University of Bergen, Bergen, Nor‑
way 
Correspondence: R.R. Bruno
Intensive Care Medicine Experimental 2020, 8(2): 000144
Introduction: The growing proportion of nonagenarian ICU patients 
challenges intensive care medicine. Due to the unclear benefit to 
patients and a high consumption of health care resources, these old-
est-old patients represent both an ethical and political problem. This 
study compared outcome differences between nonagenarian and 
octogenarian ICU patients.
Methods: 7900 acutely admitted older critically ill patients from two 
large, multinational registers were included. The primary endpoint 
was ICU-, the secondary endpoint 30-day-mortality. Baseline charac-
teristics including frailty assessed by the Clinical Frailty Scale (CFS), 
management and outcomes were compared between octogenar-
ian (80-89.9 years) and nonagenarian (≥  90 years) patients. Logistic 
regression was used to calculate a propensity score on being nonage-
narian and to evaluate univariable and multivariable associations with 
the endpoints.
Results: The nonagenarians accounted for 10% of the entire cohort. 
They evidenced higher rates of frailty (58% vs 42%; p < 0.001), but 
lower SOFA scores at admission (6 ± 5 vs. 7 ± 6; p < 0.001). Manage-
ment strategies differed with octogenarians receiving higher rates of 
organ support while nonagenarians had higher rates of life-sustain-
ing treatment limitation (40% vs. 33%; p < 0.001). ICU mortality was 
similar (27% vs. 27%; p = 0.973) in octogenarians and nonagenarians. 
However, being a nonagenarian was independently associated with 
increased 30-day-mortality after adjustment of the propensity score 
(OR 1.18 95%CI 1.02-1.38; p = 0.03).
Conclusion: Nonagenarians had higher 30-day mortality compared 
to octogenarian patients. Being a nonagenarianshould be considered 
an independent risk factor for mortality and – together with disease 
severity and pre-existing functional capacity - to effectively guide tri-
age decisions.
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Introduction: Most critically ill patients experience the disruption of 
circadian body temperature (BT) rhythm after intensive care unit (ICU) 
admission. However, there is limited evidence on the relationship 
between circadian BT variation and outcomes in patients during ICU 
stay.
Objectives: To assess the impact of circadian BT variation on progno-
sis in ICUs patients.
Methods: A multicenter retrospective cohort study was performed 
with eICU Collaborative Research Database, which comprises 139367 
patients at 335 distinct ICUs across the United States from 2014 to 
2015. Adult patients with complete records of continuous bedside 
core BT monitoring during the first 24 hours of ICU stay were included. 
According to circadian BT variation (mean night-time BT/mean day-
time BT), participants were divided into two groups: ratio  ≤  1 and 
ratio > 1. Logistic and liner regression were performed to investigate 
the relationship between circadian BT variation and prognosis (ICU 
mortality, length of ICU stay [ICU-LOS], and length of hospital stay 
[hospital-LOS]). Sensitivity analysis was conducted according to Acute 
Physiology and Chronic Health Evaluation IV (APACHE IV) ≤ 64 or > 64. 
Furthermore, an external cohort was performed with Multiparameter 
Intelligent Monitoring in Intensive Care II database.
Results: A total of 6093 patients were analyzed. Patients with cir-
cadian BT variation ≤  1 (n = 2473) had higher ICU mortality, longer 
ICU-LOS and hospital-LOS than those with circadian BT variation > 1 
(n = 3620). After multivariable adjustments, circadian BT variation ≤ 1 
increased ICU mortality (odds ratio [OR], 1.231, 95% confidence inter-
vals [CI], 1.009 – 1.502), prolonged ICU-LOS (β, −0.420, 95%CI, − 0.657 
to − 0.182), and hospital-LOS (β, −0.836, 95%CI, − 1.247 to − 0.426) in 
ICU patients. The association remained significant in sensitivity analy-
sis and external cohort.
Conclusion: Circadian BT variation may be associated with higher ICU 
mortality, longer ICU-LOS, and hospital-LOS in critically ill patients. Our 
findings will further develop our knowledge on the vital role of circa-
dian rhythm in ICU and indicated that circadian BT variation may assist 
with early risk stratification.
Reference(s) and grant ackowledgment(s)
1. Pollard TJ, Johnson AEW, Raffa JD, et al. The eICU Collaborative Research 
Database, a freely available multi‑center database for critical care research. 
Sci Data 2018;5:180178.
2. Oldham MA, Lee HB, Desan, PH. Circadian Rhythm Disruption in the Criti‑
cally Ill: An Opportunity for Improving Outcomes. Crit Care Med 2016;44(1): 
207‑217.
3. Telias I, Wilcox ME. Sleep and Circadian Rhythm in Critical Illness. Crit Care 
2019;23(1):82.
000162 
Temporary transvenous diaphragm neurostimulation 
plus lung‑protective mechanical ventilation is associated 
with greater heart rate variability after 50 hours compared 
to ventilation alone
T. Bassi1; M. Nicholas2; K. Fernandez2; M. Ornowska2; E. Rohrs2; S. Reynolds1
1Physiology, Simon Fraser University, Burnaby, Canada; 2Critical care, Fraser 
Health Authority, New Westminster, Canada 
Correspondence: T. bassi
Intensive Care Medicine Experimental 2020, 8(2): 000162
Introduction: Heart rate variability (HRV) is an accepted method 
for measuring sympathetic/parasympathetic balance and it is influ-
enced by vagal afferent signals coming from the lungs.1,2 The effect 
of lung-protective mechanical ventilation (MV) on sympathetic/para-
sympathetic nervous system balance has not been demonstrated. 
Greater R-R interval variance reflects a normal physiological state with 
parasympathetic predominance; lower R-R interval variance indicates 
sympathetic predominance, which correlates with high mortality 
and inflammation.3  Studying HRV during MV is important to better 
understand the inflammatory insult associated with MV. Temporary 
transvenous diaphragm neurostimulation (TTDN) is a novel technol-
ogy that assists MV by creating negative pressure targeting the reduc-
tion of the pressure-time-product (PTP), and may influence the HRV. 
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We hypothesize lung-protective MV progressively downregulates 
parasympathetic activity over the course of 50 hours and that MV + 
TTDN will upregulate parasympathetic activity due to more physi-
ological alveolar stretch resulting in greater HRV after 50 hours of the 
experiment.
Objectives: To compare the sympathetic/parasympathetic nervous 
system balance after 50 hours of lung-protective MV alone and with 
TTDN assistance.
Methods: We used sixteen pigs between 51-64 kg, eight under lung-
protective MV (MV-Only) and eight under lung-protective MV plus 
TTDN (MV + TTDN) for 50 hours. Ventilation parameters were set to 
achieve and maintain tidal volume 6-8 ml/kg, and PEEP of 5 cm H2O. 
TTDN targeted between 15-20% reduction in PTP during MV. The MV 
+ TTDN group received phrenic nerve stimulation every other breath 
in synchrony with MV. ECG data were analyzed over two periods after 
MV initiation; hours 0 to 6 (start) and hours 44 to hour 50 (end). Root 
mean square of the standard deviation of the R-R intervals (RMSSD) 
was chosen as the HRV time-domain method of analysis.
Results: In total, 815,658 R-R intervals were analyzed across the six-
teen subjects; 407,762 in the MV-Only group and 407,896 in the MV + 
TTDN group (p > 0.05). In the MV-Only group the RMSSD was 0.90 ms 
at the start and 0.81 ms at the end of the study; and in the MV + TTDN 
group it was 0.81 ms at the start and 0.91 ms at the end (p = 0.007, 
between groups).
Conclusion: MV resulted in a reduction of the HRV in the MV-Only 
group after 50 hours which might indicate a downregulation in para-
sympathetic activity. The MV + TTDN group showed higher HRV after 
50 hours of MV which might point towards upregulation in parasym-
pathetic activity.
Reference(s) and grant ackowledgment(s)
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Introduction: Respiratory support plays an important role in patient’s 
recovery after cardiovascular surgery. Intellivent-ASV® is a closed-loop 
ventilation mode that adjusts automatically ventilation and oxygena-
tion settings according to patient weight, lung function (as assessed 
by the ventilator) and continuous input of end-tidal carbon dioxide 
and oxygen saturation in both passive and spontaneous breathing 
patients. There is an ability to improve patient’s safety and reduce 
physician’s workload with using intellectual modes of ventilation.
Objectives: To compare the effect(s) of Intellivent-ASV and conven-
tional ventilation modes.
Methods: In this randomized controlled trial 40 adult patients were 
ventilated with conventional ventilation modes and 40 with Intel-
livent-ASV after uncomplicated cardiac surgery. Hamilton G5 ven-
tilators were used and 8 physicians were involved into the study. All 
actions of physician’s, ventilator settings and changes were monitored 
and recorded during respiratory support in ICU. Care of both groups 
was standardized, except modes of postoperative ventilation.
We compared:
 the physician’s workload, through accounting number of man-
ual ventilator settings and time they spent near the ventilator in 
every group;
 duration of tracheal intubation in ICU;
 evaluation of ventilation safety by considering driving pressure, 
mechanical power, positive end expiratory pressure and tidal vol-
ume level.
Results: There were significant differences in the duration of respira-
tory support in ICU: 226 ± 31 min (Intellivent group) vs 271 ± 78 min 
(control) (p = 0,001267).
In Intellivent group the number of manual ventilator settings and phy-
sicians time spent near the ventilator before tracheal extubation were 
lower: 0 vs 4 (2-6), and 35 (25-53) sec vs 164 ± 69 sec respectively (p < 
0,001 in both cases).
Intellivent-ASV provided a significant more protective ventilation 
through reduction in the driving pressure, tidal volume,  FiO2 and PEEP 
levels, but without differences between  PaO2/FiO2 ratio.
1. ∆P and Vt were significantly lower in Intellivent group ‑ ∆P on mechanical 
ventilation was 6 (5‑7) cm  H2O vs 7,25 (6,5‑9,5) cm  H2O (p < 0,001) and pres‑
sure support level – 5 (5‑5) cm  H2O vs 8 (7‑10) cm  H2O; Vt on mechanical 
ventilation was 6 (5,2‑7) vs 7 (6‑9,5) ml/kg/PBW (p = 0,000003).
2. PEEP and  FiO2 level were also significantly lower in Intellivent group during 
all phases of respiratory support in ICU. PEEP on mechanical ventilation 
was 5 (5‑7,5) cm  H2O vs 7 (5‑11,5) cm  H2O and  FiO2 level was 26 (22‑30) % 
vs 34 (30‑40) %. During spontaneous ventilation phase in Intellivent group 
PEEP was 5 (5‑5,5) cm  H2O vs 7 (5‑10) cm  H2O and  FiO2 26 ± 4 % vs 30 (29‑
40) %.
3. Mechanical power (simplified equation) was lower in Intellivent group 8,17 
(5,99‑10) vs 8,58 (6,34‑13,7) J/min (p = 0,0467).
There were no significant differences between the groups in Vt values 
during spontaneous ventilation: 8 (7-9) vs 8 (7-10) ml/kg/PBW in con-
trol group, as well as in undesirable events and duration of ICU and 
hospital stay.
Conclusion: Application of IntelliVent-ASV mode after uncomplicated 
cardiac surgery provides more protective mechanical ventilation and 
reduces the physician’s workload without compromising the quality of 
respiratory support and safety of patients.
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Introduction: Sepsis is a life-threatening organ dysfunction due to 
a pathological host response to an infection. Vascular barrier break-
down represents a key component of this maladaptive host response 
and the release of pre-stored Angiopoietin-2 (Angpt-2) from the 
endothelium is a direct driver of this phenomenon via deactivation of 
its target receptor “Tie2”. Currently, an Angpt-2 modulating therapy 
does not exist. Screening an FDA-drug library, we identified the anti-
fungal Bifonazole (BIFO) as a potential reducer of Angpt-2 in vitro. We 
hypothesize that BIFO might decrease circulating Angpt-2 and there-
fore, diminish capillary leakage.
Methods: Endothelial cells were isolated from human umbilical veins 
(HUVECs) and used for in vitro studies after stimulation with BIFO (RT-
PCR, immunoblot, ELISA, immunocytochemistry, transendothelial 
electrical resistance (TER)). In vivo studies were performed on endotox-
emic C57Bl6 mice treated with BIFO (lung RT-PCR, immunoblot, ELISA).
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Results: We found that BIFO can reduce spontaneous Angpt-2 release 
in a time- and dose-dependent manner in HUVECs after 8 (p < 0.05), 
12 and 24  h (veh: 15.58 ±  0.7 vs BIFO: 8.56 ±  0.8 ng/ml, p < 0.001). 
In addition, after TNF-α challenge, BIFO was still able to reduce this 
stimulated Angpt-2 release (veh: 30.3 ± 3.8 vs BIFO: 22.2 ±2.5 ng/ml, p 
< 0.01). Measuring the TER to quantify endothelial permeability, BIFO 
was sufficient to increase TER in two models of hyperpermeability 
(Thrombin and PMA) (veh: 0.82 ± 0.10 vs BIFO: 1.01 ± 0.02, p < 0.05). 
As BIFO reduced not only Angpt-2 release but also cellular content by 
27% (p < 0.05), an exocytosis-independent mechanism directly affect-
ing Angpt-2 biosynthesis seems involved. Consistently, Angpt-2 tran-
scription (mRNA) was reduced in lungs of BIFO-stimulated mice (veh: 
1.00 ± 0.38 vs BIFO: 0.55 ± 0.43, p < 0.05).
Conclusion: The antifungal BIFO can reduce release and synthesis of 
the endothelial-destabilizing factor Angpt-2 in vitro. Henceforth, our 
results suggest that BIFO might counterpart the pathophysiology of 
endothelial permeability in inflammation via a reduction of Angpt-2 
transcription (mRNA). More in vitro studies are needed to further 
investigate mechanisms of thepharmacological effect of BIFO on the 
regulation of Angpt-2. In vivo studies that are currently ongoing are 
supposed to confirm the results in a murine sepsis-model.
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Introduction: Subclavian vein catheterization has many advantages 
compared to other sites for central venous access. Unfortunately, cen-
tral venous catheter (CVC) misplacement is common (up to 9.3% after 
a right-sided catheterization). To avoid CVC misplacements, the right 
supraclavicular fossa ultrasound view can be used to confirm correct 
guidewire J-tip position in the lower part of the superior vena cava 
prior to CVC insertion.
Objectives: To demonstrate the usefulness of a real-time ultrasound 
method for guidewire positioning during infraclavicular CVC place-
ment in the right subclavian vein, and to determine the number of 
CVC misplacements occurring when using this method. The hypoth-
esis was that the incidence of misplaced CVCs could be reduced to 1%.
Methods: The study was approved by the Swedish Ethical Review 
Authority and registered as a clinical trial at clinicaltrials.gov 
(NCT03812757). Sample size calculation showed that 93 patients 
should be included. All vein punctures were performed prospectively, 
under real-time ultrasound guidance with a micro-convex probe. The 
right supraclavicular fossa ultrasound view was used to confirm cor-
rect guidewire position (Figure  1) and misplaced guidewires were 
adjusted prior to CVC insertion. A post-procedural chest X-ray was 
obtained to determine definitive CVC tip position.
Results: One hundred patients were included. Successful catheteri-
zation of the right subclavian vein was achieved in all patients. In 14 
cases the guidewire J-tip was initially misplaced in either the ipsilateral 
internal jugular vein (n = 8) or in the left brachiocephalic vein (n = 6). 
In 12 of these cases it was possible to adjust the guidewire J-tip to a 
correct position in the superior vena cava. In 2 cases it was impossi-
ble to adjust the guidewire J-tip from a position in the left brachioce-
phalic vein, and the suboptimal positions were finally accepted. Both 
CVC tips were confirmed with chest X-rays in the left subclavian vein, 
as expected. The remaining 98 CVCs all had a tip position in the lower 
part of the superior vena cava, determined by chest X-ray.
Conclusion: Although the hypothesis could not be confirmed, this 
study demonstrates that the use of the right supraclavicular fossa 
ultrasound view to guide guidewire positioning reduced the inci-
dence of CVC misplacements to 2% and thus is useful to avoid CVC 
misplacements in right infraclavicular subclavian vein catheterization.
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Introduction: The glomerular filtration rate (GFR) is an index of the 
renal filtration function, and is estimated clinically by the creatinine 
clearance (CrCl). Since the kidney is the primary excretory organ for 
most hydrophilic drugs such as beta-lactam antimicrobials, drug dos-
age is determined based on the CrCl. It is well known that kidney func-
tion changes rapidly in critically ill patients. Predictions of CrCl could 
be useful to avoid subtherapeutic drug plasma levels in hyper-clear-
ance patients and drug toxicity in hypo-clearance patients.
Objectives: The purpose of this study was to generate a daily predic-
tion of kidney function on the next day in the ICU. For this purpose, we 
developed and internally validated prediction models for CrCl on the 
next day of ICU stay in adult patients.
Methods: This study was a retrospective preplanned secondary analy-
sis of the EPaNIC multicenter randomized controlled trial database 
[1]. CrCl was calculated by daily urine output (UO), urine creatine 
(UCr), and serum creatinine (SCr). The development cohort (n = 1458 
patients, equivalent to 11726 patient-days) consisted of all ICU adult 
patients with available CrCl for the previous day. Clinical data were 
retrieved from the EPaNIC research database and from the clinical 
patient data management system database. The models were devel-
oped with gradient boosting method (GBM) machine-learning algo-
rithm for both classification and regression. We first classified whether 
CrCl would be above 130 ml/min/1.73  m2 and then regressed all the 
CrCl classified as below 130 ml/min/1.73  m2. Model performance 
(Mean ± SD) was internally validated with 10-fold cross validation for 
discrimination, calibration, net benefit analysis, coefficient of determi-
nation (R2), mean absolute error (MAE), and root mean square error 
(RMSE).
RESULTS. A total of 479 patients (32.8%), equivalent to 2077 patient-
days (17.7%), had CrCl above 130 ml/min/1.73  m2 on the next day. The 
five most important variables for both the classification and regression 
models were mean CrCl, CrCl of the previous day, age, SCr of the previ-
ous day, and UO of the previous day. As shown in Fig.  1, the classifi-
cation model had an area under the receiver operating characteristic 
Page 26 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
curve (AUROC) of 0.94 ±  0.01, calibration slope of 0.90 ±  0.09, and 
calibration in the large of 0.00 ±  0.04. At the classification threshold 
maximizing sensitivity and specificity, net benefit with respect to 
treat-none was 0.14 ±  0.04, and net benefit with respect to treat-all 
was 0.09 ± 0.07. For the remaining 979 patients having CrCl below 130 
ml/min/1.73  m2 on the next day, the regression model had RMSE of 
16.45 ± 0.91, MAE of 11.41 ± 0.86, and R2 of 0.80 ± 0.04.
Conclusion: Prediction models based on routinely collected clinical 
data were able to accurately predict CrCl of the next day in the ICU. 
These predictions could be used to more accurately determine hydro-
philic drug doses in critically ill patients. These findings should be 
externally validated.
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Introduction: Introduction/Background: Ischemia/reperfusion (I/R) is 
frequently associated with microcirculatory deterioration (1). Microcir-
culatory disturbances are associated with reduced outcome (2). Both 
colloidal as well as crystalloid fluids are used for macrohemodynamic 
optimization in I/R. However, impact of colloids or crystalloids on micro-
circulation is unclear. Aim of this study was to compare the effects of 
colloids vs. crystalloids on microcirculation of vital organs in I/R injury.
Methods: Methods: This study was performed in 32 anesthetized and 
mechanically ventilated pigs. Animals were randomized in two equal 
groups receiving either colloids (Voluven ® 6%, Fresenius Kabi ®, Bad 
Homburg, Germany) or crystalloids (Sterofundin ® ISO 1/1 E, B. Braun 
®, Melsungen, Germany)  for hemodynamic optimization. Volume 
optimization was performed before and after I/R using  consecutive 
volume loading steps of 7 ml/kg of either colloids or crystalloids until 
increases of cardiac output ≥ 15% were absent. I/R was induced by 48 
minutes of aortic cross clamping. Microcirculatory blood flow of kid-
ney, liver and small intestine was assessed using Laser-Speckle-Con-
trast-Imaging providing mean microcirculatory blood flow (mFlux). 
Cardiac output was measured using pulmonary artery thermodilution 
and arterial pressure was assessed using invasive micro-tip catheter. 
Primary outcome measures were hepatic, renal and ileal microcircu-
latory blood flow 4,5 h after I/R. Secondary outcome measures were 
macrohemodynamic parameters and laboratory findings. Statistical 
analysis was performed using mixed-model analysis for comparison 
between groups. Values are given as mean (95% confidence interval), 
two-tailed p-values of < 0.05 were considered significant.
Results: Results: Colloids significantly improved ileal mean microcir-
culatory blood flow (mFlux) compared to crystalloids 4,5 h after I/R 
(767.52 (676.47-858.57) vs. 594.24 (494.28-694.20), p = 0.007). This was 
accompanied by a significant increase in cardiac output (l/min) (3.01 
(2.71-3.30) vs. 2.94 (2.09-2.70), p = 0.008). There were no significant 
differences of renal or hepatic microcirculatory blood flow between 
colloid and crystalloid group (mFlux kidney: 509.20 (426.87-591.52) vs. 
443.41 (361.54-525.28), p = 0.304; mFlux liver: 606.06 (509.44-702.67) 
vs. 546.70 (442.10-651.30), p = 0.353, respectively). Comparison of 
colloids vs. crystalloids revealed no significant difference in regard to 
arterial pressure. While there was no significant difference in regard 
to urine output (ml) between groups (1144.82 (852.35-1537.63) vs. 
780.55 (579.98-1.049.43), p = 0.071), animals receiving colloids had 
significant lower values of serum creatinine (mg/dl) compared to crys-
talloids (2.43 (2.33-2.53) vs. 2.63 (2.52-2.74), p = 0.021).
Conclusion: Conclusions: Advantageous effects on intestinal micro-
circulation could be found for colloids. This was accompanied by 
improvements of macrocirculation. In conclusion, use of colloids may 
improve outcome in I/R injury.
Reference(s) and grant ackowledgment(s)
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Introduction: Traumatic brain injury (TBI) is a major public health 
problem. It is considered to be one of the leading causes of death and 
disability worldwide (1). After TBI cerebral blood flow (CBF) becomes 
extremely low approaching ischemic threshold (2). Concurrently, cer-
ebral blood flow velocities become strongly correlated to CBF itself post 
injury. Identification of such haemodynamic disturbances can be used to 
predict outcome in severe TBI when measured immediately post-injury 
usingTranscranial Doppler (TCD). TCD permits non invasive assessment 
of different CBF velocities as well as pulsatility index (PI) (3). Abnormal 
measurement of such indices is believed to correlate to poor outcome.
Objectives: The aim of the work was to assess the predictive value of 
early TCD in patients with severe TBI in terms of mortality and GOSE at 
3 months, and also to correlate different TCD measurements with GCS 
score and FOUR score
Methods: 120 patients with severe TBI, according to GCS, under-
went TCD within 24 hours post trauma. Middle cerebral artery (MCA) 
velocities and pulsatility index, as well as other clinical and neuroim-
aging data, were recorded and accordingly patients were divided 
into 3 groups: patients with normal TCD measurements, patients 
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with hypoperfusion and patients with vasospasm. Hypoperfusion was 
defined by meeting two out of three criteria: mean flow velocity (MFV) 
of MCA < 35 cm/sec, End diastolic velocity (EDV) of MCA < 20 cm/sec, 
PI > 1.4. Vasospasm was defined as MFV > 120 cm/sec. (4-9) Outcome 
was evaluated using the Glasgow Outcome Scale extended (GOSE) at 
3 months, as well as in-hospital mortality. TCD measurements were 
also correlated to GCS and FOUR score.
Pearson’s correlation coefficients(r) were calculated to test the relation 
between TCD and other clinical variables. A binary logistic regression 
analyses were performed then variables that showed statistically sig-
nificant result under univariate analysis were entered into a multivari-
ate analysis to identify independent predictors of outcome measures. 
Discrimination of the logistic models was assessed by calculating the 
area under (ROC) curve (10). All hypotheses were constructed two-
tailed and p ≤ 0.05 was considered significant
Results: There was a significant correlation between PI and GOSE 3 
months. There was also significant correlation between PI and mor-
tality. However, different MCA velocities did not show any correlation 
with GOSE or mortality. Strong negative correlation was recognized 
between PI and GCS and FOUR score.
Conclusion: Pulsatility index, when measured within the first 24 hours 
post-trauma, is considered a good predictor of mortality as well as 
functional outcome at 3months. Abnormal pulsatility index values cor-
relate with the severity of injury (in terms of GCS and FOUR score).
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Introduction: Creating ICU “surge capacity” was essential for the 
COVID-19 pandemic but  takes time to implement and is costly and 
disruptive. A short-range forecast was needed in early March 2020 to 
guide costly and ethically challenging decisions in England and jus-
tify immediate service re-configuration from early epidemiological 
data. The design, construction, testing, implementation, documenta-
tion, dissemination and peer-review of a computer model is typically 
a lengthy process.  Here we describe the use of agile techniques to 
develop a COVID-19 strain forecasting tool from ultra-early epidemio-
logical data building a working tool within a week.
Objectives: To develop and implement a region-specific, short-range 
ICU demand forecast based on case data from the commissioning 
regions in England using agile software development techniques to 
build a public-facing tool as rapidly as possible.
Methods: We modelled the likely increases in regional ICU bed 
demand over a 14-day horizon under an exponential assumption. 
Daily COVID-19 cases were extrapolated from cumulative data using 
log-linear regression. Stochastic models for ICU admissions and length 
of stay linked expected case incidence to excess bed occupancy. Mor-
tality and admission rates were regionally standardised. In parallel we 
developed a web application to publish updated predictions daily 
(Figure  1), with an explanatory manuscript  on  medRvix [1] and code 
on GitHub [2].
Results: We  delivered an interactive web application along with 
explanatory notes and versioned code in 7 days. Community feed-
back  allowed for a crowd-sourced review of manuscript and code. 
Users could explore the effect of changing various modelling assump-
tions interactively at a regional level. Over the preparatory time 
period, cumulative case data was well fitted by an exponential model. 
We predicted that ICU bed occupancy would grow very quickly with 
London and the Midlands predicted to be particularly hard-hit, moti-
vating an immediate effort to create as much capacity as possible.
Conclusion: Uncertainties in  modelling early epidemiological data 
notwithstanding, we accurately predicted that surge capacity would 
be required from the end of March. We were able to leverage software 
development techniques to deliver a working application on a time-
scale which was still actionable in the preparatory phase for COVID-19 
in England. Our approach demonstrates that data-driven approaches 
to emergency healthcare planning can be highly agile.
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Introduction: During the early post-operative period, children with 
congenital heart disease can suffer from inadequate cerebral perfu-
sion. Cerebral perfusion can be monitored non-invasively with the 
near-infrared spectroscopy (NIRS) cerebral oximeter, which measures 
local cerebral tissue oxygen saturation (SctO2) of the frontal lobe. In 
this study, we hypothesized that reduced SctO2 and increased dose 
of desaturation during the early post-operative period, may indepen-
dently increase the probability of reduced total IQ score 2-years after 
Pediatric Intensive Care Unit (PICU) admission.
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Methods: The study included 90 children (median age (IQR) 4 (1 to 
13) months) admitted to the PICU of the University Hospitals Leu-
ven (Belgium) and included in the PEPaNIC trial [1] and NIRS study 
[2], after cardiac surgery for congenital heart disease. Inadequate 
post-operative cerebral perfusion was characterized by computing 
themean SctO2 -and dose of desaturation (defined as SctO2 < 65%) 
from the first 12 hours of SctO2 monitoring after surgery. Trained psy-
chologists assessed the total IQ at 2-years follow-up with the Wechsler 
Intelligence Quotient (IQ) tests. The independent association between 
mean SctO2, dose of desaturation and total IQ at 2-years follow-up 
was evaluated with a Bayesian linear regression model adjusted for 
age, syndrome, nutrition strategy (early vs late parenteral nutrition), 
cyanotic cardiopathy and severity of illness with Pediatric Index of 
Mortality 3 score.
Results: The results of the Bayesian model, summarized in Table  1, 
showed that reduced mean SctO2 and increased dose of SctO2 desat-
uration below 65% during the first 12 hours of SctO-2 monitoring, 
independently increased the probability of a lower total IQ at 2-years 
follow-up. For example, a difference of 10% in the mean SctO2 during 
the first 12 hours of SctO2 monitoring would result in a loss of 0.3 to 
4 IQ points, with an 80% probability. Similarly, a dose of desaturation 
of 300 %·minutes (resulting, for instance, from a SctO2 of 60% for 1 
hour) would correspond to a loss of 0.3 to 4.8 IQ points with an 80% 
probability.
Table 1. The β estimates [80% credible interval] resulting from 
the Bayesian model are reported in the table together with the 
cumulative probability that the β estimate of the population are
strictly negative (-) or positive (+). The 80% credible interval 
indicates the range to which the β estimates of the population 
belong with 80% probability. Results were obtained by using a 
noninformative prior.
Conclusion: Reduced mean SctO2 and increased dose of SctO2 below 
65% during the first 12 hours of SctO2 monitoring, independently 
increase the probability of having a lower total IQ, 2 years after PICU 
admission. However, given the observational design of the study, no 
causal relations are proven. Whether intervention to improve SctO2 
would result in better outcomes is still unclear.
Reference(s) and grant ackowledgment(s)
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Introduction: Mechanical chest compressions (CC) are frequently 
used during prolonged cardiopulmonary resuscitation in out-of-hos-
pital cardiac arrest (OHCA), particularly in patients who do not have 
early return of spontaneous circulation (ROSC) on the scene. However, 
little is known about the characteristics of this population of OHCA 
patients, particularly after hospital admission.
Objectives: We hypothesized that the decision to initiate mechani-
cal CC could identify, by itself, a specific subgroup of cardiac arrest 
patients with more severe clinical features.
Methods: This is a post hoc analysis of a sub-group of patients in the 
TTH48 trial (NCT01689077) who received or did not received mechani-
cal CC during resuscitation manoeuvres. Baseline characteristics 
included age, sex, height, weight, neurological function before cardiac 
arrest and a prespecified set of comorbidities. Relevant data regard-
ing OHCA were recorded following Utstein templates. Resuscitation 
outcomes included survival at ICU discharge, survival at hospital dis-
charge, 6-months survival and 6-months survival with good neurologi-
cal outcome (CPC 1-2). Continuous variables are presented as median 
[IQR] and nominal variables as percentage. Mann-Whitney u-test and 
chi-square test were used for groups comparison, accordingly. A p < 
0.05 was considered as statistically significant.
Results: Out of 351 patients included in the analysis, 25.6% received 
mechanical CC. No major difference in baseline characteristics were 
observed between groups. Compared to patients that receive manual 
CC, mechanical CC patients showed significant prolonged time to 
ROSC (26 [20;38] vs 20 [15;25] min, p < 0.01). Accordingly, a greater 
percentage of patient received resuscitation drug (adrenaline: 80 vs 
57%, p < 0.01; amiodarone: 53 vs 37%, p < 0.01) and percutaneous 
coronary intervention (93 vs 79%, p < 0.01). After hospital admission, 
mechanical CC patients demonstrate worse hemodynamic and acid-
base status compared to patient who received manual CC; more spe-
cifically they showed lower systolic arterial pressure (104 [91;120] vs 
114 [97;132] mmHg, p < 0.01), higher blood lactate (5.8 [2.8;10] vs 3.2 
[1.8;5.1] mmol/l, p < 0.01) and lower base excess (-8.4 [-12.3;-4.0] vs 
-5.8 [-8.5;-3.5] mmol/l, p < 0.01). During hospital stay, mechanical CC 
patients develop adverse events more frequently, such as generalized 
seizure/myoclonus (27 vs 15%, p = 0.03), various grade of hypoten-
sion (p = 0.02) and arrhythmias (p < 0.01), greater incidence of acute 
renal failure needing continuous renal replacement therapy (17 vs 5%, 
p < 0.01). Finally, mechanical CC patients showed increased mortality 
(ICU: 22 vs 14%, p = 0.07; in-hospital: 34 vs 20%, p = 0.01; 6-months 
27 vs 15%, p < 0.01) and worse neurological outcome after 6 months 
(CPC 1-2 52 vs 71%, p < 0.01).
Conclusion: This descriptive analysis identified an association 
between patient receiving mechanical CC and worse clinical status 
after hospital admission. Moreover, mechanical CC patients dem-
onstrated poorer 6-months survival and neurological outcome. The 
longer duration of no-flow/low-flow time observed in the mechanical 
CC group could partially explain the increase severity in post-cardiac 
arrest syndrome observed in this subgroup of patients.
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Introduction: Families of critically ill persons face uncertainty and psy-
chological distress during and after their close other’s stay on an inten-
sive care unit (ICU). Poor communication, insufficient shared-decision 
making, and inadequate emotional support negatively affect their ICU 
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experience and mental health. To increase quality of care and reduce 
adverse outcomes, guidelines recommend proactive family engage-
ment and support. We thus implemented an advanced practice nurse-
led family support intervention in a 12-bed surgical-transplant ICU in 
Switzerland.
Objectives: To examine the impact of the intervention on family 
members’ satisfaction with ICU care, sense of well-being, and post-ICU 
psychological distress.
Methods: We used a mixed methods approach with a quasi-experi-
mental before and after design and an embedded qualitative study. 
Participants were family members of patients treated in ICU before 
and after introduction of the intervention, which consisted of rela-
tional family engagement, therapeutic family conversations, and facili-
tation of communication between the family and the ICU team. Data 
were collected post-ICU with the Family Satisfaction in ICU-24 Survey, 
Hospital Anxiety Depression Scale, Impact of Event Scale-Revised-6 
and semi-structured interviews. Outcomevariables of the matched 
groups were analysed with linear mixed-effects models, and qualita-
tive data using inductive content analysis.
Results: 139 family members in the control and 75 in the interven-
tion group (51% response rate) returned a questionnaire, and 19 par-
ticipated in an interview. Families in the intervention group showed 
a trend for increased overall satisfaction (difference of 5.544, 95% CI: 
− 0.11 to 11.20), a statistically significant increase in satisfaction with 
decision-making (7.258, 95% CI: 0.89 to 13.63), and a non-significant 
increase in satisfaction with care (4.178, 95% CI: − 1.53 to 9.89). Psy-
chological distress was higher in the intervention group, with was 
more pronounced for depression (difference of 1.706, 95% CI: 0.16 
to 3.25), which may be explained by considerably longer ICU stays 
and higher proportion of deaths in the intervention group. Qualita-
tive findings indicated that the intervention was beneficial for family 
well-being, as families reported to feel acknowledged, cared for, well 
informed, and supported as an individual and a family living though 
critical illness. Families experienced the intervention as essential to 
ICU care. They appreciated to have a person to turn to who was easily 
accessible, knowledgeable, and part of the ICU team.
Conclusion: Our study suggests that family members appreciate a 
specific family nursing role that offers supportive interventions and 
facilitates interaction and communication with the ICU team, and 
experience it as beneficial for their well-being. It increased their sat-
isfaction with ICU care, but was unable to demonstrate a beneficial 
impact on psychological distress.
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Introduction: Early alterations of microvascular blood flow after myo-
cardial infarction (MI) may participate in the development of multiple 
organ failure.
Objectives: The aim of this study was to assess the contribution 
of photoacoustic imaging, a hybrid technology based on laser and 
ultrasound energy coupling, to detect early oxygen saturation (sO2) 
impairment in peripheral organs (kidney, liver) after MI in mice.
Methods: An experimental preclinical study was carried out on two 
groups of six week BALB/c mice: Sham (n = 22) versus MI (n = 40). MI 
was obtained by permanent ligation of the left anterior descending 
artery within 7 days of follow-up. High resolution ultrasound was used 
to assess left ventricular (LV) function (ejection fraction (EF), Cardiac 
Output (CO) and longitudinal strain). Photoacoustic imaging  (VevoL-
AZR, ViualSonics®) was used to measure kinetics of the heart, kidney 
and liversO2after MI. Plasma biomarkers (ASAT, ALAT, creatinine, lac-
tate) were assessed.
Results: LV function was altered 4 h post-MI (LVEF: Sham 61.7% n = 
16, MI 25.7% n = 32, p < 0.0001; longitudinal strain: Sham -19.6% n = 
13, MI -7.1% n = 31, p < 0.0001; CO: Sham 11.6 mL/min n = 13, MI 7.4 
mL/min n = 24, p = 0.003). These alterations persisted after 7 days. A 
strong correlation was observed at 4h and on day 1 between LV sO2 
and longitudinal anterior myocardial strain  (r = -0.46, p < 0.0001, n 
= 81). Photoacoustic mapping showed a significant early decrease in 
sO2 level in both renal and hepatic tissues at 4h and 1 day post-MI but 
this was normalized after 7 days (Figure 1).
The kinetics of the biomarkers ASAT, ALAT and creatinine were cor-
related to a tissue alteration of sO2 at 4h. There was no correlation 
between alteration of sO2 and lactate (Figure 2).
Conclusion: Post-MI heart failure generates moderate hypoxia of the 
peripheral organs in mice. Photoacoustic imaging enables early detec-
tion of sO2 multi-organ desaturation. The mapping of sO2 organs in 
real time seems to be an accurate marker to identify microcircula-
tion alteration. This emerging imaging technology could be used to 
improve and evaluate early microvascular therapeutics.
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Introduction: The incidence of AKI in surgical patients varies accord-
ing to the type and severity of surgery, with reported rates of 19% 
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after cardiac surgery and approximately 12-13% after general and tho-
racic surgery. In a large epidemiological study of patients undergoing 
major noncardiac surgery in intensive care units (ICUs) in Brazil, 30% 
of patients had postoperative complications, and AKI was the postop-
erative complication with the second-highest occurrence rate. Post-
operative complications are common in high-risk patients after major 
surgery.
Therefore, our hypothesis is that perioperative AKI is common and is 
associated with a worse prognosis. Thus, evaluating the incidence and 
characteristics of patients with previously normal kidney function who 
underwent major noncardiac surgery and developed postoperative 
AKI, in addition to determining whether perioperative volemic adjust-
ments correlate with AKI, is relevant for adequately improving the 
therapeutic management of these patients.
Objectives: The main objective of this study was to evaluate the inci-
dence, impact on outcomes and main risk factors for developing AKI 
in patients with previously normal kidney function who underwent 
noncardiac surgery and developed AKI after admission to the ICU. 
Because of the importance of fluid balance in surgical patients, we also 
evaluated the association between this variable and the development 
of AKI.
Methods: A multicenter, prospective cohort study with patients 
admitted to intensive care units (ICUs) after noncardiac surgery was 
conducted to assess whether they developed AKI. A total of 29 ICUs 
participated and provided data on 25,500 surgeries, of which 904 
involved high-risk surgical patients who were included in the study. 
On the 28th day after surgery, the number of survivors and length of 
stay in the ICU and hospital were analyzed.
Results: The occurrence of AKI in the postoperative period was 15.8%, 
and the mortality rate of postoperative AKI patients at 28days was 
27.6%, which represented 5.2% of the overall mortality of the study 
population. AKI was strongly associated with 28-day mortality (OR = 
2.91; 95% CI 1.51-5.62; P = 0.001), and the assessment of ICU, hospi-
tal and 28-day postoperative survival identified significant differences 
between patients with and without postoperative AKI (log-rank test, P 
< 0.0001). Independent factors for the risk of developing AKI were pre-
operative anemia (OR = 7.01; 95% CI 1.69- 29.07), elective surgery (OR 
= 0.45; 95% CI 0.21 - 0.97), SAPS 3 (OR = 1.04; 95% CI 1.02-1.06), post-
operative vasopressor use (OR = 2.47; 95% CI 1.34-4.55), postoperative 
infection (OR = 8.82; 95% CI 2.43-32.05) and need for reoperation (OR 
= 7.15; 95% CI 2.58-19.79). Additionally, regarding fluid adjustment 
during the perioperative period, patients with higher fluid balance val-
ues presented an increased risk of developing AKI (OR = 1.001; 95% 
CI, 1.000-1.002). It was noted that starting on the second day after sur-
gery, the higher the fluid balance is, the more likely AKI is to develop.
Conclusion: AKI is a major complication in high-risk surgical patients 
and is associated with risk of death. Patients with anemia prior to sur-
gery who underwent elective surgery, had a higher SAPS 3, needed 
a vasopressor during the postoperative period or had postoperative 
infection or needed reoperation were more likely to develop AKI, as 
were those with an elevated perioperative fluid balance.
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Introduction: Overproduction of nitric oxide (NO) plays an impor-
tant role in sepsis-induced hypotension (1). However, a phase III 
study of L-NMMA, a non-selective NO synthase (NOS) inhibitor, was 
terminated early due to increased mortality (2). A new class of NOS 
inhibitor acts via inhibition of dimethylarginine dimethylaminohydro-
lase-1 (DDAH1). This increases levels of asymmetric dimethylarginine 
(ADMA), an endogenous methyl-arginine, which blocks NOS activity 
(3). Using a septic, hypotensive rat model, we hypothesized that indi-
rect NOS inhibition would improve haemodynamics without detri-
mental effects on cardiac output that is associated with non-selective 
NOS inhibition.
Methods: Anaesthetized male Wistar rats underwent right jugular 
venous cannulation for fluid/drug administration. Sepsis was induced 
by intraperitoneal faecal slurry (T = 0 h). Animals were recovered and 
fluid (1:1 mix of 5% glucose and Ringer’s lactate [RL]) was infused at 
10 ml/kg/h from 2 h. At 6 h, animals were re-anaesthetized with can-
nulation of the carotid artery for BP monitoring and a tracheostomy 
to secure the airway. A further bolus of RL bolus (20 ml/kg) was given. 
At 8  h, baseline measurements of BP, cardiac output (by echocardi-
ography) and blood gas analysis were taken. Animals were then ran-
domized to receive either direct (L-NMMA) or indirect (L-257) NOS 
inhibition, or to act as controls (equivalent volumes of RL). Treated 
animals received a bolus over 5 mins followed by infusion over 2 hours 
(to T = 10 h). Blood pressure was measured before and after the bolus. 
All other variables were measured hourly.
Results: Data shown as mean (± SE). B = bolus over 5 minutes. Inf 
= infusion. Index of systemic vascular resistance (SVR) calculated as 
Blood pressure (BP)/Cardiac output (CO). Statistics: 2-way RM-ANOVA 
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and post-hoc Tukey’s test. *p < 0.05 or **p < 0.01 between controls 
and drug-treated animals (n = 6/group). L-257 bolus = 30 mg/kg, inf 
= 3.75 mg/kg/h. L-NMMA bolus = 3 mg/kg, inf = 2.5 mg/kg/h.
Conclusion: In hypotensive, septic rats, both direct and indirect NOS 
inhibition significantly increased blood pressure. While we did not use 
doses of either drug that significantly impacted on cardiac output, 
indirect NOS inhibition showed a lesser increase in SVR, in keeping 
with a more desirable safety profile.
Funding: Critical Pressure Ltd.
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Introduction: Aneurysmatic subarachnoid hemorrhage (aSAH) is 
responsible for severe disabilities and death (1). Tissue hypoxia can 
occur after SAH, even with normal levels of intracranial pressure (ICP)
(2). As such, brain tissue oxygen (PbtO2) monitoring has become 
widely used. Low PbtO2  has been associated with delayed cerebral 
ischemia and worse neurologic outcome(3-4).
Objectives: The aim of this study was to assess the impact of PbtO2-
guided therapy on patients’ outcome.
Methods: Single center retrospective cohort study from January 2014 
until March 2019 including adult patient admitted to the ICU with 
poor grade aSAH, that required invasive neurologic monitoring (ICP 
+ /− PbtO2 catheter) within the first 48 hours of admission. Patients 
monitored with combined PbtO2 + ICP monitoring were compared 
with patients monitored with ICP alone. We considered as “PbtO2-
guided therapy”, a bundle of interventions aiming to increase PbtO2 
> 20 mmHg. Primary outcome was the presence of PbtO2 < 20mmHg 
and burden of tissue hypoxia.
Results: Of a total of 259 patients admitted to the ICU due to aSAH 
during the study period, 152 patients were included in the study: 96 
were monitored with ICP alone and 56 with PbtO2 + ICP; of those 
47(83.9) had at least one episode of PbtO2 < 20 mmHg and 22 (39.3%) 
received a PbtO2-guided therapy. PbtO2-guided therapy was associ-
ated with a reduction of the risk of unfavorable outcome (OR 0.03 
CI 95% 0.002-0.46, p = 0.01) and mortality (OR 0.01 CI 95% 0.16, p = 
0.002). PbtO2 < 20 mmHg was an independent predictor of poor neu-
rological outcome(OR 24.48 CI 95% 1.49-470.77).
Conclusion: In this cohort of poor grade SAH, PbtO2-guided therapy 
was an independent predictor of neurological recovery.
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Introduction: Acute respiratory distress syndrome (ARDS) is a life 
threatening complication of various illnesses such as sepsis, pneumo-
nia or cardiogenic shock. As there is no causal therapy available which 
is why the mortality of > 40% could not be significantly reduced within 
the last decades.
Activated polymorphonuclear (PMN) cells with systemic uncontrolled 
inflammatory responses and consecutive respiratory failure play a cen-
tral role in the pathogenesis of acute respiratory distress syndrome. 
The leukocyte integrin αMβ2, which can be blocked activation specific 
by novel binding protein (Designed Ankyrin Repeat protein, DARPin) 
is a promising novel therapeutic target for acute respiratory distress 
syndrome as it has recently been shown to inhibit leukocyte transmi-
gration and systemic inflammation.
Methods: ARDS was induced by intratracheal LPS instillation (5 µg/g). 
Recombinant anti-αMβ2 DARPins were produced in E.  coli. Purity of 
DARPins was assessed by SDS-Page electrophoresis. Activation spe-
cific binding of DARPins to activated mouse PMN cells was measured 
ex vivo using standard flow cytometry protocols. Disease severity 
was quantified through protein concentration and FACS analysis of 
bronchial lavage fluid. Animals were analysed on day 4 (acute phase) 
and on day 10 (chronic phase). Mice were weighed every day and 
eliminated if the weight loss was 20 % over baseline. Animals were 
treated daily i.p. with anti-αMβ2 DARPin (n = 11), PBS (n = 16) or con-
trol DARPin (n = 18). Statistical analysis was performed with one-way 
ANOVA and post hoc analysis, the survival curves were compared with 
Mantel-Cox test.
Results: 4 day survival was 100% (healthy controls) vs. 90% (anti-αMβ2 
DARPin) vs. 38% (control DARPin) vs. 56% (PBS) (p = 0.0035). Absolute 
neutrophil number per ml BAL fluid was 10 ±  4.8 (healthy controls) 
vs. 6,026  ±  4,103 (anti-αMβ2 DARPin) vs. 19,582  ±  19,132 (control 
DARPin) vs. 38,621 ± 37,791 (PBS) (p = 0.0031). The protein concentra-
tion in the BAL fluid was lower in the anti-αMβ2 DARPin group indicat-
ing a strong therapeutic effect in mice with acute respiratory distress 
syndrome (healthy controls vs. anti-αMβ2 DARPin vs. control DARPin 
vs. PBS: 0.16 ± 0.08 mg/ml vs. 0.3 ± 0.12 mg/ml vs. 0.62 ± 0.38 mg/ml 
vs. 0.77 ± 0.34 mg/dl, p = 0.0002).
Conclusion: Treating murine acute respiratory distress syndrome with 
the novel activation specific anti-αMβ2 DARPin significantly reduces 
disease severity and improves survival.
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Introduction: Sepsis induces changes in cellular metabolic, immune 
and mitochondrial function [1]. The effect of nutrition on these 
changes is mostly overlooked. In addition to a caloric source, short-
chain fatty acid butyrate may affect metabolism, immune and mito-
chondrial function.
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Objectives: To examine the therapeutic effect of butyrate in in vitro 
and in vivo models of sepsis.
Methods: Human peripheral blood mononuclear cells (PBMCs) 
from six healthy donors were incubated overnight with LPS (100 
ng/ml), heat-killed Staphylococcus aureus or Escherichia coli O18 
(PBMC:bacterium ratio 5:1) in the presence or absence of butyrate (1.8 
mM). Supernatants were collected and IL-6, IL-10 and TNF concen-
trations quantified by ELISA. Mitochondrial respiration was assessed 
using high-resolution respirometry.
A rat model of faecal peritonitis was developed to study the impact 
of butyrate in vivo. Rats were cannulated and received intraperitoneal 
injection of faecal slurry. Rats were housed in metabolic cages and, 
alongside fluid resuscitation, received intravenous butyrate infusion 
(0.6 g/kg/h) commencing 6 hours following sepsis induction. 24 hours 
following sepsis induction, splenocytes were isolated and oxygen 
consumption measured. Splenocyte membrane potential, reactive 
oxygen species (ROS), and intracellular cytokines (IL-10 and TNF) were 
assessed using flow cytometry. Non-parametric one-way ANOVA tests 
with Dunn’s correction were used for statistical analyses.
Results: Butyrate significantly reduced IL-6, IL-10 and TNF secretion 
by PBMCs. Maximal respiration and spare-respiratory capacity were 
non-significantly increased. In vivo butyrate infusion stimulated fatty 
acid metabolism as shown by a fall in the respiratory exchange ratio. 
Ex vivo splenocytes from septic rats showed significantly increased 
TNF production, which was not affected by butyrate infusion. Butyrate 
infusion decreased mitochondrial respiration, increased mitochondrial 
ROS production and membrane potential.
Conclusion: Butyrate had anti-inflammatory and mitochondrial res-
piration stimulating effects in vitro. However, in vivo butyrate infu-
sion caused mitochondrial stress in immune cells and did not impact 
immune function. Hence, beneficial effects of butyrate on immune 
cells in vitro could not be reproduced in vivo.
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Introduction: Acute respiratory distress syndrome (ARDS) is a het-
erogeneous syndrome with high mortalty. Personalized medicine 
approaches targeting patients based on their molecular phenotypes 
of ARDS might help to identify effective pharmacotherapies. The 
inflammasome-caspase-1 pathway contributes to the development of 
ARDS via IL-1β and IL-18 production. Recent studies indicate that tet-
racycline (TET) can be used to treat inflammatory diseases mediated 
by IL-1β and IL-18 while the molecular mechanism by which TET inhib-
its inflammasome-caspase-1 signaling remains unknown.
Objectives: To identify patients with ARDS characterized by IL-1β and 
IL-18 production and investigate the ability of TET to inhibit inflamma-
some-caspase-1 signaling.
Methods: IL-1β and IL-18 levels were quantified in bronchoalveo-
lar lavage fluid (BALF) from 62 patients from two ARDS referral cent-
ers with direct (viral, COVID-19 and bacterial pneumonia) or indirect 
(non-pulmonal) ARDS via multiplex assay. TET’s effect on lung injury 
and inflammation were assessed in a LPS-induced mouse model of 
direct ARDS. Murine lung injury was determined by measurement of 
i) albumin concentration by ELISA, ii) neutrophil population by FACS 
(both in BALF) and iii) histopathology. Concentration of IL-1β, IL-6, 
IL-18 and TNFα was measured by multiplex assay in BALF. The effect of 
TET on caspase-1 was tested in BMDMs after stimulation with LPS plus 
nigericin. Concentration of IL-1β and TNFα was determined by ELISA 
and cleavage of caspase-1 via western blot. Alveolar leucocytes were 
obtained from BALF of patients with direct ARDS and the effect of TET 
on IL-1β and IL-18 production was measured ex vivo.
Results: BALF levels of IL-1β and IL-18 are significantly higher in 
patients with direct than those with indirect ARDS (p < 0.05). In experi-
mental direct ARDS, TET treated mice showed significantly reduced 
weight loss and mortality (43% vs. 7%: p < 0.001) compared to PBS 
treated animals. TET treatment diminished lung injury in terms of 
lower albumin (325 ±  35 vs 144 ±  16µg/ml; p < 0.01) concentration 
and number of neutrophils. Histopathology showed reduced lung 
injury in TET-treated animals. TET decreased exclusively the concentra-
tion of IL-1β (152 ± 16 vs 86 ± 8 pg/ml; p < 0.01) and IL-18 (92 ± 7 
vs 31  ±  2 pg/ml; p < 0.05) in BALF. Immunoblot showed that TET 
reduced cleavage of the p45 caspase-1 precursor into its p20 subunit. 
TET inhibited in a dose-dependent manner production of both IL-1ß 
and IL-18 from alveolar leucocytes obtained from patients with direct 
ARDS including COVID-19 by up to 85% (p < 0.01).
Conclusion: This work demonstrates that i) patients with direct ARDS 
have significantly higher IL-1ß and IL-18 levels in their lungs than indi-
viduals with indirect ARDS, ii) TET may be effective in the treatment of 
direct ARDS including COVID-19 and iii) TET blocks the inflammasome-
caspase-1 pathway by selective inhibition of caspase-1.
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Introduction: Traumatic brain injury (TBI) has been increasing with 
greater incidence. It remains a leading cause of death (1). Cerebral 
pressure autoregulation impairment is a well-known pathology after 
TBI that worsens the prognosis and outcome (2). Transcranial Dop-
pler (TCD) can be used to assess Transient Hyperaemic response ratio 
(THRR) after carotid compression which is a well demonstrated valid 
index for cerebral autoregulation (3,4). A relative increase in mean 
flow velocity (MFV) of middle cerebral artery (MCA) above the base-
line following the release of carotid compression denotes preserved 
autoregulation and sequentially predicts good outcome, whereas 
absence of such response indicates altered autoregulation with poor 
outcome (5).
Objectives: The aim of the work was to assess cerebral autoregulation 
and its relation to outcome in patients with moderate and severe TBI 
using TCD. The primary end point is the Glasgow outcome score (GOS) 
(6) as a measure of outcome to assess THRR after carotid compression 
as an indicator of cerebral pressure autoregulation and as a predictor 
of GOS as well as a being prognostic tool. Other measures of TCD as 
MFV of MCA and Pulsatility Index (PI) were also used as predictors of 
GOS and correlated with THRR. The length of stay as well as mortality 
were recorded and correlated to THRR.
Methods: 120 patients with moderate or severe TBI according to Glas-
gow Coma Score (GCS) (7) underwent daily TCD, after intial hemody-
namic and respiratory stabilization, for 5 days post trauma. All patients 
were managed according to guidelines for the management of head 
injury of the American Association of Neurologic Surgeons (8). A com-
pression time of 10 seconds and a compression ratio of 40% or more, 
allow maximum expression of the hyperaemic response. Also carotid 
compression is accepted only when flow velocity is stable with no fur-
ther decrease during the whole period of compression otherwise the 
compression will be terminated and repeated 60 seconds later (3).
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The Patients were divided into those with normal TCD measure-
ments and those with poor cerebral circulation (MFV < 40, PI > 1.2). 
GOS scores are dichotomized into favorable or unfavorable outcomes. 
Patients in the upper two GOS outcomes groups (good recovery or 
moderate disability) are considered favorable outcome, and patients 
in other groups (severe disability, vegetative state or death) are con-
sidered unfavorable outcomes.
Pearson’s correlation coefficiets were calculated to test the relation 
between TCD and other clinical variables. Discrimination of the logistic 
models was assessed by calculating the area under (ROC) curve (9). P 
value < 0.05 was considered significant.
Results: There was a significant correlation between THRR and GOS 
(patients with THRR ≥ 1 had favorable outcome). There was also signif-
icant correlation between THRR and mortality. Also significant correla-
tion between THRR and MFV as well as PI was found. THRR ≥ 1 showed 
sensitivity of 83.3%, specificity of 72.9%, postive predictive value (PPV) 
of 82.2% and negative predictive value (NPV) of 74.5% in predicting 
patients with favorable outcome.
Conclusion: THRR provides a clinically useful index of cerebral 
autoregulation. THRR after carotid compression is a good predictor of 
GOS as well as being a prognostic tool in patients with moderate and 
severe TBI.
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Introduction: The widespread use of antibiotics poses a significant 
threat to human health because of the risk of antimicrobial resist-
ance. While piperacillin/tazobactam (TZP) is commonly used in the 
empirical treatment of severe infections in the ICU, and the drug can 
be detected in plasma up to several days after discontinuation, it is 
unclear how long piperacillin is detectable in the feces of patients. 
Given the potential impact of antibiotics on the microbiome, we 
sought to investigate fecal concentrations of piperacillin in critically ill 
patients using a newly developed sensitive method.
Objectives: The objective of this study was to describe concentrations 
of TZP in the feces of critically ill patients during intravenous therapy 
and after treatment discontinuation.
Methods: Critical ill patients without chronic or acute abdominal 
disease and receiving intravenous piperacillin/tazobactam were 
included. The regimen  consisted of a loading dose of 4,5 g of TZP 
injected over 30 minutes, followed by continuous infusion according 
to kidney function (standard therapy 16  g/24  h). Fresh stool speci-
mens were collected after a minimum of 24 hours of antibiotic treat-
ment, with up to ten samples per patient during therapy. Within ten 
minutes after collecting a stool sample, a serum sample was obtained 
for drug concentration analysis. Stool specimens collected up to one 
week after treatment discontinuation were analyzed, with a maxi-
mum of five samples.  Concentrations of piperacillin and tazobactam 
were measured by a validated and sensitive ultra-high-performance 
liquid chromatography - high resolution mass spectrometric (UHPLC-
HRMS) method, with a lower limit of quantitation (LLOQ) of 1 μg/g and 
0,5 μg/g lyophilized (lyo) feces and 1,5 mg/L and 0,5 mg/L plasma for 
piperacillin and tazobactam, respectively.
Results: Ten critically ill patients with a median age of 70,5 years 
(interquartile range (IQR) 50-74) were included. The specimens of 
one patient were excluded in further analyses due to pre-analytic 
errors. During therapy, piperacillin concentrations ranged from 18,65 
to 289,18 mg/L in plasma and 1,63 – 23000,70 μg/g in lyo feces. Tazo-
bactam concentrations ranged from 2,57 - 38,17 mg/L in plasma and 
could be detected and quantified in stool specimens of six patients 
(67%) during therapy (range 0,08-576,18  μg/g). After discontinua-
tion of therapy respectively 5 (56%) and 3 (33%) patients were found 
to have measurable fecal concentrations of piperacillin (range 5,48 - 
3477,27  μg/g) and tazobactam (range 2,27 – 531,44  μg/g) for 1 to 2 
days. In 2 patients, piperacillin and tazobactam were detectable in 
stool specimens for at least 4 to 6 days after discontinuation. Both of 
them suffered from acute kidney injury (AKI stage I and II).
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Conclusion: Both piperacillin and tazobactam are measurable in stool 
during therapy; after discontinuation of therapy, piperacillin can be 
detected in feces for up to 6 days. This may have important conse-
quences for disturbances of the microbiome and the impact of anti-
biotic therapy.
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Introduction: Septic shock is one of the deadliest diseases worldwide, 
with a mortality rate of 30-50%. Antibiotic delay and higher microbial 
loads are known to increase morbi-mortality in sepsis.
Loading doses achieve faster appropriate concentrations in plasma, 
allowing for a better bacterial kill. Bacterial kill and patient outcomes 
may be further improved by synergistic combination therapy, which 
is best established for betalactams and aminoglycosides. However, 
how the sequence of antibiotic administration impacts this synergy is 
unknown. While in vitro work suggests that giving the betalactam first 
improves bacterial clearance, the effect of antibiotic sequence has not 
been studied in vivo.
Objectives: Determine whether the sequence of antibiotic adminis-
tration impacts bacterial kill and cytokine production in a monomicro-
bial rat model of septic shock.
Methods: Our monomicrobial peritonitis rat model of septic shock 
requires the surgical implant of a gelatin capsule with a fibrinogen 
clot, alpha cellulose and a known bacterial inoculum (2*10^6 cfu 
E. coli Bort) in the peritoneum of the rat. This capsule slowly dissolves 
and generates a progresive peritoneal infection that evolves into sep-
tic shock in 12 hours.
After septic shock is stablished, we fluid resuscitate the rats, connect 
them to mechanical ventilation, and start vasopressors if needed to 
achieve a MAP goal of 70 mmHg. We experiment with the order of 
antibiotics (cefotaxime [cef ] and gentamicin [gent]) and compare 
them to monotherapy, untreated controls and sham controls, for a 
total of 7 treatment arms and 6 rats per arm. We used two doses of 
antibiotics: normal (cef 60  mg/kg, gent 10  mg/kg) and high (cef 
120 mg/kg, gent 20 mg/kg).
We measure bacterial blood counts, cytokine profile, lactate and renal 
function at different time points. Following the ethics guidelines of 
University of Manitoba, we euthanize the rat and measure organ bac-
terial counts after homogenization.
Results: Rats treated with cefotaxime monotherapy had slow initial 
bacterial clearance compared to those treated with gentamicin alone. 
This improved with the higher dose of cefotaxime. Over time the rats 
treated with gentamicin showed bacterial regrowth (postantibiotic 
effect); this was delayed in the group treated with a higher gentamicin 
dose. All combination arms showed a rapid initial bacterial kill and 
maintained bacterial clearance over time, exhibiting the strengths of 
gentamicin and cefotaxime, respectively. No significant differences 
were observed between combination arms.
All treatment arms showed similar bacterial clearance from peritoneal 
fluid and organs.
Conclusion: Combination therapy showed synergistic effects with a 
rapid and maintained bacterial clearance from the blood. Altering the 
antimicrobial sequence had nosignificant impact in our in vivo model 
of septic shock. Higher doses of antibiotics showed faster initial bacte-
rial kill with cefotaxime monotherapy, and delayed the postantibiotic 
effect of gentamicin monotherapy.
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Introduction: In the recent years a rapid increase in the age of 
patients admitted to the Intensive Care Units (ICU) was noted. Fewer 
limitations are now imposed on performing invasive treatments or 
surgery in old or even frail patients, especially when complemented 
by optimal supportive intensive care. However, little is known about 
the long term follow up of these patients.
Objectives: To evaluate the age stratified long-term all-cause mortal-
ity, after admission to the ICU. Secondly, to compare a one-year mor-
tality rate of this cohort of critically ill patients after hospital discharge, 
with that of a standard population with the same age distribution.
Methods: Retrospective cohort study of all patients admitted to a 
multipurpose ICU between 2015-2019. Patients < 18 years or admit-
ted for < 24  h were excluded. Only the first ICU admission was con-
sidered. Patients were followed until hospital discharge or death, 
whatever occurred first. One-year all-cause mortality was assessed for 
all patients. Standard Mortality Ratio (SMR) were determined at hospi-
tal discharge and at a 1-year follow-up.
We split the sample in 4 groups according to patients age at admis-
sion to the ICU: 18-50 (Adult); 51-65 (Senior); 66-80 (Old); > 80 (Very-
old). Survival curves were plotted for all 4 groups according to the 
time of ICU admission. The ratio between observed and expected 
mortality was calculated, for patients discharged alive from the hos-
pital and according to age-adjusted tables for the general Portuguese 
population.
Results: A total of 2184 patients were included. Male gender was 
predominant (57%); mean age and SAPS II Score were 66 ± 15.8 and 
40 ± 18.9. Mean ICU length of stay was 4.23 ± 4.2 days. ICU and Hos-
pital mortality were 12.1% and 19.8% (SMR 0.63). SAPSII performance 
was accurate to predict one-year mortality, rather than in-hospital 
mortality, for all age groups (Table 1).
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A Kaplan-Meyer survival curve (KM) was computed to assess the dif-
ferences between long term prognosis for the different age groups 
(Fig 1) and unveiled a statistically significant difference in the survival 
probability (log rank test, p < 0.01). A sharp drop in survival in the first 
days was noted, corresponding to the in-hospital mortality. A continu-
ous decay in survival was observed in the Old and Very-old groups 
that was less evident in the younger population.
One-year mortality rate after hospital discharge was higher in the 
older patients. The ratio between the observed and expected mortal-
ity (for an age adjusted control population) was significantly high for 
all age groups (Table 2).
Conclusion: The one-year mortality risk of critically ill patients of all 
age groups is very high, even after hospital discharge, largely above of 
the general population. SAPSII showed good accuracy to predict one-
year mortality in this cohort. Although a continuous decline in survival 
is noted in the older patients, more than 50% of the Very-old patients 
are alive 1 year after ICU admission.
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Introduction: Hypotension is known to be the most consistent mani-
festation of decompensated shock leading to major organ failure, 
and even brief hypotension is associated with increased morbidity and 
mortality. Several early warning scores have been introduced to iden-
tify patients at risk for decompensation and trigger escalation of care, 
but most of current scoring systems are unable to provide reliable, 
continuous feedback to clinicians who need to make time-sensitive 
decisions for rapidly fluctuating conditions in critically-ill patients.
Objectives: Using common vital sign data, we aim to develop a 
machine learning model to predict the initial hypotension event 
among intensive care unit (ICU) patients, and design an alert system 
for bedside implementation.
Methods: From the Medical Information Mart for Intensive Care 
III  (MIMIC-3) dataset, minute-by-minute vital signs were extracted. 
An initial hypotension event was defined as at least 5 measurements 
within a 10-minute period of systolic blood pressure ≤ 90 mmHg 
and mean arterial pressure ≤ 60 mmHg. The performance of various 
supervised machine learning models  was  measured with area under 
the receiver operating characteristic curve (AUROC) and area under 
the precision recall curve (AUPRC). A random forest (RF) classifier was 
selected, trained with 10-fold cross validation method, then applied to 
an a priori separated out-of-sample validation cohort. Risk score trajec-
tory was built from vital signs features on overlapping windows. For 
an alert system, hypotension alerts were generated using a two-step 
(stacked) approach. First, positive alerts were identified with risk score 
thresholds, then a second RF model was used to reduce false alerts, 
followed by imposing a lock-out time for alerts to decrease alarm 
fatigue.
Results: We identified 1532 subjects (1946 ICU stays) as the case 
group (experienced a hypotension event), and 1707 subjects (2585 
ICU stays) as the control group. The RF model showed AUROC of 0.93, 
0.91, and 0.88 at 15, 30, and 60 minutes before hypotension, AUPRC of 
0.77, and a low calibration score (Brier score 0.09). Mean risk score tra-
jectories revealed a clear separation with 80% of cases predicted at 15 
minutes before hypotension, and more than 60% at one hour before 
the hypotension. For the alert system, the stacked machine learning 
model with lock-out of 15 minutes produced on average 0.79 alerts/
subject/hour for future hypotension, with a positive predictive value 
(probability of developing hypotension) of 65% and sensitivity of 
92.4%.
Conclusion: Most clinically significant hypotension events in the ICU 
can be predicted from bedside physiologic monitoring at least 1 hour 
before the initial hypotension episode. Designing a practical alert sys-
tem with high sensitivity and acceptable positive predictive value for 
hypotension prediction is feasible, with low rate of alerts.
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Introduction: In mechanically ventilated patients, positive end-expir-
atory pressure (PEEP) is used to improve gas exchange and respira-
tory mechanics by preventing alveolar collapse. Recently, it has been 
demonstrated in rats, that PEEP induces diaphragm remodelling by 
altering the position and length of the muscle, causing longitudinal 
atrophy [1]. The effects of PEEP on the human diaphragm during tidal 
breathing are currently unknown.
Objectives: To study the effects of PEEP on diaphragm movement 
and configuration during tidal breathing, including velocity of muscle 
contraction.
Methods: Healthy subjects (n = 17) underwent dynamic magnetic 
resonance imaging (MRI) in five different planes during tidal breath-
ing under non-invasive ventilation with PEEP. After 30 sec, PEEP 
was abruptly increased from 2 (baseline) to 5, 10 or 15  cmH2O (ran-
domized) for 1 minute. The diaphragm dome and zone of apposition 
(ZOA) were tracked semi-automatically in every MRI frame using a 
software routine developed in Matlab (see Fig 1). Then, subjects were 
instrumented with nasogastric catheters to measure diaphragm neu-
romechanical efficiency (NME) during tidal breathing at different PEEP 
levels. Parameters were analysed using mixed models.
Results: Diaphragm tracking was successful (Fig  1). Increasing PEEP 
from 2 to 15  cmH2O resulted 1) in decreased end-expiratory total dia-
phragm length (390 (234 - 445) to 351 (295 - 408) mm respectively), 
mostly due to decreased ZOA length (178 (166 – 190) to 140 (124 - 
155) mm respectively), 2) flattening of the diaphragm with an increase 
of the radius of curvature (R in Fig 1) of 1.4 cm and 1.9 cm for the right 
and left hemidiaphragm respectively and 3) increased peak contrac-
tion velocity (14.2 (13.3 – 15.1) to 15.4 (14.0 – 16.7) mm/s respectively) 
but unchanged peak relaxation velocity and 4) decreased NME of 48% 
(37.5 - 56.6%). All mentioned effects were significant (p < 0.03) and 
reported as estimated mean (95% confidence interval).
Conclusion: PEEP affects diaphragm geometry and function during 
tidal breathing. These findings suggest that conditions to develop lon-
gitudinal atrophy in the human diaphragm are present with the appli-
cation of PEEP.
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Introduction: Ventilator associated pneumonia is still a problem in 
the intensive care unit (ICU). Noble metal coating of endotracheal 
tubes reduces the adhesion of bacteria and could reduce the inci-
dence of VAP.
Methods: A controlled prospective randomized, double blind, multi-
center study was launched in November 2018 in Liège, Belgium enroll-
ing 324 patients from 8 ICUs from 4 sites of two hospital institutions 
using endotracheal tubes for ventilated patients from Bactiguard. 
These tubes with subglottic suctioning had, for half of them, a thin 
coating of noble metals (gold, silver and palladium) firmly attached to 
their surfaces, preventing bacteria from adhering and forming biofilm. 
Coated tubes were indistinguishable from control tubes. Coated and 
control tubes were coded and remained blinded for all the partici-
pants. Patients were followed during ventilation and ICU stay up to 28 
days. Tracheal colonization, incidence of VAP, and antibiotic consump-
tion were recorded.
Results: The study ended on 5 March 2020 before the Covid-19 pan-
demic occurrence in Liège. Data are given as a whole because the 
code is not yet broken. This will be done before the European con-
vention. Among the 324 patients with a median age of 67.5 (IQR 56,5-
74,6), there were 179 men (55.4%). Their mean Charlson score was 
2 (IQR 1-4) and the mean saps II score, calculated the day of intuba-
tion, was 50.5 ± 17.5. The median length of ventilation through both 
uncoated and coatedtubes was 5 days (IQR 3-9) totaling 2202 ven-
tilatory days. No bacteria were found in tracheal sputum from 122 
patients during ventilation. Persistence of bacteria already present in 
tracheal sputum the day of intubation was documented in 38 patients 
and new bacteria were found in 76 patients. No sampling was done in 
88 patients, partially because of too short ventilation (n = 26). During 
ventilation and 2 days after extubation, there were 55 suspected epi-
sodes of VAP. The analysis of these episodes based on the presence of 
new infiltrate on X-ray exam, fever, leucocytosis, increase of the  FiO2 or 
Peep level, quantitative bacteriological result and CRP change, leads 
to reject 25 suspicions and classifies the 30 other as confirmed (n = 
2), probable (n = 12) or possible (n = 16). The overall incidence of VAP 
was 13.7/1000 ventilatory days or 9.3/100 patients. Antibiotic from any 
kind was used during 68.7 % of ventilatory days and 61.7% of ICU days. 
ICU mortality was 41.9 % and hospital mortality was 50.8%.
Conclusion: This is the first report of a randomized double blind 
study with Bactiguard tubes which will allow to define the number of 
patients for a confirmatory larger study.
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Introduction: Large numbers of observational studies have investi-
gated the association of pre-specified laboratory tests within subgroups 
of critically ill patients. This systematic review aimed to determine evi-
dence from pre-existing literature of associations between routine 
blood results and outcomes of patients admitted to critical care.
Methods: The study protocol was registered with the Interna-
tional Prospective Register of Systematic Reviews (PROSPERO; ID 
CRD42019122058). We followed the Preferred Reporting Items for Sys-
tematic Reviews and Meta-analyses (PRISMA) guidelines. [1] Searches 
were carried out using MEDLINE (PubMed) and Excerpta Medica data-
BASE from inception through 29th January 2019. Outcome measures 
were 1) critical care or hospital length of stay, 2) mortality during 
critical care or in hospital or within 90 days of critical care admission. 
Identified studies were insufficiently homogenous to calculate pooled 
effect measures and qualitative summary assessments were under-
taken.  For biomarkers showing consistent effects, we reviewed pro-
posed mechanisms and underlying hypotheses. Quality of evidence 
and risk of bias was assessed using the Newcastle-Ottawa Scale cri-
teria. [2] We evaluated study methodology including diagnostic test 
accuracy, statistical approach and covariate selection.
Results: Of 441 records identified in our search, 98 met inclusion eli-
gibility criteria. Studies analysed biomarkers individually or using a 
composite measure of two related biomarkers. The majority of studies 
were focused within mixed medical and surgical admissions (n = 62). 
All studies described retrospective data collection using cohort (n = 
84) and case-control (n = 14) designs. A total of 25 unique biomarkers 
were reported: 17 (one to four records), 5 (five to nine), and 3 (ten or 
more). RCDW was the biomarker most frequently assessed. Definitions 
varied in measurement of biomarkers and outcomes. 67.3% of studies 
measured admission values, 25.7% used repeated measures through-
out the admission period. The biomarkers showing most consistent 
effects were RCDW, platelet count, NLR and albumin. A higher RCDW, 
a lower platelet count and a higher NLR were associated with both 
mortality and increased critical care length of stay. A lower level of 
albumin was associated with mortality. Of studies reporting statistical 
methods, the majority used logistic regression and Cox proportional 
hazards analysis. Studies which adjusted for confounders selected 
covariates using stepwise selection or bivariate screening.
Conclusion: Results from previous studies have limited applicability 
as methods of analyses tended to be restrictive and open to meas-
ured and unmeasured confounders.  All identified studies focused 
on determining statistical significance prior to evaluating underlying 
pathophysiological mechanisms. Establishing a direct casual pathway 
among biomarkers and outcomes may be challenging and traditional 
statistical modelling may fail to adequately control for confounding.
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Introduction: Many patients with SARS-CoV2 severe pneumonia 
received invasive mechanical ventilation and met the Berlin definition 
for ARDS. However, there is an ongoing debate regarding their respir-
atory mechanics. Several small studies found conflicting results: some 
showed a low potential for recruitability at an early stage of mechani-
cal ventilation [1], others demonstrated a significant potential for 
recruitability, although with large variability between patients[2],[3].
Objectives: We aimed to assess lung recruitability in the first days of 
invasive mechanical ventilation in patients with SARS-CoV2 induced 
ARDS.
Methods: Single-center study in a French medical ICU.
We included patients undergoing invasive mechanical ventilation for 
SARS-CoV2 ARDS. Lung recruitability was assessed using recruitment-
to-inflation ratio (R/I) measured within 72 hours after intubation. R/I 
ratio was obtained with a drop in PEEP over a single breath manoeu-
ver, as previously described[4]. We also assessed airway opening pres-
sure (AOP) by performing a low-flow inflation[5].
Results: Twenty-three patients were included in this study; 18 (78%) 
were men with a mean±SD age, body mass index, SAPS II and SOFA 
of respectively 57 ± 13, 29 ± 6 kg/m2, 45 ± 15 and 9 ± 4 at ICU admis-
sion. The majority of them (65%, N = 15) had at least one comorbid-
ity, including hypertension (48%, N = 11), diabetes (22%, N = 5) or 
immunocompromised status (22%, N = 5). R/I ratio was measured 1 
[0;2.5] days after intubation and 14 patients (60.9%) were considered 
to have recruitable lung (R/I ratio 0.76 [0.61;1.01]) with no difference 
in baseline characteristics as compared to the 9 patients with a R/I 
< 0.5. Airway opening pressure was measured in eighteen patients 
and 4 patients (22.2%) had an AOP > 5  cmH2O (with a median of 6.50 
 cmH2O), with no significant difference between recruiters and non-
recruiters. Overall survival rate was low (43.5%), 57% in the recruiter 
group (N = 8) and 22% in the non-recruiter group (N = 2), not reach-
ing statistical difference (p = 0.197).
Data are presented as median [interquartile range] or number (percentage)
VT tidal volume, R/I ratio recruitment to inflation ratio, AOP airway opening 
pressure.
p-values refer to the comparison between recruiters and non-recruiters.
Conclusion: Of the 23 patients with SARS-Cov2-associated acute res-
piratory distress syndrome included in this study, a majority (61%)
were considered as recruitable according to measured R/I ratio and 
22% presented an AOP > 5  cmH2O. Given the large variability of 
potential for recruitment in our study, R/I ratio and AOP should be 
assessed to individualize PEEP settings for each patient.
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Introduction: Measuring Plateau Pressure (PPlat) with an inspiratory 
hold during Pressure Support Ventilation (PSV) usually gives a value 
higher than the set pressure. This measurement can be used with two 
important clinical purposes. 1) The difference between Pplat and Peak 
Pressure can estimate patient’s inspiratory effort (1) 2) Pplat, as in con-
trolled mechanical ventilation (CMV), can be used to compute driving 
pressure and the respiratory system compliance (Crs) (2).
However, an inspiratory hold performed during PSV does not always 
reveal a reliable Pplat, due to ongoing muscular activity. The param-
eters defining Pplat as reliable during PSV are not established.
Objectives: To describe the features of a reliable inspiratory hold 
during PSV. To compare 1) the derived measure of inspiratory effort 
(Pressure Muscle Index, PMI) with the direct measure of muscular pres-
sure  (Pmusc)  through esophageal pressure (Peso); 2) Crs measured 
during PSV and CMV when the two measurements are close enough 
in time.
Methods: This is an ancillary analysis of pressure and flow curves 
obtained during a multicenter observational study aimed to describe 
the incidence of patient ventilator asynchronies in moderate to severe 
ARDS (BEARDS, NCT03447288). We selected the tracings with an 
inspiratory hold in PSV and a reliable Peso. We analyzed the features of 
the readable Pplat and the correlation between 1) Crs measured dur-
ing CMV and PSV 2) PMI and Pmusc. To be deemed reliable, Pplat had 
to be flat, flow had to be 0, if inspiratory efforts were detected, 
Pplat had to be flat before and after the efforts. Univariate analysis was 
performed through t test for parametric data, Mann Whitney for non-
parametric data. Data correlation was verified by Pearson’s.
Results: 91 traces from BEARDS study (11centres, 35patients) met 
the inclusion criteria. 69/91 holds were deemed reliable (76%), 30/35 
(86%) patients had at least one readable hold, according to visual 
inspection. The duration of the flat part of the hold was 1845  msec 
[1207-2640]. The standard deviation of airway pressure (Paw) dur-
ing the hold was significantly lower in readable versus non readable 
holds (1.6 [0.7-2.7] vs 2.1  cmH2O [1.8-4.7], p < 0.005). The time to reach 
a plateau was lower in readable versus non readable holds (400 [229-
850]  vs 1740 ms  [905-3150], p < 0.001). Peso  swing was significantly 
lower in readable holds (6.2 ±  4.8  vs 11.4 ±  5.9  cmH2O, p < 0.005). 
PMI showed a strong correlation with Pmusc(R = 0.79, p < 0.001, 
Figure 1). In 21 patients, a measurement of Crs in CMV was available, 
with a strong correlation with Crs measured during PSV (R = 0.71, p < 
0.001, Figure 2).
Conclusion: A readable measurement of Pplat  could be obtained in 
most patients during PSV. Readable holds were characterized by low 
variability of Paw during the hold and by a short time to reach a stable 
plateau. When patient respiratory effort is vigorous, a reliable plateau 
might be more difficult to achieve. Pplat  might be used to reliably 
compute Crs and Pmusc during PSV.
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Introduction: Liver biopsy remains the reference standard for diag-
nosing and quantifying steatosis. Ultrasonographyis a widely accesi-
ble, cheap, harmless imaging technique for the detection of fatty 
liver and other relevant chronic liver diseases, but the reported accu-
racy and reliability have been inconsistent across studies. We aimed 
to determine whether or not it is a suitable tool to evaluate organ 
viability in potential liver donors comparing with the gold standard 
technique.
Objectives: Determine the utility of abdominal ultrasound in organ 
donors to evaluate the level of hepatic steatosis and other relevant 
chronic liver diseases as any structural alteration in the organ.
Methods: We studied 226 consecutive donors during three years (jan-
uary 2017 to december 2019) in an Intensive Care Unit from a tertiary 
referral hospital.
We correlated ultrasound findings with the results from the intraop-
erative biopsy, so we could establish the consistency between these 
two diagnostic tests calculated by an inter-rater agreement statistic 
(Kappa).
Results: Of 226 donors reviewed, 220 (97,3%) had conducted an 
abdominal ultrasound and 164 (72,6%) had a liver biopsy. 65% were 
male donors. The mean age of the donors was 60,6 years-old. 73% of 
evaluated organs were transplanted. 62,4% of ultrasonography opera-
tors were junior resident doctors. Agreement between ultrasonogra-
phy and biopsy to evaluate hepatic steatosis is described in Table  1. 
We calculated a Cohen’s Kappa coefficient (κ) of 0,19 and a weighted 
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Kappa coefficient of 0,32. The ultrasonography was also able to detect 
other relevant, macroscopic findings, like space occupying liver lesions 
or ischemic lesions.
Conclusion: In our study, hepatic steatosis evaluated by abdomi-
nal ultrasound presented very low concordance rate with anatomo-
pathological findings. Abdominal ultrasound results a very helpful 
tool to evaluate incidental structural injuries, though these could be 
uncommon findings. The use of newer quantitative ultrasound-based 
imaging techniques, which also are less operator dependent than 
traditional ultrasound, could improve the ability of ultrasound to 
detect and quantify hepatic steatosis and emerge as a solution to our 
concern.
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Introduction: Infective endocarditis (IE) is associated with considera-
ble morbidity and mortality despite advances in diagnostic and thera-
peutic modalities.
Objectives: We sought to explore the epidemiology of IE in ICU 
patients with emphasis on severity, causes, management and 
outcome.
Methods: Preliminary analysis of EPENDICUS study (EPidemiology 
and outcome of ENDocarditis in ICU patientS: a multi-centre prospec-
tive epidemiological study on infectious endocarditis in ICU patients). 
Patients with a diagnosis of IE and ICU admission were included. Data 
were collected between December 2018 and April 2020. Of the col-
lected data, demographics, comorbidities, community or healthcare-
onset, severity assessment on ICU admission, complications, surgical 
approach and ICU outcome were available for preliminary analysis. 
Continuous data are reported as median and interquartile range and 
categorical data as percentages.
Results: 73 patients were enrolled from 16 centers; median age 69 
(IQR, 59-78), 69% male, 74% had at least one comorbidity, 49% pre-
sented valvular disease, 10% had a history of previous endocardi-
tis, 7% were intravenous drug users. Median SAPS and SOFA on ICU 
admission were 52 (IQR, 45-64) and 9 (IQR, 5.25-11.75), respectively. 
Sepsis/septic shock and cardiac failure were recorded in 43% and 28% 
of the patients, respectively. Mechanical ventilation was performed in 
67% of the patients. IE was healthcare-associated in 26% cases (63% 
of them were vascular catheter- or prosthetic device-associated). A 
native valve was involved in 60% of the cases (aortic in 56%, mitral 
in 28% of the cases). Embolic complications were observed in 18% 
of the patients (cerebrovascular in 46% of them). The predominant 
(52%) pathogens were Staphylococci (Staphylococcus aureus in 61% 
of them), Enterococcus spp. in 16%, Streptococcus spp. in 10%. Surgery 
was performed in 56% patients (emergency/urgent in 33% patients). 
ICU mortality was 29%.
Conclusion: The preliminary descriptive analysis of EPENDICUS 
showed that IE cases present important severity on ICU admission 
including sepsis and septic or cardiogenic shock. IE in the ICU setting 
is associated with comorbidities and underlying valvular disease in the 
majority of the cases. A considerable number of the cases were health-
care-onset and device-associated while the predominant pathogens 
were Staphylococci. Surgery was performed in the majority of the 
patients. Enrollment and further analysis are actually ongoing.
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Introduction: Increased intracranial pressure (ICP) is one of the major 
clinical complications of acute brain injuries (ABIs) and it is associated 
with poor outcome. ICP monitoring (ICPm) is considered the standard 
of care for the management of patients with intracranial hypertension, 
even if the procedure is not risk-free, and complications may occur. 
The indications for ICPm are mostly based on traumatic brain injury 
(TBI), whereas uncertainties remain for ICPm in non-TBI (subarachnoid 
haemorrhage (SAH) and intracerebral haemorrhage (ICH)).
Objectives: The main objective of the study is to describe the current 
practice of ICPm using a worldwide sample. Aim is to quantify practice 
variations in ICPm in TBI and non-TBI patients.
Methods: The SYNAPSE-ICU is an international, prospective, observa-
tional, cohort study (NCT03257904) including patients in coma after 
acute traumatic and non-traumatic brain damage admitted to the 
ICU. From March 2018 to June 2019, all patients fulfilling the follow-
ing inclusion criteria were recruited: age > 18 years; ABI due to primary 
haemorrhagic stroke or TBI; Glasgow Coma Score (GCS) with Eyes 
score (E) = 1 and Motor score (M) ≤5 at ICU admission or within the 
first 48 hours. Data regarding the practice of ICPm insertion in both TBI 
and non-TBI patients was collected.
Results: 2504 patients were enrolled in the study (54.3% TBI, 21.7% 
SAH, 24% ICH), and 1358 (54%) of them received an ICPm during ICU 
stay (53.6% of TBI, 63.3% of SAH and 47.5% of ICH).
The most common reason for ICPm was clinical indication (n = 948, 
70.1%), followed by radiology-anatomy of injury (n = 213, 15.7%), 
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neuroworsening (n = 152, 11.2%), with no significant differences 
among primary diagnosis. Considering the type of device, in most TBI 
patients (n = 144, 72.3%) an intraparenchymal catheter was inserted, 
whereas in SAH and ICH patients DVE was the most frequently used (in 
n = 179, 53.8% and n = 151, 54.5% of patients, respectively).
In the majority of patients, the catheter was inserted in operat-
ing room (61.9%). Alternatively, the insertion was performed in ICU 
(26.9%) or in emergency department (5.5%). The procedure was per-
formed by neurosurgeons in more than 90% of cases, rarely by inten-
sivists (2.3%) or other medical specialists (0.7%).
The mean length of ICPm was 8.7 days (standard deviation, SD = 16.9) in 
TBI, 14.6 days (SD = 10.7)in SAH and 10.4 days in ICH patients (SD = 8.6).
During ICU stay, the catheter was changed in 366 patients (14.1%) 
due to fault or break (25.5%), neurosurgery procedures (22.9%), cath-
eter displacement (19.8%) or accidental removal (15.1%), site infec-
tion (4.2%) and other reasons (12.5%) including insertion of another 
device, clinical worsening and hydrocephalus. The catheter has been 
changed, on average, after 5 days from the insertion.
Conclusion: A great variability regarding ICPm practice was observed. 
The results stress the need of evidence-based recommendation 
regarding ICPm worldwide.
Reference(s) and grant ackowledgment(s)
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research portfolio.
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Introduction: Mechanistic studies of sepsis-induced myopathy are rare 
because of their complexity, both ethical and practical. Proteomics and 
metabolomics are high throughput technologies that aim to identify and 
quantify proteins and metabolites at a large scale. The analysis of pro-
tein and pathways that are involved at the cellular level, combined with 
metabolomic analysis of these pathway intermediates, could unravel 
innovative therapeutic strategies regarding muscle dysfunction in sepsis.
Objectives: We aimed to investigate the sepsis-induced myopathy 
mechanisms with integrative and cutting-edge technologies.
Methods: We conducted a prospective study in three French Intensive 
Care Units. Muscle biopsies (vastus lateralis or  rectus abdominis) were 
collected from 3 groups of patients: Septic Shock (“SS” group, n = 24), 
Cardiogenic Shock (“CS” group, n = 25) and Brain Dead (“BD” group, n 
= 18). The proteins/metabolites were extracted from muscle samples, 
then analyzed by High-Performance Liquid Chromatography-coupled 
to tandem Mass Spectrometry. We used enrichment analyses (differ-
ential analyses between two groups) to identify the impact of cellular 
pathways in muscle tissue during septic shock.
Results: Characteristics of the patients are detailed in Table  1. Prot-
eomic and metabolomic analyses allowed the identification of 2426 
proteins and 259 metabolites respectively. Despite the fact that biop-
sies were obtained from different muscle groups, proteomic analysis 
did not show any difference in the proportion of muscle fiber types. 
Auto-clustering methods (principal component analysis, hierarchi-
cal clustering) clearly differentiated the three groups, meaning that 
SS patients could be well discriminated using the proteomic and 
metabolomic datasets. Enrichment analysis was performed on the 
proteomic dataset (Figure  1). Each data point represents a biological 
pathway in the SS group, taking into account its significance (adjusted 
p-value, y-axis, logarithmic scale) and its magnitude of change (x-axis) 
compared to the CS group (Figure 1A) or the BD group (Figure 1B). The 
dotted line represents the threshold for adjusted p-value significance. 
The most strongly negatively impacted pathways (adjusted p-value 
< 0.05) were observed in the SS group: Oxidative phosphorylation; 
Valine, leucine and isoleucine degradation; Citrate cycle; Propanoate 
metabolism; Butanoate metabolism; and Beta-oxidation. Moreover, 
numerous key mitochondrial transporters, e.g. proteins that shuttle 
metabolites across the mitochondrial membranes, were no longer 
detected in the SS group. In the metabolomic dataset, fatty acid bio-
synthesis was the only up-regulated pathway in the SS group. Finally, 
consistent data in the proteomic and metabolomic datasets showed 
that anti-oxidant mechanisms have been surpassed: we observed 
increased polyamine and depletion of reduced glutathione (metabo-
lomic dataset), decreased glutaredoxin, mitochondrial thioredoxin 
and peroxiredoxin ezymes (proteomic dataset).
Conclusion: Our data provide a detailed and integrated in depth over-
view of proteins and metabolic analysis, of the pathogenesis of sepsis-
induced myopathy in ICU patients. Interestingly, the mitochondrial 
response is not as impaired in major inflammatory processes without 
sepsis (brain death) or processes combining inflammation and hypop-
erfusion without sepsis (cardiogenic shock) as it is during sepsis.
Reference(s) and grant ackowledgment(s)
1. Institut Pasteur, Paris & Direction de la Recherche Clinique et de 
l’Innovation, Assistance Publique – Hôpitaux de Paris
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Introduction: Catecholamine hypo-responsiveness is a hallmark of 
sepsis, but its pathogenesis remains elusive. The adrenergic pathway, 
from catecholamine binding to the adrenergic receptor (AR) to the 
final physiological effect is a multistep process. Knowledge about 
protein expression and localisation of different constituents of the 
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Introduction: Poor premorbid functional status (PFS) is associated 
with a twofold increase in odds of death within 12 months after inten-
sive care unit (ICU) admission in patients aged 80 years or over [1].
Objectives: We evaluated the one-year outcome of the oldest old ICU 
patients (aged 85 years or over) and the impact of PFS on outcome.
Methods: We analysed data from the nationwide Finnish Intensive 
Care Consortium database. We defined good PFS as independence 
in activities of daily living (ADL) and ability to climb stairs, whereas 
patients who were dependent on help in ADL or unable to climb stairs 
were defined as having poor PFS. Using multivariable logistic regres-
sion analysis to adjust for differences in admission types and severity 
of illness, we evaluated the independent impact of PFS on mortality.
To assess both the premorbid situation and functional outcome one 
year after ICU admission, we evaluated the patient’s ability to live at 
home and to manage five physical activities (getting out of bed, mov-
ing indoors, dressing, climbing stairs and walking 400 metres) and 
created a functional status score (FSS) based on the number of man-
ageable activities.
Results: During the years 2012-2015, 2224 (3.3%) ICU patients were 
aged 85 years or older. PFS was available for 1431 (64.3%) patients. 
PFS was good for 47.7% and poor for 52.3%. Hospital mortality was 
19.9% for patients with poor PFS, as compared to 13.3% for those with 
good PFS, p = 0.001. One-year mortality was 47.4% for patients with 
poor PFS, as compared to 30.1% for those with good PFS, p < 0.001.
Poor PFS was associated with increased mortality. For in-hospital 
death adjusted odds ratio (OR) was 1.35; 95% confidence interval (CI) 
0.97-1.88; and for 12 months death OR was 1.85, 95% CI 1.45-2.37.
For one-year survivors (n = 1244), data on the type of accommodation 
and the FSS one year after ICU admission were available for 49.8% and 
47.2%, respectively. Of those patients who had lived at home before 
ICU admission, 84.2% were still living at home one year afterwards. 
The FSS one year after ICU admission was the same or higher than the 
premorbid FSS for 69.5% of survivors. The premorbid and one-year 
FSS are presented in Fig. 1.
Conclusion: PFS is strongly associated with long-term outcome in ICU 
patients aged 85 years or older. For most survivors, functional recov-
ery was favourable.
Reference(s) and grant ackowledgment(s)
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adrenergic signalling in sepsis, including adrenergic receptors them-
selves, is sparse.
Objectives: Using our well-characterised 72 h fluid-resuscitated rat model 
of faecal peritonitis (1), where accurate prognostication can be made as 
early as 6 h, we analysed expression and membrane localisation of the 
b2-AR protein in heart tissue at early (6 h) and late (24 h) timepoints.
Methods: Sepsis was induced in male Wistar rats by i.p. injection of 
faecal slurry under general anaesthesia. The animals were then recov-
ered and i.v. fluid resuscitation was started 2 h after sepsis induction. 
Sham-operated rats (SH) were treated identically but did not receive 
the slurry. At 6 h, an echo-measured heart rate cut-off of 460 bpm was 
used to classify animals into predicted survivors (SR) and non-survivors 
(NSR). Rats were culled at either 6 h or 24 h with heart tissue collected 
and snap frozen in liquid nitrogen. To study b2-AR expression, either 
protein lysates of whole heart tissue or membrane fractions were pre-
pared and analysed by Western Blot with antibodies against b2-AR 
and PFK or Caveolin 3. Specific signals were analysed in Image Studio 
Lite 5.2. Results are presented as mean ±  SE and considered signifi-
cant at p < 0.05 (Student’s t-test).
Results: The level of expression of b2-AR myocardial protein expres-
sion did not change in survivors but declined in non-survivors being 
significantly lower than survivors at 24 h (Table  1).  Representative 
results of membrane localisation of b2-AR within different membrane 
fractions are presented in Figure 1.  Lipid rafts were observed in only 
two of the 12 gradient fractions, namely fractions 4 and 5. This was 
confirmed by cholesterol distribution and caveolin 3 staining. In sham 
operated animals and in predicted survivors at 24h, b2-AR appeared 
strongly in fraction 5, associated with the lipid rafts. In predicted non-
survivors, b2-AR was not detected in fractions 4 and 5 either at 6h or 
24h post-sepsis.
Conclusion: More severe sepsis, with corresponding poor prognosis, 
is accompanied by increasing catecholamine hyporesponsiveness. 
One cause could be a decrease in adrenergic receptor protein expres-
sion. Localisation of the b2-AR within lipid rafts is also a prerequisite 
for their normal functioning. In predicted non-survivors myocardial 
b2-AR was dissociated from the lipid rafts. Further studies are neces-
sary to identify strategies that restore adrenergic signalling in sepsis
Reference(s) and grant ackowledgment(s)
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Introduction: Hypocholesterolaemia (HCE) is a well-known hallmark 
of sepsis, a reliable biomarker of disease severity and a predictor of 
poor outcome. The pathogenesis of HCE insepsis however remains 
elusive. The plasma cholesterol level reflects the balance between syn-
thesis and ingestion versus metabolism. The rapid drop of cholesterol 
in sepsis onset suggests a leading role for metabolism in the develop-
ment of HCE.
We postulate that sepsis-induced HCE is part of a big defensive re-
organisation of the plasmalemma that includes activation of enzymes 
participating in membrane remodelling and production of bioac-
tive lipids (phospholipases, sphingomyelinases and b-glucosidases). 
b-glucosidases transfer a sugar moiety, glucose or galactose, from glu-
cosylceramide to cholesterol. The product is glycosylated cholesterol, 
which differs from cholesterol in its physical and chemical properties, 
including resistance to cleavage by cholesterol esterase, but is sensi-
tive to alkaline hydrolysis.
Objectives: To study the chemical forms of cholesterol, we ana-
lysed cholesterol levels before and after alkaline hydrolysis in blood 
obtained from septic rats.
Methods: Seven awake instrumented male Wistar rats (300  ±  50g) 
received an i.p. injection of faecal slurry followed by a i.v. fluid resusci-
tation in 2 h (1). Blood was collected before sepsis initiation (base line), 
and at 24 h post-sepsis. Total and free cholesterol were measured by 
an enzymatic method and Amplex red assay with and without cho-
lesterol esterase. Alkaline hydrolysis was performed with 2N NaOH at 
45 °C for 2 h and then neutralised by 10N HCl. Statistical analysis was 
performed using Student’s t test
Results: Plasma cholesterol dropped markedly (p < 0.05) after 24 
hours of sepsis (Table  1). This was more prominent for cholesterol 
esters (54%) compared to free cholesterol levels (21%). Of note, total 
cholesterol concentration increased after alkaline hydrolysis and was 
unchanged after 24 h sepsis.









Baseline 666±45 163±14 503±31 1081±128 (c) 
Sepsis 24h  348±18 (a) 129±6 219±13 (a) 905±90 (c) 
a=p<0.01 compared to corresponded baseline  c=p<0.01 compared total cholesterol before and 
after hydrolysis  
Conclusion: These results suggest that cholesterol is mainly present 
in blood as neither free cholesterol nor as a cholesterol ester, but 
rather as a substance that cannot be directly oxidized by cholesterol 
oxidase (ChO). However, after alkaline hydrolysis, cholesterol could be 
liberated from this substance and oxidised by ChO. Total cholesterol 
levels after hydrolysis at baseline and 24 h post-sepsis were similar, 
however the levels of any form of cholesterol without hydrolysis dif-
fered significantly. This suggests that during sepsis the proportion of 
cholesterol in this form had increased. Further analytical studies, MS 
analysis and digestion by b-glucosidases are required to identify this 
form of cholesterol and elucidate the pathogenesis of sepsis-induced 
hypocholesterolaemia.
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Introduction: ABGs are performed in acute conditions as the refer-
ence method for assessing the acid-base status of blood. Hyperventi-
lation and breath-holding are common ventilatory changes that can 
occur around the time of sampling, rapidly altering the ‘true’ status of 
the blood.
Objectives: To determine whether mathematically calculated “arteri-
alised” venous values (1) represent a more stable measure of arterial 
blood during rapid, transient, changes in ventilation.
Methods: 14 patients without cardiovascular and respiratory illnesses 
scheduled for elective surgery were studied. Following anaesthesia 
and before the start of the surgery, ventilator settings were altered 
to achieve + 100% or − 60% change in alveolar ventilation (‘over-’ or 
‘under-ventilation’), thus simulating a transient change in ventilation. 
Blood samples were drawn simultaneously from indwelling arterial 
and peripheral venous catheters at baseline and every 15s for 1min 
following the ventilatory change. Venous values were used to calcu-
late arterial equivalents of acid-base status, using the mathematical 
arterialisation method (1).
Results: Figure  1 illustrates measured arterial and calculated arteri-
alised values, shown as changes from baseline for pH and PCO2, for 
over- and underventilation. Arterial blood changes rapidly within the 
first 15 - 30s with arterialised values remaining relatively constant until 
45s.
Conclusion: In situations prompting transient changes in ventilation, 
viz. anxiety in the emergency department or spontaneous breathing 
with assisted ventilation, mathematically arterialised venous values 
may provide a more stable value of arterial acid-base status closer to 
baseline values, prior to the transient change in ventilation.
Reference(s) and grant ackowledgment(s)
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Introduction: Acute upper gastrointestinal bleeding (UGIB) is a com-
mon condition associated with significant morbidity and mortality. 
Previous studies in trauma patients  have shown low ionized calcium 
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(Ca++) levels to be associated with an increased need for transfusion 
of blood products and adverse outcome in this population.
Objectives: We hypothesized that admission Ca++ levels could pre-
dict the need for blood transfusion and surgical/angiographic inter-
vention in patients with UGIB.
Methods: We conducted a population-based retrospective cohort 
study, using the data of patients admitted to Rambam Medical center, 
Haifa, Israel due to UGIB for whom Ca++ was measured within 24 
hours before or after the endoscopy and before administration of 
blood transfusion. Patients on anticoagulants, with known varices or 
chronic liver disease were excluded as these  cause complex altera-
tions in coagulation and hemostasis.  The primary outcome of this 
study was a composite of transfusion of two or more packed red blood 
cells (PC) or a need for urgent surgical or angiographic intervention 
during the index admission. Secondary outcomes included individual 
components of the composite outcome. Multivariable logistic regres-
sion was performed to determine whether Ca++ was an independent 
predictor of these outcomes.
Results: A total of 1345 patients were included in the final analy-
sis. Hypocalcemia (Ca++ < 1.16) was recorded in 604 (45%) patients 
and 88 (7%) had Ca++ below 1 mmol/L. The rates of compos-
ite adverse outcome were significantly higher in the low Ca++ 
group,14.4% vs. 5.1%, p < 0.001. In addition, multiple transfusions 
(9.9% vs. 2.3%, p < 0.001), need for surgical/angiographic interven-
tions (5.3% vs. 2.8%, p = 0.03) and mortality (33.3% vs. 24.7%,  p < 
0.001) were significantly increased in the hypocalcemia group. Multi-
variable logistic regression analysis identified Ca+ < 1.16 as an inde-
pendent predictor of the primary and secondary adverse outcomes.
Ca++ performed better than modified Glasgow Blatchford score 
in predicting the need for multiple PC transfusion (AUC 0.72 95% CI 
0.69-0.74 vs. AUC 0.55 95% CI 0.53-0.58, p = 0.001). There was a trend 
towards a better performance of Ca++ measurements on the com-
posite adverse outcome (AUC 0.66 95% CI 0.63-0.69 vs. AUC 0.58 95% 
CI 0.56-0.61, p = 0.07).
Conclusion: Low calcium in patients with UGIB is common and asso-
ciated with an increased requirement of PC transfusion and need for 
surgical or angiographic interventions. Admission calcium levels may 
facilitate the rapid identification of high-risk patients with UGIB.  As 
Ca++ plays a key role in the coagulation cascade, coagulopathy 
may occur as Ca++ levels drop. In addition, low cardiac contractility 
and reduced systemic vascular resistance also occur when calcium lev-
els drop. Correcting hypocalcemia may serve as an additional goal in 
the treatment of the bleeding patient. Further studies should evalu-
ate the impact of correcting hypocalcemia on UGIB patients’ outcome. 
Until definitive studies are available, clinicians should consider moni-
toring Ca++ levels and  maintaining it within the normal range in 
patients with UGIB.
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Introduction: Neostigmine is used to treat critical illness related 
colonic ileus in the intensive care unit (ICU). Data on the effectiveness 
and possible complications of intravenous administration of neostig-
mine in critically ill patients are scarce. Specifically data concerning 
patients with recent intestinal anastomosis are lacking.
Objectives: The primary objective of this study was to assess the 
effectiveness of neostigmine treatment on passing stool. The second-
ary objective was to assess the rate of hemodynamic and abdominal 
complications of neostigmine treatment in critically ill patients.
Methods: In this single-centre retrospective cohort study, all con-
secutive patients treated with neostigmine on the ICU of the OLVG 
hospital (Amsterdam, the Netherlands) between 2007 and 2019 were 
included. The primary outcome was the effectiveness of neostigmine 
treatment defined as the percentage of patients with ≥ 100 ml stool, 
6 and 24 hours after the start of neostigmine. The secondary outcome 
was the rate of complications, such as bradycardia and abdominal 
complications. Bradycardia was defined as heart rate < 50/min and/
or the use of atropine after administration of neostigmine. Abdomi-
nal complications such as bowel perforation and anastomotic leakage 
were assessed by automatic database extraction and consequently 
manually reviewing all relevant patient files. We studied the incidence 
of abdominal complications between patients with- and without a 
recent (within 10 days) intestinal anastomosis.
Results: Between 2007 and 2019 a total of 1008 patients were treated 
with neostigmine. 71% of these patients were male, mean age was 66 
years (SD 13), mean SOFA score 10 (SD 3,8), mean APACHE IV 0,4 (SD 
0,3). In 414 patients (41%) ≥  100 ml stool was passed after 6 hours, 
and in 784 patients (79%) after 24 hours. Bradycardia was seen in 58 
patients (6%) and atropine was administered to 15 patients (1.5%). 
A total of 148 patients (15%) had abdominal surgery within 10 days 
prior to neostigmine treatment. Forty-nine (5%) of them had an intes-
tinal anastomosis. Twelve of these 49 patients (24,5%) developed an 
abdominal complication requiring surgery during their treatment on 
the ICU. In eleven patients an anastomotic leakage was found, and 
one patient experienced a spontaneous perforation of an diverticula. 
In 1.65% of patients (13 out of 784) without recent abdominal sur-
gery a spontaneous perforation or bowel ischemia requiring a surgi-
cal intervention was observed after neostigmine treatment. In the 
patients who underwent recent abdominal surgery without an intesti-
nal anastomosis, 7% developed an abdominal complication.
Conclusion: Neostigmine seems to be an effective treatment to 
resolve acute colonic ileus in critically ill patients. Bradycardia requir-
ing atropine was observed rarely. However, in 24.5% of patients with 
recent abdominal surgery with an intestinal anastomosis treated with 
neostigmine anastomotic leakage or diverticular perforation was 
observed.
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Introduction: Intracranial pressure (ICP) is continuously monitored in 
patients with severe Traumatic Brain Injury (TBI). Güiza et al. [1] devel-
oped a prediction model able to predict elevated ICP (defined as ICP 
> 30  mmHg for more than 10 minutes) with useful forewarning. The 
model, which was developed on the Brain-IT database [2], presented 
good calibration (Cox calibration slope 1.02,calibration–in–the–large 
= − 0.02) and good discrimination (AUC = 0.87).
It is good practice to periodically validate the performance of a pre-
diction model on new and preferably external databases. First, it is 
important to assess whether the performance of the model have dete-
riorated as a result of the changes in the clinical practice that followed 
the new Brain Trauma Foundation guidelines for TBI of 2007 and 2016. 
Second, external validation allows to assess the model generalizabil-
ity capacities. In this study, we validated the prediction model devel-
oped by Güiza et al. [1] on the Collaborative European NeuroTrauma 
Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) dataset 
[3]. This validation follows a previous external validation performed on 
data prior to 2013 [4].
Methods: The external validation included 257 patients with continu-
ous ICP and mean arterial blood pressure signals. Patients were pro-
spectively recruited between January 2015 and December 2017 as 
part of the Center-TBI dataset. In accordance with the original publi-
cation [1], the performance of the model was quantified in terms of 
Area Under the ROC Curve (AUC) and calibration. Discrimination curve 
analysis was additionally performed to quantify the clinical utility of 
the model.
Results: On the external validation dataset, the model was still able 
to predict future episodes of elevated intracranial pressure with good 
calibration (Cox calibration slope 1.22, calibration–in–the–large = 
− 0.04, see panel A) of Fig.1) and discrimination (AUC = 0.93). The dis-
crimination curve showed clinical usefulness for almost all risk thresh-
olds (respectively from 4% to 96%), as shown in panel B) of Fig. 1.
Conclusion: These results demonstrate the robustness of the predic-
tion model for elevated ICP developed by Güiza et al. [1]. The model 
shows good calibration and good discrimination even when evaluated 
on an external multi-center dataset collected 10 years later than the 
original development cohort. Future intervention studies are required 
to assess the impact of this model on patient outcome when used in 
clinical practice.
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Introduction: Microvascular thrombosis has recently been diagnosed 
in patients with COVID-19, and it has been proposed to mediate the 
pathogenesis of organ injury in this disease. While widespread pulmo-
nary microvascular thrombosis was demonstrated, reports about the 
compromise of extrapulmonary microvessels are controversial.
Objectives: To evaluate the characteristics of sublingual microcircula-
tion and skin perfusion in patients with acute respiratory distress syn-
drome (ARDS) secondary to COVID-19.
Methods: We prospectively included 27 patients with diagnosis of 
ARDS secondary to COVID-19 (positive PCR testing of nasopharyn-
geal or tracheal samples), from 4 intensive care units in Argentina. 
All patients were intubated and mechanically ventilated, received 
infusions of midazolam, fentanyl and atracurium, and anticoagulant 
prophylaxis from their hospital admission. Blood pressure, heart rate 
and norepinephrine infusion remained unchanged for 3-h before the 
measurements. Sublingual microcirculation was assessed by means of 
hand-held videomicroscopy and software-assisted analysis (1).
The respective institutional review board approved this study and 
waived patient informed consent.
We present continuous variables as median [IQR]) or mean (SD), and 
categorical variables as numbers (%).
Results:  PaO2/FiO2 was 122 ± 43, and APACHE II and SOFA score were 
12 [9-17] and 6 [3-8]. Norepinephrine (0.03 [0.01-0.17] µg/kg/min) was 
required in 12 patients (44%). D-dimer was elevated (1.30 [0.58-2.93] 
μg/mL. Median plasma lactate was normal (1.8 [1.6-2.5] mmol/L). Cap-
illary refill time was prolonged (3.5 [3.0-5.0] s).
Compared to reported normal values (1), total and perfused vascular 
density and heterogeneity flow index were high, and the proportion 
of perfused vessels, microvascular flow index, and red blood cell veloc-
ity were reduced (Table  1). The proportion of perfused vessels was 
inversely correlated with total vascular density (Pearson r = -0.41, P = 
0.03).
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Sublingual microcirculatory variables 
Total vascular density, mm/mm² 
(normal values=16.7±1.6) 
21.9±3.9 
Perfused vascular density, mm/mm² 
21.0±3.5 
(normal values=16.7±1.6) 
Proportion of perfused vessels 
(normal values=1.00±0.00) 
0.96±0.03 
Microvascular flow index 
(normal values=2.97±0.03) 
2.79±0.10 
Red blood cell velocity, µm/s 
(normal values=1331±190) 
1124±161 
Heterogeneity flow index 
(normal values=0.04±0.03) 
0.91±0.24  
Conclusion: Although most patients were hemodynamically stable, 
they had alterations in sublingual microvascular flow and capillary 
refill time. Microcirculatory abnormalities consisted in an increased 
number of unperfused vessels. Although these changes seem minor, 
compared to those described in septic shock, they represent a sev-
eral time increase from normal values. In addition, heterogeneity was 
severely augmented and flow velociry was reduced. These abnormali-
ties might contribute to the development of multiple organ failure.
The most striking result was the increase in vascular densities, a find-
ing that might be related to enhanced angiogenesis or hypoxia-
induced capillary recruitment. The association of microthrombosis 
and increased angiogenesis has been found in COVID-19 and in other 
conditions.
In summary, patients with severe COVID-19 pneumonia showed sub-
tle but consistent alterations in sublingual microcirculation and skin 
perfusion.
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Introduction: Patient-ventilator asynchronies occur when there is 
a mismatch between the ventilator’s setting and patient’s breathing 
pattern, and oudl trigger major consequences. Asynchronies are diffi-
cult to characterize when supported only by visual assessment carried 
out by inexperienced personnel, since different types may develop in 
a short time period or may even overlap with each other. Therefore, 
it would be extremely useful to have access to a method for assess-
ing irregularity and complexity which could detect Complex  Patient-
Ventilator interactions (CP-VI), including not only asynchronies of any 
kind  but also changes in the  respiratory rate, in an automated, non-
invasive and personalized fashion.
Sample Entropy (SE) is a non-linear method which measures complex-
ity and regularity. Lower  SE  value indicates more self-similarity in a 
time series of data. SE has proved to be an effective tool for investigat-
ing different types of time series data derived from various biological 
conditions in the human body. We hypothesized that analyzing tran-
sient complexity of CP-VI may provide clinically relevant information 
about asynchronies and changes in respiratory rate during invasive 
mechanical ventilation.
Objectives: Develop and validate a non-invasive method based 
on SE measurement using the entire airway pressure (Paw) and airway 
flow (Flow) waveforms to detect CP-VI, defined as the occurrence of 
asynchronies and changes in the respiratory rate.
Methods:SE  of airway flow (SE-Flow) and airway pressure (SE-Paw) 
waveforms from 92 15-minute-long segments obtained from 27 criti-
cally ill, mechanically-ventialted patients were used to develop and 
validate an automated algorithm for detecting CP-VI, defined as  a 
> 50% change in the respiratory rate, and/or > 30% asynchronous 
breaths of any type (ineffective expiratory efforts, double cycling, pre-
mature cycling, prolonged cycling, or reverse triggering) over a 3-min-
ute period.
The algorithm’s performance was compared versus CP-VI scored visu-
ally by three experts, and measured through Fleiss’s Kappa interrater 
agreement. A repeated holdout cross-validation procedure  using 
the Matthews correlation coefficient (MCC) as a measure of effective-
ness was used for optimization of different combinations of SE settings 
(embedding dimension, m, and tolerance value, r), derived SE features 
(mean, [SE-Flowmean  and  SE-Pawmean]  and maximum values, [SE-
Flowmax  and  SE-Pawmax]), and the thresholds of change (Th) from 
patient’s own baseline SE value, applying different values of Th  (15%, 
20%, 25%, 30%, 35%, 40%, 45%, 50%). We hypothesized that SE values 
would be higher in periods with CP-VI than in periods with regular 
patient-ventilator interactions
Results: Fleiss’ kappa for inter-rater agreement was 0.90 (0.87-0.93), 
indicating almost perfect agreement.  SE  was highly sensitive to 
changes in the irregularity of the respiratory pattern occurring during 
ventilation. The most accurate results for the automated detection of 
CP-VI were obtained using the maximum values of SE-Flow (m = 2, r = 
0.2, Th = 25%, [SE-Flowmax25]) and SE-Paw (m = 4, r = 0.2, Th = 30%, 
[SE-Pawmax30]) which report MCCs of 0.85 (0.78-0.86) and 0.78 (0.78-
0.85), and accuracies of 0.93 (0.89-0.93) and 0.89 (0.89-0.93), respec-
tively. Once we had determined the settings that best detected CP-VI, 
we evaluated the performance of the algorithm in the 15 repetitions 
of the cross-validation procedure. Both  SE-Flowmax25 and  SE-Paw-
max30 yielded their highest MCC values in 13 of the 15 repetitions.
Conclusion: Our non-invasive method based on  SE  measurement of 
Paw and Flow is able to detect with high accuracy CP-VI, defined  as 
the occurrence of clusters of asynchronies and changes in the res-
piratory rate, with high accuracy. Clinical relevance and usefulness of 
identifying Complex Patient-Ventilator Interactions in different clinical 
scenarios deserves to be explored.
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Introduction: Ventilator induced lung injury (VILI) is associated with 
the amount of energy the ventilator transfers to the patient, which 
is called the mechanical power (MP) [1]. In a previous study, Schmidt 
et al. demonstrated that veno-venous extra corporal membrane oxy-
genation (VV-ECMO) can reduce the amount of energy transferred to 
the lungs to maintain adequate oxygenation and ventilation [2]. How-
ever, they used a formula developed for volume controlled ventilation 
(VCV) [1], whereas 40% of the population was ventilated with a pres-
sure controlled mode (PCV) before start of VV-ECMO. This percentage 
was even a greater after the start of ECMO.
It is of utmost importance to use the right methods to calculate the 
MP. Using the formula for VCVon patients ventilated with PCV will lead 
to a systemic bias in which the MP will be underestimated.
Objectives: To describe the change of MP before and after initiation 
of ECMO using the correct calculations and to demonstrate the sys-
temic bias when using the wrong calculations.
Methods: We performed a retrospective cohort study in all patients 
admitted to the adult ICU of the LUMC on VV-ECMO for respiratory 
indications between 2011 and 2020. We calculated the mean MP 
during 6 hours pre ECMO and 6 hours after initiation of ECMO with a 
pause of ca. 2 hours after placing the patient on ECMO. Mechanical 
power was calculated with the formula MP-PCV = 0.098 * RR * Vt * 
[PEEP + ΔPinsp * (1 − e^(-Tinsp/(R*C))] as described by van der Mei-
jden et al. [3], which is suitable for PCV. We also calculated the MP in all 
patients using the formula described by Gattinoni et al. [1] MP-VCV = 
0.098 * RR * Vt * [Ppeak − 0.5 * ΔPinsp ] which is suitable for VCV and 
used by Schmidt et al. on all patients.
All patients were ventilated with an Evita -XL (Dräger, Lubeck, Ger-
many) or Hamilton 6 ventilator (Hamilton Medical, Bonaduz, Switzer-
land). Statistics were done with SPSS 25 (Armonk, NY: IBM Corp).
Results: See Table 1. for the population characteristics. The mechani-
cal power before ECMO was 34.5 J/min (sd 13.4), after start of ECMO 
the mean MP was 6.8 J/min (sd 4.0). When calculated with the VCV 
method the MP was 27.2 J/min (sd 11.1) before and 5.3 J/min (sd 
3.0) after ECMO. Ventilator settings and gas exchange parameters 
are shown in table  2. The mean difference of the MP before ECMO 
between the two calculations was 7.3 J/min and after ECMO 1.5 J/min.
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mean (sd)  
MP-PCV (J/min) 34.5 (13.4) 6.8 (4.0) 
Wrong calculation: MP-VCV (J/min) 27.2 (11.1) 5.3 (3.0) 
Mean difference MP-PCV and MP-VCV 7.3 (4.6) 1.5 (1.4) 
Percentage MP-VCV lower than MP-
PCV 
21% 22% 
pH 7.20 (0.15) 7.30 (0.10) 
pCO2 (kPa) 9.1 (3.2) 6.5 (1.6) 
pO2 (kPa) 10.8 (6.7) 9.8 (3.3) 






mean (sd)  
Ppeak (cmH2O) 33.8 (5.6) 23.2 (5.7) 
RR (/min) 29.6 (5.1) 15.0 (7.3) 
Vt (L) 0.395 (0.103) 0.224 (0.092) 
fiO2 (%) 82.9 (17.3) 49.6 (13.2) 
Conclusion: VV-ECMO lowers the mechanical power while maintain-
ing adequate oxygenation and ventilation reducing the MP with 80%. 
The MP calculation with the wrong formula underestimated the MP by 
more than 20% in this study. This study underlines that it is mandatory 
to use the correct methods to calculate the MP.
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Introduction: Delivering enteral feed or medications through an 
enteral feeding tube placed into the lung causes major morbidity. (1) 
To prevent this from occurring an accurate means of assessing enteral 
tube placement is essential. In the UK, the National guidelines for 
assessment the of enteral feeding tube position includes the measure-
ment of gastric aspirate pH ( < 5.5) and assessment of tube placement 
using x-ray if indeterminate. (1) However there is little evidence to 
support this as a safe approach in critically ill patients. (2,3)
Objectives: • Establish the prevalence of acidic pH aspirates (defined 
as a pH < 5.5) within the critical care ventilated patient cohort. • Pro-
vide clarity on the use of pH strip testing as a method confirming 
nasogastric (NG) tube position in the critically ill patient cohort.
Methods: Simultaneous pH measurements were taken for aspirates 
obtained from the NG tube, subglottic port and tracheal samples in 
106 ventilated patients from June - November 2019 at a university-
affiliated, tertiary hospital. The pH from the three sites was obtained 
and recorded once per nursing shift and electronically entered. Any 
sample taken as a non-directed bronchial lavage (NBL) also had the 
pH recorded. Baseline demographic data, relative time of NBL to sam-
pling, and presence of medications used to suppress gastric acid pro-
duction were recorded. Patient’s notes were reviewed by the authors 
for history or suspicion of aspiration, and documented episodes of 
emesis. Institutional approval was given for this work. Statistical plan: 
The distribution of pH from each site was described using descriptive 
statistics. Specific note was made of any instances of pH < 5.5. Spear-
man’s correlation was performed between subglottic and tracheal 
aspirate data.
Results: Data were included for 106 patients. Demographics include: 
mean age of 58.9 years, 78.3% referred from a medical speciality, aver-
age APACHE II score 14.6, average SOFA score 7.2, and 28.9% mor-
tality rate overall. Analysis of all aspirates collected demonstrated a 
significant proportion within both subglottic and sputum aspirates of 
a pH < 5.5, 5.3% and 6.3% respectively, see Table  1. Fifteen patients 
accounted for the 27 acidic subglottic aspirates and four patients for 
the 7 sputum aspirates. Of note, there was a large proportion of NG 
aspirates with a pH > 5.5, 70.8%.
Table 1. Summary of data points collected from subglottic, nasogastric and 
sputum aspirates 
mutupScitrsagosaNcittogbuS
Count 513 510 111 
Mean pH 6.5 5.3 6.9 
Standard Deviation 1.4 1.8 1.6 
Median pH 6.5 6.0 7.0 
Lower Range pH 6.0 5.0 6.0 
Upper Range pH 7.0 6.5 8.0 
No. pH < 5.5 27 149 7 
Percentage pH <5.5 5.3 29.2 6.3 
Analysis of simultaneous sputum and subglottic demonstrated a posi-
tive correlation, r = 0.52 (Confidence Interval 0.31 - 0.69), p < 0.0001.
Conclusion: From this study we have demonstrated a large number 
of acidic samples outside of the gastrointestinal tract, 5.3% subglottic 
and 6.3% sputum, with a simultaneously high proportion of aspects 
from the gastrointestinal tract not being acidic (70.8%). Given that the 
pH in tracheal and subglottic examples was strongly correlated, it is 
possible that the acidic pH in the airway was due to micro-aspiration 
past the cuff of the endotracheal tube. (4,5) This raises the possibility 
that any patient with significant glottic dysfunction and either macro- 
or micro-aspiration may have a an acidic tracheal pH and raises doubts 
about the validity of pH testing as a means of confirmation of correct 
placement of an enteral feeding tube in this population. The elevated 
pH in the gastric samples is to be likely due to the use of protein pump 
inhibitors as a medication for stress ulcer prophylaxis in the critically ill 
patient cohort.
The data presented here suggests that pH testing as a means of con-
firmation of enteral tube placement will not prevent feed installation 
into the lungs if the tube is misplaced and the patient has poor glottic 
function and a risk of aspiration.
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Introduction: Increased dead space, as a reflection of global lung 
injury, is an independent predictor of mortality in both the early 
and intermediate stages of Adult Respiratory Distress Syndrome 
(ARDS) (1). Ventilatory ratio (VR) is a bedside index of impaired ventila-
tory efficiency with significant association with dead space and out-
come in ARDS  (2). Severe Adult Respiratory Syndrome Coronavirus-2 
(SARS-CoV-2) disease partly differs from traditional ARDS; high dead 
space fraction may be a specific pathophysiological characteristic (3).
Objectives: To describe VR, its trend and association with mortality in 
a cohort of SARS-CoV-2 patients.
Methods: A cohort of consecutive patients affected by SARS CoV-2 
admitted to Papa Giovanni XXIII Hospital ICU (Bergamo) from Febru-
ary 22th to March 22th and requiring invasive mechanical ventilation 
was retrospectively analysed. VR, defined as [minute ventilation (ml/
min)*PaCO2 (mmHg)]/[predicted body weight *100 (ml/min)*37.5 
(mmHg)], was calculated within 48 hours since intubation. Patients 
were divided into two groups, low VR ( < 2) and high VR (≥  2)  (2). 
Demographics, ventilatory parameters (Mann Whitney test) and 
28-day mortality (Fisher’s exact test) were compared between the two 
groups.
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Results: 86 of the 115 patients enrolled had a baseline VR, with a mean 
value of 2.05 (±0.59). VR remained high over the first 15 day of ICU 
admission (mean value always ≥ 2, Figure 1). Low VR group included 
45 patients with mean VR 1.58 (±0.34); high VR group included 41 
patients with mean VR 2.53 (±0.40). The groups were similar for age, 
SOFA-score, baselines ventilatory setting and gas exchange (Table 1). 
High VR was associated with significantly increased 28-day mortality 
(odds ratio 2.83, 95% CI 1.08-7.39, p = 0.03). Comparing survivors and 
non-survivors median VR was respectively 1.87 (1.55-2.35) versus 2.22 
(1.72-2.71) (p < 0.05).
Table 1. Baseline characteristics in the two groups. 
RV)54°n(2<RV 2 (n°41) p-value 
Age 57(51-66) 64(55-69) 0.07
SOFA score 6(4-8) 7(4-9) 0.1 
Driving Pressure 11 (10-13) 11(10-14) 0.5 
PEEP 15(13-16) 15(14-17) 0.2 
Compliance 41(35-46) 41(32-46) 0.4 
PaO2/FiO2 117(98-151) 98(76-135) 0.09 
Conclusion: Patients with baseline VR ≥  2 had significantly higher 
28-day mortality in ARDS due to SARS-CoV-2; VR could be a useful 
prognostic tool.
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Introduction: Anecdotal evidence suggests COVID-19 may be associ-
ated with severe insulin resistance in critical care. Indeed, a group of 
leading diabetologists have recently established a COVID-19-Diabetes 
registry to catalogue cases of new onset diabetes and severe insulin 
resistance associated with COVID-19, positing that COVID-19 may be 
a uniquely diabetogenic virus. However, to date there has been no 
longitudinal evaluation of insulin requirements in critically ill patients 
with COVID-19 and there is no evidence to suggest these observations 
represent anything other than stress hyperglycaemia.
Methods: To address this, we conducted a retrospective observa-
tional study of contemporaneous electronic medical records of insulin 
requirements and glycaemia in patients admitted to our intensive care 
unit (ICU) with COVID-19 in March and April 2020.
Results: 54 patients with COVID-19 were admitted to our unit for 
> 24 hours during the study period and included in the analysis. We 
reasoned that the high insulin requirements observed in COVID-19 
may represent the high prevalence of severe illness. To test this, we 
analysed insulin requirements according to interventions employed to 
treat respiratory failure, namely mechanical ventilation, neuromuscu-
lar blockade, nebulised epoprostenol and proning. Increased Insulin 
requirements (units/day) and worsening glycaemia were clearly asso-
ciated with severity of illness as indicated by intensity of salvage thera-
pies required for respiratory failure (P < 0.01 for all, ordinal regression). 
In a multivariate model adjusted for age and sex, being proned during 
ICU admission and premorbid Type 1 or Type 2 diabetes, but not ster-
oid exposure or obesity, were independently associated with insulin 
requirements. To determine if COVID-19 had unique effects on glu-
cose metabolism we compared insulin requirements and glycaemia 
in COVID-19 to a cohort of non-viral pneumonitis patients admitted 
to our ICU between 2018 and 2020, matched for age, sex, BMI and 
diabetesstatus. Insulin requirements (Mean Insulin Dose (Units/day), 
COVID-19: 19.8 ± 8.3, Non-COVID-19:24.8 ± 11.2, P = NS, N = 17 per 
group) and glycaemic control (Time in range 4-10mmol/L (%), COVID-
19: 81.2 ± 26.2, Non-COVID-19: 82.1 ± 20.9, P = NS, N = 17 per group) 
were comparable between groups (Figure  1). Finally, we examined 
the short term metabolic sequalae of COVID-19 by looking at anti-
hyperglycaemic use in 31 patients discharged from our hospital after 
their ICU admission for COVID-19. All patients who were commenced 
on insulin in ICU had insulin successfully withdrawn and there was no 
new initiation of oral anti-hyperglycaemic agents in this cohort.
Conclusion: Insulin requirements in severe COVID-19 are positively 
associated with severity of respiratory failure and pre-existing diabe-
tes. They are comparable to those seen in non-COVID-19 viral pneu-
monitis and resolve in convalescence. We did not find evidence to 
support the emerging hypothesis that SARS-CoV-2 is a uniquely dia-
betogenic virus.
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Introduction: Diuretic therapy to obtain a negative fluid balance is 
often used in patients with acute respiratory distress syndrome (ARDS) 
but its aggressive application can result in decreased renal perfusion 
and kidney injury (AKI). Since skin blood flow (SBF) is highly sensitive 
to a reduction in blood flow, we hypothesized that a reduction in SBF 
during tan attempt to decrease fluid balance could be associated with 
the development of AKI.
Methods: We included hemodynamically stable (mean arterial pres-
sure (MAP) ≥ 65 mmHg without an increase in norepinephrine (NE) 
dose in the least 6 hours at least) ARDS patients (Berlin criteria) in 
which intravenous furosemide administration was used in order 
to reach a negative fluid balance. Patients with AKI at baseline were 
excluded. SBF (Periflux 5000, Perimed; index finger; Perfusion unit: PU) 
together with hemodynamic variables, the ratio of arterial oxygen par-
tial pressure to fractional inspired oxygen  (PaO2/FiO2), central venous 
oxygen saturation (ScvO2) and blood lactate concentrations were 
obtained at baseline (T0) and after 24 hours (T24). Relative changes 
in SBF during first 24 hours (ΔSBF24) was recorded. Patients were 
separated by the occurrence of acute kidney injury (AKI) (AKIN criteria) 
within 7 days after T0. Receiver operating characteristic (ROC) curves 
were constructed and reported as areas under the curve (AUC) with 
95% confidence intervals to predict AKI.
Results: Of the 36 ARDS patients (pneumonia (26), abdominal infec-
tion (8), pancreatitis (2)) we studied, 14 developed AKI (12 stage 3 and 
2 stage 1). A strategy to achieve a negative fluid balance was initiated 
73 (50-96) hours after ARDS diagnosis. At baseline, there were no sig-
nificant difference between patients with and without AKI in SOFA 
score (8 (6-11) vs 11 (7-12), p = 0.2),  PaO2/FiO2 (p = 0.5), MAP (p = 0.9), 
cardiac index (p = 0.4), lactate concentration (p = 0.1), ScvO2 (p = 0.3) 
and SBF (p = 0.1) (Table  1).  At T24, lactate concentration increased 
and SBF decreased in both groups. However, ∆SBF24% was greater 
in patients who developed AKI than in those who did not (Table  1). 
∆SBF24% had the highest AUROC (0.90 ± 0.06 [0.76-0.1]) (p < 0.01) to 
predict the occurrence of AKI, with a cut off value of 45% (sensitivity 
74%, specificity 89%) (Figure 1)
Conclusion: Monitoring of SBF can be valuable to decrease the risk of 
AKI during a negative fluid balance strategy for ARDS.
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Introduction: Randomised controlled trials represent the cornerstone 
of modern evidence-based medicine [1]. There is increasing interest in 
the reporting of randomized controlled trials to ensure that research is 
transparently described [2]. Currently, the quality of reporting within 
the critical care literature is unclear.
Methods: A systematic search was undertaken to identify all rand-
omized controlled trials published within the four highest impact fac-
tor critical care journals between 1st January 2013 and 31st December 
2016. Randomised controlled trials involving children were excluded. 
Two researchers independently selected articles and marked them 
against the Jadad scale and the CONSORT reporting guideline to 
determine if any domains were lacking.
Results: 306 trials met the inclusion criteria over the four-year study 
period. Just under half were blinded randomized controlled tri-
als (139 of 298; 46.6%), and the median number of participants was 
95 (IQR: 175.25); nine trials enrolled in excess of 1000 participants. 
Median compliance with CONSORT was 75% (IQR: 15.7%). The three 
best reported items were background and rationale (298/298; 100%), 
Interpretation consistent with results (99.3%) and statistical methods 
comparing groups for primary/secondary outcomes (99.4%). The three 
worst reported items were any changes to commencement with rea-
sons (4.3%), important changes to methods after trial recruitment, 
with reasons (11.2%) and where the full trial protocol is if available 
(17.6%). There was an improvement in reporting over time, blinded 
trials had better reporting than unblinded trials, and trials with a trial 
registration had higher compliance.
Page 51 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Conclusion: Randomised controlled trials in critical care journals 
are typically well reported but some clear weaknesses should be 
addressed. These include location of a full protocol and a detailed 
description of any changes to the study after commencement.
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Introduction: COVID19 pandemic and the consequent surge of 
patients with acute hypoxemic respiratory failure has been challeng-
ing for intensive care departments around the globe.
Objectives: To describe the main clinical charateristics and ICU out-
comes in a cohort of adult patients with severe acute hypoxemic res-
piratory failure due to COVID19 admitted between 15 March and 15 
April in the ICU Catalan network.
Methods: Consecutive patients admitted between 15 March and 15 
April in 26 ICUs, who tested positive for SARS-Cov-2 (RT-PCR in a naso-
pharingeal swab) and had severe acute hypoxemic respiratory failure 
(need of at least 10 L/min oxygen flow to keep an oxygen arterial 
saturation -pulsioximeter- above 90%, and presenting with bilateral 
infiltrates in the chest X-ray). Demographic and relevant clinical and 
physiological data were colected within the first 24h of ICU admission. 
Follow-up time was til ICU discharge. Study was approved by the Eth-
ics Committee of the the coordinating center (Hospital Universitari de 
la Santa Creu i Sant Pau).
Results: A total of 1704 patients (1187 men and 517 women) were 
admitted. Median age was 63 yr (IQR 54-70) and median BMI was 28 
kg/m2 (IQR 26-32). Most frequent comorbidities were cardiovascular 
conditions (n = 480), diabetes (n = 90), cancer/immunosuppression (n 
= 74) and COPD (n = 31). ICU mortality was 505/1704 (29,6%). Among 
patients who required invasive mechanical ventilation (82% of the 
cohort), ICU mortality was 35% (491/1388). ICU mortality very much 
differed between patients up to 60 yr (n = 705) and older than 60 yr 
(n = 999): 12,8% (90/705) and 41,5% (415/999) respectively, p < 0.001. 
The median length of ICU stay was 13 days (IQR 7-25).
Conclusion: COVID19 severe hypoxemic respiratory failure mainly 
affects men, the vast majority will require invasive mechanical ventila-
tion for a long period of time and the overall mortality is substantial. 
People older than 60 yr have a dismal prognosis.
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Introduction: The declaration of the Novel Coronavirus (COVID-19) as 
a pandemic lead to the implementation of surge plans and an increase 
in the number of intensive care units beds across most healthcare 
facilities. Health care workers (HCWs) in the ICU are frontlines of this 
crisis as they deal with critically ill patients affected by COVID-19 which 
can potentially affect their mental wellbeing and causes different lev-
els of stress and psychological disorders.
Objectives: We aimed to determine the prevalence of stress among 
HCWs involved in the management of critically ill COVID-19 patient, 
identify the risk factors associated with stress, and highlight the availa-
bility of psychological support provided to HCWs and its effectiveness.
Methods: A cross sectional multicenter, international study using a 
web-based questionnaire of 27 questions including the Perceived 
Stress Scale [PSS] for assessment of stress level. Questions to identify 
the risk factors for stress and the psychological support provided by 
each health care facility in addition to the socio-demographic charac-
teristics were included.
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Results: We received a total 1501 response from 59 countries, 526 
(35%) were from Europe, 432 (28.7%) from Asia, 283 (18.85%) from 
Africa and 159 (10.59%) from North America. A totalof 657 (43.95%) 
were senior doctors, 455 (30.43%) were nurses, 278 (18.60%) were 
junior doctors and 105 (7.04%) others (clinical pharmacists, physi-
otherapists and respiratory therapists). Most responders were male 
844 (56.22%). The overall average stress level was 22 points on the 
PSS denoting moderate stress, while 508 (33.36%) respondents had a 
severe level of stress, 788 (51.87%) respondents had moderate level of 
stress and only 223 (14.61%) had mild stress.
Fear of infection was the major concern for more than 80% of all the 
respondents, where 717 (58.5%) reported that fear of getting infected 
with COVID-19 increased their stress level while 290 (23.67%) reported 
that the fear of transmitting the infection to their families was the 
main cause of their stress.  Other contributing factors to stress were, 
the increased duty hours, the increased work load and shortage of 
staff as reported by 89 (7.26%) while the lack of (personal protective 
equipments) PPEs accounted for stress in 68 (5.63%) respondents. 
Social media and triaging COVID patients were the least causes of staff 
stress as quoted by 39 (3.1%) and 38 (3.1%) respectively.
Although 805 (53.67%) of respondents reported receiving psycho-
logical support from their facility, 689 (45.93%) reported not receiv-
ing any support. 302 (26.24%) received psychiatric counselling, 613 
(53.26%) received phone calls and motivational emails/messages, 515 
(44.74%) received phone calls for psychological support from their 
facility, 428 (37.19%) reported active listening to their concerns, 208 
(18.07%) received psychological support from the community in the 
form of positive words and applauses. 444 (38.61%) reported the psy-
chological support was somewhat effective, 371 (32.26%) said that it 
was very effective while 335 (29.19%) said that it was not effective at 
all. 829 (55.45%) tried some ways to decrease their stress like religious 
services, anxyolytics, exercise and watching movies
Conclusion: Stress level was rated to be moderate to severe among 
intensive care HCWs during this pandemic, many risk factors were 
identified emphasizing the importance of psychological support dur-
ing that unprecedented pandemic and adjusting different ways for 
mitigating such stress.
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Introduction: Psychological safety is defined as an environment “safe 
for interpersonal risk taking” (1). It allows staff to voice concerns with-
out fear of negative repercussions. This can reduce clinical error, lead 
to workplace innovation and enhance staff wellbeing (2).
The importance of psychological safety has led to the study of its ante-
cedents across many sectors  (2-4). This understanding needs to be 
built upon, focusing on the specific needs of each workplace.
Objectives: Our study had 3 objectives:
1. How psychologically safe is our intensive care (ICU) workforce?
2. How does context influence psychological safety?
3. Are there any negative consequences of psychological safety?
Methods: Participants were recruited from the multidisciplinary 
teams of 3 ICU’s within Imperial College NHS Trust. Semi-structured 
interviews were conducted, exploring attitudes towards psychological 
safety. Quantitative data were collected in the form of verbal agree-
ment with 7 statements (1) and the completion of the Safety Attitudes 
Questionnaire (SAQ) (5). Qualitative audio files were transcribed and 
analysed within NVIVO software using a thematic analysis approach. 
Quantitative data were analysed using Microsoft Excel & Graph Pad 
Prism.
Results: Interviews, verbal surveys and SAQ’s were completed by 30 
participants. 28 were in agreement that it was easy to ask for help, with 
20 agreeing that it is safe to take a risk on the team. 6 reported feeling 
that a mistake would be “held against” them [Figure 1]. The SAQ data 
corroborated this - 28 felt encouraged to report safety concerns. How-
ever, 11 were unsure this would be acted upon by management. Our 
thematic analysis highlighted areas where the context influenced an 
individual’s psychological safety [Figure  2]. These contextual factors 
included personality, culture & leadership. Counterintuitively - psy-
chologically safe teams in which individuals are encouraged to partici-
pate can lead to negative consequences for the team leader. This can 
take the form of distraction and fatigue. It was also reported that time 
taken for increased discussion and raising concerns could reduce the 
time available for other clinical work.
We demonstrated that psychological safety can be influenced by 
motivations other than patient safety – such as undermining others or 
self-promotion. [Figure 3]
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Conclusion: Our study demonstrates reassuring levels of psychologi-
cal safety within our sample of ICU staff. It also highlighted room for 
improvement – 1/3 felt at risk of repercussions after speaking up. We 
have created a model demonstrating how the context of each clinical 
scenario can influence psychological safety, and how this varies across 
different levels within the organisation. This allows leaders to iden-
tify contexts that can be modified in order to promote psychological 
safety.
Understanding the negative consequences of psychological safety 
and when they occur is important – if a clinician’s bandwidth is over-
loaded this can have implications both for employee well-being and 
patient safety. Team leaders can use this data to help foster a culture 
of openness whilst minimising the risk of negative implications.
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Introduction: Increased use of technology in Intensive Care Medi-
cine has become integral to the specialty over the last 50 years (1). 
This, accompanied by advances in medical practice, has led to larger 
quantities of data amongst ventilated patients and a need to accu-
rately record ventilator parameters to make clinical decisions (2). It is 
important to evaluate traditional paper-based data entry with new 
automated data capture in intensive care units to ensure continued 
best practice.
This audit aims to assess data collection failures in ventilator setting 
recordings amongst intubated and ventilated COVID-19 patients and 
directly contrast failures of hourly recording amongst the ICCA system 
and data entered in paper ICU flow sheets. We analysed 13,355 data 
entries over a one-week period in our ICU to compare recording failure 
of computer-based records and traditional flow sheet entry.
Objectives: The objective of this audit is to directly compare and 
analyse the performance of paper-based nurse led data entry against 
computer based patient recording. Primary end points were hourly 
recordings of the following values:  FiO2, SpO2, EtCO2, Respiratory 
Rate, Ventilator Mode, Tidal Volumes, Minute Volume, Peak Airway 
Pressure and Positive End Expiratory Pressure over a one-week period. 
By analysing the results, we aim to gain insight into the benefits and 
potential failures of automated computing in data recording as its use 
is further incorporated into clinical practice.
Methods: Hourly ventilator data record entry was retrospectively ana-
lysed for intubated patients from the 13th -19th of April in a Dublin 
teaching hospital ICU. The IT system and patient flow sheet for each 
patient were analysed. All data was available for inclusion. Patients 
who were extubated during the week were included until the hour 
of extubation. Hours when a result was not available for  FiO2, SpO2, 
EtcO2, Respiratory Rate, Ventilator Mode, Tidal Volumes, Minute Vol-
ume, Peak Airway Pressure and PEEP were recorded. These 13,355 
data points were separated by patient hours when either the ICCA sys-
tem or Nurse led patient flow sheet was used with 9270 patient hours 
in the ICCA arm and 4283 patient hours in the Paper recording arm, 
further analysis was based upon time of day, (day shift 0800-2000 and 
night shift 2000-0800). These data were then entered onto a database 
for analysis.
Results: 13,355 data entries were collated. Within the IT based ICCA 
system 4% (368 hours of 9270 hours) of data entries were unrecorded 
compared to paper flow sheet entries 7.6%, (487 hours of 4283 hours 
data entries). Of ICCA recordings that were missed 62.5% were missed 
during day shifts, (0800-2000) and 37.5% during night shifts, (2000-
0800). This contrasts with paper flow sheet entry in which 39.5% of 
data entries missed during day shifts and 60.5% during night shifts.
Results were also separated by parameter missed as percentage of 
total recorded hours. The ICCA system resulted in: End Tidal (2%), 
Peak Airway Pressure (0.728%), Minute Volume (0.65%), Tidal Volume 
(0.287%), SpO2 (0.12%), PEEP (0.12%),  FiO2 (0.077%), Ventilator Mode 
(0.066%) Respiratory Rate (0%). Percentages refer to hours missed as a 
proportion of total hours.
Paper flow sheets recording resulted in: End Tidal CO2(2.1%), SpO2 
(1.5%), Ventilator Mode (1.42%),  FiO2 (1.12%), PEEP (1%), Minute Vol-
ume (0.21%) Peak Airway Pressure (0.163%), Tidal Volume (0.14%), 
Respiratory Rate (0.02%).
Of note a range of data entry failures occurred across multiple param-
eters simultaneously. This was consistent with patient movement for 
diagnostic tests and procedures and was not removed from the data 
set.
EtCO2 performed poorly in both groups. It is hypothesised that air 
temperature and humidity change within the unit during the COVID-
19 epidemic contributed in part to these results.
Conclusion: Accurate data collection provides clinicians with the abil-
ity to make informed decisions on patient care. Our study concludes 
that ventilation parameters are recorded more accurately with the use 
of digital computer systems when total data failures are compared 
to total patient hours, (4% and 7.6%). The improved performance is 
even more clear if EtCO2 is removed as it results in 2.1% of 4% of the 
ICCA computing failures. While this confers more accurate data avail-
able for clinicians there were parameters where paper flow sheets had 
improved recording over automated data entry. These include peak 
airway pressure, tidal volume and minute ventilation while ICCA had 
improved performance in  FiO2, SpO2, ventilator setting and PEEP. 
EtCO2 had the worst recording rate amongst both modalities. We 
can conclude that the use of automated computing provides supe-
rior overall recording rates, however, nurse led paper flow sheets had 
improved recording in some parameters and recorded less proportion 
of data misses during daylight hours.
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Introduction: Peri-operative fluid management has long been iden-
tified as key to reducing post operative morbidity and mortality. 
Assessment of fluid responsiveness following administration of a fluid 
challenge can form part of a review of whether that patient requires 
additional fluid volume. (1) How the optimal fluid challenge should 
be delivered remains an area of ongoing research. Previous work has 
shown that 4 ml/kg is the minimum volume to reliably challenge the 
circulation but the rate at which the fluid should be given has not 
been fully investigated. (2)
Objectives: The primary objective was to determine if the rate of 
administration of a fluid challenge influences the percentage of 
responders and non-responders to fluid administration.
The secondary objective was to investigate whether the rate of admin-
istration influences the pharmacodynamic response to fluids in terms 
of maximum change and duration of change in haemodynamic vari-
ables including Pmsf and CO.
Methods: A prospective study of 40 post-operative patients was con-
ducted in the intensive care units at St George’s Hospital, London. 
They were randomized to receive a post operative 4 ml/kg fluid chal-
lenge over either 5 or 20 minutes. Stability criteria were assessed and 
then baseline observations including heart rate (HR), blood pressure 
(BP), mean arterial pressure (MAP), stroke volume (SV), cardiac output 
(CO), mean systemic filling pressure (Pmsf ) and central venous pres-
sure (CVP), where available, were recorded. These were repeated on 
completion of the fluid challenge and after a 5 and 10 minute inter-
val. Cardiac output measurements were recorded using a calibrated 
LiDCOplusTM monitor. Patients were considered fluid responsive if 
SV increased by more than 10% following a fluid challenge. Adequacy 
of fluid challenge was assessed as an increase in Pmsf of more than 
14%. The proportion of fluid and Pmsf responders were compared 
using Fisher’s exact test. ANCOVA models adjusted by baseline values 
and fluid responsiveness, were used to assess the impact of rate on 
haemodynamics. P values less than 0.05 were considered significant.
Results: Of the 40 patients randomized7 were excluded from analyses, as 
they did not meet stability criteria. In the group that received a fluid chal-
lenge over 5 minutes, 40% were fluid responsive and 11.1% were fluid 
responsive in the 20 minute cohort. This difference was not statistically 
significant, p = 0.1. In the 5 minute group 73.3% showed an increased in 
Pmsf of more than 14%, and 72.2% in the 20 minute group, p = 0.8. The 
rate of fluid administration does not affect the change in Pmsf, but has 
a significant effect on change in MAP (8.3 vs − 0.2 mmHg, p = 0.03), CO 
(0.6 vs − 0.3 L/min, p = 0.02) and SV (9.6 vs − 6.4 mL, p = 0.02).
Conclusion: No statistically significant difference between the rate of 
responders and non responders could be demonstrated with varying 
the rate of administration of the fluid challenge. However, a poten-
tially clinically significant difference was seen. The changes in Pmsf 
seen in both groups, suggests no difference in the adequacy of fluid 
challenge with varying rates. This may indicate a potential effect of the 
fluid challenge on venous resistance and highlights an area for future 
work.
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Introduction: It has been shown that observational studies often 
lead to biased results, even when statistical methods such as logistic 
regression and propensity score matching are used to adjust for con-
founding. This has specifically been shown for intensive care-related 
inferential problems [1, 2].
In observational critical care studies, the initiation or dose of the inves-
tigated treatment is often associated with baseline severity of illness 
and mortality risk. This causes endogeneity in estimation models (a 
correlation between the investigated treatment and the error term), 
which biases the analysis results. Endogeneity is a separate entity from 
confounding by indication, which arises through omitted variables. 
It arises from measurement error (imperfect calibration of severity-
of-illness scoring systems) and simultaneity (the decision to initiate 
treatment or the dose is influenced by the severity of illness but also 
influences the severity of illness) [2, 3].
We aimed to investigate the potential magnitude of endogeneity bias 
in the evidence base of a major intensive care guideline.
Objectives:
1. To identify which observational studies in the Surviving Sepsis Campaign 
(SSC) Guidelines’ evidence base are at risk of endogeneity and spurious 
causal inferences [4].
2. To identify which topics in the SSC Guidelines are most affected by these 
potentially biased studies.
Methods: We screened all references in the Surviving Sepsis Cam-
paign (SSC) Guidelines. We considered studies to be at risk of endoge-
neity bias when five conditions were met:
1. Observational non‑randomized study design, and;
2. Investigated an intervention whose initiation or dosing is positively or 
negatively associated with baseline severity of illness or mortality risk, and;
3. Aimed to analyse the relationship between the intervention and a clinical 
outcome, and;
4. Adjusted for baseline severity of illness by regression methods (such as 
linear, logistic or proportional hazards regression) or propensity matching, 
and;
5. Made implicit or explicit causal statements.
Results: We identified 167 observational studies in the guidelines’ 
evidence base. Sixty-five (39%) of these studies were at risk of endo-
geneity bias (Figure 1). None of these studies used a validated causal 
inference method to reduce endogeneity (e.g. an instrumental vari-
able approach.) Studies at risk of endogeneity bias were most preva-
lent among the guideline topics Fluid Therapy (5 studies) and Glucose 
Control (9 studies).
Conclusion: We found that 39% of the observational studies in the 
SSC Guidelines made causal statements while being at risk of endo-
geneity bias. The most affected topics were Fluid Therapy and Glucose 
Control. Their inclusion in a major guideline means these studies are 
not merely ‘hypothesis-generating’ and may influence treatment deci-
sions. Biased results caused by endogeneity may thus lead to patient 
harm. Clinicians and authors of guidelines should be aware of this 
potential bias.
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Introduction: The endothelial glycocalyx is a bio-active structure 
which lines blood vessels. Its importance in critical and peri-opera-
tive care is increasingly recognised.1  Shedding of key components 
of the endothelial glycocalyx such as syndecan-1, a proteoglycan, 
which bindsglycosaminoglycans, has been found to be associated 
with impaired microvascular blood flow following cardiac bypass sur-
gery.2 Glycocalyx degredation has also been found in ischaemia – rep-
erfusion in trauma patients with shock.3  Animal models have found 
antithrombin to reduce endothelial dysfunction following ischae-
mia-reperfusion injury.4  In our centre  we use a low central venous 
pressure (CVP) anaesthetic for liver resection surgery to decrease intra-
operative blood loss, which is then followed by goal-directed fluid 
therapy.5  We investigated whether there was impairment of micro-
vascular blood flow, evidence of endothelial glycocalyx shedding or 
changes in antithrombin concentrations in patients undergoing liver 
resection surgery.
Objectives: To establish:
• if there is evidence of endothelial glycocalyx shedding by measur-
ing serum concentrations of: syndecan-1, thrombomodulin, vas-
cular endothelial growth factor receptor (VEGF-R) or e-selectin 
in patients undergoing liver resection surgery
• if there were changes in antithrombin concentrations during liver 
resection surgery
• if endothelial glycocalyx shedding was related to microvascular 
blood flow.
Methods: This was a prospective observational study (REC no  14/
NE/1150) enrolling patients undergoing elective liver resection sur-
gery. Microvascular blood flow, measured using the MicroScan device 
(MicroVision Medical, Amsterdam) and physiological measurements 
were taken at pre-specified time points throughout the peri-opera-
tive period (T1, awake on day of surgery pre-operatively, T2 following 
induction of anaesthesia, T3 on exposure of the liver, T4 completion of 
liver resection prior to fluid resuscitation, T5 arrival at ICU, T6 comple-
tion of goal directed fluid therapy (GDFT)). Serum samples were taken 
from a subset of 20 patients at T2, T4 and T6. ELISA’s were carried out 
in duplicate for each sample at two dilutions. Results which fell outside 
of the standard curve were excluded from analyses.
Results: A total of 55 data sets were included in the analyses, 28 male 
and 27 female, mean age was 58 years (S.D. 13) and BMI 28.1 kg/
m2 (S.D. 5.4), 18% were smokers, 13% were diabetic and 76% had neo-
adjuvant chemotherapy.
Microvascular flow measurements decreased post-operatively and this 
fall was sustained after completion of GDFT. There was a fall in micro-
vascular flow index (MFI), proportion of perfused small blood vessels 
(sPPV) and perfused small blood vessel density (sPVD) from time 1 to 
T6 of 2.78 (2.42 – 2.98) vs 2.58 (2.08 – 2.83) p < 0.0001, 95.6 (87.4 – 99.8) 
vs 65.1 (61.3 – 66.8) p < 0.0001 and 4.85 (3.69 – 5.9) vs 5.77 (4.91 – 7.2), 
p < 0.0001 respectively.
There was a significant increase in syndecan-1 shedding and fall in 
antithrombin concentrations on completion of goal directed fluid 
therapy. Other markers of endothelial glycocalyx disruption decreased.
Table 2 – Markers of endothelial disruption (results displayed as median (IQR), Wilcoxon signed 
rank test is used to establish difference between groups) 
Biomarker Baseline  (T2) Post-operative  (T6)
syndecan-1 (pg/mL) 52.6 (42.7 – 52.6)





6.73 (5.6 – 7.6) 3.3 (2.5 – 3.7) p <0.0001 
e-selectin (ng/mL) 21.9 (10.1 – 21.9) 4.5 (2.2 – 7.5) P = 0.0001 
vascular endothelial 
growth factor receptor 
(VEGF-R) (ng/mL) 
10.4 (9.7 – 10.5) 1.7 (1.3 – 2.5) p = 0.001 
Antithrombin 110 (106 – 115) 96 (92 – 114) P = 0.04 
Syndecan-1 and other biomarkers were not related to microvascular 
perfusion parameters, morbidity or length of stay.
Conclusion: Microvascular blood flow decreased post-operatively 
and this was sustained despite completion of GDFT. There was a sig-
nificant increase in syndecan-1 concentration post-operatively, which 
may be due to disruption of the integrity of the endothelial glycocalyx 
membrane. However, there was a fall in other biomarkers, this could 
be dilutional. There was a fall in circulating antithrombin concentra-
tion which may be related to increased infiltration and binding to the 
endothelial glycocalyx following hypoperfusion. Further study of the 
glycocalyx in the peri-operative setting and its relation to microvascu-
lar blood flow is required.
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Introduction: The COVID 19 pandemic outbreak in Madrid over-
whelmed the capacities of our regional and local health system. 
Despite the local efforts to increase the critical care capacity we were 
faced with difficult decisions regarding allocation of a scarce resource. 
The optimal method for allocating critical care resources during a pan-
demic remains questionable [1].
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Objectives: To describe the cohort of patients evaluated with COVID 
19 disease and the associated factors with ICU eligibility. This study 
could provide relevant information to optimize benefits from critical 
care resources in future COVID 19 outbreaks.
Methods: This prospective observational study was conducted in a 
specialised trauma and emergency department ICU of a level-3 hos-
pital in Madrid, Spain. Our ICU staff evaluated adult patients with 
respiratory failure due to suspected COVID 19 infection at the ED. 
The decision about eligibility for ICU admission was guided using an 
institutional protocol including age, comorbidities and disease sever-
ity. We also collected data regarding gender, severity scores at time 
of evaluation (SOFA, CURB65), decision about eligibility (with inde-
pendence of ICU admission), ICU admission and in-hospital mortality. 
Data was analyzed using the software RStudio Version 1.2.5042 for 
windows. For the univariate analysis we used Chi square test for cat-
egorical variables and student T Test or Mann Whitney U Test for con-
tinuous variables. Multivariate analysis was performed with a logistic 
regression model.
Results: Between March 4th and April 20th 2020 we evaluated a total 
of 221 patients. In the univariate analysis, age, comorbid state and 
disease severity were inversely associated with ICU eligibility with sta-
tistical significance. The number of events in the non eligible group 
limited the number of explanatory variables in the multivariate model, 
we created an index of comorbid state simply adding the main comor-
bidities of each patient, SOFA score was excluded due to lack of linear-
ity. The resultant ligistic regression model showed adequate goodness 
of fit and predictive accuracy (Likelihood ratio test χ2(4) = 94.945 p < 
0.001. Pseudo R McFadden: 0.3837. Classification rate 0.85. Area under 
the curve for the ROC curve 0.8875 (95% CI [0.8365; 0.9385]). In this 
model only age and comorbidities retained statistical significance 
(Table 1).
Table 1: Comparison between eligible and non eligible patients for ICU 
admission 




OR (95% CI) 
Multi 
Age (years)  66.7 (SD 10.7) 52.3 (SD 11.8) <0.001 
0.91 (0.86-
0.95,p<0.001) 
Female 22 (39.3%) 44 (26.7%) 0.082 
0.60 (0.25-
1.41,p=0.233) 
Hypertension    29 (51.8%)  47 (28.5%) 0.002   
Diabetes 20 (35.7%) 19 (11.5%) <0.001   
OSA 12 (21.4%) 11 (6.67%) 0.004   
COPD 10 (17.9%) 3 (1.82%) <0.001   
Obesity 20 (35.7%) 41 (24.8%) 0.125   
Heart Disease 17 (30.4%) 6 (3.64%) <0.001   
Number of 
comorbidities * Ϯ 3.00[1.75;4.00] 1.00[0.00;2.00] <0.001 
0.46 (0.33-
0.65,p<0.001) 
SOFA* 3.00 [2.00;3.00] 2.00[2.00;3.00] 0.012 - 
CURB65* 2.00 [1.00;3.00] 1.00[0.00;2.00] <0.001 
0.71 (0.42-
1.15,p=0.170) 
Conclusion: The variables most associated with ICU eligibility were 
age and comorbid state proving that age was not the only factor 
accounted for. Female gender and CURB 65 was inversely associated 
with eligibility however this association was not significant in multi-
variate models.
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Introduction: Samples for diagnostic tests for SARS-CoV-2 can be 
obtained from the upper (nasopharyngeal/oropharyngeal swabs) or 
lower respiratory tract (sputum or tracheal aspirate or broncho-alve-
olar lavage - BAL). Data from different testing sites indicates differ-
ent rates of positivity1. Real-time polymerase chain reaction (RT-PCR) 
allows for semi-quantitative estimates of viral load as time to crossing 
threshold (Ct) is inversely related to viral load.
Objectives: The objective of our study was to evaluate SARS-CoV2 
RNA loads between paired nasopharyngeal (NP) and deep lung 
(endotracheal aspirate or BAL) samples from critically ill patients.
Methods: SARS-CoV-2 RT-PCR results were retrospectively reviewed 
for 51 critically ill patients from 5 intensive care units in 3 hospitals; 
Addenbrookes Hospital Cambridge (3 units), Royal Papworth Cam-
bridge (1 unit), and Royal Sunderland Hospital (1 unit). At the times 
when paired NP and deep lung samples were obtained, one patient 
had been on oxygen only, 6 patients on non-invasive ventilation, 18 
patients on ECMO, and 26 patients mechanically ventilated.
Results: Results collected showed significant gradient between NP 
and deep lung viral loads (Figure  1). Median Ct value was 29 for NP 
samples and 24 for deep lung samples. Of 51 paired samples, 16 were 
negative (below limit of detection) on NP swabs but positive (above 
limit of detection) on deep lung sample, whilst 2 were negative on 
deep sample but positive on NP (both patients were on ECMO).
Conclusion: It has been suggested that whilst SARS-CoV1 tends to 
replicate in the lower respiratory tract, SARS-CoV2 replicates more 
vigorously in the upper respiratory tract2. These data challenge that 
assumption. These data suggest that viral migration to, and prolifera-
tion in, the lower respiratory tract may be a key factor in the progres-
sion to critical illness and the development of severe acute respiratory 
syndrome (SARS). Factors which promote this migration should be 
examined for association with severe COVID-19. From a practical point 
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of view, patients with suspected severe COVID-19 should have virolog-
ical samples obtained from the lower respiratory tract where-ever pos-
sible, as upper respiratory samples have a significant false-negative 
rate.
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Introduction: The CoVID19 pandemic led to a complete reorganiza-
tion of our anesthesiology and critical care medicine department 
(composed of 8 ICU beds, 12 intermediate care unit beds (IMCU) and 
32 operating rooms (OR))(1). In order to face the increasing demand 
of ICU beds, our 12 IMCU beds were transformed into ICU beds, 40 
ICU beds were created within the 3 post-anesthesia care units of our 
hospital, leading to a total of 60 ICU beds and only 13 OR remaining 
opened. The majority of caregivers working usually in the OR worked 
in these new ICUs outside the walls from March 23d to May 7th 2020.
Objectives: One month after the end of the pandemic, we conducted 
an anonymous e-survey among caregivers of our department, with the 
aim of identifying what happened, what went right, what went wrong 
and what to do in the case of a second wave of CoVID19 infections.
Methods: This project received the approval of the research ethics 
committee of the French Society of Anesthesiology and Intensive Care 
Medicine (SFAR). Participation was free. Our survey was composed of 
10 questions with rating scales (0 to 10) to assess job satisfaction, qual-
ity of care delivered and quality of life at work, with tick box catego-
ries and free text to evaluate the main positive/negative points related 
from their experience and the main actions to be taken in case of a 
second wave, with Likert scales to evaluate the relationships between 
caregivers and on demographic data.
Results: 130 people answered our questionnaire, mainly women (n = 
84; 65%), the majority younger than 40 years old (n = 94; 72%) and 
the majority with a past experience in critical care (n = 92; 71%). The 
participation rate varied across professions: 100% for head of nurses (n 
= 3), 65% for nurses (n = 44), 45% for anesthetist nurses (n = 22), 47% 
for nurse assistants (n = 20), 100% for physiotherapists (n = 6); 100% 
dieticians (n = 2); 50% for residents (n = 16), 70% for physicians (n = 
14). The levels of job satisfaction, quality of care delivered and qual-
ity of life at work were respectively 6.9 (± 2), 7.2 (± 2) and 5.8 (± 2). 
The main positive points reported were the collaboration and solidar-
ity between colleagues (n = 76; 58%) and the feeling of being useful 
(n = 62; 48%). The main negative points reported were the working 
conditions difficulties (environment, logistics, material protection) (n 
= 95; 73%) and the lack of visibility of their schedule or hospital ICU 
organization (n = 36; 27%). The two main areas for improvement sug-
gested were the optimization of logistics organization (n = 74; 57%) 
and working within the same unit (n = 59; 45%). The majority weresat-
isfied with their relationships with physicians (n = 123; 89%), nurses (n 
= 127; 98%) or other allied health workers (n = 95; 73%).
Conclusion: During the epidemic, the 3-fold increase of ICU beds and 
the closing of the majority of OR were associated with a big change 
in the work habits of our caregivers. Despite the difficulties related to 
working conditions, caregivers have been strongly resilient with the 
complete reorganization of our department during the CoVID19 pan-
demic. The existence of an association with this new organization and 
patient outcomes must be explored.
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Introduction: Despite some new evidence, the use of noninvasive 
continuous positive airway pressure (nCPAP) during coronavirus dis-
ease 2019 (COVID-19) is still an issue. In a large population of COVID-
19 patients treated with nCPAP we aimed to identify early factors 
associated with intubation.
Methods: Post hoc analysis of an observational prospective-ret-
rospective multicentre study performed in six Italian hospitals. We 
included in this analysis all patients treated with nCPAP outside ICU 
due to COVID-19 and candidate to intubation in case of nCPAP fail-
ure. We collected demographic and clinical data at hospital entrance 
and  PaO2/FiO2 percentage increase between Venturi mask  (PaO2/FiO-
2VENT) and nCPAP  (PaO2/FiO2nCPAP) i.e., ΔPaO2/FiO2, calculated as 
 (PaO2/FiO2nCPAP -  PaO2/FiO2VENT)/  PaO2/FiO2VENT x 100.
Results: From March 1st to April 15th, a total of 397 patients with 
confirmed COVID-19 were treated with nCPAP with a full treatment 
therapeutic goal. Of these, 8% of the patients were excluded from the 
analysis as intubated on the same day nCPAP was started. Univariate 
analysis showed that among the demographic and clinical patients’ 
characteristics, age (65 (IQR, 55–71) vs. 68 (IQR 58-73) years), lactate 
dehydrogenase (LDH) (518 (IQR, 360-676) U/L vs. 654 (IQR, 486-922) 
U/L), white blood cells (6.75(IQR, 5.11-8.91)  ×  103/µL vs. 7.04 (IQR, 
5.17-10.00) × 103/µL) resulted significantly lower in patients succeed-
ing nCPAP compared to those who failed nCPAP and were intubated. 
Percentage increase in  PaO2/FiO2 (87(IQR, 7-203) vs. 44(IQR,12-120)) 
was higher in patients who succeeded nCPAP compared to those who 
failed. Male gender was also significantly associated with intubation. 
A multivariate analysis adjusting for age, gender, Charlson comor-
bidity index, percentage increase in  PaO2/FiO2, lactate, white blood 
cell count, LDH and C-reactive protein levels led to an area under 
the curve of 0.77 and confirmed that age (relative risk, 1.023; 95% CI, 
1.005-1.043), LDH (relative risk, 1.001; 95%CI, 1.000-1.001), and  PaO2/
FiO2 (relative risk, 1.002; 95%CI, 1.001-1.003), were strong predictors of 
intubation.
Conclusion: In patients with acute hypoxemic respiratory failure due 
to COVID-19 receiving nCPAP outside ICU  PaO2/FiO2, LDH at hospital 
entrance and age were predictors of intubation.
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Introduction: Amongst patients admitted to intensive care (ICU) with 
COVID-19 the reported incidence of acute kidney injury (AKI) ranges 
from 3% to 66%.[1] In the United Kingdom (UK) 26% of patients admit-
ted to ICU with COVID-19 required renal replacement therapy (RRT).[2] 
At our institution RRT in ICU is usually exclusively provided as Continu-
ous Veno-Venous HaemoDiaFiltration (CVVHDF). During early stages 
of the pandemic it became apparent that demand for RRT - driven 
by a surge in ICU admissions, high rates of AKI and shorter than usual 
filter lifespan - threatened our ability to provide timely organ support 
to critically ill patients with COVID-19, a situation that was being rep-
licated globally.[3] During the first 2 months of the pandemic in the 
UK we introduced a number of measures designed to extend our abil-
ity to provide RRT, including introduction of acute peritoneal dialysis 
(aPD) and intermittent haemodialysis (IHD).
Objectives: To describe the incidence of AKI in patients admitted to 
ICU with COVID-19 at a large teaching hospital in London, UK. To eval-
uate how the introduction of alternative modalities of RRT (aPD and 
IHD) - not usually offered in our ICU - were able to reduce dependence 
on CVVHDF. To report any complications associated with using aPD 
and IHD in these critically ill patients.
Methods: We carried out a retrospective review of patients’ electronic 
medical records as part of a departmental service evaluation (ref: 
KCC06052020AIA). We recorded baseline demographics, incidence 
of AKI (defined using KDIGO serum creatinine criteria) [4] and details 
regarding RRT received and complications of RRT for all patients 
admitted to our ICU with a diagnosis of COVID-19 between 10/03/2020 
(date of first patient admitted with COVID-19) and 10/05/2020.
Results: 177 patients with COVID-19 were admitted to the ICU. Exclud-
ing patients who were transferred from other institutions (n = 34) and 
patients with established End-Stage Kidney Disease (ESKD, n = 7) the 
incidence of AKI was 79%. Most (86%) developed severe (stage 3) AKI. 
63% of patients required RRT, which was initiated a median of 4.5 (IQR 
2-7) days after ICU admission. As of 16/06/2020, of patients who devel-
oped severe AKI, 49% had died, 8% were still admitted to the ICU, 22% 
had been discharged from the ICU but were still in hospital and 22% 
had been discharged home. Almost all ICU survivors hadrecovered 
renal function to the point of being free of RRT (95%). Median dura-
tion of RRT in those who recovered was 21 (IQR 13-29) days. Peritoneal 
dialysis catheter insertion was attempted in 41 patients and successful 
in 34 (83%). 15 patients (44%) were subsequently exclusively treated 
with aPD, whilst 19 required some supplemental CVVHDF. Common 
reasons for reverting to CVVHDF included: clinical deterioration not 
attributed to PD (n = 5); elevated urea (n = 5); fluid overload (n = 4); 
hyperkalaemia (n = 3). No patients were reported to have had dete-
rioration in ventilatory parameters or peritonitis. A reverse osmosis 
(RO) plant was installed within the ICU on 18/04/20, and IHD began 
on 20/04/20. 82 HD sessions were delivered to 15 patients. Transient 
hypotension was reported during 11 sessions (13.4%). On one occa-
sion the session was terminated due to marked hypotension. At the 
start of the pandemic 100% of RRT was delivered as CVVHDF. With 
the introduction of aPD and IHD this fell to a nadir of 39%. During the 
study period a total of 463 patient days of CVVHDF were replaced with 
either aPD or IHD.
Conclusion: In our study most patients admitted to ICU with COVID-
19 developed severe AKI. It was only possible to provide RRT to these 
patients by expanding the range of RRT modalities offered to include 
aPD and IHD.  Through close collaboration between the critical care 
and nephrology departments this was achieved rapidly, effectively 
and with no serious adverse events during pandemic conditions.
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Introduction: The energy delivered to the respiratory system during 
mechanical ventilation can be measured as mechanical power (i.e. 
work over time) and has been associated with increased in-hospital 
mortality. [1] A previously proposed concept of mechanical power 
(here referred to as Respiratory System-directed Power) [2] is easy to 
calculate but includes energy dissipated into the chest wall as well as 
static work from positive end-expiratory pressure (PEEP), both prob-
ably not causal to lung injury. These issues could be addressed by 
excluding PEEP as well as using transpulmonary pressure (PL) instead 
of airway pressure (Pao).
Objectives: To compare and assess the agreement between Respira-
tory System-directed Power and two alternative calculations in mechan-
ically ventilated patients suffering from ARDS.
Methods: Using data from a previous, randomized trial (EPVent) [3], 
mechanical power was calculated from pressure-volume loops: (1) 
Respiratory System-directed Power based on Pao and including static 
work from PEEP; (2) Respiratory System-directed Driving Power based 
on driving pressure (Pao-PEEP); (3) Lung-directed Driving Power based 
on PL change from end-expiration. Estimates were compared at base-
line using repeated measures ANOVA and Bland-Altman analysis. We 
further investigated how the study intervention – a PEEP titration to 
achieve positive PL – affected agreement among the estimations.
Results: In 4,803 breathing cycles from 53 patients, Respiratory System-
directed Power yielded a median 37.2 [IQR 24.1;51.4] J/min, followed by 
Respiratory System-directed Driving Power (14.2 [11.0;19.8]) and Lung-
directed Driving Power (13.4 [9.9;18.8] J/min, overall p < 0.001). There 
was poor agreement between Respiratory System-directed Power and 
the other two estimates (bias 24.2 [20.8; 27.7], limits -0.2 [-6.1;5.7] 
to 48.7 [20.8;27.7] J/min against Respiratory System-directed Driving 
Power and 25.6 [21.9;29.2], limits -0.5 [-6.8;5.9] to 51.7 [45.3;58.0] J/min 
against Lung-directed Driving Power) and good agreement between 
Respiratory System-directed Driving Power and Lung-directed Driving 
Power (bias 1.4 [95% CI 0.8;1.9], limits -2.3 [-3.2;-1.4] to 5.0 [4.1;5.9] J/
min). In a subgroup of 21 patients, Respiratory System-directed Power 
increased after PL-guided PEEP titration by 5.8 ±12.4 J/min (p = 0.033) 
with no change in the other estimates, increasing bias and limits of 
agreement between Respiratory System-directed Power and the other 
two estimates.
Conclusion: In mechanically ventilated patients without spontane-
ous breathing activity, inclusion of PEEP into calculation of mechani-
cal power may greatly increase the estimate. Calculations including 
PEEP show poor agreement with calculations excluding PEEP or made 
based on PL. Clinical data are required to elucidate how these differ-
ent concepts relate to patient outcome.
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Introduction: For many decades red blood cells (RBC) transfusion 
remains the main treatment for acute and even chronic anemia. How-
ever, numerous clinical trials estimatedthe risks of RBC transfusion 
ascomparable with those of anemia and associated with increased 
mortality [1]. Recognition of the fact promotes search for more rigor-
ous and less formal transfusion triggers.
Objectives: To compare blood transfusion effectiveness assessment 
based on oxygen extraction ratio (ExRO2), arterial-venous oxygen dif-
ference (A-Vdiff) and central venous oxygen saturation (ScvO2) with 
those using only blood hemoglobin (Hb) level.
Methods: Prospective observational study included 59 patients with 
mean age of 57 ± 14,3 years and initial Hb 72 ± 12,0g × l-1. ScvO2, 
ExRO2 ((CtaO2–CtvO2)/CtaO2)´100%), A-Vdiff (CtaO2–CtvO2) and 
serum lactate were measured andcalculated before and after RBC 
transfusion. According to the initial ExRO2 all the patients were 
divided between two groups – I (≥ 40,0%, n = 20) and II ( < 40%, n = 
39).
Results: After transfusion, in group IExRO2 significantly decreased 
by 9,1 ±  2,5% (p < 0,05), ScvO2 increased by 7,0 ±  2,6% (p < 0,05), 
while in group IIboth ExRO2 and ScvO2 changes were less (5,9 ± 1,0% 
and 5,9 ±  1,1% respectively, both p < 0,05). A-Vdiff after transfusion 
did not drop significantly in both groups: 0,8 ± 2,8 and 0,7 ± 1,2ml×l-
1 respectively (both p > 0,05). Serum lactate decrease was significant 
in groupI (0,5 ±  0,2mmol × l-1, p < 0,05) and negligible in group II 
(0,3 ± 0,1mmol×l-1, p > 0,05). Notably, Hb levels were similar among 
the two groups with different ExRO2 levelsbefore and after transfu-
sion. These results are presented in Table 1.
Parameters 









ExRO2, % 43,7±5,6 34,6±8,7 34,0±5,6 28,1±5,8 
ScvO2, % 55±5,3 62±8,6 64,2±6,2 70,1±5,8 
A-Vdiff, ml×l-
1
40,7±8,4 38,6±12,7 28,6±7,2 28,8±7,1 
Lac, mmol×l-1 1,3±1,0 0,8±0,5 1,1±0,7 0,8±0,7 
Hb, g×l-1 72,7±12,4 81,2±13,0 70,0±12 82,0±12,5 
Spearman correlation between ExRO2 and ScvO2 showed strong neg-
ative relationship in both groups (before 0,9 and 0,8; after 1,0 and 0,9 
respectively); the same coefficient between ExRO2 and A-Vdiff was 0,5 
before and 0,8 after transfusion. ExRO2 and Hb demonstrated weak 
negative connection: −  0,2 before transfusion in both groups, 0,1 
and–0,2 after transfusion in groups I and II respectively.
Conclusion: ExRO2 assesses anemia severity and compensation 
degree more correctly in comparison to Hb level only. This parameter 
reveals effectiveness of transfusion, and can be used as the alternative 
transfusion trigger. ScvO2 has also showed some value as blood trans-
fusion trigger, while having certain restrictions as systemic oxygen 
balance criterion because of unreliable correlation with mixed venous 
oxygen saturation.
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Objectives: There is increasing evidence of antifungal underdosing in 
the treatment of invasive disease, particularly in special populations 
such as the obese. Body size is often an important variable affecting 
drug exposure, and pharmacokinetic (PK) models of antifungal dosing 
have suggested size-based dose adjustments to achieve target drug 
exposure.
Rezafungin (RZF) is a novel echinocandin in Phase 3 development for 
treatment of candidemia and invasive candidiasis (IC) and for preven-
tion of invasive fungal disease caused by Candida, Aspergillus, and 
Pneumocystis in blood and marrow transplant recipients. Distinctive 
PK properties of RZF (e.g., long half-life, extensive tissue distribution, 
and front-loaded drug exposure) lend themselves to RZF once-weekly 
(QWk) dosing and antifungal efficacy.
Methods: To evaluate outcomes of the Phase 2 STRIVE trial of RZF 
QWk for the treatment of candidemia and/or IC compared with caspo-
fungin (CAS) once-daily (NCT02734862)1, based on patient BMI.
Results: The STRIVE trial (NCT02734862) compared the safety and effi-
cacy of RZF QWk compared with once-daily caspofungin . For this sub-
analysis, data were stratified by BMI categories of < 30 kg/m2 and ≥ 30 
kg/m2. Efficacy (overall response [resolution of clinical signs of infec-
tion + mycological eradication], mycological response, and investiga-
tor assessment of clinical response) and safety (treatment-emergent 
adverse events [TEAEs]) endpoints by treatment group were evalu-
ated, as well as PK data (area under the curve [AUC]) from RZF-treated 
patients
Mean BMI values were similar across treatment arms (26.9 kg/m2 in 
RZF Group 1 and 26.8 kg/m2 in RZF Group 2 and CAS arms). Efficacy 
outcomes at Day 14 were similar between BMI categories (Table  1). 
Rates of TEAEs were generally similar between BMI categories as well 
(Table 2), with no concerning safety trends. Following one dose of RZF 
400 mg (Week 1), the ranges of AUCs by BMI category overlapped and 
there was a minor mean difference of ~20% (lower for those with BMI 
≥ 30 kg/m2).
Conclusion: The safety, efficacy, and PK of RZF in the Phase 2 STRIVE 
trial was consistent across BMI categories. These results suggest that 
dose adjustments in obese patients are not necessary. These findings 
contribute to the evaluation of RZF in a range of patient populations 
and its ongoing development.
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Introduction: A hospitalization due to COVID-19 in the intensive 
care units (ICU) is challenging for patients, their families, and ICU pro-
fessionals. In addition to coping with the uncertainties of a widely 
unknown disease, visits is limited or even prohibited during a pan-
demic. These restrictions require special attention and trigger uncon-
ventional ways for personal contact among ICU professionals with 
families in order to provide required informations and support.
Objectives: This Delphi study aimed 1) to explore the opinions and 
experiences of experts during the COVID-19 pandemic in relation to 
supporting ICU patients and their families; and 2) to provide recom-
mendations for supporting families during a pandemic.
Methods: A two-round modified Delphi processassessed the opinions and 
experiences of experts from Germany, Switzerland, Austria and Lichten-
stein between May and June 2020. Experts included ICU professionals, 
patients, and family members. 120 experts answered anonymously the 
first online questionnaires with 33 questions based on a literature review 
and recommendations of ICU experts. Each question contained an addi-
tional comment section. The answers were analyzed and transformed into 
a second questionnaire with 16 questions and comment sections, which 
was answered by 131 experts. Data analysis will include descriptive statis-
tics and content analysis of the answers in all comment sections.
Results: First results indicate that experts perceived family support 
on ICU as highly important during the COVID-19 pandemic. Enabling 
contact amongst patients, families and clinicians is regarded essential 
to build hope and confidence. The role of a designated contact per-
son, who delivers frequent and consistent information and builds a 
supportive and professional relationship, may even be more impor-
tant. The extraordinary situation leads to the implementation of new 
communication structures to support families and to document the 
patients’ ICU stay for future processing. The use of video calls, or other 
forms of communication are mostly wanted under the condition that 
data security is guaranteed, and that enough personnel and technical 
resources are available. Some experts see a potential for application of 
such new resources beyond the current pandemic.
Conclusion: During a pandemic, virtual contacts are essential for 
COVID-19/ICU patients and respective families to gain and main-
tain faith confidence in ICU professionals and ICU treatment. Ethical 
considerations are crucial in deciding what forms of communication 
would be most appropriate, considering data security, resource distri-
bution, and the information need of patients and their families.
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Introduction: The COVID-19 pandemic brings a large number of peo-
ple experiencing critical care admissions. It is important to profile the 
physical rehabilitation required by patients admitted to hospital with 
COVID-19 in order to identify the physical side-effects of critical care 
admission and to determine the rehabilitation services required by 
this patient group.
Objectives: The aim of this study is to profile the acute rehabilitation 
pathway of people with COVID-19 admitted to critical care.
Methods: This study was a retrospective patient chart audit of all 
patients admitted to critical care with COVID-19 between March 16th 
and May 2nd, 2020. Ethical approval was granted for this study. Demo-
graphic information and information regarding critical care stay was 
collected for each patient. Physical rehabilitation was assessed against 
standardised rehabilitation milestones as per the ICU Mobility Scale.
Results: A total of 64 patients were admitted to critical care (65% 
male, mean age 60 years SD 14.1). 56 had a confirmed diagnosis of 
COVID-19 on testing, while 8 patients were classified as ‘highly suspi-
cious’ for COVID-19. A total of 14 patients died in critical care and 1 
patient remains in critical care, leaving 49 patients for inclusion in the 
rehabilitation audit. 33 (67%) of these patients were intubated, with 
an average critical care length of stay of 16 days (SD 15.1, range 2-69 
days). All patients were referred for physical rehabilitation during their 
critical care stay (range: 0-49 sessions).
On average, patients began active rehabilitation sitting over the edge 
of the bed 11 days (range 3-46 days) after ICU admission. Patients pro-
gressed to step transfers from bed to chair a mean of 1.35 days later 
and mobilised away from the bedside a mean of 4.05 days later. In 
total 26 (53%) participants experienced a documented oxygen desatu-
ration during physical rehabilitation, the majority while transferring 
out of bed and mobilising (SaO2 90-95% n = 9, SaO2 85-90% n = 11, 
SaO2 80-85% n = 4, SaO2 75-80% n = 2).
A total of 43 (88%) patients had independent mobility before admis-
sion to critical care, while 6 (12%) required mobility aid/assistance with 
mobility. On discharge from hospital 34 (69%) patients had returned 
to baseline mobility levels, while 6 patients required increased aids/
assistance with mobility when compared to baseline levels. A further 
9 patients (18%) were still receiving inpatient rehabilitation at the time 
of this audit.
Conclusion: Findings of this study indicate that patients with COVID-
19 who survived a stay in critical required inpatient physical reha-
bilitation. Once rehabilitation began, a large proportion of patients 
progressed quickly through functional mobility classifications to 
become independently mobile. A sub-set of patients in this audit have 
required extensive inpatient physical rehabilitation following a critical 
care stay.
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Introduction: Covid-19 severe ARDS is frequently associated with 
venous thrombosis and pulmonary emboli. The first events we diag-
nosed lead us to recommend a high heparin prophylaxis (4000 IU 
enoxaparin bid or 6000 IU bid if weight > 120  kg; targeted anti-Xa 
activity 0.3-0.5 UI/mL) or an Immediate use of curative anticoagulant 
therapy (enoxaparin 100 IU/kg bid or unfractionated heparin 500 IU/
kg/d; targeted anti-Xa 0.5-0.7 UI/mL).
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Objectives: To evaluate the risk factors and epidemiology of deep 
venous thrombosis (DVT) and pulmonary emboli (PE) when this strat-
egy is applied to all the Covid-19 patients with ARDS.
Methods:All the consecutive patients with severe ARDS due to SARS-
Cov2 were systematically followed until hospital discharge or day60. 
Doppler US of the vein was routinely performed to all patients. IV CT 
scan was performed as clinically indicated. We recorded daily clinical 
and biological covariates as well as antimicrobial, anticoagulant and 
anti-inflammatory therapies from ICU admission to ICU discharge. 
Patients were followed until hospital discharge or day 60. No patient 
was lost to follow-up.
We use a competing cause-specific risk model to evaluate the risk 
of DVT/PE during the follow-up (SAS 9.X, SAS system NC, USA). We 
tested variables at ICU admission and variables collected daily as 
time-dependent covariates. Variables collected at time t-1 were used 
to model even occurring at time t. A p value of 0.05 or less was con-
sidered significant. The impact of time-dependent DVT/PE on patients’ 
survival was tested using a Cox model.
Results: Of the 134 patients with Sars-Cov2 ARDS admitted in our ICU 
(age 59.5 [51; 69]; SAPSII: SOFA 5 [4; 7]), 47 (35.1%) died at day 28. 21 
developed a DVT/PE (10/21 ultimately died), 45 died without DVT/PE 
and 68 were censored alive without DVT/PE. Main characteristics of 
the patients and anticoagulant therapy used at ICUadmission are on 
Table.
The cause specific model identified high SOFA score, use of central 
vein catheter, hypothermia less than 36 °C, high BUN, high ALAT, high 
LDH, low hematocrit, high neutrophils count as risk factors of DVT/
PE. Neither anticoagulant therapy (curative vs prophylaxis) given the 
day before nor anti-Xa activity were related with DVT/PE risk. Platelet 
count, prothrombin time, fibrinogen level, fibrin monomers, D-dimer, 
troponin levels were not related to DVT/PE risk.
DVT/PE was not related to survival even after adjusting on comorbidi-
ties and SOFA score at ICU admission HR = 1.679; 95%CI [0.802; 3.512], 
p = 0.17
Conclusion: Even when using a high-risk prophylaxis, curative antico-
agulant therapy, DVT/PE occurred in 16% of cases. The risk is higher 
in patients with high SOFA score, renal and hepatic failure, high neu-
trophil count suggesting that other mechanisms than coagulation (i.e. 
endothelial activation and/or hypofibrinolysis) may concur to throm-
boembolic events.
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Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 has 
spread at great speed throughout the world. Between 15 and 25% of 
hospitalized patients infected with COVID-19 develop acute kidney 
injury (AKI).
Objectives: TTo describe the incidence, evolution and prognosis of 
Acute Kidney Injury (AKI) in critically ill patients with the COVID–19 
disease.
Methods: A multicenter, descriptive, observational study includ-
ing COVID-19 patients admitted to 19 Catalonian UCIs. Usual demo-
graphic variables, drugs, AKI development, several therapies, mortality 
and ICU/hospital stay were collected.
Descriptive statistics and logistic regression analysis for AKI develop-
ment and mortality were used.
Results: A total of 936 patients were enrolled, of whom 66% were 
men and mean age was 64(17) years. APACHE II and SOFA scores were 
13(8) and 5(4), respectively. Viral pneumonia with ARDS was observed 
in 88% of the patients. MV was required by 76% of patients, and in 
addition, 56% required prone position, 66% received vasopressors 
and 51% treatment with glucocorticoids. AKI prevalence at ICU admis-
sion was 28.4% and increased during ICU stay up to 43.6%: 29.4% was 
developed in the first 72 hours and 36% in the following 7 days. Only 
88 (9.3 %) required RRT.
AKI occurred more frequently in older patients (66 years vs 59 years), 
males (74% vs 61%), those with higher ICU scores (APACHE II: 15 vs 10, 
SOFA: 6.5 vs 5), hypertension (58% vs 42%), CPOD (9.7% vs 5.9%), CKD 
(10% vs 1, 3%), diabetes mellitus (29% vs 18%) and chronic ischemic 
heart disease (7% vs 4%).
AKI was more frequent in ARDS severe patients (59% vs 43%, p < 
0.001), in MV patients (91.5% vs 78%, p < 0.001) and required more 
prone position (69% vs 58%, p < 0.001). The treatment included Rem-
desivir (2.3% vs 0.5%, p < 0.039), interferon (32% vs 23%, p < 0.009), 
glucocorticoids in patients with shock (6% vs 1.1%, p < 0,001) and 
vasopressors (86% vs 63%, p < 0,001).
AKI patients developed more infections during ICU stay: ventilator 
associated pneumonia (VAP) (35% vs 22%, p < 0.001) and catheter 
related bloodstream infections (17% vs 11%, p < 0.021).
Risk factors associated with AKI development were age (IC 1.02-1.05), 
gender (male IC 1.4-2.9), APACHE II (1.02- 1.07), SOFA (1.1-1.2), CKD 
(3.13-21.6), Shock (2.03-4.4) and VAP (1.11-2.3).
Mortality in ICU stay was 30% and overall in-hospital mortality 33%. 
Mortality was increased in AKI patients in both groups: ICU stay (47% 
vs 15%, p < 0,001) and in-hospital (51.7 % vs 16. 5 %, p < 0,001).
AKI was an independent factor associated with mortality (IC 1.5 - 3.45). 
Mortality was higher in patients that required RRT both in the ICU (57 
% vs 44 %, p < 0.04) and in-hospital (62.5% vs 48%, p < 0.03). The dura-
tion of ICU stay was longer in AKI patients (22 vs 16 days, p < 0.001).
Conclusion: There is a high incidence of AKI in critically ill patients 
with COVID 19 disease and it is associated with higher mortality, 
increased organ failure, nosocomial infections and prolonged ICU stay.
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Introduction: Patients infected with COVID-19 are recognised to have 
a spectrum of neurological complications. In a systematic review, of 
those who survived, 65% developed delirium during their intensive 
care stay [1]. Current models assessing delirium in the Adult Intensive 
Care Unit (AICU), such as E-PRE-DELIRIC, lacks discriminant variables 
for the prediction of delirium in patients with COVID-19 [6]. Further-
more; the increased in length of stay (LOS) for those with COVID-19 
(average 20 days) invalidates models such as E-PRE-DELIRIC which has 
been modelled on an average LOS of 6 days.
The pathogenesis of delirium in AICU is thought to be a combination 
of disease severity, hypoxia, highinflammatory response and throm-
bosis; all elements present in patients with COVID-19 [3–5]. Conse-
quently, further research into mental health surrounding COVID-19 
has been set as a priority [6].
Objectives:
1. To test the validity of E‑PRE‑DELIRIC in patients with COVID‑19.
2. Develop an internally valid, COVID‑19 specific, delirium prediction model 
using Bayesian Hamiltonian Markov Chain Monte Carlo methods.
Methods: Anonymised data from SARS-CoV-2 positive patients admit-
ted to AICU at Chelsea and Westminster Hospital was collected from 
the 9th of March to the 18th of May 2020. CAM-ICU or author consen-
sus was used to identify patients who underwent delirium assessment. 
Observational, pathological, and ventilatory variables from patients 
were extracted from electronic patient records. Forward variable 
selection strategy was used in the patient’s recovery phase; this phase 
was identified through dichotomisation of their AICU stay following 
an alignment procedure that centres the patients’ stay, such that day 0 
is the day with their lowest  PaO2/FiO2 (PF) ratio. The resulting dataset 
was split into a training cohort (80%) and a validation cohort (20%).
Analysis was performed in R version 4.0. Candidate variables were 
standardised to a mean of 0 and a standard deviation of 1 prior to the 
use of BRMS as an interface to Stan. Receiver Operator Curves (ROC) 
and the Area Under the Curve (AUC) are used to demonstrate model 
performance.
Results: 66 patients were screened of which 31 were excluded result-
ing in the identification of 23 patients with delirium and 12 patients 
without delirium (Figure 1).
The alignment procedure successfully identified the recovery phase 
with U-shaped PF ratio pattern centred on the lowest ratio (Figure 2).
E-PRE-DELIRIC was found to be inaccurate in the prediction of delirium 
in patients with COVID-19 with an AUC of 48.6%. DELIPIOUS, a Bayes-
ian model with priors informed from both the delirium and COVID-19 
literature, was developed demonstrating good performance with an 
AUC of 76.7% (Figure 3). The proposed model uses biologically plausi-
ble variables that reflect the pathogenesis of delirium in COVID-19. By 
defining the recovery period and using values within, temporal rela-
tionship between the timing of the variables’ values and onset of delir-
ium is maintained. This reduces the lag-time between variable value 
and outcome given the prolonged stay of COVID-19 patients resulting 
in higher accuracy.
Conclusion: E-PRE-DELIRIC has a poor performance in those with 
COVID-19. DEPLIPIOUS uses biologically plausible variables that reflect 
the pathogenesis of delirium in COVID-19 resulting in an accuracy of 
76.7%. It requires external and prospective validation prior to its clini-
cal use.
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Introduction: A substantial proportion of Intensive Care unit (ICU) 
survivors develops psychological impairments in the aftermath of 
ICU treatment, such as post-traumatic stress disorder (PTSD), anxiety 
and depression (1). These impairments are the major determinant for 
decreased health-related quality of life (HRQoL) (2), and it is hypoth-
esized that an unmet need for information regarding ICU-treatment 
might be an important contributing factor (3). An effective evidence-
based treatment for these psychological impairments and this need for 
information is still lacking. Virtual reality (VR) exposure therapy for sev-
eral psychological disorders is effective and safe and could provide an 
adequate method to deliver the desired information of the ICU period 
(3). To date, it is unknown whether Intensive Care specific VR exposure 
in survivors of critical illness decreases psychological sequelae.
Objectives: To examine the effect of ICU-specific Virtual Reality (ICU-
VR) on psychological sequelae and quality of life.
Methods: We conducted a multicenter, randomized pilot study in ICU 
patients admitted with sepsis or septic shock and mechanically venti-
lated for ≥ 24 hours. A week after ICU discharge, patients were rand-
omized into the control or intervention group. The intervention group 
received ICU-VR, providing both exposure to the environment trauma-
tizing them in combination with information regarding several aspects 
of their ICU treatment. The control group received a static VR environ-
ment for the same duration of time. Safety of ICU-VR was assessed by 
monitoring vital signs and the simulator sickness questionnaire (SSQ). 
Psychological sequelae and HRQoL were assessed at baseline (T0) and 
2 days (T1), 7 days (T2), 1 month (T3) and 6 months (T4) after initial 
exposure to VR. Depression was assessed using the Beck Depression 
Inventory (BDI), and PTSD using the Impact of Event Scale – Revised 
(IES-R). HRQoL was assessed using the Short-Form 12 (SF-12) and the 
EuroQol 5 dimensions (EQ-5D).
Results: We included 50 patients, median age 61 years (IQR: 51-68), 
median APACHE IV score of 77 (IQR: 57-106) and an median ICU length 
of stay of 16 days (IQR: 8-31). During VR exposure, no changes in vital 
signs were observed and none of the individual SSQ items were scored 
as severe. After 1 month (T3), patients in the intervention group scored 
significantly lower on PTSD (IES-R sum score, median (IQR): 8 (3-13) vs. 
17 (12-26), P = 0.003) and depression (BDI sum score, median (IQR): 8 
(6-12) vs. 12 (8-18), P = 0.04). This effect persisted at 6 months after ICU 
discharge (T4) for PTSD (IES-R sum score, median (IQR): 5 (1-13) vs. 23 
(10-27), P = 0.01), but not for depression (BDI sum score, median (IQR): 
4 (2-12) vs. 10 (6-17), P = 0.07) (Figure). Subsequently, although we 
observed no difference in the physical quality of life between groups, 
patients in the intervention group reported a better mental quality of life 
1 month after VR exposure (Mental Component Scale (MCS-12), median 
(IQR): 57 (53-61) vs. 47 (39-49), P = 0.002), but not at 6 months after ICU 
discharge (MCS-12, median (IQR): 50 (41-58) vs. 47 (39-56), P = 0.43).
Conclusion: We demonstrate that ICU-VR decreases PTSD and depres-
sion up to 6 months after ICU discharge, is safe and improves mental 
quality of life. Further research is needed to confirm these effects on a 
larger scale.
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Introduction: Although patients with SARS-CoV-2 infection have sev-
eral risk factors for ventilator-associated lower respiratory tract infec-
tions (VA-LRTI), the reported incidence of hospital-acquired infections 
is low.
Objectives: We aimed to determine the relationship between SARS-
CoV-2 pneumonia, as compared to influenza pneumonia or no viral 
infection, and the incidence of VA-LRTI. Secondary objectives were to 
determine the relationship between SARS-CoV-2 infection and the eti-
ology and outcomes of VA-LRTI.
Methods: Multicenter retrospective European cohort performed in 
36 ICUs. All adult patients receiving invasive mechanical ventilation 
for more than 48h were eligible for this study if they had: SARS-CoV-2 
pneumonia, influenza (A or B) pneumonia, or no viral infection at ICU 
admission. VA-LRTI, including ventilator-associated tracheobronchitis 
(VAT) and ventilator-associated pneumonia (VAP), were diagnosed 
using clinical, radiological and quantitative microbiological criteria. 
All VA-LRTI were prospectively identified, and chest-X rays were ana-
lyzed by at least two physicians. Cumulative incidence of first episodes 
of VA-LRTI was estimated using Kalbfleisch and Prentice method, and 
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compared using Fine-and Gray models. This study is registered on 
ClinicalTrials.gov, NCT04359693.
Results: 1576 patients were included (568 in SARS-CoV-2 group, 482 
in influenza group, and 526 in no viral infection group). VA-LRTI inci-
dence was significantly higher in SARS-CoV2 patients (287, 50.5%), as 
compared to influenza patients (146, 30.3%, adjusted sub hazard ratio 
(SHR) 1.60 (95% confidence interval (CI) 1.27 to 2.00)) or patients with 
no viral infection (133, 25.3%, adjusted SHR 1.65 (95% CI 1.22 to 2.22)). 
VA-LRTI were mainly caused by Gram-negative bacilli (Pseudomona 
aeruginosa, Enterobacter spp., and Klebsiella spp.). VAP was associ-
ated with increased adjusted HR for 28-day mortality in SARS-CoV-2 
and influenza groups, and for duration of ICU stay in all study groups.
Conclusion: The incidence of VA-LRTI is significantly higher in patients 
with SARS-CoV-2 infection, as compared to patients with influenza 
pneumonia, or no viral infection.
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Introduction: Critically ill patients survival is increasing nowadays 
parallel to fragilty and morbidity in long therm surviving ICU patients, 
thus the role of caregivers in some cases has become essential.
Objectives: First, to evaluate the main caregiver overload of chronic 
patients roled in our Home Mechanical Ventilation Unit (driven by 
intensive care physicians) using the Zarit Burden Interview. Secondly, 
to describe the characteristics of our caregivers and patients.
Methods: The evaluation was perform with a presential interview to 
the main caregiver of all the patients included in our program during 
12 months, from January 2018 to January 2019. We applied the Zarit 
Burden interview, which classifies the caregiver as a sum of various 
items, in 3 grades: absence of overload ( < 46 points), mild overload 
(46-55), heavy overload ( > 56 points) (Figure 1). Epidemiological data 
of caregivers (age, sex, number of carers, state economical help) and 
patients (age, sex, Barthel Index, diagnostic).
Results: In 12 months, 49 patients and caregivers were roled in our 
study. Zarit Burden Scale of caregivers: 6 (12,2%) abscense of overload, 
28 (57,1%) mild overload and 15 (30,6%) with heavy overload.
Caregiver Characteristics: mean age 53,58  ±  15,61, women 38 
(77,5%); one single caregiver in 28 (57,1%); state ecomomical signifi-
cant help in 26 (53%).
Patient data: mean age 43,73 ± 13,1, man 33 (67,3%), Barthel Index 
45,42 ± 33,2 (IC95% 36,1-54,7), diagnostic: Amyotrophic Lateral Scle-
rosis ALS in 22 (45%), other myopathies and neuromuscular diseases 
16 (32,6%), dificulty in weaning 11 (22,4%) due to mechanical ventila-
tion dependency: COPD (6), critical patientpolineuromiopathy (4), oth-
ers (1). From these, NIMV (6), IMV (5).
Conclusion: In our caregivers using the Zarit Burden Scale shows that 
more than 85% have moderate-severe overload. Women is the preva-
lent carer (77%). Neumomuscular diseases is the most importante 
cause for roling our unit, becoming ALS the most prevalent disease 
(45%). This unit has become a great alternative for patients with dif-
ficult in weaining in our in intensive care units, 11 patients (22,4%) can 
be treated at home with their families, even so, bigger efforts needs to 
be performed to improve overload in caregivers.
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Introduction: ICU-acquired infections (ICU-AI) are associated with 
substantial morbidity and mortality, but there are few large-scale 
epidemiological studies and investigations of risk factors, including 
predictive biomarkers, are currently limited. Genomic-led approaches 
identified two distinct Sepsis Response Signatures (SRS1 and SRS2) 
using hierarchical clustering of leucocyte genome-wide gene 
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expression in patients admitted to ICU with sepsis [1]. The SRS1 endo-
type is characterised by features of immunosuppression and increased 
mortality.
Objectives: To elucidate the risk factors for ICU-AI, compare outcomes 
between those with or without ICU-AI, and assess the influence of SRS 
endotype on ICU-AI.
Methods: Patients in whom ICU-AI was clinically diagnosed at any 
time during ICU admission were identified from a cohort of 2054 
patients admitted with sepsis to 34 ICUs in the UK [2]. 1697 (82.6%) 
patients with an ICU length of stay > 48 hours were included in the 
analysis. Univariate analysis comparing between those with and with-
out ICU-AI was calculated for continuous variables using linear model 
ANOVA and Kruskal-Wallis test (for non-normally distributed data), 
and Pearson’s Chi-squared test (X2) (categorical variables). Logistic 
regression modelling used all potentially significant independent 
variables from univariate analysis (p < 0.2), with backward selection of 
significant variables for the final models. A weighted Cox-regression 
model was used to assess effect of ICU-AI on 6-month mortality.
Results: A total of 687 ICU-AIs were recorded. 462 (27.2%) patients 
developed one or more ICU-AI. The most common were ventilator-
associated pneumonia (n = 208, 12.3% of all patients), line-related 
infection (n = 115, 6.8%), and wound infection (n = 111, 6.5%). These 
accounted for 63.2% of all ICU-AIs. Patient demographics (age, race, 
sex, Charlson score) did not differ between those with or without 
ICU-AI. Those with ICU-AI had higher severity scores on admission 
(APACHE II score [median 18 vs 16, p < 0.001], SOFA score [median 8 
vs 6, p < 0.001]). ICU-AI was significantly associated with the level of 
organ support and steroid therapy [p < 0.001]. In those in whom SRS 
endotype had been assigned (n = 871), the last available SRS endo-
type was significantly associated with ICU-AI. In patients with the SRS1 
(immunosuppressed endotype), 30.8% (n = 89) developed an ICU-AI 
compared to 20.8% (n = 121) of those with the SRS2 (immunocompe-
tent endotype) (p = 0.002, X2). Renal replacement therapy (RRT) (OR 
1.85, 95% CI 1.11-3.09, p = 0.019) and inotropic support (OR 1.84, 95% 
CI 1.17-2.91, p = 0.009) were independent risk factors for ICU-AI. ICU-
AI was associated with increased risk of death at six months (HR 1.31, 
95% CI 1.08 – 1.61, p = 0.0056).
Conclusion: Risk factors for ICU-AI include illness severity, level of 
organ support, steroid therapy and the SRS1 transcriptomic endotype. 
RRT and inotropic support were independently associated with ICU-AI. 
ICU-AI is associated with increased mortality.
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Introduction: Patients admitted to intensive care units (ICUs) are at 
higher risk of death because of their underlying illness, often wors-
ened by the occurrence of healthcare associated infections (HAIs). The 
Simplified Acute Physiology Score (SAPS) II is one of the most used 
scoring systems to evaluate the severity of illness of patients admitted 
to ICU and to predict their risk of dying.
Objectives: The main aim of this study was to evaluate the ability of 
SAPS II to predict the risk of 7-day mortality of patients admitted to 
ICU, and to compare its performance with a machine learning algo-
rithm combining the SAPS II with additional patients’ characteristics at 
ICU admission.
Methods: For this purpose, we used data from seven biennial editions 
(i.e. from 2006-2007 to 2018-2019) of the “Italian Nosocomial Infec-
tions Surveillance in Intensive Care Units” (SPIN-UTI) project. Overall, 
3,782 patients staying in ICU for at least 7 days and those who died 
within the same timeframe constituted the test set. The training set, 
instead, was made of 4589 recovered and synthetic records. The accu-
racy of the SAPS II for predicting 7-day mortality was evaluated using 
the receiver operating characteristic (ROC) curve and computation of 
the Area Under the Curve (AUC). Next, the Support Vector Machine 
(SVM) algorithm was applied to improve the predicting performance 
of the model, by combining the SAPS II with the following variables 
collected at ICU admission: gender, origin of the patient, trauma 
patient, impaired immunity, antibiotic treatment, patient needed 
acute coronary care, surgery before ICU admission, presence of intu-
bation, presence of urinary catheter, presence of central vascular 
catheter.
Results: The proportion of deaths was 23.1% in the test set and 43.4% 
in the training set, respectively. No differences in the SAPS II and other 
patient’s characteristics at ICU admission were evident. The SAPS II 
was able to discriminate patients who died from those who did not, 
with an accuracy of 69.3% and AUC of 0.678 (95%CI = 0.657 - 0.700). 
However, the SVM algorithm improved the predicting performance of 
the model, reaching anaccuracy of 83.5% and AUC of 0.896 (95%CI = 
0.881 - 0.910). Notably, the SAPS II was the predictor which weighted 
more on the model. Indeed, both accuracy and AUC dropped to 68.4% 
and 0.653 (95%CI = 0.632 – 0.675) by removing the SAPS II from the 
algorithm.
Conclusion: The SVM algorithm - which combined the SAPS II with 
additional patients’ characteristics at ICU admission – exhibited higher 
predicting performance than the SAPS II alone. This model repre-
sented a simple tool to quickly predict patients at the highest risk of 
death at ICU admission, allowing them to be prioritized and poten-
tially reducing the mortality rate.
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Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 has 
spread at great speed throughout the world. Between 15 and 25% of 
hospitalized patients infected with COVID-19 develop acute kidney 
injury (AKI).
Objectives: To describe renal replacement therapy (RRT) in COVID-19 
patients at the admission in intensive care units (ICU).
Methods: A multicenter, descriptive, observational study of COVID-19 
patients admitted to 19 Catalonian ICUs. Patients with acute kidney 
injury (AKI) and RRT requirements were included. Data of descrip-
tive variables including severity and evolution of the AKI, associated 
complication, circuit permeability, filter duration and need of RRT at 
discharge were analyzed. Frequency and percentage (categorical) and 
mean (SD) or median (RI) (quantitative) are presented. X2/T-Fischer 
or T-Student/U-Mann Whitney were applied. Data were presented 
as frequency (percentage) and mean (standard deviation) or median 
(95%RI).
Results: A total of 934 patients were included, 66% men, mean age 
64(16.8) years. APACHE II and SOFA at admission were 13(8) and 5(4) 
respectively. Information was collected on the following comor-
bidities: arterial hypertension (45%), obesity (34%), diabetes mellitus 
(20%) and COPD (7%). Chronic kidney disease was present in 4.5% of 
patients. AKI at the ICU admission was 28.4% and increased to 44% 
during ICU stay. NSAIDs were administrated to 25.9%, contrast-media 
to 18,8% and ACE inhibitors to 10,5%. AKI patients presented ventila-
tor-associated pneumonia VAP (35.7%), UTIs (16.6%) and intravascular 
catheter-related infection (14%).
A total of 88 patients (9,3%) required RRT. At the initiation of RRT 
patients presented with KDIGO I: 2.5%, II: 6.2%, III: 91.4% (creatinine 
mean was 3.91(1.6) mg/dL). Indications of RRT initiation were: anuria 
(62%), fluid overload (51.1%), hyperkalemia (33%), sepsis (20.5%) and 
uremic syndrome (14.8%). RRT duration was 7 (RI 9) days (CVVHDF 
(62.4%), CVVHD (35.3%), CVH (2.,4%)); and iHD 3 (RI 6.5) days.
Heparin was the most commonly prescribed anticoagulant for use 
during continuous RRT (61.4%), followed by ARC (45,5%) and a minor 
percentage of no anticoagulation (6.8%). Filter/patient median was 3 
(RI 4); filter life with ARC was 2 (RI 1.23), with heparin 1.71(1.53) and 
without anticoagulation 1(1.63) days. Complications: catheter dys-
function (26.1%), early/non expected coagulation (23.9%), thrombo-
cytopenia (14.8%), bleeding (5.7%) and hypothermia (5.7%). Only one 
patient required adsorption techniques. A quarter of patients (24.7%) 
needed RRT at ICU discharge. Overall ICU mortality was 57.1% in RRT 
patients, 44.3% in AKI without RRT and 14.9% in patients without AKI.
Conclusion: A high percentage of patients required RRT for AKI at the 
admission or during ICU stay, with a mortality rate exceeding 50%.
Management and complications are not different from the usual clini-
cal practice.
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Introduction: Surgery initiates inflammation which contributes to 
postoperative morbidity and mortality.
Objectives: We aimed to assess the effects of dexamethasone on 
postoperative complications in patients undergoing major surgery.
Methods: In a multicenter, randomized, double-blind trial, patients 
over 50 years of age undergoing non-cardiac surgery with expected 
duration of more than 90 minutes were recruited from 34 centers. We 
randomly assigned patients to dexamethasone (0.2 mg.kg-1 immedi-
ately after the procedure, and on day + 1) or to placebo. Randomiza-
tion was stratified on two criteria: cancer and thoracic procedure. The 
primary outcome was a composite of major complications (including 
sepsis, pneumonia and the need for mechanical ventilation) and all-
cause mortality occurring within the first 14 days following surgery.
Results: Of the 1,222 patients, 613 patients were randomized to 
dexamethasone, and 609 to placebo. In intention-to-treat analysis 
after multiple imputation for missing data, 104 patients (17.1%) in 
the dexamethasone group and 123 patients (20.4%) in the placebo 
group had major complications or died within 14 days after surgery 
(adjusted odds ratio, 0.78; 95% confidence interval [CI], 0.59-1.04; 
P = 0.09, crude odds ratio 0.79; 95%CI, 0.60-1.07, P = 0.13). The haz-
ard ratios with dexamethasone for sepsis (including pneumonia) and 
for mechanical ventilation were respectively 0.82 (95%CI 0.61-1.12, P 
= 0.21) and 0.68 (95%CI 0.53-0.88, P = 0.003). In the a priori defined 
randomization stratum of patients with non-thoracic surgery, primary 
outcome occurred less frequently in the dexamethasone group than 
in the placebo group (P = 0.04). Adverse events were reported in 47% 
and 48.6% of patients who received dexamethasone or placebo (odds 
ratio: 0.92; 95%CI 0.74-1.15).
Conclusion: After major non-cardiac surgery, dexamethasone did not 
result in significantly less mortality or fewer major complications 14 
days after surgery. (Funded by French Ministry of Health, PHRCN 2016, 
number clinicaltrials.gov NCT03218553).
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Introduction: It is unclear when the effects of the coronavirus will 
subside and a surge in demand for critical care follow-up is antici-
pated. The requirement to provide a rehabilitation service within the 
context of social distancing and reconfigured outpatient infrastructure 
presents a set of new challenges to the delivery of optimal patient 
care.
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Objectives: 1. To explore the feasibility of managing critical care 
recovery via remote coaching enabled by smartwatch technology.
2. Report physical measures at the point of hospital discharge and on 
follow-up
Methods: The use of smartwatch ambulatory health monitoring tech-
nology in COVID-19 critical care discharges was set up across eight 
trusts in Surrey, Sussex and Kent, UK. Worthing Hospital also imple-
mented a digitally integrated multidisciplinary team (MDT) approach 
(physiotherapists, exercise physiologist, critical care, respiratory and 
general practice clinicians) using this smart watch data to support our 
critical care COVID-19 survivors.  Smartwatch data was shared by the 
patient with the MDT via synchronisation with a smartphone app. The 
MDT met remotely every 4 weeks to review patients’ progress and dis-
cuss goal setting. Baseline data was collected at discharge and follow 
up data points are at 3 months and 12 months respectively.
Results: From the first 13 patients reviewed (mean age 58, SD 10), 
mean heart rate per minute has slowed from 98 (SD 11) at hospital dis-
charge to 75 (SD 5) at six weeks, whilst daily step count has increased 
from 1187 (SD 486) to 5407 (SD 3153). Shuttle walk test distance 
increased from 69 metres (SD 78) at hospital discharge to 364 (SD 
221) on three-month follow-up, with air oxygen saturations increasing 
from 86% (SD 8) to 93% (SD 3). The MDT were able to provide a patient 
personalised follow up pathway, providing  earlier intervention than 
would have occurred with a face-to-face patient follow up.
Patient engagement with the programme was high with over 90% of 
patients regularly wearing and uploading smartwatch data. Patients 
responded well to the technology and incorporated the feedback 
from the devices into their personalised rehabilitation programmes. As 
further patients return for follow up this dataset will increase substan-
tially over time.
Conclusion: Remote rehabilitation is feasible and offers an alter-
native to traditional post critical care follow-up.  Regular, proactive 
review of smartwatch data combined with a remote MDT faciliated a 
unique, personalised and sustainable model for post critical care fol-
low up. Future work will aim to expand this model to a wider cohort of 
critical care survivors.
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Introduction: During novel coronavirus disease (COVID-19) pandemic 
outbreak, a large number of patients required respiratory support 
due to severity of the respiratory involvement. Noninvasive ventila-
tion delivered as continuous positive airway pressure (CPAP) for de 
novo acute hypoxemic respiratory failure (ARF) isstill debated. To face 
the overwhelming wave of patients, hospitals converted many gen-
eral wards in respiratory intermediate units (RICU), where COVID-19 
patients requiring respiratory support could be treated with CPAP out-
side intensive care unit (ICU).
Objectives: The study aims to investigate the role of CPAP outside ICU 
during COVID-19 pandemic, describing the clinical characteristics of 
patients and ascertaining whether the CPAP duration affects outcome 
in patients requiring endotracheal intubation.
Methods: We performed a multicenter, retrospective observational 
study in six hospitals of Eastern Piedmont Region in Northern Italy. All 
patients admitted to one of the participating hospitals from March 1st 
to April 15th 2020 with hypoxemic ARF secondary to COVID-19 infec-
tion were eligible. Inclusion criteria were: 1) age ≥  18 years, 2) res-
piratory distress and partial pressure of arterial oxygen to fraction of 
inspired oxygen ratio < 200 mmHg during low flow oxygen therapy, 3) 
CPAP initiation outside ICU. Patients were classified according to pre-
defined CPAP therapeutic goal in two subgroups: 1) full treatment, i.e. 
patients scheduled to receive intubation in case of CPAP failure; and 2) 
do-not-intubate (DNI), when CPAP was the ceiling of treatment.
Results: During the study period, 537 patients received CPAP outside 
ICU in the six Eastern Piedmont hospitals. The median age was 69 (IQR, 
60-76) years. Median CPAP duration was 4 (IQR, 1-8) days, while hospi-
tal LOS 16 (IQR, 9-27) days. According to predefined CPAP therapeu-
tic goal, 397 (74%) patients were included in full treatment subgroup, 
and 140 (26%) in the do-not intubate (DNI) subgroup. Sixty-day in-
hospital mortality was overall 34% (95%CI, 0.304-0.384), 21% (95%CI, 
0.169-0.249) and 73% (95%CI, 0.648-0.787) for full treatment and DNI 
subgroup, respectively. In the full treatment subgroup, in-hospital 
mortality was 42% (95%CI, 0.345–0.488) for 180 (45%) CPAP failures 
requiring intubation, while 2% (95%CI, 0.008–0.035) for the remaining 
217 (55%) patients who succeeded. Delaying intubation was associ-
ated with increased mortality [HR, 1.093 (95%CI, 1.010-1.184)].
Conclusion: Our study suggests that CPAP is feasible outside ICU even 
during COVID-19 outbreak. In-hospital mortality is related to thera-
peutic goal and patients with pre-set therapeutic limitations showing 
a higher mortality rate. Intubation delay is an independent risk factor 
for mortality.
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Introduction: Coronavirus disease 2019 (COVID-19) is associated with 
coagulation abnormalities leading to numerous thromboembolic 
complications. Obesity is a risk factor for severe COVID-19 disease and 
patients with obesity have relatively high leptin serum levels. In addi-
tion, high serum leptin levels are associated with hypercoagulation. 
Rotational thromboelastrometry (ROTEM®) is a digitized modification 
of thromoboelastography reported to be useful in identifying hyper-
coagulable conditions.
Objectives: The aim of this study was to determine the correla-
tion between serum leptin levels and ROTEM® profiles of COVID-19 
patients.
Methods: In a cross-sectional design, we included patients who were 
treated in the Intensive Care Unit with COVID-19 at the same time. 
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Blood samples were collected for serum leptin measurement (ELISA 
kit MD53001 IBL International, Hamburg, Germany, performed accord-
ing to the manufacturer’s instructions) and ROTEM® thomboelastom-
etry. Coagulation patterns were analyzed using extrinsic and intrinsic 
rotational thromboelastometry activators (respectively EXTEM and 
INTEM). The following variables were recorded and analyzed: clotting 
time (CT), clotting formation time (CFT), clot firmness’ amplitude after 
5 minutes (A5) and after 10 minutes (A10), and maximum clot firm-
ness (MCF). Spearman’s correlation coefficients were determined for 
all variables.
Results: Thirty-one COVID-19 patients were included, of which 23 
(74%) were male. The mean age was 62.5 years (Standard Deviation 
(SD) 9.7), and the mean BMI was 31.2 kg/m2 (SD 5.7). The median 
serum leptin level was 12.2 (range 1.0 – 85.2) ug/L. BMI was signifi-
cantly correlated to serum leptin level r = 0.49; p = 0.001. Table  1 
shows the correlation of leptin and ROTEM variables.







 0.210 0.258 
INTEM CFT -0.422 0.018 
INTEM MCF  0.262 0.154 
FIBTEM CFT -0.108 0.563 
FIBTEM MCF  0.023 0.904 
Table 2 shows the correlation of leptin and conventional coagulation variables. 
Table 2. Spearman’s correlation P-value





Prothrombin  0.143 0.350 
Fibrinogen -0.010 0.960 
Antithrombin III  0.244 0.129 
The only variable that was significantly correlated with serum leptin 
level was clot formation time, both for EXTEM and for INTEM tests. An 
inverse correlation was found, meaning that higher leptin levels were 
correlated with a shorter clot formation time. The conventional clot-
ting tests were not significantly correlated with serum leptin level.
Conclusion: ROTEM® measurements of clot formation time were 
significantly inversely correlated with serum leptin levels, which may 
indicate that leptin plays a role in the hypercoagulable state that is 
present in COVID-19 patients treated in the ICU.
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Introduction: Specific features differentiate SARS-CoV2-induced 
acute respiratory failure from the classical definition of acute respira-
tory distress syndrome (ARDS) [1]. By lung computed tomography (CT) 
it is possible to characterize extension and severity of lung damage 
and infer regional lungs mechanics during ARDS [2]. The role of lung 
CT for SARS-CoV2 related lung engagement remains to be confirmed.
Objectives: A primarily subpleural distribution of lung infiltrates 
induced by SARS-CoV2 has been hypothesized. The correlation 
between the extent of lung infiltrated and days of spontaneous 
breathing has never been tested before.
Methods: This study has been performed on CT images collected from 
20 patients affected by a severe form of SARS-CoV2 infection in need 
of intensive care. Chest CT, acquired during static conditions and with-
out contrast agent were selected. For each CT, twenty equally spaced 
images between apex and diaphragmatic dome were analyzed. Each 
CT image was divided into three subpleural regions of interest (ROIs 
- between 0 and 1 cm; 1 and 2 cm; 2 and 3 cm) concentric to the vis-
ceral pleura. Four quadrants (external non-dependent,internal non-
dependent, internal dependent, external dependent) were delineated 
for each lung, depending on figures centroids (Figure). Quadrants 
were used to differentiate between atelectasis, affecting dependent 
regions, and SARS-CoV2 specific lung infiltrates in the external and 
non-dependent regions. Four lung Hounsfield units (HU) compart-
ments were defined [3]: hyper (− 1,000 to − 800 HU), normally (− 800 
to − 500 HU), poorly (− 500 to − 100 HU) and not inflated (− 100 to 
+  100 HU). Friedman’s test (α-value < 0.05) was used for statistics. 
Days of spontaneous breathing with and without ventilatory support 
were defined for each patient.  Correlations between HU compart-
ments and days of spontaneous breathing were performed (Spearman 
correlation, rs, α-value < 0.05).
Results: Twenty-three chest CT were analyzed. Hypo-inflated and 
not-inflated compartments were significantly more represented in 
the subpleural regions of the lung (0-1 cm) compared to more central 
ones (2-3 cm), both in dependent and not dependent quadrants. Con-
sistently, the amount of normo-inflated lung was more represented 
in deeper regions of the lung. The hyper-inflated compartment was 
significantly more represented in non-dependent subpleural lung 
regions (0-1 cm). A positive correlation was found between days of 
spontaneous breathing and hypo-/not- inflated lung compartments, 
in not-dependent (rs = 0.54, p = 0.017) and external regions (rs = 
0.49, p = 0.032).
Conclusion: The primarily subpleural distribution of SARS-CoV2 spe-
cific lung infiltrates has been confirmed using objective lung-CT analy-
sis. Further, it subsequently extends towards more central regions of 
the lung. A direct correlation between extent of SARS-CoV2-induced 
lung infiltrated and days of spontaneous breathing was shown.
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Introduction: In late 2019, the virus responsible for Covid-19 was 
identified and called SARS-CoV-2. In China, 5% of Covid-19 patients 
were admitted in ICU, 2,3% were ventilated and 1,4% died. In early 
2020, Covid-19 quickly spread in Europe and was responsible for high 
mortality.  Since the start of the SARS-CoV-2 pandemic, the need for 
trials to assess the benefit of antiviral treatment, anti-cytokine drugs, 
convalescent plasma and hydroxychloroquine has been advocated by 
the world health organization. However, evidence of the efficacy of 
such strategies is still lacking.
Objectives: This observational multicentric study aimed to identify 
prognostic factors and therapies which could be valuable in mechani-
cally ventilated Covid-19 patients for respiratory insufficiency.
Methods: The method consisted in a multicentric retrospective analy-
sis in all consecutive Covid-19 patients admitted to intensive care unit 
(ICU) and mechanically ventilated for more than 24 hours from March 
1 to April 25, 2020, in 12 hospitals. The study protocol was approved 
by our Ethics Committee and, due to the retrospective nature of the 
data collected, no consent from the patient was required.
Admission date, age, sex, body mass index, underlying conditions, 
treatments, physiological values, use of vasopressors, renal replace-
ment therapy (RRT) and extracorporeal membrane oxygenation 
(ECMO), duration of mechanical ventilation, length of ICU stay, ICU and 
ventilator-free days at day 42 were collected during May 2020. A sec-
ond call for missing data was done during June 2020 in each center. 
The primary outcome was survival during the hospital stay. Secondary 
outcomes included use of vasopressors, RRT or ECMO, ICU and ventila-
tor-free days at day 42, and evolution of the main physiological values 
between days 0 and 7. Quantitative variables were reported as median 
and interquartile range (Q1-Q3). Categorical variables were expressed 
as number (%).  Simple and multiple time-dependent Cox regression 
models were used to assess the effects of factors on survival. All the 
variables which had a p-value lower than the critical level of 0.1 were 
selected for the multivariate model. A p-value < 0.05 was considered 
significant.
Results: From March 1 to April 25, 2020, out of 2003 adult patients hos-
pitalized for SARS-CoV-2 pneumonia, 361 were admitted to the 12 par-
ticipating ICUs for acute respiratory failure. Of these, 257 patients were 
ventilated for more than 24 hours and 247 were included in the data 
base. The median age of the 247 patients was 65 (57-72), and 172 (70%) 
were men. On admission, the median sequential organ failure assessment 
(SOFA) score was 6 (4-8), the median  PaO2/FiO2 ratio was 103 (82-132) 
and 128 (52%) patients were treated with norepinephrin. The median 
length of stay in ICU was 21 (12-32) days, the median survival time was 82 
days, and the mortality rate was 45%. Sixty-nine (28%) patients needed 
RRT and 215 patients (87%) were treated with norepinephrine during 
their ICU stay. Four patients (1,6%) were on ECMO. Corticosteroid therapy 
was started in 58 (23%) patients between days 0 and 7 of ICU admission 
and 225 (91%) patients received hydroxychloroquine alone or in combi-
nation with corticosteroid and/or azythromycin. The mortality rate of the 
patients who received corticosteroid was 34% (20/58) while it was 48% 
(91/189) for patients who did not (p = 0,01).
As opposed to survivors, non-survivors were older and suffered more 
often from chronic kidney disease. On admission in ICU, non-survivors 
had higher SOFA score and serum creatinine value, lower mean arterial 
pressure and diuresis. Non-survivors were also more often treated with 
norepinephrine during the first day in ICU. Survivors received more 
frequently corticosteroid and hydroxychloroquine.
Using multiple regression, the predictors of mortality were age, creati-
nine value, mean arterial pressure lower than 70 mmHg, lymphocytes 
count on day 0 and absence of corticosteroid use during the first week 
of mechanical ventilation. Survival probability was significantly higher 
in patients who received corticosteroid (p = 0,01). Survival probability 
was 75% by day 23 for patients who received corticosteroid versus by 
day 10 for those who did not.
Conclusion: Retrospectively analyzing the data of a multicenter cohort, 
we observed that mortality of patients with SARS-CoV-2 pneumoni-
atreated with mechanical ventilation was as high as 45% and median 
survival time was 82 days. In this series, the risk factors for mortality 
included age, renal and circulatory dysfunction, lymphopenia and the 
absence of corticosteroid use during the first week of mechanical ven-
tilation. Corticosteroid therapy during the first week of mechanical ven-
tilation was associated with a lower mortality (34% vs 48%) (p = 0,01).
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Introduction: In mid-February 2020, an outbreak of atypical pneu-
monia caused by Severe Acute Respiratory Syndrome CoronaVirus 2 
(SARS-CoV-2) represented the beginning of COVID-19 epidemic in 
Italy. Since then, the number of admissions in intensive care units (ICU) 
due to bilateral pneumonias progressing to Acute Respiratory Syn-
drome (ARDS) rose substantially. Lombardy, due to the high number 
of cases, created a network called ‘COVID-19 Lombardy ICU Network’ 
to manage the exponential surge of patients. With all the Data gath-
ered in these patients, we hypothesized that machine learning models 
could predict the mortality risk in these patients.
Objectives: Predicting mortality at 7, 14 and 28 days from ICU admis-
sion in COVID-19 patients using machine learning models.
Methods: Data comprises medications, comorbidities and daily venti-
lation of 1503 ICU patients from Lombardy affected by COVID-19 dur-
ing the early phase of the epidemic.
Two machine learning models where built: the first machine learning 
model was trained only with features available before ICU admission 
to investigate the predictive power of pre-existing conditions; the sec-
ond one was integrated with all the data available during the first day 
of admission in ICU.
Results: The majority (51%) of the cohort faced death; survivors were 
characterized by significantly lower age, higher length of stay and a 
minor number of comorbidities at admission. Kaplan-Meier curves 
reveal a survival percentage drop of 30% within the first 10 days, 45% 
after 20 days and reaches a plateau around day 30 where the popula-
tion is halved. As age increases, the percentage of survivors decreases, 
with lowest survival in the age cohort between 80 and 90.
Best model performance was reached when predicting mortality 
at 28 days, where average area under the curve (AUC) after multiple 
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cross-validations were respectively 0.77 and 0.79. There was no major 
difference in sensitivity and specificity between the two models 
(around 70% for both). Shortening the interval of time at 7 days led to 
a decrease in performance (AUC 0.68 and 0.72) with the model includ-
ing data from the first day in ICU performing worse overall. Mortality 
predictions at 14 days performed in between with an AUC 0.72 and 
0.73.
Conclusion: Mortality prediction performances at 28 days showed 
promising results based merely on patient information that could 
be gathered at ICU admission. Further training on the model could 
improve more its ability to assess and give a score of severity at 
admission to patients for better resource management during the 
pandemic.
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Introduction: The COVID-19 pandemic has led to unprecedented 
numbers of critically ill patients requiring prolonged mechanical venti-
lation [1]. Professional societies advocated the delay of tracheostomies 
or discouraged them altogether given the expected increase in risk of 
aerosol-generating procedure (AGP) [2]. We performed tracheostomy 
in an effort to deal with predicted pandemic related resource short-
ages and to reduce ICU weakness and hospital stay [3]. We developed 
a modified technique for the performance of percutaneous and sur-
gical tracheostomies to reduce AGP potential, with a dedicated team 
performing them, presented as another abstract.
Methods: A prospective, single centre, observational study took place 
between March and July 2020. Patients underwent tracheostomy if 
expected to require prolonged mechanical ventilation and were either 
unready for trial extubation or unfit for extubation after failing a dedi-
cated protocol for extubation within 7-15 days of intubation.
Results: Between March 2020 and July 2020, 74 patients were admit-
ted to our ICU due to COVID-19 pneumonitis. Of these, 13 patients 
(17.6%) required CPAP only and 61 patients (82.4%) were intubated. 
No patient met the extubation criteria, so 34 underwent tracheos-
tomy (15 percutaneous, 19 surgical). Patients were predominantly 
male (63.6%), with a median age of 64 years (IQR: 58-68) (Table  1). 
Only 85.3% were confirmed cases of COVID-19. The rest could not be 
tested for antibodies, but had a strongly suggestive clinical picture. At 
the time of tracheostomy, 25% were receiving vasopressor support 
and 17.9% requiring renal replacement therapy (RRT) (Figure 1). Dura-
tion of oro-tracheal intubation prior to tracheostomy was 7.5 days 
(IQR: 5-12) and length of cannulation was then 12 days (IQR: 6-17). 
ICU-LOS was 23 days (median, IQR: 15-34.5) and ward-LOS was 9 days 
(median, IQR: 5-17). Mortality was 20.6% (7 patients); death occurred 
at a median of 9 days (IQR: 4-14).Twenty six patients (78.8%) were dis-
charged home and one remains in hospital. Three patients required a 
more protracted weaning phase with prolonged ICU and ward stay; 
all of them had developed fibrosis in HRCT. After treatment with high 
dose steroids, they were successfully decanulated. Predictors of sur-
vival were: age ≤ 67 years OR = 10.5 (1.5-70.8; IQR; p < 0.05) and PEEP 
at day 4 post tracheostomy < 10 cmH20 OR = 13.8 (1.9-97.2; IQR; p < 
0.01). Comorbidity was a risk factor for death (Charlson’s comorbidity 
index OR = 0.43 [0.18-0.99; IQR; p < 0.05]). See Figure  2 for Kaplan-
Meier curves. Previous CPAP was not associated with worse outcomes.
Conclusion: In a selected cohort of COVID-19 patients tracheostomy 
is associated with good outcomes. Predictors of ICU survival in these 
patients were age ≤67 years and the ability to wean respiratory sup-
port 4 days after tracheostomy, whereas greater comorbidity is asso-
ciated with worse outcomes. Patients with prolonged weaning might 
benefit from being investigated for development of pulmonary fibrosis.
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Introduction: Covid-19 ARDS progress from hospital oxygen require-
ment to severe ARDS requiring ECMO, to final hospital discharge or 
death. The impact of antiviral therapy, corticosteroids (CS) and other 
immunomodulatory agents on the path between states is not known. 
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The Recovery trial [1] found a better day 28 prognosis when using dex-
amethasone low dose (DXM-6mg) but results are only preliminary and 
CS adverse effects not followed.
Objectives: To model COVID-ARDS states transitions from ICU admis-
sion to day 60 prognosis and evaluate the CS impact on transitions 
and final outcome.
Methods: A prospective data collection of severe COVID-19 patients 
admitted in 10 ICUs in France. Patients were followed daily until hos-
pital discharge for a maximum of 60 days. We considered a multistate 
model shown in Figure 1. The 17 possible transitions are modeled via 
a Cox proportional hazard model (Breslow method, robust variance). 
Continuous variables are discretized via nested coding using quartiles 
values and tested on transitions with more than 10 events. Covariates 
with a p-value ≤0.2 in univariate analysis are retained and the final 
model is achieved via stepwise selection (BSC criterion). CS effect is 
tested using G-computation. Confidence intervals are obtained via a 
probabilistic sensitivity analysis (500 runs).
Results: From 401 patients in OutcomeRea, 6 are excluded since 
COVID-19 was acquired in the hospital. 77.5% are male, the median 
age is 61 years. Charlson score is greater than 0 in 61% of patients, 
the median BMI is 28.3, median SAPS II is 33. The median duration 
first symptom-ICU admission is 10 days, and the median hospital stay 
before ICU is 2 days. Median lymphocytes count is 0.9×G/L, median 
C-reactive protein serum value is 157 mg/L and the median leucocytes 
is 9G/L. 28.6% have temperature > 39 °C, 26.3% received CS at admis-
sion (8.3% with dose ≤  10  mg of Dexamethasone or equivalent and 
18% with DXM 20mg or equivalent), 34.7% lopinavir/ritonavir, 6.8% 
tocilizumab, 6.3% anakinera and 11.1% hydroxychloroquine. 20% 
received more than one therapy.
64.3% were admitted in ICU with non-invasive oxygenation, 30.9% 
with invasive mechanical ventilation and 5.8% in ECMO. Overall day 60 
mortality was 32.9% and 13.4% of patients were censored.
Transition selected variables are shown on Figure 1. Antiviral therapies 
did not result in significant impact. CS decrease the risk of invasive 
ventilation but decreased the risk of successful extubation. G compu-
tation suggests no significant effect on day 60 prognosis (32.7% CI: 
23.8-43.1% and 32.7% CI:23.8-43.4% of being dead for CS and no CS, 
respectively). Low and high doses of CS provide similar effect.
Conclusion: Using a multistate model, we found that CS decrease the 
risk of invasive ventilation need but is associated with a lower chance 
of being extubated. Impact on prognosis is not significant. Possible 
causes of this delayed adverse impact (infections or other adverse 
effects) require further analyses.
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Introduction: The Recovery trial [1] found a better day 28 prognosis 
while using dexamethasone (DXM) low dose (DXM-6  mg) but results 
are only preliminary and not specific of the patients already admitted 
in ICU. Consequently, the benefit of Corticosteroids (CS) for the Covid-
19 pneumonia patients admitted in ICU on death is still under debate.
Objectives: The objective of this study was to assess a non-biased 
effect of early CS in COVID-19 pneumonia patients admitted in ICU on 
the occurrence of death by the 60-day.
Methods: We selected patients from 11 ICUs included in the French 
OutcomeReaTM group. We included patients over 18 years, with 
COVID proved by PCR, entered in database from January 2020 to May 
2020, with an ICU stay longer than two days, not transferred from 
another ICU and without decision to forego life-sustaining therapies 
on admission. We excluded patients treated with CS before ICU admis-
sion. The primary outcome was death before day 60. The interven-
tion was an early administration of CS in ICU defined by the initiation 
of a new treatment by CS at day 1 or 2 after ICU admission. We used 
Cox proportional-hazard models with ponderation with inverse prob-
ability of treatment weighting (IPTW) to model the risk of death (IPT-
WHR > 1 in favor of death).
Results: 302 patients were included. Their median age was 61.6 (53-
70) years; 78.8% were male; 58.6% had at least one comorbidity. On 
admission, SAPS II was 33(25-44); the  PaO2/FiO2 ratio was under 200 
mmHg in 74.2%; 34.8% of the patients received invasive mechanical 
ventilation, 31.8% had a temperature over 39 °C.
66 (21.8%) patients were in the Early CS subgroups (11 (3.6%) with dose 
less than 10mg of DXM or equivalent and 55 (18.2%) with DXM 20mg or 
equivalent). In the No Early CS subgroup, 96 (40.7%) received CS after 
day 2. Patients in the Early CS subgroup received more often anti-viral 
therapy and Anakinra (p < 0.01), had more hyperglycemia (p < 0.01) and 
needed more daily insulin dose (p < 0.01) during the ICU stay and tended 
to have more bacteriemia and HAP-VAP (p = 0.06 and 0.16, see table).
The mortality at day 60 was 29.4% in the study population, 34.8% in 
the early CS and 28% in the non Early CS (p = 0.28). In the IPTW analy-
sis, on day 60, early CS was not associated with an increase risk of 
death (IPTW-HR = 1.06, CI 95%, 0.67 to 1.68, p = 0.79). The results were 
similar limiting the analysis to high doses CS (IPTW-HR = 1.24, CI 95%, 
0.83 to 1.87, p = 0.29).
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Conclusion: For the COVID-19 patients just admitted in ICU, in a 
prospective cohort with daily follow-up and a use a causal inference 
model, we were not able to unmask any positive impact of early CS 
therapy on patients’ survival. Early CS was associated with hyperglyce-
mia. The absence of benefit is not related to CS doses and may reflect 
difference in case-mix and/or standard of care used. Further studies 
are required to confirm the results of the RECOVERY trial.
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Introduction: Prone ventilation has a demonstrated mortality benefit 
in moderate-severe ARDS [1]. It has been argued that the majority of 
patients with SARS-CoV-2 ARDS have preserved lung compliance and 
low lung weight and have minimal response to prone ventilation due 
to a low amount of recruitable lung tissue. [2]
Objectives: To determine the pre-prone parameters that correlate 
with P/F ratio and PaCO2 response to prone ventilation in SARS-CoV-2 
ARDS.
Methods: This is a single-centre, prospective study from the Queen 
Elizabeth Hospital Birmingham, UK. Patients undergoing invasive 
mechanical ventilation with SARS-CoV-2 pneumonia between the 
11th March and 21st April that received at least one episode of prone 
ventilation were included.  Prone ventilation was encouraged in 
patients who had an  FiO2concentration of greater than 0.6. Ventilatory 
parameters six hours before and during the first episode of prone ven-
tilation were collected. Severity of opacification on chest radiography 
was graded by two independent reviewers using a validated, semi-
quantitative opacification score ranging from 0 to 16. [3] Deadspace 
fraction was estimated using the unadjusted Harris-benedict equa-
tion. [4] Statistical analysis was performed using GraphPad Prism v.8.0. 
Continuous data are presented as median (IQR). Correlation between 
variables was analysed using a nonparametric spearman correlation 
test. A p value < 0.05 was used to determine significance.
Results: 143 patients were admitted to the ICU, of which 94 (66%) 
received at least one episode of prone ventilation for a median time 
of 16 (14 – 20) hours. P/F ratio increased by 6.6 (3.5 – 10.1) and PaCO2 
decreased by -0.03 kPa (+0.9 - −1.0) in response to prone ventilation.
Conclusion: The P/F ratio response to prone ventilation correlated with 
the degree of hypoxia prior to proning, indicating that stratifying the 
receipt of prone ventilation by the degree of hypoxia is entirely appro-
priate. The P/F ratio response did not correlate with changes in dead-
space fraction, pre-prone compliance or chest radiograph opacification, 
indicating that part of the response may be independent of lung recruit-
ment, potentially due to improvements in cardiac output, distribution of 
blood flow and shunt fraction, as suggested by Gattinoni. [5]
The PaCO2  response to prone ventilation correlated with markers of 
lung recruitment, such as changes in dynamic compliance, deadspace 
fraction and pre-prone severity of chest radiograph opacification, simi-
lar to findings from previous ARDS cohorts. [5]
In summary, the majority of patients with SARS-CoV-2 ARDS had posi-
tive P/F ratio responses with prone ventilation and receipt of this ven-
tilation strategy should be stratified by the degree of hypoxia.
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Introduction: COVID19 pandemic and the consequent surge of 
patients with acute hypoxemic respiratory failure has stretched the 
intensive care departments capacity to provide supportive treatment.
Objectives: To describe the baseline ventilator settings of adult 
patients with severe acute hypoxemic respiratory failure due to 
COVID19 admitted in the Catalan ICU network.
Methods: Consecutive patients admitted between 15 March and 15 
April in 26 ICUs, who tested positive for SARS-Cov-2 (RT-PCR in a naso-
pharingeal swab) and had severe acute hypoxemic respiratory failure, 
presenting with bilateral infiltrates in the chest X-ray and requiring 
invasive mechanical ventilation. Relevant data were colected in sta-
ble conditions shortly after intubation. Follow-up time was til ICU 
discharge. Study was approved by the Ethics Committee of the coordi-
nating center (Hospital Universitari Sant Pau, Barcelona).
Results: A total of 1704 patients (1187 men and 517 women) were 
admitted, and their median age was 63 yr (IQR 54-70). Of these, 1388 
(82%) required invasive mechanical ventilation. Median duration of 
mechanical ventilation was 14 days (IQR 7-24). Overall UCI mortal-
ity was 35% (491/1388). Prone position was implemented in 77% 
(1070/1388). ARDS criteria was met by 1220 intubated patients (88%, 
1220/1338). Cumulative survival over ICU time is shown in the Kaplan-
Meier plot.
Baseline settings and parameters (mean± std deviation) 
  All (n=1388) Alive (897) Dead (491) p (alive  dead) 
FiO2 0.64±0.19 0.61±0.18 0.69±0.21 <0.001 
PaO2, mmHg 108±43 109±44 106±43 ns 
PaCO2, mmHg 49±14 47±13 52±15 <0.001 
PaO2/FiO2 182±82 191±83 166±78 <0.001 
VT/PBW, mL/kg 6.8±1.1 6.8±1.2 6.9±1.1 ns 
RR, bpm 22±4 22±4 23±4 <0.001 
PEEP, cmH2O 12±2 12±2 12±2 ns 
Pplat, cmH2O 25±4 25±4 26±4 <0.001 
∆Paw, cmH2O 13±4 12±4 13±4 <0.001 
Crs, mL/cmH2O 36±13 37±13 35±14 <0.001 
VT, mL 424±63 425±63 423±63 ns 
Ventilatory ratio 1.98±0.7 1.90±0.7 2.13±0.8 <0.001 
Conclusion: The vast majority of acutely hypoxemic covid19 patients 
who required invasive mechanical ventilation met classical ARDS 
criteria.
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Introduction: The spectrum of kidney damage in COVID-19 has been 
mostly limited to autopsies and case reports. Here, we report the first 
case series of patients with COVID-19 who developed kidney injury 
and underwent a kidney biopsy in the Paris and its metropolitan area. 
The spectrum of kidney damage in COVID-19 has been mostly limited 
to autopsies and case reports. Here, we report the first case series of 
patientswith COVID-19 who developed kidney injury and underwent a 
kidney biopsy in the Paris and its metropolitan area.
Methods: We included all patients with COVID-19 who underwent 
a kidney biopsy between March 08 and May 19, 2020. Data were 
obtained through the review of the medical records.
Results: Forty-seven patients (80.9% men) with COVID-19 were 
included in the present study. Median age was 63 years IQR [52-69]. 
Comorbidities included hypertension (66.0%), diabetes mellitus 
(27.7%), previous history of chronic kidney (25.5%), cardiac (38.6%) 
and respiratory (27.3%) diseases. Initial symptoms were fever (85.1%), 
cough (63.8%), shortness of breath (55.3%), and diarrhea (23.4%). 
Almost all patients developed acute kidney injury (97.9%) and 63.8% 
required renal replacement therapy. Kidney biopsy analysis showed 
two main histopathological patterns, including isolated acute tubular 
necrosis in 22 (46.8%) patients, and dominant glomerular injury con-
sisting of collapsing glomerulopathy or focal segmental glomerulo-
sclerosis in 17 (36.2%) patients. Eight (17%) patients had alternative 
diagnosis, which were most likely unrelated to COVID-19. Acute tubu-
lar necrosis occurred almost invariably in the setting of severe forms 
of COVID-19, whereas patients with glomerular injury had various 
profiles of COVID-19 severity and collapsing glomerulopathy was only 
observed in patients harboring a combination of APOL1risk variants. At 
last follow-up, 16 of the 30 patients who initially required dialysis were 
still on dialysis, and 9 died from COVID-19 or related-adverse events.
Conclusion: The present study describes clinico-pathological spec-
trum of kidney lesions in yet-alive patients with COVID-19. While acute 
tubular necrosis is correlated with COVID-19 severity, the pattern of 
glomerular injury is intimately associated with the expression of APOL-
1risk variants. Whether SARS-CoV-2 directly underlies renal damage 
remains a major but unsolved issue.
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Introduction: COVID-19 caused many deaths through a dysregulated 
immune response, with resultant “cytokine storms” contributing to 
multi-organ failure [1]. Patients with severe respiratory failure have 
required extra-corporeal membrane oxygenation (ECMO) as a res-
cue therapy [2]. The oXiris adsorptive haemofilter has the capacity to 
adsorb cytokines while delivering continuous renal replacement ther-
apy (CRRT) [3]. Therefore, patients with multi-organ failure secondary 
to COVID-19 could be managed with ECMO and haemoadsorptive 
therapy as a novel approach [4]. Minimal evidence currently exists of 
its effectiveness or safety.
Objectives: To evaluate the safety and efficacy of oXiris in COVID-19 
patients on VV-ECMO with AKI.
Methods: A single-site prospective observational case series was con-
ducted from March to June 2020. Inclusion criteria were: COVID-19, 
age > 18, VV-ECMO, CRRT and severe septic shock. Data was collected 
at baseline and over three successive oXiris filters. Data included vaso-
pressor requirements, biochemical markers and vital signs. Variables 
at baseline and completion of therapy were compared using Wilcoxon 
Signed Ranks Test, two-tailed p-values (significance p < 0.05).
Results: Eight patients were included; 7 males and 1 female with a 
mean age of forty-seven. None had pre-existing renal disease and 
mean baseline creatinine on admission was 230 umol/L. Mean CRP 
was 252 mg/dL with a mean lactate of 3.12 mmol/L. The median vaso-
pressin dose fell significantly from 0.02 units/min to 0.00 units/min (p 
= 0.031), median noradrenaline dose fell significantly from 0.23 mcg/
kg/min to 0.06 mcg/kg/min (p = 0.039) and median urine output sig-
nificantly improved from 0 ml/day to 151 ml/day (p = 0.008). There 
were no adverse events reported.
Conclusion: The use of oXiris adsorbent membrane in patients requir-
ing VV-ECMO for COVID-19 with clinical evidence of a “cytokine storm” 
was safe, with no adverse events. There was also significant improve-
ment of haemodynamic stability and initial renal recovery. Further 
evaluation through a large randomised control trial is warranted.
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Introduction: Positive end-expiratory pressure (PEEP) is one of the 
main parameters for preventing lung damage and ensuring gas 
exchange during mechanical ventilation. The use of high PEEP lev-
els can lead to increase of intracranial pressure (ICP) in patients with 
massive non-traumatic subarachnoid hemorrhages (SAH). Therefore, 
the use of high levels of PEEP is limited in patients with initially high 
ICP.
Objectives: To determine the efficacy and safety of different levels of 
PEEP in patients with intracranial hemorrhage with initially increased 
ICP.
Methods: We analyzed the state of systemic and cerebral hemo-
dynamics in different levels of PEEP in critically ill patients with SAH 
in situations with initially increased ICP (n - 31). The study was not per-
formed in patients with intracranial pressure of 20 mmHg and more. 
The examined patients had Glasgow coma scale below 9. Invasive ICP 
monitoring, transpulmonary thermodilution, respiratory monitoring 
were used in all patients. The studied parameters were determined 
with an increase in PEEP from 5 cm  H2O to 10, 15 and 20 cm  H2O. 
Minute ventilation volume and PaCO2 were stable at all stages of the 
study.
Results: The initial level of ICP was 17 (16; 18) mmHg, cerebral per-
fusion pressure (CPP) - 93 (86; 107) mmHg. A decrease of global 
end-diastolic index and compensatory increase of systemic vascular 
resistance index with normal mean arterial blood pressure indicated 
a state of latent hypovolemia. Increase of PEEP to 10 and 15  cmH2O 
had no negative effects on ICP and CPP. We determined the tendency 
to decrease cardiac index, cardiac preload and to increase systemic 
vascular resistance index, stroke volume variation. High levels of PEEP 
did not lead to obstruction of extracranial venous outflow; the jugu-
lar bulb pressure were stable (Table  1). We identify increase ICP and 
decrease CPP, cardiac index, global end-diastolic index, systemic vas-
cular resistance index when PEEP were 20 cmH20. Hypovolemia lim-
ited the compensatory reserves of hemodynamics, which resulted a 
decrease in arterial and cerebral perfusion pressures.
Table 1. Parameters of systemic and cerebral hemodynamics during different levels of positive 
end-expiratory pressure in patients with high baseline intracranial pressure 



















93 (86;107) 92 (84;102) 89 (80;97) 81 (75;90) *# 
Cardiac index, 
litres/min/m2 
































14 (13;19) 15 (13;18) 14 (13;18) 15 (12,5;16,8) 
РаО2/FiO2 352 (294;390) 364 (276;402) 382 (323;429) 397 (313;440) 
(* - p<0,05 compared with PEEP 5 cmH2O, # - p<0,05 compared with PEEP 10 cmH2O).  
Conclusion: Increase PEEP up to 15  cmH2O does not have a negative 
effect on ICP and CPP in patients with initially increased intracranial 
pressure. Further increase PEEP up to 20  cmH2O can lead to increase 
ICP, to decrease mean arterial pressure and CPP. The increase ICP is 
on average 2-3 mmHg, which may be acceptable for use high PEEP in 
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conditions of stable blood pressure and significant improvement in 
pulmonary gas exchange.
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Introduction: Despite advances in medicine, death rates in Intensive 
Care Units (ICU) remain high (1). ICU patients are admitted for life 
saving organ support; however when this fails, it is vital to provide 
patients with dignified deaths. The ICU brings about unique circum-
stances that make palliative care challenging, highlighting the impor-
tance of auditing current practices. The aim of this project was to audit 
the provision of end of life care, identify areas for improvement and 
develop interventions to ensure we provide optimum care. This was 
particularly important during the COVID-19 Pandemic surge where 
we had higher than average ICU mortality rates and unique sets of 
challenges. Interventions included raising awareness through multi-
disciplinary education at various forums. We increased awareness of 
existing available tools such as electronic end of life care forms and 
prescription order sets. Trainees also had access to electronic copies 
of simple guides to facilitate discussions with patient and their families 
(2). Videoconferencing proved invaluable in allowing spiritual and psy-
chological support for parents and their families.
Methods: A retrospective initial audit was carried out by reviewing 
the electronic medical records (ISCCA) of patients who died between 
April and September 2019, following the implementation of inter-
ventions, a re-audit was carried out between March and May 2020. 
Data was collected based on NICE and FICM guidelines for end of life 
care and summarised into 6 main criteria (3,4,5). This included; Iden-
tification of dying patients, Treatment escalation and Resuscitation 
planning, Patient and Family Involvement, Symptom management, 
Comfort care, and Psychological and Spiritual needs. The data was 
analysed using simple statistical tests.
Results: There were 61 deaths during the initial audit period and 28 
during the re-audit. The re-audit showed 93% (92% initial audit) of 
patients were identified as dying in a timely manner with 86% having 
clearly documented treatment escalation and appropriate resusci-
tation planning. 93% (77% initial audit) of patients had clearly docu-
mented Patient and Family Involvement with end of life discussions. 
Spiritual & Psychological support and Comfort Care was documented 
in all patients. This was a significant improvement compared to 
41% for Spiritual & Psychological support and 26% for Comfort Care 
recorded in the initial audit. Symptom management also significantly 
improved from 13% to 100%.
Conclusion: Despite the additional challenges posed by the COVID-
19 Pandemic these results show our ICU Team continued to provide 
high quality and compassionate End of Life Care 6. We intend to con-
tinue carrying out multidisciplinary teaching sessions with input from 
Palliative care and Pharmacists. We will also encourage the use of the 
palliative care form on ISCCA to provide prompts and enable accu-
rate documentation. A laminated aide memoire flow chart (4) will also 
be available in clinical areas. End of life care is an essential skill for all 
members of the critical care team, because a good death is as impor-
tant as a good life (4).
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Introduction: Circulatory shock and infections are known to be 
among the major causes of mortality in the ICU. These critical states 
are often associated with vasodilation, which could cause a significant 
drop in blood pressure, reduced tissue oxygenation and eventually 
organ failure.
A common physiological index of metabolic dysfunction and tissue 
oxygenation is blood lactate level. In particular, vasopressor need and 
lactic acid level have been proven to provide an accurate severity of 
illness classification system [1] in predicting out-of-hospital mortality.
Objectives: The goal of this study is to identify effects of the initi-
ated vasopressor therapy as related to Lactate levels. To this extent, 
we developed a model to predict a change in blood lactate level 12 
hours after the administration of vasopressors by combining baseline 
features extracted from the electronic health records with measures 
of vasopressor responses estimated from continuously recorded ECG 
and arterial blood pressure (ABP) waveforms.
Methods: The data used in this study comes from the MIMIC-IIIDa-
tabase [2]. The study was carried out on a cohort of 123 patients 
resulting from selection of all patients undergoing vasopressor admin-
istration that passed waveform signal quality annotation and had 
matching clinical data.
Selected features were extracted from the waveform recordings con-
sidering 15-minute windows before and after vasopressor administra-
tion, as shown in Figure 1.
Clinical measurements from laboratory tests, blood gas analyses, 
pathologies, treatments and demographic information were also 
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extracted for each patient within a 12 hour window before vasopres-
sor onset.
We used all features to predict whether lactate level was normal ( < 
2 mmol/L) or abnormal ( = > 2mmol/L) 12 hours after the vasopressor 
onset.
The dataset was divided into a training set (80%) and testing set (20%). 
A Random Forest classifier was trained through a hyperparameter 
optimization with a 10-fold cross validation and grid search procedure.
Results:
Results (Figure 2) showed an AUROC = 0.84 and AUPRC = 0.57. Fea-
ture importance analysis indicated that changes of the cardiovascular 
interaction between heartbeat and blood pressures after vasopressor 
administration are predictive of an abnormal lactate 12 hours after the 
start of vasopressor therapy.
Conclusion: Autonomic measures reveal an association between the 
response of the cardiovascular system to vasopressor therapy and 
changes in blood lactate level, suggesting that ECG- and ABP-derived 
indexes may be useful for predicting lactate level changes, i.e. tissue 
oxygenation level, after initiation of vasopressor therapy.
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Introduction: Tracheostomy is a life-saving intervention and facili-
tates prolonged ventilation in critical care. However, the negative 
consequences of tracheostomy include thirst and difficulty commu-
nicating which can be the most well recalled and distressing experi-
ences for patients [1–3]. Above cuff vocalisation (ACV), also known 
as ‘talking tracheostomy’ and ‘external subglottic airflow (ESAF)’, has 
been used for > 50 years [4]. A flow of oxygen or air is applied via the 
subglottic port of the tracheostomy to restore airflow through the 
vocal cords and enable vocalisation [5–7]. Some research has also 
reported improvements to swallowing and cough, hypothesised to be 
a result of improved laryngopharyngeal sensation [5,8].
Objectives: To explore the extent of ACV use internationally, imple-
mentation approaches, risks, and benefits.
Methods: Ethical approval was obtained (MREC: 18-037). An interna-
tional online survey was disseminated May-November 2019 via social 
media and professional networks. The survey included 73 questions 
covering topics such as: tracheostomy management, prevalence, prac-
ticalities, barriers, resource use, and personal experiences and opin-
ions. Quantitative data was analysed using Microsoft Excel® (2016) 
and reported descriptively.
Results: The survey was completed by 244 healthcare professionals 
(HCPs), with one exclusion, from 9 different HCP groups and 25 coun-
tries. Respondents were primarily from critical care (85%; n = 205). 
ACV was used by 94 HCPs (39%). Most respondents had limited ACV 
experience; 54% (n = 50) had used ACV with < 10 people. There was 
a varied approach to ACV implementation (Figure  1). Most respond-
ents wait > 72 hours post-tracheostomy insertion prior to commenc-
ing ACV (n = 45; 48%), but 13 (14%) commence ACV at 0-48 hours. The 
most common complications or symptoms observed with ACV were 
patient reported discomfort (n = 54; 58%), strained vocal quality (n = 
39; 42%), and air escape via the stoma (n = 32; 34%) (Figure 2). Vari-
ous benefits were reported including: communication (n = 76; 82%), 
mood (n = 62; 67%), laryngeal sensation (n = 49; 53%), swallowing 
frequency (n = 43; 46%), reduced volume of subglottic secretions (n 
= 39; 42%), expectorating secretions (n = 37; 40%), and earlier com-
mencement of oral intake (n = 16; 17%). Incidences of more serious 
complications were observed less frequently, sub-cutaneous emphy-
sema in 1-4 patients (n = 7; 8%), air trapping in 1-6 patients (n = 10; 
11%), and bleeding in 1-30 patients (n = 10; 11%). The most extreme 
barriers to ACV implementation were lack of access to knowledgeable 
staff (n = 92; 38%), lack of access to training (n = 73; 30%), and not 
using tubes with subglottic ports (n = 74; 31%).
Conclusion: There is a varied approach to ACV implementation and 
delivery. The benefits are diverse, but minor complications are com-
mon. Future research should focus on establishing optimal implemen-
tation of ACV and developing a standardised approach to maximise 
benefits and minimise risks.
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Introduction: Prolonged weaning from invasive mechanical ventila-
tion (MV) is associated with poorer patient outcomes, including longer 
length of stay in the ICU and in the hospital and higher patient mor-
tality [1]. It is recommended to start weaning based on general res-
piratory criteria (PEEP,  FiO2…) to avoid potential delays which may 
contribute to prolonged ventilation and poor outcomes.
Objectives: To evaluate the prevalence and types of delays in initi-
ating the first separation attempt (SA) from invasive MV in patients 
enrolled in the WEAN SAFE study (WorldwidE AssessmeNt of Separa-
tion of pAtients From ventilatory assistancE; NCT03255109).
Methods: WEAN SAFE is a global, multi-centre prospective obser-
vational study that enrolled 6,167 patients in 476 centres receiving 
mechanical ventilation for at least 2 days. The time to initiation of the 
first SAs was examined in patients meeting general criteria. We consid-
ered the patients met criteria for initiating the weaning process when 
they were not receiving neuromuscular blocking agents, were on low 
dose or no vasopressors, had a PEEP < 10  cmH2O and a  FiO2 < 50%.
Patients were classified according to the WIND classification, which 
describes three different duration of weaning [2]. WIND groups were 
defined as the time from the first SA to successful weaning or death: 
group 1 within 24h; group 2: more than 1 day and less than a week; 
group 3: weaning not completed 7 days after the first SA.
Results: Of the 6167 patients enrolled, 4646 had at least 1 SA and 
could be grouped according to the WIND classification: 70% in group 
1; 14% in group 2 and 16% in group 3.
Of 4,212 patients that met criteria for weaning initiation, the median 
(interquartile range) time from these criteria to the first SA was 2 
days (0;4). In the whole cohort, 30% of the patients had a SA the very 
day they met these criteria (n = 1257) whereas this delay was longer 
than 6 days in 16% (N = 669). This delay statistically differed accord-
ing to the WIND group (Table 1). We then assessed the time difference 
between the first day patients had spontaneous breathing activity 
and the first SA. In the whole population (n = 4646) this delay was 0 
(0;3) days and was also significatively different across the WIND groups 
(Table). Delay from the first SA to the weaning termination (successful 
weaning or death) was associated with the outcomes: hospital mortal-
ity was 15.6% in group 1, 38.2% in group 2 and 35.4% in group 3 (P < 
0.001 between groups).









Time to 1st SA in patients 
fulfilling weaning criteria, 







Time to 1st SA since 








Conclusion: Delays in initiating the weaning process in patients may 
contribute prolonged mechanical ventilation and subsequent higher 
mortality. The reasons underlying these delays in initiating weaning 
need to be explored.
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Introduction: Inflammation-driven “endothelitis” appears to contrib-
ute to acute heart failure (AHF). We aimed at evaluating the proinflam-
matory status and endothelial activation, as well as their correlation, in 
human AHF, cardiogenic shock (CS) and to differentiate the same pro-
cesses in patients with the diagnosis of non-cardiogenic shock (NCS), 
namely septic shock.
Methods: Patients with AHF (n = 23), CS (n = 25) and NCS (n = 20) 
were included and blood and urine samples were collected at days 
1-2, days 3-4 and days 5-8. Blood donors were used as controls (n = 
22) at a single time point collection. Serum IL-1β, IL-6, tumoral necrosis 
factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), vascular 
cell adhesion molecule-1 (VCAM-1) and E-selectin were determined 
using Multiplex Immunoassays. Endocan was evaluated by ELISA kit.
Results: At admission, we found no significant differences in IL-1β 
concentration between groups. Admission IL-6 values (pg/mL) were 
higher in patients’ groups (controls: 2.0 ±  0.9; AHF:40.0 ±  22.3; CS: 
95.9 ±  26.4, NCS: 598.1 ±  311.5; controls vs AHF, p < 0.01; controls 
vs CS or NCS, p < 0.001). Admission TNF-α concentration (pg/mL) 
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was higher in NCS (controls: 5.4 ± 0.6; AHF:11.9 ± 3.1; CS: 9.4 ± 1.5; 
NCS:46.9  ±  8.7, controls vs NCS, p < 0.001; NCS vs CS, p < 0.001). 
Admission endocan (ng/mL) were higher in all patients’ groups (con-
trols: 1.4 ±  0.2; AHF: 6.1 ±  1.8; CS: 12.9 ±  1.9, NCS: 10.6 ±  1.4; con-
trols vs AHF, p < 0.01; controls vs CS or NCS, p < 0.001, CS vs AHF, p 
< 0.01). Admission ICAM-1 values (ng/mL) were increased in CS and 
NCS compared to controls and AHF (controls: 474.9  ±  70.7; AHF: 
412.4 ± 60.3; CS: 665.5 ± 72.6, NCS: 726.6 ± 55.3, controls vs CS, p < 
0.05; controls vs NCS, p < 0.01). Admission VCAM-1 (ng/mL) was higher 
in all patients’ groups (controls: 705.8 ±  51.0, AHF: 1840.0 ±  290.0, 
CS: 3425.0 ±  645.6, NCS: 4462.0 ±  449.7, controls vs AHF, p < 0.01; 
controls vs CS, p < 0.001, controls vs NCS, p < 0.001), while E-selectin 
presented higher values in NCS (controls: 28.7 ± 1.6, AHF: 33.1 ± 2.3, 
CS: 37.9 ±  3.7, NCS: 207.4 ±  28.6, controls vs NCS, p < 0.001, CS vs 
NCS, p < 0.001). During hospitalization, there was an overall decrease 
in TNF-α values (p = 0.02) and also a decrease in all endothelial bio-
markers (ICAM-1, VCAM-1 and E-selectin concentration - p = 0.04 
and p = 0.001 and p < 0.01, respectively) in NCS. Withinpatients, we 
observed significant positive correlations between endocan and IL-6 
and VCAM-1, between ICAM-1 and IL-1β, IL-6, VCAM-1 and E-selectin, 
between VCAM-1 and IL-6, TNF-α and all the endothelial biomarkers, 
and between E-selectin and IL-6, TNF-α, ICAM-1 and VCAM-1.
Conclusion: Proinflammatory status and endothelial cell activation 
are interrelated and significantly increased in all patient’s groups. Dur-
ing hospitalization, there is significant decrease in all endothelial bio-
markers only in NCS patients. This suggests that inflammation-driven 
“endothelitis” is constant in AHF and CS which might perpetuate and 
aggravate the prognosis heart failure.
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Introduction: Since the outbreak of the SARS-CoV-2 pandemic, there 
has been a surge of clinical risk prediction scores developed, mostly at 
the first epicentre in China [1][2][3][4]. Predicting risk of deterioration 
or severe COVID-19 related illness is of significance, both as part of a 
clinical treatment guidance as well as to highlight the likely groups 
benefitting from novel disease modifying therapies. Although many of 
the risk prediction tools were developed in multi-centre studies, their 
external clinical utility and face validity has not been established in 
independent cohorts [5].
Objectives: We attempted to validate three previously published risk-
stratification tools in a multi-centre study.
Methods: Anonymised patient data was collected as part of a service 
evaluation and audit project by the Secondary Care Group Members 
of the Welsh Government COVID-19 response from patients admitted 
to the University Hospital of Wales, a tertiary academic centre and to 
the two district general hospitals in Aneurin Bevan UHB. Due to the 
anonymised nature of the data collection, formal written consent was 
waived.
Data was collected to enable to calculate the CALL-score, the COVID-
GRAM risk score and a nomogram developed by Gong et al [1][2][3]. 
Primary outcome was a composite outcome of development of severe 
COVID-19 disease leading to ICU admission or death as described by 
the original publications. The outcome was censored at hospital dis-
charge or 30-days.
For statistical analysis receiver operating characteristics (ROC) curves 
were used to establish predictive ability. Data is presented as n (%), 
median (IQR) or ROC (95%CI) as appropriate.
Results: We collected data from 169 patients. Patients were 73 (59-
82) years old, 66 out of 169 (39.1%) were female, 32 (18.9%) had no 
significant co-morbidities, 57 (33.7%) had one and 80 (47.3%) had 
two or more comorbidities. Most prevalent comorbid conditions were 
diabetes in 42 (24.9%), COPD in 32 (19.0%) and ischaemic heart dis-
ease in 26 (15.4%) of patients. 81 (47.9%) of patients had reached the 
composite outcome of ICU admission or death, the hospital mortality 
was 33.7%. Neither of the three risk-prediction tools were able to accu-
rately predict outcome. ROC (95%CI) for the COVID-GRAM score was 
0.636 (0.550-0.722) p = 0.003, for the CALL-score 0.500 (0.411-0.589) 
p = 0.997 and for the nomogram 0.628 (0.543-0.714) p = 0.005 (Fig 1).
Conclusion: With respect to the composite outcome of ICU admis-
sion or death within our cohort, the discriminative value of all three 
predictive tools was poor. This is likely due to a variety of factors. The 
absence of calibration data to address the overfitting of the COVID-
GRAM leaves the fine-tuning of regression coefficients as potentially 
overlooked [6]. Furthermore, each of the tools had relatively small and 
homogenous training and validation cohorts, despite being multi-cen-
tred in nature, in contrast to the international datasets now available. 
Moreover, our cohort differed as older, predominantly white and car-
rying a higher comorbidity burden.
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Introduction: COVID-19 outbreak has represented a new chal-
lenge for intensivists worldwide in terms of patient and resources 
management. The decision of which ventilation strategy to adopt in 
each patient has been crucial and not guided by existing outcome 
evidence.
Objectives: We described the clinical characteristics and outcomes of 
hospitalized COVID-19 patients according to the adopted ventilatory 
strategy.
Methods: All COVID-19 patients hospitalized within the Rimini prov-
ince (340,000 residents) from February 26 to April 18, 2020 were 
included in the present observational population-based study. 
Patients were classified according to the maximum level of ventila-
tion support (oxygen, non-invasive ventilation (NIV), mechanical 
ventilation (MV)). Sixty-day mortality was computed and patient’s 
risk of death was estimated with a Cox proportional hazard analysis 
adjusted by age, sex, and administration of steroids, canakinumab, 
and tocilizumab.
Results: 1,424 symptomatic patients were identified; 522 (36.7%) were 
hospitalized, the remaining 902 (63.3%) were treated at home with no 
deaths at 60 days. 408 (78.5%) patients were treated only with stand-
ard care and oxygen supplementation during hospitalization (G1), 46 
(8.8%) patients underwent only NIV (G2), 25 (4.8%) failed a NIV trial 
and received MV (G3), and 41 (7.9%) only/or MV (G4). There was no 
significant difference in the P/F at MV inception among G3 and G4 
(p-value 0.9). Overall 60-day mortality was 24.2% and was 23.0% in 
G1, 19.6% in G2, 32.0% in G3, and 36.6% in G4 (p = 0·165). Compared 
with G1, corresponding adjusted HRs progressively increasing from G2 
to G4 (HR 1·78, 95% CI 0·79–3·98; HR 2·78, 95% CI 1·14–6·73; HR 2·97, 
95% CI 1·55–5·65, Figure).
Conclusion: Our study suggested that patients who failed a NIV trial 
did not have a worse prognosis than patients treated directly with 
MV, but the adopted strategy has helped with the optimization of the 
resources allocation.
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Introduction: Critically ill COVID-19 patients often required mechani-
cal ventilation (MV) support. For ICU nursing staff, COVID-19 patients’ 
management presented a relevant increasing in workload, espe-
cially during pronation. In this emergency scenario Clinica Luga-
nese Moncucco, identified as a COVID-19 Center by the Swiss Health 
Department, decided to introduce a specialized  ICU Physiotherapy 
Team (IPT) to support nursing staff during pronations.
Objectives: Primary outcome was to analyze complications rate in 
critically ill COVID-19 patients managed by this specialized team dur-
ing pronations. Secondary outcomes were to analyze all correlations 
between the incidence of minor complications, like pressure sores, 
and clinical data to find any potential protective factor.
Methods: A retrospective analysis on consecutive critically ill COVID-
19 patients from March 16th  to April 16th, 2020. The purpose of 
this study was to analyze the rate of major and minor complications 
related to pronation performed by the IPT.
Results: Forty-two patients were treated by specialized IPT. Pronation 
maneuvers were performed on 81% of patients with 296 pronations, 
with an average of 3.52 cycles per patient (SD 2.47). The average BMI 
was 28.3 kg/m2(SD 5.1); 36 (86%) patients were on MV (66% ventilated 
by OTI and 19% by tracheotomy), with a mean duration of MV days of 
10.5 days. The mean age was 65.61 (SD 10.95), 35 (83.3%) were male. 
The nurse workload was increased, with a median NEMS score of 34.5, 
compared to previous year (p < 0.001).
One major complication (0.3%) identified as a dislocation of endotra-
cheal tube was observed; 14 patients (33.3%) were burdened by minor 
complications like pressure sores. The  number  of pressure sores was 
correlated with ICU LOS (p = 0.001) and MV days (p = 0.001); the pres-
ence  of pressure sores was also related to ICU LOS (p = 0.029) and 
MV days (p = 0.015). No other significant correlations were found. To 
better estimate the effect of the observed data, the propensity score 
was applied, given the retrospective study design and the imbalance 
between treatment and pronation number. The propensity match 
score showed no protective pronation factor regarding the presence 
of ulcers (1.0, p = 0.448).
Conclusion: Specific pronation team resulted in a lower rate of major 
complications. The persistent high amount of minor complications 
appeared to be related rather to the disease severity than to pronation 
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gesture, suggesting that minor complications were not protected by 
pronation.
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Introduction: The Corona virus disease 2019 (COVID-19) pandemic 
touches health care systems worldwide and surpasses intensive care 
capacity in many areas. Since COVID-19 is an emerging disease, high 
quality evidence about the course of the disease and optimal treat-
ment is sparse. We envision that combining efforts of the intensive 
care community through knowledge and data is paramount to accu-
mulate insight into this novel disease.
Objectives: We set out to gather data from COVID-19 patients for 
machine learning studies from all intensive care units in the Nether-
lands. We outline the process of data collection under European pri-
vacy law in times of crisis.
Methods: We devised a multidisciplinary report on the lawful col-
lection of data from electronic health records during the COVID-19 
pandemic in close collaboration with data protection officers (DPO), 
hospital lawyers, and intensivists. Similarly, a data sharing agree-
ment was drafted based on a nation-wide template for sharing data 
between healthcare institutions. Documentation was reviewed by 
the institutional review board (IRB). All hospitals in the Netherlands 
with an intensive care unit were approached, and documentation was 
reviewed locally before permission was granted.
Results: Under European law, patient privacy is regulated in the Gen-
eral Data Protection Regulation (GDPR) (1). Both the GDPR and Dutch 
national law provide that data subjects have to give explicit consent 
for the processing of their data. We argue that during the COVID-19 
crisis, asking consent cannot be reasonably expected from health care 
workers due to a) the large number of expected patients and associ-
ated time burden in an already overstrained health care system, b) 
the danger of spreading or contracting the virus upon contact with 
patients or their families, and c) the poor clinical condition of many 
patients in the intensive care. Consent is therefore not only impracti-
cal, but often impossible. In addition, alternative forms of data collec-
tion are unavailable and selection bias would lead to unreliable data. 
As under non-crisis circumstances, we may gather COVID-19 data 
necessary for scientific purposes when we “provide for suitable and 
specific measures to safeguard the fundamental rights and interests 
of the data subject” (GDPR, Article 9, paragraph j1). Therefore, we a) 
pseudonymized data in the providing hospital, b) informed patients 
through media and local hospital outlets about the possibility to opt 
out, and c) signed data sharing agreements regulating privacy of 
patients. We currently have data sharing agreements in place with 38 
hospitals, and have received data from 32 hospitals. With this study we 
aspire to set an example for the lawful collection of data in times of a 
health crisis.
Conclusion: In times of the COVID-19 crisis, we consider large scale 
data collection pivotal to combat this novel disease and to improve 
patient outcomes. Data collection in times of crisis may be possible 
and lawful under European privacy laws.
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Introduction: One of the most common adverse events during con-
tinuous renal replacement therapy (CRRT) is hypothermia, < 35.0  °C, 
reported in 44% of all cases. Hypothermia may be less common over 
time, but available data is scarce. Hypothermia is associated with 
higher mortality rates; in a time series analysis of over 15000 admis-
sions during 8.5 years, the incidence of hypothermia (< 36.0  °C) 
decreased from 29% to 21% during the study period and was associ-
ated with ICU mortality in both medical and surgical patients. The 
older Prismaflex CRRT system uses the Barkey blood warmer, also 
known as Prismacomfort. It operates by covering the blood return 
flow with a silicon tube heat exchanger and the heat is transferred 
by the contact of the resistance heating system. The Thermax blood 
warmer on the newer Prismax CRRT system responds to changing 
treatment parameters by repeatedly adjusting heating to fulfil the 
prescribed return blood temperature. We wanted to characterize the 
occurrence of hypothermia in CRRT patients and to compare wether 
the newer Thermax warmer was more effective in protecting against 
hypothermia compared to its predecessor Barkey.
Methods: The study was registered at Clinical Trials.gov 
(NCT03973814) and approved by the Swedish Ethical Review Author-
ity (Dnr 2019-04388). A total of 9046 patients admitted to the Inten-
sive Care Unit at Skåne University Hospital, Lund, Sweden during the 
years 2006-2019 were screened and 342 patients undergoing CRRT 
were identified and included. The old Prismaflex with the Barkey 
warmer was used until November 2018, thereafter the Prismax with 
the Thermax was used. Data was extracted from the electronic patient 
database management system ICCA (IntelliSpace Critical Care and 
Anesthesia, Philips, the Netherlands) which contains complete clinical 
datasets generated during the ICU stays. Inclusion criteria: > 18 years 
of age and admission to the adult intensive care unit at Skåne Univer-
sity Hospital, Lund during the period from November 2006 to August 
2019 and treatment with CRRT during the ICU stay. Hypothermia was 
defined as < 36.0  °C. The temperature measurements (bladder, ear, 
blood) were carried out hourly. The fraction of hours in hypothermia 
were compared between the two warmers. A sensitivity analysis was 
performed where the first two hours of CRRT treatment were excluded 
in order to test if the phase of starting CRRT was the main driver of 
overall hypothermia. Means and standard deviations are presented. 
Significance was tested by using the chi squared test. For all calcula-
tions the SAS software version 9.4 (Statistical Analysis Software, Cary, 
USA) was used. Significance level was defined as p < 0.05.
Results: In total, 57741 hours were available for evaluation in the 
cohort. Prismaflex patients spent 11.43% (6112 treatment hours below 
36 °C /53465 treatment hours in total) of their time in hypothermia, as 
compared to the novel Prismax CRRT system, where 10.06% (430 treat-
ment hours below 36  °C/4276 treatment hours in total) were below 
36.0  °C (Chi-Square p = 0.0063). In the sensitivity analysis significant 
differences between the historic and novel systems prevailed; 12.7% 
as compared to 11.2% hypothermia hours (p = 0.0216). The Thermax 
blood warmer was associated with less heat loss compared to the Bar-
key warmer. This was highlighted by a mean patient temperature of 
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37  °C vs 36.5  °C correspondingly, but also by the fact that the mean 
set return temperature was 37.9 °C vs 40.9 °C. This difference in mean 
set return temperature translates to a significant (p < 0.001) difference 
in the historic Barkey system compared to the new Thermax system. 
Seemingly, an overcorrection was needed in the Barkey system, prob-
ably because of its insufficiency to maintain the sought blood tem-
perature in the patient. In addition, the use of adjacent Bairhugger 
bodywarmer was significantly less in the Thermax group compared to 
the Barkey group; 17/32 (53.1%) patients had Bairhugger compared 
to 285/310 (91.9%) (p < 0.001) and for those patients with Bairhugger 
there were more Bairhugger free hours in the Thermax group com-
pared to the Barkey group; 99.7 ±  93.4 hours without (16.7 ±  16.4 
h with) in the Thermax group compared to 73.2 ±  107.3 h  without 
(40.3 ± 45.7 h with) in the Barkey group (p < 0.01).
Conclusion: In conclusion, every tenth hour during CRRT was spent in 
hypothermia. There was a signal that the Prismax CRRT system and the 
Thermax blood warmersignificantly decreased the risk of hypothermia 
as compared to historic controls with the older Prismaflex and Barkey 
warmer, in this pilot study. Furthermore, achieving target temperature 
was easier with the new system and use of auxilliary Bairhugger body-
warmer was signifcantly less.
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Introduction: After acute phase of circulatory failure, some authors 
suggest to have a derresuscitation strategy to avoid side effects 
of fluid overload, involving mechanical or diuretic’s induced fluid 
removal (1). According to frank starling, hypovolemia should induce a 
decrease in cardiac index. We hypothesized that an absence of refill-
ing detected by an hameoconcentration, or a preload responsiveness 
before fluid removal could predict cardiac index (CI) decrease during 
mechanical fluid removal induced by renal replacement therapy.
Methods: We conducted a single center prospective diagnostic accu-
racy study in an intensive care unit of an academic French hospital. 
Primary aim of the study was to evaluate diagnostic performance of 
haemoconcentration based on proteinemia variation to detect CI 
decrease ≥  12% during mechanical fluid removal. Secondary aims 
were to evaluate diagnostic performance of passive leg raising (PLR) 
or CI trending by pulse contour analysis to detect CI decrease, and to 
describe hemodynamic variations observed during mechanical fluid 
removal. Patients were adults treated with continuous renal replace-
ment therapy, and fluid removal; and monitored by transpulmonary 
thermodilution technique. Non inclusion criteria were needs to seda-
tion or vasoactive drug adjustement, compartment abdominal syn-
drome, pregnancy. Patients experienced a fluid removal challenge 
(FRC), consisting in a mechanical fluid removal of 500 mL during one 
hour. Fluid removal was stopped if hypotension occurred. Biological 
samples with proteinemia and haemoglobin, PLR and transpulmo-
nary thermodilution were carried out just before and just after the 
FRC. We constructed Receptor Operative Characteristics (ROC) curves 
with computation of area under the curve (AUC) to evaluate diag-
nostic performance of different variables. 95% confidence interval 
was determined by bootstrap technic with 2000 repetitions. Com-
parisons between groups were analysed with a Mann-Whitney U test. 
All tests were two-sided, and p-value below 0.05 defined statistical 
significance.
Results: We included sixty-nine patients between December 2016 
and April 2020. Sixteen patients had a significant CI decrease (23% 
[CI95%  14-35]). Patient’s age was  64 [52, 72],  46 (67%) were cardiac 
surgical patients, 41 (59%) benefited from mechanical ventilation, 
29 (42%) presented arrhythmia, cumulative fluid balance at base-
line was  7% [−  1, 16], SOFA score was  12 [8, 14]. To compare with 
patient without CI decrease, patients with significant CI decrease 
presented: no variation concerning arterial pressure or heart rate; 
a preload decrease (global end diastolic volume index decrease -8% 
[CI95% − 20, − 5] vs 0 [CI95% − 4, 6]); a systemic vascular resistance 
index increase (29% [CI95% 14, 30] vs 2% [− 7, 14]); a more important 
decrease in cardiac function index (− 9% [CI95% − 16, − 2] vs – 4% 
[CI95% − 8, 3]. Hemoconcentration evaluated by proteinemia or hae-
moglobin variations, PLR before or after FRC, and CI trending by pulse 
contour analysis failed to predict CI decrease with AUC under ROC 
curve > 0.75.
Conclusion: Haemocontration variables, preload responsiveness sta-
tus and CI trending by pulse contour analysis failed to predict a CI 
decrease during FRC. As we observed several events of CI reduction, 
monitoring cardiac index with transpulmonary thermodilution tech-
nique might help to prevent deleterious effect of fluid removal.
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Introduction: Acute kidney injury (AKI) severity is classified into three 
stages on the basis of either the increase in serum creatinine (Scr) level 
or the duration and extent of oliguria by KDIGO criteria. However, the 
diagnostic and staging criteria do not take into account the duration 
of Scr elevation, which reflects the time to renal function recovery and 
could be an important potential dimension of AKI along with severity.
Objectives: we sought to explore the association between the dura-
tion of AKI based on Scr and 1-year mortality and to examine whether 
the duration of AKI offered any additional prognostic information over 
the magnitude of elevation in Scr.
Methods: This retrospective study was conducted from 2007 to 2018 
with very elderly patients (≥ 75 years) from the Chinese PLA General 
Hospital. AKI was stratified by magnitude according to KDIGO stage 
and duration (1–2 days, 3–4 days, 5–7 days, and > 7 days). The primary 
outcome was the 1-year mortality rate after AKI.
Results: During the study period,  a total of  688 AKI patients were 
included in the analysis. The median age was 88 (84–91) years. Accord-
ing to the KDIGO criteria, 317 patients (46.1%) had stage 1 AKI, 169 
(24.6%) had stage 2 AKI, and 202 (29.4%) had stage 3 AKI. Of the 688 
study subjects, we stratified patients by duration of AKI: 1–2 days (61; 
8.9%), 3–4 days (104; 15.1%), 5–7 days (140; 20.3%), and > 7 days (383; 
55.7%).
The Kaplan-Meier survival plot demonstrates that 1-year survival 
was significantly different according to both AKI stage and duration. 
As the duration of AKI increased within each strata of AKI severity as 
defined by the KDIGO criteria (magnitude), 1-year survival decreased, 
but no significant differences were found for patients with stage 1 and 
stage 2 AKI (stage 1, P = 0.526; stage 2, P = 0.818; stage 3, P = 0.016). 
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However, survival significantly changed within each strata of AKI clas-
sified by duration. Notably, the 1-year mortality rates were greater for 
those with a duration of 3–4 days, a duration of 5–7 days, and a dura-
tion of > 7 days of AKI. These relationships were confirmed when we 
examined the stratified survival plots. When patients were stratified 
by the stage of AKI, patients with increasing duration of AKI had sig-
nificantly worse 1-year survival in the group with AKI stage 3 (log-rank 
test: P < 0.001), but no differences were found in the group with stage 
1 or stage 2 (log-rank test: both  P > 0.05). In contrast, when patients 
were stratified by the duration of AKI, the magnitude of Scr increase as 
classified by KDIGO was significantly associated with 1-year mortality 
(log-rank test: P < 0.05 for all four strata).
Accordingto the multivariate regression analysis, both AKI duration (3–4 
days: HR = 3.184; 95% CI: 1.733–5.853; P < 0.001, 5–7 days: HR = 1.915; 
95% CI: 1.073–3.416;  P = 0.028; > 7 days: HR = 1.766; 95% CI: 1.017–
3.065; P = 0.043) and more advanced AKI stage (stage 2: HR = 3.063; 95% 
CI: 2.207–4.252; P < 0.001; stage 3: HR = 7.333; 95% CI: 5.274–10.197; P < 
0.001) were independently associated with 1-year mortality.
Conclusion: In conclusion, the duration of AKI in geriatric patients is 
independently associated with 1-year mortality and may adds prog-
nostic value in addition to that provided by the magnitude of Scr 
alone. These data need to be validated in other settings of AKI, and 
if found to be valid, the duration of AKI should be incorporated into 
the consensus definitions of AKI and target AKI duration for clinical 
management.
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Introduction: Acute kidney injury (AKI) is common and serious com-
plication in critically. AKI treated with continuous renal replacement 
therapy (CRRT) may alter trace element levels in critically ill patients 
and at risk for disturbances in plasma levels of trace elements due to 
the underlying illness, AKI, and dialysis 1.
Objectives: We aimed to determine trace element balances during 
CRRT in critically ill patients.
Methods: The study was conducted prospectively in intensive care 
unit (ICU). The study included patients aged ≥  18 years who were 
admitted in ICU with AKI and required CRRT support (continuous 
venovenous hemodiafiltration, CVVHDF). Serum trace elements (cop-
per, zinc, selenium, chromium and cobalt) measured were measured 
using the high performance  liquid chromatography on the first three 
days of CVVHDF and first two days after CVVHDF.
Results: We enrolled 50 patients. The median (min-max) age was 
64(18-88) years. The most common reasons for ICU admission were 
respiratory failure (34%) and metabolic disorders (20%). The median 
(min-max) baseline APACHE II score and NUTRIC score of the patients 
was 24.0 (6.0-33.0) and 5 (0-8), respectively. The mean days on CRRT 
was 2.4  ±  0.5 days. Serum copper, zinc, selenium, chromium and 
cobalt levels at all times and referance range showed Table 1. Serum 
trace elements was not significantly different from baseline at all times 
(p > 0.05).
Table 1. Serum copper, zinc, selenium, chromium and cobalt levels 
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Conclusion: End of the study, serum chromium and selenium was 
tended to increase on follow-up while cobalt, copper and zinc was 
tended to decrease on follow-up. However, the difference in these 
parameters was not statistically significant.
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Introduction: Acute kidney injury (AKI) is common in surgical 
patients. We aimed to investigate the validity of plasma and urine neu-
trophil gelatinase-associated lipocalin (NGAL) in the early detection of 
AKI and prediction of outcomes in patients undergoing major elective 
colorectal surgery.
Methods: This was a post-hoc analysis of a randomized controlled trial 
comparing oesophageal doppler and Lithium dilution cardiac output 
monitoring for intraoperative haemodynamic monitoring in high risk 
patients undergoing major colorectal surgery in a tertiary care hos-
pital. Plasma and urine samples were collected before surgery (T1), 
immediately after surgery (T2), and on postoperative day 1 (T3) and 
NGAL levels were measured. We collected baseline demographics, 
perioperative parameters, hospital and long-term mortality. We identi-
fied patients with AKI according to KDIGO criteria and compared them 
with patients without AKI.
Results: A total of 89 patients were included, of whom 12 (13∙5%) 
developed AKI. Plasma NGAL significantly increased from T1 to T3 
in both AKI (P < 0∙001) and non-AKI (P = 0∙048) patients, while urine 
NGAL did not change over time. There were no significant differences 
in plasma and urine NGAL in patients with and without AKI at all time 
points. Baseline plasma NGAL and post-operative urine NGAL were 
higher in 8-year non-survivors than survivors. AKI patients with raised 
plasma or urine NGAL had a higher long-term mortality than AKI 
patients without a raised NGAL.
Conclusion: Plasma and urine NGAL poorly predicted AKI post-colo-
rectal surgery. Both plasma and urine NGAL were higher in non-survi-
vors although further studies are needed to determine the association 
between NGAL and long-term outcomes.
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Introduction: Acute kidney injury is one of the most common com-
plications in critical care. It is associated with high mortality, increased 
length of stay and adverse long-term outcomes. Clinical decision 
support (CDS) tools have provided means of alerting clinicians to 
deteriorating patients leading to better management and improved 
outcomes. A study was conducted in two ICU units in University Hos-
pitals Bristol, UK. It involved integrating a CDS intervention based on 
Acute Kidney Injury Network (AKIN) guidelines and a care bundle con-
sisting of alerts, dashboard and order sets.
Objectives: The study involved a before (control) and after (interven-
tion) phases. It investigated the effect of the intervention on the num-
ber of patients deteriorating to higher AKI levels as well as measuring 
medication adherence. This work investigates the in-ICU costs relating 
to the length of stay of AKI patients before and after the intervention.
Methods: AKI score was calculated anytime a new urine output or 
Serum Creatinine was measured. The costs for each stage of AKI (1-3, 
according to AKIN) were calculated as the number of patients per 
stage, multiplied by the average LOS and the average cost of an ICU 
day in intensive care based on hospital averages (£1981). This pro-
vides a minimal value, as the costs associated with higher AKI levels 
are higher.
Results: Each arm of the study was run for 1 year with 2523 ICU admis-
sions in the control phase followed by 2521 ICU admissions in the 
intervention phase. The prevalence of patients developing any AKI 
decreased from 43.1% (control) to 37.5% (intervention). There was a 
reduction in the proportion of patients in each stage of AKI. This was 
accompanied with a reduction in LOS for the three levels. In control 
cohort, the mean LOS for AKI stage 1 was 6.4 days which reduced to 
5.0 days in intervention. For stage 2 and stage 3, the reduction was 
(8.2 days; control to 7.3 days; intervention) and (10.8 days; control to 
10.2 days; intervention) respectively. Overall, minimal ICU costs for all 
AKI patient days were £14,459,874 for 1018 AKI patients in the control 
phase and £10,163,738 for 870 AKI patients in the intervention phase.
Conclusion: In comparison to the control phase, the study showed 
that that the introduction of AKI guidelines and care bundle increased 
AKI vigilance, leading to proactive measures in managing AKI. This led 
to a reduction of patients with AKI in the intervention phase, accom-
panied by an overall shorter length of stay. ICU costs were reduced 
by 30% if only length of stay were to be considered as a contributing 
factor. This, however, is a rather simplified view of ICU costs. Further 
work should include the effect of treatments, long-term follow-up and 
readmission on costs.
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Introduction: COVID 19 community acquired pneumonia is a recent 
and frequent cause of admission in European intensive care units. Cur-
rently, there are many open questions regarding the management 
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and prognostic factors of these patients. Among them, its association 
with acute renal failure in patients on mechanical ventilation.
Objectives: Analysis of acute renal failure in COVID 19 patients 
on mechanical ventilation. Prognosis and factors related to its 
development.
Methods: Retrospective observational study carried out in the inten-
sive care unit of a University Hospital during the COVID 19 pandemic. 
We analysed patients admitted to the ICU with the diagnosis of Res-
piratory Failure due to pneumonia COVID 19 between 6/3/2020 and 
21/4/2020. Demographic data (age, sex), APACHE II, comorbidities, 
analytical data (ferritin, total bilirubin), length of stay, treatments 
administered (mechanical ventilation, muscle relaxant, vasoactive 
drugs, prone) and its association to acute renal failure were analysed.
Results: 67 patients received complete treatment in our hospi-
tal. 67.2% males with an average age 60 years, length of stay (days) 
14.1 ± 10, APACHE II 14.3 ± 5.2. Maximum creatinine mean value (mg/
dl) 1.48 ±  1.26, maximum ferritin mean value (ng/ml) 2310 ±  3322, 
maximum total bilirubin mean value (mg/dl) 2  ±  2.2. 100% of the 
patients required mechanical ventilation. 65.7% prone positioning, 
74.6% neuromuscular blockers and 98.5% required vasoactive drugs.
Establishing renal failure as creatinine values greater than 1.2 mg / dl, 
the results shown in Table 1 were obtained.
Creatinine > 1,2 
mg/dl
Creatinine < 1,2 
mg/dl P
Age (years) 61,3 59 0,37 
APACHE II 15,8 13,3 0,128 
Ferritine (max) 3421 1535 0,035
D-Dimer (max) 23,5 15 0,19 
Bilirubine (max) 3 1,4 0,012
Table  2 shows the mean creatinine values in patients, who require 
prone positioning, muscular blockers, have cardiovascular disease, 




Prone 1,51 1,43 0,8 
Muscular bloq. 1,49 1,46 0,9 
Sex (male) 1,81 0,8 0,002
CV desease 1,69 1,3 0,22 
Dyslipidemia 1,92 1,22 0,026
Suoerinfection 1,62 1,3 0,29 
Survivors 1,07 1,96 0,003
Conclusion: In our sample, we have associated acute renal failure with 
higher ferritin values. Likewise, we have observed higher creatinine 
values in the group of non-survivors, those with dyslipidaemia and 
men, with statistical signification.
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Introduction: Astrointestinal dysfunction may lead to increased 
mucosal permeability and leakage of endotoxin. Although corona-
viruses  are known mainly as respiratory pathogens, up to 60% of 
COVID-19 patients show gastrointestinal symptoms at admission or 
developed during hospitalization. Recent published data show how 
endotoxemia and bacterial DNA are frequently found in patients with 
COVID-19 pneumonia, indicating that loss of intestinal barrier function 
can contribute to the pathogenesis of COVID-19. In addition, patients 
who are hospitalized for extended periods in an ICU are more prone to 
superimposed infections.
Objectives: In this retrospective analysis we report our experienceof 
Polymyxin B hemoperfusion (PMX-HP) as complementary therapy for 
unresponsive endotoxic shock management in 5 patients with COVID-
19 hospitalized in our ICU ward between February and April 2020. To 
the best of our knowledge, there is no data published yet concerning 
PMX-HP use in COVID-19 patients.
Methods: In the present case series, we evaluated the impact of 
PMX-HP as adjunctive therapy in a population of patients affected by 
COVID-19 and confirmed endotoxic shock identified my measurement 
of endotoxin activity at enrollment. Hemodynamics and main clinically 
relevant outcome parameters were monitored. PMX-HP treatment 
consists of 2 hemoperfusion sessions, the second session performed 
24 hours after the first one, at a blood flow rate of 100 ml/min. Unfrac-
tionated heparin was used as standard anticoagulant.
Results: PMX-HP treatment was associated with rapid hemody-
namic stabilization  with reduction of Vasopressors Inotropic Score 
(VIS) – (from a mean value of 29 ± 15,17 to 2,60 ± 2,88 at 120 hours, 
p < 0,05), reduction in blood lactate levels  (from 2,84 ±1,43  to 
1,08 mmol/l ± 0,54 at 120 hours – p < 0,05), rapid decrease in Endo-
toxin Activity (EA) levels (from  a mean EA  value of 0,70  ±  0,10  to 
0,49 ±  0,13at 48 hours –p < 0,05) in a population affected by SARS-
CoV-2  and endotoxic shock. PMX-HP treatment resulted safe and 
well-tolerated with no device related adverse events during or after 
hemoperfusion sessions. All patients received 2 hemoperfusion 
sessions.
Conclusion. Endotoxic shock could be associated to SARS-CoV-2. 
PMX-HP can be considered for management of unresponsive endo-
toxic shock. In our cases, PMX-HP treatment was associated with 
rapid hemodynamic improvement associated with a rapid  decrease 
in vasopressor use, blood lactates and EAA levels. PMX-HP treatment 
was safe with no device-related adverse events.
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Introduction. Acute Kidney Injury (AKI) is a common complication 
in trauma with 24% of incidence in intensive care unit and it is inde-
pendently associated with increased morbidity and mortality, but also 
prolonged length of stay. The high incidence of AKI in trauma patients 
should lead to early identification of those at risk of AKI to establish a 
resuscitation strategy that aims at preventing AKI.
Methods: Detailed data of trauma patients between May, 2017 and 
May, 2019 were retrieved from icu medical records. In particular, 
patients’ demographics, hemodynamic parameters, biochemical 
parameter and fluid balance, urinary output, sCr values at baseline, 
24 hrs, 48 hrs, and 72 hrs. Shorts and long terms outcomes had been 
analysed.
Results. Based on KDIGO criteria, 45 patients developed AKI (29.4%.) 
29 patients (19.9%) developed stage 1 AKI, 16 patients (10.5%) stage 
2-3 AKI. Patients with elevated urinary biomarkers alone undergoing 
therapeutics interventions had 8.5% stage 2-3 AKI compared to 33% of 
patients with creatinine elevation only, and 50% of patients with both 
increased creatinine and AKI risk score. A number of 19 patients (23%) 
with urinary markers driven interventions progressed to higher stages 
of AKI, while 7 (8.5%) improved AKI stage.
Outcome No AKI (N=29) 







RRT 0 0 0 5 (11%) 
Ventilation free 
days 1.8(2.1) 1.7(1.4) 2.0(2.5) 1.8(1.9) 
MV length 5.9(9.3) 4.7(6.6) 7.4(10.1) 5.9(8.6) 
ICU stay 7.7(9.3) 6.3(6.7) 9.4(9.8) 7.7(8.0) 
Hospital stay 18.1(16.3) 19.3(15.6) 18.5(19.6) 19.1(17.3) 
Renal recovery NA 26(89%) 11(68.5%) 37(82.2%) 
Survival over 24 
hrs from ER 
arrival 
108(100%) 29(100%) 16(100%) 45 (100%) 
Conclusion: AKI is a frequent complication following trauma. 
Although the reduction of stage 2/3 AKI based on therapeutic inter-
ventions driven by elevated urinary  biomarkers was observed in 8% 
of patients, the use of biomarkers represent an important tool for 
the early detection of patients at high risk of AKI behind the local ICU 
experience based on multidisciplinary team.
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Introduction: Dexmedetomidine (DEX) is a common sedative agent 
that may protect against organ dysfunction such as acute kidney 
injury (AKI) by reducing inflammatory response. A recent post-hoc 
analysis1 has found that DEX treatment is associated with reduced 
AKI and mortality rate among septic patients. However, no human 
study has ever explored confounding factors that could increase AKI-
risk in NO-DEX group (i.e. nephrotoxic drugs; chronic kidney disease, 
CKD). For these reasons, we analyzed a well stratified cohort of septic 
patients that need sedative agents and have been exposed to similar 
risk factors for AKI development.
Objectives: We hypothesized that DEX could reduce AKI incidence 
when compared to NO-DEX sedative agents in septic patients.
Methods: We performed a retrospective analysis, reviewing all 
patients admitted for sepsis to our intermediate care unit (IMCU) from 
January 1st 2018 to December 31st 2019. The inclusion criteria were: 
age ≥ 18 years old; diagnosis of sepsis at admission; need of sedative 
agents for delirium. Exclusion criteria were: chronic need of hemodial-
ysis; use of sedative agents beyond delirium. NO-DEX agents included 
benzodiazepines, quetiapine and haloperidol. AKI was identified by 
KDIGO criteria. We analyzed two groups (DEX and NO-DEX) matched 
for age, SAPS2 score, SOFA score and CKD. We investigated rates of 
AKI and mortality at 90 days in the two groups. We also analyzed some 
counfounding factors such as circulatory failure (CF), use of iodinated 
contrast media (ICM), aminoglycosides, glycopeptides, colistin, ACEi/
sartans and non steroidal anti-inflammatory drugs (NSAID).
Results: We reviewed 34 patients and 22/34 respected the inclusion 
criteria (11 in DEX group; 11 in NO-DEX group). The two groups were 
well matched (SAPS 2 score: 33 ± 1 (DEX), 33 ± 3 (NO-DEX) p = 0.5; 
SOFA score: 4 ± 1 (DEX), 4 ± 4 (NO-DEX) p = 0.4; age: 70 ± 11 (DEX), 
70 ± 3 (NO-DEX) p = 0.5; CKD: 3/11 patients (DEX), 2/11 patients (NO-
DEX). We found that DEX significantly decreases AKI rate (DEX 1/11 
patients; NO DEX 6/11 patients; OR 0.08, 95% CI 0.008-0.895, p = 
0.04). We also found no significant difference in mortality at 90 days 
between the two groups(NO DEX 2/11 patients; DEX 5/11 patients; OR 
3.75, 95% CI 0.54-26.05, p = 0.2). In the Table 1 we have reported AKI 
characteristics for every single patient. About confounding factors, 
only a patient in NO DEX group received ICM, ACEi/sartans and NSAID 
all together. Remaining 5 AKI patients in NO-DEX groups did not 
receive any nephrotoxic drug. Only a patient in DEX group showed AKI 
and received colistin and DEX treatment at the same time. In conclu-
sion, the higher AKI rate in NO-DEX group was not significantly linked 
to confounding factors.
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Conclusion: DEX could reduce the incidence of AKI in septic patients 
when compared with other sedative agents. Future large randomized 
studies are necessary to confirm these preliminary findings.
Reference(s) and grant ackowledgment(s)
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Introduction: Hemodynamic instability is a frequent complication 
of continuous renal replacement therapy (CRRT) in intensive care 
patients. Postural tests (i.e. passive leg raising in the supine position 
or Trendelenburg in the prone position) combined with continuous 
measurement of cardiac output are highly reliable to identify preload 
dependence and may provide new insights into the mechanisms 
involved in hemodynamic instability related to renal replacement 
therapy (HIRRT).
Objectives: We aimed to assess the prevalence and risk factors of 
HIRRT associated with preload-dependence in ICU patients.
Methods: We conducted a single-center prospective observational 
study in ICU patients with acute kidney injury KDIGO 3, started on 
CRRT in the last 24 hours, and monitored with a PiCCO® device. The 
primary endpoint was the rate of HIRRT episodes associated with 
preload dependence during the first 7 days of CRRT. HIRRT was 
defined as the occurrence of a mean arterial pressure below 65  mm 
Hg requiring any of the following therapeutic intervention (initiation 
or increase in vasopressor dose, discontinuation or decrease of fluid 
removal by CRRT, or fluid administration). Preload dependence was 
assessed every 4 hours, and during each hypotensive episode, and 
was deemed present if the continuous cardiac index increased by at 
least 10 % during a passive leg raising test in supine patients, or 8% 
during Trendelenburg in prone patients. Data are expressed in median 
[1rst quartile-3rd quartile], unless stated otherwise.
Results: 32 patients (59% male, age 67 [58-75] year, SAPS-2 71 [49-78]) 
were included 8 [1-14] hours after CRRT initiation and studied continu-
ously for 99 [55-144] hours. 29 [18-40] hemodynamic evaluations per 
patient were performed for a total of 903 hemodynamic evaluations. 
Preload-dependence was present in 42% of the hemodynamic evalua-
tions. RRT modality was CVVH during 91% of the hemodynamic evalu-
ations and CVVHD in 9%. Ultrafiltration rate was 27 [24-31] ml.kg-1.
hr-1 in CVVH-treated patients, dialysate rate was 26 [20-29] ml.kg-1.
hr-1 in CVVHD-treated patients, and net UF was 100 [0-200] ml.hr-1. 
All patients experienced at least 1 episode of HIRRT. A median of 4 
[3-7] HIRRT episodes occurred per patient, for a pooled total of 173 
episodes. 94 episodes (54% [CI95%: 47-62%]) were associated with 
preload-dependence, 75 (43%, [CI95%: 36-51%]) without preload-
dependence, and 2 were unclassified. Therapeutic management of 
HIRRT episodes is reported in the figure below. Multivariate analy-
sis (using variables collected prior to HIRRT) identified the following 
variables as risk factors for the occurrence of HIRRT associated with 
preload-dependence: preload-dependence before HIRRT (odds ratio 
= 3.66, p < 0.001), delay since last HIRRT episode of at least 4 hours 
(OR = 0.35, p < 0.01), lactate (OR = 1.22 per 1.9 mmol/L increase, p 
< 0.01), cardiac index (0.58 per 1 L.min-1.m-2 increase, p < 0.01) and 
SOFA at ICU admission (0.90 per 1 point increase, p < 0.01).
Conclusion: In this single center study, HIRRT associated with preload 
dependence was slightly more frequent than HIRRT without preload 
dependence in ICU patients undergoing CRRT. Testing for preload 
dependence to adjust fluid removal could help preventing HIRRT inci-
dence during CRRT.
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Introduction: TIMP2 and IGFBP7 are specific biomarkers of structural 
renal injury in critically ill patients.The composite of [TIMP-2]·[IGFBP7] 
in urine is suggested to better detect and stratify acutekidney injury 
(AKI). To date, there is not enough data in medical-surgical ICUs where 
renalcritical care is essentially led by primary intensivists. We designed 
an observational study todefine our population as a first step of an 
ongoing quality improvement project in AKI inCatalonia.
Objectives: To assess the prognostic value of a single [TIMP-
2]·[IGFBP7] determination for predicting mortality at ICU admission.
Methods: Prospective, observational study in five tertiary univer-
sity intensive care units. We included medical and surgical adult 
patients with an expected ICU stay more than 24 hours. We excluded 
those pregnant, post cardiac surgery, with severe acute kidney injury 
(KDIGO3) at admission or requiring bladder washouts. Epidemio-
logical, clinical and laboratory variables were collected during more 
than 7 days of stay. [TIMP2]·[IGFBP7] ((ng/mL)2/1000) was analysed 
in an admission urine sample by Nephrocheck® Vitros 3600 platform 
(NC). Descriptive and survival analysis were made using Stata v.16. 
The descriptive results are shown in median and interquartile range 
(IQR). We stratified patients in three groups according acute kidney 
injury risk: low, NC1 < 0.3; high, NC2 0.3-2; very high, NC3 > 2 (ng/
mL)2/1000).
Results: The sample included 476 patients (Table 1), with median age 
of 61 (IQR 48-71.5) years; 271 (57%) were women. Median ICU length 
of stay was 7 (IQR 4-17) days. Patients in NC3 group had a hazard ratio 
for mortality of 2.8 compared to NC1 group (CI 95% 1.5-5.2; p = 0,001). 
According to the Kaplan-Meier curve, the probability of death at 28 
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days of admission of patients in NC3 group was 52% (CI 95% 24-68%)
(figure 1).
Table 1. Main characteristics of study population. Values expressed as either 
% or median with interquartile range (IQR) 
VARIABLE                 TOTAL (n = 476) 
Age (years) 61 (IQR 48-71.5) 
%75elameF (271/476) 
ICU length of stay (days) 7 (IQR 4-17) 
Hospital length of stay (days) 17 (IQRR 9-32) 
ICU mortality 17% (81/476)
Days on mechanical ventilation 4 (IQR 2-10) 
SOFA day 1 5 (IQR 1-8) 
APACHE II 20 (IQR 14-26) 
Baseline serum creatinine (umol/L) 76 (IQR 63-98) 
[TIMP2]·[IGFBP7] in (ng/mL)2/1000 0.07 (IQR 0.04-7.52) 
AKI (KDIGO >0) at 48 hours 30% (143/476) 
Renal replacement during ICU stay 5.5% (26/476) 
Conclusion: In our study, patients with NC > 2(ng/mL)2/1000 had 
a significant higher mortality rate compared to those with low NC 
values.
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Introduction: TIMP2 and IGFBP7 are specific biomarkers of structural 
renal injury in critically ill patients. The composite of [TIMP-2]·[IGFBP7] 
in urine is suggested to better detect and stratify acute kidney injury 
(AKI). To date, there is not enough data in medical-surgical ICUs where 
renal critical care is essentially led by primary intensivists. We designed 
an observational study to define our population as a first step of an 
ongoing quality improvement project in AKI in Catalonia.
Objectives: To analyse the predictive value of urinary [TIMP-
2]·[IGFBP7] to predict acute kidney injury in critically ill patients.
Methods: Prospective, observational study in five tertiary univer-
sity intensive care units. We included medical and surgical adult 
patients with an expected ICU stay more than 24 hours. We excluded 
those pregnant, post cardiac surgery, with severe acute kidney injury 
(KDIGO3) at admission or requiring bladder washouts. Epidemiologi-
cal, clinical and laboratory variables were collected during the first 7 
days of stay. [TIMP2]·[IGFBP7] ((ng/mL)2/1000) was analysed in an 
admission urine sample by Nephrocheck® Vitros 3600 platform (NC). 
Descriptive and predictive analysis were made using Stata v.16. The 
results are shown in median and interquartile range (IQR), sensibility 
(S) - specificity analysis (E), and predictive capability with ROC and area 
under the curve (AUC).
Results: Of 476 patients in our cohort, we selected 287 who did not 
present AKI (table 1). Median age was 59 (IQR 46-71) years; 54% were 
women. Patients with NC > 0.3 had a higher ICU mortality rate (45% vs 
20%, p = 0.032). The AUC ROC curve to predict AKI KDIGO 2-3 of NC 
during the first week of ICU stay was 0.68 (IC 95% 0.48-0.89; p < 0.001)
(figure  1). The negative predictive value for NC < 0.3(ng/mL)2/1000 
was 98% (S 44.4%, E 86.3%). The positive predictive value for NC > 2 
was 50% (S 11.1%, E 99.6%).
Table 1. Main characteristics of study population. Values expressed as either 
% or median with interquartile range (IQR) 
LATOTELBAIRAV (N=287) 
Age (years) 59 (IQR 46-71) 
%45elameF (155/287) 
ICU length of stay (days) 5 (IQR 3-10) 
Hospital length of stay (days) 17 (IQRR 9-32) 
ICU mortality 13.9% (40/287) 
Days on mechanical ventilation 3 (IQR 2-7) 
SOFA day 1 4 (IQR 1-7) 
APACHE II  18 (IQR 13-24) 
Baseline serum creatinine (umol/L) 76 (IQR 62-94) 
[TIMP2]·[IGFBP7] in (ng/mL)2/1000 0.07 (IQR 0.04-7.52) 
Conclusion: Although in our study [TIMP-2]·[IGFBP7] had a low pre-
dictive capacity to diagnose severe AKI, it showed a very high negative 
predictive value.
Reference(s) and grant ackowledgment(s)
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Introduction: Acute kidney injury (AKI) occurs frequently in patients 
after cardiac surgery and has been associated with poor outcome.
Objectives: To assess prevalence of AKI in patients admitted to inten-
sive care unit (ICU) post-cardiac surgery during an immediate postop-
erative period of 24 hours, evaluate predisposing risk factors and its 
association with outcome.
Methods: 199 (60 women) consecutive patients admitted to ICU post-
cardiac surgery participated in this study. Kidney function evaluated 
pre-operatively and at 24 hours after procedure. An increase in serum 
creatinine by 0.3mg/dl was considered as AKI, according to KDIGO 
classification.
Results: 46 patients (23.1%) developed AKI 24 hours after ICU admit-
tance. These patients received more vasoactive drugs (noradrenaline, 
vasopressin), (54% vs 26%, p < 0.001). They also had longer cardio-pul-
monary bypass (CPB) time [AKI group: 119(104 – 164) min vs no-AKI 
group: 106(80 – 142) min, p < 0.027], longer administration of seda-
tion [490(300 – 780) min vs 300(240 – 540) min), p < 0.001] and longer 
duration of mechanical ventilation support [1084(732 – 1913) min vs 
720(534 – 1073) min, p≤0.0001]. Finally, patients that developed AKI 
had significantly higher positive fluid balance during the first 24 hours 
[1038(363 – 1859) ml vs 501(23 – 1239) ml, p = 0.005].
Conclusion: There is a high prevalence of AKI in patients post cardiac-
surgery admitted to ICU. AKI is associated with vasoactive treatment, 
positive fluid balance, duration of CPB and duration of administration 
of sedation and duration of mechanical ventilation support.
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Introduction: Sepsis-induced acute kidney injury (AKI) causes high 
mortality in critical ill patients owing to elevated levels of endotoxin. 
This situation might be partially attributed to the delayed recognition 
of AKI because thecurrent diagnosis is based on either an elevation 
of serum creatinine levels or the detection of oliguria. Metabolomics 
including diverse detection platforms and multiple analysis methods 
is a potential tool for identifying small molecule biomarkers of renal 
diseases.
Objectives: This study intends to study the alterations of serum 
metabolomics in rats with sepsis-induced AKI and to find earlier bio-
markers of sepsis-induced AKI for early clinical diagnosis and treat-
ment through gas chromatography time-of-flight / mass spectrometry 
(GC-TOFMS).
Methods: A rat model of sepsis-induced AKI was established by intra-
peritoneal injection of Lipopolysaccharide. Thirty SD rats were ran-
domly divided into control group, LPS 2h group and LPS 6h group 
with 10 rats in each group. Non-targeted metabolomics screening was 
performed on serum samples of control group and sepsis-induced 
AKI groups based on Gas chromatography time-of-flight / mass 
spectrometry (GC-TOFMS) techniques. Combining multivariate and 
univariate statistical analysis, the comparisons between every two 
groups were analyzed to screen out the serum metabolites that were 
statistically altered in the early stage of AKI in rats with sepsis. Finally 
differential metabolites obtained from each intergroup comparison 
are summarized.
Results: Orthogonal partial least square discriminant analysis (OPLS-
DA) showed the obvious separation between the control group and 
the LPS 2h group, the control group and the LPS6h group, the LPS 2h 
group and the LPS 6h group. Each intergroup comparison can obtain 
a series of differential metabolites that meet the set threshold in the 
“potential biomarkers” section. The results of differential metabo-
lites obtained from each intergroup comparison are intersected and 
summarized, which suggested that three metabolites were always 
significantly different in the development of sepsis-induced AKI. The 
potential three biomarkers for sepsis-induced AKI were Malic acid, 
Methionine sulfoxide and Petroselinic acid.
Conclusion: Our findings suggested that the levels of Malic acid, 
Methionine sulfoxide and Petroselinic acid in the serum are expected 
to be candidates for early diagnosis of sepsis-induced AKI in rats.
Reference(s) and grant ackowledgment(s)
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Introduction: Acute kidney injury is frequent and serious complica-
tion after aortic surgery which increases length of hospital stay, costs, 
morbidity and mortality. Earlier recognition of patients at risk by pre-
dictive factors and identification of acute kidney injury could have 
important role on right timing of preventive and therapeutic meas-
ures and lower mortality of these patients.
Objectives: To investigate the most important preoperative and intra-
operative predictive factors for acute kidney injury 72 hours after elec-
tive infrarenal aortic surgery.
Methods: This prospective observational study was performed at 
Clinic of Anesthesia, Intensive Care and Pain Therapy and Clinic of Vas-
cular and Transplantation Surgery, Clinical Centre of Vojvodina, during 
the period of 18 months, from October 2017 till April 2019. It includes 
140 adult patient who underwent elective infrarenal aortic surgery. 
Potential predictive factors were identified out of medical records 
such as: patient history, anesthesia lists, daily therapeutic lists, vital 
parameters and laboratory values lists. The occurrence of acute kid-
ney injury was noted according to AKIN criteria. IBM SPSS version 21 
(Chicago, Illinois) was used for statistical analysis. The results were pre-
sented in tables and graphs, statistical significance was set at p value 
of less than 0,05. Standard statistical tests were applied. Multivariate 
logistic regression model was used for potential predictive factors.
Results: The cut off value of cystatin C serum concentration of 1,14 
mg/l has the highest sensitivity (82,5%), and specificity (76%) in the 
differentiation of patients who will develop acute kidney injury. The 
final model for predicting acute kidney injury in patients who under-
went elective infrarenal aortic surgery contains the following variables: 
presence of chronic kidney disease, preoperative serum concentration 
of cystatin C > 1,14 mg/l, application of colloid solutions in volume > 
500 ml during the operation and total intravascular fluid replacement 
volume > 59 ml/kg in intraoperative period. The strongest predictor of 
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AKI development was cystatin C concentration above 1,14 mg/l with a 
probability ratio of 17,811.
Conclusion: Presurgical value of cystatin C is a good predictor of acute 
kidney injury after elective infrarenal aortic surgery.
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Introduction: Acute kidney injury (AKI) is a common complication 
among patients undergoing cardiopulmonary bypass (CPB)  [1-3], 
leading to prolonged stay in the intensive care unit (ICU) and higher 
postoperative mortality  [4]. Early identification paired with effective 
intervention has reduced the frequency and severity of postoperative 
AKI [2], indicating that early diagnosis is extremely warranted.
Currently, AKI diagnosis is based on KDIGO criteria evaluating serum 
creatinine (SCr) and urine output  [5]. However, SCr has been chal-
lenged as it rises slowly after an initial insult (usually  48-72 h) and  is 
influenced by numerous non-renal factors  [6-8]. Urinary biomarkers 
have been extensively studied as promising strategy for early diagno-
sis. However, the following issues may limit urinary biomarkers from 
being widely used: (1) The detection needs specific testing facilities, 
which may not be available in all the hospitals; (2) The visible eleva-
tion can only be observed several hours after surgery  [9], which still 
delayed the treatment to get maximum clinical benefit; (3) Most stud-
ies involved with urinary biomarkers  [9-12] have been limited by the 
absence of statistical methods to account for overfitting due to small 
sample size [13] and non-linear correlation [14], leading to poor gen-
eralizability and flexibility; and (4) Urinary biomarkers prominently 
manifest tubular epithelium injury. New biomarkers for AKI induced by 
open-heart surgery are needed.
Hemolysis with subsequent free hemoglobin (fHb) released by red-
blood cells is a significant contributor to AKI among patients under-
going CPB  [15, 16]. Levels of fHb peaked 15 min after weaning of 
CPB  [17]  and patients with AKI display significantly higher fHb levels 
compared to patients without AKI  [16]. In addition, the difference 
between levels of fHb at the end of CPB and baseline (∆fHb) was asso-
ciated with AKI in pediatric patients  [18]. Whether ∆fHb or fHb ratio, 
defined as levels of fHb at the end of CPB divided by fHb at baseline, 
are independent risk factors of AKI in adult patients requires further 
investigation. Moreover, whether ∆fHb or fHb ratio could predict AKI 
remains unclear.
Therefore, we performed a secondary analysis on the control arm of 
a randomized controlled trial [3]  to determine whether  ∆fHb or fHb 
ratio, an easily detected surrogate of hemolysis, could be identified as 
an early biomarker for postoperative AKI after open-heart surgery and 
whether  incorporation of fHb ratio could improve  predictive perfor-
mance, compared with using urinary biomarkers alone.
Objectives: To determine whether free hemoglobin (fHb) ratio could 
predict AKI immediately after open-heart surgery.
Methods: This is a secondary analysis of a randomized controlled trial 
comparing the effect of nitric oxide (intervention)versus nitrogen (con-
trol) on AKI after cardiac surgery (NCT01802619) [1]. 110 adult patients 
in the control arm were included. First, we determined whether fHb 
ratio (i.e., levels of fHb at the end of CPB divided by baseline fHb) 
was associated with AKI via univariable and multivariable analyses. 
Second, we verified whether fHb ratio could predict AKI and incorpo-
ration of fHb ratio could improve predictive performance of AKI at an 
early stage, compared with prediction using urinary biomarkers alone. 
We conducted restricted cubic spline in logistic regression for model 
development. We used bootstrap-based internal validation to account 
for overfitting. We also employed concordance (c) statistic, area under 
curve (AUC) test, resampling model calibration, and likelihood ratio 
test to compare the predictive performance (i.e., discrimination and 
calibration) between competing models.
Results: Data stratified by median fHb ratio showed that  subjects 
with an fHb ratio > 2.23 presented higher incidence of AKI (80.0% vs. 
49.1%, p = 0.001), more need of renal replacement therapy (10.9% vs. 
0%, p = 0.036), and higher 28-day mortality (10.9% vs. 0%, p = 0.036) 
than subjects with an fHb ratio ≤2.23.  fHb ratio was associated with 
AKI after adjustment for pre-established factors. Among the four bio-
markers, fHb ratio outperformed other biomarkers with the highest 
AUC of  0.703  (0.600-0.806), best calibration, and minimaloptimism 
(bootstrap-adjusted AUC  0.704, 95% CI  0.592-0.804).  Incorporation 
of fHb ratio achieved better predictive performance in terms of bet-
ter discrimination (0.771 versus 0.653, p = 0.012) and calibration (p < 
0.001) at an early stage, compared with prediction using urinary bio-
markers alone.
Conclusion: fHb ratio at the end of CPB is a novel, widely applicable 
biomarker  for AKI after  open-heart surgery  and incorporation of fHb 
ratio can achieve better predictive performance at an early stage, 
compared with prediction using urinary biomarkers alone.
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Introduction: Acute kidney injury (AKI) occurs in over half of ICU 
patients and is associated with an increase in ICU and hospital mortal-
ity. The KDIGO consensus definition for AKI is based on an episode of 
oliguria or an increase of serum creatinine (Scr) above baseline Scr. In 
case no representative baseline Scr is available, an alternative based 
on the MDRD equation for estimated glomerular filtration rate (eGFR) 
may be used. In this study we evaluated the use of an MDRD estimated 
baseline Scr (MDRD-Scr) versus the use of a measured baseline Scr (BL-
Scr) on the incidence of AKI in critically ill patients.
Methods: We analysed data collected during a four-year period in 
all consecutive admitted patients in the 5 different adult ICUs of the 
Ghent University Hospital. We excluded patients who did not have a 
BL-Scr available. AKI was assessed using the KDIGO criteria for serum 
creatinine based on MDRD-Scr and BL-Scr during the first week of ICU 
admission. Precision was calculated as (BL-Scr - MDRD-Scr)/BL-Scr X 
100%, bias as BL-Scr - MDRD-Scr, and accuracy as the proportion of 
MDRD-Scr within 10%, 20%, 30% or 50% of BL-Scr (Acc10-20-30-50).
Results: Of 9,333 patients admitted, BL-Scr was available in 5,925 
patients. Of these, 43.5% developed AKI based on Scr. AKI was cor-
rectly classified in 87.2% patients. No-AKI was correctly classified 
in 89% of no-AKI patients, and AKI stage 3 was correctly in 96.1% of 
AKI-3 patients. AKI-1 and AKI-2 was only correctly classified in 50.5 resp 
54.7% (table 2). In 11.5% of patients MDRD-Scr led to classification of 
AKI in a higher stage, and in 7.5% to classification of AKI in a lower 
stage. MDRD-Scr had a sensitivity of 84.2% and specificity of 89.0% 
for diagnosis of AKI. Positive predictive value was 81.5%, and negative 
predictive value 90.7%. Precision was 27.5%, bias -0.09, and Acc10-
20-30-50 was 20.0%, 38.9%, 53.6%, and 75.3%. In Cardiac Surgery ICU 
patients precisionand bias were less and Acc was higher compared to 
Surgical ICU, Medical ICU and Burn Unit ICU patients.
Conclusion: The use of an MDRD estimated baseline Scr resulted in 
adequate classification of AKI in almost 90% of patients. There was 
an important bias and a limited accuracy when estimating baseline 
serum with the MDRD-Scr formula. For AKI stage 1 and 2 there was a 
high rate (49.5% and 45.3% respectively) of over- or underclassifica-
tion. In stage 3 AKI the accuracy was 96.1% using MDRD-Scr. When 
available, a recorded baseline creatinine value should be used as a ref-
erence of baseline Scr.
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Introduction: Acute kidney injury (AKI) is a prevalent and detrimen-
tal condition in the intensive care unit (ICU) (Silver and Chertow 2017). 
Its impact can be prevented or mitigated by timely intervention. We 
hypothesized that boosting models could accurately predict the 
impending development of AKI and provide interpretable information 
to clinicians regarding AKI risk.
Methods: We used a large cohort of 98,051 ICU encounters admit-
ted to Mayo Clinic ICUs between 2005 and 2017 to  train abstain-
Boost  (Schapire and Singer 1999)  models to predict two classes of 
AKI patients: any-AKI or moderate/severe AKI (AKI stage > 1). Models 
predicted any-AKI six hours in advance of its onset, and moderate/
severe AKI 12 hours in advance of its onset. We removed encounters 
with insufficient data prior to AKI onset, and divided the remaining 
cohort into ‘clean’ encounters (agreement between urine output [UO] 
and creatinine [Cr] for maximum AKI stage) and ‘noisy’ encounters 
(disagreement between UO and Cr for maximum AKI stage). The clean 
encounters were further divided into training and testing cohorts. 
Encounters had a total of 388 predictive features measured during 
ICU stay, including laboratory results, vital signs, medications, and 
interventions. We compared the area under the ROCs (AUROCs) of this 
model with parsimonious models (30 features for any-AKI, 31 features 
for moderate/severe AKI) selected by the Boruta method  (Kursa and 
Rudnicki 2010; Homola, Daniel, n.d.). We evaluated the importance 
and contribution of the most predictive features.
Results: Features selected by Boruta yielded nearly the same per-
formance as using the entire feature set. On the test set, the any-AKI 
model had an AUROC of 0.8301 vs. 0.8303 (all features vs. feature 
subset), while the moderate/severe model had an AUROC of 0.889 vs. 
0.891. On the noisy cohort, the models using the feature subset had 
AUROC of 0.74 (any-AKI) and 0.70 (moderate/severe AKI). Top fea-
tures from the feature subset for predicting both any AKI and moder-
ate/severe AKI included urine output and creatinine levels measured 
before AKI onset, as well as mechanical ventilation, lactate levels, and 
heart rate. The dosage of furosemide was predictive of any AKI, while 
pH and fluid balance were predictive of moderate/severe AKI.
Conclusion: This study demonstrated that parsimonious, interpreta-
ble models could accurately predict AKI in advance of its development 
or progression, allowing clinicians time to implement timely preventa-
tive measures. They provide a list of individualized risk factors for pre-
cision medicine.
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Introduction: An episode of acute kidney injury (AKI) with a require-
ment for renal replacement therapy (RRT) is associated with excess 
short- and long-term mortality, and chronic comorbidities, including 
chronic kidney disease (CKD). Follow-up after discharge from hospi-
tal is recommended. This requires detailed information transfer from 
Critical Care to the nephrology and primary care team.
Objectives: We set out to examine data from a single-centre popula-
tion of critically ill patients who received RRT during a stay in Critical 
Care and were discharged from hospital alive. We sought to ascertain 
the following:
a) Comprehensiveness of discharge documentation;
b) Rates of renal follow-up;
and c) Survival outcomes at 1 year
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Methods: We performed a retrospective review of electronic medical 
notes and patient records of patients admitted to a 54-bedded critical 
care unit at a Tertiary Care Centre in the UK between June 2017 to May 
2018 and who received RRT.
Exclusion criteria included: end-stage renal disease already receiving 
RRT; transfer from other catchment areas; and patients who died in 
hospital.
Results: A total of 433 patients received RRT, of whom 91 met the 
inclusion criteria.
Underlying co-morbidities included: hypertension (54%), diabetes 
mellitus (25%), pre-existing renal impairment (24%) and coronary 
artery disease (21%).
Review of discharge documentation from Critical Care showed: AKI 
was mentioned in 86% and need for RRT in 82% of discharge letters. 
Nephrology follow up was recommended in 47% of discharge letters. 
Only 22 of 91 patients (24%) were followed-up by the renal team. 69 
patients (76%) received medical follow-up from other specialties.
The overall survival rate was 82% at 1 year, and 70% at 2 years.
In the group followed-up by nephrologists, survival rate at 1-year was 
86%, versus 81% in the group with no follow-up. There was no differ-
ence in survival in patients followed-up by other medical specialties, 
compared to those with no follow-up.
The average serum creatinine at point of hospital discharge was 160 
μmol/L, and in survivors at 1 year it was 115 μmol/L. 7 patients were 
dependent on RRT at point of discharge, with 3 recovering renal func-
tion sufficiently to be independent ofdialysis at 1 year. 2 out of these 7 
patients were deceased at 1 year. 2 patients became newly dependent 
on RRT after 1 year.
Conclusion: Despite a large critical care capacity and a robust special-
ist renal service, our data points towards sub-optimal follow-up rates 
for this high risk patient cohort. Robust pathways at the point of dis-
charge from Critical Care may help mitigate this and ensure consistent 
follow-up.
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Introduction: Renal injury has been reported to occur in up to 60% 
of high-risk COVID-19 positive patients admitted to intensive care [1]. 
Distinct mechanisms of renal injury in COVID-19, two of those being 
hypercytokinaemia and hypercoagulability, have been reported.
Objectives: To compare rates of AKI in COVID-19 positive patients in 
the Mater Misericordiae University Hospital Critical Care and record 
data on hypercoagulability and hypercytokinaemia.
Methods: Concurrent cohort study of COVID-19 positive patients 
admitted to the Mater Misericordiae University Hospital Critical Care 
between February and May 2020; exclusion criterion was ESRF pre-
admission. AKI was defined as per the AKIN criteria. Biochemical indi-
cators of hypercytokinaemia (white cell count, neutrophils, leucocytes, 
ferritin) and hypercoagulability (d-dimer, platelets, fibrinogen) and 
data sets of individual patient’s maximum vasopressor requirements, 
days pyrexial & VTE prophylaxis were collected.
Results: 45 out of 47 COVID-19 positive patient were included (26 
males, 19 females, median age 59 (range 37-77)). 8 patients had pre-
existing chronic renal disease. 64.4% of patients developed an AKI 
with patients with d-dimer > 5 at higher risk (RR = 1.44). Thrombocy-
tosis showed no correlation whereas thrombocytopaenia was weakly 
related (RR = 1.23). Double dose VTE prophylaxis (enoxaparin 40mg 
BD) was not shown to be protective (RR 0.9). 97% of patients had 
hyperferritinaemia & 78% of patients were pyrexic for at least 24 hours. 
Pyrexia was associated with AKI (RR = 2.2), as was neutrophilia (RR = 
2.24). Maximum dose vasopressor requirement was taken as an indica-
tor of severity of cytokine storm-related hypotension. 79% of patients 
with a maximum dose of noradrenaline of > 5mcg/min developed an 
AKI (RR = 2.11).
Conclusion: Hypercytokinaemia was the most significant factor in 
development of AKI, with more vasoplegic patients likely to develop 
renal injury. Hypercoagulability was not closely related with AKI and 
higher dose VTE prophylaxis did not appear to impact the develop-
ment of renal injury in our small cohort of patients.
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Introduction: Acute Kidney Injury (AKI) is a common complication in 
critical care patients. Several biomarkers, including urinary neutrophil 
gelatinase-associated lipocalin (uNGAL), have been used in the early 
detection of AKI.
Objectives: The aim of this study was to evaluate uNGAL for the diag-
nosis and prognosis of AKI in critical ill patients with infections.
Methods: This was a prospective observational study of critically ill 
patients with infections, sepsis, or septic shock in the intensive care 
unit. Clinical and laboratory data, including daily uNGAL levels, were 
assessed. The AKI stage using the KDIGO criteria was evaluated. Sen-
sitivity, specificity, and the area under the curve-receiver operating 
characteristic (AUC-ROC) values were calculated to determine the opti-
mal uNGAL level for predicting AKI.  Ethics Approval: The study was 
approved by the Local Ethics Committee (#58317216.2.0000.0096).
Results: We had 38 patients who completed the study during the 
screening period (November 2016 to May 2018). The incidence of 
AKI was 76.3%. The hospitalization period was longer in the group 
that developed AKI, with 21 days of median, [IQR 13.5-25]; non-AKI 
group had a median of 13 days, [IQR 7-18], (P = 0.019). We found a 
direct relationship between uNGAL levels and the progression to AKI. 
Increased values of the biomarker were associated with the worsening 
of AKI (P < 0.05). The cut-off levels of uNGAL that identified patients 
who would progress to AKI were the following: (d1) > 116 ng/mL; (d2) 
> 100 ng/mL, and (d3) 284 ng/mL. The value of the fourth and last 
measurement was not predictive of patients who would progress to 
AKI. The median urinary uNGAL were also associated with mortality 
on days (1,3 and 4): d1, p = 0.039; d3, p = 0.005; d4, P = 0.005). The 
performance of uNGAL in detecting AKI patients (AUC-ROC = 0.881). 
There were no risk factors other than AKI that could be correlated with 
increased uNGAL levels on day 1.
Page 92 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
TABLE 1.  Increased uNGAL values in the progression of the KDIGO score 
(1,2,3) and without AKI. 
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Conclusion: The uNGAL had an association in its values  with the diag-
nosis and prognosis of patients with severe infections and AKI. We 
suggest that studies with a greater number of patients could better 
establish the cut-off values of uNGAL and/or serum NGAL in the iden-
tification of infected patients who are at a high risk of developing AKI.
Reference(s) and grant ackowledgment(s)
1. Hjortrup PB, Haase N, Wetterslev M, Perner A. Clinical review: Predictive 
value of neutrophil gelatinase‑associated lipocalin for acute kidney injury in 
intensive care patients. Critical Care. 2013;17(2):211.
2. This study was facilitated with great support from the Biochemistry Division 
of Hospital de Clínicas da Universidade Federal do Paraná, primarily by the 
Dr. Flávia Kazumi Shibata and Michelle Tomassini Jacques who revised the 
language.
001023 
Incidence of acute kidney injury in Covid‑19 infected patients 
compared with non‑Covid‑19 patients admitted with respiratory 
failure
A. Bhide1; HD. Aya1;JM. Low2; JK. Rane2; D. Padman3; M. Hamilton1; 
A. Rhodes4; S. Leaver5
1General Intensive Care Unit, St George’s Hospital, London, United King‑
dom; 2Intensive care unit, St George’s Hospital, London, United Kingdom; 
3Anaesthesia and Intensive Care, St George’s Hospital, London, United 
Kingdom; 4Anaesthesia and intensive care medicine, St George’s University 
Hospitals NHS Foundation Trust, Londres, United Kingdom; 5Research lead 
critical care directorate, St George’s Hospital, London, United Kingdom 
Correspondence: A. Bhide
Intensive Care Medicine Experimental 2020, 8(2): 001023
Introduction: A novel coronavirus (severe acute respiratory syndrome 
coronavirus 2, SARS-CoV-2) emerged in early December 2019 and has 
subsequently spread globally causing a pandemic. There remains clin-
ical equipoise on whether the incidence of acute kidney injury (AKI) is 
higher in those patients with acute respiratory failure caused by SARS-
CoV-2 (Covid-19) than those without Covid-19 [1, 2, 3].
Objectives: To assess whether the incidence of AKI among patients 
admitted with acute respiratory failure caused by Covid-19 infection 
is higher than those with acute respiratory failure without Covid-19 
infection. To describe the differences in AKI stages observed between 
the two groups.
Methods: This was a single centre, observational cohort study. 
Patients admitted with acute respiratory failure to the ICU at St 
George’s Hospital were recruited to the study between December 
2019 and May 2020. Covid-19 infection was detected by viral PCR of 
SARS-CoV-2 on nasopharyngeal or sputum samples. The presence and 
stage of AKI was defined as per AKIN criteria [4] and assessed on day 
0, 7 and 14 of ICU admission. Univariate analysis was conducted using 
the Chi squared test to compare the frequency of AKI between the two 
groups.
Results: 256 patients were included. 132 (51.6%) were Covid-19 
patients, whereas 124 (48.6%) were non-Covid-19 ICU patients. Over-
all, 226 (88.3%) patients had AKI over the study period; 112 (84.8%) 
within the Covid-19 group and 114 (91.9%) within the non-Covid-19 
group (c2 (1) 3.1, p = 0.058).
On ICU admission, the distribution of AKI stages between Covid-19 
and non-Covid-19 patients was similar (c2 (3) 2.0, p = 0.58).
At day 7 of admission, 127 patients were still in ICU - 88 in the Covid-
19 group and 39 in the non-Covid-19 group. There were 45 (51.1%) in 
stage 0, 8 (9.1%) in stage 1, 6 (6.8%) in stage 2 and 29 (33%) in stage 
3 within the the Covid-19 group, compared to 32 (82.1%) in stage 0, 
3 (7.7%) in stage 1, 2 (5.1%) in stage 2 and 2 (5.1%) in stage 3 within 
the non-Covid-19 group (c2 (3) 13.0, p = 0.004). At day 14, 71 patients 
remained in ICU, and the distribution of stages was similar between 
both groups (c2 (3) 4.9, p = 0.16).
Conclusion: The incidence and severity of AKI in Covid-19 infected 
patients are higher after a week of ICU admission compared with non-
Covid-19 patients admitted with respiratory failure.
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Introduction: Regional citrate anticoagulation (RCA) is commonly 
used for continuous renal replacement therapy (CRRT). Citrate accu-
mulation (CA) is a serious potential complication of RCA, and conven-
tional ways to diagnose CA such as increased total to ionized calcium 
ratio (T: I Ca ratio) are confounded by various clinical conditions and 
thus remains suboptimal [1, 2]. Blood citrate measurement emerges as 
a more direct way to determine CA but its clinical utility and optimal 
cut-off values for predicting CA remains undefined.
Objectives: To evaluate serum citrate kinetics of patients undergoing 
RCA CRRT and its correlations with clinical events and outcomes.
Methods: We prospectively recruited patients who received RCA CRRT 
and measured serial serum citrate levels at baseline, 2-, 6-, 12-, 24-, 36-, 
48- and 72-hrs after initiation. The citrate levels were correlated with 
clinical parameters and patient outcomes.
Results: 91 patients were included, of which 15 patients developed 
CA defined as a combination of elevated T:I calcium ratio > 2.5, high 
anion gap metabolic acidosis and systemic hypocalcaemia < 1mmol/L 
or escalating calcium replacement requirement. The CA group 
showed higher APACHE IV score (136.5(99.5-167.0)vs 100.0(85.0–
117.8), p = 0.003). Serum citrate levels in the CA group at 2-, 6- and 
12-hrs after initiation of RCA CRRT was significantly higher than the 
non-CA group (p < 0.05, for all) (Figure 1). The peak citrate level was 
significantly higher in the CA group 0.78 mmol/L (0.39-0.96 mmol/L) 
vs 0.38 mmol/L(0.23-0.67 mmol/L) in the non-CA group, p = 0.01). The 
serum citrate level correlated with the T:I Ca ratio at 6, 12, 24 and 36 
hrs (r = 0.52, 0.65, 0.53 and 0.59 respectively, p all < 0.05). Using a 2-hr 
serum citrate cut-off of 0.33 mmol/L, the sensitivity and specificity for 
predicting development of CA were 0.90 and 0.75 respectively (ROC 
AUC 0.83, p = 0.001) (Figure 2). Peak serum lactate level was higher in 
the CA group [10.4mmol/L (7.1 – 17.7 mmol/L) vs. 2.70 mmol/L (1.78 – 
5.25 mmol/L), for CA vs. non-CA respectively, p < 0.001) and a cut-off 
value of 6.15 mmol/L also showed good predictive value for develop-
ment of CA (sensitivity/specificity: 0.7/0.61, ROC AUC 0.82, p < 0.001).
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Conclusion: Patients who develop CA show higher serum citrate lev-
els over time, and the 2-hr citrate level shows good predictive value 
for subsequent development of CA in patients receiving RCA CRRT.
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Introduction: Acute Kidney Injury presents one of the most com-
mon organ failures on the intensive care unit. We consider renal 
replacement therapy in all patients with Acute Kidney Injury level 
3 and issues of potassium homeostasis, fluid balance or metabolic 
acidosis. At University Hospitals of Morecambe Bay NHS Founda-
tion Trust (UHMBT) we use continuous veno-venous haemodiafiltra-
tion (CVVHDF)  as modality with citrate anticoagulation (PRISMAFLEX 
dialysis machines) and aim for an effluent volume of 20-25ml/kg/h as 
per KDIGO Acute Kidney Injury Guidelines (2012); but, once we have 
decided on need for filtration and all is set up and ready to go,  we 
often reflect on achieving prescribed target dose.
Objectives: To audit our perfomrance of achieving the target dose of 
CVVHDF
Methods: We prospectively audited all patients needing CVVHDF 
between July 2019 to October 2019 at our critical care unit at Royal 
Lancaster Infirmary, UHMBT, England, UK. We recorded demographics 
and  indications, total length of, downtime of and reasons for discon-
tinuing CVVHDF as much as effluent flow to be achieved and deliv-
ered, type of anticoagulation used, hourly fluid removal and type of 
vascular access.
Results: We sampled 23 data sets, 13 male and 10 female. The average 
age of patients was 62 years with an actual average body weight of 86 
kg. Length of stay on our critical care unit varied from 2 to 19 days with 
an average of 8.56 days. Indications for RRT included: 18 for acido-
sis, 9 for hyperkalaemia, 4 for anuria/fluid balance and 2 for uraemia. 
Average total length of CVVHDF was 100.39 hours (4.18 days) with 
actual CVVHDF delivered for an average of 72.78 hours (3.03 days). 
This means there was on average a 28% downtime of CVVHDF dur-
ing dependancy. Reasons for stopping CVVHDF during dependancy 
included: access problems, recirculating e.g. for radiological examina-
tions, blood flushed back, filter clotted and air in circuit. Effluent flow 
was prescribed as per actual body weight (kg) according to a prepopu-
lated prescription chart suplied by PRISMAFLEX and was 37.95ml/kg/h 
on average. The prepoluated chart accounted for a 15% down time. 21 
patients were anticoagulated using citrate and 2 with heparin. Fluid 
removal varied from 0-100ml/h as per clinical need and was decided 
by consultants. 19 patients had internal jugular vein and 4 had femoral 
vein vascular access for CVVHDF, none had subclavian venous access 
due to risk of pneumothorax.
Conclusion: We prescribed effluent flow rates for all patients. 
However, we experienced a 28% downtime of CVVHDF during 
dependancy. The prepopulated prescription chart by PRISMAFLEX 
only accounted for 15% of downtime. The likelyhood of not achieving 
target effluent rates of at least 20-25ml/kg/h would have been high. 
We are, therefore, now recording our delivered effluent rate hourly on 
the critical care bedside chart and are calculating the average deliv-
ered rate per day, so adjustments to effluent rates can be made in 
order to achieve the recommended minimum of 20-25 ml/kg/h.
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Introduction: Regional citrate anticoagulation in continuous renal 
replacement therapy (CRRT) offers longer filter life spans, lower bleed-
ing complications, fewer blood transfusions and  is recommended as 
the first line for anticoagulation  despite  associations with  a range of 
metabolic complications including hypocalcaemia.1-6 Mild hypoc-
alcaemia is common and appears protective in critically ill patients 
yet severe hypocalcaemia during CRRT is  associated with increased 
mortality.7,8 How hypocalcaemia on CRRT competes with other end-
points according to citrate and non-citrate anticoagulation is unclear.
Methods: Patients commencing CRRT in a single centre between 
Mar 2016 and Feb 2018 spanned a transition from non-citrate to 
citrate based anticoagulation in May 2017. Patient characteristics, 
biochemical data and  endpoints of hypocalcaemia, filter/access dys-
function, death, elective discontinuation and recovery were analysed. 
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Hypocalcaemia was defined as mild, moderate or severe by a systemic 
ionised calcium (iCa) of < 1.13, < 1.0 and < 0.9mmol/l. A competing 
risk analysis visualised time to events for the above endpoints and iCa 
< 1.0 to reflect censoring events which terminate CRRT, with log-rank 
tests to statistically compare the groups.
Results: 220 patients were identified during the period. 113 patients 
were pre citrate; of the 107 after the transition 3 were excluded for not 
receiving citrate based therapy. Patient characteristics by anticoagula-
tion regime were similar. The main precipitants for renal dysfunction 
were septic shock 43.3%, cardiogenic shock 11.1% and hypovolaemia 
9.2% (P = 0.945). Non-Citrate patients received a mean cumulative 
total of 88.2h CRRT vs 113.7h for citrate (P = 0.128). 28 day mortality 
was not significantly different (41.6% vs 37.5%, P = 0.538).
Pre-treatment mean iCa was 1.12 in the non-citrate and 1.15 in the 
citrate group (P = 0.111). The proportion of patients experiencing an 
episode of hypocalcaemia ( < 1.13, < 1.0 and < 0.9) was 67.3%, 12.4%, 
and 2.7% for non-citrate and 93.3%, 26.0%, and 5.8% for citrate (P < 
0.02  for < 1.13 & < 1.0). The proportion of non-citrate and citrate 
patients stopping CRRT on first exposure for filter/access dysfunction 
was 19.5% vs 8.7%, death 11.5% vs 22.1%, recovery 15.9% vs 13.5%and 
elective discontinuation 53.1% vs 55.8% respectively (overall P = 
0.038). At 24h 18.6% of the non-citrate group had stopped CRRT due 
to filter/access dysfunction, compared to 5.7% in the citrate group (p 
= 0.009). Hypocalcaemia ( < 1.0) had occurred in 5.3% vs 18.3% for the 
non-citrate vs citrate group (p = 0.02).
Conclusion: Although mild and moderate hypocalcaemia was more 
common in the citrate group no treatments were ceased or adverse 
events reported due to hypocalcaemia. The competing risk of filter/
access dysfunction was significantly higher in the non-citrate group. 
Differences in other endpoints during the first treatment reflected 
longer uninterrupted CRRT delivery in the citrate group. Existing rec-
ommendations on citrate-based anticoagulation appear justified.
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Introduction: Acute kidney injury (AKI) in critically ill COVID-19 
patients is common and is associated with higher mortality1. The pan-
demic has placed ICUs under an unprecedented burden, and provi-
sion of RRT has been challenging.
Over 7 weeks we admitted 75 COVID-19 positive patients to our com-
bined 59 bedded ICUs. Of those, 61% developed AKI and 40% required 
continuous renal replacement therapy (CRRT). In April, NHS England 
highlighted the difficulties with supply lines for RRT machines and dis-
posables. Our hospital had 14 CRRT machines for the ICUs.
Objectives: An alternative strategy for RRT was needed, preferably 
effective and relatively unshackled by supply line issues of routine 
CRRT, usable with current infrastructure and affordable. The alter-
native needed to cover this crisis and provide increased future RRT 
capacity. Intermittent haemodialysis (IHD) and SLED were the 2 main 
options. SLED is modified IHD, where therapy occurs daily and has 
shown to be safe and efficacious2.
Methods: Surge capacity meetings between intensivists, neph-
rologists, pharmacists and nurse managers explored alternative 
RRT options for their relative risk/benefit, cost/benefit strategy and 
feasibility assessment for its physical provision and training, with 
potential problems identified via web-conferencing3. Plumbing and 
architecture were reviewed and assessed for capability to provide 
reverse osmosis (RO) water interface to ICU.
A strategy to provide clinical care alongside ongoing maintenance 
work was devised. With manufacturer’s support, a focused train-
ing programme and protocols were developed. A business plan was 
submitted to hospital authorities for funding approval. The current 
demand for RRT and available supply of disposables was assessed. An 
appropriate manufacturer was identified by seeking multiple quotes.
Results: SLED was chosen as it combines the benefits of IHD (less time 
on RRT) with those of CRRT (haemodynamic stability)4.
Time to proceed to setup of a SLED service was 3 days followed by 8 
days to commencement of works. These were completed in two of the 
ICUs within 2 days, during which the areas were isolated from clinical 
care for RO/water softener works. In total 5 RO machines and 10 SLED 
machines (SC + Quanta, QD Technologies) were set up in 4 separate 
ICU areas, thereby increasing our number of RRT machines by 70%. 
The machines provide standard bicarbonate-based dialysis at high-
flow (500 mL/min) and low-flow (300 mL/min) rates, supporting treat-
ment times up to 8 hrs. The machine cost for acquisition was £25,000 
including set-up. Quanta staff trained 18 nurses in 10 days including 
practice development nurses who will become the future trainers. 
ICU developed protocols for the use of SLED and prescriptions were 
designed into our eMR platform (Epic, WI, USA).
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Conclusion: Surveillance of local and national demands on RRT 
alerted us to the need for surge provision of RRT. Rapid procurement 
and phased installation allowed introduction of a new RRT modality 
during a pandemic. As well as sparing stocks of RRT consumables in 
the short term, the longer-term improvement in ICU resilience will 
help manage potential future waves of COVID-19 and threats from 
other emerging infections. We are now disseminating this learning 
across the local, national and international ICU community.
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Introduction: Regional citrate anticoagulation (RCA) is the gold 
standard anticoagulation for continuous renal replacement therapy 
(CRRT) as it reduces both clotting of the circuit and systemic bleeding 
events. There is no clear evidence that mode of therapy improves mor-
tality, but dialysis may be superior to filtration in improving filter life 
span as it removes the filtration ratio and reduces the reliance on fault-
less venous access and high blood flows. We present data comparing 
protocols for post dilution continuous veno-venous haemofiltration 
(CVVH) and continuous veno-venous haemodialysis (CVVHD) with or 
without RCA available for CRRT in critically ill patients.
Methods: 3 hospitals in the same NHS Trust (providing CRRT to gen-
eral critical care patients (no cardiac surgery) for ~350 patients a year) 
followed the same CRRT protocols but the larger site offers a protocol 
with RCA as first line anticoagulation. In June 2019 all sitesswitched 
from the Nikkiso Aquarius ® system (CVVH and RCA via post dilution 
method) to the BBraun OMNI® system (CVVHD). Recent audit (Sep-
tember – November 2019) coupled with historical data (September–
November 2017) collected in the same way on each site, was used to 
compare filter life span across protocols. Heparin infusion into the fil-
ter or no anticoagulation was used when RCA was either not available 
or contraindicated. Only one site had data for CVVH with no RCA.
Results: In total 173 patients who used 524 filters were analysed 
(table 1).
When censored for reasons other than clotting, there was a significant 
advantage in filter survival of CVVHD over CVVH when RCA was availa-
ble (p < 0.0001) (graph 1). There was no difference between protocols 
that used CVVH and CVVHD when RCA was not available (p = 0.64) 
but CVVH with RCA available, was significantly better than CVVHD 
when RCA is not available (p = 0.02).







Consecutive patients 41 24 50 58 
































Filter life span (hrs) 27 20 58 20 
Significantly fewer filters per patient are used with a CVVHD protocol 
containing RCA compared to the other protocols (2.2 (1-10); p = 0.028)
Conclusion: CRRT Protocols that contain RCA as first line anticoagu-
lation significantly improve filter life span. There is a significant addi-
tional advantage in using dialysis alone over filtration.
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Introduction: The Coronavirus disease (COVID-19) pandemic brought 
extraordinary demands on many Intensive Care Units (ICU) in the UK. 
Our ICU faced an unprecedent rate of admissions [ref1], with 32.7% 
of patients requiring Renal Replacement Therapy (RRT) for Acute Kid-
ney Injury (AKI) [ref2]. Pre-pandemic, our conventional RRT was Con-
tinuous Veno Venous Haemofiltration (CVVHF), favoured over other 
modalities in view of more stable haemodynamic profile [ref3]. With 
a shortage of RRT machines, consumables, and trained workforce, we 
explored NxStage Pure Flow System and Cycler (NxS) as an alternative 
to provide portable intermittent haemodialysis (iHD) as RRT in ICU.
Methods: This study was designed as a service evaluation to review 
NxS safety and efficacy, including all patients with COVID-19 and 
AKI Stage 3 by KDIGO criteria treated with NxS between 24/04 and 
24/06/2020. Exclusion criteria were liver failure or haemodynamic insta-
bility requiring vasopressors. Study approval SE20/015 (28/05/2020).
Results: Ten consecutive patients were included, 9/10 male, all of 
Black, Asian and Minority Ethnicity; mean age 54.9 years (SD 11.7). 
7/10 had diabetes, 6/10 had hypertension, one had chronic kidney dis-
ease. All patients had radiological features typical for COVID-19 and 7 
had positive nasopharyngeal swab. In the first 24 hours in ICU, mean 
APACHE II score was 19.8 (SD 5.7) and  PaO2/FiO2 ratio 137mmHg (SD 
69). All patients were intubated and ventilated during admission.
45 NxS treatments were delivered over two months, with a median 
of 3.5 days of NxS per patient (IQR 1.5-8), versus 14 days of CVVHDF 
(IQR 8-22.5). 5 of 45 treatments were aborted: 3 secondary to vascu-
lar access mechanical issues, one for change in therapeutic priority, 
and one for hypotension requiring metaraminol. Adverse events per 
patient are detailed in the table below.
7/10 patients developed hypokalaemia during NxS, requiring replace-
ment in 24 of 45 treatments, without any arrhythmia. 36 treatments 
were delivered through standard vascath, and 9 through TesioCath. 
We report one bleeding episode from TesioCath site, but no episodes 
of catheter-associated thrombosis, nor any pneumothorax secondary 
to dialysis catheter insertion. We report 3 episodes of dialysis catheter 
associated sepsis, versus 26 septic episodes from other sources.
The pH variation over NxS treatment remained stable and no 
patient was acidotic at the end of NxS treatment. Serum lactate level 
increased during all treatments, by virtue of the lactate buffer used, 
and decreased to the normal reference range within five hours of NxS 
completion in 31 of 45 cases, without clinical sequelae in the remain-
ing cases.
Efficacy was described by achieving the target fluid balance in 40/45 
treatments, and reducing blood urea nitrogen (BUN) post-NxS com-
pared to pre-NxS in 37/45 treatments (on average 5.1 mmol/l less than 
pre-NxS BUN samples, p < 0.01 on paired t test). 
8/10 patients survived to ICU discharge or last follow up; 3 have been 
discharged home, 2 remain in hospital and 3 in ICU. Mean ICU length 
of stay was 38.7 days (SD 16.8). At ICU discharge, median eGFR was 73 
mL/min/1.73  m2 (IQR 14 – 84) with no dialysis dependence.
Conclusion: This pilot project was developed and delivered through 
necessity, and it was not designed to compare or displace the use of 
CVVHF by iHD in ICU [ref4], but proved that NxS is safe and effective 
in selected patients in order to preserve the use of CVVHF for patients 
who are haemodynamically unstable or with liver failure.
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Introduction: Critically ill patients are at high risk for pulmonary 
embolism (PE) (1). However, the diagnosis of this potentially fatal dis-
ease often goes unnoticed, as symptoms are nonspecific and other 
clinical conditions can manifest with similar features (2). Prediction 
rules, usually used in emergency departments, such as the Wells and 
Geneva scores, are not validated in this population. Therefore, the best 
diagnostic approach to investigate critically ill patients with suspected 
PE remains uncertain.
Objectives: The aim of the present study was to assess the Wells and 
the revised Geneva scoring systems as predictors of PE in critically ill 
patients.
Methods: From July 2018 to November 2019, adult patients admit-
ted to the intensive care unit (ICU) at the Hospital de Clínicas de Porto 
Alegre were considered eligible for the study if they had a pulmonary 
computed tomographic angiogram (CTA) as a confirmatory imaging 
study for suspected cases of PE. Clinical data was collected and the 
Wells and the revised Geneva scores were calculated. The researcher 
who calculated the scores was unaware of the CTA result. Two radi-
ologists independently reviewed the scans to diagnose the presence 
of PE based on the presence of filling defects in the pulmonary artery 
or its branches. The discriminative power of the Wells and revised 
Geneva scores to predict risk of PE was determined by receiver operat-
ing characteristic curve (ROC) analysis.
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Results: Eighty critically ill patients were prospectively included in the 
study. The mean age of the patients was 59 ±  14 years, 52.5% were 
female, with a mean SAPS 3 score of 61 ± 16. The main cause for ICU 
admission was acute respiratory failure (62%), followed by cardiac 
arrest (17%) and shock (11%). The incidence of PE was 39% (n = 31). 
Segmental PE was the most common classification (58%), followed 
by main artery PE (32%), subsegmentary PE (6.5%) and lobar PE (3%). 
Inter-observer agreement for PE diagnosis was very good (ƙ = 0.89). 
The mean Wells score in patients without PE was 3.0 ± 1.9 vs. 4.2 ± 2.7 
in patients with PE (p = 0.027). The mean revised Geneva score was 
5.0 ±  3.0 in patients without PE vs. 6.0 ±  4.0 in patients with PE (p 
= 0.08). Figure  1 shows the ROC curves of the Wells and the revised 
Geneva scores, respectively. The area under the curve (AUC) for the 
Wells score was 0.64 (CI 0.51-0.77) and for the revised Geneva score 
AUC was 0.60 (CI 0.47-0.73).
Conclusion: Wells and revised Geneva scores are not reliable pre-
dictors of PE in critically ill patients. These negative results, obtained 
prospectively, reinforce the importance to search for alternatives for a 
better diagnostic approach to PE in this population.
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Introduction: The term severe community acquired pneumonia (CAP) 
identifies the group of patients with CAP who require admission to 
intensive care units (ICU). The incidence of severe acquired pneumo-
nia has increased in the last decade and is one of the main infectious 
causes of admission in ICU.
Objectives: The aim of this study is to review and describe severe CAP 
patients in a level II hospital ICU, analyzing the patients’ profile, micro-
biology isolations and treatment.
Methods: A retrospective observational study was performed. Con-
secutive critically ill CAP patients receiving treatment in level II hospi-
tal polivalent ICU were reviewed from january 1, 2018 to november 30, 
2019. Categorical variables were analyzed using chi-square tests, and 
continuous variables were analyzed by T Student or ANOVA. Significa-
tion level was stablished as p < 0.05.
Results: A total of 41 consecutive eligible individuals were reviewed. 
Mean age was 60.24 (± 8), mean APACHE II was 16.77 (± 8), mean hos-
pital stay was 16 days (± 23.24). 63.45% were men. 25% were inmu-
nosupressed. 41.5% had COPD. The main reason for admission was 
respiratory failure in 87.8% of patients, followed by shock (need of 
vasoactive drugs). 14.6% required intubation as an initial respiratory 
support. NIMV was initiated in 48.8.%, HFO in 26.8% and conventional 
oxygen in 9.8%. Finally, 48.8% of pacients required mechanical ventila-
tion (20/41). There was no statistically signifcant difference between 
NIMV and GNAF failure. The initial empiric treatment was a betalac-
tamic (ceftriaxone) and a macrolid (claritromicina) or quinolone (levo-
floxacine) in 78% of cases. 17% received broad espectrum treatment 
(piperaciline-tazobactam or imipenem). 2.5% received only ceftriax-
one. In 21 cases there was microbiology isolation: respiratory virus 
were isolated in 10 cases (Influenza 4, VMC 3, HVS 2 and adenovirus 
1). In 6 patients S.pneumoniae was isolated. H. Influenzae, E Coli and P 
Aeruginosa in one case each. Comparative analysis between bacterial 
and virical pnumonia is shown in the table below:
Mortality rate was 14.6%. Hospital stay, inmunosuppression, vasoac-
tive drugs requirement and mechanical ventilation requirement were 
found to be independent mortality risk factors.
Conclusion: In our ICU patient’s profile, mortality risk factors and 
mortality rate are similar to other series of cases. A high percentage 
(48.8%) required mechanical ventilation. It should be noted that the 
incidence of viral and bacterial pneumonia had the same number of 
cases. Bacterial pneumoniae seems to lead to a longer hospital stay 
and mortality but more studies would be required.
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Introduction: Extracorporeal membrane oxygenation (ECMO) sup-
port in acute respiratory failure may be lifesaving, but bleeding and 
thromboembolic complications are common. The optimal anticoagu-
lation strategy balancing these factors remains to be determined.
Objectives: This study was carried out to determine whether a low-
dose prophylactic heparinization strategy is associated with similar 
rates of oxygenator changes while reducing bleeding events when 
compared to a high-dose therapeutic heparinization strategy.
Methods: We conducted a retrospective unblinded observational 
cohort study between 04/2015 – 02/2020 in two ECMO referral centres 
in Germany in patients receiving veno-venous (VV)-ECMO support for 
acute respiratory failure for > 24h and unfractionated heparin (UFH) 
for anticoagulation. One centre routinely applied low-dose hepariniza-
tion aiming for a partial thromboplastin time (PTT) of 35-40s and the 
other routinely used a high-dose therapeutic heparinization strategy 
aiming for an activated clotting time (ACT) of 140-180s. We assessed 
number of and time to ECMO oxygenator changes, 15-day freedom 
from oxygenator change, major bleeding events, thromboembolic 
events, 30-day ICU mortality, activated clotting time and partial 
thromboplastin time, red blood cell transfusions and platelet trans-
fusions. Primary outcome was the occurrence of oxygenator changes 
depending on heparinization strategy; main secondary outcomes 
were the occurrence of severe bleeding events and occurrence of 
thromboembolic events.
Results: Of 375 screened patients receiving VV-ECMO support, 218 
were included in the analysis (117 high-dose group; 101 low-dose 
group). Disease severity measured by SAPS II score was 46 (IQR 36-57) vs 
47 (IQR 37-55) and ECMO runtime was 8 (IQR 5-12) vs 11 (IQR 7-17) days 
(P = 0.003). There were 14 oxygenator changes in the high-dose group 
vs 48 in the low-dose group. Freedom from oxygenator change at 15 
days was 73 vs 55% (adjusted HR 2.74 [95% confidence interval 1.2-6.5]; 
P = 0.023) (Figure). Severe bleeding events occurred in 23 (19.7%) vs 14 
(13.9%) patients (P = 0.256) and thromboembolic events occurred in 8 
(6.8%) vs. 19 (19%) patients (P = 0.007). Mortality at 30 days was 33.3% 
vs 30.7% (P = 0.11). Mean ACT in the high-dose group (158s [IQR 151-
165]) and PTTs (48s [IQR 41-57] vs 38s [IQR 34-42]) corresponded well 
with predefined target ranges. Red blood cell and platelet transfusions 
were less frequent in the high-dose group (6 [IQR 2-10] vs 8 [IQR 6-19] P 
< 0.001 and 0 [IQR 0-1] vs 4 [0-10], P < .001, respectively).
Conclusion: Compared with low-dose heparinization, high-dose hep-
arinization during ECMO support was associated with lower rates of 
oxygenator changes and thromboembolic events, but with a numeri-
cally higher number of bleeding events.
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Introduction: Acute Respiratory Distress Syndrome (ARDS) is cur-
rently diagnosed by the Berlin definition, which does not include a 
direct measure of pulmonary oedema, endothelial permeability, pul-
monary inflammation, coagulation or oxidative stress. A diagnostic 
test that could capture these processes might improve the diagnosis 
of ARDS. We hypothesized that biomarkers of these processes have 
good diagnostic accuracy for ARDS.
Methods: Medline and Scopus were searched with broad keyword 
criteria and selection was performed by two independent researchers. 
Inclusion criteria were: (1) original research, (2) that reported diagnos-
tic accuracy, (3) used a minimal invasive test for (4) pathophysiologi-
cal mechanisms of ARDS and (5) compared the results to a relevant 
control group. The primary outcome was the diagnostic accuracy per 
test, categorized by pathophysiological mechanism, control group 
and analyzed biomaterial. Secondary, the methodological quality was 
assessed with Quadas-2 tool. Biomarkers that had an area under the 
Receiver Operating Characteristic curve (AUROCC) of more than 0.75 
and were studied with minimal bias against an unselected control 
group were considered to be promising.
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Results: The search led to 929 independent articles of which 42 were 
included. The median AUROCC for all evaluated tests was 0.80 (25th to 
75th percentile: 0.72 – 0.89). The type of control group influenced the 
diagnostic accuracy (Figure 1, p = 0.01). Higher risk of bias was associ-
ated with higher diagnostic accuracy (AUROCC 0.74 for low bias, 0.78 for 
medium bias and 0.84 for high bias studies; p = 0.0021). Club Cell pro-
tein 16 (CC16) and soluble receptor for advanced glycation end-products 
(sRAGE) in plasma and three biomarkers of oxidative stress in breath 
showed good diagnostic accuracy in low bias studies that compared 
ARDS patients to an unselected intensive care unit (ICU) population.
Conclusion: This systematic review revealed only three diagnostic 
tests that fulfilled stringent criteria for a promising biomarker in a low 
bias setting. For implementation into the clinical setting, prospective 
studies in a general unselected ICU population with good methodo-
logical quality are needed.
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Introduction: Acute Respiratory Distress Syndrome (ARDS) is currently 
diagnosed by the Berlin definition, which involves subjective criteria 
and leads to late diagnosis. There is a demand for a non-invasive bed-
side method to diagnose ARDS. Three metabolites in breath, of which 
octane was the most important, showed good diagnostic accuracy 
when analysed with gas chromatography and mass spectrometry 
(GCMS). However, mass-spectrometry is unsuitable for a point-of-care 
(POC) test. Therefore, we aimed to develop a POC test that measures 
octane in exhaled breath of invasively ventilated intensive care unit 
(ICU) patients at trace amounts (parts-per-billion). We hypothesized 
that the breath analyser (BA) can reliably detect octane in exhaled 
breath of mechanically ventilated ICU patients.
Methods: Two steps were taken in development of the BA. A labora-
tory BA was validated in healthy subjects with calibration measure-
ments. Comparison to gold standard GCMS was performed in healthy 
subjects and in patients receiving mechanical ventilation. Subse-
quently, the BA was further developed into a POC BA, which was also 
calibrated and then used for assessment of exhaled breath of venti-
lated ICU patients. Accuracy of the BA was reflected by repeatability 
between duplicate samples and reproducibility for detecting a known 
amount of octane. Octane concentration was based on the area under 
the curve (AUC), which was extracted from the chromatogram and 
compared to known values from calibration measurements.
Results: Five healthy subjects and 40 patients were included for 
assessment with the laboratory BA, 12 patients were included for 
validation of the POC BA. A linear association with an R2 of 0.99 was 
reached with the laboratory BA with breath samples spiked with 
octane. In contrast, reproducibility with GCMS was moderate (R2 = 
0.68). In patients 40 duplicate measurements were performed with 
the laboratory BA and 25 duplicate measurements with the POC BA. 
In 5 out of 25 measurements with the POC BA, one of the octane peaks 
could not be fitted due to co-elution or a noisy signal. The repeatabil-
ity was strong for the laboratory- and POC-BA, with an intraclass cor-
relation coefficient (ICC) of 0.87 and 0.95 and a coefficient of variation 
of 17% and 8%, respectively (Figure 1 and 2).
Conclusion: The laboratory- and POC-BA were both able to accurately 
detect trace amounts of octane in exhaled breath of ventilated ICU 
patients. Reproducibility was acceptable and repeatability was good. 
Further validation and implementation steps are needed to progress 
to a POC breath test for diagnosing ARDS in ventilated ICU patients.
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Introduction: The estimate of pleural fluid volume on chest ultra-
sound (CUS) (1) helps to decide on pleural drainage in relation to 
weaning of the ECMO and IPPV. The method of multiplying maximum 
transverse pleural separation at the lung base in mm by 20 has been 
constructed on medical mechanically ventilated patients (1). The 
method may fail in severely consolidated lungs encircled by pleural 
fluid.
Objectives: To test the established method of pleural fluid estimation 
in haevily consolidated lungs and to find optimal way of the volume 
assessment.
Methods: 35 pleural effusions were drained in 28 mechanically ven-
tilated patients (APACHE II 26.3 ± 5, SOFA 10.9 ± 2) with severe lung 
consolidation of 4th degree on CUS at least in basal lung regions and 
no better than 3rd degree in the apical regions. All were prospectively 
observed while treated on VV, VAV or VA ECMO. All drainages were 
performed by intensivists by blunt forceps technique, most of them 
with 12F chest drain (CD).
Results: The maximum pleural separation was 23  ±  6mm, corre-
lating with separation at the lateral chest wall (19 ±  8mm,r = 0.79). 
The dorsal and frontal separations were 16 ±  7mm and 16 ±  7mm, 
respectively. The classic (1) method of pleural fluid estimate corre-
lated weakly with pleural fluid volume (r = 0.32) and produced a mean 
underestimation error of −  371  ±  207ml contrasting with drained 
830 ± 209ml. Better correlation was found for the frontal pleural sepa-
ration (r = 0.44,p < 0.05). The volume of pleural fluid may be estimated 
with equation V[ml] = 620 + 13*frontal separation [mm] which results 
in a mean prediction error of 156 ± 101 ml. Similarly, the sum of basal, 
lateral and ventral pleural separations (51 ±  15 mm) correlated with 
drained volume (r = 0.42, p < 0.05) showing mean prediction error of 
159 ± 100 ml.
Conclusion: The known CUS assessment of volume of pleural fluid 
largely underestimates reality in severely consolidated lungs sur-
rounded by potentially misleadingly thin layer of circumferential effu-
sion. The multiple measurements are feasible paying attention to a 
degree of lung consolidation and separation of pleural layers under 
the frontal chest wall.
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Introduction: Blunt thoracic trauma is a major risk factor for devel-
opment of Acute Respiratory Distress Syndrome (ARDS). Although 
blunt thoracic trauma is recognized as a specific risk factor for ARDS 
development, other predictors of early ARDS have not been precisely 
defined in this group patients.
Objectives: To define specific predictors that can identify patients 
who are at greater risk of ARDS development in an early resuscitation 
phase (first 48 hours) after blunt thoracic trauma.
Methods: During one-year study period, 50 patients with blunt tho-
racic trauma who were treated in intensive care unit after the initial 
resuscitation in Emergency center- Clinical center of Vojvodina were 
included in our study. Data were analyzed using SPSS 20.0 software. 
Differences between groups of patients were assessed by Student´s 
t-test. Categorical variables were compared using chi-square test. Sta-
tistical significance (p) was set at a value of 0.05.
Results: 16 patients (32%) developed early ARDS during the first 48 
hours after blunt thoracic trauma. Patients who developed ARDS 
received higher volumes of hydroxyethyl starch (HES) (1607 ± 594.15 
vs. 678.57  ±  530.79. p≤0.05) and fresh frozen plasma (FFP) 
(662.85 ± 616.51 vs. 365.35 ± 894.64. p≤0.05) during the first 48 hours 
after the trauma. Thoracic Trauma Severity Score (TTS) and Injury 
Severity Score (ISS) were significantly higher in patients with ARDS in 
comparison to patients who did not develop ARDS (TTS: 13.29 ± 3.12 
vs. 9.25 ± 4.30; ISS: 51.92 ± 20.94 vs. 34.5 ± 17.23. p≤0.05). Patients 
with ARDS had significantly lower values of Glasgow coma score 
(GCS): (9.69 ± 4.88 vs. 13.48 ± 3.05. p≤0.05).
Conclusion: Significant predictors of ARDS development in patients 
with blunt thoracic trauma are multiple traumatic injuries defined with 
higher values of ISS and TTS score, presence of traumatic brain injury 
with lower values of GCS and administration of higher volumes of col-
loids and FFP.
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Introduction: The pathophysiology of Coronavirus disease 2019 acute 
respiratory distress syndrome (C-ARDS) might have some peculiarities 
distinguishing it from ARDS of other etiology. Preliminary data suggest 
a unique contribution of vascular dysfunction induced by inflamma-
tion and microthrombosis to the imbalances in ventilation and perfu-
sion within the lung [1].
Objectives: To characterize with electrical impedance tomogra-
phy (EIT) the distribution of ventilation and perfusion in a cohort of 
patients affected by C-ARDS and to compare these findings with data 
collected in ARDS patients.
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Methods: We included 19 patients with C-ARDS between March 2020 
and April 2020 and 50 patients with ARDS between March 2019 and 
December 2019 admitted to the Intensive Care Unit of the Ospedale 
Maggiore Policlinico (Milan, Italy). Gas exchanges and the distribution 
of ventilation and perfusion measured by EIT were assessed at posi-
tive end expiratory pressure (PEEP) of 5  cmH2O for C-ARDS and at clini-
cal PEEP for ARDS patients. Perfusion was obtained through injection 
of 10 mL of a 5% saline bolus during end-inspiratory occlusion. Dead 
space fraction was calculated as the percentage of pixels ventilated 
but not perfused, while shunt fraction as those perfused but not venti-
lated. Data are presented as median [IQR], differences between groups 
were assessed by Mann-Whitney on ranks test.
Results: Gas exchange and respiratory data are summarized in 
Table 1.
*Mann-Whitney test, C-ARDS vsARDS. PBW: predicted body weight
Compared to patients with ARDS, patients with C-ARDS showed no 
differences in tidal volume (Vt) and respiratory mechanics. Efficiency 
of ventilation was more impaired in C-ARDS, as indicated by higher 
respiratory rate, PaCO2 and ventilatory ratio. Accordingly, EIT docu-
mented a higher dead space fraction (23% [13; 29] vs 12% [5; 19], 
C-ARDS vs ARDS, p < 0.01). (figure 1A). Hypoxemia was more severe in 
C-ARDS, but shunt fraction didn’t differ (figure 1B).
Conclusion: Compared to ARDS of other etiology, C-ARDS is charac-
terized by more severe hypoxia and less efficient CO2 clearance, even 
in the presence of preserved mechanics. The mechanisms underlying 
derangements of gas exchange during C-ARDS may differ from ARDS, 
with increased dead space likely playing a key role.
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Introduction: Since the SARS-CoV-2 pandemic, countries are over-
whelmed by critically ill Coronavirus disease 2019 (COVID-19) patients. 
As ICU capacity becomes limited we characterized critically ill COVID-
19 patients in the Netherlands.
Methods: In this case series, COVID-19 patients admitted to the ICU of 
the Jeroen Bosch Hospital were included from March 9, 2020. COVID-
19 was confirmed by a positive result by a RT-PCR of a specimen col-
lected by nasopharyngeal swab. Clinical data were extracted from 
medical records.
Results: All patients were admitted to the ICU due to acute hypox-
emic respiratory failure in absence of hemodynamic instability. The 
mean age was 64 ±  10 years, the mean BMI was 30.1 ±  7 and 73% 
were men. Thirty percent of patients had no comorbidities. With 33%, 
hypertension was the most common comorbidity.
Of the 68 admitted patients, 62 were in need of invasive respiratory 
support (91%). Six patients were successfully treated with high flow 
oxygen therapy. Six patients initially treated with a high flow oxygen 
cannula deteriorated requiring invasive mechanical ventilation.
Among the mechanically ventilated patients, 77% required ventilation in 
prone position during their stay in ICU according to our local protocol. The 
average length of invasive ventilation was 22.5 days (range 3-53 days).
Renal replacement therapy was required in 14 (21%) patients.
Venous thromboembolism was recognized in 40% of patients. In 20 
patients pulmonary embolism was diagnosed, 1 patient developed a 
deep venous thrombosis of the forearm and 6 patients developed a 
catheter related thrombus. These complications occurred despite reg-
ular thrombosis prophylaxis.
The overall mortality of our patients was 20.5%.
Conclusion: The survival rate of COVID-19 critically ill patients in our 
population is lower than previously reported. Dedicated selection and 
screening of patients before potential admission to the ICU could be a 
possible explanation for this low mortality. Thrombotic complications 
were commonly found and merit additional clinical attention.
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Introduction: Influenza A (Influenza H1N1) is one of the great epidem-
ics of our time. It had a great repercussion due to the associated morbid-
ity and mortality, been moderate-severe ARDS one of the most common 
forms of presentation that requires prolonged admission to the ICU.
Methods: Retrospective, descriptive study of patients admitted in ICU 
from 2009 to 2019, with H1N1 influenza diagnosis. Clinical, epidemio-
logical and result-related variables were analyzed. Quantitative vari-
ables are expressed as mean and standard deviation, while qualitative 
variables are expressed as ratios and absolute value.
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Results: A total of 78 patients were collected. Mean age was 47 years 
+/− 16.77. 53.8% were women. APACHE II average upon admission: 
14 +/− 7.23 and average SOFA at admission: 5.5 +/− 3.83
Between the comorbidities: 41% of the patients presented COPD, 
33.3% BPH, 32.1% Obesity and 21.3% had Heart disease and 
Dyslipidemia.
The 66.7% of the patients received previous NIMV; 74.4% required 
MV. Mean duration of MV was 15 days +/− 14.68. Most of the patients 
required pulmonary recruitment maneuvers, and Prone Position was 
needed in 35.9%. Renal failure was presented in 50% of the patients, 
and 21.8% of them required RRT. Tracheostomy, due to weaning, was 
performed in 39.7% of the patients.
Between risk factors Alcoholism (OR 9,025 p 0.042 IC 1,079 - 75.51), 
Malignancy (OR 41.45 p 0.001 IC 4.47 - 384,437) and Autoimmune Dis-
ease (OR 7.3 p 0.042 IC 1,075 - 49.65) were the most frequent.
When the sample was divided into two groups, survivors and non-sur-
vivors, it was observed that the deceased patients were older (Median 
46 years vs. 53 years), and presented greater renal failure (38.18% vs. 
78.26%) with a greater need for RRT (28.57% vs. 61.11 %) as well as 
greater severity in the Berlin Criteria for distress (severe ARDS 38.18% 
vs. 78.26%).
The length of stay in the ICU was 13 days +/− 18.47. The ICU observed 
mortality was 29.5% and the hospital mortality 33.33%.
Conclusion: Severe ARDS caused by H1N1 Influenza associates great 
morbidity and mortality, being a very relevant pathology today in 
Intensive Care Units.
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Introduction: Excessive inspiratory effort in mechanically ventilated 
patients with acute respiratory distress syndrome (ARDS) increases 
stress and strain in the lungs leading to ventilator-induced lung 
injury (VILI). The use of neuromuscular blocking agents (NMBAs) 
can however, synchronize with ventilator, but the impact of use of 
NMBAs on ventilation distribution and lung volume has not been 
fullyinvestigated.
Objectives: The objective of this study was to examine the impact of 
NMBAs on ventilation homogeneity and end-expiratory lung volume 
(EELV) evaluated by electric impedance tomography (EIT) in ARDS 
patients with strong inspiratory effort.
Methods: In this retrospective study, we performed off-line analysis 
of EIT data previously recorded before and after NMBA. The ventila-
tion homogeneity was evaluated using EIT measures, the proportion 
of ventilation distribution (ventral and dorsal lung regions, expressed 
in percentage to a tidal volume = 100%), center of ventilation, spatial 
dispersion in regional distribution of tidal breath (global inhomoge-
neity index: GI index). End-expiratory lung impedance (EELI), which 
is corresponding to EELV was measured and changes in EELI from at 
before NMBA administration were calculated and expressed as a per-
centage of tidal impedance change at before NMBA administration. 
These EIT measures and oxygenation after NMBA administration were 
compared to the data measured before administration of NMBA. For 
the comparison, paired t-test or Wilcoxon rank sum test were used for 
statistical analysis as appropriate.
Results: The EIT data of 6 patients (mean age 54) were analyzed. In 
all the patients rocuronium was administrated because of the strong 
inspiratory effort and asynchrony with ventilator. The mean propor-
tions of ventilation distribution in ventral and dorsal region before 
NMBA were 39 ± 14% (mean ± SD) and 61 ± 14% respectively, indi-
cating that the active movement of diaphragm induced the predomi-
nant distribution of tidal volume to the dorsal region. After NMBA, the 
inspired gas distributed evenly (48 ± 11% to ventral and 52 ± 11% to 
dorsal region). GI index were decreased after administration of NMBA 
in 5 cases (before NMBA: 53 ±  4% after NMBA: 44 ±  7%). The EELI 
showed increase in 4 cases and decrease in 2 cases, the mean differ-
ence in EELI between before and after administration of NMBA was 
26 ±  59% (95% confidence interval, -35 to 88%). Mean difference in 
 PaO2/FiO2 ratio increased after NMBA (before NMBA: 127 ± 34 mmHg, 
after NMBA: 177 ± 77 mmHg), however no significant difference was 
detected.
Conclusion: After administration of NMBA, the ventilation inhomoge-
neity was decreased by suppressing strong inspiratory effort, resulting 
in better oxygenation. In addition, NMBAs might maintain EELV by 
controlling not only inspiratory effort but also active expiration.
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Introduction: In ARDS patients, mechanical ventilation should mini-
mize ventilator induced lung injury. The mechanical power which is 
the energy per unit time released to the respiratory system accord-
ing to the applied tidal volume, PEEP, respiratory rate and flow should 
reflect the ventilator induced lung injury. However similar levels of 
mechanical power applied in different lung size could be associated 
to different effects.
Objectives: Aim of this study was to assess  the role both of the 
mechanical power and of the transpulmonary mechanical power, 
normalized to predicted body weight, respiratory system compliance, 
lung volume and amount of aerated tissue on intensive care mortality.
Methods: Retrospective analysis of ARDS patients previously enrolled 
in seven published studies. All patients were sedated,  paralyzed and 
mechanically ventilated. After 20 minutes from a recruitment maneu-
ver, partitioned respiratory mechanics measurements and blood gas 
analyses were performed with a PEEP of 5  cmH2O while the remain-
ing setting was maintained unchanged from the baseline. A whole 
lung CT scan at 5  cmH2O of PEEP was performed to estimate the lung 
gas volume and the amount of well inflated tissue. Univariate and 
multivariable Poisson regression models with robust standard error 
were used to calculate risk ratios and 95% confidence intervals of ICU 
mortality.
Results: 222 ARDS patients were included, 88 (40%) died in ICU 
[Table 1]. Mechanical power was not different between survivors and 
non-survivors 14.97 [11.51-18.44] vs. 15.46 [12.33-21.45] J/min and did 
not affect intensive care mortality.
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The multivariable robust regression models showed that the mechani-
cal power normalized to well inflated tissue (RR: 2.69 [95% CI: 1.10-
6.56] p = 0.029) and the mechanical power normalized to respiratory 
system compliance (RR 1.79 [95% CI: 1.16-2.76], p = 0.008) were inde-
pendently associated with intensive care mortality after adjusting 
for age, SAPS II and ARDS severity. Also, transpulmonary mechani-
cal power normalized to respiratory system compliance and to well 
inflated tissue significantly increased intensive care mortality (RR 1.74 
[1.11-2.70] p = 0.015; RR 3.01 [1.15-7.91] p = 0.025). [Figure 2].
Conclusion: In our ARDS population there is not a causal relationship 
between the mechanical power itself and mortality, while mechanical 
power normalized to the compliance or to the amount of well aerated 
tissue is independently associated to the intensive care mortality. Fur-
ther studies are needed to confirm this data.
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Introduction: SARS-CoV-2, the causative organism of COVID-19, is 
known to trigger a hyperinflammatory acute respiratory distress syn-
drome (ARDS) in a subset of patients leading to rapid deterioration 
and respiratory failure. This is associated with raised inflammatory 
markers and carries a poor prognosis. At present there is a paucity 
of interventions available to clinicians to treat this. Glucocorticoids 
are a plausible treatment option for this presentation given their 
established application in reducinginflammatory burden and associa-
tion with improved outcomes in ARDS. Targeted use of methylpredni-
solone in patients with COVID-19-induced ARDS has been anecdotally 
reported to improve outcomes but limited data to support this is 
available.
Objectives: To examine outcomes in patients with severe ARDS sec-
ondary to COVID-19 treated with methylprednisolone, identify predic-
tors of favourable response and any associated risk factors with poor 
outcomes.
Methods: We conducted a single centre case-control study in a Lon-
don district general hospital intensive care unit. 27 participants with 
confirmed SARS-CoV-2 infection, severe ARDS and biochemical evi-
dence of hyperinflammation receiving invasive mechanical ventila-
tory support between 01/02/2020 and 26/05/2020 were included. 21 
patients treated with minimum of one dose of methylprednisolone 
(1 g/day or 1 mg/kg/day) were identified as the case group, and com-
pared with a control group of 6 patients requiring an  FiO2 ≥  0.6 for 
> 48 hours who received no corticosteroids during ICU admission. 
Outcomes were measured from first dose of methylprednisolone in 
the case group and after requiring a fraction of inspired oxygen  (FiO2) 
≥ 0.6 for 48h in the control group. Primary outcome was 28-day mor-
tality. Secondary outcomes included  FiO2, C-reactive protein (CRP) and 
ferritin at 48h and day 7. Data on timing of methylprednisolone initia-
tion, demographics and comorbidities were also collected.
Results: 28-day mortality was 38.1% (8) in the methylprednisolone 
group vs 66.7% in the control group (4), odds ratio 0.31 (95% CI 0.045 
to 2.08, p = 0.358). 52.3% (11) required an  FiO2 ≤ 0.5 on day 7 in the 
methylprednisolone group vs 0% in the control group (p = 0.0003). As 
a predictor of 28-day survival, an  FiO2 ≤ 0.5 at day 7 had a sensitivity of 
100% (95% CI: 71.5 to 100%) and a specificity of 75.0% (95% CI: 41.3 to 
92.7%)(p = 0.0002). In participants receiving > 48 h methylpredniso-
lone, an absolute reduction in  FiO2 requirement at day 7 of 0.25 (0.15 
to 0.35, p = 0.0002) and an 85.1% relative reduction in CRP at day 7 
(69.6 to 93.1%, p = 0.0002) was observed. Higher age was associated 
with mortality in the methylprednisolone group (p = 0.003).
Conclusion: Methylprednisolone may reduce early mortality in 
COVID-19 patients with severe ARDS and is associated with lower oxy-
gen requirements and CRP at day 7.
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Introduction: Prone positioning has been proposed as a key aspect 
of care in ARDS (1), more than ever with emergence of COVID-19 pan-
demic (2), but sometimes at the cost of burdensome procedure and 
serious adverse events. Bed verticalization (standing upright) could 
be an efficient alternative to prone position.  Semi-seated position 
(45-degree head-up, 45-degree legs-down) have already been stud-
ied and shew promising results (3, 4), but to our knowledge no study 
has evaluated the mechanical and physiological impacts of complete 
patient verticalization (standing upright) during ARDS.
Objectives: To evaluate the safety and physiological effects of bed 
verticalization of sedated and ventilated COVID-19 patients with ARDS 
(CARDS).
Methods: Patients were gradually verticalized, using a dedicated 
bed, at 0°, 30°, 60° and 90° by steps of 30 minutes. At each position 
step, multiparametric measurements were performed, including 
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hemodynamic data with pulmonary artery catheter, ventilatory 
parameters, end-expiratory lung volume (EELV), esophageal pressures 
and gazometric parameters.
Results: Ten out of 30 were included for this interim analysis. No seri-
ous side effects or adverse event occurred during the verticalization 
procedures. Mean arterial pressure, and cardiac output remained sta-
ble in different patient position. EELV of predicted body weight (PBW) 
increased significantly from 23 (15; 29) to 35 (28; 39) mL.kg-1, between 
baseline to 90°. Alveolar strain was significantly lower (0.28 [0.19; 0.46] 
to 0.18 [0.15; 0.24]). Although static compliance decreased (36 [27; 
43] to 25 [19; 32] mL.cmH2O-1.kg-1, baseline and 90° position, respec-
tively, P = 0.01), transpulmonary driving pressure did not increased 
significantly between these two steps (7 [5; 11] to 9 [5; 11]  cmH2O, P = 
0.9), as well as total mechanical power (10 [8; 13] to 10 [9; 16] J.min-1, 
P = 0.5).
Conclusion: Bed verticalization in ARDS is feasible, safe, and shows 
promising results on respiratory mechanic with minimal impact on 
hemodynamics. The rest of inclusions and data are needed to con-
clude on verticalization efficiency and eventually to identify some 
responders patients.
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Introduction: Respiratory failure is the most severe form of clini-
cal presentation of SARS COV 2 pandemic infection. 10% of hospital 
admissions required to be treated in Intensive Care Units (ICU).
Objectives: To describe clinical characteristics and respiratory pat-
terns in critically ill patientsadmitted in ICU with SARS COV 2 infection.
Methods: Retrospective study in a community hospital with a 17 bed 
ICU. We included patients with confirmed SARS COV 2 respiratory 
infection. Variables analyzed were clinical characteristics, respiratory 
support requirements, respiratory rate and inspiratory fraction of oxy-
gen in Emergency room,  PaO2/FiO2 ratio at admission, 24, 48 and 72 
hours, peep,  FiO2 requirements and mortality.
Statistical analysis: Data were analyzed by SPSS 18 and quantitative 
variables were expressed as a mean ± standard deviation.
Results: Twenty consecutive patients were included. Mean age was 
61,7 ±8,25. 65% male and 35% female. Apache II at admission was 
10,3 ± 4,21 and SOFA score 3,45 ± 1,87. Chest CT was performed in 
20% of the patients. Predominant chest radiograph findings were 
bilateral lung involvement in 90% of cases. Mean PEEP at admission 
was 11,88 ± 1,85 and inspiratory fraction of oxygen was 65,94 ± 18,9. 
Non-invasive ventilation BIPAP mode was used in 5% and high flow 
oxygen therapy in 45% of the admitted patients. Mechanical ventila-
tion was prescribed in 80% of patients, in 56,3% of them high flow 
oxygen therapy was used before intubation. Prone ventilation was 
indicated in most of the patients, 93,8%. Mortality was 30%, figure 1 
shows  PaO2/FiO2 ratio based on mortality.
Conclusion: Mechanical ventilation requirement and prone ventila-
tion at ICU admission was common in SARS COV 2 critically ill patients.
Improvement of  PaO2/FiO2 in first 48 hours of ICU admission was 
related with better prognostic.
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Introduction: Despite wide application of high frequency oscillatory 
ventilation (HFOV) in neonates with respiratory distress, little has been 
reported about its rescue use in preterm infants
Objectives: We aimed to evaluate the therapeutic effects of HFOV in 
preterm neonates with refractory respiratory failure, investigate the 
parameters during HFOV and the independent risk factor for 120-day 
outcomes.
Methods: We retrospectively analyzed data collected prospectively 
(January 2014-December 2018) in multiple neonatal intensive care 
units of tertiary-level medical centers in Taiwan. All premature infants 
(gestational age < 34 weeks) receiving HFOV as rescue management 
for refractory respiratory failure were included.
Results: We analyzed the demographics, pre- and daily post-HFOV 
mechanical ventilation settings and use of adjunctive therapies, thera-
peutic responses and 120-day outcome data for 668 preterm neonates 
with refractory respiratory failure. The median (IQR) gestational age 
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and birth weight were 27.3 (25.3-31.0) weeks and 915.0 (710.0-1380.0) 
g, respectively. Pre-HFOV use of cardiac inotropic agents and inhaled 
nitric oxide were 70.5% and 23.4%, respectively. The oxygenation 
index (OI),  FiO2, and AaDO2 were markedly increased after HFOV ini-
tiation (all p < 0.001), and can be decreased within 24-48 hours (all p 
< 0.001) after use of HFOV. 547 (81.9%) patients had a good response 
to HFOV within 3 days. The final in-hospital mortality rate was 34.7%. 
No association was found between specific primary pulmonary dis-
ease and survival in multivariate analysis. Initial severity of respira-
tory failure, response to HFOV treatment, occurrence of sepsis, severe 
hypotension and patients with underlying perinatal asphyxia were 
independently associated with the 120-day mortality.
Conclusion: Nearly two-thirds of preterm infants with severe res-
piratory failure had well response to HFOV, mostly within the first 48 
hours. For preterm infants with sepsis, severe hypotension and perina-
tal asphyxia, alternative strategies are warranted and urgently needed 
to investigate, in order to optimize outcomes.
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Introduction: Spain has been one of the most affected countries 
by the SARS-COV2 pandemic with thousands of cases in Madrid. 
The healthcare overload and excessive number of critical patients 
increased the capacity of the ICU. Due to assitance pressure, many of 
the patients with acute respiratory failure de novo had to be treated 
at the beginning with conventional respiratory support, CPAP systems 
and NIMV before their admission in ICU.
Objectives: To analyse the evolution, average hospital stay and mor-
tality of our patients who received respiratory support with CPAP, 
HFOT or BiPAP before their admission in the ICU. Comparing with the 
critical patients admitted after conventional oxygen therapy failed.
Methods: Retrospective observational study completed in an ICU of 
a second degree hospital. During the pandemic, ICU beds went from 
14 to 39. We analysed the patients with diagnosis of acute respira-
tory failure and severe atypical pneumonia by SARS-COV2 admitted 
from 6/3/20 to 21/4/20. Patients who are still admitted at the time of 
data collection are excluded. Demographic variables, medical history, 
APACHE II, days elapsed from hospital admission to ICU admission, 
presence of associated organic failure, need for rescue treatment in 
refractory hypoxemia (prone position, neuromuscular relaxation) were 
collected. We also gathered analytical parameters of bad prognosis 
(creatinine, bilirubin, ferritin, D-dimer), days of ICU stay and mortality. 
Statistical analysis is performed using the IBM®SPSS Statistics 23 tool.
Results: We analyse 90 patients. Only 67 received full treatment at our 
centre due to the lack of beds. All requiring invasive respiratory sup-
port, of whom 46.3% of these patients (31) received respiratory sup-
port with CPAP or NIMV systems prior to admission in the ICU. In the 
subgroup analysis, we did not find statistical significant differences 
in terms of age, gender, personal history, APACHE II or development 
of organ failure. No differences were found in the number of prones, 
tracheostomies or need of neuromuscular blockers. There were not 
differences in the analytical parameters nor in the number of super-
infections, neither in the ICU stay nor in mortality. The only difference 
was in the days elapsed from hospital admission and ICU admis-
sion, being 5.6  ±  6.15 days in patients who received non-invasive 
respiratory support prior to ICU admission versus 3.03 ± 2.48 days in 
patients who did not (p < 0.05)
Conclusion: In our sample, the patients diagnosed with refractory 
hypoxemia who were treated with non invasive respiratory devices 
had not a worse evolution, longer ICU stay or increased mortality.
We did find a difference in the time elapsed between hospital admis-
sion and ICU admission. Patients who were treated with non invase 
respiratory devices were admitted later than patients who did not 
require them.
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Introduction: The high heterogeneity of ARDS contributes to para-
doxical conclusions from previous investigations of rosuvastatin for 
ARDS. Identification of the population (phenotype) who could benefit 
from rosuvastatin is a novel exploration for precise treatment of ARDS.
Methods: The patient population for this analysis consisted of unique 
patients with ARDS enrolled in the SAILS trial (Rosuvastatin vs. Pla-
cebo). Phenotypes were derived using consensus k means clustering 
applied to routinely available clinical variables within 6 hours of hos-
pital presentation before receiving placebo or rosuvastatin. Kaplan–
Meier statistic was used to estimate the 90 day cumulative mortality 
for screening specific population who could benefit from rosuvastatin, 
with cut-off value as P < 0.05.
Results: The derivation cohort included 585 patients with ARDS. Of 
the 4 derived phenotypes, phenotype 3 was identified as “specific 
population who could benefit from rosuvastatin” since rosuvastatin 
resulted in a significant reduction in 90 day cumulative mortality for 
ARDS (hazard ratio [HR] 0.29 [95% CI 0.09, 0.93]; P = 0.027). Mean-
while, there were no significant differences in baseline characteristics 
between those assigned to rosuvastatin and those assigned to pla-
cebo. Additionally, rosuvastatin markedly improved the free of cardio-
vascular failure (10.08 ± 3.79 in Rosuvastatin group vs 7.31 ± 4.94 in 
Placebo group, P = 0.01) and coagulation abnormality (13.65 ± 1.33 vs 
12.15 ± 3.77, P = 0.02) to day 14 in phenotype 3. Patients classified as 
phenotype 3 exhibited but not limited to the relative higher platelet 
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count (390.05 ±  79.43×10^9/L), lower CRP (20.23 ±  11.99μg/L) and 
Creat (1.42 ± 1.08 mg/dl), compared with patients classified as other 
phenotypes. Besides that, rosuvastatin seemed to increase 90 day 
mortality for patients in phenotype 4 (HR 2.76[95% CI 0.09, 9.93], P = 
0.076), with its adverse effect on the reduction of free of renal failure 
to day 14(4.70 ± 4.99 vs 10.17 ± 4.69, P = 0.01). Patients in phenotype 
4 showed a relative severe illness baseline features particularly renal 
failure.
Conclusion: This secondary analysis of SAILS trial identified the spe-
cific population who can benefit from rosuvastatin using machine 
learning applied to clinical variables at the time of hospital presenta-
tion, which uncovered a novel value of rosuvastatin for the treatment 
of ARDS, with validation clinical trials to be warranted to assess these 
further.
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Introduction: The novel human coronavirus, severe acute respiratory 
syndrome coronavirus-2 (SARs-CoV-2), was declared a global pan-
demic by the World Health Organization on March 11, 2020. Hence, 
there is an urgency to find effective treatment. Of those patients 
afflicted in the United States, many have required treatment with ven-
tilator secondary to acute respiratory distress syndrome (ARDS). Data 
are needed regarding the benefit of treatment and prevention of the 
cytokine storms in COVID-19 patients with Tocilizumab.
Objectives: There are over 5.8 million confirmed cases and 360,412 
deaths have been identified worldwide as of May 28, 2020 due to 
SARs-CoV-2 (COVID-19). Our study showed improved survival out-
come in COVID-19 ARDS patients treated with Tocilizumab.
Methods: Clinical outcomes data for patients admitted to Orange 
Regional Medical Center with confirmed COVID-19 from Mar 15, 2020 
to Apr 20, 2020 were identified through electronic health record chart 
review. We conducted a retrospective case-control study in confirmed 
COVID 19 positive patients with ARDS requiring mechanical ventila-
tion and compared outcome in terms of mortality and length of stay 
amongst those who received Tocilizumab as treatment modality 
opposed to those that did not.
Results: A total of 94 patients with COVID-19 ARDS were analyzed. 
44 were in the study group and 50 in the control group. We tried to 
match both group as close as possible in terms of age, sex, BMI and HS 
score- calculated using inflammatory markers- ferritin, triglycerides, 
AST and fibrinogen. The median age was 55.5 years in the study group 
and 66 in the control group, difference was not statistically significant. 
Average HS score was 114 in the Tocilizumab group and 92 in the con-
trol group, difference was statistically significant with P < 0.0001. Also, 
the patients in the study group had elevated levels of IL-6, triglycer-
ides, AST, ferritin which were statistically significant with p < 0.0001 
when compared to the control group. Length of stay was longer, 
average 17.9 days in the Tocilizumab. Survival rate was much lower at 
48 % in the control group and 61.36 % in patients who received Toci-
lizumab with significant P value of < 0.00001. The number needed to 
treat (NNT) was 7.48, if we treat 8 patients with Tocilizumab, 1 will not 
die.
Conclusion: Cytokine Release Syndrome (CRS) occurs in a large num-
ber of patients with severe COVID-19, which is also an important cause 
of death. IL- 6 is the key molecule of CRS, so IL-6R antagonist Tocili-
zumab may be of value in improving outcomes. In our study Tocili-
zumab group seemed to have improved survival outcome.
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Introduction: The severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2)  can  infect  the endothelium  leading to  microvascular 
endothelialitis. The endothelial glycocalyx (eGC) plays an essential role 
in maintaining endothelial function.
Objectives: To investigate if injury to the eGC can be found in critical 
ill Covid-19 patients
Methods: Sublingual assessment of the  eGC via  sublingual dark 
field  imaging was performed  in 19  critically ill Covid-19 patients 
within 24h after  intubation  and in 10 controls.  Blood  samples 
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were analyzed for markers of endothelial and eGC injury. A 3D micro-
fluidic flow assay was performed to examine eGC ex vivo in naïve and 
Heparanase-2 overexpressing endothelial cells (ECs).
Results: In Covid-19 patients, transmembrane proteins such as  Syn-
decan-1 and sTie2 were increased in the circulation indicting patho-
logical shedding.  Hpa-1, a key regulator of eGC, and its enzymatic 
activity were unchanged. In contrast, its protective counterpart Hpa-2 
was  profoundly  reduced (median (IQR) 18.7 (10.6-31.1) U/ml vs. 4.7 
(2.6-5.6) U/ml, p = 0.014). Ex vivo stimulation of ECs with serum from 
Covid-19 patients  was  sufficient to lower Hpa-2 transcription and to 
induce glycocalyx damage that could be rescued  by  lentiviral  Hpa-2 
overexpression.  Consistently,  in vivo imaging of  the  eGC  revealed 
a  reduced thickness  (increased  perfused boundary region (PBR) 1.9 
(1.8-1.9) μm vs. 2.1 (1.8-2.2)μm, p = 0.009) in Covid-19.
Conclusion: In critically ill patients with Covid-19,  early endothe-
lial injury involves the integrity of the glycocalyx. Acquired Hpa-2 defi-
ciency might be a potentially causative factor. These observations may 
trigger novel therapeutic interventions aiming at protecting endothe-
lial function.
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Introduction: Understanding the progression and optimum man-
agement of the COVID-19 as a “new disease” is of vital importance for 
healthcare workers worldwide to improve severe disease outcomes.
Objectives: The main purpose of the study is to investigate the pro-
gression of critically ill patients with confirmed COVID-19 infection in 
the ICU.
Methods: All consecutive patients who were admitted in the ICU of 
the Nicosia General Hospital, Cyprus due to severe COVID-19, between 
March 10th and May 1st, 2020 were reviewed. A confirmed case of 
COVID-19 was defined as a positive result on a reverse-transcriptase-pol-
ymerase-chain-reaction (RT-PCR) assay of a specimen collected either 
from nasopharyngeal swab or bronchial secretions. Data was collected 
regarding respiratory, cardiovascular, infectious, and other parameters.
Results: A total of 19 patients with confirmed COVID-19 were identi-
fied. Their mean age was 64, while 74% were men. Obesity (63%) and 
hypertension (53%) were the most common risk factors for ICU admis-
sion. Most patients were admitted with severe respiratory failure (68%) 
and all required mechanical ventilation. Patients were categorized in 
four groups of ventilation, based on H or L ventilation phenotype in 
association with co-morbidities. The first category were L phenotype 
patients that seemed to benefit from a few days of mechanical ven-
tilation. These patients suffered from no of minor comorbidity. The 
second category L phenotype patients that seemed to suffer from ICU 
complications and had a prolonged weaning process. These patients 
had several comorbidities and/or older age. The third category were H 
phenotype patients that eventually changed to L phenotype. Among 
this group the patients exhibited radiological and ultrasonographic 
signs of atelectasis. Prone positioning seemed of great benefit in these 
patients. It may be argued that the transition from H to L phenotype 
may be due to the improvement of atelectasis rather than a change or 
improvement of lung inflammation. This group exhibited obesity with 
a high waist circumference partially explicatory of the high atelectasis 
rate found. Lastly the category “classic” ARDS patients or pure H phe-
notype. They had the worst outcome since they suffered from severe 
ARDS. 68% of patients required vasopressor support, and 42% devel-
oped AKI during their stay. Diarrhea was common with a median day 
of onset of 8 days. Lactate levels above 2 mmol/L in the first four days 
of admission were correlated with a negative outcome. Eight patients 
(42%) were successfully discharged from the ICU, 7 (39%) died and 4 
patients remain in the ICU.
Conclusion: Obesity and male gender are significant risk factors for 
ICU admission. Ventilation phenotype on admission and during hospi-
talization may be predictive of outcome. Mechanical ventilation, lower 
PEEP values and early prone position may provide more favorable out-
comes especially in L phenotype patients.
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Introduction: Acute pancreatitis (AP) is described as a common cause 
of acute respiratory distress syndrome (ARDS). Paradoxically, despite 
exponential increase in ECMO (ExtraCorporeal Membrane Oxygena-
tion) use over the past decade1, literature remains very poor concern-
ing its use in these patients2.
Objectives: Our objective was to describe the use of ECMO in this spe-
cific population.
Methods: French multicentric retrospective study. All adult patients 
on ECMO for an ARDS secondary to AP between 2010 and 2020 were 
included in the analysis. Demographic data, AP severity, respiratory 
complications and outcomes were collected. Results are expressed in 
median [interquartile range] and proportions.
Results: Twenty-five patients with severe ARDS following PA requiring 
ECMO were identified, of which 5 were secondarily excluded (4 ECMO 
post-cardiac arrest, 1 for aspiration pneumonia unrelated to PA).
Patients were young (47 [38-60] years) and obese (body mass index 
30 [26-34] kg/m2) men (90%) admitted for a severe AP (BISAP 2 score 
[1-2]), mainly of alcoholic (45%) and biliary (20%) origin. They pre-
sented a median sequential organ failure assessment (SOFA) score of 
8 [4-13] at admission and a simplified acute physiology score (SAPS 2) 
of 50 [34-61].
Prior to ECMO initiation, ventilatory characteristics were as follows: 
tidal volume of 6.9 [5.7-8.6] mL/kg of ideal body weight, positive end-
of-expiration pressure of 10 [8-12]  cmH2O and a plateau pressure of 
30 [30-32]  cmH2O. Associated adjuvant therapies were neuromuscu-
lar blockades (100%), prone positioning (30%) and nitric oxide (30%). 
Before ECMO initiation, patients had a median pH of 7.26 [7.20-7.38] 
and a P/F ratio of 58 [52-82].
ECMO support was mainly venovenous (80%) with details presented 
in the Table. Thirteen patients (65%) underwent at least one surgical 
intervention under ECMO, mainly for digestive ischemia or abdominal 
compartment syndrome. Outcomes are listed in the Figure.
Page 108 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Conclusion: ECMO appears to be an acceptable therapy for ARDS sec-
ondary to AP due to the young age and limited comorbidities of these 
patients. In particular, the need for abdominal surgery does not seem 
to change the risk-benefit balance and should not contraindicate 
ECMO in this population. A study comparing this cohort to AP in ARDS 
without ECMO will provide more answers and is currently underway.
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Introduction: Since the end of 2019 the world is enthralled by the 
novel COVID-19 pandemic, putting extreme pressure on Intensive 
Care Units. The general advice for patients with progressive respira-
tory failure due to COVID-19 disease was to start invasive mechani-
cal ventilation (MV) early in the clinical course. This was based on the 
assumption that COVID-19 led to a moderate to severe ARDS requiring 
MV with PEEP and to prevent patient self-inflicted lung injury (P-SILI)
[1]. In addition, non-invasive ventilation and High-Flow Nasal Can-
nula (HFNC) were discouraged because of the perceived risk of aerosol 
formation leading to disease transmission. However, it has become 
increasingly clear that patients with COVID-19 do not necessarily 
develop typical ARDS and the transmission risk of HFNC is considered 
comparable to conventional oxygen therapy [1-3]. HFNC is a validated 
therapy that can prevent intubation in patients with progressive 
hypoxemic respiratory failure and can also be used outside the ICU [4]. 
We hypothesize that implementation of HFNC in the pre-ICU setting 
can successfully reduce the need for MV and ICU-admission of COVID-
19 patients.
Objectives: To investigate to what extent HFNC can prevent MV 
in patients with progressive hypoxemic respiratory failure due to 
COVID-19.
Methods: We performed a multicenter prospective cohort study 
between March 2020 and June 2020 on the regular pulmonary wards 
of an academic and teaching hospital in Rotterdam, the Netherlands. 
Patients on the regular wards with progressive hypoxemic respiratory 
failure due to COVID-19 while being treated with maximum oxygen 
(O2) therapy (peripheral O2 saturation < 92% or high work of breath-
ing), started with HFNC. Maximum O2 therapy before HFNC consisted 
of 15L O2/min flow via a non-rebreathing mask (NRM) in one center 
and 6L O2/min flow via a nasal cannula in the other. Patients with con-
traindications for HFNC (such as hypercapnia, severe hypoxia) were 
excluded and intubated directly. Patients vital parameters (peripheral 
O2 saturation, respiratory rate (RR)) and ROX-scores were monitored 
after one hour, followed by every two hours during HFNC. In case of 
an increasing oxygen demand or exhaustion, assessed by the corre-
sponding ROX-scores, MV was initiated [5].
Results: HFNC was initiated in a total of 30 patients for progressive 
respiratory failure on conventional O2 therapy (n = 25 nasal cannula; 
n = 5 NRM). Patients started HFNC after a median of 3 days (IQR: 1-4) 
after hospital admission, while having symptoms for a median of 11 
days (IQR: 9-15). The median peripheral O2 saturation and RR at start 
of HFNC was 94% (IQR: 93-96) and 28/min (IQR: 24-32) respectively. 14 
out of 30 (47%) were eventually intubated after a median of 12 hours 
(IQR: 8-24) after starting HFNC. 2 out of 5 on an NRM (40%) were intu-
bated versus 12 out of 25 (48%) on a nasal cannula. Median ROX-score 
at time of intubation was 4.82 (IQR: 4.60-4.98). Reasons for intubation 
were hypoxia (n = 1) and somnolence (n = 1) but mainly exhaustion 
(n = 12) defined as a RR ≥ 30/min with corresponding low ROX-scores. 
Patients stabilizing on HFNC continued therapy for a median of 5 days 
(IQR: 2-8) before switching to a nasal cannula.
Conclusion: Our study suggests that HFNC may prevent intubation in 
a relevant proportion of COVID-19 patients with isolated hypoxemic 
respiratory failure.
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Introduction: Lung and chest wall tissues absorb the dissipation of 
the energy during lung inflation through their viscoelastic proper-
ties. These can be represented by the Mount  rheological model that 
consists of a Maxwell body (lung and chest wall viscoelastic elastance 
(E2) and resistance (R2) arranged in series) in parallel with the standard 
lung and chest wall elastance and resistance, according to the follow-
ing equation: Pvisc(ti) = R2 V’ (1- exp(-ti/τ2)) (1)
where Pvisc(ti) represents the viscoelastic elastic pressure dissipation 
into lung/chest wall during inflation time (ti), V’ the inflation flow and 
τ2 the lung/chest wall viscoelastic time constant (τ2 = R2/E2).
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Lung and chest wall viscoelastic properties have not previously been 
described during acute respiratory distress syndrome (ARDS) accord-
ing to presence or absence of expiratory flow limitation (EFL).
Objectives: We aimed at assessing the relation-ship between EFL 
and viscoelastic dissipation characteristics of lung/chest wall in ARDS 
patients.
Methods: This is a secondary analysis of a previously reported study 
on ARDS patients meeting the Berlin definition criteria (1). Patients 
were intubated, sedated and paralyzed. Airway and esophageal pres-
sures and flow signals were recorded in semi-recumbent position at 
PEEP 5, 10 and 15  cmH2O. At PEEP 5, EFL was assessed by the atmos-
pheric method as previously reported (2). Patients were classified as 
flow-limited (FL) or non-flow-limited (NFL). At each PEEP a 5-s end-
inspiratory occlusion was performed at baseline ventilator settings. 
We used the single breath method (2) to estimate the viscoelastic 
elastance (E2,L and E2,cw) and resistance (R2,L and R2,cw) of lung and 
chest wall, respectively. Values are shown as median (1st-3rd quartiles) 
and compared between FL and NFL at PEEP 5 by using Wilcoxon rank 
test. The effect of EFL, PEEP and their interaction was further tested by 
linear mixed-effects model.
Results: Twenty-five ARDS patients were included. Eight were FL and 
17 NFL. At PEEP 5, E2,L and R2,L were significantly higher in FL than 
in NFL patients, amounting to 12 (10-4) vs. 6 (5-8)  cmH2O/L (P = 0.03) 
and 7 (5-10) vs. 4 (2-6)  cmH2O/L/s (P = 0.04), respectively. Chest wall 
E2,cw and R2,cw were not different between FL and NFL patients. 
PEEP had no effect on viscoelastic constants but EFL had a significant 
effect on E2,L and E2,cw without interaction between PEEP and EFL. 
Over all PEEP levels, E2,L was 11 (7-14) in FL and 5 (4-7)  cmH2O/L in 
NFL (P = 0.02) and E2,cw was 2 (1-4) in FL and 3 (1-3)  cmH2O/L in NFL 
(P = 0.003).
Conclusion: In ARDS, lung viscoelastic constants are significantly 
higher in FL than in NFL patients. The mechanisms behind this finding 
should be explored.
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Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 
(SARS-CoV-2) is an atypical Acute Respiratory Distress Syndrome 
(ARDS), characterized by an initial direct viral insult that could lead to 
a disproportionate inflammatory response that worsens lung function 
[1]. To date it is unknown if steroids may be a strategy in viral ARDS [2]. 
We tested the hypothesis that methylprednisolone reduces mortality 
at 28 days.
Objectives: Determine the effect of methylprednisolone on mortal-
ity at 28 days, on mechanical ventilation (MV) free days and major 
complications.
Methods: From February 22nd  to March 22nd, 130 consecutive 
patients admitted in 6 ICUs of Ospedale Papa Giovanni XXIII (Bergamo) 
were retrospectively enrolled. Age, Charlson comorbidity index, SOFA 
score and  PaO2/FiO2 ratio (P/F) at admission were collected. We com-
pared 67 control patients (control group) with 63 receiving methyl-
prednisolone (steroid group) at either low dose (1 mg/kg/day, n = 58) 
for 10 days or up to three high dose boluses (1000 mg, n = 5). Primary 
outcome was mortality at 28 days. Secondary outcomes were MV-free 
days and secondary infections. Baseline characteristics and MV-free 
days were compared in two groups using Mann Whitney test. The 
association with mortality and infection was evaluated with Fisher 
exact test.
Results: In our population median age was 62 (IQR 14), 107 (82%) 
were male, 115 (88%) required intubation.
In the steroid group all patients received methylprednisolone within 
the first 14 days after ICU admission, median therapy duration was 
10 days (IQR 10). Steroid and control groups were similar in terms of 
age, Charlson comorbidity index, SOFA score and P/F. Methylpredni-
solone was associated with reduced mortality at 28 days (OR 0.35, 95% 
CI 0.17-0.77, p 0,009). No differences were observed in MV-free days, 
secondary infections and septic shock. The table summarizes baseline 





Age, median (IQR) 61 (12) 60 (11) ns 
Charlson comorbidity index, median 3 (2) 2 (2) ns 
(IQR) 
SOFA score, median (IQR) 6 (2) 6 (2) ns 
PaO2/FiO2, median (IQR) 110 (59) 109 (69) ns 
Secondary infections, n (%) 30 (52) 25 (40) ns 
Septic shock, n (%) 20 (32) 15 (26) ns 
MV-free days, median (IQR) 0 (15) 0 (8.5) ns 
Mortality at 28 days, n (%) 14 (22) 30 (45) *  
Conclusion: In our cohort of SARS CoV-2 patients, immunomodula-
tion therapy with methylprednisolone was associated with reduced 
mortality at 28 days.
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Introduction: Patients with chronic obstructive pulmonary disease 
(COPD) have recurrent exacerbations that contribute to their clinical 
impairment (1). Computed tomography (CT) scanning can distinguish 
the underlying changes driven the airflow limitation, and many stud-
ies have showed the main pathological characteristics of emphysema, 
airway wall thickening and reduced lumen caliber (1–3).
CT has been used to quantify emphysema by detecting low attenua-
tion areas (LAA%), and quantitative parameters of the parenchyma 
on inspiration and expiration allow indirect evaluation of small airway 
obstruction. While the quantification of emphysema by CT imaging 
has been well established and validated, the quantification of airway 
disease has proven to be more difficult to stablish. The segmental and 
subsegmental bronchial wall area percent (WA%) have been found to 
be correlated with the forced expiratory volume in 1 s (FEV 1) (1–3).
Objectives: To estimate the association between radiological findings 
and the need for intensive care unit (ICU) or mortality in patients hos-
pitalized by the emergency room with COPD exacerbation.
Methods: Prospective cohort study with adults attended in the emer-
gency room of three reference hospitals in Medellín (Colombia), who 
consulted for acute exacerbation of COPD and required hospitaliza-
tion between 2017 and 2020. Inspiratory and expiratory scans were 
performed. Morphometric assessment of the airways ([WA%] and air-
way inner luminal area [Ai]), as well as extent of emphysema (LAA%), 
were performed using 3D Slicer software. Data were collected from 
the segmental and subsegmental generations of the apical segment 
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of the right upper lobe (RB1) and the posterior-basal segmental and 
subsegmental bronchi of the right lower lobe (RB10). LAA thought 
to reflect emphysematous destruction of the lung parenchyma were 
defined using a Hounsfield Unit threshold of −  50 (%LAA-950). The 
association between radiological measurements and inpatient death 
or admission to ICU was explored by locally weighted regression 
(LOWESS) and simple univariate logistic regression models.
Results: Among 1411 eligible patients, 326 (23%) were included. The 
main exclusions were pneumonia (30%), limiting to perform the CT 
(24%) and terminal illness (11%). The median age was 74 years (IQR 
66 - 82) and 56% were women. Smoking history (86%) and exposure 
to biomass (61%) were the main risk factors. Hospital mortality rate 
was 2.5% and 40 (12.3%) patients required admission to ICU, with 43 
(13.2%) patients with the outcome of interest. The means of WA% 
were: RB1 segmental 64.6 (58.8-70.7), subsegmental 70.3 (64.5-75.5), 
and RB10 segmental 63.3 (57.5-70.6), subsegmental 69.4 (62.8 -76.1). 
The mean for extent of emphysema (%LAA-950) was 14.7% (4.2-29.3). 
In univariate logistic regression analyzes, all radiological measure-
ments showed no association with the outcome of death or need for 
ICU (Table 1).
Table 1. CT variables 
Morphometric variable Odds Ratio (95% CI) 
Mean airway wall area percent (%) [WA]   
B1 Segmental 0.99 (0.96 – 1.02) 
B10 Segmental 1.01 (0.98 – 1.04) 
Mean airway inner luminal area (mm^2) [Ai]   
B1 Segmental 0.99 (0.98 – 1.02) 
B10 Segmental 0.99 (0.98 – 1.01) 
  yrtemuloV  
%LAA-950 0.99 (0.97 – 1.02) 
15th percentile 1.00 (0.97 – 1.01) 
Conclusion: Morphometric assessment of the airways and the extent 
of emphysema did not differ between patients with and without the 
outcome of death or need for ICU.
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Introduction: COVID-19 may be associated with severe respira-
tory failure that, for patients requiring invasive ventilation carries an 
estimated mortality of 49% in the UK (1). A prominent feature of the 
disease is the development of thromboembolic complications that, 
despite thromboprophylaxis, occurs with an incidence of approxi-
mately 50% (2,3). We evaluated the presenting characteristics and out-
comes of the patients admitted with COVID-19 in our ICU, particularly 
as regards to the development of thromboembolic complications.
Methods: Baseline characteristics, respiratory variables, coagulation 
and inflammatory parameters and ICU mortality were collected retro-
spectively on all patients admitted with either PCR-confirmed or clini-
cally diagnosed COVID-19.
Results: Between March and May 2020 59 admissions with COVID-
19 were recorded. Thirty-two patients (58%) required invasive venti-
lation and 27 patients (48%) received therapeutic anticoagulation. 
Thromboembolic  complications occurred in 8 patients (14%) and 
50% of those died. Of the patients that had ischaemic complications 
5 (63%) were on prophylactic and 3 (38%) on therapeutic anticoagu-
lation. Six patients developed haemorrhagic complications and 2 of 
those required blood transfusion. Mortality in the intubated patients 
was 47%. There was no difference in the mortality of patients that 
received therapeutic anticoagulation versus those that did not. Fac-
tors associated with mortality included CRP and respiratory variables, 
whereas D-dimer was associated with the development of thrombo-
embolic complications. Maximum CRP in the first 72 hours of admis-
sion was significantly higher in the patients that died (mean (SD) 311 
(80) vs 207 (86) mg/L, p = 0.0002); > 300 mg/L was associated with 
> 70% mortality. Minimum S/F ratio (median [IQR]) within the first 72 
hours of admission in non-survivors vs survivors was 149 [114-165] vs 
192 [157-269], p = 0.0004.  Patients with lowest S/F < 150 and ≤100 
had 60% and > 80% mortality respectively. Both D-dimer on admission 
and mean D-dimer during ICU stay were higher in the patients that 
experienced thromboembolic complications.  However,  there was no 
association between APTTR, anti-Xa, or Fibrinogen values with either 
mortality or the of thromboembolic complications (Figure).
Conclusion: Our analysis shows a lower incidence of thrombotic 
complications compared to other centres, likely because of  our low 
threshold for anticoagulation.  Therapeutic anticoagulation was not 
associated with improvement in outcomes and that was likely a result 
of patient selection, as those with clinically severe disease received 
therapeutic anticoagulation. Similar to other studies, D-dimer and CRP 
levels were associated with poor outcomes and may be used for prog-
nostication and to guide anticoagulation treatment (4,5).
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Introduction: SARS-CoV-2 overwhelmed intensive care units capac-
ity around the world. In this circumstances providing high complexity 
and resources consuming techniques as ECMO was a challenge.
Objectives: To describe characteristics and outcomes of patients 
receiving ECMO to support complications related with COVID-19 
infection.
Methods: ECMO decision was based on ELSO recommendations for 
SARS-CoV-2 pandemic after discussion between ECMO team members 
(which consisted of cardiac surgeons, cardiologists and intensive care 
medicine specialists). Clinical records were analyzed to obtain relevant 
demographic, gas exchange and mechanical ventilation characteris-
tics and outcomes. Descriptive statistics were performed.
Results: From February to May 2020 around 230 patients ( > 95% 
invasive mechanical ventilation application) with SARS-CoV-2 diag-
nosis were admitted to the intensive care units of the two study cent-
ers and ECMO was used in 6 patients. Two H1N1 patients (with 0% 
mortality) were also subjected to ECMO during this time period but 
were excluded of this analysis. Five patients had ARDS as main diag-
nosis and reason for ECMO (veno-venous) while one had a diagnosis 
of miopericarditis and cardiogenic shock secondary to COVID-19 and 
veno-arterial ECMO was used. All patients were male, mean APACHE 
II was 15 ±  7, age 51 ±  4 years, post intubation  PaO2/FiO2 ratio was 
152 ±  57mmHg (131 ±  28mmHg when miopericarditis patient was 
excluded), PaCO2 55 ± 12mmHg, pH 7.32 ± 0.1, tidal volume 442 ± 38 
ml (always below 8ml/kg PBW) and PEEP 13.8  ±  1.6  cmH2O and 
none of them had evidence of right ventricle failure. All veno-venous 
patients were in protective mechanical ventilation settings including 
prone position at the time of ECMO decision which occurred at day 
13 ± 8 of admission and after 10 ± 7.16 mechanical ventilation days. 
In two patients ECMO was started after extubation failure and restart 
of mechanical ventilation. Variables at the time of ECMO start were 
 PaO2/FiO2 ratio 89 ± 14mmHg, PaCO2 74 ± 15mmHg, pH 7.35 ± 0.07, 
tidal volume 412 ± 30 and PEEP 12 ± 2.4  cmH2O. In the veno-arterial 
patient ECMO was started in the admission day without data of respir-
atory failure. ECMO was used during 13 ± 7 days, survival was 66% and 
intensive care unit length of stay 56 ± 25 days (one patient remained 
in the ICU at the time of analysis). No differences in the analyzed vari-
ables were found between survivors and not survivors.
Conclusion: In this cohort of patients with severe COVID-19 infection 
ECMO showed encouraging results. Mortality was below the usual 
reported data. However length of stay was high. As long as material 
and human resources were available and well-coordinated, ECMO 
could be delivered in a safe way in times of SARS-CoV-2 pandemic.
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Introduction: Multiple studies report that patients with COVID-19 
have a high incidence of arterial and venous thromboses despite 
standard prophylaxis1,2,3. Although this has led to recommendations 
for higher anticoagulant dosing4 in patients on ICU, it is unclear if this 
will reduce thrombotic complications.
Objectives: 1. To  quantify  the difference in thrombotic events 
between ICU and ward level patients.
2. To ascertain whether a higher prophylactic low molecular weight 
heparin (pLMWH) dose regime for ICU patients conferred protection 
from developing thromboses.
Methods: We collected data retrospectively on patients admitted to 
medical wards between 8th Apr 2020 to 22nd Apr 2020, who were PCR 
positive for SARS-CoV-2. Data collected included the use of prophylac-
tic or therapeutic anticoagulation, clinically detected thrombotic com-
plications or bleeding.
We also collected data on patients admitted to ICU from 15th  Mar 
2020 to 14th Jun 2020 with PCR confirmed COVID-19. These patients 
received either standard pLMWH, or, following introduction of new 
guidance, ‘enhanced’ pLMWH.
Results: 83 ward admissions were identified, of which 53 had stand-
ard pLMWH, 18 were already on therapeutic anticoagulation, and 12 
received neither. 1 patient developed a venous thromboembolism 
(VTE) (1.2%). 2 patients, both on pre-admission therapeutic anticoagu-
lation, had bleeding complications (2%).
73 ICU patients were identified; 13 VTE events (12 PE and 1 DVT) (18%). 
A further 20 filter-related line thromboses occurred, amongst 22 
receiving CVVH. In total 29 patients (40%) experienced intra or extra-
corporeal thrombotic events.
34 patients received standard pLMWH, whilst 39 received enhanced 
thromboprophylaxis or therapeutic anticoagulation initiated prior to 
development of any thrombotic event. Peak D-dimer was higher in 
patients developing thrombotic events or bleeding, (median 1410 vs 
5374,p < 0.0001); none of the other measures were significantly differ-
ent in either group (Table 1).







Median age (range) 62 (55) 61 (60) 
% (95% CI) female 10 [29% (17-46%)] 10 [26% (15-41%)] 
Median (range) APACHE 
II score 12 (18) 14 (24) 
Median (range) admission 
D-Dimer 384 (13033) 423 (36213) 
Median (range) Peak D-
Dimer 2566 (12944) 1491 (58383) 
% (95% CI) ventilated 25 [74% (57-85%)] 33 [85% (70-93%)] 
% (95% CI) developing 
pulmonary or deep vein 
thrombosis 
6 [18% (8-34%)] 7 [18% (9-33%)] 
% (95% CI) Bleeding 
complications 2 [6% (2-19%)] 5 [13% (6-27%)] 
Conclusion: Thrombotic events were significantly more common 
amongst patients admitted to ICU than those who had ward level 
management only. Although the rate of these events was higher, we 
found no signal that increasing pLMWH doses was effective, and may 
have been associated with an increased risk of bleeding.
Baseline inequalities between our groups and relatively small num-
bers mean that these conclusions should be tested in larger data sets 
and trials of enhanced thromboprophylaxis are warranted.
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Introduction: On Feb  20,2020, the first patient with  COVID-19  in 
Italy developed respiratory failure and was admitted to the ICU and 
the  number of  recorded  cases  increased rapidly  throughout the 
country.
Objectives: Strong from Chinese  experience and with  2 week-gap 
from  Lombardy, we organized our hospital (AOUI of Verona, Italy) 
from 60 to 114 ICU beds.
We aimed to describe our COVID-19 critically ill patients.
Methods: Prospective observational study of all  COVID-
19-confirmed  critically ill  patients,treated at  our  ICUs between 
6 March to 23 April, 2020.
Date of final follow-up was June 25, 2020.
Demographic and daily  clinical data were collected, including data 
on clinical management, respiratory and other organ failure, manage-
ment and outcome.
Results: Of the  122  pts included, the median  age was  65 (56-71) yrs 
and 96 (78,7%) were male.
66 (54%) had cardiovascular disorders, 24 (20%) were obese, 17 (14%) 
had dyslipidemia, 20 (16%) had diabetes, 20 (16%) were current smok-
ers, 16 (13%) had COPD.
34 (28%) patients were directly admitted from the ED, 60 (49%) from 
a medical ward and 27 (22%)  were  transferred  from another hospi-
tal. The mean duration of symptoms before hospital admission was 7 
days and 9 days before ICU admission.
The most common symptoms on admission to the hospital were 
shortness of breath (dyspnoea, 91 [74.2%]) and cough (60 [49.5%]).
At ICU admission, APACHE II and SOFA scores were 20 (13-28) and  8 
(5-11), respectively.
Lymphocytopenia was present  (0.5 [0.1-0.8] 109/L); CRP was 137 (61-
194) mg/L, PCT was 0.3  (0.2-0.8) ng/mL. Total CPK, LDH and D-Dimer 
were 131 (77-339) U/L, 421 (311-505) U/L and 1265 (570-2032), respec-
tively; arterial lactate was 1.2 (0.9-1.6) mmol/L.
P/F  at baseline was  81 (65-118); 117 pts (96%) received invasive 
mechanical ventilation and after tracheal intubation P/F was 115 (98-
149], TV was 495 (450-500) mL, RR was 17 (15-20) apm, PEEP was 11 
(10-12)  cmH2O, PPlat was 20 (18-22)  cmH2O, DP  was 9 (8-10)  cmH2O 
and compliance was 47.25 mL/cmH2O.
2 pts (1.6%) were treated with Sildenafil, 5 (4%)  received iNO and  3 
(2.5%) needed ECMO.
All received  hydroxychloroquine, 112 (92%) lopinavir–ritonavir, 
12(9.8%) remdesivir, 18(15%) tocilizumab. On D1 104 (86%) pts were 
under antibiotic therapy. 28 day ICU mortality was 18.9%. ICU LOS was 
13 (2-40) for survs and 7 (1-35) for non survs.
Conclusion: Almost all our COVID-19 patients received a homogene-
ous management schema and invasive mechanical ventilation and 
ICU mortality was less than 20%.
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Introduction: Patients suffering from Severe Acute Respiratory Syn-
drome Coronavirus 2 (SARS-CoV-2) disease develop an atypical form 
of ARDS characterized by severe hypoxemia and preserved lung 
mechanics1. Prone positioning (PP) is successfully used as a rescue 
therapy for severe hypoxemia in classic ARDS. Its effects are not yet 
clear in SARS-CoV-2.
Objectives: To describe the effects of PP on gas exchange and res-
piratory mechanics in a group of severely hypoxic patients with 
SARS-CoV-2.
Methods: From February 22th to March 22th, consecutive SARS-CoV-2 
patients admitted to the ICUs of Papa Giovanni XXIII Hospital in Ber-
gamo, were studied. PROSEVA study group criteria were used to iden-
tify modalities and clinical indications to PP2. Data about ventilation 
(positive end-expiratory pressure (PEEP), driving pressure (DP), com-
pliance of respiratory system (Crs)) and gas exchange  (PaO2/FiO2 (P/F 
ratio) and PCO2) were collected at three time points: before (supine_
pre), at the end (prone) and after 6 hours (supine_post) of each ses-
sion. Data were analyzed using repeated measurements ANOVA 
followed by Dunnet post-hoc analysis.
Results: Among 115 SARS-CoV-2 patients admitted to the ICU receiv-
ing mechanical ventilation, 71 were pronated. 80%patients were male, 
mean age and BMI were 60 ± 10 and 30 ± 5, similarly to the rest of the 
population. At the beginning of mechanical ventilation P/F ratio and 
Crs were 123 ±  63 and 40 ±  11 ml/cmH2O. Median time to the first 
prone session was 1 (0;3) day. 25 patients (35%) were pronated once 
while the remaining 46 needed more than a session. Table shows the 
results of the PP.
Major complications occurred in 16 cycles (11%): severe hypoxemia in 
7, pneumothorax in 1, airway-related complications in 4, pulmonary 
embolism in 2 and cardiovascular instability in 2 cycles.
Conclusion: PP resulted in a significant increase in P/F ratio despite no 
effect on respiratory mechanics. These data suggest that PP could be 
used as rescue therapy for severe hypoxemia in SARS-CoV-2.
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Introduction: Identification of risk factors associated with mortality in 
coronavirus disease 2019 (COVID-19), could promote rapid and proper 
allocation of resources. (1)
Objectives: We sought to identify early detectable risk factors associ-
ated with 120-day mortality in subjects with COVID-19 admitted to the 
Intensive Care Unit (ICU).
Methods: We included all consecutive adult patients with COVID-19 
admitted to the ICU at our institution between February 22 and March 
22, 2020. 
COVID-19 was defined according to at least one between clinical, radi-
ological and/or laboratory criteria. 
Variables were considered if clinically relevant, promptly available and 
were excluded if their accuracy was not verifiable (e.g. viral exposure 
and date of start symptoms, which were self-reported).
First, we used univariable logistic regressions to explore risk factors 
associated with 120-day mortality.  
Secondly, variables with a p value at least inferior to 0.05 at univariable 
analyses were included in a multivariable logistic regression model; 
to avoid overfitting, we limited the number of regressors to 1 variable 
every 15 outcomes.
Finally, we computed a ROC curve of the multivariate analysis and its 
relative area under the curve (AUC) in order to assess the discrimina-
tive power of the model.
Results: In our cohort of 130 patients, 51 patients (39.2 %) died within 
120 days after ICU admission.
TABLE 1 Univariable analyses Multivariable analysis
Variable OR (95% CI) p value
OR (95% 
CI) p value
Age (year) * 1.14 ( 1.09 - 1.21 ) < 0.001
1.13 ( 1.07 - 
1.19 ) < 0.001
BMI * 1.01 ( 0.94 - 1.08 ) 0.77 – –
Male sex ˆ 1.01 ( 0.40 - 2.61 ) 0.99 – –
COPD ˆ 10.3 ( 1.68 - 197 ) < 0.05
5.54 ( 0.74 - 
115 ) 0.14
RR admission > 24 bpm 
ˆ
0.91 ( 0.38 - 2.10 
) 0.83 – –
CPAP/NIV to TI ( days 0.96 ( 0.80 - 1.15 0.68 – –
)*   )
ACE-I therapy ˆ 2.32 (0.8 - 7 )   0.12  – –
Blood group 0 ˆ 1.66 ( 0.69 - 3.94 ) 0.25 – –
Blood group A  ˆ 0.54 ( 0.22 - 1.25 ) 0.15 – –
SOFA * 1.29 ( 1.10 - 1.54) < 0.05 
1.28 ( 1.06 - 
1.57 ) < 0.05 
 TABLE  1: ACE-I = Angiotensin Converting Enzyme Inhibitors, BMI = 
Body Mass Index, bpm = breath per minute, COPD = Chronic Obstruc-
tive Pulmonary Disease, CPAP = Continuous Positive Airway Pres-
sure, NIV = Non Invasive Ventilation, RR = Respiratory Rate, SOFA = 
Sequential Organ Failure Assessment, TI = Tracheal Intubation * = per 
unit increase, ˆ = true 
We identified age, COPD and SOFA- score as independent predictors 
of mortality at 120 days (see Table 1).  
In the multivariable model, both age and SOFA- score were associated 
with mortality and the AUC of the relative ROC curve was 0.84.
Conclusion: Facing the unpredicted trajectory of the still ongoing 
outbreak of COVID-19, we identified a “three early-detectable vari-
ables” model associated with 120-day mortality in critically ill COVID-
19 patients.
If confirmed in other cohorts, our findings could promote the develop-
ment of a mortality-predicting score, improving resource allocation in 
COVID-19 pandemic.
Reference(s) and grant ackowledgment(s)
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Introduction: A substantial proportion of critically ill COVID-19 
patients develop thromboembolic complications (ref 1-3). It is unclear 
what the optimal dose of thromboprophylaxis is for critically ill COVID-
19 patients and whether higher doses are associated with lower mor-
tality rates.
Objectives: To evaluate the association of initial dosing strategy of 
thromboprophylaxis in critically ill COVID-19 patients and the risk of 
death, thromboembolism, and bleeding.
Methods: This was an observational cohort study in a 600-bed 
emergency hospital in Stockholm, Sweden. All critically ill COVID-19 
patients admitted to two ICUs in March and April 2020 were eligible. 
Exclusion criteria were short length of stay, ongoing anticoagula-
tion therapy due to diagnosed thromboembolic disease, or no initial 
thromboprophylaxis in the ICU. Patients were categorized into three 
groups according to initial daily dose; low (2500-4500 IU tinzaparin 
or 2500-5000 IU dalteparin), medium ( > 4500 IU but < 175 IU/kg of 
body weight tinzaparin or > 5000 IU but < 200 IU/kg of body weight 
dalteparin), and high dose thromboprophylaxis (≥ 175 IU/kg of body 
weight tinzaparin or ≥ 200 IU/kg of body weight dalteparin). The three 
study groups reflected a gradual increase in dose of thromboprophy-
laxis during the study period.
Results: A total of 152 patients were included, out of which 67 
received low dose thromboprophylaxis, 48 medium dose thrombo-
prophylaxis, and 37 high dose thromboprophylaxis. Demographic 
andclinical characteristics were similar in the three groups at baseline. 
Mortality was lower in patients treated with high (13.5%) vs medium 
(25.0%) and low dose thromboprophylaxis (38.8%), p = 0.02. The 
multivariable hazard ratio of death was 0.33 (95% confidence interval 
0.13–0.87) with high vs low dose thromboprophylaxis when adjusted 
for sex, age, body mass index, Simplified Acute Physiology Score III 
and invasive respiratory support. There were fewer thromboembolic 
events in patients treated with high (2.7%) vs medium (18.8%) and low 
dose thromboprophylaxis (17.9%), p = 0.04, but no difference in the 
proportion of bleeding events, p = 0.16.
Page 114 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Initial dosing strategy of 
thromboprophylaxis












28-day mortality, No. (%)
43 (28.3)  26 (38.8) 12 (25.0) 5 (13.5) 0.02 
Secondary Outcomes
ICU-free days alive 
during 28 daysfrom ICU-
9 (0 – 21)  0 (0 – 20) 11 (0 – 19) 




<28 days, No. (%) 22 (14.5)  12 (17.9) 9 (18.8) 1 (2.7) 0.04 
Bleeding events <28 
days,No. (%) 16 (10.5)  8 (11.9) 7 (14.6) 1 (2.7) 0.16 
(a) tinzaparin, 2500-4500 IU OD; or dalteparin, 2500-5000 IU OD, (b) 
tinzaparin, >4500 IU OD to <175 IU/kg of body weight OD; or dalteparin, 
>5000 IU OD to <200 IU/kg of body weight OD, (c) tinzaparin, ≥175 IU/kg of 
body weight OD; or dalteparin, ≥200 IU/kg of body weight OD, (d) P-values for 
differences across exposure categories were obtained using Fisher’s exact test 
for categorical and Kruskal-Wallis test for continuous data.  
Conclusion: Among critically ill Covid-19 patients, high dose throm-
boprophylaxis was associated with a lower risk of death and a lower 
cumulative incidence of thromboembolic events compared with 
lower doses. There was no difference in the proportions of bleeding 
events between the groups.
Reference(s) and grant ackowledgment(s)
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Introduction: The main objetive is to analyse the organisation of 
ECMO in our country
Methods: A national questionnaire was performed(January 2019-
2020) consisting in questions about pre-ECMO management, accesi-
bility of the technique, characteristics of the ECMO team, quality, 
safety, training and membership of the EuroELSO.
Results: 86(29%) ICU units answered. In 57% (n = 49) ECMO 
was established. Only 8 regions of 17 have an ECMO retrieval team. In 
the management before ECMO: in 95 %(n = 81) prone position was 
trialled prior to ECMO. In 43% (n = 36) ECMO was considered if prone 
position was not sucessfull in 12-24h. In 65 % (n = 55) ECMO was 
considered if  Pa/  FiO2 ≤100. In the hospitals with established ECMO, 
63%(n = 41) do not have a specialised team. The Intensivist is the one 
that most frequently does the cannulation (40%(n = 15) and manage-
ment (95%(n = 37)). V-V ECMO is the type most frequently used and 
ARDS is the most frequent indication. There is a large heterogeneity in 
the number of cases done per centre ranging from centres that have > 
70 cases per year (n = 2) to centres that do > 10 cases (n = 23). Hypo-
volaemia and recirculation are the most frequent complications. 93% 
(n = 39) of  the ICUs recognise that they do not do a monthly ECMO 
educational or simulation session. 81%(n = 35) do not belong to 
EuroELSO and 74 %(n = 31) do not participate in the ECMO registry.
Conclusion: There is a wide heterogeneity of the accesibility of ECMO 
in Spain. There is a high rate of trial of prone position prior to ECMO, 
as per current recommendations. A significant number of ICUs do not 
reach the minimal number of cases recommended by ELSO Criteria. 
There is ample heterogeneity in the teams and mangement. There is 
room from improvement in education,simulation, and membership of 
EuroELSO.
001040 
Validation of clinically applicable techniques for measurement 
of end‑inspiratory lung volume
L. Roesthuis1; H. Van Der  Hoeven1; J. Doorduin2; L. Heunks3
1Intensive care, Radboud University Medical Center, Nijmegen, Nether‑
lands; 2Donders institute for brain, cognition and behaviour, department 
of neurology, Radboud University Medical Center, Nijmegen, Netherlands; 
3Intensive care volwassenen, Amsterdam UMC, Amsterdam, Netherlands 
Correspondence: L. Roesthuis
Intensive Care Medicine Experimental 2020, 8(2): 001040
Introduction: Dynamic hyperinflation may develop in patients with 
chronic obstructive pulmonary disease (COPD) and asthma due to 
dynamic airway collapse or due to airway narrowing by bronchospasm 
or bronchial wall edema. Dynamic hyperinflation during controlled 
mechanical ventilation may result in barotrauma and hemodynamic 
instability. To limit these risks, it is important to quantify pulmonary 
hyperinflation. Tuxen et  al. (1,2) demonstrated that maintaining end-
inspiratory lung volume (Vei) below 1.4 L (or below 20 mL/kg when 
corrected for ideal body weight) prevents development of adverse 
effects related to pulmonary hyperinflation.
Objectives: To validate two clinically applicable bedside techniques 
for the measurement of Vei.
Methods: Vei was assessed using three techniques: i) Gold stand-
ard: the patient exhaled from end-inspiration in a calibrated glass 
tube with liquid level indicator. ii) Formula based on physiology: (Vt 
* Pplateau)/(Pplateau – PEEPtotal)), with Vt the tidal volume, Pplateau 
the plateau pressure obtained after an inspiratory occlusion maneuver 
and PEEPtotal the positive end-expiratory pressure obtained after an 
expiratory occlusion maneuver. iii) Ventilator maneuver: measuring 
the expired volume using the flow sensor of the ventilator during pas-
sive exhalation from end-inspiration during pressure support ventila-
tion. Vei was determined using these three techniques in each patient 
with 5 minute interval. The gold standard was repeated after the three 
measurements to exclude changes in respiratory mechanics due to 
the study protocol.
Results: Seventeen patients were evaluated. Vei according to the 
gold standard was 16.08 ± 1.17 mL/kg. Vei according to the formula 
and ventilator maneuver had a low bias but large limits of agree-
ment (0.64 ±  6.70 mL/kg and 0.46 ±  6.48 mL/kg, respectively) and 
were moderately correlated with the gold standard (r^2 = 0.47 with 
P = 0.0035 and r^2 = 0.56 with P = 0.0009, respectively). Vei accord-
ing to the gold standard did not change due to the study protocol: 
0.21 ± 1.73 mL/kg as compared to the initial Vei measurement.
Conclusion: In patients with airflow obstruction it is important to 
quantify pulmonary hyperinflation to limit risks associated with hyper-
inflation. We showed that using a formula to estimate Vei and a ven-
tilator maneuver to measure Vei are too cumbersome to use at the 
bedside, due to low agreement and moderate correlations compared 
to the gold standard to measure Vei.
Reference(s) and grant ackowledgment(s)
1. 2. Williams TJ, Tuxen DV, Scheinkestel CD, Czarny D, Bowes G. Risk factors for 
morbidity in mechanically ventilated patients with acute severe asthma. 
Am Rev Respir Dis 1992; 146: 607‑615.
2. 1. Tuxen DV, Lane S. The effects of ventilatory pattern on hyperinflation, 
airway pressures, and circulation in mechanical ventilation of patients with 
severe air‑flow obstruction. Am Rev Respir Dis 1987; 136: 872‑879.
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Introduction: The humanopathogen coronavirus CoVid-19 may 
cause life threatening pneumonia. 20% of those tested positive show 
severe signs of hypoxic respiratory failure, with 5% needing inten-
sive care unit treatment, with a reported mortality between 30-60% 
(Grasselli,JAMA) While knowledge about the disease is increasing, no 
firm recommendations concerning treatment strategies have been 
made.
Objectives: The humanopathogen coronavirus CoVid-19 may cause 
life threatening pneumonia. 20% of those tested positive show 
severe signs of hypoxic respiratory failure, with 5% needing inten-
sive care unit treatment, with a reported mortality between 30-60% 
(Grasselli,JAMA) While knowledge about the disease is increasing, no 
firm recommendations concerning treatment strategies have been 
made.
Methods: From January 2020 to June 2020 data of all patients with 
respiratory failure who tested positively for SARS-COV-2, treated 
in the ICU of the Asklepios Klinik Langen, Germany, were sampled. 
We differentiated between those patients who required extracor-
poreal membrane oxygenation therapy (ECMO) and those who did 
not. Comorbidities, clinical examination and laboratory values were 
recorded. In case ECMO therapy had been necessary, we noted which 
type we used as well as the patients’ outcome.
Results:
Median time to invasive ventilation (d) 4,2 3,2 
Median time of invasive ventilation (h) 776 363,8 
21ymotsoehcarT 4 
Median time to tracheostomy (d) 1 1 
Thrombotic event 6 3 
6xarohtomuenP 2 
Presenting Laboratory Values
White blood cell count (G/l) 10,7 9,7 
Lymphocyte count (G/l) 9,7 13,9 
C-reactive protein (mg/dl) 255 148,6 
PCT (µg/l) 10,3 4,18 
Ferritin (µ/l) 1932 1903 
D-dimer (mg/l) 29,1 11,94 
Troponin (µg/l) 277 26,3 
Lactate (mmol/l) 2,5 1,1 
Creatine kinase (U/l) 1195 217,78 
SOFA score 5,1 1,2 
SAPS II 35,6 28,1 
SARS-Cov IgA 10 5,8 
SARS- Cov IgG 12 6 
Respiratory Paramters on intubation
Bilateral infilttrates on chest x-ray/typical CT-scan 13 14 
382OiF:2OaP 205,2 
Median symptom onset to intubation (d) 4,2 3,2 
Median time to admission 3,2 8,3 
Outcome
Median ICU stay (d) 32,5 11,9 
9htaeD 2 
9 2  
All patients n=27 ECMO without 






Hypertension, adiposity, pulmonary diseases, diabetes yes yes 
Presenting symptoms
Conclusion: Patients with ARDS caused by SARS-COV-2 treated with 
ECMO had a two times higher death rate compared to ARDS caused by 
other diseases (Combes, EOLIA). Especially patients of hospitals with 
lower care levels who underwent prolonged prone position with con-
trolled ventilation and higher ventilation pressures had a more serious 
course of the disease and suffered from more complications com-
pared to the patients who had immediate access to ECMO therapy if 
required.
Reference(s) and grant ackowledgment(s)
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NEJM 2018.
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Introduction: Among patients with COVID-19, there is a high preva-
lence of cardiovascular disease, and it has been reported that 22% of 
critically ill patients experience myocardial injury from the infection.1
The British Society of Echocardiography and The European Associa-
tion of Cardiovascular Imaging advise performing a focused TTE, on 
patients during the COVID -19 pandemic.2,3
In our critical care unit we performed a full standard TTE on COVID-
19 + patients and we report the impact on the management of these 
patients.
Methods: This prospective study took place in the 36 bed critical care 
unit of the Mater Hospital. Critically ill COVID-19 + patients who had a 
TTE(s) were included. The studies were performed by an intensivist, or 
cardiac physiologist.
Results: Fifty-three COVID-19 + patients were admitted to critical 
care between 31/3/20 -17/6/20. Thirty-six TTE studies were performed 
on 22 patients. Indications; haemodynamic shock (11), assess RV (7), 
assess LV (12), ? endocarditis (6). Mean age; 60 ±11 years, male (n = 
12) median critical care length of stay; 17 (12, 32) days, mean SOFA 
score 5 ±  2. Non- invasive ventilation (n = 2) and mechanical venti-
lation (n = 17). Thirteen patients received vasoactive medication, 4 
patients required Extra Corporeal Membranous Oxygenation.  Seven 
patients died.
Table 1. Baseline characteristics 
  Total  n= 22  
CAD n = 4     (18%)     
Valvular heart disease  n = 3     (13%)     
Congestive heart disease  n = 1     (4%) 
Hypertension n = 9     (40%) 
Atrial fibrillation  n = 1     (4% ) 
COPD  n = 1     (4%) 
Asthma n = 4     (18%) 
Diabetes n = 6     (27% ) 
Chronic kidney disease  n = 4      (18%) 
ACEi /ARB use  n = 7      (31% ) 
CAD: Coronary Artery Disease, COPD: Chronic Obstructive Pulmonary Disease, ACEi: 
angiotensin converting enzyme inhibitor, ARB  angiotensin receptor blocker. 
Seven patients had 1 normal TTE. Seven patients had 19 TTE ‘s with 
echocardiographic abnormalities that did not immediately change 
management; including reduced LV EF, left ventricular hypertrophy, 
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regional wall motion abnormalities, diastolic dysfunction, cor pulmo-
nale, tricuspid  regurgitation and pericardial effusion. Eight patients 
had 10 TTE’s which led directly to a change in management. These are 
summarized in Table 2.
Table 2. TTE studies that led to change in management 
Indication TTE Findings Management change Outcome 
Assess RV  RV severe dilatation, pressure overload LV 
Cancellation 
discharge critical care S 
Haemodynamic 
shock 
Severe LV hypertrophy 




tamponade effect IR guided drainage S 
Assess  LV  Normal LVEF Grade 2 diastolic dysfunction ACEi + diuretic  S 
Assess LV  Normal LVEF Grade 1 diastolic dysfunction ACEi S 
Assess LV   Normal LVEF left ventricular hypertrophy 
BP control GTN 
before extubation S 
Haemodyanmic 
shock 
Pericardial effusion, RV 
collapse IR guided drainage D 
Haemodynamic 
shock  
Pericardial effusion, RV 
collapse IR guided drainage D 
Query 
endocarditis 
No vegetations, evidence 
hypovolaemia Fluid therapy S 
Assess RV  RV severe  dilatation  Nitric oxide +  sildenafil  S 
RV: Right ventricle, LV: Left Ventricle, LVEF Left ventricular ejection fraction, IR: 
interventional radiology, BP: Blood pressure, GTN: Glyceryl trinitrate, D: Dead, S: Survived.  
No Intensivist or cardiac physiologist involved in the study became 
infected with COVID-19.
Conclusion: Critically ill COVID-19 positive patients may develop car-
diovascular pathologies in addition to myocardial injury. We recom-
mend a standard TTE in such patients in order to diagnose and effect 
management changes as appropriate.
Reference(s) and grant ackowledgment(s)
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2. 2. D. Augustine, et al. British Society of Echocardiography Clinical Guidance 
regarding providing echocardiography during the COVID .pandemic.https 
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Introduction: COVID-19 was declared a global pandemic by the 
World Health Organization (WHO) on March 11th 2020. The first case 
of COVID-19 identified in the Republic of Ireland was on February 
29th 2020.
Objectives: Our aim was to collect data in order to examine clinical 
characteristics of COVID-19 patients admitted to Critical Care (ICU/
HDU) in an inner-city, university-affiliated, 570-bed, tertiary referral 
centre in Dublin, Ireland.
Methods: Prospective data collection took place from the arrival of 
the first COVID-19 positive patient to our ICU on March 8th 2020 until 
June 1st 2020.
Results: During the study period, 46 patients were admitted to Criti-
cal Care with symptoms of COVID-19. 45/46 (98%) were identified as 
COVID-19 positive by oro/nasopharyngeal specimens. 1 patient out of 
46 (2%) was confirmed by bronchoalveolar lavage (BAL).
The median age was 59. 28/46 (61%) were male and 18/46 (39%) were 
female. In total, 28/46 (61%) patients required invasive mechanical 
ventilation, which lasted greater than 2 days forall.
The most common comorbidity was hypertension in 16/46 (35%) of 
patients, followed by both obstructive pulmonary disease and dia-
betes mellitus in 11/46 (24%) patients, chronic kidney disease (CKD) 
in 8/46 (17%) and ischemic heart disease in 7/46 (15%). 7/46 (15%) 
patients were healthcare workers and 4/46 (9%) were identified as 
positive contacts
The most predominant symptom was dyspnoea in 37/46 (80%) 
patients, followed by cough in 19/46 (41%), fever in 16/46 (35%), myal-
gia in 8/46 (17%), diarrhoea in 8/46 (17%) and altered consciousness 
in 1/46 (2%). 41/46 (89%) patients were lymphopaenic. 22/46 (47%) 
patients were proned for > 16 hours per day. 4/46 (9%) patients were 
placed on extracorporeal membrane oxygenation (ECMO). At the end 
of the study period, 5/46 (11%) patients remain in Critical Care.
Conclusion: The first patient tested positive for COVID-19 in Ireland 
in February 2020. It was essential to collect data on this novel virus as 
it presented to our Critical Care Unit. We identified the most promi-
nent clinical characteristic in order to deliver effective treatment. In 
total, two thirds of patients presenting to Critical Care required inva-
sive mechanical ventilation. Almost 70% survived their Critical Care 
admission, while 15% died. The clinical symptoms and co-morbidities 
of patients admitted to our ICU were comparable to that seen interna-
tionally at this time [1, 2].
Reference(s) and grant ackowledgment(s)
1. 2. Wang, D., Clinical Characteristics of 138 Hospitalized Patients With 2019 
Novel Coronavirus‑Infected Pneumonia in Wuhan, China, B. Hu, et al., Edi‑
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2. 1. Guan, W.J., Clinical Characteristics of Coronavirus Disease 2019 in China, 
Z.Y. Ni, et al., Editors. 2020: N Engl J Med. p. 1708‑1720.
3. No funding received.
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Introduction: Prior to the World Health Organisation declaring a 
pandemic in March 2020, research efforts into coronavirus disease 
2019 (COVID-19) were rapidly gathering pace.[1] Simultaneously in 
the UK, final year medical students were graduating early,[2] having 
completed their core studies, to join the workforce as junior doctors. 
Locally, research training including a Good Clinical Practice course 
and close support from research clinicians was provided to some new 
doctors, offering a unique opportunity for involvement in pandemic 
research studies at the outset of their medical careers.
Objectives: To describe the challenges associated with recruiting to a 
pandemic study at a UK District General Hospital serving a population 
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of over 500,000,[3] and inform preparations for research during a pos-
sible ‘second-wave’ or future pandemics. A core focus was obstacles to 
recruitment.
Methods: Patient screening and recruitment was conducted in 
accordance with the GenOMICC study protocol.[4] Demographic data 
were anonymously collected for patients screened and deemed eligi-
ble. The Chi-Squared or Two-Tailed Fisher’s Exact Test were used to 
compare enrolment into the study according to demographic charac-
teristics. Statistical significance was taken as p < 0.05.
Results: Approval for recruitment was given on 19th April 2020 and 
the first patient recruited on 21st April. Over 6 weeks, 39 eligible 
patients were identified. 6 were approached directly and in 33 an 
opinion sought from relatives as the patients lacked capacity due to ill-
ness severity. 26 patients were enrolled, 5 declined, and 8 died during 
the process. 23 were recruited by the newly qualified doctor and 3 by 
research nurses.
There was no significant difference in enrolment according to sex (p 
> 0.99), age (p = 0.15), BMI (p = 0.21), or 60-day mortality (p = 0.48). 
There was a trend towards lower enrolment in Black, Asian and Minor-
ity Ethnic (BAME) groups compared with white patients (p = 0.05). The 
predominant reason for enrolment was a desire to improve under-
standing of COVID-19. Reasons for declining included fears of sharing 
genetic data and lack of acute benefit to the patient.
Conclusion: Newly qualified doctors can play a valuable role in the 
recruitment of patients to priority pandemic studies when other staff 
have been redeployed. Our analysis identifies several challenges to 
conducting observational pandemic research; notably timely set up to 
capture the population affected when the condition has a high early 
mortality, and communication when constrained by infection control 
requirements for a highly contagious airborne pathogen. The sugges-
tion of lower recruitment from the BAME population – if real – would 
be of particular concern given the urgent need to determine the 
extent to which genetic factors contribute to apparently worse out-
comes in these patients.[5]
Reference(s) and grant ackowledgment(s)
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2. [2] BMJ 2020;368:m1227
3. [3] Royal Berkshire NHS Foundation Trust. Vision 2025, Our Strategy. 2018.
4. [4] https ://genom icc.org/uk/
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Introduction: Acute exacerbation of chronic obstructive pulmonary 
disease (eCOPD) can lead to hypercapnia and respiratory acidosis. 
It is a major determinant in health status. Non-invasive ventilation 
(NIV) is the gold standard therapy as it reduces work of breathing and 
improves gas exchange. However, for some patients NIV fails and intu-
bation is needed which exposes them to mechanical invasive ventila-
tion (MIV) complications and weaning difficulties. For those patients 
extracorporeal carbon dioxide removal (ECCO2R) may be an option.
Methods: We conducted a single center retrospective analysis on suc-
cessive eCOPD patients for whom NIV failed and didn’t have limita-
tion for MIV. For the first step (from January 2010 to February 2015) 
we observed blood gas measurements, respiratory rates and compli-
cation rates on 26 eCOPD patients treated with MIV after NIV failure. 
Then, for the second period (from February 2015 to February 2019) 
we observed the same parameters for 28eCOPD patients failing NIV 
for whom ECCO2R was performed with the iLA activve, iLA kit (Xenios 
Novalung, Heilbronn, Germany) device at a targeted blood flow of 1 L/
min.
Variables are reported as mean +/− sd. Quantitative values are com-
pared with t test (95% confidence interval) and qualitative values with 
Pearson’s Chi-squared test with Yates’ continuity correction. Population 
distribution was tested with the Shapiro-Wilk normality test.
Results: The two groups were comparable at baseline in demograph-
ics : gender, BMI, SAPS and age : respectively in the ECCO2R and MIV 
group SAPS 48 +/−15 and 50 +/−14, age 66,1 +/−11,4 years and 
71,4 +/−11 years. pH and PaCO2 are showed in Figure  1. The res-
piratory rate 6 hours before ECCO2R was 27,00 +/−8,37 and 22,18 
+/−3,79 at decannulation (p = 0,22). In the MIV group, respiratory 
rate 6 hours before intubation was 25,88 +/−3,83 and 21,25 +/−5,44 
at extubation (p = 0,30).
We were able to avoid MIV for 25 patients (89,3%) in the ECCO2R 
group.
Complications for patients affected are listed in Table  1. The ECCO2R 
duration was 5,7 +/−4,2 days and in the MIV group ventilation lasted 
28,2 +/−42,5 days. In the MIV group, 5 patients had an extuba-
tion failure and 6 patients had autoextubated. ECCO2R was stopped 
because of recovery for 20 patients, complication for 6 patients (with 
a mean duration of ECCO2R of 5,7 days) and death for 2 patients. MIV 
was stopped because of recovery for 17 patients, tracheotomy for 2 
patients and death for 7 patients.
Length of stay in the Intensive Care Unit for the ECCO2R and the MIV 
group was 19 +/−15,5 days and 31 +/−42,2 days respectively (p = 
0.18). Length of stay in the hospital for the ECCO2R and the MIV group 
was 29.46 +/−21.1 days and 50.58 +/−52.4 days respectively (p = 
0.06). Mortality at 28 days and 90 days was 8% and 14% respectively in 
the ECCO2R group and 16% and 30% in the MIV group.
Conclusion: Our results show that ECCO2R is feasible and brings sig-
nificant improvement on pH and PaCO2 with relatively low complica-
tion rate.
Evidence for a mortality benefice of ECCO2R in eCOPD patients failing 
NIV therapy has yet to be proven in a larger randomized study.
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Introduction: The risk/benefit ratio of corticosteroids for patients 
with COVID19-related acute respiratory failure has not been yet 
established.
Objectives: We compared the outcomes of patients receiving dexa-
methasone (DEXA) vs. methylprednisolone (METHYL), and the effects 
of rescue, short-term/high-dose pulses of glucocorticoids (BOLUS).
Methods: Consecutive patients admitted from March 1st to April 30th 
2020 to the general ICU of a tertiary care hospital for COVID19 were 
enrolled. As per Institutional protocol, from March 1st severe cases 
were given DEXA; as of April 10th the protocol was modified and 
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METHYL was suggested. On top of that, physicians were allowed to 
administer a 3-day course of 1000 mg/day of methylprednisolone in 
case of refractory hypoxemia within the first week of treatment.
Results: We enrolled 81 consecutive patients, 69 (85%) males, age 
60 ±  10 years. At ICU admission SAPS II was 27 ±  7 and SOFA 4 [3; 
6] points. 46 patients (56.8%) received DEXA, whereas 30 (37%) had 
METHYL; 5 patients did not receive corticosteroids. The groups were 
well-matched for age, comorbidities and severity at admission. No dif-
ferences were found in the duration of mechanical ventilation (11 [7; 
17] vs. 11 [8; 18] days, p = 0.7021), ICU mortality (37.0 vs 43.3%, p = 
0.578), incidence of VAP (47.8 vs 53.3%, p = 0.639) or bacteremia (39.0 
vs. 36.7%, p = 0.829). A significantly lower number of patients who 
had DEXA received a rescue BOLUS (34.8 vs. 66.7%, p = 0.007).
36 patients (44.4%) received a rescue BOLUS: they were more likely 
to be female (25.0 vs. 7.0%, p = 0.021) and obese (38.9 vs. 8.9%, p = 
0.002). Table 1 shows the outcomes of patients who did vs. those who 






Duration of mechanical 
ventilation (days) 9 [4; 16] 13 [8; 21] 0.0074 
Duration of pressure support 
ventilation (days) 2 [1; 5] 4 [2; 9] 0.0349 
ICU length of stay (days) 13 [9; 19] 18 [11; 26] 0.0287 
Ventilator-free days (days) 12 [0; 22] 6 [0; 19] 0.0580 
ICU mortality – n (%) 15 (33.3) 17 (47.2) 0.204 
Patients who developed VAP – n 
(%) 17 (37.8) 23 (63.9) 0.020 
Number of VAP per patient 2 [1; 2] 2 [1; 2] 0.6898 
Patients who developed 
bacteremia – n (%) 14 (31.1) 17 (47.2) 0.138 
Number of bacteremias per 
patient 1 [1; 2] 2 [1; 2] 0.2748  
Conclusion: we were unable to find any difference between DEXA or 
METHYL on the explored outcomes; high-dose BOLUS of glucocorti-
coids seemed to be associated with a higher duration of mechanical 
ventilation and a higher incidence of complications. Further, prospec-
tive investigations are needed to confirm these results.
Reference(s) and grant ackowledgment(s)
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Introduction: Barotrauma is a well-known complication of invasive 
mechanical ventilation and it has been anecdotally reported in criti-
cally ill patients with COVID-19.
Objectives: To analyse the incidence and factors associated with 
development of barotrauma in a cohort of COVID-19 patients.
Methods: Retrospective case series of consecutive patients with 
laboratory-confirmed COVID-19 admitted from March 1st to April 
30th 2020 to the general ICU of a tertiary care hospital. Data regard-
ing the use of CPAP before ICU admission, as well as the parameters of 
mechanical ventilation during the ICU stay were collected. Barotrauma 
was defined as pneumothorax, pneumomediastinum or subcutaneous 
emphysema by means of clinical examination, lung ultrasound, chest 
XR or CT scan.
Results: 81 patients were enrolled in the study; age was 60 ± 10 years, 
69 (85%) were male. 16 patients (20%) developed barotrauma. Table 1 









Age (years) 59 [53; 68] 68 [58; 73] 0.0496 
COPD – n (%) 3 (4.7) 1 (6.3) 0.798 
SAPS II score (points) 26.5±6.2 27.8±7.3 0.5024 
SOFA score at ICU admission (points) 4±2 5±2 0.6070 
Awake prone position – n (%) 32 (57.1) 5 (38.6) 0.224 
Onset of symptoms to hospital 
admission (days) 7 [5; 10] 7 [5; 10] 0.8519 
Hospital admission to CPAP (h) 5 [1; 45] 8 [2; 15] 0.4400 
Beginning of CPAP to ICU admission 
(h) 53 [19; 96] 47 [28; 132] 0.7519 
Duration of CPAP before ICU 
admission (days) 2 [1; 4] 3 [1; 5] 0.7046 
Respiratory system compliance at ICU 
admission (ml/cmH2O) 51.9±13.3 49.4±13.3 0.5286 
Plateau pressure at ICU admission 
(cmH2O) 24.3±3.1 24.8±3.4 0.5797 
Number of prone-positioning cycles 3 [1; 6] 5 [4; 7] 0.0289 
Duration of controlled mechanical 
ventilation (days) 6 [3; 10] 11 [9; 14] 0.0011 
Duration of assisted mechanical 
ventilation (days) 3 [1; 5] 5 [1; 13] 0.0790 
Incidence of VAP from S aureus – n 
(%) 20 (31.3) 6 (37.5) 0.633 
ICU length of stay (days) 11 [6; 18] 13 [7; 17] 0.9766 
ICU mortality – n (%) 23 (35.9) 10 (66.7) 0.030 
3 patients already had barotrauma at ICU admission; in the remaining 
cases, barotrauma was diagnosed after 14 [10; 22] days of mechani-
cal ventilation. At the diagnosis, 3 patients (19%) were spontaneously 
breathing, 5 (31%) were receiving pressure support ventilation and 8 
(50%) controlled ventilation; in patients undergoing mechanical ven-
tilation PEEP was 11.6 ± 2.6  cmH2O and Plateau airway pressure was 
28 ± 5  cmH2O.
Conclusion: Barotrauma is a frequent, severe, late complication in 
mechanically ventilated COVID-19 patients. An older age and a longer 
course of controlled mechanical ventilation seem associated with the 
development of barotrauma.
Reference(s) and grant ackowledgment(s)
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Introduction: The Neutrophil-to-Lymphocyte Ratio (NLR) is an expres-
sion of systemic inflammation in multiple immunologic, cardiovas-
cular, and cancer diseases. An excesive inflammatory answer to SARS 
Cov2 can lead to acute respiratory distress that increases mortality
Objectives: We considered 1/- studying characteristics of patients 
with Covid19 admitted to Intensive Care Unit (ICU) due to SARS Cov2 
severe pneumonia; and 2/- analysing if NLR and other inflammatory 
markers are associated with poor prognosis
Methods: We included Covid patients admitted to our ICU, with acute 
respiratory failure that required invasive mechanical ventilation (IMV). 
We analysed different inflammatory markers at the momento of ICU 
admission: NLR, plasmatic lymphocites (L), fibrinogen, D dimer (DD), 
and C-Reactive Protein (CPR). Statistical analysis with STATA version 
13.
Results: We analysed 63 patients, mean age of 62.3 years (SD 11.3), 
63% were males. The most frequent risk factor was high blood pres-
sure. Mean stay in ICU was 26.4 days (SD 19.4), and mean hospital 
stay was 59.4 days (SD 19.3). 71% of patients needen prone position, 
13 patients (20%) suffered pulmonary barotrauma, and 29 patients 
(46%) died in ICU. All patients that survived in ICU were discharged to 
home.
In the study of prognostic factors, we found that patients who died, 
had a higher NLR (33.40 vs 15.75, p < 0.001), and more lymphopenia 
(772 vs 1540, p = 0.004). We did not find significant differences in 
DD or PCR values. Patients with barotrauma had a higher NLR than 
patients without it (43.51 vs 18.76, p < 0.001) and there were not differ-
ences in the other inflammatory markers studied. Patients wth longer 
mechanical ventilation and longer ICU stay, did not present differences 
in NLR or L, but had higher DD (7509 vs 2364, p = 0.002). In multiple 
regression analysis, RNL and L at ICU admission, were independent risk 
factors of mortality (AUC ROC curve 0.75 IC: 0.62-0.87) and pulmonary 
barotrauma (AUC ROC curve 0.75 IC: 0.59-0.90). However these param-
eters did not correlate with ICU stay nor days of IMV.
Conclusion: Neutrophyl-to-lymphocyte ratio at ICU admission,  is 
a  simple low cost  index that has  important prognostic value in 
patients with severe SARS-Cov2 pneumonia.
Reference(s) and grant ackowledgment(s)
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Introduction: Bronchoalveolar lavage (BAL) is the current gold-stand-
ard for the differential diagnosis of alveolar infiltrates in immunosup-
pressed patients. Its reported diagnostic yield has been between 30 to 
67%, but its results have marginal repercussions on treatment options 
and prognosis. Performing BAL is not risk free and with the develop-
ment of non-invasive techniques, the clinical relevance of BAL inestab-
lishing the etiology of acute respiratory failure (ARF) has recently been 
questioned.
Objectives: 1) To assess the diagnostic yield of BAL in establishing the 
etiology of ARF; 2) To compare the mortality rate between patients 
subjected to BAL or not; and 3) To evaluate the impact of BAL on time 
until diagnosis in hematologic patients admitted to the intensive care 
unit (ICU) with ARF.
Methods: Retrospective cohort study. Inclusion criteria: hemato-
oncological patients admitted to a tertiary hospital’s ICU due to ARF 
between January 2012 and June 2020 (8.5 years). Exclusion criteria: 
patients without infiltrates on chest radiography at admission. Pri-
mary endpoint was diagnostic yield of BAL, defined as the identifica-
tion of microbiological agent or exclusion of other causes. Secondary 
endpoints were intra-ICU mortality rate, 30-day mortality rate, survival 
time and time until etiological diagnosis.
Results: A total of 79 hematological patients were included in 
the study, of which 34 (42.5%) were female, with a mean age of 
59.01  ±  16.59 years. Twenty-one (26.3%) of the patients were sub-
jected to BAL. Age, gender and need for mechanical ventilation were 
comparable between groups. Mean SOFA at admission, mean APACHE 
II and the number of neutropenic patients were significantly higher in 
the non-BAL group (p < 0.05).
BAL contributed to the etiological diagnosis in 47.37% of the clini-
cal cases. Mortality rate was lower in the BAL group either evaluated 
as Intra-ICU mortality rate (38.1% for BAL vs. 71.9% for non-BAL, p = 
0.006) or 30-day mortality (42.9% vs. 75.4%, p = 0.013). Survival time 
was longer in the BAL group (19.00 vs. 5.00 days, p = 0.002). On a mul-
tivariate analysis including APACHE II or OFA at admission and neutro-
penia, APACHE II was a significant confounding factor in the mortality 
rate difference between the 2 groups; yet, when analyzing survival 
time controlling for these same factors, BAL remained significantly 
associated with longer survival times (p = 0.003). We found no differ-
ences between the groups on the frequency of etiological diagnosis, 
time to diagnosis or duration of mechanical ventilation.
Conclusion: BAL is a useful diagnostic tool for acute respiratory failure 
in selected hematological patients in which diagnosis is not possible 
by non-invasive techniques.
Reference(s) and grant ackowledgment(s)
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Introduction: A review of proning in non-intubated patients with 
Covid 19 who presented to a tertiary referral ICU.
Objectives: This small retrospective study investigates 16 patients 
admitted to our ICU who were treated with awake proning.
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The primary outcome studied was the difference in oxygen saturation 
before and 1 hour after self proning.
Secondary Outcomes include;decrease in the respiratory rate, increase 
in PF ratio, rates of subsequent intubation and the length of time 
proning was tolerated.
Methods: We conducted a retrospective chart review of consecutive 
patients admitted to our ICU between 31/03/20 to 25/04/20. Covid 19 
diagnosis was confirmed by oropharyngeal and nasopharyngeal PCR. 
52 patients with Covid 19 were admitted to our ICU during this time, 
16 of whom self proned.
We document the changes in oxygen saturations, PF ratio and respira-
tory rate before and one hour after proning.
We also note the duration proning was tolerated in each session and 
how many proning sessions patients received.
Results: RESULTS
Oxygen saturations improved on average 3.6% on proning (range 1 to 
6.8%; median 3.7%).
The average pre-proning O2 saturation was 94% (on supplemental 
oxygen delivered by nasal prongs or Venturi mask).
Patients who required intubation had a poorer response to proning 
from the outset with an mean improvement in oxygen Saturations of 
only 2.2% (range 1- 3.7% median 2%) compared with 4.6% (range 2 to 
7% median 4.5%) in the patients who did not require intubation.
The day of illness when proning was initiated was similar in both 
groups (8.8 v 8.0).
Overall, the PF ratio post proning improved by an average of 6.9kPa 
(ranging from 2.3 kPa to 23 kPa: median 4.5kpa). The PF ratio improved 
significantly more on self proning in those patients that did not 
require intubation (9.14kPa compared to an average improvement of 
only 5.4 kPa in those who required intubation)
PF ratios were lower from the outset in the patients who were subse-
quently intubated after trial self proning-average PF ratio 17.1 (range 
PF 14.6- 21.4: median 17) compared to PF ratio of 25.9 in patients who 
did not require intubation.
Proning was tolerated well with only one patient unable to continue 
for more than an hour.
The average hours proned per session was 2.7 hours; ranging from 1 
hour to 8hours per session.
The number of sessions ranged from 1 to 13 sessions.
The Respiratory Rates after proning did not significantly change with 
proning 25.4 to 24.4 average. 7 patients out of the 16 patients were 
ultimately intubated (43%).
All patients survived to ICU discharge.
Conclusion: CONCLUSIONS
This study adds to a body of observational evidence that awake prone 
position improves oxygenation in the non-intubated patient with res-
piratory failure and that it is well tolerated in short sessions.[i]Limita-
tions include small sample size and its retrospective nature.
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Introduction: The coronavirus disease 2019 (Covid-19) pandemic, 
mainly affects the respiratory system and the evolution into acute res-
piratory distress syndrome (ARDS) is the main cause of admission in 
ICU. It is known now that the Covid-19-induced ARDS presents some 
unusual characteristics compared to common ARDS. Although the 
practice of prone positioning (PP) is part of the actual recommenda-
tions in Covid-19 severe ARDS management (based on common ARDS 
trials), there is, to our knowledge, no studies which assessed the effi-
cacy of prone positioning on blood oxygenation and mortality in this 
context.
Methods: We performed a monocentric analysis of prospectively 
collected data in the medical ICU of Bichat-Claude-Bernard Hospi-
tal (France) between January and June 2020. Covid-19 confirmed 
patients, admitted for ARDS, who required intubation and prone posi-
tioning (practiced for a  PaO2/FiO2 (P/F) ratio < 150 mmHg after positive 
end-expiratory pressure (PEEP) optimization) were included. P/F ratio 
before and after the first PP were collected, and response was defined 
as [(P/F after PP – P/F before PP)/ P/F before PP] X 100. A response was 
considered significant if ≥ 20%. We analyzed predictors of significant 
response and day 60 (d60) mortality.
Results: 42 patients were included. 31 patients were dead at d60 
(mortality rate: 64.5%). No difference in baseline characteristics were 
found between survivors and decedents (Table 1). Compliance (mean 
28.9 vs 29 ml/cmH2O) at the time of prone position did not differenti-
ate survivors from decedents (Table 1).
In the overall population, the response was high, with a mean rate of 
94.4% and was correlated with a better outcome at d60 (mean 145% 
vs 76%, p = 0.038, Wilcoxon test, Figure 1). Significant response to first 
PP was observed in 73.8%. 10/11 (90.9%) in d60 survivors responded 
to first PP vs 21/31 (67.7%) in d60 decedents (p = 0.23, Fischer test, 
Table 1).
Higher response remained associated with a lower d60 mortality after 
adjustment on age, extra-respiratory components of SOFA at day 
1 and first Covid-19 viral load recovered from the respiratory tract 
(adjusted OR (per % of response) [CI] = 0.992 [0.98;1], p = 0.0618)
Significant response was not associated to age, body mass index, 
severity at admission, first Covid-19 viral load, time from intubation to 
PP or compliance.
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Conclusion: In our study, patients with severe Covid-19 induced ARDS 
mainly responded to the first PP, although mortality rate was high. 
Using a 20% increase threshold, no difference was found regarding 
response rate to first PP between patients alive and dead at day 60. 
However, the response was significantly better in the d60 survivors. 
This suggests that the threshold used to define our endpoint may be 
too low to use it as a predictive factor. These results tendto highlight 
that response to first PP is correlated with survival.
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Introduction: Coronavirus disease 2019 (COVID-19) is associated 
with hypercoagulable states and high incidences of thromboembolic 
complications. Conventional coagulation tests show trends of coagu-
lopathy, but currently no test reliably identifies COVID-19 patients at 
increased risk of developing thromboembolic complications. Rota-
tional thromboelastrometry (ROTEM®) is a point-of-care device that 
evaluates viscoelastic changes during coagulation and may provide 
valuable information to identify patients at risk of developing throm-
boembolic complications.
Objectives: The aim of this study was to evaluate ROTEM® profiles of 
COVID-19 patients in identifying thromboembolic complications.
Methods: All patients diagnosed with COVID-19 admitted to the ICU 
in April 2020 were enrolled in this single-center, retrospective obser-
vational study. Blood samples were collected for ROTEM® throm-
boelastometry. Coagulation patterns were analyzed using extrinsic, 
intrinsic and fibrinogen rotational thromboelastometry activators 
(respectively EXTEM, INTEM and FIBTEM). ROTEM® patterns were ana-
lyzed for all COVID-19 patients and were compared between patients 
with and without thromboembolic complications. Hypercoagulability 
was defined as a reduction in clot formation time (CFT) and a maxi-
mum clot firmness (MCF) above the upper limit of the normal refer-
ence values.
Patients who were clinically suspected to have a thromboembolic 
complication underwent additional imaging. The decision for imaging 
was based on clinical features and was at the discretion of the attend-
ing intensivist.
Additionally, ROTEM® parameters were compared with conventional 
coagulation parameters including, partial thromboplastin time (PT), 
activated partial thromboplastin time (APTT), fibrinogen, and platelet 
count.
Results: ROTEM® patterns of forty-seven COVID-19 patients were ana-
lyzed. Ten patients (21.3%) developed thromboembolic complications 
during ICU admission, all being pulmonary embolisms confirmed by 
CT-scan. MCF in EXTEM was lower in patients with and without throm-
boembolic complications (75.0 vs. 77.9 mm, p = 0.047). COVID-19 
patients with thromboembolic complications had an increased CFT 
compared to patients without complications in EXTEM (54.1 vs. 42.9 s, 
p = 0.001) and INTEM (53.3 vs. 43.5 s, p = 0.03). EXTEM clot firmness 
at 5 minutes (A5) was significantly decreased in patients with throm-
boembolic complications compared to patients without complications 
(58.5 vs. 64.3 mm, p = 0.009).
The conventional coagulation tests showed no significant differences 
between patients with and without thromboembolic complications.
Univariate linear analysis identified nine variables for multiple regres-
sion analysis. None of the ROTEM® variables were associated with 
thromboembolic complications in the multiple linear regression 
model. ROTEM® variables could not predict the risk of developing 
thromboembolic complications (R2 = 0.266; F (9,37) = 1,489; p 0.188).
Conclusion: ROTEM® patterns of COVID-19 patients showed no clini-
cal significant differences between patients with and without throm-
boembolic complications. Hence, our study does not support the use 
of ROTEM® in identifying COVID-19 patients at risk for developing 
thromboembolic complications.
001165 
The mobile ECMO team to retrieve refractory ADRS patients ‑ 
justify the results the efforts ?
JKM. Fichte1; M. Schoeffner1; S. Ullrich1; A. Starl1; A. Ernst1; HB. Hopf1
1Anesthesia and perioperative medicine, Asklepios Klinik Langen, Langen 
(Hessen), Germany 
Correspondence: J.K.M. Fichte
Intensive Care Medicine Experimental 2020, 8(2): 001165
Introduction: Mortality rates of patients with ARDS still are around 
45% (Combes, NEJM). Since the resources for delivering an ECMO ther-
apy are available only in a minority of hospitals, mobile ECMO teams 
have been established by ECMO centres to retrieve ARDS patients 
from primary or secondary care hospitals after implanting an ECMO 
system on side and consecutively transporting the patient in an ECMO 
centre. However, data on survival rates of those patients compared to 
patients who were implanted in the ECMO centre are scarce. Accord-
ingly we retrospectively examined the data of our patients in which 
the ECMO system has been implanted in the submitting hospital with 
emphasize on survival rates compared to those primarily admitted to 
our ECMO centre.
Methods: We examined the data of all patients retrieved by our ECMO 
team in primary and secondary hospitals who had called our ECMO-
support hotline. All patients had been initially admitted in hospitals in 
the Rhine-Main region from January 2017 till June 2020. We restricted 
our evaluation to patients with ARDS
We divided the patients in two groups - ECMO implantation in the 
requesting hospital or in our hospital. We retrospectively noted the 
following variables: type of cannula, CPR before or during ECMO 
implantation, the frequency of palliative treatment, mortality rate. We 
compared the data of the ECMO patients implanted at the requesting 
hospital with those of the patients who were implanted at our hospi-
tal. Primary outcome variable was hospital mortality rate. Secondary 
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outcome variables: SAPS II score, sofa-score, incidence of acute renal 
failure, time to weaning off the ventilator, duration of ICU stay.
Results: From 2017-2020 we treated 234 patients with ECMO on our 
intensive care unit. 170 patients have been admitted directly to our 
hospital. 66 patients have been retrieved from external clinics with a 
majority of patients who suffered from severe acute respiratory dis-
tress syndrome (ARDS) of different origins.
Remarkably is the extremely higher survival rate with ECMO treatment 
in patients initiated already at an external clinic. 36% compared to 
55% of deceased patients in the in hospital patients group.
Table1 : All patients with external ECMO- implantation by the mobile ECLS/ECMO-team of 
the Asklepios Klinik Langen
ECMO mobile survived deceased palliative care CPR
patients (n) 2017-202066 42 (64%) 24 (36%) 21 (88%)  9 (14%) 
ARDS      (n) 2017-
2020 46 30 (65%) 16 (35%) 15 (94%)  4 (9%) 
Table 2: All patients of the Asklepios Klinik Langen with in house ECMO implantation 
In hospital patients survived deceased palliative care CPR
patients (n) 2017-
2020 170 73 (43%) 93 (55%) 73 (79%) 95 (56%) 
ARDS      (n) 2017-
2020  27 16 (59%) 11 (41%) 8 (73%) 9 (33%)  
Conclusion: Our results suggest, that ECMO treatment, if required is 
more helpful to improve mortality the sooner the better. Especially 
patients with ARDS obviously seem to benefit from immediate treat-
ment changes to ECMO therapy which gets along with shorter venti-
lation times, lower ventilation pressures, less sedation of the patients 
and spontaneously breathing patients. Patients initially admitted 
to external hospitals have been presented for ECMO therapy only 
after having exploited all other possible treatment options. Presum-
ably ECMO should become more than only a rescue treatment, but 
a more and earlier considered option to improve mortality in serious 
medicalconditions.
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Introduction: Despite the fact that videolaryngoscopy has largely 
improved laryngoscopy, endotracheal intubation (ETI) is still a two-
handed procedure. While the first hand holds the videolayngoscope, 
the second hand is required to introduce the endotracheal tube (ETT). 
Shuttlescope® is a novel laryngoscope that allows performing both 
laryngoscopy and delivering of the ETT with the same hand, leaving 
an extra hand free. This may improve safety by allowing continuous 
oral suction in difficult scenarios.
Objectives: Our hypothesis was that Shuttlescope® videolaryngo-
scope allows similar efficiency in ETI than conventional laryngoscope 
while improving safety by allowing simultaneous suction. Main objec-
tive was to compare efficacy and safety of endotracheal intubation 
with Shuttlescope® and Macintosh laryngoscope by intensivists in a 
simulated difficult scenario.
Methods: We conduct a randomized cross-over trial to assess efficacy 
and safety of Shuttlescope® videolaryngoscope compaired to Macin-
tosh laryngoscope in a manikin model (AirSim, TrueCorp®). A difficult 
scenario which required continuous suction was designed, with a 
modified yaunkauer suction tip capable to determine suction time. 
All operators were intensivists from the service de Médecine Intensive 
Réanimation (Bordeaux, France) who received a rigorous 15 min stand-
ardized training on the new device and technique, which they didn’t 
experience before. Three attempts with each device were compaired 
for each operator. The primary endpoint was a combination of time 
to intubation and success rate. Secondary endpoints were cumulative 
suction time and capability to aspirate continuously. Mean times and 
proportions were compaired with the T-Student and chi-square test, 
respectivelly.
Results: In total, 20 operators participate to the study. After ran-
domisation, 10 intensivists started ETI with the Shuttlescope® and 10 
started with Macintosh, providing a total of 60 intubations with each 
device. Mean time for ETI with Macintosh laryngoscope compaired to 
Shuttlescope® was 14 s [6-37] and 11 s [6-28], p < 0.001, respectively. 
Success rate was 100% of ETT in the trachea with both devices (p = 
N.S). Mean suction time was 2 sg [1-10] with Macintosh and 3.6 sg 
[2-10], with Shuttlescope® (p < 0.001). Finally, only 5% of ETI done with 
Macintosh could be performed with a continuous suction compared 
to 90% with Shuttlescope® (p < 0.001).
Conclusion: Shuttlescope® is a novel device that allows safe and easy 
ETI while leaving the right hand of the operator free during the pro-
cedure. It allows effective suction which may confer a relevant advan-
tage in situations with a high risk of aspiration.
Reference(s) and grant ackowledgment(s)
1. Shuttlescope®, a novel laryngoscope. Is one‑handed endotracheal intuba‑
tion feasible? European Journal of Anaesthesiology (Volume 37, e‑Supple‑
ment 58, June 2020)
2. SHUTTLESCOPE®, a novel laryngoscope for one‑handed endotracheal 
intubation: one helping hand can make a difference. 2nd World Airway 
Management Meeting 2019. 13 ‑ 16 Nov, 2019 | Amsterdam, NL.
3. ‘Building Better Future for Health Challenge’ in Australia
4. MIT‑Harvard Medical School Healthcare Bootcamp
5. ‘Ignite Ideas Grant’ by the Queensland Government in Australia
000243 
Combined cell therapy and anticoagulants as a treatment 
for acute respiratory distress syndrome
M. Camprubí‑Rimblas1; A. Areny2; L. Morales‑Quinteros3; 
R. Guillamat‑Prats4; N. Tantinyà4; L. Blanch5; A. Artigas6
1Centro de investigación biomédica en red enfermedades respirato‑
rias (ciberes i i3pt), Universitat Autònoma de Barcelona, Cerdanyola del 
Vallès, Spain; 2Institut d’investigació i innovació parc tauli (i3pt), Univer‑
sitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain; 3Intensive 
care, Hospital Universitari Sagrat Cor ‑ Grup Quirónsalut, Barcelona, Spain; 
4Institut d’investigació i innovació parc taulí (i3pt), Centro de Investigación 
Biomédica en Red de Enfermedades Respiratorias, Sabadell, Spain; 5Insti‑
tut d’investigació i innovació parc taulí i3pt, Parc Taulí Hospital Universi‑
tari, Sabadell, Spain; 6Department of intensive care medicine, Corporacion 
Sanitaria Universitaria Parc Tauli, Barcelona, Spain 
Correspondence: M. Camprubí‑Rimblas
Intensive Care Medicine Experimental 2020, 8(2): 000243
Introduction: The lungs of patients with acute respiratory distress 
syndrome (ARDS) are characterized by an acute inflammation and an 
increased procoagulant activity. Recent evidence suggests the ben-
eficial effects of cell therapies and nebulized anticoagulants for ARDS 
(1,2). Considering the different mechanism through which cell thera-
pies and antithrombin act in ARDS, we propose a combined admin-
istration of these therapies to potentiate their therapeutic properties 
and face the different pathways and processes involved in the patho-
physiology of ARDS.
Objectives: Determine the therapeutic benefit of a combined cell 
therapy (alveolar type II cells (ATII), mesenchymal stem cells (MSC), 
supernatant (SN) ATII, SN MSC) with antithrombin in vitro in a cocul-
ture of ATII and alveolar macrophages injured with lipopolysaccharide 
(LPS).
Methods: Cocultured ATII and alveolar macrophages isolated from rat 
lungs were injured with LPS (10 ng/ml). Two hours after the injury a 
combined cell therapy (ATII, MSC, SN ATII, SN MSC) with antithrombin 
(0.1  IU/ml) was administered. The effect of the administered treat-
ments was assessed by the analysis of proinflammatory mediators 
and coagulants factors via qRT-PCR at 18 h. Data are expressed as 
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mean±SEM. Statistical analysis was performed using One-Way-ANOVA 
and Newman-Keuls post-hoc test (statistical significance p≤0.05).
Results: Proinflammatory mediators and coagulant factors were sig-
nificantly increased after LPS administration (Figure). After administer-
ing the different treatments the expression of IL1β, IL6, TF and PAI-1 
was not as high as in the LPS group.
Conclusion: The results indicate that combined cell therapy with 
antithrombin are able to attenuate inflammation and coagulation 
in vitro in a coculture of ATII and macrophages. Further studies need 
to be performed to elucidate the effect of both treatments in the dif-
ferent processes involved in lung injury.
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Introduction: This talk will share trials and tribulations of creating 
National randomized controlled study during Corona pandemic.This is 
a study designed to assess the therapeutic value of intravenous tocili-
zumab administered as single 8mg/Kg dose compared to placebo in 
patients affected by SARS-CoV2 infection with a pulmonary manifesta-
tion causing hypoxia
Objectives: Aim of the study is to test the hypothesis that an anti-
IL6 treatment can be effective in calming the virus-induced cytokine 
storm, blocking deterioration of lung function or even promoting a 
rapid improvement of clinical conditions, preventing naso-tracheal 
intubation and/or death. In additon, lessons learned from institutional 
and national  ethics committee submissions, safety board review and 
revisions, creating digital data capture, and data monitoring will be 
shared.
Methods: When COVID 19 pandemic started in China we approached 
government offices for support and stategy. A protocal was devel-
oped and implementation plans were established. When ethical 
approval was granted in one medical institution digital electronic data 
capture platform was created, tested and launched. We recruited all 
Intenisve care and infectious disease units, to join the national study. 
After national Ministry of health approval was granted each hospital 
needed institutional approval. Within 1 week, 6 other centers recieved 
approval, recieved study drug and started recruting patients. Nurses 
trained medical centers on data capture and protocol adherence. 
Zoom and whatsapp platforms were utilized for training. Close Data 
monitoring was preformed at base hospital.
Results: At present 20 patients have been recruited and by time of 
presentation many more will be added. We will demonstrate change 
from baseline in cytokines IL-1β, IL-6, IL-8 and TNF-α [ Outcome data 
-mortality, length of Hosptial and ICU stay, ventilation days,and ven-
tilation methods. In addition, technologies used to organzie and 
manage multi center- multi disciplanary communications in an rand-
omized placebo controlled drug study during Corona epidemic will be 
shared and discussed.
Conclusion: Sharing lessons learned in creating, organizing and 
managing a multi center mulit-disciplinary national randomized con-
trolled trial is vital for applying in order to duplicate during the next 
pandemic.
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Introduction: Alterations of the microbiota can cause a dysregulation 
of the immune system locally and systemically, facilitating the clinical 
progression in different pathologies with inflammation as ALI.
Objectives: To assess changes in lung and intestinal microbiome in 
a murine model of acute lung injury (ALI) and subsequent treatment 
with an anti-IL-33 antibody.
Methods: Experimental model in which 36 male BALB/c mice were 
included (CEEA: JME-16-0025). ALI was induced at Day 1 by the intra-
nasal administration of lipopolysaccharide (LPS) at a dose of 8mg/kg. 
Treatment with Anti-IL-33 (3.6µg/day) or placebo (saline) was admin-
istered, intraperitoneally, at days 2, 3 and 4. On day 5, body weight 
gain was registered and bronchoalveolar lavage (BAL), lung, feces and 
blood samples were collected. The studied groups were: 1) Control 
group without ALI including those treated with placebo or anti-IL-33 
(CTL-PCB, n = 6 and CTL-Anti-IL33, n = 6), 2) Experimental group with 
ALI and placebo (ALI-PCB, n = 12) and 3) Experimental group with ALI 
and anti-IL-33 (ALI-Anti-IL-33, n = 12). Microbiome was assessed by 
the analysis of 16SrRNA in BAL and feces and bioinformatic analysis 
was performed. Cell count, total protein and IL-33 levels were meas-
ured in BAL fluid. IL-33 levels were also measured in blood samples. 
ALI was assessed by histology and wet-to-dry lung weight ratio (W/D). 
The data was expressed as mean (standard deviation) or as median 
(interquartile range). Significance was set to p < 0.05. The comparison 
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of the microbiome between samples was carried out by correspond-
ence analysis with the QIIME and UNIFRAC programs.
Results: Intestinal microbiota showed a greater richness but not eve-
ness (α diversity) in comparison with lung microbiota (p < 0.000) in 
all groups. Differences between the microbial communities (beta-
diversity) in gut CTL, ALI-PCB and ALI-Anti-IL-33 groups were observed 
(Bray Curtis, Permanova 0.027, Permdisp > 0.05, ANOSIM 0.0797, p = 
0.062). Clear differences in microbial communities were observed in 
the three groups when comparing gut vs lung (Unweighted Unifrac, 
Permanova = 0.001, Permdisp > 0.05, ANOSIM 0.5025, p = 0.001). ALI-
PCB group compared with the CTL group presented a decreased in 
the body weight gain [-11.5 (6.2) vs 2.8 (1.8), p < 0.001], an increase 
in the W/D [0.16 (0.02) vs 0.10 (0.00), p < 0.001] and higher neutrophil 
percentage [69.4 (67.4-71.1) vs 2.7 (2.0-3.1), p < 0.001], protein levels 
[596.2 (462.8-760.8) vs 112.0 (81.5-194.9), p < 0.001] and IL-33 levels 
[26.1 (25.2-29.6) vs 15.1(11.1-20.1), p = 0.004] in BAL. It also showed 
higher rates of proteinaceous debris [1.1 (0.7) vs 0.0 (0.0), p = 0.01] and 
polymorphonuclear (PMN) cells in alveolar and interstitial space [1.7 
(0.4) vs 0.0 (0.0), p < 0.001; 1.1 (0.4) vs 0.0 (0.0), p = 0.002]. Differences 
between gut and lung communities were lower in ALI groups than 
in CTL groups, showing a greater similarity in the lung-gut microbial 
communities in this group (p < 0.001).
Treatment with Anti-IL-33 compared with placebo reduced the W/D 
[0.13(0.02) vs 0.16(0.02), p = 0.02], the BALF neutrophil percent-
age [63.1(52.6-68.1) vs 69.4(67.4-71.1); p = 0.03], the interstitial PMN 
[0.4(0.5) vs 1.1(0.4), p = 0.01] and proteinaceous debris [0.3(0.4) vs 
1.1(0.7), p = 0.02]. Anti-IL-33 treatment did not reverse the observed 
changes in the microbiome of both echosystems.
Conclusion: ALI modifies the respiratory microbiome, resembling 
lung microbiota to intestinal. Anti-IL-33 could partially restore the ALI-
induced histopathological and biochemical but no the microbiome 
changes. Treatment directed to restore microbiomein ALI could be a 
new therapeutic target independent to anti-inflammatory approach.
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Introduction: It is questioned whether spontaneous breathing (SB) 
should be used in early Acute Respiratory Distress Syndrome (ARDS). 
Recent papers have reported concerns regarding SB, for the potential 
of triggering the so-called patient self-induced lung injury (1). Despite 
a clear improvement in ventilatory strategies, we still lack knowledge 
that could make SB fully protective. Assessment of potential parenchy-
mal injury must take into account stress and strain as the real physical 
quantities acting on the lung structures. Moreover, the lack of infor-
mation regarding regional lung mechanics and deformation at the 
acinar level is likely the main determinant of these unresolved issues.
Objectives: Aim of the present study was to investigate regional lung 
Strain and Stress during continuous positive airway pressure (CPAP) 
ventilation, in an animal model of mild ARDS during SB.
Methods: Mild experimental ARDS  (PaO2/FiO2 ratio of 250 mmHg) 
was induced in anesthetized pigs (n = 5) breathing at three positive 
end-expiratory pressure (PEEP) levels during CPAP: 12, 6 and 0  cmH2O. 
Computed tomography (CT) of the lung was performed at Functional 
Residual Capacity (FRC) and then during uninterrupted CPAP breath-
ing at the three PEEP levels. Airway pressure and flow together with 
gastric and esophageal pressures were acquired simultaneously to CT 
execution. One lung slice above the diaphragm dome was continu-
ously exposed and successively analysed. By analysing representative 
breaths at each PEEP level, regional Strain and Stress (transpulmonary 
pressure, PTP) were computed in three regions of interest (ROI) of the 
lung: nondependent, middle and dependent.
The obtained data were successively analysed for statistical signifi-
cance by applying ANOVA test for repeated measurements with α = 
0.05 (SigmaPlot, Systat Soft.,USA).
Results: When decreasing PEEP from 12 to 0  cmH2O, regional lung 
Strain decreased from 0.78 ± 0.17 to 0.37 ± 0.10 (p < 0.001) respec-
tively. Regional lung Stress was significantly higher at PEEP 12 
(4.30 ± 0.90  cmH2O) than PEEP 6 (3.83 ± 0.70  cmH2O), but the highest 
PTP values were recorded at PEEP 0 (5.00 ±  1.1  cmH2O) (p < 0.001). 
Stress significantly increased in all the studied ROIs passing from PEEP 
0 to 6 and from 0 to 12  cmH2O. Both stress and strain were signifi-
cantly higher in dependent ROIs than in middle and non-dependent.
Conclusion: This study shows that high regional Stress and Strain 
occur during spontaneous breathing in dependent ROIs and at the 
two extremes of the PEEP spectrum: high regional Stress is present 
during CPAP at the lowest extreme (PEEP 0) whereas high regional 
strain at the highest one (PEEP 12). Titrating PEEP to reach the best 
compromise between preventing both lung regional strain and stress 
can enable a fully protective CPAP ventilation during SB.
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Introduction: Lung tissues absorb the dissipation of the energy dur-
ing lung inflation through their viscoelastic properties. These can be 
represented by the Mount  rheological model that consists of a Max-
well body (lung viscoelastic elastance (E2) and resistance (R2) arranged 
in series) in parallel with the standard lung elastance and resistance, 
according to the following equation: Pvisc(ti) = R2 V’ (1- exp(-ti/τ2)) (1)
where Pvisc(ti) represents the viscoelastic elastic pressure dissipation 
into the lungs during inflation time (ti), V’ the inflation flow and τ2 the 
lung viscoelastic time constant (τ2 = R2/E2).
Objectives: In present study we aimed at assessing the effect of 
supine versus prone position on global and regional E2,L and R2,L 
at different positive end-expiratory pressure (PEEP). We also ana-
lyzed the relationship of regional E2,L and R2,L to lung collapse and 
overdistension.
Methods: This is a secondary analysis of a previous study in 6 pigs in 
whom ARDS was induced by surfactant depletion (1). Overall Trans-
Pulmonary pressure (PL) was measured as Paw minus esophageal 
pressure. Regional dorsal and ventral PL were obtained by subtract-
ing Paw from dorsal and ventral pleural pressure, respectively. Pleu-
ral pressure was measured directly into the anterior and posterior 
6th intercostal space. Lung ventilation was measured with electri-
cal impedance tomography (EIT). Animals were ventilated in volume 
controlled mode at constant flow inflation,  FiO2  100% and tidal vol-
ume (VT) 6 ml/kg. After ARDS induction the lungs were recruited and 
then PEEP was reduced from 20 to 5  cmH2O by steps of 5  cmH2O. E2,L 
and R2,L were obtained by fitting the global and regional PL during 
a 5s end-inspiratory hold to equation 1 as initially proposed (2) . The 
effect of PEEP and position was analyzed by a linear mixed-effects 
model. The lung collapse and overdistension was measured by EIT as 
the change in impedance pixel-by-pixel during the decremental PEEP 
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trial. Correlation was assessed by Spearman Rho coefficient. Values are 
median (1st-3rd quartiles).
Results: The fitting of data to equation  1 was successful in every 
instance.
Conclusion: Prone position does not significantly change the lung vis-
coelastic properties in an ARDS porcine model of surfactant depletion.
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Introduction: It has been proposed that SARS CoV2 patients requir-
ing invasive mechanical ventilation represent a particular type of 
ARDS with a different ventilatory profile, being managed with lower 
pressures, as well as having a distinguished physiopathology element 
involving blunted hypoxic pulmonary vasoconstriction. Therefore, we 
might expect a specific hemodynamic profile of these patients, with 
less prevalence of right ventricular (RV) failure.
Objectives: To describe the hemodynamic profile, measured by con-
ventional monitoring as well as echocardiography, of the patients 
with ARDS caused by SARS CoV2 admitted to the ICU and treated with 
protective mechanical ventilation.
Methods: From April to May 2020, we performed a single-centre, pro-
spective, observational study, which included consecutive patients 
with a diagnosis of ARDS caused by SARS CoV2 who required treat-
ment with invasive mechanical ventilation and who had no previous 
cardiac nor respiratory chronic condition. The patients were managed 
with a protective ventilatory strategy. Hemodynamic parameters, 
as well as echocardiographic biventricular function and respiratory 
mechanics were measured.
Two transthoracic echocardiograms, separated by an interval of 30 
minutes, were performed during the first 72 hours after initiation 
of mechanical ventilation. The first one with parameters set by the 
attending physician following our approach of reaching a SaO2 > 90% 
with a low PEEP high  FiO2 strategy. The second echocardiogram was 
performed after either increasing the PEEP 2-4  cmH2O if a  FiO2 > 60% 
were necessary to reach the SaO2 goal or increasing the  FiO2 to 100% 
if the SaO2 goal were reached with a lower  FiO2. A third echocardio-
gram was performed 72h hours later with the ventilatory adjustments 
considered by the physician in charge of the patient. Arterial blood 
gas analysis was performed previously to each echocardiogram.
Results: We included 8 patients. Respiratory and hemodynamic vari-
ables are shown in Table 1. All patients showed hemodynamic stabil-
ity with a median of MAP > 75 mmHg, both at baseline and 72h later 
and low dose norepinephrine was used in one of them. We observed 
that in both groups, and particularly in the PEEP group, ventilatory 
changes did not have a negative effect on hemodynamics except by 
a trend to a decrease in the pulmonary acceleration time. All patients 
had preserved both left and right ventricular ejection fraction. None of 
the patients developed RV failure. A slight increase in PEEP tended to 
worsen pulmonary compliance but this was not followed by a hemo-
dynamic worsening.
Conclusion: Despite the low oxygenation levels, this cohort of 
patients with SARS CoV2 shows hemodynamic stability and presents 
normal RV function. An increase in PEEP tends to worsen pulmonary 
mechanics but without an enormous impact in hemodynamics. This 
hemodynamic profile could be related with a blunted hypoxic pulmo-
nary vasoconstriction and could be relevant at the time of choosing 
the best management strategy for this kind of patients.
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Introduction: In February 2020, Italy reported the first cases of novel 
coronavirus  disease  (COVID-19) requiring admission to ICU for acute 
respiratory failure (ARF)[1]. Lung ultrasound (LUS)  is useful in ARF for 
lung assessment and  monitoring[2]:  performed bedside avoiding 
transport to radiology, it is easily repeatable and it doesn’t involve fur-
ther healthcare providers, thus limiting potential exposure to COVID-
19 contamination[3].
Objectives: To describe LUS patterns at admission to ICU  in patients 
with COVID-19.
Methods: Retrospective observational study; analysis of the LUS per-
formed within the first 24 hours from admission to ICU. We computed 
the  LUS score, from 0 (normal aeration) to 3 (complete loss of aera-
tion),  in  6 standard regions per hemithorax  and registered lung fea-
tures (subpleural/lobar consolidations, pleural irregularities, sliding, 
artefacts distribution, pleural effusion)[2].
Results: We  present  the first 13 patients admitted to our ICU  (77% 
males, median age 64  [56-73]  year-old, median BMI 28  [26-29] kg/
m2).  They were all examined under pressure-controlled ventilation 
(median PEEP 14 [11-15]cmH2O,  FiO2 > 50% in 85% of patients). In all 
patients, we observed bilateral distribution of pathological findings, 
with at least one area with  B-pattern  (score > 1  -  100%)  and  pleural 
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irregularities (100%). We frequently observed  subpleural consoli-
dation (85%)  and lobar  consolidation (77%);  lung  sliding  was fre-
quently reduced in anterior fields  (92%).  The median  LUS score was 
18 [14-19]. Small pleural effusion was visualized in 3 patients (23.1% - 
median interpleural distance 0.8 cm). 23.1% of patient  had a  bacte-
rial  overinfections, confirmed with positive BAL; they all had lobar 
consolidations.
Conclusion: LUS  features of COVID-19  include bilateral loss of 
aeration with diffuse B-pattern, pleural irregularities and frequent 
subpleural consolidations. Lobar consolidations may suggest 
bacterial overinfection.
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Introduction: Coronavirus disease 2019 (COVID-19) is a potentially 
severe acute respiratory infection which presents most commonly as 
a pneumonia, complicated by hypoxaemic respiratory failure in up to 
41.8% of patients(1). Pandemic COVID-19 has placed unprecedented 
pressures on critical care services. Safe delivery of respiratory support 
on a large scale has proved a major challenge. High flow oxygen ther-
apy (HFOT) and continuous positive airway pressure (CPAP) devices 
are recommended by interim guidance but significant controversy 
remains over their use for COVID-19-associated hypoxaemic respira-
tory failure(2,3).
Objectives: We describe the real-world use of HFOT and CPAP in a sin-
gle centre during the COVID-19 epidemic. We ask: 1. What respiratory 
parameters predict failure of respiratory devices in COVID-19? 2. Can 
the ROX index be used to monitor HFOT for COVID-19? 3. Does HFOT 
compare to CPAP for management of hypoxaemic respiratory failure 
in COVID-19?
Methods: Data were collected retrospectively for all patients admit-
ted to a single hospital with confirmed or probable COVID-19 between 
27/03-06/04/20. Confirmed COVID-19 was defined by laboratory PCR 
testing of respiratory samples. Probable COVID-19 was defined as high 
clinical suspicion with negative COVID-19 testing. Outcomes were 
defined as severe (death or intubation) and non-severe (no intuba-
tion) at 30 days. Digital notes review captured demographic, clinical 
and respiratory parameters. Qualitative data were compared with the 
Fisher exact test. Quantitative data were compared with the Student’s 
t-test.
Results: Of 239 adults with confirmed (221, 92.4%) or probable COVID-
19 (18, 7.6%), 149 patients received HFOT and/or CPAP. 45 (30.3%) and 
104 (69.7%) patients had severe and non-severe outcomes respec-
tively. 60 patients received HFOT and/or CPAP in 78 episodes of device 
use (Table  1). Mean  PaO2/FiO2 (PF) ratios for patients initiating CPAP 
were lower than for those initiating HFOT (Table 1). In patients receiv-
ing HFOT, ROX index at all time points was significantly lower in those 
with severe versus non-severe outcomes (Figure  1). The mean ROX 
index at 0 to 12 hours was less than 4.88 in the severe outcome group, 
and above 4.88 in the non-severe group. For all patients receiving res-
piratory support devices, PF ratio was significantly lower in those with 
severe versus non-severe outcomes (Figure 2).
Table 1. Summary data for patients receiving HFOT and/or CPAP
HFOT CPAP
Severe Non-severe Severe Non-severe
Total (n, % all 
device use) 30 (38%) 17 (22%) 24 (31%) 7 (9%) 





















ROX index at 12 
hours HFOT (mean, 
range)
4.83 
(2.2 – 7.6) 
7.69 
(4.7 – 10.8) 
- - 
First device (n, % all 
device use) 19 (24%) 16 (21%) 16 (21%) 4 (5%) 
Only device (n, % all 




3.2 (0 – 9) - 4.5 (0 - 12) - 
Conclusion: Data from our single site retrospective cohort study sug-
gest ROX index parameters may predict failure of HFOT, and PF ratio 
may predict failure of HFOT and CPAP in COVID-19 consistent with 
non-COVID-19 literature(4). In our study, clinicians favoured CPAP 
for individuals presenting with more severe hypoxaemic respiratory 
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failure making comparisons between HFOT and CPAP challenging. 
However HFOT was associated with successful outcomes in certain 
patients. ROX index may be useful in selecting this sub-group and war-
rants prospective study.
Reference(s) and grant ackowledgment(s)
1. 4. Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, et al. An 
index combining respiratory rate and oxygenation to predict outcome 
of nasal high‑flow therapy. Am J Respir Crit Care Med [Internet]. 2019 Jun 
[cited 2020 May 11];199(11):1368–76. Available from: https ://www.atsjo 
urnal s.org/doi/10.1164/rccm.20180 3‑0589O 
2. 3. Lyons C, Callaghan M. The use of high‐flow nasal oxygen in <scp> 
COVID </scp> ‐19. Anaesthesia [Internet]. 2020 Apr 20 [cited 2020 May 
11];anae.15073. Available from: https ://onlin elibr ary.wiley .com/doi/
abs/10.1111/anae.15073 
3. 2. World Health Organization. Clinical management of severe acute respira‑
tory infection when COVID‑19 is suspected (v1.2). WHO [Internet]. 2020 
[cited 2020 May 11];1–21. Available from: https ://www.who.int/publi catio 
ns‑detai l/clini cal‑manag ement ‑of‑sever e‑acute ‑respi rator y‑infec tion‑when‑
novel ‑coron aviru s‑(ncov)‑infec tion‑is‑suspe cted
4. 1. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated with 
Acute Respiratory Distress Syndrome and Death in Patients with Coronavi‑
rus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020
000470 
Estimation of respiratory work and mechanical power transmitted 
to ARDS patients
G. Ferrigno1; N. Rodrigo  Castroviejo2; A. Tejero  Pedregosa2; V. Losada 
Martínez2; R. Beltrán Bernáldez2; C. Sanmartino  Gonzalez2; D. Monge 
 Donaire2; LL. Beltran Martínez2; C. Tarancón Maján2; A. Marcos Gutiérrez2
1Intensive Care Unit, Hospital Virgen De La Concha, Zamora, Spain; 2Inten‑
sive care, Hospital Virgen De La Concha, Zamora, Spain 
Correspondence: G. Ferrigno
Intensive Care Medicine Experimental 2020, 8(2): 000470
Introduction: Mechanical ventilation (MV) is vital for the manage-
ment of patients with acute respiratory distress syndrome (ARDS). In 
recent years there has been important technological development. 
Along with technological advances and a better understanding of res-
piratory pathophysiology, it has been determined that MV can have 
deleterious effects on these kinds of patients.
Objectives: to estimate respiratory work by means of the pressure-
time product (PTP) and the Campbell’s diagram (WOB), to estimate 
different parameters related to  ventilator induced lung injury  (VILI) 
according to classical and rheological theories: driving pressure (DP), 
stress index (SI) and mechanical power (PM)
Methods: Data were collected from adult patients connected to MV 
with ARDS criteria as proposed in the Berlin definition. The Fluxmed® 
respiratory mechanics monitor was used after insertion of an esopha-
geal pressure probe and placement of a flow sensor (Image 1). Param-
eters related to VILI were collected:  DP, SI and  MP  was calculated 
according to the formula proposed by Gattinoni. PTP and WOB were 
also calculated with the FluxReview® software (Picture  2). Data were 
collected for 5 minutes after esophageal probe insertion, in volume 
controlled mode and under the effects of  a  neuromuscular blocking 
agent. The variables are presented as an average (95% CI). Hypothesis 
contrast for mean difference was performed with Mann-Whitney test.
Results: 8 patients with the following baseline characteristics were 
included. Age 69.4 (61.6-77.2) years, sex 87.5% men, weight 71.6 (60.3-
83) kg,  height  166.8 (158.1-175.4) cm, APACHE 26 (9.2-42.8), SAPSII 
53.3 (42-64.5), SOFA 6.9 (3.4-10.4). Patients were ventilated with Vt 7.6 
(6.6-8.7) ml/kg, PEEP 9.8 (7.9-11.6)  cmH2O,  FiO2 0.63, FR 22 (18.7-25.3) 
rpm.  PaO2/FiO2 was 140.5 (88-193) mmHg. PTP of the respiratory sys-
tem was 9.5 (7.8-11.2)  cmH2O x sec., with an elastic component of 49.6 
% (37.6-61.5) % and a resistive component of 43 % (33.4-52.5) %. The 
elastic WOB was 4.3 (3.2-5.5) cmH20 x l, expiratory resistive WOB was 
2.8 (1.8-3.8) cmH20 x l, inspiratory resistive WOB was -3.4 (-4.5-2.2) 
 cmH2O x l.  DP  was 13.6 (10-17.2)  cmH2O,  MP  10.2 (7-13.4) J/min and 
SI 0.95 (0.8-1.1). Mortality was 62.5% and duration of MV was 16.6 (5.5-
27.8) days. A statistically significant difference was observed  in the 
level of PEEP among survivors and non-survivors: 3  cmH2O (0.2 -6) p < 
0.05. Differenceswere also observed in MP 5.9 J/min (1.5-10.3) and PTP 
2.7  cmH2O x sec. (0.5-5.4) but without reaching statistical significance 
(p = 0.053).
Conclusion: Advanced monitoring and knowledge of the different 
theories that explain VILI may allow us to optimize MV programming 
and reduce the damage associated with it.
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Introduction: SARS-CoV2 is a novel pathogen which, in humans, can 
lead to respiratory failure and acute respiratory distress syndrome 
(ARDS)(1). Prone ventilation has been shown to improve mortality in 
patients with severe ARDS(2). From early case reports in SARS-CoV2 
infected patients and previous literature on ARDS, we hypothesised 
that prone ventilation may play a role improving oxygenation(2)(3).
Prone positioning for patients receiving non-invasive ventilation 
has been demonstrated to improve oxygenation in a case series(4). 
Given potential issues with resource allocation and simplicity of this 
measure, patients requiring NIV were encouraged to self prone(5). 
We used SpO2:Fi02 (SPF) ratio as a surrogate for Pa02/Fi02 (PF) ratios 
these have been shown to have a linear relationship with PF ratios 
previously(6).
Objectives: 1. To assess the impact of prone ventilation on P:F ratios 
for invasively ventilated patients with SARS-CoV2 infection with severe 
ARDS.
2. To assess impact on SpO2:Fi02 ratio, intubation rates and patient 
compliance with prone positioning for conscious patients with SARS-
CoV2 infection receiving NIV
Methods: Retrospective observational cohort study of patients with 
severe ARDS secondary to SARS-CoV2, admitted to the ICU receiv-
ing mechanical ventilation in the prone position for at least twelve 
consecutive hours. Prone Ventilation occurred as per local protocol, 
aiming for 18 hours prone per day. All patients receiving manda-
tory mechanical ventilation received lung protective ventilation as 
per ARDSNET protocol 6ml/kg PBW, with titrated PEEP. For pron-
ing patients received a bolus of non-depolarising muscle relaxant 
and a weight based atracurium infusion for the duration of prone 
ventilation.
In the self prone group we assessed patients who had non invasive 
ventilatory support who had any proning event.
Results: 17 patients with SARS-CoV2 infection at MMUH received 
prone position invasive mechanical ventilation (3 during veno-
veno extra corporeal life support). This was associated with a mean 
improvement in P:F ratio of 16 kPa during the first episode of prone 
ventilation. This improvement declined with subsequent episodes. 
Patients received a mean of 4.2 episodes of prone ventilation. The rate 
of improvement in PF ratio was greatest in the first 6 hours of proning 
and declined from hour 6-17.
11 patients undertook awake prone positioning whilst receiving NIV. 
The average number of awake proning events was 5.4 events per 
patient. The mean Sp02 / Fi02 ratio prior to the first self prone event 
was 179 There was an average best increase in SpFi02 ratio of 33.6. In 
the awake proning group only 18% of patients required mechanical 
ventilation.
Conclusion: In our cohort of patients who received prone ventilation 
for severe ARDS secondary to SARS-CoV2 there was an improvement 
in their PF ratios, the greatest benefit was seen in the first 6 hours of 
the prone period. This is consistent with data previously seen in other 
causes of ARDS. Although not all patients demonstrated a significant 
improvement in SPF ratio on self proning, we note that this interven-
tion may have avoided intubation for some patients where patient 
adherence to the protocol was high.
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Introduction: Coronavirus Disease 2019 (COVID-19) presented as a 
challenge to Intensive Care Units (ICU). An effort is still being made to 
clarify the main features and the impact of invasive mechanical venti-
lation (IMV) in outcomes.
Objectives: To describe the characteristics of an ICU COVID-19 popu-
lation and to analyze the evolution of the decision on the ideal ven-
tilation moment and the impact on mortality between invasively 
ventilated and non-invasively ventilated patients.
Methods: Retrospective cohort study of Polymerase Chain Reac-
tion confirmed SARS-COV-2 adult patients admitted to an ICU in the 
interior north of Portugal between March 23 and May 23, 2020. Data 
collection on clinical characteristics and management decisions was 
performed. Patients were grouped according to the oxygen or venti-
lation support mode: group 1 – IMV; group 2 - non-invasive ventila-
tion, high flow nasal canula and facial mask oxygen. Variables were 
analyzed using the SPSS statistical software and the significance level 
used was 0.05.
Results: During the study period were admitted 20 patients, 60% 
were women, the median age was 67.5 years [44; 87].
Seventeen patients (85%) were admitted for respiratory failure, 35% of 
whom with  PaO2/FiO2 ratio below 100mmHg, 2 patients (10%) for sep-
tic shock in context of gastroenteritis and 1 patient with acute coro-
nary syndrome and mild respiratory symptoms.
The median SAPS II at admission was 34 [15; 50], the mortality rates in 
the ICU and at 30 days were 25% and 35%, respectively.
When analyzing the ventilation support, 60% required IVM and 55% 
were proned. When comparing groups, group 1 mortality was clini-
cally significative higher (p = 0.055) and had a significative longer ICU 
stay (p = 0.006). In terms of laboratorial features on admission there 
wereno differences between groups. Regarding COVID 19 and ICU 
complication, group 1 had more superinfections (p = 0.019), but with-
out impact in mortality. Otherwise, we found no differences in renal, 
cardiac or thromboembolic complications.
Within group 1, the median  PaO2/FiO2 ratio was initially higher, mainly 
in the first month. As time went by and experience accumulated, a 
tendency to tolerate lower ratios before invasive ventilation and an 
inverted ratio between the number of ventilated and non-ventilated 
patients can be seen.
Conclusion: Patients who received IMV had a higher rate of infection 
and a significantly longer stay in ICU with impact on mortality.
Initially patients were invasively ventilated earlier in accordance with 
studies and expert opinion, however with experience, non-invasive 
strategies were preferred without impact in the outcomes. The deci-
sion not to ventilate was well tolerated and allowed patients to 
overcome infection without the need to be ventilate, even under 
traditional “mandatory” ventilation ratios. Outcomes like neurologi-
cal dysfunction were not evaluated but we raise the hypothesis that 
non-ventilation probably spares that dysfunction, as well as decreases 
secondary lung infection.
The main limitation of this study is the small sample. Further large-
scale studies would be interesting analyzing the mortality and 
prevalence of post-ICU impairment in ventilated and non-ventilated 
patients.
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Introduction: On 11 March 2020, the WHO characterised COVID-19 as 
a pandemic. At that point, in the UK, there were only 364 patients with 
proven coronavirus infection and only seven deaths. We could, how-
ever, glimpse the possible future from the horrors that struck Italy and 
China. We therefore began plans to upskill and re-organise our work-
force, both medical and nursing staff.
Objectives: Due to resource limitations, non-respiratory doctors and 
nurses would have to learn how to manage patients with COVID-19 
related respiratory failure. Consequently, we wanted to ensure that staff 
were as well prepared and confident in their new roles as possible.
Methods: We developed ‘Respiratory Failure Escalation Guidelines’ 
and a twice daily, two-hour teaching session delivered by a team of 
experienced doctors and nurses from Acute and Respiratory Medi-
cine and Intensive Care (ITU). These started with a lecture on the 
basics of respiratory failure and its management - including the use of 
High Flow Oxygen Therapy (HFOT), Continuous Positive Airway Pres-
sure (CPAP) and Non-Invasive Ventilation (NIV) - followed by a dem-
onstration of our hospital’s respiratory support devices with time for 
hands-on experience. We advertised the training to all members of 
the multidisciplinary team, from all specialties, working within the 
hospital.
Results: Between 17 March and 15 May 2020, we had 435 confirmed 
attendees (as per registers collected during teaching times). The 
below pie charts demonstrate the broad professional backgrounds 
(Fig. 1) and specialties (Fig. 2) of the attendees.
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We received post-course feedback from 64 attendees, across differ-
ent departments and professions, which was overwhelmingly positive 
(Fig.  3). Many requested further teaching on the subject, even sug-
gesting annual training, and around 72% of respondents attended 
our associated courses, suggesting there was a genuine desire for this 
type of education.
Conclusion: During the first wave of the pandemic, 78 patients with 
COVID-19 requiring enhanced respiratory support were managed on 
wards previously unfamiliar with this treatment modality. The educa-
tional sessions were essential in building the confidence of our staff 
in managing COVID-19 related respiratory failure throughout the hos-
pital and were extremely well received. In response to their requests 
for further teaching, and in order to facilitate ongoing learning and 
revision, we developed complementary material including respiratory 
support device set-up videos, online presentations and e-assessment 
modules accessible to all staff through the Trust’s intranet.
The key lessons we learned from the development and delivery of these 
training sessions were as follows:
 Truly multidisciplinary training is both possible and effective. The 
skill mix and varied backgrounds of the participants appeared to 
have no negative effects on the sessions.
 We did not have the time available to deliver the longer sessions 
normally used in nurse-training. Instead, we adopted an approach 
more typical of medical education. This style was, nevertheless, 
warmly received by all participants and showed that shorter ses-
sions may be effective for future nurse-training in our Trust.
 As the programme developed, the importance of providing 
resources in a variety of formats became increasingly clear. Our 
complimentary resources, developed by the same team of edu-
cators, was easily accessible to all staff to review whenever they 
wished.
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Introduction: ARDS ventilator management is one of the most dif-
ficult tasks in the ICU. Monitoring lung mechanics and oxygenation 
parameters is one of the keys in this entity, and provide useful infor-
mation about the evolution as well as prognosis.
Methods: Retrospective, descriptive study of patients admitted in 
ICU from 2017 to 2019, with H1N1 influenza diagnosis, ARDS and 
MV. Clinical, epidemiological and result-related variables were ana-
lyzed, between them: MV and sedative timing, needs of vasoactives, 
renal failure, prone position,  PaO2-FiO2, A-aO2 gradient, OI, OSI,  PaO2, 
PaCO2, ICU mortality and UCI length of stay, as well as SOFA, APACHE 
II. Quantitative variables are expressed as mean and standard devia-
tion, while qualitative variables are expressed as ratios and absolute 
value.
Results: A total number of 17 patients were included. 52.9% were 
men, with a mean age of 53.93  ±  years. APACHE and SOFA scores 
at the ICU admission were 5.65 ± 3.06 and 13.88 ± 3.53respectively. 
Prone position was needed in 58.8% of the patients. Length of 
mechanical ventilation was 17.7 ±  9.47 days; sedatives were needed 
an average of 17.47  ±  9.47 days. 58.8% of the patients developed 
renal injury, 29.4% among them needed RRT.
When the sample was divided into two groups, survivors and non-
survivors, statistically significant differences (p < 0.05) were observed 
in oxygenation parameters:  PaO2-FiO2, A-aO2 gradient, OI, and OSI. 
There were no significant differences (p 0.07) in  PaO2 and pCO2. The 
best cut-points were:  PaO2-FiO2 202.5 (S 83.3%; E 72.7%); A-aO2 gradi-
ent was 193.18 (S 66.7%; E 72.7%), OI 9.21 (S 66.7%; E 72.7%), and OSI 
8.66 (S 83.3%, E 72.7%).
The length of stay in the ICU was 21.71 ±  11.53 days. ICU observed 
mortality was 35.29%.
Conclusion: An increase in mortality risk was observed in those 
patients who kept  PaO2-FiO2 values < 202 and OI > 9.21.
Oxygenation parameters monitoring in ARSD patients provide prog-
nosis value and allow for the assessment in the day-to-day patient 
situation.
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Introduction: Covid-19 has resulted in a proning pandemic. Intensive 
care units (ICUs) across the world have proned more patients in March 
and April 2020 than they would expect to in a year. The prone posi-
tion is thought to improve the condition of patients with COVID-19 
by increasing recruitment in dorsocaudal regions of the lung, reduc-
ing alveolar shunt and increasing tidal volume(1). Putting patients in 
the prone position, along with the necessary frequent head-turns, has 
well-recognised risks and complications(2). The increased need for this 
labour-intensive procedure, combined with overstretched staff with 
varied levels of ICU experience, has led to a surge in the number of 
proning-related complications.
Objectives:
1. To identify the number of patients with COVID‑19 admitted in ICU at 
Queen’s Hospital on 23rd April 2020 that had been proned during their 
admission
2. To determine the number of complications that occurred secondary to 
proning and head‑turns
3. To design and implement a simple, efficient and effective method of reduc‑
ing common complications
Methods: Retrospective data collection from all patients admitted 
in Queen’s Hospital COVID-19 ICU on 23rd April 2020. The number 
of patients that had been proned during their admission, the dura-
tion of each prone period and any complications that occurred were 
recorded. Directed by the most common complications, and by the 
Faculty of Intensive Care Medicine guidelines(3), we designed a 
graphic highlighting five simple checks to be carried out before each 
proning/head-turn, and five simple checks to be carried out after-
wards (Fig. 1).
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Results: 31 patients with COVID-19 were admitted in ICU at Queen’s 
Hospital on 23rd April 2020. 22 (71%) were proned during their admis-
sion. 17 (77%) of these patients experienced at least one complication 
secondary to being proned. There was a total of 52 prone periods, 
with an average duration of 27.8 hours. The occurrence of different 
types of complications are shown in Table 1.
Table 1. Complications secondary to proning and head-turns 
Complications Number of patients 
Percentage of proned 
patents 
Nasogastric tube removal 12 55% 
Facial pressure sores 8 36% 
Endotracheal tube removal to level 
needing replacing 2 9% 
Central venous access removal 1 5% 
Retro-orbital haematoma 1 5% 
Conclusion: There has been a high rate of complications secondary 
to proning during this period of the COVID-19 pandemic. Our results 
show that 77% of patients who were proned experienced at least one 
complication. The consequences of these ranged from the need to 
replace an NG tube to potentially permanent loss of sight. Going for-
ward, we have implemented our proning checks graphic by displaying 
it across the ICU, attaching it to dedicated proning equipment packs 
and explaining it to members of the proning team. We continue to 
monitor its effect and strive to improve ways of protecting our patients 
from these complications.
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Introduction: Percutaneous dilational tracheostomy is usually per-
formed blindly, entry into the trachea can be visualized using bron-
choscopy. With SARS COV 2 pandemic, measures to perform the 
procedure safely for protecting healthcare personnel from undue 
risk of exposure and infection must be taken. To delay the procedure 
has been recommended due to a significant risk of viral transmission 
because it is an aerosol-generating procedure.
Objectives: The aim of the present study are: to describe the clinical 
experience in the realization of tracheostomy guided by bronchos-
copy in critically ill patients with SARS COV 2 infection and to analyze 
the complications related to the procedure.
Methods: Retrospective study in a 17 bed medical-surgical ICU dur-
ing two months: march and april 2020. We included patients with 
confirmed SARS COV 2 respiratory infection. Variables analyzed were 
clinical characteristics and outcome, day of tracheostomy during ICU 
admission, duration of procedure, complications related with the tra-
cheostomy. Statistical analysis: Data were analyzed by SPSS 18 and 
quantitative variables were expressed as a mean ± standard deviation.
Results: Twenty consecutive patients with confirmed SARS COV 2 
infection were admitted in ICU. Mean age was 61,7 ±8,25. 65% male 
and 35% female. Apache II at admission was 10,3 ±  4,21 and SOFA 
score 3,45  ±  1,87. Mechanical ventilation was required in 80% of 
patients. In nine patients, 45%, tracheostomy was performed, all the 
procedure were performed guided by videobronchoscopy to avoid 
the use of laringoscopy and to distance itself from the oral cavity and 
airways during the procedure during withdrawing orotraqueal tube. 
Mean duration of procedure was 5 minutes and 19 seconds.
No major complications related with the procedure were described, in 
two patients first attempt of needleinsertion failed and with the bron-
choscope the positioning of the needle were directly visualized before 
entry into the trachea and a guidewire was introduced (figure 1). Four 
patients developed hypoxemia during the procedure, they had no 
clinical significance and were transient.
Conclusion:
• Video bronchoscopy visualization during tracheostomy mini-
mizing risk for healthcare practitioners in SARS COV 2 infected 
patients.
• Bronchoscopy facilitates optimal visualization of the wall of the 
trachea, to locate the correct needle entrance during percutane-
ous dilational tracheostomy improving safety of the procedure.
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Introduction: During COVID 19 pandemic, many considerations have 
been discussed about tracheostomy in ICU patients, in terms of effi-
cacy, timing, and health care professionals safety. Tracheostomy is an 
aerosol generating procedure and therefore some recommendations 
have been proposed: skilled intervening staff, surgical technique, full 
personal protective equipment (PPE) use and negative pressure envi-
ronment if possible. However in our medical ICU we were not able to 
apply some of these recommendations.
Objectives: To describe and analyse patient and staff safety of bed-
side percutaneous tracheostomy in COVID-19 patients in a medical 
ICU
Methods: We recorded data of consecutive patients diagnosed with 
ARDS secondary to COVID 19 who required extended mechanical ven-
tilation and tracheostomy during their ICU stay. We registered demo-
graphic data, mechanical ventilation parameters, information about 
the procedure and we finally prospectively evaluated SARS-CoV-2 
transmission to health care professionals.
Results: We included 35 COVID-19 mechanically ventilated patients; 
tracheostomy was performed in 11 patients (31%). Negative pressure 
environment was unavailable. Percutaneous technique with single 
dilator was applied at bedside in ICU. Previous ultrasound assessment 
was implemented and bronchoscopy was used as a standard of care 
during the procedure. The mean duration of the procedure was 38 
minutes [35.1- 40.9]. Nine out of 11 tracheostomies (81.8%) were per-
formed by critical care resident doctors (4th-5th year of training). Only 
4 patients (36.36%) had negative SARS-CoV-2 PCR at the moment of 
the procedure. PPE including fluid-resistant gown, ocular protection 
(goggles or face shield), gloves and FFP3 mask, was used in all cases. 
Median of mechanical ventilation days up to tracheostomy was 21 [20-
24].  Any technique complication was detected. SARS-CoV-2 PCR and 
serology (IgM/IgG) were negative in all staff participants after a proper 
window period.
Conclusion: Despite not following all the expert opinion recom-
mendations regarding tracheostomy in COVID-19 patients, no safety 
events occurred to our patients and no SARS-CoV-2 transmission to 
healthcare providers was detected.
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Introduction: Up to a third of patients in intensive care requiring pro-
longed mechanical ventilation receive a tracheostomy. In the United 
Kingdom, this equates to around 15,000 tracheostomies annually. 
Tracheostomy insertion aims to facilitate ventilator wean through 
reducing dead space and improving secretion clearance. They can be 
performed either surgically or percutaneously. Tracheostomy timing 
has been an area of controversy in the literature, with some groups 
advocating that early insertion can lead to reduced sedative use, faster 
ventilator wean, shorter hospitalisation and reduced mortality.
Objectives: In 2013, a large randomised controlled trial, TracMan, was 
carried out assessing the impact of early versus late tracheostomy 
insertion on outcomes. This audit aimed to compare outcomes follow-
ing tracheostomy insertion in our tertiary intensive care to those of the 
TracMan study.
Methods: All ventilated patients undergoing tracheostomy (either 
surgically or percutaneously) in 2019 were included (n = 53). Patients 
undergoing emergency tracheostomy, intra-operative tracheostomy 
during elective head and neck surgery and with a pre-existing tra-
cheostomy were excluded. Data was collected from electronic health 
records retrospectively.
Results: In contrast to the TracMan study where 89% of tracheosto-
mies were performed percutaneously, we performed only 17% this 
way. This introduced quite a significant time delay between decision 
to insertion of tracheostomy. Often patients were clinically deteriorat-
ing prior to going to theatre for a surgical tracheostomy, resulting in 
even further delays. “Short neck” was cited as the most common rea-
son for referral for a surgical tracheostomy. More complications were 
seen in the cohort receiving surgical tracheostomies, however this 
group contained higher risk patients. Early tracheostomy also reduced 
the risk of complications. Contrary to the TracMan population, our 
patients achieved ventilator wean faster when tracheostomy was per-
formed earlier, which we felt was related to differing definitions of this 
term. Similar, early tracheostomy reduced length of stay on intensive 
care and shortened time on sedation. Mortality was also higher in the 
group receiving late tracheostomy.
Conclusion: Overall, duration from decision to insertion of trache-
ostomy was shorter when a percutaneous approach was chosen. If a 
percutaneous approach is feasible, this should therefore be prefer-
able over a surgical approach, as it expedited tracheostomy insertion, 
reduced length of stay and appeared to be associated with fewer com-
plications. Similarly, identifying patients for early tracheostomy inser-
tion should be advocated, given the improved outcomes seen in our 
unit.
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Introduction: In the United Kingdom (UK), consensus guidelines for 
airway management were published early in the COVID-19 pandemic 
making recommendations to support clinicians during this potentially 
challenging intervention (1). Adaptions to existing guidance for airway 
management in critically ill adults from the Difficult Airway Society (2) 
included: use of personal protective equipment (PPE), preferential use 
of the best skilled airway manager to maximise chance of first-pass 
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success, avoidance of aerosol-generating procedures (such as non-
invasive ventilation, high flow nasal oxygenation), and use of reli-
able well practiced techniques (including videolaryngoscopy where 
appropriate).
Objectives: Areas of the West Midlands were some of the worst 
affected by the COVID-19 pandemic in the UK (3). We aimed to gain 
insight into the experiences of clinicians involved with airway man-
agement during the COVID-19 pandemic in this region.
Methods: An online survey was distributed to multiple centres within 
the West Midlands region of the UK. Clinicians who had experience 
of endotracheal intubation in patients with confirmed, suspected, or 
unknown COVID-19 status were asked to reflect upon their experience 
of one patient intubation.
Results: 127 clinicians from 16 hospitals including 3 large university 
hospitals responded to the online survey, most were consultant grade 
(56.7%). Clinicians self-reported an average approximate number of 
pandemic intubations of 7.35 (range 1-30).
When asked to reflect on a single intubation, clinicians reflected on 
intubations in ICU (42.5%), emergency departments (20.5%), wards 
(8.7%), and theatre (28.3%). Appropriate PPE was available in 96.1%. 
The most senior clinician available intubated in 65.4%.
Clinicians reported first pass success in 93.7% of responses. Most 
intubators reported use of videolaryngoscopy (74.8%), however 26% 
reported not using this equipment regularly and 5.5% did not feel 
confident with their equipment. Despite a high success rate, difficul-
ties were reported in 15.1%. The most common was desaturation. 
Other common difficulties included equipment or environment unfa-
miliarity, lack of skilled support.
When asked what advice they would give to colleagues, frequently 
occurring themes included: ensuring familiarity with equipment, use 
of a checklist, use of videolaryngoscopy, and availability of a second 
intubator. Desire for simulation and equipment familiarisation was 
highlighted in multiple responses, and in one example a clinician 
attributed their success to a simulation session performed in the week 
prior.
Conclusion: Experiences from clinicians in this region highlight the 
specific challenges encountered involved in airway management 
of patients with COVID-19, in particular highlighting the importance 
of advance preparation for intubation when faced with unfamiliar 
circumstances. Simulation sessions, use of checklists and standard 
operating procedures for emergency intubation may contribute to 
maintaining preparedness for intubation in this challenging patient 
group.
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Introduction: Community-acquired pneumonia COVID 19 has been 
a recent and frequent cause of admission to intensive care units 
worldwide. Its rapid expansion and high number of cases mean that 
there are many open questions regarding its management, treatment 
and prognostic. The performance of a tracheostomy in the affected 
patients is one of these questions.
Methods: A retrospective, observational study was carried out with all 
the patients admitted to the Intensive Care Unit at a University Hos-
pital with the diagnosis of COVID-19 pneumonia. All patients who 
require mechanical ventilation support and tracheostomy during the 
pandemic were included.
Results: 37 patients were analysed. 70.3% of the sample were men 
(26/37). Average age 59.4 ±  9.4. APACHE II 14.8 ±  4.67. The average 
days of mechanical ventilation prior to performing a tracheostomy 
was 11 ± 2.66. Three of them were completed during the first week. 
Percutaneous tracheostomy was performed in 86.5% (32/37) of the 
cases; 31/37 in the course of the second week and 3 of them after the 
first two weeks. The average days from tracheostomy to decannula-
tion was 17.7 ±  10.6. 17 patients have been decannulated (46%). 16 
of these 17 patients have been discharged from the hospital. The char-
acteristics of surviving and non-surviving patients are shown in the 
Table 1.
Survivors Non survivors p
N 26 11   
Age 59 60,5 0,68 
Sex (M) 65% 81,8% 0,28 
APACHE II 14,2 16 0,4 
Cardiovascular 
history 57,7% 45% 0,57 
Respiratory 
history 7,6% 18,1% 0,34 
Other medical 
history 34,6% 18,1% 0,28 
Prone 77% 100% 0.09 
Neuromuscular 
blockers 88,4% 100% 0,33 
Days to 
traqueostomy 11 11 1 
Percutaneous 
procedure 88,4% 81,8% 0,47  
Conclusion: We present the results of 37 patients who required a tra-
cheostomy as a part of the management of COVID 19 pneumonia. We 
describe the performance and the prognostic of the technique
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Introduction: Critically ill burns patients frequently require a trache-
ostomy, but pose particular challenges including airway and/or neck 
swelling, face and neck grafting and high oxygen and ventilation 
requirements. Grade 2Devidence exists for percutaneous dilation 
technique (PDT) over surgical technique (ST) in the burns setting[1]. 
ST is associated with lower costs when performed at the bedside or in 
association with another surgical procedure [2].
Objectives: We sought to compare the rate and severity of compli-
cations between PDT and ST in critically ill burns patients, within a 
regional burns critical care unit.
Methods: Retrospective data was collected over 33 months (May 2017 
to February 2020) from all admissions to a regional burns critical care 
unit. Basic demographic data was collected in addition to data regard-
ing technique, staff performing tracheostomy and tracheostomy 
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complications during hospital stay. Complications were classed as 
severe or not severe based on the necessity for significant ventilator 
changes, transfusion or tracheostomy change/bronchoscopy. Aver-
ages were expressed as medians with interquartile ranges. Mann Whit-
ney-U analysis was used for non-parametric continuous data and X2 
Fisher’s exact test for categorical data using SPSS (IBM corp). A p-value 
< 0.05 was considered significant.
Results: From 71 admissions, 49 required ventilation and 13 patients 
required a tracheostomy. Of these 13 tracheostomy patients, the 
median burn surface area was 23% (IQR 37%), 46% (n = 6/13) had 
inhalational injuries of grade 2 or worse and 92% (n = 12/13) had 
burns involving their neck. ST was employed in 70% of cases. Demo-
graphic data showed overall homogeneity between the PDT and ST 
groups. However the ST group had a greater proportion of males, 
severe inhalational injuries and burns involving the neck was although 
not significant. The average time between intubation and tracheos-
tomy formation was comparable between groups. Decannulation 
time also did not differ significantly. The majority of tracheostomies 
were performed in the theatre setting (n = 12/13) to coincide with 
debridement or skin grafting. PDT was performed predominantly by 
senior trainee anaesthetists (75%) and in the theatre setting with sur-
gical presence. All STs were performed by consultant surgeons, using 
an open approach.
At least one pre-procedural concerns was highlighted in 69% of all 
cases, including ventilatory concerns (3) (e.g. pneumonia, frequent 
desaturation), oedema at desired tracheostomy site (2), neck burns (2), 
distorted anatomy (1) and presence of graft at tracheostomy site (1). 
Similar rates of pre-procedural concerns were highlighted for ST and 
PDT cases (6/9 vs 3/4 respectively)
Early complication rate was greater with ST, with the majority being 
considered severe such as dislodgement, stomal leak, significant 
bleeding, surgical emphysema and occlusion due to malposition. PDT 






Age (years) 38(23) 55.5 (16.75) 0.266 
Weight (kg) 74.5 (28.3) 89 (16.4) 0.559 
Male Sex 1 (25%) 6 (67%) 0.266 
Inhalational injuries grade ≥2 1 (25%) 5 (56%) 0.559 
Burns to neck 3 (75%) 9 (100%) 0.308 
Burns Surface Area (%) 26 (17.5) 23 (47) 1.00 
Time to tracheostomy 
formation (days) 9.5 (6.75) 8 (3.0) 1.00 













Conclusion: Tracheostomies in critically ill burns patients are associ-
ated with a high risk of severe early complications[3]. We observed a 
higher rate of early complications (loss of airway and bleeding) in ST 
vs PDT. Although this data appears to favour PDT, the ST group had 
more pre-procedural concerns (e.g. more neck burns, distorted neck 
anatomy, oedema and inhalational injury) and therefore represent a 
higher risk group. We believe a national database is required to cap-
ture tracheostomy technique and complications to enable recommen-
dations in this high risk specialised cohort.
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Introduction: The National Tracheostomy Safety Project (NTSP) pro-
duces resources to improve multidisciplinary management of tra-
cheostomies [1]. However, tracheostomy tube emergencies on the 
Intensive Care Unit (ICU) differ significantly to the rest of the hospital. 
We therefore created new algorithms specific to ICU with emphasis on 
the use of capnography.
Methods: The algorithms were designed using ‘Plan, Do, Study, Act’ 
(PDSA) cycles to sit alongside existing NTSP bedhead tracheostomy 
or laryngectomy signs and use a stepwise approach suitable for any 
member of the multidisciplinary team to use in an emergency. We use 
the headings: ‘Tracheostomy: with patent upper airway’ and ‘Laryn-
gectomy: Neck-ONLY breather’ to emphasise that while both patients 
are ‘neck breathers’ only the laryngectomy patient is an obligate neck 
breather [2]. Using a multidisciplinary bedside training programme, 
using the ‘tea trolley’ method to provide 10-15 minute teaching ses-
sions for each staff member [3], we familiarised staff with the algo-
rithms and enabled them to employ them in a low fidelity simulation 
tool.
Results: We trained 67 staff members including all grades of nurses 
and doctors. 100% of participants preferred our algorithms to the 
NTSP algorithm, judging them to be clearer and easier to follow in 
an emergency. 100% of participants recommended this training pro-
gramme to other ICUs.
Conclusion: In ICU the patient with a tracheostomy is often ventilator-
dependent, capnography-monitored and displacement is more com-
mon than obstruction. This necessitates a different pathway to that 
on the wards (where obstruction is more common). Our ICU-specific 
algorithms were preferred and easier to follow. Conversely the NTSP 
algorithms, while an excellent teaching resource, can become over-
whelming in an emergency due to excessive detail.
Reference(s) and grant ackowledgment(s)
1. 1. National Tracheostomy Safety Project. http://www.trach eosto my.org.uk 
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2. 2. Paulich et al. Anaesthesia74:947, 2019
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Introduction: Many patients with COVID-19 require long-term 
mechanical ventilation. Early tracheostomy may offer a route to wean-
ing ventilation, decreased sedation, and reduced cardiovascular sup-
port for intensive care patients. However, at the peak of the COVID-19 
pandemic, advice in the UK was to wait for 14 days and/or a negative 
COVID-19 test due to perceived risks to the operator [1,2].
Objectives: To determine the impact of early percutaneous trache-
ostomies ( < 10 days after intubation) on sedation andvasopressor 
requirements. In addition, we examine whether modifications to 
reduce viral exposure avoided COVID-19 transmission to the treating 
team.
Methods: We conducted a retrospective analysis of all mechanically 
ventilated COVID-19 patients receiving tracheostomies at a single-
centre general intensive care unit in the UK from 19 March to 29 June 
2020 (n = 31). This involved a modified percutaneous technique to 
minimise aerosol generation. We compare patient sedation and car-
diovascular support over a five-day follow-up period, as well as 30-day 
discharge and mortality, with an indicative control group of five clini-
cally similar patients who did not receive a tracheostomy as they were 
transferred to different hospitals for exogenous reasons of ICU bed 
capacity. The treating team were also screened for COVID-19 antibod-
ies > 2 weeks after the procedures.
Results: Compared to baseline preceding tracheostomy, patients 
showed a decrease in both sedative and cardiovascular support 
requirements with no similar improvements in the control group. 
Median sedative requirements decreased from an average of over 10 
mg/hr of both morphine and midazolam or equivalent to less than 5 
mg/hr of both five days after tracheostomy, whilst median sedation 
remained above 10mg/hr of both for the controls. Median noradrena-
line decreased from 5 to 0 mcg/min over the same period, whilst the 
control group increased from 2.66 to 8 mcg/min. After 30 days, 15 
tracheostomy patients (48.3%) had been discharged from hospital, 
two (6.5%) were receiving ongoing care on step-down wards, and 14 
were deceased (45.1%). Of the indicative control group, after 30 days 
since meeting the criteria for tracheostomy two (40%) had been dis-
charged and three (60%) were deceased. Of the 31 procedures only 
two involved complications (6.4%); both featured transient desatura-
tion and hypoxia but neither resulted in lasting sequelae. In addition, 
we find that all clinicians involved with tracheostomies received nega-
tive COVID-19 antibody tests.
Conclusion: In a small sample size, we demonstrate the potential for 
early tracheostomy as a strategy for reducing sedative and vasopres-
sor requirements. This may improve outcomes for mechanically venti-
lated patients in a pandemic setting without compromising the safety 
of the treating team.
The authors acknowledge Aisling Corcoran, Becca Parrott, and Cheryl Pit-
tuck for helpful data assistance.
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Introduction: The most serious form of COVID 19 infection mani-
fested itself with a high number of patients with severe and long-
standing ARDS, many of whom required a tracheostomy during the 
course of their illness. Currently, there is no consensus on the best 
time to perform tracheostomies. According to current recommenda-
tions, in the SARS-COV-2 pandemic situation, it is recommended to 
perform a tracheostomy after 10 to 14 days of mechanical ventilation 
(MV) to minimize exposure to the viral load that exists in earlier stages 
and for a better selection of patients.
Objectives: The objective of this study is to compare the results of 
patients with ARDS secondary to SARS-COV-2 that required a trache-
ostomy because of prolongued mechanical ventilation in two Inten-
sive Care Units (ICU) in Spain
Methods: We carried out a retrospective observational study in 
the period between March and June 2020, in which SARS-COV-2 
patients that developed ARDS and required a tracheostomy were 
divided in two groups. We considered early-tracheostomy patients 
as the ones who had a tracheostomy during the first 14 days of MV 
and late-tracheostomy after the 14th day. Data are presented as the 
mean ± standard deviation (SD), the median with the 25 -75 percen-
tiles and the frequencies with percentages, as appropriate. Continu-
ous variables were analyzed with Student’s t-test or the Mann-Whitney 
test, and categorical variables were analyzed with the chi-square test 
or Fisher’s exact test. A level of statistical significance was set for val-
ues of p < 0.05
Results: 57 patients were included, of whom 73.7% were men, the 
mean age was 60.4 years old (± 13.2). APACHE II at admission was 
21.5 (± 8.1) and SOFA 8.9 (± 8.1). 29.6% of the patients were obese, 
43.9% had a history of HT and 22.8% were diagnosed with diabetes. 
At admission 29.8% had severe ARDS and 56.1% moderate ARDS. The 
CURB-65 and PORT-PSI mean were 2.07 (± 0.8) and 4.09 (± 0.8) respec-
tively. In 42% of patients, an early tracheostomy was performed (12.1 
(± 1.7) days) and 58% late (17.4 (± 2.7) days).
The duration of MV in the early TQT group was 23.5 days (20.2-33)) and 
in the late 30 days (25-41) (p 0.049); no significant differences were 
found in the days of ICU stay or in mortality.
Conclusion: In our series, patients with early-tracheostomy required 
fewer days of MV; however, we did not find significant differences in 
the days of ICU stay or mortality. These findings are similar to other 
studies in non SARS-COV-2 patients.
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Introduction: The COVID-19 pandemic has generated significant dis-
cussion of different means to reduce the risk of transmission to the 
clinician tasked with intubating an infected patient. Appropriate per-
sonal protective provides a barrier and video laryngoscopy increase 
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the distance between the clinician and the respiratory tract, however 
additional proposed methods such as translucent plastic boxes have 
been show to be less than helpful. We present a simulation to exam-
ine the implications of the deliberate use of suction during the airway 
management of a patient with a respiratory infectious disease, and 
to examine a technique that may serve to reduce respiratory droplet 
emissions and potentially increase the safety of the procedure for the 
clinician.
Methods: The right mainstem bronchus of the 7-Sigma mannequin 
was coupled with two medication nebulizer systems filled with diet 
tonic water, which fluoresces on contact with ultraviolet (UV) light. 
The nebulizers are then connected to two separate medical flow-
meters set to 15 L per minute flow. The left mainstem bronchus and 
esophagus of the mannequin are occluded to enhance thenebulizer 
gas flow through the mannequin to the oropharynx.  The fresh gas 
flow through the nebulizer units produces a fine mist/aerosol, which 
is visible in the room air when illuminated by UV light. Two separate 
60-watt UV lights, which are placed immediately to the sides and 
behind the endoscopist—to minimize the exposure of UV light to the 
endoscopist’s eyes—are utilized to illuminate the aerosol mist.
When the clinician introduces the suction catheter into the orophar-
ynx, the stream of aerosolized ceases to be visible as it is fully diverted 
into the stream of the suction. Utilizing the Suction Assisted Laryngo-
scopy and Airway Decontamination (SALAD) technique, the intuba-
tion can continue while leaving the suction catheter in place in the 
hypopharynx.
Results: This simulation shows the potential for a medical suction 
system to decontaminate the air space directly above the mouth of a 
mannequin emitting a nebulizer aerosol that is visible on UV light; and 
furthermore, it demonstrates the “intraoral” and “hypopharyngeal” 
decontamination of the nebulizer aerosol during simulated tracheal 
intubation.  Battery-powered suction systems, such as those used on 
code carts and by prehospital providers, typically draw approximately 
25 to 30 L per minute of gas through the suctionsystem. This airflow 
is equivalent to 1 cubic foot per minute. Though this volume is small, 
and it is dubious at best to predict whether this procedure would 
improve clinical safety of airway management in the presence of a res-
piratory infectious disease especially if the patient were to forcefully 
cough. Indeed, this implies that proper PPE, adequate paralysis and 
formal protocols are mandatory to maintain caregiver safety during an 
airway management procedure.
Conclusion:
The concept here is to reduce the potential inoculum that the car-
egiver’s PPE is exposed to during the procedure, such that the filtering 
capability of their respiratory protection mask is not overwhelmed.
Proactive use of the suction should prove to reduce the exposure of 
the physician PPE to a large inoculum of infectious respiratory parti-
cles if it accompanies the intubation attempt. Keeping the suction 
alongside the laryngoscope but above the esophagus and larynx 
could further help to reduce the airborne infectious respiratory par-
ticles in a patient under full induction and paralysis during intuba-
tion. Further focused studies are warranted.
000205 
Real time assessment of diaphragmatic muscle motion with Tissue 
Doppler Imaging; data from a single‑center observational study 
in ICU patients
A. Kefalidou1; E. Doumaki1; S. Savvidou1; I. Iordanidou1; E. Soilemezi1; 
M. Tsagourias1; D. Matamis1
1Icu, Papageorgiou General Hospital, Thessaloniki, Greece 
Correspondence: E. Soilemezi
Intensive Care Medicine Experimental 2020, 8(2): 000205
Introduction: Diaphragmatic Tissue Doppler Imaging (TDI) allows 
real time assessment of the diaphragmatic tissue motion velocity. TDI 
of diaphragmatic tissue motion has been studied very little so far in 
adults, and no information exists regarding its referrence values nor its 
clinical significance in ICU patients.
Objectives: To determine whether TDI-derived parameters can dif-
ferentiate patients who succeed from patients who fail a spontaneous 
breathing trial.
Methods: In consecutive ICU patients undergoing a T-tube trial, the 
following TDI-derived parameters were measured: Peak Contraction 
Velocity (PCV), defined as the maximal diaphragmatic velocity dur-
ing contraction, measured in cm/sec; Peak Relaxation Velocity (PRV), 
defined as the maximal diaphragmatic velocity during relaxation, 
measured in cm/sec; TDI–derived Maximal Relaxation Rate (TDI-MRR), 
defined as the slope of the initial steepest part of the diaphragmatic 
motion velocity curve during relaxation, measured in cm/sec^2. 
Measurements are presented as medians with 25th-75th interquar-
tile ranges (IQR). Areas under the receiver operating characteristic 
(AUROC) with 95% Confidence Intervals (95%CI) have been calculated.
Results: A total of 116 patients were included (67 succeed and 49 
failed weaning). Baseline patient characteristics: 87 (75.2%) males, 
aged 66.2 ±  12.5 years old, median 6 days under mechanical venti-
lation, reason for ICU admission: respiratory failure 18.9%, multiple 
trauma 13.8%, sepsis 13.8%, coma 5.2%. Groups did not differ in their 
baseline characteristics, but in TDI-derived measurements: PCV was 
1.36 (IQR 1.06-1.79) vs. 2.02 (IQR 1.28-2.89) cm/sec, p = 0.001; PRV 1.36 
(IQR 0.96-1.78) vs. 2.70 (IQR 1.41-4.86)cm/sec, p < 0,001; and TDI-MRR 
10.31 (IQR 5.66-13.74) vs. 21.75 (IQR 11.83-38) cm/sec^2, p < 0.001, for 
weaning success and weaning failure patients respectively. AUROC 
for PCV, PRV and TDI-MRR were 0.712 (95% CI 0.607-0.816, p < 0.001), 
0.772 (95%CI 0.677-0.867, p < 0.001) and 0.804 (95%CI 0.716-0.893, p < 
0.001), respectively.
Conclusion: The results of this study suggest that TDI-derived meas-
urements may serve as good markers for predicting success in a spon-
taneous breathing trial in ICU patients.
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Introduction: There is no ideal method for determination of PEEP 
in ARDS patients. We compared the effects of an EELV-guided versus 
 PaO2 guided PEEP determination on respiratory mechanics and oxy-
genation during the first 48 hours in moderate to severe ARDS.
Methods: Twenty-two patients with moderate to severe ARDS admit-
ted to an academic MICU were randomly assigned to  PaO2-guided 
(n = 11) or to an EELV-guided PEEP determination (n = 11) group. 
Incremental PEEP trial was performed by increasing PEEP by 3  cmH2O 
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steps from 8 to 20  cmH2O and in each step EELV and lung mechan-
ics were measured in both groups. EELV was measured with a modi-
fied nitrogen multiple breath wash-out/wash-in technique. In the 
 PaO2-guided group, optimal PEEP was accepted as the minimum PEEP 
level associated with  PaO2 ≥ 60 mmHg and  FiO2 ≤ 0.60. In the EELV-
guided group, optimal PEEP was accepted as the PEEP that caused a 
> 10% increase in EELV. Oxygenation and respiratory mechanics were 
measured under the determined PEEP at 4, 12, 24, and 48th hours. 
Results are presented as median [25-75th percentile]. Friedman and 
Spearman’s rho tests were used where appropriate. P value < 0.05 is 
accepted as statistically significant.
Results: As seen in the Table after the incremental PEEP trial, over 
the 48 hours of the study,  PaO2 and  PaO2/FiO2 increased in the EELV-
guided group as compared to  PaO2-guided group. EELV, static com-
pliance (Cs), driving pressure, and strain remained similar in the two 
groups. In all patients, the median value of EELV change (∆EELV) dur-
ing incremental PEEP trial was 25%. As seen in the Table in patients 
with ∆EELV > 25% (n = 11)  PaO2,  PaO2/FiO2 and Cs increased over time 
in 48 hours, whereas they did not change in those with ∆EELV ≤25% 
(n = 11). There was a negative correlation between EELV and driving 
pressure measured at 48th hour of the study period (r = -0.77, p < 
0.001).
Table: Gas Exchange and respiratory mechanics in PaO2 guided versus EELV guided groups, 
and between groups with ∆EELV >25% and ≤25% over 48 hours 
4th hour 12th hour 24th hour 48th hour p value * 
PaO2, mmHg 
   PaO2 guided 
   EELV guided 
∆EELV > 25% 





















PaO2/FiO2      
   PaO2 guided 
   EELV guided 
∆EELV > 25% 





































   PaO2 guided 











∆EELV > 25% 











Driving pressure   
PaO2 guided 
   EELV guided 
∆EELV > 25% 






















   PaO2 guided 
   EELV guided 
∆EELV > 25% 





































* Friedman tests were conducted to test whether there is a significant 
change in the variables within each group.
Conclusion: Compared to  PaO2-guided PEEP determination, EELV-
guided PEEP determination resulted in greater improvement in oxy-
genation over time. Patients who had > 25% improvement inEELV 
during a PEEP trial had greater improvement in oxygenation and com-
pliance over 48 hours. Measurement of EELV might not only help to 
determine optimal PEEP but also imply lung recruitability in patients 
with moderate to severe ARDS.
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Introduction: Existing clinical practice guidelines support the use of 
neuromuscular blocking agents (NMBA) in acute respiratory distress 
syndrome (ARDS). However a recent large randomized clinical trial 
(RCT) has questioned this practice. Therefore, we updated a previous 
systematic review to determine the efficacy and safety of NMBAs in 
ARDS.
Methods: We searched MEDLINE, EMBASE (October 2012 to July 
2019), the Cochrane (Central) database, and clinical trial registries 
(clinicaltrials.gov, ISRCTN Register, and WHO ICTRP) for RCTs compar-
ing the effects of NMBA as a continuous infusion versus placebo or no 
NMBA infusion on patient-important outcomes for adults with ARDS. 
Two independent reviewers assessed methodologic quality of the pri-
mary studies and abstracted data.
Results: Seven RCTs, including four new RCTs, met eligibility criteria 
for this review. These trials enrolled 1,598 patients with moderate to 
severe ARDS at centres in the United States, France, and China. All 
trials assessed short-term continuous infusions of cisatracurium or 
vecuronium. The pooled estimate for mortality outcomes showed sig-
nificant statistical heterogeneity, which was only explained by a sub-
group analysis by depth of sedation in the control arm. A continuous 
NMBA infusion did not improve mortality when compared to a light 
sedation strategy with no NMBA infusion (relative risk [RR] 0.99; 95% CI 
0.86 - 1.15; moderate certainty; P = 0.93). On the other hand, continu-
ous NMBA infusion reduced mortality when compared to deep seda-
tion with as needed NMBA boluses (RR 0.71; 95% CI 0.57 - 0.89; low 
certainty; P = 0.003). Continuous NMBA infusion reduced the rate of 
barotrauma (RR 0.55; 95% CI 0.35 - 0.85, moderate certainty; P = 0.008) 
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across eligible trials, but the effect on ventilator-free days, duration of 
mechanical ventilation, and ICU-acquired weakness was uncertain.
Conclusion: Inconsistency in study methods and findings precluded 
the pooling of all trials for mortality. Earliest trials suggested a mor-
tality reduction with a continuous NMBA infusion; however, when 
compared to the current practice of ARDS management with lighter 
sedation, use of continuous NMBA infusion did not reduce the risk of 
death. In both situations, a continuous NMBA infusion may reduce the 
risk of barotrauma, but the effects on other patient-important out-
comes remain unclear.
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Introduction: The coronavirus disease 2019 (COVID-19) pandemic 
has led to rapid exhaustion of intensive care facilities across the UK 
and the world. The use of anaesthetic machines for long term venti-
lation as an off label use received regulatory clearance in this setting. 
We compare the survival outcomes of COVID-19 patients between 2 
groups - those ventilated on anaesthetic machines and on those on 
standard ventilators. This was a retrospective observational case series 
conducted at Epsom and St Helier university hospitals in London.
Methods: 63 patients admitted to our intensive care unit with con-
firmed SARS-CoV2 (severe acute respiratory syndrome coronavirus-2) 
infection between 07 March and 27 April were included in this case 
series. These patients were either ventilated on anaesthetic machines 
or conventional ventilators depending on the availability of these 
machines. All the patients were treated with similar management pro-
tocols. The mortality rates, APACHE 2 scores and the length of venti-
lator days of the deceased patients were compared between the two 
groups.
Results: The mean±standard deviation (SD)  APACHE2 score in the 
anaesthetic machine group was 14.21  ±  4.05 and in the ventila-
tor group was 19.72 ±  5.66; p-value 0.0002. The mean±SD number 
of ventilator days was 6.87 ±  4.3 and 8.36 ±  6.68 in the anaesthetic 
machine and ventilator groups respectively (p-value 0.41). The mortal-
ity rate in the anaesthetic machine group was 80% and in the ventila-
tor group was 66.66%; p value 0.82.
Conclusion: There was no difference in outcomes between the 
patients ventilated on conventional ventilators versus those with 
anaesthetic machines. However, the results could be different if the 
APACHE scores were similar.
Anaesthetic machines were not intended for long term ventilation and 
their use in the times of such pandemics seem justified and essential 
when the availability of the conventional ventilators is limited. This is 
important because having a back up stock / inventory of conventional 
ventilators anticipating the occasional pandemic may not be viable 
financially for most healthcare organisations.
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Introduction: In ARDS patients, controlled mechanical ventilation 
- either volumetric or pressometric - is commonly employed. Several 
studies investigated the effects of inspiratory flow on clinical param-
eters.1 Yet, a systematic approach to this issue is still lacking, and so 
are its clinical consequences.
Objectives: To appraise the effects of four different inspiratory flow 
waveforms on gas exchange, pulmonary mechanics and hemodynam-
ics during volume-controlled mechanical ventilation.
Methods: Within 72 hours from the diagnosis of ARDS, patients were 
enrolled. Supine position, myorelaxation and esophageal pressure 
monitoring were inclusion criteria. Volume-controlled ventilation with 
Hamilton S1 (Hamilton Medical, Bonaduz, CH) was instituted as it fol-
lows: Tidal Volume 6-8 ml/kgIBW, Plateau Pressure ≤25 cm  H2O, PEEP 
as described by the high-PEEP/low-FiO2  branch of the LOV study.2 
Patients were randomized to receive: square (SQ), decelerated (DE), 
sinusoidal (SIN), and trunk decelerated (TDE) waveform. After 20 min 
of clinical stabilization following each waveform change, data were 
collected and analyzed.
Results: Twenty-six patients were enrolled and randomized. Gas 
exchange, pulmonary mechanics and hemodynamic data are clus-
tered on the basis of inspiratory waveform (Table 1). Significant differ-
ence was observed in peak inspiratory flow (Figure 1) between DE and 
TDE (p < 0.001), SQ (p < 0.001) and SIN (p = 0.001); among TDE and 
SIN (p < 0.001); between SQ and SIN (p < 0.001). Nevertheless, varia-
tions in terms of gas exchange, pulmonary mechanics and hemody-
namics resulted shy of statistical relevance.
Table 1. Grouped gas exchange, pulmonary mechanics and hemodynamics 




707.9±121.1 475.5±74.1 423.1±88.7 598.1±105.1 <0.01 
Ppeak (cm 
H2O) 28.3±4.8 27.1±4.5 28.4±4.9 28.4±4.8 0.719 
MAPaw (cm 
H2O) 16.6±2.6 15.9±2.5 15.5±2.6 15.6±2.7 0.428 
ERS (cm 
H2O/l) 20.6±6.9 20.1±6.7 19.6±6.2 20.4±6.6 0.964 
EL(cm H2O/l) 13.4±6.3 13.7±4.2 12.6±5.7 13.5±6.1 0.918 
ECW (cm 
H2O/l) 7.1±2.2 6.4±2.8 7.1±2.1 6.9±2.3 0.746 
∆PL (cm H2O) 13.1±4.2 13.7±4.2 12.6±3.8 13.3±3.9 0.813 
EELV (ml) 1321.5±584.7 1271.2±556.2 1304.8±645.9 1314.9±585.9 0.990 
MP (J/min) 16.9±4.4 16.4±4.8 16.9±4.1 17.4±4.5 0.883 
MAP (mmHg) 76.4±9.1 76.1±10.8 77.7±14.5 77.5±10.6 0.939 
  DE TED SQ SIN p 
HR (bpm) 82.1±15.7 80.4±14.3 84.0±16.9 83.5±16.7 0.852 
PaCO2 (mmHg) 49.70±9.92 51.74±11.55 52.76±11.78 52.18±11.34 0.776 
PaO2/FiO2 187.85±42.46 185.4±44.7 179.9±38.9 182.5±37.7 0.909 
Data are displayed as mean±SD. Ppeak, Peak Pressure; Pplat, Pla-
teau Pressure; MAPaw, Mean Airway Pressure; ERS, Respiratory Sys-
tem Elastance; EL, Lung Elastance; ECW, Chest Wall Elastance;  ∆PL, 
Transpulmonary pressure; EELV, End-Expiratory Lung Volume; MP, 
Mechanical Power; MAP, Mean Arterial Pressure; HR, Heart Rate; 
PaCO2, Arterial partial pressure of CO2;  PaO2/FiO2, arterial partial pres-
sure of O2 to inspired fraction of O2 ratio.
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Conclusion: In our study, the application of different inspiratory wave-
forms resulted in sensible variations of peak inspiratory flow. Never-
theless, this did not translate in relevant shifts of clinical parameters.
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Introduction: Advanced respirator technologies provide auto-
mated stepwise PEEP-increases in parallel with the measurement of 
functional residual capacity (FRC) and static pulmonary compliance 
(C_stat). While this PEEP-trial (PT) may help facilitate optimal PEEP-
setting, it also carries the risk of haemodynamic instability due to the 
reduced venous return. We hypothesized that a standard PT with step-
wise increases in PEEP of a total of 8  cmH2O might result in substantial 
haemodynamic changes. Since heart lung interactions have been sug-
gested to diagnose volume responsiveness, the PT could be used as a 
combined approach to optimize ventilation and haemodynamics.
Methods: In 50 mechanically ventilated patients (Carescape R860; GE; 
pressure-controlled ventilation; PF-ratio of 249 + −83) and PiCCO-
monitoring, an automated five step PEEP-trial was performed. PEEP 
was increased from values of 4 cmH20 below, to 4  cmH2O above the 
present PEEP-level. PiCCO-data, ventilator settings, FRC and C_stat 
were measured at baseline and after each increase.
Results: Mean values for most haemodynamic parameters including 
heart rate, MAP, CVP, global end-diastolic volume index GEDVI, stroke 
volume index SVI, stroke volume variation SVV, extravascular lung water 
index EVLWI and cardiac power index CPI were not significantly differ-
ent at the end compared to the start of the PT. Mean cardiac index CI 
decreased significantly as the heart rate decreased with increasing PEEP. 
PEEP (5,1 ± 1,7 vs. 12,8 ± 2,4  cmH2O; p < 0.001) and FRC (1493 ± 588 vs. 
1940 ± 778 ml; p < 0.001) were significantly higher after the PT, while all 
other respiratory data including tidal volume and C_stat were not differ-
ent after the PT. Individual maximum values during the PT were signifi-
cantly higher for tidal volume (461 ± 151 vs. 526 ± 126 mL; p < 0.001) and 
C_stat (38 ± 21 vs. 48 ± 23 mL/cmH2O; p < 0.001) compared to baseline.
Conclusion: 1.) The PT did not impair haemodynamics. While the PT 
is haemodynamically safe, its use to detect volume deficiency appears 
to be low. 2.) Adjustment of PEEP in response to PT data substantially 
improves FRC, C_stat and tidal volume.
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Introduction: A tracheostomy (TSY) is a well-recognised means to pro-
vide a safe interface for weaning off prolonged mechanical ventilation, 
especially in those with severe respiratory failure. Aerosol generating 
procedures (AGPs) are associated with significant cross infection risks 
to healthcare workers with deaths reported, including those of ENT 
surgeons. No national consensus exists on the role or timing of TSY in 
COVID-19 pts. Initially TSYs were requested ad-hoc based on clinical 
need. However, with the dynamic and rapidly evolving pandemic it 
became clear an agreed pathway was required with clarity on indica-
tions and timing of the procedure. We present a tertiary centre experi-
ence of creating a novel TSY pathway for long stay COVID-19 patients.
Methods: Regular multidisciplinary team (MDT) discussions between 
intensivists, ENT surgeons and operating room staff provided a forum 
to address and discuss all relevant issues, concerns and risks (both 
to patients as well as staff) of undertaking a TSY in COVID-19 pts. An 
agreed step-wise approach was instituted with potential for review. 
Consecutive COVID-19 positive pts admitted to ICU at a tertiary refer-
ral centre over 8 weeks were included. Contemporaneous electronic 
case notes and results were retrospectively reviewed.
Results: The step-wise plan agreed was as follows
1. Avoid TSY before 14 days
2. TSY only in patients with favourable prognosis
3. Need for TSY agreed by 2 ICU Consultants
4. Aim percutaneous TSY as first option if possible
5. Surgical TSY following MDT discussion
6. All procedures to be undertaken under full PPE
MDT meetings took place at set times, 3 times a week. The order of 
patients for surgical TSY was also agreed.
During this time 72 COVID pts were admitted to ICU with 59/72 (82%) 
intubated and mechanically ventilated; their characteristics are shown 
in Table 1.
The median time from admission to intubation was 1 (range 0-34) day 
and from intubation to TSY 16 (2-34) days. TSY was performed in 27/59 
(46%) of patients; with a surgical approach 24/27 (89%) being com-
monest. Median time from decision for TSY and the procedure was 4 
(0-26) days. Median time from TSY to spontaneous breathing trial was 4 
(2-19) days and to decannulation was 12 (6-24) days. There were no TSY 
related complications. 13 patients were successfully primarily extubated 
at a median time of 10 (3-17) days after endotracheal intubation.




Age (years) – mean (standard deviation) 57.9 (± 12.7) 
Male sex – n (%) 53 (74%) 
BMI – mean (standard deviation) 29.1 (± 6.2) 




N 6lacigolorue (8%) 
Diabetes 10 (14%)  
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Conclusion: Engagement of key stakeholders is essential to create 
a streamlined TSY pathway for COVID-19 pts. Clarity and agreement 
between multiple specialties has helped provide an effective service 
without an increased infection risk to staff.
Reference(s) and grant ackowledgment(s)
1. National tracheostomy safety program guidelines http://www.trach eosto 
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Introduction: Specific respiratory features, ventilatory management, 
and outcomes of patients with acute respiratory distress syndrome 
(ARDS) caused by coronavirus disease 2019 (COVID-19) have not been 
well established yet.
Objectives: The aim of this observational study was to describe char-
acteristics of confirmed ARDS COVID-19 patients that received inva-
sive mechanical ventilation (MV) and other adjunctive therapies.
Methods: From March 12th to April 8th 2020, this prospective, mul-
ticenter, observational, cohort study enrolled patients with COVID-19 
ARDS admitted to the ICU, in 28 hospitals, with a 28-day follow up. 
Patient medical data were collected into an anonymized online data 
acquisition system (CoVid19.ubikare.io). Inclusion criteria: > 18 y/o, 
intubated and mechanically ventilated, confirmed SARS-CoV-2 infec-
tion using PCR-based tests, and ARDS, as defined by the Berlin crite-
ria. Recorded data included demographics, ventilator parameters, 
adjunctive therapies, disease chronology (initiation of MV, ventilator-
free-days, ICU-length-of-stay), discharge from ICU and 28-day mortal-
ity. Patients were stratified by severity of ARDS. Descriptive variables 
were expressed as percentage, mean and standard deviation (SD), 
or median and interquartile range (IQR), as appropriate. To compare 
variables, Student t-test or Mann-Whitney test and one-way ANOVA 
or Kruskal-Wallis test for numerical variables, and Chi squared test or 
Fisher exact test for categorical variables were used. Time to event 
curves were plotted using the Kaplan-Meier method and analyzed 
with log-rank test and univariable Cox regression analysis.
Results: A total of 504 patients were included: 96 (19.0%) with mild, 
235 (46.6%) with moderate, and 173 (34.3%) with severe ARDS. Median 
(IQR) values were:  PaO2/FiO2 127 (88-182) mmHg, VT 6.9 (6.3–7.8) ml/
kg PBW, PEEP 12 (10-14)  cmH2O, Crs 35 (28-45) ml/cmH2O, Pplat 24 
(20-28)  cmH2O, and driving pressure 12 (9-14)  cmH2O. Recruitment 
maneuvers (RM) were used in 414 (82%) without differences between 
groups. Prone position was used in 385 (76%) patients, and neuromus-
cular blocking agents (NMBA) were used in 340 (66%) patients. Degree 
of ARDS severity was associated with significant differences in the 
use of prone position (p = 0.001) and NMBA (p = 0.008). There was a 
higher likelihood of discontinuation of MV (p = 0.006), ICU discharge 
(p = 0.010) and 28-day survival (p = 0.004) with decreasing severity 
of ARDS. All-cause 28-day mortality was 18% (94 patients). The risk of 
28-day mortality was higher in severe ARDS compared to moderate 
ARDS [hazard ratio (RR) 0.47 (95%CI: 0.30-0.76), p = 0.002].
Conclusion: On average, in this large series, COVID-19 ARDS patients 
were managed with standard practice of lung-protective mechanical 
ventilation frequently associated to RM and prone position. General 
clinical features, ventilatory management, and 28-day outcome did 
not differ from other causes of ARDS. The degree of ARDS severity was 
a significant prognostic factor.
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Introduction: A new coronavirus (SARS-CoV-2) emerged from China 
in December 2019, causing an severe acute respiratory distress syn-
drome (ARDS) that rapidly spread to become a pandemic.
Objectives: To describe patients admitted to a medical Intensive Care 
Unit (ICU) in a second-level university Hospital due to severe ARDS 
related to COVID-19 infection.
Methods: Retrospective and descriptive analysis between March and 
April 2020 of critically ill patients with COVID-19-related severe acute 
respiratory distress syndrome admitted to a medical ICU. The follow-
ing parameters were analyzed: demographic values (gender, age, 
severity scores, comorbidities), hemodinamic instability, renal failure, 
respiratory failure (ventilatory mode,  FiO2 level, PEEP, prone ventila-
tion, continuous neuromuscular blockade (NMB), endotracheal tube 
exchange, tracheostomy, days spent under mechanical ventilation), 
laboratory parameters (lactate dehydrogenase (LDH), low white blood 
cell (WBC) count, C-reactive protein (CRP), D-dimer, serum ferritine), 
length of ICU stay and outcomes.
Results: 22 patients (19 male, 3 female) were admitted, mean age: 
67 ± 6,1 ( < 60 years old:4, 60-70 years old: 13 (59%), > 70 years old: 
7). APACHE II score: 26 ±  7, SOFA : 7,5 ±  1,9. Comorbidities: chronic 
airflow limitation (CAL): 4, obesity (BMI > 30): 5 (22,7%), hypertension: 
13 (59%), diabetes: 4. Inotropic support: 6 (27,3%), renal failure (con-
tinuous renal replacement therapy(CRRT)): 3 (13,7%), respiratory sup-
port: 22 (100%), ventilatory mode: pressure 14 (64%), volumen 8,  FiO2 
(max): < 0.6: 5, between 0.6-0.8: 12 (54,5%), > 0.8: 5. PEEP (max): < 9 
 cmH2O:3, between 9-12: 13 (60%), > 12: 6. Prone ventiltation: 18 (81%): 
within the first 24 hours:8, after 24 hours: 10. Continuous NMB: 14 
(64%). Reintubation: 4 (18%), endotracheal tube exchange (obstruc-
tion):7 (32%), tracheostomy:5 (22,7%), 4 surgical tracheostomy (3 
difficult airway, 1 coagulopathy), 1 percutaneous. Time spent under 
mechanical ventilation: 18 ± 8,5 days. Laboratory parameters: 14 LDH, 
10 low WBC count, 19 (86%) CPR, 18 (81%) D-dimer, 19 (86%) serum 
ferritine. Length of ICU stay: 19,8 ±8 days. Outcome: 18 (81,8%) dis-
charged (alive), 3 deaths, 1 still in ICU.
Conclusion: According to our series, the type of patient admitted 
with COVID-19 related severe acute respiratory distress syndrome 
(ARDS) was a male between 60-70 years old, with hypertension and/or 
obesity, under mechanical ventilation (pressure mode:64%) and  FiO2 
(within the first 24 hours): 0.6-0.8 (54,5%), PEEP 9-12  cmH2O (60%), in 
prone positioning (81%) and continuous NMB infusion (64%), requir-
ing tracheostomy (22,7%) and a 81,8% of survival rate.
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Introduction: Ventilator associated pneumonia (VAP) is the com-
monest complication of mechanical ventilation and is a major cause 
of morbidity and mortality. VAP incidence varies based on definitions, 
but has been estimated to affect between 8-28% of patients(1). The 
SARS-CoV-2 pandemic has resulted in a large increase in the numbers 
of patients being mechanically ventilated. We examine the incidence 
and cause of VAP in COVID positive and negative individuals during 
the first wave of SARS-CoV-2 in a UK tertiary care intensivist unit.
Objectives: To determine the incidence of suspected VAP in patients 
with COVID-19.
Methods: We performed a retrospective chart review of all patients 
admitted to Addenbrooke’s hospital requiring mechanical ventila-
tion with confirmed SARS-CoV-2 for 7weeks up to and including the 
1/5/2020. Patients were defined as having a suspected VAP based on 
worsening oxygenation or increased sputum combined with systemic 
inflammation (pyrexia and/or raised neutrophil count) and radiologi-
cal features (new or progressive chest x-ray infiltrates), confirmed VAP 
required positive quantitative microbiological culture or molecular 
detection of a pathogenic organism.
Results: 64 COVID-19 positive patients required invasive ventila-
tion, receiving a median 15 (IQR 10-22) days of ventilation and a total 
of 1017 ventilator days. 53 (83%) developed a suspected VAP, with 
26 cases confirmed by microbiology. The incidence density of sus-
pected VAP amongst all COVID-19 positive intubated patients was 52 
cases per 1000 ventilator-days. ICU Mortality was 56% in this cohort, 
amongst those who did not develop suspected or confirmed VAP it 














Conclusion: VAP rates appear to be high amongst patients with 
COVID19, reflecting both their prolonged need for ventilation(1) and 
critical-illness induced immunosuppression(2). The rate reported here 
may reflect the diagnostic modalities used, as early on endotracheal 
aspirate (which over-estimates true incidence) (3) was used until we 
developed a safe system for bronchoscopic sampling. Gram-negative 
organisms predominate. The extent to which VAP mediates the high 
mortality seen remains uncertain but calls for antibiotic stewardship, 
vigilance, and detailed work in this area.
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Introduction: An atypical behavior of ARDS caused by COVID-19 has 
been suggested, since several patients with profound hypoxemia had 
close to normal respiratory system compliance (Crs). However, data 
confirming this assumption are scarce, and there is still controversy on 
the most appropriate oxygenation and ventilation strategies for these 
patients.
Objectives: We performed a secondary analysis of an observational 
study to compare clinical features, ventilatory management and clini-
cal outcomes in COVID-19 ARDS patients on mechanical ventilation 
(MV) with normal and low Crs.
Methods: From March 12th to April 8th 2020, a prospective, multi-
center, observational, cohort study that enrolled patients with COVID-
19 ARDS admitted to the ICU in 28 hospitals was performed, using a 
specifically designed online anonymized data acquisition system 
(CoVid19.ubikare.io). Inclusion criteria: > 18 y/o, intubated and MV, 
confirmed SARS-CoV-2 infection from a respiratory tract sample using 
PCR-based tests, and ARDS, as defined by the Berlin criteria. Recorded 
data: demographics, ventilator parameters, adjunctive therapies, dis-
ease chronology (initiation of MV, ventilator-free-days, ICU-length-of-
stay), discharge from ICU and 28-days in-hospital mortality. Patients 
were stratified as having normal Crs (≥  50 ml/cmH2O) or low Crs ( < 
50 ml/cmH2O) according to baseline values. Descriptive variables 
were expressed as percentage, mean and standard deviation (SD), or 
median and interquartile range (IQR), as appropriate for each variable. 
To compare variables across groups, Student t-test or Mann-Whitney 
test and one-way ANOVA or Kruskal-Wallis test for numerical vari-
ables, and Chi squared test or Fisher exact test for categorical variables 
were used. Time to event curves were plotted using the Kaplan-Meier 
method and analyzed with log-rank test and univariable Cox regres-
sion analysis.
Results: A total number of 504 patients were included. From the 286 
patients (56%) with Crs data, median baseline was 35 [28-48], 216 
(75.5%) were classified as having low Crs and 70 (24,5%) as having 
normal Crs. Time from symptoms onset to MV showed no differences 
between groups [11 (ICR: 8-15)]. There were no significant differences 
in  PaO2/FiO2 between patients with normal or low Crs and the venti-
lation strategy (VT and PEEP) did not vary. Although the distribution 
of patients with normal or low Crs showed significant differences 
in driving pressure, both at baseline [9 (IQR: 6–10) vs 12 (IQR: 10–16) 
 cmH2O, p < 0.001] and at maximum values [12 (IQR: 9–15) vs 16 (IQR: 
12- 18)  cmH2O, p < 0.001], these differences were not associated with 
ARDS severity. No differences were observed in the use of recruitment 
maneuvers and prone positioning. The probability of discontinuation 
from MV and the probability of ICU discharge did not increase with 
normal Crs. The risk of 28-day mortality was not impacted by Crs.
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Conclusion: We found a median baseline Crs similar to non-COVID-19 
ARDS patients, and 75% of patients had low Crs right after initiation 
of MV. No differences were found in ventilation management and 
outcomes.
Reference(s) and grant ackowledgment(s)
1. Ranieri VM, Rubenfeld GD, Thompson BT, et al; ARDS Definition Task 
Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 
2012;307(23):2526‑2533.
2. Gattinoni L. Chiumello E, Caironi P, et al. COVID‑19 pneumonia: different 
respiratory treatment for different  
phenotypes? Intensive Care Medicine 2020; https ://doi.org/10.1007/s0013 
4‑020‑06033 ‑2.
000621 
Ventilating the COVID19 patient: Experience from a tertiary 
hospital
R. Neto1; D. Adrião1; AL. Rios1; P. Fernandes1; P. Castelões1
1Intensive care department, Centro Hospitalar de Vila Nova Gaia/
Espinho, Vila Nova de Gaia, Portugal 
Correspondence: R. Neto
Intensive Care Medicine Experimental 2020, 8(2): 000621
Introduction: Corona Virus Disease 2019 (COVID-19) is a life-threat-
ening viral infection caused by a new strand of the coronaviridae 
family[1], that was declared a pandemic by WHO on March 11th. The 
most severe form of the disease is characterized by severe hypoxemic 
respiratory failure with a need for ventilatory support. Despite fulfill-
ing the Berlin ARDS Criteria, these patients have severe hypoxemia 
with a near-normal lung compliance, differing from traditional ARDS 
patients[2]. This presented a new challenge for Intensivists, who had 
to develop new ventilatory strategies.
Objectives: Study the ventilatory dynamics of COVID-19 patients and 
their impact on critical care outcomes.
Methods: Retrospective observational cohort study of all patients 
with a laboratory confirmation of SARS-CoV-2 infection, admitted to 
the Intensive Care Unit (ICU) of a tertiary Hospital in Northern Portugal, 
from March 15th to May 10th.
Results: During the study period, 264 COVID-19 patients were admit-
ted to our hospital and 36 required ICU admission. Median age was 
62 years [58,25 -65,75] and the majority were male (63.9%). Median 
ICU stay was 16 days [7.0-23.5]. 86.1% of patients required invasive 
mechanical ventilation, with a median duration of 17 days [8-24]. One 
patient required veno-arterial extracorporeal oxygenation. Mean pO2/
FiO2 ratio at admission was 174.1 ±67.4. pO2/FiO2 ratio at admission 
and variation during the first 48h of stay were not associated with 
ICU length of stay (p = 0.063 and p = 0.820, respectively) or dura-
tion of invasive mechanical ventilation (p = 0.103 and p = 0.916, 
respectively).
At admission, median Positive End-Expiratory Pressure (PEEP) levels 
were 9cmH20 [8-10] and patients were ventilated with an average 
7.6 ±  1.1 ml/kg of tidal volume. During the total length of ICU stay, 
median PEEP levels were 8.5cm H20 [7.7 -9.7] and patients were ven-
tilated with 7.6 ±0 .9ml/kg of tidal volume. Average driving Pressure 
levels at admission and during ICU stay were 14.6 ±4.8 and 12.8 ± 3.9, 
respectively.
Neuromuscular block perfusion was used in 64.5% of patients and 
54.8% of patients required at least one period of prone position (mean 
duration of 3.6 ±2.7 days). Due to prolonged weaning, 33.3% of 
patients were tracheostomized.
During the ICU stay 9 (25%) patients died. Non-survivors had signifi-
cantly lower pO2/FiO2 ratio (168.3 VS 176.0, p = 0.001), higher driv-
ing pressures (15.40 vs 11.7, p = 0.018) and lower tidal volumes (6.95 
vs 7.85; p = 0.022) during ICU stay. No other ventilatory variable 
was associated with ICU mortality. At the time of analysis, 1 patient 
remained in the ICU and only 9 (25%) patients were discharged from 
the hospital.
Conclusion: COVID-19 patients require lengthy periods of invasive 
mechanical ventilation, with higher tidal volume strategies than 
normal ARDS patients and high rates of tracheostomy as part of the 
ventilatory weaning strategy. The retrospective nature and low sam-
ple size are the study main limitations.
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Introduction: Spontaneous breathing in hypoxemic respiratory fail-
ure can lead to Patient self-inflicted lung injury (P-SILI) due to various 
factors related to intense inspiratory effort with high transpulmonary 
pressures (1,2).
Objectives: To evaluate respiratory mechanics, Effort (PTP/min), Work 
of breathing (WOB), and delta muscle pressure (Dpmus) in patients 
with COVID-19 pneumonia during mechanical ventilation (MV), with 
three ventilatory strategies during spontaneous ventilation, as well as 
in passive mode.
Methods: We have studied eleven patients with COVID-19 pneumonia 
mechanically ventilated during volume-controlled ventilation (CMV), 
pressure support ventilation (PSV) with inspiratory pressure 10/PEEP 
10  cmH2O, airway pressure release ventilation (APRV) 20/0  cmH2O with 
expiratory time for 75% peak flow expiratory (Pef ) and double CPAP 
(CPAPd) 20/10  cmH2O. Respiratory signals: Flow, airway pressure and 
volume were recording from the Medibus protocol of the Evita Dräger 
ventilator, at 125 htz, using personal software. The three components 
of the equation of motion for the respiratory system: elastance (Ers), 
Resistances (Rrs) and total PEEP (PEEPt) were obtained in the passive 
mode using multiple linear regression. In support pressure, we use the 
inspiratory, expiratory occlusion manoeuvres for Ers, and the measure-
ment of the time constant (t), as the time required to empty the lung 
2/3 of its tidal volume to obtain Rrs. In this way, the signals of Pres-
sure Muscular, alveolar and total pressure were obtained. Parameters 
related to the respiratory drive, effort, work of breathing, and breath-
ing pattern were calculated in each ventilatory mode, cycle by cycle. 
The clinical and demographic characteristics were collected. Data 
were analyzed for descriptive methods and expressed as mean±SD, 
coefficient of variation (CV) and medians (IRQ).
Results: N 11 cases. Sex M 7 (63%). Age (y): 63 ± 9.81. Died 4. ApacheII 
Score 18.92 (17.25-20.75). BMI 28.58 ±  2.43. MV, days 12 (5.25-21.7). 
P/F 194.8 ± 49.64 mmHg;  FiO2 0.48 ± 0.08 mmHg. PCO2 53.09 ± 15.59 
mmHg. ECMO-vv 1.
Conclusion: We have found an elevated respiratory driver in almost 
all patients COVID-19, associated with high inspiratory effort, although 
with wide dispersion. That is not controlled with any spontaneous 
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mode tested that resemble VNI; and this could be a cause of potential 
P-SILI.
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Introduction: COVID-19 is a pandemic associated with acute respira-
tory failure [1].  Management of critically ill  COVID-19 patients with 
severe hypoxemia is associated with high mortality [2].
Objectives: To reduce ICU length-of-stay (LOS), mechanical ventila-
tion (MV) and mortality implementing a standardized “care map”.
Methods: A retrospective analysis was conducted on consecu-
tive COVID-19 patients admitted in ICU for severe pneumonia in our 
Center in Lugano. A standardized multidisciplinary approach was 
implemented to improve patients monitoring using a) uniform patient 
selection for ICU admission, b) a low-PEEP strategy and c) an enlarged 
pharmacologic venous thromboembolism (VTE) management.
1. Dyspnea, mental confusion or SpO2 less than 85% were criteria for ICU 
admission.
2. Ventilation approach employed low PEEP values (about 10  cmH2O in pres‑
ence of lung compliance > 40 mL/cmH2O) and  FiO2 as needed. In presence 
of lower lung compliance ( < 40 mL/cmH2O) PEEP value was increased to 
about 14  cmH2O.
3. Enlarged prophylactic anticoagulation (Enoxaparine 60 mg bid SC if 
weight > 80 Kg, Enoxaparine 40 mg bid SC if weight < 80 Kg, Unfractioned 
Heparin in case of AKI) with daily ultrasound Color‑Doppler lower limbs and 
plasmatic D‑dimer level monitoring was performed; in case of suspected or 
confirmed thromboembolism, treatment was switched to therapeutic anti‑
coagulation (Enoxaparine 1 mg/Kg bid SC – Unfractioned Heparin in case 
of AKI at 14 UI/Kg/day in perfusion, adapted according to anti‑Xa values).
Results: From March 16th  to April 12th  2020, 48 patients were pre-
sented to be evaluated for ICU admission. Twenty-two of them were 
not admitted, they have been carefully monitored and presented a 
100% of overall survival at 30 days.
Forty-one patients were admitted to ICU: 26 from the Internal Medi-
cine Department, 10 from Emergency Department and 5 transferred 
from other hospitals. Mean SAPS was 45 (SD 18.4), mean NEMS was 
30 (SD 10.4). Thirty-four (82.9%) patients needed MV; low PEEP val-
ues based on BMI (PEEP 11 ±  3.8 (10-12)  cmH2O if BMI < 30 kg/m2; 
PEEP 15 ± 3.26 (12-18)  cmH2O if BMI > 30 kg/m2) was employed. Six 
patients (14.6%) presented major VTE phenomena. According to VTE 
prophylaxis strategy, 15 (36.5%) patients were treated through proph-
ylaxis, 26 (63.4%) were managed by full therapeutic anticoagulation. 
No patient presented bleeding complication, nor clinical sign requir-
ing anticoagulation removal.
Median duration of MV was 7 days; the median LOS was 9 days. After 4 
weeks, 25 patients (61%) were discharged from ICU, 4 (9.7%) were still 
under MV, 2 were transferred to another hospital;  ICU mortality rate 
was 24.3%. P/F ratio had daily improvement during first 72 hours (p < 
0.0001).
Conclusion: Our multidisciplinary program allowed to reduce MV 
days, ICU LOS and mortality in COVID-19 critical care patients; a stand-
ardized “multimodal approach” could be the base for further specific 
patients’ management in this emergency clinical scenario.
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Introduction: Postextubation respiratory failure is associated with 
bad prognosis, leading to reintubation within 72 hours in up to 50% of 
cases. A model to identify which patients are at high risk of failure can 
be useful to improve outcome.
Objectives: To design a model to identify those patients with high risk 
of postextubation failure
Methods: Post-hoc analysis of a randomized clinical trial (reference). 
Variables associated with postextubation respiratory failure and rein-
tubation were tested by multiple logistic analyses. Then, using logit 
methodology, we designed models to predict postextubation respira-
tory failure and reintubation. We calculated the area under the curve 
(AUC) for each model.
Results: We analyzed 950 patients extubated after a successful SBT, 
199 (21%) of them developed respiratory failure, and 104 (11%) 
needed reintubation. The variables related with postextubation res-
piratory failure were respiratory rate (RR) > 25x’ at the end of SBT (OR 
1.73, p = 0.02), duration of MV > 4 days (OR 1.75, p = 0.001), SatO2/
FiO2 < 240 (OR 1.89, p = 0.002), and neoplastic disease (OR 1.62, p = 
0.02). Reintubation was only associated with duration of MV > 4 days 
(OR 1.86, p = 0.005) and RR > 25 at the end of SBT (OR 1.99, p = 0.002). 
The AUCs were low in both models (0.63 for respiratory failure and 
0.60 for reintubation).
The model classified patients in 3 groups of risk for respiratory failure. 
The actual rate of respiratory failure in patients classified as low risk 
was 13%, 22% at middle risk and 34% at high risk of failure patients.
The model also classified patients in 3 groups of risk for reintubation. 
The reintubation rate was 7% in patients in low risk, 14% in patients in 
middle risk, and 24% in patients in high risk of reintubation.
Conclusion: RR > 25 bpm, length of MV > 4 days, SatO2/FiO2 < 240 
and neoplastic disease were related with higher postextubation 
respiratory failure. Only the length of MV > 4 days and RR > 25 were 
related with reintubation. Despite low AUC, both models for respira-
tory failure and reintubation identified 3 groups of patients with very 
different risks.
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Introduction: Respiratory failure requiring mechanical ventilation due 
to COVID 19 pneumonia has been the principal cause of admission 
to Intensive Care during the months of March, April, May and June in 
Europe.
Objectives: We present a sample with the factors that we have associ-
ated with mortality in patients on mechanical ventilation.
Methods: A retrospective, observational study was performed with all 
the patients admitted to the Intensive Medicine Service at a University 
Hospital with the diagnosis of Community-acquired pneumonia due 
to COVID 19.
Variables analysed age, sex, APACHE II, mechanical ventilation, length 
of stay, laboratory values, prone, neuromuscular blocking drugs, tra-
cheostomy and mortality during their stay in intensive care.
Results: 90 patients were analysed. 40% (36/90) have been dis-
charged. The sample has a mortality rate of 34.4% (31/90) and 25.1% 
(23/90) have been transferred.
Excluding the transferred patients, analysing the 67 patients who 
received complete treatment in our hospital: Length of stay 14.1 ± 10, 
average age 60 years, APACHE II 14.3  ±  5.2. 67.2% males. Average 
worst creatinine result 1.48 ± 1.26 mg/dl, Average worst ferritin value 
2310 ±  3322 mg/l, Mean value of worst total bilirubin value 2 ±  2.2 
mg/dl. 100% of the patients required mechanical ventilation. 65.7% 
prone position, 74.6% neuromuscular blockers and 98.5% vasoactive 
drugs. Tracheostomy was performed in 45.3% of the patients. The 
table shows the values in the group of survivors and non-survivors.
  Survivors Non survivors P
Age 56,9 63,4 0,006 
Sex (Male) 55% 80% 0,026 
APACHE II 12,6 16 0,03 
Length of stay 16,5 11,5 0,042 
Creatinine Max. 1 1,96 0,003 
Bilirrubine Max. 1,71 2,4 0,2 
Ferritine Max. 1836 2990 0,2 
D Dimer 17,2 19,9 0,67 
CV desease 38,8% 51% 0,21 
Pulmonar desease 19,4% 19,3% 0,6 
Dyslipidemia 27,7% 48% 0,069 
Traqueostomy 51% 37,4% 0,2 
Prone 52,7% 80% 0,015 
Neuromuscular 
Bloq.
58% 93% 0,001 
Conclusion: In our sample the need of prone position, neuromuscu-
lar blocking drugs in relation to distress severity have been related 
to increased mortality. Furthermore, acute renal failure, age and sex 
(male) are statistically significantly related factors.
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Introduction: Covid-19 pneumonia can lead to a severe respiratory 
failure requiring invasive ventilation. Inverse-ratio APRV is a ventilation 
mode in which Tidal Volume (VT) is delivered during a short decrease 
in pressure. The expiration phase is interrupted before the expiratory 
flow reaches zero (1). This refers to the concept of Time Controlled 
Adaptive Ventilation (TCAV) (2).
Inverse-ratio Airway Pressure Release Ventilation (APRV) was proposed 
as a ventilation mode for ARDS in a monocentric randomized study 
showing a reduction in ventilation time in the APRV group  (3).  We 
report our experience of switching patients from conventional 
ventilation (volume control or pressure support) to APRV in two 
French ICUs during the Covid-19 pandemic.
Methods: Seventeen consecutive patients who have completed a 
6-hour APRV trial in April 2020 were studied (we excluded 3 patients 
on VV-ECMO and 3 who were unable to be maintained on APRV).
Initial APRV settings were:  P-high  28 cmH20, T-high 3.5 sec-
onds, P-low 5  cmH2O and T-low 0.5 seconds. T-low was then immedi-
ately adjusted to obtain a sufficient tidal volume and the expiratory 
flow curve was observed to ensure an interruption of the release 
phase at around 50 to 75% of the peak expiratory flow. P-low was sel-
dom set to 0  cmH2O due to concerns of alveolar pressure reaching the 
set P-low (in case of inappropriately long T-low) and was frequently set 
to 5  cmH2O as it was by Zhou et al  (3). Within the first hour of APRV, 
blood gases were measured to detect an eventual increase in PaCO2 
and ifnecessary, increase the respiratory rate (by decreasing T-high).
Results: The mean (±  SD)  PaO2:FiO2 ratio increased from 126 (±  28) 
to 178 (± 53) after 6 hours of APRV (p < 0.001). In 12/17 patients, the 
PF ratio increase was of more than 20%. Two patients presented a 
decrease of the  PaO2:FiO2 ratio after 6 hours of APRV. Median (inter-
quartile range) ventilation time before the APRV trial was of 14 (8-19) 
days. At baseline, 12 of the 17 patients were on Volume Assist Con-
trol and 5 patients were on Pressure Support. After 6 hours of APRV, 
the mean Tidal Volume was of 6.5 (± 1.7) ml. There was no significant 
hemodynamic impairment appearing during APRV and an eventual 
increase in PaCO2 during the first hour of APRV was managed by 
increasing respiratory rate (i.e. shortening Thigh) and/or increasing 
tidal volume (i.e. increasing T-low).
Conclusion: To conclude, in our severe ARDS covid19 patients, the use 
of inverse ratio APRV was well tolerated and associated with a marked 
improvement in oxygenation parameters. This could be explained by 
the high recruitability potential in some cases of Covid-19 associated 
ARDS (4,5).
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Introduction: Spontaneous Breathing Trial (SBT) is an established test 
for evaluating the capability of the patient to breathe without venti-
lator assistance before a scheduled extubation. Among the different 
techniques used to perform SBT, Automatic Tube Compensation (ATC) 
calculates the pressure drop across the endotracheal tube and pro-
vides with a breathing assistance that counteracts it. In that way ATC 
acts as a within-cycle closed loop.
Objectives: To conduct a system review (SR) with a network meta-
analysis (NMA) that compares the effect of ATC with other techniques 
for SBT in terms of test tolerance and extubation success.
Methods: This NMA of published studies was conducted following the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines. Studies were identified using MEDLINE, Web 
of Science, Cochrane Register of Controlled Trials, LILACS and cita-
tion review. The inclusion criteria used the PICO approach. Patients 
are adults, intubated in the ICU; Intervention is ATC; Control is either 
the patient (before/after) or another non-ATC intervention; Outcome 
is either physiologic or patient-centered depending on the category 
the study falls into. Two authors, independently and blinded each to 
otherselected studies for inclusion (JB and PCF). Were excluded animal 
studies, other languages than English, Spanish or French, not in full 
text format (eg. abstract or letter were excluded) and reviews.
Data analysis. Publication bias was analyzed with a funnel plot for the 
endpoint extubation success. Relative risk (RR) with random-effects 
models were used to pool the effect of each SBT technique. Statistical 
significance was set at P < 0.05 with a two-tailed test. Data were ana-
lyzed using “netmeta” library from R package.
Results: Four of the 108 studies included the ATC as a SBT representing 
769 patients and 4 interventions (ATC100% + Continuous Positive Air-
way Pressure (CPAP) < 7.5cmH2O [n = 319], CPAP < 7.5  cmH2O [n = 120], 
Pressure Support (PS)  5cmH2O + CPAP < 7.5 cmH20 [n = 30] and T-tube 
[n = 300]. In terms of successful SBT, the probability of being the best 
(in decremental order) were: ATC100% + CPAP < 7.5  cmH2O (reference 
group), CPAP < 7.5cmH2O,  PS5cmH2O + CPAP < 7.5 cmH20 and T-tube. 
For extubation success the decremental order from the best to the worst 
was: ATC100% + CPAP < 7.5  cmH2O, PS5  cmH2O + CPAP < 7.5 cmH20, 
T-tube and CPAP < 7.5 cmH20. No publication bias was identified.
Conclusion: ATC100% associated to CPAP < 7.5cmH2O may be the 
best technique in terms of SBT and extubation success.
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Introduction: Ventilator-induced diaphragmatic dysfunction is 
known to be one of the main causes of prolonged mechanical ventila-
tion. We hypothesized that patients who failed spontaneous breath-
ing (SBT) due to respiratory muscle weakness are more likely to need 
longer duration of mechanical ventilator support than patients who 
failed SBT not because of inspiratory muscle weakness but because 
of abnormal respiratory mechanics which potentially improves rap-
idly. Proportional assist ventilation with load adjustable gain factors 
(PAV+) is the ventilator mode that calculates the pressure generated 
by patient (Pmus) and patient’s work of breathing (WOBpt) during 
spontaneous breathing.
Objectives: We investigated whether Pmus and WOBpt estimated by 
PAV+ during SBT can predict duration of mechanical ventilation in 
patients who failed SBT.
Methods: This study was a prospective observational study in a sin-
gle center in Japan.All patients over 18 years old who were mechani-
cally ventilated and failed SBT using a mode of PAV+ with a support 
rate 20% were included. We recorded the average of WOBpt, peak 
inspiratory pressure (Ppeak), compliance and resistance measured by 
PAV+ during SBT. We also calculated the peak Pmus from Ppeak. The 
primary outcome of this study was duration of mechanical ventilation. 
We defined prolonged mechanical ventilation group as patients who 
failed at least three weaning attempts or require > 7 days of weaning 
after the first SBT.
Results: A total of 20 mechanically ventilated patients who failed 
SBT were included. All patients weaned from mechanical ventilator 
eventually. 3 patients were categorized into prolonged mechanical 
ventilation group. The medians of WOB, Pmus, compliance and resist-
ance measured by PAV+ were 0.600(0.580-0.780), 24.00(20.60-24.60), 
48.00(41.00-56.00), 5.900(5.000-8.200) in prolonged mechanical ven-
tilation group and 0.700(0.560-0.800), 21.60(11.72-25.60), 50.00(35.00-
64.00), 5.900(5.000-8.200) in non-prolonged mechanical ventilation 
group respectively without significant differences in all variables.
Conclusion: There are no significant differences in Peak Pmus and 
WOBpt estimated by PAV+ during failed SBT between prolonged 
mechanical ventilation group and non-mechanical ventilation group 
in this interim analysis with the small sample size. Larger sample size is 
needed to further investigate our hypothesis.
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Introduction: Volume control (VCMV) and Pressure control mechani-
cal ventilation (PCMV) are the main modes of respiratory mechani-
cal support. Linear regression analysis (LRA) and Fourier analysis (FA) 
are methods used for the linear evaluation of Respiratory system (RS) 
mechanics, independently of the mode of ventilation and without 
intervening with the ventilators settings.
Objectives: The present study attempts a comparison of RS mechan-
ics on linear basis between two different modes of mechanical ventila-
tion (MV): VCMV and PCMV.
Methods: The Airway Pressure (Paw) and Flow (V’) signals were digi-
tally acquired from 25 intubated and mechanically ventilated patients 
in the Red Cross Hospital ICU. Data were recorded under VCMV and 
PCMV with stable ventilatory settings (frequency, VT and PEEP). The 
off-line analysis, included the tidal volume (VT) calculation by numeri-
cal integration of V’ and the application of LRA and FA with the aid of 
a specifically developed software. The calculated mechanical param-
eters were: RS Elastance (Ers), RS Resistance (Rrs), End Expiratory Pres-
sure (EEP). The Error of the applied models (RMSD) according to both 
techniques were also evaluated. Comparisons for every index between 
the four applied instances were evaluated with the aid of Analysis of 
Variance (p = 0.05).
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Results: All calculated indices are presented in the following table as 





























































Applied comparisons revealed not significant differences for every 
mechanical index in all studied cases (p > 0.05). Nevertheless, FA 
showed a tendency for higher Rrs values especially in patients with 
underlying obstructive disorder, which is in accordance with previous 
findings of ours. The same issue is true for the Error of the applied lin-
ear modeling.
Conclusion: Respiratory mechanics are equivalently evaluated with 
the aid of two different linear methods (LRA and FA) under two dif-
ferent modes of MV (VCMV and PCMV). Our results reinforce the appli-
cability of both calculating techniques and also suggest that both 
modes of MV have almost identical mechanical effect on respiration. 
Further research in homogenous conditions concerning the underly-
ing respiratory disorder (COPD, ALI, ARDS e.t.c.) would further clarify 
the issue.
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Introduction: Approximately 60% of ventilated patients are affected 
by weakness of the diaphragm at the time of the first spontaneous 
breathing trial  [1, 2]. A possible non-invasive intervention to pre-
serve diaphragmatic function is magnetic stimulation of the phrenic 
nerve [3]. Since safety instructions state a minimum distance to mag-
netically sensitive objects of at least 1 m and prohibit the use near 
life-sustaining equipment, it is currently unknown if such stimulation 
would be safe in an intensive care unit (ICU) environment.
Objectives: This investigation aimed to  (1) measure distances 
between patients and life-sustaining medical equipment in a typi-
cal ICU surrounding  and  (2) measure the magnetic fields generated 
by stimulation coils  (located at the patient’s neck) at the patient and 
surrounding medical equipment with regard to safety in a pilot study.
Methods: A typical ICU patient room was simulated and equipped at 
the Berliner Simulations- und Trainingszentrum at Charité – Univer-
sitätsmedizin Berlin (full data set) and at the Inselspital Bern (distances 
to devices measured only). A resuscitation manikin was used to simu-
late the patient position in bed. Stimulations were performed using 
the PowerMag Research 100 Stimulator® (MAG & More GmbH, Munich, 
Germany) with a butterfly coil (PMD70-pCool) generating a single, 
biphasic stimulus at maximum intensity. Magnetic field intensity B in 
Tesla  [T]  was measured at various distances vertical to the center of 
the coil (table 1) and raw data analyzed. Furthermore, possible heating 
of the metal bed rails and ECG electrodes was investigated using 85% 
intensity, a frequency of 20 Hertz [Hz] and 2-3 sequences with a length 
of 5-10 s and 0 mm safety distance.
Table 1. Measurements of the magnetic field intensity at different distances with a single 
stimulus at 100% power. Direction means position of the sensor to the stimulation coil.
# Power [%] Stimulus Distance [mm] Direction
1 100 Single 0 
center of the stimulation 
coil  
2 100 Single 20 
vertical to center of the 
stimulation coil 
3 100 Single 30 
vertical to center of the 
stimulation coil 
4 100 Single 70 
vertical to center of the 
stimulation coil 
5 100 Single 300 
vertical to center of the 
stimulation coil 
6 100 Single 400 
vertical to center of the 
stimulation coil 
7 100 Single 150 
horizontal to stimulation 
coil  
Results: Distances were 1.2 m and 0.8 m to the ventilator, 1 m and 1 
m to the perfusors and 0.7 m and 1 m to the touch panel or vital sign 
monitor in Berlin and Bern, respectively.
The magnetic field intensity declined with rising distance to the coil 
(figure 1). It illustrates the results of our measurements at different dis-
tances tothe coil during stimulation. At 40 cm distance, only general 
signal noise could be observed.
The heating test resulted in heating of the bed rail to 70 ° C and a 
safety stop of the coil at the temperature of 40 °C. The ECG electrodes 
did not heat up. The ECG signal at the monitor showed artefacts dur-
ing stimulation as known from surgical equipment. Direct stimulation 
of the perfusor did not lead to any obvious malfunction.
Magnetic field intensity was measured at six points vertical to the center 
of the stimulation coil and once horizontal to the center of the stimulation 
coil. Stimulation was done with 100% power. Magnetic field intensity B is 
measured in Tesla [T].
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Conclusion: In standard ICU environment, the distance of magneti-
cally-sensitive objects to the coil can be lower than 1 m. The magnetic 
fields in this experiment declined with distance from the stimulator. 
The measurements are providing relevant information for the risk-
benefit assessment of magnetic coils to stimulate the phrenic nerve 
in an ICU environment. With only 40% intensity necessary to generate 
sufficient tidal volume [3], field intensity should be even lower in clini-
cal practice.
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Introduction: Flow-controlled ventilation (FCV) guarantees a con-
stant gas flow during in- and expiration. Coupled with direct intratra-
cheal pressure measurement, it allows for a precise determination of 
dynamic lung compliance and ventilation can be adjusted accordingly.
Objectives: Aim of this study was to investigate correlation of 
observed tidal volume and lung compliance in individualized FCV, 
based on dynamic compliance measurements, compared to state-of-
the-art pressure-controlled ventilation (PCV) in lung healthy- and lung 
injured animals.
Methods: Anaesthetized pigs were ventilated with either FCV or PCV 
over a period of 10 hours in lung healthy animals (FCV n = 6, PCV n 
= 6), and 2 hours after oelic acid induced acute respiratory distress 
syndrome (ARDS) (FCV n = 8, PCV n = 8). FCV was individualized with 
compliance guided positive end-expiratory (PEEP) and peak pressure 
settings. PCV was performed with a PEEP of 5  cmH2O and a peak pres-
sure set to achieve a tidal volume of 6-8 ml/kg in lung healthy animals 
and a tidal volume of 6 ml/kg and compliance guided PEEP titration 
in lung injured animals as a lung protective low tidal volume strategy. 
Tidal volume and pressure measurement were recorded directly from 
the respirator; compliance was calculated subsequently. As a surro-
gate parameter of lung stiffness compliance was then correlated to 
applied tidal volume.
Results: Overall, applied tidal volume showed a significant correlation 
to lung compliance (r = 0.704, p < 0.001) in individualized FCV. Lung 
healthy animals showed a slightly lower correlation (r = 0.375, p = 
0.0014) compared to ARDS animals (r = 0.734, p < 0.001). Obviously, in 
PCV there was no correlation since tidal volume was set to 6-8 ml/kg in 
lung healthy and 6 ml/kg in lung injured animals.
Conclusion: Compliance guided pressure settings in FCV showed a 
significant correlation of applied tidal volume to lung compliance as a 
surrogate parameter of lung stiffness. Thus, we hypothesize individu-
alized FCV to be a more lung protective ventilation strategy as applied 
tidal volumes are based on individualized lung mechanics measure-
ments. “One size does not fit all”, even if best standard of care low tidal 
volume ventilation is performed.
000450 
Increased non‑aerated lung in healthy swines undergoing 
progressive decrease of respiratory rate with  ECCO2R
G. Colussi1; I. Marongiu2; A. Mazzucco3; E. Scotti1; R. Maia1; G. Dal 
 Santo2; E. Garbelli2; D. Dondossola4; G. Lopez5; G. Fumagalli1; A. Damia1; 
M. Battistin1; O. Biancolilli1; S. Gatti6; A. Zanella1; E. Spinelli1; T. Mauri1; 
A. Pesenti1
1Department of anesthesia, critical care and emergency, Fondazione 
IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milano, Italy; 2Depart‑
ment of pathophysiology and transplantation, University of Milan, Milano, 
Italy; 3Thoracic surgery and lung transplantation unit, Fondazione IRCCS 
Ca’Granda Ospedale Maggiore Policlinico, Milano, Italy; 4Liver transplant 
and general surgery unit, Fondazione IRCCS Ca’Granda Ospedale Mag‑
giore Policlinico, Milano, Italy; 5Department of pathology, Fondazione 
IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milano, Italy; 6Center 
for preclinical research, Fondazione IRCCS Ca’Granda Ospedale Maggiore 
Policlinico, Milano, Italy 
Correspondence: G. Colussi
Intensive Care Medicine Experimental 2020, 8(2): 000450
Introduction: Extracorporeal  CO2 Removal  (ECCO2R) allows ultrapro-
tective ventilation avoiding hypercapnia and thus can be used in 
ARDS patients with the aim of reducing the ventilation load to the 
lungs [1], but only a few studies investigated the effects of a decrease 
in respiratory rate during  ECCO2R.
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Objectives: The aims of our study were: to investigate the effects of 
decreased respiratory rate during  ECCO2R on respiratory mechanics, 
oxygenation, hemodynamics and the development of atelectasis.
Methods: Six female pigs were sedated and paralyzed; volume con-
trolled ventilation was set with TV 10 ml/Kg, PEEP 5  cmH2O and res-
piratory rate (RR) 24 bpm. Animals underwent surgical cannulation of 
the right iliac and jugular veins, then were placed on v-v ECLS (iliac-
jugular) with extracorporeal blood flow maintained at 1.5 L/min. RR 
was reduced in three 8-hours steps to 18, 12 and 6 breaths/min while 
keeping same TV and PEEP, inspiratory time was adapted to maintain 
I:E = 1:2. Gas flow was adjusted to maintain  PaCO2 30-40 mmHg. At 
Baseline and at the end of each step respiratory, hemodynamic, ECLS 
and gas exchange parameterswere collected, and end-expiratory 
chest CT scan was performed.
Results: All animals completed the study protocol. During progres-
sive decrease of RR the  VCO2 of the membrane lung progressively 
increased to maintain a stable  PaCO2. The mechanical power progres-
sively diminished, while plateau pressure, compliance and  PaO2/FiO2 
ratio worsened. Mean pulmonary artery pressure rose. Quantitative 
analysis of CT scan showed increase in the non-aerated lung compart-
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Mean Airway 
9.2±0.7 9.8±0.7  8.7±2.1 8.3±0.5 p=0.276 
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*Post-Hoc Holm-Sidak p<0.05 vs RR24    #Post-Hoc Dunnett’s on Ranks p<0.05 vs RR24 
When dependent and non-dependent lung regions are analyzed sepa-
rately, it can be noted that the increase in non-aerated compartment 
is larger in the dependent regions of the lung (see Figure below : Two-
way RM Anova:region p = 0.022, RR p = 0.007, interaction p < 0.001; 
Post-Hoc: # p < 0.05 NDEP vs DEP § DEP p < 0.05 vs RR24).
Conclusion: In healthy lungs decreased respiratory rate during 
 ECCO2R allows a reduction of the ventilatory load to the lung at the 
expense of worsening oxygenation and compliance. Atelectasis pro-
gressively develop mainly in the dependent lung.
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Introduction: Transmission of infectious diseases through patient-
derived aerosols (bioaerosols) may increase the prevalence of a dis-
ease in the general population[1]. In the critical care setting, aerosol 
therapy is often used concurrently with mechanical ventilation in 
the treatment of patients with respiratory issues[2]. If these patients 
are infectious, the breaking of the circuit, and subsequent potential 
release of patient-derived bioaerosols during nebuliser refill has the 
potential to impact the health of caregivers near the patient. Unlike 
conventional nebulisers, the Aerogen Solo nebuliser is designed to 
not require breaking of the ventilator circuit when refilling.
Objectives: To assess the potential for release of patient-derived bio-
aerosols into the local environment during drug refill of a vibrating 
mesh nebuliser (VMN) during mechanical ventilation.
Methods: A mechanical ventilator (Bellavista, IMT Medical, Switzer-
land), with a dual limb circuit (RT200, Fisher & Paykel, New Zealand) 
incorporating a heat moisture exchange filter (HMEF) (Intersurgical, 
UK) at the patient side of the wye, was set to simulate an adult ventila-
tion pattern (Vt 500 mL, 15BPM, & I:E Ratio 1:1). A VMN (Aerogen Solo, 
Aerogen, Ireland) was placed between the HMEF and the endotra-
cheal tube (ETT) (8.0mm, Flexicare, UK). An experimental breath actu-
ated aerosol generator was placed at the end of the ETT to generate 
simulated exhaled patient-derived bioaerosol, using saline (0.9%, 
Braun, Germany). Aerosol concentrations of particles sized between 
0.5 and 20 µm per cm3 were recorded using two Aerodynamic Particle 
Sizers (APS, Model 3321, TSI Inc., US) positioned at 30 cm and 90 cm 
from the nebuliser. Test runs were 10 minutes in duration. An initial 
two-minute period without simulated bioaerosol being generated 
established ambient aerosol concentrations. Testing (in triplicate) was 
completed with the VMN in the circuit with the silicon medication cup 
cap opened or closed for the 10-minute test period.
Results: Results are illustrated in Figure 1.
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Conclusion: There was no increase in particle concentration noted 
over the 10-minute test period. Results on average ranged from 6–10 
particles per cm3 across all tests at both distances and were in line 
with ambient levels, also recorded at 6–10 particles per  cm3. Variations 
in ambient levels are due to localised conditions during testing. The 
results of this study confirm that there is no release of patient-derived 
bioaerosol through the VMN with the silicon plug opened or closed 
during mechanical ventilation.
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Introduction: Mechanical ventilation damages the alveolar epithe-
lium through increased and cyclical stretch due to non-physiological 
distribution of tidal volume.1 This, combined with shear stress from 
repeated opening and closing of alveoli in atelectatic regions, trig-
gers the release of proinflammatory cytokines such as IL-1β, IL-6 and 
IL-8.2Excessive cyclic stretch induces cell membrane leakage, causing 
a spillover of intracellular contents.3 In addition, injured cells release 
alarmins that elicit a local pro-inflammatory response.4 If the injury to 
lung epithelium progresses such that the compartmentalization of the 
alveoli is lost, these cytokines translocate into the circulation and have 
the potential to cause secondary organ injury that leads to multi-sys-
tem organ failure, which contributes to morbidity and mortality.5 This 
is known as biotrauma. Contracting the diaphragm during mechanical 
ventilation may reduce atelectrauma that leads to biotrauma.
Objectives: We studied diaphragm contractions elicited by trans-
venous phrenic nerve stimulation (TTDN) delivered in synchrony with 
the inspiratory phase of ventilation as a method to reduce lung injury 
and biotrauma in a sedated, preclinical, ICU model with non-injured 
lungs.
Methods: Human-sized pigs were sedated and ventilated under 
mock ICU conditions for 50 hours. They were ventilated with protec-
tive volume control, and one group received temporary transvenous 
diaphragmaticneurostimulation during inspiration on every second 
breath (MV + TTDN group) while the other did not (MV group). IL-1β, 
IL-6 and IL-8 were measured in BAL fluid and serum.
Results: BAL fluid concentrations were not significantly different for 
IL-1β (14324 pg/ml MV group vs. 9287 pg/ml MV + TTDN group, p = 
0.27), IL-6 (210.7 pg/ml MV group vs. 186.2 pg/ml MV + TTDN group, 
p = 0.67), or IL-8 (15814 pg/ml MV group vs.15401 pg/ml MV + TTDN 
group, p = 0.99). Serum concentrations were significantly lower in the 
MV + TTDN group for IL-1β (434.6  pg/ml MV group vs. 104.1  pg/ml 
MV + TTDN group, p = 0.02), IL-6 (182.1 pg/ml MV group vs. 30.7 pg/
ml MV + TTDN group, p = 0.03), and IL-8 (35.0  pg/ml MV group vs. 
13.2 pg/ml MV + TTDN group, p = 0.04).
Conclusion: BAL washings were taken both at the start and the end 
of the experiment and the initial wash may have initiated an inflam-
matory process that was independent of ventilation, confounding 
the BAL cytokine results. Transvenous phrenic-nerve-stimulated dia-
phragm contraction combined with protective mechanical ventilation 
on every second breath reduced biotrauma in healthy porcine lungs 
that were ventilated for 50 hours.
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Introduction: The OxVent [1] is a low-cost volume control mechani-
cal ventilator designed to be rapidly produced at scale to meet a 
large and sudden increase in ventilators’ need, like during the COVID-
19 pandemic. It is based on a pneumatic core component driven by 
compressed air flow controlled by a solenoid valve. Near-patient 
spirometry measures delivered tidal volume and solenoid actuation 
is adjusted by a closed feedback loop. Expiration occurs through a 
commodity mechanical PEEP valve. The device has been characterised 
on the bench to meet the UK rapidly manufactured ventilator system 
requirements [2].
Objectives: Determine the performance of the OxVent in uninjured 
and lung-lavaged pigs.
Methods: Variations in PEEP and tidal volume were set on the OxVent 
in a protocolised manner both before and after surfactant depletion 
with saline lung lavage in 4 anaesthetised and paralysed pigs (30 (1) 
kg; mean (SD)). Set tidal volumes (VTset) ranged from 170 to 340 mL (6 
to 11 mL/kg). Respiratory rate (RRset) was set at either 16 or 28 min-1 
to maintain minute ventilation around 170 mL/min/kg. PEEP was var-
ied between 5, 10 and 20  cmH2O (PEEPset). Airway flow and pressure 
waveforms were measured independently (Datex-Ohmeda Capnomac 
Ultima) and analysed to determine actual tidal volume (VTact) and 
PEEP (PEEPact). End-expiratory lung volume (EELV) was measured 
using a sulphur hexafluoride washout technique.
Results: Lung lavage decreased respiratory system compliance from 
22 (5) to 15 (5) mL/cmH2O (P < 0.001), EELV from 570 (158) to 272 (97) 
mL (P = 0.04), and  PaO2/FiO2 ratio from 438 (39) mmHg to 298 (133) 
mmHg (P = 0.11), all measured at PEEP 5  cmH2O. Airway resistance 
was 7.8 (2.8)  cmH2O/L/s.
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VTact correlated with VTset (R2 = 0.71, gradient of regression line 
1.02), mean bias was -1 [-11 to 9] mL (mean [95% confidence interval]) 
with 95% limits of agreement -90 [-107 to -73] mL and 88 [71 to 105] 
mL. PEEPact was 3.9 (1.2), 8.1 (1.9) and 13.7 (14.8)  cmH2O for PEEPset 
of 5, 10 and 20  cmH2O respectively. Airway pressure did not drop to 
PEEPact immediately during expiration, but remained 2.7 [2.5 to 2.9] 
and 1.1 [1.0 to 1.2]  cmH2O above PEEPset respectively at 50% and 75% 
of the expiratory period. End-expiratory flow was 50 (17) and 88 (15) 
mL/s respectively at PEEPset 5 and 20  cmH2O.
The presence of lung injury did not alter any outcome measure.
Conclusion: The OxVent delivered tidal volumes and PEEP similar to 
those set over a wide range in uninjured pigs and those with a saline-
lavage lung injury model. The commodity PEEP valve was unable to 
maintain PEEP at the set value and our tests identified an expiratory 
flow limitation, which was not apparent on bench-top testing. This 
flow limitation was PEEP-dependent, suggesting that the valve was 
the culprit. The system has since been redesigned following profiling 
of the valve. Rapidly developed safety critical devices for pandemic 
use should still be thoroughly tested in vivo over a range of typical 
usage scenarios to mitigate all possible risks to patients.
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Introduction: ‘Mechanical Power of ventilation’ (MP) is a summary 
variable that includes tidal volume (VT), respiratory rate (RR), flow and 
driving pressure (ΔP), all the components that play a role in VILI [1]. 
MP has been shown to be associated with important patient–centered 
outcomes [2]. The complex interplay between its components makes 
it difficult to set a ventilator so that the least amount of energy per 
time (MP) is transferred from the ventilator to the respiratory system in 
an individual patient. Adaptive Support Ventilation (ASV) is a closed–
loop mode that provides pressure–controlled or pressure–support 
ventilation depending on patient’s activity. With ASV, all components 
that can cause VILI are under control of the ventilator.
Objectives: The aim of this study is to compare MP under ASV and 
under conventional ventilation.
Methods: We calculated and compared MP in 12 patients under 
standard ventilation in which VT, peak- and driving pressure, and RR 
were set by experienced caregivers, with MP in 12 patients under ASV. 
Patients were sedated and without spontaneous breathing activity. 
MP was calculated three times per day over the first 4 days of ventila-
tion, using the following equation [3]: 0.098 * VT * RR * (Ppeak- ½ * ΔP)
A linear mixed model regression was used to assess the effect of time 
(as random factor) on MP. The regression was adjusted for ventila-
tion mode and gender as fixed factors, and the APACHE IV score as a 
covariate. A p-value < 0.05 was considered significant. This pilot study 
was performed on the ICU in the Reinier de Graaf hospital in Delft, the 
Netherlands, from march till august 2019.
Results: Median MP was 15.1 [6.1–32.0] J/min with ASV versus 22.9 
[4.9–49.1] J/min with conventional ventilation (mean difference 6.2 J/
min). MP with ASV was lower at all time points data were collected. 
Linear mixed model regression analysis showed that the factor ven-
tilation mode was statistically significant (95%–confidence interval 
1.45 to 11.62, P = 0.013). With ASV, VT was not different form that with 
pressure controlled ventilation, but Ppeak and RR were significantly 
lower (P = 0.012)(Figure 1).
Conclusion: Findings of this pilot study suggest that concerning the 
MP transferred from the ventilator to the respiratory system, ASV is 
superior to standard ventilation. This effect is not achieved by simple 
limitation of VT alone, but by a reduction in applied pressure and RR. 
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Introduction: Expiratory Flow Limitation (EFL) is an inability to exceed 
a certain flow regardless of the pressure exerted, which accounts for 
60% of extubation failure. However, a spontaneous breathing trial 
(SBT) method that suits for this specific condition is uncertain.
Objectives: We aimed to evaluate an effect of 30-minute T-piece and 
30-minute pressure support ventilation (PSV) on a success rate of extu-
bation in patients with EFL.
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Methods: We conducted a non-inferiority randomized controlled trial 
comparing 30-minute T-piece SBT and 30-minute SBT with PSV (PS 6 
 cmH2O and PEEP 5  cmH2O) in mechanically ventilated patients with 
EFL who were considered as readiness to wean. The primary outcome 
was successful extubation (72-hour ventilator free after extubation). 
Secondary outcomes were a reintubation rate, time to reintubation, 
and a success rate of SBT.
Results: A total of 40 ventilated patients with EFL were recruited. The 
majority of them were male (62.5%) with the median age of 72[IQR 21] 
years. The most common cause of acute respiratory failure was the 
intrapulmonary cause (87%). The eligible patients were randomized 
into 2 groups: 21 patients in the T-piece group and 19 patients in the 
PSV group. The success rates of extubation were not significantly dif-
ferent between 2 groups: 85.71% in the T-piece group and 84.21% in 
the PSV group, p = 0.62. There were no significant differences in the 
reintubation rate (9.52 % in the T-piece group VS 5.26% in the PSV 
group, p = 0.54), time to reintubation (41 hours in the T-piece group 
VS 6.5 hours in the PSV group, p = 0.221) and the SBT success rate 
(95.24% in the T-piece group VS 89.47% in the PSV group, p = 0.462).
Conclusion: Among the patients with EFL, the 30-minute T-piece 
SBT was non-inferior to the 30-minute SBT with PSV in terms of the 
successful extubation, successful SBT, reintubation rate and time to 
reintubation.
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Introduction: Patients with severe coronavirus disease 2019 (COVID–
19) often need admission to an intensive care unit (ICU) for invasive 
ventilation [1]. This new disease often challenged the caregiver to ini-
tiate ventilation in a lung protective manner. The ‘mechanical power 
of ventilation’ (MP), a summary variable that includes all components 
that play a role in worsening of lung injury, is associated with outcome 
in patients with ARDS from another cause. Fully–automated ventila-
tion has been shown to reduce MP in patients not having COVID-19 
[2]. Whether fully–automated ventilation affects MP in COVID-19 
patients is uncertain.
Objectives: The aim of this study is to compare MP under INTEL-
LiVENT–ASV, a fully–automated mode of ventilation, versus conven-
tional ventilation in COVID–19 patients.
Methods: Observational crossover study performed in the ICU in the 
Reinier de Graaf Hospital in Delft, The Netherlands, during the first 
months of the outbreak from march till May 2020. Ventilation vari-
ables and parameters, necessary to calculate MP, were collected in 
31 invasively ventilated COVID–19 patients—2 hours during pressure 
controlled ventilation (conventional ventilation) and 2 hours during 
INTELLiVENT–ASV (fully–automated ventilation). During conventional 
ventilation, tidal volume (VT) peak and driving pressure (Ppeak and 
ΔP), and respiratory rate (RR) were set by the caregivers strictly fol-
lowing the local guideline for invasive ventilation. During fully–auto-
mated ventilation, these settings were under control of the ventilator, 
and a target etCO2 and SpO2 was set as targeted with conventional 
ventilation. MP was calculated using the following equation [3]:
0.098 * VT * RR * (Ppeak- ½ * ΔP)
Mean MP during conventional ventilation and fully–automated were 
compared using paired T-test; a p-value < 0.05 was considered statisti-
cally significant.
Results: Mean MP under conventional ventilation was 31.5 J/min 
(SD 13.9) and 22.4 J/min (SD 9.2) under fully–automated ventilation 
(mean difference 9.1 J/min; 95%–confidence interval 6.1 to 12.2, P = < 
0.0001). Individual data are shown in the figure.
Conclusion: INTELLiVENT–ASV is superior to conventional ventilation 
with respect to the amount of energy transferred from the ventilator 
to a patient’s respiratory system in invasively ventilated COVID-19 
patients.
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Introduction: ARDSNet demonstrated 22% increased mortality in 
patients ventilated at 11.8 ml/kg rather than 6.2 ml/kg, with the pro-
motion of lung inflammation as a possible mechanism for its deleteri-
ous effects [1].  Lung protective ventilation however, depends on the 
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correct assessment of the patient’s Ideal Body Weight (IBW). Meas-
urement and accurate recording of IBW is, therefore, of fundamental 
importance in the Intensive Care Unit (ICU), to enable implementation 
of lung protection strategies.
Objectives: Assessment of recording of patient weight in a UK District 
General Hospital ICU, with analysis of implications in discrepancies 
between recorded weight and IBW as measured by ulna-length, on 
lung-protective ventilation strategies.
Methods: Collection of recorded weights for 49 patients admitted to 
ICU between 06/11/2019–27/11/2019 and comparison to IBW using 
ulna-length measurement to calculate IBW.
Results: IBW was not the recorded weight in any patients (22 female; 
27 male), with only actual body weight (ABW) recorded, derived from 
visual estimation, measured weight, or from pre-admission notes. 
The recorded weight was, on average, 1.3 times higher than IBW as 
derived from ulna-length measurement. Had 8  ml/kg tidal volumes 
been used on patients at the recorded weight, the mean equivalent 
tidal volume delivered would have been 10.5  ml/kg of IBW (median 
9.92 ml/kg), giving an average higher tidal volume of 147 ml. For the 
16 obese patients in the sample (BMI > 30) the corresponding values 
were 13.04 ml/kg of IBW and 296 ml.
Conclusion: In the UK, 28.7% of the population are obese (BMI > 30) 
with 3.6% morbidly obese (BMI > 40) [2], constituting around 20% of 
ICU admissions [3]. Obese individuals are more prone to Acute Res-
piratory Distress Syndrome [4] due to de-recruitment and atelecta-
sis as well as a decreased Functional Residual Capacity [5], and thus 
have been posited as a population requiring more aggressive imple-
mentation of ventilation protection strategies. Yet this is precisely the 
population most prone to erroneous recording of their IBW, and thus, 
overventilation, due to failure to proactively record IBW rather than 
ABW. Whether through ulna-length derived values or through direct 
measurement of patient height, recording of IBW with a standardised 
method should be a high priority for any patients admitted to ICU.
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Introduction: Bronchoalveolar lavage (BAL) is a useful tool for the 
diagnostic evaluation and often performed under mechanical venti-
lation. The concerns about performing BAL in hypoxemic patients are 
shunt caused by administrated fluid and/or loss of lung aeration dur-
ing procedure, resulting in impairment of oxygenation. In mechani-
cally ventilated patients positive end-expiratory pressure (PEEP) could 
maintain lung volume during BAL, however, the impact of BAL on 
regional ventilation and aeration has not been fully investigated. Elec-
trical impedance tomography (EIT) can evaluate lung volume, regional 
ventilation non-invasively in a real-time at the bedside. Fluid instilla-
tion in the lung decreases impedance value.
Objectives: The objective of this study was to examine the change in 
lung impedance throughout the BAL procedure in acute respiratory 
distress syndrome (ARDS) patients.
Methods: The moderate ARDS patients with bilateral ground-glass 
opacity were included. All patients were ventilated with pressure-
controlled ventilation with PEEP of 5 to 10  cmH2O. We monitored 
end-expiratory lung impedance (EELI), which is impedance value at 
the end of expiration and corresponds to end-expiratory lung volume. 
The measurements were performed at four time points, (1) before BAL, 
(2) during fiberoptic examination, (3) after instillation of fluid for lav-
age, (4) 15 min after completion of BAL. The value of EELI at before BAL 
was defined as baseline, and changes in EELI from at before BAL were 
calculated at each time point and expressed as a percentage of tidal 
impedance change at before BAL. The change in EELI was analyzed by 
one-way ANOVA with repeated measures and Turkey test as post-hoc 
analysis. PaO2/FIO2 ratio before and after BAL was compared by paired 
t test.
Results: Five patients were included. The entire procedure was fin-
ished within 20  min in all cases. Mean collected volume of fluid was 
45% of administered fluid. EELI significantly changed during the entire 
course of the procedure (P =  0.024). EELI at after instillation of fluid 
for lavage was significantly decreased from at before BAL (mean val-
ues: − 53 ± 16%, P = 0.030). However, EELI was recovered gradually 
after removal of bronchoscopy towards the level of at baseline, show-
ing no significant difference at 15 min after completion of BAL (mean 
values: −43 ± 16%, P = 0.103) compared to at before BAL. Mean dif-
ference in PaO2/FIO2 ratio between before and after BAL was −4 ± 20 
(95% confidence interval, −60 to 52) and no significant difference was 
detected.
Conclusion: Lung impedance value significantly decreased during 
BAL, probably due to saline instillation, collapse in the lung during the 
procedure etc. However, it recovered promptly resulting in mainte-
nance of oxygenation.
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Introduction: Pulmonary dysfunction in trauma patients may be 
induced by a variety of causes. In addition to the trauma-related eti-
ologies, mechanical ventilation itself may contribute to the deterio-
ration of respiratory function through ventilator induced lung injury 
or the impairment of respiratory muscle function. Ventilator-induced 
diaphragmatic dysfunction (VIDD) is an entity induced by the inactiv-
ity during invasive mechanical ventilation, associated with a profound 
loss of diaphragm muscle mass.
Methods: In order to assess the incidence of VIDD in polytrauma 
patients we performed an observational, retrospective, longitudinal 
study which included 24 polytraumatized patients, who were mechan-
ically ventilated for at least 48  h and underwent two chest CT scans 
for clinical reasons during their ICU stay. Diaphragmatic thickness 
was measured by two independent radiologists on coronal and axial 
images, at the level of celiac plexus. Statistical analysis was performed 
using MedCalc 14.1, applying T-test and correlation tests.
Results: Mean age in the study group was 59  years old, APACHE 
II score had a mean value of 19 and the Injury severity score 35. The 
mean duration between chest CT scans was 7  days. The thickness 
of the diaphragm was significantly decreased on both the left and 
right sides (left side: −  0.82  mm axial p =  0.034; −  0.79  mm coro-
nal p =  0.05; right side: −  0.94  mm axial p =  0.016; −  0.91 coronal 
p =  0.013). In addition, we obtained a positive correlation between 
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the number of days of mechanical ventilation and the difference 
between the two measurements of the diaphragm thickness on both 
sides (r = 0.5; p = 0.02). There was no statistically significant correla-
tion between the body mass indexes on admission, use of vitamin C or 
N-acetyl cysteine and the differences of diaphragmatic thickness.
Conclusion: Considering prioritization of life-threatening injuries 
in the trauma care, secondary dysfunctions such as VIDD are often 
overlooked. This study provides evidence of early impairment of dia-
phragm after mechanical ventilation in polytraumatized patients. 
Moreover, we obtained that a prolonged period of mechanical ventila-
tion is proportional with the loss of diaphragmatic thickness.
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Introduction: We hypothesized that the lack of benefit of low vs. high 
positive end-expiratory pressure (PEEP) in patients with acute res-
piratory distress syndrome may partly come from a difference in the 
dynamic behavior of the active expiratory valve in ICU ventilators.
Objectives: Our goal was to compare the resistance of the expiratory 
valve across current ICU ventilators on the bench.
Methods: Seven current ICU ventilators (C5, C6, Carescape, PB980, 
ServoU, V500 and V680) were attached to an ASL 5000 lung model set 
in passive condition with compliance 20 ml/cmH2O and resistance 5 
cmH2O/L/s. Ventilators were set in volume-controlled mode with a 
tidal volume of 0.8 L and respiratory rate of 10 breaths/min. Flow and 
pressure were measured just before the exhalation valve. PEEP was 
set at 5, 10 and 15 cmH2O. Flow and pressure signals were acquired at 
200 Hz (Biopac 150). On three consecutive breaths the instantaneous 
expiratory resistance was computed as the pressure drop to atmos-
phere divided by the flow. The valve opening delay was measured 
as the maximal slope of pressure-flow relationship from zero flow to 
peak flow. Finally, the time spent with PEEP above or below the set 
value, ie the pressure-time product (PTP) was computed. The median 
value of instantaneous expiratory resistance was taken as the primary 
end-point. Median (1st–3rd quartiles) were compared by two-factor 
ANOVA. P-value was set to P<0.0007 to take into account the number 
of comparisons done.
Results: The median instantaneous expiratory resistance was sig-
nificantly different between ventilators and PEEP with a significant 
interaction between them. Therefore, ventilators were compared at 
each PEEP. Between C5, C6, Carescape, PB980, ServoU, V500 and V680, 
the median expiratory resistance was 3.9 (3.5–4.7), 3.0 (3.0–3.1), 20.9 
(15.8–24.9), 27.4 (26.5–43.2), 13.8 (13.6–13.9), 4.4 (4.0–4.6) and 34.3 
(33.7–33.8) cmH2O/L/s, respectively, at PEEP5 (P < 0.0007 with all pair-
wise differences P > 0.0007). Over all PEEP, the corresponding opening 
delay was 0.080 (0.077–0.082), 0.082 (0.080–0.085), Carescape 0.110 
(0.105–0.110), 0.100 (0.085–01.05), 0.072(0.062–0.072), 0.145 (0.115–
0.150) and 0.075 (0.070–0.080), respectively. Over all PEEP PTP was 
2.8 (2.1–7.4), 6.8 (6.7–7.3), 2.4 (2.1–2.4), 3.5 (2.7–3.6), 1.8 (1.8–2.1), 2.8 
(2.7–2.9), and 5.7 (5.4–5.9) cmH2O.
Conclusion: We found on the bench that the resistance of active expir-
atory valve significantly differ between seven current ICU ventilators.
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Introduction: COVID-19 pandemics has set the healthcare system to a 
shortage of ventilators. Among the strategies to overcome this burden 
one is to divide the same ventilator to more than one patient.
Objectives: We aimed at assessing tidal volume (VT) delivery and 
air recirculation during expiration when one ventilator is divided to 
2 patients. We designed the study to mimic nonsymmetrical impair-
ment in respiratory mechanics.
Methods: We performed a bench study in a research lab taking part 
of a University medical ICU. Four ventilators (V500, Servo-I, Monn-
alT60 and Elisee350) were attached to A and B test-lungs (QuickLung) 
through a dedicated flow-splitter (Michelin, France). A 50 mL/cmH2O 
Compliance (C) and 5 cmH2O/L/s Resistance (Rp) were set in both (C1 
condition), C50Rp20 in A/C20Rp20 in B (C2), C20Rp20 in A/C10Rp20 in 
B (C3), and C50Rp20 in A/C20Rp5 in B (C4). Each ventilator was set in 
volume-controlled (VCV) and pressure-controlled (PCV) mode target-
ing 0.8L as delivered global volume. VT was measured from a pneumo-
tachograph placed immediately before each lung. Values are median 
(1st–3rd quartiles) and compared between ventilators by Kruskal-Wal-
lis test in each condition.
Results: In VCV VT was greater in A than in B by a factor of 1.83 
(1.22–2.07), 2.14 (1.68–2.15), and 1.65 (1.27–1.67) for C2, C3 and C4 
conditions, setting A to risk of overdistension. In PCV targeted VT was 
maintained in each lung for A in C2 (0.388L (0.321–0.540)) and C4 
(0.445L (0.416–0.454)), but not in C3 (0.180L (0.169–0.368)). The corre-
sponding VT in B were 0.230L (0.147–0.342), 0.320L (0.185–0.338), and 
0.09L (0.08–0.18), respectively. Recirculated air was substantial in VCV, 
53 mL in C4, setting risk to cross-infection, but negligible in PCV.
Conclusion: Dedicating one ventilator to two or three patients is feasi-
ble. For safety reasons, due to dependence of VT to C and risk of cross-
contamination, the ventilator should be set in PCV in order to maintain 
adequate in VT at least in one patient when C and/or Rp changes 
abruptly and monitoring of VT should be done carefully.
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Introduction: Esophageal pressure monitoring could help clinicians 
to better tailor ARDS-patients ventilatory setting, to reduce the risk 
of VILI; however, it has been mainly used in clinical research and not 
in daily clinical practice, mostly because of technical difficulties and 
the inability to obtain easy and accurate measurements. Recently, an 
automatic monitoring system (Optivent, Sidam Srl, Modena, Italy), 
able to directly measure both airway pressure and esophageal pres-
sure, has been released.
Objectives: Aim of this study was to compare measurements of res-
piratory mechanics in ARDS patients by using a dedicated manual 
device, assumed as gold standard, with those obtained by two other 
systems: Optivent and a bedside equipment. We focused on end-
expiratory esophageal pressure, end-expiratory transpulmonary pres-
sure and lung stress.
Methods: Forty mechanically ventilated sedated and paralyzed ARDS 
patients admitted in the intensive care unit (ICU) from February to 
September 2019, were enrolled. Patients were ventilated with a tidal 
volume between 6–8  ml/kg of predicted body weight and a respira-
tory rate to maintain an arterial pH between 7.30 and 7.45. Esophageal 
pressure was measured by using a radiopaque catheter equipped with 
a balloon (Nutrivent, Sidam Srl., Modena, Italy). Measurements of the 
airway pressure and esophageal pressure during end-inspiratory and 
end-expiratory pauses were performed at three levels of PEEP, ran-
domly applied: clinical level, 50% higher and 50% lower.
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  •  Optivent system: Optivent is an automatic self-calibrating system 
composed by a touchscreen monitor directly connected to the patient 
with a real time airway and esophageal pressure measurements;
  • Bedside system: This hybrid system is composed by the ventila-
tor and the patient’s hemodynamic monitor. Airway pressure was 
measured by the mechanical ventilator and esophageal pressure 
by a pressure transducer (TruWave/VAMP Plus, Edwards Lifes-
ciences, Unterschleissheim) connected to a hemodynamic moni-
tor.
 • Dedicated system: The airway and esophageal pressure were 
measured by pressure transducers and recorded on a personal 
computer using a specific software for subsequent analysis (Col-
ligo, Elekton, Milan, Italy).
Results: End-expiratory esophageal pressure measured by the dedi-
cated system, the bedside system and Optivent were 10.0 ± 4.2, 10 ± 
4 and 9.9 ± 4.0 cmH2O, respectively. End-expiratory transpulmonary 
pressures, respectively computed with data acquired by the dedicated 
system, bedside system and Optivent, were -1.6 ± 4.6, -1.4 ± 4.5 and 
-1.2 ± 4.3 cmH2O. Lung Stress values, respectively computed with 
data acquired by dedicated system, bedside system and Optivent, 
were 14.0 ± 5.8, 15.0 ± 6.6, and 15.0 ± 6.1 cmH2O. Both Optivent and 
the bedside system exhibited a high correlation with the dedicated 
system for all the three investigated variables. The respective bias and 
limits of agreement between the dedicated system and Optivent and 
between the dedicated system and the bedside system were as fol-
lows: end-expiratory esophageal pressure, 0.25 cmH2O, (−0.4 to 0.9) 
and −0.1 cmH2O (−1.9 to 1.7); end-expiratory transpulmonary pres-
sure, −0.6 cmH2O (−1.7 to 0.4) and −0.4 cmH2O, (−2.2 to 1.5); lung 
stress −0.9 cmH2O (−3.00 to 1.10) and −1.50 cmH2O (−4.4 to 1.4).
Conclusion: Both Optivent and the bedside system present clinical 
acceptability in measuring esophageal pressure and its derived vari-
ables. The possibility to apply one of these systems could make the 
measurement of esophageal pressure easier, with a consequent wider 
application in clinical practice.
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Introduction: In northern France during March of 2020, a surge in 
patients presenting withinfection and acute respiratory failure (ARF) 
from the novel 2019 coronavirus prompted urgent action. The surge 
created a heavy burden on French hospital facilities and finances. This 
paper contains an assessment of the health and cost benefits obtained 
by the construction of a temporary intermediate care unit(IMCU) 
with an advanced remote monitoring system. Facilities that include 
anIMCU in combination with ICUs have demonstrated significantly 
lower mortality rates in large multinational studies. [1] Improved 
health outcomes were an expected result. Furthermore, the addition 
of real time patient remote monitoring in the form of telemedicine 
in ICUs has been proven to reduce both mortality and length of stay 
(LOS) within critical care. [2] Over a three-day period, a team built a 
temporary IMCU with an advanced monitoring system in Avicenne 
Hospital,Bobigny France.
Methods: Mimicking modern ICU and emergency department telem-
onitoring systems, the network in the IMCU consisted of a 10-bed 
facility connected to a central workstation. The central worksta-
tion allowed a staff-worker who remained isolated from the infected 
patients to monitor respiratory data and pulse oximetry.
The system would display real time data along with patient alarms 
through aconnection to a dedicated USB port on a portable life-sup-
port ventilator, (TrilogyEvo, Philips Respironics, USA). The workstation 
had dedicated software to reviewall patient data and it included a 
mathematical algorithm determining the degree ofpatient-ventilator 
asynchrony.[3] This station contained an early warning system(EWS) 
to alert the clinical staff in the IMCU when it was appropriate to 
intervene.
Results: As a result, 40 patients were treated during the month of 
April in the AvicenneIMCU. Twenty-four patients (60%) treated at the 
IMCU had ARF but wereconsidered ineligible for ICU due to frailties 
such as age (≥80) or high-riskcomorbidities. The expected mortality 
of this critical population with ARF is near49% [4, 5]. 4 patients in this 
cohort (17%) died, thus exceeding survival expectations. 12 patients 
(30%) were admitted into the IMCU due to a progression from mild to 
severe Covid19 related hypoxemia. Within this cohort, 4 patients(33%) 
progressed to the ICU. 4 patients (10%) were admitted into the IMCU 
following discharge from the ICU, and 1 patient (25%) was readmitted 
to the ICU.
The incidence of alerts prompting intervention were HR (<50 or >120) 
= 3.1 ±7.5  alarm/hour, SpO2 (<90) = 8.1 ±10.0 alarm/hr and leak 
(>40L/min) = 6.7±12.9    alarm/hr. (Total = 17.9 alerts/hour). 280 ICU 
bed days were spared in the month of April 2020 due to the construc-
tion of this ICU. According to the cost data collected from 7 European 
countries, the average daily cost in ICU is approximately 1850€, result-
ing in a computed savings of 518  k€ [6].
Conclusion: The construction of a temporary IMCU, using advanced 
telemonitoring with anEWS, successfully improved patient outcomes 
and reduced the financial burden on the hospital system. The fre-
quency of interventive care recorded within this unit was once per 3.5 
minutes on average. Without alerts, this level of care would require 
continuous, rotating bedside contact by staff. Consequently, the 
directed interventions from the central workstation may have reduced 
exposure times.
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Introduction: Routine use of lower tidal volumes (TVs) for the 
mechanical ventilation of patients with ARDS results in decreased 
mortality and increases the number of days without ventilator use [1]. 
Severe COVID-19 pneumonia has been associated with the develop-
ment of ARDS as characterised by the Berlin definition [2]. A multi-cen-
tre preliminary audit was undertaken to identify whether ventilated 
COVID-19 related ARDS patients were receiving optimal TVs, as recom-
mended by the Faculty of Intensive Care Medicine (FICM) and Inten-
sive Care Society (ICS) ARDS management guidelines [3].
Objectives: As a result of the audit, three main areas for improvement 
were identified.
1. To achieve accurate calculations for ideal body weight (IBW) and target 
TV
2. To improve documentation of IBW and target TV
3. To achieve TVs no greater than 6 ml/kg
Methods: A ‘tidal volume calculator’ tool was developed using Micro-
soft Excel, which was simple, colour coded and kept on all Intensive 
Care Unit (ICU) computer desktops. This tool was designed to use 
height to calculate IBW and, if the patient’s height was unavailable, 
could also be utilised to calculate height from ulna length. IBW was 
subsequently used to calculate a target TV. Staff received training on 
how to apply the tool.
Two snapshot audits were carried out in April and May 2020 at two ICUs. 
The first was conducted prior to the tool’s introduction with the second 
two weeks after its implementation. All patients receiving mechanical 
ventilation, except those spontaneously breathing, were included. Data 
was extracted from patient notes, charts and ventilator settings.
Results: The initial audit included 14 patients. Six patients did not have 
an IBW documented. Three patients had documented IBWs that were 
12  kg, 15  kg and 23  kg greater than the weight calculated using the 
tool, leading to increased tidal volume targets. Only three patients were 
achieving TVs of 4–6 ml/kg. Eleven patients were achieving a TV greater 
than 6 ml/kg, with two of these achieving a TV of greater than 8 ml/kg.
The follow-up audit included ten patients. This revealed that all 
patients had an IBW clearly documented. Moreover, nine patients 
were achieving TVs within 4–6 ml/kg, with only one patient found to 
be achieving a TV greater than 6 ml/kg.
Conclusion: This audit cycle revealed that initially adherence to lung pro-
tective ventilation and documentation of IBW was poor. In some instances, 
documented IBW was vastly different to the calculated IBW, suggesting 
that in these situations actual body weight may have been used.
In a time when clinicians were being redeployed to support ICU, this sim-
ple tool was shown to support staff by clearly calculating and displaying 
IBW and target TV for reference. This directly led to improved adherence 
to lung protective ventilation and optimisation of patient care.
Limitations include that no consideration was made for overall patient 
outcome, and only a snapshot of achieved TVs from ventilators were 
recorded; daily/weekly trends were not studied.
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Introduction: End tidal CO2 (ETCO2) monitoring is a standard for all 
intubated patients in the pre-hospital environment. ETCO2 is used as 
surrogate marker for determining plasma CO2 concentration (pCO2) 
in intubated patients as pCO2 measurement is not readily available 
in the resource limited pre-hospital environment. Maintenance of 
normocapnia (4.4–5  kPa) is crucial for neuroprotection in critically ill 
patients.
Objectives: The objective was to determine whether ETCO2 can serve 
as a reliable surrogate marker for pCO2.
Methods: Data was retrospectively collected from the Air Ambulance 
Kent, Surrey and Sussex hospital database for critically ill non-trauma 
patients conveyed to the William Harvey Hospital between September 
2017 and March 2019. The latest pre-hospital ETCO2 value was paired 
with pCO2 values from initial blood gas results. Patient demograph-
ics, pre-hospital haemodynamic instability (use of vasopressor), other 
blood gas parameters and mortality within the same admission were 
also recorded. The paired data sets were analysed using the Mann-
Whitney test.
Results: 18 data sets that met the inclusion criteria were generated. 
Median ETCO2 and pCO2 was 4.4 kPa (IQR 3.9-4.8 kPa) and 7.3 kPa (6.5-
9.4 kPa) respectively. Median difference between ETCO2 & pCO2 was 
significant 3.0 kPa (p<0.001, CI 2.6-3.6 kPa). Median ETCO2,pCO2 and 
difference was 4.4 kPa (IQR 4.0- 4.5 kPa), 7.2 kPa (IQR 6.5-8.0 kPa) and 
3.3 kPa (IQR 2.1-3.6 kPa) respectively in patients who survived. Median 
ETCO2, pCO2 and difference was 4.3 kPa (IQR 4.0-4.5 kPa), 8.3 kPa (IQR 
7.0-11.3 kPa) and 3.0 kPa (IQR 2.9-4.5 kPa) respectively in patients who 
died. Median difference was not significantly associated with mortal-
ity (p = 0.69). The median difference between the pCO2 and ETCO2 
in cardiovascularly stable vs unstable patients was 3.0 kPa and 3.4 kPa 
and was not statistically significant (p = 0.59).
Table 1: Comparison of ETCO2 and PCO2 values




ETCO2 18 4.4 [3.9, 4.8]        0   
PCO2 18 7.3 [6.5, 9.4] 3.0 (2.6, 3.6) <0.001
(*) Differences calculated as PCO2 – ETCO2 
Measurement Stable Unstable P-value 
  n Median [IQR] n Median [IQR]   
ETCO2 7 4.5 [4.0, 5.5] 11 4.3 [3.5, 4.4] 0.13 
PCO2 7 7.3 [6.5, 8.8] 12 7.6 [6.6, 10.7] 0.93 
CO2 difference (*) 7 3.0 [2.5, 3.3] 11 3.4 [2.1, 4.5] 0.59 
(*) Differences calculated as PCO2 – ETCO2  
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Conclusion: ETCO2 is an unreliable surrogate marker of pCO2 and 
consistently underestimates the true pCO2 value by 3.0  kPa [C.I 2.6-
3.6  kPa]. The use of vasopressor does not appear to significantly 
impact the ETCO2 and pCO2 difference. Hence ETCO2 should not be 
used to determine normocapnia in the pre-hospital environment.
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Introduction: Lung protective ventilation (LPV) is an essential strategy 
in the management of patients mechanically ventilated due to severe 
respiratory failure, including those with COVID-19. When utilised, LPV 
has been proven to reduce absolute mortality by 8.8% and signifi-
cantly increase ventilator free days (1). Despite this, a recent study of 
459 ICUS’s from across 50 countries found that only 65% of patients 
received adequate LPV and 35% actually received potentially harmful 
volumes [2]. To manage the increased numbers of mechanically venti-
lated patients during the COVID-19 pandemic, a ventilation team was 
created to support the management and adherence to LPV targets.
Objectives: To evaluate the impact of a multi-faceted approach to 
ventilatory management on adherence to LPV targets.
Methods: A new supportive ventilation team was created, utilising 
existing members of the physiotherapy service with training taking 
place in March 2020, with a focus on promoting compliance with LPV. 
After an initial training period, this team implemented a multi-faceted 
approach to ventilatory management. This included measurement 
of patient height on admission and calculation of  ideal body weight, 
documented LPV targets in each bed space on whiteboards and twice 
daily physiotherapy led ventilation ward rounds to review and amend 
ventilator settings as required. Hourly tidal volume data was collected 
for all patients mechanically ventilated over a 2 month period during 
the COVID-19 pandemic (April–May 2020) and compared to a 2 month 
baseline period (January–February 2020). Primary outcome was com-
pliance with target tidal volumes of < 8  ml/kg, with secondary out-
come was PEEP/FiO2 compliance. Data was analysed using Chi Square 
test.
Results: A total of 62,656 hours of mechanical ventilation were 
included for analysis, with the results presented in table. 1. The intro-
duction of the ventilation team was associated with a significant 
increase in compliance with target tidal volumes of < 8 ml/kg (76% vs 
69%, p<0.0001) and a significant reduction in occurrence of volumes 
>10  ml/kg (4% vs 10%, p<0.0001). No significant differences were 
observed with regards to PEEP/Fi02 compliance.






n 25237 38529   
< 8mls / kg (hours) 17290 (69%) 28086 (76%) <0.0001 
> 10mls / kg 
(hours) 
2590 (10%) 1424 (4%) <0.0001 
Conclusion: The implementation of a specialist ventilation team was 
associated with a significant improvement in compliance with LPV 
targets for tidal volumes. This also led to a significant reduction in the 
percentage of ventilation hours in which patients may receive poten-
tially harmful tidal volumes.
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Introduction: An increasing number of patients required prolonged 
mechanical ventilation during the recent COVID-19 pandemic. The 
associated shortage of ICU beds and monitoring devices magnified 
the need of simple tools to properly titrate the level of ventilator assis-
tances. Observation of breathing pattern with utilization of accessory 
muscles, rapid or shallow breathing, or the inspection of ventilator 
waveforms are not useful to asses breathing efforts in a quantitative 
way. Thus, appropriate bedside monitoring of inspiratory effort is 
strongly required.
Objectives: We investigated whether bedside-available indices such 
as the ultrasonographic changes in diaphragm thickening ratio (TR) 
and the tidal swing in central venous pressure (ΔCVP) are reliable 
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estimates of respiratory effort, as assessed by the tidal swing in esoph-
ageal pressure (ΔPes).
Methods: Fourteen critically-ill patients were enrolled (age 
64±7 years, BMI 29±4 kg/m2), after 6 [3; 9] days from onset of assisted 
ventilation. A three-level pressure support trial was performed, at 10 
(PS10), 5 (PS5) and 0 cmH2O (PS0). In each step, the esophageal and 
central venous pressure tidal swing were recorded, as well as dia-
phragm ultrasound.
Results: The reduction of pressure suppor was associated with an 
increased respiratory rate and a reduced tidal volume, while minute 
ventilation was unchanged. ΔPes significantly increased with reduc-
ing support (5 [3; 8] vs. 8 [14; 13] vs. 12 [6; 16] cmH2O, p<0.0001), as 
did the diaphragm TR (9.2±6.1 vs. 17.6±7.2 vs. 28.0±10.0%, p<0.0001) 
and the ΔCVP (4 [3; 7] vs. 8 [5; 9] vs. 10 [7; 11] cmH2O, p<0.0001). ΔCVP 
was significantly associated with ΔPes (R2=0.810, p<0.001), as was dia-
phragm TR, albeit with a lower coefficient of determination (R2=0.399, 
p<0.001).  In a multivariable, linear, fixed-effects regression, only 
ΔCVP was significantly associated with ΔPes (coefficient: 1.45±0.16, 
p<0.001), while diaphragm TR was not (coefficient: −0.07±0.05, p = 
0.184).
Conclusion: In patients with COVID-19-associated respiratory failure 
undergoing assisted mechanical ventilation, ΔCVP is a better estimate 
of inspiratory effort than diaphragm ultrasound.
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Introduction: In the past decades noninvasive ventilation (NIV) has 
obtained an important role in the treatment of patients with acute 
respiratory failure (ARF). Most NIV studies have been conducted in an 
intensive care unit (ICU) setting. There are studies which have shown 
that NIV can be performed safely and effectively outside the ICU. The 
outcome of patients failing NIV in an intermediate care unit remains 
to be established. The aim of the current study was to investigate the 
safety and feasibility of providing acute NIV in a heterogeneous group 
of patients with ARF in an intermediate care unit.
Methods: This study was a retrospective analysis of patients admit-
ted to the intermediate care unit of Amsterdam UMC, location VUmc 
between January 2010 and January 2016. Patients with acute respira-
tory failure were included as well as those whose respiratory status 
slowly deteriorated, whatever underlying disease. Patients with CPAP 
at home or obstructive sleep apnea syndrome (OSAS) were excluded. 
Patients were subdivided into two categories: Hypercapnic failure and 
non-hypercapnic failure before the start of NIV. In both groups we 
analyzed admission source and their outcome (discharge destination).
Results:
RESULTS. 
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NIV at intermediate care (n=241):
 No arterial blood gas before start NIV (n=14)
 Hypercapnia (n=75):
Endotracheal intubation (n=23): 4 patients died and 19 survived
No endotracheal intubation (n=52): 23 patients died and 29 sur-
vived
 Non hypercapnia (n=152):
Endotracheal intubation (n=43): 10 patients died and 33 survived
No endotracheal intubation (n=109): 19 patients died and 90 sur-
vived
The admission diagnosis was heterogeneous: 36% of all the patients 
who received NIV was admitted to the intermediate care unit primar-
ily for respiratory failure. The duration of NIV treatment ranged from 1 
hour to more than 40 hours. Overall 61 of the 241 patients treated with 
NIV died within 28 days of the start of NIV on the intermediate care. 
They died either in de intermediate care unit (33 patients), or in the 
ICU after the transfer from intermediate care unit (12 patients), or else-
where (16 patients). Patients dying in the intermediate care unit had 
do-not-intubate orders.
Conclusion: We found that it is feasible to treat patients with NIV in 
an intermediate care unit, both for hypercapnic and non-hypercapnic 
indications. There is a need for more studies to confirm the safety of 
providing NIV in an intermediate care setting.
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Introduction: C-reactive protein (CRP) is an acute inflammatory pro-
tein known to increase in those with COVID-19 pneumonia caused 
by the novel SARS-CoV-2 virus. Several studies have correlated an 
increased in pneumonia severity in those with higher CRP levels. 
Patients with severe/critical COVID-19 infections often require addi-
tional support with oxygenation and ventilation in the intensive care 
unit (ICU) in the form of Continuous Positive Airway Pressure (CPAP) or 
invasive mechanical ventilation (IMV).
Some critical care societies had advised during the initial phases of 
the 2020 pandemic for an “earlier” intubation in those with hypoxia 
resistant to standard oxygen therapy. Intubation and mechanical 
ventilation comes with its own risks, from the difficulty of intubating 
the critically ill patient to other ventilator associated complications in 
those who may have improved on CPAP alone. With CPAP there are 
concerns over viral aerosolization transmission to healthcare staff 
and insufficient hospital oxygen supply if it is extensively used during 
pandemic. A proportion of those started on CPAP will deteriorate and 
require intubation, but as yet there seems to be little evidence if CRP 
can help predict those who might deteriorate.
Objectives: To see if the initial peak CRP in patients started on 
CPAP can predict those who will go on to need invasive mechanical 
ventilation.
Methods: We included patients accepted to the Intensive Care Unit 
(ICU) during February to May 2020 who presented with viral pneu-
monia (either a laboratory confirmed SARS-CoV-2 viral PCR test or 
strong clinical suspicions of a COVID-19 infection) causing hypoxia 
refractory to standard ward oxygen supplementation. Patients in ICU 
were either immediately intubated and mechanically ventilated (pri-
mary IMV), or started on CPAP. No high flow nasal oxygenation was 
used at this hospital. Some of these patients improved on CPAP only 
and were successfully stepped down from ICU to the wards. Others 
on CPAP deteriorated and were subsequently intubated (CPAP fail-
ure). Excluded from the study were; patients on CPAP who died in 
ICU, patients who had a limit on respiratory therapeutic level of care 
to CPAP only, or were on still on CPAP in ICU at time of data collec-
tion. All patients included had their CRP (mg/L) measured at hospital 
admission and 1st peak level.
The results are presented as full sets of numbers for respective groups. 
Statistical analysis was performed using Kruskal-Wallis test.
Results: A total of 40 patients with viral pneumonia were identified. 
Of those in the CPAP group, 3 were excluded from analysis. This meant 
there were 70.3% (n=26/37) in the CPAP arm and 29.7% (n=11/37, 
mean age 67) who underwent primary IMV. Of those who started on 
CPAP 62.0% (n=16/26, mean age 56.4) were successfully discharged 
with only CPAP, while 38.5% (n=10/26, mean age 55) failed CPAP and 
underwent secondary intubation.
Patients for whom CPAP was successful had a mean peak CRP of 240 
(110, 145, 153, 162, 173, 228, 230, 244, 245, 254, 268, 287, 304, 324, 350 
and 359). Those who failed CPAP and underwent secondary intuba-
tion had a mean peak of 353 (204, 283, 298, 323, 329, 338, 345, 346, 
526 and 538). For the primary intubation group the mean peak CRP 
was 342 (192, 212, 237, 314, 345, 345, 349, 349, 377, 493 and 547).
The difference in the peak CRPs was found to be statistically significant 
between the CPAP only group when compared to the CPAP failure 
group (p = 0.0098). The difference between the CPAP only group and 
primary IMV was also significant (p = 0.023).
Time difference between the date of peak CRP and date of intuba-
tion from failure of CPAP ranged between 4 days prior to 6 days post 
intubation. Only in half of the cases (n=5/10) did the CRP peak before 
intubation.
Time taken from starting CPAP to CPAP failure on ICU was between 
1-8 days (median 3.5).
The 1  month mortality was higher in the primary intubation group 
at 45.5% (n=5/11). There were 2/16 deaths (12.5%) in the CPAP only 
group and 3/10 (33.3%) who died in the failed CPAP group.
Conclusion: Whilst a small study, these results seem to indicate that 
patients with a higher peak CRP on CPAP with COVID-19 pneumonia 
are more likely to fail CPAP support and require intubation than those 
with lower values. However at present we cannot advocate the use 
of peak CRP as a predictor for CPAP failure with current data showing 
that CRP peaked in half cases after intubation. The authors feel that a 
larger population is needed to see if the peak CRP (or CRP at time of 
ICU admission) could be used to prognosticate CPAP failure in COVID-
19 pneumonias.
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Introduction: Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) outbreak was declared pandemic on March 2020, due 
to increasing number of cases around the world. Patients with SARS-
CoV-2 can develop coronavirus disease 2019 (COVID-19), which has 
resulted in high rates of intensive care unit (ICU) admission 1. Alter-
natives to endotracheal intubation (ETI) such as continuous Positive 
Airvway Pressure (C-PAP) were adopted to supply the lack of ICU 
beds during this extraordinary pandemic. C-PAP can be used such as 
a “bridge” to ETI in intermediate care units (IMCU) or in general wards.
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Objectives: We hypothesized that C-PAP can reduce ETI and mortality 
rates when compared to standard oxygen (SO) in COVID-19 patients 
with moderate-to-severe acute respiratory failure (ARF).
Methods: We performed a retrospective analysis, reviewing all COVID-
19 patients with moderate-to-severe ARF and admitted to our IMCU 
from March 1st to March 31st 2020. The inclusion criteria were age ≥ 
18 years old; diagnosis of COVID-19 by a nasopharyngeal swab; mod-
erate-to-severe ARF at IMCU admission (PaO2/FiO2 ratio < 200 mmHg 
during oxygen therapy at a flow rate >10 L/min for at least 15 min-
utes); oxygenation with SO or helmet CPAP (stand-alone system) for 2 
consecutive hours at least. Exclusion criteria were: not confirmed diag-
nosis of COVID-19 infection; do-not-intubate order. We analyzed two 
groups (C-PAP and SO) matched for age, SAPS2 score, SOFA score and 
PaO2/FiO2 at IMCU admission. We also collected demographic charac-
teristics and we investigated rates of ETI and hospital mortality.
Results: We reviewed 93 patients and 42/93 respected the inclusion 
criteria (21 in SO group; 21 in C-PAP group). The two groups were well 
matched (PaO2/FiO2 ratio at admission: 86 ± 20 (C-PAP), 92 ± 17 (SO) 
p = 0.3; SAPS 2 score: 29 ± 2 (C-PAP), 35 ± 7 (SO) p = 0.2; SOFA score: 
3 ± 2 (C-PAP), 3 ± 2 (SO) p = 0.4; age: 62 ± 3 (C-PAP), 64 ± 10 (SO) p 
= 0.2). Demographic characteristics are shown in Table 1. Patients in 
C-PAP group were more frequently intubated (14/21) than patients in 
SO group (8/21) although in not statistically significant way (OR 3.25, 
95% CI 0.92 to 11.51, p = 0.07). We also found no significant difference 
in rate of hospital mortality [C-PAP 8/21, SO 6/21, OR= 1.54, 95% CI 
0.42 to 5.61, p = 0.51] between the two groups (see Figure 1).
Conclusion: C-PAP did not reduce ETI and mortality rates when com-
pared to SO in COVID-19 patients with ARF.
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Introduction: While the optimal mode of respiratory support in 
severe COVID-19 disease has been the subject of ongoing debate, 
non-invasive ventilation (NIV) has been included in management 
guidelines from WHO (1), NHS England (2) and the Surviving Sepsis 
Campaign (3). NIV is an effective treatment for mild-moderate acute 
respiratory failure with evidence of mortality reduction when com-
pared to mechanically ventilated or spontaneously breathing patients 
(4). There is the risk of nosocomial transmission via viral aerosolisation 
(5-6), however NIV may offer benefits over an early invasive ventila-
tion strategy in terms of resource allocation and preventing morbidity 
from intubation and mechanical ventilation (IMV), especially in health-
care settings with limited invasive ventilation capacity. There are a 
number of evolving safety considerations alongside this.
Objectives: To characterise and describe initial outcomes of patients 
receiving a trial of NIV in a small, single centre intensive care unit in 
London. We aim to assess whether NIV is a safe therapy in pandemic 
surge planning, and understand its impact on the need for IMV in 
anticipation of future waves of COVID-19 infection.
Methods: Data was collected retrospectively on 44 patients admitted 
with severe respiratory failure during the first wave of the COVID-19 
pandemic between March and April 2020, all of whom received NIV 
as part of their initial critical care management. Data was collected on 
age, gender, BMI, requirement for IMV, and survival. We collected data 
on critical care staff infection rates during the same period as part of 
hospital wide audit.
Results: Of the 44 patients, 35 (79.5%) were male and 9 (20.5%) were 
female. Median age of the group was 56 (IQR 52–64), and median 
BMI was 29 (IQR 27–34). Overall 40.9% of patients died. 23 (52.3%) 
of patients went on to require IMV, on average after 56 hours of NIV. 
60.9% of those who required IMV subsequently died, whereas 19% of 
those who only received NIV for respiratory support died. Key char-
acteristics for both sub-groups were similar. Median APACHE II score 
and Clinical Frailty Score (CFS) for those who required IMV was 16 (IQR 
13-17) and 2 respectively and 15 (IQR 12-19) and 2 for patients who 
remained on NIV only. Prior to commencing NIV, baseline median 
SpO2 was 91% and FiO2 requirement was 80% in both groups. Impor-
tantly, there was marked improvement in Pa02, FiO2, and SpO2 2-4 
hours after starting NIV, with Pa02 increased to 9.67 kPa, FiO2 require-
ment reduced to 60% and SpO2 increased to 95%. There was greater 
improvement in PaO2 2-4 hours after starting NIV in the NIV only sub-
group when compared to those who required IMV (10.45  kPa NIV, 
8.98 kPA IMV). Average length of time to discharge home from critical 
care admission was reduced from 17.2  days in the IMV sub-group to 
15.9 days in the NIV only sub-group. We did not note any increase in 
staff sickness rates in comparison with other departments, including 
emergency medicine, general medicine and anaesthetics.
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Conclusion: Our data suggests there are benefits of administering a 
trial of NIV for respiratory failure in COVID-19. We demonstrate that in 
a significant proportion of cases it prevented or delayed IMV despite 
similar clinical severity at time of admission, and we also observed 
rapid improvements in work of breathing and oxygen requirements 
after initiation of NIV. This could ensure that invasive ventilators are 
kept free for those requiring emergent IMV. Survival was similar to 
national outcomes (7). NIV is not without its complications and there-
fore frequent review of these patients for escalation of their care is 
important. Particular consideration needs to be given to staff safety, 
including adequate supply of appropriate protective equipment, hos-
pital ventilation and airflow dynamics, and an adequate supply of oxy-
gen and consumables needs to be ensured.
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Introduction: Performing diagnostic fiberoptic bronchoscopy in criti-
cally ill patients may produce arterial blood gas and hemodynamic 
changes. The use of High-flow nasal oxygen therapy (HFOT) could 
decrease these complications.
Objectives: To compare the incidence of complications in the two 
studied oxygen therapy modalities during fiberoptic bronchoscopy.
Methods: Forty critically ill patients without invasive mechanical 
ventilation were consecutively collected. Their responsible physician 
decided to perform diagnostic fiberoptic bronchoscopy suspecting 
lung infection. Twenty patients received HFOT (Flow 60Lt /min and 
FiO2 40%) and 20 received conventional oxygen therapy (nasal can-
nula at 5 Lt/min). The fiberoptic bronchoscopy was performed at bed 
side. Variables were collected before, during and 2 hours after per-
forming the bronchoscopy. All the patients were sedated with Dex-
medetomidine Hydrochloride. Delta of oxygen saturation was defined 
as the difference between the initial saturation and the lowest satu-
ration during bronchial fibroscopy measured by pulse oximetry. The 
data was compared with the Mann-Whitney test. Data are presented 
in median and interquartile range.
RESULTS. The main results are shown in the table below. 
VARIABLES 




    P  
Age (years) 51 [28,72] 44 [30,70] 0.86 
Days of 
hospitalization 
5 [2,10] 4 [2,5] 0.11 
SAPS III 
(admission) 
44 [36,60] 49 [40,59] 0.68 
PAM (before study, 83 [76,94] 94 [84,104] 0.4 
mmHg) 
Sat O2 (before 
study, %) 
96 [92,98] 95 [92,99] 0.85 
FR (before study) 18 [15,20] 18 [14,26] 0.59 
PAM (during study, 
mmHg) 
76 [70,97] 89 [71,97] 0.5 
Sat O2 (during 
study, %) 
94 [89,96] 90 [85,94] 0.43 
FR (during study) 19 [17,22] 19 [17,26] 0.28 
Delta Sat O2 
(during study, %) 
2 [1,3] 5 [2,10] 0.01 
PAM (two hours 
after study, mmHg) 
82 [72,87] 81 [76,91] 0.6 
Sat O2 (two hours 
after, % 
92 [87,96] 94 [91,96] 0.38 
FR (two hours 
after) 
18 [15,20] 19 [16,22] 0.37 
Conclusion: The use of high-flow oxygen therapy is related to a lower 
decrease in saturation compared to conventional oxygen therapy.
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Introduction: Barotrauma, including both pneumothorax and pneu-
momediastinum, is a well-known complication of prolonged non-inva-
sive ventilation (NIV) [1]. Vigorous respiratory efforts lead to increased 
transpulmonary pressure and to patient self induced lung injury [2]. In 
Coronavirus Disease 2019 (Covid-19), correct timing to declare failure 
of NIV and proceed to intubation and invasive ventilation is unknown. 
We tested the hypothesis that in Covid-19 prolonged NIV is associated 
with barotrauma.
Objectives: To describe incidence of barotrauma in Covid-19 and its 
onset time from hospital admission.
To evaluate association between barotrauma and duration of NIV in 
Covid-19.
Methods: We retrospectively enrolled 104 consecutive Covid-19 
patients, admitted to our ICU from February 22nd to March 22nd, 
requiring intubation after failure of NIV. Age, sex and SOFA score were 
collected at ICU admission. Diagnosis of barotrauma was confirmed 
by radiological evidence (ultrasound/chest x-ray, chest CT) during the 
first 2  weeks from ICU admission. Different time intervals (from hos-
pital admission to intubation (T1) and from beginning of NIV to intu-
bation (T2)) were compared between patients with barotrauma and 
controls, using the Mann-Withney test. We then identified a subgroup 
of barotrauma patients, defined “early”, characterized by occurrence 
of barotrauma before or within the first 24 hours after intubation. We 
compared this group with controls with the Mann-Whitney test.
Results: Mean age was 61±10, 84 (80.7%) were male and median 
SOFA score was 6 (range 4-8). Barotrauma occurred in 15 patients 
(14%), at a median time of 8 days (IQR 6-12) from hospital admission. 
No differences were found either in T1 (median days 3, IQR 2-5.5 vs 
5, IQR 2-9, p ns), or in T2 (median days 2, IQR 1-4 vs 3, IQR 2-6, p ns) 
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between controls and patients with barotrauma. However 6 patients 
had an early barotrauma; in this subgroup, T2 was longer in patients 
who developed early barotrauma compared to controls (Table).
Time intervals Controls (n=89) Early Barotrauma (n=6)  
T1, days (median, IQR) 3.0 (2.0-5.5) 6.5 (2.5-13.2) 
T2, days (median, IQR) 2.0 (1.0-4.0) 6.0 (1.7-9.2)* 
*p<0.05 between early barotrauma and controls   
Conclusion: In Covid-19 barotrauma had an incidence similar to other 
forms of acute respiratory failure. However, early barotrauma was asso-
ciated with prolonged use of NIV.
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Introduction: The decision to use non-invasive ventilation (NIV) 
to treat acute respiratory diseases in the ICU avoids intubation and 
reduces invasive mechanical ventilation risks [1].
Objectives: To investigate the patients who started NIV in our ICU and 
study their failure and mortality rates.
Methods: Retrospective single-centre study of all patients admitted 
during a five-year period who received NIV, except for chronic thera-
peutic purposes. Data of demographics, mortality scores, cause for 
NIV and NIV failure (defined as intubation need) of 167 patients were 
recorded and processed with SPSS 23. NIV failure was studied, exclud-
ing patients on a weaning strategy.
Results: The average age was 70  years, with a mean SOFA score on 
admission of 8.7 compared with 6.6 at discharge. The mean ICU stay 
was 10 days with NIV duration of 53 hours. The patients admitted were 
mainly medical, with only 10.8% admitted due to emergency surgery. 
Half the patients had previous respiratory diseases, accounting COPD 
with 44.3%, 46.7% had cardiovascular pathology and 36.5% had res-
piratory illnesses. The number of patients who started NIV due to 
COPD and acute cardiogenic pulmonary oedema was similar (16.8%), 
while 11.4% had pneumonia. 13.6% were on mechanical ventilation 
weaning. Considering all patients, 36.5% had NIV failure rate and 
32.3% of mortality rate.
Patients who survived were younger (69.2 vs 72.7  years), had better 
scores on admission (SAPS II 51 vs 64; APACHE II 26.9 vs 31.6; SOFA 
7.7 vs 10.7), had less need for haemodynamic support (27 vs 54%) and 
less time gap between admission and NIV start (45 vs 70 hours). These 
patients had more respiratory and cardiovascular diseases than those 
who died and there were fewer patients in need for NIV due to pneu-
monia (9.7 vs 14.8%). About 28% of patients that lived had NIV failure 
compared with those that did not (54%).
A significant difference was observed in those who failed NIV trial with 
those who did not with in between admission and discharged SOFA 
score (on admission 7.27 vs 10.34; on discharge 5.56 vs 8.34), aminer-
gic support (42 vs 58%), ICU stay (6 vs 15 days) and mortality rate (21 
vs 48%). Average SAPS II score of those who survived and did not fail 
NIV trial was 47 compared with 59 in intubated patients. Failed NIV 
survivors had higher pH levels (7.28 vs 6.7), while the opposite hap-
pened within those who succeeded NIV trial (7.07 vs 7.28).
Conclusion: Patients who had the best outcomes had more comor-
bidities, opposing to the higher percentage of pneumonia in between 
those who died. Despite studies showing a SAPS II score > 34 to be 
independently related to NIV failure [2], our patients who succeeded 
had an average score of 47. Although indications for NIV trial in 
patients with a pH >7.25 [3, 4], there was no significant pH difference. 
NIV is a useful treatment and more studies are needed to identify early 
factors associated with higher mortality.
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Introduction: Noninvasive ventilation (NIV) is considered as the 
standard treatment for moderate to severe exacerbations of Chronic 
Obstructive Pulmonary Disease (COPD). However, the way to withdraw 
NIV after stabilization is not well established.
Objectives: We performed a National Survey to disclose this issue in 
clinical practice.
Methods: A national survey was launched to Spanish hospitals hav-
ing general or respiratory ICU through the intensive (SEMICYUC) and 
pulmonology (SEPAR) national societies. The survey was carried out 
between January and March 2019.
One response per Unit was analyzed (that of the NIV expert or the 
head of the service in his absence). Characteristics of the center, spe-
cialty and withdrawal strategies are collected: time of beginning of 
disconnection, direct or progressive withdrawal, type of progression, 
with or without analytic control (arterial or venous), among others.
Data analysis was conducted using SPSS Version 21.0. The data are 
presented as n (%); p value < 0.05 were considered statistically signifi-
cant doing contingency tables and using the Chi-Square or the Fisher 
test.
Results: We received a total of 179 responses, leaving us with 141 after 
the elimination of double responses. The final analysis was performed 
on 129 answers after eliminating 12 answers from third level hospitals 
that do not admit this pathology (AECOPD).
Responses from 129 units were analyzed, 84(60%) by intensivists and 
57(40%) by pulmonologists. The 54.6% were tertiary hospitals.
96.6% of physicians (n 128) perform blood gases to decide to initiate 
disconnections. The use of an arterial sample is more common among 
pulmonologists than among intensivists (94.7% vs 66.2%, p<0.05).
Only in 26 units (20.3%) is direct withdrawal attempted and it is more 
frequent among intensivists (28.2% vs 10.5% p<0.05).
When they make a progressive withdrawal, 42.2% extend the discon-
nections, 6.9% decrease the support and 51% combine both. Night-
time NIV is indicated in 88.4% of cases.
The majority of the respondents required hemodynamic stability 
(82%), respiratory rate <30 b/min (98%) and blood gas analysis (97%), 
for making decisions. Venous blood gas samples were used in 21% 
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of the cases. Pulmonologists conducted progressive withdrawal and 
used arterial blood gases significantly more often than intensivists.
Conclusion: To our knowledge, this is the first descriptive study of NIV 
withdrawal in patients with AECOPD.
The criteria for initiating withdrawal are fairly homogeneous, although 
some different strategies may be evident depending on the specialty.
Pulmonologist usually do withdrawal progressively and use arterial 
blood gases more often than intensivists.
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Introduction: Unilateral diaphragm dysfunction (UDD) is an under-
diagnosed condition. Of the benign causes, the most common is the 
idiopathic type. Other causes include complications of cardiac surgery, 
trauma, metabolic derangements, as well as some infections. It has 
been postulated that the functional diaphragm increases in strength 
and compensates for the dysfunctional side thus the asymptomatic 
state in the majority of patients. However, in a smaller group this dys-
function may lead to dyspnea, sleep-disordered breathing, exercise 
intolerance, fatigue and even respiratory failure.
Objectives: We report the outcome of symptomatic UDD patients 
implanted with DP to treat the isolated dysfunction
Methods: This is an IRB approved retrospective analysis of a prospec-
tive, non-randomized interventional experience at a single institution. 
Patients underwent laparoscopic diaphragm mapping and electrode 
implantation. Post implantation patients were evaluated radiographi-
cally with either chest radiography or fluoroscopic sniff test, reported 
symptoms and diaphragm electromyography (dEMG) using the 
implanted DP electrodes. Success was considered when there was 
improvement or recovery in 2 of the 3 data points
Results: In the diaphragm dysfunction database, 62 patients with 
UDD were identified. Etiologies of the paralysis codified into 7 groups: 
idiopathic (n = 27), chest/thoracic procedure (n = 13), neck/shoulder 
surgery/injection (n = 8), trauma (n = 4), infection (n = 3), chemo/
radiation (n = 3), Parsonage Turner’s syndrome (N = 3), and post liver 
transplant (n = 1). The average age was 60 ± 10 years. All patients had 
significant respiratory symptoms and abnormal chest radiographs. 
Symptom duration was greater than 6  months in 49 patients (79%). 
Fifty-nine (95%) had fluoroscopic evaluation of the diaphragm with 
51% showing paradoxical motion; the others showed no movement.
Post implantation, 44 (70.9%) of patients reported improvement 
in symptom, 46 (74%) had improvement in dEMG and 23 (37%) had 
improved radiologic testing. Thirty nine patients (62.9%) had recovery 
of 2 data points. Recovery rate was at 63.2% and 40% in patients with 
symptom duration greater than 6 and 18  months respectively. Addi-
tionally, there was a significant improvement in those with paradoxical 
motion 78% compared to those without paradoxical movement (59%).
Conclusion: DP can play a significant role in patients with sympto-
matic UDD. It could be offered as a treatment modality in UDD where 
the diaphragm can be electrically stimulated prior to proceeding with 
plication procedures
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Introduction: The outcome for COVID-19 patients undergoing a trial 
of continuous positive airway pressure (CPAP) prior to invasive ventila-
tion is unclear. There may be a role for avoiding invasive ventilation at 
the risk of worsening outcomes for those failing such a trial, however 
there is a lack of definitive evidence.
Objectives: To identify prognostic factors which may indicate a suc-
cessful CPAP trial for COVID-19 patients and determine the effect of 
CPAP on mortality for those invasively ventilated after a CPAP trial.
Methods: A prospective cohort study of adult patients admitted to 
the ICU with COVID-19 pneumonitis in respiratory failure. Primary out-
come: failure of CPAP trial resulting in invasive ventilation. Secondary 
outcome: mortality in patients requiring invasive ventilation after a 
CPAP trial.
Results: 45 patients underwent a trial of CPAP during the study 
period. 33 (73%) patients failed the trial and required invasive ven-
tilation. There was no significant difference in age, Clinical Frailty 
Score, Extended Medical Research Council Dyspnoea Score (eMRCD), 
APACHE and SOFA scores (see Table 1). All patients over 70 years failed 
their CPAP trial. Patients undergoing a successful trial had shorter 
duration of ICU and hospital stay (see Table 2). 14 (42%) patients died 
after they failed a CPAP trial. 12/22 (55%) patients undergoing invasive 
ventilation without CPAP died.
PAPC
Failed CPAP & 
subsequently intubated 
Age (Years) 
Mean 54.6 56.4 
Median 53.0 58.5 
Clinical Frailty Score 
Mean 1.5 1.5 
Median 1.0 1.0 
eMRCD 
Mean 1.4 1.3 
Median 1.0 1.0 
APACHE 
Mean 11.4 12.6 
Median 10.0 12.0 
SOFA 
Mean 2.2 2.9 
Median 2.0 2.5 
Table 1. Comparison of attributes on admission between patients receiving successful CPAP and 
those failing CPAP and requiring invasive ventilation. 
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PAPC
Failed CPAP & 
subsequently intubated 
ICU Length of Stay (Days)
Mean 2.8 21.9 
Median 2.0 22.5 
Hospital Length of Stay 
(Days) 
Mean 15.1 34.1 
Median 13.0 32.5 
Table 2. Comparison of ICU and hospital length of stay between patients receiving successful 
CPAP and those failing CPAP and requiring invasive ventilation. 
Conclusion: Mortality for patients undergoing a CPAP trial does not 
appear to be increased. All patients over 70 years failed CPAP. Success-
ful CPAP trial results in reduced ICU and hospital stay.
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Introduction: Prone positioning increases oxygenation by recruit-
ing dorsal lung regions and drain airway secretions, improves gas 
exchange and survival in ARDS. We described efficacy of prone posi-
tioning in awake non-intubated spontaneously breathing COVID-19 
positive patients with hypoxemic acute respiratory failure.
Methods: We studied 26 awake non-intubated spontaneously breath-
ing patients with hypoxemic respiratory failure treated with prone 
positioning. Patients were kept in prone positioning for two hours in 
each session and four such sessions were given to patients in 24 hours. 
SPO2, PaO2, RR and hemodynamics were measured before prone 
positioning (PRE), 60 minutes of prone positioning (PRONE) and after 
one hour of the completion of session (POST).
Results: 26 patients (12 males and 14 females) non-intubated spon-
taneously breathing with SPO2 <94% on 0.4 FiO2 were treated with 
prone positioning. One patient required intubation and was shifted to 
ICU, rest 25 patients were discharged from HDU. Mean hours of prone 
positioning was 19.4 ± 2.06 hr. There was significant improvement 
in oxygenation (increase in PaO2 from 53.15 ± 6.0 mmHg to 64.23 ± 
6.96 mmHg in PRE and POST sessions respectively, likewise there was 
increase in SPO2). No complications were noted with various sessions.
Conclusion: Prone positioning was feasible and improved oxygena-
tion in awake non-intubated, spontaneously breathing COVID-19 
patients with hypoxemic acute respiratory failure.
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Introduction: Survival of patients with hematologic malignancies 
(HM) admitted to Intensive Care Units (ICU) have been changing over 
the years. Nevertheless, still exists some reluctance in intensive care 
providers to admit and treat patients with these diseases. The ability 
to identify key prognostic variables of outcome within the first days 
may help to recognize those who are most likely to benefit from ICU 
therapy.
Methods: We studied a retrospective cohort of 56 adult patients with 
HM admitted to a non-hematologic ICU between January 2015 and 
September 2019. Patient’s baseline characteristics, organ failure scores 
and outcome were analyzed in order to identify clinically useful prog-
nostic factors.
Results: Median age was 56  years. The most common hematologic 
diseases were acute myelogenous leukemia (17; 30%), malignant 
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lymphoma (16; 29%), acute lymphoblastic leukemia (6; 11,4%) and 
multiple myeloma (5; 8,6%). Primary reason for ICU admission were 
septic shock (30; 54%), respiratory failure (11; 20,3%), acute kidney 
injury AKIN >= 2 (5; 9%) and gastrointestinal complications mainly due 
to upper gastrointestinal bleeding (3; 5,7%). Median time in-hospital 
before ICU admission was 10 days and the median duration of ICU stay 
was 6 days. Median ICU and in-hospital mortality were 57 and 68,5%, 
respectively. Median SAPS II score was 56 with an estimated mortal-
ity of 59,6%. Median SOFA score 48 and 24 hours before ICU admis-
sion was higher in non-survivors group (6 vs 4 and 9 vs 7, respectively). 
Mortality was higher in patients with acute leukemia, septic shock and 
need for mechanical ventilation and vasopressor support during ICU 
admission.
Conclusion: Higher mortality in patients with HM admitted to the 
ICU was associated with more severe illness and respiratory or hemo-
dynamic instability. Organ failure scores done before admission may 
suggest delay on ICU admission and worst outcome.
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Introduction: Patients affected by hematologic malignancies admit-
ted to an Intensive Care Unit (ICU) have been a subject of debate 
for many years. Reported survival rates are low, especially in those 
patients who develop several organ failures.
Objectives: To determine the factors associated with ICU mortality in 
patients with hematologic malignancies.
Methods: Study period: January 2015 to December 2019. It has been 
collected demographic variables, severity scores, hematological char-
acteristics, organ dysfunctions, microbiological data, length of stay 
and ICU and hospital mortality. Statistical analysis includes qualitative 
variables, presented as proportions and 95% confidence interval (CI); 
quantitative variables have been presented as medians and 95% CI. 
Shapiro-Wilk test has been used for the assessment of normality. The 
univariate analysis was performed using the simple linear regression 
test. ICU mortality was determined in the multivariate analysis using 
the logistic regression test.
Results: n = 84. Males 0.61 (95%CI: 0.5 to 0.7). Age: 57.5 years (95%CI: 
52.5 to 61.5). Hematologic therapies: hematopoietic stem cell trans-
plant 0.38 (95%CI: 0.28 to 0.48); intra-ICU chemotherapy 0.14 (95%CI: 
0.08 to 0.23). Severity scores and biomarkers on admission: APACHE II 
27 (95%CI: 25 to 28); SOFA 8 (95%CI: 7 to 9); procalcitonin 4 (95%CI: 
0.9 to 19.5). Acute respiratory failure (ARF) was the main reason for 
admission 0.5 (95%CI: 0.4 to 0.6), followed by sepsis 0.34 (95%CI: 
0.24 to 0.44). The proportion of patients with positive blood cultures 
on admission was 0.21 (95%CI: 0.13 to 0.31), all of them of unknown 
focus. Pathogen most frequently isolated: Escherichia coli 0.33 (95%CI: 
0.14 to 0.59). Organ dysfunctions developed in ICU: ARF 0.85 (95%CI: 
0.76 to 0.91); shock 0.64 (95%CI: 0.54 to 0.74); renal failure 0.64 (95%CI: 
0.54 to 0.74); coma 0.14 (95%CI: 0.08 to 0.23). Life support measures: 
high flow nasal cannula 0.3 (95%CI: 0.21 to 0.41); non-invasive ventila-
tion 0.47 (95%CI: 0.36 to 0.57); invasive ventilation 0.7 (95%CI: 0.65 to 
0.83); continuous renal replacement therapy (CRRT) 0.34 (95%CI: 0.24 
to 0.44). The ICU stay was 9  days (95%CI: 6.9 to 14) and the hospital 
stay was 18 days (95%CI: 15 to 23). The ICU mortality was 0.46 (95%CI: 
0.36 to 0.57) and the hospital mortality was 0.59 (95%CI: 0.48 to 0.69). 
Variables significantly associated with mortality: APACHE II (OR 1.1; 
95%CI: 1.04 to 1.19); SOFA (OR 1.21; 95%CI: 1.04 to 1.4); shock (OR 3.7; 
95%CI: 1.4 to 9.8); ARF (OR 12; 95%CI: 1.5 to 100); invasive ventilation 
(OR 30.4; 95%CI: 3.8 to 241.1); CRRT (OR 3; 95%CI: 1.16 to 7.7). Regard-
ing multivariate analysis, the variable which independently explains 
mortality is invasive ventilation (OR 22.7; 95%CI: 2.8 to 184.9).
Conclusion: The main determinant of mortality in patients admitted 
to the ICU due to hematologic malignancies is the acute respiratory 
failure and the need of invasive ventilation.
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Introduction: ICU admission and organ support in patients with 
hematologic malignancies with systemic organ failure is still debat-
able, given the high associated mortality and absence of reliable out-
come predictors (1,2).
Objectives: Identification of prognostic factors in patients with hema-
tologic malignancy and multisystemic organ failure admitted to an 
ICU. Mortality and functional outcome 3-months and 1-year after ICU 
discharge were the primary and secondary outcomes, respectively.
Methods: Retrospective, single centre study from a tertiary care, uni-
versity hospital. Clinical and laboratory data from patients with hema-
tologic malignancies admitted to ICU, from June 2014 to June 2019, 
were extracted from electronic registries. Functional assessment was 
performed through clinical registries plus phone contact and scored 
according to Eastern Cooperative Oncology Group (ECOG) scale. Sta-
tistical analysis was performed through  IBM®  SPSS® Statistics 25.
Results: We included 100 patients (112 ICU admissions), mostly male 
(60%) with a median age of 60  years old [inter-quartile range (IQR): 
45-65], median SAPS II of 56 (IQR: 19-129) and median admission 
SOFA of 9 (IQR: 2-22). Acute leukemia (34.8%), non-Hodgkin lym-
phoma (25.9%) and multiple myeloma (13.4%) were the most preva-
lent diagnosis. Most of the patients had active disease (70%) and were 
under treatment, half of them on first line. 25% had been submitted 
to allogeneic stem cell transplant. Septic shock (40%) and respiratory 
failure (38.4%) were the most frequent causes for ICU admission. Dur-
ing their ICU stay, 80% had respiratory failure (50% received invasive 
mechanical ventilation) and 68.8% had cardiovascular failure; half of 
the patients had 3 or more organ failures. We observed a 54% ICU, 
38% hospital, 28% 3 months and 26% 1 year survival rates. Main cause 
of death was refractory shock (37%). Each additional organ failure 
was associated with lower survival probability by univariate analysis, 
except for neurologic failure; age was not a predictor of early death; 
by multivariate analysis, only respiratory failure and mechanical 
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ventilation were associated with lower survival (HR 11.59, 95% CI 1.56 
– 86.45, p = 0.02 and HR 3.05, 95% CI 1.41 – 6.57, p = 0.01, respectively). 
Type of hematologic malignancy and disease status at ICU admission 
were not predictors of ICU survival (Fig.  1 and 2, respectively). One 
month after ICU discharge, lower ECOG scores were associated with 
higher survival (p<0.001). One year after ICU discharge, 74% of the sur-
vivors had ECOG score 0 or 1 and 68.4% were in complete remission.
Conclusion: Patients with hematologic malignancy and multiorgan 
failure are at increased risk of death, however timely ICU care can 
still be associated with 40% survival. Mechanical ventilation, but not 
hematologic diagnosis nor age, was associated with lower survival 
probability. Importantly, patients surviving ICU admission attain good 
functional state at 1-year.
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Introduction: Organ dysfunction is one of the main reasons for admis-
sion to intensive care unit (ICU) and it is associated with higher mortal-
ity. Acute renal injury (AKI) might occur not only because of general 
reasons but it is also associated with haematological malignancy itself, 
treatment and complications.
Objectives: The aim of our study was to analyse AKI in critically ill 
oncohaematological patients.
Methods: We retrospectively analysed data of oncohaemathological 
patients who were admitted to the 3rd ICU in Vilnius university hos-
pital Santaros clinics from 13 07 2017 to 27 12 2019. Inclusion criteria 
were: oncohaematological malignancy, age > 18 years, arterial or cen-
tral line inserted, signed informed consent form. AKI was diagnosed 
according to KDIGO and RIFLE scoring systems. Baseline creatinine 
level was calculated at least 6  months before admission to ICU. Lev-
els of creatinine were taken and recorded on admission to the hospital 
and ICU. Decision to admit patient to ICU and/or start renal replace-
ment therapy was made by ICU doctor in charge. All of the continuous 
renal replacement therapies were performed with Prismaflex machine 
using citrate anticoagulation and CVVHDF mode. The effluent dose 
was prescribed by attending ICU doctor. SOFA score was calculated on 
admission to ICU. Statistical analysis was performed with R statistical 
package. A p-value of less than 0,05 was considered to be statistically 
significant.
Results: 117 patients (67 males and 50 females with the average age 
of 59,86 ± 15,26) were included into the study. The baseline creati-
nine was 91,07  μmol/L ± 59,34, creatinine on admission to hospital 
was 118,96 ± 91,86, on admission to ICU 130,37 ± 94,61. Incidence 
of acute renal injury on admission to hospital according to KDIGO 
and RIFLE score were 35 (29,91%) and 15 (12,82%) on the admission 
to ICU 48 (41,03%), 19 (16,24%). Patients with KDIGO stage 31 had 
lower arterial pH (7,41 vs 7,46, p value < 0.05), lower BE (-4,0 vs -0,2, 
p value < 0,05), higher lactate (1,3 vs 2,0, p-value < 0,001) on admis-
sion to ICU. Patients with AKI according to RIFLE on admission to ICU 
had higher creatinine on admission to hospital (151 vs 75, p-value < 
0,001). CVVHDF was used for 30 (25,42%) patients. Higher proportion 
of patients who received CVVHDF had renal injury according to RIFLE 
not only in ICU (52,63% vs 20,20%, p value < 0,05), but also on a ward 
(46,66% vs 22,33%, p value < 0,05). Patients who received CVVHDF had 
lower arterial pH (7,37 vs 7,45, p value < 0,05), lower BE (-5,9 vs -0,3, p 
value < 0,001), higher lactate (2,1 vs 1,4 p value < 0,05), higher creati-
nine on admission to hospital (108 vs 82,5 p value < 0,05), higher cre-
atinine on admission to ICU (174,5 vs 86, p value < 0,05). Patients who 
received CVVHDF had higher ICU mortality and worse overall survival 
(83,33% vs 38,64%, p value < 0,0001, 96,67 vs 64,77, p value < 0,001).
Conclusion: Acute renal injury is common in critically ill oncohama-
tological patients. Higher incidence is seen if diagnosed with KDIGO 
scoring system. Patients with AKI and those who received renal 
replacement therapy had more derangements on arterial blood 
gases. Patients who received CVVHDF had signs of acute renal injury 
already on a ward they also had higher ICU mortality and lower overall 
survival.
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Introduction: Patients with septic shock have a very high mortal-
ity rate despite of aggressive treatment in intensive care unit (ICU). 
Prognosis of oncohaematological patients is even worse. High dose 
vitamin C therapy received a lot of attention over the last years as a 
supplementary therapy which could lead to improvement during sep-
tic shock.
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Objectives: The aim of our study was to evaluate the impact of high 
dose vitamin C therapy during septic shock in oncohaematological 
patients.
Methods: We retrospectively analysed data of oncohaematological 
patients with septic shock who were admitted to the 3rd Intensive care 
unit from 13 07 2017 to 19 02 2019 in Vilnius university hospital San-
taros clinics. Inclusion criteria were: oncohaematological malignancy, 
age > 18  years, septic shock, arterial or central line inserted, signed 
informed consent form. Sepsis and septic shock were defined as per 
SEPSIS-3 definition. When noradrenaline dose reached 0,1 mcg/kg/
min. patients received vitamin C 1500 mg every six hours i/v together 
with hydrocortisone 50  mg every six hours i/v, thiamine 200  mg i/v 
once per day supplementary to the standard treatment of septic shock 
according to local practice. Control group consisted of oncohaemato-
logical patients with septic shock who didn‘t receive high dose vitamin 
C therapy. High dose vitamin C therapy was stopped when patients 
became haemodynamically stable. Statistical analysis was performed 
with R statistical package. A p-value less than 0.05 was considered to 
be statistically significant.
Results: 71 patients with haematological malignancies were admit-
ted to ICU. 36 patients were diagnosed with sepsis and 33 of them 
had septic shock. 23 patients received high dose Vitamin C therapy. 9 
patients were excluded from the analysis due to the violation of dos-
age of vitamin C. Final analysis included 14 patients who received high 
dose vitamin C therapy. Control group consisted of 10 patients.
Patients in high dose vitamin C group were older (65,57 vs 53,95, p 
< 0.0027), they had a higher SOFA score on day1, day2 and day3 in 
intensive care unit (accordingly 8,64 vs 6,2*, 10,62 vs 7,12**, 10,09 vs 
5,92***, p value *- 0.0534, ** - 0.0051, *** - 0.002597). Arterial pH, BE, 
lactate did not differ between groups on arrival to intensive care unit 
(accordingly 7.46 vs 7,43 (p = 0,44), BE -2,99 vs 0,53 (p = 0,48), lactate 
1,9 vs 1,2 (p = 0.09)). Intensive care unit survival of patients treated 
with high dose vitamin C therapy was 21,43% (3/14) compared with 
47,37% (9/19) in standard treatment group (p value 0.1258). There was 
no difference in terms of intravenous fluids (per hour), time spent in 
intensive care unit, length of vasopressor therapy and renal replace-
ment therapy between the groups (149.15  ml vs 131,1  ml, 69,5  h vs 
71 h, 62 h vs 10 h and 50% (7/7) vs 26,32% (5/19)).
Conclusion: High dose vitamin C therapy didn’t improve survival of 
oncohaematological patients with septic shock. Patients with high 
dose vitamin C had higher SOFA scores on the first, second and third 
days in intensive care unit.
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Introduction: Since the beginning of the new SARS-CoV2 pandemic, 
numerous biological and clinical findings have been described 
through the literature. Lymphopenia is one of them and is found in 
nearly all severe cases (1). Little is known about the lymphocyte sub-
set in this pathology, despite interesting data that could help to better 
understand SARS-CoV2 infection.
Objectives: To review the lymphocyte subpopulations in SARS-CoV2 
infected patients admitted in our ICU.
Methods: Observational, retrospective and descriptive study. We 
reviewed all our SARS-CoV2 patients admitted in our ICU between 
march 2020 and may 2020 and selected patients who had lympho-
cytes subset requested at admission. Epidemiological data, hemo-
globin, leucocyte count, leucocyte population, and lymphocyte 
subpopulation (studied by flow cytometry) were collected.
Results: Of 46 patients admitted in our ICU (22 beds), 10 had lympho-
cyte subset requested. Mean age (+/- SD) was 56,18 years (+/- 11). All 
of these 10 patients were critical SARS-CoV2 pneumonia, requiring 
mechanical ventilation within their stay. 5/10 patients required VV-
ECMO. All patients were HIV negative.
8/10 patients had low CD4+ T-lymphocyte count (317/mm3 +/-94), 
with proportionally more profound alteration in CD8+ T-lymphocyte 
count (82/mm3 +/-30). The T-Lymphocyte Helper/Suppressor ratio 
was elevated in most of the patients (7/10), with mean value of 4,3 
(+/-2). No patient had a ratio less than 1. There was an increase in pro-
portion of circulating B lymphocytes (24% +/-10%), with normal abso-
lute value (148/mm3 +/-53). All patients had normal NK cells value 
(75/mm3 +/-31).
Opportunistic infections are classically described in patients hav-
ing specific risk factor (malignancies, solid organ transplant, specific 
drugs) or HIV patients having CD4+ count lower than 200/mm3 (2) 
which was the case in only 2/10 patients (lowest value of 126/mm3).
Conclusion: Lymphocytes are playing an important role in the main-
tenance of immune system function. Subsets are uniformly affected 
with low CD4+ and CD8+ T-lymphocyte, higher ratio, and increased 
proportion of circulating B lymphocytes. These findings are correlated 
to the severity of the disease (2), but underlying consequence of it is 
unknown. Potential treatment aimed to restore a better immune func-
tion as used in cancer immunotherapy or tested in sepsis might be a 
promising tool to correct those alterations(3).
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Introduction: Cytokine release syndrome (CRS) is a clinical syndrome 
derived from the massive release of cytokines after immunotherapy, 
which can range in severity from a flu-like illness to multiorgan dys-
function syndrome.
Objectives: To describe the clinical profile of CRS and to identify risk 
factors for developing CRS and for CRS severity after Chimeric Antigen 
Receptor (CAR) T-cell therapy.
Methods: Retrospective study that included those patients treated 
with CAR T-cell therapy in the Advanced Therapies in Hematology Unit 
(UTAH) at Vall d´Hebron University Hospital (Barcelona) from August 
2018 to December 2019. The UTAH is a 12-bed, monitored unit, staffed 
by Hematologists, with the support of a multidisciplinary team includ-
ing ICU, Neurology, Pediatrics, Infectious Diseases, Microbiology, 
Immunology and Pharmacy specialists. Patients were admitted before 
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CART-cell infusion for lymphodepletive chemotherapy and were fol-
lowed up during at least 10 days after CAR T-cell infusion, per proto-
col. CRS and immune effector cell-associated neurotoxicity syndrome 
(ICANs) were defined and graded according to ASTCT Consensus (Biol 
Blood Marrow Transplant 2019; 25: 625-38). We considered CRS onset 
in the first 72 hours after CAR T-cell infusion as early CRS (eCRS), and 
severe CRS (sCRS) as CRS grade >1. Chi-Square, Fisher´s test, T test, U 
Mann-Whitney and logistic regression were employed as appropriate. 
Quantitative variables are reported as median (IQR) and categorical as 
frequency (%).
Results: Forty-one patients, 31 (76%) male with a median age of 57 
(47-66) years, were treated with anti-CD19 CAR T-cells for refractory 
non Hodgkin lymphoma (38, 93%) and acute lymphoblastic leukemia 
(3, 7%). Costimulatory domains for CAR T-cells were 4-1BB and CD28 
in 39 (95%) and 2 (5%) patients, respectively. Thirty (73%) developed 
CRS:13 (32%) grade 1, 16 (39%) grade 2, and 1 (2%) grade 3. All of 
them had fever, with a median peak temperature of 38.4ºC (38-39), 
13 (32%) developed hypotension that required fluid bolus and 11 
(27%) hypoxemia requiring supplemental oxygen (6 liters per minute 
or less in 10 and 30 lpm administered with high-flow nasal cannula in 
1 patient). Time from CAR T-cell infusion to CRS was 4 (2-6) days. Ten 
(33%) patients developed eCRS. Duration of CRS was 5 (3-8) days. Toci-
lizumab was used in 8 (20%) patients and was associated with reso-
lution of CRS in all treated cases; one patient (2%) needed a second 
dose to control CRS. Moreover, 8 (20%) patients developed ICANs, at a 
median of 7 (5-9) days after CAR T cell infusion; 1 (2%) grade 1, 6 (15%) 
grade 2 and 1 (2%) grade 3. Seven of these 8 patients developed ICANs 
after CRS onset. Patients with ICANs grade 2 and 3 were treated with 
corticosteroids with complete resolution in all patients. Baseline bio-
markers were not predictors of CRS (Table 1). Patients with sCRS had 
earlier CRS onset, higher temperature, higher CRP at day 1 of of CRS, 
higher CRP peak, LDH peak and interleukin 6 peak levels (Table  2). 
After multivariate analysis, peak temperature (OR 44.6, 95% IC 1.6-
1243, p = 0.025) and early CRS (OR 39.7, 95% IC 1.2-1279, p = 0.038) 
were associated with severity. Most patients were successfully  man-
aged in the UTAH, with only 2 requiring admission to the ICU. No fatal 
events were observed due to CAR T-cell related toxicity.
Table 1. Baseline biomarkers in patients with and without CRS 
Variable All (n=41) No CRS (n=11) CRS (n=30) p value 
CRP (mg/dL) 3 (1.1-8.7) 1.6 (1.1-7.8) 3.1 (1.5-11.4) 0.311 
LDH (UI/L) 594 (399-1084 441 (332-659) 650 (416-1405) 0.499 
Ferritin (ng/mL) 741 (396-1578) 1426 (387-1542) 702 (406-1695) 0.547 
Table 2. Characteristics of CRS depending on severity 





Day 1 of CRS         
CRP 
(mg/dL) 3 (1.7-8.7) 1.8 (1.7-3) 5.4 (3-18.4) 0.029 
Peak value         
CRP 
(mg/dL) 12.3 (6.7-25) 8.9 (6.6-9.8) 19.8 (13.6-42.4) 0.016 




269.3) 46.5 (20-63.7) 
214.5 (72.3-
317.8) 0.001 
  Temp (ºC) 38.8 (38.2-39.1) 38.4 (38.1-38.5) 39.1 (38.8-39.3) <0.001 
Early CRS 10 (33) 1 (8) 9 (53) 0.017 
Conclusion: Most patients treated with CAR T-cell therapy presented 
some adverse event, including CRS and/or ICANs. Resolution was fast 
in most cases, with no fatal events in our cohort. These results were 
achieved with a proactive multidisciplinary approach, leading to an 
early detection and appropriate therapy. Peak temperature and early 
onset of CRS may be useful to identify those patients with higher CRS 
severity.
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Introduction: Over the last two decades, the number of cancer 
patients requiring ICU care has dramatically increased with 15% of ICU 
beds occupied by cancer patients. Thus, in the following years inten-
sive care medicine will become a key component in the management 
of these patients.
Objectives: Our aim was to describe the cohort of patients with solid 
organ cancer admitted to a tertiary hospital ICU and analyze factors 
associated with survival.
Methods: Seven-year (2010-2017) retrospective study, including 
adult patients with solid organ cancer who required ICU admission. 
Chi-Square, Fisher´s test, T test, U Mann-Whitney and Cox´s regres-
sion (including all significant variables in the univariate analysis) 
were employed as appropriate. Quantitative variables are reported as 
median (IQR) and categorical as frequency (%).
Results: Two hundred patients were included, 107 (54%) were male 
with a median age of 60 (50-68) years. Lung cancer was present in 
53 (27%), followed by colon 27 (14%), breast 16 (8%) and ovary 15 
(7%). One hundred and six (53%) had metastatic disease. Most of 
the patients (181; 91%) were on ECOG 0-2 and Charlson Index was 9 
(5-11). Respiratory failure was the reason for ICU admission in 72 (36%) 
patients, shock in 41 (21%), respiratory failure and shock in 33 (17%), 
urgent surgery in 36 (18%) and central nervous system involvement in 
12 (6%). Neutropenia was present in 27 (14%). SOFA score at day 1 was 
6 (4-9). Eighty-four (42%) had a lower SOFA score at day 3 and 60 (30%) 
at day 5. One hundred and twenty-five (62%) required vasopressors 
(VP), 89 (45%) invasive mechanical ventilation (IMV), 72 (36%) nasal 
high flow (NHF) and 18 (9%) renal replacement therapy (RRT). Of those 
patients treated with NHF, 24 (33%) were intubated, while 35 (49%) 
were not intubated after improvement in their condition and 7 (10%) 
because of a do not intubate order. ICU mortality affected to 50 (25%) 
and in-hospital mortality to 86 (43%). Differences between hospital 
survivors and non-survivors are detailed in Table  1. Patients requir-
ing RRT (HR 2.7, 95% IC (1.1-6.8) p = 0.036) and those who did not 
decrease their SOFA score at day 5 (HR 2.3 IC 95% (1.1-4.9) had higher 
in-hospital mortality after multivariate analysis.
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Table 1. Characteristics of hospital survivors and non-survivors 
Variable Survivors (n=114) Non-survivors (n=86) p value 
Age (years) 59 (50-68) 61 (48-69) 0.420 
Male 53 (49%) 38 (44%) 0.537 
Lung cancer 22 (20%) 30 (35%) 0.021 
Charlson 9 (5-10) 7 (5-10) 0.478 
Metastasis 57 (56%) 49 (60%) 0.767 
Neutropenia 14 (13%) 13 (15%) 0.648 
NHF 35 (32%) 37 (43%) 0.117 
IMV 31 (29%) 57 (67%) <0.001 
VP 61 (57%) 61 (73%) 0.021 
RRT 5 (4%) 13 (15%) 0.012 
SOFA day 1 5 (2-7) 7 (3-11) 0.001 
No decrease in SOFA       
  Day 3 21 (27%) 25 (49%) 0.01 
  Day 5 10 (18%) 23 (64%) <0.001 
Conclusion: Hospital mortality of oncologic patients that require 
ICU admission remains high. Mortality may be more dependant on 
organ failure development and need for organ support suggesting 
that these patients may benefit of an earlier ICU admission. Persistent 
organ failure is associated with worse outcomes and, therefore, this 
information could be useful in the bedside clinical decision making 
process during an ICU trial, although clinical global assessment must 
prevail.
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Introduction: Chimeric antigen receptor-modified T (CAR-T) cells 
are a revolutionary treatment for patients with advanced blood can-
cers. A proportion of these patients will develop significant toxicities, 
requiring critical care management. Our hospital was one of 7 in the 
UK approved for the treatment of relapsed/refractory high-grade lym-
phoma and refractory acute lymphoblastic leukaemia (ALL).
Objectives: To describe our experience with lymphoma and ALL 
patients, who received CAR-T CD19 cells and were admitted to the 
intensive care unit (ICU).
Methods: From January 2019 until May 2020, patients with diffuse 
large B cell lymphoma (DLBCL), transformed follicular lymphoma, pri-
mary mediastinal B-cell lymphoma (PMBCL) or ALL, who were infused 
with CAR-T CD19 cells and developed ≥ grade 2 Cytokine Release Syn-
drome (CRS) and Immune Effector Cell Associated Neurotoxicity Syn-
drome (ICANS) were analysed.
Results: Sixty-one patients underwent CAR-T therapy during the 
study period, with 21 (34%) requiring admission to ICU . The mean age 
at presentation to ICU was 57 years and 76% of the admissions were 
males. All patients were receiving broad spectrum antibiotics and 19% 
of treatments were broadened in ICU and an antifungal was added.
CRS/sepsis (n=12, 57%) was the most common documented reason 
for admission to ICU, with a proven infection documented in only 2 
patients. The reasons for admission are shown in figure  1. Median 
duration of ICU stay was 4 (range 1-21) days. Grade 2 CRS was docu-
mented in 12 patients (57%) for a median duration of 2 (range 0-6) 
days. Grade 3 CRS was seen in 6 patients (29%) for 1-3 days. No patient 
progressed to grade 4 CRS during their ICU stay. Six patients had grade 
1 ICANS each for a median duration of 4 (2-6) days, whereas another 6 
had grade 3 ICANS for 2 days (1-4).
During their ICU stay, 9 patients (48%) required vasopressors for a 
median duration of 2 (1-3) days. Three patients (14%) needed mechan-
ical ventilation with a median duration of 5 (4-9) days and 2 patients 
needed renal replacement therapy for a median duration of 4 (1-7) 
days. IL-1, IL-6 antagonists and steroid administration are shown in 
figure  2. Three patients (14%) died in ICU, all in multi-organ failure. 
Two deaths were attributed to invasive pulmonary aspergillosis and 
the third to disease progression. Further 7 patients that were dis-
charged alive from ICU, died before hospital discharge from disease 
progression.
Conclusion: A significant number of patients receiving CAR-T therapy 
will need admission to ICU, requiring various level of organ support. 
Differentiation between CRS and neutropenic sepsis was difficult, and 
all patients stayed on antibiotics for the duration of their ICU stay. The 
observed ICU mortality (14%) was in accordance to the one reported 
in international literature and no deaths were attributed to treatment 
toxicity. Close collaboration between haematology and ICU is war-
ranted for the optimal management of CAR-T patients.
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Introduction: Since the beginning of the COVID-19 pandemic, rapid 
evidence was suggesting a pro-coagulant state (1).
There are currently insufficient data to recommend for or against the 
use of thrombolytics or increasing anticoagulant doses for VTE proph-
ylaxis in hospitalised COVID-19 patients outside the setting of a clinical 
trial (2). Currently, the guidance adopted by the national institute of 
health recommends anticoagulation treatment risk to be assessed on 
individual patient basis and therapeutic anticoagulation to commence 
in the event when it’s clinically indicated (2), namely when patients 
develop thrombo-embolic manifestations.
Objectives: We have undertaken a retrospective data analysis of the 
patients admitted to our hospital between Mid February to mid April 
2020 with COVID-19 illness to ITU and to the general wards. We have 
established the number need to treat for both patients groups based 
on a single outcome (death), in an effort to establish a possible benefit 
from starting anticoagulation earlier to ward patients as ITU patients.
Methods: Drug history was identified through hospital records for 
confirmed patients with COVID-19 disease to identify patients who 
have been on anticoagulation prior to hospital admission for an inde-
pendent reason. For both groups (ward patients and ITU patients) the 
outcome was established as Death or improvement at the time of data 
collection. Total number of cases explored for ITU is 51 patients, com-
pared to 156 patients on the ward.
Results: For ITU patients the NNT(number needed to treat) to pre-
vent adverse outcome (death) =2, with an absolute risk reduction of 
52.17% and a CI (confidence interval) for NNT =1.5-2.6.
For ward patients the NNT =4, with an absolute risk reduction of 
23.4% and a CI of 2.2-162.0.
Conclusion: The above mentioned results does not support chang-
ing the current practice to starting therapeutic anticoagulation on 
ward patients “empirically”. The risk assessment therefore is to be con-
ducted on individual basis and assessed for each patient individually.
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Introduction: Post-cardiac arrest patients with return of spontaneous 
circulation have a very low survival rate and poor prognosis despite 
aggressive treatments. Prediction these patients’ prognosis is impor-
tant for planning the treatment of the patients and providing informa-
tion to their families. Several studies have reported body mass index 
(BMI) as a prognostic factor in post-cardiac arrest patients, which is 
called “obesity paradox”. In this study, researchers aimed to investi-
gate the relationship of LBM with the prognosis of post-cardiac arrest 
patients.
Methods: This retrospective cohort study included adult patients of 
out-of-hospital cardiac arrest between January 2015 and August 2018. 
The enrolled patients were divided into 2 groups based on clinical out-
comes (cerebral performance category score, 1 to 2 and 3 to 5) and 
compare the characteristics of these two groups. Association of LBM 
with good neurologic outcomes (CPC score 1 to 2) was analyzed by 
dividing patients into quartile segment by their LBM. Predictive value 
of optimal cutoff points of LBM in post-cardiac arrest patients was 
evaluated.
Results: A total 169 patients were analyzed (CPC score 1 to 2, n=55; 
CPC score 3 to 5, n=114). Patients’ age, frequency of witnessed cardiac 
arrest, initial shock rhythm, post-hospital flow time, estimated cardiac 
arrest, and LBM were different in the two groups (p <0.05). LBM was 
associated with the prognosis of post cardiac arrest patients in the 
4th  quartile segment.  Cutoff point of lean body mass for prediction 
of cardiac arrest outcomes was 48.34 (sensitivity = 0.600, specificity = 
0.763, accuracy = 0.710) and the predictive value was 0.68 (95% confi-
dence interval, 0.60 to 0.75).
Conclusion: High LBM is related to good neurological prognosis 
of patients after cardiac arrest. The increase in muscle mass due to 
exercise is interpreted as showing positive effects on hypoxic injury 
in cardiac arrest and reperfusion injury after return of spontaneous 
circulation.
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Introduction: Various randomized clinical trials reported no differ-
ences in outcome when mechanical chest compressions (CC) were 
used in cardiac arrest patients [1-3]; however, in these trials mechani-
cal CC were systematically applied soon after ALS arrival to evaluate 
its effectiveness compared to manual CC. The evidence regarding the 
impact of mechanical CC on mortality in patients with refractory out-
of-hospital cardiac arrest (OHCA) and prolonged resuscitation efforts, 
when mechanical CC are initiated later, is scarce.
Methods: This is a post hoc, propensity score (PS) analysis of OHCA 
patients who received or did not received mechanical CC during 
resuscitation manoeuvres in the TTH48 trial. A predefined set of covar-
iates (recruiting centre, age, height, weight, gender, location of OHCA, 
witnessed OHCA, initial cardiac rhythm, bystander cardiopulmonary 
resuscitation, automatic external defibrillator used, time from OHCA 
to basic life support, time from OHCA to advanced life support, resus-
citation drugs used, intubation on scene) were explored and used for 
developing a PS for the receipt of mechanical CC using multiple binary 
logistic regression. The PS was then applied as an adjustment factor, 
together with the receipt of mechanical CC, in a Cox proportional haz-
ard model to estimate the impact on 6-months mortality.
Results: Out of 351 patients included in the analysis, 25.6% received 
mechanical CC. No major differences in baseline characteristics were 
observed between groups, except for prolonged time to ROSC (26 
[20;38] vs 20 [15;25] min, p<0.01) and more frequent use of resusci-
tation drug (adrenaline: 80 vs 57%, p<0.01; amiodarone: 53 vs 37%, 
p<0.01) in the mechanical CC group. The Cox proportional hazard 
models did not show a significant impact of the probability to receive 
mechanical CC and the receipt of mechanical CC on 6-months mor-
tality (1.676 [0.580-4.842], p = 0.34 and 1.683 [0.925-3.061], p = 0.09, 
respectively). We computed another PS including time from OHCA 
to ROSC to the same covariates used previously; in this case, the pre-
dicted probability to receive mechanical CC was significantly associ-
ated with 6 months mortality (3.713 [1.437-9.599], p < 0.01).
Conclusion: When time to ROSC was included in the PS, the likelihood 
to receive mechanical CC during cardiac arrest significantly correlated 
with 6-months mortality while receipt of mechanical chest compres-
sions did not. The same association was not observed when time to 
ROSC wasn’t accounted in the PS. The longer duration of resuscitation 
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efforts observed in patients that received mechanical CC could explain 
the results. Notably, mechanical CC, per se, was never associated with 
mortality.
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Introduction: The occurrence of in-hospital cardiopulmonary arrest 
(CPA) is associated with worse outcomes. Identifying the most at-risk 
patients is crucial to ensure greater vigilance and a more “offensive” 
posture in these cases.
Objectives: Characterization of patients admitted by NSTEMI with 
progression in Cardiac Arrest (CPA). Creation of intra-hospital CPA pre-
dictor score in this population and comparison with 2 recently pub-
lished SAFER and CHADS2 scores in international publications.
Methods: Multicenter study conducted over a period of 7  years and 
9 months. Patients without diagnosis of NSTEMI, with CPA as a symp-
tom of hospital admission or without information on the occurrence of 
in-hospital CRP were excluded from the study.
Results: A total of 10430 patients were admitted, 95 of whom had 
in-hospital CPA. Patients with CPA were older, with more hypoten-
sive profile and Killip class > 1. Electrocardiographic changes (LBB 
(left bundle block), RBB (right bundle block) and ST depression) were 
also more frequent in this group, as well as the use of IAB, Invasive 
Mechanical Ventilation and temporary PM.
By logistic regression  6 CPA predictor variables were identified: 1) 
admission SAP ≤ 125 mmHg (1 point), 2) Killip class> 1 at admission 
(1 point), 3) LBB at admission EkG (2 points), 4) RBB on admission EkG 
(1 point), 5) ST depression on admission EkG (1 point), 6) CHB (com-
plete heart block) / VT / cardiogenic shock within the first 24 hours 
after admission (2 points). This allowed the creation of 3 risk groups 
according to the score obtained: low risk (0-2 points), medium risk (3-4 
points) and high risk (5-7 points).
ROC curves were created comparing the new score with the SAFER 
and CHADS2 score. The new score was found to have a higher predic-
tive power than the 2 previously reported scores (AUC: 0.723; 95% CI 
0.714-0.731; p-value <0.05).
Conclusion: Our study allowed us to create a new score that is easy 
to apply on a daily basis. Internal and external validation is crucial to 
assessing its true impact.
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Introduction: The quality of chest compressions is very important in 
improving prognosis in patients following cardiac arrest. High qual-
ity chest compressions leads to increased cardiac output and main-
tains perfusion of systemic organs. Thus, resuscitation team members 
should evaluate the degree of systemic organ perfusion to improve 
the quality of chest compressions during cardiopulmonary resuscita-
tion (CPR).
End tidal carbon dioxide (EtCO2) is one of the most useful physiologi-
cal markers to evaluate the degree of systemic organ perfusion during 
CPR. EtCO2 is an indicator of cardiac output and reflects pulmonary 
perfusion, but EtCO2 measurement requires intubation, which is not 
easily and rapidly performed.
In contrast, cerebral tissue oxygen saturation can be rapidly assessed 
during CPR, and serves as a possible indicator of return of spontane-
ous circulation (ROSC). Cerebral tissue oxygen saturation can be eas-
ily assessed by placing oximeter probes on the patients’ forehead. 
Increase in cardiac output and pulmonary perfusion improves sys-
temic oxygenation and elevates regional cerebral tissue oxygen satu-
ration. Studies that elucidate the relationship between cerebral tissue 
oxygen saturation and EtCO2 during CPR are warranted.
Objectives: We investigated the relationship between cerebral tissue 
oxygen saturation and EtCO2 to determine if cerebral tissue oxygen 
saturation can evaluate the quality of chest compression during CPR.
Methods: This is an observational study conducted from April to Sep-
tember 2019. Patients arrived in a state of cardiac arrest at the emer-
gency department of Yamagata University Hospital in Japan. Cerebral 
tissue oxygen saturation was measured by near infrared spectroscopy 
(NIRO-200NX, Hamamatsu photonics, Japan) during CPR.
We assessed cerebral tissue oxygen saturation using two approaches. 
The first is TOI, which represents the ratio of oxygenated haemoglo-
bin to total haemoglobin and the second is SnO2, which is the ratio 
between the change in oxygenated haemoglobin and change in total 
haemoglobin. We also measured EtCO2 following intubation. We 
compared cerebral tissue oxygen saturation with EtCO2 every minute 
in cases in which both parameters were measured.
Results: Seven cases were included, and the median age was 81 years 
old. Three of the seven cases achieved ROSC, but none survived 
for one month. The median values for EtCO2, TOI, and SnO2 were 
14.0  mmHg (inter quartile range (IQR): 10.0-18.0), 37.7% (IQR: 32.4-
42.7) and 38.2% (IQR: 17.8-59.5), respectively. The correlation coef-
ficient between TOI and EtCO2 was 0.681 (95% confidence interval 
(95%CI) 0.559-0.774, p<0.001), and between SnO2 and EtCO2 was 
0.459 (95%CI 0.288-0.601, p<0.001), respectively.
Conclusion: This study showed a strong correlation between tissue 
oxygen saturation and EtCO2. This suggests that cerebral tissue oxy-
gen saturation may reflect the degree of cardiac output that results 
from chest compressions during CPR.
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Introduction: Activation of a systemic inflammatory response after 
cardiac arrest (CA) due to whole-body ischemia/reperfusion injury 
complicates recovery and may lead to organ dysfunction. Neutrophilic 
granulocytes are rapidly reacting inflammatory cells that play a role in 
ischemia/reperfusion injury. Myeloperoxidase (MPO) and resistin are 
released from activated neutrophils. MPO is involved in the generation 
of reactive oxygen species upon neutrophil activation. Resistin has a 
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dual role in inflammation, it increases the production of several pro-
inflammatory cytokines but inhibits neutrophil migration.
Objectives: We tested the association of MPO and resistin levels with 
6-month neurological outcome in ICU-treated out-of hospital cardiac 
arrest (OHCA) patients.
Methods: We analyzed blood samples taken upon ICU admission and 
at 48 hours from 108 OHCA patients with shockable rhythm included 
in the COMACARE study. We defined 6-month cerebral performance 
category (CPC) 1-2 as good and CPC 3-5 as poor outcome. We cal-
culated area under receiver operating characteristic curve (AUC) to 
determine association of biomarker levels with poor outcome. We 
tested the relationship between return of spontaneous circulation 
(ROSC) delay and admission biomarker levels with linear regression.
Results: At ICU admission, median (Interquartile range, IQR) concen-
tration of MPO was 97 (46-170) ng/mL in good and 98 (52-197) ng/
mL in poor outcome groups, and of resistin 39 (25-57) ng/mL in good 
and 43 (29-64) ng/mL in poor outcome groups. At admission the AUC 
for the association of MPO levels with poor outcome was 0.52 (95% 
CI 0.41 – 0.64) and for resistin 0.57 (95% CI 0.46 – 0.69). At 48  h the 
median (IQR) concentration of MPO was 92 (50-163) ng/mL in good 
and 104 (50-138) ng/mL in poor outcome groups, and of resistin 
83 (57-146) ng/mL in good and 86 (53-172) ng/mL in poor outcome 
groups. At 48 h the AUC values were 0.47 (95% CI 0.36 – 0.58) (MPO) 
and 0.52 (95% CI 0.40 – 0.64) (resistin). The linear regression analysis 
showed that MPO levels at the time of admission were associated 
with ROSC delay (B 4.8, 95% CI 0.75 - 8.9, p-value 0.02). The same was 
observed for admission levels of resistin (B 0.77, 95% CI 0.09 – 1.45, 
p-value 0.03).
Conclusion: Duration of ischemia is associated with ICU admission 
levels of MPO and resistin, suggesting neutrophil involvement in the 
systemic inflammatory response after CA. The markers showed no 
ability to predict long term neurological outcome.
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Introduction: Cardiac arrest (CA) leads to activation of the inflamma-
tory system due to whole body ischemia-reperfusion injury. Osteo-
pontin (OPN), an extracellular matrix protein produced by many 
tissues and Proprotein convertase subtilisin/kexin 9 (PCSK9), a regula-
tor of cholesterol homeostasis, play a role in the low-grade inflamma-
tion leading to coronary artery disease (CAD).
Objectives: Since CAD is the most important cause for CA, we tested 
if the release of OPN and PCSK9 is increased in the acute inflamma-
tion after out-of-hospital cardiac arrest (OHCA) and hypothesized, that 
they have prognostic value.
Methods: We studied blood samples of 112 patients with OHCA and 
shockable rhythm included in the COMACARE study. Biomarker lev-
els were measured at the time of ICU admission and at 24, 48 and 
72 hours. We used 6-month cerebral performance category (CPC) as 
the main outcome and defined CPC 1-2 as good and CPC 3-5 as poor 
outcome. We evaluated the association of admission biomarker levels 
with outcome using area under receiver operating characteristic curve 
(AUC) analysis. We assessed temporal differences in biomarker levels 
with linear modeling with restricted maximum likelihood estimation 
(REML).
Results: Median (interquartile range IQR) concentration of OPN was 
53 (41-79) ng/mL at admission, 160 (100-190) ng/mL at 24  h, 240 
(170-360) ng/mL at 48 h and 240 (190-320) ng/mL at 72 h. For PCSK9 
the concentrations were 160 (100-210) ng/mL at admission, 110 (74-
160) ng/mL at 24 h, 160 (92-220) ng/mL at 48 h and 240 (170-330) ng/
mL at 72 h. The predictive value of OPN at admission was weak (AUC 
0.548, 95% confidence interval, CI 0.43-0.66) and similar results were 
observed for PCSK9 (AUC 0.551, 95% CI 0.44-0.67). With linear mod-
eling we observed an effect of sample collection timepoint (F 98, P < 
0.01) and poor outcome (F 6.8, P = 0.01) on OPN concentration. Sam-
ple collection timepoint had an effect (F 78, P < 0.01) on PCSK9 con-
centration but poor outcome did not show a statistically significant 
effect. The interaction of sample collection timepoint and poor out-
come did not show a statistically significant effect on the concentra-
tions of OPN or PCSK9.
Conclusion: Cardiac arrest is followed by changes in OPN and PCSK9 
concentrations and the temporal course of OPN response differs 
between 6-month neurological outcome groups. The biomarkers did 
not have clinically relevant predictive value at ICU admission.
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Introduction: The Hampshire & Isle of Wight Air Ambulance (HIO-
WAA) works alongside the ambulance service to provide a Prehospi-
tal Critical Care (PHCC) team to the south central region of England. It 
responds between the hours of 0700 - 0200 to both medical emergen-
cies and major trauma, either by road or by helicopter. In November 
2018, HIOWAA adopted a new database (ARCnet) to support its com-
mitment to a robust clinical governance frame
Objectives: This report reviews cases of medical (i.e. non-traumatic) out-
of-hospital cardiac arrests (OOHCA) attended by the HIOWAA team from 
the inception of the database to the end of December 2019 (13 months).
Methods: The ARCnet database was interrogated for all cardiac arrests 
from the beginning of November 2018 to the end of December 2019. 
Cases were included where HIOWAA attended the scene and the patient 
had received chest compressions at any point. Likely or confirmed trau-
matic cardiac arrests were excluded. Retrospective review of the patient 
record forms (PRFs) were then carried out and key data collected.
Results: A total of 192 cases of non-traumatic cardiac arrest were iden-
tified over the study period. The median age was 61 (IQR 50-71; range). 
Over two thirds of patients were male (133 [69.3%] vs 58 [30.2%]).
Most missions were in the more populated urban and suburban main-
land areas in the south of the region (Southampton, Portsmouth and 
the M27 corridor), with another cluster around Basingstoke. Overall, 
106 patients (55.2%) were conveyed to hospital with HIOWAA.
The majority of patients conveyed were taken to hospital by road (99 
[94.3%]). Six patients (5.7%) were taken to their destination hospital by 
air, of which 5 were from the Isle of Wight (IOW) and one from Winches-
ter to University Hospital Southampton (UHS). All patients transported 
by air had established return of spontaneous circulation (ROSC) prior to 
transfer and were either fully conscious and self-ventilating (2 patients) 
or sedated and ventilated (4 patients). In one case the mode of transport 
was not recorded and could not be established from the patient record.
A doctor and paramedic crew attended 107 missions (55.7%) and 
85 (44.3%) were attended by a paramedic only crew. Initial 999 calls 
occurred between the hours of 20:00-08:00 for 22 missions (11.5%).
The initial rhythm in most patients was non-shockable (i.e. asystole or 
pulseless electrical activity [PEA]). A quarter of patients had ROSC prior 
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to the arrival of HIOWAA. Of the remainder, a quarter subsequently 
achieved ROSC while treated by HIOWAA.
Cardiac arrest was witnessed in 126 patients (65.6%), unwitnessed in 
58 (30.2%) and not recorded or unknown for 8 patients (4.2%). Of wit-
nessed arrests, 102 patients (81%) received documented bystander 
CPR of which 67 (53.2%) had ROSC on arrival in ED. Unwitnessed 
arrests received bystander CPR in 41 patients (70.7%), did not receive 
bystander CPR in 10 (17.2%) and was not recorded in 7 (12.1%). Of the 
10 patients that were neither witnessed nor received bystander CPR, 
two (20%) had ROSC on arrival in the ED.
A number of interventions were performed in both groups. In survi-
vors, prehospital emergency anaesthesia (PHEA) was carried out in 24 
patients (29.3%), vasopressors post-ROSC in 34 (41.5%) and ongoing 
intravenous sedation in 31 (37.8%). In non-survivors, life was declared 
extinct on scene in 81 patients (73.6%)
Conclusion: Our data is consistent with known determinants of out-
come following cardiac arrest (witnessed cardiac arrest, bystander 
CPR and shockable rhythm all associated with higher chance of ROSC). 
Increasing age was associated with a lower chance of survival. In suc-
cessful resuscitation, key interventions performed by the PHCC team 
not available to standard ambulance crews related primarily to post-
resuscitation care following ROSC. In unsuccessful resuscitation, the 
PHCC team was also able to support decision-making and aid prog-
nostication with the aid of ultrasound, which allowed termination of 
futile treatment without admission to hospital in the majority of cases 
without ROSC.
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Introduction: Prolonged depletion of oxygen and glucose during 
cardiac arrest may result in cytotoxic cerebral oedema. In cytotoxic 
oedema, water diffusion within the brain becomes restricted. Diffu-
sion Tensor Imaging (DTI) allows quantification of diffusion restric-
tion through Fractional Anisotropy (FA, the directionality of diffusion) 
and Mean Diffusivity (MD, the amount of diffusion). White matter FA 
appeared a promising outcome predictor after prolonged postanoxic 
coma [1, 2]. We now investigate predictive values of FA and MD in 
both grey and white matter, 2-4 days after cardiac arrest.
Objectives: To study differences in diffusion restriction of the brain 
using FA and MD, between comatose patients after cardiac arrest with 
good and poor neurological recovery, and estimate predictive values.
Methods: In an ongoing prospective cohort study, 33 comatose 
patients after cardiac arrest underwent 3T brain MRI 3±1  days after 
return of spontaneous circulation. From the DTI sequence, we calcu-
lated FA and MD of the whole brain, grey matter (GM) and skeleton-
ised white matter (WM). MD and FA are likely influenced by free water, 
e.g. cerebrospinal fluid and vasogenic oedema. Other than in previous 
studies, we corrected MD and FA for the influence of free water [3]. As 
predictive marker, we calculated the percentage of brain volume with 
severe oedema, defined as MD<500*10-6. We compared FA and MD 
between patients with good (Cerebral Performance Category (CPC) 
1-2) and poor (CPC3-5) outcome at 6 months and estimated predictive 
value based on a preliminary logistic regression model.
Results: Patients with poor outcome (n=16) showed significantly 
lower whole brain mean FA and MD (FA: 0.31, MD: 544*10-6) than 
patients with good outcome (FA: 0.34, MD: 589*10-6, p = 0.01, p = 
0.01). MD within the GM showed the highest between-group differ-
ence (poor: 532*10-6, good: 585*10-6, p = 0.03). Patients with poor 
outcome had a significantly larger proportion of the brain with severe 
cytotoxic oedema (poor: 20%, good: 5%, p = 0.01). In a preliminary 
prediction model, we could predict poor outcome at 100% specificity 
with 75% sensitivity (95%CI: 46-93%, figure 1)
Conclusion: MD and FA of grey and white matter differ between 
patients with good and poor outcome, and hold potential to add to 
prediction of neurological recovery of comatose patients after cardiac 
arrest. The study is ongoing and updated results will be presented.
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Introduction: There are approximately 60,000 out-of-hospital cardiac 
arrests (OOHCA) in the UK each year. Less than 10% of these patients 
survive to discharge (1) and hypoxic-ischaemic brain injury (HIBI) is 
common (2). HIBI can cause a range of sequelae from mild cognitive 
impairment to brain death.
Prognostication for HIBI post OOHCA remains difficult. The European 
Resuscitation Council (ERC) suggests a multimodal approach to prog-
nostication including electroencephalogram (EEG), brain imaging and 
Neuron Specific Enolase (NSE) (2).
Objectives: To ascertain if there is a relationship between NSE, long-
term neurological outcome and quality of life in OOHCA survivors.
Methods: This study was carried out at a tertiary centre with 31 critical 
care beds and was approved by the local research committee. The crit-
ical care electronic database was retrospectively analysed for OOHCA 
patients who survived to ICU discharge between May 2017 and 
November 2018. Patient demographics, NSE values, EEG and imaging 
reports were obtained for each patient.
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Follow up telephone contact was made with each patient at least 
14  months following ICU discharge. Verbal consent was obtained 
to collect anonymised information. A single investigator, who was 
blinded to NSE values, conducted all patient interviews. Neurological 
outcome was stratified using in-house standardised questions and the 
validated Cerebral Performance Category (CPC) (3).
Patients were asked to subjectively assess their QoL on a locally 
devised numerical scale (Figure 1).
Results: Thirty-two patients (36.0%) survived to hospital discharge, 
four patients had subsequently died and two were not contactable; 
these patients were excluded from analysis. Eighty four percent of 
patients were male, the median age was 65 and 66% had known car-
diovascular disease. Twenty patients (77%) had an NSE level. Data were 
analysed using Mann Whitney U test.
There were 3 patients with a poor neurological outcome (defined as 
CPC≥3) therefore it is a small patient group for analysis. However, 
there was no significant relationship between NSE and neurologi-
cal outcome (good outcome defined as CPC 1 or 2, poor outcome as 
CPC≥3) p = 0.0963.
Conclusion: The 72-hour NSE result in survivors showed no relation-
ship with neurological outcome post-OOHCA at 14 months. It is note-
worthy that the patient with the highest NSE had the worst outcome. 
Previous in-house research has shown an NSE of >64.5  μg/L (100% 
specificity, 78% sensitivity) correlates with poor neurological outcome 
(4). One study suggests the NSE ratio at 48 and 24 hours can be used 
as a reliable prediction of outcome, which should be further investi-
gated in our patient group (8). Larger scale follow-up studies should 
therefore be conducted to further assess the use of NSE in prognosti-
cation of long-term neurological outcomes for OOHCA patients.
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Introduction: Recent studies [1] suggested a potential role of P25/30 
SSEP in prediction of neurological outcome after OHCA. However it is 
not clear whether any particular patterns of 20-30msec SSEP complex 
could potentially improve the already established predictive value of 
N20.
Objectives: The main objective of this study is the integrated analysis 
of the 20-30 msec SSEP complex in order to identify all possible pat-
terns and their potential prognostic value.
Methods: Single-centre, prospective, observational study. Adult 
comatose survivors of OHCA with Targeted Temperature Management 
[TTM] [normothermia], neuroprotection and organ support on ICU. 
SSEP recorded 24-36 h post return of spontaneous circulation. Analy-
sis of the 20-30msec SSEP complex was performed by 2 independent 
interpreters: 1. The amplitude of both N20 and P25/30 was meas-
ured bilaterally from an agreed baseline. An amplitude threshold of 
0.5microvolt [mcV] determined the presence or absence of each SSEP 
component. 2. The Peak To Peak Amplitude (PTPA) of the 20-30msec 
complex (peak of N20 to peak of P25) was also measured bilaterally. 
The largest PTPA was used to test potential correlations with patients’ 
neurological outcome. Short term neurological outcome assessed 
at hospital discharge used the cerebral performance category [CPC] 
score: favourable outcome 1-2, unfavourable outcome 3-5.
Results: Data from the first 52 patients: 37 male, 15 female, median 
age 59.5  years. OHCA rhythm: 31 VF, 21 asystole. Cause of OHCA: 38 
cardiac, 13 non-cardiac, 1 unknown. Median anoxic time 25  min. 
Median Temperature [T] in the first 24  h 36oC. Median time of SSEP 
recording 25 h. Median T during SSEP recording 36.1oC. The prelimi-
nary clinical and neurophysiological analysis has done for the first 48 
patients. 23 patients had favourable and 25 had unfavourable neuro-
logical outcomes. Among the 23 patients with a favourable outcome, 
both N20 and P25/30 SSEP were present in all. Among patients with an 
unfavourable outcome, both N20 and P25/30 were absent in 22, and 
N20 was absent but P25/30 was present in 3.
Use of 0.5 mcV as a threshold for the N20-P25/30 presence provided 
an objective method to minimise inter-interpreter variability and limit 
the effect of background noise in the analysis of the SSEP.
Median N20 amplitudes were consistently lower than P25/30 median 
amplitudes in patients with both favourable [N20: 1.325mcV, P25/30: 
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2.6mcV] and unfavourable outcomes [N20: 0.275mcV, P25/30: 
0.35mcV].
The highest PTPA was ≥1.20mcV in all patients with a favourable out-
come [range 1.2-15.7mcV, median 3.825mcV], whereas in patients 
with an unfavourable outcome the highest PTPA was ≤1.3microV 
[range 0.1-1.3mcV, median 0.5mcV]. In the latter group, the PTPA 
was ≤1.0 mcV in all except 1 patient [1.3mcV]. PTPA values between 
1.1 and 1.3mcV could be correlated with both outcomes. We are fur-
ther investigating whether separate measurement of N20 or P25/30 
amplitude could be used in this patient cohort as a distinctive feature 
between outcomes.
Conclusion: Addition of P25/30 in the analysis of 20-30msec SSEP 
complex may potentially increase N20’s positive predictive value for 
the short term favourable neurological outcome after OHCA. Analysis 
of P25/30 does not affect N20’s already established negative predictive 
value.
Direct PTPA measurements of the 20-30 msec SSEP complex provides 
an easy to measure value for future objective quantitative assess-
ments. Preliminary results suggest PTPA of <1.1mcV is associated with 
an unfavourable neurological outcome whereas a PTPA of >1.3mcV 
appears to be associated with a favourable neurological outcome. As 
the number of patients increases, it will become clearer whether the 
above suggestions will be consistently reproduced and are statistically 
significant.
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Introduction: Out-of-hospital cardiac arrest (OHCA) carries a low sur-
vival rate, especially in rural areas. Coronary artery disease (CAD) rep-
resents the most common cause of collapse. Predictors of survival 
have been described in the literature. However, most studies have 
been conducted in city areas. Therefore, little is known about the 
resuscitation performances of emergency medical services (EMS) in 
non-city areas.
Objectives: We sought to perform a quality control assessment on 
the management of acute coronary syndrome (ACS) complicated with 
OHCA in non-urban areas. We explored standard parameters, resusci-
tation settings, pre- and in-hospital response times, lactate level, cath 
lab findings and clinical outcomes at 30 days.
Methods: The location of our institution consists of non-urban areas 
with a low population density. Built at the top of a hill, the hospital 
was initially founded in 1903 to treat patients suffering from tubercu-
losis. In this context, we performed a retrospective mono-center study 
including 40 patients resuscitated from OHCA with ACS.
Results: Parameters associated with 30-day mortality included age, 
no-bystander CPR, no use of AED, non-convertible rhythm, duration 
of CPR, recurrence of cardiac arrest, epinephrine dose, cardiac dys-
function, LAD culprit lesion and delivery time intervals (cath lab/ICU 
admission). Particularly, lactate level, distance from hospital, duration 
of pre-hospital management (no-flow, low-flow) and delayed response 
times (EMS arrival, ER admission) were predictive of early mortality.
(35%), D30: 6 (43%); >70 yrs 
=9(23%), D30: 5 (56%), D4: 4 
(80%) 
(30%), D30: 6 (50%); Use of AED: 28 
(70%), D30: 9 (32%); Non 
convertible rhythm: 6 (15%), D30: 5 
(83%), D5: 4 (80%); Convertible rhythm: 
34 (85%), D30: 10 (29%); Recurrent 
cardiac arrest: 7 (17%), D30: 6 (86%), D0: 
4 (67%) 
No-flow: 0’=27 (67%), D30: 5 
(18%); <5’=30 (75%), D30: 6 
(20%); >5’=10 (25%), D30: 10 
(100%); Low-flow: <5’=2 
(30%), D30: 0 (0%); <10’=15 
(37%), D30: 0 (0%); <15’=22 
(55%), D30: 1 (4%); >15 
min=18 (45%), D30: 14 (78%), 
D6: 10 (71%) 
Epinephrine: ≤1 mg=15 (38%), D30: 1 
(7%); 2-5 mg=16 (40%), D30: 7 (44%); >5 
mg=9 (22%), D30: 7 (78%); Lactate: <5 
mmol/l=25 (63%), D30: 2 (8%); 5-10 
mmol/l=11 (27%), D30: 9 (81%), D6: 6 
(66%); >10 mmol/l=4 (10%), D30: 3 
(75%), D6: 4 (100%)
LVEF: <30%=16 (40%), D30: 
12 (75%); 30-50%=9 (22%), 
D30: 9 (22%); >50%=15 (38%), 
D30: 1 (6%); Cardiogenic shock: 
11 (27%), D30: 9 (82%), D6: 6 
(67%); Culprit lesion: LAD=24 
(60%), D30: 12 (50%), D6: 9 
(75%); RCA=13 (32%), D30: 3 
(23%); LCX=3 (8%), D30: 0 
(0%) 
Distance from hospital: <10 km=23 (57%), 
D30: 5 (22%), D6: 2 (40%); <20 km=34 
(85%), D30: 9 (26%), D6: 5 (55%); >10 
km=17 (43%), D30: 11 (65%), D6: 8 
(73%); >20 km=6 (15%), D30: 6 (100%), 
D6: 5 (83%)
MMT arrival: <10’=19 (48%), 
D30: 0 (0%); 10-15’=15 (37%), 
D30: 9 (60%), D6: 6 (67%); 
>15’=6 (15%), D30: 6 (100%), 
D6: 4 (67%); ER admission: 
<50’=13 (32%), D30: 0 (0%); 
>50’=27 (68%), D30: 15 (56%), 
D6: 10 (67%); >80’=10 (25%), 
D30: 7 (70%), D6: 4 (57%) 
Cath lab admission: <30’=10 (25%), D30: 
1 (10%); 30-60’=14 (35%), D30: 5 (36%), 
D6: 3 (60%); >60’=16 (40%), D30: 9 
(56%), D6: 6 (67%); ICU admission: 
<60’=27 (67%), D30: 5 (18%), D6: 2 
(40%); >60’=12 (30%), D30: 8 (67%), D6: 
5 (63%)  
Table : 30-day mortality related to patient characteristics, resuscitation settings, 
time intervals and  demographic parameters. 
Age: <50 yrs=7 (17%), D30: 1 
(14%); 50-60 yrs=10 (25%), 
D30: 3 (30%); 60-70 yrs=14 
No bystander CPR: 12 (30%), D30: 11 
(92%), D6: 7 (64%); bystander CPR: 28 
(70%), D30: 4 (14%); No use of AED: 12 
Conclusion: Pre-hospital emergency care of patients with cardiac 
arrest remains challenging, particularly in non-city areas. Beyond the 
usual prognostic factors, it would appear that demographic param-
eters and pre-hospital time intervals represent major determinants of 
mortality. Therefore, shortening response times and prompt delivery 
to hospital facilities may help to improve the prognosis, rather than 
prolonged pre-hospital management. Further RCTs are needed to 
assess the effect of the ‘scoop and run’ approach versus the ‘stay and 
play’ approach in this setting.
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Introduction: Data are insufficient to address the association of dis-
patcher-assisted bystander cardiopulmonary resuscitation (DA-BCPR) 
before emergency medical services (EMS) arrival with the likelihood of 
an initial shockable rhythm after out-of-hospital cardiac arrest (OHCA). 
We hypothesised that more patients who received DA-BCPR would 
have initial shockable rhythm than those without bystander CPR (No-
BCPR) and that DA-BCPR has an equivalent effect on the likelihood of 
initial shockable rhythm to that of bystander CPR without dispatcher 
assistance (Non-DA-BCPR).
Objectives: We aimed to examine the incidence rate of initial shock-
able rhythm according to the type of bystander CPR performed after 
OHCA in relation to bystander CPR duration.
Methods: The study included 114,473 patients (age, ≥18 years) who 
had an OHCA with a presumed cardiac origin witnessed by a layper-
son in a prospectively recorded Japanese nationwide Utstein-style 
database from 2013 to 2017. Patients who received public-access defi-
brillation before arrival of the EMS were excluded. The patients were 
divided into 3 groups as follows: DA-BCPR (n=42,709), Non-DA-BCPR 
(n=16,979), and No-BCPR (n=54,785). The primary end point was ini-
tial shockable rhythm recorded by the EMS after arrival. A Cox propor-
tional hazards model was applied to reflect the different bystander 
CPR durations before/after propensity score (PS) matching.
Results: The crude rate of the initial shockable rhythm in DA-BCPR 
(21.7%, 9254/42,709) was significantly higher than those in Non-DA-
BCPR (18.5%, 3133/16,979) and No-BCPR (17.5%, 9569/54,785; both 
p<0.0001). Before PS matching, age (adjusted hazards ratio [aHR] for 
1 year decrement, 1.01; 95% confidence interval [CI], 1.01–1.01), rural 
area (aHR, 1.27; 95% CI, 1.25–1.29, p<0.0001), male sex (aHR, 1.12; 95% 
CI, 1.11–1.14, p<0.0001), arrest witnessed by family members (aHR, 
1.06; 95% CI, 1.05–1.08, p<0.0001), and presence of bystander CPR 
(p<0.0001) were associated with substantially higher initial shockable 
rhythm rate at EMS arrival. As for the type of bystander CPR, we found 
no significant differences between DA-BCPR and Non-DA-BCPR in the 
association with the likelihood of initial shockable rhythm as follows: 
before PS matching, aHR of DA-BCPR for initial shockable rhythm com-
pared with Non-DA-BCPR, 1.00; 95% CI, 0.99–1.03 (p = 0.52); after PS 
matching, aHR, 0.99; 95% CI, 0.97–1.02 (p =0.56). As compared with 
No-BCPR, DA-BCPR was positively associated with initial shockable 
rhythm before (aHR, 1.17; 95% CI, 1.16–1.19; p<0.0001) and after PS 
matching (aHR, 1.07; 95% CI, 1.05–1.08; p<0.0001). Non-DA-BCPR was 
also positively associated with initial shockable rhythm before (aHR, 
1.16; 95% CI, 1.14–1.19; p<0.0001) and after PS matching (aHR, 1.03; 
95% CI, 1.00–1.05; p = 0.04) as compared with No-BCPR.
Conclusion: The patients who received DA-BCPR after witnessed 
OHCA due to presumed cardiac causes were more likely to have an ini-
tial shockable rhythm than those who did not receive bystander CPR. 
Moreover, DA-BCPR had the same multivariable-adjusted association 
with the likelihood of initial shockable rhythm as Non-DA-BCPR.
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Introduction: The association of dispatcher-assisted bystander car-
diopulmonary resuscitation (DA-BCPR) before emergency medical ser-
vices arrival with the likelihood of initial shockable rhythm in children 
with out-of-hospital cardiac arrest (OHCA) is unclear. We hypothesised 
that more children with OHCA who received DA-BCPR would have ini-
tial shockable rhythm than those without bystander CPR (No-BCPR) 
and that DA-CPR has an equivalent effect on the likelihood of initial 
shockable rhythm to that of bystander CPR without dispatcher assis-
tance (Non-DA-BCPR).
Objectives: We aimed to examine the incidence rate of initial shock-
able rhythm according to the type of BCPR after OHCA in children. 
We aimed to examine the incidence rate of initial shockable rhythm 
according to the type of BCPR after OHCA in children.
Methods: We included 2198 paediatric patients aged 8 to 17  years 
with a witnessed OHCA who were identified from a prospectively 
recorded Japanese registry from January 2005 to December 2017. 
Patients who received public-access defibrillation before arrival of the 
emergency medical services were excluded. The patients were divided 
into 3 groups according to the type of BCPR as follows: DA-BCPR 
(n=564), Non-DA-BCPR (n=466) and No-BCPR (n=1168). The primary 
end point was initial shockable rhythm recorded by the emergency 
medical service. A Cox proportional hazards model was applied to 
reflect the different bystander CPR durations before/after propensity 
score (PS) matching.
Results: The crude rate of the initial shockable rhythm in DA-BCPR 
(24.3%, 137/564) was significantly higher than that in No-BCPR (11.0%, 
129/1168; p<0.0001). No significant difference was found between 
DA-BCPR and Non-DA-BCPR (27.0%, 126/466) in terms of the crude 
rate of the initial shockable rhythm (p = 0.31). Before PS matching, 
rural area (adjusted hazards ratio [aHR], 1.20; 95% confidence inter-
val [CI], 1.07–1.35, p<0.01), male sex (aHR, 1.18; 95% CI, 1.07–1.31, 
p<0.01), and Non-DA-BCPR compared with No-BCPR (aHR, 1.14; 95% 
CI, 1.00–1.29, p<0.05) were associated with substantially higher initial 
shockable rhythm rate at EMS arrival. As for the type of bystander CPR, 
DA-BCPR was positively associated with the initial shockable rhythm 
after PS matching (aHR, 1.27; 95% CI, 1.11–1.45; p<0.0001) when com-
pared with No-BCPR. Non-DA-BCPR was positively associated with the 
initial shockable rhythm after PS matching (aHR, 1.41; 95% CI, 1.22–
1.63; p<0.0001) when compared with No-BCPR. However, we found 
no significant difference between DA-BCPR and Non-DA-BCPR in their 
association with the likelihood of initial shockable rhythm after PS 
matching (aHR, 0.98; 95% CI, 0.83–1.16; p = 0.81).
Conclusion: Paediatric patients aged 8 to 17 years who received DA-
BCPR after a witnessed OHCA were more likely to have an initial shock-
able rhythm than those who did not receive bystander CPR. Moreover, 
DA-BCPR had the same multivariable-adjusted association with the 
likelihood of initial shockable rhythm as Non-DA-BCPR.
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Introduction: The current guidelines for cardiopulmonary resusci-
tation (CPR) after out-of-hospital cardiac arrest (OHCA) recommend 
the use of a universal basic life support termination-of-resuscitation 
(BLS-TOR) rule for emergency medical service (EMS) providers that 
was developed to identify adult patients with refractory OHCA eligible 
for field termination of CPR. However, the BLS-TOR rule is not recom-
mended for children with refractory OHCA due to lack of evidence. We 
hypothesized that the establishment of outcome prediction criteria in 
the field for children with OHCA may be useful for better utilization of 
hospital healthcare resources and reducing attendant hazards for the 
EMS personnel.
Objectives: We aimed to develop and validate outcome prediction 
criteria children with OHCA that may aid EMS personnel in deciding to 
which hospital should they transport the patients.
Methods: We analysed the records of 20,872 children (age <18 years) 
who experienced OHCA treated by the EMS providers. Data were 
obtained from a prospectively recorded Japanese nationwide Utstein-
style database for a 13-year period (2005–2017). Outcome measures 
were specificity and positive predictive value (PPV) of the newly devel-
oped criteria in predicting 1-month poor outcomes, namely, unfa-
vourable neurological outcomes, defined as Cerebral Performance 
Categories score 3 to 5 (CPC 3–5), and mortality. Patients were divided 
into the development (2005–2014, n=16,660) and validation (2015–
2017, n=4212) groups.
Results: The overall 1-month mortality and 1-month CPC 3–5 rates 
were 88.5% (18,471/20,872) and 95.6% (19,944/20,872), respec-
tively. Multivariate logistic regression analyses for the development 
group showed that the EMS personnel could predict poor outcomes 
in patients if the patients met all of the following three prehospital 
criteria before performing EMS-initiated interventions in the field: 
asystole as the initial rhythm recorded by EMS personnel, OHCA unwit-
nessed by laypersons, and no bystander-administered intervention. 
For patients meeting all three criteria, the specificity and PPV for pre-
dicting 1-month CPC 3–5 were 97.8% (95% confidence interval [CI], 
96.4%–98.7%) and 99.6% (95% CI, 99.4%–99.8%), respectively, for the 
development group and 97.1% (95% CI, 94.1%–99.8%) and 99.6% 
(95% CI, 99.1%–99.8%), respectively, for the validation group. The 
specificity and PPV of predicting 1-month mortality were 91.9% (95% 
CI, 90.6%–93.1%) and 96.5% (95% CI, 95.9%–97.0%), respectively, for 
the development group and 91.8% (95% CI, 89.3%–93.7%) and 94.4% 
(95% CI, 92.7%–95.8%), respectively, for the validation group.
Conclusion: With high specificity and PPV for predicting the 1-month 
unfavourable outcome, the EMS personnel could predict poor out-
comes if children with OHCA met all three criteria, namely, asystole as 
the initial recorded rhythm, OHCA unwitnessed by laypersons, and no 
bystander CPR, soon after arrival of the EMS personnel at the patients’ 
site.
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Introduction: Recent international out-of-hospital and in-hospital 
cardiac arrest statistics show that despite a decrease in heart disease 
and stroke mortality, the burden of disease remains on top of socie-
ty’s health problems. There is a high variation in survival to hospital 
discharge and survival with functional recovery between different 
regions and different countries. Early identification of predictors for 
mortality and poor long-term neurological outcome in patients who 
survive the initial phase of cardiac arrest may provide critical informa-
tion for physicians and facilitate clinical approach.
Objectives: The aim of this study was to identify the mortality rate 
of out-of-hospital and in-hospital cardiac arrest in our institution and 
to determinate the association between variables available from the 
patient’s history and status at intensive care unit admission with mor-
tality rate and neurological outcome. In subgroup analysis, we intend 
to study the impact on mortality of performing emergent coronary 
angiography on non-ST-segment elevation myocardial infarction 
(NSTEMI) patients.
Methods: We performed a retrospective review of all patients with 
the first diagnosis of “cardiac arrest” (CA) admitted to our intensive 
care unit (ICU) from 31 May 2015 to 31 May 2020. Patient selection and 
information collection were obtained through medical records. Out-
comes were early mortality, including in-hospital and 1  month after 
discharge mortality, and neurological function as defined by the Cer-
ebral Performance Category (CPC) scale after CA.
Group comparisons between survivals and non-survivals were per-
formed using the Student-T test or Mann-Whitney U-test for continu-
ous variables and Pearson chi-square test or Fisher test for categorical 
variables. For mortality outcome, multivariate logistic regression anal-
ysis with forward stepwise selection was performed to assess the asso-
ciation between the variables with statistically significant differences 
between the two groups. Correct adjustment of the model was ana-
lysed by the Hosmer and Lemeshow Test, and the ROC curve. A p-value 
less than 0.05 is statistically significant. Statistical analysis was per-
formed using SPSS software version 25.0 (IBM, Armonk, NY, USA).
Results: Of the 114 patients included, 42 (36.8%) admitted to our 
ICU with the diagnosis of cardiac arrest were non-survivors and 72 
(63.2%) were discharged alive from the hospital and survive at least 
one month after. We observe no significant difference between mor-
tality rates of in-hospital CA (64.6%) versus out-of-hospital CA (59.4%) 
(p = 0.60). Univariate logistic regression analysis found the follow-
ing factors associated with mortality: age greater than 75  years old 
(p-value<0.01), asystole or pulseless electrical activity (PEA) as cardiac 
rhythm at presentation (p-value = 0.03), total cardiopulmonary resus-
citation (CPR) time greater than 5 minutes (p-value = 0.02), Glasgow 
coma scale (GCS) after the return of spontaneous circulation (ROSC) 
less than 5 (p-value<0.01) and another cause for CA besides acute 
ST-elevation myocardial infarction (STEMI) (p<0.01). In multivari-
ate logistic regression, only GCS after ROSC less than 5 (odds ratio = 
3.63, 95%CI = [1.25;10.56], p-value=0.02) and another cause for CA 
besides STEMI (odds ratio = 4.88, 95%CI = [0.98;24.34], p-value=0.05) 
proved to be predictive factors of mortality. Regarding the predic-
tors of poor neurological prognosis, we identified the following vari-
ables as significant: CPR time  greater than 5 minutes (p-value=0.03, 
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95%CI = [-8.82;-0.37]) and GCS after ROSC less than 5 (p<0.01, 95%CI 
= [2.26;5.34]). Analytic parameters at admission (pH, lactate, bicarbo-
nate, calcium, magnesium, potassium, phosphate and haemoglobin) 
and comorbidities (hypertension, diabetes mellitus, prior myocardial 
infarction and heart failure) show no significant difference on mortal-
ity or neurological prognostic. In subgroups analysis of acute coro-
nary syndromes (n=35), we observed 21 patients with STEMI and 14 
patients with NSTEMI. Between NSTEMI patients, 12 were submitted to 
coronary angiography, which 7 required percutaneous coronary inter-
vention (PCI). We show no significant difference between mortality on 
NSTEMI patients submitted to emergent coronary angiography versus 
conservative approach (p = 1.00).
Conclusion: Our risk prediction model identified GCS after ROSC 
and cause of CA as important factors determining survival outcomes. 
Others factors like patient age, CPR time and cardiac rhythm at pres-
entation showed less importance. We identified CPR time and GCS 
after ROSC as major predictors of a poor neurological prognosis. We 
showed no difference in early mortality for NSTEMI patients submitted 
to immediate invasive strategy.
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Introduction: Within the UK, health care outcomes following admis-
sion to hospital either ‘in-hours’ or ‘out-of-hours’ has recently gained 
significant interest. Variation in service availability and staffing levels 
across the week may have an impact on this. However, specialist NHS 
services, such as Heart Attack Centres (HAC) and ICU are mandated to 
run a fully operational service 24-hours a day, 7-days a week.
Objectives: We have undertaken a service evaluation of all patients 
admitted to ICU at a Central London HAC, who suffered an OOHCA 
within the last five-years.
Methods: All patients who suffered an OOHCA and admitted to the 
ICU at a Central London HAC were identified and clinical notes were 
reviewed. We classified ‘in-hours’ attendance to HAC as Monday- Fri-
day from 08:00 - 17:00 (excluding public holidays). All hours outside of 
these periods were considered ‘out-of-hours’. This service evaluation 
was registered locally.
Results: Of the 279 patients admitted to ICU following an OOHCA, 
102 (36.6%) patients attended in-hours with 177 (63.4%) out-of-hours. 
Despite the fact that the patient cohort attending in-hours was sig-
nificantly older than those attending out-of-hours, timing of HAC 
admission showed no significant impact upon whether patients had 
a primary percutaneous intervention (PPCI), time taken for admission 
to ICU, ICU length of stay or survival to ICU and hospital discharge or at 
1-year post cardiac arrest (Table 1).
Table 1 
All 
patients In-Hours Out-of-Hours p-value
Number of patients 279 102 177 N/A 
Median age (years) 63.0 67.5 61.0 0.010
Survival to ICU discharge 58.8% 55.9% 60.5% 0.455 
Survival to hospital 
discharge 52% 52.0% 52.0% 0.998 
One-year survival 42.2% 50.0% 49.7% 0.964 
MRS of survivors 1.89 2.13 1.75 0.219 
Median Temperature 35.82 35.77 35.84 0.194 
Frequency of PPCI before 
GICU admission 78.9% 83.3% 76.3 0.164 
Median time taken for GICU 
admission (mins) 185 187 184 0.267 
Median length of stay on 
GICU (days) 6.81 6.50 6.83 0.230 
Irrespective of time of day, attending either during the week (67.4%) 
or at the weekend (32.6%) had no impact on frequency of PPCI or hos-
pital survival rate (Table 2).
Table 2 
Week Day Weekend p-value
Frequency of PPCI before GICU 
admission 153 (81.4%) 67 (73.6%) 0.137 
Survival to hospital discharge 98 (52.1%) 47 (51.6%) 0.940  
Conclusion: In our hospital experience, timing of admission had no 
significant impact on patient outcome. There was no greater length 
of time taken to be admitted to the ICU or length of stay on the unit. 
However, although not statistically significant, there was a greater ten-
dency to perform a PPCI before admission to ICU when attending in 
hours or during a week day. This may be due to greater availability of 
staff or laboratory space.
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Introduction: Survival following ROSC from OOHCA is poor. Data 
from the London Ambulance Service suggests admission to a Heart 
Attack Centre (HAC) may improve outcome with 45.1% of patients sur-
viving to hospital discharge, independent of initial heart rhythm1.
Objectives: We investigate the effect of patient demographics, coro-
nary angiography, PPCI and temperature on survival and neurological 
outcomes in all patients admitted to our ICU in the last 5-years.
Methods: A single centre, retrospective analysis of all OOHCA patients 
admitted to ICU from 2015-2019. We used hospital data on patient 
demographics, coronary angiography reports, temperatures during 
the first 24 hours and patient survival. Neurological outcomes of survi-
vors were determined by modified rankin scale (MRS).
Results: 279 patients were admitted to ICU, of which 58.8%, 52.0% 
and 42.2% survived to ICU discharge, hospital discharge and 1  year 
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post-cardiac arrest respectively. Although males were more likely 
to be admitted post-OOHCA compared to females (76.4% vs 23.3%), 
males had a significantly better 1 year survival despite equivalent sur-
vival at ICU discharge (males 45.5%, females 30.1%, p = 0.033).
Table 1: Outcome divided by gender. 
 Survival Male Female p-value
ICU (%) 58.68 58.46 0.97 
Hospital (%) 53.99 44.62 0.19 
1-year (%) 45.54 30.77 0.03
Age did not affect survival at unit discharge (age of survivors 62.0 vs 
non survivors 65.0, p = 0.215) but there was a significant difference at 
hospital discharge (survivors vs non-survivors 60.0 vs 66.0 respectively, 
p = 0.007). Gender did not affect age of survivors at hospital discharge 
(median male age=60, female=63, p = 0.190) or by 1  year (median 
male age=60, female=58, p = 0.38) nor did BMI (median BMI of survi-
vors 26.78 v non-survivors 27.68 (p = 0.254)). The median MRS for sur-
vivors at hospital discharge was 1.89. Univariate analysis showed that 
gender was not a predictor of neurological outcome (Median MRS for 
males=2, females=1, p = 0.26) nor was age (p=0.25).
Table 2: Effect of coronary angiography on patient survival, MRS scores 
Angiography No angiography p-value
Total 220 59 - 
% Hospital 
survival 53.6 45.8 0.448 
% 1-year survival 52.3 40.7 0.114 
MRS 1.94 1.59 0.271 
Median Temp 
(°C) 35.86 35.64 0.478 
and temperature. 
Coronary stenting was not shown to be a predictor of survival, quality 
of survival or average temperature (Table  3). Temperature had a sig-
nificant effect on survival but there was no correlation between mean 
temperatures and MRS in survivors (p=0.24).
Table 3: Effect of coronary stent insertion on outcome. 
Stent inserted No stent inserted p-value
Total 127 84 - 
% Hospital 
survival 56.6 51.0 0.527 
 % 1-year 
survival 55.0 50.0 0.471 
MRS 1.74 2.14 0.258 
Median Temp 
( C) 35.86 35.85 0.889 
Table 4: Effect of temperature on outcome. 
Temperature on 
Admission Mean
Total 35.1 35.8 
Died before hospital 
discharge 34.7 35.5 
Hospital Survival 35.4 36.0 
p-value < 0.0001 <0.0001 
Conclusion: Our data suggests our hospital had favourable outcomes 
compared with London. Negative outcomes after OOHCA may be 
associated with a colder initial and first 24-hour average temperature 
and a poorer 1-year outcome for those of female gender. Further work 
is required to understand these associations.
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Introduction: “Highly malignant” EEG patterns are predictive of poor 
neurologic outcome in comatose survivors from cardiac arrest. To 
identify such patterns, the referring intensive care clinician depends 
on the neurophysiologist report. An alternative to plain text EEG 
descriptions could be a short report confirming or denying the pres-
ence of EEG patterns compliant with the standardized EEG pattern 
categories “highly malignant”, “malignant” and “benign” as proposed 
by Westhall et al. We hypothesised that identification of EEG patterns 
known to have a specific prognostic association may be difficult in 
plain text EEG neurophysiologist reports.
Objectives: To test whether the plain text EEG reports, or the EEG 
short statements granted higher degree of correct identification of 
prognosis.
Methods: Volunteering ICU clinicians in two university clinics were 
introduced to 17 authentic plain text neurophysiologist reports and 
three reports limited to a short statement declaring that “highly malig-
nant”, “malignant” or “benign” EEG patterns were present. They were 
asked to classify how the described EEG patterns would impact the 
neurologic prognosis of a comatose patient. The standardised scenario 
included a high neuron specific enolase (NSE), but other neurologic 
tests and neuroimaging were inconclusive. In consequence, the clini-
cian’s perception of the prognostic value of the EEG neurophysiolo-
gist report would affect the neurological prognostication according 
to international guidelines. The primary outcome was the proportion 
of clinicians who correctly identified the poor neurologic prognosis 
inferred by the “highly malignant” EEG patterns. Secondary outcomes 
were how “malignant” and “benign” EEG patterns were classified.
Results: Fifty-seven intensive care clinicians, 36 of whom were special-
ists, participated in the study. “Highly malignant” patterns consistent 
with poor neurologic prognosis were correctly identified by 73% in the 
plain text reports and by 93% in the short statements. “Malignant” pat-
terns consistent with no impact on prognosis were correctly identified 
by 27%. A “benign” pattern consistent with a positive impact on prog-
nosis were correctly identified by 58% in plain text reports.
The ICU clinicians' (n=57) appreciation of prognosis listed per standardized 
EEG short statement. 
EEG short statement "Highly malignant" "Malignant" "Benign" 
Prognosis poor 53 (93%) 34 (60%) 0 
Prognosis not affected 4 (7%) 23 (40%) 4 (7%) 
Prognosis positive 0 0 53 (93%) 
Conclusion: ICU clinicians exposed to standardized EEG short state-
ments defining the presence or absence of “highly malignant” EEG 
patterns, compared to plain text EEG neurophysiologist reports, are to 
a higher degree able to correctly identify a poor neurological progno-
sis in comatose survivors of cardiac arrest.
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Introduction: Evidence shows that the mortality rate and the effects 
derived from a CPRlower if care response is improved and the survival 
chain amongst hospital is optimised. In this sense, medical staff’s life 
support techniques training is essential, as it goes without saying that 
this improves the survival rates. Having said this, we proceed to exam-
ine the assessment results from the CPR training programme which 
started in 2017 and 2018 in a university tertiary hospital.
Objectives: The main objective of this project is to provide training 
for basic and advanced life support based on clinical simulations to a 
certain number of healthcare workers (nurses and medical assistants). 
Furthermore, didactic methods will be assessed using quality surveys.
Methods: Theory and practice classes were conducted by qualified basic 
and advanced life support teachers in groups of 12-15 healthcare work-
ers. Advanced CPR mannequins as well as airway material were used. 
The participants were also provided with online access to extra teaching 
material. Finally, the participants had to fill in the satisfaction survey.
Results: There were 38 sessions in which 695 healthcare workers took 
part. Only 60% of the nurses and 38% of the medical assistants who 
participated were familiar with CPR, and 22% of the participants had 
never been present during a CPR. The programme received positive 
feedback. 90% of the participants were satisfied with aspects such 
as the teachers’ teaching skills, the possibility to participate and the 
understanding of the theory.
Conclusion: The CPR training conducted in 2017 and 2018 has 
allowed healthcare workers to update the CPR knowledge they need. 
The use of clinical simulations has been regarded as effective in order 
to acquire skills to deal with risky situations. The professionals consid-
ered the training they received was excellent.
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Introduction: Catecholamines are recommended as the first-line 
drugs to treat hemodynamic instability after out-of-hospital cardiac 
arrest (OHCA) [1,2]. However, the benefit-to-risk ratio of catecho-
lamines in the critical setting is dose dependent and their effect 
on metabolism and organ function early after OHCA has not been 
investigated.
Objectives: The aim of the analysis was to investigate the association 
between catecholamine and metabolism and organ function parame-
ters during the first 72 hours after OHCA as well as to assess the impor-
tance of catecholamines dose for short-term survival.
Methods: The Post-Cardiac Arrest Syndrome (PCAS) pilot study was a 
prospective, observational, multicenter study. The details of the pro-
ject were described elsewhere [3]. The endpoints of the prespecified 
analysis presented here were: 1. Lactate concentration as an indicator 
of oxygen delivery/anaerobic metabolism and neuron-specific enolase 
(NSE) as a brain injury marker, both assessed every 24 hours, over the 
first 72 hours after OHCA, 2. in-hospital mortality. Risk factors: 1. Nor-
epinephrine dose (µg/kg/min), 2. Cumulative dose of catecholamines 
(µg/kg/min), 3. Vasoactive-inotropic score (VIS)
Results: Simple and multiple linear regression analysis showed that 
norepinephrine dose and cumulative catecholamines dose are both 
independent predictors of lactate concentration on admission, at 24 
and 48 hours after OHCA (Table 1). Furthermore, norepinephrine dose 
and cumulative catecholamine dose were independent predictors of 
NSE concentration on admission (r=0.466, p<0.0001; r=0.158, p=0.01) 
and at 24 hours after OHCA (r=0.327, p=0.04; r=0.345, p=0.003). The 
VIS was independently correlated with NSE concentration on admis-
sion (r=0.61, p<0.0001). Cumulative catecholamine dose as well as VIS 
on admission were significantly associated with in-hospital mortality in 
univariate and multivariate analysis. Norepinephrine dose on admission 
was associated with in-hospital mortality in univariate analysis (Table 1).
   Table 1. Impact of catecholamine dose on lactate concentration within the first 
48 hours after OHCA and on in-hospital mortality. 
Multiple regression 
model* ß coefficient r coefficient t Stat  p-value 
Norepinephrine dose on 
admission 
  
2.264 0.238 2,743 0.007 
Norepinephrine dose 24h 
after OHCA 
3.283 0.36 4.138 <0.0001 
Norepinephrine dose 48h 
after OHCA 
1.856 0.314 3.21 0.001 
Cumulative catecholamine 
dose 
 on admission 
0.073 0.184 2.091 0.03 
Cumulative catecholamine 
dose 24h after OHCA 0.099 0.4291 4.959 <0.0001 
Cumulative catecholamine 






OR (95% CI);p-vaule 
Norepinephrine dose on 
admission 
  
2.330 (1.106 – 
4.909); 0.04 





2.14 (1.876 – 
2.654);0.02 1.09 (1.003 – 1.189); 0.04 
VIS on admission 
  
3.54 (3.104 –
3.967);0.001 1.04 (1.011 – 1.073); 0.006 
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Conclusion: Dose of catecholamines administered early after OHCA 
is associated with lactate and NSE concentration, which may suggest 
their importance for impaired tissue oxygen delivery, enhanced anaer-
obic metabolism and organ injury. Dose of catecholamines on admis-
sion is related with in-hospital mortality after OHCA.
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Introduction: Extracorporeal Cardiopulmonary Resuscitation (ECPR) 
is internationally recognised as an intervention to enable physiologi-
cal support of patients in refractory cardiac arrest. The evidence base 
for this type of support comes from a mixture of both cohort and case 
series and is applied to specific group of patients. To assess the poten-
tial benefit of an ECPR service a review of 2 years of patients present-
ing to the Emergency Department with out of hospital cardiac arrest 
was undertaken.
Methods: Inclusion criteria were defined based on evidence available 
and the practice undertaken in other parts of the UK. These criteria were; 
age <60 years, witnessed arrest, immediate bystander CPR, >10 minutes 
of resuscitation but <45 minutes of CPR on arrival in the Emergency 
Department, the presence of electrical activity. Postcodes were also 
looked at to assess the distances from the department within a 10 km 
and 20 km radius. Timings of cases were assessed to give an overview 
of in hours (08:00 to 17:00) and out of hours (17:00 to 08:00) workloads. 
Data was taken from Emergency Department presentations recorded as 
cardiac arrest, with a presentation review from electronic systems.
Results: 109 patients were identified over a two-year period between 
January 2018 to December 2019. This was split into 46 patients in 
hours and 63 patients out of hours. Not accounting for age or CPR 
extending beyond 45 minutes, 17 patients (36.9%) met the criteria in 
hours and 19 patients (30.1%) out of hours. However, when exclud-
ing patients with CPR ongoing longer than 45 minutes on arrival there 
were 11 patients (23.9%) in hours and 11 patients (17.4%) out of hours. 
Further considering patients that were 60 years or younger found that 
only 6 patients (13.0%) in hours and 3 patients (4.7%) out of hours met 
criteria for extracorporeal resuscitation. Considering in hours cases 
there were 35 within 20  km and 30 within 10  km. Considering dis-
tances for cases out of hours there were 43 within 20 km and 40 within 
10  km of Aberdeen Royal Infirmary. All the patients that met criteria 
died in the Emergency department.
Conclusion: Over two years the case load for patients that meet the 
criteria for ECPR in the local areas is low, and even when considering a 
24-hour period it remains a small number of patients. However, when 
considering service implementation, it is important to note that all 
the patients meeting criteria died in the Emergency Department and 
that there is a significant number of cardiac arrest cases within close 
traveling distance of Aberdeen Royal Infirmary. Due to this there may 
be an reasaonable argument for the development of an ECPR service. 
Any service development would need to consider the pathway of care 
that is delivered from the pre-hospital setting as well as the instigation 
of ECPR in the hospital as timeframes for establishing a patient on VA-
ECMO are crucial to overall outcome. More work is needed to further 
develop local cardiac arrest care in the North-East of Scotland.
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Introduction: The neurological prognosis of comatose survivors of 
cardiac arrest is recommended to be multimodal (1). Somatosensory 
Evoked Potentials (SSEP) is one of the methods used. Bilateral absence 
of cortical SSEP response is associated with poor prognosis. As a tool 
for hospitals lacking the SSEP modality, Daubin et  al. constructed a 
scoring system based on clinical signs and electroencephalography 
(EEG) aiming to predict the absence of the cortical N20-signal (2).
Objectives: We applied this scoring system to assess the need for 
the SSEP modality as a potential addition to the current multimodal 
prognostic examinations of comatose survivors of cardiac arrest in the 
Sahlgrenska University Hospital, Gothenburg, Sweden.
Methods: Survivors of out-of-hospital cardiac arrests (OHCA) who 
remained unconscious >72 hours after return of spontaneous circula-
tion (ROSC) were classified according to the scoring system. We had to 
assume that EEG patterns classified according to Westhall et  al. scored 
similar points as EEG classified according to Synek which was used by 
Daubin (3, 4). Using the cut-off values defined by its authors, the propor-
tion of patients with predicted absent N20-signal on SSEP was calculated.
Results: 37 patients with OHCA were included and 13 (35%) of these 
were predicted to have bilaterally absent N20-signals based on the 
total score on day 3, 48-72 hours after ROSC.
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Conclusion: Using the scoring system constructed by Daubin et  al. 
(2) with minor adaptations, we calculated that one third of patients 
with OHCA, who remained unconscious >72 hours after ROSC, would 
have absent cortical signals on SSEP. Hence, the use of SSEP would be 
meaningful in at least the other two thirds of OHCA patients. These 
results are essential for the dimensioning of a future SSEP service for 
the intensive care units in the Sahlgrenska University Hospital.
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Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) 
for refractory out-of-hospital cardiac arrest (OHCA) recently developed 
with disappointing limited survival (1) and still requires more selective 
inclusion criteria.
Objectives: To evaluate clinical benefit of an ECPR protocol in OHCA 
and to investigate potential predictive variables on admission.
Methods: Between 2011 and 2020, we analysed 80 ECPR candidates 
admitted in 2 Belgian reference centres. From 2016 an ECPR protocol 
based on 6 prehospital criteria was implemented (no flow < 3 min-
utes, low flow < 60 minutes, initial shockable rhythm, end-tidal CO2 > 
15 mmHg, age < 65 years and absence of comorbidities). Scoop-and-
run strategy and admission metabolic criteria for resuscitation discon-
tinuation were also evaluated.
Results: Twenty-six (32%) OHCA patients benefited from ECPR, their 
hospital survival rate was 43% (n=9/21) after protocol implementa-
tion. Prehospital inclusion criteria did not discriminate survivors and 
nonsurvivors (p=0.92). By contrast, any transient return of spontane-
ous circulation (ROSC) before ECPR (89 vs. 17%, p=0.002), higher serum 
bicarbonate (14.0 (10.6 -15.2) vs. 7.5 (3.7 - 10.5) mml/l, p = 0.019), lower 
base deficit (14.9 (11.9- 18.2) vs. 21.6 (17.9 -28.9) mmol/l, p=0.039) and 
initial lactate < 900 mg/dl (5/9 vs. 1/12, p=0.046) were associated with a 
more favourable outcome. Best cut-offs were bicarbonate > 10 mmol/L, 
base deficit < 18 mmol/L, lactate < 900 mg/L and fibrinogen > 1,8 g/l 
(figure). Four patients became organ donors after brain death.
Conclusion: This observational study shows that, in ECPR candidates, 
base deficit on admission and any transient ROSC before cannulation 
were significantly associated with better survival. Integration of ROSC 
and base deficit into inclusion criteria for ECPR in refractory OHCA 
could improve resources allocation.
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Introduction: In-hospital cardiac arrest (IHCA) is common and associ-
ated with a high mortality rate. However, it has received little attention 
compared with other critical cardiovascular conditions.
Objectives: This study is aimed to analyze the association between 
IHCA patients and healthcare related risk factors.
Methods: Data for this study enrolled IHCA patients from 14 regional 
hospitals, 2 district hospitals, and 5 medical centers between 2013 
June to 2018 December. Primarily, the registry enrolled patients once 
“collapse” event was disclosed regardless of the witness, and a total of 
7,731 cases was included initially. Patients with index hospitalization 
for Out-of-Hospital Cardiac Arrest (OHCA), IHCA patients without acute 
life support (ALS) attempt, undetermined sex, Age £18 or 3 120 years 
old, and patients with “do not resuscitate (DNR)” consent were 
excluded. Finally, a total of 5,306 patients were included in the analysis
Results: As for overall IHCA patients, HR for mortality was higher in 
older patients (HR = 1.11), and those underwent vasoactive agents 
in ALS (HR = 1.20). While, initial rhythm as ventricular fibrillation (HR 
= 0.62) reduced the risk of mortality in IHCA patients. With regard to 
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subgrouping IHCA patients in ICU and ER, patients underwent vasoac-
tive agents in ALS (HR = 1.19) had poor survival. Whereas, better sur-
vival was reported in patients with initial ventricular tachycardia (HR 
=0.63) and ventricular fibrillation (HR = 0.59). Regarding patients in 
general wards, old age (HR = 1.21) and shift between 24:00 to 08:00 
(compared to 08:00~17:00) (HR = 1.26) lead to poor outcome.
Conclusion: The majority of initial detected rhythm in IHCA patients 
was non-shockable. Factors for poor survival included old age, over-
night shift, and vasoactive agents. While, better survival was noted in 
patients with witness, those underwent targeted temperature man-
agement, and those with initial detected ventricular fibrillation. With 
regard to conditions at discharge, patients with regained conscious 
and those with good neurologic performance had better survival.
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Introduction: Among cardiac arrest (CA) survivors, post CA syndrome 
is responsible for poor outcome and is one of the main causes of 
deaths in these patients1,2. Lactate enriched solutions could exerts 
positive effects on the heart, where the myocardial reperfusion injury 
is responsible for a consistent fraction of the organ damage3-5. Sev-
eral protocols have demonstrated how an ischemic post-conditioning 
strategy based on lactate-enriched solutions could reduce the mag-
nitude of the reperfusion injury6,7, but no study has investigated the 
impact of hypertonic sodium lactate (HSL) infusion on macro-hemody-
namic variables after CA.
Objectives: To investigate the hemodynamic impact of the infusion 
of HSL after resuscitation in an experimental model of cardiac arrest
Methods: 27 adult domestic pigs were enrolled in the study. After 
proper sedation and preparation, including endotracheal intubation, 
invasive arterial pressure monitoring and pulmonary artery catheter, 
a ventricular fibrillation was induced via a pace-maker wire and left 
untreated for 10 minutes, when cardio-pulmonary resuscitation (CPR) 
were started at the rate of 100/minute with Lucas III device and con-
tinued for 5 more minutes. After the first minute of CPR and eventu-
ally after 7 minutes, an injection of Adrenaline was provided and at 
the end of the 5 minutes an electric shock (200 J) was delivered and 
repeated every minute to achieve Retour of Spontaneous Circula-
tion (ROSC). The animals were divided as follow: 9 as control group 
received a bolus of crystalloids during CPR and infusion during 12  h 
after ROSC (G0); 9 received HSL both during CPR and after ROSC (G1) 
and 9 received a bolus of crystalloids during CPR and HSL infusion 
after ROSC (G2). HSL solution was prepared by diluting into inject-
able sterile water a 2  mEq/mL solution (Monico spa, Mestre, Italy) to 
achieve a 1 M solution with calculated osmolarity of 2000 mOsm/L.
Results: All the animals in the study achieved ROSC. No differences 
were found between groups in the distribution of sex and weight, as 
well as in number of shocks needed to achieve ROSC, adrenaline dose, 
first end tidal CO2 measurement or baseline pH. To investigate differ-
ences on dependent variables over time between groups, a general 
linear mixed model was used. Arterial lactate levels were higher in the 
group of animals which received HSL (G1-G2) compared to G0 during 
the study course (p<0.001). To achieve the same mean arterial pres-
sure level of 65  mmHg, there was a significantly lower requirements 
for vasopressors between groups over the study period (p<0.01) and 
in the post-hoc analysis with Bonferroni correction, there was a sig-
nificant difference between G0 compared to G1 (p<0.001) and G2 
(p<0.001), but not between G1 and G2 (p=0.55).
Conclusion: In animals treated with continuous HSL infusion there is a 
significantly lower requirements of vasopressors in the first hours fol-
lowing resuscitation after cardiac arrest.
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Introduction: Current international guidelines recommend the pres-
ence of a family member during cardiopulmonary resuscitation (CPR) 
as this has beneficial psychological effects for relatives witnessing the 
event [1;2]. Contrary, there is only sparse data on the quality of team 
performance and the psychological well-being of health-care workers 
during relative-witnessed CPR.
Objectives: This prospective randomized trial investigates the effects 
of a family witness on team performance and perceived stress levels in 
simulated cardiac arrests.
Methods: 325 teams of 3 to 4 physicians each were randomized to 
perform CPR in a simulated cardiac arrest in the presence or absence 
of a family witness (trained actor). Additionally, teams were rand-
omized to designated or emergent leadership. Video-recordings 
obtained during CPR simulations were used for data analysis. The 
perceived task load was assessed by the NASA task load index (TLX), 
Primary endpoint was percentage of “hands-on” time. Secondary out-
comes included adherence to treatment algorithms, the perceived 
task load and the effects of designated leadership on primary and sec-
ondary outcomes.
Results: In groups with a present relative, verbal interaction occurred 
cumulatively during 105 ± 66 sec, representing 27 ± 16% of the study 
time. Teams without a leader had significantly more verbal interaction 
with the relative (123 ± 75 sec vs. 96 ± 58 sec, p = 0.014) correspond-
ing to 33 ± 20% vs 24 ± 14% (p = 0.001) of the study time. Primary 
outcome: percentage “hands-on” time was 86.6 ± 6.3% in the relative 
present groups vs. 87.3 ± 5.6% in the control groups (p = 0.25). Sec-
ondary outcomes: time to first defibrillation was 81 ± 38 sec in groups 
with a relative present and 77 ± 41 sec in control groups (p = 0.49). 
Designated leadership had no effect on medical performance mark-
ers. The presence of a relative was associated with significantly higher 
NASA-TLX ratings for the domains “temporal demands” (p < 0.001) 
and “frustration” (p < 0.001) while there was a borderline difference 
(p = 0.057) for the domain “mental demand” and no significant dif-
ferences for “effort” (p = 0.62) and “performance” (0.96). Designated 
leadership had no significant effect on NASA-TLX ratings.
Conclusion: The presence of a relative during simulated CPR sig-
nificantly increased the perceived task load for resuscitation teams 
without impairing their medical team performance measures. Having 
designated team leaders was associated with decreased verbal inter-
action with the relative but had no effect on the perceived work load 
or the team performance. Thus, resuscitation teams seem capable to 
cope with the additional psychological burden imposed by a family 
witness.
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Introduction: The population of ACHD patients continues to grow in 
the USA1,2,3. There exists a paucity of data in the realm of evidence-
based critical care medicine management of ACHD patients.
Objectives: To analyze our ACHD population with respect to clinical, 
anatomical, and physiological characteristics in order to understand 
associations to Intensive Care Unity (ICU) morbidity and outcomes. 
This information will serve to improve clinicians’ ability to under-
stand the various factors that influence outcomes in critically ill ACHD 
patients with unplanned and post-operative ICU admissions.
Methods: Retrospective chart review was completed on all ACHD 
patients with ICU admissions between 01/2015–12/2018. Demo-
graphic, anatomic, and physiologic characteristics were recorded. 
We examined associations between these characteristics and patient 
outcomes.
Results: There were 134 ICU admissions ages 18 to 79. 71% (n= 95) 
were admitted after elective cardiac surgery and 29% (n= 39) were 
non-surgical, unplanned admissions. Factors associated with ICU 
Length of Stay (LOS) in the elective, surgical cohort are shown in the 
table. Right Ventricle (RV) dysfunction was associated with more ven-
tilator days (median 2.0 vs 1.0, p=0.009) and a higher rate of Acute 
Kidney Injury (AKI) after cardiac surgery (57% vs 19%; p=0.001). NYHA 
class 3 or 4 vs 1 or 2 was associated with increased post-operative 
complications (56% vs 22%; p=0.001) and AKI (44% vs 17%; p=0.004). 
Post-operative arrhythmia was associated with increased ventilator 
days (p=0.0002). For unplanned admissions, higher lactic acid was 
associated with AKI (p=0.01), increased ICU LOS (p=0.02) and ventila-
tor days (p=0.016).








Physiology class 3,4 vs 1,2 80(n=76) vs 20(n=19) 2.0 vs 1.0 0.03 
NYHA 3,4 vs 1,2 43(n=41) vs 57(n=54) 3.0 vs 1.0 0.01 
Tobacco use vs none 33(n=31) vs 67(n=64) 3.0 vs 1.0 0.03 
LV Dysfunction vs none 13(n=12) vs 87(n=83) 5.0 vs 1.0 0.01 
RV Dysfunction vs none 24(n=23) vs 76(n=72) 5.0 vs 1.0 0.0001 
Shock vs no shock 47(n=45) vs 53(n=50) 3.0 vs 1.0 0.0001 
Redo sternotomy vs none 
prior
48(n=46) vs 
49(n=47) 2.5 vs 1.0 0.04 
Arrhythmia 29(n=28) vs 71(n=67) 4.0 vs 1.0 0.003 
Conclusion: Clinical characteristics of ACHD patients are associated 
with ICU morbidity and outcome. By better understanding these 
associations we may improve critical care management in the ACHD 
population.
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Introduction: Right ventricular (RV) function is increasing recognised 
as a contributing factor to outcome in cardiogenic shock (CS) post ST 
elevation myocardial infarction (STEMI). This was previously demon-
strated with regards to long term outcome1, but not short term.
Objectives: In this study we sought to determine the correlation 
between RV dysfunction and 28-day mortality in CS post STEMI with 
impaired left ventricle (LV).
Methods: Retrospective analysis of 100 patients admitted to intensive 
care unit (ICU) with CS post STEMI. Medical history, culprit lesion, clini-
cal data, echocardiography data including multiple parameters of RV 
and LV. Clinical and Echocardiographic parameters were correlated 
with 28-days mortality.
Results: 100 patients admitted over 3 years period were included. Mean 
age 62.6± 12.7y, 78% were male, 38% suffered out of hospital cardiac 
arrest and 28-day morality was 37%. Non-survivors had no statistically 
significant difference in age, gender, medical history or culprit lesion. 
Non-survivors had significantly higher acute physiology and chronic 
health score II (APACHE II, 20±6 v 15±4 p .0001), creatinine (133 (IQR 114 
– 210) v 103 (96 – 150) mmol/L, p .005), lactate (5.2 (IQR 2.5 – 8) v 3 (2.2 – 
5.2) mmol/L p .03) and lower mean arterial pressure (50±1 v 55±7 mmHg, 
p .02). Tricuspid annulus peak systolic velocity by tissue doppler (RV S’) 
was significantly lower in non-survivors (10±3.5 v 12±3.3  cm/s, p .03). 
Otherwise all parameters were comparable. In multivariate analysis of 
significantly significant clinical and echocardiographic parameters, RV S’ 
was found to be an independent predictor of 28-days mortality. In uni-
variate analysis RV S’ significantly predicted outcome (OR 1.2, 95% CI 
1.1 – 1.4 p .04) (Figure 1A). RV S’ of 10.5 cm/s exhibited best sensitivity 
and specificity in receiver operator curve analysis (64% and 65% respec-
tively, area under the curve 0.66 95% CI 0.52 – 0.80, p .02) for prediction 
of 28-days outcome. Kaplan-Meier survival curves revealed 85% survival 
for RV S’ > 10.5 cm/s and 53% for RV S’ < 10.5 cm/s and the curves were 
significantly different (log rank p .01) (Figure 1B).
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Figure  1. RV S’ prediction of survival. A. Univariate analysis of RV S’ 
association with 28-days outcome. Kaplan-Meier survival curves of 
28 days mortality using RV S’ cut-off value of 10.5 cm/s.
Conclusion: RV dysfunction influences short term outcome in patients 
admitted with CS post STEMI and impaired LV. RV S’ was an independ-
ent predictor of 28-days mortality and a cut-off of 10.5 cm/s was able 
to predict outcome with reasonable sensitivity and specificity.
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Introduction: Septic shock, a form of distributive shock, is charac-
terized by decreased organ perfusion due to severe peripheral vaso-
dilation in the setting of sepsis and dysregulated host inflammatory 
response to infection that is unresponsive to adequate fluid resuscita-
tion. It is unclear what the ideal third line vasopressor is after norepi-
nephrine and vasopressin.
Objectives: We conducted a retrospective cohort study, examining 
patients with septic shock who were not responsive to maximal doses 
of two vasopressors and required a third agent; we compared patients 
who received angiotensin II versus any other vasopressor as their third 
agent.
Methods: Patients included in the study were admitted to the ICU 
between July 2017 and March 2019. Eligible patients were at least 
18-years-old, with catecholamine-resistant hypotension, defined as 
those who require a total sum catecholamine dose of >0.2 µg/kg/min 
to maintain MAP between 55 and 70 mmHg, typically a combination 
of norepinephrine and vasopressin. After screening patients who did 
not meet inclusion criteria and those with incomplete data points, a 
total of 50 patients were studied, 29 in the angiotensin II group, 21 in 
the control group. Primary endpoint was the change in mean arterial 
pressure- MAP. Secondary endpoints included total length of ICU stay.
Results: In our 50 patients, there was a statistically significant increase 
in MAP at three hours in the angiotensin II group compared to the 
control group (16.3 mmHg vs. 4.3 mmHg; p = 0.0304). Overall, calcu-
lated lactic acid clearance at 3 hours in the angiotensin II group was 
better than in the control group (13.39% vs -57.2%), but this was not 
statistically significant (p = 0.1338). There was no significant difference 
in ICU length of stay.
Conclusion: Initiation of an angiotensin II agonist as a third-line agent 
showed a statistically significant improvement in mean arterial pres-
sire at 3 hours compared to a traditional third-line agent. Further 
prospective studies are required to evaluate clinical outcomes in the 
intensive care unit.
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Introduction: Pulmonary thromboembolism continues to be a high 
incidence pathology, with a high mortality rate, whose treatment 
depends on the risk of mortality at 30 days. In low and intermediate 
risk thromboembolisms the indicated treatment is anticoagulation, 
and in high risk thromboembolism fibrinolysis if it is not contrain-
dicated. Patients with intermediate-high risk do not have a clearly 
defined treatment since fibrinolysis has shown an increase in the 
incidence of bleeding without an improvement in survival, with 
thrombectomy being a therapeutic possibility in this group of 
patients.
Objectives: Evaluate clinical and echocardiographic evolution in 
patients with acute intermediate-high and high risk pulmonary throm-
boembolism (PTE).
Methods: Patients collected between January 2016 and August 2019 
with diagnosis of PTE of intermediate-high risk, defined by the guide-
lines of the European Society of Cardiology as positive markers of 
myocardial damage, right ventricular dysfunction measured by echocar-
diogram and stable hemodynamically; and high risk, hemodynamically 
unstable; who underwent mechanical thrombectomy in the first 24 
hours of admission in ICU with aspiration of approximately 70 to 80% of 
the thrombus. Thrombectomy was performed in 42 patients, transtho-
racic echocardiogram (ETT) was performed at admission and 24 hours 
post-procedure, collecting parameters of right ventricle dysfunction 
(TAPSE, Wave S, right ventricle diameter [RV], pulmonary hypertension 
[HTP]); arterial blood gas at admission and after 24 hours to calculate 
PaFi; and clinical assessment of the patient at admission and 24 hours 
after thrombectomy. The analysis of the data obtained comparing the 
situation before and after the procedure was carried out.
Results: Echocardiographically: significant improvement was 
obtained in the diameter of the RV (46’34 ± 4’71  mm at 42’13 ± 
6’37  mm, p <0.05), TAPSE (15’29 ± 3’63  mm at 18’49 ± 3’98  mm, p 
<0’05), S wave (9’45 ± 1’93  cm / sg at 11’9 ± 3’26  cm / sg, p <0’05) 
and not significant of the HTP (50’63 ± 13’80  mmHg at 46’81 ± 
19’14  mmHg, p0’256). Analytically: significant improvement of the 
PaFi (186’87 ± 127’9 to 287’58 ± 97’348, p <0.05). Clinically there was 
no significant improvement in chest pain, dyspnea or hemodynamic 
instability.
Conclusion: Mechanical thrombectomy in patients with acute pul-
monary thromboembolism of intermediate-high and high risk is an 
effective technique that significantly improves the parameters of right 
ventricular dysfunction and the oxygenation of patients. There was 
no significant improvement in clinical aspects such as dyspnea, chest 
pain or hemodynamic stability.
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Introduction: Veno-arterial membrane oxygenation (VA-ECMO) is a 
promising therapeutic option for patients with refractory cardiogenic 
shock or circulatory failure. However, as mortality rate of VA-ECMO-
treated patients still remains high, there is a need for early outcome 
parameters reflecting on therapy success or futility.
Objectives: In the present study we investigated whether the liver 
enzyme levels in patients that survived the first four days of VA-ECMO 
therapy could serve as prognostic marker, hypothesizing that Bilirubin 
has the potential to be a mortality marker in this cohort.
Methods: The present study is a retrospective single center cohort 
study approved by the Ethics Committee of the Heinrich Heine Uni-
versity Duesseldorf (Reference Number 5141R). Adult patients over 
18  years of age who received VA-ECMO therapy for refractory car-
diogenic shock or circulatory failure between 2011 and 2018 were 
included. VA-ECMO was deployed either at the home center or by the 
local team on-site in external hospitals. Only patients who survived 
the first four days of VA-ECMO therapy were included into the analy-
sis. For quantification of liver function Bilirubin was analysed at prede-
fined time points (day 0, 5, 10, 15). The primary endpoint was all-cause 
in-hospital mortality. The association between Bilirubin and mortality 
was examined by receiver operating characteristic curve (ROC) and 
the area under the curve (AUC) as well as univariate and multivari-
able cox regression. In a sensitivity analysis, patients with shock-liver 
(defined as GOT > 10 x cutoff (=35 U/l)) were excluded.
Results: A total of 438 patients received VA-ECMO therapy during the 
observation period. Based on the inclusion criteria, 298 patients (mean 
age 59±14  years) remained for statistical analysis. Overall mortal-
ity rate was 42.6% (n=127). The AUC in the ROC for Bilirubin on day 
five was 0.72 [95% confidence interval (CI): 0.66-0.78]. Youden-Index 
showed a cutoff for Bilirubin on day five of 2.23  mg/dl with a sensi-
tivity of 0.70. Cox regression with multivariable adjustment revealed 
a significant association between Bilirubin on day five and mortality 
with a hazard ratio (HR) of 2.24 [95% CI: 1.53- 3.30]. After excluding 
patients with shock liver from the sensitivity analysis, this association 
was still significant (HR 2.08 [95% CI: 1.33-3.26]. ROC for patients with-
out shock liver revealed an AUC of 0.67 [95% confidence interval (CI): 
0.59-0.75].
Conclusion: Based on the results of the current study, an increase in 
serum Bilirubin on day 5 in patients receiving VA-ECMO therapy cor-
relates independently with mortality regardless of the presence of 
shock liver. Thus, Bilirubin might serve as a prognostic marker in these 
patients and may be used as an indicator for early recognition of prob-
lems as well as optimization of VA-ECMO therapy.
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Introduction: Prognostic stratification of acute coronary syndrome is 
of vital importance, determining the strategy in these patients.
Objectives: The aim of this study was to analyze the importance of 
TIMI Risk score (TRS) as a prognostic tool of non-ST-segment elevation 
acute coronary syndrome (NSTEACS).
Methods: Retrospective analysis of all patients consecutively admit-
ted with NSTEACS, from January 2016 to December 2018. Clinical and 
epidemiological characteristics and prognostic variables were studied, 
completing follow-up for a median of 24 months.
Results: We included 824 patients, 33.9% women. In 76.4% of cases 
the acute coronary event corresponded to an unstable angina and 
the other 23.6% to a non-Q wave myocardial infarction. 65.3% of 
the patients had a TRS moderate to high risk (C3), corresponding to 
patients with higher comorbidity (Charlson Index 2.9 ± 2.2 vs. 1.4 ± 
0.6, p = 0.0001).
Highest scores in the TRS associated with greater development of 
heart failure (3.6 ± 1.2 vs. 2.6 ± 1.3, p = 0.0001) and mortality (3.9 ± 
1.1 vs. 2.7 ± 1.3, p = 0.0001) during in-hospital period. This relation-
ship remained after completing the long-term follow-up (3.5 ± 1.2 
vs.2.6 ± 1.3, p = 0.0001 for heart failure and 3.6 ± 0.9 vs. 2.6 ± 1.3, p = 
0.0001 for mortality).
After adjustment, the TRS predicted higher risk of presenting compli-
cated forms of acute
Coronary events both during in-hospital and long-term follow-up (OR 
1.6, 95% CI, 1.3–2.0 and OR1.3, 95% CI, 1.1–1.4, respectively).
Conclusion: The TIMI Risk score is a valuable tool in the prognostic 
stratification of Patients admitted for non-ST-elevation acute coronary 
syndrome.
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Introduction: Acute coronary syndrome (ACS) continues to be one 
of the most frequent admission pathologies in an intensive care unit 
(ICU). There are some predictors and risk factors that could indicate a 
higher probability of mortality during the first year.
Objectives: To analyze factors associated with one-year mortality in 
patients with ACS admitted to the ICU.
Methods: Retrospective descriptive study conducted in a 12-bed 
ICU from January 2017 to September 2019. Demographic variables, 
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comorbidities, type of ACS and location, left ventricular ejection frac-
tion (LVEF), Killip, severity scales, responsible artery, complications 
and mortality. Statistical analysis: categorical (frequencies and per-
centages) and numerical variables (mean and standard deviation or 
median and interquartile range). Comparisons: X2 test (percentages) 
and Student test (means). Multivariate logistic regression. Statistical 
significance with p<0.05.
Results: 278 patients were included. Deceased in the first year after 
ACS 56 (20.14%) vs. 222 survivors (79.86%): male (58.9% vs. 80.2, 
p=.001), age (73.88 [±10.99], p=.001), smoking (21.4% vs. 43.7%, 
p=.002), high blood pressure (64.3% vs. 38.7%, p=.001), diabetes mel-
litus (DM) (51.8% vs. 33.8%, p=.013), previous coronary lesions (30.4% 
vs. 16.2%, p=.016), chronic heart failure (26.8% vs. 3.2%, p<.001), 
chronic kidney disease (CKD) (19.6% vs. 3.6%, p<.001), COPD (14.4% 
vs. 3.6%, p=.006), cerebrovascular disease (14.3% vs. 4.1%, p=.009), 
heart rate (97.32 [±27.18] vs. 79.70 [±17.19], p<.001), systolic blood 
pressure (100.04 [±25.49] vs. 119.54 [±20.99], p<.001), TIMI (5.91 
[±3.42] vs. 2.84 [±2.12], p<.001), GRACE (216.73 [±50.56] vs. 149.01 
[±38.53], p<.001), CRUSADE (59.17 [±15.79] vs. 29.45 [±17.0], p<.001), 
previous acute myocardial infarction (51.8% vs. 29.3%) p<.001, LVEF 
(38.03 [±15.48] vs. 52.84 [±11.51], p<.001), norepinephrine usage 
(38.5% vs. 1.8%, p<.001), dobutamine usage (25% vs. 1.4%, p<.001), 
shock (61.1% vs. 2.3%. p<.001), hypotension (18.5% vs. 5.9%, p=.006), 
cardiac arrest (18.5% vs. 4.1%, p=.001), atrial fibrillation / flutter (11.1% 
vs. 2.7%, p=.016), kidney complication (9.3% vs. 2.3%, p=.028), inva-
sive mechanical ventilation (25.5% vs. 3.2%, p<.001). Multivariate 
analysis: age (OR 1.22, 95% CI [1.09-1.37], p<.001), Killip IV (OR 5871.59, 
95% CI [1.06-32626571.9], p=.049), shock (OR 251.56, CI 95% [10.02-
6317.5], p=.001), COPD (OR 12.5, 95% CI [1.10-141.72], p=.041), CKD 
(OR 88.1, 95% CI [7.87- 987.8], p=.041), LVEF (OR 0.92, 95% CI [0.88-
0.97], p=.010). AUROC: 0.978, 95% CI [0.958-0.998].
Conclusion: Age, COPD, CKD, Killip IV on admission and shock during 
ICU stay behaved as independent predictors of mortality after 1 year 
from ACS. Higher LVEF and DM were associated with greater survival.
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Introduction: Acute coronary syndrome (ACS) is one of the main 
causes of death worldwide. The improvement in the control of car-
diovascular risk factors, diagnosis and treatment, has increased the 
diseases’ prevalence. Therefore, its mortality has diminished. However, 
the proportion of sudden death remains the same. Studying mortality 
related factors has proven crucial for the prevention of the disease.
Objectives: To analyze factors associated with 28-day mortality in 
patients with ACS admitted to the ICU.
Methods: A retrospective descriptive analysis on a prospective cohort, 
performed in a 12-bed ICU from january 2017 to september 2019. Vari-
ables: demographic, comorbidities, ACS type and location, left ventric-
ular ejection fraction (LVEF), Killip, severity´s scales, responsible artery, 
complications and mortality. Statistical analysis: categorical (frequen-
cies and percentages) and numerical variables (mean and standard 
deviation). Comparisons: test of X2 (percentages), Student’s t (means). 
Multivariate logistical regression. Statistical significance with p <0.05.
Results: 389 patients were included, 292 male (75.1%) and 97 female 
(24.9%). 28  day mortality: 46 (11.8%). Deceased vs. survivors: male 
(56.5% vs. 77.6%, p=.002), age (73.30 [±11.17] vs. 62.72 [±12.16], 
p<.001), DM (56.5% vs. 32.9%, p=.007), hypertension (63% vs. 43.4%, 
p=.042), smoking (23.9% vs. 42.9%, p=.044), previous coronary lesions 
(30.4% vs. 15.7%, p=.014), previous acute myocardial infarction (26.1% 
vs. 12.8%, p=.016), COPD (15.2% vs. 4.1%, p=.007), chronic kidney 
disease (15.2% vs. 5.5%, p=.023), chronic heart failure (30.4% vs. 
4.1%, p<.001), NSTEMI (43.5% vs. 54.8%, p=.148), systolic blood pres-
sure (94.67 [±20.89] vs. 117.61 [±20.97], p<.001), HR (100.22 [±26.29] 
vs. 78.30 [±17.50], p<.001), LVEF (32.62 [±12.73] vs. 53.36 [±11.49], 
p<.001), TIMI (6.30 [±3.55] vs. 3.07 [±2.28], p<.001), GRACE (226.06 
[±53.11] vs. 150.30 [±38.84], p<.001), CRUSADE (59.74 [±17.56] vs. 
29.58 [±16.97], p<.001), dobutamine usage (31% vs. 1.7%, p<.001), 
noradrenaline usage (45.2% vs. 2.3%, p<.001). Invasive mechanical 
ventilation (28.9% vs. 2.9%, p<.001), shock (72.7% vs. 2.6%, p<.001), 
cardiac arrest (20.5% vs. 4.4%, p<.001), hypotension (12.8% vs. 5.9%, 
p=.008), kidney-related complications (11.4% vs. 1.8%, p=.004). Mul-
tivariate analysis: age (OR 1.18, 95% CI [1.04-1.32], p=.010), LVEF (OR 
0.85, 95% CI [0.77-0.93], p=.001), COPD (OR 7.66, 95% CI [1.01-57.84], 
p=.048), Killip IV (OR 628.42, 95% CI [7.28-54261.48], p=.005), shock 
during ICU stay (OR 95.35, 95% CI [6.85-1327.48], p=.001). AUROC: 
0.989, 95% CI [0.979-0.998].
Conclusion: Age, COPD, Killip IV on ICU admission and shock during 
the patient’s ICU stay, behaved as independent 28-day mortality pre-
dictors after an ACS. LVEF was associated with higher survival rate.
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Introduction: Patients older than 75  years are often underrepre-
sented in published acute coronary syndrome (ACS) studies, although 
they make up a significant and ever-increasing portion of this popu-
lation. Mortality from ACS progressively increases with age and 
remains high among elderly and very elderly patients. It was shown 
that elderlies receive optimal treatment and myocardial revasculariza-
tion less often than young patients [1], however, if revascularization is 
performed, hospital mortality decreases, 6-month survival improves, 
and the risk of stroke does not increase [2]. Currently, further studies 
are needed on the ACS course features in patients of older age groups 
to develop optimal treatment tactics for this category of patients in 
order to reduce in-hospital mortality and the incidence of long-term 
complications.
Objectives: To assess the clinical status, comorbidities, complications, 
in-hospital mortality and it structure in depend of age and acute coro-
nary syndrome (ACS) type in case of early invasive strategy.
Methods: Retrospective all-over study was carried out in ICU of High 
Medical Technologies Center, Kaliningrad, Russia. 1353 patients with 
ACS and emergency and urgent myocardial revascularization in the 
2014–2016  years period were included in the study. The first group 
(gr.1) consisted of 984 patients younger than 75 years old, and the sec-
ond group (gr.2) was compound of 369 patients aged 3 75. We were 
performed the analysis of anamnestic, clinical and laboratory data 
from medical documentation.
Results: The average age in the gr.1 was 60±8,6 years old, in the sec-
ond — 80,1±4,2. There was significantly myocardial infarction and 
stroke anamnesis burden, and reduced ejection fraction (EF), conges-
tive heart failure, valve disorders, atrial fibrillation prevalence in very 
elderly patients.
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There was no significant difference in ACS structure in studied groups 
(47,8% in gr.1 vs 45,5% in gr.2, p=0,512 for ST elevation myocar-
dial infarction) . There were more frequent severe manifestations of 
acute heart failure (AHF) and cardiogenic shock cases (Killip III—5,9% 
vs 11,4% (p=0,002); Killip IU 2,1% vs 9,1% (p<0,0001) in the first and 
second group respectively), higher score of GRACE ischemic risk and 
higher bleeding risk in very elderly patients in compare with persons 
younger than 75 years old. “First Medical Contact – balloon” time did 
not significantly differ in the studied groups (86±19,1 vs 94±21,3 min-
utes, p=0,072 for emergency PCI or 48,6 (95%CI 24-136) vs 34 (95%CI 
25-45) minutes, p=0,084 for urgent PCI in group 1 and group 2. All-
cases in-hospital mortality was 3,1% in the group 1, and 10% in very 
elderly patients, p<0,0001. ST elevation myocardial infarction mortal-
ity was 5% among patients younger than 75 years old and it was 20% 
among very elderly patients, p<0,0001. Non-ST elevation myocardial 
infarction+unstable angina mortality didn’t significantly differ in stud-
ied groups and composed 0,97% and 0,99%, p=0,52. In-hospital mor-
tality from AHF (2% in the group1 vs 6,5% in the group 2, p<0,0001) 
and percutaneous coronary intervention complications (stent throm-
bosis and no-reflow) (0,5% vs 2,4%, p=0,01) was significantly differ-
ent depending on age. AHF mortality didn’t differ among different 
age patients with preserved and mid-range EF, but it had significant 
difference in patients with reduced EF: 7,3% in the gr.1 и 18,6% in the 
gr.2 (p<0,0001). Studied group didn’t differ from the rate of gastro-
intestinal bleedings and major bleedings (0,7% in gr.1 vs 1,4% in gr.2, 
p=0,225).
Conclusion: ACS has more severe clinical course in very elderly 
patients in comparison with persons younger than 75 years old. Early 
invasive strategy is effective in spite of age and ACS type. Fatal out-
comes from percutaneous coronary intervention complications and 
AHF are more frequent in very elderly patients. ACS in-hospital mortal-
ity with the AHF as main reason is the prevalent mortality reason in 
very elderly patients with reduced EF. Otherwise, the structure of com-
plications and mortality is similar in patients of different ages.
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Introduction: Coronary heart disease (CHD) is a leading cause of 
death.  Accurate prediction of risk of death after acute coronary syn-
dromes (ACS) is important for prognostication and decision making 
about treatment and management of these patients.
Objectives: To analyze predictive factors associated to 90-day mortal-
ity in patients admitted to intensive care unit (ICU) with an ACS.
Methods: Retrospective descriptive analysis of patients admitted in a 
12-bed ICU performed from January 2017 to September 2019. Demo-
graphic variables, comorbidities, type of ACS,  left ventricular ejection 
fraction (LVEF),  initial Killip, extension,  coronary arteries affected, risk 
scores (TIMI, GRACE, CRUSADE), complications and mortality  have 
been registered.Statistical analysis: categorical (frequencies and per-
centages) and numerical variables (mean and standard deviation). 
Comparisons: test of X2 (percentages), Student’s t (means). Multivari-
ate logistic regression. Statistical significance with p <0.05.
Results: 380  patients were included,  287 (75.52%)  males  and  93 
(24.47%)  females. 90-day mortality: 51 (13.4%). Non survivors vs. sur-
vivors: male  (56.9% vs. 78.4%, p=.001),  age  (73.94 [±10.94] vs. 62.44 
[±12.05], p<.001),  diabetes mellitus  (54.9% vs. 32.5%, p=.008),  high 
blood pressure  (64.7% vs. 43.2%, p=.016), smoking (21.6% vs. 43.2%, 
p=.012), previous coronary lesions (29.4% vs. 15.8%, p=.018), previous 
ACS (27.5% vs. 12.5%, p=.005), COPD (13.7% vs. 4.3%, p=.014), chronic 
kidney disease  (15.7% vs. 5.2%, p=.011),  congestive heart failure 
(27.5% vs 4.3%, p>.001),  STEMI (39.2% vs. 55.6%, p=.029),  systolic 
blood pressure  (97.63 [±24.13] vs. 117.75 [±20.63], p<.001),  heart 
rate (100.18 [±25.68] vs. 78.06 [±17.15], p<.001), LVEF (34.84 [±13.47] 
vs. 53.46 [±11.42], p<.001), TIMI (5.91 [±3.43] vs. 3.04 [±2.27], p<.001), 
GRACE (220.86 [±48.89] vs. 149.09 [±38.08], p<.001), CRUSADE (59.81 
[±16.75] vs. 29.10 [±16.80], p<.001), number of implanted stents (2.48 
[±1.25] vs. 1.91 [±1.25], p=.045), dobutamine usage (27.7% vs. 1.8%, 
p<.001),  norepinephrine usage (42.6% vs. 2.1%, p<.001).  Invasive 
mechanical ventilation (28% vs. 2.5%, p<.001), shock (67.3% vs. 2.4%, 
p<.001),  cardiac arrest  (20.4% vs. 4.3%, p<.001), infectious compli-
cation (6.1% vs. 1.2%, p=.05),  kidney complication  (10.2% vs.  1.8%, 
p=.008). ICU length of stay (LOS) (4.65 [±7.05] vs. 2.43 [±3.32], 
p=.031).
Multivariate analysis: age  (OR 1.14, IC 95% [1.05-1.24], 
p=.001), LVEF (OR 0.91, IC95% [0.86-0.96], p=.002), Killip III (OR 80.40, 
IC 95% [2.45-2633.07], p=.014), shock (OR 27.65, IC95% [4.34-175.95], 
p=.004). AUROC: 0.976, IC 95% [0.958-0.993].
Conclusion: Age, Killip III at ICU  admission and shock during ICU 
stay were found as independent predictive factors for 90-day-mortal-
ity in patients diagnosed of ACS. LVEF was an independent predictor 
of survival.
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Introduction: Pulmonary thromboembolism it’s still a high incidence 
pathology with a high mortality risk. Depending on the hemody-
namic situation of the patient, it is classified as massive, if the patient 
is hemodynamically unstable; or submassive if the patient does not 
have hemodynamic instability. But do the clinical, ecocardiographic 
and blood tests improve depending on the type of pulmonary 
thromboembolism?
Objectives: Analyze the clinical, echocardiographic and analytical 
differences between patients with acute massive (hemodynami-
cally unstable) and submassive (hemodynamically stable) pulmonary 
thromboembolism (APE).
Methods: Recruited patients between January 2016 and August 2019 
with a diagnosis of submassive pulmonary embolism (hemodynami-
cally stable); and massive pulmonary embolism (hemodynamically 
unstable); who underwent mechanical thrombectomy in the first 
24 hours of admission with aspiration of between 70 and 80% of the 
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total thrombus. 42 thrombectomies were collected, performing tran-
sthoracic echocardiogram (TTE) at admission and at 24 hours post-
procedure analyzing parameters of right ventricle dysfunction (TAPSE, 
Wave S, right ventricle diameter [RV], pulmonary hypertension [HTP]); 
arterial blood gas at admission and at 24 hours to calculate PaFi; and 
clinical assessment of the patient at admission and at 24 hours. We 
compare between patients with massive and submassive pulmonary 
thromboembolism.
Results: A significant relationship was found between diabetes melli-
tus and massive thromboembolism (30’8% patients, p <0.05); syncope 
being the significant manifestation among patients with massive PE 
(57.7%, p <0.05). Radiologically, the involvement of the main pulmo-
nary arteries was significantly associated with massive PE (100%, p 
<0.05). Echocardiographically no significant differences were found 
in the parameters of right ventricular dysfunction (diameter, TAPSE, S 
wave or pulmonary hypertension) between massive or submassive PE. 
The echocardiographic improvement by TAPSE was significant among 
patients with submassive PE, improving the figures from 15’83 ± 2’23 
to 20’17 ± 2’85 (p <0.05) 24 hours after procedure.
Conclusion: Massive pulmonary embolism is significantly related to 
DM, syncope and involvement of major pulmonary arteries. Echocar-
diographic improvement of the right ventricle is significantly earlier in 
submassive PET after mechanical thrombectomy.
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Introduction: Tricuspid valve replacement (TVR) is seldom performed 
in cardiac valve surgery, and there are currently no clinical guidelines 
suggest which type of prostheses is better in tricuspid valve position. 
This meta-analysis was performed to compare the results of mechani-
cal and biological prostheses for TVR.
Methods: We searched Pubmed, Cochrane, Embase, Clinical trial data-
bases to collect all the related studies published during recent 10 years 
(from January 1, 2000 to October 31, 2019). A random-effects model 
was used to evaluate the OR (odds ratios) and its 95% CI (confidence 
intervals) of time-to-event related effects of the surgical procedures, 
every study’s quality evaluated by the Newcastle-Ottawa Scale (NOS).
Results: A total of 13 retrospective studies including 1407 patients 
were analyzed. There were no statistically differences between 
mechanical and biological prostheses with respect to prosthetic 
valve failure [OR=1.35, 95% CI(0.21,2.96), P=0.46], bleeding[OR=0.68, 
95% CI(0.33,1.40), P=0.29], reoperation[OR=1.00, 95% CI(0.59,1.72), 
P=0.99], early mortality [OR=1.13, 95% CI(0.58,2.18), P=0.73]and 
long-time survival [OR=1.06, 95% CI(0.68,1.66), P=0.80]. A trend 
toward greater risk of thrombosis can be seen in mechanical prosthe-
ses [OR=0.19, 95% CI(0.06,0.65), P=0.008, I2=0%].
Conclusion: In tricuspid valve position, mechanical valve prostheses 
has a higher risk of thrombosis than biological prostheses, but no sta-
tistically differences between mechanical and biological prostheses 
with respect to prosthetic valve failure, bleeding, reoperation, early 
mortality and long-time survival. The more specific conclusion need to 
be further proved by large-sample, multi-center, randomized, double-
blind and control trials.
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Introduction: Left ventricular outflow tract obstruction (LVOTO) is a 
relatively uncommon but severe condition that may lead to hemody-
namic impairment. It can be elicited by morphological (left ventricular 
hypertrophy, sigmoid septum, prominent papillary muscle, prolonged 
anterior mitral valve leaflet) and functional (hypovolemia, low after-
load, hypercontractility, catecholamines) factors.
Objectives: We sought to determine the incidence of the most severe 
form of LVOTO in septic shock patients and describe the therapeutic 
effects of vasopressin.
Methods: 527 patients in septic shock were screened for LVOTO over 
a period of 29  months. All were mechanically ventilated and treated 
according to sepsis bundles, including pre-load optimization and nor-
epinephrine infusion. Vasopressin was added in addition to norepi-
nephrine to reduce the adrenergic burden and decrease LVOTO.
Results: 10 patients were diagnosed with the most severe form 
of LVOTO including SAM (systolic anterior mitral valve motion) 
and severe MR (mitral regurgitation) with pulmonary oedema. The 
median norepinephrine dosage to obtain a mean arterial pressure of 
>/=70 mmHg was 0.58 mcg/Kg/min (IQR 0.40-0.78). All patients had a 
hyper-contractile left ventricle, septal hypertrophy, significant LVOTO 
(peak gradient 78 [56-123] mmHg) associated with SAM and severe 
MR with pulmonary oedema. Vasopressin (median 4  IU/h) allowed a 
significant reduction of norepinephrine (0.18 [0.14-0.30] mcg/kg/min; 
p=0.01), LVOT gradient (35 [24-60] mmHg; p=0.01) and MR with a sig-
nificant paO2/FiO2 increase (174 [125-213] mmHg; p=0.01).
Conclusion: Vasopressin allowed a reduction of norepinephrine with 
subsequent LVOTO reduction and hemodynamic improvement of the 
most severe form of LVOTO which represented 1.9% of all septic shock 
patients.
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Introduction: Impaired enteral perfusion and mechanical ventila-
tion, with inability to swallow, play a major role in the bioavailability 
of antiplatelets. Data on the use of glycoprotein IIb/IIIa receptor inhibi-
tors (GPI) in acute coronary syndrome patients presenting with cardio-
genic shock is sparse.
Objectives: Evaluate the impact of the use of GPI on the outcome 
(MACE/death) of patients (P) admitted with CS.
Methods: Retrospective study from 01/10/2010 to 08/01/2019. All P 
admitted for CS in the context of ACS were selected. Exclusion criteria: 
Killip class I-III, lack of information about APT during hospital length. 
We created 2 groups based in the use/absence of GPI during hospital 
length.
Results: 329 P were admitted, hypertension and dyslipidaemia were 
the most frequent comorbidities. Mean Systolic and diastolic pressure 
at admission of 96±33 and 59±21 mmHg, respectively. Haemoglobin 
at admission of 13,1±2 g/dl. platelets on admission of 221±89 x 103/
mm3.
Comparing the 2 groups we found out GPI was preferred in younger 
P (p<0,001), with higher levels of haemoglobin and platelets (p=0,04 
and P00,046, respectively) and was associated with higher use of intra-
aortic balloon (p=0,003). Also, 100% of patients with GPI performed 
coronary angiography.
Comparing the occurrence of MACE/death during hospital length we 
only found differences at cardiac arrest (higher in the group with GPI, 
p=0,003). There weren’t any differences regarding other MACE and 
death between the 2 groups. Furthermore, we haven’t seen any differ-
ences regarding bleedings complications in patients using GPI.
Conclusion: With a lack of specific randomized trials in CS the same 
recommendations apply as for other types of acute coronary syn-
drome. Our study suggests that GPI may be beneficial in this high-risk 
group of patients in whom a delayed onset of action of oral antiplate-
let therapy would be expected. More selected trials are needed to clar-
ify which is the best pharmacological option for these patients.
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Introduction: Factors associated with time delay to angiography in 
acute st-elevation myocardial infarction - a retrospective cohort study 
in Northern Finland
Objectives: Chest pain is a common mission (16.4%) for emergency 
medical service (EMS) but only in 10,5% there is a acute myocardial 
infarction (AMI) behind the symptom. (1) Delay in percutaneous cor-
onary interversion (PCI) with AMI is associated with increased heart 
failure and mortality (2). Aim of this study was to examine time inter-
vals of EMS and factors associated
Methods: Study was conducted in hospital district of Northern Ostro-
bothnia, Finland between 2014- 2016. Study included all the patients 
diagnosed with STEMI  that underwent angiography within 24 hours 
from arrival to hospital and had been transported to hospital by EMS. 
We defined angiography delayed if it was performed over 120 minutes 
from first medical contact.
Results: 330 patients met the inclusion criteria in the study period. 
Time from first medical contact to angiography  (TFMCA)  was <120 
minutes with 231 patients (70.0%). In multivariant analysis, OR  for 
TFMCA  over 120 minutes was higher if there was absence of chest 
pain (OR 2.46 95% CI (1.18-5.13), P=0.016), dyspnea (OR 3.11 95% CI 
(1.54-6.28), P=0.002), treatment protocol not followed (OR 2.41 95% CI 
(0.99-5.80), P=0.050), treatment started at health care center (OR 3.64 
95% CI (1.39-9.48), P= 0.008) and distance to hospital over 100 km (OR 
11.87 95% CI (6.14-22.93), P<0.001).
Conclusion: We demonstrated patient and ems related factors, that 
were associated with TFMCA time over 120 minutes.
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Introduction: Regarding prognosis, patients with a non-ST eleva-
tion myocardial infarction (NSTEMI) are a heterogeneous population. 
Therefore, early risk stratification at admission is essential. GRACE 
score estimates risk of death, including in-hospital death. ACTION ICU 
score predicts the risk of NSTEMI complications requiring ICU care.
Objectives: To evaluate and compare GRACE and ACTION ICU scores 
as predictors of in-hospital death (IHD) and in-hospital major adverse 
cardiovascular events (IHMACE) in our center population using real-
life data.
Methods: Based on a single-center retrospective study, data collected 
from admissions between 1/01/2016 and 11/12/2019. Patients with 
cardiac arrest or hemodynamically unstable patients at admission 
were excluded. GRACE and ACTION ICU scores were calculated, using 
Killip-Kimball classification as a surrogate of heart failure at admission. 
Logistic regression analysis and ROC curve analysis were performed to 
assess their performance as predictors of IHD and IHMACE.
Results: We identified 389 patients with NSTEMI, 63.5% were males 
with an average age of 68.7±12.6  years old. Regarding past medi-
cal history, 75.1% were hypertensive, 38.8% had diabetes, 54.8% had 
dyslipidaemia, 6.2% had chronic kidney disease, 3.1% had chronic 
obstructive pulmonary disease, 29.0% had a previous acute coro-
nary syndrome (ACS) and 28.5% had been submitted to coronary 
revascularization.
Mean GRACE score was 132.4±1.8 and median ACTIVE ICU score was 
4±4. Median heart rate was 77±23 bpm, median arterial pressure was 
146±38 mmHg, 88.7% had Killip-Kimball classification II-IV, 25.7% had 
ST-depression at admission. Logistic regression analysis confirmed 
that GRACE score was a good predictor of IHMACE (p<0.001) and 
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IHD (p=0.005) in our population. ACTIVE ICU score was also a predic-
tor of both IHMACE (p<0.001) and IHD (p=0.005). ROC curve analysis 
revealed that GRACE and ACTIVE ICU scores are accurate at predicting 
risk of IHMACE (area under curve (AUC) 0.726 and 0.737, respectively) 
and IHD (AUC 0.886 and 0.868, respectively).
Conclusion: This study confirms that, in our population, both scores 
are accurate at predicting the outcomes. As expected, GRACE score 
was slightly more accurate at predicting IHD while ACTIVE ICU score 
was more accurate at predicting IHMACE.
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Introduction: Acute coronary syndrome (ACS) and atrial fibrillation 
(AF) are frequent disorders and it is not uncommon for AF to be pre-
sent at admission of ACS. However, the presence of an arrhythmia can 
make the diagnosis of ACS more challenging and, therefore, it may 
increase in pre-hospital and admission delay in diagnosis.
Objectives: To evaluate if the presence of AF or other rhythms at 
admission had influence in the period from symptom to first medical 
care, time from first medical care and admission and overall time from 
symptoms to admission.
Methods: Based on a multicenter retrospective study, data collected 
from admission between 1/10/2010 and 8/01/2019. Patients were 
divided into 3 groups: A – sinus rhythm, B – AF, and C - other rhythms 
at admission. Patients without data on previous cardiovascular history 
or uncompleted clinical data were excluded. Chi-square test, T-stu-
dent test and Mann-Whitney U test were used in the analysis.
Results: 15927 patients were included, 14637 in group A (91.9%), 
1049 in group B (6.6%) and 241 in group C (1.5%).
Group B (GB) patients were older (65±13 vs 75±10 vs 73±13, p<0.001) 
and had higher rates of comorbidities such as arterial hyperten-
sion (67.1 vs 83.2 vs 79.2%, p<0.001), diabetes (30.4 vs 36.0 vs 36.9%, 
p<0.001), previous history of stroke (6.7 vs 14.9 vs 11.7%, p<0.001), 
peripheral artery disease (4.8 vs 8.9 vs 4.6%, p<0.001), chronic kidney 
disease (4.7 vs 10.5 vs 10.4%, p<0.001) and dementia (1.5 vs 4.2 vs 
3.1%, p<0.001) but fewer smokers (31.0 vs 8.7 vs 20.2%, p<0.001).
At presentation GB had lower rates of STEMI (42.6 vs 33.6 vs 50.6%, 
p<0.001), were more frequently admitted by the emergency room 
(53.8% vs 62.6% vs 61.3%, p<0.001) and had higher heart rates at 
admission (77±18 vs 91±29 vs 68±30, p<0.001).
The three groups were similar regarding times from symptoms to first 
medical care, times from first medical care and admission and overall 
times from symptoms to admission, rates of multivessel disease and 
culprit lesion in ST-segment elevation myocardial infarction (STEMI).
Regarding in-hospital adverse events, group B and group C had higher 
rates of de novo heart failure (13.0 vs 29.7 vs 26.6%, p<0.001), sustained 
ventricular tachycardia (1.5 vs 3.1 vs 3.7%, p<0.001), cardiac arrest (2.8 
vs 4.9 vs 7.1%, p<0.001), stroke (0.6 vs 1.7 vs 0.4%, p<0.001) and death 
(2.7 vs 9.0 vs 10.4%, p<0.001).
Conclusion: The rhythm at admission does not seem to have an effect 
in the time until medical care. Nevertheless, it was associated to worse 
prognosis and complications.
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Introduction: Atrial Fibrillation (AF) complicates approximately 10% 
of acute coronary syndromes (ACS) and it is, therefore, important to 
access its impact on prognosis and identify patients with higher risk 
of AF.
Objectives: To evaluate predictors of early onset (<48  h) and late 
onset (≥48 h) de novo atrial fibrillation (AF).
Methods: Based on a multicenter retrospective study, data collected 
from admissions between 1/10/2010 and 8/01/2019. Patients were 
divided in two groups: A – patients that presented early onset de 
novo AF (EOAF), and B – patients that presented late onset de novo 
AF (LOAF). Patients without data on previous cardiovascular history or 
uncompleted clinical data were excluded. Logistic regression was per-
formed to assess predictors of de novo AF in ACS. Survival analysis was 
evaluated through Kaplan Meier curve.
Results: Population - 257272 patients (pts) with ACS. Group A (GA) - 
584 pts (2.3%); group B (GB) - 360 pts (1.4%).
GA were younger (73±13 vs 77±10, p<0.001) with a higher prevalence 
of smokers (21.3% vs 12.1%, p<0.001). GB had higher rates of diabetes 
mellitus (40.1% vs 30.2%, p<0.001), angina (30.8% vs 21.4%, p<0.001), 
previous ACS (22.5% vs 15.4%, p=0.006), previous revascularization 
(percutaneous coronary intervention 14% vs 9.5%, p=0.032; coronary 
artery bypass surgery 8.4% vs 3.9%, p=0.004).
GA had more chest pain (76.1% vs 67.3%, p=0.001), more ST-seg-
ment elevation myocardial infarction (56.8% vs 46.9%, p=0.003) and 
were admitted directly to the cath lab more often (21.7% vs 13.4%, 
p=0.001). Normal QRS at admission was more common in GA (80% vs 
70.2%, p<0.001) and complete right branch block (CRBB) was more fre-
quent in GB (13.5% vs 6.7%, p<0.001).
GB had lower hemoglobin (Hb) levels at admission (12.9±2 vs 
13.4±1.9, p<.001), first medical evaluation >120 minutes after symp-
toms onset (FME>120  m) more often (71.6% vs 57.8%, p<0.001) and 
more in-hospital diuretics usage (72.8% vs 54.3%, p<0.001). Logistic 
regression confirmed that FME>120 m (OR 1.6, p=0.005, CI 1.15-2.22), 
Hb≤12 g/dL (OR 1.53, p=0.018, CI 1.02-2.18), CRBB (OR 1.72, p=0.043, 
CI 11.02-2.92) and diuretics usage (OR 2.18, p<0.001, CI 1.57-3.01) were 
predictors of late onset AF.
140 LOAF patients and 236 EOAF patients had 1  year of follow up. 
Event-free survival was higher in EOAF than LOAF (80,3% vs 5,9%; 
p=0.002, OR 2.072).
Conclusion: LOAF patients seem to have a poorer prognosis com-
pared to EOAF.
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Introduction: Left ventricular (LV) dysfunction is potentially harmful 
in the critically ill patient as it might compromise circulatory status. LV 
dysfunction can be triggered by many conditions in the critically ill e.g. 
myocardial infarction, toxic cardiomyopathy, hypoxia or severe stress 
(Takotsubo syndrome). The gold standard for diagnosing left ventricu-
lar function is echocardiography, but it might not be feasible to screen 
all ICU patients without discretion.
Objectives: This study evaluated troponin T, NTproBNP and ECG as 
more readily available surrogate markers for heart failure in critically 
ill patients.
Methods: This is a secondary analysis of a single-center prospective 
observational study which consecutive patients were examined with 
echocardiography (ClinicalTrialsID: NCT03787810). Included patients 
were examined with echocardiography according to the recommen-
dations from ESC [1] within 24 hours from admission to the general 
ICU in our hospital. All echoes were recorded and blindly reviewed by 
an independent examiner. Blood samples were analyzed for high sen-
sitive troponin T (hsTnT) and NTproBNP and an ECG was obtained in 
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conjunction with the echocardiography of the patients. Heart failure 
was defined as having an LV ejection fraction <50%.
Results: A total of 411 patients were included in the final analysis of 
whom 64 (16%) had an EF<50%. Measurement of hsTnT and NTproBNP 
was available in 314 (76%) and 277 (67%) patients, respectively. An 
ECG was obtained in 374 (91%) patients. A sensitivity analysis showed 
that the population having measurement of cardiac biomarkers or 
an ECG-recording was a representative sample of the whole study 
population.
Levels of hsTnT were higher in patients with an EF<50% (median, 
IQR 27 [12-64] vs 176 [62-503], p<0.001), as was also the case with 
NTproBNP (median, IQR 683 [212-2810] vs 4175 [1570-12900], 
p<0.001). An ECG with q-waves, ST-elevation, ST segment depression, 
negative T-waves or bundle block branch were all significantly associ-
ated with an EF<50%.
Using ROC curves, the area under the curve (AUC) for hsTnT to detect 
an EF<50% was 0.81. The best-cut off value was 68 ng/L with a sensi-
tivity of 75%, a specificity of 75%, a positive predictive value (PPV) of 
40% and a negative predictive value (NPV) of 93% in the detection of 
an EF<50%. The AUC for NTproBNP to detect an EF<50% was 0.79. The 
best cut-off value was 1230 ng/l with a sensitivity of 84%, a specific-
ity of 60%, a PPV of 60% and a NPV of 95%. The ECG finding with the 
highest predictive value was an ECG with any pathology which had a 
sensitivity of 92%, a specificity of 38%, a PPV of 23% and a NPV of 95% 
for detection of an EF<50% (Table).
A lower ejection fraction was associated with an increased risk of 
30 days mortality (<0.001). Levels of hsTnT and NTproBNP were both 
associated with an increased risk of 30-days mortality (p<0.001). Both 
biomarkers were also significantly associated with an increased risk 
of death when adjusting for SAPS 3 score, age and EF in % (p=0.024 
and p=0.025, respectively). An ECG with any pathology was associated 
with an increased risk of 30-days mortality (p=0.005) but not when 
adjusting for SAPS 3 score, age and EF in % (p=0.813).
  hsTnT>68ng/l NTproBNP>1230ng/l ECG with any pathology 
Sensitivity 75% 84% 92% 
Specificity 75% 60% 38%
PPV 40% 60% 38% 
NPV 93% 95% 95% 
Conclusion: The cardiac biomarkers hsTnT and NTproBNP and ECG 
are only moderate in detection of heart failure in a mixed population 
of critically ill patients. However, the high negative predicitive value of 
these biomarkers, as well as a normal ECG, could be used to rule out 
heart failure in the critically ill.
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Introduction: Cardiac assistance with venoarterial ECMO (ECMO-VA) 
is increasingly being used in patients with heart failure as a bridge to 
cardiac transplantation in code 0.In our study, we study how this fact 
influences the evolution of transplanted cardiac patients in ICU.
Methods: Review of cardiac transplants between January 2013-March 
2020 that required ECMO-VA pre-transplantation in a retrospective, 
descriptive study. Age, EuroscoreII value, vasoactive drugs require-
ments and stay times, as well as troponin concentration values and 
mortality rates were analyzed. A basic descriptive analysis and com-
parisons were performed with the appropriate statistical tests.
Results: 74 patients were included in the study. Pre-transplant ECMO 
was implanted in 9 patients (12,2%), 2 of them in INTERMASC 1. No sta-
tistically significant differences in ECMO-VA group age were reported 
compared to elective transplant group[E1] . No significant differences 
were reported between the groups compared to Euroscore II, Apache 
II score or lactate and bilirrubine concentration levels. However, 
patients with pre-transplant ECMO-VA had higher average of ICU stay 
than the elective[E2] (40,4±21,5 vs 10,5±9,6, respectively) p<0,001. 
Ultrasensitive T troponin levels were significantly higher in ECMO 
(10568,8±16351,3 vs 2582,8±1975,3, p<0,001). Hours of treatment 
with vasoactive drugs as dobutamine (569,6±595,5 vs 133,1± 73,4, 
p<0.001) and norepinephrine (560± 370,9 vs 55,9±59,5, p<0.001) 
were significantly higher in the ECMO group compared to elective 
group, respectively. Mortality was significantly higher in the pre-trans-
plant ECMO group (44.4%) compared to a elective transplants (10.8%).
Conclusion: Transplanted cardiac patients in urgency 0 with pre-
transplant ECMO-VA had significantly higher ICU stay than elective 
patients, with higher troponin numbers, longer periods of vasoactive 
drugs treatment, and higher mortality rates than those reported in 
elective transplants.
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Introduction: Actually, copeptin is an additional biomarker for the 
early rule-out of myocardial infarction in patients in emergency 
department or with early-onset chest pain. It also, have been associ-
ated with severity of the post cardiac arrest syndrome, 1-year mortal-
ity in ST-segment elevation acute myocardial infarction patients or the 
identification of major trauma, hospital admission and blood transfu-
sion in adult trauma patients.
Objectives: To explore the association between early measurements 
of copeptin and hepatocyte growth factor with hospital and 1-year 
follow-up mortality, in patients with acute myocardial infarction.
Methods: We prospectively measured hepatocyte growth factor and 
copeptin in blood samples collected at hospital arrival in consecu-
tive patients diagnoses of type 1 acute myocardial infarction during 
8 months, and prospectively we follow-up them to measure hospital 
and 1-year follow-up mortality.
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Results: 84 patients were included in the study, 55 patients (65%) 
were male with a mean age of 70.3 (± 13.56) years. 25 patients (29.8%) 
had an ST-segment elevation myocardial infarction.
Hospital mortality was 11.9%, 1-year follow-up mortality was 21.4%.
Mean copeptin levels were higher in patients who died during hos-
pital admission (145.60 [52.21-588.50] vs. 24.79 [10.90-84.82] pmol/L, 
p=0.01) or during follow-up (112.28 [25.10-418.27] vs. 23.82 [10.96-
77.30] pmol/L, p= 0.02). There were no differences on hepatocyte 
growth factor levels between patients who died or no during hospi-
tal admission (381.05 [189.95-736.65] vs. 355.24 [175.55-521.76] pg/
ml, p= 0.73) nor during follow-up (350.00 [175.05-555.08] vs. 345.53 
[183.68-561.15] pg/ml, p= 0.679)
Copeptin measured at hospital arrival was found to be independently 
associated with hospital mortality, hazard ratio 1.004 [1.001–1.007], 
p=0.011; and 1-year follow-up mortality, hazard ratio 1.004 [1.001–
1.007], p=0.010. Conversely, hepatocyte growth factor measured at 
hospital arrival was not found to be independently associated with 
hospital mortality (hazard ratio 1.000 [0.999–1.001], p=0.794) nor 
1-year follow-up mortality (hazard ratio 1.000 [0.999–1.001], p=0.396).
Conclusion: Copeptin measured at hospital arrival, but not the hepat-
ocyte growth factor, is an independent marker of mortality in patients 
with acute myocardial infarction.
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Introduction: Cardiac injury has been reported to be a major compli-
cation associated to COVID-19, with reported incidences ranging from 
7 to 28% patients (1, 2). It has even been associated with increased 
mortality(1). Circulatory failure due to cardiogenic shock or fulminant 
myocarditis has been described in some case reports (3). It has been 
reported that 95% of COVID-19 patients on mechanical ventilation 
require norepinephrine (NE)(4), nonetheless, no systematic data have 
been reported about the hemodynamic profiles, cardiac function, 
or incidence of acute cor pulmonale (ACP), in critically ill COVID-19 
patients.
Objectives: To perform a systematic characterization of cardiac func-
tion in COVID-19 mechanically ventilated patients using  critical care 
echocardiography.
Methods: The echocardiographic group of Sociedad Chilena de 
Medicina Intensiva (SOCHIMI) prospectively included COVID-19 
patients admitted to ICU and connected to mechanical ventilation. A 
comprehensive echocardiographic assessment has been done within 
the first 12 hours of mechanical ventilation in four University Hospitals 
of Santiago.
Results: 60 patients were consecutively included. The mean age was 
58±12 y.o., 42 (70%) were male. APACHE II was 13±4 and SOFA 6±2. 
Forty seven (78%) patients required low doses of NE (0.05 ± 0.06 mcg/
kg/min), median cardiac output was 4.9 [IQR 4.4-6.1] L min-1 and Lac-
tate was 1.4 [1.0-1.9] mmol/L.
Forty three (72%) patients exhibited a left ventricular ejection fraction 
(LVEF) >60% (hyperkinetic), 16 patients had LVEF between 45 and 60% 
(normokinetic) and one patients had hypokinetic heart function (LVEF 
<45%)(6). Right ventricle function was preserved in 55 (92%) patients 
(TAPSE >17 m)(7). In eighteen patients (30%) mild right ventricle dila-
tion (right to left ventricular area ratio between 0.6-0.8) was observed 
and four (7%) patients exhibited moderate acute cor pulmonale (right 
to left ventricular area ratio between >0.8). In addition, no correlation 
was observed between LVEF and troponin levels. Echocardiography 
parameters are shown in the Table.
Conclusion: The most frequent hemodynamic profile of mechani-
cally ventilated patients with severe COVID-19 pneumonia was a nor-
modynamic circulatory state with hyperkinetic cardiac performance, 
associated with normal intravascular volume and normal tissue per-
fusion. In contrast with usual ARDS, severe acute cor pulmonale was 
not observed in this COVID-19 patient series. Although some cases of 
circulatory failure have been described, our data suggest that cardiac 
dysfunction is not a frequent feature of COVID-19. Further studies are 
necessary to assess the dynamic changes in cardiac performance over 
time.
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Introduction: Atrial septal defects (ASD) are common but rarely 
symptomatic. Alteration of right (Rt) and left (Lt) sided pressures may 
create a gradient across the interatrial septum causing shunt. If right-
to-left shunt (RLSh) occurs, systemic hypoxaemia may ensue.
Objectives: To use 3 cardiac anatomical variants and physiological 
manipulation thereof to demonstrate how intracardiac gradients can 
be manipulated to both unmask and improve RLSh.
Methods: Case 1: 77  year old male with good biventricular function 
underwent tissue aortic valve replacement for aortic stenosis with 
epicardial pacing postoperatively. He failed extubation due to hypox-
aemia. CXR, bronchoscopy and CTPA were normal. With ongoing dete-
rioration (P/F ratio 10, PEEP 14) transoesophageal echocardiography 
(TOE) showed a large secundum ASD with continuous RLSh. Reducing 
pacing from 100  bpm to 60  bpm reduced shunt and increased pO2 
from 10.1  kPa to 32.3  kPa on the same ventilator settings. Unfortu-
nately, oxygenation could not be managed by manipulation of cardiac 
filling pressures non-invasively and he recovered after surgical correc-
tion of his ASD.
Case 2: 51 year old female with a background of Arrhythmogenic Right 
Ventricular Cardiomyopathy was admitted in cardiogenic shock on 
inotropes and underwent LVAD implantation. On day 7 postopera-
tively, she developed severe hypoxaemia. CXR was clear but oxygena-
tion poor: P/F ratio 14 with PEEP 10. TOE demonstrated a previously 
undetected large PFO with continuous right to left shunt. Oxygena-
tion could not be improved despite reducing PEEP or LVAD RPM. She 
underwent Amplatzer closure of the PFO and recovered before being 
listed for transplantation.
Case 3: 40 year old male presented with fulminant lymphocytic myo-
carditis requiring pVAECMO and subsequent Total Artificial Heart 
(TAH) placement. He was readmitted a year later with bacterial pneu-
monia and fluid overload requiring intubation. TAH rate was increased 
to optimise pulmonary offloading and Lt vacuums manipulated to 
maximise this. Despite improved radiographic appearances and pul-
monary compliance, oxygenation failed to resolve with a P/F ratio 
of 11, PEEP 10. TOE was undertaken which showed a small PFO with 
continuous RLSh. Increasing Rt vacuum + iNO improved systemic 
oxygenation. After a few days, oxygenation worsened due to pulmo-
nary congestion. Lt vacuum was increased coupled with diuresis. As 
chamber fills fell, both vacuums were increased. This maximised both 
systemic and pulmonary haemodynamics without provoking further 
shunt. He subsequently weaned from the ventilator before being dis-
charged home.
Results: All 3 cases demonstrate a variety of techniques capable 
of managing RLSh across the IAS. Understanding of the physiology 
involved, particularly with mechanical devices is important.
Conclusion: RLSh can be a consequence of iatrogenic unloading of 
the left side of the heart. Management may be physiological, inter-
ventional or surgical. In the setting of unexplained hypoxaemia and in 
the right clinical setting, TOE is an essential part of investigation whose 
utility should not be overlooked. A high index of suspicion is needed 
and this diagnosis should not be forgotten.
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Introduction: Acute coronary syndrome (ACS) is a group of clinical 
diseases which occur as a result of acute myocardial ischemia, whether 
it be secondary to obstruction of coronary flow (atherosclerotic coro-
nary artery disease) or to an imbalance in myocardial oxygen sup-
ply and demand, based on the fourth definition of acute myocardial 
infarction. Classic risk factors for coronary artery disease include older 
age, arterial hypertension, smoking, diabetes mellitus and family his-
tory of ischemic heart disease.  In Colombia, the current scale of the 
disease in terms of risk factor prevalence is unknown.
We determine individual and clinical factors associated with acute 
coronary syndrome and their association with the presence of coro-
nary atherosclerosis, documented using cardiac catheterization in 
patients in an intensive care unit during the first half of 2018, in the 
city of Bogota.
Objectives: To determine individual and clinical factors associ-
ated with the presence of atherosclerotic coronary artery disease in 
patients with acute coronary syndrome in an intensive care unit, dur-
ing the first half of 2018 in the city of Bogota.
Methods: It is a cross-sectional study which included 223 patients 
diagnosed with coronary syndrome, and who received cardiac cathe-
terization during the first half of 2018. We performed a bivariate analy-
sis of the individual and clinical characteristics, using the Chi-squared 
test to determine their level of association with the dependent vari-
able, i.e., the presence of atherosclerotic coronary artery disease. We 
performed a multivariate analysis through logistic regression to deter-
mine the independent risk factors. A p-value ≤ 0.05 was considered 
significant.
Results: We found that 1 in 5 patients diagnosed with acute coronary 
syndrome does not show significant atherosclerotic coronary artery 
disease in their catheterization. 25% of patients with acute coronary 
syndrome are under 50 years old. Men show a greater prevalence, at 
65%. Contrary to what we expected, there was no statistically signifi-
cant association in the variables that are widely described in literature, 
such as hypertension, smoking, or family history and personal his-
tory of ACS. Out of the individual and clinical characteristics assessed 
in this study, a history of Diabetes Mellitus  (OR. 4.9, CI 1.680 – 14.393, 
p 0.004)  and the presence of changes in the admission electrocar-
diogram (OR. 2.96, IC 1.285 – 6.854, p 0.011) had the greatest statistical 
significance.
Conclusion: This study shows that the variables that better account 
for the probability of evidence of atherosclerotic coronary artery dis-
ease in the catheterization of patients with acute coronary syndrome 
are a history of diabetes mellitus and the presence of electrocardio-
graphic changes at the moment of diagnosis. These findings can give 
the clinician additional tools when deciding on the risk stratification 
strategy, thus avoiding unnecessary invasive procedures, and reduc-
ing the risk of complications and other considerations that derive from 
this.
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Introduction: Although a possible association between chronic kid-
ney disease and coronary artery disease or acute myocardial infarc-
tion has been identified, the impact of end-stage-renal-disease (ESRD) 
under dialysis on long-term prognosis after an acute myocardial 
infarction (AMI) is uncertain. Therefore, this study was to evaluate the 
specific impact of the patient with ESRD under dialysis on survival 
after a first AMI through a retrospective analysis of data from the Tai-
wan National Health Insurance Research Database.
Methods: This was a nationwide, propensity score-matched case-
control study of patients admitted to hospitals between January 2000 
and December 2012 with a primary diagnosis of a first AMI. Among the 
186,326 prospective patients, 8056 patients with a confirmed diagno-
sis of ESRD under regular dialysis were identified. A propensity score, 
one-to-one matching technique was used to match 8056 controls to 
the AMI group for analysis. Controls were matched on the following 
variables: sex, age, hypertension, dyslipidemia, diabetes, peripheral 
vascular disease, heart failure, cerebrovascular accidents, end stage 
renal disease, chronic obstructive pulmonary disease, and percutane-
ous coronary intervention.
Results: The 12-year survival rate was significant lower in AMI with 
ESRD group than control group (log rank p<0.01). No matter male or 
female, the survival rate was significant lower in AMI with ESRD group 
(log rank p<0.0001). In both younger (Age<65 years) and older cate-
gory, the survival rate was also lower in AMI with ESRD group (log rank 
p<0.0001). The survival rate of patients who had received PCI manage-
ment was comparable among patients in the ESRD and control groups 
(log rank p < 0.0001).Similarly, the rate of survival among patients who 
did not receive PCI management was comparable for both the ESRD 
and control groups (log rank p <0.001).
Conclusion: In this nationwide study, using matched-case control we 
provide evidence of a possible effect of end-stage-renal-disease on 
the survival after a first AMI. Independent of sex and age, and revascu-
larization management, ESRD plays an important role in the long-term 
outcome of AMI patients.
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Introduction: It is common to find ourselves in intensive care units 
with patients with difficult blood pressure control. In many occasions, 
the impossibility of administering oral antihypertensive therapy is 
added.
Objectives: to describe the utility of the use of clevidipine as a safe 
and effective antihypertensive in different medical and surgical 
pathologies, in an Intensive Care unit.
Methods: Single-center, descriptive and retrospective study of a series 
of cases. We included patients admitted to our unit for any pathology 
between January 2018 and December 2019, treated with clevidipine 
for blood pressure control. The software used was IBM SPSS v.20.
Results: A total of 20 patients were included, 17 males (85%) and 3 
females (15%) with a mean age in the range of 58 ± 14.9  years. The 
pathologies that led to admission were: 7 (35%) coronary, 5 (25%) neu-
rological, 3 (15%) vascular, 2 (10%) hypertensive crisis, 2 (10%) heart 
failure and 1 (5%) postoperative period of general surgery. The mean 
APACHEII score was 14.4 ± 6.5. It was recorded as a history of known 
arterial hypertension on admission in 15 patients (75%).
Different combinations of antihypertensive drugs were started prior to 
the use of clevidipine in 12 patients (60%), the most frequent being: 
a combination of three oral antihypertensive drugs plus IV nitroglyc-
erin in 4 of them (20%); ACE inhibitors plus BB in 2 (10%) and IV nitro-
glycerin monotherapy in 2 (10%). In 8 patients (40%) clevidipine was 
chosen as the first option due to contraindication for the use of other 
antihypertensive drugs and / or the impossibility of oral intake.
The maximum average dose used was 6.24  ml / h (3.12  mg / h) for 
about 2.35 days until optimization and / or onset of action of the dif-
ferent oral antihypertensives. Very good tolerance to the drug was 
observed without registering any side effect for which the therapy had 
to be suspended.
Conclusion: The main indication for clevidipine is the reduction of 
blood pressure in the perioperative environment. We consider that it 
is also a useful alternative for a rapid control of blood pressure in other 
clinical settings, also reducing the length of stay in the Intensive Care 
Unit, with the consequent improvement in the therapeutic efficiency 
of this type of patient. However, more randomized prospective studies 
would be necessary to corroborate these conclusions.
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Introduction: High risk pulmonary embolism (PE) should be moni-
tored in an Intensive Care Unit (ICU) because of the severity and high 
mortality it has. However, there is controversy regarding the monitor-
ing and treatment of patients with intermediate-risk PE, since they 
are initially hemodynamically stable patients, but with a high risk of 
deterioration.
Objectives: In order to optimize its management, the ICU of the San 
Cecilio University Hospital has created a protocol in collaboration with 
the Emergency, Pneumology and Internal Medicine units.
Methods: Prospective, descriptive study over a period of four months. 
Patients with diagnosis of acute PE in the Emergency Department or in 
the hospital ward are included, with the following criteria:
- PE diagnosed by CT-scan.
- Hemodynamic stability.
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- Suspected right ventricular dysfunction on CT-scan and elevation of 
cardiac markers (troponin and NT-proBNP).
A transthoracic echocardiogram was performed in the first 24 hours to 
evaluate right ventricular function.
Results: 29 patients met the inclusion criteria. The mean age was 
69  years, being 41% women and 59% men. APACHE-II average of 9 
and dyspnea as the main symptomatology (79% of patients). 100% 
presented some echocardiographic alteration consisting of RV dila-
tation, systolic dysfunction, or pulmonary hypertension. Three of the 
patients presented a torpid evolution towards high-risk PE, being able 
to be diagnosed and treated early with systemic fibrinolysis, which 
conditioned a favourable subsequent evolution normalizing RV sys-
tolic function.
The rest of the patients has a standard anticoagulant regimen and 
evolved properly, although all of them have persistent echocardio-
graphic alterations 5-7 days after the treatment begin.
Conclusion: Patients with diagnosis of intermediate-risk PE benefited 
from closer monitoring thanks to the existence of a consensus proto-
col for the management of these patients, since the initial unsatisfac-
tory evolution of three of them towards high-risk PE was diagnosed 
early, allowing an early approach.
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Introduction: Cardiac surgery produces a systemic inflammatory 
response syndrome (SIRS) that has been highly related with lung 
injury. This reaction is associated with abnormalities in gas exchange, 
such as increased pulmonary shut fraction. Inhaled nitric oxide (iNO) 
plays a roll of potent dilator of pulmonary vessels and improves 
such a ventilator/perfusion mismatche. Indirect indices for assess-
ing impaired ventilation, such as dead space fraction and ventilatory 
ratio, have been used in acute respiratory distress syndrome (ARDS) 
and other respiratory failure. However, no studies have evaluated how 
much iNO improves shunt rate in cardiac surgery patients with post-
operative pulmonary dysfunction using these formulas.
Objectives: We conducted to eavluate the effectiveness of iNO ther-
apy for cardiac surgey patients with respiratory failure or right herat 
failure using indirect indicies.
Methods: We retrospectively reviewed the medical records of 19 
adult cardiac patients treated with iNO postoperatively between July 
2018 and March 2020. iNO was used to pulmonary hypertension and 
respiratory failure in patients who had undergone total arch replace-
ment (n=9), valve replacement (n=8) and coronary artery bypass graft 
(CABG) (n=2). Hemodynamic measurements, dead space fraction and 
ventilatory ratio before iNO and again 6 and 12 hours after administra-
tion were examined. The effect of iNO infusion on arterial oxygenation 
was quantified using the PaO2/FiO2(P/F) ratio. The data were analyzed 
by using student’s t test. And we assessed the correlation between 
these indices and P/F ratio using Pearson correlation coefficient.
Results: Average administration duration of iNO (20  ppm) was 54.4 
hours. Eight patients underwent emergency or urgent operation and 
all had type A aortic dissection. There was no significant difference in 
mean pulmonary artery pressure, however P/F ratio increased signifi-
cantly from 182 to 265 (p<0.05) at12 hours after initiation. Mean arte-
rial pressure and cardiac index did not change before and after used 
iNO. Although P/F ratio at 6 hours after initiation increased, it did not 
reached statistical significance. Improving oxygenation was associated 
with decreasing impaired ventilation measured by dead space fraction 
and ventilatory ratio at 12 hours after initiation. There was a significant 
negative correlation between VR and P/F ratio (Pearson, r=-0.5; CI, 
-0.78 to -0.05). The improvement of oxygenation due to the vasodila-
tory effect of iNO was proved.
Conclusion: In cardiac surgery patients, calculating dead space frac-
tion and the ventilatory ratio during using iNO proved indirectly how 
iNO improve oxygenation without deterioration of the circulation 
indices. From these results, the vasodilatory effects of nitric oxide 
improved shunt fraction and oxygenation
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Introduction: Atrial fibrillation and atrial flutter are the most com-
mon cardiac arrhythmias in patients admitted to the intensive care 
unit (ICU) after cardiac surgery. Even in the ICU environment short 
episodes can be missed and left untreated.[1,2] If a clear increase of 
stroke risk in patients with postoperative AF/AFl (POAF) is established 
this might implicate that POAF should be detected meticulously and 
treated expeditiously.
Objectives: The primary aim of the current study was to establish 
thromboembolic stroke risk during hospital admission in patients 
with POAF in the first week after cardiac surgery in our institution. The 
secondary aim was to study the association of clinical characteristics 
including the occurrence of POAF with occurrence of thromboembolic 
stroke during hospital admission in patients after cardiac surgery.
Methods: A single-center retrospective observational study was 
performed with all consecutive cardiac surgery patients admitted 
postoperatively to the ICU of our institution between 2009 and 2010.
[3,4] Brain imaging was studied for the occurrence of thromboem-
bolic stroke (other subtypes of stroke were censored) during hospital 
admission and POAF was monitored meticulously for seven days after 
cardiac surgery. The proportion of patients with POAF among patients 
with thromboembolic stroke was compared to those without throm-
boembolic stroke and odds ratios (ORs) were calculated with corre-
sponding 95% CI using logistic regression analyses. To assess which 
characteristics were associated with occurrence of thromboembolic 
stroke, a stepwise backward regression analysis was performed.
Results: Of the 910 patients included in this study POAF occurred in 360 
patients (40%) during the first seven days after cardiac surgery, and 26 
patients (2.9%) had a thromboembolic stroke during hospital admission. 
The proportion of patients with POAF among patients with thrombo-
embolic stroke (65%) was higher compared to those without throm-
boembolic stroke (39%): adjusted OR 3.01 (95% CI; 1.13 – 8.00). POAF, a 
history of peripheral vascular disease, a higher EuroSCORE and a longer 
duration of surgery were associated with thromboembolic stroke.
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Conclusion: POAF within seven days after cardiac surgery was asso-
ciated with a threefold increased risk for a thromboembolic stroke 
during hospital admission. POAF, a history of peripheral vascular dis-
ease, a higher EuroSCORE, and a longer duration of surgery were inde-
pendent risk factors for thromboembolic stroke directly post-cardiac 
surgery of which POAF was the strongest independent predictor. Peri-
operative prophylaxis or expeditious treatment of POAF may therefore 
prevent early stroke after cardiac surgery.
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Introduction: In patient with shock, fluid therapy is tailored to optimize 
cardiac preload and tissue perfusion. Oral tap water administration is 
known to be associated with an improvement of blood pressure and 
cardiac output in non-critically-ill patients (1). Whether water digestive 
absorption is impaired in critically ill and whether tap water administration 
increase stroke volume in preload dependent patients remains uncertain.
Objectives: to determine the safety and effectiveness of tap water 
administration (via naso-gastric tube) in preload dependent patient 
with shock.
Methods: We performed a monocentric open label, randomize clini-
cal trial in Dijon teaching hospital. Randomization was stratified on 
stroke volume (SV) change induce by passive leg raising. The study was 
approved by an independent ethics committee (Ethics Committee No. 
2018-A03368-47, NCT03951519). Inclusion criteria were: aged 18  years 
or older, suffering from acute circulatory failure (systolic blood pressure 
< 90 mmHg, and/or mean blood pressure < 65 mmHg, and/or need for 
infusion of vasopressor amines, and/or skin mottling, and/or diuresis < 
0.5 ml/kg/h for 2 hours ≥, and/or arterial lactate level > 2 mmol/l), with 
stroke volume change following passive leg raising over 10%, and with no 
contraindication to a nasogastric tube. Exclusion criteria were: permanent 
atrial fibrillation, hypothermia, concurrent participation in another study, 
and pregnant women. Patients were assigned to receive either 500  ml 
of nasogastric tap water (at room temperature) or 500 ml of intravenous 
(IV) saline solution over a 15 minutes period. The primary endpoint was 
the change in stroke volume at the end of fluid administration expressed 
as percentage. Secondary endpoints were mean arterial pressure, car-
diac output and oxygen delivery changes following fluid administration. 
Safety was assessed by the incidence of adverse events (arrythmia, vomit-
ing, abdominal distension, worsening arterial lactate and death).
Results: Fifty patients were randomized. Most of patients (70%) had 
septic shock. Baseline SV did not differ between the two groups. The 
median change in SV with fluid expansion did not differ between the 
two groups (22% [16;51] vs 21% [16;35], p=0.578). The number of 
fluid responsive patients (i.e. SV > 15% between baseline and end of 
fluid expansion) did not differ between the two groups (n=19 (76%) 
vs n= 18 (72%)). In the two groups, blood pressure and oxygen deliv-
ery increased, with no differences between groups (table 1). The inci-






























































Table 1. Change in the hemodynamic parameters induced by Tap water and IV saline  
administration.
Conclusion: There was no difference between SV change induce 
by the administration of 500  ml of enteral tap water and SV change 
induced by the administration of 500 ml of IV saline solution. The inci-
dence of adverse event did not differ between groups. The adminis-
tration of enteral tap water for fluid expansion appear to be safe and 
effective. Further studies are needed to confirm our results.
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Introduction: Extracorporeal membrane oxygenation (ECMO) is a fun-
damental tool in refractory cardiorespiratory failure, however, compli-
cations are common and can be severe (1).
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Objectives: The purpose of this study was to evaluate the different 
complications occurring in patients with refractory cardiogenic shock 
(CS) supported with veno-arterial ECMO.
Methods: Data was collected prospectively from 2010 to 2020, 
patients with CS having received VA-ECMO were reviewed retrospec-
tively. Baseline demographic variables, cause of CS, ECMO characteris-
tics and complications were analyzed using SPSS software, version 20.
Results: We included 92 patients who received 101 VA-ECMO. Median 
age was 54 (interquartile range IQR 42-63), 64% were male. Causes of 
CS were mostly decompensated advanced heart failure (32%), acute 
myocardial infarction (26%), post-cardiotomy (21%), post-surgical pul-
monary thromboendarterectomy (13%) and acute myocarditis (7%).
A peripherally VA-ECMO was established in 91% of cases. The median 
length of ECMO was 186 hours (IQR 5.4 – 13  days), median ICU stay 
18  days (IQR 12-33  days). In our series, device related complica-
tions were as follows: bleeding from cannula site occurred in 35% of 
patients, requiring surgical intervenction in 9% of them. One patient 
suffered an unintended decannulation. Lower limb ischemia after 
femoral cannulation occurred in 22%, which is comparable to the lit-
erature (2). Limb amputation was required in 3% of patients. Thrombi 
formation in the oxygenator membrane was found in 19% of cases, 
3% required urgent membrane replacement.
Patient related complications may be due to profound shock at the time 
of ECMO cannulation, or to the ECMO itself. Acute renal failure occurred 
in 68% of patients, half of which received renal replacement therapy 
(RRT). Major neurological complications were recorded: 9% of patients 
suffered from anoxic brain injury frequently related to previous car-
diac arrest, 2 patients had a central nervous system (CNS) hemorrhage 
and CNS infarction was observed in 4% of patients. Only three of these 
patients diagnosed with stroke, either hemorrhagic or ischemic, were 
weaned from ECMO and discharged with good neurological recovery. 
Infectious complications occurred on 48% patients, mostly catheter-
related bacteremia (27%) and ventilator-associated pneumonia (19%).
Global survival rate during ECMO support was 68%, with 43% of 
patients being discharged home. Severe complications had an enor-
mous impact in outcome, regardless of the initial CS cause. After 
hemorrhagic stroke or anoxic brain injury survival was as low as 21%. 
However, some complications as the need of RRT were met with 34% 
survival, maybe due to the removal of inflammatory cytokines (3).
Conclusion: Patients needing VA-ECMO for CS have an already slim 
chance of survival. Complications may further increase their morbidity 
and mortality. A better understanding of their incidence and charac-
teristics is paramount to a better management of these patients and 
to achieving better outcomes in the future.
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Introduction: MINOCA is defined by the AMI criteria, absence of 
obstructive coronary artery disease (≥50%), and no other cause for 
the clinical presentation. Research studies of MINOCA reported a 
12-month mortality of 4.7% (95% CI 2.6–6.9), consistently demon-
strating a better prognosis than for those with AMI and obstructive 
coronary disease. Therefore we can no longer dismiss patients with 
MINOCA as having false-positive AMIs but need to consider the poten-
tial benefit of statins and ACE inhibitors/ blockers.
Objectives: To describe the characteristics of patients admitted in 
the ICU with acute coronary syndrome, differentiating between the 
groups of acute myocardial infarction with and without coronary 
obstruction (MINOCA)
Methods: An observational study that includes all patients (N = 
498) admitted for ACS in HUVN- ICU’s Coronary Unit from January to 
December 2015. The ARIAM registry was used and computerized med-
ical records were reviewed to collect data not included in the registry. 
Patients who did not undergo cardiac catheterization, echocardiogra-
phy, or did not have the study variables recorded in their history were 
excluded. The data obtained was collected in an SPSS sheet and was 
subsequently evaluated in terms of descriptive statistics with mean, 
standard deviation (SD) and frequencies, and comparisons were made 
between the groups with and without coronary artery disease, using 
Student’s T test for quantitative variables and Chi square test for quali-
tative variables.
Results: The study includes 391 patients, 270 (69.2%) men and 120 
(30.8%) women. The mean age was 62.9 (SD 12.6). The most com-
mon reason for admission was STEMI (49%) and 83.4% were in a Kil-
lip I clinical situation. The most prevalent cardiovascular risk factors 
were: hypertension (59.5%), dyslipidemia (50.5%), smoking (34.6%), 
type 2 Diabetes Mellitus (33.8%). LVEF at discharge was 53.2 (DS 10). 
83.6% of the patients had coronary lesions, but only 62.4% were dis-
charged with dual antiplatelet therapy. 16.4% had no coronary lesions; 
however, only 19 (3%) were considered MINOCA and received treat-
ment. After 3  years, 7.7% of patients had another myocardial infarc-
tion, 16.4% were hospitalized due to cardiovascular causes, 0.8% had 
a recovered cardiorespiratory arrest, and mortality was 3.3% (17). 
Patients without coronary obstruction were more frequently women 
(56.5 vs. 44.5% p <0.01), younger (61 ± 10.8 vs. 65.7 ± 12.9  years, p 
= 0.06) and with a better cardiovascular risk profile (DM 15 vs 30.8% 
p <0.01, dyslipidemia 23.7 vs 55.8%, p <0.01, hypertension 33.4 vs 
56.6%, p = 0.06 and tobacco 28.8 vs 54.6%, p = 0.02).
Conclusion: - Admissions to the ICU´s Coronary Unit with significant 
coronary lesion are much more frequent, which makes a reliable com-
parison between both groups difficult.
- MINOCA patients were more frequently women, younger and with a 
better cardiovascular risk profile. They are underdiagnosed and under-
treated at hospital discharge.
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Introduction: Critically ill patients have a mixture of intravascular vol-
ume depletion, low systemic vascular resistance, and decreased cardiac 
output, which makes responses to attempts at volume resuscitation 
difficult to predict. The objectiveness of this study was to determine 
the value of passive leg raising (PLR)-induced changes in the carotid 
volumetric blood flow, as assessed by carotid Doppler, which can pre-
dict volume responsiveness in a heterogeneous group in the ICU.
Methods: The following patients were enrolled in the study: 1. Patients 
who present with clinical and laboratory evidence of sepsis/septic shock. 
2. Patients who present with evidence of fluid loss due to hyperosmolar 
hyperglycemia syndrome (HHS). 3. Patients who present with a picture 
of acute renal failure with no obvious etiology. Common carotid artery 
Doppler is performed before and after PLR to determine the carotid 
volumetric blood flow using the formula: Carotid Volume Flow = Cross 
sectional Area (A) X Time Average Velocity (TAV) ml/s. A is obtained as 
π x radius (D2), A = D2 x 0.785. A patient whose carotid volume flow 
increased by > 20% following PLR was considered a fluid responder. We 
based our estimate on the study done by Paul Mark et al1.
Results: 36 patients were enrolled in the study, 67% were male; with 
an average age of 48 ±18 years. The increase in carotid volume flow 
by > 20% following PLR was significant in fluid responders (p <0.05). 
Eighteen patients (50%) had sepsis/septic shock, five of them were 
fluid unresponsive and required a vasopressor. In the other thirteen 
patients of the same group, hypotension and tachycardia resolved 
with limited fluid resuscitation. We also admitted twelve patients with 
HHS, ten of those patients were fluid responsive and required limited 
fluid resuscitation. The other two patients were fluid unresponsive and 
required maintenance fluid. We also admitted six patients with acute 
renal failure with no apparent etiology, three of those patients were 
fluid responsive and required controlled fluid resuscitation. The other 
three patients were fluid unresponsive and required inotropic support 
for heart failure.
Conclusion: Our study supports the concept of a hemodynamically-
guided, restricted fluid resuscitation strategy in the hemodynami-
cally unstable ICU patients. Initial fluid resuscitation in those patients 
should be limited and guided by an assessment of fluid responsive-
ness through the estimation of carotid volume flow following PLR.
Reference(s) and grant acknowledgment(s)
1. The author has no conflict of interest to declare
2. 1. The Use of Bioreactance and Carotid Doppler to determine Volume 
Responsiveness and Blood Flow Redistribution Following Passive Leg Rais‑
ing in Hemodynamically Unstable Patients. Paul E Mark, Alex Levitov, Alisha 
Young, Lois Andrews. Chest. 2013; 143(2):364‑370.
000048 
Safety and effectiveness of temporary cardiac pacing 
with the new kronosafe system
R. Vicente‑Miralles1; DA. Martín‑Langerwerf1; JM. Nuñez1; A. Marco1; 
AD. Sangio1; C. Oliver1; A. Davila1; L. Montes1; P. Gracia1; S. Sanchez1; 
MC. Prieto1
1Intensive care unit ‑ cardiac stimulation, Vinalopo University Hospi‑
tal, Elche, Spain 
Correspondence: R. Vicente‑Miralles
Intensive Care Medicine Experimental 2020, 8(2): 000048
Introduction: Temporary Cardiac Stimulation with active-fixation 
leads has demonstrated to be more effective and safer than the other 
done without fixation(1,2,3). Nowadays doesn’t exist a pacemaker to 
do it and physicians usually use definitive cardiac stimulation devices 
(leads and generator) off label. We have developed a new subjection 
system called  KronoSafe®, that allows us to hold all the external part 
of the temporary pacemaker. With our new subjection system, we pro-
vide the security that the procedure needs against device detachment 
or intravascular infection.
Objectives: The aim of this study was to demonstrate the effective-
ness and safety of temporary cardiac stimulation with active-fixation 
leads subjected with the new KronoSafe  System®.
Methods: The study was approved by the Clinical Research Eth-
ics Committee of our hospital. We include all consecutive patients 
underwent temporary cardiac stimulation over 6  months at our cen-
tre. A 65 cm active-fixation lead was implanted throw the left jugular 
vein to right ventricle apex and connected to a reusable generator. 
We measure R wave sensed, lead impedance and threshold every 48 
hours. Complications related with cardiac stimulation were collected: 
pace/sense failure, lead or generator detachment and right ventricle 
perforation. We also describe how much time the patient was in the 
intensive care unit and standard hospitalization floor under temporary 
pacing.
Results: 12 patients were included. Every 48 hours medium of R wave 
sensed was 10-9,56-9,98-9,71  mV; lead impedance was 673-584-573-
569 Ohm and the threshold was 0,63-0,42-0,47-0,46 V No complication 
was registered. The average duration of temporary cardiac stimulation 
was 7,6 days (min 44 h– max 600 h), 24 hours in ICU and 157 hours in 
standard hospitalization floor.
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Conclusion: 1- Temporary Cardiac Stimulation with active-fixation 
leads is safer than conventional temporary stimulation and a safe pro-
cedure outside ICU.
2- This kind of temporary cardiac pacing allows an early discharge 
from ICU.
3-  KronoSafe® can provide the security that this procedure needs.
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Introduction: The presence of No-reflow (NR) during primary coro-
nary intervention (PCI) in STEMI is associated with worse outcomes 
and higher mortality. Different strategies have been studied to 
decrease NR’s incidence without success.
Objectives: To asset if there is a reduction in NR’s incidence depend-
ing on the time of administration of unfractionated heparin (UFH) in 
patients with STEMI, before or during PCI.
Methods: We perform a retrospective cohort study that includes 
patients diagnosed of STEMI treated with PCI during 2017 and 2018 
in our hospital. Patients who had out-of-hospital cardiac arrest, those 
who were treated with fibrinolysis and those withouth reperfusion 
treatment or without obstructive coronary artery disease in PCI were 
excluded. We compare 2 groups, in the first one UFH was adminis-
tered during PCI, and in the second one UFH was administered previ-
ously. Arterial flow was analyzed at the beggining and at the end of 
PCI, using TIMI scale. We also analyzed NR’s incidence, mortality and 
complications.
Results: 389 patients were included, with ages between 61,38 ± 12,6 
in group 1 vs 64,4 ± 12 in group 2 (p=0.02). The studied variables are 
shown in table  1, there weren’t statistically significant differences in 
cardiovascular risk factors or previous pharmacological treatment 
between the groups. Arterial flow at the begging of PCI and the inci-
dence of in-hospital major bleeding were similar in both groups (TIMI 
> 1 -> 48.9% in group 1 vs 52% in group 2, p=0.56) (1.4% (n=2) vs 
1.6% (n=4); p=0.9) respectively. Mortality rate was 5,9% (N=8) vs 4,4% 
(N=11) (p=0,52).
Statistically significant difference was found in NR’s incidence, 12,9% 
(N=18) vs 6,4% (N=16) (p=0,0028), with an OR of 2,1 (IC 1,07-4,41) 
(p=0,036).
The multivariable analysis shows that the lack of previous administra-
tion of UFH is associated with an increase in NR (Or: 2.48 [1.20-5.33]; 
p=0.014) and major age too (OR 1.04 (1.009-1.07), p=0.008), getting 
renal insufficiency out of the analysis.
Table 1. Sample’s baseline characteristics: 
Total 
N = 398 
Group 1 (UFH 
during PCI) N = 
139 
Group 2 (previous 
UFH) N = 250 P 
Age 63.4% +/- 12.4 61.38 +/- 12.6  64.4 +/- 12.0 0.021 
Male 79,7 % 77,7 % 80,8 % 0.46 
Arterial 
hypertension 29 % 27,3 % 30 % 0.6 
Smoker 15,4 % 17,3 % 14,4 % 0.45 
Diabetes 20,3 % 22,3 % 19,2 % 0.5 
Dislipemia 64,2 % 51,8 % 51,6 % 0.7 
Previous renal 
insufficiency 6,2 % 7,2 % 5,6 % 0.7 
TIMI > 1 before 
angioplasty 50,9 % 48,9 % 52 % 0.56 
Anti IIB/IIIA 36,8 % 38,8 % 35,6 % 0.52 
NR 8,7 % 12,9 % 6,4 % 28 
In-hospital 1,5 % 1,4 % 1,6 % 0.9 
bleeding
Stent thrombosis 2 % 0 % 0,5 % 0.54 
Mortality 4,9 % 5,9 % 4,4 % 0.52 
Table 2. Multivariable analysis with logistic regression; dependent variable: 
NR 
PROelbairaV
Previous UFH 2.48 (1.20-5.12) 0,014 
Age 800,0)70.1-10.1(40.1
Conclusion: Early UFH administration is a protective factor against NR 
and is associated with a better outcome after PCI in STEMI.
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Introduction: Dipyridamole based triple antiplatelet therapy (TAPT) 
on stroke prevention and long-term outcome was unknown. Our 
study is aimed to evaluate long-term efficacy and safety of dipyrida-
mole based TAPTafter acute myocardial infarction (AMI).
Methods: This is a nationwide, case–control study involving 186,112 
first AMI patients. We adopted a ratio of 1:4 propensity score matching 
based on multiple variables. Finally, we enrolled4,540 patients in the 
dual antiplatelet therapy (DAPT) group and 1,135 patients in the TAPT 
group in our final analysis.
Results: Overall survival rate was comparable between two groups 
of patients (log-rank P = .0569), regardless ofsex. In age subgroup, 
TAPT group showed poor survival in younger patients (log-rank P = 
.0072), but no survival difference compared with DAPT group in older 
patients.There was no extra benefit of TAPT for patients after AMI 
regardless of types of myocardial infarction (MI).DAPT was superior 
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to TAPT for patients underwent percutaneous coronary intervention 
(PCI) (log-rank P = .0022). TAPT did not reduce cumulative event rate 
of recurrent MI or recurrent stroke in patients after AMI. TAPT increased 
cumulative intracerebral hemorrhage (ICH) rate (log-rank P = .0026) 
but did not affect cumulative event rate of gastrointestinal (GI) bleed-
ing free survival. Dipyridamole did not contribute to AMI survival.
Conclusion: TAPTdid not contribute to overall AMI survival, and did 
not reduce recurrent rate of MI or stroke. TAPT increased ICH ratewith-
out effect onthe incidence of GI bleeding compared with DAPT.
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Introduction: Early use of dual anti-platelet therapy (DAPT) in ST ele-
vation myocardialinfarction (STEMI) can reduce stent thrombosis and 
further save the patients. However,  it is still difficult to set up  ambu-
lance paramedics DAPTsystem for patients after STEMI. Therefore, the 
aim of this studyis to investigate improving use of DAPTin ambulance 
for acute myocardial infarction patients in a city-based program.
Methods: A multidisciplinary team among 15 hospitals, fire bureau and 
departmentof health, Kaohsiung city government was organized since 
2016. The key interventionsinclude Asian first innovativecity-based pre-
hospital ambulance paramedic STEMI dual anti-platelet medicationon-
line instruction system, direct chewing DAPT at ambulance, training 
programfor ambulance paramedics, 24 hours STEMI interpretation and 
on-line intrusctionteam. The consecutativeSTEMIdiagnosed by ambu-
lance electrocardiogram system were enrolled from Jan. 2011 toDec. 
2018 in Kaohsiung city. The patients weredivided into three group: pre-
interventional group from 2011-2015, Interventionalgroup from Jan to 
Dec 2016 and post-interventional group from 2016 to 2018.
Results: Thepercentage of ambulance DAPT use in adequate STEMI 
patients increased from 0% in pre-interventional group, to 2.8% ininter-
ventional group and to 57.8% in post-interventional group (p<0.001). 
Inthese STEMI patients received DAPT at ambulance, there was not any 
bleeding complications.Furthore, the mortality was 0% in these patients.
Conclusion: This study showed, from 2011 to 2018, innovative city-
based pre-hospitalambulance paramedic STEMI dual anti-platelet 
medication on-line instruction system  can improve  percentage of 
ambulance DAPT use and also outcomes inSTEMI patients.
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Introduction: After cardiovascular (CV) surgery, clinicians must 
identify patients at high risk to develop mortality/morbidity from 
multi-organ failure, and should quantify it through time to intensify 
treatment. The SOFA score is an objective tool in predicting outcomes 
in patients with severe sepsis1.
Objectives: This study identified the association of SOFA score with 
organ dysfunction/failure, death or clinical improvement in patients 
who underwent CV surgery.
Methods: This is a single-center prospective cohort study that included 
63 patients, ≥19 years old, admitted at the Surgical Intensive Care Unit 
(SICU) ≤3 days, who underwent any CVS (cardiopulmary bypass, valve, 
congenital and vascular surgeries). The Institutional Ethics Review Board 
(IERB) of the institution approved the study in accordance with the ethi-
cal principles set forth in the Declaration of Helsinki and the National 
Ethical Guidelines for Health and Health-related Research of 2017. 
Informed consent was obtained prior to the conduct of the study.
The SOFA variables were obtained pre-operatively and post-oper-
ative at day 0 and day 3. The score was computed using the Qx 
 calculator®.  Total maximum SOFA  (TMS SOFA) and the delta SOFA 
(ΔSOFA) were also calculated.
Results:SOFA score analysis. The SOFA score was compared pre-oper-
atively, on Day 0 post-operative and day 3 post-operative. In addition, 
the SOFA variables were also compared on these three periods. Table 4 
compared the SOFA score and the SOFA variables on these periods. 
ΔSOFA score  and the individual SOFA parameters (except for serum 
creatinine and bilirubin levels) were significantly different in the three 
periods (p<0.001).
TABLE 4. SOFA score and SOFA variables 




PaO2 95 (85.6 to 112) 203 (147 to 241) 130 (98 to 165) <0.001
FiO2 21 (21 to 80) 60 (60 to 100) 21 (21 to 100) <0.001
Platelet count 254 (217 to 288) 169 (116 to 195) 177 (125 to 261) <0.001
MAP 83 (72 to 93) 93 (85 to 98) 84 (75 to 90) <0.001
Use of 
inotropes 1 (1 to 1) 3 (1 to 4) 1 (1 to 4) <0.001
GCS 15 (15 to 15) 10 (10 to 19) 15 (10 to 15) <0.001
Creatinine 0.9 (0.79 to 1.13) 
0.9 (0.68 to 
1.13) 
0.85 (0.68 to 
1.03) 0.203 
Urine output 1500 (1150 to 1900) 
2450 (1790 to 
3100) 
1800 (1350 to 
2120) <0.001
eGFR 93.2 (68.8 to 106.5) 
95.4 (68 to 
112.9) 
99 (72.2 to 
115.8) <0.001
Bilirubin 1.04 (0.81 to 1.58) 
1.7 (1.23 to 
2.68) 
1.52 (0.92 to 
2.14) 0.391 
SOFA score 1 (0 to 2) 7 (6 to 9) 2 (1 to 3) <0.001
PaO2 partial pressure of oxygen FiO2 fraction of inspired oxygen in the air MAP mean arterial 
pressure GCS Glasgow coma scale eGFR estimated glomerular filtration rate SOFA sequential 
organ failure assessment score 
Predictors of organ dysfunction, failure and mortality.  Valvular 
surgeries, platelet count and bilirubin levels, as well as the MAP, were 
shown to be predictors of outcome (P valve 0.032, 0.006, 0.023 and 
0.041 respectively). In patients undergoing valvular surgeries, they 
have more than 3 times risks to develop organ failure/dysfunction or 
mortality as compared to those who underwent other cardiovascular 
surgeries (OR 3.1429,  1.1068 to 8.9245 95% CI, 0.032 p-value). Post-
operatively, for every unit increase in platelet count, the odds of devel-
oping organ failure/dysfunction or mortality decreased by 0.94% (OR 
0.9906, 0.9839 – 0.9974 95% CI, 0.006 p-value). Post-operatively, for 
every unit increase in MAP, the odds of developing organ failure/dys-
function or mortality decreases by 5.31% (OR 0.9469, 0.8987 – 0.9977 
95% CI, 0.041 p-value). Post-operatively, for every unit increase in bili-
rubin, the odds of developing organ failure/dysfunction or mortality 
increased by 103% (OR 2.0303, 1.1013 – 3.7429 95% CI, 0.023 p-value).
Conclusion: Exposure of patients undergoing CV surgery to the 
bypass machine may lead to deleterious sequelae explaining the high 
TMS SOFA and ΔSOFA score in the immediate post-operative period. 
As organ dysfunction improves or deteriorates in the succeeding 
days after intervention, it is coupled to a corresponding decrease or 
increase of the said scores. Our study showed that the SOFA score is 
a simple, reproducible, and readily available tool that could assist the 
clinician in intensifying treatment in this subset of patient; thereby, 
decreasing the risk for morbidity or death.
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Introduction: Right ventricular failure (RVF) after left ventricular assist 
device (LVAD) implantation increases morbidity and mortality1. Nitric 
oxide inhalation (NOi) is frequently used to prevent and treat RVF. Pre-
vious studies reported a few preoperative hemodynamic predictors of 
RVF such as CVP/PCWP (pulmonary wedge pressure) ratio, RV stroke 
work index1,2. However, the criteria to wean of and stop NOi are not 
fully standardized.
Objectives: The aim of our study was to investigate the risk fac-
tors and the outcome of restart of NOi after cessation in LVAD 
implantation.
Methods: A retrospective medical review was performed on 79 
patients who underwent continuous flow type of LVAD (CF-LVAD) 
implantation and received NOi at the arrival of ICU (intensive care unit) 
rom April 2014 to March 2019 at Osaka University Hospital. Patients 
under 18  years of age and those who underwent biventricular assist 
device implantation were excluded. Univariate and ROC analysis were 
performed to clarify the risk factors and cut-off value. This retrospec-
tive study was approved by the clinical research ethics committee of 
Osaka University Hospital (Ethical Committee number 19244).
Results: One patient without PA catheter was excluded. Of the entire 
78 patients, 17 (22%) restarted NOi within 48 hours after cessation. In 
hemodynamic parameters just before cessation of NOi, CVP and CVP/
dPAP (diastolic pulmonary pressure) ratio was higher in patients with 
restart of NOi (p<0.01). ROC analysis showed Area Under the curve 
(AUC) of CVP was larger than that of CVP/dPAP (p<0.05). Cut-off value 
were 11 mmHg in CVP (sensitivity 0.88, specificity 0.75), and 1.3 (sensi-
tivity 0.77, specificity 0.79) in CVP/dPAP ratio. Compared with patients 
without restart of NOi, patients with restart of NOi had shorter ventila-
tor-free days within 28 days [13 days (interquartile range, 0–20 days) 
vs. 23 days (interquartile range, 19–26 days), p< 0.01] and longer ICU 
length of stay [22  days (interquartile range, 12–44  days) vs. 10  days 
(interquartile range, 7–16 days), p< 0.01].
Conclusion: CVP and CVP/dPAP ratio are useful criteria to discontinue 
NO inhalation. Also, restart of NO inhalation decreases ventilator-free 
days within 28 days and increases ICU length of stay.
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Introduction: Ambulatory blood pressure monitoring (ABPM) per-
mites the evaluation of 24 hours blood pressure pattern.
Objectives: Our aim was to evaluate a possible negative influence of 
the presence of Type 2 Diabetes mellitus (T2DM) on 24 h. ABPM pat-
tern, vascular risk profile and severity of left ventricular (LV) function in 
patients with Acute Heart Failure (AHF).
Methods: In 122 patients with AHF we compare clinical features of 42 
(65±9 years / 87,5% males) with T2DM versus 80 (63±11 years / 68,3% 
males) non-T2DM.
In addition to clinical examination and analytical parameters, all 
patients underwent a 24 h, ABPM and echocardiogram and evaluation 
of degree of severity LV Dysfunction.
Results: Patients with T2DM had higher (p <0.001) prevalence (%) of 
Hypertension (75 vs 46.7), dyslipidemia (65.6 vs 28.3), obesity (47 vs 
43), and worse renal function (fGe: 64.7 vs 72.3 ml/min/1.75m2). Etiol-
ogy IC: Hypertensive and/or ischemic heart disease: 75% vs 60%. Mean 
Values of 24 h ABPM measurements are in table 1.
Table 1 
Mean Values 
(mmHg) T2DM p NonT2DM
24. SBP 116 ± 16 <0.05 111 ± 15 
Daytime SBP 117 ± 15 <0.05 112 ± 15 
Nightime SBP 114 ± 18 <0.04 108 ± 16 
24h DBP 65 ± 7 ns 65 ± 8 
Daytime DBP 67 ± 8 ns 67 ± 9 
Nightime DBP 64 ± 7 ns 69 ± 9 
Pulse Pressure 50 ± 13 0.05 46 ± 11 
Nocturnal PP 51 ± 15 0.05 47 ± 12 
No significant differences in DBP between groups, but patient with 
T2DM present higher average values  (p <0.05) of SBP 24  h (mmHg): 
116/111); daytime (117/112) and nightime (114/108); higher 24  h 
Pulse Pressure (50 vs 46  mmHg) and non-dipper pattern frequency 
(84.7 vs 79.35), as well as a greater proportion of patients with moder-
ate/severe LV dysfunction (87.6 vs 81.7%) (p <0, 05).
We also observed worse NYHA functional class in T2DM patients: 
NYHA II-III 84,4 vs 58,3%, p< 0,001.
Conclusion: In patients with AHF, the presence of T2DM contributes 
to show greater hypertensive and/or ischaemic ethiology, further 
deterioration of 24 h ABPM pattern and worse left ventricular myocar-
dial function.
T2DM can be considered as a risk factor and worsening of heart failure. 
24 h ABPM may contibute to a better prognostic evaluation in these 
patients.
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Introduction: Dynamic arterial elastance (Eadyn) has been shown to 
be a dynamic parameter for arterial load assessment and to predict 
arterial pressure response to volume administration1. Since volume 
administration is a key part of hemodynamic resuscitation, arterial 
load assessment and knowledge of arterial pressure response to vol-
ume administration have lately become of particular interest. This is 
especially relevant in aortic repair, since maintenance of adequate 
spinal cord, renal and visceral perfusion pressure is a key element of 
peri-operative management. Although several studies could show 
that changes in cardiac preload and afterload influence Eadyn, the 
impact of changes in vascular properties, like aortic repair, have not 
been assessed so far2.
Objectives: To date the effect of changes in vascular properties, like 
aortic repair, on dynamic arterial elastane have not been assessed sys-
tematically. Therefore the aim of this study was to test whether aortic 
repair affects dynamic arterial elastance and its ability to predict arte-
rial pressure response to volume administration.
Methods: The study was designed as prospective observational trial 
in 18 domestic pigs. Animals were anaesthetized and mechanically 
ventilated. Hemodynamic data were obtained using transcardiopul-
monary thermodilution and pulse contour analysis. 4 consecutive 
volume loading steps each consisting of 6 ml/kg bodyweight hydrox-
yethyl starch were performed in baseline conditions and repeated 6 
hours after hybrid aortic repair. Aortic repair was performed using a 
hybrid-graft technique consisting of a thoracic stent graft and open 
re-insertion of the abdominal and iliacal branches. An increase in 
mean arterial pressure (MAP) > 15% was considered as a positive pres-
sure response. Values are given as mean (95% confidence interval), 
two-tailed p-values of <0.05 were considered significant.
Results: In baseline conditions Eadyn decreased (1.20 vs. 0.94, 
p<0.001) during volume loading and presented with an AUC of 0.84 
(0,73-0.95). After aortic repair Eadyn also decreased (0.97 vs. 0.85, 
p=0.08) during volume loading while the ability to predict pressure 
response decreased to an AUC of 0.56 (0.38-0.74). Baseline values were 
significantly changed after aortic repair (1.20 vs 0.97, p< 0.05)
Conclusion: Eadyn values were significantly changed after aortic 
repair. Further Eadyn was not able to predict arterial pressure response 
to volume administration when vascular properties changed after 
thoracoabdominal aortic repair
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Introduction: Minimally invasive volume status assessments are 
highly required in emergency and critical care medicine, such as the 
respiratory variation of inferior vena cava (IVC) [1]. Previously, we 
focused on cardiac variation of major veins as a new index of it [2,3], 
and reported the association between cardiac variation of internal 
jugular vein (IJV) and stroke volume (SV) via venous return [3]. This is 
the first study which evaluated the cardiac variation of IJV in the emer-
gency department.
Objectives: The purpose of this study was to confirm the efficacy of 
cardiac variation of IJV as an indicator for hemodynamics related to 
fluid volume.
Methods: This is a single-center prospective observational study. 
Patients over the age of 20 with need of fluid resuscitation who came 
in by ambulance were included from August 2019 to March 2020. 
Those who were severely ill and needed immediate treatments were 
excluded.
Cardiac variation of right IJV cross section area and respiratory vari-
ation of IVC diameter were evaluated by echography, SV, stroke vol-
ume variance (SVV) were evaluated by ClearSight system (Edwards 
Lifesciences, Irvine, CA, USA), and vital signs were recorded before 
infusion. Then, after infusion of 500  mL crystalloid, SV, SVV and vital 
signs were recorded again. To evaluate cardiac variation, we applied 
speckle tracking technique with ACUSON S2000 HELX EVOLUTION 
(Siemens, Munich, Germany). Collapse index was calculated by fol-
lowing formula; collapse index = (maximum – minimum) / maximum. 
Fluid responsiveness was defined as SV increase after infusion of 15% 
or more. The setting of age, gender, height, and weight were fixed in 
ClearSight measurement to shorten the evaluation time before treat-
ment and provisional SV were recorded. Since the provisional SV is 
higher with age, we analyzed the provisional SV divided by age.
The primary outcome was fluid responsiveness. We evaluated the cor-
relation with IJV cardiac variation, IVC respiratory variation or SVV. The 
secondary outcome was SV before infusion. We assessed correlation 
with IJV cardiac variation.
Results: Among 12,009 patients visiting emergency department 
during the study period, 103 patients were included in analysis. 
The mean age of patients was 74.0  years old, 55.3% were male, and 
37.9% responded to fluid infusion. The mean collapse index of IJV 
cardiac variation was 15.6±13.6%. Collapse index of IJV cardiac vari-
ation (16.8±14.9% vs 13.6±10.9%, p=0.24) and collapse index of IVC 
respiratory variation (41.8±27.5% vs 45.6±27.6%, p=0.53) were not 
different between those with and without fluid responsiveness, and 
SVV (p= 0.02) before infusion showed significant difference. On the 
other hand, correlation was found between collapse index and SV/age 
(r=0.25, p=0.01).
Conclusion: Not IJV cardiac variation and IVC respiratory variation, 
but only SVV was correlated to fluid responsiveness. IJV cardiac index 
was　associated with SV in emergency clinical setting similarly with 
the previous study.
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Introduction: To diagnose the cause of acute respiratory failure (ARF) 
in the emergency department (ED) is difficult. In particular, the differ-
ential diagnosis between hydrostatic pulmonary oedema (HPO) and 
other lung diseases is often challenging. Today, the diagnosis of HPO 
is mainly based on clinical criteria and the dosage of B-type natriuretic 
peptide, which is costly and suffers from some false positives, espe-
cially in case of renal failure. Since HPO is due to transfer of a signifi-
cant volume of plasma through the pulmonary capillary barrier toward 
the interstitium and alveoli, it has been demonstrated that this volume 
is large enough for inducing haemoconcentration, whose level reflects 
the volume of lung oedema. However, the diagnostic accuracy of 
haemoconcentration in a population of dyspnoeic patients in the ED 
has never been investigated.
Objectives: To evaluate whether the variation of haemoglobin 
concentration (ΔHb) over the first hours of treatment in dyspnoeic 
patients allows discriminating HPO from other causes of dyspnoea 
and ARF.
Methods: We retrospectively collected data of patients admitted to 
a medium-size ED for dyspnoea and ARF as leading problem, and for 
whom at least two Hb measurements (one at ED admission and one 
within the next 6 hours) were available. Patients were excluded if data 
regarding therapeutic management, radiological and biochemical 
investigations were not retrievable and if they were not subsequently 
admitted to an hospital ward. Two expert investigators, unaware of ΔHb, 
defined a posteriori the cause of dyspnoea as HPO and non-HPO, accord-
ing to clinical, instrumental and biochemical findings. The ability of ΔHb 
to detect HPO as the main cause of dyspnoea was evaluated through 
the area under the receiver operating characteristic (AUROC) curve.
Results: Between November 1st, 2018 and December 31st, 2019, 
1391 dyspnoeic patients were admitted to our ED. 572 patients were 
included in the analysis, among which 174 (30.4%) were diagnosed 
with HPO. HPO patients showed a significantly higher value of Hb at ED 
presentation compared to non-HPO (12.8[11.5–14.1]g/dL vs. 12.2[10.8–
13.7]g/dL, respectively; p=0.002). At 6 hours from admission and the 
beginning of therapeutic management, relative ΔHb was significantly 
higher in HPO than in non-HPO patients (-8.4[-11.4 to -5.8]% vs. 0.7[-
1.9–3.6]%, respectively; p<0.0001). The AUROC for ΔHb to detect HPO 
was 0.896[0.889–0.903] (sensitivity and specificity 0.81[0.80–0.84] and 
0.90[0.87–0.92], respectively) with a cut-off of -4.3%. When absolute 
ΔHb was considered, similar results were observed (-1.0[-1.5 to -0.8]
g/dL vs. 0.1[-0.2–0.4]g/dL, respectively; p<0.0001), with an AUROC 
of 0.892[0.885–0.899] (sensitivity and specificity 0.82[0.80–0.83] and 
0.88[0.87–0.90], respectively) and a cut-off value of -0.6 g/dL.
Conclusion: A reduction of Hb concentration ≥4.3% over the first 
hours of treatment reliably identifies HPO as the main cause of dysp-
noea and ARF in patients admitted to the ED.
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Introduction: Critical-care echocardiography (CCE) has been recently 
recognize by the Echocardiography Working Group of the Cardio- vas-
cular Dynamics section of the European Society of Intensive Care Med-
icine (ESICM) and several studies have shown its growing importance 
in the critical patient.
Objectives: To evaluate biventricular systolic and diastolic function 
in ICU patients. To estimate the delay in performing the echocar-
diogram, as well as its prognostic influence in patients with different 
pathologies.
Methods: Echocardiographic studies conducted during the period 
2018-2019 were reviewed and the parameters of systolic (LVEF by 
Simpson and Teicholz method, TAPSE) and diastolic (E/A and E/e’ 
ratio) function as well as preload parameters (diastolic LV volume, infe-
rior vena cava diameter) were collected. The delay in carrying out the 
study from the time of admission and the distribution by shifts (morn-
ing, afternoon, night) of these wereanalyzed. The influence of systolic 
and diastolic dysfunction on mortality and ICU stay was evaluated. The 
variables are expressed as a mean (95% CI).
Results: 197 patients with the following baseline characteristics were 
included. Age 68.8 (66.9-70.7)  years, sex 64.6% men, weight 75.4 
(72.6-78.2) kg, height 165.3 (163.9-166.7) cm, APACHE 17.8 (16.5-19.1), 
SAPS  II 41.8 (39.2-44.3), SOFA 4.8 (4.2-5.4). The reason for admission 
was: sepsis/septic shock 14.8%, heart failure 12.3%,  acute  coronary 
syndrome 12.3%, pulmonary embolism 10.3%, acute respiratory fail-
ure 8.7%, cardiorespiratory arrest 7.2%, neurocritical 5.6%, acute  on 
chronic respiratory failure  5.1%, trauma 2.6%, myopericarditis 2.6%, 
other 17.9%. The average stay was 7.8 (6.1-9.5) days, with a mortality 
rate of 20%. Systolic function was 41.7% (39.6-43.9) % Teicholz, 48.8% 
(39.7-57.8) %  Simpson, 20.3 (19-21.6) mmTAPSE. Diastolic function 
was: E/A 1.8 (1.2-2.4), E/e’ 12.5 (11-13.9). The  LVEDV  was 106.4 (99.9-
112.9) ml and the IVC was 17.8 (16.5-19) mm. 4.1 (3.6-4.6) images and 
2.9 (2.4-3.3) video clips were archived per study. The study was per-
formed at 45.1 (31.9-58.3) hours after admission, the distribution by 
shifts was: morning 63.1%, afternoon 25.6% and night 11.3%. Statisti-
cally significant differences (ANOVA test) were observed in the Simp-
son LVEF (p=0.006) and the E/A ratio (p=0.007) between the different 
diagnostic groups, with the heart failure and  cardiac arrest  groups 
showing the highest degree of dysfunction. The presence of systolic or 
diastolic dysfunction did not influence ICU stay or mortality.
Conclusion: Conclusions:  Routine echocardiographic evaluation of 
critical patients provides information on systolic and diastolic func-
tion. It can guide treatment and advise on prognosis.
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Introduction: Haemodynamic parameters play an essential role in 
intensive care units. Stroke volume variance (SVV) and pulse pressure 
variance (PPV) are used for predicting fluid responsiveness in mechan-
ically ventilated patients.
Objectives: However, their applicability is limited as they require sinus 
rhythm and controlled ventilation modes which both is only avail-
able in 43% of ICU patients (Huber et al., 2018). This study’s goal was 
to investigate the impact of change in ventilation pressure (Pinsp) on 
change in SVV and PPV in pressure-controlled ventilated patients. Due 
to former studies (Sakka, Becher, Kozieras, & van Hout, 2009; Vieillard-
Baron et al., 2016), we hypothesized that there’s a significant correla-
tion between tidal volume(VT), Ppeak, Pmean, lung compliance and 
SVV or PPV. It was aimed to generate a formula using multiple regres-
sion to predict deltaSVV and deltaPPV in dependence of ventilation 
parameters.
Methods: In total 43 pressure-controlled ventilated patients from ICU 
were investigated. Transpulmonary thermodilution (TPTD; PiCCO, Pul-
sion Medical Systems SE, Germany) was performed before and after 
a change in inspiratory pressure (Pinsp) on the ventilator machine 
(EvitaXL,Drägerwerk® AG & Co. KGaA, Germany and Carescape™R860, 
GE Healthcare, Germany). Magnitude of change in Pinsp was based 
on medical indication due to arterial blood gas analysis or weaning. 
Patients were measured at least once and not more than eight times, 
resulting in 90 total measurements. We compared deltaSVV and del-
taPPV to deltatVT, deltaPpeak, deltaPmean and lung compliance. Due 
to multiple measurements in some individuals we analysed the within-
subject correlation using ANCOVA and between-subject correlation 
using subjects’ means(Bland & Altman, 1994).
Results: No significant (p<0.05) within-subject or between-subject cor-
relation could be shown between deltaSVV/ deltaPPV and deltaVT, 
deltaPpeak, deltaPmean, lung compliance. No formula using ventila-
tion parameters as predictors for deltaSVV and deltaPPV in multiple 
regression could be generated.
Conclusion: Former findings of correlation between VT and SVV or 
PPV could not be confirmed in our study. Further investigations need 
to be performed to find out more about these discrepancies in results.
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Introduction: In intensive care medicine, digital health technologies 
promise to improve outcomes [1], yet their implementation is lagging 
behind, challenged by various factors [2].
We aimed to explore influencing factors to the implementation of a 
remote patient monitoring platform in an intensive care unit (ICU) and 
suggestions for improving the implementation performance of novel 
digital health technology in ICU.
Methods: The study was conceived June–November 2019 in an ICU 
of a German university hospital during the implementation of Vital 
Sync 2.4 (Medtronic plc) as an additional tablet computer based 
remote patient monitoring to the primary patient monitoring. After 
IRB approval (EA1/031/18), seven semistructured interviews with key 
stakeholders—closely involved in the implementation process—were 
conducted. The interview guideline was developed on the basis of 
findings of a previous study [3] and the Consolidated Framework for 
Implementation Research [4]. Transcripts were analyzed following an 
inductive approach [5].
Results: Main obstacles identified by interviewees were lack of staff 
commitment due to little and non-persistent leadership engagement, 
unequal distribution of workload for the project among professions, 
technical instructions not reaching all staff members, limitations of the 
intervention in its current version, and low perceived benefit of remote 
monitoring for ICU staff. High stress levels in the ICU and an increased 
workload due to a complex set-up of the system that was additional to 
the primary monitoring system obstructed regular usage.
Suggestions to improve implementation of novel digital applications 
in the ICU aimed to enhance staff engagement through the nomina-
tion of specific responsible staff members for the implementation 
process, continuous technical instructions and feedback workshops 
as well as transparent and early communication of the project aims. 
The intervention should provide a high intuitivity, interoperability 
with other devices, and a clear advantage for its usage. Regarding the 
implementation site, a ward with a lower staffing ratio per patient, less 
fluctuation of staff members, and less patient turnover was suggested. 
For example, patients with a relatively weak indication for admission 
to the ICU could be remotely monitored on a normal ward.
Conclusion: A technologized setting with many different devices 
and a high stress level of staff make the ICU a particular environ-
ment for the implementation of new technology. Staff engagement 
and identification with the intervention are essential for effective 
implementation and could be enhanced through persistent leader-
ship engagement, regular instructions, and early, transparent com-
munication of the intervention. Intuitivity and interoperability are 
indispensable intervention features for implementation success. 
However, the additional benefit of remote monitoring in the ICU was 
regarded as low, other settings were perceived as more suitable for 
this technology.
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Introduction: The end-expiratory (EEXPO) test detects preload 
responsiveness by observing changes in cardiac index (ChangeCI) dur-
ing a 15-sec interruption of ventilation at end-expiration. First, it is not 
clearly established whether a simple measurement of the changes in 
arterial pulse pressure (ChangePP) during EEXPO could reliably reflect 
ChangeCI and detect preload responsiveness. Second, if it was the 
case, this should allow the shortage of the EEXPO test. Indeed, many 
devices measuring CI do not display the beat-to-beat value of CI but 
average it over several seconds, so that the EEXPO test must be long 
enough for allowing significant changes to appear. ChangePP, which 
are instantaneously measured, might require a shorter test to be evi-
denced, but this has to be proven.
Objectives: First, to test whether beat-to-beat ChangePP measured 
during a 15-sec EEXPO detect preload responsiveness. Second, to eval-
uate whether it is still the case when test’s duration is shortened.
Methods: In 30 mechanically ventilated patients we performed a 
15-sec EEXPO. PP was continuously and digitally recorded. CI was 
measured by pulse contour analysis (PiCCO2 device). Patients were 
defined as “preload responders” if CI increased ≥10% during a passive 
leg raising.
ChangePP was calculated as the difference between the mean of PP 
values over the last 5 seconds of tests (both for 15-sec and 10-sec 
EEXPO) and the baseline value. The ability of ChangePP to detect 
preload responsiveness through the EEXPO test was evaluated 
through the area under the receiver operating characteristic curve 
(AUROC). The same analysis was repeated on a validation cohort of 126 
patients enrolled from previous studies, in which real-time ChangePP 
during EEXPO had been already recorded.
Results: In the prospective cohort, 15 patients were preload respond-
ers and 15 preload non-responders. ChangePP during 15-sec EEXPO 
was significantly higher in responders than in non-responders (11[8–
15]% vs. 2[1-4]%, respectively, p<0.0001). ChangePP during 15-sec 
EEXPO detected preload responsiveness with an AUROC of 0.90±0.05 
(sensitivity 0.85, specificity 0.84, cut-off 5%). When the duration of 
EEXPO was shortened to 10 seconds, ChangePP during EEXPO was 
still larger in responders than non-responders (11 [8–14]% vs. 3[2–3]%; 
p<0.0001). ChangePP during a 10-sec EEXPO detected preload respon-
siveness with an AUROC of 0.88±0.07 (sensitivity 0.84, specificity 
0.85, cut-off 5%). The analysis on the validation cohort showed similar 
results for ChangePP, with AUROCs of 0.89±0.07 for 15-sec EEXPO and 
0.91±0.05 for 10-sec EEXPO.
Conclusion: Real-time measurement of PP during EEXPO detects 
preload responsiveness, even when the duration of the test is short-
ened to 10 seconds. This opens the possibility of assessing preload 
responsiveness without any need for cardiac output monitoring in 
ventilated patients.
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Introduction: Alarm fatigue on intensive care units (ICU) is defined as 
a sensory overload due to an excessive number of alarms from medi-
cal devices, which can result in desensitization to alarms and missed 
alarms [1].
Objectives: We assessed to what extent ICU staff at a university hospi-
tal experiences alarm fatigue from patient monitoring alerts, whether 
false alarms are perceived to disrupt patient care, and what strategies 
staff developed to handle alarms, such as adjusting or communicat-
ing thresholds or pausing alarms when examining patients. Because 
patient monitoring is a multidisciplinary team effort, we also aimed to 
uncover differences between health professions in the ICU.
Methods: A survey study was conducted with ICU staff from four 
ICUs of a German university hospital between November 2019 and 
January 2020 after IRB approval (EA1/031/18). We designed a web-
based 12-item questionnaire based on literature analyses and focus 
groups [2–6], and distributed it by email to all 270 ICU staff members, 
which included both physicians and nurses. The response format 
was a 5-point Likert-type scale (e.g., never - always). We cleaned and 
analysed the data with R in combination with the packages tidyverse 
and infer [7]. Statistical analyses included median values with boot-
strapped 95% confidence intervals and permutation tests to com-
pare the distributions of responses of nurses and physicians. An item 
median was considered statistically significant (*) when the 95% boot-
strap confidence intervals of the median did not include 3, which indi-
cates the response sometimes.
Results: Eighty-nine of the 270 ICU staff members (33%) completed 
the questionnaire. 63%* of the respondents had always or often so 
much to do that they could not respond to alarms quickly enough. 
45% always or often ignored alarms that keep repeating, 24% stated 
to overhear critical alarms often, and 22% were always or often over-
whelmed by too many alarms. The majority strongly agreed or agreed 
that false alarms disrupt patient care (76%*), and reduce trust in 
alarms (63%*). 82%* of participants reported to always or often adjust 
alarm settings (e.g., alarm thresholds) individually for each patient, but 
documentation of adjustments of alarm settings in the patient data 
management system was always or often omitted by 76%*. 29% of the 
respondents stated to always or often set the alarms of patient moni-
tors on Pause when examining the patient. Between nurses and physi-
cians, no significant differences of the median values of the items were 
revealed.
Conclusion: Our results suggest that both ICU physicians and nurses 
experience noticeable alarm fatigue due to false alarms which could 
harm patients. To remedy this situation, alarm management in the ICU 
should be optimized such as by more targeted and regular use of the 
alarm pause function, and by introducing a hospital-wide standard 
operating procedure for alarm management.
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Introduction: Knowing trends in pulmonary blood flow (PBF) and 
shunt fraction (Qs/Qt) could guide hemodynamic and respiratory 
management and improve outcomes in critically ill patients. PBF and 
shunt fraction are typically determined invasively using systemic and 
pulmonary arterial catheters and repetitive blood gas analyses. We 
present a porcine study utilizing novel techniques to obtain PBF and 
shunt measurements via the breathing tube.
Objectives: We tested whether PBF and Qs/Qt can be measured 
via the breathing tube by means of a new monitoring system (VQm 
PHM™, Rostrum Medical Innovations Inc., Canada).
Methods: 9 pigs (70-88 kgs) were anesthetized, intubated and instru-
mented with a systemic and pulmonary artery catheter and a pump-
driven extracorporeal circuit connecting the right and left atrium to 
produce shunt. Qs/Qt was measured at baseline and pump flows of 
1L/min and 3L/min. Additionally, in four animals, cardiac output (CO) 
was increased to 130% of baseline using dobutamine. Measurements 
of PBF and shunt fraction from the VQm PHM and the reference were 
conducted at baseline and during interventional periods (increased 
CO or shunt, respectively).
VQm PHM estimated PBF using the differential Fick equation and 
sequential gas delivery (SGD). VQm PHM assessed Qs/Qt by meas-
uring the decay of N2O after breathing FiN2O of 30% for 25 breaths 
(N2O challenge). The number of breaths required to reach an end-tidal 
value of 2.5% of the end-tidal after cessation of the N2O challenge was 
calculated and expressed as shunt index (SI). These values were com-
pared to PBF and Qs/Qt calculated by means of bolus thermodilution 
and the Berggren equation, respectively1. PBF was estimated by sub-
tracting shunt fraction from thermodilution-derived CO. Agreement 
between the two methods was assessed by Bland-Altman analysis.
Results: For PBF, 17 paired measurements of the VQm PHM and refer-
ence were obtained. The mean difference between paired values was 
0.21 L/min, and the 95% limits of agreement were –2.15 and 2.57 L/
min. For Qs/Qt, 64 paired measurements of the VQm PHM SI and refer-
ence were obtained. The mean difference between paired values was 
–0.22, and the 95% limits of agreement were –1.34 and 0.89.
Conclusion: These results suggest that the VQm PHM measurements 
of PBF and Shunt Index were able to track changes in PBF and shunt 
fraction in anesthetized pigs.
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Introduction: The monitoring of hemodynamic parameters to 
assess the cardiovascular status and the efficiency of therapy is of 
high importance in critically ill patients. Due to increased interest in 
advanced hemodynamic monitoring (AHM) several new devices were 
introduced within the last years. In this context, the new E-PiCCO 
device (GE Healthcare, Helsinki, Finnland) recently became available.
Objectives: To compare the E-PiCCO device with the established 
 PiCCO® device (PULSION Medical Systems, Munich, Germany) and to 
quantify the impact of proper and improper settings on AHM.
Methods: Both devices are based on pulse contour (PC) analysis and 
transpulmonary thermodilution (TPTD). Sixteen adult intensive care 
patients (8 female, 8 male, age 35-88  yr) undergoing clinically indi-
cated AHM with  PiCCO® were enrolled in this study. All patients had 
femoral (FEM) as well as jugular (JUG) central venous catheter (CVC). 
In these patients, 30 measurement sequences were completed, with 
one sequence consisting of 5 TPTDs (divided into 3 measurements by 
 PiCCO® and 2 by E-PiCCO). Each of the 5 TPTDs included 3 cold saline 
injections of 15 ml. Usually, the measurements are performed in JUG 
site, whereas the  PiCCO® device also allows the measurement in FEM 
CVC site by applying a built-in correction formula. The E-PiCCO device 
only allows correct JUG CVC site measurements. For comparison both 
devices were used in the proper and improper way. Proper use: JUG 
 (PiCCO® and E-PiCCO) and FEM with correction formula (only  PiCCO®); 
improper use: FEM (E-PiCCO and  PiCCO® without correction formula). 
The following hemodynamic parameters were estimated by both 
devices: cardiac index (CI) by PC (PCCI) and by TPTD (TDCI), indexed 
global end-diastolic volume (GEDVI) and extravascular lung water 
(EVLWI). These were compared by Bland–Altman analysis. IBM SPSS 26.
Results: Mean PCCI in [L/min/m2] were 3.75, 3.64, 3.96, 3.92, 3.99 
for  PiCCO® JUG, E-PiCCO JUG, E-PiCCO FEM,  PiCCO® FEM corrected, 
 PiCCO® FEM uncorrected, respectively. In the same order, mean val-
ues for TDCI in [L/min/m2] were 3.73, 3.59, 3.90, 3.94, 4.01; for GEDVI 
in [ml/m2] 855, 810, 1067, 815, 1116; for EVLWI in [mL/kg] 9.33, 9.27, 
10.3, 10.3, 10.4, respectively. The mean bias between E-PiCCO and 
 PiCCO® in JUG site were: -0.11 (PCCI), -0.14 (TDCI), -47.3 (GEDVI), -0.07 
(EVLWI), with limits of agreement (LOA, 1.96 SD, ±95% CI) of ±0.55, 
±0.45, ±117, ±1.48, respectively, and the percentage error of 15, 12, 
14, 16%, respectively. The bias results for the comparison of E-PiCCO 
in FEM and  PiCCO® in JUG were: 0.21 (PCCI), 0.17 (TDCI), 212 (GEDVI), 
0.97 (EVLWI), with LOA of ±0.71, ±0.74, ±286, ±3.83, respectively, and 
the percentage error of 18, 18, 26, 37%, respectively.
Conclusion: The E-PiCCO measurements showed only small differ-
ences to the  PiCCO® device when used in JUG site. As in this study, 
 PiCCO® JUG is considered as the gold-standard, the improper meas-
urement with the E-PiCCO in FEM site shows a considerably higher 
error but except for EVLWI would still meet the “Critchley-Criterion” 
(1). In conclusion, the E-PiCCO device is a reasonable alternative to 
the  PiCCO® device. When using the devices improperly, especially 
EVLWI and GEDVI showed higher discrepancies than TDCI and PCCI 
measurements.
Reference(s) and grant acknowledgment(s)
1. Critchley, L. A., & Critchley, J. A. (1999). A meta‑analysis of studies using bias 
and precision statistics to compare cardiac output measurement tech‑
niques. J Clin Monit Comput, 15(2)
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Introduction: The correct placement of the central venous catheter 
(CVC) has to be verified by chest radiography. The technique guided 
by intracavitary electrocardiogram (EKG-IC), allows a correct place-
ment of the catheter avoiding radiological control. The classic method 
of CVC placement by EKG-IC places the test electrode at the end of the 
procedure (when passing the catheter through the guidewire). We 
have made a modification of this method by performing the check by 
connecting the electrode to the guidewire when it is placed through 
the dilator. This modification allows the guide to be repositioned 
through the dilator and avoids the new puncture and restart of the 
procedure if the guide is in an extrathoracic location.
Objectives: Compare the correct placement of the CVC in the two 
methods studied and validate the modified CVC placement method 
by EKG-IC.
Methods: Fifty patients in whom CVC was placed were prospec-
tively collected. Two methods were evaluated, conventional method 
(seldinger technique) and a modified method guided by EKG-IC. The 
method to be used was indicated by the doctor responsible of the 
patient. The location of the catheter was evaluated by chest radiog-
raphy. The radiologist who evaluated the radiography was unaware of 
the method used. Correct CVC placement was defined with radiologic 
landmark of the lower third of the SVC (zone2): under the carina but 
within the first 3 distal cm(1). The data are presented in median, inter-
quartile range and number and percentage as appropriate.
Results:
VARIABLE  CONVENTIONAL N=25  
EKG_IC 
MODIFICATED N=25 P= 
Procedure Time, 
Minuts 12 (7,19) 13 (9,19) 0,66 
Zone 1 9 (36) 3 (12) 0.05 
Zone 2 3 (12) 18 (72) <0,01 
Zone 3 12 (48) 4 (16)  0,02 
Zone out  1 (4)  0 (0) 0,31 
Conclusion: In this patient sample, the modified CVC placement 
method by EKG - IC significantly allowed correct placement. This mod-
ified method, in addition to avoiding control radiology, would avoid 
puncturing again if the catheter location is extrathoracic.
Reference(s) and grant acknowledgment(s)
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Introduction: Prompt anticoagulation and coagulation monitoring 
is an essential aspect of patients during extracorporeal membrane 
oxygenation (ECMO) therapy. Heparin infusion is the gold standard 
regarding anticoagulation during ECMO. Nevertheless, resistance to 
heparin may arise that may be difficult to diagnose and manage.
Methods: A search of the literature on PubMed, Google Scholar and 
Scopus with the keywords “ECMO or ECLS” and “heparin resistance” 
was conducted. Published case reports and series written in English 
were included with adult patients. Abstracts were not included in the 
review. A case of heparin resistance during ECMO from our ICU is also 
presented.
Results: The mechanism and pathophysiological process that leads to 
the development of heparin resistance is not fully understood, how-
ever acquired antithrombin (AT) deficiency is a recognized causative 
factor. The Extracorporeal Life Support Organization (ELSO) recom-
mends that in established heparin resistance AT-III levels are main-
tained within the normal range in patients on ECMO by administration 
of fresh frozen plasma (FFP) or AT-III concentrate. Nevertheless, Ciolek 
et al (2017) mentioned in pediatric ECMO patients that AT-III repletion 
was associated with high cost, significant increases in anticoagulation 
parameters, and no significant change in the heparin infusion rate. In 
total 6 studies in the international literature were identified regarding 
heparin resistance during ECMO therapy. The studies identified are 
summarized in Table 1. Three of the 6 studies studied the use of Arga-
troban during heparin resistance in a total of 13 patients with good 
results regarding safety, cost, and ease of administration. The other 
three studies suggested the use of Bivalirudin, FFP and ATIII adminis-
tration, respectively.
A 29-year-old woman with a history of obesity, hypothyroidism and 
polycystic ovary disease was admitted to the ICU of the Nicosia Gen-
eral Hospital with type I respiratory failure due to COVID-19 infection. 
On the 4th day of mechanical ventilation, she presented severe res-
piratory deterioration. A decision was made to proceed with VV ECMO 
support. Heparin infusion was initiated with a target to maintain aPTT 
1.5 to 2 times initial patient values. During the first 48 hours of ECMO 
support the patient was unable to maintain anticoagulation targets 
despite progressively increased heparin dose, furthermore she pre-
sented signs of thrombosis on her left index finger. ATIII levels were 
in the normal range and the anti-PF4 test was negative. FFP adminis-
tration was unable to reduce the heparin dose. Heparin infusion was 
stopped and anticoagulation with Argatroban was initiated. During 
Argatroban administration the patient presented a non-clinically sig-
nificant bleeding from the tracheostomy and the ECMO intravenous 
cannulas. There were no apparent thrombotic events and the throm-
bosis on the index finger resolved without intervention. The patient 
was successfully weaned off the ECMO after 10 days and made a full 
recovery.
Conclusion: It seems that patients with heparin resistance have higher 
mortality rates during ECMO highlighting the need for developing 
alternative anticoagulation strategies. The recommended ELSO guide-
lines of ATIII or FFP administration in heparin resistance during ECMO 
may be costly, and ineffective. The role of Argatroban, as alternative 
anticoagulation, in this group of patients should be further researched 
to establish both safety and efficacy.
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Introduction: Transthoracic echocardiography (TTE) is regularly 
requested in critically ill patients. However to date there has been 
limited data published on the association between TTE results and 
patient outcomes.
Objectives: The purpose of this study was to assess the prognostic 
function of transthoracic echocardiography in the intensive care unit.
Methods: A retrospective, cross sectional, single centre study, was 
performed. All patients admitted to the Intensive care unit (ICU) over 
the 13-month period (January 2018- February 2019) were included. 
Baseline characteristics were obtained from the Clinical Information 
System. All TTE’s were performed by a cardiac physiologist with final 
approval of reports from a consultant cardiologist. Echocardiographic 
reports were extracted from the Cardiovascular Information System. 
ICU and hospital outcomes were extracted from the ‘Acubase Ltd’ 
system.
Results: Three hundred and fifty eight patients were admitted to the 
ICU over the 13 month period (55% Male, Mean age 59±17 years). Just 
under one-third of all patients received a TTE during their ICU admis-
sion (N=115/358).
Results included; normal left ventricular (LV) function; n= 56, left 
ventricular hypertrophy (LVH); n= 19, LV dysfunction; n=19, moder-
ate to severe valvular pathology +/– LV dysfunction; n=9, right ven-
tricular (RV) dysfunction; n= 7. Five TTE’s were not reported therefore 
excluded from our study.
Each TTE subgroup was then tested against the study population as a 
whole to assess for any significant impact on patient outcome such as 
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Patients with reduced LV function were found to have a significant 
increase in ICU mortality when compared to the study population 
(42% n=8/19 vs 22% n=81/358: p=0.04). This patient cohort was also 
found to have a longer ICU length of stay (10 vs. 4 days p= 0.018). Hos-
pital mortality and length of stay did not differ significantly between 
groups.
Of note the patients with moderate to severe valvular pathology 
(+/- impaired LV function) were found to be older (71 ±11 vs.59 ± 17 
P=0.03) yet outcomes did not differ significantly when compared to 
the study population as a whole.
Patients found to have right ventricular dysfunction or left ventricular 
hypertrophy were not found to have a significant increase in mortality 
rate or length of stay.
Conclusion: A finding of moderate to severe LV dysfunction on Tran-
sthoracic Echocardiography in ICU setting, is associated with a signifi-
cant increase in ICU mortality and length of stay.
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Introduction: Milrinone is an inodilator drug widely used in the treat-
ment of both surgical and non-surgical patients with severe heart fail-
ure. These patients often present with acute renal failure (ARF), and 
a substantial proportion will require continuous renal replacement 
therapy (CRRT).
Several studies indicate an increased risk of supratherapeutic plasma 
Milrinone concentrations in patients with ARF not treated with CRRT. 
This has led to guidelines advising Milrinone dosage reduction for 
these patients, as supratherapeutic plasma concentrations may 
increase the risk of serious adverse effects such as arrhythmias and 
hypotension.
Data on Milrinone pharmacokinetics in patients receiving CRRT is 
sparse and based on one study of 6 patients [1]. Accordingly, no pre-
scribing guidance exists for Milrinone dosing during CRRT.
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Objectives: The objective of the present study is to describe Milrinone 
plasma concentrations in relation to the therapeutic index, in patients 
receiving intravenous Milrinone infusion while on CRRT.
Methods: A prospective observational descriptive study including 
intensive care patients > 18  years receiving intravenous Milrinone 
infusion while on CRRT. Both patients with low cardiac output syn-
drome following cardiac surgery, and patients with non-surgical acute 
decompensated heart failure are included.
Milrinone prescribing including dosage, and settings and duration of 
CRRT are at the discretion of the attending intensive care doctors. We 
expect to include approximately 15 patients.
Guided by results from a pilot study, arterial plasma samples are col-
lected at 8, 16, 24, 36 and 48 hours after initiation of Milrinone infusion 
and/or CRRT, and once every 24 hours thereafter. Plasma sampling 
is continued until Milrinone infusion is discontinued. An additional 
plasma sample is collected prior to initiation of CRRT, in case Milrinone 
infusion is initiated before CRRT.
The arterial whole blood samples are centrifuged on site. Plasma is 
obtained and stored at -80 °C until analysis is performed. Milrinone 
plasma concentrations will be quantified using liquid chromatography 
tandem mass spectrometry (LC-MS/MS).
Milrinone plasma concentrations versus time after initiation of CRRT 
will be described and stratified according to different dosages of Mil-
rinone infusion. Milrinone concentrations will be described according 
to therapeutic index. The study will not have power to evaluate rela-
tionship between Milrinone concentration and outcomes.
Results: The study is still recruiting. Inclusion is expected to finish 
October 1 2020. Results on the Milrinone plasma concentration analy-
sis will be presented.
Conclusion: This study reflects common practice of the use of Mil-
rinone while on CRRT. The results from this study will clarify further 
whether specific dosing recommendations should be considered for 
patients receiving Milrinone infusion while on CRRT.
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Introduction: Obstetric hemorrhage is the main cause of maternal 
morbidity and mortality in developing countries.1 Despite the fact 
that the anti-shock garment (AG) is an alternative for the management 
of obstetric hemorrhage, there is no evidence about when is the opti-
mal time of its withdrawal.2.
Objectives: To determine the predictive capacity of the shock 
index, and the delta of the shock index, to determine hemodynamic 
instability, after the removal of the antishock garment in obstetric 
hemorrhage.
Methods: This is a prospective diagnostic test validation study. It 
evaluates the shock index (SI) and the shock index delta (ΔSI) prior 
to removal of the AG as a predictor of hemodynamic instability after 
removal of the AG. This study focuses on patients with obstetric 
hemorrhage admitted to a second level ICU of a hospital in Ecuador 
between the months of March and December of 2019. Sensitivity (Se), 
Specificity (Sp), positive and negative predictive values were studied, 
and the positive and negative Likelihood Ratio (LR) calculated.
Results: Thirteen patients were included, with a mean age of 
25.6 years (17–34), with an Apache II mean of 6.4 (2–17) and estimated 
mean bleeding volume of 1875  ml. (500-2500) The main etiology of 
bleeding was uterine atony (69%), 15% had placental retention, 7% 
had placenta previa, and 7% of women experienced a grade III vagi-
nal tear at the time of childbirth, with the average shock index at ICU 
admission of 1.04 (0.8–1.6). The mean of the SI before the removal of 
the AG was 0.88 (0.71–1.03) in the patients who remained stable after 
their removal, and the mean of the SI was 0.89 (0.83 - 1.0) in those who 
showed instability, with an Se of 50% and Sp 66%, a positive LR 1.47 
and a negative LR 0.75. Additionally a ΔSI of 0.21 (0.05-0.58) was found 
for those who remained stable, and 0.07 (0.01–0.22) for those who pre-
sented hemodynamic instability, with Se 75%, Sp 85%, positive LR of 3 
and LR. negative of 0.33.
Conclusion: The Shock Index and shock index delta, are not good pre-
dictors of hemodynamic instability after removal of the shock garment 
in patients with obstetric hemorrhage. However, more studies are 
required with major samples.
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Introduction: It has been previously shown that general intensive 
care nurses are able to perform bedside examination of deep vein 
thrombosis by compression ultrasound test with a high degree of reli-
ability.1 Another challenge in critically ill patients is the diagnosis of 
central venous catheter-related thrombosis (CRT). Therefore, we con-
ducted prospective observational study to compare the diagnostic 
reliability of vascular Point-of-Care duplex ultrasound (compression 
ultrasound test combined with colour doppler imaging) in diagnostics 
of CRT performed by general intensive care nurses in the setting of 
intensive care unit with the examination performed by intensive care 
physicians, the experts in vascular ultrasound.
Methods: Prior to the study, each nurse participating in the study 
completed two-hour training in duplex ultrasound and examined 5 
patients under supervision. Then, intensive care unit (ICU) patients 
with central venous catheter placed more than 48 hours in the catch-
ment area of the inferior or superior caval vein underwent duplex 
ultrasound performed by the nurse. On the same day, the examina-
tion was repeated by an ICU physician. In the case of catheter place-
ment in the internal jugular vein or subclavian vein, jugular, subclavian 
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and axillar vein were examined bilaterally by a nurse and a physician. 
When a catheter was placed in the femoral vein, patients underwent 
duplex ultrasound of the femoral and popliteal region of both lower 
extremities. The results of the examinations of each patient were 
blinded until both tests were performed. The calculations evaluating 
the reliability of the test were applied.
Results: A total of 160 patients of age 62.9±12.3 years were included. 
The prevalence of CRT of 41% has been found in our sample. The 
overall sensitivity, specificity, positive predictive value, negative pre-
dictive value, and accuracy of the examination performed by general 
intensive care nurses were 71.2%, 100.0%, 100.0%, 83.3% and 88.2%, 
respectively.
Conclusion: The results of our study indicate that general ICU nurses 
are able to perform bedside examination of CRT by duplex ultrasound 
with an excellent specificity but only with a moderate sensitivity after 
a brief predefined training.
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Introduction: Acute Kidney Injury (AKI) is a frequent complication for 
COVID-19 patients admitted to Intensive Care Unit (ICU) and is inde-
pendently associated with higher mortality. The patophysiology of 
COVID-19 related AKI is supposed to be multifactorial: haemodynamic 
alteration due to high levels of PEEP may play a role.
Objectives: We investigate if higher central venous pressure (CVP) 
and higher positive end expiratory pressure (Peep) were associated to 
higher incidence of AKI and if AKI was related to 28 days mortality.
Methods: 130 consecutive COVID-19 patients admitted to the Inten-
sive Care Unit (ICU) at Bergamo General Hospital for acute respira-
tory failure from 22th February to 22th March were enrolled. AKI was 
defined by KDIGO criteria. Age, sex and SOFA score were collected at 
ICU admission. Mean values of PVC and Peep during the first 14 days 
in ICU were compared between AKI group and controls, using Mann 
Whitney test. The association between AKI and mortality was evalu-
ated with Fisher exact test.
Results: In our population median age was 62 (IQR 14), 107 (82%) were 
male and median SOFA score was 6 (range 4–8). 74 (57%) patients 
developed AKI; 17 (13%) in stage 1, 16 (12%) in stage 2, and 41 (31%) 
in stage 3; 22 patients (17%) required continuous renal replacement 
therapy (CRRT).
28  days mortality among AKI group was significantly higher (46% vs 
18% p-value 0.0008).
Furthermore mean values of PVC and Peep were higher in AKI group 
compared to controls; relevant data are represented in the Table 1.
Table 1. 
 )47=n( IKA )65=n( slortnoc  p 
Age (y) 59 (51-66) 63 (56-70) ns 
Gender M/F (%) 43/13 (77/23) 64/10 (86/14) ns 
SOFA (%) 5 (4-6) 6 (4-8) 0.011 
Median Peep (cmH2O) 13 (10-14) 14 (13-15) 0.0028 
PVC (mmHg) 11 (9-13) 13 (10-15) 0.0067 
28 days mortality, n (%) 10 (18) 34 (46) 0.0008 
Data are presented as median and interquartile range. Two groups 
are compared using Mann Whitney test for continuous variables and 
using Fisher’s exact test for categorical variables
Conclusion: Our data confirm that AKI represent a risk factor for mor-
tality in COVID patients (odds ratio 3.9, 95% IC 1.8–8.8). Both higher 
PEEP and PVC are significantly associated with AKI, suggesting that the 
haemodynamic impact of high intrathoracic pressure may be involved 
in its pathogenesis.
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Introduction: Implications of lactate clearance in patients with acute 
heart failure (AHF) in intensive care unit (ICU) setting is limited. A 
recent report suggests that a 24-hour lactate clearance (Δ24lac) of less 
than 19% could have a negative prognostic role in septic patients in 
ICU, therefore we conducted a study to assess the prognostic value of 
Δ24lac for mortality in AHF.
Objectives: To compare the Δ24lac with clinical variables and mortal-
ity in AHF.
Methods: We conducted an observational retrospective cohort with 
critical patients from a single center in an intensive care unit (ICU) in 
Mexico City, Mexico. Demographic, comorbidities and laboratory data 
was collected for all patients. We estimated the acute physiology and 
chronic health evaluation (APACHE) II score, and Δ24lac. Additionally, 
treatment with vasoactive agents, diuresis, fluid balance was assessed 
during first 24 hours and length of stay (LOS). Primary outcome was 
28-days mortality.
Results: Data from 100 patients was included, 63% male, with mean 
age 63.1 (SD ± 10.6) years and mean BMI 28.8 (SD ± 2.7) Kg/m2. Most 
frequent comorbidities were COPD, Hypertension and chronic kidney 
disease and diabetes in 34, 32, 19% and 13%, respectively. Cardiogenic 
shock was observed in 54%; Systolic and diastolic dysfunction was 
documented in 23 and 27%, respectively. APACHE II score with median 
of 25 (RIQ 22–27.5) and Δ24lac < 19% in 42%; Overall mortality 35%, 
median LOS 8 (7-9) days. Variables on admission were similar for mor-
tality and Δ24lac groups were similar. Treatment with levosimendan 
was higher in mortality group. 94.3 vs. 70.8%, p=0.006; when stratified 
according to Δ24lac, we found that patients with < 19%, patients with 
requirement of inotropic support with levosimendan was a strong pre-
dictor for mortality [HR = 10.9 (IC95% 1.4–84.7, p=0.02)], in contrast to 
Δ24lac > 19% [(HR = 5.6 (IC95% 0.74–42.6, p=0.09)]. Further multivari-
ate analysis and stratifications found no association with other Δ24lac 
cutoff values, comorbidities, fluid balances and vasopressor support.
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Conclusion: Cardiogenic shock with requirement for inotropic sup-
port in subjects with AHF was associated with mortality and inade-
quate tissue perfusion. Failure to stablish associations with AHF clinical 
variables with mortality is likely explained by methodological limita-
tions (e.g. lack of a control group). We present additional evidence 
supporting the use of Δ24lac as prognostic marker of global tissue 
hypoxia in circulatory shock, however further controlled studies and a 
prospective design may be needed to explain the role of this marker 
in AHF.
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Introduction: Measurement of cardiac output (CO) is an important 
diagnostic maneuver and adds valuable information for the manage-
ment of critically ill patients. However, estimation of CO in limited 
resource settings may be limited in terms of accessibility to non-
invasive, continuous, reliable, reproducible methods. Pulse pressure 
variation (PPV) and plethysmographyc variability (PV) are dynamic and 
widely extended indicators that in certain conditions may be useful to 
estimate CO, however, information regarding its reliability is scarce. 
Therefore, we propose a study with information obtained from PP and 
PV with other clinical variables and a proposed simplified equation to 
estimate CO with echocardiography as gold standard.
Objectives: To develop a simplified method to estimate CO with PPV 
and PV.
Methods: We conducted a transversal study in critical patients with 
sepsis recruited from a single center in an intensive care unit (ICU) in 
Mexico City, Mexico during 2019 through 2020. We calculated the real 
CO as stroke volume (SV) per minute measured by echocardiogram; 
PP was defined as the difference between systolic (DP) and diastolic 
pressure (DP); The proposed Estimated CO formula was calculated as 
follows: estimated CO = PP* heart rate (HR) * k; where k was defined as 
the estimated difference in SV in mm Hg and was adjusted according 
to variability of the PP and plethysmography patterns. We determined 
correlation with Pearson coefficient (r) and absolute agreement with 
intraclass correlation coefficient (CCI) of estimated CO compared to 
the gold standard.
Results: Data from 53 patients was analyzed. We included 6 PV wave 
patterns and k values: type 1 and 2 (group 1), k = 0.9; type 3 and 
4  k=1.2 (group 2) and type 5 and 6, k=1.4 (group 3). Additionally, if 
patients showed clinical signs of hypoperfusion we adjusted the k 
value for groups 1,2 and 3 to 1.2, 1.6 and 2, respectively. Estimated CO 
correlated with echocardiogram r=0.76, (p<0.01) and CCI = 849 (IC 
95% = 0.739 - 0.912, p<0.01). 
Conclusion: We present a simplified and accessible approach for 
CO estimation with PPV and PV in critical care patients. This method 
may be cost effective and easily performed in low-income and limited 
resources settings, however, additional studies should be considered 
for further external validation and the possible role and clinical impli-
cations of PPV and PV for clinical outcome and mortality is yet to be 
defined in prospective clinical trials.
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Introduction: Evaluation of fluid responsiveness in critically ill 
patients is challenging. Echocardiographically obtained variation 
in inferior vena cava (IVC) and superior vena cava (SVC) have shown 
promise in their ability to address this challenge. However, they have 
been predominantly used to assess fluid responsiveness in patients 
with sepsis, and it is less clear whether they apply to patients under-
going cardiac surgery. Additionally, left ventricular surface area (LVSA) 
has been shown to be correlated with stroke volume and in a study 
by Cannesson et. al. respiratory variation in LVSA (∆LVSA) obtained by 
transesophageal echo (TEE) automatic border detection was shown to 
predict fluid responsiveness (Cannesson et al., 2006).
Objectives: The primary purpose of this study was to assess whether 
variation in SVC diameter, during positive pressure ventilation, is pre-
dictive of volume responsiveness in cardiac surgical patients. Addi-
tionally, ∆LVSA was assessed for ability to predict fluid responsiveness.
Methods: This prospective study enrolled patients undergoing elec-
tive or semi-elective cardiac surgery and was conducted in operating 
theaters at a tertiary care academic hospital. Volume challenges were 
administered pre-sternotomy and cardiopulmonary bypass (pre-CPB) 
and after sternal closure (post-CPB) to patients under general anesthe-
sia with standardized mechanical ventilation settings. Hemodynamic 
measurements and TEE images were collected before and after each 
volume challenge. Cardiac output (CO) was obtained from TEE images 
as previously described (Vieillard-Baron et. al., 2004) and fluid respond-
ers were defined by an increase in CO of 11% or more after a volume 
challenge. The SVC diameters (Dmax and Dmin) were measured over 
a respiratory cycle and the SVC collapsibility index (SVC-CI) was calcu-
lated as (Dmax - Dmin)/Dmax and expressed as a percentage. SVC-CI 
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was compared between fluid responders (FR) and non-responders 
(NR) to determine if there is a significant difference and the optimal 
SVC-CI threshold was determined for optimizing the sensitivity and 
specificity. Additionally, LVSA was measured over the respiratory cycle 
and ∆LVSA was calculated as (SA max- SA min)/SA max, expressed as a 
percentage. ∆LVSA underwent the same analysis as SVC-CI.
Results: 11 out of 20 enrolled patients (55%) were fluid responders. 
There was no difference in heart rate, mean arterial pressure or CVP 
between responders and non-responders. Pre-CPB SVC-CI was greater 
in R vs. NR but not statistically significant (0.18 ± 0.15 vs. 0.11 ± 0.05; 
p=0.456). Pre-CPB SVC-CI threshold of 15% was found to be most pre-
dictive of fluid responsiveness with an area under the receiver operat-
ing curve (AU-ROC) of 0.62 (0.41 – 0.84, 95% CI), NPV of 50% and PPV 
of 75%. Post-CPB SVC-CI was also greater in R vs NR but not statisti-
cally significant (0.18 ± 0.12 vs. 0.11 ± 0.05; p=0.241). Post-CPB SVC-
CI>11% was most predictive of fluid responsiveness with an AU-ROC 
of  0.66 (0.41 – 0.84, 95% CI), 58% NPV and 75% PPV.  Pre-CPB  ∆LVSA 
was greater in R vs NR (0.08 ± 0.13 vs 0.01 ± 0.08) but did not reach 
statistical significance (p=0.151) and Post-CPB  ∆LVSA was minimally 
greater in R vs NR (0.08 ± 0.06 vs 0.05 ± 0.11) and not statistically sig-
nificant (p=0.456). Pre-CPB ∆LVSA>10% was predictive of fluid respon-
siveness with an AU-ROC of 0.79 (0.65-0.94, 95% CI), NPV of 62% and 
PPV of 100%. Post-CPB ∆LVSA>2% was predictive of fluid responsive-
ness with AU-ROC of 0.63 (0.42 – 0.84, 95% CI), NPV of 68% and PPV 
of 64%.
Conclusion: Our study shows that SVC-CI is not a useful measure for 
predicting fluid responsiveness in cardiac surgical patients either pre 
or post-operatively. Post-sternotomy there are multiple changes to 
the cardiopulmonary physiology (to PVR, SVR, venous capacitance, 
RV, pericardium, etc.) which may be some of the reasons why SVC-CI 
is not predictive of FR in this population. SVC-CI not being predictive 
of FR pre-CPB may be potentially due to the fact that these were elec-
tive or semi-elective surgical patients (and not ICU patients in septic 
shock, like in most other studies). These findings suggest that perhaps 
the lack of venous return is not the only mechanism for tidal changes 
in stroke volume with respiration. It is also possible that SVC-CI is not 
as good of a predictor of FR as was demonstrated in early studies since 
many later studies had different optimal thresholds and less impres-
sive predictive values.
Although the differences in  ∆LVSA pre-CPB did not reach statisti-
cal significance,  ∆LVSA>10% was helpful  in predicting fluid respon-
siveness pre-sternotomy with a PPV of 100% and NPV of 62%. These 
findings suggest that  ∆LVSA is likely a marker of preload status with 
higher  ∆LVSA indicating lower preload and therefore more potential 
for enhancing the CO with a preload challenge. ∆LVSA was not helpful 
in predicting fluid responsiveness post-sternotomy. It is possible that 
losing the integrity of the pericardium makes ∆LVSA a less reliable pre-
dictor of preload and therefore fluid responsiveness.
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Introduction: Survival after coronary revascularization surgery is 
influenced by many variables. Poor left ventricular function (LVF) is 
believed to be associated with worse outcomes (1).
Objectives: We aim to study the outcome measures at varying levels 
of LVF.
Methods: A single center retrospective descriptive study. According 
to the simplified American Society of Echocardiography classification 
(2), patients were divided into three groups: Group I - severe impair-
ment of LVF; EF < 30% (38 patients), Group II - mild-moderate impair-
ment of LVF; EF 30% to 51% (182 patients), and Group III - normal LVF; 
EF > 52% (186 patients). The outcome variables were compared, and 
mortality was used as the primary outcome.
Results: The mean age of patients was 55.34 ± 9.9 years. The mortality 
rate was significantly higher in Group I compared to the other groups 
(13.2% in Group I vs. 2.2% and 1.6% in Groups II and III, respectively; 
p = 0.007). Patients in Group I had a significantly higher incidence of 
postoperative acute kidney injury (AKI) (47% in Group I vs. 28.6% and 
22.6% in Groups II and Group III, respectively; p = 0.007). No significant 
differences were found between the studied groups for postoperative 
atrial fibrillation (POAF), length of ventilation, length of stay (LOS) in 
intensive care, and length of (LOS) stay in the hospital.
Conclusion: Among patients undergoing coronary surgery, preop-
erative left ventricular function appears to influence short-term out-
comes. Patients with severely impaired left ventricular systolic function 
had higher mortality, more complications, particularly AKI, and 
needed more pharmacological and mechanical circulatory support.
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Introduction: Rapid response team (RRT) was initially regarded as full-
time working team. However, because of several reasons such as lack 
of professional manpower, cost effectiveness and size and require-
ment of each hospital, part-time RRT was introduced. Outcome of 
part-time RRT recently suggested similary efficacy compared to full-
time RRT. However it is difficult to make a head-to-had comparison 
and there are no available data comparing the efficacy of part-time 
and full-time RRT. Authors sought to investigate the intensity of RRT 
and incidence of in-hospital cardiopulmonary resuscitation (CPR).
Methods: Dong-A University Hospital – a tertiary referral center with 
1,000 beds – started to operate RRT in April 2017 as a part-time RRS 
operating 8 hours on weekdays. In March 2018, RRT operation time 
was extended to 15 hours on weekdays and finally, extended to 24 
hours a day, 7 days a week on February 2019.
We retrospectively reviewed the incidence of in-hospital cardiopul-
monary resuscitation (CPR) according to stepwise extension of RRT 
operation.
Results: For the study period (36 months before and 33 months after 
RRT implementation), 113,394 patients admitted and 127 cases of CPR 
occurred. For the 36  months before RRT implementation, the next 
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initial RRT period (11 months), the second RRT period (11 months), and 
the third RRT period (11  months), CPR per 1000 admission was 1.27, 
1.08, 0.90 and 0.86 (p = 0.381).
In logistic regression analysis, Age, Hospital length of stay, Charlson-
comorbidity score, and incremental intensity was independently asso-
ciated with CPR development (Table 1).
<Table 1> 
  Univariate Multivariate 
variables OR 95% CI p OR 95% CI p
Age 1.040 1.026-1.055 <0.001 1.038 1.023-1.053 <0.001 
Hospital length of 
stay 1.010 1.006-1.013 <0.001 1.009 1.006-1.013 <0.001 
Charlson-
comorbidity score 1.038 1.020-1.055 <0.001 1.044 1.025-1.063 <0.001 
RRT intensity 0.849 0.719-1.002 0.053 0.787 0.663-0.934 0.006 
Sex 0.646 0.452-0.924 0.017 0.715 0.499-1.025 0.068  
Conclusion: The incremental intensity of RRT operation is associated 
with decremental tendency of in-hospital CPR rate suggesting the 
more CPR prevention efficacy with the more operation time of RRT.
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Introduction: Mortality due to septic shock is around 40% globally (1), 
these reach figures close to 70% in peripheral areas devoid of health 
systems with capacity to manage patientswith intensive care require-
ments. Given the impossibility of opening intensive careunits in these 
regions, several options have been raised, such as telemedicine, 
referral systems, training of non-intensivist health personnel, among 
others.
Objectives: We propose in this study, to establish the impact on mor-
tality in patients with septicshock, of the establishment of an early 
identification program  and transfer to a reference ICU, with 24-hour 
availability of acceptance of these patients.
Methods: Prospective observational descriptive study, between Janu-
ary 2016 and October2019, in the intensive care unit of the Hospital de 
San José in Bogotá Colombia, of patients diagnosed with septic shock, 
who were treated by transfer from the regionof Guainía-Amazonas, 
within the MIAS program (Integral model of health care) (2).
Results: Twenty-three patients with septic shock or multi-organ dys-
function secondary to sepsis were attended, mean age 44.1  years, 
APACHE II 16.68 with expectedmortality of 24%. 25% of infections cor-
respond to tropical infections, the mostcommon being tuberculosis 
and secondly malaria. Within the non-tropical etiology, 40% sepsis of 
lung origin and 12% soft tissue sepsis. 60% of the patients requiredin-
vasive mechanical ventilation and 80% vasopressor support. In 90% of 
patients the empirical antibiotic management was beta-lactam antip-
seudomonas + inhibitor. Only in 36% of the patients, the etiological 
germ was isolated, with 45% grampositive cocci, 30% gram negative 
bacilli and the remaining 30% atypical germs, viruses, fungi and myco-
bacteria. Gross mortality was 12%.
Conclusion: The implementation of rapid care models with immedi-
ate transfer services to intensive care units, reduces mortality by up 
to 50% in patients with septic shock in the region of the Colombian 
Amazon. Tropical, respiratory and skin and soft tissue infections con-
stitute the main and most serious diseases.
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Introduction: The strengthening of research infrastructure is key 
for the advancement of academic medicine in critical care. However, 
while there have been dramatic clinical developments in Asian critical 
care in the last few decades, research has lagged behind.
Objectives: The aim of this study was to describe the current status of 
academia in critical care in Japan, South Korea, and Singapore, particu-
larly from the research environment perspective.
Methods: This was a cross-sectional questionnaire survey conducted 
between June 2019 and January 2020. We included all physician mem-
bers of the Japanese Society of Intensive Care Medicine (JSICM) and 
the Korean Society of Critical Care Medicine (KSCCM) as of June 2019, 
and intensivists in Singapore as of November 2019. The questionnaire 
was drafted by two content experts and validated through pre-deter-
mined testing with a clinical sensitivity test and a specificity table. We 
collected data on the characteristics of the participants and their affili-
ated institutions, the research environment such as funding and sup-
port for personnel, and ethics boards and their role. We investigated 
the association between the presence of time dedicated to research 
and the number of research publications in English (1–10 versus >10) 
among the participants with at least one English original article.
Results: In total, 490 responded (response rate: 5.6%) to the survey 
and all responses were included for analysis. The clinical experience in 
critical care was 20 years or more in 41%, 10–19 years in 42%, 6–9 years 
in 14%, and 2–5 years in 3%. Forty-eight percent of the respondents 
held a university faculty appointment. Fifty-five percent worked for a 
university-affiliated hospital while 45% worked for a community hos-
pital. Fifty-one percent reported that they used 50% or more of their 
work hours for bedside patient management in the intensive care unit. 
Thirty-four percent replied that there was at least one dedicated staff 
member for research work (epidemiologist or biostatistician) available 
in their hospitals. Twenty-four percent had dedicated time for research 
within their full-time work hours. When looking at the respondents 
with at least one original article in English language as a first or cor-
responding author, the odds to have more than 10 of the English 
publications for whom with protected time for research was 3.3 (95% 
confidence intervals: 1.8–6.1) compared to those without.
Conclusion: We found that many critical care physicians in the three 
countries had limited support for their research work and that dedi-
cated time for research was positively associated with the number of 
research publications. The research environment and infrastructure in 
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these countries require substantial enhancement for better research 
productivity.
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Introduction: Mild traumatic brain injury (mTBI) is a frequent cause of 
emergency department (ED) visits in France, with a substantial impact 
on healthcare utilization and ED costs. Blood-based, brain biomarker 
tests such as S100B and a combination of glial fibrillary acidic protein 
(GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) have been 
shown to accurately identify mTBI patients who do not have intracra-
nial lesions (ICL), potentially reducing the need for computed tomog-
raphy (CT) scanning.
Objectives: To assess the cost-effectiveness of the GFAP + UCH-L1 
compared with S100B for screening adults with suspected mTBI pre-
senting to an ED.
Methods: We developed a decision tree model to estimate the costs 
and health outcomes of using two biomarker tests in patients present-
ing to the ED with suspected mTBI (Glasgow Coma Scale of 13–15). 
Model parameters were extracted from peer-reviewed papers, clinical 
guidelines, and expert opinion. The diagnostic test accuracy meas-
ures were extracted from the pivotal trial (GFAP + UCH-L1) and a 
meta-analysis (S100B). Lifelong costs (2020 €) and health outcomes 
were calculated from a French healthcare system perspective and 
discounted over time at 2.5%. Cost for the GFAP + UCH-L1 test was 
assumed to be the same as the S100B test. In this model, patients with 
a positive biomarker receive a CT scan to confirm the presence of ICLs. 
Depending on the biomarker test outcome and the CT results (where 
relevant), patients may be discharged immediately from the ED, kept 
for <24-hour observation, admitted to a short stay general ward, or 
admitted to a neurosurgery ward. Patients with ICLs not identified by 
the biomarker (false negatives) could suffer from delayed treatment 
and poorer health outcomes. Clinical outcomes, including Glasgow 
Outcome Score and radiation-induced cancer were used to calculate 
quality-adjusted life years (QALYs). One-way and probabilistic sensitiv-
ity analyses were conducted to manage uncertainty.
Results: In a hypothetical cohort of 1,000 patients, the GFAP + UCH-
L1 biomarker was associated with a decrease of 48 CT scans compared 
to S100B (769 versus 817, respectively). In the same cohort, the GFAP 
+ UCH-L1 biomarker resulted in €4,785 overall savings and a minor 
improvement of 0.08 QALYs. In probabilistic sensitivity analysis, at the 
willingness to pay threshold of €50,000 per QALY, there is 63% prob-
ability of the GFAP + UCH-L1 test to be cost-saving and a 73% prob-
ability to be cost-effective when compared to S100B.
Conclusion: The findings of this cost-effectiveness model show that 
for patients with suspected mTBI who present to an ED, compared to 
S100B, screening with the GFAP + UCH-L1 test is associated with cost 
savings and a reduction in CT scans, while resulting in similar health 
outcomes.
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Introduction: Extravasation is the accidental injection or leakage of 
fluid into the subcutaneous or perivascular tissues. Risk of extravasa-
tion injury related to intra venous therapy is between 10-30% result-
ing in varying complications (1). Extravasation associated with Central 
Venous Catheters (CVCs) is rarer but consequences can be severe, 
potentially requiring skin grafts or even leading to death (2,3). This is 
minimised by ensuring the line is secured at appropriate depth and by 
potency (toxicity) of drugs in the line. Currently there is no guidance 
on selection of drugs to ports on CVC. On a Quad lumen CVC, there is 
6 cm from the distal to the proximal port, increasing risk if toxic drugs 
are placed on the proximal port. Distal ports are traditionally utalised 
for Central Venous Pressure (CVP) however evidence suggests there is 
no difference in accuracy when CVP is on distal or proximal port (4).
Objectives: Minimising risks of extravasation with CVCs in Critical 
care.
Methods: Data was collected from a tertiary centre based in the West 
Midlands, UK. It is a large Critical care unit (CCU) with over 100 beds 
with specialised cardiac, neurology, trauma, burns, surgical and liver 
patients, over 4 units. Data was collected by 2 auditors in 2019 over 
2  days across all patients within CCU who had a CVC. The following 
was assessed: were CVCs sutured to the hilt, what length/type of CVC 
was used, which port was transducing CVP and which “Toxic drugs” 
were on the proximal port. We defined “Toxic drugs” as inotropes, neat 
potassium and 50% magnesium.
Results: Of 61 Critical Care patients, 51 patients had an internal jugu-
lar, 4 femoral and 6 subclavian CVC. 21% of the lines were not sutured 
at the hub. 77% of lines used the distal port to transduce the CVP 
which is current practice and 6% on Proximal. 41% of the lines had a 
Toxic drug on the proximal line.
Conclusion: This quality improvement project demonstrated that 
extravasation risks for CCU patients could be further minimised by 
ensuring CVCs are sutured at the hub, and careful selection of toxic 
drugs to the most distal ports. Changing the location of CVP monitor-
ing from the distal port may help facilitate this. This is a cost neutral 
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way or minimising extravasation risk and promoting patient safety in 
Critical care.
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Introduction: 
Delayed Discharge : Defined as ‘the period of continued hospital stay 
after a patient is deemed medically fit to leave hospital but is unable 
to do so for non-medical reasons’.(1)
Costs of NHS in England associated with delayed discharge are 
approximately 100 million GBP per year and resulted in 1.2 million bed 
days lost in 2013-14.(2)
Objectives: 
FICM Edition 2 June 2019: Guidelines for the provision of intensive care 
services.
Discharge from critical care to a general ward must occur within four 
hours of the decision and must occur between 07:00 and 21:59.
QIPP Reference 16-17 S4-Trauma
National standard that all discharges from adult critical care should be 
made within 4 hours of a clinical decision to discharge.
Compliance of UHNM to national guidance and FICM guidance
Methods: 
Retrospective observational study
12 month period from Jan-Dec 2019
All admissions to adult critical care
Extract CCMDS information from 4D auditing software
Wardable date input by nurses after consultant ward round and coun-
ter checked by validator
>4 hours after ready date
Convert hours delayed to days
HRG code * Days Delayed = Cost of delay
Results: 
921 (86.4%) delayed discharges
1,096 days
Average 1.2 days delay per patient
Cost over the year £1,919,252
Average 3 beds/day
70 band 5 salaries
Conclusion: 
Delayed discharge is recognised to be a system level problem requir-
ing effective team working within hospitals and coordination between 
health and social care .
Adverse outcomes of delayed discharge include :
For patients:
an association with increased risk of mortality,Hospital–acquired infec-
tions, mental ill health
a reduction in patient’s mobility and activities of daily living
For health care staff
Stress, diversion from a primary focus on patient care and deleterious 
interprofessional relationships,all with potentially harmful
implications for patient’s health and well being
As well as impact on inpatient costs, there are additional economic 
repercussions for other services.
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Introduction: Critical Care consultant led outreach services (Outreach) 
are set to assist the hospital wards in the prompt detection and care of 
the acutely unwell and deteriorating patients. The patients on the gen-
eral wards are referred to the Outreach if their National Early Warning 
Score (NEWS 2), which in the UK may range from 0 up to 20 maximal, 
reach certain thresholds or if there appear any other significant con-
cerns. According to the algorithm printed on NEWS-2 charts: values 5 
or more (or 3 in one parameter) trigger an urgent patient’s review by 
the parental team; values 7 or more trigger the urgent automatic refer-
ral to Outreach team. After a prompt review by an outreach consultant 
and a senior nurse, the decision is made whether the patient needs 
an urgent Critical Care admission. In more reassuring cases, patients 
continue to be managed on the wards under a close supervision by 
the Outreach. Unfortunately, some of the patients have multiple co 
morbidities and their physiological reserve is very limited. Therefore, 
any potential Level 2 or Level 3 technological organ support would be 
futile. In those cases a difficult (but necessary) decision is made that 
the ward based care should be the ceiling of treatment for the patient. 
This group of patients is very diverse in the setting of a district general 
hospital. Nevertheless, there are certain similarities within this cohort. 
Typically, these patients are frail and old with concurrent chronic ill-
nesses and a poor excercize tolerance. The vast majority are medical 
patients with sepsis of various origins. Their increased NEWS reflects 
patients’ acute deterioration and impending organ failure. Therefore, it 
is paramount that such decisions are absolutely correct. Thus, we have 
conducted a retrospective, observational, single centre study of the 
relevance of NEWS magnitude to the outcomes of the hospital wards’ 
patients referred to the outreach service, but deemed not to be appro-
priate for critical care admission secondary to their comorbidities and 
a limited physiological reserve. The project has been approved by the 
Health Research Authority, reference number is 268879.
Methods: We followed up 152 patients admitted to our hospital 
between 1/12/2017 and 24/12/2018 who at any point were referred 
to Outreach, but deemed not appropriate for any critical care organ 
support as above. The ceiling of care would be at Level 1 (ward-based 
care only).
The analysed data included NEWS and a fraction of inspired oxygen 
(FiO2) (delivered through an appropriate device) as documented 
at the time of Outreach referral; mortality in-hospital and for up to 
3  months after the hospital discharge, if happened; length of hospi-
tal stay (LOS), age, gender and diagnosis on admission. The patients’ 
groups were defined as: “hospital non survivors or HNS”; if died within 
three months after the date of discharge - “3 months non survivors or 
3mNS” and, if survived for more than 3 months - “3 months survivors 
or 3mS”.
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The statistics are presented as medians with interquatile ranges or 
means with standard deviation. Comparisons between groups were 
made using Wilcoxon rank sum test for non-normally distributed data. 
We used logistical regression for associations and reported results as 
odds ratios with 95% confidence interval. Time dependent outcomes 
were assessed with Kaplan Meier analysis as hazard ratios. Length of 
stay data were modelled using Poisson regression.
Results: The hospital mortality (HNS) was 46.7% (71 patients). 3mNS 
comprised 15.8% (24 patients). 3mS constituted 37.5% (57 patients).
Median (quartiles 1 and 3) NEWSs were: HNS – 7 (5.5-9), 3mNS – 7 
(5-8.25), 3mS – 6 (5-8). There was no statistically significant difference 
between the groups.
Median FiO2 levels were: HNS – 35% (28-60), 3mNS – 28% (23.25-60), 
3mS – 28% (24-40). There was a trend for a better survival in patients 
on lower FiO2.
Median patients’ age was: HNS – 75, 3mNS – 74.5 and 3mS – 73 years.
Median lengths of hospital stay (LOS) were: HNS – 8 (4-13) days, 3mNS 
– 19 (9.5-31) days, 3mS – 20 (11-30) days.
Subsequently, the sample was split in: patients with NEWS “5 and 
above” (123/152) median NEWS 7 (6-10) and with NEWS “4 and below” 
(29/152) median NEWS 3 (2-4)
Their respective: hospital mortality was 47.2% versus 44.8%, 3 months 
mortality was 15.4% versus 17.2% and 3  months survival was 37.4% 
versus 38%.
Conclusion: High NEWS scores are not associated with worse 30 days 
or 3 months mortality in this patients’ cohort.
High NEWS scores are associated with shorter LOS within the survivors 
group.
Chronological age does not appear to be a risk factor.
No particular diagnosis strongly predicts in-hospital mortality.
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Introduction: The concept of ICU follow-up clinics arose in 1993 in 
the United Kingdom to identify and rehabilitate patients with post-
intensive care syndrome (PICS)(1). Recently, an increasing number of 
ICUs had organized the same program to assess patient’s conditions 
after ICU discharge. In Belgium, we do not have a national guideline 
or recommendation for the ICU follow-up program as in the UK and 
Netherlands for instance(2,3). We therefore performed a national sur-
vey to assess Belgian ICU follow-up practice.
Methods: This Survey was designed based on the International Hand-
book of Survey Methodology sponsored by the European Association 
of Methodology (EAM) and the Revised WAPOR Code of Ethics, 2011 
(WAPOR – World Association for Public Opinion Research). The Sur-
vey has been endorsed by the Belgian Society of Intensive Care (SIZ). 
We developed a closed and self-enumerated questionnaire that had 
initiated its content validated by four experts and a pilot phase. After 
the validation process, in March 2019, the questionnaire and the 
cover letter were addressed to directors of ICUs in Belgian hospitals 
electronically (one per ICU). The questionnaire was anonymous, and 
no electronic tracker was used to identify the responders. Two weeks 
following the distribution, a reminder letter and the link to access 
the questionnaire were resent by email. After eight months, a new 
reminder was sent by the Belgium Society of Critical Care, trying to 
increase the response rate.
Results: Thirty-six out of 82 potential respondents (43%) completed 
the Survey. Specifically, 35% (16/46), 46% (12/26), and 80% (8/10) of 
respondents were considered from Flanders, Wallonia, and Brussels-
Capital, respectively. Six centers (17%) have an ICU follow-up program 
currently running. When we analyzed the profile of patients involved, 
the ICU length of stay, and the duration of mechanical ventilation 
were the two mean criteria to select eligible patients. Only one of the 
six centers received external funding to support this program; two of 
the five remaining centers used internal financial support to afford 
the ICU follow-up activities. Thirty centers did not run an ICU follow-
up clinic. The main reasons were the lack of human resources (20/30 
67%) and financial constraints (12/30 40%). Seven centers (23%) also 
justified the lack of ICU follow-up program with the absence of clinical 
need and of current evidence for benefits. Only 4 (13%) centers were 
not interested in starting an ICU follow-up clinic if possible.
Conclusion: The use of an ICU follow-up program is implemented in 
a minority of Belgian ICUs. Funding and human resources are critical 
issues to solve and promote this activity in more centers.
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Introduction: Levosimendan is a calcium sensitizer developed for 
intravenous use in hospitalized patients with acute heart failure (AHF) 
(1).
Aim of this study is to observe the cardiac function’s index, Mean 
Arterial Pressure (MAP) and diuresis after the administration of Levo-
simendan (G1) rather than control group (G2) started 12 hours before 
cardiac surgery (2).
Objectives: In this prospective observational study 47 patients con-
secutive admitted in ICU of “Città di Lecce Hospital- GVM Care and 
Research” with AHF (Ejection Fraction <40%) were included.
Methods: Patients admitted in ICU were randomized to receive either 
Levosimendan infusion duration up to 24 hours(0,1 mcg/Kg/min) (G1) 
(18 patients).
Patients undergoing urgent cardiac surgery, severe ipotensive syn-
drome or left ventricular ejection stenosis were excluded (29 patients).
Measurement were collected at TO (before to start Levosimendan infu-
sion), T1 (in operation room before to start cardiac surgery), T2 (when 
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was interrupted extra corporeal circulation), T3 (in Intensive Care Unit) 
and T4 (24  h after Levosimendan administration). Were recordered 
major functional cardiac index such as Ejection Fraction, Stroke Vol-
ume, Cardiac Output and TAPSE with echocardiography transesofa-
geal (T0, T1, T2) and transthoracic (T3, T4) and were collected Mean 
Arterial Pressure, ScvO2, lactate in blood gas analysis, diuresis.
Pvalue of 0,05% was considered statistically significant.
Results: Echocardiografy showed no statistically significant difference 
in Stroke Volume (p=0.8) and Cardiac Output (p=0.99) between two 
groups. In both groups SV and CO parametres increased progressively 
rather than baseline, expecially in G1.
Ejection Fraction increased significantly at any time vs baseline in G1 
(p<0,049), whilst they remained stable over time in G2.
TAPSE was stable during the study period in G2, while the trend 
increased progressively only in G1. Howewer no statistically difference 
between groups.
Comparisons between groups showed similar ScvO2 levels at baseline, 
whilst they significanlty increased in G1 vs G2 at T2, T3 and T4 (p>0.05) 
as anaerobic metabolism’ index.
In both groups lactate levels increased during the study period espe-
cially at T2, but non statistically difference between G1 vs G2. In post-
operative times blood-gas assessment showed impaired lactate values 
in G1 vs G2.
The analysis found that diuresis was lower in patients treated with 
Levosimendan (G1) vs placebo (G2) in 24 hour after surgery. Perhaps 
no statistical difference between two groups.
No patient had adverse reactions or oversensitiveness to Levosi-
mendan infusion.
Conclusion: The preliminary data of the study support these conclu-
sions: (i) the optimal dosing is 0.1 mcg/kg/min for 24 hours of Levo-
simendan did not increased the SV and CO value, whilst increased EF 
statistically significant (ii)lactate concentration in gas analysis decrease 
in patients treated with Levosimendan, whilst also suggest that Levo-
imendan improved ScvO2 (iii) levosimendan did not enhance the 
diuresis in G1 vs G2 and (iv) Levosimendan infusion should be started 
before surgery to exert its preconditioning effect.
Levosimendan infusion sustained haemodynamic improvement in the 
acute heart failure patients.
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Introduction: Communication with and participation of families and 
patients during their stay in an intensive care unit (ICU) has evolved 
over the last decades, by means of different approaches, such as: 
family-centred rounds, daily updates, electronic patient portals and 
interdisciplinary family meetings. Family-centred care is desired by 
patients and families, and evidence suggests that it may improve user 
outcomes, and reduce burnout and moral distress among clinicians. 
This patient/family-centred approach is challenged during large-scale 
disasters, where movement restrictions are implemented to preserve 
public safety/health.
In March 2019, our hospital following Public Health England guid-
ance, restricted patients’ family and friends (PFFs) visitation rights in 
response to the COVID-19 pandemic.
Objectives: We describe the setting up of a service to communicate 
with patients’ families.
Methods: A service improvement project in a tertiary London hospi-
tal, during the 2020 novel COVID-19 pandemic. The Trust increased its 
beds from 81 to 140 to cope with the surge in patients and a total of 
10 critical care (CC) areas were developed (increased from 5). As quar-
antine and national guidance prevented relatives from visiting the 
hospital, we explored the possibility of creating a dedicated team of 
professionals that would focus on communications with patients’ fami-
lies and friends (PFFs)
Results: A dedicated team of redeployed healthcare professionals was 
assembled on 25th March (family liaison team, FLT), with a total of 40 
people volunteering. The vast majority (75%) were medical consultant 
grade. Their background specialty is shown in figure 1 and their main 
responsibilities in figure 2. The teams were allocated to each CC area, 
with a maximum ratio of 1:10 and underwent 2 1-hourly webinars 
around basic family communication skills. The following routine was 
followed: at 8am the FLT attended the doctors’ handover and identi-
fied any patients who had deteriorated overnight in order to update 
their families. They then communicated with the medical team after 
the ward round and transferred the information to the next of kin of 
each patient. Video calls were facilitated during the day, depending on 
the availability of the family and the bedside nurse. Until May 10th, the 
FLT has facilitated over 12,000 (video-) calls and communicated with 
>90% of PFFs daily.
We defined the FLT responsibilities as follow: daily medical updates, 
facilitation of video calls, information, provision and suppor for 
families visiting (visiting was allowed for deteriorating patients or 
approaching end of life), obtaining social history if not completed at 
time of admission, communicate information to medical and nursing 
team and identification of families/friends with specific needs (young 
children, impending bereavement, social and psychological support) 
and refer them to the appropiate services.
We also developed a document to serve as a guide for the FLT during 
the communications with PFFs, which included: introduction to the 
team, how to give daily updates and how to manage difficult conver-
sations if patients were deteriorating.
Conclusion: Non-CC professionals have been pivotal in continuing the 
patient-family connection in our institution during the pandemic. The 
model is successful, requiring moderate training for the FLT. Further 
evaluation both for the team and around PFF satisfaction is currently 
underway.
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Introduction: Since December 2019, Coronavirus Disease-2019 
(COVID-19) spread rapidly all over the world, resulting in pandemic 
[1,2,3]. Through high hospitalization rates and via potentially exponen-
tial expansion of the disease, the COVID-19 crisis places a tremendous 
strain on healthcare systems, especially on limited numbers of hospital 
and Intensive Care Unit (ICU) – beds and equipment [4,5].
Objectives: The aim of this study was to elucidate the possible 
dependency of ICUs in European Countries with Austria as a pars pro 
toto in particular on long transglobal supply chains and its potential 
vulnerability by reported shortages of essential medicines and limited 
capacities in times of globalization and asserted economic advantages 
versus the pandemic threat of COVID-19 [4,5,6].
Methods: From 3 April to 8 April 2020 we performed a short survey 
with heads of Austria’s ICU-wards in different institutions following a 
structured questionnaire to enquire their personal experience and 
assessment.
At that time containment measures with exit restrictions, starting on 
16 March 2020, has lasted for a time span of three weeks. Due to the 
dynamic situation during pandemic with constantly changing export 
bans and travel restrictions especially represents a current snapshot of 
the situation in that time.
Results: We surveyed nearly half of the head physicians of ICUs 
(n=40) in Austria [7]. 55 percent (n=22) are already treating COVID-
19 affected patients at their ICU department. Only 45 percent (n=18) 
of them had received the amount of personal protective equipment 
they deemed enough, and 90 percent (n=36) of surveyed ICUs were 
already informed about shortage supplies concerning personal pro-
tective equipment. (Fig. 1) 45 percent (n=18) already reported infec-
tions within their medical personnel. According to the estimation of 
heads of ICUs the duration of pandemic should not last more than 
6 weeks averagely without facing difficulties in storage and availabil-
ity of supply. 35 percent (n=14) already reported supply difficulties in 
several pharmaceuticals, whereas 73 percent (n=29) were informed or 
already warned by their economic or purchase departments about fur-
ther potential or real shortages concerning essential pharmaceuticals 
in near future. Detailed results are illustrated in Fig. 2.
Fig 1. Results concerning equipment of all surveyed ICUs
and in dependence of hospital type
ICUs and in dependence of hospital type 
Fig 2. Results concerning pharmaceuticals of all surveyed
Conclusion: Summarizing the results of our survey we would like to 
draw attention to the lessons we can learn from the COVID-19 crisis 
in the EU: European Countries with Austria as a pars pro toto should 
establish a national production of key equipment and disposables,at 
least a minor part of PPE as well as key pharmaceuticals. European 
countries need to improve far distance supplies and invest in main-
taining critical infrastructure especially in those with limited capacities 
such as health care in general and ICUs in particular.
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Introduction: We present an early analysis and account of our expe-
riences using our primary non-invasive ventilation (NIV machine), 
Respironics V60  ventilator®, as a first line expansion for invasive 
ventilation.
Objectives: Review how the V60 ventilator may be used for invasive 
ventilation
Methods: We obtained 25 V60 units for critical care. Our surge plan 
was shaped by staff familiarity with the V60 versus staff unfamiliarity/
limited supply of consumables for Anaesthetic Machines
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We maximised staff protection from aerosolised SARS CoV-2 dur-
ing V60 use by adding a Clear-Therm 3 HMEF (1541)® to allow circuit 
breaks. We used Pressure Control Ventilation (PCV) as our mandatory 
mode, which was not used prior to COVID19. Spontaneous/Timed 
(S/T) mode was used for support ventilation.
Laminated setup guides for circuits and initial settings were attached 
to all machines supported by comprehensive face-to-face and video-
conferencing training delivered to all relevant staff.
Results: The V60 ventilator has formed a significant part of our surge 
response, used in 30 out of 81 (37%) patients. These patients received 
572 ventilator days, with 239 on a V60 (42%).
Key issues arising from use were filter saturation, oxygen consumption 
in PCV vs S/T mode, requirement for increased pressure support for 
CPAP equivalence and the lack of an inspiratory hold for recruitment 
manoeuvres.
The proximity of the HMEF to nebuliser caused frequent filter satura-
tion and high resistance. Filter issues were noted in 11 (37%) patients. 
This was worse in cases using nebulised epoprostenol (epo). Using a 
trial of epo 15 ng/kg/min for 30 min we could identify patients better 
suited to ventilation with a full service (Servo-i) ICU ventilator.
Oxygen usage of V60 was much higher than the anticipated 
10-15LPM. In PCV on 100% O2 the V60 used 46LPM, at 60% 21LPM, 
making patient transfer difficult.
We created a recruitment manoeuvre which was used successfully in 9 
(30%) patients. Settings of RR to 10, i-time 3 s, IPAP 40, EPAP 25 were 
used for this.
Though V60 ventilators were unable to invert ratios >1:1, 2 patients 
were proned on V60 ventilation, 1 died but the other has been dis-
charged from intensive care.
Lastly, we noted the standby function would continue producing aero-
sol by blowing when disconnected. However the V60 loads its previ-
ous settings when switched on, and does this in <5  s, so on/off was 
used in place of standby.
Conclusion: The V60 ventilator is a viable invasive ventilator if prob-
lems are addressed. With appropriate patient selection it can spare 
full-service ventilator capacity, and at 25% of cost of our full-service 
ICU ventilator it allowed a cost-effective expansion of our ventilator 
fleet.
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Introduction: Family satisfaction is an important indicator for quality 
improvement of intensive care units. Compliance with implemented 
protocols are often poor.
Objectives: The purpose of this study was to describe levels of fam-
ily satisfaction with the care provided in a Tunisian intensive care unit 
(ICU).
Methods: It was a prospective observational and descriptive study 
involving family members of patients admitted in a Tunisian medical 
ICU between November 2018 and Mai 2019. Family members of adult 
patients, staying at an ICU for ≥48 hours, were included. A question-
naire to measure family satisfaction with care provided in the ICU 
was developed. Family members were asked to complete the ques-
tionnaire and to provide information about their own demographics. 
Data on patient’s baseline characteristics were abstracted from charts 
retrospectively.
Results: Ninety-three family members completed the questionnaire. 
Demographic characteristics of study related patients were: male, 
76(81.7%) mean age, 56.6±15.4  years; respiratory distress at admis-
sion, 79(84.9%); mean length of stay, 14.4±18.5  days. Respondents 
characteristics were: mean age, 39±13 years; female, 51(54.8%); first-
degree parents 48(51.6%); mean waiting delay, 42.4±28.1mn.
Twenty-eight (30.1%) of respondents were satisfied with overall care. 
Families reported good satisfaction with the waiting room atmos-
phere, visitor’s number and coordination and teamwork staff respec-
tively in 56(60.2%), 33(35.5%) and 28(30.1%). Families reported the 
least satisfaction for the availability and communication by nurses. 
Responses to family satisfaction questionnaire are displayed in Table 1.
Table 1 : Responses to questionnaire : Family satisfaction with intensive care unit (ICU) 
experience (N=93)
Good n(%) Fair n(%)
Poor 
n(%)
-Waiting delay before visits 
-Visit duration 
-Visitors’ number 
-Completeness of information about 
patient’s condition 
-Atmosphere of the waiting room 
-Psychological support of family members
-Availability of nurses 
-Availability of physicians 
-Management of anxiety and depression of
their patients 
-Medical secret respect 
-Courtesy, respect, and compassion 
toward patient 
-Pain’s patient management 
-Coordination and teamwork by staff 
-Communication by nurses 
-Psychological support of their patients 


















































Conclusion: Most family members were satisfied with the care pro-
vided in the intensive care unit. Communication and availability of 
nurses were areas with potential for improvement.
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Introduction: Critically ill patients are exposed to stressful conditions 
and may experience discomforts from multiple sources. Modification 
of the physical and psychological stressors would contribute positively 
to the short-term and long-term outcomes during the ICU stay and 
after the discharge.
Objectives: To explore self-perceived discomforts in critically ill 
patients.
Methods: A prospective cohort study was performed in medical ICU 
and anesthesiology department between September 2018 and Mars 
2019. All patients admitted during the study period were included. 
Patients with diminished mental capacity, unable to communicate or 
refusing to participate in the study were excluded. Patient discom-
forts were assessed using the 16 items self-reported discomfort ques-
tionnaire on discomforts in ICU patients (IPREA). Patients were asked 
to rate the severity of each discomfort experienced during their ICU 
stay using a 10-point numerical rating scale (example: 0 = no pain and 
10 = worst pain possible). Patients characteristics were recorded from 
medical patients ‘charts.
Results: One hundred twenty patients completed the questionnaire. 
51(42%) patients were admitted in the medical ICU. Clinical character-
istics were: female, 60 (50%); mean age, 47.9±18.5 years; mean length 
of stay, 10±2  days; acute respiratory failure, 39 (32.5%); invasive 
mechanical ventilation, 48 (40%); noninvasive mechanical ventilation, 
72(60%); tracheostomy, 18 (15%).
The four highest discomforts were the absence of a phone, pain, sleep 
deprivation and limited visiting hours and the 4 lowest discomforts 
were feeling of cold, hunger, bed-related discomfort and feeling of 
heat. Self-perceived discomforts of the 16-item IPREA are displayed in 
Table 1.
 Table1: IPREA questionnaire for assessing self-reported discomforts perceived by the 
      critically ill patients 
Items Mean score ±SD/10
N 72.3±4.5esio
Excess of light 5.1±3.28 
Bed related discomfort 5.0±3.25 






Discomfort du to tubes 5.6±3.53 
Lack of privation 5.9±3.58 
Anxiety 5.7±3.38 
Isolation 5.3±3.54 
Limited visits hours 6.1±3.12 
Absence of phone 6.6±3.42 
Lack of information 5.8±3.44 
Conclusion: The findings of this study shed light on the difficulties 
that Tunisian ICU patients may experience and that could adversely 
affect their outcomes.
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Introduction: On February 18, 2020 the first Italian case of coronavi-
rus disease 19 (COVID-19) was identified in Lombardy. It was central-
ized in our hospital Fondazione IRCCS Policlinico S. Matteo, in Pavia. 
[1] Because of the rapid outbreak, the number of dedicated ICU beds 
was increased up to 72, even adapting operating rooms (OR) to a 
6-beds intensive care unit (ICU). As described in this case report, we 
treated there an obese COVID-19 patient with acute respiratory dis-
tress syndrome.
Methods: On ICU admission, a 33-years-old super-obese patient (body 
mass index, BMI 52  kg/m2) presented respiratory distress and critical 
hypoxemia, despite CPAP helmet. We promptly proceeded to video-
laryngoscopy intubation for invasive mechanical ventilation (MV). Past 
medical history revealed diabetes mellitus and psoriasis. Respiratory 
symptoms and fever began a week before. COVID-19 was confirmed 
by the reverse-transcription polymerase chain reaction analysis of the 
bronco-alveolar lavage. We faced several problems during admission: 
the limited respiratory mechanics data of an anaesthesia workstation 
(Flow-i®,  Getinge,  Göteborg, Sweden), the unfeasibility of oesophageal 
pressure measurement [2] and the difficulties to obtain a computed 
tomography scan due to the high BMI. However, we used available lung 
ultrasound (LUS) scan to quantify lung de-aeration [3] and set the posi-
tive end-expiratory pressure (PEEP) level up to 20 cmH2O. [4] (Figure 1) 
According to the LUS posterior consolidations and the anterior-lateral 
interstitial pattern [5] we carried out 12-16 hours prone positioning 
cycles [6,7] on neuromuscular blocking agents continuous infusion and 
proper sedation. Prophylactic antimicrobial therapy was carried out with 
azithromycin, ceftriaxone and trimethoprim/sulfamethoxazole. Prophy-
lactic heparin dosage (6000  IU q12h) was adjusted according to anti-
FXa monitoring, without major bleedings. [8] On day 1 the patient was 
enrolled in the convalescent plasma experimental treatment protocol. 
[9] On day 15,  Klebsiella Pneumuoniae  ESBL ventilator-associated  pneu-
monia occurred, with clinical status worsening. Antimicrobial therapy 
was then adjusted with meropenem. On day 19, percutaneous trache-
ostomy was performed to facilitate MV weaning. Intravenous sedation 
was de-escalated implementing oral sedatives, [10] without delirium or 
agitation.
Figure 1:PaO2/FiO2 compared to PEEP (cmH2O) and LUS score  
Results: On day 41 the patient was transferred to another ICU on 
assisted MV. Discharging was mandatory: our ICU was closed after the 
COVID-19 cases reduction in Italy, to allow return to surgical activity.
Conclusion: According to our experience, despite the limited 
resources it is possible to treat successfully a super-obese patient with 
severe COVID-19 infection in an OR converted into ICU.
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Introduction: Palestinian authority, population 2.8 million, is a low 
resource country facing COVID-19 pandemic, neighboring high 
resource country fighting the epidemic. In preparing ourselves, we 
creating a disaster committee, included private and governmental 
hospitals CEOs, infectious disease specialists and Intensivists.
Objectives: To share lessons learned, barriers overcome, discuss 
ethical and social implications of decisions made in the low resource 
country.
Methods: Epidemiological and national statistics will be demon-
strated, dealing with unestablished infrastructures and utilizing the 
existing resources. Enforced early total lockdown while saving lives 
had many ethical and social implications.
Results: 547 confirmed infected, 4 COVID-19 related deaths all in pro-
visional, urgently created ICUs. 40513 COVID-19 tests were performed. 
High risk population testing positive COVID-19 were workers transit-
ing daily into neighboring countries (75%), medical staff (3.7%), tourist 
industry related personnel (20.3%).
Conclusion: Early enforced lockdown the most effective governmen-
tal decision preventing population from getting sick. However, the 
burden of ethical, social and economic consequences is still being 
evaluated and will be discussed in this abstract.
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Introduction: During the Coronavirus disease 2019 (COVID-19) out-
break (1), the mission of our intensive care unit (ICU) team was to pro-
vide intensive care to whoever needed intensive care. Upon reaching 
the plateau of the outbreak in Italy, 7 wards were dedicated to high 
dependency units, counting approximately 100 beds [including 50 
level-2 beds delivering forms of non-invasive ventilatory assistance such 
as continuous positive airways pressure (CPAP), non-invasive ventilation 
(NIV) and high flow nasal cannula (HFNC)] The outreach team provided 
senior ICU decision support using a Goals Of Care Bundle (Figure 1).
Methods: We retrospectively evaluated data  from 125 patients 
referred to the outreach team from March 22– April 22, 2020 and 
outcomes after a minimum of 15-days follow-up.The data analysis 
refers to three subgroups of COVID-19 patients:patients admitted to 
the wards with respiratory symptom and receiving a ceiling of care 
decision (PCEI); patients requiring more detailed observation or inter-
vention including non-invasive forms of ventilatory support and con-
sidered eligible level-3 care, if needed (PWARD); patients admitted to 
the ICU within 24 h after the after the evaluation of the outreach team 
(PICU).
Results: From March 22 to April 22, 2020, 125 consecutive adult 
patients with a confirmed diagnosis of COVID-19 [a median (IQR) of 
25% (21% –27%) of the overall number of COVID-19 positive patients 
admitted to the Humanitas Research Hospital] have been referred 
to the outreach team (Figure  2). Overall, 61 patients (48.8%) were 
included in the PCEI group, 30 in the PWARD  and, finally, 34 in the 
PICU.  The median (IQR) number of patients receiving non-invasive 
respiratory support in the wards (including either helmet CPAP or NIV 
delivered by facemask or HFNC) was 9 (4–16), with a maximum of 19 
patients on March 28.
The overall in-hospital mortality of COVID-19 patients (including the 
emergency department, wards and ICU) in the considered period was 
26.8%, while the overall ICU mortality was 21.9%. At the end of the fol-
low-up, 19 patients in the PCEI group (31.1%), 29 in the PWARDgroup 
(96.7%) and 26 in the PICUgroup (76.2%) were discharged from hospi-
tal, to either home or rehabilitation facilities. Moreover, 41/65 patients 
in th e PCEI group (67.2%) died in hospital as compared to none in the 
PWARD and PICUgroups (p < 0.0001).
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Conclusion: In a context of hospital and ICU surge, implementation of 
a dedicated Critical Care Outreach was associated with proper alloca-
tion of ICU resources, a low rate of cardiac arrest calls and no emer-
gency intubations in the ward.
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Introduction: The COVID-19 pandemic created many challenges 
for ventilator surge capacity. Solutions included use of anaesthetic 
machines and the repurposing of Non-Invasive Ventilators. Use of Phil-
lips Respironics V60 Non-Invasive  Ventilator® in invasive, mandatory 
ventilation is previously unreported. Here, we describe our outcomes 
repurposing the V60 ventilator for COVID19 critical care admissions in 
a single UK tertiary centre.
Objectives: To describe the use of V60 Ventilators during a pan-
demic emergency. We focus on their utility, problems and place in our 
response going forward.
Methods: We performed retrospective analysis of all swab or BAL con-
firmed COVID19 positive cases admitted to intensive care in a Univer-
sity Teaching Hospital for 7  weeks upto 1/5/20. Descriptive statistics 
were performed using Microsoft Excel.
Results: 82 patients were admitted to intensive care with confirmed 
COVID19. Of these, 30 were ventilated with a V60. These 30 patients 
recieved 572 ventilator days with 239 days (42%) delivered by a V60. 
The mean ventilator days were 19.1 with 8 V60 ventilator days. A V60 
was used for Mandatory ventilation in 19 patients, of these 12 were 
ventilated on a V60 immediately following intu. 11 used a V60 for 
spontaneous ventilation/weaning only.
In total 14 patients failed on a V60 and were changed to a full-service 
ICU ventilator (Servo-i): 2 for non-clinical reasons, 2 for bronchoscopy, 
1 for ECMO, 2 for humidified circuits, 2 for proning and 2 for dyssyn-
chrony. 93% of these failures occurred in the patients requiring man-
datory ventilation and those with more severe ARDS, only 1 occured 
in the spontaneous ventilation only group. Proning was performed 
in 2 patients whilst ventilated on a V60, of which 1 survived to ICU 
discharge.
A total of 64/82 COVID19 patients admitted to critical care have either 
been discharged from ICU or died. 39 (61%) were alive at ICU dis-
charge and 25 (39%) died. For the patients ventilated on a V60 at any 
point 18/26 (69%) where discharged from ICU alive and 8/26 (31%) 
died. For those not ventilated on a V60 at any point 21/38 (55%) left 
ICU alive and 17/38 (45%) died.
Conclusion: When a V60 was used, it was able to provide 239/572 
(42%) of ventilator days. However a universally high failure rate, 13/16 
patients (81%), in those with moderate-severe ARDS when used for 
mandatory ventilation makes it clear that it cannot be used as a direct 
replacement for an ICU ventilator. If used in carefully selected patients, 
with experienced staff, it can contribute significantly to surge capac-
ity by sparing ICU ventilators for those requiring advanced respiratory 
support. At 25% cost of a full-service ICU ventilator it can, when used 
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appropriately, allow for cost-effective surge expansion of ventilator 
capacity.
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Introduction: We present the experience of a UK single tertiary centre 
in managing supplies of essential critical care medications during the 
COVID-19 pandemic.
Objectives: To identify challenges and solutions in managing supplies 
of essential critical care medications during the COVID-19 pandemic.
Methods: During the surge of COVID-19 patients, shortages of propo-
fol 2%, fentanyl, norepinephrine and atracurium were experienced. To 
facilitate safe sedation, a policy was developed to prioritise short-act-
ing agents for light sedation and patients likely to accumulate other 
agents. Combinations of long-acting agents including morphine and 
midazolam were used for deep sedation and a nurse-led bolus dosing 
strategy was used in selected patients.
A coordinated switch to 1% propofol was made, requiring staff train-
ing and dietetic input for calorie differences. Shortages of atracurium 
were managed with bolus regimes of pancuronium.
To maintain supplies of noradrenaline, an alternative unlicensed for-
mulation was received. We coordinated the local setup of a Central-
ised Intravenous Additive Service for preparation of noradrenaline 
pre-filled syringes. This mitigated risks of incorrect concentrations or 
diluents and reduced nursing workload, particularly given use of non-
critical care nursing staff.
Availability of Continuous Veno-Venous Haemodiafiltration (CVVHDF) 
sets and fluids has been challenging, requiring supply management 
on a regional level. Locally, risk of shortage was mitigated through 
elective filter breaks, requirement for Consultant approval for restart 
following clotting and judicious use of exchange rates. A protocol for 
the addition of potassium to potassium-free fluids was also developed.
Figure  1 demonstrates the baseline and peak demand across the 
region for each of these therapies.
Throughout the surge, real-time administration data was able to be 
extracted from the local electronic prescribing system for all critical 
drugs, facilitating timely and more accurate planning of management 
strategies.
Results: There were challenges related to timely availability of drugs 
in areas where Aerosol Generating Procedures were performed. We 
installed additional controlled drug cupboards and fridges in isolation 
areas and emergency drugs in each bed space drug locker, so drugs 
could be available quickly whilst maintaining storage and governance 
requirements.
To manage the shortage of CVVHDF supplies, work to plumb reverse 
osmosis water supplies to our ICUs has been completed. This has 
allowed the use of Sustained Low Efficiency Dialysis (SLED) in selected 
patients.
Conclusion: Our response locally has focused on rapid-response 
amendments to formulary with new policies and adaptations to usual 
practice to support use of alternative agents. A prospective, pragmatic 
and flexible approach has been required with actions to mitigate, 
rather than eliminate, risk. This has minimised the need for emer-
gency, unplanned changes in policy.
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Introduction: The 1st of May 2019 a rapid response system (RRS) was 
established at Queen Ingrid’s Hospital, Nuuk, Greenland to ensure 
immediate assistance to patients suffering from critical illness, trauma 
or are in cardiac arrest. A rapid response team (RRT) composed of 
physicians, nurses, patient transporters and laboratory technicians is 
triggered by an early warning system (EWS). The EWS is defined by 
certain thresholds, such as deviating vital parameters or mechanism of 
trauma. Queen Ingrid’s Hospital have a capacity of approximately 100 
beds, including 4 in the intensive care unit. The emergency personnel 
are on call from their homes.
Objectives: The objective of the study is to describe the incidence, 
typical location, type of event (i.e. critical illness, trauma or cardiac 
arrest) and triggers activating the RRT. Furthermore, we want to meas-
ure certain quality indicators and describe the outcome of the patients 
managed by the RRT.
Methods: From 1st of May 2019 until the 1st of May 2020, we plan to 
examine and collect data from the electronic health record each time 
the RRT is deployed. Here we obtain information on the type of event, 
vital parameters, mechanism of trauma and treatment given (e.g. intu-
bation, medicine). Furthermore, we obtain information on the time of 
death.
Results: During the first 11 months the RRT have treated 88 patients 
corresponding to 1,83 per week. The patients had a median age of 
55 (interquartile range (IQR) 31-67) and 53 (60.2%) being male. 25 
patients (28.4%) have been in cardiac arrest, 25 (28.4%) suffering 
from traumas and 38 (43.2%) presented with critical illness. 71 (80.7%) 
were received as out-of-hospital patients while 17 (19.3%) were hos-
pitalized. The 30-day survival for patients in cardiac arrest, critically 
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ill patients and patients suffering from trauma was 13.7%, 84.2% and 
88.0%, respectively.
Conclusion: In 2019 a RRS was established at Queen Ingrid’s Hospital, 
Nuuk, Greenland. To monitor and evaluate the system, we plan to col-
lect data from the first year after implementation. Preliminary results 
from the first 11 months indicate that the system is frequently being 
activated and especially from the emergency room.
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Introduction: After severe acute respiratory syndrome coronavirus 
2 outbreak in Wuhan, China, coronavirus disease 2019 (COVID-19) 
spread out in a pandemic. [1] On February 20, 2020 the first Italian case 
of secondary transmission was centralized in our hospital Fondazione 
IRCCS Policlinico San Matteo, in Pavia. The rapidly growing numbers in 
Northern Italy [2] imposed our hospital to increase greatly the already 
available 31 intensive care unite (ICU) beds [3].
Methods: On March 14, 2020, after the surgical activities suspension, 
we converted in a short time (8 hours) a surgical unit (SU) into a 6-beds 
COVID-19 ICU, reaching the hospital total capacity of 72 ICU beds.
Results: This cardiothoracic SU was square-shaped with four operat-
ing rooms (OR) on the corners, connected by an interior passage. We 
isolated this area with a double filter system in the pre-operative hold-
ing areas: a “clean filter”, at the entrance, was reserved for disposable 
personal protective equipment [4] wearing, while a “contaminated” 
one, at the exit, was for undressing procedures. In the interior cor-
ridor we allocated the drugs storage, while a blood gas analyser and 
a point-of-care coagulation monitoring system were already in place. 
An ultrasound machine, a fibre optic bronchoscope and a defibrillator 
were also available (Figure 1).
Outside this space we set up a “control unit” area, equipped with a cen-
tralized parameters monitoring system and a video surveillance sys-
tem, with a camera in each OR.
Communications were possible thanks to an internal telephone line 
and professional walkie-talkies.
In a situation of ICU ventilators shortage, three beds were equipped 
with Servo 900  C® ventilators (Siemens Elema, Solna, Sweden) kept as 
back up machines till then, while the others had the Flow-i® anaesthe-
sia workstations (Getinge, Göteborg, Sweden) routinely used in the 
SU. The wall gas aspiration system was connected to the ventilators 
expiratory valve, preventing airdrops dispersion. Essential devices, 
such as monitoring tools and aspiration systems, were already avail-
able in each OR. In a limited resources context this was an undoubted 
advantage, compared with the rearrangement of a traditional ward.
Many of the nurses and health workers employed were ordinarily 
working in this SU. Medical staff was composed of anaesthetist-inten-
sivist physicians and residents, most of them with an anesthesiological 
background.
We performed daily bedside lung ultrasound (LUS) monitoring to 
minimize the use of traditional imaging, reducing transports to the 
radiology department. Moreover, with limited lung mechanic meas-
urements availability, we used LUS to titrate ventilation settings. [5,6]
 Figure 1: ORs rearrangement into a COVID-19 dedicated ICU.  
Conclusion: According to our positive experience, during a health 
emergency OR represents a real and feasible source of ICU beds, 
quickly available and easy to set-up.
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Introduction: The idea of shared decision making (SDM) was first 
proposed in 1972, with gradually increasing its importance as the 
upsurging interest in patient centredness and autonomy in health 
care interactions since the 1970 s. It has became the major care model 
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enbodying patient centered care and physician-patient equality inter-
action. Hospice palliative care among terminal critical illed patient, 
determined by two separate specialist based on the Hospice Palliative 
Care Act definition, has long been poorly accepted owing to cultural 
mis-understanding, especially among Chinese. By retrospective cohort 
data analysis, we try to unvealed the impact of introducing SDM on 
hospice palliative care in terminal critical adult ICU patients
Methods: Medical record of medical center adult ICU admitted ter-
minal critical illed patient from Jan. 1st, 2017 to Dec. 31th, 2019 was 
retrospectively reviewed, and further subdivided into pre-SDM and 
post-SDM (after Oct. 1st, 2018) intervention period for analysis. Ter-
minal critical illed was defined as ICU admitted patient fit following 
criteria including advanced malignancy, end-stage motor neuron 
disease, decompensated heart failure with NYHA Fc IV, oxygenation 
or ventilator dependent pulmonary and airway disease, liver cirrhosis 
Child-Pugh C with episodes of hepatic encephalopathy, hemodialysis 
dependent acute or chronic renal failure, extremely elderly associ-
ated organic psychosis or central nervous system degeneration, and 
fulminant critical condition, which post tolerated available treatment 
without clinically improvement determined by two separate special-
ist. Decision about withdrawal, discontinuing, or refusing any add-on 
life supporting management was considered as palliative care. Data 
including SDM impact on palliative decision associated withdraw or 
withhold rate, ventilator dependent days, length of ICU stay, length 
of hospital stay, means of withdraw or withhold, and average medical 
cost were collected. SPSS was applied for statistically analysis, and a p 
value less than 0.05 was considered significant difference.
Results: Medical records from total 9198 patients from Jan. 1st, 2017 
to Dec. 31th, 2019 were reviewed based on tertiary medical center 
adult ICU record. According to inclusion criteria, 56 patients out of 
5209 patients fit terminal critical illed patient during the pre-SDM 
(before Oct. 1st, 2018) in compared to 153 patients from 3989 patients 
in post-SDM (after Oct. 1st, 2018), and 173% improvement over identi-
fying terminal critical illed patient impressed. In compared to pre-SDM, 
post-SDM terminal critical illed patient had less ventilator dependent 
days(23.9+/-18.5 v.s 21.2+/-16.7, p< 0.05), shorter length of ICU stay 
(24.9+/-19.2 v.s 21.8+/-15.3, p< 0.05), and shorter length of hospital 
stay (31.2+/-25.9 v.s 27.6+/-23.3, p< 0.05). The most often chosen 
withdrawal is hospice endotracheal tube extubation, and the most fre-
quent chosen withhold is vasopressor pump prescription. After SDM 
was introduced, ventilator days, length of ICU stay, and length of hos-
pital stay of terminal critical illed patient was found reduced 2.7 days, 
3.1  days, and 3.6  days individually in compared to each other. The 
average medical cost was also decreased after SDM introduced.
Conclusion: Our retrospective cohort study from a single medical 
center adult ICU revealed introducing shared decision making on hos-
pice palliative care over terminal critical illed patient might improve 
palliative decision associated withdrawal or withhold rate, reduce ven-
tilator days, length of ICU stay, and length of hospital stay. Introducing 
shared decision making on hospice palliative care over terminal criti-
cal illed patient reduce futile medical treatment and associated exces-
sive medical cost.
Keywords: shared decision making, hospice palliative care, terminal 
critical illed patient.
000712 
Reducing breathing system transmission of Covid‑19: The 
Addenbrooke’s experience
J. Gutsell1; Y. Yang1; M. Jeffrey1; A. Conway‑Morris1; R. Mahroof1; J. Martin1
1Department of anaesthetics & intensive care medicine, Addenbrooke’s 
Hospital, Cambridge University Hospitals NHS Foundation Trust, Cam‑
bridge, United Kingdom 
Correspondence: Y. Yang
Intensive Care Medicine Experimental 2020, 8(2): 000712
Introduction: The SARS-Cov-2 coronavirus partly spread via aero-
solisation. To reduce nosocomial infection within our ICU it was nec-
essary to effect equipment and behavioural changes. We provide 
an experiential narrative of a single UK tertiary centre of the adapta-
tions to reduce viral particulate load, and steps to disseminate this 
information. Subsequent issues and how these were resolved, are 
then described.
Objectives: To identify aerosol generating procedures (AGP) 
within ICU and to create a breathing circuit aiming to minimise viral 
transmission.
Methods: We adopted a pragmatic approach, intending a log 5-6 
reduction in viral exposure. Equipment and procedural changes were 
implemented to effect this change. We replaced current heat and 
moisture exchangers (HME) with high efficiency filters (HEF) after com-
paring manufacturer values for bacterial vs viral efficiency. We adopted 
a modified RSI technique using apnoeic oxygenation was encouraged, 
with bagging avoided. An ‘optimal’ breathing circuit setup was pro-
posed (see Fig 1). Setup then focused on ensuring expired gas always 
passed via a HEF, and that circuit breaks occurred distal to this. Specific 
high risk situations were considered; if circuit breaks were necessary, 
these occurred during apnoea with ventilators on standby and port-
able ventilators and bag valve masks ventilate to air, though not via 
expiratory limb - we focused on education to address this issue.
Results: Filter saturation was the most serious difficulty we encoun-
tered. The combination of Aerogen nebulisers, and in particular epo-
prostenol nebulisers, caused abrupt occlusions of HEF risking airway 
emergencies. We considered both modifiable and non-modifiable fac-
tors to manage occult respiratory gas loss:
 Modifiable consideration included positioning of capnography 
sampling, which exhaust to air, post-filter. Aerogen nebulisers 
required distal placement relative to the HME. We received reas-
surance from the manufacturer that these nebulisers had not pro-
duced detectable leak during normal use.
 Non-modifiable concerns included that ‘suction above cuff’ 
endotracheal tubes were not easily clamped, thus this was dis-
couraged owing to ineffectiveness and risk of damage. We 
adopted a practice of paralysis with ventilator standby during 
planned disconnection. Similarly, portable suction devices lack 
viral filters and any use had to be treated as an AGP.
As a number of modifications to usual practice were required, multi-
disciplinary education was necessary. Regular tutorials were available, 
with time for discussion regarding airway management. Teaching was 
available within ICU, dynamically changing as the situation developed.
Conclusion: Through consideration of changes to usual equipment 
and behaviours, we were able to achieve effective reduction in viral 
transmission in the context of an emergent pandemic.
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Introduction: At any moment of their exercise, residents of intensive 
care medicine (ICM) confront insurmountable stress. This is mainly due 
to the critical situations they encounter, especially as it is associated 
with lack of experience. Debriefing is a tool designed to relieve this 
stress and transform the error in learning.
Objectives: to assess the application of debriefing in clinical situations 
in residents of ICM and to inquire about their expectations.
Methods: Descriptive survey, focusing on residents of ICM from all 
over Tunisia after their consent. Data were collected using a 30-ques-
tions computerized questionnaire developed on the “Google Forms” 
platform which was sent to their personal email addresses. The topics 
investigated their experiences of debriefing after critical situations, the 
interest and expectations brought to debriefing in real practice.
Results: 100 responses were collected from 220 questionnaires sent 
representing a participation rate of 45,5%. 70% of participants were 
of female gender. The mean of cumulated semesters at the study time 
was 4 ± 2. In 90% of cases, the senior doctor on call being at home 
with displacement and in 10% of cases the senior being on site. More 
than 10 calls per guard were recorded, in a quarter of interrogated 
residents, in order to manage a critical situation. 57 residents partici-
pated in a debriefing as part of simulation training whereas 86 have 
experienced it in clinical practice. In 40% of the cases, the Debriefing 
took place with a staff of several teaching doctors. 74 of the partici-
pants gave a satisfaction score between 3 and 5 out of 5. In this case, 
debriefing concerned the diagnostic discussion and the taken atti-
tude. 95% preferred a collective debriefing than the individual one. 
44% of the participants experienced at least one emotional shock 
during their course and they affirm the necessity of defusing even out-
side of a debriefing in 40% of cases. 52% of residents have claimed the 
ideal time for debriefing would be on day 1 of the managed critical 
situation and day 0 was considered in 32% of residents. Considering 
those who rated more than 6 out of 10, the expectations from debrief-
ing in the studied population were: improvement of theoretical skills 
(92/100), improvement of technical skills (82/100) coordination within 
the team (89/100) and psychological interest (appeasement, guilt-
free…) (87/100).
Conclusion: Our survey confirms the value of debriefing in clinical 
practice among ICM residents, both in the theoretical as technical 
skills and in psychological management.
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Introduction: Shortage of both ventilators and ICU beds over-
whelmed further health care systems during COVID-19 pandemia1,2. 
Early tracheostomy (TRQ) can possibly reduce the duration of mechan-
ical ventilation (MV) and ICU lenght of stay but counterbalanced with 
an increased risk for health-care workers3. COVID-19 is a clinical con-
dition with easy-to-predict prolonged MV and a high mortality rate1.
Objectives: Modified “failure-free days” combined outcome focused 
on resources (respirators and ICU beds) could contribute to decide the 
optimal timing of TRQ in consumed health care systems during future 
viral pandemia periods 1,4.
Methods: Multicenter retrospective cohort study including consecu-
tive TRQ patients diagnosed with COVID-19 in 8 spanish high-volume 
centers. The case selection, timing and technique of TRQ based on 
weekly burden degree in ICUs: the greater the burden the earlier and 
the higher the TRQ and surgical procedure rates. Modified ventila-
tor and ICU bed-free days (VFD and BFD respectively) within 28 and 
60-day time frame were defined as follows, respectively: VFD/BFD= 
28/60-x if successfully liberated from MV/discharged to ward x days 
after initiation/admission and VFD/BFD= 28/60-x if subject dies within 
28/60  days of MV/admission. Modified VFD and BFD were calculated 
for different timings (10, 14 and 20 days) and compared with multivari-
ate ANOVA test. Matching bias was exluded with a propensity score.
Results: TRQ was performed in 48% of intubated patients; 504 trache-
ostomized patients were finally included. Table  1 shows the prelimi-
nary results of 143 patients. The median (IQR) time under MV was 23d 
(19-32); mortality rate was 49.2% and surgical TRQ was performed in 




(≤10d / 14d / 20d)
Delayed TRQ
(>10d / 14d / 20d)
Time under MV, d (median) 25.3 / 24.7 / 25.9 29.7 / 35 / 46.6 
Mortality rate, % 54 / 45 / 50 50 / 60 / 57 
VFD at 28d, d 6.6 / 6.1 / 5.2 4.1 / 2.4 / 1.4 
BFD at 28d, d 3.9 / 3.1 / 2.7 1.9 / 1.2 / 1.4 
VFD at 60d, d 34.7 / 35.7 / 34.4 31.3 / 26.4 / 17.3 
BFD at 60d, d 30.5 / 32.1 / 30.6 27.9 / 22.9 / 14.8 
Conclusion: Pending definitive results, we conclude that ICU 
resources could be optimized with early tracheostomy at 10d accord-
ing to the 28-d modified VFD and BFD outcome under the conditions 
of the COVID-19 pandemia.
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Introduction: Frequent communication with a patient’s relatives 
is a part of normal ICU care, however has been challenged by inten-
sified clinical care demands of the COVID-19 pandemic.1,2 Regular 
visiting and communication with the ICU team is a priority for many 
families and crucial to coping.3 Visiting loved ones at the end-of-life 
is fundamental within many cultures and is a crucial part of the griev-
ing process for the bereaved.4 Restrictions to hospital visiting policies 
during the COVID-19 pandemic have left relatives unable to visit their 
loved ones in ICU and receive face-to-face updates from clinicians and 
nurses.5-7 It is unclear how UK ICUs are dealing with this challenging 
situation.
Objectives: We aimed to investigate how UK ICUs are approaching 
relative communications and visiting during the COVID-19 pandemic.
Methods: This web-based snapshot survey was delivered between 
16th April and 24th May 2020 and was open to UK ICUs. It was com-
pleted by individual clinicians regarding practices of the ICU they were 
currently working at during the COVID-19 pandemic.
Results: There were replies from 134 individual NHS ICUs with 
COVID patients for analysis. All units reported that visiting was more 
restricted than in normal times. Twenty-nine (22%) units reported 
that no relative visiting was allowed, 71 (53%) reported visiting was 
allowed at end of life only and 30 (23%) reported visiting was allowed 
for vulnerable or end of life patients.
Nearly all ICUs (n=130, 97%) were updating families daily. Most ICUs 
were initiating the family update (n=120, 92%). Daily phone calls were 
routinely initiated by the medical team in 75 (55%) ICUs and by the 
nursing team in 50 (37%) ICUs. Thirty-nine (29%) units used a dedi-
cated team for regular family updates. Video calling was being used by 
63 (47%) ICUs.
Do not attempt resuscitation and end of life family discussions were 
commonly done by consultants (n=132, 99%), followed by PGY4-7 
doctors (n=60, 45%). Six (4%) units reported that PGY1-3 doctors may 
have these discussions. These discussions were most frequently phone 
calls initiated by the ICU medical team (N=129, 96%). Video calling 
was utilised by 24 (18%), and 15 (11%) reported that discussion may 
occur in person.
Conclusion: Relative visiting to UK ICUs during the COVID-19 pan-
demic has been severely restricted compared to normal times. Despite 
visiting restrictions, many units are adapting to support family visit-
ing for end of life patients. ICUs are actively contacting families daily 
to provide updates, most commonly by ICU medical teams and many 
units have developed bespoke family communication teams. Modern 
technology has been utilised to deliver video calling by many ICUs.
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Introduction: ICU care often generates daily blood tests, which can 
provide essential diagnostic information. However, protracted blood 
sampling may contribute to anemia in ICU patients, with knock-on 
negative impacts on patient outcome. In addition, testing without 
clinical indication contributes to healthcare spending, creating an 
avoidable cost burden. We therefore set out to investigate the pro-
portion of blood sampling that could have been avoided, as well as 
its total cost.
Objectives: We audited adherence to a departmental standard that 
no greater than 25% of blood sampling should be without clear clini-
cal indication. This follows a 2015 audit of the same department, in 
which 46% of blood tests (n=339) were deemed unnecessary over 70 
patient days, reducing to 41% with intervention.
Methods: We limited eligible patient data to blood samples collected 
after the first 48 hours of admission, to exclude stable post-surgical 
admissions. Patient data was collected between 21 January 2020 and 
17 February 2020. Indications were listed for each of the seven most 
common blood tests: full blood count, urea & electrolytes, liver func-
tion tests, CRP, magnesium, phosphate, and clotting. These were 
stratified according to patient level of care in a 16-bed unit, with 10 
Level 3 (ICU) beds and 6 Level 2 (HDU) beds. Daily blood tests were 
deemed indicated if the patient required advanced end-organ sup-
port (such as mechanical ventilation, vasopressors, or continuous 
veno-venous hemofiltration), if previous tests were acutely deranged, 
or if requested by a senior practitioner.
Results: 191 patient days were audited, with 1096 blood tests ordered 
total (Level 3: n=715, Level 2: n=388). Of all tests performed, 31.5% 
(n=345) were unindicated (Level 3: 22.4%, Level 2: 48.2%). The rate of 
blood sampling without clear clinical indication was within the depart-
mental standard of 25% for CRP (13.1%), full blood count (15.4%), 
and urea & electrolytes (18.1%). Liver function tests (51%), magne-
sium (42.2%), phosphate (42.7%), and clotting (40.4%) failed to meet 
departmental guidelines, as did all blood tests requested for Level 2 
patients. A potential cost of £2101 was estimated for all blood tests, 
with £505 unindicated.
Conclusion: We found that common blood tests in ICU are ordered 
regularly without clear clinical indication. We further determine that 
liver function tests, magnesium, phosphate, and clotting are ordered 
regularly without considering their diagnostic value.
This data also demonstrates that a regimen of testing without indica-
tion can significantly impact the running cost of an intensive care unit 
at a district general hospital. This may be a consequence of a critical 
care blood test set available on our electronic requesting system. Fol-
lowing the COVID-19 pandemic, we aim to introduce clearer guide-
lines on appropriate daily testing, to reduce the burden on patients 
and our healthcare system.
Our department will look to re-audit our practice following changes, 
to determine the degree of impact.
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Introduction: In December 2019, a pneumonia of unknown cause was 
detected in Wuhan, China. A novel strain of coronavirus (SARS-CoV 2) 
was identified as the cause. The virus spread rapidly and the World 
Health Organization declared a Public Health Emergency of Interna-
tional Concern on 30 January. Worldwide, cases of new coronavirus 
disease (COVID-19) began to increase exponentially with Italy, Spain, 
France and the UK reporting the highest rates of new infections within 
Europe. Northwick Park Hospital, a large district general hospital in 
North West London was one of the first UK centres to experience a 
surge in COVID-19 admissions requiring ICU level care. In relation to its 
baseline critical care capacity, it was one of the worst hit centres in the 
UK and a substantial increase in transfers to neighbouring hospitals 
was necessary to ensure safe, quality care was maintained.
Objectives: We provide an overview of the ICU surge experience due 
to COVID-19 admissions from Northwick Park Hospital. We establish a 
timeline, focusing on several distinct themes including capacity, staff-
ing, operational issues and training. Data on admissions, transfers and 
patient demographics is included.
Methods: All available data from the period 16 February to 12 May 
2020 (coinciding with the peak ICU surge) was collected via audit of 
in-house electronic reporting systems (PathPoint, ePRO, ICE) and infor-
mal channels (NHSMail).
Results: We present a timeline detailing the challenges faced dur-
ing the surge around establishing and maintenance of bed capacity; 
adoption of new staffing ratios, rotas and redeployment; equipment 
and medication supply; establishing new surgical pathways and 
‘returning to normal’.
A total of 257 patients with COVID-19 were admitted to the ICU. 
Length of stay on the unit ranged from 1 to 41 days. Maintenance of 
spare capacity was facilitated by transfers to other sites within the 
North West London Critical Care Network. 124 patients were trans-
ferred to satellite sites with 11 patients repatriated. Of the 22 admis-
sions to the London Nightingale Hospital, 19 were from Northwick 
Park. The highest number of transfers off site in one day was 16. With 
the expanded ICU capacity, the peak number of inpatients in a 24-hour 
period was 57 and the highest admissions for one day was 15.
The ICU population had several risk factors which have since been 
shown to be associated with worse outcomes in COVID-19, namely 
age, ethnicity and obesity. Of the total admissions, 75% fell within the 
51 to 80 years of age group, 84% were from a Black, Asian or Minor-
ity Ethnic background, and 58% were classified as either overweight 
or obese by BMI.
Conclusion: We report our experience of preparing for, receiving and 
management of the initial ICU surge of COVID-19 patients. We present 
a timeline, our patient population and report on several of the chal-
lenges we faced.
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Introduction: The COVID-19 pandemic led to an unprecedented 
demand for critical care beds across the world(1). North Central Lon-
don (NCL) Sustainable Training Partnership (STP) critical care capacity 
expanded by over 100%(2), presenting extreme pressures on staff and 
consumables, with significant logistical challenges.
Objectives: The NCL transfer team was established on 3rd April 2020, 
with the primary aim to manage the safe movement of critically unwell 
patients to decompress overwhelmed critical care units and opti-
mise patient care. The secondary aim was to alleviate the workload of 
stretched referring units by organising the logistics of transfer, relaying 
clinical patient information and mobilising a dedicated transfer team 
to retrieve the patient, whilst protecting the resources at the referring 
site. (Diag. 1).
Methods: A central point of contact was established to streamline 
referrals with real-time updates of bed capacity across the sector. 
Three dedicated consultant-led teams were created and responsible 
for the movement of patients both in and out of the sector.
The Hub provided operational support to the transfer teams and sec-
tor hospitals. Ambulances provided by London Ambulance Service 
(LAS) were matched with teams at their base hospitals (Diagram  1). 
The Hub created a central gateway through which activity and out-
comes could be recorded for quality improvement. A COVID-19 trans-
fer app was designed in partnership with InforceHub (data analytics 
company), ensuring NHS data security governance.
Results: A total of 81 transfers were performed during April 2020, with 
a peak of 7 transfers per day. No critical incidences were reported. 60 
patients were transferred in sector, follow up showed a 48% 30-day 
mortality, with men aged between 60-69 most affected, comparable 
to ICNARC data (3). 68% represented BAME groups, with a propor-
tional mortality of 48%, comparable to Caucasian group at 50% in this 
data set.
The most prevalent complications within 30 days of admission were: 
PE/DVT (40%), renal failure requiring haemofiltration (36%), and ongo-
ing ventilatory failure requiring proning, (42%). This is a small data set 
with inherent limiting factors.
Conclusion: NHS England (NHSE) project that the demand for critical 
care across London will continue to increase with plans to double the 
critical care capacity (2).
Critical transfers for specialist care and bed capacity will continue to 
require a co-ordinated response for the benefit of patients and work-
force. The NCL transfer hub provided a valuable service during this 
novel pandemic. An NHSE advisory group is producing a National 
business case for a new Pan-London Critical Transfer Service.
As board advisors, our collective experiences and expertise will help 
to shape a broader and cohesive vision for critical care transfers in 
London.
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Introduction: Bath Tea trolley is a  teaching initiative that has shown 
excellent results improving knowledge, skills and satisfaction of health 
professionals. It is based on a bedside discussion between the instruc-
tor and the trainee about a topic always related to the current care of 
the patient. The teaching session does not last more than 5 minutes 
and always includes tea and cake as a refreshment. The combination 
of peer-to-peer bedside  learning, relevant topic, and tea and cake 
as an element to facilitate the learning break, make the Tea Trolley a 
powerful learning tool. Vygotsky’s, Wenger’s, Bateson’s levels of learn-
ing, Malinowski’s,   Akerlof  strategy and Rich’s class and gender con-
struction concept support this educational tool.
Objectives: Discuss the theoretical framework behind Bath Tea Trol-
ley as educational tool.
Methods: The interventions and results of the innitiatives that 
included Bath Tea Trolley and elements of the intervention were 
reviewed and the theoretical framework behind them analysed.
Results: Bath Tea trolley has shown excellent results on either learning 
progress and trainee satisfaction. Bath Tea Trolley has been utilised as 
teaching tool with different learning topics related to critical care.
It has been tried in other clinical settings. From teaching sessions on 
airway rescue techniques and maternal sepsis, to acute kidney injury 
and hypoglycaemia, it has proved very successful—analysis feed-
back forms indicates that  after receiving tea trolley training  98% of 
staff have felt more confident in one or more of the aspects that were 
covered.
This teaching technique has potential in many settings includ-
ing anaesthetic rooms, wards, emergency departments, outpa-
tient departments, GP surgeries, and administration areas. It can be 
adapted to suit different learning and teaching styles (visual, auditory, 
verbal, physical, one-on-one, group), grades of participants, and previ-
ous levels of experience.
So far, it has been included in 54 projects in Bath, with 2977 staff ‘educa-
tional encounters’ to date. It has been utilised in 39 other UK hospitals 
and Internationally in countries as Australia, Canada, USA, France and 
Germany.
The elements of the intervention were analysed from the theoreti-
cal point of view.  The combination of  peer-to-peer bedside  learning, 
relevant topic and tea and cake as an element to facilitate the learning 
break make the Tea Trolley a powerful learning tool. Vygotsky’s theory of 
“Zone of Proximal Development” and “Scaffolding”, Wenger’s hypothesis 
of “Situated learning”, Bateson’s levels of learning, Malinowski’s concept 
of ”Reciprocity”,  Akerlof’s “Tit-for-tat” strategy and Rich’s class and gender 
construction concept support this powerful educational tool.
Conclusion: Tea trolley is based on a peer-to-peer bedside learning in 
which the instructor offers tea and cake to facilitate a short break 
that allows the intervention. It has shown to be an excellent teaching 
tool and has been utilised in different clinical settings nationally and 
internationally.
Every element of this intervention is supported on a solid theoretical 
framework. Peer-to-peer interaction is supported on Vygotsky’s theory 
of “Zone of Proximal Development” and “Scaffolding”, bedside offers 
the adequate learning context as per Wenger’s hypothesis of “Situ-
ated learning” and Bateson’s levels of learning, tea and cake leans on 
Malinowski’s concept of  ”Reciprocity”,   Akerlof’s “Tit-for-tat”  strategy 
and Rich’s class and gender construction concept.
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Introduction: The Covid19 pandemic saw a large-scale redeploy-
ment of doctors in the UK. In expanding Intensive Treatment Unit (ITU) 
capacity, doctors at St Bartholomew’s Hospital, often with little or no 
prior ITU experience, were asked to staff this area at short notice.
To support the transition we created a half day face-to-face Sideskill-
ing Workshop (SW) prior to redeployment, aimed at non-ITU physi-
cians. We surveyed them after two months of working in ITU to assess 
the impact of the SW on their self-assessed performance and morale.
Objectives: To assess the impact of the SW for non-ICU doctors being 
redeployed to ICU.
To assess perceived change in knowledge, confidence, and anxiety as 
a result of SW.
Methods: Senior ITU clinicians and the education team developed a 
syllabus of key topics which we felt would be most useful to doctors 
being redeployed.
The SW consisted of 4 stations:
1. Assessment and monitoring of the ITU patient
2. ITU observation chart, drug chart, and infusion pumps
3. Introduction to Invasive Ventilation
4. Proning a ventilated patient
Evaluation was performed as an anonymous, online post hoc survey.
Candidates were asked questions regarding:
 their perceived knowledge pre-SW, immediately post-SW, and 
after working on ITU
 their agreement with statements regarding the impact of the SW 
on their anxiety and confidence surrounding redeployment
 their experiences, indicating the most beneficial element of the 
SW and suggested improvements
Answers were indicated on a 5-point Likert scale, and others given as 
comments.
Results: 34 of 104 candidates responded. 58% had no previous ITU 
experience. Candidates reported a mean of 1.6 point increase on a 
5-point Likert scale (1 = no knowledge, 5 = expert knowledge) across 
all knowledge domains investigated. Ventilation knowledge had 
the lowest pre-SW score (1.4/5), and saw the largest mean increase: 
1.94.44% indicated the ‘crisis atmosphere’ increased or strongly 
Page 229 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
increased their ability to take in information. 71% agreed or strongly 
agreed that knowledge gained from the SW was useful for working 
in ITU and 79% agreed or strongly agreed that the SW helped them 
deliver good patient care during redeployment.
82% reported decreased anxiety and 88% reported increased confi-
dence regarding the prospect of working in ITU following the SW; 84% 
agreed or strongly agreed that the SW reassured them they would be 
well supported in ITU.
The structured patient assessment, ventilator knowledge, and reassur-
ance/confidence featured prominently in the comments.
Suggested improvements included more interactivity and simulation.
Conclusion: The results demonstrate improved self-perception of 
knowledge in all aspects of ITU care explored by the workshops. 
Candidates also reported allayed anxiety, improved confidence, 
and increased camaraderie. Our workshops serve as a good model 
for future induction of doctors that are redeployed during further 
Covid19 surges, both for improving knowledge and maintaining well-
being, and could serve as a foundation for further ITU education.
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Introduction: Patients with persistent or chronic critical illness (P/CCI) 
require adaption of their clinical management plan and goals of care 
from an acute to a rehabilitative focus. Development and implementa-
tion of quality improvement (QI) tools such as daily or rounding check-
lists focused on actionable processes of care are needed as existing 
QI tools were not developed with P/CCI patients in mind. Actionable 
processes are those over which clinicians have direct control and are 
able to action.
Objectives: To develop end-user (patients, family, all professions 
of the ICU interprofessional team) consensus on the most important 
actionable processes of care for inclusion in tools designed to improve 
quality and consistency of patient/family-centred care for P/CCI 
patients and family.
Methods: Systematic review, end-user qualitative interviews with 
touch-point video, and 3 round (R) Delphi consensus of actionable 
processes. Participants rated actionable processes on 9-point Lik-
ert scales. Actionable processes considered critical for inclusion in 
future development of QI tools were those sored between 7-9 on the 
Likert scale by ≥70% of participants and between 1-3 by <15% of 
participants.
Results: During item generation phase, we screened 13,130 refer-
ences, included 114 primary studies (24,251 participants), 102 reviews 
and 94 abstracts and identified 40 distinct actionable processes of care. 
Interviews with P/CCI survivors/family (N=17) identified 15 actionable 
processes with 3/15 (20%) distinct from the systematic review. Inter-
views with clinicians (N=31) identified 35 actionable processes with 
4/35 (11%) distinct from other item generation procedures (Total=47). 
Following iterative discussion to combine similar processes remov-
ing redundancy and to word as actionable processes in lay terms, 
31 actionable processes were included in Delphi R1. Nine additional 
actionable processes suggested by Delphi participants were added to 
R2 (Total=40). Response rates were 83% (138/166) R1, 79% (109/138) 
R2 and 74% (81/109) R3. Of the 40 actionable processes, 34 (85%) were 
considered critical for inclusion in future QI tools. The top 3 action-
able processes with the highest proportion of clinician, ICU survivor, 
and family participants considering them critical for inclusion were (1) 
establish and track rehabilitation/physiotherapy goals including early 
mobilization while still in the ICU (99%); (2) assess and manage symp-
toms (i.e., pain, breathlessness, tiredness, thirst) (98%); and (3) review 
ongoing need for drugs used for sedation and decrease their use as 
able (98%). Actionable processes not considered critical for inclusion 
were (1) limit physiologic monitoring and routine blood tests (54%); 
(2) offer chaplaincy/spiritual support to the patient and family (57%); 
(3) provide activities to promote relaxation (e.g. music, pet visitation) 
based on patient preferences (62%); (4) de-escalate (including change 
to oral instead of IV drugs) or stop ICU pharmacotherapy and restart 
previous comorbidity pharmacotherapy (62%); (5) enable appropriate 
and timely discharge planning (67%); and (6) conduct multi-discipli-
nary rounds that include non-ICU subspecialty teams (68%).
Conclusion: The large number of items considered critical for inclu-
sion in QI tools reflects the complex and multi-factorial needs of PCCI 
patients and families. Further consensus building work is planned to 
enable development and testing of QI tools.
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Introduction: Given the intense healthcare demand of COVID patients 
(COVp) during the pandemic, ICU beds had to be tripled. Non-COVID 
patients (nCOVp) were reduced to a lower number than they used to 
be. Ordinary hospital activity was interrupted due to the high COVID 
patients demand.
Objectives: To analyze the nCOVp admitted in our ICU during the 
pandemic in contrast to those admitted in the same period of time the 
previous year.
Methods: A restrospective descriptive observational study of nCOVp 
admitted in our ICU during the pandemic, from March 14th to June 1st 
2020, versus the patients admitted in the same period of time the pre-
vious year. The number of COVp-nCOVp patients were analyzed, also: 
sex, age, provenance, diagnosis, severity, hospital stay and nCOVp 
mortality, as well as the admissions in the same period of time in 2019.
Results: From March 14th (admission of the first COVp) to May 4th 
2020, 48 COVp were admitted in our ICU (last COVp the 1st June). In 
the meantime, 32 nCOVp were admitted, whereas 101 patients were 
admitted in 2019. It’s a polyvalent ICU with 10 beds, which were 
expanded during the pandemic to 36 beds. High occupation period 
(HOP) was from March 14th to April 13th 2020, in which 40/48 (83,3%) 
COVp and 4/32 (12,5%) nCOVp were admitted. Over this period in 
2019, 37/101 (36,7%) patients were admitted. 2020 nCOVp: 23 (71,9%) 
were males, with a mean age of 54,8 y.o. (CI 95% 49,5-61,2). 18 patients 
(56,2%) came from emergency department. Ten patients (31,2%) were 
admitted because of different etiologies of shock, which was the most 
frequent reason for admission, followed by: acute coronary syndrome 
(ACS) 6 (18,7%), cardiac arrhythmias (CA) 3 (9,3%), cardiorespiratory 
arrest (CRA) 3 (9,3%), neurological disorders (ND) 3 (9,3%), acute res-
piratory failure (ARF) 3 (9,3%), polytrauma (PT) 2 (6,2%), and 2 (6,2%) 
oncological surgery postoperative (OSP). The average APACHE II was 
20,8 (CI 95% 16, 2-25,4) and 27 (CI 95% 19, 6-34,4) during HOP, with 
an average hospital stay of 5,5  days (CI 95% 2, 3-8,7) and 9 (28,12%) 
patients died, two of them during HOP. As for the patients admitted in 
2019: 61 (60,4%) were males, with an average age of 63,8 y.o.(IC 95% 
60,5-67,1). 80 patients (79,2%) came from the emergency department. 
The most frequent reason for admission was ACS with 23 patients 
(22,8%) followed by: ARF 15 patients (14,9%), shock 14 patients 
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(13,9%), CA 13 patients (12,9%), ND 7 patients (6,9%), OSP 7 patients 
(6,9%), CRA 5 patients (4,9%). The average APACHE II score was 15 (CI 
95% 13, 6-16,4), and the average hospital stay of 3,8 days (CI 95% 2,8-
4,7). 12 patients died (11,9%).
Conclusion: During the pandemic, there has been a significant reduc-
tion of non-COVID admissions in our ICU. 2020 patients had a higher 
APACHE II score, a longer hospital stay and an increase in mortality 
regarding 2019 patients.
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Introduction: Unnecessary blood tests in the critically ill lead to 
adverse patient outcomes and significant financial cost. It has been 
shown that 90% of patients admitted to critical care will be anaemic 
by day 3 of their stay (1). Several physiological mechanisms that pro-
tect against anaemia are impaired in the critically ill (2), and repeated 
blood tests make a significant contribution towards iatrogenic anae-
mia. Unnecessary blood tests can also lead to organ dysfunction, pro-
longed length of stay, and increased mortality. Unnecessary blood 
tests also incur significant expense, with one study estimating blood 
tests cost £362,587.80/year was spent per year on blood tests (3).
Objectives: This review aims to identify the outcomes of routine 
blood tests, rationale and behaviours underpinning routine blood 
tests in critically ill patients, and possible strategies to reduce this in 
the future.
Methods: A scoping review was conducted in accordance with Arksey 
and O’Malley’s principles (4). As there is not a large amount of quality 
data in this area, a scoping review was chosen over a literature review 
to allow greater flexibility. This review did not attempt to evaluate 
the quality of the literature as there is not enough quality data pub-
lished yet. A PEO format was used to formulate the research question. 
OVID, EMbase and Medline were searched with the key terms ‘inten-
sive care’  and  ‘routine blood tests’. 432 articles were identified and 
reduced to 17 articles which were included in the final review. The-
matic analysis was conducted on the texts included in the final review 
in accordance with Braun and Clarke’s key steps (5).
Results: Three key themes were identified, with associated subthemes 
- outcomes of routine blood tests, the rationale underpinning this, and stat-
egies to reduce this.  Patient centred outcomes featured heavily in the 
analysis, as this is clinically most important, and widely undisputed. The 
literature demonstrated that unnecessary blood tests can lead to iatro-
genic anaemia, organ dysfunction, increased length of stay and mor-
tality. The relationship between iatrogenic anaemia and an increased 
need for transfusion was less concrete, with some studies demonstrat-
ing a reduction in RBC transfusion and others failing to demonstrate a 
difference. Significant financial costs were associated with unnecessary 
blood tests and the follow up incurred, as well as the cognitive demand 
on clinicians of reviewing blood results. Rationale behind routine and 
unnecessary blood tests was discussed in several papers. Rationale was 
influenced by clinicians knowledge, time constraints on the decision 
maker, and reflex ordering. It is often easier to adopt a ‘one-size-fits-
all’ strategy when it comes to blood tests in order to minimize deci-
sion making. Additionally, less experienced clinicians have a tendency 
to order more blood tests and a lack of guidelines in this area means 
there is significant variation between clinicians. Environmental factors 
influencing routine blood tests were the presence of central/arterial 
lines, increased frequency of blood tests in intensive care and increased 
use of point of care testing. Several strategies were employed by the 
literature, with bundled interventions demonstrating the best out-
comes. Staff education for nurses and clinicians was a common theme. 
There were no local/national/international guidelines identified which 
needs addressing to underpin practice in this area. This can be further 
supported by equipment such as low-volume blood tubes, paediatric 
blood tubes and blood conservation sampling devices (BCSDs). Modifi-
cation of checklists and electronic ordering systems also play an impor-
tant part in reducing the amount of unnecessary blood tests.
Conclusion: This scoping review has identified several themes in the 
literature which provide evidence that routine blood tests can lead to 
adverse outcomes for patients, and unnecessary costs for healthcare 
organizations. Some key behaviours and influencing factors have been 
identified as important reasons for routine blood tests, that can be tar-
geted in order to change practice. This review has identified several 
promising strategies to reduce the amount of unnecessary blood tests 
in ICU, which when combined can lead to better patient care.
The results of this scoping review will inform ongoing work in this 
area and may help to develop consensus led national guidelines and 
a gold standard model for blood tests in ICU. The authors hope to 
develop consensus around new guidelines and implementation of a 
package of change incorporating several of the strategies identified in 
this review. It is anticipated that this scoping review will help to inform 
core outcomes to measure future progress in this area.
Reference(s) and grant acknowledgment(s)
1. 1. Society for the Advancement of Blood Management. (2018). 5 Things 
Physicians and Patients Should Question. Retrieved from Choosing Wisely: 
https ://www.choos ingwi sely.org/wp‑conte nt/uploa ds/2018/07/SABM‑
Choos ing‑Wisel y‑List.pdf
2. 2. Page, C., Retter, A., & Wyncoll, D. (2013). Blood conservation devices in 
critical care: a narrative review. Annals of Intensive Care, 14.
3. 3. Cumber, E., Channon, L., & Wong, A. (2017). Blood tests in the intensive 
care unit: a necessary cost? 37th International Symposium on Intensive 
Care and Emergency Medicine.
4. 4. Arksey, H., & O’Malley, L. (2003). Scoping Studies: Towards a Methodologi‑
cal Framework. International Journal of Social Methodology, 19‑32.
5. 5. Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Quali‑
tative Research in Psychology, 77‑101.
000976 
Collaboration in Covid‑19 crisis: an international survey 
on supervision, quality and safety, and collaboration 
amongst (redeployed) ICU personnel
M. Hennus1; JQ. Young2; M. Hennessy3; K. Friedman4; B. De  Vries5; R. Hoff6; 
E. O’connor7; A. Patterson8; G. Curley9; K. Thakker10; M. van  Dam11; D. van 
 Dijk11; W. Van  Klei6; O. Ten  Cate12
1Pediatric Intensive Care, University Medical Center Utrecht, Utrecht, 
France; 2Psychiatry, Donald and Barbara Zucker School of Medicine 
at Hofstra/Northwell, Hempstead, United States of America; 3School 
of medicine, Trinity College, Dublin, Ireland; 4Medicine, Donald and Bar‑
bara Zucker School of Medicine at Hofstra/Northwell, Hempstead, United 
States of America; 5Quality and patient safety, UMC Utrecht, Utrecht, Neth‑
erlands; 6Anesthesiology, UMC Utrecht, Utrecht, Netherlands; 7Anaesthe‑
sia and intensive care, St James hospital, Dublin, Ireland; 8School of medi‑
cine, Trinity College, Dublin, United Kingdom; 9Department of anaesthesia 
and critical care medicine, Royal College of Surgeons in Ireland, Beaumont 
Hospital, Dublin, Ireland; 10Research, Zucker Hillside Hospital, Hempstead, 
United States of America; 11Intensive care center, UMC Utrecht, Utrecht, 
Netherlands; 12Center for research and development of education, UMC 
Utrecht, Utrecht, Netherlands 
Correspondence: M. Hennus
Intensive Care Medicine Experimental 2020, 8(2): 000976
Page 231 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Introduction: To meet Covid-19 demands, intensive care units (ICU) 
had to rapidly expand capacities with help of health care workers 
redeployed outside their regular scope of practice. During the height 
of the pandemic, (re-)deployed ICU personnel was surveyed regarding 
level and quality of supervision, quality and safety of care provided, 
and interprofessional collaboration.
Methods: In an international, prospective, observational cohort sur-
vey study, physicians, nurses and allied health personnel, redeployed 
at ICUs in Utrecht, New York and Dublin completed the survey. Data 
analysis focused on: Supervision; Quality and safety of care; Collabo-
ration, communication and atmosphere; Recruitment, scheduling and 
team composition; Organization and facilities.
Results: Quality and safety of care were perceived as lower than usual 
but acceptable by the majority respondents (n=368). Supervision, was 
rated less than optimal but overall quality was acceptable to good. 
Where IC-trained nurse-to-patient ratios decreased most critically 
(Utrecht), nurses were most critical about supervision and quality of 
care. The working atmosphere was overwhelmingly felt as collabora-
tive and supportive. Continuity of working environment and team 
composition, informal (‘curbside’) consultations and availability of pro-
tocols were critical mediators.
Conclusion: A surge of critically ill patients can be accommodated by 
IC trained personnel on expanded or new ICUs when assisted by rede-
ployed non-ICU trained personnel. Although quality of care, supervi-
sory capacity, training background and experience were compromised 
to meet COVID-19 demands, key features to maintain acceptable 
quality of care included stable teams matching less with more expe-
rienced personnel allowing for adequate supervision, better than nor-
mal interprofessional collaboration and a robust culture of informal 
consultation.
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Introduction: The COVID-19 pandemic has led to an increase in ICU 
referrals and admissions across the UK during 2020 [1]. Intensive care 
beds are a limited and expensive resource and decisions on patient 
admission are often very challenging [2]. Proformas help to stand-
ardise documentation and decision logging during patient referrals 
[3]. They provide easily accessible evidence in case of a future referral 
and allow audit of decision-making processes. A preliminary survey of 
doctors working in a DGH ICU was undertaken to assess the current 
referral and admission process in expectation of an increased volume 
of work.
Objectives: As a result of the survey, three main areas for improve-
ment were identified:
1.  To maintain a record of all ICU referrals and decision-making 
processes
2.  To reduce the time taken for documentation of referrals and 
admissions
3.  To improve the quality and appropriateness of referrals from par-
ent specialities
Methods: A proforma was designed for dual use as a referral and 
admission document. All referrals were recorded on paper and staff 
received training on how to apply the proforma. After assessment of 
each referral, irrespective of admission outcome, a completed copy of 
the proforma was placed in both the patient’s notes and a dedicated 
referrals folder.
After one month, a further survey was designed to assess the response 
post-implementation of the proforma. All referrals made over a three-
month period between April and June 2020 were audited.
Results: The initial survey received 12 responses. Prior to the COVID-
19 pandemic, documentation of any referral or admission took on 
average 10-15 minutes. All survey participants felt that referring teams 
did not have a good understanding of the role of ICU care and esti-
mated that up to 40% of all referrals received were inappropriate.
The follow-up survey received 14 responses. Implementation of the 
proforma reduced the time taken to document a referral or admission 
on average by 5-10 minutes. Twelve participants found the proforma a 
useful aid, helping to provide clear documentation and ease commu-
nication between ICU team members.
Less than 9% of the referrals made between April and June 2020 were 
admitted to ICU with over 32% of referrals deemed unsuitable for fur-
ther escalation. Approximately 50% of referrals were made by regis-
trars, with 13% discussed by consultants. The median age of patients 
referred was 67.5 and the most common reason was for respiratory 
deterioration.
Conclusion: This quality improvement project successfully reduced 
the time taken to document ICU referrals and admissions. Use of a 
proforma has provided many benefits, including standardisation of 
documentation, decision logging and improvement of intra- and 
inter-team communication.
Only a small proportion of patients referred to ICU have been suitable 
for admission. A teaching session is being designed so that referral 
information can be fed-back to parent specialties. Referrals will be re-
audited after this.
Data analysis of this project has been limited by incomplete proforma 
documentation from participating users.
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Introduction: With early reports from other countries of the enor-
mous strain COVID-19 had placed on healthcare systems, a decision 
was made at Buckinghamshire Healthcare NHS Trust to increase the 
capacity of Critical Care beds and redeploy junior doctors from other 
specialities to prepare for a rapid surge in patient numbers.
To facilitate ongoing daily review of patients, a structured assessment 
proforma was produced to be used in all Critical Care areas for COVID-
19 patients.
Principles by which the proforma were designed included: easy and 
rapid to complete (by doctors with limited ICU experience), enables 
rapid decision-making by senior ICU doctors, ensures thorough and 
appropriate reviews.
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The benefits of protocolisation in ensuring patient safety, standardis-
ing assessments, and minimising error have previously been detailed 
in the literature(1,2).
This project aimed to determine whether the implementation of 
a structured assessment proforma had enabled appropriate daily 
ICU reviews to be conducted despite the challenges posed by the 
pandemic.
Methods: A structured assessment proforma was produced by mem-
bers of the Consultant body, agreed by the department, and subse-
quently disseminated to Critical Care areas in early April.
Clinical records of all patients admitted to ICU within a random one-
week period were reviewed.
An online survey was sent out to all junior doctors working on ICU. The 
survey asked two key questions:
 How confident they felt in conducting an ICU review prior to 
using and with the proforma.
 How likely they felt they were to omit important information 
prior to using and with the proforma.
Answers were recorded as a score between 0 and 10 and paired-sam-
ples t-tests conducted.
Results: All proformas completed within a random one-week period 
(30/05/2020 to 05/06/2020) were reviewed (n=47), from a total of 8 
patients admitted on ICU with COVID-19.
The date was written on 100% and time on 89.4% of proformas. 97.9% 
of the proformas contained an appropriate A to E assessment (as 
defined by completion of the proforma), 100% contained a summary 
of main clinical issues, and a documented plan. 100% of the profor-
mas had a named doctor completing it and 85.1% had a clearly docu-
mented Consultant.
17 doctors completed the survey (sent out on 29/05/2020).
There was a significant difference in confidence prior to using (mean 
score = 6, SD = 3.41) and with the proforma (mean score = 8.76, SD = 
1.09); t(16) = –3.62, p = 0.003.
There was a significant difference in how likely doctors felt they were 
to omit important information prior to using (mean score = 4.76, SD 
= 2.54) and with the proforma (mean score = 7.12, SD = 2.37); t(16) = 
–2.59, p = 0.02.
Conclusion: Implementation of a structured assessment proforma has 
enabled appropriate daily ICU reviews to be conducted despite the 
surge in patient numbers during the pandemic.
With a possible second wave on the horizon, it may be prudent for 
other hospitals to implement a similar proforma to facilitate daily 
reviews of COVID-19 patients on ICU.
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Introduction: On March 8th a regional law planned a new Hub and 
Spoke system for time-dependent pathology in order to allocate 
resources for an expected increase in COVID patients [1] and to divide 
hospital pathways to prevent further diffusion of the pandemia. By 
Regional Decree Niguarda Hospital (Milan) become Hub, for direct 
admission of major traumas, strokes and neurosurgical emergencies 
as well as Hub secondary referral for 16 Spoke hospitals. The serving 
area was at least of 6376970 inhabitants (63.4% of the total Lombardy 
population). Duration of Hub function was from March 8th to May 8th 
.3,4 Therefore the Hospital augmented our NICU beds from 11 to 20 
beds.
Objectives: The aim of the study was to report the main findings of 
the Hub activity.
Methods: All patients admitted since the 8th of March to the 8 of 
May to the Neurointensive care unit of the Niguarda Hospital were 
selected. The patients admitted in the same period of the previous 
year (2019) was also selected as control group. All the data were retro-
spectively obtained from the institutional clinical reports. The medical 
staff remained the same, increasing work commitments by 25%. The 
nursing staff was increased by 23 untrained nurses. Access to our ICU 
was allowed only after negative nasal swab and bronchoalveolar lav-
age for COVID-19 (patients were held in a dedicated room for 6 hours 
while waiting for the results). Family visiting and interviews were 
unchanged. The activity of the Hub center lasted 2 months, infact once 
the COVID epidemic the Regional Government declared since the 8th 
of May to revert the system [2].
Results: 151 consecutively patients were admitted to our ICU in 2020 
compared to 60 in 2019. Table 1 shows patient characteristics. Twelve 
of them became utilized organ donor accounting for 2/3 of all the 
organ donors in Lombardy. In the same period of the 2019 utilized 
organ donors from Niguarda were 3 (7.8% of the 38 organ donors in 
our region)The absolute number of patients was 2.5 times compared 
to 2019, for all the quota of patients arriving from Spoke areas (Fig-
ure 1).Figure 2 shows the occupation rate trend showing a progressive 
increase in the occupation rate along the days even once the CODIV 
patients in the Lombardy ICU was in a progressive and constant reduc-
tion. An increase of withdrawal-withholding was observed.
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Conclusion: The comparison between the trends of the amount of 
COVID patients in Lombardy and of the amount of patients entering 
our Hub shows the support given to the system. In Lombardy a lack 
of available ICU beds was evident [3]. In such extraordinary condition 
the creation of an emergency Hub and spoke system seemed to have 
indirect benefits.
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Introduction: By previous collected retrospective cohort data analy-
sis, our team revealed introducing shared decision making on early 
Tracheostomy(less than 14  days) in prolonged intubated critical 
patient improve total Tracheostomy rate, reduce ventilator days and 
length of hospital stay, and shorten the Tracheostomy decision time 
delay.
Methods: Medical record of tertiary medical center adult ICU admit-
ted respiratory failure patient from Jan. 1st, 2018 to Dec. 31th, 2019 
was retrospectively reviewed as post-SDM(after Jan. 1st, 2017) inter-
vention follow up period for analysis. Data including total Tracheos-
tomy rate, early and late Tracheostomy rate, ventilator weaning rate 
and ventilator days, in-hospital mortality, and length of hospital stay 
of prolonged intubated patient were collected. SPSS was applied for 
statistically analysis, and a p-value less than 0.05 was considered sig-
nificant difference.
Results: By inclusion and exclusion criteria, medical records from 
366 patients from Jan. 1st, 2018 to Dec. 31th, 2019, who were consid-
ered prolonged intubated s/p Tracheostomy SDM, were applied for 
further analysis. Among them the early and late Tracehostomy rate 
was 41% and 69% individually. In compared to previous reported 
pre-SDM data, ventilator weaning rate(289(79.2%) vs. 89(69.3%), 
p< 0.05), ventilator days(39.3+/-20.5 vs. 42.3+/-17.3, p< 0.05), in-
hospital mortality((10.3%) vs. 7(3.3%), p: 0.737), and length of hospi-
tal stay(61.2+/-23.4 vs. 64.3+/-29.2, p: 0.04) of prolonged intubated 
patient. The continued impact on introducing SDM was impressed, 
with improving ventilator weaning rate, reduced ventilator days, and 
shortening the length of hospital stay of prolonged intubated patient 
by 3 days for each in compared in between groups. The Tracheostomy 
decision making time delay was found 6  days less after SDM intro-
duced was also consistently noted.
Conclusion: Our retrospective cohort study follow-up data revealed 
introducing shared decision making on early Tracheostomy in pro-
longed intubated critical patient persistently improve total Tracheos-
tomy rate, improve ventilator weaning rate, reduce ventilator days and 
length of hospital stay, and shorten the Tracheostomy decision time 
delay.
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Introduction: Resuscitation Code Status is a controversial topic that 
often fails to obtain truly informed consent and is highly contextual 
depending on the nature and severity of illness. While studies have 
identified DNR status in ICU patients as a risk factor for mortality and 
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adverse events, no literature has targeted elderly, critically ill patients 
for whom these conversations were intended.
Objectives: Our study aimed to assess the relationship between code 
status and mortality in critically ill, elderly patients admitted to the 
ICU. As a secondary outcome, we sought to analyze the impact of an 
informed code status discussion on resource utilization. Specifically, 
our study focused on ascertaining if critically ill, elderly patients with 
DNR code status have different hospital outcomes relative to similarly 
ill patients who are full code.
Methods: Data for this retrospective study was obtained through a 
review of medical records at Sault Area Hospital, an accredited 289 
bed large community hospital in Northern Ontario spanning a 5-year 
period. During this time,  613 patients were admitted to the ICU, 163 
of whom met the inclusion criteria of being ≥70  years of age and 
APACHE II score ≥20. A Kaplan-Meier Survival Curve examined survival 
to hospital discharge comparing DNR and full code groups. DNR code 
status was defined as omission of cardiopulmonary resuscitation in 
the event of a cardiac arrest.
Results: 64 patients (39.3%) had a DNR order based on a documented 
conversation within 72 hours of admission. The remaining 99 (60.7%) 
patients were deemed to be full code.There was a significant associa-
tion between DNR status and increased mortality (p=0.004). Patients 
with DNR code status stayed fewer days in ICU (7.7  days (±3.6) vs. 
9.9  days (±8.3),p=0.03) and used less resources (4.5 diagnostic 
images/pt (±3.4) vs. 6.2 diagnostic images/pt (±6.4), p=0.02; 0.9 con-
sultations (±1.1) vs. 1.1 consultations (±0.9),  p=0.48) than similarily 
ill patients who were full code with no benefit in long term survival 
at 21 days. Patients with full code status had a higher average cost of 
hospital and ICU admission in comparison to patients with DNR status 
(59,704.70CND/pt. vs 49,589.10CND/pt. respectively).
Conclusion: Our study has demonstrated the benefit of having early, 
informed code status discussions in the ICU. In our study population, 
DNR code status is associated with significantly reduced resource 
utilization. Furthermore, no mortality benefit was seen in DNR vs full 
code patients after 21 days suggesting that resuscitation limits may be 
objectively placed in long stay, elderly ICU patients.
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Introduction: In 2015, NHS England published the National Safety 
Standards for Invasive Procedures (NatSSIPs), based on analysis of 
Never Events, Serious Incidents and near misses. These standards 
provided the basis for the creation of Local Safety Standards for Inva-
sive procedures (LocSSIPs). To meet our ITU standards, at least 90% of 
invasive procedures performed should have a LocSSIP completed: this 
takes the form of a specific checklist, conducted by a team pre-, dur-
ing, and post-procedure.
Objectives: To assess LocSSIP compliance in our Intensive Treat-
ment Unit (ITU) with a view to generating solutions for improved 
compliance
Methods: We consulted the paper notes for all patients resident on 
two ITU wards to take a ‘snapshot view’ of compliance at a single point 
in time.
In situ invasive devices and corresponding LocSSIPs were identi-
fied from the patients’ notes and recorded. Devices to be recorded 
included: Dialysis Catheters, Arterial Catheters, Peripherally Inserted 
Central Catheter (PICC) line, Central Venous Catheters, Tracheostomy, 
Bronchoscopy, Chest Drain, Extracorporeal Membranous Oxygenation 
(ECMO) Catheters, and Endotracheal Tubes.
Results:
 There were a total of 27 devices in situ across both ICU wards
 Only devices that were in situ at the time of data collection were 
audited for an accompanying LocSSIP
 Of 27 invasive devices, LocSSIPs were only identified for 3, a 
compliance rate of 11.1%
 The only devices for which LocSSIPs had been recorded were tra-
cheostomies and CVCs





Dialysis Catheter 1 0 0 
Intercostal Drain 2 0 0 
PICC Line 2 0 0 
Tracheostomy 4 2 50 
Central Venous 
Catheter 9 1 11 
Arterial Catheter 9 0 0 
Conclusion: The barriers to implementing LocSSIPs in the 2018 NatS-
SIP implementation survey include: lack of time, staff culture, limited 
expertise, and poor clinical engagement.
Education on LocSSIPs is already part of doctors’ induction and nurse 
education. The time taken to conduct a LocSSIP checklist is not sig-
nificant. Staff culture of LocSSIPs being considered ‘someone else’s 
problem’, and not in the forefront of the team’s mind may play a part. 
However, given that details of the procedure are often recorded elec-
tronically, it seems that the systemic culture of not having the LocSSIP 
easily available is a significant factor in its omission. The team is usu-
ally at least a doctor and a nurse, so educational reinforcement must 
target both groups. We are contacting our device manufacturers to try 
and attach our LocSSIP forms to the kit used for the procedures – this 
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would ensure a visual reminder and access to the form is easy for each 
procedure.
001101 
Communicating with relatives of patients admitted to critical care 
during the Covid‑19 pandemic
D. El‑Dalil1; C. Morris2; G. Gibbon1
1Critical Care, Queens Medical Centre, Nottingham, United Kingdom; 2Crit‑
ical care, Nottingham City Hospital, Nottingham, United Kingdom 
Correspondence: D. El‑Dalil
Intensive Care Medicine Experimental 2020, 8(2): 001101
Introduction: Relatives of patients in critical care experience high 
levels of stress and anxiety [1,2,3]. Prioritising good communication 
and facilitating visiting are the most important factors in meeting the 
needs of families [2]. During the COVID-19 pandemic, infection control 
procedures have prevented family and friends from visiting their loved 
ones, potentially having a negative psychological impact on patients’ 
relatives [3].
Objectives: To develop a system to ensure comprehensive and effec-
tive communication with the relatives of patients admitted to critical 
care at Nottingham University Hospitals Trust during the Covid-19 
pandemic.
Methods: A multidisciplinary forum developed a communication 
strategy whereby the next of kin was updated daily and then asked to 
relay information to other friends and family. This was an iterative pro-
cess guided by online feedback from junior doctors and nursing inter-
views. Feedback from medical and nursing staff was explored using 
thematic analysis and utilised to refine the programme.
Results: Informal comments from patients’ relatives have been largely 
positive and feedback from doctors and nurses suggest the process 
was achievable. Data collected from 55 online feedback forms and 16 
nursing interviews were analysed and 7 main themes and 4 sub themes 
were identified. Overarching themes included ‘Updates are Important’ 
and that there is a ‘Role for Doctor and Nurse Updates’. The theme ‘Be 
Flexible’ identified that daily updates were sometimes overwhelming 
and may contribute to relative anxiety. Other themes included ‘Utilise 
Video Calling’ and creating a ‘Universal Communication Document’.
Conclusion: Feedback from Doctors and Nurses has shown that the 
process is feasible and acceptable to both groups of staff. Continuing 
to pro-actively contact a named relative daily is important and ensures 
relatives are well informed in the absence of visiting times. We aim to 
collect formal feedback from patients’ relatives to evaluate how well 
we are meeting their needs. A communication booklet is in develop-
ment to help aid clarity of documentation and to provide a single area 
for recording communications. We will be exploring simulation based 
teaching in managing difficult conversations over the phone.
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Introduction: Burnout Syndrome (BOS) is the result of chronic expo-
sure to stress in the workplace and is characterized by emotional 
exhaustion, depersonalization and reduced personal accomplishment 
(1). Moral Distress (MD) occurs when individuals are placed in  situa-
tions that are at odds with their core values and have little power to 
make changes (2). BOS and MD is a rising problem in Medicine and 
in Intensive Care in particular, not only affecting healthcare providers 
(HCPs)and their families but also affecting the quality of care provided 
by the HCPs (3,4). In a recent survey done in our ICUs, we found a high 
prevalence of BOS and MD amongst all groups of health care profes-
sionals using the MBI. While the MBI is well validated to detect BOS 
and MD, it lacks the depth to identify causes of BOS and MD.
Objectives: To perform an in-depth analysis of causes of BOS and 
Moral distress amongst HCPs in an academic intensive care unit using 
focus group methodology.
Methods: Focus groups were conducted with HCP groups and were 
cohorted based on professional designation to facilitate psychological 
saftey. The session were open to all members of the health care team 
and participation was voluntary. The focus group interview guide used 
in the sessions underwent iterative review and explored the daily work 
environment at both the organizational and individual level. It probed 
around burnout, moral distress, team dynamics, currently used coping 
strategies and interventions that were thought to be helpful in build-
ing resilience.
All sessions were audiotaped and transcribed verbatim. A qualitative 
software (Quirkos - www.quirk os.com) was used to store, sort, index 
and code the information provided in the session. All transcripts were 
read individually and codes to relevant passages were collected under 
themes, disagreements were resolved by consensus.
Results: We were able to recruit 35 HCPs for 6 focus groups: 1 group 
with MDs, 1 group with RTs and 4 groups with RNs, capturing 19% of 
the RNs, 20% of the RTs and 43% of the physicians.
There was a great degree of overlap between themes associated with 
BOS and MD. We were able to identify three overarching themes caus-
ing BOS and MD: organizational issues, exposure to high intensity situ-
ations and poor team experience. These themes were further broken 
down into multiple subthemes, again with a high degree of overlap 
between BOS and MD.
When asked about coping strategies for dealing with workplace stress-
ors participants in all groups named self-constructive (e.g. performing a 
workout) and self-destructive examples (e.g. excessive alcohol intake).
Particpants suggested multiple strategies around interventions that 
they felt would help build resilience. These interventions can be cat-
egorized according to the three major themes.
1.  Organizational: Improved staffing and infrastructure, improved 
education
2.  Exposure to high intensity situations: implementation of regular 
debriefing sessions, de-stigmatizing the need for support, mental 
health wellness days, long-term follow up of ICU survivors, and 
addressing workplace violence.
3.  Poor team dynamics: improved relationship builiding (inter and 
intra-professional), teaching respectful communication and 
behaviour, acknowledgement of hard work and job well done, sup-
port for just-culture, hospital leadership engagement and manage-
ment support.
Conclusion: We found three main themes when looking at associa-
tions with BOS and MD in our ICU HCPs: Organizational, exposure to 
high intensity situations and poor team dynamics. Some of the sugge-
tions provided by the participants for interventions to reduce BOS and 
MD are challenging to execute while others are doable (e.g. regular 
debriefing sessions, improved communication) and should be consid-
ered for implementation.
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Introduction: Chronic obstructive pulmonary disease (COPD) in Asia 
was different from Europe in higher cigarette smoking rate and more 
severe air pollution. Varies inhaled COPD medications had safety con-
cern in acute myocardial infarction (AMI). The aim of this study was 
to investigate the effect of COPD in Asia AMI patients and real world 
safety of COPD medications in AMI patients.
Methods: We conducted a nationwide cohort study extracted data 
from the Taiwan National Health Insurance Research Database. 
Patients who hospitalized between 2000 and 2012 with a primary 
diagnosis of first AMI were included. Among the 186,112 prospec-
tive AMI patients, COPD was diagnosed in 13,065 (7.0%) patients. AMI 
patients without COPD were 1:1 matched by propensity score match-
ing. AMI cohort was further divided to STEMI and NSTEMI cohort. 
STEMI without COPD was matched by propensity score. Cox propor-
tional hazards regression model was used to estimate adjusted hazard 
ratios (HR) with 95% confidence intervals (95% CI).
Results: During 12  years follow up, there were 18405 (77.65%) and 
16093 (67.89%) deaths in AMI with COPD and without COPD group, 
respectively. The adjusted hazard ratio (aHR) of mortality in AMI with 
COPD group was 1.12 (95% CI 1.09 to 1.14). In STEMI with COPD group, 
aHR was 1.20 (95% CI 1.14 to 1.25). NSTEMI with COPD, aHR was 1.07 
(95% CI 1.04 to 1.10). Using short-acting inhaled bronchodilators in 
AMI patients increased mortality (short acting beta-agonist: aHR 1.2, 
95% CI 1.16 to 1.23, short acting muscarinic antagonist: aHR 1.3, 95% 
CI 1.26 to 1.34). Corticosteroids using also increased 10% mortality 
(aHR 1.10, 95% CI 1.07 to 1.14). However, long acting inhaled broncho-
dilators reduced mortality (long acting beta-agonist: aHR 0.87, 95% CI 
0.81 to 0.94, long acting muscarinic antagonist: aHR 0.82, 95% CI 0.69 
to 0.96).
Conclusion: In Asia, AMI patient with COPD was associated with 
higher mortality compared with those without COPD. Guideline rec-
ommended AMI medications decreased mortality in patient with 
or without COPD, but they were underused in Taiwan. Using inhaled 
short-acting bronchodilators and corticosteroids in AMI patient 
reduced survival. On the contrary, long acting inhaled bronchodilators 
were associated with survival benefit. Appropriate COPD medications 
and adequate standard AMI medications in AMI patient were equal 
crucial in improving long term survival.
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Introduction: Post-intensive Care Syndrome (PICS)  is a major health 
problem that describes impairment in their physical, cognitive, or 
mental health status. Neurophatic pain (NP) is related with worst pain-
related interference and poor quality of life (QoL). Despite of that, the 
role of NP in Critical Illness survivors (CIS) and its relationship with PICS 
has been not establish.
Objectives: The goal of this study was to evaluate the prevalence and 
impact of NP in CIS, and its relationship with anxiety, depression and 
post-traumatic stress disorder (PTSD), majors PICS components
Methods: We conducted a prospective  12-month follow-up study. 
Patients admitted in ICU were consecutively recruited and were evalu-
ated before ICU discharge, and at 3 and 12 months after. Evaluations 
included: NP (DN4: Douleur Neuropathique en 4 Questions); pain 
intensity and pain related-interference (BPI-LV: Brief Pain Inventory 
Long Version); anxiety and depression (HAD Test: Hospital Anxiety 
and Depression Scale); QoL (EuroQoL Test 5 dimension, 3 levels); PTSD 
(PTSD Checklist–Civilian Version).






BPI INTENSITY >3 78,6 37 37,5 
BPI 
INTERFERENCE>3 84,1 42,6 46,2 
DN4>4 25,7 37 24,4 
HAD ANXIETY   39,6 31,7 
HAD DEPRESSION   28,3 31,7 
PTSD POSITIVE   15,7 24,3 
Results: A DN4 test positive was related with a major pain intensity 
(BPI intensity score >= 3), worse pain-related interference (BPI interfer-
ence score >= 3), worse value of EuroQoL visual analogue scale and 
more depression in the 3 and 12-month follow-up, and more anxiety 
and PTSD in the 12-month (p<0,05).
Conclusion: Neuropathic pain is common in Critical Illness survivors, 
affects their QoL and interferes with their daily live activities. Moreo-
ver, its related with anxiety, depression, and PTSD, key components of 
PICS.
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Introduction: The mineralocorticoid receptor (MR) belongs to the 
steroid receptor superfamily. Discoveries from the past two decades 
reveal that MRs are expressed in non-epithelial cells and exert numer-
ous additional functions beyond electrolyte handling in the distal 
tubule of the kidney. The recent identification of MRs in immune cells 
has led to novel functions of MR, such as modulation of immunity and 
inflammation. The MR is unique in this family in that it has two ligands, 
aldosterone and cortisol. Aldosterone and cortisol have a similar affin-
ity for the MR.
Objectives: To evaluate the expression of MR in peripheral polymor-
phonuclear cells in critical illness for a 13-day period.
Methods: Forty-two mechanically ventilated, steroid-free patients 
were studied. Blood samples were collected on admission in the ICU 
and on days 4, 8, and 13, to measure MR expression. Twenty-five age- 
and sex-matched subjects were used as controls.
Results: Compared to healthy controls, severely ill patients on admis-
sion in the ICU exhibited a 12-fold lower MR mRNA expression [0.08 
(0.04-0.92); p< 0.0001]. During ICU stay, MR expression levels remained 
reduced up to day 13. More specifically, on day 4 patients exhibited 
8-fold reduced levels [0.13 (0.04-0.41); p< 0.001], on day 8, 5-fold 
[0.20 (0.05-0.50); p< 0.01] and on day 13, 14-fold [0.07 (0.05-0.25); p< 
0.001]. This was corroborated by the fact that compared to admission, 
MR expression levels during the stay period remained unaltered. The 
MR-downstream target gene galectin-3 (GAL3) also exhibited reduced 
expression on ICU admission, compared to healthy controls [0.51 
(0.37-0.68); p< 0.0001].
Conclusion:MR exhibits a very low expression in critically ill patients, 
and remains low during the 13-day observation period. The down-
stream target of MR, GAL3, as expected is also low on ICU admission.
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Introduction: Specialized weaning centres (SWCs) provide an alter-
nate model of care to the ICU for patients requiring prolonged 
mechanical ventilation. Many studies representing numerous coun-
tries report short term outcomes of SWCs; limited data describe mor-
tality beyond 1  year. Furthermore, comparative data on long term 
outcomes with a control group representing PMV patients who remain 
in an ICU setting are lacking. Quantification of long-term survival, 
healthcare utilization and costs of patients experiencing PMV informs 
patient/family decision making, healthcare spending policy, and 
understanding of specialized weaning centres (SWC) as an alternate 
care model.
Objectives: To compare long-term healthcare utilization, costs, and 
survival trajectory of Canadian SWC patients with a matched cohort of 
≥21-day stay ICU patients.
Methods: Retrospective longitudinal (2004-2016, 12-year) study. 
We linked patients discharged alive identified from the clinical/qual-
ity database of the Prolonged-ventilation Weaning Centre (PWC) 
(Toronto, Canada) to Canadian health administrative databases. We 
used 1:1 matching (age, sex, Charlson Comorbidity Index, income 
quintiles) to patients experiencing prolonged ICU stay only. We cre-
ated multivariable Cox proportional hazard models of survival and 
time to home discharge.
Results: We matched 228 SWC to 228 prolonged ICU stay survivors 
(456 patient cohort); 42% had Charlson score of >4. Mean (SD) dura-
tion of SWC admission was 62.2 (85.7) days with mean (SD) 95 (87.7) 
ICU days before SWC admission. Mean (SD) ICU LOS of the prolonged 
ICU cohort was 43.4 (32.7) days. SWC survivors required more ICU 
admissions, hospital and ICU days 12  months before index admis-
sion. Six months and 12 months following unit discharge, more SWC 
patients required ICU admission (30.3% vs 16.7%, P<0.001), with 
more frequent (and longer) hospital and ICU admissions, specialist 
visits, and billable procedures. Median costs were $10,853 (6-months) 
(P=0.01) and $13,138 (12-months) (P=0.004) higher for SWC survi-
vors. At 12-years, hospitalization/ICU admissions and hospital days 
were similar. SWC survivors consumed more ICU bed days (25 (106.3) 
vs 7.8 (21.9), P=0.02) and cost more healthcare dollars ($135,975 vs 
$119,763, P=0.02). There was no difference in home discharge (hazard 
ratio (HR) 1.30, 95% confidence interval (CI) 0.95-1.80). Survival was 
not different (72% vs 61% dead at 12 years; HR 1.18, 95% CI 0.93-1.50). 
Longer length of index hospital admission (HR 1.02, 95% CI 1.00-1.04 
per month increase) was associated with increased survival whereas 
increasing numbers of care location transfers was associated with 
decreased survival (HR 0.88, 95% CI 0.79-0.98).
Conclusion: SWC patients used more acute healthcare services 
before index admission suggesting greater medical fragility and after 
unit discharge with higher public healthcare costs. Repatriation of 
non-weaned patients to acute settings due to limited long-term care 
resources may have influenced this finding. Survival trajectory was 
similar.
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Introduction: The Intensive care setting has  undergone  major para-
digm shifts over the years with the  ability to expand beyond  the 
physical ICU setting and the transition to continuous monitoring and 
appropriately minimising invasive procedures. We performed a large 
retrospective cohort study to analyse the changes to in-hospital mor-
tality after ICU discharge over time.
Methods: A retrospective cohort study on patients discharged 
from ICU in a District General Hospital between 2000-2020. Pallia-
tive patients and  missing patient data were excluded. Patient search 
was obtained via ward watcher software. Total patient number was 
12762 and following exclusion 9081 were included. The patients 
were grouped into in-hours (08:00-17:59) and out of-hours (18:00-
07:59)  depending on the hour of discharge. The mortality data was 
collected  and  then compared over 5-year increments to evaluate 
progression over time. The results underwent statistical Chi Square 
analysis. 
Results: A total of 9081 patients discharged alive from ICU were 
studied. Mean age 62.7 years (range, 16-98), 4861 (53.5%) were male, 
4220 (46.5%) were female. The overall in-hospital mortality was 744 
(8.2%). The mortality rate in 5 year  increments from 2000 to 2020 are 
9.53%, 10.33%, 10.37% and 5.42% respectfully. The most recent 5 years 
showed a statistically significant drop in mortality of 4.95% (p-value < 
0.00001) to the 2010-2015 group. The results show a consistent higher 
mortality for those discharge out of hours.
Conclusion: Measure taken place over the years have shown improve-
ment in in-hospital mortality after ICU discharge. Several factors have 
potential to influence the result such as demographics, improve-
ments in ward care and ICU paradigm shifts. It is rational to note the 
significant changes have occurred over the latter 10  years, with little 
differences from 2000 to 2015. Essential work is  require  to highlight 
the key factors influencing the result.
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Introduction: Ammonia, generated from the deamination of amino 
acids, is a constituent of all human body fluids. Elevated serum ammo-
nia is commonly observed in patients with hepatic diseases, but large 
and multicenter studies on the association of serum ammonia levels 
with clinical outcomes in a broad population of adult patients are 
scant.
Objectives: The study was aimed to assess the association of serum 
ammonia upon admission during initial intensive care unit (ICU) stay 
with ICU and in-hospital mortalities.
Methods: This retrospective observational cohort study included 
2,703 adult patients with available admission serum ammonia meas-
urements from 335 ICUs within 208 hospitals in eICU Collaborative 
Research Database (eICU-CRD). Ammonia levels were divided into 
deciles, and the ICU mortalities within ammonia deciles were assessed. 
Univariable and multivariable logistic regression analyses were per-
formed to analyze the relationship between serum ammonia and mor-
talities. The covariates included demographics, Acute Physiology and 
Chronic Health Evaluation (APACHE) IV score, treatments, and diseases 
diagnosed during the first 24 h of ICU stay. Model discrimination was 
assessed by the calculation of the receiver operating characteristic 
curve and reporting the area under the curve (AUC). Interaction and 
subgroup analyses were conducted to determine whether the effect 
of ammonia on mortalities varied in patients with or without hepatic 
diseases.
Results: The median of serum ammonia was 39 (23–65) µg/dL. Totally, 
we defined three ammonia categories: < 47  µg/dL, 47  µg/dL to 
111 µg/dL, and ≥111 µg/dL, corresponding to low, intermediate, and 
high ICU mortality. ICU and in-hospital mortalities in the three ammo-
nia categories were 7.59%, 16.52%, and 32.72% and 14.05%, 22.96%, 
and 42.28%, respectively. Increased ammonia was significantly associ-
ated with increasing ICU mortality (per 10 µg/dL increase: odds ratio, 
1.069 [ 95% confidence intervals, 1.048–1.091]; Intermediate vs. Low: 
1.935 [1.445–2.592]; High vs. Low: 4.239 [2.916–6.162]), and in-hospital 
mortality (per 10 µg/dL increase: 1.060 [1.040–1.081]; Intermediate vs. 
Low: 1.440 [1.127–1.839]; High vs. Low: 3.249 [2.330–4.529]). Adding 
ammonia to APACHE IV score improved the AUC from 0.826 to 0.839 (P 
< 0.001) for ICU mortality and 0.806 to 0.813 (P = 0.001) for in-hospital 
mortality. Interaction and subgroup analyses demonstrated consistent 
results in patients with or without hepatic diseases. In patients with 
hepatic disease, serum ammonia levels were significantly associated 
with the ICU and in-hospital mortalities (1.053 [1.025–1.081], 1.040 
[1.015–1.067], per 10  µg/dL increase), the results were similar in the 
non-hepatic disease group (1.078 [1.051–1.106], 1.071 [1.046–1.096], 
per 10 µg/dL increase).
Conclusion: Serum ammonia levels upon admission might be an early 
risk factor for higher ICU and in-hospital mortalities in ICU patients.
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Introduction: Emergency laparotomy (EL) is among one of the most 
common surgical operations. Previous studies have shown that emer-
gency surgery is associated with higher morbidity and mortality com-
pared to elective surgery1-4. It has also been reported that patients 
with direct intensive care unit (ICU) admission after EL have signifi-
cantly high mortality5. However, there are no studies comparing the 
impact of direct and delayed admission from recovery room (RR) to 
ICU on the outcome.
Objectives: Aim of the study was to compare outcomes between 
direct and delayed ICU admission after EL.
Methods: The study was a retrospective single center registry study. 
Data were collected from operation registry and ICU patient data man-
agement system´s database of Oulu University Hospital. All patients 
undergoing EL and admitted to ICU directly from the operation room 
(OR) or from the RR between the January 2005 and May 2015 were 
included. Appendectomies, cholecystectomies, laparotomies due 
traumas or gynecological reasons and patients less than 16  years of 
age were excluded.
Results: There were a total of 450 patients in the study. A total of 
323 (71.8%) patients were admitted directly from OR to ICU and 127 
(28.2%)patients were admitted to ICU from the RR. The patients 
admittet directly to ICU were younger, had higher SOFA-scores and 
lower first portoperative day (POD) CRP-levels. There were no differ-
ences in short-term mortality between the groups, but 5-y mortality 








Age (y) 65 [54-76] 71 [] <0.001 
Male Gender 183 (56.7) 69 (54.3) 0.655 
SOFA adm 6[4-8] 5[3-7] 0.02 
1pod CRP 169[100-253] 238[159-302] <0.001 
Hospital mortality 47 (14.6) 16 (12.6) 0.591 
30-d mortality 61 (18.9) 22(17.3) 0.700 
90-d mortality 78 (24.1) 32 (25.2) 0.816 
5y- mortality 54.3% 67.7% 0.015 
Conclusion: Younger patients were more often admitted directly to 
ICU from OR. Patients admitted to ICU from RR had higher CRP at first 
postoperative day. Short-term prognosis was not dependent on tim-
ing of the ICU admission in this patient cohort. Higher long-term mor-
tality can be explained by the age distribution of the study population.
Reference(s) and grant acknowledgment(s)
1. 1. Peponis T, Bohnen JD, Sangji NF, et al. Does the emergency surgery 
score accurately predict outcomes in emergent laparotomies? Surgery. 
2017;162(2):445‑452. Accessed Feb 18, 2020. https ://doi.org/10.1016/j.
surg.2017.03.016.
2. 2. al, Havens JM, et. The excess morbidity and mortality of emergency gen‑
eral surgery. ‑ PubMed ‑ NCBI. . . https ://www‑ncbi‑nlm‑nih‑gov.pc124 152.
oulu.fi:9443/pubme d/25757 115. Accessed Feb 16, 2020.
3. 3. Scott JW, Olufajo OA, Brat GA, et al. Use of national burden to define 
operative emergency general surgery. JAMA Surg. 2016;151(6):e160480. 
Accessed Mar 10, 2020. https ://doi.org/10.1001/jamas urg.2016.0480.
4. 4. al, Sharoky CE, et. Outcomes of hospitalized patients undergoing 
emergency general surgery remote from admission. ‑ PubMed ‑ NCBI. . . 
https ://www‑ncbi‑nlm‑nih‑gov.pc124 152.oulu.fi:9443/pubme d/28689 604. 
Accessed Feb 16, 2020.
5. 5. Vester‑Andersen M, Lundstrøm LH, Møller MH, Waldau T, Rosenberg J, 
Møller AM. Mortality and postoperative care pathways after emergency 
gastrointestinal surgery in 2904 patients: A population‑based cohort study. 
Br J Anaesth. 2014;112(5):860‑870. Accessed Mar 13, 2020. https ://doi.
org/10.1093/bja/aet48 7.
Page 239 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
000177 
Trained ICU doulas can provide early psychological support 
to the critically ill patients
L. Karnatovskaia1; K. Varga2; P. Schulte3; G. Ognjen1; K. Philbrick4
1Division of pulmonary and critical care, Mayo Clinic, Rochester, United 
States of America; 2Affective psychology department, Eötvös Loránd Uni‑
versity, Budapest, Hungary; 3Division of biomedical statistics and informat‑
ics, Mayo Clinic, Rochester, United States of America; 4Department of psy‑
chiatry and psychology, Mayo Clinic, Rochester, United States of America 
Correspondence: L. Karnatovskaia
Intensive Care Medicine Experimental 2020, 8(2): 000177
Introduction: Over a third of critical illness survivors suffer from men-
tal health problems following hospital discharge. Memories of delu-
sional experiences are a major risk factor. Research on the formation 
of fear demonstrates that if mitigating information about a traumatic 
event is introduced during the time of memory formation or upon its 
subsequent recall, the emotional experience of the memory may be 
modified. Given that semantic processing continues during altered 
states of consciousness, and that the thinking process of the criti-
cally ill is characterized by heightened suggestibility, we adapted an 
approach based on positive suggestions to provide early psychologi-
cal support for the critically ill in parallel with medical treatment.
Objectives: We used trained ICU doulas to provide an interven-
tion targeting the vulnerable time period when memories are being 
formed.
Methods: Adult patients on mechanical ventilation and/or vasopres-
sors were recruited for this single-arm prospective study. Intervention 
was administered daily during the ICU stay in parallel with medical 
treatment. Approach consisted of three phases: informing the patient 
about details of their ICU treatment while providing positive reframing 
and pre-framing of the events in their clinical course; actively involv-
ing the patient in the treatment process once they were able to com-
municate; and debriefing prior to ICU dismissal to clarify potential 
memory distortions. As a secondary analysis, subjects were compared 
to a historic cohort of patients receiving standard care in the ICU using 
adjusted linear regression models. Interactions with mechanical ven-
tilation assessed whether the relationship depended on ventilation 
status.
Results: Forty-three patients received the intervention provided by 
two trained ICU doulas for an average of 5  days with each session 
lasting an average of 20 minutes. Questionnaires were administered 
following ICU transfer. Compared to historical controls (N=299), inter-
vention was associated with reduced Hospital Anxiety and Depression 
Scale (HADS) – Depression subscale (adjusted mean difference esti-
mate=-1.3, 95%CI=(-2.6, 0.0), p=0.049). In a model with ventilation 
interaction, intervention was associated with reduced HADS-Anxiety 
subscale among ventilated patients (estimate=-2.0, 95%CI=(-3.6, 
-0.3), p=0.019), but not among those without mechanical ventilation 
(p=0.73). There was insufficient evidence to suggest an association 
with MoCA-Blind or IES-R subscores. These initial results suggest the 
intervention may be beneficial.
Conclusion: Positive therapeutic suggestion is a unique approach 
aimed to reduce formation of traumatic memories and to humanize 
critical care. It was feasible to successfully intervene on 43 critically ill 
patients. Testing the intervention on a wider scale with randomized 
treatment arms is warranted.
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Introduction: Patients on mechanical ventilation (MV) can develop a 
ventilator associated event (VAE), which is associated with higher mor-
bidity and mortality. The new Centers for Disease Control (CDC) VAE 
definition, updated early 2020, replaces prior surveillance criteria. [1] 
The most inclusive VAE definition is the ventilator associated condition 
(VAC), requiring at least two consecutive calendar days of MV stability 
followed by two consecutive calendar days of increased MV support 
(defined as lowest change [Δ] PEEP ≥ 3 or FiO2 ≥ 20% maintained 
>= 1 hour, hereafter ΔPEEP or ΔFiO2). Although VAC is designed as 
a population-level surveillance definition, it was developed by expert 
consensus and has not been validated on population data.
Objectives: The aims are to evaluate VAC definition performance by 
clinical outcomes and to optimize the definition in prediction of clini-
cal outcomes when applying different ΔPEEP, ΔFiO2, and time-win-
dow combinations.
Methods: We utilized the multi-center eICU Collaborative Research 
Database [2–4][5] Inclusion criteria: ICU stay ≥ 4  days, MV ≥ 4  days, 
with PEEP and FiO2 data availability. Exclusion criteria: age < 18 years. 
ΔPEEP was examined in a range of 1 to 7 and ΔFiO2 was examined 
from 10% to 60% above stability baseline. The time-windows for sta-
bility and deterioration were varied by calendar days [CDC definition] 
and rolling 24-hour time windows from the start of MV. Within these 
time-windows, patients with VAC and without VAC were compared by 
in-hospital mortality log odds ratios.
Results: From a total of 200,859 patients in the eICU database, we 
identified 8,230 patients who met our inclusion criteria (Table 1).
For patients with VAC, the mortality log odds ratio heatmap by calen-
dar day (Figure 1a) stratifies at ΔPEEP ≥ 4 and ΔPEEP ≥ 6. Increasing 
the ΔFiO2 criteria increases mortality log odds at the expense of sen-
sitivity. Heatmap color gradations suggest greater increases of ΔPEEP 
and ΔFiO2 clusters mortality into mild, moderate, and severe VAC. 
Similar trends are seen in 24-hour time-windows from the start of MV 
to determine stability and deterioration periods in Figure  1b. Unlike 
calendar day, the 24-hour time-window allows equitable comparison 
of MV periods between all patients.
Conclusion: This data-driven approach validates CDC VAC surveillance 
criteria in a publicly available ICU dataset. Furthermore, data analysis 
shows that the VAC definition can be improved to differentiate mild, 
moderate, and severe VAC by redefining time-windows, ΔPEEP, and 
ΔFiO2.
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Introduction: A series of previous guidelines recommended van-
comycin trough concentration (VTC) should be maintained at 
10–20 mg/L to avoid drug resistance and 15–20 mg/L to improve the 
clinical outcomes of patients with severe infections. However, the lat-
est consensus suggested that VTCs with a target of 15–20 mg/L should 
no longer be recommended based on existing data of efficacy and 
nephrotoxicity in patients with serious MRSA infections. To date, the 
optimal target of VTC for critically ill patients who receive vancomycin 
remains unclear considering limited evidence.
Objectives: The aim of this study was to explore the association 
between serum VTC and mortality in intensive care unit (ICU) settings.
Methods: This multicenter, retrospective cohort study included 7,975 
patients from 335 different ICUs at 208 hospitals in the eICU Collabora-
tive Research Database. Serum VTC was continuously monitored, and 
mean serum VTC, calculated by dividing the sum of all collected VTCs 
by the frequency of VTC monitoring, was investigated as a continuous 
and categorical variable. Patents with different mean serum VTCs were 
classified into four groups: <10  mg/L, 10–15  mg/L, 15–20  mg/L, and 
>20 mg/L. Multivariable logistic regression, interaction, and subgroup 
analyses were performed to investigate the relationship of mean VTC 
with hospital and ICU mortalities.
Results: Hospital mortality rates were 13.7%, 15.1%, 19.4%, and 
25.8% and ICU mortality rates were 7.8%, 8.8%, 12.1%, and 17.1%, 
respectively, in the four groups. After adjusting for age, sex, ethnic-
ity, body mass index, Acute Physiology and Chronic Health Evaluation 
IV (APACHE IV) score, the use of ventilation, dialysis, and vasopres-
sor, and diagnoses at ICU admission, mean VTC, as a continuous vari-
able, was positively correlated with hospital (odds ratio [OR], 1.032, 
95% confidence interval [CI], 1.024–1.041) and ICU (OR, 1.037, 95% 
CI, 1.028–1.047) mortalities. Moreover, as a categorical variable, a 
mean VTC of 10–15 mg/L failed to reduce hospital (OR, 0.973, 95% CI, 
0.802–1.180) and ICU (OR, 1.002, 95% CI, 0.785–1.279) mortalities, and 
mean VTCs of 15–20 mg/L and >20 mg/L were significantly associated 
with higher hospital (OR, 1.232, 95% CI, 1.015–1.496; OR, 1.747, 95% CI, 
1.437–2.123) and ICU (OR, 1.301, 95% CI, 1.021–1.658; OR, 1.858, 95% 
CI, 1.459–2.368) mortalities than mean VTC <10 mg/L. The interaction 
analysis had no statistical significance, and similar results persisted in 
the patients with different APACHE IV scores.
Conclusion: An increasing serum VTC was associated with incremen-
tal hospital and ICU mortalities in critically ill patients. Therefore, our 
results do not support the use of serum VTC as a monitoring indicator 
for vancomycin regimens in critically ill patients, and the necessity of 
vancomycin therapeutic drug monitoring based on VTC needs to be 
investigated in future prospective studies.
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Introduction: Previous studies have explored several different 
approaches to assess breathing changes and to evaluate their prog-
nostic value. However, the relationship between spontaneous respira-
tory rate variability (RRV) using the coefficient of variation (CV) and 
mortality in intensive care units (ICU) patients remains to be unclear.
Objectives: To investigate the association between spontaneous RRV 
and clinical outcomes in ICU patients.
Methods: Adult patients having spontaneous RR records during the 
first 24 hours after ICU admission with an ICU length of stay (LOS) 
≥1  day were enrolled from eICU Collaborative Research Database. 
The CV of RR was calculated as standard deviation/mean×100%. Then 
patients were divided into low RRV group (CV of RR ≤20%) and high 
RRV group (CV of RR >20%). The outcomes included ICU mortality, hos-
pital mortality, and LOS in ICU. Logistic regression was performed to 
investigate the relationship between spontaneous RRV and outcomes. 
External validation was also conducted in patients from Multiparam-
eter Intelligent Monitoring in Intensive Care II database.
Results: Based on the CV of RR results, 36,880 patients were divided 
into two groups: low RRV group (n=24490) and high RRV group 
(n=12390). The rate of ICU and in-hospital mortality, and long ICU 
LOS were found significantly higher in low RRV group than in high RRV 
group (2.7% vs. 2.3%, P=0.034; 5.7% vs. 5.1%, P=0.018; 5.6% vs. 4.8%, 
P=0.001; respectively). Multivariate regression analysis showed that 
compared with high RRV, patients with a low RRV had a higher ICU 
mortality (odds ratio [OR]: 1.225, 95% confidence interval [CI]: 1.056–
1.422), higher in-hospital mortality (OR: 1.155, 95% CI: 1.041–1.282), 
and a longer ICU LOS (OR: 1.199, 95% CI: 1.084–1.327) after adjusting 
for covariates. Furthermore, external validation conducted in 13,506 
patients revealed that low RRV showed an OR of 1.329 (P<0.001) for 
ICU mortality, 1.267 (P<0.001) for in-hospital mortality, and 1.357 
(P<0.001) for long ICU LOS. In addition, the Cox proportional hazards 
models also confirmed the significantly association between spon-
taneous RRV and 90-day (hazard ratio [HR]: 1.295, 95% confidence 
interval [CI]: 1.165-1.439), 180-day (HR: 1.316, 95% CI: 1.195-1.450), and 
1-year mortality (HR: 1.300, 95% CI: 1.191-1.418).
Conclusion: The low RRV may serve as an independent risk factor for 
ICU mortality, hospital mortality and LOS in ICU in critically ill patients. 
To our knowledge, this is the first attempt to measure the spontane-
ous RRV by CV based on continuously monitored records and confirm 
its prognostic value in two large multicenter ICU database.
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Introduction: Critically ill patients are vulnerable to the alteration 
of acid-base homeostasis and plasma electroneutrality, which is pro-
foundly influenced by the serum chloride level. Abnormally low or 
high serum chloride levels were associated with adverse outcomes 
in intensive care unit (ICU) settings. However, the serum chloride lev-
els of most patients in ICU are within a relatively normal range, and 
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among those patients, the prognostic implication of serum chloride 
levels has scarcely been assessed.
Objectives: To analyze the relation of admission serum chloride levels 
with ICU mortality.
Methods: The multicenter retrospective cohort study recruited 
59,807 patients from the eICU Collaborative Research Database 
(eICU-CRD), which includes data from 335 distinct ICUs throughout 
the continental United States between 2014 and 2015. The clinical 
records of adult patients with a single hospital admission and serum 
chloride level, measured during the initial 24 hours of first ICU stay, 
between 96  mEq/L and 111  mEq/L were analyzed in the present 
study. Restricted cubic splines were used to visualize the relationship 
between serum chloride levels and ICU mortality. Patients were cat-
egorized into low (<104 mEq/L) or high (≥104 mEq/L) chloride groups. 
And multivariable logistic regression models were further used to 
explore the association between serum chloride levels and ICU mor-
tality. We also performed an external validation in the Multiparameter 
Intelligent Monitoring in Intensive Care II Database.
Results: The multivariable logistic regression models revealed that for 
every unit increase in serum chloride level, there was an 8% decline 
in mortality [odds ratio (OR) 0.92, 95% confidence interval (CI) 0.90–
0.93]. And restricted cubic splines revealed that the risk of ICU mor-
tality increased rapidly with serum chloride level decreased to lower 
than 104  mEq/L. In comparison to those with serum chloride levels 
≥104  mEq/L, patients with serum chloride level <104  mEq/L had a 
higher risk of mortality (OR 1.64, 95% CI 1.49–1.81). In external vali-
dation cohort with 16,543 patients, we found a consistent result that 
patients in the low chloride group also had an increased risk of ICU 
mortality (OR 2.16, 95% CI 1.82–2.56).
Conclusion: Our study revealed that, within a relatively normal range, 
the admission serum chloride level is still independently and inversely 
associated with ICU mortality. And a serum chloride level below 
104  mEq/L may increase the mortality risk in critically ill patients, 
which may facilitate early risk stratification and improve fluid manage-
ment for critically ill patients in the future.
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Introduction: Lactate dehydrogenase (LDH), widely synthesized in 
muscle, liver and red blood cells, is one of the key enzymes in the gly-
colytic pathway. Although serum LDH is correlated with the outcomes 
of septic patients, whether serum LDH impacts on mortality in unse-
lected ICU patients remains unclear.
Objectives: To investigate the potential relationship between serum 
LDH levels and ICU and hospital mortalities.
Methods: Patients with serum LDH measurements during the initial 
24 h of first ICU stay from 335 ICUs within 208 hospitals in eICU Collab-
orative Research Database (eICU-CRD) were included in this retrospec-
tive observational cohort study. Patients were divided into four groups 
according to quartiles of the serum LDH levels. The associations of 
serum LDH with ICU and hospital mortalities were assessed using uni-
variable and multivariable logistic regression analyses. The covariates 
included Acute Physiology and Chronic Health Evaluation IV (APACHE 
IV) score, demographics, treatments performed between admission 
and LDH tested, and diseases diagnosed during the first 24  h of ICU 
stay. Interaction and subgroup analyses were performed for those 
patients who had different levels of APACHE IV score.
Results: The overall cohort comprised 1,981 patients. ICU and hos-
pital mortalities in the four groups were 7.33%, 10.10%, 14.86% and 
23.34%, P < 0.001; 11.0%, 15.56%, 22.09%, and 30.99%, P < 0.001; 
respectively. Univariable logistic regression analysis showed that 
serum LDH level was significantly associated with mortalities. Using 
the Q1 (lowest quartile) as a reference, the odds ratios (95% confi-
dence intervals) with ICU and hospital mortalities of Q2, Q3 and Q4 
were 1.420 (0.907–2.222), 2.206 (1.450–3.356), and 3.848 (2.585–5.728) 
and 1.491 (1.027–2.164), 2.294 (1.612–3.266), and 3.633 (2.584–5.108), 
respectively. After further adjustment for all covariates, the influence 
of serum LDH on ICU and hospital mortalities were similar (ICU mor-
tality, Q2 vs. Q1: 1.019 [0.606–1.713]; Q3 vs. Q1: 1.676 [1.037-2.710]; 
Q4 vs. Q1: 1.747 [1.086-2.809]; hospital mortality, Q2 vs. Q1: 1.193 
[0.777–1.832]; Q3 vs. Q1: 1.931 [1.290-2.889]; Q4 vs. Q1: 2.066 [1.378-
3.098]). In addition, a linear association between serum LDH quartiles 
and ICU and hospital mortalities (ICU: 1.243 [1.075-1.438]; hospital: 
1.300 [1.148-1.473]) were found. When stratified by APACHE IV score < 
61 (975 patients) and ≥ 61 (1006 patients), no significant interaction 
was observed and similar results persisted in the patients with differ-
ent APACHE IV scores.
Conclusion: The level of serum LDH may aid in the early identification 
of critically ill patients for higher risks of ICU and hospital mortalities.
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Introduction: Albumin plays an essential role in the maintenance of 
colloid osmotic pressure and is involved in several physiological and 
pathological processes, such as keeping vascular permeability, binding 
and transporting numerous endogenous and exogenous compounds, 
regulating of acid-base balance, scavenging free radical, and inhibiting 
platelet function as well as antithrombotic effect. An abnormally low 
serum albumin level (SAL) was common in intensive care unit (ICU) 
and was related to adverse outcomes. However, the optimal SAL was 
inconsistent across different studies.Albumin plays an essential role in 
the maintenance of colloid osmotic pressure and is involved in several 
physiological and pathological processes, such as keeping vascular 
permeability, binding and transporting numerous endogenous and 
exogenous compounds, regulating of acid-base balance, scavenging 
free radical, and inhibiting platelet function as well as antithrombotic 
effect. An abnormally low serum albumin level (SAL) was common in 
intensive care unit (ICU) and was related to adverse outcomes. How-
ever, the optimal SAL was inconsistent across different studies.
Objectives: The study was aimed to assess the association of SAL with 
hospital and ICU mortalities in critically ill patients.
Methods: This retrospective multicenter cohort study includes 36,448 
patients extracted from the eICU Collaborative Research Database 
(eICU-CRD) from 335 distinct ICUs throughout the continental United 
States. Patients with single hospital admission and having albumin 
records in the initial 24 h of the first ICU admission in eICU-CRD data-
base were included. The outcomes of this study were ICU and hospital 
mortalities. Restricted cubic splines and logistic regression were per-
formed to investigate the relationship between SAL and mortalities.
Results: The restrictive cubic splines revealed a rapid increase of ICU 
mortality when SAL declined to around 3.5  g/dl. Thus, 36,448 ICU 
patients were divided into two groups according to the SAL ≤ and 
> 3.5  g/dl. Patients with SAL ≤ 3.5  g/dl (n = 28,972) had higher ICU 
and hospital mortalities than those with SAL > 3.5  g/dl (n = 7476; 
9.8% vs 4.2%, P < 0.001 and 14.7% vs 5.9%, P < 0.001, respectively). 
After adjusted for demographic factors, Acute Physiology and Chronic 
Health Evaluation IV score, treatments before admission SAL examina-
tion and primary diagnoses, logistic regression models showed that 
SAL ≤ 3.5 g/dl was independently correlated with higher risks of ICU 
and hospital mortalities [odds ratio (OR): 1.161, 95% confidence inter-
val (CI): 1.012–1.331, P = 0.033 and OR: 1.415, 95% CI: 1.259–1.590, P 
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< 0.001, respectively]. Furthermore, the association between SAL, 
as a continuous variable, and mortalities in patients with SAL ≤ or > 
3.5 g/dl were assessed, respectively. The results showed that SAL was 
inversely associated with ICU and hospital mortalities (OR: 0.976, 95% 
CI: 0.968–0.984, P < 0.001; OR: 0.958, 95% CI: 0.952–0.965,P < 0.001, 
respectively) in the SAL ≤ 3.5 g/dl group, but the associations were not 
found in the SAL > 3.5 g/dl group.
Conclusion: Patients with SAL ≤3.5  g/dl had higher risks of ICU and 
hospital mortalities than those with SAL > 3.5  g/dl. Among patients 
with SAL ≤ 3.5 g/dl, increasing SAL was associated with an incremen-
tal improvement of survival in critically ill patients. Therefore, a SAL 
≤ 3.5 g/dl may serve as an optimal therapeutic target for exogenous 
albumin infusion in ICU.
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Introduction: Global warming leads to increased exposure of human-
kind to meteorological variation, including short-term weather 
changes. Weather conditions involve changes in temperature, heat 
and cold, in air pressure and in air humidity. Every single condition 
influences the incidence and mortality of different diseases such as 
myocardial infarction and stroke.
Objectives: This study investigated the impact of weather conditions 
on short- and long-term mortality of critically ill patients admitted to 
an Intensive Care Unit (ICU).
Methods: A total of 4321 medical patients (66±14 years, 2638 male) 
admitted to a German ICU over five years were retrospectively inves-
tigated. Meteorological information (mean, maximum and minimum 
air temperature, air pressure and humidity) for the same period was 
retrieved. The influence of absolute weather parameters, different 
seasons, sudden weather changes (delta 24  h) including “warm” and 
“cold” spells on ICU- and long-term mortality was analyzed. Significant 
results (p<0.05) were adjusted for SAPS-2 scores. Additionally, sub-
groups of patients older than 75 years, patients with myocardial infarc-
tion and with pneumonia were investigated.
Results: After correction for SAPS-2, no impact of meteorological con-
ditions on mortality was found. Different seasons, sudden weather 
changes, “warm spells” or “cold spells” did not affect the outcome. In 
a subgroup analysis, none of the subgroups demonstrated increased 
mortality during the studied weather conditions. Additionally, no dif-
ference between males and females could be found.
Conclusion: Sudden weather changes and seasonal variations have 
no impact on short- and long-term mortality in critically ill patients.
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Introduction: Anion gap (AG), which is the difference between 
unmeasured anions and unmeasured cations, has been used to evalu-
ate acid-base statues and guide the management of intensive care 
units (ICUs) patients. However, there were controversies in the rela-
tionship between AG and mortality.
Objectives: To evaluate the association between AG and ICU mortal-
ity in a large sample of ICU patients.
Methods: We retrospectively enrolled adult patients with com-
plete serum sodium, potassium, chloride, and bicarbonate in the 
first 24  hours of initial ICU stay from 335 ICUs at 208 hospitals 
across the United States in eICU Collaborative Research Database. 
AG and corrected AG by serum albumin (cAG) were calculated as 
[sodium]+[potassium]-[chloride]-[bicarbonate] and AG+2.5(4.4-albu-
min). The ICU mortalities in patients with different deciles of admission 
AG or cAG were assessed, respectively. Multivariable logistic regres-
sion models were applied to investigate the association between AG 
or cAG, as continuous and dichotomous variable, and ICU mortality. 
Interaction analysis between AG or cAG and acute physiology and 
chronic health evaluation (APACHE) IV score was assessed for the asso-
ciation with ICU mortality.
Results: A total of 15,927 patients with AG (10,442 patients with 
cAG) entered into the final cohort. After adjustment for demograph-
ics, APACHE IV score, lactate, and diseases diagnosed during the first 
24 h of ICU stay, elevated admission serum AG or cAG, as continuous 
variable, were related with increased ICU mortality (odds ratios [95% 
confidence intervals]: AG, 1.024 [1.011-1.037); cAG, 1.017 [1.002-
1.032]). Furthermore, the ICU mortality was higher in patients with 
the highest three deciles of admission AG (>16.90  mEq/L, 18.9% vs. 
9.8%, P<0.001) or cAG (>21.45 mEq/L, 22.7% vs. 11.0%, P<0.001) than 
those with the lowest seven deciles of admission AG (≤16.90 mEq/L) 
or cAG (≤21.45 mEq/L). In multivariable models, AG >16.90 mEq/L or 
cAG >21.45 mEq/L were associated with higher risks of ICU mortality 
(AG: 1.027 [1.077-1.354]; cAG: 1.171 [1.023-1.341]) compared with AG 
≤16.90 mEq/L or cAG ≤21.45 mEq/L. Interaction analyses showed that 
the association between AG (P Interaction =0.226) or cAG (P Interac-
tion =0.067) and ICU mortality could not be modified by APACHE IV 
score.
Conclusion: Elevated admission serum AG or cAG might be an early 
risk factor for ICU mortality.
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Introduction: Heart rate (HR) variations, such as HR variability, HR tur-
bulence, resting HR, and nighttime mean HR have been recognized as 
independent predictors of mortality. However, it is unclear whether 
the circadian changes in HR influence the risk of death in the intensive 
care unit (ICU).
Objectives: To evaluate the relationship between the circadian varia-
tion of HR and the mortality among critically ill patients.
Methods: The records of 4760 patients were extracted from the Mul-
tiparameter Intelligent Monitoring in Intensive Care II (MIMIC II) data-
base. The circadian variation in HR was evaluated as nighttime mean 
HR/daytime mean HR. Participants were divided into two groups 
according to the median score of the circadian variation in HR: group A 
(≤0.98) and group B (>0.98). The endpoints were ICU, hospital, 30-day, 
and 1-year mortality. Multivariable logistic regression models and Cox 
proportional hazards models were used to investigate the relationship 
between circadian HR variation and mortality in ICU. Sensitivity analy-
ses were also conducted in different Sequential Organ Failure Assess-
ment (SOFA) scores subgroups.
Results: Patients in group B (n=2471) had higher mortality than those 
in group A (n=2289). After multivariable adjustments, the associations 
of circadian HR variation with ICU mortality (odds ratio [OR], 1.419; 
95% confidence interval [CI], 1.097-1.835; P =0.008), hospital mortal-
ity (OR, 1.394; 95% CI, 1.122-1.747; P =0.004), 30-day mortality (hazard 
ratio [HR], 1.283; 95% CI, 1.085-1.518; P =0.004), and 1-year mortality 
(HR, 1.215; 95% CI, 1.064-1.387; P =0.004) were statistically significant. 
Furthermore, the association became more statistically remarkable 
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in patients with higher SOFA scores (≥6 subgroup) in the sensitivity 
analysis.
Conclusion: The circadian HR variation may predict short-term and 
long-term mortality in critically ill patients, especially in patients with 
higher SOFA scores.
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Introduction: Platelets are involved in coagulation system, immune 
system, inflammation and stress responses. Abnormal platelet counts 
have been linked to increased mortality in critically ill patients. How-
ever, the optimal platelets count target remains unclear.
Objectives: The study is designed to explore the relatively optimal 
range of platelets count in critically ill patients with real world data; 
Furthermore, the relationship between the platelets count and mortal-
ity in ICU was also studied.
Methods: This is a multicenter and retrospective cohort study using 
the eICU Collaborative Research Database (eICU-CRD) with author-
ized access. The restricted cubic splines were used to explore the 
crude relationship between platelets count and mortality. We derived 
an optimal range of platelet counts and analyzed the association 
between the optimal range of platelet counts and mortality. Multivari-
able logistic regression models were used to further explore the asso-
ciation between the level of platelet counts and mortality in intensive 
care unit (ICU). The sensitivity analyses were performed in patients 
with sepsis or not.
Results: In total, 49,875 adult patients with platelet counts within 
24 hours of admission to the ICU were included. According to the 
restricted cubic splines, the optimal range of platelets count was 
125–185×109/L (reference group). Patients were divided into lower 
platelet group(<125×109/L), higher group (>185×109/L) and refer-
ence group (125–185×109/L). Compared with those in the reference 
group, patients with lower platelet counts and higher platelet counts 
are associated with a higher hospital mortality ([odds ratio (OR) 1.226, 
95% confidence interval (CI) 1.116–1.347]; OR 1.276, 95% CI 1.278–
1.381; respectively) and ICU mortality (OR 1.260, 95% CI 1.127–1.409; 
OR 1.284, 95% CI 1.166–1.413; respectively) after adjustment for a 
series of variables. The results of subgroup analyses are consistent 
with overall population.
Conclusion: The optimal range of platelet counts was 125–185×109/L 
in critically ill patients. platelet counts lower than 125×109/L or higher 
than 185×109/L may increase the mortality in ICU.
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Introduction: An annual review of suicides in the UK (Office for 
National Statistics) for 2018 showed a significantly higher rate of 
deaths by suicide than the previous year [1]. This was the first reported 
increase since 2013. Deliberate and accidental drug overdose cases 
that result in critical care admission often require a period of artificial 
ventilation and may also require renal replacement therapy. Identify-
ing trends in admission could improve the ability for ICU to plan with 
regards to budget and resources.
Objectives: To review whether there has been a change in the num-
ber of patients admitted to a 16-bed adult ICU during a 16 year period 
and whether it is possible to identify seasonal variations.
Methods: The WardWatcher database for a single 16-bed adult criti-
cal care unit was interrogated for the period January 1993 to Septem-
ber 2019. To account for different classification and coding, search 
terms containing the following were deemed suitable: overdose, self-
harm, poison, suicide. Hanging and asphyxia were not included in 
the search. Duplicated information was removed manually. Data was 
analysed according to year, season and outcome (ie. death or survival 
to ICU discharge). There was insufficient information available to inves-
tigate method of overdose. Statistical analysis was performed using R 
version 3.6.3 (Austria-Vienna).
Results: A database of 12,671 patients was reviewed and 331 cases 
involving drug overdose were identified. The dataset showed a mini-
mum of 2 and maximum of 33 overdoses per year, with a median num-
ber of 10 (IQR 5-16). The raw time series for the data demonstrates an 
increasing trend. Using a bias-corrected and accelerated bootstrap 
percentile method, we estimated the 95% confidence interval for the 
r2 value of 0.41 to be between 0.17 and 0.64. This suggested there was 
a small positive association between the number of total overdoses 
over time.
Analysis by season suggested that the highest percentage of over-
doses were admitted in Spring (annually 20th March to 20th June), 
accounting for 28.01% (93) of total overdose admissions. The numbers 
were, however, closely clustered for all four seasons.
Out of the 331 patients, 315 (95%) survived to discharge from ICU. 
There was not enough data to study their course following this, such 
as their neurological outcomes. No trends by year or season were 
observed due to the small number of deaths in this period.
Conclusion: By reviewing a large dataset over a prolonged period 
of time we were able to show that an increase in suicide death rates 
at a national level, as reported by ONS, was not accompanied by an 
increase in ICU admissions at a local level. This study showed that 
there has been a relatively poor increase in the annual number of 
overdoses admitted to this particular ICU since 1993 with a median of 
10 per annum.
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Introduction: Ventriculo-arterial coupling (VAC), is a major deter-
minant of cardiovascular efficiency in terms of the ratio between 
work required for the stroke volume relative to the total work for the 
contraction.
Objectives: Aim of this study was to investigate the relationship 
between ventricular-arterial coupling (VAC) and in-hospital outcomes 
and to evaluate its prognostic value in critical ill patients.
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Methods: We evaluated 333 (age 66,8±15,4  years, male 67,3%) con-
secutive patients admitted in ICCU of our hospital. Blood pressure and 
trans-thoracic cardiac ultrasound were collected for assessment of left 
ventricular elastance (Ees), arterial elastance (Ea) and VAC calculated 
through Chen’s method. In-hospital we recorded events related with 
acute heart failure and study population was stratified according to 
events development (need for invasive and NIV, amine, IABP, CVVHD, 
anuria, MOF, and death).
Results: In our population 190 pts (57%) presented in-hospital com-
plications, and 143 (43%) didn’t. Ea and VAC were found to be signifi-
cantly higher in the first group than in the latter, and a trend toward 
decrease for Ees was observed in the first group (Figure). VAC resulted 
a strong and independent predictor of in-hospital clinical outcomes 
[odds ratio (95% confidence interval): 2,016 (1.287–3,159); P=0.002] 
even after univariate and multivariate analysis adjusted for age, dys-
lipidaemia, diabetes, obesity, coronary artery disease and chronic kid-
ney disease.
Conclusion: Assessment of VA coupling might be an additional non-
invasive parameter that can be used to  determine prognosis in criti-
cally ill patients. Although those encouraging results, the benefit of 
such an approach for understanding the pathophysiology of altered 
hemodynamic profiles and to guide the therapeutic strategies, has to 
be confirmed in larger clinical trials.
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Introduction: During the first year, ICU survivors show a greater use 
of health services and a high percentage become chronic patients in 
addition to presenting high rates of hospital readmission (up to 47%) 
and mortality (17%). The most common consequences, after admis-
sion in ICU, are included in what has recently been called Post-Inten-
sive Care Syndrome (PICS).
Objectives: To determine the frequency of appearance of the Post-
Intensive Care Syndrome (PICS) in patients and their main caregiver, 
treated in an Intensive Care Unit (ICU), 3 months after discharge.
Methods: Prospective observational study in a 14-bed ICU for 
12 months. Inclusion criteria were admission> 7 days and at least one 
of the following: mechanical ventilation (invasive or non-invasive)> 
3 days, sepsis or shock. Patients with cognitive impairment or severe 
dependency prior to admission were excluded. The variables analyzed 
(physical, cognitive and psychoemotional), were assessed using vali-
dated scales and physical examination in the follow-up consultation. 
The presence of overload from the main caregiver was assessed using 
two validated scales. Prevalence was measured as the percentage of 
cases of patients with PICS identified of the total number of patients 
discharged with risk criteria.
Results: Of the 52 patients who presented risk factors for develop-
ing PICS, 36 were discharged from the unit. Of the 25 patients who 
attended the follow-up consultation at 3  months, 18 had PICS. The 
fundamentally affected dimension was physical 55.5%, followed 
by psycho-emotional 27.7% and cognitive 16.6%. In all the cases of 
patients with PICS, the main relative had caregiver overload.
Conclusion: The frequency of PICS at three months after ICU discharge 
is at least 50% in patients with risk factors. In all cases presented by the 
patient, their primary caregiver is affected too. The high frequency of 
this syndrome would require adopting measures for it to be foreward, 
and follow-up as well as therapeutic approach, both for patients and 
for their main caregivers.
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Introduction: Cardiogenic shock (CS) is the fatal common path of 
some of the most prevalent diseases in the world (1), yet its manage-
ment is not straightforward. Veno-arterial extracorporeal membrane 
oxygenation (VA-ECMO) use as a rescue therapy for refractory cases is 
growing in popularity (2).
Objectives: The purpose of this study was to evaluate the different 
outcomes of patients with refractory CS supported with VA-ECMO, 
stratified by etiology, in the short-term and after 1-year follow-up.
Methods: Data was collected prospectively from 2010 to 2020, 
patients with CS having received VA-ECMO were reviewed retrospec-
tively. We analysed baseline demographic variables, cause of CS, ECMO 
characteristics, complications and global survival (at ECMO weaning, 
hospital discharge, and after 1 year), using SPSS software, version 20.
Results: We included 92 patients who received 101 VA-ECMO. The 
median age was 54 (interquartile range IQR 42-63), 64% were male. 
Causes of CS were: decompensated advanced heart failure (32%), 
acute myocardial infarction (AMI) (26%), post-surgical pulmonary 
thromboendarterectomy (13%), post-cardiotomy, (10%), acute myo-
carditis from infectious, toxic or metabolic causes (7%).
Before VA-ECMO cannulation 61% of patients were supported by an 
intraaortic balloon pump.
A peripherally VA-ECMO was established in 91% of cases. The median 
length of ECMO was 186 hours (8 days, IQR 5.4 – 13 days), median ICU 
stay 18 days (IQR 12-33 days).
The global survival rate during ECMO support was 68%, with 43% of 
patients being discharged home, and all of them were alive one year 
later. Patients with reversible causes of cardiogenic shock (acute myo-
carditis, right ventricular failure following pulmonary embolism) fared 
better overall, with a 100% survival rate.
In 50% of patients with CS secondary to AMI (with previous normal or 
unknown cardiac function) a “bridge to decision” strategy was imple-
mented. Sixty-four percent were weaned from ECMO, but only 37% of 
weaned patients survived. A heart transplantation was made in 83% of 
the survivors of this subgroup.
Patients with CS secondary to acute decompensation of previous car-
diopathy were usually placed in the “bridge to transplant” category. 
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Out of 32 patients, half of them died, but in those succeeding into get-
ting a heart transplantation (59%), global survival was of 83%.
Postcardiotomy CS patients requiring VA-ECMO had a global survival 
of 43%, the most common surgeries needing this kind of support 
being pulmonary thromboendarterectomy and valvular surgery with 
previous systolic dysfunction.
One year after hospital discharge, 39 out of the 40 surviving patients 
remained alive and out of the hospital.
Conclusion: Refractory CS patients are a very heterogeneous cohort. 
Outcomes were far better in potentially reversible causes of CS like 
acute myocarditis. VA-ECMO offers an effective support tool for these 
patients, achieving favorable results at hospital discharge and after 
1-year follow-up.
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Introduction: With an increasingly aging and co-morbid population 
coupled with the increasing demand on NHS intensive care beds it is 
more important than ever to have a clear understanding of the ben-
efit added by admission to intensive care for mechanical ventilation. In 
addition there is an increasing drive to provide patients with the infor-
mation allowing them to make an informed decision regarding their 
escalation plan. Currently despite making up only 4% of the popula-
tion, octogenarians account for around 10% of ICU admissions in the 
developed world [1].
We set out to perform a retrospective study looking at the previ-
ous 4  years of intensive care admissions for mechanical ventilation 
at Peterborough City Hospital. We then compared the survival of all 
patients <80 years old with the survival of patients 80 years and over. 
For the 80 and over age group we then compared the medical admis-
sion vs surgical admission survival outcome.
It should be noted that the intensive care department already puts a 
strong emphasis on requiring a good pre-morbid state prior to admis-
sion to the ICU, and all admissions are approved by an intensive care 
consultant. Therefore, the patients with a high frailty score deemed 
unlikely to benefit from mechanical ventilation, are not reported in 
these figures.
Objectives: To compare intensive care survival between patients 
younger than 80  years and those patients 80  years and over.  To 
compare the above patient’s hospital survival once they have been 
stepped down from intensive care.
To compare whether medical vs surgical admission in 80 and over 
affects survival.
Methods: Data was extracted from Intensive Care National Audit & 
Research Centre (ICNARC) and is based on data exclusively from PCH.
Results: Over a 4-year period (2015–2019) 1025 patients received ven-
tilatory support in PCH’s ICU. Of these 99 (9.7%) were ≥80.
52.5% of ≥80 survived ICU and 41.4% were discharged home (11.1% 
dying in hospital post ICU). Compared with 74.4% of <80’s surviving 
ICU and 68.3% being discharged home (6.1% dying in hospital post 
ICU).
Even though the vast majority of octogenarians admitted to PCH’s ICU 
for mechanical ventilation had a very good pre-morbid status, com-
pared to all those <80, they had a 21.9% lower chance of ICU survival 
and 27.1% lower chance of being discharged home.
Overall 91.7% of all patients <80 discharged from ICU were subse-
quently discharged from hospital. This is to be compared with only 
78.8% of the ≥80 cohort who are stepped down, showing they are 
12.9% less likely to be discharged after an ICU admission.The data 
also shows a year on year increase in numbers of patients admitted for 
mechanical ventilation 232 patients in 2015-2016, 244 in 2016-2017, 
261 in 2017-2018 and 288 patients in 2018-2019. There is also a gen-
eral trend of increasing numbers of octogenarians being ventilated ie: 
18 in 2015-16 and 31 in 2018-2019.
Age Total patients Survived ICU Survived Hospital
<80 years 926 689 632 
≥80 years 99 52 41 
Table1. Total numbers of patients admitted to ICU for mechanical ventilation 2015-2019. 
Results:part 2, medical Vs surgical admission for ≥80  year olds 
between 2015–2018.
Medical patients represented 63.2% of ≥80 ICU admissions for 
mechanical ventilation with 35% of these patients surviving to be 
stepped down to the ward. Of those stepped down 100% were dis-
charged home.
Of the surgical patients a higher percentage of 77% survived to be 
stepped down to the ward with 67% of these being discharged home.
Therefor hospital survival was 35% for medical patients ≥80 and 
52.4% for surgical admissions ≥80.
(Patients were excluded from part 2 of this study if it wasn’t clear if 
they were medical or surgical (16 patients). 2019 data for part 2 was 
not readily available at time of this project (31 patients)).
Conclusion: The data from this study, shows that overall an octoge-
narian with a good pre-morbid status stands a 41.4% chance of surviv-
ing the acute hospital admission. This percentage varies from some of 
the reported data, however in our study, we only include those who 
have received mechanical ventilation.
It can be speculated that should all octogenarians requiring mechani-
cal ventilation be admitted to ICU, rather than those with a good 
pre-morbid status, mortality among this group of ≥80 s would be sig-
nificantly increased.
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Introduction: Hyperlactacidemia is a marker of organ dysfunction 
widely used in critically ill patients with a direct relation with tissue 
hypoxia, but it is difficult to draw conclusions with isolated lactate 
values.
The topic of lactate kinetics has been gathering increased interest and 
decreasing blood lactate concentrations have been associated with 
better outcomes.
However, controversy remains over what is the better cut-off value to 
use when considering prognosis. In studies that were conducted in a 
24-hour period a 10% cut-off has been proposed. A new study from 
2019 proposed 19% as the ideal cut-off.
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In the present study we aimed to investigate the prognostic impact of 
two different values of lactate variation in the first 24 hours of critically 
ill patients admited to a polyvalent intensive care unit (ICU).
Methods: We conducted a retrospective investigation of a prospec-
tively gathered database collecting subjects admitted to a single ICU 
from January 2014 to December 2018. Inclusion criteria stated a lac-
tate value above 2,0 mmol/L on admission.
The maximum value of lactate concentration in the first 2  days was 
collected in order to calculate its variation in the first 24 hours after 
admission. Data on ICU mortality, ICU length of stay, days of invasive 
mechanical ventilation (IMV), need for vasopressors and renal replace-
ment therapy (RRT) were also collected.
We performed the same statistical analysis for the two cut-off values: 
10% and 19%. The primary end-point was the association between 
lactate variation in the first 24 hours and ICU mortality. The secondary 
end-points were association between lactate variation and ICU lenght 
of stay, days of IMV, need of vasopressors and need of RRT.
Results: A total of 674 patients (male=409, age (mean  ±  SD) = 
63.4±16,3 years) were included. The global mortality rate was 39,9%.
Analysis of mortality showed a statistically significant association with 
both cut-offs (p<0.001), higher with a lower lactate variation.
A decreased lactate variation was associated with the need for vaso-
pressors (p=0.001 for 10% and 19%) and RRT (<=10% with p=0.003; 
<=19% with p=0.010). The ICU length of stay had a statistically sig-
nificant association with a lactate variation <=10% (p=0.015) but 
not with <=19% (p=0.057). We did not find a significant associa-
tion between IMV days and lactate variation (<=10% with p=0.647; 
<=19% with p=0.312).
The 10% cut-off showed a sensitivity of 71% (95% CI 67-76) and speci-
ficity of 54% (95% CI 48-60) for mortality compared to a 64% sensitivity 
(95% CI 59-68) and 62% specificity (95% CI 56-67) for the 19% cut-off.
Conclusion: Both cut-offs were associated with ICU patients’ mortality. 
Only the 10% cut-off was significantly associated with the ICU length 
of stay.
When analyzing sensitivity and specificity, we could not find a statisti-
cally significant difference between cut-offs. However, given that the 
10% cut-off has a greater sensitivity we would select this value for our 
clinical practice.
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Introduction: Negative psychological sequelae following an ICU 
admission remain a prevalent issue for critical illness survivors. Delu-
sional memories are the biggest modifiable risk factor. Mitigating the 
negative character of formed memories may be possible during a 
critical window of initial memory consolidation when the memories 
are malleable. Previously, psychological support based on positive 
suggestions (PSBPS) was identified as a viable psychotherapeutic 
intervention in the ICU setting. Given that the spectrum of emotional 
support doulas provide is very similar to PSBPS, we trained doulas to 
work in the ICU setting. Introducing themselves as “members of the 
team”, doulas provided daily PSBPS sessions throughout the patients’ 
ICU stays.
Objectives: Acceptance of the intervention is a vital part of the 
intervention’s success. We have therefore evaluated feedback from 
patients and their families regarding the intervention.
Methods: Following ICU discharge, patients and their family members 
who were present during the intervention were asked to provide their 
impressions of the intervention including open-ended and multiple 
choice questions.
Results: Of the 48 patients who received the intervention, all pro-
vided feedback. 40 patients recalled a team member explaining what 
was happening to them and 37 found this comforting. 29 recalled a 
team member holding their hand and 28 found this comforting. When 
asked what made them feel better while in the ICU, 34 recalled specific 
aspects with themes summarized in the table; others had no factual 
memories. Nine family members who had witnessed an interventional 
session also provided feedback. When asked what they thought about 
the intervention, all provided positive feedback. Family members were 
also asked if the doula interaction was helpful to them, and again all 
also responded positively. Representative themes are provided in the 
table.
Patient Perspective  (number of responses)
Things that made 
me feel better in 
the ICU
-Positive Interaction with team/feeling cared for (15) 
-Being comforted/feeling secure (8) 
-Reassurance/explanations of medical course (5) 
-Family presence (4) 
-Being alive (2) 
Family Perspective (number of responses)




-All aspects (3) 
-Spending time with family (1) 
-Providing compassion (1) 




-Explaining things/answering questions (4) 
-Providing comfort/human touch/reassurance (4) 
-Showing caring team approach (1)  
Conclusion: Patients and their families welcomed ICU doulas provid-
ing psychological support during the ICU stay. Patient responses high-
light the importance of personal interaction with care team members 
during the ICU stay. Family member responses are uniformly positive 
regarding the intervention.
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Introduction: Many mental disorders can arise after critical illness, 
including anxiety, depression and post traumatic stress disorder 
(PTSD). Those psychiatric disorders can impair the quality of life of ICU 
survivors.
Objectives: The study aimed to estimate the frequency PTSD, anxiety 
and depression among ICU survivors and to investigate the relation-
ship between those psychiatric disorders.
Methods: It is a mixed method study conducted in a 9-bed medi-
cal ICU of Farhat teaching hospital from January 2017 to January,31 
2018 including all ICU survivors beyond 3  months after discharge. 
Information regarding demographic and clinical characteristics were 
obtained from medical records. At 3  months post-ICU discharge, the 
patients were contacted by phone to complete the Hospital Anxiety 
and Depression Scale (HADS) and Impact Event Revised Scale (IES-R). 
Spearman’s correlation test was done to find the association between 
PTSD, anxiety and depression among ICU survivors.
Results: Three hundred ninety-three patients were admitted during 
the study period. One hundred ninety-one (48.6%) were discharged 
alive, 56(29.3%) were never successfully contacted and 21(11%) died 
within the 3  months’ period. One hundred fourteen patients fulfilled 
the inclusion criteria and were enrolled in the study.
Clinical characteristics were: mean age, 56±17.8 years. The majority of 
patients were males, 66(57.9%); current alcohol consumers, 13(11.4); 
median Charlson comorbidity index, 1[1-2]; Respiratory distress, 
79(69.3%); median SAPS II at admission, 25[17-31]; invasive mechani-
cal ventilation, 47(41%); vasopressors, 13(26%); median of duration 
of IMV, 0[0-4]; length of stay, 6[4-10]; Median IES-R, 19[14-28]; median 
HADS A, 4[ 3-10]; median HADS D, 5[ 4-6]. Twenty-five (21.9%) patients 
met diagnostic criteria for PTSD (IESR≥ 37). Twenty-four (21%) patients 
had anxiety (HADS A>11) and only eleven (9.6%) had depression 
(HADS D>11).
There was significant correlation between PTSD and anxiety (r=0.662; 
p=0.000) and PTSD and depression (r=0.473; p=0.000). There was also 
a statistically significant correlation between anxiety and depression 
(r=0.196; p=0.037).
Conclusion: Psychiatric disorders after clinical illness are common. 
There was a strong and significant statistical correlation between anxi-
ety and PTSD, PTSD and depression, and anxiety and depression in ICU 
survivors at 3 months post ICU discharge.
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Introduction: A substantial number of patients treated in ICUs suffer 
from a loss of health-related quality of life (HRQoL) in the aftermath 
of their critical illness. This is due to new or worsened physical, cog-
nitive or psychological impairments, collectively referred to as the 
Post-Intensive Care Syndrome (PICS). As a result ICU survivors have 
more consultations with their general practitioner (GP) after their ICU 
treatment (1). Relatives of ICU patients are also at risk of developing 
psychological impairments, referred to as PICS Family (PICS-F). The 
General Practitioner (GP) may have a pivotal role in the aftercare of ICU 
survivors and their relatives. However data on the perceived bounda-
ries for GPs to become involved in PICS (-F) care is largely lacking.
Objectives: To identify perceived boundaries for GPs to become 
more involved in post-ICU care and identify possible targets for 
improvement.
Methods: 769 Dutch GPs were approached to fill out a self-composed 
questionnaire to assess the following questions: 1) What is the cur-
rent state of knowledge regarding PICS and PICS-F 2) How often is the 
GP confronted with PICS-related symptoms in his practice? 3) Who is 
responsible for recognition and treatment of PICS in the opinion of the 
GP? and 4) What is the current state of information sharing between 
the hospital/ICU and the GP concerning ICU treatment and is the GP 
satisfied with this information?
Results: 258 GPs responded to the questionnaire. As much as 58% of 
these GPs was not familiar with PICS and 44% not with PICS-F prior to 
receiving the questionnaire, although annually 2 (median, IQR: 1-3) 
patients and 3 (median, IQR: 1-3) relatives of ICU patients visit their GP 
with impairments compatible with PICS(-F). Patients most frequently 
present themselves to GPs with fatigue, psychological or cognitive 
impairments. GPs refer these patients to a psychologist or to a general 
practice assistant, while only 15% of the GPs were familiar with the 
concept of dedicated ICU follow-up clinics. GPs report that they feel 
responsible for both recognition and treatment of PICS-related seque-
lae in their patients, but they have insufficient knowledge. Up to 87% 
of GPs expressed a wish to obtain more knowledge about PICS(-F) via 
an e-learning or by providing education for GPs. Furthermore, infor-
mation sharing between the hospital/ICU and the GP in its present 
state is suboptimal and could therefore be improved, for instance by 
including information regarding the long-term consequences of ICU 
treatment in the discharge letter of patients.
Conclusion: Although PICS(-F) is a widely recognized problem within 
the ICU community, the majority of Dutch GPs is not familiar with 
PICS(-F)-related sequelae, but nevertheless feel a responsibility to 
recognize and treat them. GPs want to be educated preferably via an 
e-learning or educational programs, and informed about the long-
term consequences of ICU treatment and existing ICU follow-clinics in 
the discharge letter, to improve GP’s involvement in post-ICU care.
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Introduction: Renal replacement therapy (RRT) is commonly per-
formed in patients admitted to the intensive care unit (ICU). However, 
it is associated with high morbidity and mortality and its relevance is 
sometimes questioned in elderly patients in particular when they suf-
fer from other premorbid illnesses.
Objectives: We sought to evaluate the long-term outcomes and qual-
ity of life (QOL) of elderly patients who survived critical illness requir-
ing renal replacement therapy (RRT).
Methods: We retrospectively identified all patients aged over 55 
admitted to our ICU between January 2015 and April 2018 who 
received RRT for acute kidney injury (AKI). We assessed their vital sta-
tus by cross-referencing our hospital database and the Swiss national 
death registry. Mortality and time to death were recorded. Patients still 
alive at the time of the study underwent a phone interview. They were 
asked about their dialytic status and their quality of life was evalu-
ated using an EQ-5D survey with visual analog scale (VAS). Results 
were stratified according to patients’ age group (group 1, G1: “55-64 
yo”; group 2, G2: “65-74 yo”; group 3, G3: “>75 yo”) and comparisons 
between these groups and European standards were made.
Results: During the study period, 354 eligible patients were admit-
ted to our ICU. Of those, 173 (48.9%) died during the index hospital 
admission (150 in ICU and 23 on the ward). After a median follow-up 
of 2.7 years (IQR 1.6), a further 62 had died with a mean time to death 
for hospital survivors of 149.9  days (IQR 450.4). Hence, 119 patients 
were still alive at the time of the study. We successfully contacted 96 
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(80.7%) of them and 83 (69.7%) were included in the study (G1: 24, G2: 
44, G3: 15). Among the survivors, only 6 (7.2%) were still RRT depend-
ant at time of the study. Median EQ-5D and VAS scores were respec-
tively 6 (IQR 2) and 75 (IQR 30). Pain and mobility issues were the most 
frequent items quoted in the survey. Group comparisons are shown 
in figure 1. Both score were lower in patients in G3 compared to the 
other two groups (both p values < 0.01). However, they were compa-
rable with EQ-5D index population norms of aged matched patients 
(1).
Conclusion: The need for renal replacement therapy identifies a popu-
lation at very high risk of mortality with a survival of 33% at 2.5 years. 
However, quality of life for survivors was acceptable and comparable 
to age matched control population.
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Introduction: The ability of first responders to deliver appropriate 
care after medical emergencies determines positive outcomes for 
patients. Clinicians’ skills, best practice, and knowledge are gained 
from basic life-support courses, unfortunately often lost due to a lack 
of hands-on practice.The purpose of debriefing is to facilitate the iden-
tification of errors, and eventually develop plans to improve future 
performances specifically to both individual and team achievement. 
It also refers to a valid approach for correcting clinical behavior, and 
allows clinicians to reflect on knowledge, skills, attitude or teamwork 
revealed during a clinical event that if modified would benefit other 
patients in similar situations.At our institute a well-structured Rapid 
Response System (RRS) has been implemented;when a patient dete-
riorates a Medical Emergency Team (MET) is called to the bedside of 
the patient in crisis.The MET is summoned to the bedside between 80 
and 100 times a year, and is composed of health care responders: an 
anesthesiologist,3 nurses, an aide, and a clinical clerk who is involved 
in alerting and initiating the RRS.Anesthesiologists and nurses are 
trained in basic life support (BSL)/advanced cardiac life support/pedi-
atric advanced life support, and aides are trained in BLS regularly (once 
every two years). So far, at the end of a crisis, the debriefing has been 
left as optional for the team despite the fact that it has always been 
taught and performed regularly during ACLS/PALS training sessions.
Furthermore,anesthesiologists and senior nurses have been receiving 
training in how to conduct a structured debriefing after clinical crisis.
The questionnaire was submitted as a part of a larger and multifaceted 
quality improvement project aimed at implementing regular post cri-
sis debriefing, and to detect areas of improvement .
Methods: This is a descriptive, structured and voluntary, anonymous, 
non-funded, self-administered cross-sectional survey conducted at 
a 78-bed medical institute accredited with Joint Commission Inter-
national standards and focused on all solid organ transplantation 
medicine. The Quality and Patient Safety Department approved the 
conduction of the survey. The need for ethics committee approval 
was waived given the voluntary nature of the survey.The aim of the 
survey was to generate hypotheses and identify critical issues among 
responders, to guide educational activities, and to detect the attitudes 
of the personnel toward debriefing implementation as routine .The 
survey was developed by three investigators based on a review of 
the theoretical basis of survey elaboration, reappraisal of the relevant 
literature in the field of communication, team dynamics, and debrief-
ing, which later was piloted by the quality department for clarity of 
the questions.We conducted a Web-based survey sent by e-mail with 
a link to a total of 593 potential responders involved in clinical activ-
ity:118 physicians, 342 clinical nurses, 97 aides, and 36 unit clerks.The 
survey was anonymously self-administered on a voluntary basis by the 
respondents, and submitted online using a Survey Monkey system.The 
survey was conducted using 17 multiple-choice questions organized 
in four domains:Respondent characteristics;adherence to resuscitation 
guidelines and assessment of value of training; teamwork and leader-
ship and awareness of mutual respect;professional development and 
debriefing .We recorded respondents’ characteristics inherent to work 
activity: years of service at the institute, clinical role, ward of principal 
activity, and number of emergency conditions experienced in previous 
years. The survey was checked for content validity by members of the 
quality coordinating team at the hospital.Survey results were analyzed 
using descriptive statistics (numbers and percentage). Chi-square test 
or Fisher’s exact tests were applied where appropriate. Exploratory 
data analyses with contingency tables were prepared to illustrate dif-
ferent responses among groups according to roles, years of service at 
the hospital and number of yearly-managed conditions experienced.
Data management and statistical analysis were done with SAS 9.4 by 
SAS Institute Inc., Cary, NC, USA.
Results: Response rate to the survey was 25% (148 healthcare work-
ers). Of all respondents, 86% were employed >10  years, 75% were 
involved in ≤5 emergencies over the previous year. Resuscitation 
guidelines were considered fully applied by 55%; 64% of respondents 
considered the teaching program as sufficient. Of all participants, 97% 
were aware of the importance of teamwork dynamics, 79% were aware 
of the importance of the personal performance, and 52% considered 
emergencies as valid opportunities for professional growth.Leadership 
was considered important by 45% of respondents; debriefing imple-
mented by 41%, and considered a potentially useful tool by 85%.
Conclusion: We hypothesize that quality improvement programs 
based on debriefing implementation and communication may 
improve the outcome during emergency conditions, and increase sat-
isfaction for the operators. Future prospective studies are needed to 
substantiate this hypothesis.
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Introduction: Fragility assessment in very elderly patients (≥ 80 years) 
is inversely associated with short-term survival. In this regard, we 
believe that the implementation of this scale to all ICU patients on 
admission, regardless of age, can provide us with additional objective 
information.
Objectives: To assess the impact of fragility, defined by the Clini-
cal Frailty Scale (CFS), on hospital mortality of ICU admitted patients 
regardless of their age.
Methods: Prospective observational study evaluating the role of frailty 
on patients admitted to a medical-surgical ICU from October 2016 
to April 2019. Patients who required transfer to another centre dur-
ing their admission were excluded. Analysed variables were age, sex, 
comorbidities, SAPS 3, SOFA, type of patient, hospital stay before ICU 
admission, length of stay and outcome at discharge. We also included 
other variables of clinical interest during ICU admission. Fragility was 
estimated using the CFS scale, using a cut-off value of ≥ 3. Continuous 
variables are presented as median and interquartile range. To analyse 
the association with hospital mortality, a univariate and multivariate 
analysis was performed using backward logistic regression and recur-
sive partitioning using CHAID tree to estimate special risk populations.
Results: 1462 patients were included. Mean age of 66  years (55-74), 
42% women. Medical reason for admission in 54.5%. SAPS 3 46 (38-56), 
SOFA on admission 2 (0-10). Average ICU length-of-stay of 2 days (1- 4), 
and time in-hospital after ICU discharge of 6 days (3-12). ICU survival 
was 96.8%, and hospital survival was 93.8%, with a rate of ICU read-
missions of 3.2%. The CFS was 3 (2-3). The significant results regarding 
hospital mortality obtained from the multivariate analysis are shown in 
Table 1. Recursive partitioning model established that the greatest risk 
factor for mortality in the population was the development of neuro-
logical failure during ICU admission, with a mortality rate of 31% (51% 
in frail patients vs 17% in non-fragile patients: p <0.0001). Regarding 
patients without neurological failure, the main risk factor for mortality 
was presenting a CFS > 3 before ICU admission, with a mortality rate of 
3.2% (11.2% in frail patients vs 1.2 in non-fragile patients: p <0.0001).
Conclusion: The fragility index is an independent factor of hospital 
mortality in patients requiring ICU admission. The other factors identi-
fied are the need for mechanical ventilation, the need for preventive 
isolation or the development of organ failure.
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Introduction: The ideal intensive care unit (ICU) design creates a ‘heal-
ing environment’ humanizing the medical setting, minimizing envi-
ronmental stressors for healthcare professionals (HCP) and families 
while supporting patient recovery1,2. Due to the multifactorial nature 
of ICU design, understanding the effect on patient, family and staff 
outcomes is complex and remains limited.
Objectives: To conduct a scoping review of studies of ICU design 
features. Specifically, to map outcomes and measures evaluating the 
effect of these features on patients, family and HCPs. Data will inform 
future studies evaluating new or existing ICU designs.
Methods: In consultation with an information specialist, we iteratively 
designed and executed a search strategy across seven databases from 
January 2007 to May 2020. All research designs were eligible as long as 
studies explored the effect of ICU design features on patients, family 
and/or HCPs. Reviewers independently confirmed study eligibility, one 
reviewer extracted data with accuracy confirmed by a second.
Results: Of the 18,577 citations screened; 49 studies met inclusion 
criteria; most (41/49, 84%) were published after 2012. 28 (57%) stud-
ies evaluated a newly built or renovated ICU/ICU room, the remainder 
evaluated existing ICU designs or features. We grouped studies into 12 
design feature categories, the most common being light (25/49, 51%), 















*All categories were categorised for multi-design feature studies and 
therefore the % do not sum to 100. 
We identified 67 distinct outcomes. Patient clinical outcomes were 
included in most studies with the most commonly reported being 
length of stay (13/49, 26%), mortality (10/49, 20%) and psychological 
outcomes such as delirium occurrence (9/49, 18%) and duration (5/49, 
10%). Objective ICU/ICU workspace physical environment outcomes 
were reported in only 8/49 (16%) studies and included physical/visual 
accessibility (3/49, 6%), sound levels (3/49, 6%), light levels (2/49, 4%), 
and corridor utility/traffic patterns (1/49, 2%). Most commonly meas-
ured HCP reported outcomes were staff experience/perception (12/49, 
24%), staff stress (4/49, 8%), team interaction (3/49, 6%) and team 
collaboration (3/49, 6%). Only 5/49 (10%) studies measured patient 
reported outcomes; 7/49 (14%) studies measured family reported 
outcomes.
Conclusion: The last decade has seen an increase in studies evaluating 
the effect of ICU design. However, few studies characterise objective 
environmental characteristics and fewer use patient or family reported 
outcome or experience measures. Our findings can inform design of 
future studies evaluating new or existing ICU designs.
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Introduction: It has been previously reported that there are differ-
ences in the care given within the ICU between men and women1,2, 
and that men have a lower probability of being discharged from the 
ICU given equal disease burden as women3. To date there are no satis-
factory explanation as to why that is. The aim of this study is to inves-
tigate if any differences exist between men and women regarding the 
level of intensive care provided, given equal disease burden.
Objectives: To investigate differences in mechanical ventilation, inva-
sive monitoring, vasoactive treatment, placement of dialysis catheters 
and central venous catheters between men and women in the ICU.
Methods: This is a retrospective cohort study of 9067 ICU patients 
admitted to the Karolinska University Hospital Stockholm, Sweden, 
between 2006-2016. Data was extracted from the ICU medical record 
(PDMS,  Clinisoft®, GE Healthcare). Differences in use of  mechani-
cal ventilation, invasive monitoring, vasoactive treatment, echocar-
diograms, placement of dialysis catheters and central venous 
catheters  based on the sex of the patient were analysed using  uni-
variate and multivariable logistic regressions, adjusted for Estimated 
Mortality Rate (calculated using SAPS3 and Apache II), Charlsons 
comorbidity index and age. Subanalyses were performed on patients 
diagnosed with sepsis, cardiac arrest and respiratory disease.
Results: Approximately one third (36.4%) of the patients were women. 
Overall, men received more mechanical ventilation (57.7% vs 51.9%, 
OR 1.28 95% CI 1.17 – 1.40), more central dialysis catheters (11.8% vs 
9.9%, OR 1.21 95% CI 1.05 – 1.40) and vasoactive treatment (49.3% 
vs 46.6%, OR 1.61 95% CI 1.06 – 1.28). Of the 1799 patients admitted 
with a respiratory disease, men were more likely to receive mechani-
cal ventilation (55.5% vs 50.0%, OR 1.22 95% CI 1.01 – 1.49). Among 
patient diagnosed with cardiac arrest (n=536), men were more likely 
to receive a central venous line (80.3% vs 71.9%, OR 1.60 95% CI 1.04 
– 2.45). Women did not receive more of any of the items investigated.
Conclusion: We conclude that differences in the level of intensive care 
provided to men and women exists. Knowing that baseline level of dis-
ease has been adjusted for, it is clear that this finding warrants further 
investigation.
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Introduction: The development in critical care during the past dec-
ades have improved ICU outcome and long-time survival (1), even in 
highly co-morbid patients. This, in combination with increasing frailty 
in the ICU case mix, have increased the number of ICU survivors with 
a poor physical and psychical capacity at the time of discharge (2) and 
thus, a rising demand for individualised rehabilitation. Furthermore, 
increasing awareness of post intensive care syndrome (PICS) related 
sequels, further increases the demand for an adapted and individual-
ised aftercare to preserve function and improve health-related quality 
of life (HRQoL) (3).
Current data suggests that rehabilitation actions should be initiated 
early and that programs for PICS prevention and family/ patient cen-
tred care (PCC) have favourable effects on ICU outcome and poten-
tially reduce anxiety and PTSD in patients and relatives (4). Early 
initiation of rehabilitation actions has been shown both feasible and 
safe to perform (5).
Objectives: To investigate the feasibility and safety of a PCC and early 
rehabilitation program in a general ICU.
Methods: Setting: A feasibility and safety study in a 12 bed ICU in a 
university hospital in Sweden.
Population: 21 consecutive adult ICU patients with an ICU LOS > 48 h 
and on mechanical ventilation were subjected to a PCC program 
containing early initiated rehabilitation. A multi-professional team 
performed daily physiotherapeutic interventions and psychosocial 
activities parallel with normal ICU care procedures. During the study 
period the mean age of the ICU population was 58 years (73% male). 




 Achievement of sedation (RASS)/ pain (BPS, NRS), physiothera-
peutic targets (MMS) and Psychosocial asssessmet (MoCA)
 Ability to perform PCC/ family support
 Patient/ family participation
 Frequency of ICU Diaries
 Risk assessment for physiotherapy
 Adverse events
Results: The full program was completed in 88% of the patients. 
The physiotherapy program was fully applicable in all patients while 
patient cognitive limitations prevented cognitive assessment during 
the study period.
Sedation (RASS </= -2) targets were met within 4d. BPS /NRS were 
completed in 80% of the patients during the first week
Interactive rounds were feasible in > 80% after two days and diaries 
were kept in 80% of all patients. Integrity issues at rounds and inability 
for relatives to participate were common (>70%).
Low risk for rehabilitation procedures were scored in 66% of the 
patients, 27% at intermediate and 7% at high risk
No adverse events were recorded
Conclusion: The suggested program was highly feasibly, could be 
safely performed and could be executed with a high level of partici-
pation. Dropouts or late initiation were commonly due to the level of 
sedation and cognitive impairment which also limited the progression 
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rate of the physical rehabilitation and made cognitive assessment 
impossible during the ICU stay. Co-morbidity or severity of organ 
dysfunction did not prevent execution of the program but required 
minor adaptions. Interactive rounds were well received by all staff and 
patients but required procedural and timely adaption for ensuring 
patient integrity and to encourage family participation. To enhance 
and facilitate paramedical participation and integration of relatives, 
ICU work schedules have to be adapted accordingly.
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Introduction: COVID 19 pandemic affected thousands of people in 
Spain. Younger and older people have been infected, even some peo-
ple without any previous medical history were admitted in a critical 
care units.
Objectives: Determine if there are any comorbilities related to the 
increased lenght of stay in ICU and the prognosis of the patients with 
COVID 19 pneumonia.
Methods: Retrospective observational study conducted in an inten-
sive care unit of a university Hospital. During the pandemic, ICU beds 
went from 14 to 39. We analysed the patients admitted to the ICU 
with the diagnosis of respiratory failure due to COVID 19 pneumonia 
between 6/3 and 21/4 2020. Patients who are still admitted at the time 
of data collection and those who moved to another centre due to lack 
of beds are excluded. Demographic data (age, sex), APACHE II, comor-
bidities (arterial hypertension, previous pulmonary pathology, dyslipi-
demia, diabetes mellitus and obesity) are analyzed. We describe the 
relationship between comorbidities, length of stay and mortality rate. 
Statistical analysis is performed using the  IBM®SPSS Statistics 23 tool.
Results: 67 patients are analysed. Male: 65.6% (44/67). Average age 
60  years, APACHE II 14.3 ± 5.2, average stay 14.1 ± 10  days. 80.5% 
(54/67) had previous pathology: cardiovascular 44.8% (30/67) (HT 
41.7% (28/67)). Pulmonary 19.4% (13/67) (asthma 7, 4% (5), SAHS 5.9% 
(4), COPD 2.9% (2)). 71.6% had other comorbidities (48/67) (dyslipidae-
mia 40.2% (27), diabetes 22.3% (15). 19.4% (13/67) did not present any 
disease prior to their admission to the ICU. 100% of patients received 
invasive mechanical ventilation since admission. Characteristics and 





Yes No P Yes No P Yes No P Yes No P
Characteristic
s 30 37   13 54   13 54   25 42   
Sex (male) 76,6% 
59,4






% 0,3 64% 69% 0,43
Apache II 14,7 14 0,68 14,3 14,3 0,9 11,89 14,9 
0,12
5 17,1 12,35 
0,00
2 
Ferritine 1526 2856 0,14 2440 2285 0,9 3000 2100 0,4 2156 2389 0,8 
Creatininie 1,69 1,31 0,2 1,2 1,55 0,37 1,3 1,5 0,6 1,9 1,22 0,02
Bilirrubin 2,27 1,8 0,4 1,6 2,1 0,48 2,5 1,9 0,47 2,65 1,6 0,07
Prone 66,6% 64% 
0,3
4 53,8% 68% 
0,2
4 60% 66% 0,48 80% 57% 0,04
Traqueostomy 50% 41,6% 
0,3
4 50% 44% 
0,4





Mortality rate 46,6% 59% 0,2 53,8% 
53,7
% 0,6 30% 50% 
0,17
4 40% 61% 0,06
Lenght of stay 13,6 14,6 0,67 11,2 14,9 
0,2
4 13 14,4 0,6 15 13,5 0,6  
Conclusion: In our sample, we did not find statistically significant 
differences between the medical personal history of cardiovascular 
pathology (AHT), pulmonary disease or dyslipidemia and length of 
stay or mortality rate of critically ill patients on mechanical ventilation 
for COVID 19 pneumonia. Medical history of dyslipidaemia is related 
with higher creatinine values in our sample.
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Introduction: Conflicting results have been reported regarding the 
potential impact of obesity on intensive care unit mortality and sepsis. 
Sepsis and obesity independently have high incidence and mortality 
rates. Physiological consequences of obesity increase the risk of com-
plications and the possibility of slow recovery from sepsis. However, 
obese patients with sepsis had a lower mortality rate than non-obese 
patients for the first time in 1999 and it was described as obesity sur-
vival paradox.
Objectives: To evaluate the relationship between body mass index 
(BMI) and intensive care outcomes and development of sepsis in criti-
cal patients.
Methods: A retrospective cohort study involving > 18-year-old 
patients who were followed up in a tertiary care medical intensive 
care unit from January 2015 to December 2019. Patients’ age, gen-
der, arrival diagnosis, APACHE II score, SOFA score, BMIs, comorbid 
diseases, presence of infection during ICU admission and follow-up, 
invasive (IMV) and noninvasive mechanical ventilation (NIMV) states, 
CRP and Procalcitonin levels were recorded. According to their BMI 
patients were classified as, “underweight” <20  kg / m2, “normal” 
20-25 kg / m2, “overweight” 25-30 kg / m2, “obese” 30-40 kg / m2 and 
“morbid / super obese ”> 40 kg / m2 and compared for intensive care 
outcomes and sepsis development. IBM SPSS version 23 program was 
used for data analysis.
Results: A total of 410 patients, 54% of whom were male and the 
mean age was 71 ± 15, were included in the study. When categorized 
according to body mass indexes, 6% of patients were underweight, 
36% were normal, 32% were overweight, 20% were obese, 6% were 
morbidly obese. Overweight, obese and morbid obesity were sig-
nificantly higher in women than in men (p = 0.001). Hospitalization 
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APACHE II score was significantly higher in the underweight and nor-
mal patient groups than in the other patient groups (p = 0.013).Sepsis 
was detected in 113 (28%) cases; 4% of them were underweight, 35% 
normal, 32% overweight, 21% obese and 7% morbid obese. There was 
no statistical difference in terms of sepsis and SOFA scores between 
the groups (p = 0.232 and p=0.111). Besides no difference was identi-
fied in terms of hospital acquired and ventilator associated pneumo-
nia development and the causative pathogens. Ninety-three patients 
(23%) resulted in mortality; 8% was in underweight, 43% in normal, 
%33 in overweight, %13 in obese and %3 in morbid obese groups (p = 
0.031). BMI was evaluated as one of the significant risk factors for mor-
tality (26 ± 5 in exitus group and 28±7 in discharge group; p=0.007). 
One hundred and twenty-eight (31%) patients received IMV and 187 
(46%) patients received NIMV. There was no statistical significance in 
the distribution of patients who underwent invasive MV (49% in nor-
mal group, 51% in overweight and obese group, p = 0.285). NIMV 
administration was higher in overweight and obese patients group 
(61%) (p = 0.008). While no difference was observed between the 
groups in terms of invasive MV duration, NIMV duration was found to 
be longer in obese and morbidly obese patients (p = 0.018). There was 
no statistically significant difference between the groups in terms of 
length of ICU and hospital stay (p> 0.05).
Conclusion: With this study, it has been shown that disease severity 
and mortality were lower in overweight and obese critical patients; 
the rate and duration of NIMV usage is higher. But there was no rela-
tionship between BMI and sepsis and length of ICU and hospital stay. 
Studies with more patient number are needed to demonstrate the 
exact effect of BMI on sepsis development and ICU results.
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Introduction: There are many risk factors for impaired cognitive function 
and neurologic damage in intensive care patients including pre-existing 
cognitive impairment, metabolic factors, mechanical ventilation, pro-
longed exposure to sedative drugs, sepsis and systemic inflammation. 
Neurologic problems are frequently associated with other critical illnesses 
in ICU patients and they may have an influence on ICU outcome.
Objectives: Aim of this study was to investigate whether neurologic 
problems have any impact on ICU outcome and to determine what are 
the risk factors for the development of neurologic problems after ICU 
admission in pulmonary ICU patients.
Methods: This retrospective observational single center study was 
performed an University hospital ICU and patients admitted between 
2015 and 2019  years were included in the study. Frequency of 
neurologic problems at admission, their impact on mechanical venti-
lation (MV), infections, ICU length of stay and mortality, development 
rate of neurologic problems during ICU stay and risk factors for them 
were investigated.
Results: 360 patients were included in the study and there were neu-
rologic problems in the 130 of them (36%) (Group 1). They were stroke, 
parkinson’s disease, Alzheimer, neuromuscular diseases, delirium and 
muscle weakness acquired in intensive care unit. NIV requirement 
rate was less than the patients without neurologic problems (group 
2) and requirement of mechanical ventilation was significantly more 
frequent in this group (37% & 19%, p<0.05). Duration of MV was sig-
nificantly longer in the Group 1 also(19±27& 8±6, days p:0.003). 
Lastly neurologic problems was independent risk factor for extuba-
tion failure(OR:3). In the presence of neurologic problems length of 
ICU stay was significantly longer and they were independent risk 
factor(OR:3) for the increased length of ICU stay more than 10 days.
When infectious findings were analyzed sepsis rate was significantly 
higher before and after ICU admission. Urinary and pulmonary infec-
tion rates were also significantly higher in these patients.
Neurologic complications developed median 7 days after ICU admis-
sion in the 19% of the patients. Most frequent ones were delirium and 
muscle weakness acquired in intensive care unit. Neurologic prob-
lems developed after ICU admission increased mechanical ventila-
tion requirement 3 times as an independent risk factor. Risk factors for 
ICU acquired neurological problems were existance of sepsis during 
admission(OR:2.01, 95%CI:1.02-4, p:0.045) and longer MV durations 
before ICU admission(OR:1.05, 95%CI:1.004-41.103, p:0.033). Neuro-
logical problems were not independent risk factor for mortality.
Conclusion: Neurologic problems did not increase mortality but caused 
more frequently mechanical ventilation requirement, more extubation 
failure and longer ICU stay in this study population. Additionally our 
data suggest that having sepsis during admission and longer length of 
MV prior to admission may increase neurological complication rate.
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Introduction: Infection with severe acute respiratory syndrome coro-
navirus 2 (SARS-CoV-2) has become a rapidly spreading pandemic. 
Extracorporeal Membrane Oxygenation (ECMO) has become a rescue 
therapy for some refractory critically ill patients. COVID-19 studies to 
date showed that patients with abnormal liver tests are at higher risk of 
progressing to severe disease1,2,3. ECMO patients being the most criti-
cally unwell patients, we have used our case series of all patients with 
COVID-19 on ECMO admitted to the intensive care unit to describe the 
dysfunction of blood liver tests and some potential causes.
Methods: We included into our case series a total of 18 SARS-CoV-2 
positive patients undergoing VA/VV/VAV ECMO as rescue therapy at 
a university-affiliated tertiary care centre from March 1st to May 28th 
2020. Liver test abnormalities were defined as the elevation of the fol-
lowing liver enzymes in serum: ALT >40 U/L, AST >40 U/L, gamma-glu-
tamyltransferase (GGT) >49 U/L, alkaline phosphatase (ALP) >135 U/L, 
and total bilirubin (TBIL) >17.1 lmol/L. Patients who had raised ALT 
and/or AST more than 3× the upper limit unit of normal (ULN) were 
classified as hepatocyte type; patients who had raised ALP or GGT 
twice the ULN were classified as cholangiocyte type; and patients who 
had a combination of both ALT/AST elevated more than 3× the ULN 
and ALP/ GGT twice the ULN were classified as mixed type.
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Results: Of the 18 patients mean age was 47.5(27-59)years with 
94% being male.100% had abnormal liver results. No patient had 
documented liver disease prior to hospitalization. Average BMI was 
30.4,64% having pre-existing T2DM and 52% having essential hyper-
tension. Average APACHE2 Scores was 19[6-32]. 88% commenced VV-
ECMO, 12% VA-ECMO with average duration of 30.4 days. 23% had a 
hepatocellular picture, 13% cholangiocyte, 11% mildly raised LFTs and 
43% a mixed type picture. 83% had preserved synthetic function. On 
examination of causes, 70% had normal echocardiography, 11% global 
biventricular failure and 19% mild- moderately impaired RV function. 
70.5% patients were on pipercillin/tazobactum, 47% clarithromycin, 
41% co-amoxiclav 23% levofloxacin, 11.7% had oseltamivir at the time 
of the liver injury. 5% (1 patient) was on parenteral nutrition. 11.7% 
had documented fatty liver on US during their ICU stay. Mortality was 
11.7%. Ferritin levels were wide ranging [390-38,000] with mean of 
5800 and median of 3100. Average platelets count 150 x109/L.
Conclusion: From previous studies, we know those who had abnormal 
liver test results, especially in hepatocyte type or mixed type, had signifi-
cantly higher risks of developing severe disease secondary to SARS-CoV-2 
3. 100% of our patients had abnormal liver tests while requiring ECMO 
representing the most critically unwell SARS-CoV-2 population.Mixed 
hepatocellular/cholangiocyte picture was the most prevalent at 43%, 
as seen in previous studies4 with no correlation between type of liver 
dysfunction and mortality.The liver dysfunction in our study was higher 
than previously reported3,4 and with no previous history of underlying 
liver disease, suggesting that liver damage in patients with coronavirus 
infection might be directly caused by the viral infection of liver cells as 
suggested by previous studies due to SARS-CoV-2 might directly bind-
ing to ACE2-positive cholangiocytes to dysregulate liver function5. It 
is also possible that the liver impairment is due to drug hepatotoxicity, 
which might explain the large variation observed across the different 
cohorts. There was no direct correlation appreciated between antimicro-
bials and liver dysfunction in our population.In addition, immune-medi-
ated inflammation, such as cytokine storm and pneumonia-associated 
hypoxia, might also contribute to liver injury or even develop into liver 
failure in patients with COVID-19 who are critically ill3. Ferritin levels 
were wide ranging [390-38,000] with mean of 5800 suggesting systemic 
inflammatory process. High positive end expiratory pressure and aggres-
sive ventilator strategies can cause RV strain/ pressure overload. While 
our patients had reduced ventilation on ECMO 33% had RV dysfunction. 
This right ventricular dysfunction can be associated with severe hepatic 
congestion. The primary pathophysiology involved in hepatic dysfunc-
tion is either passive congestion from increased filling pressures or low 
cardiac output and the consequences of impaired perfusion.Cardiogenic 
ischemic hepatitis may ensue compounding the insult6. It is important 
to identify RV strain on echo and avoid precipitating factors such as fluid 
overload and aggressive ventilation. Early consideration for extracor-
poreal support is important in these patients to avoid RV failure from 
medical management of respiratory failure. Our case series suggests that 
there might be concomitant liver injury as a consequence of the critical 
illness or than direct viral damage on the hepatocytes C19. Attention to 
modifiable factors and further research into liver injury in SARS-CoV-2 
is key with the emphasis on clinical management of these severely ill 
patients that may consequently impact on liver function.
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Introduction: There is limited evidence to guide UK based critical care 
management in patients with novel coronavirus disease 2019 (COVID-
19) despite high demand for this service. Throughout the pandemic, 
emerging trends and initial outcome data have been important to 
modifying practice. Risk factors for severe disease in the general popu-
lation have been described [1] but their impact on intensive care out-
come is unclear.
Objectives: This is a detailed assessment of local management and 
outcomes for an east London district general hospital, following the 
first peak of infection and aims to inform future patient care.
Methods: Adult patients (>18  years) who tested positive on PCR for 
COVID-19 or those with strong clinical suspicion for COVID-19, admitted 
to critical care for intubation and ventilation between 14/03-01/05/2020 
were identified. Patients transferred to other hospitals pre-extubation, 
were excluded, as were four patients who remained on invasive ventila-
tion. Epidemiological, clinical, biochemical, temporal and outcome data 
was collected. Continuous data was analysed with Student’s t-test /Mann 
Whitney’s U test and Fisher’s exact test was used for categorical data.
Results:
Thirty-nine patients met the inclusion criteria; overall there were 15 
survivors. There was no significant difference in co-morbidity preva-
lence, however Asian ethnicity was more highly represented in non-
survivors. Illness duration prior to hospital or critical care admission 
did not differ significantly, nor did time from hospital to ICU admission, 
during which the majority received advanced respiratory support. Pre-
intubation PaO2/FiO2 ratio was not statistically different between sur-
vivors and non-survivors (median 78.3 vs 82.5 respectively; p = 0.584). 
Median ICU stay in survivors was 9.0 days (range 3.0-24.0) and hospi-
tal admission 17 days (range 11.0-35.0). CRP values were significantly 
higher in those who died at the initial hospital presentation (p=0.032) 
and ICU admission (p=0.013). Neutrophil to lymphocyte ratio (NLR) 
was significantly higher in non-survivors at both hospital admission 
(p=0.020) and ICU admission (p=0.0003). ICU admission D-dimer 
showed a trend towards higher levels in the non-survivors.
Conclusion: The APACHE II score appears helpful in predicting COVID-
19 mortality and may aid clinical decision making. Higher ICU admis-
sion CRP and neutrophil count in non-survivors may suggest a bacterial 
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superinfection or increased pro-inflammatory response. NLR ≥3.13 plus 
age ≥50 has been proposed as a useful early indicator of severe disease 
[2]. Higher NLR in our non-survivors could suggest extension to its use as 
an early indicator of ICU mortality. Lack of significant difference in comor-
bidities, age, PaO2/FiO2 ratio, ferritin and D dimer may suggest these 
indicators of more severe disease do not impact so greatly on critical 
care survival, though noting our sample size is small. Significantly higher 
noradrenaline and paralysis use, plus trend towards proning in non-sur-
vivors is likely reflective of disease severity. Patients who are from Black, 
Asian or minority ethnic (BAME) backgrounds are over-represented in our 
study, consistent with emerging national evidence [3].
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Introduction: Transition from the Intensive Care Unit (ICU) to the general 
ward represents a challenge for the critical care patient. Some patients 
will have an unfavourable evolution, which may be potentially avoidable. 
A short-term follow-up programme (FU-P) may identify patients at risk of 
deterioration, with a potential to improve quality of care [1].
Objectives: Evaluate the impact of a post-discharge short-term FU-P 
on patients from a Critical Care Department (CCD).
Methods: Prospective interventional study performed in a tertiary 
hospital in Northern Portugal. All patients with an ICU stay > 48 hours 
or intermediate care stay >72 hours or tracheostomized patients were 
included in the follow-up programme. Patients were excluded if not 
eligible to be readmitted in the ICU. Follow-up programme consisted 
of a medical evaluation by an intensivist at 24, 48 or 72 hours after dis-
charge to the ward and a review of the clinical case with the attending 
physician. Patients were discharged from the follow-up programme if 
they presented no organ dysfunction after the visit.
Results: Between September 15th 2019 and March 15th 2020, 29.6% 
of the patients admitted to the CCD (n=153) were included in the FU-P. 
The majority were male (65.4%) with a median age of 66 years [52.5 – 76]. 
Median ICU length of stay was 6 days [4-12.5], 56% of patients required 
invasive mechanical ventilation (IMV), for a median of 6 days [3-13], and 
10.1% were tracheostomized. Most patients were evaluated at 48 hours 
post-discharge. 20 patients were discharged from the hospital and 1 
died before the first evaluation. Median Glasgow coma scale (GCS) and 
median Barthel Scale at follow-up were 15 and 60, respectively. At follow-
up, 16.4% of patients presented some level of pain according to visual 
analogue scale (VAS). ICU-acquired weakness (ICUAW) was diagnosed 
in 23.1% of patients. Length of ICU stay (p<0.001) and duration of IMV 
(p<0.001) were significantly associated with ICUAW. Intensivist’s visit 
resulted in a medical action in 15.0% of patients. 2 patients were readmit-
ted. Admission due to urgent surgery was significantly associated with 
the need for medical intervention (OR 3.38, p=0.01), as well as longer 
IMV duration (p=0.03) and higher VAS pain levels (p=0.03).
Ten patients died and the median time to hospital discharge was 
7  days [3.0-16.5]. Longer duration of IMV (p=0.015) and lower GCS 
scores (p=0.05) were significantly associated with hospital death. No 
other variables were associated with hospital mortality.
Conclusion: This short-term follow-up programme was essential to 
improve the quality of care provided to our patients, while maximizing 
communication between Intensivists and attending physicians. This is a 
feasible programme that helps to identify deteriorating patients and further 
analysis will allow to improve eligibility criteria to better allocate resources.
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Introduction: To date, there are about 280,000 confirmed COVID 19 
cases in the UK with about 40,000 deaths. Reviewing Public Health 
England data, the first wave of the COVID 19 pandemic seems to have 
passed. Our national peak was at the end of March and the beginning 
of April 2020. The same trend we observed at our local critical care unit 
and in view of preparedness for a second wave, we analysed our own 
data from COVID 19 positive patients.
Objectives: We are reviewing our perfomrance during the COVID 19 
pandemic and are using the data and reflection to prepare for a sec-
ond wave.
Methods: We collected demographic data and other variables of all 
adult male and female patients confirmed positive with COVID 19 by 
nasal/oropharyngeal swab. All patients were admitted to critical care 
at Royal Lancaster Infirmary, University Hospitals of Morecambe Bay, 
Lancashire, UK, in March and April 2020.
Results: We had 21 adimission in total, 16 males (76.2%) and 5 females 
(23.8%), with an average age of 62.14 years. The clinical frailty score was 
on average 2.05, characterising our patients as ‘generally well’ with ‘no 
active disease symtpoms’. The APACHE score on average was 15.43 and 
length of symptoms (defined as shortness of breath, cough, pyrexia) pre 
admission to hospital was 8.05 days on average. The predominant past 
medical histories were hypertension, diabetes mellitus and hypercho-
lesterolaemia and 57.1% presented with fulminant four quadrant con-
solidation on admission chest x-ray (due to ARDS). Patients admitted to 
critical care were either in the emergency department (47.6%) or on the 
respiratory ward (42.9%). Patients that came to us from the emergency 
department were on a 15 l/min non-rebreather mask and patients from 
the respiratory ward were treated with eith High Flow Nasal Cannulae, 
CPAP or Venturi. Average length of hospital to critical care admission 
was 17 hours, but when patients were admitted directly from the emer-
gency department the time reduced to 2-5 hours. We observed markers 
for multi-organ involvement: positive D-dimer (on average 611.5  ng/
ml), elevated procalcitonin (6.43  ng/ml), elevated highly sensitive car-
diac troponin HsCTNI (on average 1035.92 ng/l). Average length of stay 
on ITU was 8.33  days with intubations of 7.85  days. Our patients were 
all ventilated by Draeger Evita XL ventilators and modes included CPAP/
ASB, BiPAP and APRV. 6 patients were proned, 3 patients were referred 
for ECMO (all declined) and 1 patient received a tracheostomy to sup-
port weaning from the ventilator. Cardiovascular support was delivered 
for 8.5 days on average and 3 patients also received renal replacement 
therapy (CVVHDF). Patients were extubated to High Flow Nasal Cannulae 
based on better patient tolerance than CPAP mask and ability to deliver 
higher concentrations of oxygen when compared to usual face mask. 
52% of our patients died (11 in total) and 43% survived (9 in total). One 
patient is still on critical care past day 60 of the admission. All patients 
that survived to ITU discharge also survived to hospital discharge and 
are still alive as per our Lorenzo electronic record system (3 months post 
admission). Stay on the repsiratory ward pre discharge home lasted for 
an average of 3.6 days. One out of the 21 patients developed a pulmo-
nary embolism after discharge from ITU. The patient was subsequently 
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anticoagulated by direct oral anticoagulants. All patients will be followed 
up in 6 months time in our local respiratory out-patient clinic.
Conclusion: Reviewing our local data, outcomes are very much in 
line with the national COVID 19 ICNARC data. Our predominat patient 
on ITU would be a male diabetic hypertensive patient, over 60, well & 
independant in activities of daily living with primarily two organ fail-
ures, respiratory and cardio-vascular. Mortality was 52%. Those that also 
progressed to multi-organ failure involving the renal system displayed 
a 100% mortality. The most hypoxic patients were proned and ventila-
tor modes were changed to APRV, but numbers are too small to deduct 
correlations with survival benefit. The review of data has helped us to 
strategically plan for a potential second wave of COVID 19.
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Introduction: Clinical frailty describes a syndrome of reduced physi-
cal, physiological and cognitive reserves. Frail patients who are admit-
ted to critical care have a higher mortality rate and prolonged hospital 
stays [1,2]. However, the Clinical Frailty Score (CFS) [3] has only been 
validated for use in patients aged 65 years and older.
Objectives: We aimed to assess the prevalence of clinical frailty and the 
associated mortality and morbidity in all admissions to a tertiary mixed 
medical and surgical intensive care unit (ICU) during a 6 month period.
Methods: We retrospectively reviewed electronic records of adult 
patients admitted to the Royal Liverpool University Hospital ICU 
between July and December 2018. Clinical Frailty Scores (CFS) were 
calculated using information documented in patient notes. Patients 
with a CFS of ≥5 were categorised as frail. Demographic data, mortal-
ity and length of stay (LOS) were also collected.
Results: During the period reviewed 424 patients were admitted to 
ICU, of which 62% were medical and 38% surgical patients. The prev-
alence of frailty was 32.5% (138 patients). Both ICU and hospital LOS 
were longer in frail patients (7.3 and 30.8 days, respectively) compared 
to non-frail patients (6.5 and 23.4 days, respectively).
The table below outlines the ICU, hospital and one year mortality 
rates of frail and non-frail patients aged <65 years compared to those 
≥65 years. Frail patients in both age categories were less likely to sur-
vive ICU and hospital admission and less likely to survive to one year.
<65 years ≥65 years
























































Conclusion: Frail adult patients admitted to ICU are less likely to survive 
their admission and less likely to survive to one year compared to non-frail 
patients, irrespective of age. Further research should be conducted to vali-
date the Clinical Frailty Score in patients <65 years of age, in order to facili-
tate evidence-based discussions regarding admission to critical care.
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Introduction: The most common indications for peripartum ICU 
admissions are hypertensive diseases of pregnancy and obstetric 
hemorrhage. Admission indications are well-reported, (1,2) but hemo-
dynamic and laboratory details rarely are. We characterize laboratory 
values and vital signs according to admission diagnosis in peripartum 
ICU admissions.
Methods: Retrospective study, IRB approval, 2011-15, an annual birth 
rate >11000. General maternal characteristics, obstetric characteristics, 
management and ICU admission details including hemodynamics and 
laboratory test results were assessed. P-value of 0.05 or less was con-
sidered statistically significant.
Results: 96 out of 56,865 women had a peripartum ICU admission. 
The most common admission diagnosis was PPH (post-partum hemor-
rhage) (n=35, 38.5%), followed by hypertensive diseases of pregnancy 
(n=19, 20.9%), and respiratory complications (n=13, 14.3%). 98.9% 
were admitted post-partum. Mean (SD) ICU LOS was 4.5 (9.2) days. 
62.6% required mechanical ventilation. Demographic and obstetric 
data according to ICU admission diagnosis are shown in Table  1. We 
compared women with each diagnosis to the rest of the ICU cohort. 
Women with PPH had a lower platelet count and temperature, table 2. 
Women with hypertensive diseases of pregnancy had higher blood 
pressure and different laboratory results including higher creatinine, 
urea and liver enzymes, table 3. Women with respiratory complications 
had lower oxygen saturations, and a higher temperature, table 4.
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Conclusion: In characterizing demographic, obstetric, hemodynamic 
and laboratory data according to the admission diagnosis, we report 
unique findings. Notable findings included a lower admission temper-
ature among women with PPH, possibly associated with a higher rate 
of packed cells administration, and a lower gestational age and higher 
incidence of liver and renal dysfunction among women with hyperten-
sive diseases of pregnancy. Considering our findings, the maternal ICU 
population might be more heterogeneous than previously reported 
and patient assessment and care should be individualized accordingly.
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Introduction: Studies indicate high rates of psychological morbidity 
amongst patients following admission in an intensive care unit (ICU), 
including acute stress disorder which is predictive of post traumatic 
stress disorder (PTSD).[1-3] The recent emergence of covid-19 has had 
a profound impact on patients, with additional psychological burdens 
implicated with ICU admission.
Objectives: We aimed to establish the prevalence of acute stress dis-
order in a single cohort of covid-19 patients discharged from ICU, and 
to assess which variables could be correlated to their psychological 
outcomes.
Methods: Data was prospectively collated following local audit 
approval in a UK district general ICU over a 3 month period between 
March and May 2020. Patients diagnosed with covid-19, who survived 
ICU care and were discharged to the ward, were eligible for inclusion. 
A validated screening questionnaire called the “Acute Stress Disorder 
Scale” was used to assess the acute stress disorder score (ASDS), the 
primary outcome.[4] Variables including APACHE II score; CAM-ICU 
score; duration of stay and sedation in ICU; insertion of tracheos-
tomy; and receipt of invasive ventilation were recorded. A “covid-19 
score” was formed to observe the impact of covid-19 specifically on a 
patient’s psychological experience of social isolation.
Results: 75 patients were admitted to ICU, with 22 patients discharged to 
the ward. 9 patients were included for screening; the other 13 patients eli-
gible for inclusion had been discharged to the community on commenc-
ing screening so were unable to participate. The median ASDS score was 
39 (IQR 33-54). 3 patients recorded ASDS scores of ≥52, which as an inde-
pendent cut-off score can predict PTSD with a sensitivity and specificity of 
91% and 86% respectively. There was a strong positive correlation between 
ASDS and duration of stay in ICU and sedation (Table 1). There was a weaker 
correlation with “covid-19 scores” and APACHE II scores. 8 patients had docu-
mented CAM-ICU scores, with 6 patients screened as positive.
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Conclusion: In this cohort of covid-19 patients, there is a high inci-
dence of acute stress disorder following admission into ICU. There 
appears to be a strong correlation between ASDS and duration of ICU 
stay and sedation. No statistical significance can be derived from these 
data. Further large studies with long-term follow-up are required to 
assess if acute stress disorder in this cohort of covid-19 patients is sta-
tistically linked to PTSD.
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Introduction: Patients admitted at the ICU and their family mem-
bers experience many different stressors, which make them prone for 
developing psychological disorders like Post Traumatic Stress Disorder 
(PTSD), anxiety, depression and cognitive dysfunction, also called the 
post-intensive care syndrome (PICS and PICS-Family). Patients with 
SARS- CoV-2 infection with acute respiratory failure requiring ICU care 
and mechanical ventilation are isolated from their loved ones and 
face an uncertain course of the disease. Most patients have long ICU 
length of stay with prolonged sedation, analgesia and even muscular 
blocking agents. Due to longer sedation and mechanical ventilation 
post-ICU COVID-19 patients will have impaired recall of the ICU stay 
accompanied by hallucinations or delusions with increased risk of 
PTSD. The use of an ICU diary for the patient could help fill in memory 
gaps, gain a sense of reality and complete their fragmented illness 
narrative.
Objectives: The aim of this study is to evaluate the effect of a doc-
tor and nurse driven ICU diary on the occurrence of impaired mental 
health in patients admitted with a SARS-CoV-2 infection and their fam-
ily members.
Methods: An observational cohort study of SARS-CoV-2 patients 
treated in the ICU of Elizabeth-Tweesteden Hospital in Tilburg, The 
Netherlands will be conducted. Adult patients admitted at the ICU 
because of respiratory insufficiency due to SARS-CoV-2, who are 
mechanically ventilated, are included. During treatment in the ICU the 
ICU staff initiates a written diary with additional photographs of the 
patient during treatment. Family members will also be stimulated to 
make a contribution to this diary. After discharge to a ward, the ICU 
diary will be continued by nurses of the ward and an ICU nurse practi-
tioner, who is guiding the transfer and treatment on the ward.
After hospital discharge patients’ mental health will be monitored on 
our post-ICU aftercare clinic at 3, 6 and 12  months after discharge. 
Anxiety, depression and PTSD, cognitive dysfunction and quality of 
life will be screened in patients and their relatives. The Psychosocial 
Screening Instrument for adult trauma patients (PSIT), a validated tool, 
will be used for screening for anxiety, depression and PTSD. Cognitive 
dysfunction will be screened using the Cognitive Failure Questionnaire 
(CFQ) and quality of life will be assessed by the Short Form Health Sur-
vey 36 (SF-36). The recollection of patients’ memory of the ICU stay will 
be evaluated by the ICU memory tool.
Results: The quantitative data of the PSIT, CFQ, SF-36 will be com-
pared over time and between patients and their relatives. Participants’ 
characteristics including the recollection of memory will be reported 
and if necessary multivariate analysis will be computed.
Conclusion: This study will contribute to the research on ICU diaries 
and pioneers on the psychological problems of PICS of SARS-CoV-2 
patients and the use of ICU diaries in this group.
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Introduction: Post-intensive care syndrome (PICS) affects 50-70% of 
ICU survivors. ICU patients as well as their close relatives are at risk of 
developing PICS symptoms comprising Post Traumatic Stress Disor-
der (PTSD), anxiety or depression. Post-ICU patients having delusional 
memories may have a higher risk for developing PTSD symptoms. 
(Jones, Griffiths, Humphris, & Skirrow, 2001). Little is known about the 
mental health of patients who have complete loss of memory without 
fragmented or delusional memories. ICU diaries may contribute to the 
recollection of memories or completion of a fragmented illness narra-
tive. We hypothesize that the use of ICU diaries will increase memory 
recollection of patients’ ICU stay.
Objectives: The aim of this study is to evaluate the effect of ICU dia-
ries on the recollection of ICU memories. Secondary, we investigate 
the occurrence of impaired mental health in patients with and without 
memories of their ICU stay.
Methods: Post-ICU patients, admitted to the ICU from January 2015 to 
January 2017, were included. During ICU treatment the diary was writ-
ten by either ICU staff and/or patients’ relatives. During follow-up at 
the outpatient ICU aftercare clinic, 12 weeks after hospital discharge, 
patients were screened for complete loss of memory of the ICU period. 
PTSD symptoms were screened by the Impact of Event Scale-Revised 
(IES-R). The Hospital Anxiety and Depression scale (HADs) was used to 
assess anxiety or depression symptoms.
Results: A total of 174 patients were included, of which 83 men and 
91 females, with respectively a mean ICU stay of eleven and nine 
days. Of the males 48 had an ICU diary and 35 had memories of their 
ICU stay. Of the females 33 had an ICU diary and 49 had memories 
of their ICU stay. A multivariate analysis was conducted on the fac-
tors that may influence having memories of the ICU. Patients with 
a diary had three times higher odds of having memories (OR 3.37 
(95%CI: 1.51 – 7.51, p=0.003). Of the patients who had an ICU diary, 
there were significantly more men than women who had no ICU-recall 
(p=0.013). Patients were divided into two groups; 1. Complete loss of 
ICU memory. 2. Complete recall, fragmented or delusional memories. 
Ten patients without any memory of their ICU stay had an IES-R score 
of ≥ 33, considered a probable case of PTSD, compared to twenty-two 
patients with any memory of their ICU stay (p= 0.04). HADs scores 
were not significantly different between both groups.
Conclusion: ICU diaries may contribute to the recollection of memo-
ries of an ICU stay. Having any kind of memory of the ICU admission 
seems to result in a higher risk for developing PTSD symptoms. This 
study suggests a difference of the effect of ICU diaries between males 
and females, however further research is needed to elucidate whether 
this matter is clinically relevant.
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Introduction: Survivors of acute subarachnoid haemorrhage (aSAH) 
may suffer from long-term neurological disability but also from cog-
nitive impairment, anxiety and depression. These symptoms can also 
be related to the Post Intensive Care Syndrome (PICS) defined as new 
or worsened impairment in physical, cognitive, psychological domains 
after ICU treatment. The prevalence of PICS after aSAH is not exactly 
known and the syndrome is poorly understood.
Objectives: The aim of the study was to investigate the prevalence of 
PICS and examine ICU- and patient related risk factors.
Methods: We conducted an observational cohort study of post- ICU 
patients after aSAH, who were evaluated in our post-ICU aftercare 
clinic three months after hospital discharge. Patients were included 
between January 2012 and December 2016. Patients were screened 
for physical complaints, anxiety, depression and PTSD symptoms using 
respectively an in-hospital developed questionnaire, the Hospital 
Anxiety and Depression scale (HADS) and the Impact of Event-Revised 
questionnaire (IES-R). Subjective cognitive complaints were assessed 
by asking three questions about short-term memory deficits, concen-
tration problems and speed of thinking.
Results: In total, 110 patients visited the post-ICU aftercare clinic after 
aSAH. When looking at the separate domains of PICS the prevalence of 
anxiety and depression was 24.3% and 19.6%, respectively. PTSD was 
seen in 28.6% of the patients. There was a high prevalence of cognitive 
complaints; lack of concentration (63.6%), short-term memory prob-
lems (45.8%) and reduced speed of thinking (60.9%). Fatigue (75.0%) 
and limitations in daily activity (74.1%), muscle weakness (42.6%), pain 
(37.4%) and weight loss (32.1%) were the top five most reported phys-
ical complaints. Thirty per cent of patients had PICS symptoms related 
to all three domains of physical, cognitive and psychological function-
ing. Only 6 (5.5%) patients had no complaints. High prevalence of PICS 
symptoms was reported even in good outcome aSAH patients.
Conclusion: In post-ICU patients suffering from aSAH there is a high 
prevalence of PICS. Even in patients with good outcome after aSAH 
high prevalence of PICS symptoms was reported. Future studies con-
cerning PICS should focus on the full domain of complaints compris-
ing PICS.
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Introduction: Obstetric admissions to an Intensive Care Unit (ICU) 
may be considered a marker of morbidity but are a rare event because 
pregnant women are usually young and healthy. The incidence var-
ies between 0.4 to 16% of critical care admissions or 0.7 to 13.5 per 
1000 deliveries. Reasons for admissions are conditions related to preg-
nancy (haemorrhagic events, preeclampsia, eclampsia or puerperal 
infections) or conditions unrelated to pregnancy (congenital and val-
vular heart disease, pulmonary hypertension, etc). These patients rep-
resent a challenge to intensivists due to the physiological adaptations 
and pathological concerns during puerperium.
Objectives: The aim of present study is determining the incidence, 
epidemiological characteristics and outcomes of postpartum women 
who required ICU admission.
Methods: A retrospective cohort study of all obstetric admissions in a 
Portuguese 10-bed ICU between January 2015 to January 2020.
Results: In the period from January 2015 to January 2020, 17 obstet-
ric patients were admitted to our ICU, representing 1.3% of all ICU 
admissions and 1,7 per 1000 deliveries. The mean patient’s age was 
32.5  years (21-45  years old) and the mean of gestational age was 
36.9  weeks (28.1-40.7  weeks). Out of all women, 55.6% were primi-
parous, all of them were single pregnancies and all were admitted in 
postpartum care, most patients (76,5%) were admitted in immediate 
postpartum period.
Most common delivery type was caesarean in 88.2% women, instru-
mented delivery in 5.9% and eutocic delivery in 5.9%. The three most 
common causes of admissions were obstetric haemorrhage in 6 cases 
(33.3%); HELLP Syndrome in 4 cases (22.2%) and pneumonia in 3 cases 
(16.7%). Both instrumented and eutocic deliveries had obstetric haem-
orrhage as cause of admission.
The median length of ICU stay was 4  days. The most common inter-
ventions during ICU admission were transfusion of blood products in 
8 patients (47.1%), mechanical ventilation in 9 patients (52.9%), with 
3 patients for a period <24 hours. Only 2 patients needed vasopres-
sors and 1 patient needed Renal Replacement Therapy. The mean of 
APACHE II score was 10 and SAPS II was 23. One patient died, with 
a maternal mortality rate of 0,1 per 1000 deliveries. This casualty 
was a 45-years-old woman who was admitted with a pulmonary 
thromboembolism.
Conclusion: Although obstetric admissions to ICU may be considered 
a marker of morbidity, there are few national studies to investigate 
these admissions. In our study, these patients accounted for 1.3% of 
total admissions or 1,7 per 1000 deliveries. These rates are very het-
erogeneous between ICUs and it may be explained by several fac-
tors, including the number of ICU beds or the existence of maternal 
and child centres where women are followed when there is a potential 
problem in pregnancy or prepartum.
The length of ICU stay is 4  days and the most common reasons for 
ICU admission are hypertensive disorders of pregnancy and obstetric 
haemorrhage and it is comparable with other studies. These patients 
typically have a short length of ICU stay and low hospital mortal-
ity. The only fatality case reported is the oldest pregnant woman. 
Increased maternal age is related to many complications during preg-
nancy and delivery, thus we need to be considered as a risk factor. 
Obstetric patients in ICU are a challenge that needs a multidisciplinary 
approach.
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Introduction: According to European Directorate for the Quality of 
Medicines & HealthCare “traceability is the ability to trace each blood 
component unit from donor to its final destination (patient, medicinal 
products manufacturer, disposal) & vice versa.” It is mandatory proce-
dure & prerequisite for Hemovigilance Networks. Ideally, Blood Trans-
fusion Services (BTS) should be able to trace every blood unit they 
issue.
Traceability is achieved by recording transfusion data (component’s 
unique identification number, patient’s data) in electronic files of com-
puter systems and/or in paper-forms, both in BTS & clinical ward.
Nurses contribute to implementing traceability since their actions 
mark the beginning & the end of a transfusion. Therefore, it is vital to 
train them on traceability-issues.
Objectives: To measure effectiveness of educational interventions 
regarding traceability, which were implemented in 2018 in the 8-bed-
ICU of an oncology hospital, by recording the change in traceability 
levels, the years before (2017) & after (2019) implementing relevant 
educational activities.
Methods: During 2017 & 2019, 84 & 91 patients respectively were 
hospitalized in the ICU. All 20 ICU nurses were trained on traceability 
issues during 2018 (lectures, distribution of printed material in the 
ward, training in small groups or individually) by a BTS doctor. Training 
effectiveness was checked in two ways:
1.Nurses answered a traceability-relevant questionnaire in 2017 & 
2019 (before & after implementing educational activities). Change in 
percentage of correct answers was recorded.
2.All blood products transfused before (2017) & after (2019) training 
interventions were traced (both as a whole & per blood component 
category). In our hospital, transfusion-data are recorded in paper files 
(ICU) & in electronic files (BTS). A BTS Health Visitor checked & collated 
all data recorded in both files. Transfusions were described as “con-
firmed” only when the patient’s & unit’s data were identical in both 
files- otherwise, they were described as “probable”.
Results were statistically evaluated (t-test).
Results: 1.A significant improvement in the percentage of ques-
tionnaire correct answers before & after training interventions was 
recorded (81.66% and 95.83% respectively).
2.Results regarding traceability are depicted in Table 1. The lack of sta-
tistical significance in platelet/plasma results is attributed to low trans-
fusion numbers.
Table 1: Traceability of blood transfusion (years 2017 and 2019) 
  2017 (84 patients) 2019 (91 patients) Statistics 





Red Blood  
Cells 








Fresh Frozen  
Plasma 








C: Confirmed transfusion, P: Probable transfusion, T: Traceability 
(confirmed/total) 
I: Improvement, CI: Confidence Interval  
Conclusion: 1. Implemented educational interventions contributed to 
the improvement of ICU nurses’ knowledge & practices on traceability 
issues.
2. Auditing cases of non-traceability per nurse, could help in plan-
ning targeted training to nurses with frequent “probable transfusion” 
results.
3. Repeated training can strengthen & consolidate proper traceability 
practices, enhance safety of all involved in transfusion chain (blood 
donor, patient, staff) & upgrade quality of health services provided.
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Introduction: Outbreaks of the coronavirus disease 2019 (COVID-19) 
epidemic have been causing worldwide health concerns since Decem-
ber 2019. Most of the patients admitted in ICU fulfill acute respiratory 
distress syndrome. Little is known about the heterogeneity of those 
patients and their outcomes.
Objectives: Identification of more homogeneous subgroups of 
COVID-19 patients admitted in ICU with similar characteristics, inde-
pendently of any outcome measures.
Methods: We included patients admitted for COVID-19 disease to one 
of the French ICU participating in the French Outcomerea© prospec-
tive cohort between March 1st and April 31th 2020 and having a ICU 
length of stay longer than 72 hours.We recorded baseline character-
istics including age, comorbidities, BMI and severity and main labora-
tory features at day 3 including blood cell counts, Ferritin, CRP, DDimer 
and the evolution of all those indices between admission to day 3.
Heterogeneity was explored using a Hierarchical clustering in a princi-
pal component approach. Random forest algorithm allowed the iden-
tification of the most important predictors in each sub group.
Results: 357 patients still alive at day 3 could be included. The median 
age was 61 [52; 70] years, 277 (77.6) were male, the median body mass 
index was 28.4 [25.4; 32], the median charlson score was 1 [0; 3]. At day 
3, the median SOFA without respiratory was 3 [1; 4] and the median 
SOFA respiratory was 3 [2; 3]. At day 28, 147 (41.2) were still under 
mechanical ventilation or died including 104 (29.2) dead patients.
Finally, 5 sub-groups could be identified.
Cluster A (N=76, 21%, 28% mortality) was characterized by quite old 
patients (63 [55; 72.5] years old), with multiorgan failure at day 3, and 
low lymphocytes, monocytes and neutrophils levels which tended to 
decrease from day 1 to day 3 with a moderate increase of CRP and fer-
ritin levels.
Cluster B (N=79, 22%, 23% mortality) had younger patients (53 [48; 61] 
years old), mainly with respiratory failure and the lowest inflammatory 
syndrome at day 3.
Cluster C (N=95, 26.7%, 31% mortality) gathered quite old patients (64 
[55; 73] years), with a less severe respiratory failure, but others organ 
failures, and with a moderate inflammatory syndrome.
Cluster D (N=100, 28%, 34% mortality), was remarkable for the sever-
ity of their patients at day 3 with multi organ failures and for their 
inflammatory profile with high level of ferritin, CRP and neutrophils at 
day 3.
Cluster E (N=7, 2%, 29% mortality) gathered young, obese patients 
with multi organ failure and high level of inflammation.
Conclusion: This clustering approach revealed several profiles of 
COVID-19 patients, with several levels of organ failures and variations 
in inflammation markers, highlighting for some immunosuppression 
and others hyper-inflammatory conditions.
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Introduction: Various comorbidities have been described as risk fac-
tors for severe COVID-19. The impact of smoking on COVID-19 severity 
has been previously reported in several meta-analyses limited by small 
sample sizes and poor methodology.
Objectives: To rigorously quantify the effects of smoking on COVID-
19 severity, including hospital and critical care outcomes.
Methods: This review was registered on PROSPERO a priori, 
CRD42020180920, and adhered to PRISMA guidelines. Two authors 
independently searched Medline, Embase, CENTRAL and Web of Sci-
ence for studies published between December 1, 2019 and April 24, 
2020, with an updated search on June 2, 2020. The COVID-19 resource 
centres of major journals were also screened for relevant studies. All 
clinical studies reporting the smoking status of hospitalised patients 
presenting with different severities of disease and/or at least one clini-
cal endpoint of interest (disease progression, ICU admission, need for 
mechanical ventilation and mortality) were included. Smoking history 
included current and former tobacco smokers or e-cigarette users. 
Studies with insufficient information to distinguish outcomes based 
on smoking status were excluded. Random effects meta-analyses 
of pooled raw data were employed for each outcome with sufficient 
data. Results are presented as risk ratios (RR) with corresponding 95% 
Confidence Intervals (CI). Study quality was independently assessed 
using the Newcastle-Ottawa Scale.
Results: After screening 1050 papers, we analysed the findings of 47 
eligible studies reporting on 32849 hospitalised COVID-19 patients. 
Of these, 8417 (25.6%) reported a smoking history, comprising 1501 
current smokers, 5676 former smokers and 1240 unspecified smok-
ers. Current smokers had an increased risk of presenting with severe 
COVID-19 (RR 1.80, 95% CI 1.14-2.85; p=0.012), as well as severe or 
critical COVID-19 (RR 1.98, 95% CI 1.16-3.38; p=0.012), compared to 
former and never-smokers. However, the increased risk of in-hospital 
mortality was not statistically significant (RR 1.46, 95% CI 0.83-2.60; 
p=0.192). Compared to never-smokers, patients with a smoking his-
tory had a significantly increased risk of severe COVID-19 (RR 1.31, 
95% CI 1.12-1.54; p=0.001), severe or critical COVID-19 (RR 1.35, 95% 
CI 1.19-1.53; p<0.001), in-hospital mortality (RR 1.26, 95% CI 1.20-1.32; 
p<0.001), disease progression (RR 2.18, 95% CI 1.06-4.49; p=0.035), 
and need for mechanical ventilation (RR 1.20, 95% CI 1.01-1.42; 
p=0.043).
Conclusion: Smokers are vulnerable to increased severity of COVID-19 
and worse in-hospital outcomes. In the absence of current targeted 
therapies against COVID-19, governments, policymakers and other key 
stakeholders must focus on preventative and supportive strategies to 
reduce morbidity and mortality in this patient population.
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Introduction: Influenza virus infection is an important cause of mor-
tality worldwide, leading to 250000 to 500000 deaths each year in the 
developed world. Mortality is caused by the primary viral infection, 
but also by influenza-associated pulmonary co-infections.
Objectives: Our retrospective observational study aimed to test the 
hypothesis that there is a difference in mean values of clinical data on 
ICU admission day, among patients with confirmed influenza infection 
who died and patients who survived in both Medical and Surgical ICU 
served to a community hospital.
Methods: From January 2006 to October 2019, 1332 patients admit-
ted to our ICU. From these, 25 (1.87%), 14 males and 11 females, were 
indicated with the diagnosis of severe influenza infection. Mean age 
61.08  years, length of stay (LOS) 17.68  days, days under mechanical 
ventilation (MVD) 13.6  days. The patients separated into two groups. 
Group A involved all patients who survived ICU and group B all 
patients who died in ICU. We looked for statistically significant differ-
ences (p-value two-tailed) between the medians values of two groups, 
using the unpaired Mann - Whitney test or the unpaired t-test Welch 
corrected according to the normality test, according to clinical data on 
the ICU admission day.
Results: We detected no statistical difference between the two groups 
according: Temperature: (p=0.3022), MAP: (p=0.1750), HR: (p=0.1410), 
RR: (0.2800), Na: (p=0.4029), k: (p=0.1539), BUN: (p=0.1384), Cr: 
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(p=0.0675), WBC: (p=0.1340), Ht: (p=0.4889), PaO2: (p=0.3680), 
pH: (p=0.1096), albumin: (p=0.0576), glucose: (p=0.1139), Bilirubin: 
(p=0.9359), PaCO2:(p=0.2966), glucose: (p=0.1139), PaO2/FiO2 ratio: 
(0.2364). We only detected statistical significant higher group B value 
according HCO3: (0.040).
Conclusion: According to our data, there was no statistical difference 
detected between the two groups according to all clinical parameters 
we measured, except HCO3 values, which were lower in patients who 
died. Our data suggest that even though pH didn’t achieve to make a 
difference, acid-base disorders may be so important to make as give a 
priority to these patients, as more likely to have a more severe illness.
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Introduction: Many advances in the care of high-risk surgical patients 
have been made. Nevertheless, temporal trends in outcomes in this 
population of patients in developing countries are lacking.
Objectives: This study aimed to investigate trends in mortality and 
complications in high-risk surgical patients over a ten-year period.
Methods: Ethical approval was obtained N. 1.570.327-2016. Data from 
two prospective multicenter cohort studies (SCORIS AND BRASIS stud-
ies) conducted by AMiB Network from 2008 to 2018 to address the 
outcomes of high-risk surgical patients in Brazil were compared. All 
non-cardiac surgical patients admitted to intensive care units (ICU) 
were daily followed up to hospital discharge to determine complica-
tions and mortality.
Results: Individual patient data from 1,491 high-risk surgical patients 
(904 patients from BRASIS study and 587 from SCORIS study) in 50 
ICUs were enrolled in this analysis. table 1.
Baseline characteristics 
 Variable Original Cohort Matched Cohort 








Male, n (%) 363 (61.9%) 
605   
(67%) 0.40 277 (54.4%)265 (53.3%)0.56 
Age (y), 
mean±SD 71.1± 7.4 69.5± 7.0 0.07 62.2±16.5 61.9±16.5 0.83 
ASA Score     0.16     0.76 





(57.8%)   272 (53.6%)278 (54.8%)  





(42.2%)   230 (45.2%)230 (45.2%)  
SOFA score 
median (mi-
max) 5.0 (0-20) 4 (0-19) 0.04 4.0 (0-19) 3.0 (0-19) 
0.06 
The crude hospital mortality rate decreased from 20.6% (95% CI, 17.1 
to 24.6%) in 2008 to 8.9% (95% CI, 7.0 to 11.2%) in 2018. After adjust-
ing for baseline Sequential Organ Failure Assessment (SOFA) Score, 
age and type of ICU, patients enrolled in 2018 (10.1%; 95% CI, 7.5 to 
13.4) compared those enrolled from 2008 (16.1%; 95% CI, 12.8 to 20.0) 
exhibited a lower risk of hospital death (OR, 0.58; 95% CI, 0.40 to 0.85; 
P= 0.005) and ICU mortality rate, 5.5% in 2018 and 11.2% in 2008 (OR, 
0.46; 95% CI, 0.29 to 0.75; P= 0.001).
The frequency of infection decreased significantly from 19.8% in 2008 
to 2.9% in 2018 (OR, 0.12; 95% CI, 0.07 to 0.21; P< 0.001) while general 
rate of complications did not differ between the two periods, 34.8% 
(95% CI, 29.8 to 40.3%) in 2008 and 33.8% (95% CI, 28.9 to 39.2%) in 
2018.
Conclusion: Over the 10-year period between 2008 and 2018, mortal-
ity and incidence of infection improved in high-risk surgical patients 
admitted to Brazilian intensive care units, however general complica-
tions rate remained unchanged.
Reference(s) and grant acknowledgment(s)
1. Lobo SM, Rezende E, Knibel MF, Silva NB, Paramo JA, Nacul F, et al. Epidemi‑
ology and outcomes of non‑cardiac surgical patients in Brazilian intensive 
care units. Rev Bras Ter Intensiva. 2008;20(4):376‑84.
2. Acknowledgements: To the data collection BRASIS study group, Israelita 
Albert Einstein Hospital and Barretos Cancer Hospital for the support to 
the study. The study was endorsed by the Brazilian Network of Research in 
Intensive Care (AMIBnet).
000931 
“A tidal wave of patients”: effects of COVID‑19 on a busy district 
general hospital serving a large BAME population
S. Bakare1; M. Wilson2; J. Borkowski3
1Anaesthetics and Intensive Care Medicine, London North West Univer‑
sity Healthcare NHS Trust, London, United Kingdom; 2Anaesthetic, London 
North West University Healthcare NHS Trust, London, United Kingdom; 
3Intensive care, London North West University Healthcare NHS Trust, Lon‑
don, United Kingdom 
Correspondence: S. Bakare
Intensive Care Medicine Experimental 2020, 8(2): 000931
Introduction: Northwick Park Hospital (NPH) is a busy District General 
Hospital in Northwest London serving the Harrow, Brent and Ealing 
Councils which are very multi-ethnic areas with a dense BAME popu-
lation. NPH has a tertiary Infectious Diseases Unit, is one of the busi-
est A&E Departments in the UK and  is in close proximity to London 
Heathrow, one of the busiest airports in the world.(1) NPH became 
the epicentre of the COVID-19 Pandemic in the UK in Mid-March as 
the country transitioned from the containment to the delay phase of 
pandemic management. A  “Tidal Wave”(1)  of COVID-19 patients hit 
NPH early with cases doubling every two days before moving across 
the country. NPH was reconfigured and its services upscaled (one of 
the first in the country) in anticipation and duly surpassed its base-
line 22 Intensive Care Unit (ICU) beds during the transition. (2) Over 
4  weeks, ICU Beds increased to 70, and CPAP capabilities also quad-
rupled seperately. Despite this increase, half of the over 260 COVID 
patients admitted to our ICU were transferred to other hospitals within 
our North West London critical care network (NWCCN) to manage the 
significant increase in demand and alleviate pressure
Objectives: We aim to illustrate the increased burden the COVID-19 
pandemic put on our critical care services and the impact of the pan-
demic on the largely BAME population served by our hospital by com-
paring our admissions between March and May 2020 to the same time 
period in 2019.
Methods: Data was collected from our ICNARC Database and analysed 
using Simple Statistical Method.
Results:
• 87% higher admissions between March and May 2020 compared 
to the same period in 2019. A total of 379 Patients admitted to 
the ICU. 70% of which were diagnosed with COVID-19.
• Mortality Rate in 2020 was 26% vs. 22% in 2019. COVID-19 Sub-
group (CS) analysis showed a mortality rate of 44%.
• Average APACHE Scores were lower in 2020, 17% vs. 23% in 
2019. CS was also 17.
• Organ Support
 •  Increased Ventilatory Support 74% in 2020 vs. 54% in 2019. 
85% in CS.
 •  Decreased RRT 21% in 2020 vs. 37% 2019. 22% in CS.
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 •  Significantly Increased CVS Support 95% in 2020 vs. 38% in 
2019. 100% in CS
Ethnicity
•  Increased BAME admissions 73% in 2020 vs. 49% in 
2019. 83% in CS
Gender
•  Increased Male admissions 74% in 2020 vs. 60% in 
2019. 80% in CS
Conclusion: Our Data shows there was both an increase in the num-
ber of patients and the proportion of patients requiring organ support, 
with BAME and Male patients disproportionally affected in line with 
recent publications (3). Despite the 4-fold increase in our critical care 
capacity (the generally accepted protocol that left other centres with 
excess capacity), our systems were stretched during these unprec-
edented times to the extent we had to transfer half our patients out 
(4). The mutual aid response by NWCCN and the dedication of the hos-
pital multidisciplinary teams at all levels whose lives were also severely 
disrupted helped maintain patient care and safety throughout this 
period.
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Introduction: The fast worldwide spread of Coronavirus disease 2019 
(COVID-19) and the resulting dramatic pandemic have stimulated 
clinical research to describe patients risks and evolution. Neutrophil-
to-lymphocyte ratio (NLR) has shown its prognostic value in cardiovas-
cular diseases, cancer, infections or inflammatory diseases, probably 
because it is correlated to the level of dysregulation of the immune 
response. We therefore studied the association between NLR and in-
hospital death or intensive care unit (ICU) admission in patients hospi-
talized with COVID-19.
Methods: We retrospectively analyzed a cohort of patients with con-
firmed COVID-19 admitted to the MontLegia Hospital (Liège, Belgium) 
between 15/03/20 to 04/05/20. We recorded baseline data including 
biological and clinical features, as well as ICU admission and hospital 
mortality.
The independent association between NLR and the composite out-
come of ICU admission and/or hospital mortality was assessed with 
multivariable logistic regression.
Results: Two hundred and thirteen patients were admitted to our hos-
pital with a confirmed diagnosis of COVID-19 (polymerase chain reac-
tion positive for SARS-CoV-2) during the study period, among which 
92 (43.2%) were admitted to the ICU and/or died during the hospital 
stay (composite primary outcome).
The median (interquartile range (IQR)) NLR was significantly higher 
for patients with the composite primary outcome (7 (4.8-11.6)  ver-
sus  4.6 (3.1-6.6), p<0.001). At hospital admission, patients with the 
composite primary outcome had a worse oxygenation (SpO2 / FiO2 
3.8 (223-399) versus 323 (304-424), p<0.001), a higher creatinine level 
(1.14 (0.84-1.66) versus 0.92 (0.79-1.21) mg/dL, p=0.006) and a higher 
C-reactive protein (CRP) level (108 (64-183)  versus  67 (32-125) mg/L, 
p<0.001).
The area under the receiver operating characteristic curve describing 
NLR as a predictor of ICU admission and/or death was 0.71 (95% con-
fidence interval (CI) 0.63-0.77), which was significantly different from 
the non-discrimination line (p<0.001). The threshold with the best 
global predictive value for ICU admission and/or death, according to 
the Youden index, was 6.1 (sensitivity 66.3%, specificity 74.4%).
After adjustment for potential confounders, NLR remained associated 
with ICU admission or death: adjusted odds ratio (OR) 1.1, 95% CI 1.04-
1.17, p=0.002. Patients with an NLR ≥ 6.1 had a 5.72-fold increased 
risk of ICU admission or death (adjusted OR 5.72, CI95% 2.80-11.71, 
p<0.001).
Conclusion: The NLR is independently associated with ICU admis-
sion or death during hospital stay for the patients hospitalized with 
COVID-19. In association with other clinical and biological variables, 
this risk marker should be useful in helping the clinicians to identify 
the patients needing a close monitoring.
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Introduction: Hepatic injury(HI) and failure are observed in up to 20% 
of patients in intensive care units and are associated with increased 
morbidity and mortality. Secondary or acquired liver injury and failure 
such as hypoxic liver injury, cholestatic dysfunction in critical illness, 
sclerosing cholangitis in critical illness, and drug-induced liver injury 
(DILI) represent the most frequent forms of hepatic injury in critical ill-
ness. More importantly, retrospective population studies showed that 
liver injury was not mentioned in the diagnosis or in the physician´ s 
discharge letter in 52–68% of cases. On the other hand definition of HI 
influences the incidence, prognosis, mortality, and treatment manage-
ment of the diseases.
There is no uniform definition of hepatic injury in critically ill patients. 
According to some studies, total bilirubin levels greater than 2 mg/dL 
represent a cutoff in daily practice. Others use 2-fold to 3-fold eleva-
tion of ALP/AST, alkaline phosphatase (AP) and/or gamma-glutamyl 
transpeptidase (GGT) to define it.
Objectives: Aim of this study is to compare HI definitions in pulmo-
nary ICU patients with secondary hepatic injury.
Methods: This retrospective cohort study was performed in an Uni-
versity Hospital Pulmonary ICU. Patients with hepatic injury included 
in the study. 478 patients were included in the study. We compared 
3 definition of hepatic injury 1. hepatic criteria of the SOFA score (HI-
SOFA: biluribin>2  mg/dl), 2. 2017 definition of American Collage of 
Gastroenterology (HI-ACG1), 2017 definition of American Collage of 
Gastroenterology without borderline patients (HI-ACG2) and 3. 2019 
Page 263 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
EASL DILI definition (HI-EAS).To define if HI is cholestatic, hepatocellu-
lar or mixed we calculated R ratio. We also calculated severity of HI in 
all patients.
Incidence, consistency (level of agreement-Kappa statistics), correla-
tions, sensitivity and specificity of the definitions were also calculated 
for each definition taking one of them as gold standart. Lastly mortal-
ity rates according to 3 different definition were also calculated.
Results: As can be seen in table  1 and 2 HI incidence and mortality 
rates are highly variable across the definitions and there is no good 
aggrement and correlation between them. Sensitivity and/or specific-
ity numbers were also low in general also.
Conclusion: These results showed that definition of HI according to 
biluribin or ALT/AST or together changes HI diagnosis. To standardize 
epidemiologic data, diagnosis, severity assessment, treatment of HI we 
need a generally accepted definition for ICU patients.
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Introduction: Coma - a formidable disorder of consciousness caused 
by a various etiological factors. According to some authors, the mortal-
ity rate of patients in coma may be higher than 87.0% [1]. For this rea-
son more and more factors, increasing the mortality of coma patients 
rate, are being sought and investigated.
Methods: 82 Intensive Care Unit patients retrospective analysis was 
performed. Chosen patients who had a score of 8 or less, according to 
the GCS and were not medically suppressed. Mortality rate and influ-
ence of the risk factors of the patients in coma were observed. 95.0% 
significance level p≤0.05 was chosen for significance evaluation.
Results: Male patients made 53.7% (n = 44).  The average age of 
patients was 67.6 ± 15.2 years. The outcomes of coma patients’ mor-
tality makes 65.9% (n = 54).
In 74.0%  of the dead patients had metabolic etiology coma, 
p=0.004.  According to the ROC test, metabolic etiology 
coma  increased the odds ratio for mortality by  3,8 times,  the area 
under the curve 71.8%, the sensitivity 61.5% and the specificity 80.0%.
In 80.6% of the dead patients had 5 or less score by Glasgow coma 
scale, p<0.001. According to the ROC test, 5 and less points in the GCS 
increased the odds ratio for mortality by 16.7 times, the area under the 
curve 81.7%, the sensitivity 92.6% and the specificity 57.1%.
In 83.3% of the dead patients experienced tachycardia which occurred 
more than 100 beats per minute, p<0.001. According to the ROC test, 
tachycardia more than 100 beats per minute increased the odds ratio 
for mortality by 7.1 times, the area under the curve 78.0%, the sensitiv-
ity 74.1%, and the specificity 71.4%.
In 88.9% of the dead patients creatinine concentration was higher 
than 170 μmol/l, p= 0.038. According to the ROC test, creatinine value 
more than 170  μmol/l, increased the odds ratio for mortality by 5.5 
times, the sensitivity 30.0%, and the specificity 92.6%.
In 76.9% of the dead patients had lactate value more than 3.5 mmol/l, 
p= 0.05. According to the ROC test, lactate concentration more than 
3.5 mmol/l, increased the odds ratio for mortality by 5.9 times, the sen-
sitivity 82.0%, and the specificity 57.0%.
Conclusion: 1. Mortality rate of coma patients was 65.9%. 
2. Mortality rate of coma patients increases due to coma of metabolic 
origin, GCS ≤5, tachycardia >100 beats per minute, creatinine concen-
tration >170 μmol/l, lactate concentration > 3.5 mmol/l.
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Introduction: The pandemic of COVID-19 has overcrowded our ICUs. 
In Italy, the country besides China with the most patients with COVID-
19 until March 29, 2020, up to 12% of all positive cases required ICU 
admission. The median time from symptom onset to the development 
of pneumonia was approximately 5  days, and the median time from 
symptom onset to severe hypoxaemia and ICU admission was approxi-
mately 7–12 days.(1)
Data from Wuhan, China, concluded that older patients (>60  years) 
were more likely to exhibit severe and critical COVID-19 conditions; 
patients with chronic disease were more prone to severe forms of 
COVID-19 and regarding the symptoms, dyspnea, chest tightness, 
diarrhea, fatigue, dizziness, muscle ache, and unconsciousness were 
significantly linked to severe COVID-19 cases.(2) Prediction of trajec-
tory of illness from symptom onset is difficult, and prognostic tools 
and biomarkers are urgently needed. (3)
Objectives: etermination of factors that predict this rapid respiratory 
deterioration may help to anticipate rapid need for intubation and res-
piratory support. This work relates patient status at ICU admission and 
the time to invasive ventilation, complications and outcome.
Methods: This is a retrospective study of all patients admitted to a 
tertiary hospital ICU in Portugal. Primary outcomes were mortality, 
time of mechanical ventilation; Secondary outcomes were association 
with higher APACHEII, SAPSII and greater need for invasive ventilatory 
maneuvers (like pronning).
Results: Between March 17th and May 10th 2020 were admitted 36 
SARS-CoV-2 patients to our ICU, 10 of those were direct admissions 
from the emergency department. The other 26 ICU admissions were 
transfers from wards and the majority (35%) only after 72 h of hospital 
stay. 31% during the first 24 h after admission.
There was no difference in APACHE II and SAPS II scores between the 
two groups at ICU admission: direct admissions from the emergency 
department or from the wards. There was a positive association 
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between the need for pronning maneuvers and longer time-to-ICU 
(p=0,008), although there was no difference in admission PO2/FiO2 
ratio.
Conclusion: There was no identified correlation between mortality 
and time-to-ICU admission.
We should look into other parameters as predictors of prognosis.
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Introduction: ICU outcome can be predicted using multiple methods, 
these tend to be retrospective, time consuming and require a large 
number of data points.
The National Early Warning Score 2 (NEWS2) is a widely used severity 
of illness scale to detect the acutely unwell and deteriorating patient 
from the end of the bed (1). A Rockwood Clinical Frailty Score (CFS) 
(2) can be easily calculated following discussion with the patient, their 
family or review of clinical notes. It has been demonstrated that a 
higher CFS correlates with a worse ICU outcome (3), studies looking at 
NEWS2 and ICU outcome are not widely published.
We hypothesise that a higher CFS and NEWS2 will correlate with a 
higher ICU and 30-day mortality. Combined, both provide a snapshot 
assessment of the patient and may help inform future decision making 
with regards to ICU admission and predicted outcome.
Objectives: To determine the effect of CFS and NEWS2 on ICU mortal-
ity and 30-day mortality.
Methods: Observational data was collected on 106 patients admit-
ted in ICU between 9/01/2020 and 12/03/2020. CFS was calculated by 
ICU clinicians from reviewing the patient, nursing and therapy notes, 
as well as speaking to the patient or family members where possible. 
This score was based on the patients status two weeks prior to admis-
sion to ICU. NEWS2 was calculated from the last set of observations 
performed prior to admission to ICU. The primary outcome was ICU 
mortality, secondary outcomes were 7-day and 30-day mortality. The 
data was collected in Microsoft Excel and analysed.
Results: Data was collected on 106 patients. There were 62 patients 
admitted under medicine, 32 emergency surgical cases and 12 elec-
tive surgical cases. The average age of patients was 64. Overall ICU 
mortality was 20.8%.
A CFS of 5 or more was used as a cut off to indicate frailty. 24.5% of 
patients had a CFS of 5 or more. Patients were further stratified into 
a low (0-4), medium (5-6) or high (>7) NEWS2 category. Patients with 
a CFS ≥5 (38.5%) had a higher ICU mortality than those with a CFS <5 
(15%). Patients with a high NEWS2 had a higher ICU mortality (32%) 
than those with a low NEWS2 (11%) (Figure 1).
Figure 2 shows survival at 7 and 30 days in each of the NEWS2 catego-
ries, divided into those with a CFS <5 and ≥5.
Conclusion: Our data shows that frail patients, with a high NEWS2 
have a higher ICU and 30-day mortality rate than patients without 
frailty and a low NEWS2. Larger scale studies should be performed to 
further investigate this, as well as correlating this data with existing 
ICU outcome predictor tools such as APACHE II. Future use of the CFS 
and NEWS2 as an ‘end of the bed’ assessment tool may help to aug-
ment decision making with regards to ICU admissions and predicted 
outcomes.
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Introduction: Aged patients represent a significant proportion of 
patients who require admission to the Intensive Care unit (ICU). 
Advanced age is associated with higher mortality and adverse out-
comes in ICU, however according to some studies is not only the age 
that determines the prognosis, co morbidities and previous health sta-
tus could affect the outcome as well.
Objectives: The aim of this study was to evaluate the possible effect 
of age, co morbidities, reason for admission to the ICU, length of stay 
in ICU and the final outcome.
Methods: Our study included157 patients aged 68 and older that 
were admitted to the ICU from January 2018 till September 2019. 
Demographic parameters, admission diagnosis, underling diseases, 
ICU length of stay and finally outcome were recorded.
Results: We enrolled 157 patients, 85 males, 72 females with mean 
age 74,6 years. They main reasons for admission were 1st.post opera-
tive (after elective operation) 64 patients 2nd. trauma 40 patients, 3rd. 
acute respiratory failure 30 patents, 4th. sepsis 23 patients. Out of 157 
patients the 112 had co morbid medical illness (e.g. ischemic heart 
disease, arterial hypertension,diabetes mellitus, COPD, chronic renal 
failure). The mean length of stay was 23 days but it ranged from 1 to 
65 days. Out of 157 patient 95 were discharged from the ICU and 62 
patient died. Post operative patients independently from the age and 
co morbidities had the best outcome and discharged earlier from ICU 
than other etiological groups. There were not differences in the out-
come as far as the gender was concerned,
Conclusion: Reasons for mortality appear to be multifactorial in 
elderly patients. High age alone is not a factor to predict morbidity 
and mortality in ICU patients. Previous health state-co morbidities and 
the reason for admission in the ICU play a very important role for the 
final outcome.
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Introduction: Sequential Organ Failure Assessment (SOFA) score is 
a practical method to describe the severity of multi-organ failure. 
It has been suggested that SOFA score could be employed as a tool 
to predict outcome and as an endpoint in interventional trials (1). To 
justify these assumptions all SOFA components should carry compa-
rable weights as outcome predictors. SOFA score was introduced in 
1996 and has remained unchanged to date, although there have been 
changes in clinical practice (2).
Objectives: The aim of this study was to investigate if SOFA score 
components are comparable in association with in-hospital mortality.
Methods: We performed a  national observational cohort study  on 
adult (18 years of age or older) patients admitted to 26 Finnish inten-
sive care units (ICUs) between 2012-2015. SOFA score was deter-
mined as the most severe  SOFA  score  component value within the 
first 24 hours after admission to ICU. We performed statistical analysis 
employing age- and sex-adjusted multivariable logistic regression.
Results: We included 67 095 admissions after excluding 4 289 read-
missions and 112 admissions with missing in-hospital mortality data. 
Total in-hospital mortality was 11.4%. Multivarible logistic regression 
revealed that increase in SOFA points was associated with higher risk 
of in-hospital death in respiratory (age-adjusted odds ratio [OR] 1.40, 
95% confidence interval [CI] 1.36-1.44, p<0.001) per point; in coagu-
lation (OR 1.22, 95% CI 1.18-1.26, p<0.001); in hepatic (OR 1.36, 95% 
CI 1.31-1.42, p<0.001); in cardiovascular (OR 1.16, 95% CI 1.14-1.19, 
p<0.001); in neurologic (OR 1.72, 95% CI 1.69-1.75, p<0.001), and in 
renal component (OR 1.63, 95% CI 1.59-1.66, p<0.001).
Conclusion: We found that all SOFA score components have inde-
pendent predictive value. However increased risk of in-hospital death 
per SOFA score point was not comparable between components. Car-
diovascular component has the weakest and neurologic component 
has the strongest association with increased in-hospital mortality 
(Figure 1).
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Introduction: The GRACE Score is a prospectively studied scoring sys-
tem which stratify patients with diagnosed ACS to estimate in-hospital 
and 6-month to 3-year mortality. Knowing patient’s risk earlier may 
help with management and prognostication. Recent studies refer that 
CHADS2 could be as useful as GRACE score in this scenario.
Objectives: To compare GRACE and CHADS2 scores regarding MACE, 
in-hospital mortality and 1-year mortality in Portuguese population.
Methods: Retrospective study during a period of 8 years + 8 months. 
Only NSTEMI patients were admitted in the study. GRACE and CHADS2 
groups, based on mortality risk, were created and compared regarding 
MACE and mortality.
Results: 7537 patients were admitted. Male predominance (70,9%) 
and mean age of 67 ± 13  years. Hypertension (73,2%), diabetes 
(34,4%) and dyslipidaemia (61,4%) were the most frequent comor-
bidities. 85% were submitted to angiography with DA being the most 
common culprit vessel (33,2%). Multivessel disease in 55,1% of the 
patients. MACE occurred in 5,1% of the cases with 1,9% of the patients 
dying in hospital.
60,8% of the patients presented a high risk (GRACE score) compared 
with CHADS2 score (7,6%). We verified a predominance of low risk 
patients in this last score. ROC curves were created and the results 
were compared. Comparing the occurrence of MACE during hospi-
tal length we found that GRACE was a better predictor than CHADS2 
(AUC(grace) 0,708 versus AUC(chads2) 0,598, p<0,001). We also point 
out the best performance of GRACE score when we compare in-hos-
pital (AUC(grace) 0,834 versus AUC(chads2) 0,669, p<0,001) and 1-year 
death (AUC(grace) 0,667 versus AUC(chads2) 0,645, p = 0,045).
Conclusion: Our study has reinforced the idea that the GRACE score 
remains an extremely reliable score today.
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Introduction: Patients following intensive care unit hospitalization 
may present disability and dysfunction in their physically and cogni-
tive function.(1)(2)
Objectives: We investigated the quality of life of patients following 
discharge from the intensive care unit and we assessed the role of sup-
port by the family members.
Methods: This retrospective study conducted at the University Hospi-
tal of Thessaly and included patients who stayed for at least 48 hours 
in ICU and were alive at discharge between 2014 and 2019. The quality 
of life was assessed by the questionnaire SF-36.
Results: A  total of 671 were included. The SF score overall was 
51.32. There were correlations between SF score and daily dura-
tion of support by spouses  (r=0.2046, p=<0.0001)., friends  (r=-
0.2536, p=<0.0001) and duration of hospitalization (r=-0.2324, 
p=<0.0001). Patients who were supported by their spouses for more 
than 8 hours daily or patients who were supported by their friends 
for more than 3 times/week or were hospitalized for less than 10 days 
had increased SF compared to the rest of the cohort [mean(SD) 
54.49(28.07) vs 50.14, (28.69), p=0.05 and 58.07 (28.54) vs 45.20 
(27.93), p=<0.0001, and 68.45, 27.57) vs 49.07 (27.53)p=<0.0001, 
respectively].
Conclusion: The present study shows that the quality of life of patients 
following ICU discharge may be positively affected by the support 
from spouses or friends.
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Introduction: Patients diagnosed with end stage renal failure (ESRD) 
who are likely to be hospitalized due to comorbidites, advanced age, 
immuncompression caused by uremia and phagocyte disfunction.
Objectives: The aim of this study is to procpectively monitor and eval-
uate the clinical and laboratory features of the patients with ESRD in 
the intensive care unit(ICU).
Methods: This study was performed prospectively in the Medical ICU. 
Patients in need of ICU admission, over 18  years old and diagnosed 
with ESRD were included in the study.
Results: A total of 100 patients were included in the study. The mean 
age of patients was 68±14  years.The most common reason for ICU 
admission were sepsis/septic shock (26%) and respiratory failure 
(21%).The most common causes of ESRD were diabetes mellitus (DM) 
(49%) and hypertension (HT) (21%). Mean APACHE II score was 22± 6. 
Median SOFA score was 8 (min:2-max:19). A total of 52% of patients 
received dialysis treatment (96% of hemodialysis, 4% peritoneal 
dialysis) before admission to ICU. The length of ICU stay was 7 (min:2 
max:36) days. Cox regression analysis was performed to determine the 
factors affecting mortality. APACHE II score was identified as an inde-
pendent risk factor that determined mortality. (OR:1.059, 95 CI, 1.01-
1.09, p=0.015). ICU mortality rate was 45%.
Conclusion: As a result of this study, DM was the most common cause 
for ESRD. High APACHE II score was identified as an independent 
risk factor for mortality in ICU with end stage critically ill renal failure 
patients.
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Introduction: The Sequential Organ Failure Assessment (SOFA) score 
was created in 1994, in an effort to describe organ dysfunction/fail-
ure over time in the critically ill, and has been widely used in medical 
practice ever since. However, the need for future alterations was high-
lighted by the original paper, as better parameters could be suggested 
by future re-evaluation and updated data. Thus, additional studies are 
appropriate for re-evaluating current parameters of the SOFA score, as 
well as possibly providing a modified version with higher accuracy for 
outcome prediction.
Objectives: This study aimed to test the accuracy of a modified SOFA 
score as a mortality predictor by using different parameters for neuro-
logical and gastrointestinal evalutation.
Methods: A prospective cohort was performed in a Brazilian private 
tertiary hospital between June and November 2018. Inclusion criteria 
were adult patients in the intensive care unit (ICU) under nutrology 
follow-up. Demographic and clinical characteristics, nutritional status, 
laboratory results, physiological parameters, use of medical devices 
and outcomes were collected from electronic and physical medical 
records.
Glasgow Coma Scale (GCS) and Richmond Agitation-Sedation Score 
(RASS) were used to determine the neurological component in SOFA 
and RSOFA, respectively. Total bilirubin and the Acute Gastrointestinal 
Injury (AGI) score were used to determine the gastrointestinal com-
ponent in SOFA and ASOFA, respectively. AGI score and RASS were 
used to determine the gastrointestinal and neurological components 
of ARSOFA, respectively. To test our hypothesis, accuracy of the SOFA, 
ASOFA, RSOFA and ARSOFA scores to predict mortality was deter-
mined by the area under the curve (AUC) using the Receiver Operating 
Characteristic (ROC) curve.
Results: During the study period, 52 patients met the inclusion cri-
teria and were included. Patients’ demographic characteristics were: 
median age 73.9 [60.47-84.01]; male, 25 (48.1%); on admission: 26 
patients were on mechanical ventilation (50%), mean SAPS III was 52.3 
(±15.5), mean APACHE II was 23.2 (±11.4), mean SOFA score was 3.7 
(±2.5) and 33 (63,5%) individuals had sepsis. The AUC of the SOFA, 
RSOFA, ASOFA an d ARSOFA scores were 0.813, 0.831, 0.793 and 0.807, 
respectively. See the attached figures.
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0.793 and 0.807, respectively. See the attached 
Conclusion: The RASS scale and bilirubin level as neurological and 
gastrintestinal components, respectively, had higher accuracy for mor-
tality prediction than the GCS and the AGI score. Therefore, the use of 
the RSOFA score should be encouraged over traditional SOFA score. 
The ASOFA and ARSOFA scores, which used the AGI scale, must not be 
used as it had lower accuracy than currently used bilirubin levels.
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Introduction: Understanding the risk factors and early predictors of 
the severe course of the disease allows us to choose the right treat-
ment tactics.
Objectives: To identify risk factors and predictors of poor outcom in 
patients with COVID-19 pneumonia.
Methods: We performed a retrospective analysis of the treatment 
results of 118 patients admitted to ICU of Tver Regional Hospital in 
April-May 2020. The mortality rate was 61% (72 from 118 patients). 
Patients were assessed according to 21 clinical and laboratory indica-
tors using a multivariate analysis of the obtained data.
Results: Using the comparative and ROC analysis, we selected 4 
most informative predictors of the development of the lethal out-
come from 17 initial indicators. These 4 predictors were used to build 
a multidimensional regression equation. In the obtained regression 
equation, each of the 4 qualitative predictors had a certain weight: 
age over 65.5  years (31 points), SOFA score > 3.5 (29 points), serum 
creatinine > 149.5 μmol / l (25 points), the ratio of CRP (mg/l) to the 
relative number of lymphocytes (%) > 8.18 (16 points). The obtained 
regression equation allows us to assess the risk of death (AUC 0.859, 
95% CI 0.792-0.927, see Figure 1). The risk of death increased to 93% 
(CI 89-97%), OR = 12.85, (95% CI 4.8-34.2, p = 0.0000) when a sum of 
values approached to 50.5 points. It is also possible to use a simplified 
regression equation, where each of 4 predictors means 1 point (AUC 
0.840, 95% CI 0.767-0.913). In patients without the risk factors the 
probability of death was 7.7%. If any 1 predictor was noted, the proba-
bility of death was 30%, two - 61.9%, three - 96%. None of the patients 
with 4 risk factors at the admission survived.
 Figure 1. ROC-curves for the functions of predicting the development of letality in patients with 
COVID-19
Conclusion: The group of the highest risk for adverse outcomes in 
patients with COVID-19 is represented by patients over 65  years of 
age who have signs of impaired renal function and/or a pronounced 
inflammatory reaction upon admission.
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Introduction: The vast majority of patients with severe acute res-
piratory syndrome coronavirus 2 (SARS-CoV-2) infection are primarily 
admitted to the Intensive Care Unit (ICU) for mechanical ventilation. 
The role of multi-organ failure during ICU admission as driver for out-
come remains to be investigated yet.
Objectives: The aim of the study was to determine whether patients 
who survive the ICU develop a lower (i.e. decreasing) Sequential Organ 
Failure Assessment (SOFA) score over time compared to patients that 
die in the ICU.
Methods: Prospective cohort of mechanically ventilated critically ill 
with SARS-CoV-2 infection.  The study includes 81 participants (23% 
women) of the MaastrICCht cohort of whom 54 reached primary out-
come at follow-up.  The median length of stay was nine days, with 
a maximum of 30.  The study includes a total of  1101 serial SOFA 
scores, an  established score to evaluate multi-organ function in the 
ICU on a daily basis. The cohort was divided into survivors (n=28, dis-
charged from the ICU) and non-survivors (n= 26, died during their ICU 
stay). Serial data were analysed using linear mixed-effects models.   
Trial registration: Netherlands Trial Register number NL8613.
Results: On admission the mean SOFA score was 7.8±2.8. Survi-
vors  improved on average one SOFA score point more per four days 
(95% CI: 2.5-9) than non-survivors. Adjustment for age, sex, the pres-
ence of  chronic lung, renal and liver disease,  body-mass index, dia-
betes mellitus and cardiovascular risk factors, and Acute Physiology 
and Chronic Health Evaluation II score did not change this result. This 
association, however, was stronger for women than men (P-interaction 
0.006).
Conclusion: The decrease in SOFA score associated with survival 
strongly suggests involvement of multi-organ failure during the clini-
cal course of mechanically ventilated patients with SARS-CoV-2 infec-
tion. Surviving women appeared to improve faster than surviving 
men. Serial SOFA scores may unravel an unfavourable trajectory and 
guide decisions in mechanically ventilated patients with SARS-CoV-2.
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Introduction: It has been observed that some physiological param-
eters are altered in the hours prior to a critical hospital event. With the 
application of early warning systems by evaluating the physiological 
parameters of patients, they can be classified as low, intermediate or 
high clinical risk of suffering a critical event, reducing or anticipating 
the risk ofcritical events.
Objectives: Analyze the capacity of clinical alert and describe the 
characteristics of patients who suffer a critical event in a conventional 
ward.
Methods: Prospective, observational and multicenter study. The 
patients admitted to the conventional plant who suffered a critical 
event from February to May 2019 were analyzed.The NEWS-2 (NHS 
Early Warning Score-2) was calculated to stratify the patient’s clinical 
risk prior to the event: low (<5), medium (5-6) and high (> 6) or some 
parameter of the NEWS-2 = 3.
Qualitative variables are expressed as percentages and quantitative 
variables are expressed as means and standard deviations (SD).
Results: 231 patients from 5 hospitals in Catalonia were included. 
Table 1: describe the main characteristics of the population.





Event occurs at night or on a holiday (%) 53 
Cause of the event related to the admission (%) 72 
Active infection at the time of the event (%) 46 
Patient monitored prior to the event (%) 44.6 
NEWS-2 at the time of the event . mean (SD) 8,.2 (3.8) 
Some parameter of the NEWS-2 = 3, 48 h before the event. 
mean (SD) 7.1 (3.7) 
Some parameter of the NEWS-2 = 3, at the moment of the 
event (%) 69.7 
Some parameter of the NEWS-2 = 3, 48h before the event (%) 53.7 
)5.02(6.71)DS(naem,yatsfognollatipsoH
06)%(ytilatromlatipsoH
Critical event: unexpected admission to the ICU 27%, ICU consulta-
tion without admission 22%, non-resuscitable death on the ward 37% 
PCRIH 9%. Medical Service: Internal Medicine (44.6%), Onco-Hema-
tology: 22.6%. Frequency in taking constants: <6 h (35.1%), 6 h (21%), 
8  h (34%),> 8  h (9.2%). Nursing: patient ratio: 1: 8 (40%), 1:14 (23%), 
1:10 (18%). Most frequent pre-event infection: respiratory 56%. Cause 
of the event: Hypoxemia (39%). 72% of patients received supplemen-
tal pre-event O2. In 42% of the cases some of the NEWS-2 parameters 
were missing, 60% the Respiratory F. and 10% the Sat. O2.Figure  1 
describes the clinical risk calculated using the NEWS-2 at the time of 
the event and 48 h before.
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Conclusion: A medium and high clinical risk up to 48 h prior to a criti-
cal event in a conventional plant is frequent. Respiratory function is 
the most affected and its clinical record is the most incomplete.
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Introduction: It has been observed that some physiological param-
eters are altered in the hours prior to a critical hospital event. With the 
application of early warning systems by evaluating the physiological 
parameters of patients, they can be classified as low, intermediate or 
high clinical risk of suffering a critical event, reducing or anticipating 
the risk of critical events.
Objectives: To analyze the clinical alert capacity and the factors 
related to the mortality of patients who suffer a critical event in a con-
ventional ward.
Methods: Prospective, observational and multicenter study. The 
patients admitted to the conventional plant who suffered a critical 
event from February to May 2019 were analyzed.Demographic and 
clinical data were collected. The NEWS-2 (NHS Early Warning Score) 
was calculated to stratify the patient’s clinical risk prior to the event: 
low (<5), medium (5-6) and high (> 6) or some parameter of the 
NEWS-2 = 3.  Qualitative variables are expressed as percentages and 
were compared using the Χ2-test, quantitative variables are expressed 
as means and standard deviations (SD) and were compared using Stu-
dent’s t-test. Multivariate logistic regression was performed for hospi-
tal mortality.
Results: 231 patients from 5 ICU hospitals in Catalonia were included. 
Prior to the nursing event, between 1 and 4 medical alerts per patient 
were performed in 75% of the events, and between 1 and 2 medical 
consultations per patient were performed in 58% of the events. Hos-
pital mortality was 60%. Table 1 shows the factors related to mortality.
Table 1                    Variables ALIVE DEAD p < 0,05 
Age mean (SD) 62,56 (17,1) 76,8 (12,2) 0,001 
Hospital discharge < 30 days (%) 24,6 75,4 0,001 
Event occurs at night or on holiday (%) 37,6 62,4 0,001 
Pacient comes from chronic center (%) 13,2 86,8 0,001 
Medical pacient (%) 62,7 37,3 0,001 
Cause of admission related to critical 
event (%) 34,3 65,7 0,001 
Some parameter of the NEWS-2 = 3, 
Pre- Event  (%) 
26,7 73,3 0,001 
Some parameter of the NEWS-2 = 3, 
48 h before the event (%) 
26,9 73,1 0,001 
Figure  1 shows the relationship between hospital mortality and Pre-
Event risk and 48 before the event.
Figure  2 shows the multivariate analysis of the factors related to 
mortality.
Conclusion: The mortality of patients admitted to the conventional 
ward who present a critical event is very high and is related to the level 
of clinical risk of the patient prior to the event.
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Introduction: It has been observed that some physiological param-
eters are altered in the hours prior to a critical hospital event. With the 
application of early warning systems by evaluating the physiological 
parameters of patients, they can be classified as low, intermediate or 
high clinical risk of suffering a critical event, reducing or anticipating 
the risk of critical events.
Objectives: Objectives: to analyze the clinical alert capacity and 
describe the characteristics of the patients who suffer a critical event 
in the conventional ward.
Methods: Prospective, observational and multicenter study. The 
patients admitted to the conventional plant who suffered a critical 
event from February to May 2019 were analyzed.The NEWS-2 and 
qSOFA of the patients who had active infection at the time of the 
event were calculated, and the risk of progressing to sepsis / septic 
shock was assessed: NEWS-2 low (<5) and high (≥ 5) and qSOFA: low 
(0-1) and high (2-3).  Qualitative variables are expressed as percent-
ages and were compared using the Χ2-test, quantitative variables are 
expressed as means and standard deviations (SD) and were compared 
using Student’s t-test. Multivariate logistic regression was performed 
for hospital mortality.
Results: 231 patients from 5 ICU hospitals in Catalonia were included. 
46% of patients had an active infection at the time of the event, the 
most frequent type of infection was respiratory (56%).  44% evolved 
towards sepsis / septic shock, Figure 1 shows the prognostic capacity 
of the NEWS-2 and qSOFA score.
Hospital mortality was 62%. Table  1 shows the relationship between 
hospital mortality and factors related to infection.
Table 1                   Variables ALIVE DEAD p < 0,05 
Age mean (SD) 62,9(16,4) 74,5(12,7) 0,001 
Patient comes from chronic center (%) 11,8 76,5 0,014 
qSOFA= 2- 3 (%) 22,2 77,8 0,004 
NEWS-2 Pre- Event  ≥5 (%) 30,7 69,3 0,001 
NEWS-2  48 h before the event ≥5 (%) 26,7 73,3 0,001 
Some parameter of the NEWS-2 = 3, 
Pre- Event  (%) 
25 74 0,001 
Some parameter of the NEWS-2 = 3, 
48 h before the event (%) 
26,9 73,1 0,001 
Figure  2 shows the multivariate analysis of the factors related to 
mortality.
Conclusion: The infection is present in a very high percentage of 
patients at the time they present a critical event in the conventional 
plant, presenting a high mortality that can be predicted by qSOFA and 
NEWS-2 up to 48 hours prior to the event.  In our population, qSOFA 
better predicts evolution to sepsis / septic shock than NEWS-2 in these 
patients.
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Introduction: Cirrhotic patients often develop severe complica-
tions requiring ICU admission. The evolution in treatments and liver 
transplant programs have improved the prognosis of critical cirrhotic 
patients, a fact that has facilitated their admission to the intensive care 
units (ICU). However, knowledge on the pathogenesis, diagnosis and 
treatment of these complications and the prognostic assessment of 
critical cirrhotic patients is still limited.
Objectives: To know survival prognosis of cirrhotic patients admitted 
to the ICU and the prognostic value of general scores for critically ill 
patients and those specific for cirrhosis.
Methods: Prospective, descriptive and analytical study. All patients 
admitted to our ICU from April 2017 to May 2020 with a history of liver 
cirrhosis were evaluated and were followed after 90  days of admis-
sion. Different variables such as age, sex, cirrhosis etiology, reason 
for admission, laboratory data, APACHE II and SOFA scales at baseline 
and specific scales score (Child-Pugh, CLIF-SOFA, Life Score and MELD) 
were registered upon admission, 7  days and discharge or death. The 
need for invasive mechanical ventilation, continuous renal replace-
ment therapy or vasoactive support, as well as the development of 
infectious complications, were also noted.
Statistical analysis: qualitative variables are expressed as percentages. 
For quantitative variables, measures of central tendency and disper-
sion were used. The comparison of quantitative variables was per-
formed using the Student T test. Chi-square test was used to compare 
qualitative variables. ROC curves were built to evaluate the ability of 
prognostic scores to predicte mortality at 90 days of admission.
Results: One hundred and one patients (77 men) were included; age 
56.61 ± 11.41 years. APACHE II mean at admission was 22.38 ± 10.08. 
SOFA average 9.06 ± 4.89. Average MELD 20.73 ± 9.91. 43.6% (n = 44) 
presented Child-Pugh C. 43.6% (n = 44) had CLIF-SOFA grade 3 and 
35.6% (n = 36) had an intermediate risk Life- Score. Mortality in the 
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ICU and at 90 days was 41.6% and 53% respectively. Statistical analy-
sis showed worse APACHE II, SOFA and MELD values at admission (p 
0.000) in patients who died in the ICU and at 90 days. There were no 
significantly differences regarding age. Analysis of ROC curves showed 
that the SOFA (0.738) and APACHE II (0.762) calculated in the first 24 h 
of admission predicted mortality at 90 days whereas the AUC of spe-
cific scores were 0.783 for Child-Pugh and 0.780 for MELD.
Conclusion: Cirrhotic patients who died during their stay in the ICU or 
at 90 days of follow-up showed significantly higher values in all prog-
nostic scores at admission compared to those who survived. Child-
Pugh and MELD seem to be the better predictors of 90-day mortality.
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Introduction: Covid-19 pandemic has conditioned a high demand for 
critical care beds. The develop of a prognostic score could help to bet-
ter management of health resources.
Objectives: Our aim was to obtain a prognostic prediction model for 
critically ill patients with severe SARS-COV-2 coronavirus infection 
(Covid-19).
Methods: Prospective observational study of patients with diagno-
sis of Covid-19 admitted to critical care units of the H.G.U Gregorio 
Marañón. Epidemiological data, previous comorbidities, clinical and 
analytical data, specific treatments administered, organic support 
used, complications during stay and final outcome, were collected.
Descriptive data were described as medians with interquartile range 
(IQR) and as percentages for categorical data. The continuous vari-
ables were categorised according to maximum discrimination point 
by the area under the receiver operating characteristic curve (AUROC). 
Univariate analysis was performed using a simple logistic regression 
(OR). The predictive model was obtained by means of multiple logis-
tic regression analysis. For model validation, its discrimination capac-
ity (AUROC), its calibration capacity (Hosmer-Lemeshow test) and its 
quality diagnostic indices (sensitivity, specificity, positive and negative 
predictive value), were analysed.
Results: One hundred and fifty patients were included, 71% male. 
Age was 61 years (49-71) and Charlson Comorbidity Index 1 pts (0-3). 
Severity scores were: APACHE II 16 pts (12-20), SOFA 6 pts (4-8). 88% 
of patients required mechanical ventilation, 77% prone-position and 
63% vasopressor therapy. Acute renal failure was present in 33% (10% 
needing renal replacement therapy). 77% presented any complication. 
Some specific treatment was administered in 98%. Hospital mortality 
was 40.5%.
In the univariate analysis the variables related to mortality were: Age 
(decades) OR 1.59; 95% CI 1.21-2.09, Charlson I. OR 1.40; 95% CI 1.14-
1.72, SOFA > 3 pts OR 3.03; 95% CI 1.06-8.63, Mechanical ventilation 
OR 13.1; 95% CI 1.69-101.78, Prone‑positioning OR 2.93; 95% CI 1.27-
6.75, Vasopressors OR 4.45; 95% CI 2.05-9.68, Atrial fibrillation OR 
3.58; 95% CI 1.63-7.87, C‑reactive protein OR 1.03; 95% CI 1.01-1.06, 
Procalcitonin OR 1.05; 95% CI 1.01-1.10, IL‑6 400 pg/ml OR 6.31; 95% 
CI 2.55-15-61, D‑dimer 4000 ng/ml OR 7.00; 95% CI 3.36-14.57, Lac‑
tate 2 mmol/l OR 7.26; 95% CI 3.47-15.21
The prognostic predictive model included the following variables: 
age (decades) (OR 1.72; 95% 95% CI 0.98-2.99), Charlson I. (OR 1.44; 
95% 95% CI 0.92-2.26), SOFA > 3 pts (OR 5.59; 95% CI 0.89-34.79), 
IL‑6 > 400  pg/ml (OR 4.05; 95% CI 1.15-14.18), D‑Dimer> 4000  ng/
ml (OR 11.85; 95% CI 2.95-57.66), Lactate > 2  mmol/l (OR 5.41; 95% 
CI 1.56-18.68).
The model obtained (figure 1) had a good discriminatory capacity: 
AUROC 0.90; CI 0.84-0.96, a proper calibration (Hosmer-Lemeshow 
test): Chi-square 3.38, p = 0.9, and good diagnostic quality indices: S 
81%, E 81%, PPV 0.73, NPV 0.87, VPR 4.26, VNR 0.23.
Conclusion: In our experience, the predictive model created using 
clinical and analytical data obtained early on ICU admission, was able 
to discriminate the prognosis of Covid-19 patients.
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Introduction: The purpose of triage in the Emergency Department 
(ED) is to prioritize incoming patients and to identify those who can-
not wait to be seen (1). One of the most widely used triage tools is the 
Emergency Severity Index (ESI), which includes a five-level scale with 
ESI 1 describing a patient that requires immediate life-saving interven-
tion/resuscitation and ESI 5 a non-urgent patient (2). COVID19 has set 
new challenges in the organization and practice of emergency and 
critical care medicine, prompting for re-evaluation of existing tools.
Objectives: To assess the effects of the “lockdown” on ED visits and the 
relationship between ESI 1 patients and short-term outcomes in the 
era of COVID19, in a tertiary Greek hospital.
Methods: ED data from Sismanoglio General Hospital, a tertiary Greek 
hospital in Athens metropolitan area, was retrospectively studied 
from 1/1/2020 to 30/6/2020. In Greece, a full “lockdown” was imposed 
between 13/3/2020 and 4/5/2020.
Results: The number of ED visits per month was significantly affected 
by “lockdown”. We noted 42.2% reduction in total ED visits during 
March-April compared to January-February and 41.7% compared 
to March-April 2019. After the “lockdown” period a 24.1% increase in 
the number of ED visits was seen (Fig.1). Interestingly, the peak of epi-
demic in Greece did not influence ED attendances for immediate life-
threatening conditions (Fig.2). In our analysis patients assessed as ESI 
1 constituted 0.46% of all ED patients for the 6-month period. Further-
more, in the group of patients triaged to ESI 1, 20.8% died, 65.3% were 
admitted to the ICU and 13.9% were admitted to the ward. None was 
discharged home from the ED (Fig. 3).
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Conclusion: Our data is consistent with other reports of dramatic 
falls in ED attendances amid the outbreak of SARS-CoV-2, due to fear 
of contracting the disease (3,4). However, we noticed that individuals 
with critical illness (ESI 1) found their way to the ED at any given time 
during the coronavirus crisis. From previous research we know that 
most ESI 1 patients are admitted to ICU, while some die in the ED (5,6). 
Our results show that during COVID19 crisis, ESI 1 was associated with 
high likelihood of ICU admission and death in the ED, suggesting that 
it remains a useful tool for predicting short-term outcomes of critically 
ill ED patients.
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Introduction: Clinical information systems (CIS) have been developed 
in intensive care units (ICU) to aggregate information, promote opera-
tional efficiency, and obtain accurate records. However, in settings 
wherein hospital electric medical record (hEMR) systems have oper-
ated, the differences in the operability and performance between CIS 
in ICUs and hEMR systems and the constraints of cooperation of both 
the systems can lead to new errors when using both the systems in 
ICUs. However, the incidence rate and the type of errors recorded at an 
early-stage after implementation of CIS in ICUs are unknown.
Objectives: To investigate the incidence rate and the type of errors in 
ICUs for 9 months after implementation of CIS.
Methods: CIS (PrimeGaia, Nihon Kohden, Tokyo, Japan) was intro-
duced into our medical and surgical ICU (18 beds, nursing-to-patient 
ratio 1:2) and intermediate medical care unit (IMU, 15 beds, nursing-
to-patient ratio 1:4) at a university hospital (1,335 beds). After imple-
mentation and a 3-month training period, CIS was used in all the 
patients starting in April 2019.The data of incidents and accidents 
in the ICU and IMU in the 9-month period after the launch of the CIS 
(from January to September 2019) were extracted from the hospital’s 
incident reporting system, and the incidence rate was determined. In 
our incident reporting system, errors have been divided into two cat-
egories: “incident” (indicating no error or error that caused no harm 
such as near-misses) and “accident” (indicating error resulting in harm 
and error resulting in patient death). Poisson distribution was used 
to calculate the 95% confidence interval (CI) of the incidence rate of 
events.
Results: From January to September 2019, CIS was used in 942 (90%) 
of the 1,046 patients admitted to ICU and in 1,278 (89%) of the 1,439 
patients in IMU. The total length of stay in ICU and IMU was 3,854 and 
2,728 patient–days, respectively, and the duration of using CIS was 
3,200 and 2,311 patient–days, respectively. The number of incidents 
and accidents was 123 in ICU and 140 in IMU. The incidence rates of 
events were 31.9 (95%CI 25.5–38.0) and 51.3(43.2–60.6) events per 
1000 patient–days, respectively. The number of incidents and acci-
dents related to CIS were 18 (15%) in ICU and 15 (11%) in IMU. The inci-
dence rates of events were 5.6 (3.3–8.9) and 6.5(3.6–10.7) events per 
1000 CIS operation patient–days, respectively.
The major background factors for the incidents and accidents related 
to CIS were unfamiliarity with its operations (11/33), inadequate coor-
dination between the CIS and hEMR (11/33), specifications of the CIS 
(7/33), and others (4/33).
Conclusion: Our study has revealed that 12% of the incidents and 
accidents in ICU and IMU were related to CIS and that the incidence 
did not vary with the management intensity of care units. The errors 
during the early stages after implementation of the CIS occurred 
because of unfamiliarity with its operation, inadequate coordination 
between CIS and hEMR, or the specifications of CIS.
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Introduction: With the outbreak of the Corona virus SARS-CoV-2, 
communication with family members became even more challenging 
and critical than it had been in the first place. Group meetings for fami-
lies which we usually convened every week were no longer possible 
due to the prohibition on gathering, and therefore we were in need 
of a solution that would meet the needs of patients and their families. 
On April 10, all family visits were stopped in order to prevent infec-
tion. This situation created a new reality, where family members could 
not visit the unit at all and could not see their loved ones. This reality 
required us to make a quick assessments and response to the situa-
tion, understanding that the emotional burden would weigh heavily 
on the families.
Objectives: Our objective was to find a way to preserve the criti-
cal connection and communication lines between the families in the 
ICU to their loved ones and the staff in a way that met their emotional 
needs, while operating within the existing limitations that were neces-
sary to prevent the spread of the virus.
Methods: The program was implemented on four levels: (1) Initiated 
conversations of physicians with the primary caregiver: From April 
10th until May 5th the doctors made phone calls to family members 
of 42 patient. (2) Video calls of the single UI with the families via tab-
let: During video calls that were connected and accompanied by the 
social worker, the families could see the patient and speak to them. 
(3) Providing telephone information by the nursing staff: Since the 
family members did not enter the unit at all, it was decided that the 
information they provided would be slightly more detailed than usu-
ally acceptable and tailored to their needs. (4) A video that provides 
general information to families, in order to familiarize them with the 
unit, the management team, and the nature of the outpatient care: 
The video was created as a replacement for family gatherings where 
information is usually transmitted. The video will be used in the future 
as it was found to be helpful as a day to day tool as well.
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Results: As a result of the program, we were able to positively influ-
ence intensive care patients’ families, include them in the treatment 
process without being physically present in the unit, and maintain 
quality communication that influences their motivation and com-
mitment to the care plan and hospitalization provided by their loved 
ones. We received immediate positive feedback from the families that 
took part, verbally, via text messages and thank you letters. In addi-
tion, there was a decrease in the amount of pressure and phone calls 
to the nursing station from families who were trying to get informa-
tion, once they started getting the information in an organized way 
initiated by the multi-professional staff.
Conclusion: The coronavirus, which has spread rapidly around the 
world, has tested the readiness of the health system to cope with pan-
demic conditions and the entire system has had to reformulate coping 
methods in many areas including communication between patients 
and their families in isolation and risk of infection. The program was 
implemented on four levels that combined the knowledge and prac-
tice we accumulated and is the basis upon which we added more 
knowledge during each shift. We hope to continue developing as we 
proceed.
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Introduction: Medication errors have been a frequent and safety-rel-
evant problem in medical care for years[1]. In this context, the lack of 
standardized, automatic, reliable, consistent documentation and infor-
mation systems represents a major obstacle. The high dependency on 
manual input in many steps of the process is a particular challenge[2].
Objectives: This work aimed to analyze the medical records of inten-
sive care unit (ICU) patients admitted to a large university hospital in 
Germany, as well as to explore and propose an information technology 
(IT) standard to build an interoperable medication interface.
Methods: We accessed a series of databases to collect the information 
about 81 medications that were frequently used in our ICUs from the 
hospital’s IT department, pharmacy, as well as the ICU’s Patient Data 
Management System (PDMS). We further obtained data drawn from 
the most comprehensive German medication register, the ABDA/
ABDAMED database[3]. To gather data according to European stand-
ards, we used information available on the European Directorate for 
the Quality of Medicines and HealthCare (EDQM)[4].
We oriented our search with the Health Level Seven International 
(HL7) standards and definitions[5] with the IT architecture and guide-
lines of our institution. To ensure fulfillment of the HL7 v2.3.1 require-
ments, we selected the following data components: medication name, 
Pharmacy Central Number (PZN), institution-specific material number 
used in the electronic medical record (EMR), Pharmacy Product Num-
ber (PPN), Global Trade Item Number (GTIN), National Trade Item Num-
ber (NTIN), Anatomical Therapeutic Chemical (ATC),  Arzneistoffkatalo
g/German drug substance catalogue (ASK), and EDQM standards for 
administration method, intended site, and routes of administration. 
Finally, we compiled the data into a single data set.
Results: Most medications documented data was not digitalized and 
therefore not interoperable (e.g. pharmacy and PDMS databases). 
Moreover, we found that it is difficult to access the data mostly due to 
a deep fragmentation throughout the stakeholders. We observed that 
the interoperability problems were not a specific difficulty of our hos-
pital but a nationwide challenge, due to the lack of standardization.
Nonetheless, we could build a unified and standardized database out 
of the information of each mentioned database according to the HL7 
guidelines of our institution, which led us to generate examples of 
codes for communication between different IT systems. We present an 
example below (Figure 1).
Conclusion: Our results show that it is a challenge to achieve stand-
ardization and therefore interoperability of medical records within 
the different IT platforms used in intensive care medicine. However, 
we proposed a solution based on international standards that may be 
applied to a broader spectrum of processes, such as the digitalization 
of the discharge medication from the ICU to the normal ward.
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Introduction: Best of breed informatics systems have an unclear 
evidence base for delivering clinically efffective support over paper-
based systems or large institutional electronic health records (Ruben-
feld, 2004; Morrison, 2008).  During the COVID 19 pandemic, King’s 
College Hospital admitted over 2000 patients with COVID 19, 190 of 
whom required an admission for critical care. Severity in our popula-
tion was higher than seen in other UK centres, in part due to the high 
incidence of renal failure (50%). We assessed the use and effective-
ness of a best-of-breed critical care informatics system in this unprec-
edented period of operational and clinical strain.
Objectives: To use SQL reports and general database to assess the 
scope and effectiveness of a rapid electronic/informatics systems 
expansion during the COVID 19 pandemic in a central London critical 
care service.
Methods: The configuration of the ICCA system was compared post 
COVID 19 to that pre-COVID 19. In addition, pre-existing and new ad 
hoc SQL queries were constructed from the Intellivue, Critical Care & 
Anaesthesia Informatics System (ICCA, Philips HealthCare) database 
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using Sequel Server Management Studio 17. These were used to 
assess changes to configuration and workflow support; activity; elec-
tronic workflow alerts and adverse event capture.
Results: The ICCA informatics support system was rapidly expanded 
from 51 to 196 licensed support beds, including Census Page and Dash-
board expansions. Over the pandemic period 1022 healthcare profes-
sionals were added to the system users database. 506 additional client 
computers were also added. Remote service review was set up for anaes-
thesia, renal, cardiology, diabetes, haematology and nutrition teams. The 
system and systems team provided a bespoke pathophysiological 
flowsheet and designed three clinical reports to support strategic man-
gement of overall clinical operations, renal replacement and airway man-
agement. 29 major urgent prescription changes were delivered to reflect 
supply chain breakdown and the need to deliver new COVID 19 trials. 
This included changes to sedation regimens, muscle relaxants, fluids 
and electrolyte replacement. There were also several hundred individual 
text changes to prescription/administration of medications to support 
the major category updates. System screening was used to issue 1288 
workflow support alerts during the pandemic period. Commonest alerts 
were around sedation levels; ventilator driving pressure; patient allergies 
and patient identity. Importantly, several operationally important system 
updates were developed. A visual basic solution was written to provide a 
physical paper medication chart to go with the patient at discharge and 
the servers received improved power redundancy to decrease down-
time. Finally, the system captured 159 adverse incidents that were not 
reported in the institutional ‘Datix’ system.
Conclusion: We have described the rapid and effective expansion of 
a critical care informatics system from 51 beds to 196 beds during the 
COVID 19 pandemic response of a large critical care service. The level 
of rapid adaptation may not have been possible on paper or across an 
institutional EHR.
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Introduction: Focused Intensive Care Echo (FICE) is a training scheme 
developed by the UK Intensive Care Society to train clinical practitioners in 
the use of echocardiography in intensive care. [1] Learning a new physical 
skill normally requires one-to-one tuition. With an increasing demand for 
FICE courses there is therefore increasing demand for faculty; ensuring the 
quality of the faculty is maintained can become difficult. For many faculty 
intensive courses (such as Advanced Life Support), instructor courses and 
mentorship schemes exist to ensure the future faculty meet the expected 
standard.[2] Currently there is no such scheme for FICE faculty.
Objectives: Our aim was to develop a mentorship scheme for pro-
spective faculty to ensure new faculty were supported through the 
course and to ensure standards were met to guarantee the quality of 
teaching desired on our FICE course.
Methods: Nine prospective faculty candidates, who were all FICE (or 
equivalent) qualified, were recruited to teach on two FICE courses held 
on consecutive days in October 2019. Prior to the course an anony-
mous online survey was conducted to gain background information 
and their pre-course teaching confidence. Throughout the course the 
candidates were then paired with experienced FICE faculty to support 
their teaching; at the end of the course candidates received written 
feedback, including an overall assessment as to whether it was felt 
they could be recommended as full faculty in the future. Following this 
another anonymous online survey was conducted to review the experi-
ence of the faculty candidates and to assess any changes in confidence.
Results: Table 1 shows the demographics of the faculty candidates:
Table 1: Demographics of faculty candidates 
rebmuN
Qualified ≤5 years 
Qualified  5 years 
2 
7 
Echo experience ≤2 years 
Echo experience > 2 years 
7 
2 
Had previously recieved formal teaching instruction e.g. GIC 
course? 5 
3?sesruocohcenothguatylsuoiverpdaH
Seven of the faculty candidates completed the post course question-
naire. Confidence improved in all aspects assessed (Figure  1) with 
every candidate at least feeling “OK/assistance only needed occa-
sionally” following the course. Comments relating to the mentorship 
included “well supported”, “constructive” and “good opportunity”. 86% 
of candidates agreed absolutely that all people who want to mentor 
on a FICE course should do something similar and that it will improve 
the quality of mentorship. 71% found the paper feedback useful. All 
faculty candidates apart from one were recommended as full faculty; 
the one not recommended has been invited to attend again as a fac-
ulty candidate to increase their confidence.
Conclusion: With the increasing need for FICE faculty we have shown 
that a faculty mentorship scheme is practical and well received by the 
faculty candidates. This is a low cost method of providing structured 
mentorship to prospective faculty, without the need for specialised 
instructor courses. We believe that by rolling this mentorship scheme 
out nationwide it will ensure that we continue to develop a pool of 
quality faculty to meet the increasing demand for FICE courses.
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Introduction: Intraabdominal hypertension (IAH) is well-documented 
causes of morbidity and mortality in the critically ill and may affect 
almost every organ system (1). The Abdominal Compartment Society 
(WSACS) developed a medical management algorithm with a stepwise 
approach according to the evolution of the intra-abdominal pressure 
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and aiming to keep IAP ≤ 15 mm Hg (2). Point of care ultrasound as a 
bedside modality in the critical care patients, could be used as an adju-
vant point-of-care tool during IAH management.
Objectives: To test the role of Point of Care Ultrasound (POCUS) in the 
medical management of patients with IAH.
Methods: We conducted a Prospective observational study and 
enrolled fifty-three consecutive adult critically ill patients admitted to 
the medical critical care unit (CCU) of Ahamdi hospital with risk fac-
tors for IAH. Those who met the inclusion criteria were allocated to 
undergo POCUS and small bowel ultrasound as an adjuvant tool in 
their IAH management
Results: A total of 22 patients met the inclusion criteria and were 
included in the study (Table 2) Following step 1 of the WSACS IAH medi-
cal management algorithm, ultrasound was used for NGT placement, 
confirmation of correct positioning, and evaluation of stomach con-
tents. Ultrasound was comparable to abdominal X-ray but shown to be 
superior in determining the gastric content (fluid vs. solid) and diagno-
ses gastric paresis in 2 cases. Ultrasound also proved useful in (table 3): 
(1) evaluating for intestinal obstruction. ((2) identification of large bowel 
contents; (3) identification of patients that would benefit from bowel 
evacuation (enema) as an adjuvant to lower IAP; (4) and in the diagnosis 
of moderate to large amounts of free intra-abdominal fluid. Small bowel 
obstruction and were present on four patients and confirmed with CT 
abdomen, and two of the patients underwent surgical intervention 
for mesenteric vessel occlusion and transmenteric internal hernia. Six 
patients were identified to have ileus in septic patients and responded 
to prokinetic drugs. Enema treatment was found to empty the bowel 
incompletely in 72%, 56% and 42% of the times on days 1, 2 and 3 
respectively. colonoscopy decompression was not needed in any of 
our patients. Four patients with cirrhosis that were admitted with upper 
gastrointestinal bleeding and hepatic encephalopathy (out of a total of 
8) were found to have large amounts of ascites and the US-guided para-
centesis was carried out. The average amount of ascites removed was 
3600 ± 1.6 mL and resulted in a significant drop in the IAP average from 
21 ± 4.1 mm Hg to 13 ± 2.0 mm Hg in all four patients.
Conclusion: POCUS can be used in nonoperative management of 
IAH and ACS. It is an important tool in the diagnosis and treatment in 
patients with IAH.
Reference(s) and grant acknowledgment(s)
1. 2. Andrew W. Kirkpatrick, Derek J. Roberts, Jan De Waele…etal. Intra‑abdom‑
inal hypertension and the abdominal compartment syndrome: updated 
consensus definitions and clinical practice guidelines from the World 
Society of the Abdominal Compartment Syndrome. Intensive Care Med 
(2013) 39:1190–1206
2. 1. Cheatham ML, Malbrain ML, Kirkpatrick A, et al: Definitions and patho‑
physiological implications of intra‑abdominal hypertension and abdominal 
compartment syndrome, Am Surg 77(Suppl 1): S6‑S11 2011.
3. None.
000175 
Comparison of linear and sector array probe for handheld lung 
ultrasound in invasively ventilated ICU patients
M. Smit1; J. De  Vos1; L. Pisani1; L. Hagens1; C. Almondo1; N. Heijnen2; 
R. Schnabel2; I. Van der  Horst2; D. Bergmans2; M. Schultz1; L. Bos1
1Department of intensive care, Amsterdam University Medical Centers, 
University of Amsterdam, Amsterdam, Netherlands; 2Department of inten‑
sive care, Maastricht UMC+, Maastricht, Netherlands 
Correspondence: M. Smit
Intensive Care Medicine Experimental 2020, 8(2): 000175
Introduction: International guidelines do not recommend a specific 
probe for assessment of lung aeration using Lung Ultrasound (LUS). 
The aim of this study was to assess the concordance between linear 
and sector array probes of a handheld ultrasound device in assess-
ment of lung aeration in invasively ventilated Intensive Care Unit (ICU) 
patients.
Methods: This study included invasively ventilated patients admit-
ted to the ICU expected to be ventilated > 24 hours. A trained exam-
iner performed a 12–region LUS exam with a linear and a sector array 
probe. In each image the LUS aeration score and the ‘number of B–
lines’ was determined. The LUS aeration score was defined as; ‘0’, A–
pattern; ‘1’, B1–pattern; ‘2’, B2–pattern; or ‘3’, C–pattern. Adding LUS 
aeration scores of all regions resulted in a global LUS aeration score 
[Crit Care.  2007;11(1):205]. Agreement between the two probes was 
calculated using intraclass correlation coefficients (ICC).
Results: 30 LUS exams were performed in 19 mechanically venti-
lated ICU patients resulting in a total of 328 pairs of images. 29 pairs 
of images were excluded for analysis because the images from the 
linear probe were unable to score (UTS) (Table 1). ICC’s calculated for 
the remaining images revealed a good concordance for the LUS aera-
tion score for individual images, ICC: 0.73 (CI: 0.67–0.78), ‘number of B–
lines’, ICC: 0.79 (CI: 0.72–0.83) and global LUS aeration score, ICC: 0.74 
(CI: 0.52–0.87).






A B1 B2 C UTS Total
A 185 7 2 4 14 212 
B1 23 10 1 2 8 44 
B2 6 7 23 1 3 40 
C 5 1 1 21 4 32 
UTS 0 0 0 0 0 0 
Total 219 25 27 28 29 328 
Conclusion: There is a good concordance between linear and sector 
array probes of a handheld ultrasound device in assessment of lung 
aeration patterns in mechanically ventilated ICU patients. However, in 
roughly 10% of the images acquired using the linear probe the aera-
tion pattern could not be scored.
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0 No image visualization 2 1 5 2 
1 
Visualization 
of less than 
70% of the LV 
walls 
15 2 9 4 
2 
Visualization 
of 70% to 95% 
of the LV walls 
3 8 2 3 
3 
Visualization 
of 95% to 
100% of the 
left ventricle 
(LV) walls. 
0 9 4 11 
Conclusion: In mechanically ventilated critically ill patients with poor 
acoustic window, SEEH causes significant improvement in echocardi-
ography image quality without significant change in hemodynamic 
parameters. This improvement occurs in the absence of auto-PEEP.
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Introduction: The lung interference due to mechanical ventilation is 
known to cause poor acoustic window making transthoracic echocar-
diography difficult1.Interference of the lungs is least during expiration 
however, this period is too short for interpretation.End Expiratory hold 
has potential to improve acoustic window by reducing lung inter-
ference.End Expiratory hold of 15 seconds acts like a fluid bolus and 
changes cardiovascular physiology especially during last five seconds 
limiting it’s application solely for improving acoustic window2.We 
hypothesized that a Short End Expiratory Hold (SEEH) of eight seconds 
improves acoustic window leading to superior echocardiographic 
image quality without significant hemodynamic changes.
Objectives: Primary objective of the study was to determine effect of 
SEEH on image quality score. Secondary objectives of the study were 
to determine the change in IVC diameter and Carotid Doppler peak 
velocity (ΔCDPV) with SEEH. Tertiary objective was to look for presence 
of any Auto-PEEP revealed during SEEH.
Methods: Twenty patients on mechanical ventilation with poor acous-
tic window during point of care echocardiography examination were 
assessed for both apical four chamber(A4C) and parasternal short 
axis(PSAX) view, video clips of six second duration were recorded both 
with tidal ventilation and with eight second SEEH. Assessors blinded 
to the intervention scored the video clips based on the quality of the 
image using a previously validated scoring criteria3.Clips were scored 
from 0 (no image visualization), 1 (visualization of less than 70% of 
the  left ventricle(LV)  walls), 2 (Visualization of 70% to 95% of the LV 
walls) to 3 (visualization of 95% to 100% of the LV walls). Increase in 
one or more point was considered significant. To determine hemody-
namic effects of SEEH on change in IVC diameter and Carotid Doppler 
peak velocity (ΔCDPV) were noted at the baseline and just before end 
of SEEH. Any change (Δ) more than 14% was considered as signifi-
cant4. Auto-PEEP displayed on the ventilator at the end of SEEH was 
noted.
Results: In A4C view baseline worst median image quality score dur-
ing tidal ventilation was 1(Interquartile range(IQR) 1-1) and in PSAX 
view was 1 (IQR 0.25-2) which with SEEH improved to 2 (IQR 2-3) for 
A4C view and 3 (IQR 1-3) for PSAX. 18 out of 20 (90%) patients in A4C 
view and 11 out of 20(55%) patients for PSA had at least one point 
increment in worst image quality score with SEEH. The median ΔCDPV 
was 1.95%(IQR 1-3.175) and median change in IVC diameter was 4.45% 
(IQR 0-7.925) indicating no significant hemodynamic change due to 
SEEH. Median auto-PEEP was found to be 0.55(IQR 0-1.075) cm H2O 
indicating absence of auto-PEEP.
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Objectives: To determine the frequency, timing of appearance and 
type of pulmonary complications in critically ill parturients in an 
obstetric unit in Sierra Leone.
Methods: Prospective observational study conducted between July 
2018 and February 2019 in critically ill parturients admitted to the 
high dependency unit (HDU) of Princess Christian Maternity Hospital 
in Freetown, Sierra Leone. Twelve–regions lung ultrasound examina-
tions were performed on admission, after 24 and 48 hours, and in case 
of respiratory deterioration, using a low frequency (2.5–5 MHz) convex 
probe.
Primary endpoint was the proportion of parturients with one or 
more pulmonary complications, stratified for presence of respira-
tory distress. Secondary endpoints included timing and types of 
complications, and their association with ‘poor outcome’, defined as 
a composite of transfer for escalation of care or death. The study was 
approved by the Sierra Leone Ethical Research Committee on June 5, 
2018 and registered at clinicaltrials.gov (NCT 03828630).
Results:Measurements and main results. 166 patients were enrolled 
(median age 25  years [IQR 22-30]). A total of 383 LUS examinations, 
median 2 [2–3] LUS per patient, were performed. Of all patients, 34% 
presented with or developed respiratory distress during HDU stay; 35 
patients (21% [95%–confidence interval 15 to 28%]) had one or more 
pulmonary complications, the majority diagnosed on admission.
Acute respiratory distress syndrome (period prevalence 4%) and 
hydrostatic pulmonary edema (4%) were only observed in patients 
with respiratory distress. Pneumonia (2%), atelectasis (10%) and pleu-
ral effusion (7%) were present irrespective of respiratory distress. In 
patients in whom ultrasound excluded pulmonary complications, res-
piratory distress was related to anemia or metabolic acidosis. In total, 
18 out of 166 patients met the composite endpoint of a poor outcome 
(11%). Pulmonary complications were associated with an increased 
risk of poor outcome (odds ratio, 5.0 [95%–confidence interval 1.7 to 
14.6]; P=0.003).
Conclusion: One out of five critically ill parturients admitted to the 
HDU of a resource–limited obstetric unit developed one or more pul-
monary complications. Lung ultrasound contributed to address the 
cause of respiratory distress by identifying or excluding ARDS, pulmo-
nary edema, pneumonia, atelectasis and pleural effusion. These com-
plications were associated with a poor outcome.
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Introduction: Chest radiography (CXR) and computerized tomog-
raphy (CT) scan are the standard methods for lung imaging in diag-
nosing COVID-19 pneumonia in the intensive care unit, despite their 
limitations. This study aimed to assess the performance of bedside 
lung ultrasound examination by a critical care physician, in the diagno-
sis of COVID-19 pneumonia in acute admission to the ICU.
Methods: The study is an observational, prospective, single‐center 
study conducted in the intensive care unit of Adan General Hospital 
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Introduction: Point-of-care-ultrasound is a useful diagnostic instru-
ment on critical care units. Its diagnostic accuracy supersedes chest 
x-ray and is similar to chest CT(1). However, the effect it has on man-
agement strategies is less clear.
Objectives: Our objective is to quantify the impact of thoracic ultra-
sound on ICU management.
Methods: This prospective observational study was conducted at 
a tertiary ICU. The study was approved by the local medical ethics 
committee and the need for consent was waived.A treating intensiv-
ist recorded a diagnosis and management plan before and after a 
thoracic ultrasound. Changes in management and diagnoses were 
recorded. Patient characteristics, fluid balance and whether the 
changes were carried out within 8 hours were extracted from the elec-
tronic health records.
Results: Thirty-seven thoracic ultrasound examinations were included. 
Management changes occurred in 22 (59.5%). Seventeen (77.3%) out 
of these 22 had their management changes carried out within 8 hours. 
The thoracic ultrasound yielded a new diagnosis in 13 (35.1%) exami-
nations. No significant effect was observed for management changes, 
patient characteristics, or fluid balance within 8 hours.
Conclusion: This single-arm observational study shows that a majority 
of thoracic ultrasounds alter patient management plans with feasible 
changes. More research is needed to give conclusive evidence regard-
ing patient centric outcomes like mortality, duration of mechanical 
ventilation and time to discharge.
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Introduction: Critically ill parturients have an increased risk of devel-
oping pulmonary complications. Lung ultrasound could be effective 
in addressing the cause of respiratory distress in limited–resource set-
tings[1] with high maternal mortality.
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Introduction: Patients infected with COVID-19 are at increased 
risk of thromboembolic complications as demonstrated in autopsy 
findings(Wichmann et  al) and observational clinical studies(Helms 
et al).
Recognising this increased risk, our intensive care unit started a 
screening programme using compression ultrasound to detect 
venous thrombosis.
Methods: From 1st April 2020, any patient admitted to our adult 
intensive care unit with proven or suspected COVID-19 underwent 
compression ultrasound of the external iliac veins to popliteal trifur-
cation and the internal jugular veins. This scan was carried out shortly 
after admission to ICU and repeated weekly until ICU discharge.
Scans were performed by medical staff trained in compression ultra-
sound. Any scans felt to demonstrate thrombus meriting antico-
agulation were reviewed by a senior clinician with experience in 
compression ultrasound. Any doubt or disagreement prompted fur-
ther assessment by a radiologist or sonographer.
Results: Twenty-two consecutive patients with a diagnosis of COVID-
19 pneumonia were cared for in ICU during this project. The demo-
graphics are summarised below.





Co-morbidities - n. (%)








APACHE Score - median (IQR) 16 (14-19) 
APACHE Mortality - median (IQR) 23.4 (19.2-28.6) 
Interventions - n. (%)
Invasive mechanical ventilation 22 (100) 
Muscle relaxant infusion 21 (95.5) 
)4.68(91noitisopenorP
Renal replacement therapy 8 (36.4) 
Fifteen patients (68.2%) were found to have thrombus of varying 
severity on compression ultrasound. Eight were judged to merit treat-
ment with anticoagulation.
Of the eight patients that were anticoagulated, 7 were diagnosed on 
compression ultrasound screening. Five were found to have lower 
from Apr 10, 2020, till May 10, 2020. Adolescent or adult with suspi-
cion of COVId19 infection transferred to ICU with fever or suspected 
respiratory infection, plus one of the following: respiratory rate > 30 
breaths/min; severe respiratory distress; or SpO2 < 93% on room air 
(1). Patients admitted directly from ER to ICU after performing the 
reverse transcriptase-polymerase chain reaction (RT-PCR) and send 
to the central virology in Kuwait. A certified intensivist in critical care 
ultrasound performed the lung ultrasound within 12 hours of admis-
sion to ICU and blinded to the result of the RT-PCR, if available at the 
time of examination. The four signs at lung ultrasound COVID-19 
pneumonia are (2):
1. B-lines as Bilateral patchy distribution of multiform clusters, both in 
separate and coalescent forms, sometimes giving the appearance of a 
shining white lung. They can arise from one point of the pleural line 
and small peripheral consolidations and spread down like rays main-
taining their brightness until the edge of the screen without fading.
2. Bilateral diffuse irregularities of the pleural line.
3. Absence of significant pleural effusion.
4. Presence of multiple subpleural consolidations of various size.
The treating physician confirmed the diagnosis of COVID-19 pneu-
monia by a set of clinical features, inflammatory markers, biochemical 
profile studies, RT-PCR test, and CXR.
Results: Out of 57 patients with suspected COVID-19 pneumonia, 46 
(80.7%) were confirmed. Mean age 51 with a range of 39 to 69 years 
and 32 (76%) men.
In the group of patients with confirmed COVID-19 pneumonia 
(table 1), 44 (98.6%) LUSs revealed the four signs suggestive of COVID-
19 pneumonia (sensitivity 95.6%, CI 85%‐99.5%).Two patients pre-
sented with unilateral lobar pneumonia and without other ultrasonic 
signs of COVID-19 pneumonia but positive RT-PCR. The group with-
out COVID-19 pneumonia and negative RT-PCR were 10 (90%) had 
LUS negative for COVID-19 pneumonia (specificity 90.91%, 95% CI 
58.72%‐99.77%). One case declared positive by LUS, and with negative 
RT-PCR, it was a case of non-Hodgkin lymphoma post-radiation pul-
monary fibrosis and presented with hypertensive pulmonary edema. 
The other cases of negative LUS and negative RT-PCR where three 
cases on chronic dialysis and pulmonary edema, a 25-year-old woman 
with miliary tuberculosis and severe myocarditis, three cases of 
NSTEMI and pulmonary edema, a 26-year-old man with uncontrolled 
hypertension, renal failure and possible vasculitis, one case of diabetic 
ketoacidosis and right basal pneumonia and another case of hyper-
tensive pulmonary edema with UTI.
Two cases where considered COVID-19 pneumonia by the treating 
team despite negative RT-PCR because the clinical picture, lab find-
ings, and CT chest finding keeping with COVID-19 pneumonia in con-
cur with the ultrasound chest. Pleural effusion was not detected in any 
patient with confirmed COVID-19 pneumonia.
Table 1. Lung ultrasound and RT-PCR profile in patients with respira-




















LUS+ 44 1 
95.6 90.9 97.8 83.3 10.5 0.05 
LUS- 2 10 
RT-PCR 
RT-PCR+ 44 0 
95.6 100   0.04 100 84.6 
RT-PCR - 2 11 
LUs, lung ultrasound; positive (+) or negative (−) for the abnormality; COVID-19 pneumonia 
present or absent based on final diagnosis;   
Conclusion: LUS pattern is sensitive and specific for diagnosing 
COVID-19 pneumonia in acutely admitted patients to ICU with respira-
tory involvement.
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limb DVTs, 2 of which were bilateral. Two patients had occlusive 
thrombus in an internal jugular vein. One patient was anticoagulated 
following thrombolysis for a clinical diagnosis of massive pulmonary 
embolus.
Patients with proximal femoral vein DVTs were treated in the prone 
position more times (median 5 [4-6]) than those without (median 2 
[1-5]). They were also more likely to have a higher Body Mass Index 
(median 32 [31-36] vs 27.5 [25-36]).
Eight patients had non-occlusive thrombus in an internal jugular vein, 
not considered large enough to merit systemic anticoagulation and all 
were associated with central venous catheters sites.
Five patients underwent computed tomography pulmonary angio-
grams (CTPA), all of which were negative.
Two patients suffered bleeding complications during anticoagulation 
therapy, one developed minor haematuria and one life threatening 
spontaneous retroperitoneal haemorrhage requiring embolisation.
Conclusion: Given the recognised risk of thromboembolic complica-
tions in critically unwell COVID-19 patients, the higher prevalence of 
severe disease in obese patients(Simonnet et al, Caussy et al) and the 
frequent use of prone position ventilation, we feel that DVT screening 
merits consideration as a routine part of the care of these patients.
Compression ultrasonography is a simple, non-invasive bedside inves-
tigation that uses existing technology that is familiar to critical care 
staff.
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Introduction: Acute Kidney Injury (AKI) is a common complication of 
COVID-19 critical illness but the pathophysiology is uncertain. Much 
of the limited current evidence comes from autopsies demonstrating 
the presence of viral inclusion bodies within tubular epithelial cells 
alongside endothelial injury and erythrocyte aggregation within peri-
tubular capillaries. These findings contribute to the hypothesis that 
COVID-19 disease induces widespread changes in vascular endothelial 
cells and that resultant changes in regional blood flow may be impor-
tant in the pathogenesis of COVID-19 related critical illness. We used 
contrast enhanced ultrasound (CEUS) and echocardiography to study 
renal perfusion and global blood flow and compared our findings with 
measurements taken in a group of septic shock patients and healthy 
volunteers.
Methods: Prospective case-control study. Renal perfusion variables 
were assessed with contrast enhanced ultrasound (CEUS); macrovas-
cular blood flow was assessed using Doppler analysis of large renal 
vessels; echocardiography was used to assess right and left heart func-
tion and cardiac output.
Results: CEUS derived parameters were reduced in in COVID-19 asso-
ciated AKI compared to healthy controls (perfusion index 3415 v 548 
a.u., p=0·001; renal blood volume 7794 v 3338 a.u., p=0·04). Renal 
arterial flow quantified using time averaged peak velocity (TAPV) 
was also reduced compared to healthy controls (36·6 v 20·9  cm/s, 
p=0.004) despite cardiac index being similar between groups (2.8 v 
3.7 L/min/m2, p=0.07) and right heart function being normal. There 
were no differences in CEUS derived or cardiac parameters between 
COVID-19 and septic shock patients but patients with septic shock had 
more heterogeneous perfusion variables.
Conclusion: Both large and small vessel blood flow is reduced in 
patients with COVID-19 associated AKI compared to healthy controls, 
which does not appear to be a consequence of right or left heart dys-
function. A reno-vascular pathogenesis of COVID-19 AKI seems likely
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Introduction: Weaning from mechanical ventilation in critically-ill 
patients is associated with many factors, baseline muscle thickness is 
one of them [1,2].
Objectives: To determine whether baseline diaphragm (Tdi), rectus 
femoris (RF) and vastus intermedius (VI) muscle thickness (TRF and 
TRF+VI) are associated with weaning.
Methods: The study was performed between 1st April-30th June 2019 
and 1st October 2019-31st March 2020. Right Tdi, TRF and TRF+VI 
were measured by ultrasonography within 36 hours of intubation and 
diaphragmatic excursion (DE) was evaluated at the first spontaneous 
breathing trial in adult critically-ill patients. Successful weaning was 
defined as extubation without reintubation within 7  days after extu-
bation. Reintubation or death within 7  days after extubation were 
grouped as weaning failure. Two groups were compared in terms of 
ultrasonographic measurements and clinical features.
Results: A total of 62 patients were enrolled in the study. The patients 
(n=24) who had no attempt for weaning were excluded from the anal-
ysis. Clinical features and ultrasonographic measurement results of 
weaning groups are shown in the Table. In the weaning failure group 
(n=15), the median body mass index (BMI), DE,  TRF+VI were lower 
while the median clinical frailty scale (CFS), duration of mechanical 
ventilation, ICU and hospital mortality rate were higher. The median 
baseline diaphragm thickness was similar in two groups. In ROC 
analysis, AUC for TRF+VI was 0.71 (95% CI: 0.51-0.90; p=0.035), with 
21 mm cut-off having sensitivity of 82% and specificity of 57%. Logis-
tic regression analysis revealed TRF+VI<21 mm as the only predictor 
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of weaning failure with an odds ratio of 7.6 (95% CI: 1.1-52.8, p=0.04) 
after adjusting for BMI and CFS.







Age, years 61[50-70] 71 [55-80] 0.15 
Female sex* 8 (34.7) 4 (26.6) 0.72 
Body mass index, kg/m2 26.1 [24.1-31.3] 23.5 [21.1-25.6] 0.04
Charlson co-morbidity score 3 [1-5] 4 [3-6] 0.22 
Nutrition risk in the critically-
ill (NUTRIC) score 5 [4-6] 5 [4-6] 0.26 
Clinical fraility scale 4 [3-6] 6 [5-7] 0.02
APACHE II 24 [13-26] 16 [14-21] 0.06 







PaO2/FiO2 171 [90-208] 106 [88-179] 0.15 
pH 7.37 [7.20-7.45] 7.37 [7.31-7.44] 0.34 
PaO2, mmHg 69.0 [60.0-89.0] 62.2 [55.4-83.1] 0.15 
PaCO2, mmHg 37.0 [28.5-52.0] 37.8 [32.1-55.4] 0.28 
ICU length of stay, days 18 [11-34] 26 [21-52] 0.12 
Hospital length of stay, days
31 [17-54] 
(n=21) 
37 [26-64] 0.42 
Mechanical ventilation 
duration, days 8 [4-14] 18 [8-23] 0.004





Time to first spontaneous 
breathing trial, days 7 [4-11] 8 [4-15] 0.47 












TRF+VI, mm 23.6 [21.3-27.1] 
14.0 [12.3-26.2] 
(n=14) 0.03
*number (%), others median [IQR]; Tdi: diaphragm thickness, DE: 
diaphragmatic excursion, TRF: rectus femoris thickness, VI: vastus 
intermedius 







Conclusion: TRF+VI lower than 21 mm,measured by ultrasonography 
within 36 hours of intubation, was associated with weaning failure 
among critically-ill patients.
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Introduction: Point of care ultrasound (POCUS) is a valuable tool in 
intensive care medicine. During the COVID-19 pandemic there has 
been significant interest in the utility of POCUS as an aid to manage-
ment of critical illness.
Preliminary work indicated characteristic lung ultrasound findings 
in COVID-19: pleural thickening, pleural irregularity, presence of B 
lines, consolidations, absence of pleural effusions, and resolution to A 
lines during recovery (1). Echocardiographic features associated with 
COVID-19 include: hyperdynamic cardiac function, acute cardiomyo-
pathy, right ventricular dysfunction, and diffuse myocardial inhibition 
(2).
Objectives: We aimed to validate these preliminary findings in a UK 
cohort of ICU patients with severe COVID-19.
Methods: All invasively ventilated patients admitted to a single ICU in 
a single centre in the UK with severe COVID-19 illness confirmed by RT-
PCR who underwent routine POCUS examination during their admis-
sion were included. Lung ultrasound and focused echocardiography 
were performed using standardised protocols (3).
Results: Five patients with a mean age of 58.4  years were included. 
Except for a previously well slim female, all were overweight or obese 
male patients with pre-existing hypertensive disease. The patients 
were severely ill with a mean APACHE II score of 27 (range 17-34) and 
mean P:F of 14.2 kPa (7-27).
Patients were scanned between day 5 and 10 of their ICU admission 
(mean day 7.8). None had been treated prone. All patients had evi-
dence of pleural thickening, irregularity of the pleural lines, and pres-
ence of B lines. Only 2 patients had evidence of subpleural or overt 
consolidations. One patient had a small pleural effusion.
Three patients were receiving vasopressor therapy. One demonstrated 
hyperdynamic heart function associated with left ventricular sys-
tolic impairment. Three patients exhibited signs of right ventricular 
dysfunction.
Conclusion: In a cohort of severely ill mechanically ventilated patients 
with COVID-19 in the UK, we identified similar POCUS features to the 
preliminary findings reported by clinicians working in China notably 
a universal presence of pleural irregularity and a high burden of right 
ventricular dysfunction. An important finding in our cohort was the 
infrequency of lung consolidations, a finding thought to be present in 
the most severe loss of lung aeration (4).
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Introduction: Since 1989 when Jardin (1) introduced bedside ultra-
sonography in his ICU, lung US has become increasingly popular in the 
ICU community. In our center, the value of LUS is becoming apparent 
and fellows in training are interested in learning this important tech-
nique. We initiated a simple learning program and followed 2 fellows 
in their learning trajectory.
Objectives: To determine the time needed to develop basic LUS skills 
in the ICU.
Methods: After a literature review the modified Bedside Lung Ultra-
sound in Emergency (BLUE)- protocol (2) was selected for implemen-
tation, (excluding the venous vascular part of the protocol for deep 
vein thrombosis). An introductory session was organized, lead by an 
experienced lung US specialist, entailing a 30-minute instruction for 
knobology and a protocol trial run in 2 patients. Patients selected were 
admitted to ICU and in need of O2-therapy. Patients below 18 year of 
age, patients after thoracic and cardiac surgery and morbidly obese in 
whom limited LUS resolution was expected, were excluded. Patients 
were selected, in whom objectifiable lung lesions were most expected. 
Patients could only be included once. Length of time for the examina-
tion was noted and findings describing the different LUS study points 
were noted and retrospectively compared to classic radiological find-
ings (chest X-Ray (CXR) and/or CT) and medical history. These data 
were subsequently analyzed.
Results: A total of 63 patients were included in the study over a period 
of 1 month divided over 2 ICU fellows. One fellow performed 45 exam-
inations (71%), the other 18 (29%).Time of study. Mean study time of all 
examinations (n=63) was 254 seconds (sd=104). In the first 15 exami-
nations mean time was 380 s (sd=106), the second was 261 s (sd=33), 
the third 246 s (sd=52), dropping to a mean of 148 s (sd=31), in the 
last 18 examinations (p<0.001 compared to all previous periods). 
The maximum time of examination in the last period was 195 s. Find-
ings according to BLUE protocol. In a total of 63 patients: PLAPS profile 
15(23.8%); A profile: 29 (46%); A’ profile 2 (3.2%); B profile: 8 (12.7%); B’ 
profile 2(3.2%); AB profile 2 (3.2%); undetermined 5 (7.9%). Compari-
son of LUS to CXR and medical history. In 50 (79.4%) patients findings 
on LUS confirmed CXR and medical history. In 7 (11.1%) patients LUS 
likely fell short. In 6 (9.5%) patients LUS had added value to previous 
findings on CXR and from medical history.
Conclusion: The learning curve for LUS in the ICU is steep. After a 
short introduction, within about 50 examinations fellows could per-
form lung US with confidence within just over 2 minutes. LUS findings 
proved robust or had added value compared to CXR and medical his-
tory in 89% of examinations, comparable to results in the literature.
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Introduction: During the months of March to May we have experi-
enced in Spain the consequences of the COVID 19 pandemic. Different 
factors can be related to the evolution of a pathology, both those of 
the pathology and the patient, as well as those derived from the high 
number of cases in a short period of time. Below we intend to ana-
lyze the different factors that are related to the evolution of COVID-19 
pneumonia in our area.
Objectives: Describe the distribution and main characteristics of the 
patients. admitted to the ICU for COVID-19 pneumonia during the 
pandemic period.
Methods: Descriptive study carried out in a multipurpose ICU with 12 
beds of critical care and 21 semi-critical care. All the patients admit-
ted for COVID-19 related pneumonia admitted during the pandemic 
period were included.
Statistics: Qualitative variables are expressed as percentages and 
quantitative variables they are expressed as means and standard devi-
ations (SD).
Results: 95 patients were admitted from March 14 to April 24. Were 
enabled 50 ventilators in 5 critical areas, reaching 40 intubated 
patients simultaneously. Figure  1: shows the distribution of income 
by week. 60% of admissions occurred in the first 2  weeks. Table1: 
describes the maincharacteristics of the patients.
100% of patients received Kaletra, Hydroxychloroquine and Azithro-
mycin, 40% also received Tozilucimab, 34% Interferon and 58% corti-
costeroids. Table 2: describes other clinical characteristics and aspects 
related to mechanical ventilation.
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ICU mortality was 19% and hospital mortality 20%.
Table 1                 Variables   
 )01( 6,85 )DS( naem ,sraey( egA
 17 )%elam( xeS
SOFA entry ≤  67 )%( 5 
Rockwood frailty scale upon admission ≤ 3 (%) 100 
ICU stay (days, mean (SD)) 13.1 (12.9) 
Hospital stay (days, mean (SD)) 25.4 (16.7) 
Cardiovascular history (%) 52.6 
Immunosuppression history (%) 4.2 
Background taking corticosteroids (%) 0 
 4.3 )%( dnuorgkcaB AF
 1.2 )%( yrotsih sisobmorhT
Background taking blood thinners (%) 1.1 
 4.11 )%( yrotsih cirtaihcysP
Antecedent taking antipsychotics (%) 1.1 







Conclusion: The distribution of ICU admission for COVID-19 
related  pneumonia required quadrupling the capacity of ventilated 
patients in the first 2  weeks of the pandemic. The characteristics of 
the admitted patients, their location and resources used for treatment 
were conditioned by this aspect.
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Introduction: Urosepsis contributes significantly to the epidemiology 
of sepsis. Urosepsis is divided into community-acquired or hospital-
acquired, depending upon the origin of infection acquired either from 
the community or from the health care setup. The literature about 
community-acquired urosepsis (CAUs) is limited and studies are small 
powered.
Objectives: Aim of our study was to know the epidemiology, bacteri-
ology, severity and outcome of CAUs patients.
Methods: All patients admitted from the emergency department to 
the surgical intensive care unit (SICU) with urosepsis over a period of 
10  years were identified and included retrospectively from the SICU 
register.
Results: During the study period 302 patients admitted with CAUs. 
The common etiology was obstructive uropathy (60%). Local Arabic 
population outnumbered the non-Arabic population (164/54.3%) and 
there were equal number of patients from both genders, 75% had 
acute kidney injury (AKI). Thirty eight percent patients had percuta-
neous nephrostomy and 24.8% patients underwent endoscopic stent 
insertion to relieve the obstruction. Ninety three percent patients were 
admitted with septic shock and 71.5% had bacteraemia.
The common bacteria (36.1%) was extended-spectrum beta-lacta-
mase (ESBL) producing bacteria, with a predominance of E. coli (ESBL) 
(31.5%) and 54% required change of antibiotics to carbapenem. Eighty 
two percent patients had ARDS (acute respiratory distress syndrome). 
Patients with bacteraemia had a statistically significant AKI, ARDS and 
septic shock (P<0.001). Male patients had significantly higher inci-
dence of oliguria, intubation and ARDS (P<0.05). Eight patients died of 
urosepsis giving mortality of 2.6%.
Conclusion: Patients obstruction to the flow of urine was the com-
mon cause for the CAUs. Urosepsis patients had a higher bacteraemia 
rate, corresponding to higher incidence of organ dysfunction and sep-
tic shock. ESBL bacteria were frequently causing urosepsis, requiring 
initial antibiotic to be changed to carbapenem. Mortality of our uro-
sepsis patients were lower than mentioned in the literature.
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Introduction: The Respiratory Intensive Care Unit at the Sheba Medi-
cal Center consists of 14 beds with ~ 470 admissions per year. The 
patient are exposed to infectious risk factors, suppressed immune 
status and are monitored via many central line catheters. Therefore, 
they are unable to cope with further infections. The data from the 
hospital’s infection prevention unit were shown to be alarming in 
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terms of Carbapenemase-producing Enterobacteriaceae (CPE). CPE 
can produce a broad spectrum of infections; it is associated with high 
mortality and very limited therapeutic options. CPE cases outbreaks 
are mostly attributed to patient-to-patient transmission via healthcare 
workers. The challenge we faced with was to locate the source of the 
infection and solve it.
Methods: Active CPE surveillance included twice-weekly rectal screen-
ing of all patients. A case was defined as a patient detected with OXA- 
48 CPE >72 hours after admission. Sevral meetings were scheduled 
between hospital’s infection prevention unit and the department staff, 
in order to define the source of the outbreak. Over the course of the 
several months samples were calculated from patients and their units. 
A root-cause analysis “Fish Bone” method was used to investigate the 
results. The clone was detected in 16 sink traps.
Results: From January 2016 to May 2017, 32 OXA-48 CPE cases were 
detected, 81% of these were S. marcescens. The common factor in 
all cases was the use of relatively large amounts of tap water. Educa-
tional intervention that engaged the ICU team led to high adherence 
to ‘sink-contamination prevention guidelines’. No additional infections 
detected for 12 months.
Conclusion: Finding the source of CPE outbreak was necessary for the 
educational intervention and collaboration with the team of ICU to 
reduce the contagion of OXA-48 producing Serratia marcescens. Due 
to the fact that it is not possible to predict where the next infection 
will stem from, it is important to sample all sites of the patient environ-
ment, to conduct a multidisciplinary brainstorming session to increase 
the chances of finding the source.
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Introduction: Patients admitted to the ICU are exposed to risk fac-
tors such as: use of antibiotics, prolonged fasting, enteral and / or 
parenteral nutrition and proton pump inhibitors (PPI). These factors 
influence and promote an imbalance in the intestinal microbiota 
(Dysbiosis). As a result, there are multiple alterations that can develop 
locally and systemically, such as the increase in antibiotic resistance, 
decrease in immunoregulation and increase in pathogenic bacteria.
Objectives: Our objective was to study with molecular (metagen-
omic) techniques the variation suffered by the intestinal microbiota 
of the previously healthy patient who enters the ICU and the possible 
dysbiosis generated during the time of admission.
Methods: Patients admitted to the ICU are exposed to risk factors such 
as: use of antibiotics, prolonged fasting, enteral and / or parenteral 
nutrition and proton pump inhibitors (PPI). These factors influence 
and promote an imbalance in the intestinal microbiota (Dysbiosis). 
As a result, there are multiple alterations that can develop locally and 
systemically, such as the increase in antibiotic resistance, decrease in 
immunoregulation and increase in pathogenic bacteria.
Our objective was to study with molecular (metagenomic) techniques 
the variation suffered by the intestinal microbiota of the previously 
healthy patient who enters the ICU and the possible dysbiosis gener-
ated during the time of admission.
Results: The fecal microbiome of 30 patients was analyzed, 21 of 
them with three samples (M1, M2) and the remaining 9 with two 
samples (M1, M2 and M3). A total analysis of 81 rectal swabs was 
done. According to the UniFrac (unweighted) beta diversity analysis, 
samples from previously healthy ICU patients show a different over-
all composition of the intestinal microbiota than they have one week 
after admission. Alpha diversity decreased significantly in the M3 sam-
ples compared to the admission samples. Taxonomic alterations in the 
samples (M3) included the enrichment of intestinal pathogens such as 
Enterococcus and the disappearance of several usual pathogens such 
as Prevotella and Peptoniphilus.
Conclusion: Our study showed that critical patients undergo rapid 
dysbiosis after admission to the ICU, promoting the development of 
possible infectious complications. Such alterations could be a target to 
study and develop therapies aimed at restoring a healthy microbiome 
in critical patients.
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Introduction: Infections affect 54% while antimicrobials (AM) are 
prescribed to 70% of ICU patients [1]. The heterogeneity managing 
infectious diseases (ID) in different ICUs remains a main obstacle for 
stewardship programs. Easy, fast transmissibility and AM resistance are 
of global concern. Altogether, they make the assessment of manage-
ment, knowledge and training for intensivists an essential step toward 
improving outcome from ID in the ICUs.
Objectives: To explore the practice of Infectious diseases manage-
ment in different ICUs.
Methods: An International cross sectional descriptive and analytical 
internet based open survey of Intensivists. The survey consisted of 25 
closed and open-ended questions divided into 4 sections including 
free text annotations. Likert and semantic scales were used in 4 ques-
tions. After external peer-review, it gained endorsement by the ESICM. 
It was hosted on SurveyMonkey (July 30, 2019) and was available for 
82 days. Invitations were shared on social media and by emails sent to 
the ID section members of the ESICM.
Results: The survey was initiated by 561 respondents from 82 coun-
tries. The 470 (83.8%) respondents who completed the survey were 
analysed. Respondents had a median ICU experience of 10 years (IQR 
5-19) and were trained in Intensive Care Medicine as a sole specialty 
(30%), or dual along with anaesthesia (35.3%) or medicine (30.2%). 
76.2% of the respondents were practicing as full-time Intensivists and 
63.4% in University hospitals. 34% of the participants were from low- 
and middle-income countries (LMICs). The latter were more frequently 
working in smaller hospitals in the private sector compared to those 
from high-income countries (HICs) (23.1% versus 9%, p<0.001 and 
32.5% versus 8.1%, p<0.001 respectively).
Only 2/3 of participants had adequate knowledge of the ID diagnos-
tic capabilities in their hospitals. Despite expert opinion is available 
within 1 hour for 82.5% of them, the initiation of AM was protocol-
ised in 68.5% of cases, and half of Intensivists seldom request non-ICU 
opinion. Most frequently, Intensivists sought non-ICU expert opinion 
in immunocompromised patients and in case of Extended or Pan-
resistant microorganisms as well as fungal infections (63%, 43%, 55%, 
and 32% respectively). At the time of the survey, only 27.2% of Inten-
sivists felt a need for expert opinion in case of viral infections.
Stewardship program was in place in just 66% of ICUs, and a regular 
microbiology round is lacking in about 40% of them. The implemen-
tation of Stewardship programs differed significantly between LMICs 
and HICs (61.9% versus 68.1%, p=0.013).
Satisfaction with ID training and knowledge among Intensivists was 
low at 43.2%; even less in those working in LMICs (28.8%, p<0.001). 
95.5% of Intensivists think addressing such gap can improve patients’ 
outcome and decrease cost and AM resistance.
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Conclusion: From Intensivists’ prospect, there is a need to improve 
training and knowledge in the field of ID. Stewardship programs are 
not universally implemented and ID management follow mostly a pro-
tocolised approach.
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Introduction: The increasing emergence and spread of drug-resistant 
pathogens all over the world has become catastrophic world health 
problems. In fact, we experienced an uncontrollable outbreak of 
multidrug-resistant pathogens and ICU closure for 3 weeks in January 
2013. Based on the experience, we built an infection control bundle 
including contact precautions for every patient in the ICU, carrying 
personal alcohol-based hand rubs, cohorting patients who acquired 
drug-resistant pathogens, active surveillance cultures once a week, 
and enhanced environmental disinfection in January 2013.
Objectives: The purpose of this study is to evaluate the effectiveness 
of the systemic infection control bundle approach against acquisition 
of drug-resistant pathogens.
Methods: This was a retrospective historical control study conducted 
from April 2008 to March 2019 in 18-bed ICU of a tertiary care hospital 
in Japan. Every patient admitted to the ICU during the study period 
was eligible. Patients were divided into 2 groups: Conventional (from 
April 2008 to December 2012) or Intervention (from January 2013 
to March 2019).The primary outcome was the number of hospital-
acquired MRSA. We defined hospital-acquisition as the isolation of 
MRSA after 48 hours of hospitalisation.
Results: A total of 13,047 patients were included during the study 
period. There were 5,128 patients in the control group (39.3%) from 
2008 to 2012 and 7,919 patients in the intervention group (61.7%) 
from 2013 to 2019. The hospital-acquisition of MRSA was observed 
284 patients (5.5%) in the control group and 150 patients (1.9%) in the 
intervention group. The interrupted time-series analysis suggested 
that the intervention was significantly associated with reduced hos-
pital-acquisition of MRSA [risk ratio, 0.342(95% confidence interval, 
0.282-0.416); <0.01].
Conclusion: The Bundle approach could be an effective strategy to 
prevent hospital-acquisition of drug-resistant pathogens in ICUs.
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Introduction: Catheter-related blood stream infection (CRBSI) is a 
common serious infection and associated with increased mortality in 
intensive care units (ICUs). One of the most important strategies to 
prevent CRBSI is to minimize the duration of central venous catheteri-
zation. So We built a medical team consisting of doctors, nurses and 
pharmacists in ICU to discuss whether patients needed central venous 
catheter (CVC) in terms of monitoring hemodynamics and administer-
ing drugs, and recommend catheter removal to attending physicians 
every day in April 2019.
Objectives: The purpose of this study is to evaluate whether our 
team-based approach could shorten the total duration of catheteriza-
tion and reduce CRBSI.
Methods: This was a retrospective historical control study conducted 
from April 2018 to January 2020 in the ICU of a tertiary care hospital in 
Japan. Every patient admitted to the ICU during the study period was 
eligible if they were inserted CVC. Patients were divided into 2 groups: 
Conventional group (from April 2018 to March 2019) or Interventional 
group (from April 2019 to January 2020). We set the primary endpoint 
as onset of CRBSI. The secondary endpoints included the duration of 
central venous catheterization, the length of ICU stay and hospital 
mortality. CRBSI was defined as bloodstream infection in patients with 
CVC, not related to another site.
Results: We included 490 patients: 259 in the Conventional group and 
231 in the Interventional group. The reduced tendency of CRBSI was 
observed in the Interventional group, though nonsignificant [hazard 
ratio, 0.249 (95% confidence interval, 0.054-1.141; p = 0.067)]. The 
Interventional group was significantly associated with reduced dura-
tion of central venous catheterization (5 days vs 7 days; p < 0.001). No 
difference was observed in the length of ICU stay and in-hospital mor-
tality between groups.
Conclusion: The team-based approach to assess CVC necessity could 
shorten the duration of central venous catheterization and might 
reduce CRBSI.
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Introduction: Bacteremia is an important problem in intensive care 
units (ICUs) due to high rates of antimicrobial resistance and mortality. 
Especially  Stenotrophomonas maltophilia  (SM) is an important patho-
gen that induced nosocomial infections. However, the risk factors for 
SM bacteremia in critically ill patients admitted to the ICU who are 
not immunocompromised, such as hematological tumor patients and 
malignant tumor patients, are unknown.
Objectives: We conducted a propensity score matching analysis using 
control patients with the other Gram negative bacteremia in ICU.
Methods: This study was conducted at ICU in the Saiseikai Utsunomiya 
Hospital, a critical care center in Tochigi, Japan. The medical charts of 
ICU- acquired bacteremia were retrospectively reviewed between Jan-
uary 2013 and March 2020. ICU acquired bacteremia was defined as 
at least one positive blood culture together with clinical features com-
patible systemic inflammatory response syndrome and occurring ≥ 72 
hours after ICU admission. Gram-positive bacteremia and fungemia 
were excluded. Because, these bacteremia are likely to have different 
initial treatment options. Because of the relatively few SM group, for 
multivariable modeling we performed a propensity score analysis with 
1:1 matching with age, sex, neutropenia, and APACHEII score.
Results: Of 345 bacteremia, 92 (27%) were included, and 15 (4%) of 
which were SM bacteremia.
Propensity score matching identified 14 patients in each cohort. With 
propensity score matching, there were no significant difference in 
30 days mortality and 90 days mortality between SM bacteremia and 
the other Gram negative bacteremia.
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However, the length of hospital stay was significantly longer in SM 
group (66  days vs 106  days,P<0.005). Days to positive blood culture 
from ICU admission were longer in SM group(15  days vs 24  days, 
p<0.005). The ratio of carbapenems and anti-MRSA drugs used in com-
bination was significantly higher in the SM bacteremia group(28% vs 
64%, p<0.05), and the administration duration was also significantly 
longer than the other bacteremia group (0.8 days vs 6.0 days, p<0.05). 
Use rate of the extracorporeal membrane oxygenation (ECMO), there 
was no significant difference but higher in SM bacteremia than the 
other bacteremia at 70% and 0%, respectively.
Conclusion: Our study showed that SM should be considered as the 
causative bacteria that developed after prolonged ICU stay. And, in 
addition to the previously known risk factor for immunosuppression, 
longer combination use of broad spectrum antibiotics use was could 
be risk factor of SM bacteremia in ICU settings. Although there was no 
significant difference in mortality, it was found that the acquisition of 
SM bacteremia in ICU prolongs the hospitalization period.
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Introduction:Acinetobacter baumannii (AB) has high resistant to car-
bapenems and other antibiotics and has become an increasingly 
important cause of intensive care units (ICU) nosocomial infections.
Factors increasing significantly the risk of ventilator-associated pneu-
monia (VAP) due to Acinetobacter spp. include long duration of hos-
pital stay, longer time on mechanical ventilation (MV), prior episode 
of sepsis, and prior antibiotic use. A preexistent acute-phase response 
can reduce the proinflammatory responses to AB, which is associated 
with an impaired bacterial clearance.
Objectives: The purpose of this study is whether the risk factors for 
VAP by multidrug-resistant AB (MDR-AB) are the previous infections, 
the prior antibiotic uses, and a longer duration of mechanical ventila-
tion, or not.
Methods: Retrospectively analysis of medical records of 209 patients 
receiving bronchoscopy due to suspected VAP during mechanical 
ventilation in ICU from January 2011 to December 2019 in Konyang 
University hospital, South Korea. Pathogens were isolated by a quan-
titative bacterial culture and susceptibility test of the lower respiratory 
specimens using bronchoscopy.
Results: 116 patients excluding 93 patients that met exclusion criteria 
were available for analysis.
54 patients (46.5%) of VAP patients had MDR-AB. 48 patients (41.4%) 
of patients was received mechanical ventilation due to infections, 
including 44 pneumonia patients (91.6%). Although the 28 days mor-
tality was 29.6% of VAP by MDR-AB, there was no significant differ-
ence between MDR-AB and other pathogens. There was no significant 
difference in late onset VAP between MDR-AB and other pathogens 
(85.2% vs. 80.6%, p = 0.518).
The previous infections including pneumonia were more frequent in 
those with VAP by MDR-AB than in those with other pathogens (51.9% 
vs. 27.4%, p = 0.007). The risk factor for VAP by MDR-AB was not associ-
ated to the prior antibiotic uses (OR = 6.737, 95% CI; 0.800-56.765, p 
= 0.079), but was associated with the previous infections in a logistic 
regression analysis (OR = 2.361, 95% CI; 1.061-5.250, p = 0.035).
Conclusion: The risk factor for VAP patients by MDR-AB are associated 
with the previous infections rather than the prior antibiotic uses, irre-
spective of the duration of mechanical ventilation.
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Introduction: IV fosfomycin is used particularly in difficult-to-treat or 
complex infections, caused by both Gram-positive and Gram-negative 
pathogens including multidrug-resistant strains. Despite its clinical 
use for almost five decades, data on the use of Intravenous (IV) fosfo-
mycin in clinical routine is still limited. We intent to observe the effec-
tiveness and safety of intravenous fosfomycin in real-life setting.
Objectives: The primary objective is to observe the current clinical use 
of IV fosfomycin. Secondary objectives are clinical outcome, impact of 
variables on mortality and adverse events.
Methods: Multicentric retrospective study conducted among recipi-
ents of IV fosfomycin for the treatment of multi-drug resistant organ-
ism (MDRO) infections from 4 tertiary care centers from India. Medical 
records were analyzed for clinical diagnosis, pathogen, fosfomycin 
posology, adverse events with CCI, Pitts, qSOFA score.
Results: Overall, 309 patients received IV fosfomycin of which 17% 
were immunocompromised. Main indications for fosfomycin admin-
istration were bacteremia (45.3%), pneumonia (15.8%), septic shock 
(14.3%), UTI (13.9%). Common pathogens were K. pneumoniae 
(43.3%), E.  coli (21.7%), polybacterial (20.8%), Pseudomonas spp. 
(11.7%), Staphylococcus spp. (2.9%). Average dose of fosfomycin was 
9.8 ± 4.06 g/d (Range: 1 g to 24 g/d) administered for average dura-
tion of 4.66 ± 3.68 days (Range: 1-16 days). Hypokalemia was the most 
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common (62.1%) adverse event observed followed by hypernatremia 
(24.2%). Overall clinical improvement was observed in 55% patients. 
Immunocompromised status, Pitts score, CCI, qSOFA score and hyper-
natremia were associated with significant impact on survival (Table 1).




Age 61.91 ± 15.24 58.99 ± 16.58 0.14 
Sex (M) 98 (57.64%) 95 (68.34%) 0.05 
Charlsons comorbidity 
index (CCI) 1.11± 1.11 3.22 ± 1.96 <0.0001 
Immunocompromised 22 (12.94%) 30 (21.58%) 0.04 
Septic shock 19 (11.17%) 25 (17.98%) 0.10 
Pitts score (Overall) 2.32 ± 2.52 3.51 ± 2.22 <0.0001 
qSOFA score 1.44 ± 0.86 1.85 ± 0.95 0.0003 
Enterobacteriaceae 101 (59.41%) 87 (62.58%) 0.63 
Complicated UTI 42 (24.7%) 11 (7.9%) 0.0001 
Average dose (g/d) 
(Excluding ≥ 24 hrs 
dosing) 
11.88 ± 3.83 
(n=134) 
11.62 ± 4.32 
(n=117) 0.92 
Average duration (d) 4.71 ± 3.81 4.50 ± 3.21 0.77 
Hypokalaemia 110 (64.7%) 82 (58.9%) 0.34 
Hypernatremia 31 (18.2%) 44 (31.6%) 0.007  
Conclusion: IV fosfomycin was used across different indications and 
sites of infection in critically ill patients with clinical improvement in 
55% patients. Hypokalemia is very common adverse event in practice; 
however, hypernatremia is associated with increased association with 
mortality in our study.
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Introduction: Carbapenem resistant Gram-negative bacterial 
(CRB) infections constitute a significant menace for healthcare sys-
tems, especially in high endemicity countries, such as Greece. Lim-
ited therapeutic options and high mortality rates call for prompt 
recognition and isolation of CRB carriers, preventing patient-to patient 
transmission.
Objectives: To evaluate the prevalence of intestinal colonization with 
CRB on admission to Intensive Care Unit (ICU), assess the rate of CRB-
related infections and identify risk factors.
Methods: This is a retrospective observational study that included all 
patients admitted to the ICU of a tertiary hospital in Greece, between 
September 2019 and March 2020. Rectal swabs for CRB detection were 
collected upon ICU admission in the first 24 hours. Medical records 
of the patients were reviewed for evaluation of age, sex, source of 
ICU admission, previous antibiotic therapy, comorbidities, CRB infec-
tions and length of ICU and hospital stay. Rectal swabs were cultured 
for screening at Brilliance CRE agar; in all positive results resistance to 
imipenem and meropenem was confirmed with susceptibility testing 
and phenotypical methods of carbapenemases production. We used 
chi-square with Yates’ correction to compare categorical attributes, 
Kruskal-Wallis Test for the medians and t-test for the means of numeri-
cal variables, with a p value <0.05 statistically significant.
Results: A total of 158 patients were admitted to the ICU during a 
6-month period. All of them were screened for intestinal colonization 
with CR-GnB. Among them, 27 patients (17%) were colonized with one 
or more Carbapanemase producing (CP)-CRB strains, with Klebsiella 
pneumoniae being the most prevalent (74%), followed by Acinetobac-
ter baumanii (37%) and Pseudomonas aeruginosa (7.4%). Predisposing 
factors for CRB colonization were the presence of comorbidities, the 
source of ICU admission with over 85% transferred from another acute 
care setting (ICU, non-ICU ward), recent antibiotic exposure (100%), 
and hospital admission in the previous 6  months (52%) (table1). The 
rate of CRB infections among carriers was 52% (n=14/27). In all but 
three patients the colonizing and infecting strains were the same. 
Median time from rectal screening to infection was 10d. The most 
common site of infection was the lung in ten patients (37%), followed 
by primary bloodstream infection in seven (26%). Baseline characteris-
tics among colonized patients with CRB infections and non-CRB infec-
tions were not significantly different, except for the length of ICU and 
hospital stay (table1).














Median age (IQR), years² 71(29-89) 72 (39-89) 69 (29-86) 0.13 
Hospital stay pre-ICU³ 17.4 (14.6) 12.2 (13) 21.9 (14.4) 0.1 
Hospital admission in the 14 (52%) 8 (62%) 6 (43%) 0.34 
Chronic pulmonary 
Chronic Kidney 
18 (85%) 9 (69%) 9 (64%) 0.89 
7 (26%) 4 (31%) 3 (21%) 0.91 
7 (26%) 4 (31%) 3 (21%) 0.91 
13 (48%) 7 (54%) 6 (43%) 0.85 
3 (11%) 2 (15%) 1 (7%) NA 
3 (11%) 1(7%) 2 (14%) NA 
Length of ICU stay² 8(5-26) 5 (4-8) 25.5(12.25-50.25) 0.0014* 
Length of hospital stay² 32.5(12.75-53) 14(10.5-27) 39(34-54.5) 0.008* 
 □Chi-square Test, 2Kruskal-Wallis (days, median, IQR), 3t-test (days, mean, SD) 
*P<0.05
Conclusion: Our findings suggest that CRB carriers admitted to the 
ICU suffer from an increased risk of developing CRB infections with 
high mortality rate, and significantly prolonged ICU and hospital stay. 
Surveillance cultures on admission and early patient and staff cohort-
ing may limit CRB transmission and guide empirical treatment in case 
of subsequent infection.
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Introduction: Studies of patients admitted to intensive care units 
(ICU) with sepsis have shown that thyroid function abnormalities are 
associated with adverse outcomes. It has also been suggested that 
patients’ thyroid levels prior to critical illness could affect sepsis mor-
tality, even at subclinical levels(1). As thyroid dysfunction is common 
in the general population, this may represent a modifiable risk factor 
for sepsis(2,3). To our knowledge, the association between thyroid sta-
tus and risk of bloodstream infections (BSI) has not previously been 
investigated in a large population-based study.
Objectives: To determine if thyroid hormone levels in the general 
population is associated with future risk of BSI and mortality.
Methods: Thyroid function  was measured  in  35,263  Norwegian men 
and women  participating  in the second  HUNT Study(HUNT2, 1995-
97).  Thyroid function was defined as Thyroid Stimulating Hormone 
(TSH) levels combined with free thyroxine (FT4) and total triiodthyro-
nine (T3). HUNT2 data was linked to prospective information from the 
Mid-Norway Sepsis Register (MNSR), on  clinically relevant  BSI  from 
local and regional hospitals until 2011. TSH levels where classified into 
six categories. Most of the BSI patients had sepsis. We evaluated the 
risk of first-time BSI, of all causative agents and by the most common 
infecting bacteria E. coli, S. aureus and S. pneumoniae. Risk of mortal-
ity was assessed within 30 days of BSI and and all cause-mortality dur-
ing the whole follow-up period. We used  Cox regression  to estimate 
hazard ratios with 95% confidence interval, using TSH 0,5-1,4 mU/L as 
reference.
Results: After excluding participants with known thyroid disease, 
31,707 HUNT2 participants where eligible for follow-up of BSI. During 
a median of 14,8 follow-up years, 1,138 experienced at least one epi-
sode of BSI and 198 died within 30 days. Table 1 show the hazard ratios 
adjusted for age, sex, socioeconomical status, BMI and smoking. The 
higher TSH levels showed some association with development of BSI, 
but the results have a low precision and the confidence interval is also 
in agreement with no association. The results where robust for further 
adjustments of comorbidities (data not shown). The observed pattern 
displayed in Table  1 did not change across follow-up of sepsis due 
to E. coli, S. aureus and S. pneumoniae or for 30-day mortality after BSI.
Conclusion: We found an association between higher TSH levels and 
a lower risk of hospitalizations and mortality due to BSI. However, the 
width of the confidence intervals also coincides with no risk differ-
ence. All participants with abnormal levels of TSH where advised for 
further investigations, leaving a possibility that our associations could 
have been stronger in an untreated population.
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Introduction: Since December 2019 a pandemia of new acute respira-
tory distress syndrome due to coronavirus disease (C-ARDS) has been 
reported worldwide, with high need of intensive care admission and 
mechanical ventilation. A high frequency of obesity among patients 
admitted to ICUs for C-ARDS has been demonstrated; in previous stud-
ies, Body Mass Index (BMI) has been described as a major risk factor for 
ICU admission and ARDS severity.
Objectives: The aim of the study was to investigate if C-ARDS patients 
had a higher BMI compared to a previous population of ARDS patients.
Methods: We conducted a retrospective analysis of 140 consecutive 
C-ARDS patients admitted to the intensive care units of San Paolo 
Hospital in Milan and of Maggiore Hospital in Lodi from February 
25th 2020 to April 19th 2020. All patients had a laboratory-confirmed 
SARS-CoV-2 infection diagnosis by RT-PCR on nasopharyngeal swabs. 
We compared C-ARDS patients with 247 consecutive ARDS patients 
enrolled in previous studies and ongoing studies.
Results: BMI was significantly higher in C-ARDS compared to ARDS 
(28 [25–31] kg/m2 vs 25 [22–29] kg/m2, p<0.0001). We found a sig-
nificantly higher percentage of overweight and obese patients in 
C-ARDS than ARDS patients admitted to the ICU (49% vs 33% and 
29% vs 16%, p<0.0001). At the time of ICU admission, mechanically 
ventilated C-ARDS patients had PaO2/FiO2 ratio significantly lower 
(120 [90–165] vs 169 [127–216] with positive end-expiratory pres-
sure (PEEP) level significantly higher (12 [10–14] cmH2O vs 10 [10–12] 
cmH2O, p<0.0001). According to the ARDS Berlin definition, we found 
that the percentages of severe ARDS patients was significantly higher 
in C-ARDS patients (36% vs 13%, p<0.0001).
Conclusion: We found that, among patients admitted in ICU and 
requiring mechanical ventilation, C-ARDS population had both a 
higher percentage of patients with BMI ≥ 25 and higher percentage 
of patients with severe ARDS compared to “other ARDS”. Our results 
suggest that a possible relationship between higher BMI and develop-
ment of severe ARDS patients could exist among C-ARDS patients.
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Introduction: Healthcare personnel working in contact with severe 
patients are a risk group for which annual vaccination against influ-
enza A is recommended.
Objectives: To identify the adherence rate to the influenza A vaccine 
among healthcare personnel in the Intensive Care Units (ICUs) of Cata-
lonia during 2018-2019 season. Describe and analyze the reasons for 
non-vaccination in different worker groups.
Methods: Multicentre, observational and cross-sectional study based 
on an anonymous paper survey sent to healthcare personnel from 
19 ICUs in Catalonia. Healthcare workers were classified as physicians 
(including residents and fellows) and non-physicians [nurses and 
Auxiliary Nursing Care Technician (TCNA)]. The survey included soci-
odemographic and basic clinical information related to knowledge 
regarding anti-influenza vaccination guidelines as well as attitudes 
regarding campaigns and recommendations made by the competent 
authorities. Reasons for non-vaccination were classified as either per-
sonal, professional or scientific. Chi-square and t-test were used for the 
statistical analysis and p<0.05 was considered statistically significant. 
The study was approved by the PSMar Clinical Research Ethics Com-
mittee (No. 2019/8495/I).
Results: Among 917 answered surveys, 730 (69%) were properly 
completed and included in the study. 79% of the participants were 
women and the mean age of the total sample was 39 (12) years old. 
170 surveys (23.3%) corresponded to physicians and 560 (76.7%) to 
non-physicians (421 nursing and 139 TCNA). Total vaccination rate was 
43.4% and it was higher in physicians compared to non-physicians 
(66.5% vs. 36.4%; p<0.000). Vaccination was more frequent in men 
than in women (57.1% vs. 39.8%, p<0.000). Factors related to the deci-
sion of vaccination were self-protection (86%) and patient protection 
(63%). Reasons for non-vaccination in physicians (n=57;33.5%) and 
non-physicians group (n=356;63.6%) were scientific [no protection 
of the vaccine (8.7% vs. 23.7%, p=0.011), financial motivations related 
to vaccination campaigns (5.3% vs. 19.5%, p=0.008), the possibility 
of contracting the flu with the vaccine (1.8% vs 17.3%, p=0.002) and 
low effectiveness of the vaccine (28.1% vs. 36.5%, p=0.217), personals 
[forgetfulness (24.6% vs. 8.1%, p=0.000), lack of time (24.6% vs. 6.7%, 
p=0.000) and fear of side effects (21.1% vs. 25.9%, p=0.433)] and 
professional as inconvenience on the vaccination site (7% vs. 0.5%, 
p=0.004). Overall 57% of healthcare personnel included in this study 
(31.6% of physicians and 5.9% of non-physicians; p<0.001) has either 
no intention or doubts about being vaccinated in the 2019-2020 cam-
paign. The most effective reported factor influencing the decision to 
vaccination were hospital teaching sessions (60%) and social media 
(40%).
Conclusion: Vaccination rate among ICU healthcare personnel is low, 
however it is higher in physicians than in non-physicians. Reasons for 
non-vaccination differ between both worker groups. A low percentage 
of ICU workers are decided to be vaccinated next season. To stress in 
the evaluated factors related to vaccination and non-vaccination could 
be helpful in design and establish measures to promote vaccination 
among ICU healthcare personnel
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Introduction: Our 350 bed center (10 ICU beds) assisted 2200 COVID-
19 patients in the period March to June 2020, of whom 90 were admit-
ted to ICU. A great healthcare challenge.
Objectives: To describe the characteristics of COVID-19 critically ill 
patients admitted to the ICU.
Methods: RRetrospective descriptive study including critically ill 
COVID-19 patients admitted to the ICU from March 2020 to June 2020. 
Variables: sociodemographic, comorbidities, COVID-19 treatment, 
adverse drug reactions, severity scores at ICU admission, organ sup-
ports, complications, ICU and hospital stay/mortality. A descriptive 
analysis was performed. Continuous variables have been expressed as 
median/ interquartile range and categorical as percentage.
Results: 90 COVID-19 patients confirmed by PCR were included. 10 
patients were excluded due to transfer to another hospitals. Mean 
age 65 years (56-72); 68% male; symptoms began 9 (7-15) days before 
admission. Main comorbidities were obesity 43% and hypertension 
41%. Hospital stay before ICU admission was 3 (2-6) days. APACHE II 
15 (10-18), SAPS 3 56 (48-65), SOFA at ICU admission 5 (3-8); 94% were 
admitted for severe respiratory failure, PaO2/FiO2 85 (66-125), 84% 
required invasive mechanical ventilation (MV), 4% non-invasive MV, 
and 11% high flow nasal cannula. Videolaryngoscopy device was used 
to intubate in 95%; 74% needed prone position, with a median of 2 
cycles (1-3) per patient, MV 9 (2-22) days, 23% needed tracheostomy, 
56% required vasopressors, 4% continuous renal replacement ther-
apy. At ICU admission the mean white blood cell count was 9300µL 
(6222-13330), absolute lymphoctyte count 700µL, LDH 479U/L (350-
582), D-dimer 1.97  µg/ml (0.76-7.6), At the first 48  h ferritin levels 
was 1713  ng/ml (1020-2481) and IL-6 130  pg/ml (38-358). COVID-19 
treatments: hydroxychloroquine 90%, lopinavir/ritonavir 91%, inter-
feron beta-1b 41%, azithromycin 75%, tocilizumab 49%, remdesivir 
1%, systemic glucocorticoids 75%, anticoagulation 40% prophylactic, 
14% intermediate dose, 45% therapeutic dose. Adverse drug reactions 
were 26%; 12% suffered thromboembolic events and 16% haemor-
rhagic events, 46% required change of anticoagulant drug, 5% devel-
oped antiheparin antibodies. Nosocomial infection was diagnosed in 
51%, with an outbreak of Stenotrophomonas maltophilia affecting 
21% of patients. ICU stay: 12 (5-25) days, ICU mortality 53%, Hospital 
mortality 56%.
Conclusion: COVID-19 patients have shown a high mortality, con-
ditioned by their respiratory evolution, with an infrequent use of 
non-invasive MV and high flow nasal cannula; associated with a high 
incidence of nosocomial infection and a delayed ICU admission.
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Introduction: Selective digestive decontamination (SDD) have been 
associated with reduced mortality and lower ICU-acquired rates How-
ever, the effect SDD in areas where multidrug-resistant Gram-negative 
bacteria are endemic is of great interest.
Methods: This study was conducted in a 30-bed-medical-surgical ICU. 
All consecutive patients admitted to the ICU from October 1, 2011 
to September 30, 2019 expected to require tracheal intubation > 48 
hours were given SDD (SDD study group) with a 4-day course of intra-
venous cefotaxime, plus enteral colistin, tobramycin, nystatin in an 
oropharyngeal paste and in a digestive solution. Oropharyngeal and 
rectal swabs were obtained on admission and once weekly. We used 
ENVIN nosocomial infections (NI) criteria. We compared all patients 
admitted to ICU with ICU NI from October 1, 2010 to September 30, 
2011 (non-SDD group) to the SDD study group. A univariate and a 
multivariate logistic regression analysis were performed. For each one 
of the infections the incidences per 1000  days of exposure in each 
cohort and the corresponding relative risks were obtained using the 
Poisson regression. Statistical significance was p ≤ 0.05.We analyzed 
colistin- and tobramycin-resistant colonization and also antibiotic con-
sumption as Defined antibiotics Daily Doses (DDD).
Results: Results are shown in Tables 1, 2 and 3.
There were no statistical significant differences between both groups 
in type of admission or demographic data. Patients with SDD had 
significantly less Extended Spectrum Betalactamase (ESBL), Gram 
Negative Bacteria Multirresistant (GNB-MR) and  Acinetobacter 
spp infections. We had also a significant reduction in ventilator associ-
ated pneumonias (VAP), urinary infections and other secondary bac-
teremias and antibiotic resistant bacteria infection (ARB) rates, in SDD 
group versus non SDD. There was no infection by Clostridium difficile. 
Colistin-resistant colonization was 16,5% and tobramycin-resistant col-
onization was 25,7% of samples. There was a decrease on the DDD/100 
ICU stays after SDD.
Conclusion: After 8  years applying SDD a significant reduction of 
infections by ESBL, GNB-MR and Acinetobacter, was observed. A signifi-
cant decrease of VAP, secondary bacteremias, urinary and ARB infec-
tions rates was also shown. An antibiotic consumption reduction was 
found after SDD. Low rates of colistin- and tobramycin-resistant coloni-
zation bacteria were observed
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Introduction: Antibiotic use in hospitals, also in intensive care units 
(ICUs), is often inappropriate or unnecessary. Overuse of antibiotics 
drives antibiotic resistance. There are merely two ways to reduce the 
quantity of antibiotic use: not to start or early withdrawal. In ICUs the 
latter is far more acceptable. Even though emerging evidence sug-
gests that reducing the duration of antibiotic therapy is safe for vari-
ous types of infections, antibiotic therapy is commonly prescribed 
longer than recommended in daily practice. Professional performance 
of recommended care may be influenced by a large variety of factors. 
It is unclear, however, which factors influence the chosen duration of 
antibiotic therapy.
Objectives: The objective of this systematic literature review was to 
identify factors of antibiotic therapy duration in hospitals, with a spe-
cial focus on ICUs.
Methods: A systematic literature search was conducted using Pub-
Med, Embase, PsycINFO and Web of Science from 2000 onwards. All 
qualitative, quantitative and mixed-method studies in any language, 
concerning adults, and performed in an in-hospital setting were 
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eligible for inclusion. Studies were included if they reported original 
data on determinants of antibiotic therapy duration. The identified 
factors were categorized using the comprehensive, integrated check-
list of determinants of practice as develop by Flottorp et al. (2013).
Results: Seventeen articles were included in this review, of which 
one specifically focussed on the ICU. Several determinants influenc-
ing duration of antibiotic therapy were found (see Table  1 for some 
examples). Most of these were factors related to individual health 
professionals (e.g. knowledge and skills, cognitions and attitudes, pro-
fessional behaviour), followed by professional interactions (e.g. team 
processes, communications and peer influences), patient factors (e.g. 
patients’ perceived needs), and guideline factors (e.g. (in)consistency 
with other guidelines, feasibility of the recommendations, quality of 
the recommendation).
Table 1. Factors influencing duration of antibiotic treatment, classified according to the 










Knowledge and skills  
Doctors don’t know how to re-evaluate/stop 
antibiotics 
Cognitions (including attitudes and emotions) 
Feeling of personal responsibility for an infectious 
complication 
Professional behaviour  
Personal longstanding preferences of the surgeons 
3. Patients 
factors
(Older) age of patient 
Severity of infection 
4. Professional 
interactions  
Team process (Etiquette, Group culture) 
Type of surgical (sub)specialty 
Type of medical specialty (surgical vs. general 
medical) 
Communication and influence 
Lack of supervision leaving junior staff to make 
complex medical decision 
Inmput from a specialist in infectious diseases 
5. Incentives 
and resources
(Shortage of) human resources  
(Lack of) system that facilitates stopping of 
antibiotics  
6. Capacity for 
organizational 
change
No formal encouragement to conduct review and 




Safety from litigation for a complication 
Conclusion: Only a few original studies have been performed inves-
tigating determinants of antibiotic therapy duration, with a remark-
able lack of ICU studies. To design the most appropriate and effective 
improvement intervention, interventions need to be informed by clear 
information on determinants of behaviour. This review provides the 
first step for the development of effective behavioural interventions 
to optimize duration of antibiotic therapy. Further studies need to be 
conducted, specifically at ICUs, to gain more insight into factors that 
influence professional behaviour regarding the duration of antibiotic 
therapy.
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Introduction: Faecal peritonitis is a common cause of sepsis and ICU 
admission leading to up to 29% hospital mortality, prolonged ICU and 
hospital length-of-stays and increased costs. Risk factors associated 
with prognosis vary in different published studies.
Objectives: To analyse clinical, analytical, surgical, microbiological 
and physiological factors associated with poor prognosis (defined by 
ICU and hospital mortality, need for ICU readmission and prolonged 
ICU and hospital length-of-stay), within a cohort of ICU patients with 
the diagnosis of secondary peritonitis.
Methods: Retrospective single-centre observational cohort study 
from January 2015 to June 2018. Patients included suffered second-
ary peritonitis due to hollow viscera perforation, both as a reason for 
admission and/or during ICU stay. Quantitative variables are shown 
as mean and standard deviation, or as median with the interquartile 
range in case of failure to comply with normality. Qualitative variables 
are expressed as percentages. Multivariate analysis with binary back-
ward stepwise logistic regression was performed. Odds ratio of the 
predictor variables of ICU mortality and bad prognosis are shown.
Results: 130 patients were recruited. Median age of 65 years (55-74), 
45% were women. SAPS 3 median of 53.5 (43 - 65), ICU median stay 
7 days (4 - 12) and ICU hospital stay 14 days (8 - 21). Readmission rate 
of 6.2%. ICU mortality 5.4% and hospital mortality 9.2%. In the multi-
variate analysis, endocrine comorbidity showed an OR 3.611 (CI 95%: 
1.217-10.715; p=0.021), need for mechanical ventilation OR 12.275 
(CI 95%: 1.974-76.327; p=0.007), need for parenteral nutrition OR 
5.747 (CI 95%: 1. 565-21,101; p=0.008), faecal peritonitis OR 2,908 (CI 
95%: 1,176- 7,192; p=0.021), need for new surgery after peritonitis OR 
79,746 (CI 95%: 6,718- 946,643; p=0.001) and SOFA at day 1 above 7 
OR 6,939 (CI 95%: 2,208-21,814; p=0.001). Microbiological variables 
showed no correlation with bad prognosis.
Conclusion: Clinical, physiological and surgical characteristics showed 
a relationship with poor prognosis of patients with secondary peritoni-
tis. Microbiological variables did not.
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Introduction: Anidulafungin is commonly used for the treatment of 
abdominal diseases caused by Candida spp. in critically ill patients.
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Objectives: To analyze the variability in the pharmacokinetics (PK) of 
anidulafungin and its diffusion in ascitic fluid in patients admitted to 
an Intensive Care Unit (ICU).
Methods: A prospective, observational, and descriptive pharmacoki-
netic study in a single ICU. Included were all patients, who received 
intravenous anidulafungin from October 2014 to June 2019 with a 
loading dose of 200  mg followed by 100  mg/day as maintenance 
dose and for whom the extraction was possible. Extraction of plasma 
samples and ascites fluid was performed at the second day of treat-
ment [valley or predose (Cmin) and/ or peak (Cmax) at the end of 
the infusion]simultaneously whenever possible. Demographic vari-
ables, pathological, analytical history and PK data were included. 
Quantitative variables are described as means (standard deviation) 
or medians (interquartile range) and qualitative variables as relative 
frequencies. This project was approved by the PSMar Committee for 
Clinical Research Ethics (No. 2016/6987/I)
Results: A total of 10 patients aged 65 (10.6) years, 6 (60%) men, Body 
Mass Index (BMI) 26.2 (3.6) kg/m2. 6 (60%) of them hadsurgical pathol-
ogy. A total of 14 plasma and ascites fluid extractions were performed. 
The analytical values  corresponding to the day of extraction were: 
mean serum creatinine of 1.09 (0.53) mg/dL, albumin 3.17 (0.96) mg/
dL and a median bilirubin 4.9 [2, 3-17.8] mg/dL. PK data: Mean Cmin 
3.4 (1.5) mg/dL and Cmax 5.4 (3.2) mg/dL in plasma; mean concentra-
tion in ascitic fluid 1.11 (0.8) mg/dL. Ratio Cascitic/Cmin plasma was 
calculated in 5 patients with a median of 0.23 [0.17-0.29]. In one case, 
ascites fluid levels could be extracted at Cmin, Cmax, 4 h and 6 h after 
one administration. Anidulafungin concentrations were 0.52 mg / dL, 
0.51 mg / dL, 0.59 mg / dL and 0.68 mg / dL, respectively. The concen-
trations of anidulafungin observed in ascites fluid were higher than 
the epidemiological cut-off points (ECOFF value) of this echinocandin 
for the different Candida spp species, which ranged from 0.015 mg/L 
for C. albicans to 0.25 mg/L for C. krusei.
Conclusion: The mean anidulafungin penetration in ascitic fluid was 
low, 23%. However, the concentrations reached in ascites fluid could 
be sufficient to treat Candida spp since they exceed the epidemiologi-
cal cut-off points.
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Introduction: Infections represent at least half of the clinically rel-
evant complications in critically ill burn patients, and are one of the 
most frequent causes of death in this population. Selective Digestive 
Decontamination (SDD) is an infection prevention and control strategy 
conceived to minimize infections and, thus, it may have potential ben-
efits in burn patients.
Objectives: We aim to assess the trend in the incidence of infections, 
type of microorganisms and use of antimicrobial agents before and 
after the implementation of SDD in a Burns Unit (BU).
Methods: We conducted a retrospective observational study in a 
5-bed BU of a University Hospital. We collected data from all the 
patients admitted to the BU within a baseline period without SDD 
(2  years) and an SDD period (8  months). Chi-square, Student’s T and 
Mann-Whitney U tests were applied for comparisons, as appropriate.
Results: A total of 48 patients were included, of which 35% received 
SDD (n=17). We did not find any statistically significant differences 
between baseline and SDD periods in terms of age (62 vs 61 years-old, 
p=0.86), gender (71% vs 65% male, p=0.65), BSA (23 vs 20%, p=0.52), 
smoke inhalation injury (32% vs 24%, p=0.53), APACHE-II (19 vs 16, 
p=0.08), ABSI (7 vs 6, p=0.50) or mortality (26% vs 12%, p=0.25). Our 
findings are depicted in the Tables.
Table 1. Incidence of infections, before and after the implementation of SDD. 
Baseline 
period SDD period p-value 
All infections 
Incidence 58% 47% 0.46 
Nº episodes/patient 1.94 0.88 0.20 
Days to event 11 (5–15) 21 (6–30) 0.05 
Bacteraemia 
Incidence 16% 6% 0.31 
Nº episodes/patient 0.23 0.06 0.25 
Days to event 22 (20–27) 54 (54–54) 0.38 
Respiratory infections 
Incidence 36% 29% 0.67 
Nº episodes/patient 0.81 0.35 0.25 
Days to event 6 (5–11) 7 (5–17) 0.69 
Skin and soft tissue infections 
Incidence 32% 24% 0.53 
Nº episodes/patient 0.90 0.47 0.38 
Days to event 16 (12–31) 30 (27–32) 0.26 
Table 2. Type of microorganisms before and after the implementation of 
SDD. 
Baseline 
period SDD period p-value 
Staphylococcus aureus infections 3% 12% 0.24 
Streptococcus pneumoniae 
infections 10% 0% 0.19 
Other Gram-Positive infections 32% 6% 0.04 
NF Gram-Negative bacilli 23% 18% 0.69 
infections 
Enterobacteriaceae infections 29% 6% 0.05 
infections 
Enterobacteriaceae infections 29% 6% 0.05 
Table 3. Use of antimicrobial agents before and after the implementation of 
SDD. 
  Exposed patients, % Days of treatment, P50 (P25–P75) 







NAP penicillins 40 29 0.48 4 (2–8) 8 (6–9) 0.29 
AP penicillins 36 21 0.34 6 (4–10) 13 (4–14) 0.35 
Cephalosporins 48 93 0.01 7 (17–21) 4 (4–6) 0.27 
Carbapenems 44 50 0.72 11 (3–15) 
18 (3–
23) 0.52 
Glycopeptides 16 0 0.11 12 (5–19)     
Quinolones 28 14 0.33 9 (4–7) 5 (3–7) 0.24
Aminoglycosides 8 0 0.28 10 (9–11)     
Nitroimidazoles 8 0 0.28 7 (5-8)     
Oxazolidinones 48 43 0.76 8 (4–12) 5 (3–10) 0.51 
Macrolides 8 0 0.28 8 (7–9)      
Conclusion: SDD was significantly associated with a later onset of all 
types of infection, a lower incidence of Enterobacteriaceae and other 
Gram-Positive infections, and a higher exposure to cephalosporins. A 
nonsignificant downtrend was observed in the incidence of all types 
of infection, use of antimicrobial agents (except cephalosporins) and 
mortality.
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Introduction: Use of antimicrobial agents is a common intervention in 
the management of the critically-ill patient admitted to the intensive 
care unit (ICU). Optimizing antimicrobial use is imperative to reduce 
infection-related morbimortality and to limit the emergence of multid-
rug-resistant microorganisms (MDRMs).
Objectives: To describe the results of the implementation of an anti-
microbial stewardship program (ASP) in the ICU of a University Hos-
pital in Spain, after a year of operation (from mid-2018 to mid-2019).
Methods: A multidisciplinary ASP working group was created (inten-
sivist, microbiologist, pharmacist, preventivist and nurse). Theoretical 
need for antimicrobial agents use was assesed in daily meetings of 
the group, whenever a result of a microbiological test was available, 
taking into account the clinical setting, infectious syndrome, isolated 
organism and antimicrobial pharmacology. Non-mandatory recom-
mendations concerning optimization of antimicrobial treatment were 
proposed to the attending physician after each meeting, including de-
escalation (switch to narrower spectrum or discontinuation of treat-
ment), adequacy (change to same spectrum or start a new treatment), 
optimization (duration, dose or route of administration) and escala-
tion (switch to broader spectrum). We report antimicrobial utilization 
expressed as daily defined dose (DDD) per 100 bed-days (BD) in the 
ASP period and in previous periods.
Results: We held 260 meetings during the study period, where 230 
recommendations were proposed over 110 patients (64% male, aged 
63±15), with a 96% of adherence. Intervention proposal was more 
frequently triggered by blood cultures (47%) and respiratory samples 
(30%), with Gram-negative bacteria being the most frequent isolated 
type of microorganism (41%). Most interventions were advised over 
respiratory infections (46%), followed by abdominal organs (17%) and 
urinary tract infections (15%).
Antimicrobial stewardship use was fundamentally proposed as de-
escalation (67%), but also as adequacy (15%), optimization (13%) and 
escalation (5%). Most interventions were advised over linezolid (22%) 
and the groups of carbapenems (21%) and penicillins (13%). Antibiotic 
utilization, expressed as DDD/100 BD, decreased from 175 in 2017 (no 
ASP), to 154 in 2018 (ASP implemented) and to 136 in 2019 (ASP fully 
operational).
Conclusion: We found a broad adherence rate to the ASP-group 
proposed recommendations. De-escalation was the most common 
intervention, specially in clinically relevant groups of antibiotics. We 
observed a downtrend in antibiotic use after the implementation of 
the ASP.
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Introduction: Critical care patients are at particular risk of contract-
ing a nosocomial infection within the critical care unit1. Nosocomial 
infection is a major cause of mortality and morbidity for critical care 
patients and a leading factor in increased treatment costs2. However, 
many patients are at risk of hospital acquired infection pre admission 
to the critical care unit which adversely impacts on patient outcomes3. 
Methicillin-Resistant Staphylococcus Aureus (MRSA) Bactereamia4, 
Vancomysin-Resistant Enterococci (VRE)5 and Clostridium Deficile 
(CDiff)6 are leading hospital and critical care aquired nosocomial 
infections, Limited data exist on the impact of hospital versus criti-
cal care unit acquired infection on patients critical care length of stay 
(LOS) and critical care mortality.
Objectives: To compare impact of admission versus critical care unit 
acquired MRSA, VRE and C. Diff on critical care patient mortality and 
critical care LOS.
Methods: A retrospective analysis of all patients (critical care stay 
48 hours or more) admitted to one of four critical care units (54 beds 
in total) at one central London hospital between March 2011 and 
December 2018. Patients with MRSA, VRE or C. Diff status reported to 
United Kingdom’s Intensive Care National Audit and Research Centre 
(ICNARC) were included in the analysis. Admission NI was defined as 
an infection diagnosed within 48 hours of admission. Critical care NI 
was defined as any new infection diagnosed 48 hours or more post 
admission.
Results: There were 22,320 critical care patient admissions during the 
study period with an average age of 56.3 years and mortality rate of 
12.7%. 21,909 (98.1%), 3041 (15.2%) and 4791 (21.4%) of patients were 
screened for MRSA, VRE and C. Diff respectively. 411 patients tested 
positive for MRSA (40% female, mean 55.9 years), with 40 (9.73%) unit 
acquired. Unit versus admission MRSA mortality rate was 12.1% (N=5) 
versus 13.5% (N=5) respectively (p = 0.81). 632 patients tested posi-
tive for VRE (35.1% female, average age 55.5 years), with 90 (9.1%) unit 
acquired. Unit versus admission VRE mortality rate was 39.2% (N=44) 
and 23.9% (N=126) respectively (p = 0.008). 310 patients tested posi-
tive for C. Diff (44.5% female, average age 58.9 years), with 147 (47%) 
unit acquired. Unit versus admission C. Diff mortality rate was 13.2% 
(N=20) and 20.7% (N=126) respectively (p = 0.078). Mean and median 
LOS for admission MRSA, VRE and C. Diff were 9.5/5 days, 11.2/6 days 
and 10.9/6days respectively. Mean and median LOS for unit MRSA 
bacteraemia, VRE and C. Diff were 29.5/22  days, 43.8/25  days and 
25.5/6 days respectively.
Conclusion: This study highlights that there is no significant impact 
on mortality rates if patients contract admission versus unit MRSA 
bacteraemia. Patients who contract unit VRE bacteraemia are at a 
significantly higher risk of mortality compared to patients infected 
pre admission. In contrast, patients who are infected with C. Diff pre 
admission are at a significantly higher risk of mortality as compared to 
unit patients. Despite variance in mortality, patients with unit MRSA, 
VRE and C. Diff had increased LOS. Sub-categorisation of C. Diff and 
VRE mortality risk should include admission/unit infection and differ-
ences in LOS and patient mortality rates highlight the need for height-
ened surveillance of VRE and C. Diff within the critical care, parallel 
with MRSA surveillance levels.
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Introduction: Although trachebronchitis (VAT) and ventilator-asso-
ciated pneumonia (VAP) are two different clinical entities, they have 
some factors in common in terms of clinical and microbiological diag-
nosis, treatment and prognosis. The result of the evaluation of patients 
with these type of ventilator-associated respiratory infections can 
be interpreted differently if clinical and epidemiological factors are 
considered.
Objectives: To describe the concordance between clinical and epide-
miological diagnosis, and, as a secondary objective, to know the clini-
cal an epidemiological characteristics as well as the rates of VAT and 
VAP.
Methods: Retrospective and descriptive study carried out between 
1st May 2015 and 31st October 2017 of patients admitted to our Inten-
sive Care Unit (ICU). Sources: ENVIN-UCI study, Department of Preven-
tive Medicine, electronic medical record and retrospective review of 
imaging studies by radiology specialist. Parameters analized: age, gen-
der, date of admission, intubation and discharge, comorbidities, micro-
organisms, antibiotics, associated infections and mortality. Statistical 
analysis: qualitative values (presented as absolute and percentages), 
quantitative values (presented as mean and standard deviation). Con-
cordance between clinical diagnosis (data from ENVIN-UCI) and epide-
miological diagnosis (data from Department of Preventive Medicine) 
was measured using kappa coefficient.
Results: 290 patients needed mechanical ventilation (MV) with 4523 
stays (patients x mean days under MV). VAP rate: 3,98 and VAT rate: 
10,39. ICU infections: 65 (18 VAP, 47 VAT) and according to Preventive 
Medicine: 43 (19 VAP and 24 VAT). In imaging studies reviewed by radi-
ology specialist, coincidence with ICU diagnosis was found in 70% of 
the infections and in 60% of diagnosis made by Preventive Medicine. 
The concordance observed between clinical and epidemiological 
diagnosis in VAT and VAP according to Landis and Koch was: moder-
ate in VAP (kappa value: 0,56; CI 95%: 0.35-0,78) and fair in VAT (kappa 
value: 0,32; CI 95%: 0,13-0,51). In the bivariate analysis, relationship 
was only found between concordance and length of stay.
Conclusion: Moderate agreement was observed in VAP and fair in VAT. 
None of the parameters studied were associated with no concordance, 
except for the length of stay
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Introduction: Many critically ill patients infected with SARS COV 2 
have worse clinical course or die in ICU due to secondary infections.
Objectives: The aim of the present study is to describe the infectious 
complications in patients admitted in ICU with confirmed respira-
tory infection by Sars-Cov-2, and to assess factors related with these 
complications
Methods: Retrospective case series of consecutive critically ill patients 
admitted in ICU of a community hospital with severe pneumonia 
caused by SARS COV 2. Microbiological analysis of bronchoscopic 
bronchoalveolar lavage (BAL), urine antigen, PCR for Influenza and 
blood cultures were performed at ICU admission. We categorized 
infections as coinfections, within the first 72 hours in ICU, and those 
with a later onset. We analyzed if the use of corticoid therapy was 
related with developing infectious complications. Medical history, 
microbiological cultures, ICU length of stay and mortality were col-
lected. Statistical analysis: Data was analyzed by SPSS 18 and quantita-
tive variables were expressed as a mean ± standard deviation.
Results: Twenty patients were included. Mean age was 61,7±8 years 
old. 80% required mechanical ventilation. Mortality was 30%. Positive 
PCR SARS COV 2 resulted in 100% of BAL samples. Pneumococcal urine 
antigen test and Influenza resulted negative in all cases.
ICU length of stay was significatively longer in patients who developed 
bacterial infections; 20,11±11.4 days vs 10.5 ± 7.29 days in the non-
infected group (p<0,05). Regarding fungal infections, ICU length of 
stay was longer in infected 23.5 ± 10.36 days vs 11.27 ±8.3 (p<0,05).
In seven patients, 35%, BAL performed at ICU admission resulted posi-
tive: 2 patients with Staphylococcus, 3 with Candida spp. and 2 cases 
with bacterial/fungal co-infection. Candida isolation was associated 
with previous corticosteroid treatment.
During the ICU stay, 56,25%, developed ventilator associated pneu-
monia caused by Candida spp, Pseudomona aeruginosa, Klebsiella aero-
genes. 30% developed urinary tract infection, half of these cases due 
to Candida spp. In 30% it was described as bacteremia and 10% pre-
sented catheter-related bloodstream infection.
Dividing the described infections by previous corticosteroids use:
Previous 
corticosteroid 
      n: 10
     No 
corticosteroid
       n:10
Fungal infection 1 1 
Fungal + Bacterial infection 5 3 
Bacterial infection 1 2 
No infection 3 4 
The most frequent isolation were Candida spp 10 (C albicans 7+C par-
apsilosis 2+C guillermondii 1), Pseudomona aeruginosa 7, Enterococcus 
faecalis 5, Klebsiella spp 4 and Staphylococcus aureus 4.
Conclusion: Fungal infections were frequent in critically ill patients 
withs SARS COV2 infection, probably related with corticosteroid 
therapy.
ICU length of stay was associated with more incidence of infections. 
Gram positive predominate first days of ICU admission and gram-neg-
ative infections in the later phase of ICU stay.
Health care associated infections were more frequent than 
co-infection.
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Introduction: Extensive purulent-necrotic wounds are one of the 
urgent and unresolved problems in purulent surgery [1,2,3]. However, 
along with this, adequate surgical treatment often leads to the forma-
tion of extensive post-necrectomy wounds, the independent healing 
of which is impossible due to their significant size [4,5]. One of the 
effective treatment methods in this category of patients is the use of 
local vacuum aspiration [6,7].Extensive purulent-necrotic wounds are 
one of the urgent and unresolved problems in purulent surgery [1,2,3]. 
However, along with this, adequate surgical treatment often leads to 
the formation of extensive post-necrectomy wounds, the independent 
healing of which is impossible due to their significant size [4,5]. One of 
the effective treatment methods in this category of patients is the use 
of local vacuum aspiration [6,7].
Objectives: Improve the treatment results of patients with extensive 
purulent-necrotic wounds caused by erysipelas.
Methods: In this work, we present data on the results of treatment 
of 89 patients with necrotic complications of erysipelas with the use 
of vacuum therapy in combination with autodermoplasty. The defect 
sizes varied from 20 to 152 cm2. The effectiveness of vacuum therapy 
was evaluated based on the dynamics of clinical manifestations, deter-
mining the degree of microbial contamination in the wound, analy-
sis of the cellular composition of wound prints, phagocytic number, 
phagocytic activity of neutrophils, determination of the index of com-
pletion of phagocytosis.
Results: Patient wound cleansing during preparation of a wound for 
transplantation in the control and main groups occurred after 5.1 ± 
0.5  days from the start of treatment, the appearance of granulation 
tissue after 8.1 ± 0.6  days, and granulation tissue covered the entire 
surface of the wound after 11.0 ± 0.4  days. Upon admission to the 
clinic, patients underwent surgical treatment, consisting in opening 
a purulent focus, necrectomy. Purulent discharge was observed from 
the wound, there was redness of the skin around the wound, edema, 
local temperature increase, fibrinous-purulent plaque and pain on 
palpation of the wound edges. After installing a vacuum aspirator, the 
general condition and general well-being of patients improved mark-
edly, by the 5th day, wound cleansing and the appearance of granu-
lation were noted. In parallel with cleansing the wound surface from 
necrosis and filling them with granulation tissue, local regional signs 
of inflammation disappeared. The degree of microbial contamination 
ranged from 1.9 ± 0.7 × 104 to 2.6 ± 0.5 × 104 / g of tissue.
It should be noted that patients of both groups needed autodermo-
plasty to close skin defects.
Skin transplantation was performed in the second phase of the wound 
process with bacterial contamination of the wound less than 102 CFU 
per 1  g of tissue and upon receipt of a regenerative type of wound 
exudate cytograms.
The use of a vacuum apparatus contributed to the metered pressing 
of the skin flap to the wound surface, reliable fixation of the skin flap 
and, to a certain extent, improved local microcirculation. Carried out 
autodermoplasty was effective in all cases. When using vacuum in the 
postoperative period in the main group, the engraftment of the skin 
flap accounted for 82% of the wound surface, and in patients of the 
control group, without vacuum therapy in the postoperative period, 
the engraftment amounted to 75% of the surface.
Conclusion: The use of vacuum therapy for 4–5  days in a continu-
ous aspiration mode (–125 mm Hg) helps to purify a purulent wound, 
shortens the first phase of the wound process and potentiates the fill-
ing of the wound surface with mature granulation tissue (p <0.005).
It is advisable to use an isolated vacuum in skin plasty in clinical prac-
tice in patients with purulent-necrotic wounds and with a necrotic 
form of erysipelas to heal extensive skin defects.
Reference(s) and grant acknowledgment(s)
1. 1. Palm HG, Hauer T, Simon C, Willy C. [Vacuum‑assisted closure of head and 
neck wounds]. HNO. 2011;59(8):819‑30. 2. Baisch A, Hörmann K, Goessler 
UR, Sauter A, Riedel F. [Vacuum‑assisted closure of nonhealing wounds in 
head and neck reconstructive surgery]. HNO. 2007;55(5):392‑8. 3. Hsia JC, 
Moe KS. Vacuum‑assisted closure therapy for reconstruction of soft‑tissue 
forehead defects. Arch Facial Plas Surg. 2011;13(4):278‑82. 4. Powers AK, 
Neal MT, Argenta LC, Wilson JA, DeFranzo AJ, Tatter SB. Vacuum‑assisted 
closure for complex cranial wounds involving the loss of dura mater. J 
Neurosurg. 2013;118(2):302‑8. 5. Bovill E, Banwell PE, Teot L, Eriksson E, Song 
C, Mahoney J, et al. Topical negative pressure wound therapy: a review of 
its role and guidelines for its use in the management of acute wounds. Int 
Wound J. 2008;5(4):511‑29. 6. Kairinos N, Hudson D, Solomons M. Depth 
of penetration of negative pressure wound therapy into underlying tis‑
sues. Wound repair and regeneration : official publication of the Wound 
Healing Society [and] the European Tissue Repair Society. 2009;17(3):456. 
7. Kairinos N, Solomons M, Hudson DA. Negative‑pressure wound therapy 




Using ointments Argosulfan in treatment of purulent wounds
J. Fuss1; A. Voloboyeva2; V. Polovyj3
1Regional hospital of Pustomyty, Lviv, Ukraine; 2Icu, Regional hospital 
of Pustomyty, Lviv, Ukraine; 3General surgery, Bukovinian State Medical 
University, Chernivtsi, Ukraine 
Correspondence: J. Fuss
Intensive Care Medicine Experimental 2020, 8(2): 000549
Introduction: In the structure of surgical pathology, the leading place 
is occupied by purulent-inflammatory diseases of soft tissues [1], 
which are associated with the infectious process in the skin and cel-
lular spaces caused by pathogenic or opportunistic flora [2]. Patients 
with this pathology make up 20–45% of all surgical patients [3,4]. The 
rapid development of the resistance of microorganisms to the antibac-
terial drugs used requires the selection of the most effective method 
for the local treatment of wound infections. To solve this problem, 
antibacterial preparations containing silver are actively used in mod-
ern practice [5,6].
Objectives: Evaluation of the effectiveness of the treatment of puru-
lent wounds with Argosulfan ointment in a surgical hospital.
Methods: 264 patients who were admitted to the hospital in 2018-
2020 with purulent wounds of various etiologies were treated. All 
patients were divided into 2 groups: group I (n = 156) included 
patients in whom, in the postoperative period, ointment dressings 
with silver sulfathiazole were used for local treatment of wounds; 
group II (n = 108) included patients who in the postoperative period 
for topical wound treatment used ointment dressings with antibacte-
rial ointments - bactroban.
Upon admission to everyone, a wound was opened and a puru-
lent cavity was drained, or primary surgical treatment of an infected 
wound in the first day after admission. Wounds were washed with an 
antiseptic solution, an aseptic dressing was applied. Patients in both 
study groups received the same broad-spectrum antibacterial therapy. 
Local treatment of purulent wounds began the next day after surgery. 
The following indicators were studied in dynamics: the nature of the 
wound discharge, the presence of edema and hyperemia of the tissues 
around the wound, the timing of the cleansing of the wound defect, 
the results of microflora culture and sensitivity to antibacterial therapy 
on the 1st, 5th, 10th day after the operation.
Results: Absence of hyperemia of the skin around the wound and soft 
tissue edema in group I averaged 4.3 ± 1.7  days, in group II - 5.5 ± 
2.5 days (t = 0.379; p <0.05).
Sterile inoculation from the wound on the 5th day was observed in 
42.3% of patients in group I, and only 5.9% in group II. Statistically sig-
nificant differences between the groups were obtained: χ2 = 33.68; p 
<0.05.
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In group I, a decrease in bacterial contamination by 50% was noted in 
57.3% of patients, in group II - in 47.4%. There were no statistically sig-
nificant differences between the groups: χ2 = 2.47; p <0.05.
In group I, sterile discharge on the 10th day was observed in 100% of 
patients, in group II - only in 88.5%. Statistically significant differences 
between the groups were found: χ2 = 12.2; p <0.05.
In group I, wound cleansing from pus and fibrin and the appearance of 
granulations on the 5th day were noted in 87.8% of patients, in group 
II - only in 35.9%. Statistically significant differences between the 
groups were revealed: χ2 = 57.07; p <0.05.
In group I, wound cleansing from pus and fibrin and the appearance 
of granulations on the 10th day were noted in 100% of patients, in 
group II - only in 88.5%. Statistically significant differences between 
the groups were obtained: χ2 = 12.2; p <0.05.
Conclusion: Use of Argosulfan ointment can improve the results 
of treatment of patients with purulent pathology of soft tissues and 
reduce the risk of secondary infection in comparison with the use of 
traditional antibacterial ointments - by reducing bacterial contamina-
tion, faster cleaning of the postoperative wound from pus and fibrin.
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Introduction: Association of Macrophage activation syndrome (MAS) 
and infections has been documented earlier in literature however, 
there have been case reports and isolated cases and we did not come 
across a big series on above in association with infections. This com-
munication delineates a case cohort of macrophage activation syn-
drome secondary to infectious diseases.
Objectives: To study the epidemiology and pattern of common vari-
ables in a cohort of Macrophage activation syndrome associated with 
an infectious etiology..
Methods: Setting: Sixty bedded multidisciplinary ICUs of tertiary care 
units.
Methodology: Consecutive patients suspected of macrophage activa-
tion syndrome fulfilling diagnostic criteria as per HLH 2004 trial were 
included for a duration dated first January 2017-till date with an infec-
tious disease etiology were included. They were evaluated with a focus 
on demographics, SOFA scores, ALT levels, AST levels, Hemoglobin, 
platelet counts, serum creatinine levels, bone marrow findings, inci-
dence of AKI, LDH levels, splenomegaly, length of stay and mortality. 
Death/discharge from ICU were considered as end points. Statistical 
analysis was done using SPSS version 23.
Results: Total of thirty-seven patients with high grade fever were 
included (n=37, M: F-24:13) with age distribution of 44.8±14.3 years 
(Range-21-70). SOFA scores were 14.8±2.2 (Range-10-18) and length 
of stay (LOS) was 10.4±3.31  days (Range-5-17). Hemoglobin lev-
els were 11.7±2.8(Range 7.9-17.5) gm/dl and platelet counts were 
60324.32± 25075.50 (Range12,000 -90,000). AST and ALT levels were 
164± 54 (Range-61-263) and 164.9 ± 48.7 (Range-82-247) respec-
tively [Ref <30]. Serum triglycerides, Serum ferritin levels, D-Dimer 
and LDH levels were 326± 34.6 mg/dl (Range-290-410), 1530.4±909.7 
(Range 740-4500) ngm/ml,4000±1640  ng/ml (Range 3260-5900) and 
295±15.7 (Range- 190-384) units/l respectively. The incidence of AKI 
for the entire cohort was n=17(45.9%) with serum creatinine levels 
1.44± 1.08 (Range-0.5-5.8) mg/dl. Bone marrow was consistent with 
hemophagocytosis in n=22(59.5%). In hospital mortality was n=6 
(16.2%) and splenomegaly was noted in n=19(51.4%). The etiology 
included Dengue n=7 (18.9%), Typhoid n=10(27%), HIV n=4(14.8%), 
Malaria n=5 (18.5%), COVID 19 n=3(8.1%) and gram-negative infec-
tions n=8(29%). On statistical analysis only Platelet levels and Fer-
ritin levels had an association with mortality (p value 0.0003S and 
0.00001S).
Conclusion: MAS remains a suspect cause in any new onset fever in 
ICU. Its associations with infectious diseases and ability to alter out-
comes should prompt an early recognition for the same. This com-
munication documents a bad prognosis with thrombocytopenia and 
elevated ferritin levels in these cohorts.
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Introduction: Colonizations and infections by multi-drug-resistant 
(MDR) bacteria are a common occurrence in patients treated in the 
Intensive Care Units. Most donors have previously been treated in 
these intensive care units and may therefore have colonizations or 
infections from these pathogens. In this study, we analyze whether 
the organ recipients of donors who were colonized or infected with an 
MDR bacteria develop an infection with the treatment challenges that 
this would entail.
Methods: Consecutive deceased organs donors in a critical care unit 
from a tertiary hospital with high donation activity were registered 
for 72 months (January-14 to December-19). We included in the study 
organ donors with MDR bacteria isolates and traced the transplanted 
organs and the MDR isolates in their corresponding recipients. Meth-
ods consisted in an active detection of any colonization by MDR bacte-
ria through screening with swabs twice a week. As for the diagnosis of 
infection is made according to clinical, analytical and imaging criteria 
(as in the case of pneumonia) . For each case of nosocomial infection, 
further variables were documented, such as confirmed pathogens, 
date of infection, and temporal association of the infection with 
devices (tracheal tube, central venous catheter, urinary catheter).
Results: From 385 deceased organ donors, we detected 31 patients 
colonized or infected by MDR bacteria. In average, they were 67 years 
old with an ICU stay of 9  days. From these 31 organ donors, we fol-
lowed the 59 patients who received a graft from a donor with a posi-
tive culture for MDR bacteria. Transmission of the MDR pathogen was 
detected in two receptors: a Methicillin- resistant Staphylococcus 
aureus (MRSA)bacteremia whose donor was treated 36 hours before 
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the donation and a urinary tract infection for Klebsiella. pneumoniae 
BLEE from an untreated donor due to the fact that isolates identifica-
tion results were obtained after donor death and transplantation.
Conclusion: The transmission of MDR bacteria from organ donors to 
organ recipients is a rare occurrence. In our series, the use of organs 
from MDR bacteria-colonized donors is safe for recipients of these 
organs in terms of MDR pathogen transmission.
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Introduction: COVID 19 pneumonia is exceeding the intensive care 
units capacity worldwide. It is important to analyse the results to 
tackle the disease successfully.
Objectives: To analyse the characteristics of the patients admitted to 
the ICU during the COVID 19 pandemic.
Methods: Retrospective observational study conducted in an inten-
sive care unit of a university Hospital. During the pandemic, ICU beds 
went from 14 to 39. We analysed patients admitted to the ICU with the 
diagnosis of respiratory failure due to COVID 19 pneumonia between 
6/3 and 21/4 2020. Patients who are still in the ICU at the time of data 
collection were excluded. Demographic data (age, sex), APACHE II, 
comorbidities (hypertension, previous pulmonary pathology, dyslipi-
daemia, diabetes mellitus, obesity), laboratory data (creatinine, ferritin, 
total bilirubin), length of stay and treatments administered (mechani-
cal ventilation, muscular blockers, vasoactive drugs, prone position-
ing) were collected.
Results: 90 patients were analysed. Male 67.8% (61/90). Average age 
60.6 ± 9.6  years. APACHE II 14.3 ± 5.1. 48.9% (44/90) had cardiovas-
cular history of which AHT 46.6% (42/90). Chronic lung disease 20% 
(18/90) (asthma 5.5% (5), OSAHS 5.5% (5), COPD 4.4% (4), OSAHS + 
asthma 3.3% (3)). 65.5% (59/90) had other comorbidities (Diabetes 
mellitus 23.3% (21), dyslipidaemia 35.5% (32). 26.6% (24/90) had no 
previous pathology. Length of stay (days): 12 ± 10.1. The average of 
the maximum creatinine, ferritin and total bilirubin values  were: cre-
atinine 1.45 ± 1.23  mg / dl, ferritin 2244 ± 3193  ng / ml and total 
bilirubin 1.8 ± 2  mg / dl. 100% of the patients required mechanical 
ventilation. Prone positioning was performed in 57.8% (52/90), infu-
sion of muscular blocker 77.7% (70/90) and vasoactive drugs 96.7% 
(87/90). Microbiological isolation was observed in 45.6% (41/90) of the 
patients. 40% (36/90) were discharged and 25.1% (23/90) were trans-
ferred to another centre due to lack of beds. Mortality rate was 34.4% 
(31/90).
Conclusion: As in other series, males predominate in the group of crit-
ically ill patients. Among the most frequent comorbidities correlated 
to COVID 19 pneumonia, we find arterial hypertension, dyslipidaemia 
and diabetes mellitus. Mortality is high despite the low average age 
and the absence of severe comorbidities. 25% of hospitalized patients 
were transferred so their evolution is unknown, mortality and length 
of stay may be underestimated.
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Introduction: Bacterial or fungal coinfection and secondary infections 
have an important role in comorbidity and mortality in COVID 19 criti-
cal patients. The typical COVID-19 clinical manifestations and labora-
tory findings make it quite challenging for the clinician to suspect and 
actively look for a different microbiological agent.
Objectives: To describe and analyse the microbiological isolations 
in the COVID-19 patients treated in our ICU (Príncipe de Asturias 
hospital).
Methods: A retrospective observational study was performed. All the 
critically ill COVID-19 positive patients who received treatment in our 
ICU (a polivalent, level II hospital ICU) were reviewed (from march 6, 
2020 to april 21, 2020). Demographical, main laboratory findings, type 
of microbiological samples and isolated agents were collected. Chi-
square tests, T Student or ANOVA were used. Signification level was 
stablished as p<0.05.
Results: A total of 67 patients were enrolled in our study. Microbio-
logical isolations were positive in 45.6% of patients, all of them were 
secondary infections. In 18 patients >1 isolation was found. The 
microorganisms isolated were: S. Aureus 11 cases, Coagulase-Negative 
Staphylococcus 12 (8 Epidermidis, 1 Hominis), E. Faecium(8), E. Faeca-
lis(7), Pseudomonas(9), E. coli(4), Klebsiella(2), Serratia(3), Haemophil-
lus (1). Strenotrophomonas (2). Acinetobacter(1), Corynebacterium(1). 
Candida was the fungus most frequently isolated (12); it is remarkable 
that it was isolated in endotraqueal aspirates (ETA) in 6 cases. There 
was one case of aspergillosis. The most frequently positive sample was 
ETA (28); followed by blood cultures (19). The most frequently isolated 
agent in ETA was Pseudomonas (10) and S. Aureus (10), 2 were SAMR. 
In blood cultures, the most frequently isolated agents were S. Epider-
midis, E. Faecalis and E. Faecium (6 each), followed by S. Aureus (4). We 
found 5 catheter related bacteriemias (S. Epidermidis 3, SAMR 1, Pseu-
domonas 1) and 7 bacteriemic pneumonia (SAMS 3, Pseudomonas 2, 
E. Coli 1 and SAMR 1).
We didn’t find statistically significant the assotiation between micro-
biological isolation and any of the patients’ underlying diseases 
(p=0.528), nor with vasoactive support (p=0.43), nor with need of 
neuromuscular blockers (p=0.25), nor with mortality (p=0.5).
Need for prone position, traqueostomy and media hospital stay were 
associated with microbiological isolations with statistical significance 
(p value in table).
Comparative analysis between positive microbiological isolations’ 
group and negative is shown in the table below.
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Microbiological isolation 
Yes No P 
Sex (masculine) 55% 59% 0,49
APACHE II 14 14.65 0.73
Ferritine (ng/ml) 2184 2479 0.7 
Creatinine (mg/dl) 1.6 1.3 0.29
Bilirrubin (mg/dl) 2.1 1.9 0.7 
%56enorP 39% 0.033 
%97ymotsoeuqarT 37% 0.001 
Microbiological isolation 
Yes No P 
Mortality rate 55% 58% 0.5 
Leght of stay (days) 18.6 8.3 0.005 
Conclusion: Secondary infections in COVID-19 patients are a frequent 
finding in our group (48%), being more frequent than in other pub-
lished series of cases. In our study microbiological isolations were 
associated to longer hospital stay, prone position and traqueostomy 
with with statistical significance.
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Introduction: Coronavirus disease 2019 (COVID-19) is a respiratory 
infection caused by a newly emergent coronavirus, SARS-CoV-2, that 
was first recognized in Wuhan, China, in December 2019. There is cur-
rently no approved treatment for COVID-19. Convalescent plasma has 
been used as a treatment in other recent epidemics, including SARS-
CoV-1, Ebola, and MERS.
Objectives: We have designed a study with the main objectives to 
evaluate the safety and efficacy of the administration of anti-SARS-
CoV-2 plasma from recovered COVID-19 donors to critically ill COVID-
19 patients.
Methods: The study design is a prospective, multi-center, rand-
omized, open-label trial comparing convalescent, ABO-compatible, 
anti-SARS-CoV-2 methylene blue-treated (MBT) plasma plus standard 
medical treatment (SMT) to SMT alone in a 2:1 ratio. Eligible patients 
are those hospitalized for COVID-19 (tested positive for SARS-CoV-2) 
and admitted to the ICU for respiratory support due to severe pneu-
monia (lung infiltrates). Patients will be eligible for inclusion within 48 
hours of ICU admission. Exclusion criteria are prior anaphylactic reac-
tions to blood products or methylene blue, severe acute renal or heart 
failure, and refractory shock. The study has been approved by the 
applicable regulatory authorities (https ://clini caltr ials.gov/ct2/show/
NCT04 28070 5).
Results: Enrollment target is approximately 100 symptomatic COVID-
19 adults. Interim analyses will be performed every 30 patients. Study 
variables will be collected daily during hospitalization from day 2 
through 29±1. All patients (independent of hospitalization status) will 
be monitored daily until day 10. Study visits for discharged patients 
have been scheduled on days 15±1 and 29±1. The primary assess-
ment is all-cause mortality through day 29. Secondary assessments 
are: change in National Early Warning Score [NEWS] from baseline, 
time to clinical response [NEWS ≤ 2 for 24  h], time to ICU discharge 
and hospital discharge, duration of mechanical ventilation and oxygen 
therapy and absolute value and change from baseline in the Ordinal 
Scale. Change from baseline in quantitative SARS-CoV-2 viral load and 
in quantitative anti- SARS-CoV-2 IgM and IgG antibodies will be meas-
ured. In addition, patients will be monitored for treatment-emergent 
adverse events for the entire study period.
Conclusion: The contribution of the study results to COVID-19 therapy 
would be the validation of the efficacy and safety of convalescent anti-
SARS-CoV-2 MBT plasma in critically ill patients.
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Introduction: The current SARS COV 2 pandemic has led to a global 
crisis in the health system. In ICUs we have the recent past of a dec-
ade ago with the H1N1v Influenza pandemic, since this time annually 
admissions in ICU of several cases of Influenza A infections have been 
described.
Objectives: The aim of the study were to describe clinical features of 
patients admitted in ICU with SARS COV 2 infections occurred during 
this epidemic time and to compare clinical characteristics and out-
come with severe 2009 pandemic Influenza A (H1N1)v infections and 
2010-2011 Influenza season infections.
Methods: Comparative study that included a prospective cohort of 
patients with SARS COV 2 severe infections and an historical group 
of patients with 2009 pandemic and 2010-2011 seasonal Influenza A 
H1N1v pneumonia. Setting: ICU of a community hospital. We included 
patients with confirmed SARS COV 2 respiratory infection. Variables 
analyzed were clinical characteristics, APACHE II at admission, res-
piratory support requirements, ICU lenght of stay, radiological pat-
tern, serum reactive C protein (PCR) and procalcitonin (PCT) levels, 
leukocite count (WBC) and mortality. Statistical analysis: Data were 
analyzed by SPSS 18 and quantitative variables were expressed as a 
mean ± standard deviation.
Results: Forty five patients were included, 18 with pandemic 2009 
Influenza A H1N1v pneumonia, 7 with Seasonal Influenza A 2010-
11 pneumonia and twenty consecutive patients with SARS COV2 
pneumonia. At present, 14th may 2020, three patients are currently 
admitted to ICU. Comparative table shows clinical characteristics and 
outcome.
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Mortality 16,7% 28,6% 30%  
Conclusion: The clinical profile and outcome of SARS COV2 pneumo-
nia differs considerably from those caused by Influenza in critically ill 
patients.
Despite no differences in the scales of severity at ICU admission were 
observed, severity of respiratory failure and the need for mechanical 
ventilation is greater in SARS COV2 infections.
Increased hospital length of stay and more healthcare-related 
infections could justify the worst patient prognosis in SARS COV 2 
pneumonia.
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Introduction: According to published epidemiological data, critical 
care is needed by 5% of COVID-19 patients [1]. An impressive effort 
from ICU teams allowed to multiply their capacity by two or three-fold, 
trying to cover the continuous need [2,3].
Objectives: To report ICU admissions related to COVID-19 at a polyva-
lent ICU of a second-level hospital, with eight beds available in sum-
mer, and 10 in winter (0.47-0,59 ICU beds/10,000 inhabitants).
Methods: Retrospective study of ICU patients (>18  years old) with 
nasal/throat swabs or bronchial aspirate positive for SARS-CoV-2 
by PCR, between March 5th  and May 7th, 2020. Patients transferred 
to other centres and those still in ICU were excluded. The local IRB 
approved the study. Patients were treated according to current 
national protocols. After analysis of clinical characteristics, we per-
formed a multivariate analysis to check the causes and associated fac-
tors of ICU mortality. Statistical analyses performed using SPSS 20.0.
Results: 75 patients presented a positive PCR; 49 finally included. 
Median age 65 years (IQR: 59-72); 65.3% men. 61.2% came from hos-
pital ward. 93.9% presented on admission respiratory failure due to 
pneumonia. 73.5% suffered from some comorbidity (44.9% cardio-
vascular, 42.9% endocrine, 12.2% malignancy, 10.2% respiratory, 6.1% 
chronic liver disease, 6.1% neurologic and 4.1% chronic renal disease). 
Table 1 shows relevant clinical data. Median ICU length-of-stay 12 days 
(IQR 9-19.5). Survival upon ICU discharge was 77.1%.
Regarding multivariate analysis, no statistically significant association 
was noted between mortality and comorbidities (p=0.126) except 
cardiovascular comorbidity (OR 4.8, CI95%: 1.2-26.4; p=0.028) when 
performing a multivariate backward stepwise regression model. Albeit 
no organic failure (OF) presented individual association with mortality, 
we did find an association with the number: a threshold value of 4 OF 
was associated with ICU mortality (p<0.001). We also observed a statis-
tical trend between mortality and number of days on MV: 19.88 days 
in non-survivors vs 14 among survivors (p=0.056). Finally, we did not 
find any relationship between severity scores (SAPS3, Clinical Frailty 
Scale, SOFA on admission) and mortality.
Table 1. Relevant clinical data
Variable All adults (N=49)
Organ failure (number, 
percentage) 
Cardiovascular 40 (81.6) 
Respiratory failure 45 (91.8) 
Kidney failure 22 (44.9) 
Hepatic failure 8 (16.3) 
Hematologic 10 (20.4) 
Neurological 12 (24.5) 




Invasive MV 44 (89.8) 
ARDS diagnosis 43 (87.8) 
Need for reintubation 4 (8.2) 
Days on MV (median, IQR) 11 (9.3-19.8) 
Percutaneous tracheostomy 2 (4.1)
Prone positioning 25 (51) 
Neuromuscular blockade 36 (73.5)  
Conclusion: In our cohort, mortality was significantly associated with 
cardiovascular comorbidities (OR 4.8) and a higher number of asso-
ciated organ failures. The present study tries to highlight the impor-
tance of  inclusive strategy based on multidisciplinary collaboration 
and maintenance of well-established protocols despite adversities [4].
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Introduction: Responsible for 5.9% of all UK critical care admis-
sions  (M Woodhead, 2006), community acquired pneumonia (CAP) is 
a common cause of critical care admission. Antibiotics are vital in the 
treatment of CAP but their use is associated with morbidity such as 
colitis, infection with resistant organisms and kidney injury. The use 
of investigations to identify a causative organism may facilitate better 
antibiotic stewardship (I Johnson, 2017).
The 2009 British Thoracic Society (BTS) guideline recommends that 
patients admitted to critical care with severe CAP should have blood 
cultures, sputum or other respiratory samples for microscopy, culture 
and sensitivity (MC&S), urine pneumococcal and legionella antigen 
testing performed(Lim WS, 2009).
In this audit cycle, on finding adherence to BTS guidelines at our insti-
tution to be low, we used a simple aide-memoire for nursing staff and 
doctors requesting investigations for patients with CAP and dem-
onstrated improved adherence with an increase in identification of 
causative pathogens in severe CAP. Our intervention was simple, inex-
pensive and resulted in significant improvement in the investigation 
of severe CAP, adherence to guidelines and more precise microbiologi-
cal diagnosis in patients with severe pneumonia.
Methods: 20 consecutive adult patients with a diagnosis of CAP 
admitted to a London ICU December 2018 - February 2019 were 
identified. We excluded patients <18  years and those with hospital 
acquired pneumonia. Using the electronic patient record (EPR), we 
noted investigations performed and results.
On discussion with nurses and junior doctors responsible for order-
ing investigations, it became clear that while an ‘atypical screen’ was 
commonly requested, there was poor understanding of what tests 
were then required. We made a laminated card listing required inves-
tigations for patients with severe CAP and attached this at eye line to 
computer monitors where tests are requested on the unit to serve as 
a visual prompt to staff requesting investigations. We listed investiga-
tions as they appear on our electronic requesting system to ensure 
that the correct search terms were used.
The following winter, the audit was repeated to re-assess compliance 
with guidelines.
Results: There was improvement in testing across all investigations. 
There was significant increase in legionella and pneumococcal antigen 
testing, respiratory virus PCR, blood cultures and mycoplasma DNA. 
The proportion fully investigated as per BTS guidelines rose by 40% 
(11.5930%  to  61.3271% P=0.006). The commonest missing test was 
sputum culture. The percentage of patients with a causative organism 
identified for their CAP rose by 30% (-0.1759% to 53.6369% p=0.05)
Conclusion: CAP is a common cause of admission to intensive care. If 
investigated thoroughly, most patients will have an underlying organ-
ism identified, allowing for a narrower spectrum of antibiotic, which 
should not be forgotten in the context of COVID19.
Simple aide memoirs can bring clarity to poorly understood terms 
such as ‘Atypical screen’.
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Introduction: Circulating antibody-producing B cells secrete anti-
body following context-dependent stimulation by pathogen antigens. 
Secreted antibody from lymphocytes harvested and ex vivo cultured 
from patients with infection (antibodies-in-lymphocyte supernatant, 
ALS, assay) could be used as a diagnostic test that, unlike conventional 
serology, removes the requirement for convalescent sampling.
Objectives: We compared the diagnostic accuracy of ALS assay with 
standard molecular tests for respiratory syncytial virus (RSV), globally 
the most prevalent cause of childhood pneumonia.
Methods: We enrolled children admitted to Patan Hospital, Nepal, 
with a clinical diagnosis of pneumonia from October 2016 to June 
2017. Peripheral blood mononuclear cells (PBMCs) were separated 
from whole blood and cultured for 48 h using standard methods. We 
used a IgG ELISA to RSV F protein (Fitzgerald) to calculate antibody 
concentrations in ALS. We compared ALS to RSV F protein to the 
results of the NxTAG Luminex Respiratory Pathogen Multiplex PCR 
panel (Luminex Corp, USA) on nasopharyngeal (NP) swab specimens 
from the same patients.
Results: Of 280 children admitted to hospital, 83 (30%) had primary 
endpoint pneumonia on chest radiographs (PEP). RSV was detected 
from NP specimens by PCR in 29/280 (10%) children, of whom 5/29 
(17%) had PEP. Blood samples were taken a median of 4 days following 
onset of symptoms. There were significantly decreased concentrations 
of IgG to RSV in ALS samples from patients in whom RSV was detected 
in comparison with others (Figure 1).
Conclusion: Children with RSV pneumonia (by PCR of NP specimens) 
had lower ALS to RSV F protein than children with other pneumonia 
etiologies. This result supports the lack of protective humoral immu-
nity induced by either RSV infection, or previous RSV vaccines.
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Introduction: The Coronavirus disease 2019 (COVID-19) pandemic, 
caused by the Severe Acute Respiratory Syndrome Coronavirus 2 
(SARS-CoV-2), led in spring 2020 to a worldwide crisis. In the majority 
there is a mild course, however in up to respectively 20% and 5% there 
is a severe  and even critical presentation. Initial reports from China 
and Italy showed poor outcome for patients admitted to Intensive 
Care Unit (ICU), particularly for the elderly. We focused in our analysis 
on the outcome of younger patients admitted to ICU.
Methods: In this retrospective, single-center cohort study, we assessed 
clinical outcome of younger patients by comparing those aged below 
66 years with those aged 66 years and above. We further divided the 
former group in 2 cohorts, namely patients with (young+RF (risk fac-
tor)) and without (young-RF) any comorbidity including obesity (BMI > 
30). Between March 13 and May 15, patients admitted with confirmed 
COVID-19 to ICU were consecutively screened. Exclusion criteria were 
COVID-19 cases without respiratory failure and  Do Not Resuscitate 
(DNR) order at admission. Primary outcome was mortality, secondary 
outcome were need for mechanical ventilation (MV), duration of MV, 
proportion successfully weaned off ventilator, length of ICU stay (ICU-
LOS), incidence of associated organ failure and  rate of recovery. The 
latter was assessed at day 10, 14, 21 and 28 by using an ordinal clini-
cal scale: 1. no hospitalization; 2. at hospital; 3. at ICU; 4. ICU with high 
flow oxygen therapy (HFOT) or non-invasive ventilation (NIV); 5. MV; 6. 
dead. Mann-Whitney U, χ2 or Fisher’s exact tests were used as appro-
priate and analyses were performed using SPSS.
Results: Of the 61 patients screened, 55 were eligible (6 patients 
excluded: 5 with DNR-code, 1 patient who didn’t suffer from respira-
tory failure). Median age overall was 66  years (IQR 57-78) and males 
(M) were predominant, especially in the younger group (overall 
65% M, young 80% M vs old 53% M, p=0.038). The younger cohort 
accounted for 45% (n=25),  one-third of them had no comorbidities 
at all  (n=9/55, 16%). Most frequently reported concomitant pathol-
ogy was obesity (overall 27%, median BMI 27.5; young 32% vs old 
23%, p=0.303), hypertension (overall 49%, young 40% vs old 57%, 
p=0.218), cardiovascular disease (overall 33%, young 16% vs old 
47%, p=0.0.016) and  diabetes (overall 29%, young 12% vs old 43%, 
p =0.11). There was a significantly higher incidence of obesity and 
hypertension in the young+RF cohort (50%, p=0.0088 and  63%, 
p=0.003) compared to the young-RF cohort.
Overall ICU  mortality was 32%. Even though the fatality rate for 
younger people was lower (young 22% vs old 40%, p=0.158), this 
was not statistically significant due to high mortality in the young+RF 
group (36% for young+RF vs 40% old, p=0.786), while none of 
the young-RF group died (vs 36% for young+RF, p=0.0465). More 
than half of the patients (n=31/55, 56%) required MV, without sig-
nificant differences between young and older patients (52% vs 60%, 
p=0.551), although only 11% (n=1/9) of the young-RF group ended 
up with MV versus three-quarters of the young+RF group (p= 0.002). 
Prone ventilation was applicated in 16 cases (n= 16/31,  52%). Forty-
five percent of the  ventilated patients were successfully weaned off 
the ventilator (46%  young vs 44% old, p NS; 100% young-RF vs  42% 
young+RF, p=0.154). Duration of MV for survivors was shorter for the 
younger vs the elderly (11.73 vs 18.76 days, p=0.66) and for younger-
RF vs younger+RF (8.38 vs 15.07 days), but none of these differences 
were significant.  ICU-LOS  didn’t differ among the different cohorts 
with a median duration of 10  days overall (young 11.5 vs old 9, 
p=0.59; young-RF 9 vs young+RF 13, p 0.26). Incidence of severe asso-
ciated organ failure was slightly lower in the younger population (24% 
vs old 33%, p=0.448), with kidneys as most vulnerable organ. None 
of the young-RF patients experienced any severe associated organ 
failure while young+RF patients had even higher incidence of such 
an extrapulmonary manifestation than the elderly (38% vs 33%, 
p=0.777). Younger people tended to recover faster than the elderly, 
particularly the  young-RF group  outperformed the other cohorts 
with significantly higher proportions of patients clinically improving 
on the ordinal clinical scale  by 1 point as evaluated at day 10 (89%, 
p=0.06),  14  (89%, p=0.013)  and 21(100%, p=0.005) as well as by 2 
points at day 28 (100%, p=0.01).
Conclusion: This study demonstrates that younger people can be 
severely hit by COVID-19 as well. Only those without any comorbidities 
at all have better clinical outcome in terms of mortality, MV require-
ment,  associated organ failure and rate of recovery. As functional 
outcome after surviving remains unclear, caution and prevention 
remain mandatory for patients in all age groups, irrespective of their 
comorbidity.
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Introduction: Coronavirus disease 2019 (COVID-19) was first reported 
in Wuhan, China in December 2019. Many studies have since focused 
on identifying parameters by which to risk stratify patients. Elevated 
d-dimer levels have been reported in up to 46% of patients (1), with 
higher levels noted in patients requiring intensive care unit (ICU) 
admission (2). A recent systematic review including six retrospective 
cohort studies conducted in China, found raised admission d-dimer 
levels are significantly associated with increased mortality in COVID-
19 (3). Given patients present at different time points in their ill-
ness, measuring d-dimer at admission may not accurately represent 
the potential severity of infection. We therefore sought to evaluate 
whether this association was maintained in a United Kingdom patient 
cohort when maximal d-dimer was measured.
Objectives: The aim of this study was to investigate the association 
between maximum d-dimer and both ITU admission and mortality in 
patients with COVID-19.
Methods: This retrospective single-centre study included patients pre-
senting to West Middlesex University Hospital (London, United King-
dom) with a laboratory confirmed diagnosis of COVID-19. We selected 
a sample of 150 consecutive survivor and non-survivors. Patients in 
which no d-dimer sample was taken were excluded, giving a total 
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sample analysed of 99 survivors and 118 non-survivors.  In all cases, 
electronic medical records were used to obtain the highest d-dimer 
value during admission, survivor status, and whether  ITU admission 
occurred. Median and mean d-dimer values were calculated, and con-
fidence intervals (CI) used to assess statistical significance.
Results: D-dimers were elevated in 74.7% of survivors and 94.9% of 
non-survivors with mean d-dimers of 2683  µg/mL (Standard devia-
tion [SD] 4350, CI 857) and 3588 µg/mL (SD 3790, CI 683) respectively, 
and median d-dimers 1070  µg/mL  and 2200  µg/mL  respectively. In 
patient admitted to ITU the mean and median d-dimer was 5597 µg/
mL (SD 5272, CI 1654) and 3377 µg/mL respectively. In patients with 
ward-based care the mean d-dimer was  2635  µg/mL and median 
d-dimer 1600 µg/mL (SD 3184, CI 456). No differences were statistically 
significant (p<0.05).
Conclusion: This study supports previous studies in China showing 
d-dimer levels are commonly raised in COVID-19 positive patients (1, 
4, 5). However, in contrast, we found no significant difference between 
d-dimers in survivors and non-survivors. Similarly, we found patients 
admitted to ITU had higher d-dimers than ward-based patients sup-
porting the findings of Wang et al. (2) but this was not statistically sig-
nificant. This may reflect differences in the studied patient populations, 
or more likely could be attributable to the different approach adopted 
in this study of measuring maximal  rather than admission d-dimer. 
Overall, these findings suggest parameters other than d-dimer may be 
more useful clinically in risk stratifying COVID-19 patients and predict-
ing need for ITU admission or mortality.
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Introduction: Acute kidney injury (AKI) is a frequent complication 
seen in patients with COVID-19 infection admitted to intensive care. 
National UK data indicates 26% of patients admitted to critical care 
with COVID-19 infection require renal replacement therapy (RRT), 
61% of whom died (1). This has significant implications for resource 
utilisation. Better understanding of this disease and requirement for 
renal support will not only help plan local services but may also give 
insights into improved treatment and preventative strategies.
Objectives: We aimed to assess the incidence of AKI and need for RRT 
in critically ill patients with COVID-19 in a single large UK tertiary cen-
tre. The association between need for RRT and the presence of several 
co-morbidities as well as overall mortality was also examined. These 
local findings were also compared with national data.
Methods: Contemporaneous electronic medical records were ret-
rospectively reviewed for all patients admitted to ICU for 10  weeks 
from March 2020 in a single large UK tertiary centre. Data extracted 
included demographics, co-morbidities, fluid balance, creatinine, 
eGFR, RRT, APACHE II score and outcome. AKI was defined as per the 
KDIGO criteria (2) and renal recovery defined as free from RRT for over 
48 hrs.
Results: A total of 93 patients with COVID-19 were admitted to ICU 
during this period. The median age was 62 and 28 (30%) were female. 
51 (56%) developed AKI and RRT was provided in 33 (36%). The overall 
ICU mortality was 35%, excluding 2 patients who remained in ICU at 
the time of reporting. Factors associated with the development of AKI 
are shown in Table 1. Multiple regression analysis retained APACHE II 
and requirement for mechanical ventilation as significant associations 
with the development of AKI (Table 2), with similar results for require-
ment for RRT.
AKI (51) No AKI (42) P value
Median age 
(range) 64 (17-82) 57 (28-77) 0.05 
Female sex (n/%) 14 (27%) 14 (33%) 0.53 
Hypertension 19 (37%) 14 (33%) 0.69 
Diabetes 10 (20%) 10 (24%) 0.62 
Obesity (BMI >30) 21 (41%) 15 (36%) 0.59 
Chronic Kidney 








17 (14-19) 12 (9-16) <0.0001 
Diuretic use in 
ICU 36 (72%) 29 (69%) 0.76 
Total Furosemide 
dose (mg) (median, 
IQR)
165 (60-260) 260 (89-510) 0.65 
Mechanical 
ventilation 48 (94%) 30 (73%) 0.005 
Median (IQR) ICU 
Length of stay 19 (9-29) 15 (7-24) 0.03 
ICU Survival 25 (50%) 34 (83%) 0.001 
Table 1 : Clinical and demographic factors associated with AKI 
Table 2 : Binary logistic regression for Independent association with the
development of AKI
Odds ratio (95% CI) P value
Age (per year increase) 1.0 (0.9-1.03) 0.45 
CKD (presence) 2.7 (0.4-19.2) 0.32 
APACHE II (per 1 
point increase) 1.2 (1.1-1.4) 0.002 
Mechanical ventilation 11.2 (1.6-80.7) 0.016 
Conclusion: COVID-19 patients in our cohort experienced a high 
rate of AKI and need for RRT, although rates were in keeping with 
those seen in other causes of acute respiratory distress syndrome (3). 
Although AKI was associated with a higher risk of death, this is mostly 
explained by the severity of presenting illness. We found no evidence 
that diuretic therapy was independently associated with the develop-
ment of AKI or need for RRT.
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Introduction: Studying the characteristics of infections acquired 
within the ICU during the last 5 years.
Methods: Descriptive study, based on the data collected in the ENVIN 
- ICU base of our medical-surgical unit, collected during the months of 
the official participation period. To do this, we have selected infections 
acquired within the ICU from 2015 to 2019. We will describe the loca-
tion of the infection, the most frequently isolated microorganisms, the 
number of infections that received antibiotic treatment, appropriate 
antibiotic treatment
Results: During the official ENVIN-ICU registration periods from 2015 
to 2019, there are 132 records of infections acquired intra ICU. Of these 
132, the most frequent locations in decreasing order are: pneumonia 
related to mechanical ventilation or intubation (27), tracheobronchitis 
associated with mechanical ventilation (21), bacteremia of unknown 
focus (18), non-surgical infection of the digestive system (10), bacte-
remia secondary to abdominal infection (9), bacteremia secondary to 
catheter infection (9), bacteremia secondary to respiratory infection 
(8), urinary tract-related urinary infection (6), other infection (6). The 
most frequently isolated microorganisms in these records of intra-ICU 
infection are: pseudomona aeruginosa 13.74% (n = 18), enterococcus 
faecium 12.21% (n = 16), klebsiella pneumoniae 9.16% (n = 12), staph-
ylococcus epidermidis 8.40% (n = 11), stenotrophomonas maltophilia 
5.34% (n = 7), escherichia coli 5.34% (n = 7). Of the 132 registered 
intra-ICU infections, 87.88% (n = 116) received antibiotic treatment. Of 
those treated with antibiotherapy (n = 116), 79.17% (n = 24) of pneu-
monias associated with mechanical ventilation received the appropri-
ate antibiotic treatment, 100% (n = 5) of urinary tract-related urinary 
tract infections, 71.43% (n = 21) of bacteremia primary and secondary 
to catheter infection, 75% (n = 20) of bacteremia secondary to infec-
tion of another focus, and 78.26% (n = 46) of those classified as other 
intra-ICU infections.
Conclusion: In the period 2015-2019 of ENVIN-ICU registration in our 
unit, the most frequent intra-ICU infections acquired were pneumo-
nia and tracheobronchitis associated with mechanical ventilation and 
bacteremia of unknown focus. The most frequently isolated microor-
ganisms are pseudomonas aeruginosa, enterococcus faecium, and 
klebsiella pneumoniae. Receiving antibiotic treatment in 87.88% of 
these infections, being correct in a very high percentage.
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Introduction: During the CoVID-19 pandemic, healthcare profession-
als are taking the risk of becoming infected or infecting their families. 
Spain is the country with the highest number of infected healthcare 
professionals worldwide.
Objectives: Our aim was to study the attitudes and beliefs of these 
professionals during the current pandemic.
Methods: Descriptive study conducted by using an online question-
naire – based on an earlier one – which was sent to healthcare profes-
sionals at the national level, during the week March 20-27, 2020.
Results: Healthcare professionals returned 971 completed question-
naires. A total of 803 (82.7%) participants thought that they did not 
have suitable PPEs to protect them from infection with CoVID-19. 
In spite of this, 606 (62.4%) of them were ready to work, even with a 
higher-than-usual risk of becoming infected at work and getting ill. 
Furthermore, 815 (83.93%) participants were ready to work more 
hours than usual and 697 (71.78%) were ready to work in a different 
workplace. Finally, 669 (68.9%) of them put their duties towards their 
families before their responsibility at work.
Conclusion: Remarkably high professional commitment has been 
observed among Spanish healthcare workers in the current pandemic. 
They were ready to work even when many of them considered that 
they did not have suitable PPEs, and were thus taking a higher than 
usual infection risk. However, they put the health of their relatives 
before their duties at work.
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Introduction: Veno-Venous Extra Corporeal Membrane Oxygenation 
(VV-ECMO) requires central access with either bifemoral cannulae (FF), 
a bicaval dual lumen cannula in the internal jugular vein (JJ) or femoral 
access with jugular return (FJ) (1). Bacteraemia secondary to cannula 
site infection in patients supported by VV-ECMO poses an increased 
risk in this group. Currently there is little published work on ECMO can-
nula site infections however, evidence based on central venous cath-
eter infections is considered to be, in part, transferable.
The relevance of the site of central venous catheters to incidence of 
bacteraemia in critically unwell patients is controversial. Some stud-
ies suggest that the femoral site poses a higher risk of catheter infec-
tion (2) whilst others suggest there is no significantly increased risk 
in using the femoral vein compared to the jugular vein (3). Work on 
central lines for dialysis may be more valid than other types of central 
access as dialysis lines are not used for drug delivery, whilst also being 
exposed to a continuous flow (4).
Objectives: To assess whether the incidence of bacteraemia in 
patients cannulated for VV-ECMO varies based on cannulation site.
Methods: Data was collected for patients admitted to the Intensive 
Care Unit at Aberdeen Royal Infirmary, a centre for VV-ECMO, between 
February 2014-February 2020. We carried out a retrospective audit of 
the cannulation site in each patient and the number that developed 
a bacteraemia. Bacteraemia was defined as a positive blood culture 
result in the time period between cannulation date up until 48 hours 
after decannulation (2,4). Data on duration of cannulation, cannula-
tion to bacteraemia time and location of patient at time of cannulation 
was also collected.
Results: Sixty patients were identified. Of these, 35 had a bicaval dual 
lumen cannula in the internal jugular vein, 24 had bifemoral cannula-
tion and 1 patient had femoral access with jugular return. Ten bacte-
raemias were identified overall. A larger proportion of patients with 
bifemoral cannulation developed bacteraemias and mean time to 
infection in these patients was shorter. Sixty percent of the bacterae-
mias identified were due to a staphylococcal organism.
Conclusion: Our results suggest that VV-ECMO patients with femoral 
cannulae placed are more at risk of bacteraemia. This is in keeping 
with previous work on central venous catheter infections showing 
that femoral lines increased infection risk despite a shorter duration of 
insertion2.
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One patient developed two separate bacteraemias, one of which was 
caused by Streptococcus mitis, an organism found in the oropharynx 
and therefore a bacteraemia which is unlikely to have originated from 
the ECMO cannulae. This highlights the difficulty in discerning if a 
bacteraemia is truly secondary to ECMO cannulation, especially in the 
absence of line tip culture.
The impact of ECMO cannula related bacteraemia on mortality can-
not be accurately assessed. Whilst it is important to consider infection 
risk when selecting cannulation insertion site, other factors will affect 
decision making such as ease of transfer, risk of thrombosis, risk of 
mechanical complications at time of insertion, ease of proning and the 
patient’s Body Mass Index.
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Introduction: There is scare information of bacterial and/or fungal 
infections (coinfections or superinfections) in critical ill patients with 
COVID-19 pneumonia.
Objectives: The objetive of the study is evaluate bacterial and/or 
fungal infections in respiratory viral infections and discuss antibiotic 
empirical management.
Methods: This is a multicentre, observational and retrospective study. 
Patients with confirmed COVID-19 and other respiratory virus infec-
tion which required ICU admission were recruited from October 2018 
to April 30th 2020. We described the population and distribution of 
infections.
Results: We evaluated 112 critical patients with respiratory virus infec-
tions. 58 critical care patients with COVI-19 and a further 54 patients 
with other respiratory infections. COVID-19 patients had significantly 
less respiratory co-infection (3 vs 29; p˂0.001). 96% of patients were 
treated with antibiotics at admission. In comparison with those with 
other respiratory infection, superinfection was not significantly higher 
(46 vs 31; p=0.1). Probable/possible ventilator associated pneumonia 
was the most frequent source of infection (29%) in COVID-19 patients 
while in other respiratory virus infection were bacteriamia and urintary 
tract infection (25%). In COVID-19 patients the most frequent bacteria 
involved was Pseudomonas aeruginosa (24%) while the most frequent 
in other respiratory virus were Coagulase-negative Staphilococcus 
(29%)
Conclusion: In COVID-19 patients the incidence of coinfection is low 
(3%). Because of this fact, empirical antibiotic at admission should be 
closely evaluated. In this group, the incidence of superifection was 
46%; ventilator associated pneumonia and pseudomonas aureginosa 
were the most frecuent source and etiology.
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Introduction: When the Coronavirus Disease 19 (COVID-19) pandemic 
emerged in spring 2020, there was no effective treatment available. In 
a recent randomized clinical trial dexamethasone (DXM), a pure glu-
cocorticoid agonist, was shown to have a beneficial impact on out-
come of patients with Acute Respiratory Distress Syndrome (ARDS). 
As severe COVID-19 is characterized by an excessive systemic inflam-
mation, we gradually implemented DXM in our therapeutic strategy, 
although initial guidelines didn’t support systematic use of steroids, 
based on former data with viral infections and ARDS. This study evalu-
ates the impact of DXM on the outcome of  patients with COVID-19 
admitted to our Intensive Care Unit (ICU).
Methods: In this retrospective, single-center cohort study, we con-
secutively screened all confirmed COVID-19 patients admitted to ICU 
between March 13 and May 15 and compared patients who received 
DXM (DXM group) to those who didn’t (no-DXM group). Exclusion 
criteria were length of ICU stay less than or equal to 5 days, COVID-
19 positive case without respiratory failure and  Do Not Resuscitate 
(DNR)  order at admission. Subgroups we analyzed were mechani-
cally ventilated patients and patients getting DXM prior to initiation 
of mechanical ventilation (MV). Primary outcome was mortality, sec-
ondary outcomes were need for MV, duration of MV, proportion suc-
cessfully weaned off ventilator, ICU-length of stay (ICU-LOS), rate of 
recovery, incidence of associated organ failure and incidence of infec-
tions. Rate of recovery was assessed at day 10, 14, 21 and 28 by using 
an ordinal clinical scale: 1. nohospitalization; 2. at hospital; 3. at ICU; 4. 
ICU with high flow oxygen therapy (HFOT) or non-invasive ventilation 
(NIV); 5. MV; 6. dead. Mann-Whitney U, χ2 or Fisher’s exact tests were 
used as appropriate and analyses were performed using SPSS.
Results: Of the 61 patients screened, 47 were eligible (14 patients 
excluded: 8 with ICU-LOS ≤ 5 days, 5 with DNR-code, 1 patient who 
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didn’t suffer from respiratory failure). Eighteen cases (38%) received 
dexamethasone, 6 of them before intubation. Baseline characteris-
tics and severity of disease scores (APACHE II, SAPS II and worst SOFA 
score day 1 to 5) were similar in both groups. Median age was 67 years 
(IQR 57-78) overall, patients in the DXM group tended to be younger 
(63, IQR 54-71) than those in the no-DXM group (70, 62-78), although 
statistically not significant (p=0.203). Up to two-thirds were male 
(DXM 72% vs no-DXM 62%, p=0.475). Nearly all our patients received 
hydroxychloroquine, frequently in combination with azithromycin. 
Rarely tocilizumab (DXM 17%, no-DXM 3%, p= 0.54) or remdesivir 
(only one patient, in the DXM group) was associated.
Overall ICU mortality was 31% (DXM 33% vs no-DXM 28%, p=0.67). Up 
to almost three quarters of the DXM group were ventilated, compared 
to 55% of the no-DXM group (p=0.96). This higher proportion is rather 
due to selection bias than caused by DXM, as the drug was frequently 
started after initiation of MV. In both groups, a similar proportion of 
patients has been successfully weaned off the ventilator (DXM 54% 
vs no-DXM 56%, p=0.87). MV duration (26.2 (IQR 18.9-32.1) vs 10.0 
days (IQR 7.5-18.6, p=0.05)) and ICU-LOS (21 (IQR 14-40) vs 9 days 
(IQR 8-14), p=0.019) were both significantly longer in the DXM group. 
Proportion of patients clinically improving as assessed by an ordinal 
scale at several points in time was lower in the DXM group compared 
to those of the no-DXM group, although not statistically signifi-
cant. Moreover, incidence of severe associated organ failure in the 
DXM group was twice as high as in the no-DXM group (44% vs 21%, 
p=0.75) with kidneys as the most affected extrapulmonary organs, 
with respectively up to 40% and 10% requiring Renal Replacement 
Therapy (p=0.75). There were more nosocomial infections reported in 
the DXM-group than in the no-DXM group (56% vs 17%, p=0.04).
Similar findings were observed in the MV-subgroup (total of 29 
patients with 13 getting DXM) with comparable mortality (46% vs 
44%, p=0.581) for both groups but longer duration of MV (26.2 vs 
10.0 days, p=0.05), trend to longer ICU-LOS (40 vs 26 days, p=0.11) 
and slower recovery (8% clinically improved with 2 points at day 28 
for DXM vs 56% for no-DXM patients, p=0.006) in the DXM group. Inci-
dence of severe associated organ failure (62% vs 38%, p=0.198) and 
nosocomial infections (69% vs 25%, p=0.017) was higher as well in 
this group.
Finally, 5 out of 6  patients (83%) getting DXM prior to intubation 
responded well, while only one patient further deteriorated ending up 
on the ventilator and deceased eventually.
Conclusion: On the one hand,  we couldn’t demonstrate a beneficial 
impact of DXM on the outcome of patients for COVID-19 with even a 
higher incidence of ICU-acquired infections in the DXM group. On the 
other hand, the vast majority of patients getting the drug prior to intu-
bation didn’t further deteriorate suggesting a possible positive effect 
of prompter administration. Due to the small size and the study design 
with a presumably sicker DXM cohort, it is difficult to draw any firm 
conclusions. Further research is warranted to establish the role and the 
perfect timing of administration of DXM to treat COVID-19.
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Introduction: Web-based distance-learning is increasingly used dur-
ing the COVID-19 pandemic. OxPal is a pre-established medical educa-
tion partnership between University of Oxford medical students and 
their counterparts in Palestine. Our work has shown online learning to 
be feasible and effective for knowledge sharing to the occupied Pales-
tinian territories (oPt)1. In response to the COVID-19 pandemic, OxPal 
rapidly organised and conducted a lecture on the virology and epide-
miology of COVID-19. In feedback, the most common request was for 
further teaching on COVID-19 management (13/36 requests), which 
was supported by focus group discussion. Conducting teaching inter-
nationally raises unique challenges in understanding and responding 
rapidly to local needs.
Objectives: We seek to evaluate the feasibility and efficacy of interac-
tive, real-time online tutorials on the management of COVID-19 as a 
method for knowledge sharing to the oPT during the pandemic.
Methods: Our established network was used to advertise tutorials to 
medical students and clinicians in the oPt (>800 unique emails and 
2 social media platforms). Tutorials were conducted by a critical care 
consultant via Zoom. A systematic approach to management of severe 
COVID-19 was provided. The lecturer’s local guidance was shared and 
its evidence base discussed. Feedback was elicited via an online sur-
vey. The primary outcomes were attendance and learner-reported 
change in confidence in COVID-19 management. As of June 2020, 3 
such sessions have been conducted and placed on Youtube2.
Results: Primary outcome data is shown in Table  1. Feedback came 
from students at all medical schools in the oPT, from levels spanning 
Year 4 Medical Student to Resident doctor.
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When asked to rate tutorial quality on a 1-5 scale, 7/8 respondents for 
Lecture 1 rated tutorial quality as 4 (Good); for Lecture 2 4/9 respond-
ents rated the tutorial quality as 4 (Good) and 2 rated it as 5 (Excellent). 
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7/8 and 7/9 described the difficulty of Lectures 1 and 2 respectively as 
‘3- About right’ on a 1-5 scale.
Conclusion: Online distance-learning is feasible and effective for 
knowledge sharing to the oPt during the COVID-19 pandemic. We saw 
a drop in attendance over 3 sessions. This could be due to a reduction 
in new cases in the oPt in that time (May to mid-June 2020)3, reducing 
perceived need. There were also medical school examinations in June. 
Therefore, lecture plans must be made in response to immediate need 
and be systematically adaptable as the target population’s situation 
changes.
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Introduction: Throughout 2016 to 2018 our centre enrolled in a 
national programme that aimed to study the good practices in infec-
tious diseases prevention and to implement a national bundle. This 
project was conducted due to Portugal’s high rates of nosocomial 
infections, reaching almost twice the European numbers in 2013, with 
substantially high expenses on health [1].
Methods: Two different types of infections were studied in our inten-
sive care unit (ICU): central venous-catheter (CVC) related bacteremia 
and intubation-associated pneumonia. Collaborative Breakthrough 
was implemented and results were analysed.
Results: Our ICU represents 2,2% of the national patients studied (in 
19 hospitals), with an average age difference of 3 years older than the 
national mean. Despite a high variability, the mean duration period 
in the ICU was similar to the other hospitals studied, with an aver-
age 10,6 days stay. Our mortality was slightly higher than the studied 
(18% mortality), but with no high variability throughout the years ana-
lysed, in oppose to our higher SAPS II scores values, that averaged 49, 
in comparison with a national SAPS II score mean of 44. Our patients 
mostly diverged on the necessity for antibiotics, with only 16% need, 
compared with 51% nationally. Also showing smaller values were the 
need for intubation (58 vs 75%) and the average intubation period (5,7 
vs 6,6 days).
The results of the infectious outcomes were consistent and improving 
throughout the years [2]. Both CVC placement and intubation num-
bers per patient were lower in our ICU than expected. In 2015 there 
were 0,7 blood infections per 1000 days of CVC, with a reduction to 
0,6 in 2019, one year after the national program (representing a 14% 
reduction). Nationally there was a significant reduction of 23%, but 
rarely reaching values lower than one blood infections per 1000 days 
of central venous access. On the other hand, the number of intuba-
tion-associated pneumonia reported was reduced by 68% in our ICU 
for the past 10 years, in comparison to a 30% national reduction, with 
only 1% of patients admitted to our ICU in 2019 suffering intubation-
associated pneumonia.
Conclusion: Hospital-acquired infections are a significant health issue 
[3]. Several guidelines and protocols have been implemented world-
wide, aiming for its reductions. A lot has been accomplished the past 
decade, but there is still a lot that can be done, as this national pro-
gram has come to show us.
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Introduction: The pandemic caused by SARS-CoV-2 is an epidemio-
logical emergency that has led to the rapid search for effective treat-
ments to reduce the complications and improve the survival rate of 
the population affected by this virus.
One of the main complications that can result from SARS-CoV-2 is the 
cytokine storm or hypercytokinemia: a syndrome characterised by the 
elevation of inflammatory markers, such as D-dimer, interleukin-6, fer-
ritin and C-reactive protein, which, in addition, leads to clinical and 
radiological deterioration. In light of this inflammatory response, some 
therapies have been considered, such as corticosteroids in high doses 
or monoclonal antibodies like Tocilizumab (anti-IL-6) or Bevacizumab 
(anti-IL-2).
Although scientific associations have not endorsed the use of immu-
noglobulins as immunomodulators, this therapy could be considered 
for those patients with refractory acute respiratory distress syndrome 
(ARDS) and contraindications to previous treatments (due to sus-
pected superinfection, among other causes).
Objectives: To describe our experience in the use of immunoglobulins 
in CoVid-19 patients with refractory ARDS with inflammatory response 
criteria and contraindications to the immunomodulatory therapy.
To describe radiological evolution, changes in the inflammatory 
markers, mortality and complications after the administration of 
immunoglobulins.
Methods: Retrospective, descriptive, observational study conducted 
in the Intensive Care Unit of the Hospital Universitario Reina Sofía in 
Córdoba, Spain.
Epidemiological variables, complications, mortality, radiological con-
trols and inflammatory markers (interleukin-6, D-dimer, ferritin, C-reac-
tive protein, lymphocytes) were collected in three different stages: 
immediately before, during and after administering a course of immu-
noglobulins in doses of 2 g per kg of the patient’s body weight over a 
period of 3 to 6 days.
At the time of writing, some of the patients involved are still in the 
Intensive Care Unit.
Results: Of the total number of patients admitted to our ICU due to 
CoVid-19 (n=41), 8 received treatment with immunoglobulins. 3 of the 
patients were women; one of them died. One of the patients is still in 
ICU and the rest were discharged. The average age was 59.8 years old.
The time elapsed between the admission to the ICU and the initial 
treatment with immunoglobulins ranges from 3 to 8 days.
After analysing the data, we noticed the average of all inflammation 
reactants had decreased, while lymphocytes had increased after the 
immunoglobulins treatment:
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Before During After 
C-reactive protein 257 151 85 
136,31remid-D 13,604 6,293 
Interleukin-6 1,263 296 295 
842,5nitirreF 5,614 1,520 
Lymphocytosis 0.78 1.16 1.39 
(Mean values) 
There was a significant response in the decrease of the interleukin-6 
(n=7). D-dimer dropped over 50% in 3 patients. Ferritin decreased 
over 50% in 3 of the cases. One of the patients showed elevation of 
theinterleukin-6, ferritin and D-dimer, probably due to superinfection. 
The CRP also fell by half in other 3 cases. Only one patient suffered 
from thrombotic events (thrombophlebitis in inferior vena cava).
While monitoring the affected pulmonary fields in the serial chest 
x-rays, we noticed a drop in the average of affected fields: 3.12 before 
the treatment, 3.8 during and 2.5 after the treatment.
We also observed an improvement in the lymphopenia of our patients. 
However, it should be noted that in 3 of the 5 patients who developed 
an increase of absolute lymphocytes and of their white blood cell per-
centage, this was due to a general increase of the leukocytosis.
Conclusion: In cases of refractory ARDS and increase of the inflamma-
tory response in CoVid-19 patients admitted to ICU with contraindica-
tions to monoclonal antibody therapy or to corticosteroid therapy in 
high doses, we could consider administering 1 g of immunoglobulin 
per kg of the patient’s body weight for a time period between 3 and 
6 days.
Studies with a larger sample size are required to confirm the effective-
ness of immunoglobulins in this group of CoVid-19 positive patients.
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Introduction: COVID-19 has challenged our health system and our 
standard practices. Mechanically ventilated (MV) COVID-19 patients 
have long intensive care unit (ICU) stays [1] increasing their exposure 
to nosocomial infections (NI).
Objectives: In a perspective of quality improvement, we studied the 
incidence of NI and use of broad-spectrum antibiotics (BSA) in MV 
COVID-19 patients.
Methods: We collected data retrospectively for every MV COVID-19 
patient admitted to our 18- to 38-bed expanded ICU between 01.03. 
and 30.04.2020. ICU days, ventilation days (VD), catheter days (CD), use 
of BSA, fever days (> 38°C) and c-reactive protein (CRP) were recorded. 
Each suspected NI, defined by the introduction of BSA ≥ 48h after 
admission or repeated administration of BSA after an antibiotic free 
period ≥ 48h, was reviewed by an infectiologist. NI were confirmed 
using CDC criteria [2] for ventilator associated pneumonia (VAP), 
central line associated blood stream infections (CLABSI), urinary tract 
infections (UTI), or clinical evidence for septic shock (SS) and bactere-
mia (BE) from another origin.
Results: Of 54 COVID-19 patients, 37 MV patients (69%) spent a total 
of 672 ICU days, with 504 VD and 545 CD. They had fever during 26.5% 
of ICU days. Median peak CRP was 309 mg/l (IQR, 264-365) after a 
median stay of 3 days (IQR, 2-5). Among 31 suspected NI, 21 (68%) NI 
were confirmed: 4 VAP, 6 CLABSI, 1 UTI, 8 SS and 2 BE from another 
origin. The incidence of VAP and CLABSI was respectively 7.9/1000 VD 
and 11/1000 CD. Our 2019 annual incidence for VAP and CLABSI was 
3.9/1000 VD and 1.7/1000 CD. Global incidence of confirmed NI was 
31.3/1000 ICU days.
Conclusion: The incidence of confirmed VAP and CLABSI was higher 
in MV COVID-19 patients than in our standard ICU population of 2019. 
COVID-19 patients might have a greater risk of NI due to anatomical 
barrier disruption and maladaptive immune response, but other fac-
tors such as cohorting of several patients in the same room, using 
gloves for self-protection with insufficient replacement and temporary 
deviation from standardized procedures could have contributed to 
the incidence of NI. BSA were often prescribed early during ICU stay, 
reflecting physician’s anxiety facing this new disease and the difficulty 
to diagnose NI. Severe COVID-19 pneumonia induces a prolonged 
fever, high inflammatory state, diffuse lung infiltrates and protracted 
respiratory failure, which makes classical criteria for VAP less specific. In 
that setting, NI definitions should be refined to find an optimized set 
point for BSA introduction, avoiding under- and overuse.
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Introduction: COVID-19 pandemic has been a challenge for health-
care professionals. This is a virus that seemed to follow a clinical pat-
tern with an intense inflammatory response and thrombogenic load, 
for which we don’t have a specific treatment.
Objectives: Different therapeutic strategies for COVID-19 have been 
used to target the viral replication, to limit the inflammatory response 
and to avoid thrombotic complications. We describe the prescribed 
treatment of COVID-19 patients (COVp) admitted in our ICU during the 
pandemic. This treatment was based on the protocol of our center, the 
availability of drugs and the published literature at the time.
Methods: A retrospective descriptive observational analysis about 
treatment of COVp admitted in our ICU during the pandemic, from 
March 13 to May 4, 2020, along with the ICU clinical evolution of the 
same patients under these treatment guidelines.
Results: From March 13th to May 4th 2020, 48 COVp were admitted 
in our ICU: 31 males (64,6%), with an average age of 57,7 y.o. (CI 95% 
54,6-60,9) and APACHE II score 17,25 (CI 95% 15,6-18,7). The time lapse 
from the onset of symptoms until admission in ICU was 8,8 days (CI 
95% 7,6-10,1). The average white bloodcells when entering was 9,8 
x 109/L (CI 95% 8,3-11,3), PCR 169 mg/L (CI 95%141-197), D dimer 
5841 ng/ml (CI 95% 1737-9945), ferritin 1807 ng/ml (CI 95% 1726-
1888) and 37 patients (77,1%) had a lymphocyte count < 1.0 x 109/L. 
Upon admission to the ICU, all patients were treated with hydroxy-
chloroquine, 33 patients (68,8%) with azithromycin associated and 
47 patients (97,9%) with lopinavir/ritonavir. Methylprednisolone was 
administrated to 44 patients (91,7%), of which 13/44 (29,5%) 40 mg/8h 
with variable duration (discretion of the responsible physician), and 
31/44 (70,4%) 500 mg/24h for five days. Interferon beta-1b was admin-
istered to 38 patients (79,2%), tocilizumab to 10 patients (20,8%), and 
anakinra to 4 patients (8,3%). Enoxaparin was given to 44 patients 
(91,7%): 18/44 (37,5%) with antithrombotic prophylaxis dose, 20/44 
(45,4%) with 1 mg/kg/24h and 6/44 (13,6%) with 1 mg/kg/12h. Forty 
patients (83,3%) needed invasive mechanical ventilation with an aver-
age duration of 22,2 days (IC 95% 17,3-27); 35 patients (72,9%) needed 
vasopressors and 6 patients (12,5%) renal replacement therapy. Our 
patients showed: tetraparesis that increased the mechanical ventila-
tion and the UCI stay days, 22 patients (45,8%); delirium, 21 patients 
(43,8%); nosocomial infection, 17 patients (35,4%); arrhythmias, 11 
patients (22,9%) (9/11 atrial fibrilation and supraventricular tachycar-
dia); and vascular thrombosis, 2 patients (4,2%). The average ICU stay 
was 23,1 days (CI 95% 18,4-27,8). 13 patients died (27%).
Conclusion: All our patients were treated with hydroxychloroquine 
and most of them with lopinavir/ritonavir, methylprednisolone and 
interferon beta-b1. Half of them received higher heparin doses than 
those used for antithrombotic prophylaxis.
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Introduction: Patients with sepsis and septic shock have altered 
antimicrobial pharmacokinetics, which often results in suboptimal 
drug concentrations. Septic patients are also at risk for infections with 
resistant organisms such as Pseudomonas aeruginosa. Combination 
therapy against P. aeruginosa infections is still debatable.
Objectives: This study aims to investigate whether there is any syn-
ergistic benefit, in terms of bacterial killing and suppression of emer-
gence of resistance, of a meropenem-ciprofloxacin combination 
therapy in comparison to monotherapy with the same antibiotics 
against P. aeruginosa in septic patients with altered pharmacokinetics, 
using a dynamic Hollow-Fiber Infection Model (HFIM).
Methods: Two intermediate to resistant P. aeruginosa isolates code 
numbered 27 (MICmeropenem of 4 mg/L and MICciprofloxacin of 1 
mg/L) and 40 (MICmeropenem of 16 mg/L and MICciprofloxacin of 1 
mg/L) were evaluated in a 5-day HFIM investigation. Changes of the 
total and resistant bacterial populations were evaluated using quanti-
tative cultures. The studied regimens were equivalent to 2 g of mero-
penem every 8 h (30 min infusion), 600 mg of ciprofloxacin every 8 
h (45 min infusion) and the combination of the same antibiotics. The 
doses and pharmacokinetic simulations were based on recommenda-
tions and data from previous studies on critically ill patients (1, 2).
Results: In both HFIM investigations, combination therapy achieved 
considerably greater bacterial killing and resistance suppression com-
pared to the monotherapies. The monotherapies started to fail after 
24 h, with increased bacterial concentrations of 3-6 log10 CFU/ml. 
From there, strain 40 plateaued at 8-9 log10 CFU/ml after 48 h. Strain 
27 continued increasing from 3-6 log10 CFU/ml at 48 h until reaching 
9-10 log10 CFU/ml at 120 h. In contrast, the combination therapies 
suppressed bacterial growth from 6 h and onward. Additionally, the 
monotherapies had accelerated growth of resistant subpopulations 
reaching 8-9 log10 CFU/ml, while no resistance was detected in the 
combination therapies.
Conclusion: This study suggests a synergistic benefit of combination 
therapy with meropenem and ciprofloxacin against P. aeruginosa in 
critically ill patients with altered pharmacokinetics. Our findings sup-
port empirical combination therapy against P. aeruginosa, especially 
for resistant isolates.
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Introduction: Since the beginning of SARS-CoV2 outbreak, paucity 
of data has been published regarding rate of co-infection and super 
infection. Most guidelines have recommended empirical antimicro-
bial for mechanically ventilated patients admitted in ICU (1). In the 
meantime, the differentiation between bacterial super infection and 
bacterial colonization of the respiratory tract has been challenging 
especially with the hyperinflammatory state of critical cases admitted 
in ICU.
Consequently, high prescription rate of antibiotics has been described 
in the literature for SARS-CoV2 patients but no data has been pub-
lished on antibiotic consumption specifically in ICU patients.
Objectives: Our main objective is to evaluate the antibiotic con-
sumption (Days Of Therapy, antibiotic prescribed, timing within ICU 
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hospitalization) in our critical SARS-Cov2 patients and evaluate the 
potential effect on antimicrobial resistance.
Methods: In an observational, retrospective and monocentric study, 
we reviewed antibiotic prescription (name, duration, indication) of 
all SARS-Cov2 patients admitted in our ICU between march 2020 and 
may 2020. β-Lactams were then stratified by their tendency to drive 
antimicrobial resistance based on classification developed by Weiss 
and al. (class 1 to 6) (2).
Results: Between march 2020 and may 2020, 44 critical SARS-CoV2 
have been admitted to our ICU (22 beds). We have been able to col-
lect data from 41/44 patients. Mean age at admission was 63 years. 
83% received mechanical ventilation (34/41 patients), for a total of 505 
days, and 24% (10/41 patients) received ECMO therapy, for a total of 
172 days. Mortality in our unit was 50%. All but one patient received 
hydroxychloroquine and 38/41 patients received azythromycine as it 
was recommended by our national Belgian guidelines. Both medica-
tions were given during 5 days.
92% received an antibiotic at some point during their ICU stay. Based 
on recommendations, 46% (19/41 patients) received empirical therapy 
at admission despite the fact that none of our patients were in shock. 
Considering co-infectionas positive microbiology within the first 48 
hours after admission, then 17% were in that case. First antibiotic pre-
scription for the rest of the cohort occurred for 9/41 patients within 
the first week and for 6/41 patients within the second week.
From 682 patient ICU days, 396 Days Of Therapy (DOT) of antibiotics 
were documented, representing 581 DOT/1000 patient-days. Prescrip-
tion was distributed as follows: 26% for amoxicilline-clavulanate, 23% 
for piperacilline/tazobactam, 12% for cefuroxime, 7% for ceftriaxone, 
ceftazidime, and vancomycine, 6% for meropenem, 5% for amikacine, 
2% for amoxicilline, flucloxacilline, temocilline, ciprofloxacine, and 1% 
for cefepime.
37% of all antibiotics were at least classified as class 4 (2), and 44% of 
prescription had an anti-pseudomonal coverage. Non effective pre-
scription (pathogen with documented resistance to the antibiotic pre-
scribed) in 8% of cases (33/396 DOT).
Conclusion: Antibiotic consumption was in the range of previously 
described consumption from general ICU outside of SARS-CoV2 pan-
demic : De Bus and al. reported 1232 DOT/1000 patient-days (3). Con-
sumption decrease would have been possible by avoiding empirical 
administration at admission (absence of shock in all patients), and use 
of newly available technique like RT-PCR.
Concern about antimicrobial resistance need to be emphasized, 
resulting from increased patient exposure to antimicrobials, often 
suboptimally or inappropriately used (4). Indeed, on the one hand 
hyperinflammatory state might have increased the likelihood of anti-
biotic prescription in case of bacterial superinfection. And on the other 
hand long duration of ventilation and previous antimicrobial exposure 
might have prompted the clinician to prescribe a broad spectrum 
antibiotherapy.
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Introduction: Tigecycline is a last-resort antibiotic to treat severe 
infection caused by multidrug-resistant bacteria. It may induce 
decreased blood glucose, as described elsewhere [1-3]. In the drug 
inserts, incidence of decrease in blood glucose is labeled as <2%. In 
the critically ill patients, severe infection is common; however, the 
impact of Tigecycline reducing blood glucose remains to be assessed.
Objectives: This study is to determine if Tigecycline reduces blood 
glucose in critically ill patients with severe infection and further iden-
tify the factors associated with decreased blood glucose.
Methods: We retrospectively studied critically ill patients who 
received Tigecycline in the ICU department of the Sixth’s People Hos-
pital in Shanghai, China from January, 2018, through July, 2019. Mixed-
model repeated measure was utilized to compare the mean blood 
glucose before and after Tigecycline administration. The two phases 
(before and after Tigecycline administration) and daily blood glucose 
(measured at 6am, 2pm and 10pm) were presented as two repeated 
factors. Other factors were considered covariates or between-subjects 
factors in the model, including sex, age, comorbidity, prognosis, dura-
tion and dosage of Tigecycline administration, and intravenous glu-
cose infusion. Multivariate linear regression model was employed to 
determine the association of above-mentioned factors with decrease 
in blood glucose. Moreover, binary logistic regression was utilized to 
determine the factor associated with hypoglycemia that was defined 
as a decrease ≥2.8 mmol/L in the study. Receiver operating charac-
teristic (ROC) and its area under curve (AUC) were then employed to 
evaluate the factor in predicting hypoglycemia. All analyses were per-
formed using SPSS Statistics, version 23.0 (IBM Corporation, Armonk, 
NY). A P value <0.05 was considered statistically significant.
Results: A total of 168 patients were studied, including 105 male and 
63 female, with an average age of 64.2 ± 15.8 yrs. After Tigecycline 
administration, daily blood glucose at three points of time signifi-
cantly decreased (P<0.001), regardless of other factors. The decrease 
in blood glucose, defined as the difference between the minimum 
blood glucose before and after Tigecycline administration, was posi-
tively correlated with death (β=0.78, P=0.016), maximum decrease 
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in blood glucose within 24 hrs (β=0.67, P=0.032), and duration of 
administration (hrs) (β=0.004, P<0.001). Hypoglycemia was identified 
in 19 patients (11.3%), which was determined to be associated with 
death (OR=3.71, P=0.014) and maximum decrease in blood glucose 
within 24 hrs (OR=1.18, P=0.002). The AUC for the maximum decrease 
in blood glucose within 24 hrs was determined to be 0.76 (95%CI, 
0.66-0.86) and best cutoff value was 4.35 mmol/L (sensitivity, 0.90; 
specificity, 0.53).
Conclusion: Tigecycline significantly reduces blood glucose in the 
critically ill patients with severe infection. In addition, decrease in 
blood glucose is associated with risk of death, duration of Tigecycline 
administration, and maximum decrease in blood glucose within 24 
hrs, further suggesting usage with extreme caution. A decrease ≥4.35 
mmol/L in blood glucose may predict hypoglycemia, which would 
facilitate early warning in the critically ill patients.
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Introduction: Influenza virus infection is an important cause of mor-
tality worldwide, leading to 250000 to 500000 deaths each year in the 
developed world. Mortality is caused by the primary viral infection, but 
also by influenza-associated pulmonary co-infections.
Objectives: Our retrospective observational study aimed to evalu-
ate the difference in the outcome of patients with influenza infection 
requiring admission to both Medical and Surgical Intensive Care Unit 
(ICU) served to a community hospital, according to nursing and sever-
ity indexes.
Methods: From January 2006 to October 2019, 1332 patients admit-
ted to our ICU. From these, 25 (1.87 %), were indicated with the diag-
nosis of severe influenza infection. The patients separated into two 
groups. Group A involved all patients who survived ICU and group B all 
patients who died in ICU. We looked for statistically significant differ-
ence (p-value two-tailed) between the medians values of two groups, 
using the unpaired Mann - Whitney test or the unpaired t-test Welch 
corrected according to the normality test, according to nursing (Age, 
sex, LOS, MVD) and severity (Simplified Acute Physiology Score: SAPS 
II, predicted mortality by SAPS II, Acute Physiology and Chronic Health 
Evaluation: APACHE II, predicted mortality by APACHE II, Glasgow 
Coma Scale: GCS) indexes.
Results: We detected no statistical difference between the two 
groups according: age (p=0.6314), sex (p=1.000), GCS (p=0.3830), 
LOS (p=0.9979), MVD (p=0.4342), predicted mortality by SAPS II score 
(p=0.2001)
We detected statistical significant higher group B value according to 
APACHE II score (p=0.0281), predicted mortality by APACHE II score 
(p=0.0276), SAPS II score (p=0.0356)
Conclusion: According to our data, demographic data and nursing 
indexes were about the same among the two groups. On the other 
hand, severity scores like APACHE II score and SAPS II score were both 
statistically significantly higher in group B, assuming that patients who 
died in ICU admitted to ICU in more severe illness. But, only predicted 
mortality by APACHE II score achieved to be statistically significantly 
higher in group B. Our data suggest that we can use the APACHE II 
severity score as an accurate severity score in these patients.
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Introduction: Antibiotic Stewarship Programs, in Spain known as 
PROA, are becoming increasingly important in both hospital and 
primary care. These programs work on optimizing antibiotic (ATB) 
prescribing to improve patient prognosis, minimize adverse effects, 
monitor the onset of resistance, and ensure the use of cost-effective 
treatments.
Objectives: In this work we review the performance of a PROA team 
in an ICU.
Methods: The authors present a descriptive analysis of the daily per-
formance of a team of intensivists dedicated to infections, with the 
application of PROA in a polyvalent UCI, during the year 2019, com-
paring to the previous year. The interventions carried out by the PROA 
team were: general recommendations, initiate, de-escale, shift or stop 
ATB, sampling for cultures, pk/pd optimization, and consults directly 
made by other doctors to the PROA team.
Results: During 2019, 632 interventions have been made. The recom-
mendation was initiating ATB treatment in 38.1% of them, and dis-
continue it in 63,45%, with an adherence of 91.1%, higher than the 
previous year (87.9%). Non-adherence was observed in interventions 
about days of ATB treatment (35.71%), discontinuation of antibiotic 
therapy by negative cultures (17.85%) and general recommendations 
made to the responsible physician (16%). Adherence was observed 
mainly in interventions about days of treatment, general recommen-
dations, de-escalation of ATB and culture- directed ATB treatment. The 
interventions that most often motivated the onset of ATB were: cul-
ture - directing ATB treatment (28.63%), de-escaling (22.82%), expand-
ing spectrum (15.76%) and initiate empirical treatment in cases of 
suspected infection (12.45%). The most frequently used ATBs on inter-
ventions were 3rd generation cephalosporins (cefotaxime 15.35%), 
ureidopenicillines (piperacillin-tazobactam 9.5%), and aminoglyco-
sides and linezolid (8.2%). 63.44% of interventions recommended the 
suspension of ATB treatment, the most common reasons were: days of 
ATB treatment (37.65%), de-escalate (21%), negative cultures (10.22%) 
and a few times the suspension because a limitation of therapeutic 
effort. The most frequently discontinued ATBs were ureidopenicillines 
(piperacillin-tazobactam 21.7%), aminoglycosides (amikacin 9.23%), 
3rd generation cephalosporins (cefotaxime 9%), linezolid (6.5%) and 
azoles (6.23%). Regarding inquiries made to the PROA team by the UCI 
team, the advices given were not initiate ATB, not changing antimicro-
bial therapy and extending the spectrum, with an adhesion of the doc-
tors of 100%. In addition, a total of 100 recommendations have been 
made (15.8%) with 91% adhesion relative to contact isolations (22%), 
microbiological sampling (20%), initiation of ATB therapy (13%) and 
not starting ATB or non-indicated ATB treatment (9%). Overall mor-
tality in 2018 was 10.95%, and 10.67% in 2019 (not significant). It has 
been observed a trend for the reduction of multi-resistance since the 
implementation of the PROA. The rates of BMR infection during ICU 
stay have been 1.55/100 patients and 2.9/1000 days of stay in 2018, 
and 1.22/100 patients and 2.47/1000 days of stay in 2019.
Conclusion: The interventions carried out have had a high adhesion, 
which reflects the trust placed by the doctors responsible towards 
the PROA UCI team. These interventions have resulted in a decrease 
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in multidrug-resistant bacteria in the ICU, antimicrobial consumption 
and a better ATB policy, with no implications for mortality. It is impor-
tant to give out the results obtained to positively strengthen its good 
work and to be able to identify areas of improvement.
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Introduction: The full spectrum of COVID-19 infection ranges from 
an asymptomatic disease, through mild respiratory tract illness to a 
severe pneumonia and acute respiratory distress syndrome (ARDS), 
including multiorgan failure and death. This novel coronavirus induces 
the release of inflammatory cytokines, and it is the disruption of the 
immune response that can lead to multiorgan dysfunction and ARDS 
(1). Coagulopathy in COVID-19 infection is correlated with mortality, 
with D- dimer levels being of particular importance as biomarker (2).
Objectives: To describe the pathological findings of post-mortem 
lung biopsies in patients who died of SARS-CoV-2 infection.
Methods: A prospective observational study of post-mortem lung-
biopsies in patients who died of COVID-19 was conducted. Biopsies 
were obtained by 14G tru-cut from March 31 to May 25, 2020 in the 
ICU of the Fundación Jiménez Díaz in Madrid. Morphological studies 
were performed using immunohistochemical techniques (IHQ). On the 
last day of admission, data regarding the epidemiology, respiratory 
mechanics and severity of disease was collected.
Results: In total, 16 patients were studied (100%H). The median age 
was 63 years (IQI 56-66 years). The most frequent previous medical his-
tory included: ETS 31%, LD 31%, DM 18% and OM 31%. Median of pre-
vious admission day was 28 (IQI14-39). Median APACHE II 14. Days of 
admission to ICU were 27 (range 1-44). The median number of days on 
MV was 24. Tracheotomy was performed in 63%. The ventilatory mode 
was volume control in 100%, with an average tidal volume of 6.21 ml/
kg of predicted body weight. This resulted in a plateau pressure of 31 
cmH20, a driving pressure of 21 cmH20 and a static compliance of 17.5 
ml/cmH2O. Regarding arterial gases: pH of 7.29 (IQ of 7.17-7.38), pCO2 
of 74(IQ 53-87) and a PaO2/FiO2 ratio of 64 (IQ 58-108). The average 
laboratory values were: D-dimer (DD) 3860 μg/L, lymphocytes 850 
(abs), platelets 138000 μl, Hb 8.5 g/L, creatinine 1 mg/dl, PCR 13.6 mg/
dl, ferritin 892 ng/mL. All patients received prophylaxis with LMWH. If 
the DD was higher than 3000µg/l, the LMWH was administered at ther-
apeutic dose (1 mg/kg/24h). Diffuse alveolar damage and frequent 
formation of hyaline membranes were observed in 100% (Fig. b), 44% 
presented pneumonia in cryptogenic organization. It should be noted 
that 78% of the patients had frequent capillary microthrombosis(Fig. 
a). In addition, the IHQ showed intense expression of CD163+ mac-
rophages as well as CD8.
The results showed diffuse alveolar damage and hyaline membrane 
formation in all patients, and capillary microthrombosis in more than 
75% of them. In the pre-mortem analysis the DD was higher than 
3,000µg/l in more than half of cases. The frequent finding of CD163+ 
macrophages represents the histopathological substrate for the mac-
rophage activation syndrome seen in these patients.
Conclusion: Our results confirm the hypothesis that SARS-Cov-2 
may trigger a macrophage activation syndrome, as well as an state 
of hypercoagulability, which would support the implementation of 
immunosuppressive and anticoagulant treatment, beside supportive 
therapy.
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Introduction: Analyzing which antibiotics have been used more fre-
quently as empirical treatment in our unit over almost two decades 
and the duration of their use
Methods: Descriptive study based on the data collected in the ENVIN 
- ICU base of our medical-surgical unit, collected during the months 
of the official participation period. We describe the most frequently 
used antibiotics (meropenem, piperacillin-tazobactam, levofloxa-
cin, azithromycin and linezolid), their percentage of use and average 
duration of treatment, analyzing two time periods, 2002-2009 and 
2010-2019
Results: During the period 2002-2009, there were 916 records of 
antibiotics, the most used was levofloxacin 13.32%, with an average 
duration of 6.71 ± 4.99 days, piperacillin-tazobactam 12.77% and an 
average of 7.37 ± 4.41 days, meropenem 4.91% and an average of 8.40 
± 6.07 days, linezolid 2.07% and 7.74 ± 68.48 days on average, azithro-
mycin 0.22% with an average of 4’00 ± 0’00 days.
During the period 2010-2019 there were 1570 records of antibiotics, 
the most used was meropenem 17.26% with an average duration of 
6.22 ± 4.92 days, piperacillin-tazobactam 15.16% and 5.81 ± 4.17 
days, linezolid 12.23% and 5.38 ± 3.60 days, levofloxacin 7.45% and 
4.84 ± 4.02 days, azithromycin 3.444% with an average of 3.96 ± 1.38 
days. Extracting only the data for the year 2019, there are 204 records, 
the most used antibiotic is piperazillin tazobactam 20.59% and 5.52 ± 
3.41 days, meropenem 19.12% and 5.87 ± 3.11 days, linezolid 14’71% 
and 5’17 ± 3 ‘27 days, azithromycin 4’90% and 4’40 ± 1’78 days, levo-
floxacin 1’47% and 5’67 ± 2’31 days.
Conclusion: We observe that the most used antibiotics have been 
modified, shortening their time of use, during the study period. 
Highlight the decrease in the use of levofloxacin and the increase in 
azithromycin, in addition to the frequent use of piperacillin-tazobac-
tam maintained over time for almost two decades.
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Introduction: Descriptive analysis of the population admitted to our 
medical-surgical ICU in the last two decades.
Methods: Descriptive study based on the data collected in the ENVIN 
- ICU base of our medical-surgical unit, collected during the months 
of the official participation period. We divided the total number of 
patients into two periods: 2002-2009 and 2010-2019, and studied 
characteristics such as: age, sex, APACHE, SAPS II, underlying disease 
(medical, surgical, trauma, coronary), deaths, days of ICU stay, origin of 
the patients (hospitalization unit, another ICU, their home, long-stay 
center).
Results: During the period 2002-2009, 1114 patients were registered. 
The average age was 61,44 ± 14,67 years old, 62,48% male. The aver-
age score on the SAPS II scale was 29,77 ± 12,63 points, and APACHE 
was 16,61 ± 8,53 points. The base disease registered was medical 
79,44%, surgical 11,22%, trauma 1,53%, coronary 7,81%. The origin of 
the patients (n=466) prior to ICU admission was a 25.99% hospitali-
zation unit, another ICU 2,07%, home addres 12,95%, long-stay center 
0,90%. Regarding mortality (n=1109) 176 deaths occurred (15,87%).
During the period 2010-2019, 2533 patients were registered. The aver-
age age was 63,12±14,80 years, with 67,11% males. The average SAPS 
II score was 30,64±16,35 points and in APACHE 15,19±8,70 points. 
The registered base disease was medical 48,72%, coronary 40,43%, 
surgical 9,87% trauma 0,99%. Its origin prior to income (n=2531) 
was his home 61,39%, one hospitalization unit 31,35%, another ICU 
6,20%, long stay center 0,99%. Regarding mortality (n=2513) 322 were 
recorded death (12,81%).
Conclusion: Throughout these two decades, there are an increasing 
number of registered patients, whose most frequent origin was their 
home, with the medical reason persisting as the most frequent, and 
finding a decrease in mortality. Coronary patients go from 7 to 40% in 
the second decade, wich could partially explain the decrease in mor-
tality, without affecting the severity of the patients.
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Introduction: The full spectrum of COVID-19 infection ranges from 
an asymptomatic disease, through mild respiratory tract illness to a 
severe pneumonia and acute respiratory distress syndrome (ARDS), 
including multiorgan failure and death. This novel coronavirus induces 
the release of inflammatory cytokines, and it is the disruption of the 
immune response that can lead to multiorgan dysfunction and ARDS 
(1). Growing evidence suggests that asubgroup of patients with severe 
disease might experience a deregulated systemicinflammation in con-
junction with cytokine storm syndrome, leading to death (1, 2). There 
is an increasing interest on describing the histopathology of COVID-19 
infection in different organs, through the study of samples obtained 
by means of core needle biopsies or full necropsies. Extending our 
knowledge will allow a better understanding of the disease and the 
development of new therapeutic targets.
Objectives: To describe the histopathological changes of the bone 
marrow in patients who died in ICU due to SARS-CoV-2 infection
Methods: A prospective observational study of bone marrow biopsy 
(BMB) in patients who died of COVID19 was carried out in the ICU of 
the Fundación Jiménez Díaz in Madrid from March 31 to May 25, 2020. 
Morphological and immunohistochemical (IHQ) studies were per-
formed on the samples. Epidemiological, severity and analytical data 
were also collected.
Results: 4 BMBs were performed. 100% of patients were male. The 
median age was 60 years (IQI 56-65). The most frequent past medical 
history were: LD and morbid obesity in 50%, ATH in 25%. The APACHE 
II at 24h of admission was 13.5. The mean number of days of admission 
to the ICU was 14.5 days (IQI 3.5-25) with 23 days of MV. Prone venti-
lation was performed in 75% and tracheostomy in 50%. The median 
of values in the pre-death analysis was: D-dimer 4209 μg/L, fibrinogen 
816 g/dl, lymphocytes 400 abs, platelets 83,000/μl, Hb 10.35 g/L, cre-
atinine 1.15 mg/dl, PCR 37.8 mg/dl, ferritin 892 ng/mL, LDH 332 u/L, 
total bilirubin 1.3 mg/dl and lactic 2.4 mmol/L. They were treated in 
75% of cases with LPV/RTV, hydroxychloroquine and 250 mg meth-
ylprednisolone pulses, in 50% of them with interferon alpha-2b and 
only one patient received tocilizumab. Histiocytic hyperplasia with 
hemophagocytosis (Fig. a) was observed in 75% of patients and non-
specific inflammatory myelopathy in one patient.
The BMB results show findings consistent with the diagnosis of 
hemophagocytic histiocytosis (HH). HH is a common finding associ-
ated with severe viral problems and represents the histological coun-
terpart of the macrophage activation (MAS) suffered by these patients. 
Macrophage activation syndrome (MAS), also known as hemophago-
cytic lymphohistiocytosis (sHLH), is characterized by the overactiva-
tion of cytotoxic T cells with hemophagocytosis by macrophages and 
a massive release of inflammatory cytokines. For these reason it is clas-
sified within the cytokine storm syndromes.
Conclusion: In our series, not all cases met the diagnostic criteria of 
HLH, but we do consider that it represents the histological substrate 
for MAS in these patients, supporting the indication of immunomodu-
latory treatment.
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Introduction: To know how the general use of antibiotics in an ICU 
has evolved over two decades.
Methods: Descriptive study, based on the data collected in the ENVIN 
- ICU base of our medical-surgical unit, collected during the months of 
the official participation period. To do this, we have divided the total 
number of patients collected into two periods: 2002-2009 and 2010-
2019. To study the evolution, we are going to describe the number of 
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antibiotics per patient with antibiotics, relationship days without anti-
biotics / patient stays with antibiotics, most frequent causes of antibi-
otic indication, description of the use of antibiotics used (empirical or 
specific, change of treatment, Reason for change). The qualitative vari-
ables will be expressed in percentages.
Results: During the first period, the number of antibiotics per patient 
with antibiotics was 2.21, while in the second period it was 2.53. 
The ratio of days without antibiotics / patient stays with antibiot-
ics was 0.19 in the first period and 0.21 in the second period. In the 
first period, the use of 1760 antibiotics was recorded, the most fre-
quent indication was other prophylaxis with 34.20%, hospital infec-
tion extra ICU 25.06%, community infection 21.59%, hospital infection 
intra ICU 18.01%. In the second period, the use of 2624 antibiotics 
was recorded, the most frequent indication was community infection 
33.16%, extra-ICU hospital infection 25.76%, intra-ICU hospital infec-
tion 19.36%, another prophylaxis 10.75%. Regarding the reason for 
antibiotherapy, in the first period the empirical treatment was 82.12% 
and in the second 76.74%. Antibiotic treatment (empirical or spe-
cific) produced a change of 25.73% in the first period, and 21.79% in 
the second period. The reasons for the change in antibiotherapy dur-
ing the first period were a poor clinical evolution 38.26%, unknown 
33.56%, microorganisms not covered 21.48%, others 4.03%, toxicity 
(Adverse effects) 2.01%, spectrum reduction 0.67%, resistance during 
treatment 0%. The reasons for the change in antibiotherapy during 
the second period were the reduction of the spectrum 41.91%, poor 
clinical evolution 28.68%, microorganisms not covered 13.73%, others 
7.60%, toxicity (adverse effects) 6.37 %, resistance during treatment 
1.47%, unknown 0.25%.
Conclusion: In this descriptive study, it is observed how over two dec-
ades (coinciding with the implementation of the Zero projects), more 
antibiotics have been used, having more days free of antibiotherapy, 
changing the most frequent cause of antibiotic indication, and high-
lighting the largest use of de-escalated antibiotics today.
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Introduction: Rapid spread of SARS-CoV-2 pandemic (COVID-19) has 
taken traditional ICU capacity to the limit worldwide. A demand over-
coming availability has forced intensivists to select the patients who 
can benefit the most from admission. Predictive models based on rou-
tine clinical data may be valuable in the decision-making process.
Objectives: We aim to assess whether chronic comorbidities and lab-
oratory tests drawn at presentation are good predictors of mortality in 
patients with severe SARS-CoV-2 infection (COVID-19) admitted to the 
Intensive Care Unit (ICU).
Methods: We conducted a retrospective observational single-centre 
study in the ICU of a University Hospital in Spain, over 3 months. All 
the patients who were admitted to the ICU with PCR-confirmed severe 
SARS-CoV-2 infection were included. Past medical history, laboratory 
tests drawn at presentation and clinical outcomes were obtained from 
the electronic medical record. Association among each variable and 
mortality was evaluated by bivariate analysis (Chi-square, Student’s T 
and Mann-Whitney U tests, as appropriate). Potential explanatory vari-
ables from bivariate analysis were used to build a multivariate logistic 
regression model to predict mortality.
Results: We included 87 patients, 77% male, age 60±12 years-old [sur-
vivors 56±12 vs non-survivors 67±10, p<0.01], BMI 27 (25–32) kg/m2 
[survivors 27 (26-32) vs non-survivors 27 (24–32), p=0.94], APACHE-II 
17±6 [survivors 14 vs non-survivors 20, p<0.01], mechanical ventila-
tion 93% [survivors 59 vs non-survivors 41, p=0.73], hospital mortality 
38%. Our findings are depicted in Tables 1 and 2. Our model (Table 3) 
showed  76.2% sensitivity and 89.7% specificity to predict mortality 
(area under the ROC curve 0.91).
Table 1. Association of chronic comorbidities with mortality. 
Overall 





Hypertension 30 20 45 0.01 
Asthma 8 9 6 0.59 
COPD 3 0 9 0.02 
Hypothyroidism 11 9 15 0.40 
Ischemic heart 
disease 5 0 12 0.01 
Diabetes 14 7 24 0.03 
Neoplasia 13 9 18 0.22 




median (IQR) p-value 
Leukocytes, ×10³/µl 7.1 (5.4–9.5) 7.7 (5.8–14.7) 0.69 
Lymphocytes, ×10³/µl 0.8 (0.5–1.1) 0.6 (0.3–0.8) 0.01 
D-dimer, ng/ml 685 (399–1041) 641 (531–2070) 0.65 
High sensitivity troponin I, 
ng/l 9 (5–17) 35 (13–225) <0.01 
Creatinine, mg/dl 0.9 (0.7–1.1) 1 (0.7–1.3) 0.15 
C-reactive protein, mg/l 123 (61–216) 108 (59–179) 0.39 
Procalcitonin, ng/ml 0.2 (0.1–0.3) 0.3 (0.1–0.7) 0.11 
Lactate, mmol/l 1.6 (1.3–2.2) 1.8 (1.4–2.3) 0.43 
Table 3. Multivariate logistic regression model to predict mortality. 
tneiciffeoC Standard error 
Odds ratio (95% 
CI) p-value 
Age, per year 0.112 0.05 1.12 (1.01–1.23) 0.02 
Gender, female 0.915 1.01 2.45 (0.35–17.99) 0.36 
Hypertension, yes 0.996 0.87 2.71 (0.49–14.88) 0.25 
Diabetes, yes 0.586 1.24 1.80 (0.16–20.32) 0.64 
Lymphocytes, per 
1×10³/µl –3.944 1.53 0.02 (0.01–0.39) 0.01 
Creatinine, per mg/dl –0.045 0.13 0.96 (0.74–1.23) 0.72 
Troponin, per ng/L 0.006 0.01 1.01 (0.01–1.02) 0.18 
Intercept –6.274 3.099   0.04  
Conclusion: In our series, mortality in severe SARS-CoV-2 infections 
requiring admission to the ICU was significantly associated with age 
and APACHE-II.
A prediction model based upon basic demographic data (age and 
gender), chronic comorbidities (hypertension and diabetes) and 
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laboratory values at presentation (lymphocytes, creatinine and tro-
ponin) is able to reliably predict mortality in this patient population.
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Introduction: Infections caused by A. baumannii are associated with 
high mortality and healthcare costs. In critical care settings, the inci-
dence of acquired resistance of A. baumannii to commonly prescribed 
antibiotics is increasing, rendering the treatment of the relevant infec-
tions rather challenging and compromising patients’ outcomes.
Objectives: To prospectively record the incidence, clinical characteris-
tics, treatment and outcome of infections caused by pandrug – resist-
ant (PDR) A.baumannii in critically ill patients.
Methods: The study was performed at a 19-bed polyvalent intensive 
care unit (ICU). All the mechanically ventilated patients with docu-
mented infection caused by PDR A. baumannii, from November 2018 
until February 2020 were enrolled in the study. Concentrations (MICs) 
were determined by the broth microdilution method, as indicated by 
the CLSI. Disease severity was evaluated by APACHE-II and SOFA score 
on ICU admission. Patients’ demographics, clinical characteristics, 
treatment and outcomes in 7 and 30 days were recorded. Clinical suc-
cess was defined by a lessening of the signs and symptoms of infec-
tion, while microbiologic success was considered, as the eradication of 
the pathogen from cultures.
Results: Ten patients (mean age ± SD= 58 ± 17 yrs, 8 males/2 
females) with documented infection due to A. baumannii were 
enrolled in the study. Regarding comorbidities, diabetes mellitus was 
present in 3 (30%) pts, arterial hypertension in 5 (50%) pts, and coro-
nary artery disease in 3 (30%) pts. APACHE-II score in ICU admission 
was 18±7, while SOFA score was 8±3. Bloodstream infection was pre-
sent in 6 (60%) pt. Among them, central line associated bloodstream 
infection (CLABSI) was observed in 5 (83%) pts, and primary bactere-
mia in 1 (17%) pt. Ventilator associated pneumonia (VAP) was diag-
nosed in 4 (40%) pts. Mean length of stay of enrolled patients in the 
ICU, prior to infection, was 18.5±10 days. Regarding prior colonization, 
PDR-A.baumannii was isolated in stool and bronchial secretion surveil-
lance cultures of 8 (80%) pts. 7 (70%) pts had received broad spectrum 
antibiotics prior to infection due to A.baumannii, while 5 among them 
had also received intravenous and nebulised colistin. All patients were 
empirically treated with combinations of colistin, high dose ampicillin/
sulbactam (A/S), rifampicin or tigecycline with broad spectrum anti-
biotics (meropenem or ceftazidim/avibactam), for 14±4 days. Clinical 
and microbiological success was observed in 7 (70%) of patients. In 
two patients (20%), blood cultures remained positive, while in another 
patient, A.baumannii infection was complicated with meningitis. ICU 
mortality in 10 days of infection was 30%. ICU mortality was signifi-
cantly associated with SOFA score (p<0.05). Mean length of stay in ICU 
after infection was 39±17 days.
Conclusion: Broad use of antibiotics has increased the isolation rate 
of PDR-A.baumannii in critical care settings. Antibiotic combinations 
might offer a therapeutic benefit, as a result of possible synergistic 
effect. Further studies are required in order to elucidate the thera-
peutic options and clinical outcomes of infections caused by PDR 
pathogens.
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Introduction: Antibiotics resistant Gram-negative rod (GNR) bacte-
remia is increasing worldwide every year. Diagnosis of nosocomial 
Gram-negative rod monobacteremia (N-GNRM) in critically ill patients 
has been associated with prolonged hospitalization in intensive care 
units (ICUs) and a higher rate of mortality. The identification of patho-
gens, the pervasiveness of multiple antibiotic resistance, and risk fac-
tors for resistant strains are helpful in selecting appropriate empirical 
antibiotic therapy to reduce hospitalization time and mortality. The 
aim of this study was to identify the risk factors for the development of 
nosocomial multiple antibiotic resistance strains and mortality.
Methods: A retrospective cohort study was performed, analyzing the 
data of patients treated in ICU after 72 hours of hospitalization, with 
positive gram-negative rod monobacteremia over a period of 10 years.
Results: Over the year 2009-2018, 261 cases of N-GNRM were identi-
fied. The detected pathogens include: 31.8% (n=83) Acinetobacter 
spp., 19.9% (n=52) Klebsiella spp., 18% (n=47) Escherichia coli and etc. 
Monobacteremia caused by P. aeruginosa was detected only in the last 
three years of the researched period, from 4 (8.5%) cases in 2016 to 7 
(28%) cases in 2018 (p <0.05). The sensitivity to Imipenem was 88.8% 
(n = 206), to Meropenem 85.4% (n = 199), to Amikacin 65.1% (n = 
142), to Cefoperazone / Sulbactam 61.6% (n = 141) and to Piperacillin 
/ Tazobactam 48% (n = 120). 61.6% (n=161) of all the cases studied, 
had multiple antibiotic resistance, out of which 39.8% (n=104) was 
extensively drug-resistant (XDR) (p <0.001). Of all Acinetobacter spp., 
XDR made up 69.9% (n=58) (p <0.001). The identified risk factors for 
bacteremia in resistant strains include male gender (p = 0.012), age 
>= 65 year old (p = 0.010), hospitalization in ICU >= 16 days (p = 
0.012), and the duration of mechanical lung ventilation (IMV) >= 14 
days (p <0.001). In a multivariate analysis, 69.3% (n=181) of mortality 
was associated with male gender (p = 0.001), acute kidney injury with 
the need for hemodialysis (AKI-HD) (p = 0.001) and shock (p <0.001).
Conclusion: Over a ten-year period, the most common cause of 
N-GNRM in ICU was Acinetobacter spp., dominated by XDR strains. 
Male gender, older age, prolonged stay in ICU and longer duration 
of IMV were identified as risk factors for multiple antibiotic resist-
ance strains. Furthermore, male gender, acute kidney injury with the 
need for hemodialysis and shock, were related to almost 70% rate of 
mortality.
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Objectives: INTRODUCTION
Invasive fungal disease (IFD) caused by Candida spp. is associated 
with longer hospital duration and higher mortality rates for the 
critically ill.1-3 For such patients, treatment with an echinocandin is 
recommended first-line therapy.4 Rezafungin (RZF) is a novel, next-
generation echinocandin in Phase 3 development for treatment of 
candidemia and invasive candidiasis (IC) and for prevention of IFD 
caused by Candida, Aspergillus, and Pneumocystis in blood and marrow 
transplant recipients.
Objectives: To evaluate outcomes of the Phase 2 STRIVE trial of RZF 
QWk for the treatment of candidemia and/or IC compared with caspo-
fungin (CAS) once-daily (NCT02734862)5, based on ICU status and 
APACHE II scores.
Methods: Patients in STRIVE were randomized to 1 of 2 doses of RZF 
(400 mg QWk or 400 mg in Week 1, then 200 mg QWk [400 mg/200 
mg], the latter being studied in Phase 3) or CAS (70 mg on Day 1, then 
50 mg QD) for ≥14 days. For this ad-hoc subanalysis, data were strati-
fied by ICU status (no ICU or ICU admission within Days 1–4) and by 
APACHE II score category (<10, 10-19, and 320). Efficacy (overall suc-
cess [resolution of clinical signs of infection + mycological eradica-
tion], mycological success, and investigator assessment of clinical cure 
at Day 14; and 30-day all-cause mortality) and safety (treatment-emer-
gent adverse events [TEAEs]) endpoints were evaluated.
Table 2. Outcomes by Treatment Group and APACHE II Score – 
STRIVE mITT Population 
Number of Patients (%)a   
  APACHE II Score    
  









PooledN=25 CASN=9    
  21 (58.3) 12 (75.0) 43 (74.1) 20 (60.6) 16 (64.0) 6 (66.7)   
  22 (61.1) 13 (81.3) 45 (77.6) 20 (60.6) 17 (68.0) 6 (66.7)   
  24 (66.7) 13 (81.3) 47 (81.0) 21 (63.6) 18 (72.0) 6 (66.7)   
  2 (5.6) 0 4 (6.9) 5 (15.2) 8 (32.0) 3 (33.3)   
aAPACHE II data not available for efficacy outcomes from 6 patients (N=3 
each, RZF Pooled and CAS) and for safety outcomes in 7 patients (N=3, RZF 
Pooled; N=4, CAS). 
APACHE II=Acute Physiology and Chronic Health Evaluation. 
Results: Efficacy rates among RZF-treated patients admitted to 
the ICU were similar to or higher than those with no ICU admission 
(Table 1). On the primary efficacy endpoint of overall response, 75% of 
the RZF-treated ICU cohort and 60.7% of the non-ICU cohort achieved 
overall success. In CAS-treated patients, efficacy rates were lower 
among the ICU cohort than in the non-ICU cohort (Table 1). In general, 
response rates with RZF were comparable across APACHE II scores and 
response rates with CAS were lower in patients with higher APACHE 
II scores (Table  2). Analysis of TEAEs by ICU status and by APACHE II 
scores showed no concerning trends or differences between RZF and 
CAS; not surprisingly, higher numbers of SAEs were seen in patients 
with ICU admission (vs no admission) and with APACHE II scores ≥20 
(vs scores <20) (data not shown).
Conclusion: This Phase 2 subanalysis demonstrated RZF efficacy in 
patients admitted to the ICU and across APACHE II scores, and the 
safety of rezafungin in these subpopulations was comparable to that 
of caspofungin. While RZF outcomes appeared worse in the lower acu-
ity patients, this was primarily due to the high numbers of indetermi-
nate outcomes (i.e., missing data and lost to follow-up) among these 
patients. These findings contribute to the evidence of RZF safety and 
efficacy in a broad range of patients and support the ongoing Phase 3 
development of RZF for the treatment of candidemia and IC (ReSTORE; 
NCT03667690).
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Introduction: Analysis of Outcomes by Geographic Region of Enroll-
ment in STRIVE, the Phase 2 of Rezafungin for the Treatment of Candi-
demia and Invasive Candidiasis (IC)
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Objectives: Rezafungin is a novel echinocandin in Phase 3 develop-
ment. STRIVE (NCT02734862)1 is the global, Phase 2 trial of rezafungin 
once-weekly for treatment of candidemia and/or IC versus standard of 
care. Results of STRIVE were evaluated by geographic region to assess 
for differences in the complete trial population
Methods: Data were stratified by region of enrollment (EU vs North 
America [NA]) and analysed for differences in patient demograph-
ics and baseline characteristics, treatment patterns, and efficacy 
outcomes.
Results: Patients enrolled in EU (N=131) were older than in NA 
(N=76) (mean, 64 vs 52 years, respectively) and were predominantly 
male (61.1%) and White (93.1%). The NA population was 50% male 
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and comprised 23.7% Black or African-American patients. On average, 
NA patients weighed more and had higher BMI (+2.3 kg/m2).
The same leading Candida species were isolated at baseline in both 
regions but with differing distribution. Candida albicans comprised 
44% of EU isolates, and proportions of Candida parapsilosis, Candida 
glabrata, and Candida tropicalis were similar (13-18%). In NA, C. albi-
cans accounted for 52% of isolates, followed by 25% C. glabrata and 
7% each for C. parapsilosis and C. tropicalis.
In both regions, 55% of patients received 8-14 days of IV treatment; 
27% of EU patients received >14 days versus 18% in NA. Fewer 
patients in EU were switched to oral step-down (24.4% vs 42.7% NA). 
The NA population had a higher proportion of patients with IC (26.3% 
vs 17.6% EU).
Outcomes were comparable between regions except for higher rates 
of overall success in EU patients treated with rezafungin 400 mg in 
Week 1 followed by 200 mg once weekly, compared with the NA 
cohort.
Conclusion: The Phase 2 STRIVE trial demonstrated few differences by 
region in demographic and baseline characteristics. The EU popula-
tion was slightly older, and NA patients were generally heavier. Non-
albicans species were predominant in the EU and comprised almost 
half of the NA isolates. Efficacy by region showed no consistent trends, 
although interpretation of efficacy-related differences are limited by 
group size. Results of this analysis may inform future evaluation of 
data from the rezafungin clinical trial program.
Reference(s) and grant ackowledgment(s)
1. 1. Thompson GR, Honore PM, Horcajada JP, Hites M, Bassetti M, Mena K, 
Navalta L, Viani R, Sandison T, Pappas P. Rezafungin Clinical Safety and 
Efficacy in the Treatment of Candidemia and/or Invasive Candidiasis: Com‑
bined Results from the STRIVE Phase 2 Trial Parts A and B. Trends in Medical 
Mycology; October 11‑14, 2019; Nice, France.
2. None
001129 
Related factors to mortality in patients admitted to the ICU due to 
COVID‑19 pneumonia
J.  Ruiz1; T. Moreno López2; J. Llabata1; E. Lucas  Romero2; M. De La Maza 
 Segovia3; R. Algarte1; F. Meza  Samaniego2; E. Piacentini1; B. Sánchez 
González1; J. Trenado1
1Intensive care department, Mútua Terrassa University Hospital, Terrassa, 
Spain; 2Internal medicine department, Mútua Terrassa University Hospi‑
tal, Terrassa, Spain; 3Anesthesiology and resuscitation department., Mútua 
Terrassa University Hospital, Terrassa, Spain 
Correspondence: B. Sánchez González
Intensive Care Medicine Experimental 2020, 8(2): 001129
Introduction: During the months of March to May we have experi-
enced in Spain the consequences of the COVID 19 pandemic. Different 
factors can be related to the evolution of a pathology, both those of 
the pathology and the patient, as well as those derived from the high 
number of cases in a short period of time. Below we intend to ana-
lyze the different factors that are related to the evolution of COVID-19 
pneumonia in our area.
Objectives: Describe the related factors to mortality in patients admit-
ted to the ICU due to COVID-19 pneumonia during the pandemic 
period.
Methods: Descriptive study conducted in a polyvalent ICU with 12 
critical care beds and 21 semi-critical beds. All patients admitted for 
COVID-19 pneumonia during the pandemic period were included.
The qualitative variables are expressed as percentages and were com-
pared using the X2-test, the quantitative variables are expressed as 
means and standard deviations (SD) and were compared using the 
student’s t test. A logistic regression model was constructed with ICU 
mortality as a dependent variable.
Results: 95 patients were admitted, Table 1 describes the main charac-
teristics of the patients.
RESULTS. 95 patients were admitted, Table 1 describes the main characteristics of the patients. 
Table 1 
selbairaV
Age (years, mean (SD))  58.6 (10) 
Sex (male%) 71 
SOFA at admission ≤ 67)%(5
Rockwood frailty scale at income ≤ 3(%) 100 
Multi-organ failure (%) 16 
Shock (%) 6 
Acute kidney failure (%)  11.6 
ICU long of stay (days, mean (SD))  13.1 (12.9) 
Hospital stay (days, mean (SD)) 25.4 (16.7) 
ICU mortality (%) 19 
Hospital mortality (%) 20 
100% of the patients received Kaletra, hydroxychloroquine and 
Azithromycin as treatment, 40% in addition, Tozilucimab, 34% inter-
feron. On March 31th, the corticosteroid treatment protocol was 
implemented in the institution, 62% of patients were admitted before 
this date (first 2 weeks) and 58% of patients were treated with corticos-
terioids. Table 2 show the factors related to ICU mortality.
Table 3 shows the logistic regression analysis for mortality in the ICU 
after adjusting for possible confounding factors.
Conclusion: Only a relationship between mortality in the ICU and 
previous cardiovascular comorbidity is observed, as well as with the 
development of acute renal failure and nosocomial pneumonia. How-
ever, other aspects that should be considered in the face of a possible 
new outbreak are the use of corticosteroids, the doses of sedation and 
muscle relaxants and the appearance of delirium.
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Introduction: During the months of March to May we have experi-
enced in Spain the consequences of the COVID 19 pandemic. Different 
factors can be related to the evolution of a pathology, both those of 
the pathology and the patient, as well as those derived from the high 
number of cases in a short period of time. Below we intend to analyze 
the different factors that are related to the evolution of COVID19 pneu-
monia in our area.
Objectives: Describe the corticosteroids use related factors in the 
treatment of covid-19 pneumonia in patients admitted in ICU during 
the pandemic period.
Methods: Descriptive study carried out in a polyvalent ICU. All 
patients admitted because of COVID-19 pneumonia during the coro-
navirus outbreak were included.
A corticosteroid treatment protocol was established for patients with 
severe covid-19 pneumonia whose institutional implementation was 
on 03/31/2020.
Statistics: Qualitative variables are expressed as percentages and 
were compared using the Χ2-test.
The quantitative ones are expressed as means and standard deviations 
(SD) and were compared using the t-Student test.
A logistic regression model was constructed with treatment with corti-
costeroids as a dependent variable.
Results: Table 1 describes their main features.
Table 1               Variables   
Age (years, mean (SD)) 58.6 (10) 
17)%elam(xeS
SOFA at admission ≤ 5 (%) 76 
Rockwood frailty scale at income ≤
3(%) 100 
Multi-organ failure (%) 16 
6)%(kcohS
Acute kidney failure (%) 11.6 
ICU long of stay (days, mean (SD)) 13.1 (12.9) 
Hospital stay (days, mean (SD) 25.4 (16.7) 
ICU mortality (%) 19 
 Hospital mortality (%) 20 
100% of patients received all Kaletra, Hydroxychloroquine and Azithro-
mycin treatment.
40% of them, in addition, received Tozilucimab and 34% of them 
received interferon too.
55 patients (58%) were treated with corticosteroids and 52 of them fol-
lowed the institutional protocol started on March 31.
Table 2 shows corticosteroids use related factors.
Table 3 shows the logistic regression analysis with the use of corticos-
teroids as a dependent variable.
Conclusion: After adjusting for different confounding variables, a sta-
tistically significant relation is maintained between the use of corticos-
teroids for treatment of patients with COVID-19 pneumonia admitted 
in ICU and infusion days of propofol and remifentanil. However, its 
relation with other aspects (tendency to fewer days in mechanical 
ventilation and less ICU and hospital mortality) should be taken into 
account for future outbreaks and studies.
Reference(s) and grant ackowledgment(s)
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Introduction: During the months of March to May we have experi-
enced in Spain theconsequences of the COVID 19 pandemic. Different 
factors can be related to theevolution of a pathology, both those of 
the pathology and the patient, as well asthose derived from the high 
number of cases in a short period of time. Below we intend to ana-
lyze the different factors that are related to the evolution of COVID-19 
pneumonia in our area.
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Objectives: To analyze the clinical utility of measuring D-dimer and 
Ferritin in patients admitted to the ICU with COVID-19 pneumonia 
during the SARS-CoV-2 outbreak.
Methods: Descriptive study carried out in a polyvalent ICU. All the 
patients admitted for pneumonia-COVID-19 during the pandemic 
period. Analytical measurements of d-dimer and ferritin were made 
from admission to hospital discharge. All patients had minimum 2-3 
weekly measurements of these values.
Statistics:ROC curve analysis was performed for the maximum value 
of D-dimer and Ferritin and the difference between the minimum and 
maximum value (delta) of these parameters regarding different clinical 
variables.
Results: 95 patients were admitted. Table 1: describes the clinical vari-
ables analyzed with ROC curve with respect to the value of D-dimer 
and Ferritin.
Table 1               Variables   
Age (years, mean (SD)) 58.6 (10) 
 17 )%elam( xeS
SOFA at admission ≤ 5 (%) 76 
Pulmonary embolism (%) 13 
Patient receives anticoagulation (%) 26 
Patient receives corticosteroids (%) 58 
ICU long of stay (days, mean (SD)) 13.1 (12.9) 
Hospital stay (days, mean (SD) 25.4 (16.7) 
ICU mortality (%) 19 
Hospital mortality (%) 20 
13 cases of pulmonary embolism (PE) were diagnosed, 3 of them were 
from the main pulmonary artery, 5 of them from segmental pulmo-
nary artery, 1 of them from small glass and 5 of them from subseg-
mental arteries. In the group of 22 descoagulated patients, PE was 
only confirmed in 5 cases. Figure 1: represents the behavior of the ROC 
curves for ICU mortality and corticosteroid treatment.
Figure  2: represents the behavior of ROC curves for diagnosis of PE 
and anticoagulated pacient.
As the best result, we look at the area under the curve (AUC) for ICU 
mortality with respect to the delta of the D-dimer that shows a value 
of 0.711 with a 95% CI (0.561-0.861) and a significance asymptotic: 
0.016. An increase in D-dimer between 5500 and 6000 ng / mL is 
related to ICU mortality with a sensitivity between 0.77-0.61 and speci-
ficity between 0.68 / 0.69. The AUC for anticoagulated patient and PE 
shows the relationship of the D-dimer value and its delta to empiri-
cally anticoagulate a patient but not to diagnose PE.
Conclusion: The behavior of the maximum values of D-Dimer and 
Ferritin, as well as its delta, showed no prognostic neither diagnos-
tic utility for PE and no utility in therapeutic decision-making in ICU 
hospitalized patients with COVID-19 relatedpneumonia. The need for 
routine measurement of these parameters in this group of patients 
should be assessed.
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Introduction: During the months of March to May we have experi-
enced in Spain the consequences of the COVID 19 pandemic. Different 
factors can be related to theevolution of a pathology, both those of 
the pathology and the patient, as well asthose derived from the high 
number of cases in a short period of time. Below we intend to ana-
lyze the different factors that are related to the evolution of COVID-19 
pneumonia in our area.
Objectives: Describe the main characteristics of the patients admit-
ted in ICU due to covid-19 related pneumonia during the coronavirus 
outbreak.
Methods: Descriptive study carried out in a polyvalent ICU with 12 
beds for critical care and 21 for semi-critical care. All patients with 
covid-19 related pneumonia admitted in ICU in the outbreak were 
included in the study.
Statistics: Qualitative variables are expressed as percentages and quan-
titative variables are expressed as means and standard deviations (SD).
Results: 95 patients were entered,Table 1 described the main clinical 
characteristics of the patients.
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Table 1               Variables   
Age (years, mean (SD)) 58.6 (10) 
17)%elam(xeS
SOFA at admission ≤ 5 (%) 76 
Rockwood frailty scale at income ≤
3(%) 100 
Multi-organ failure (%) 16 
Patient receives anticoagulation (%) 26 
Acute kidney failure (%) 11.6 
ICU long of stay (days, mean (SD)) 13.1 (12.9) 
Hospital stay (days, mean (SD) 25.4 (16.7) 
ICU mortality (%) 19 
Hospital mortality (%) 20 
Table 2: describes other clinic characteristics and complications.
Table  3 describes respiratory failure and mechanical ventilation 
characteristics
ICU mortality was 19% and 20% at hospital discharge.
Conclusion: Patients admitted in ICU for COVID-19 related pneumo-
nia presented severe hypoxemia as the main organ affectation upon 
admission, requiring protective ventilation. Prone ventilation and tra-
cheostomy were performed in a high percentage of patients. Infec-
tious complications, PE and delirium were frequent.
Reference(s) and grant ackowledgment(s)
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Introduction: During the months of March to May we have experi-
enced in Spain theconsequences of the COVID 19 pandemic. Different 
factors can be related to theevolution of a pathology, both those of 
the pathology and the patient, as well asthose derived from the high 
number of cases in a short period of time. Below we intend to ana-
lyze the different factors that are related to the evolution of COVID-19 
pneumonia in our area.
Objectives: Describe the factors related to delirium in patients admit-
ted in ICU due to COVID-19 pneumonia.
Methods: Descriptive study carried out in a polivalent ICU. All patients 
admitted because of pneumonia by COVID-19 during the pandemia 
period were included. It was considered that a patient presented delir-
ium by the ICU medical teams’ clinical diagnosis. Delirium treatment 
was confirmed and adequated together with a psychiatry team desti-
nated to ICU.
Statistics: Qualitative variables were expressed as percentages and 
were compared using the X2-test, quantitative were expressed as 
means and standard deviations (SD) and were compared using T-Stu-
dent test. A logistic regression model with delirium as dependent vari-
able was constructed.
Results: 95 patients were admitted, 35.6% presented delirium during 
ICU admission and 16% at discharge to hospitalization plant. 66’3% of 
all patients were intubated. 100% received Kaletra, Hydroxicloroquine 
and Azithromycin as treatment, additionally, 40% received Tocili-

















Antipsychotic treatment at discharge to hospitalization 
plant % 26.8 
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Table 2 shows factors related to delirium.
Table  3 shows logistic regression analysis of delirium as dependent 
variable.
Conclusion: The patients admitted at our ICU due to COVID-19 pneu-
monia presented a high delirium incidence. Different factors as intuba-
tion and mechanical ventilation were associated with its development, 
aswell as sedation and muscle relaxants. However, it should be noted 
the statistically significant association after adjusting by different con-
fusion factors between delirium with mortality in ICU, nosocomial 
infection appearance and prone ventilation.
Reference(s) and grant ackowledgment(s)
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001173 
Co/Super infection in critical SARS‑CoV2 pneumonia
B. Rodrigues De  Castro1; A. Knapen1; LP. Moulaert1; P. Henin1; JB. Mesland1
1Icu, CH Jolimont, La Louvière, Belgium 
Correspondence: J.B. Mesland
Intensive Care Medicine Experimental 2020, 8(2): 001173
Introduction: Knowledge and understanding about SARS-CoV2 
pathology is still poor. Viral pneumonia are known to promote co-
infection or secondary bacterial infection. Diagnosis might be difficult 
between colonization of the respiratory tract and real infection. We 
need to be aware of specific patterns of infection as it is crucial for 
empiric prescription when needed.
Objectives: To review microbiological data regarding our critical 
SARS-Cov2 patients and evaluate if there is specific patterns of bacte-
rial co-infection and super infection.
Methods: In an observational, retrospective and monocentric study, 
we reviewed microbiological data (blood culture, endotracheal aspi-
rate, bronchoalveolar lavage) of all SARS-Cov2 patients admitted in 
our ICU between march 2020 and may 2020. If the same bacteria grew 
in different sample, it was counted as a unique episode.
Results: Between march 2020 and may 2020, 44 patients have been 
admitted to our 22 beds ICU for critical SARS-CoV2 pneumonia. Mean 
age at admission was 62,44 years (range 38 years – 83 years). 37/44 
patients received mechanical ventilation, for a total of 638 days, and 
13/44 patients received ECMO therapy, for a total of 249 days. ICU Mor-
tality of our cohort is 50%.
From our routine microbiology testing from tracheal aspirate, 34/44 
patients had documented positive culture. 80 specimens were identi-
fied, distributed in order of prevalence as : Klebsiella species for 20% 
(Klebsiella pneumoniae for 8,75%, Klebsiella oxytoca for 6,25%, Kleb-
siella aerogenes for 3,75%, Klebsiella varicola for 1,25%), Pseudomonas 
aeruginosa for 13,75%, E. Coli for 8,75%, Proteus species for 7,5% (Pro-
teus mirabilis for 3,75%, Proteus vulgaris for 2,5%, Proteus hauseri for 
1,25%), Staphylococcus aureus for 7,5% (MSSA for 6,25%, MRSA for 
1,25%), Enterobacter species for 6,5% (Enterobacter cloacae for 3,75%, 
Enterobacter asburiae and kobei for 1,25%), Citrobacter koseri for 
3,75%, Hafnia alvei for 2,5%, Streptococcus pneumoniae for 2,5%, Ser-
ratia species for 2,5%, Haemophilus influenzae for 1,25%. We noted a 
high number of Candida albicans positive specimens (13,75%), which 
is not considered to be able to be an agent of pneumonia.
We performed 16 bronchoalveolar lavage (BAL). 87,5% were pre-
dominantly neutrophilic. Regarding Pneumocystis jirovecii, indirect 
immunofluorescence using monoclonal antibodies were negative 
in all patients. All but one patient had BAL galactomannan negative, 
and none of our patients had positive respiratory culture for Asper-
gillus fumigatus. Multiplex RT-PCR was requested in 6 patients. 2/6 
were strongly positive for HSV, and all were negative for Pneumocystis 
jirovecii.
12/44 patients developed at one time during their ICU stay an episode 
of bacteremia. 9/12 were secondary to ventilatory associated pneu-
monia. From our cohort, 17% had co-infection at admission (consider-
ing co-infection as positive microbiology within the first 48 hours in 
our ICU).
Conclusion: To conclude, we did not find typical organism described 
in community acquired pneumonia as being prevalent in SARS-CoV2 
pneumopathy. Most of our positive microbiology were Gram negative 
bacteria, typical of ventilatory associated pneumonia. Indeed patients 
had to be mechanically ventilated during prolonged period of time. 
None of our patient had documented PCP or invasive pulmonary 
aspergillosis (IPA), as opposed to case series who found until one-third 
of patients with putative IPA(1)(2).
Reference(s) and grant ackowledgment(s)
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Introduction: The incidence of infection with severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV 2) worldwide is still on the rise and 
the prevention and treatment of coronavirus disease - 2019 (COVID-
19) still a major challenge. Among those existing medications used for 
COVID-19 are intravenous immunoglobulins (IVIG) which are known 
for their anti-inflammatory effects and approved in several immune 
mediated disorders, including Kawasaki syndrome. Several case 
reports showing beneficial effects of IVIG administration in COVID-19 
patients have been reported recently (1-5)
Objectives: To compare clinical outcomes and biomarkers in patients 
with severe COVID-19 treated with standard of care (SoC) alone or 
with SoC and IVIG.
Methods: Data from a cohort of severely ill COVID-19 patients requir-
ing intensive care at a center of excellence in Turkey was analysed 
retrospectively. A subgroup of patients received high-dose IVIG 
(Octagam 5%) treatment at 0.4 g/day for 5 consecutive days in addi-
tion to SoC according to a site-specific treatment algorithm and was 
compared to those patients receiving SoC alone. Clinical outcome 
measures included duration of specific treatment modalities, time to 
start of mechanical ventilation, change in ventilation mode, ICU and 
hospital discharge, and overall survival. Plasma biomarkers of inflam-
mation  (CRP, ferritin, PCT, IL-6, D–dimer, leukocytes) were measured 
at baseline and 6 days after ICU admission and treatment start. Imbal-
ance in APACHE II scores was addressed by propensity-score-match-
ing; otherwise Kaplan-Meier and multiple regression models were 
used.
Results: Data from 93 patients were included into analysis. Of these, 
51 had received IVIG plus SoC and 42 were treated with SoC alone. 
In both groups, about 75% of patients were male and patients had 
comparable BMI and blood group distribution as well as compara-
ble vital signs. The IVIG group was slightly younger (mean: 65 vs. 71 
years) and had slightly lower baseline disease scores (mean APACHE II: 
20.6 vs. 22.4; mean SOFA: 5.0 vs. 7.0). Apart from IVIG, patients in both 
groups were treated with hydroxychloroquine, favipiravir, azithromy-
cin, oseltamivir, tocilizumab/anakinra, methylprednisolone, and/or 
ascorbate. Analysis showed that overall survival (OS) was 61% in the 
IVIG and 38% in the control group. After controlling for imbalances at 
baseline, there remained a trend for better OS (OR: 2.2, 95%CI: 0.9-5.4, 
p=0.091) and a significantly longer median survival (68 vs. 18 days, 
p=0.014). Moreover, IVIG treatment significantly reduced CRP levels by 
46% within 6 days compared to SoC alone (p=0.049), but had no rel-
evant effect on any other inflammation marker measured.
Conclusion: Adjunct treatment with IVIG might add to the currently 
limited armamentarium against COVID-19, especially due to its well-
known anti-inflammatory properties. However, results need to be con-
firmed in a randomized, controlled trial.
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2020:105974. Epub 2020/04/17.
3. 3) Cao W, Liu X, Bai T, Fan H, Hong K, Song H, et al. High‑Dose Intra‑
venous Immunoglobulin as a Therapeutic Option for Deteriorating 
Patients With Coronavirus Disease 2019. Open forum infectious diseases. 
2020;7(3):ofaa102. Epub 2020/04/08.
4. 4) Lanza M, Polistina GE, Imitazione P, Annunziata A, Di Spirito V, Novella C, 
et al. Successful intravenous immunoglobulin treatment in severe COVID‑
19 pneumonia. IDCases. 2020;21:e00794‑e.
5. 5) Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multi‑
system Inflammatory Syndrome in Children During the Coronavirus 2019 
Pandemic: A Case Series. J Pediatric Infect Dis Soc. 2020;9(3):393‑8.
6. This retrospective study was sponsored by Octapharma AG, Lachen, 
Switzerland
001183 
Microbiological profile of infections in patients admitted 
by COVID‑19 to the intensive care unit (ICU)
S. Ramiro González1; MDM. Molina  Morales1; CM. Rodríguez Mejías1; 
J. Machado  Casas1
1Medicina intensiva, Hospital Universitario Virgen de las Nieves, Granada, 
Spain 
Correspondence: S. Ramiro González
Intensive Care Medicine Experimental 2020, 8(2): 001183
Introduction: Coronavirus infection (COVID-19) produces a severe 
acute respiratory syndrome that in up to 5 - 10% of cases requires 
admission to the ICU, with overinfection being one of the most fre-
quent complications during a stay in this Unit.
Objectives: To describe the main intra-ICU infections according to 
location and microbiological germ isolated in patients admitted for 
COVID-19.
Methods: Retrospective descriptive study conducted with the data 
collected for the ENVIN registry in the period from March 13, 2020 
to April 30, 2020 in the ICU of the Virgen de las Nieves Hospital in 
Granada.
Patients over 18 years old with a stay of more than 24 hours were 
included. Baseline characteristics: age, sex, degree of severity (APACHE 
II), mean stay, ICU mortality and extrinsic risk factors. The type of intra-
ICU infections are exposed according to the isolated microorganism 
and the location of the infection.
Results: A total of 60 patients admitted to the ICU of our hospital are 
included, 80% of which are male, with a mean age of 60.03 ± 11.25 
years and with APACHE II at admission of 13.76 ± 5.65 years. The aver-
age stay in the ICU was 21.11 ± 13.45 and the mortality was 38.18%. 
Among the extrinsic risk factors, more than 80% of these patients 
required an artificial airway, 98.33% carried a central venous catheter 
and 98% a urinary catheter and 60% had received antibiotherapy prior 
to admission to the ICU.
The rate of intra-ICU infections was 90 infections per 100 patients 
admitted, the most frequent location being bacteremias of unknown 
focus and secondary to catheter infection (50%), followed by pneumo-
nias associated with mechanical ventilation (27.59%) and urinary tract 
infections (13.79%). In the case of bacteremias, up to 67.74% of large 
positive microorganisms were isolated, most frequently E. Faecalis and 
S. epidermidis, and up to 16.13% candida spp. Faecalis (50%), followed 
by Candida spp.; on the other hand, in pneumonias associated with 
mechanical ventilation, 57.14% of gram-negative bacilli stand out, 
among them Pseudomona aeruginosa and klebsiella pneumoniae, 
and up to 19% of fungal isolation.
Conclusion: A high rate of intra-ICU infections is observed in patients 
admitted for COVID-19, the most frequent being labacteremia of 
unknown focus and secondary to catheter infection. This high rate of 
infections may be justified by the high percentage of invasive devices 
used as well as by the degree of complexity and severity of these 
patients.
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Introduction: Coenzyme Q10 (CoQ10) is a lipid-soluble vitamin-
like compound present in the inner membrane of the mitochondria, 
where it transports electrons from complexes I and II to complex III of 
the mitochondrial respiratory chain (MRC). CoQ10 removes free radi-
cals, inhibits the initiation and propagation of lipid peroxidation in cel-
lular membranes, and aids in the regeneration of other antioxidants, 
such as vitamin E and C.  CoQ10 levels in septic ICU patients have 
been investigated by a limited number of studies. The possibility that 
CoQ10 plasma concentrations exhibit time course changes from the 
initial period of critical illness to sepsis and septic shock, remains cur-
rently unexplored.
Objectives: We sought to investigate whether in a group of initially 
non-septic, critically ill patients, coenzyme Q10 (CoQ10) changes dur-
ing progression from critical illness to sepsis and septic shock and 
assess its associations with inflammatory biomarkers, and intensive 
care unit (ICU) outcome.
Methods: This was an observational analysis on 63 initially non-sep-
tic ICU patients. CoQ10 was sequentially measured on admission in 
the ICU (baseline) and at sepsis and septic shock onset. Additionally, 
CoQ10 was measured in 25 age and sex-matched healthy controls. 
Inflammatory biomarkers were determined at baseline.
Results: On ICU admission and prior to sepsis development, patients 
had lower CoQ10 levels compared to healthy controls (0.89 vs. 1.04 
µg/ml, p< 0.01). At sepsis onset, CoQ10 levels decreased to 0.63 µg/ml, 
p<0.001, and at septic shock (N= 14) to 0.42 µg/ml, p<0.0001. Baseline 
CoQ10 correlated with low density lipoprotein (r2= 0.409, p= 0.002), 
and tended to negatively correlate with IL-8 and TNF-α. CoQ10 at sep-
sis was not associated with ICU mortality.
Conclusion: Initially non-septic, critically ill patients have lower 
CoQ10 on ICU admission compared to healthy controls, with a further 
decrease in sepsis and septic shock, suggesting that CoQ10 depletion 
is related to sepsis severity. CoQ10 is a component of the mitochon-
dria, and supplementation might improve mitochondrial function in 
septic shock.
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Introduction: Acute renal failure has been studied extensively, mainly 
to try to minimize pharmacological toxicity. Early administration of 
appropriate and correctly dosed antibiotics is one of the cornerstones 
of sepsis treatment. At present, the opposite situation is also disturb-
ing, in which there is an augmented renal clearance (ARC), because it 
could affect the outcome of these patients.
Objectives: The purpose was to determine the prevalence of the phe-
nomenon of relevant augmented renal clearance (> 170mL/min/1.73 
m2, rARC) and analyze the characteristics of these patients.
Methods: Multicenter, observational, prospective, epidemiological 
study in the critically ill patient with sepsis. 18 hospitals were recruited 
where 3 prevalence points were made, calculating the glomerular fil-
tration rate (GFR) in 4-hour urine collection sample. The characteristics 
of these patients were compared with those with non-rARC group 
(GFR 90-170mL/min/1.73 m2). A descriptive analysis and a univariate 
analysis were performed. A type I error <0.05 was considered statisti-
cally significant. The results are given in medium and 95%CI.
Results: 561 patients of 65.5 (63.5-66.5) years were included. We focus 
on those 116 patients with TFG> 90 ml/min/m2. Of these 116 patients, 
34 (29.31%) were classified in the rARC group and 82 (70.7%) in the 
non-rARC group. The rARC patients were younger 59.5 (51-64) years 
vs. 64.5 (61-70) years, P=0.03. However, the sex ratio was also: 55.9% 
in rARC vs. 68.3% in non-rARC, P=0.56. Mortality was also similar in 
both groups: ICU mortality was 11.8% in rARC vs. 14.6% in non-rARC, 
P=0.94. In-hospital mortality was the same: 17.6% in rARC vs. 17.1% in 
non-rARC, P=0.56. And length of stay (LOS) was also similar: ICU-LOS 
was 15.5 (13-36) days in rARC group, vs. 20.5 (15-27) days in non-rARC, 
P=0.56. And HOSP-LOS was 34 (15-53) days in rARC group, vs. 34 (27-
43) days in non-rARC, P=0.3.
Conclusion: Relevant-ARC is found in almost 30% of ICU patients. 
rARC patients are younger. Conversely, sex is similar, and so is mortal-
ity and length of stay.
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Introduction: Sepsis and multiple organ dysfunction syndrome 
(MODS) accompanied by an increase of catabolic reactions, which 
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include activation of lipolysis. Assessment of lipolysis activity allows us 
to judge the severity of the patient’s condition and its changes during 
treatment. It may also be necessary to determine the amount of nutri-
tional support.
Objectives: To develop a method for assessing lipolysis activity by 
the composition of blood plasma fatty acids in patients in abdominal 
surgery.
Methods: A prospective case-control study of the composition of 
blood plasma fatty acids was performed in 31 patients after abdomi-
nal operations during the first 24  h after admission in the intensive 
care unit (ICU). The patients were divided into two groups: group 1 (n 
= 15) - without sepsis and MODS, group 2 (n = 16) - the presence of 
sepsis and MODS. Sepsis and MODS were established by the criteria of 
the 2016 SCCM / ACCP conference.
Measurements of the composition of fatty acids were carried out on 
gas chromatographs ГX–1000, ЦBET–800 (Russian Federation). Final 
identification was carried out using the method of chromatography-
mass spectrometry using Thermo Scientific DSQ II (USA). The deter-
mination of the proportion of individual fatty acids was carried out by 
the internal normalization method using the Unichrom-97 spectro-
metric information recording system.
Statistical processing of the results was performed using the SPSS and 
Statistica 7.0 programs. Data are presented as medians and quartiles. 
Differences between groups were determined by the Mann-Whitney 
U test.
Results: Of the 31 patients, there were 19 men and 12 women, age 
40 (35-46) years, height 172 (168-175) cm, body weight 80 (64-92) kg. 
Patients in groups with no statistical differences in sex, age, weight, 
height. The Apache III score was significantly higher in the group 2 of 
53.0 (39.2-74.7) points vs 33.3 (9.9-53.2) points (p=0.01). The duration 
of treatment in the ICU was significantly higher in the group 2 of 11 
(5-15) days vs 2 (2-3) days (p<0.001). Mortality in the group 1 - 0%, in 
the group 2 - 25%.
Patients had the following pathology: acute pancreatitis - 7, chronic 
pancreatitis - 11, cholelithiasis - 5, acute intestinal obstruction - 3, 
abdominal trauma - 4, peptic ulcer with perforation - 1. They per-
formed laparotomy - 26, laparoscopy - 5 relaparotomy - 3.
It was found that in the composition of total plasma lipids, the total 
proportion of palmitoleic and oleic fatty acids increases. If in patients 
of the group 1 this proportion is 18.2 (16.2-19.6)%, then in patients of 
the group 2 it is 27.9 (24.5-31.3)% (p<0.001).
The construction and analysis of the receiver operating characteristic 
curve for the method is performed. It was established that the area 
under the curve is 0.929 with a 95% confidence interval from 0.837 to 
0.978 (p <0.0001), sensitivity 87.5%, specificity 93.3%, threshold 21.7%.
Conclusion: The increase in the proportion of palmitoleic and oleic 
fatty acids in the composition of total blood plasma lipids reflects an 
increase in lipolysis activity.
Assessing the activity of lipolysis allows us to judge the intensity of 
catabolic processes in the body in patients.
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Introduction: Precision medicine is considered to be the means to 
improve outcome of sepsis patients in the future. Statistical analyses 
applied to results may uncover high degrees of associations between 
markers or interventions and outcomes; however, even high degrees 
of association do not necessarily imply a predictive value of an inter-
vention. Precision medicine requires prediction; thus attributing pre-
dictive value to associations diverges from this path and may lead to 
erroneous conclusions that can ultimately harm patients.
Objectives: To determine whether and to what extent published liter-
ature in sepsis with claims of prediction in their titles in fact do provide 
relevant measures of prediction in their abstracts. Our core premise 
was that abstracts, as the most informative summaries of published 
papers, should always confirm the claims of the title by reported statis-
tical methodology that pertains to predictive utility.
Methods: A systematic search was performed using NCBI PubMed 
on Jan 27, 2020, aiming to identify articles that contain the terms 
sepsis and prediction in the titles using the following search term: 
sepsis[Title] AND (prediction[Title] OR predict[Title] OR predicts[Title] 
OR predictive[Title] OR predicting[Title]) AND (hasabstract[text] AND 
“humans”[MeSH Terms]). General terms and defined measures of indi-
vidualized prediction, as well as other reported statistical methodolo-
gies related to associations, were extracted from the abstracts of these 
papers. Prediction metrics were defined as measures derived from 
individualized predicted outcomes or probabilities, while association 
metrics were defined as measures pertaining to group results.
Results: In total, 518 articles, published between 1978 and 2019, were 
identified. Of these, 34 were excluded due to non-relevance to this 
systematic assessment. The remaining 484 articles, published in 227 
unique journals, comprised our study sample. Of these articles, 36% 
(n=173) did not report metrics of predictive utility, while the remain-
ing 64% (n=311) included at least one metric of predictive utility in 
their abstracts. Of the abstracts that reported measures of predictive 
utility, the most common reported metrics were ROC AUC (70%), sen-
sitivity (40%) and specificity (36%). Of the abstracts without measures 
of predictive utility, 54% did not define their methodology, while 28% 
performed logistic regression and 15% performed Cox models. Full 
review of the 173 undefined manuscripts revealed that more than 75% 
(n=117) were actually describing a relationship based upon associa-
tions only, while 17% (n=31) contained some measure of prediction.
Conclusion: We demonstrate evidence that more than one-third of 
abstracts from papers that claim to provide insights on prediction in 
the sepsis literature actually provide no methodology to evaluate 
prediction in their abstracts. In most cases, these manuscripts offer 
a measure of association or no defined methodology at all. When no 
information was available in the abstract, more than 75% of these 
manuscripts did not provide measures of prediction and often claimed 
prediction while using only tests of association. Such confusion may 
ultimately harm patients, for instance by undergoing unnecessary and 
inappropriate treatment of abnormalities that proves not to be predic-
tive despite statistically significant associations.
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Introduction: Endothelial cells are involved in the pathogenesis 
of sepsis and organ dysfunction caused by sepsis. There is no well-
established method in clinical practice for evaluating endothelial 
injury in sepsis. Endothelial microparticles (MPs) (EMPs) are extracel-
lular vesicles derived from the cellular membranes of injured or apop-
totic endothelial cells, which suggests that EMPs may be a marker for 
endothelial injury in sepsis.
Objectives: To examine whether the number of EMPs is increased in 
patients with sepsis and reflects the severity of sepsis.
Methods: This prospective observational study was performed to 
examine the numbers of circulating EMPs in patients with sepsis using 
flow cytometry (ethics committee approval: 2018-1-353). We collected 
platelet-poor plasma (PPP) from patients diagnosed with Sepsis-3 on 
admission and on days 2, 3, 5, and 7 of hospitalisation. We also col-
lected PPP for a non-sepsis control group from patients who were 
admitted to the intensive care unit after undergoing scheduled head 
and neck surgery on admission and on days 2, 3, and 5 of hospitali-
sation. EMPs were defined as CD31+/CD41- MPs [platelet endothelial 
cell adhesion molecule  (PECAM)+ EMPs], CD144+ MPs [vascular 
endothelial (VE)-cadherin+ EMPs], CD62E+ MPs (E-selectin+ MPs), 
CD54+ MPs [intercellular adhesion molecule (ICAM)-1+ EMPs], and 
CD106+ MPs [vascular cell adhesion molecule (VCAM)-1+ EMPs] MPs.
Results: We examined the numbers of circulating EMPs in 72 patients 
with sepsis (sepsis, 29; septic shock, 43) and 30 non-sepsis patients. 
The numbers of all types of EMPs were significantly higher in patients 
with sepsis than in non-sepsis patients during the study period, except 
for VCAM-1+ EMPs on admission. The numbers of PECAM+ and VE-
cadherin+ EMPs, the expressed endothelial antigens of which are 
rich in endothelial cell intercellular junctions and regulate endothe-
lial junctional integrity and permeability, were significantly higher in 
patients with septic shock than in those with sepsis until day 5. On the 
other hand, the number of E-selectin+ EMPs, which are endothelial 
adhesion molecules induced by inflammatory stimuli, such as E-selec-
tin, ICAM-1, and VCAM-1, on admission was significantly higher in 
patients with septic shock than in patients with sepsis. The numbers of 
PECAM+, VE-cadherin+, and E-selectin+ EMPs on admission, as well as 
PECAM+ EMPs on day 2, were significantly higher in patients who died 
in the hospital than those in survivors.
Conclusion: The number of EMPs significantly increased in patients 
with sepsis, which may suggest that an increase in the number of 
EMPs may reflect endothelial injury in sepsis. Furthermore, the num-
bers of PECAM+ and VE-cadherin+ EMPs are higher in patients with 
septic shock than in patients with sepsis and might be novel markers 
of the severity of septic endothelial injury.
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Introduction: The presence of sepsis on patients’ admission to the 
intensive care unit (ICU) is associated with adverse outcomes [1]. It has 
been demonstrated that many patients suffer additional infectious 
and septic episodes, which might increase mortality [2].
Objectives: Our aim is to delineate the incidence and clinical char-
acteristics of the secondary sepsis event in comparison with sepsis 
on admission in a setting of endemic difficult-to-treat Gram-negative 
microbial infections.
Methods: Secondary ICU-associated sepsis was defined as a second 
septic event, >48 hours after admission. Data were retrieved from the 
records of all patients admitted in our 16-bed mixed ICU between July 
2015 and December 2017. We excluded patients with an ICU stay of 
<48hs. We described continuous variables as median (IQR) and cat-
egorical variables as number (percentage) and we performed com-
parisons with Mann-Whitney, Wilcoxon test and chi-square test, where 
appropriate. We used survival analysis to evaluate ICU mortality.
Results: Sixty-five septic patients (65 episodes), 42 (64.6%) male, and 
35(53.4%) medical, were analyzed. Their age, Charlson comorbid-
ity index, APACHE II, and SOFA on admission were 73 (65-79) years, 
4 (3-5), 24 (18-27.5), and 10 (8-12), respectively. The most commonly 
encountered primary septic focus was intraabdominal (46.2%), and 
42(64.6%) patients were in septic shock. A pertinent culture displayed 
a pathogen in 35 (53.8%) episodes, and Gram-negative isolates pre-
vailed (26/35, 74.3%).
Sixteen (24.6%) patients presented secondary sepsis on day 9(6-15.5), 
an isolate was identified in 93.7% of events, and  Acinetobacter bau-
mannii was isolated in 8/15 events (53.3%). The presence of hypother-
mia on the day of both episodes was the same (20%); temperature and 
white blood cells did not differ between the events.
Regarding the outcome, overall ICU mortality was 46.2%. The Kaplan-
Maier curve analysis of 30-day mortality did not show any difference 
between patients with and without secondary sepsis. However, sec-
ondary sepsis was associated with prolonged length of stay in the ICU 
(21 vs. ten days, p=0.001). Eventually, more patients died after their 
first month in the critical care department (ICU mortality of 75% vs. 
37%, p=0.02).
Conclusion: In a setting of endemic difficult-to-treat Gram-negative 
bacteria, secondary sepsis, on top of primary sepsis, can lead to both 
prolonged hospital stay and late mortality.
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Introduction: Frailty increases the risk of morbidity and mortal-
ity in patients with critical illnesses. However, most previous studies 
evaluated a heterogeneous population. The specific characteristics 
of patients with sepsis according to frailty in the intensive care units 
(ICUs) remains unclear.
Objectives: We aimed to investigate the association between frailty 
and characteristics, clinical features, and outcomes among patients 
with suspected infection in ICUs.
Methods: This is a secondary analysis of the Japanese Association 
for Acute Medicine Sepsis Prognostication in Intensive Care unit and 
Emergency room (JAMA SPICE)-ICU study, which was a multicenter 
study of patients with suspected infection. We included adult patients 
(≥18 years) with suspected infection who were admitted to ICUs. 
Frailty was evaluated using the Canadian Study on Health and Aging 
Clinical Frailty Scale (CFS)[1]. As previous reported [2], baseline patient 
characteristics and outcomes were compared between three frailty 
groups: fit (scale 1–3), vulnerable (scale 4) and frail (scale 5–9). We 
also performed a subgroup analysis of patients with sepsis, which was 
defined based on sepsis-3 criteria. The Kaplan–Meier survival curve for 
90 days was also drawn.
Results: We enrolled 650patients with suspected infection, includ-
ing 599 (92.2%) patients with sepsis, for this study from the SPICE-ICU 
database. Patients with a median rating of 3 (3-5) according to the 
CFS, were included: 337 (51.8%) were fit, 109 (16.8%) vulnerable, and 
204 (31.4%) frail. Comorbidities were more prevalent in frail and vul-
nerable patients than in fit patients. The APACHE II scores for fit, vul-
nerable, and frail patients were 18 (12–25), 22 (17–28), and 21 (15–27), 
respectively (p<0.01). The body temperatures of patients were as 
follows: fit 37.5 (36.5–38.5)°C; vulnerable 37.5 (36.4–38.6)°C; frail 37.0 
(36.3–38.1)°C (p<0.01). Regarding the laboratory data, the CRP level 
in fit, vulnerable and frail patients were 13.6 (4.6-24.5) mg/dl, 12.1 
(3.9-24.9) mg/dl, 10.5 (3.03-21.0) mg/dl, respectively (p < 0.01). There 
was no statistically significant difference regarding organ dysfunc-
tion among the groups. In-hospital mortality did not differ statistically 
according to frailty: fit 55/335 (16.4%); vulnerable 23/107 (21.5%); frail 
45/203 (22.2%), p = 0.19. Kaplan–Meier survival curves showed that 
there was little difference in the mortality rate among groups during 
the acute phase. However, vulnerable and frail patients tended to die 
after the acute phase while the fit did not, although the difference 
was not statistically significant (p = 0.25, Figure). Compared to fit or 
vulnerable patients, fewer frail patients were discharged to home: fit 
125/280 (44.6%); vulnerable 36/84 (42.9%); frail 40/158 (25.3%).
Conclusion: Frailty was associated with a poor response to inflamma-
tion of infection.Frail and vulnerable patients with suspected infection 
including sepsis tended to have poor outcomes after the acute phase 
in their clinical courses.
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Introduction: Immune responses in sepsis involve simultaneous 
activation and suppression of circulating leukocytes. These immune 
responses are often associated with mortality [1]. Alterations in mito-
chondrial functionality of monocytes and lymphocytes are associ-
ated with immune suppression, severity of sepsis, and mortality [2-4]. 
Monocyte HLA-DR expression is an important marker for monitoring 
immune alterations during sepsis [5]. We postulated that immune dys-
function with decreased monocyte HLA-DR expression during sepsis 
may be induced by a bioenergetic shutdown.
Objectives: To assess the correlation between mitochondrial function 
(as measured by mitochondrial membrane potential (ΔΨm) and ROS 
production), and immune cell functionality (measured by monocyte 
HLA-DR expression) during the time-course of sepsis.
Methods: Septic and pre-operative control patients were recruited at 
the ATTIKON University Hospital in Athens, Greece. Whole blood was 
collected at four different timepoints (days 1, 2, 4 and 7 after admis-
sion) for septic patients and at one timepoint for control patients. 
Whole blood was lysed and stained with anti-CD14 to identify mono-
cytes, TMRM and MitoSox as measures of ΔΨm and ROS production, 
anti-HLA-DR for HLA-DR receptor expression, and Annexin-V and 
7AAD as markers for apoptosis and cell death. Appropriate positive-, 
negative-, and isotype controls were used. Samples were measured 
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using a BD FC500 flow cytometer and analysed using FlowJo. Prism 
was used for statistical analysis with Kruskal-Wallis non-parametric 
tests comparing different groups at day 1, and a repeated measures 
mixed ANOVA model to analyse trends over time within groups.
Results: 16 septic patients (10 survivors), and 13 pre-operative control 
patients were enrolled. There were no differences in  ΔΨm between 
the three groups on day 1. A change over time was found for all sep-
tic patients (P=0.02), without any differences between survivors and 
non-survivors. Higher levels of mitochondrial ROS were found in non-
survivors on day 1 compared to controls (P=0.02). No differences were 
however found over time for either survivors or non-survivors. Com-
pared to controls, HLA-DR expression was lower in septic patients on 
day 1 (P=0.05 for survivors). HLA-DR expression recovered over time in 
survivors (P=0.003 versus non-survivors).
Conclusion: Bioenergetic alterations (mitochondrial ROS produc-
tion and ΔΨm) do not explain the reduction in HLA-DR levels in sepsis 
patients.
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Introduction: Diagnosing sepsis remains difficult because it is not a 
single disease but a syndrome with various pathogen- and host fac-
tor-associated symptoms. Sepsis-3 was established to improve risk 
stratification among patients suspected with infection based on organ 
failures but it has been still controversial compared with previous 
definitions.
Objectives: We aimed to investigate characteristics according to 
whether patients who met sepsis-2 (severe sepsis)1 and sepsis-3 defi-
nitions2 among patients with suspected infection in ICU.
Methods: This was a multicenter, prospective cohort study. It con-
ducted by 22 intensive care units (ICUs) in Japan. Adult patients (≥16 
years) with newly suspected infection from December 2017 to May 
2018 were included. All patients were admitted to the ICUs in study 
hospitals. Patients were divided into four groups according to whether 
they met each definition or not: (both) sepsis-2 and sepsis-3; sepsis-2 
and no sepsis-3; no sepsis-2 and sepsis-3; and no sepsis-2 and no sep-
sis-3. Characteristics and in-hospital mortality were compared accord-
ing to the groups.
Results: In total, 652 patients with suspected infection were admitted 
to 22 ICUs during the study, of whom 558 (85.6%) met the sepsis-2 def-
inition and 600 (92.0%) met the sepsis-3 definition. The sepsis-2 and 
sepsis-3 definitions comprised different individuals, and 527 (80.8%) 
patients met both definitions (sepsis-2 and sepsis-3). Thirty one exclu-
sively met the sepsis-2 (sepsis-2 and no sepsis-3) and 73 exclusively 
met the sepsis-3 (no sepsis-2 and sepsis-3) definition. A total of 21 
patients did not meet either definitions (no sepsis-2 and no sepsis-3). 
Systemic inflammatory response syndrome (SIRS) positive (≥2) among 
patients with sepsis-2 and sepsis-3; sepsis-2 and no sepsis-3; no sep-
sis-2 and sepsis-3; and no sepsis-2 and no sepsis-3 were 100%; 100%; 
68.5%; and 66.7%, respectively. Quick sequential organ failure assess-
ment (qSOFA) positive (≥2) among patients with sepsis-2 and sepsis-3; 
sepsis-2 and no sepsis-3; no sepsis-2 and sepsis-3; and no sepsis-2 and 
no sepsis-3 were 66.8%; 35.5%; 27.4%; and 14.3%, respectively. In-
hospital mortality among suspected infection, sepsis-2, and sepsis-3 
patients was comparable (19.2%, 21.7%, and 20.0%, respectively). In-
hospital mortality among patients with sepsis-2 and sepsis-3; sepsis-2 
and no sepsis-3; no sepsis-2 and sepsis-3; and no sepsis-2 and no sep-
sis-3 were 22.0%; 16.1%; 5.5%; and 0%, respectively. Patients who met 
sepsis-3 shock definition had higher in-hospital mortality than those 
who met sepsis-2 shock definition (27.4% vs 34.3%).
Conclusion: Most patients with suspected infection admitted to ICU 
meet sepsis-2 and sepsis-3 definitions. They were less suitable for 
risk stratification in this setting. However, in-hospital mortality did 
not occur if patients did not meet any criteria. Better criteria might 
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be developed by better selection and combining elements in both 
definitions.
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Introduction: In septic patients - besides a rapidly beginning therapy - 
the effective search for the inflammatory focus is imperative to reduce 
morbidity and mortality. Therefore the prior diagnostic steps entail 
laboratory and imaging investigations (i.e. computer tomography). If 
these do not lead to any concrete result, transesophageal echocardi-
ography (TEE) is recommended to exclude an infective endocarditis 
(IE). As the lethality of infective endocarditis can be up to 30%, TEE is 
an important diagnostical tool in intensive care medicine. In this study 
we investigated the role of TEE to detect a septic focus in patients on 
medical intensive care units especially without underlying cardiac dis-
ease as until now it is still unclear.
Methods: We conducted a retrospective 10 years analysis of non-car-
diac medical intensive care unit patients with sepsis of unknown origin 
but without preknown heart disease, who underwent a TEE to detect 
IE as the focus of the inflammation. We collected data about labora-
tory findings, risk-scores, TEE-results, DUKE-criteria and mortality.
Results: From 1925 septic patients 108 (6%) underwent a TEE and 
were included in the study (average age 60 years, 61% male). Among 
these patients 15 (14%) were diagnosed an IE and six (42%) of them 
died. APACHE II- as well as SOFA-score were lower in patients with 
IE compared to patients with another septic focus (23 vs 27 and 9 vs 
11), but showed statistical significance. Neither leucocytes (18.1 vs 
20.6 G/l), CRP (20.8 vs 13.4 mg/dl), procalcitonin (32.9 vs 17.9 ng/ml) 
nor body temperature (36.9 vs 37.2 °C) showed significant differences 
between both groups. Positive blood cultures were found in 80% 
of patients with IE and in 42% of the others. Comparing the results 
of the modified DUKE-criteria the patient with IE met in average 1.5 
major criteria and 2.1 minor criteria. Patients without IE (0.2 major and 
1.4 minor criteria) met significantly less criteria (p<0.001). Those who 
left the intensive care unit alive received their TEE significantly earlier 
(p=0.001).
Conclusion: This study demonstrates the relevance of TEE in sep-
sis of unknown focus and without underlying cardiac disease. Due 
to the high incidence of IE in septic patients in combination with an 
increased morbidity and mortality a transesophageal echocardiog-
raphy should be carried out as soon as possible when having such 
patients on a medical intensive care unit. Clinical findings in patients 
with infective endocarditis show a high heterogeneity, so that the 
diagnosis is hard to make – especially in patients without preknown 
heart disease. Neither laboratory findings nor scoring systems were 
unequivocal or groundbreaking.
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Introduction: A dysregulated host response, which is a cornerstone of 
the pathophysiology of sepsis, induces alteration in vital signs. Elderly 
patients have a blunted host response, which may influence vital sign 
alterations and clinical outcomes of sepsis. We investigated the differ-
ent associations between the vital signs and mortality in elderly and 
nonelderly patients with sepsis.
Methods: The current observational study was retrospectively con-
ducted. A prospective multicenter severe sepsis cohort acquired 
from 59 Japanese ICUs (FORECAST, n=1148) was used for the deriva-
tion analyses. Significant results were tested for replication using two 
validation cohorts of severe sepsis (JAAMSR, prospective multicenter 
cohort from Japan, n=624; SPH, a sigle center cohort including differ-
ent ancestry [Canada], n=1004). Patients were categorized into elderly 
and nonelderly groups (age ≥75 or <75 years). The associations of the 
vital signs (body temperature [BT], heart rate, mean arterial pressure, 
systolic blood pressure, respiratory rate) within 24 hours of severe sep-
sis diagnosis and 90-day in-hospital mortality (primary outcome) were 
studied using Cox regression analysis.
Results: Nonelderly patients (n=628) with BT<36.0 °C showed signifi-
cantly increased 90-day mortality (P=0.025, adjusted hazard ratio 1.70, 
95% CI 1.07–2.71) in the derivation cohort. While those with BT>38.3 
°C showed decreased trend for mortality (P=0.11, adjusted hazard 
ratio 0.71, 95% CI 0.47–1.08). In the validation cohorts, nonelderly 
patients with BT<36.0 °C showed significantly increased mortality 
(JAAMSR, P=0.0024, adjusted hazard ratio 2.05, 95% CI 1.29–3.26; 
SPH, P=0.029, adjusted hazard ratio 1.36, 95% CI 1.03–1.80), and those 
with BT>38.3 °C displayed significantly decreased mortality (JAAMSR, 
P=0.0043, adjusted hazard ratio 0.51, 95% CI 0.32–0.81; SPH, P=0.018, 
adjusted hazard ratio 0.76, 95% CI 0.61–0.95). These differences were 
not observed in elderly patients in all the three cohorts. Associations 
between the other four vital signs and mortality were not different in 
elderly and nonelderly patients.
Conclusion: Among the vital signs, body temperature showed sig-
nificantly different effects on mortality between nonelderly and 
elderly patients. Nonelderly severe sepsis patients with hypother-
mia and fever showed decreased and increased mortality, respectively. 
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However, mortality in elderly patients was not associated with body 
temperature.
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Introduction: Pulmonary vascular endothelium is a key modulator in 
acute respiratory distress syndrome (ARDS) development (1). Recent 
investigations suggest that greater systemic endothelial activation 
might be associated with poor outcome of mechanically ventilated 
patients with sepsis (2).
Objectives: The aim of this study was to investigate serum biomarkers 
of alveolar capillary damage (sRAGE, endocan, angiopoetin-2) as out-
come predictors in mechanically ventilated patients with sepsis.
Methods: A prospective, observational pilot study was conducted on 
mechanically ventilated patients with sepsis admitted in the ICU of 
the Institute for pulmonary diseases of Vojvodina (IPDV) from January 
until March 2018. Diagnosis of sepsis was based on Sepsis-3 criteria (3) 
and ARDS was defined by using Berlin criteria (4). Blood samples for 
the assessment of serum biomarkers (sRAGE, endocan, angiopoetin-2) 
were taken within the first 24 hours from starting the mechanical 
ventilation.
Baseline demographic data, Charlson comorbidity index, arterial 
blood gas analysis, Tidal volume, PEEP value, complete blood count 
and biochemistry findings (procalcitonin, CRP, lactate, creatinine, bili-
rubin) were collected. Severity of illness was defined by Acute Physiol-
ogy and Chronic Health Evaluation II (APACHE II) and Sequential Organ 
Failure Assessment (SOFA) score.
Results: A total of 24 mechanically ventilated patients treated in 
the ICU of IPDV were included. Average age was 54,8 and 33,3% of 
patients were males. The Berlin criteria for ARDS met 14 patients 
(58,3%). Average APACHE II score at ICU admission was 22,71±6,9 and 
average SOFA score 7,13±2,74. ICU mortality was 37,5%.
There were no differences observed in levels of biomarkers with 
respect to 28-day mortality for sRAGE, angiopoetin-2 and endocan, 
as shown in Table  1. Subset of ARDS patients had significantly lower 
values of angiopoetin-2 (9,93±7,04 vs 16,31±7,7, p=0,047) comparing 
to patients without ARDS. Regrading hospital mortality and ventila-
tor free days, there was no statistically significant difference between 
sRAGE, angiopoetin-2 and endocan. There was no correlation between 
values of specific biomarkers.
Biomarker 28 day mortalitydied 
28 day 
mortalitysurvived p value 
sRAGE 3031±1818 3052±1983 0,979 
angiopoetin-2 15.6±8,8 10,4±6,6 0,118 
endocan 5,62±3,94 5,34±3,56 0,855 
Table 1. Correlation between 28-day mortality and biomarkers of alveolar capillary damage.  
Conclusion: Our results suggest that mechanically ventilated patients 
with ARDS have different expression of alveolar capillary damage bio-
markers comparing to patients without ARDS. Biomarker changes are 
less useful for prediction of other hospital outcomes in our study.
Reference(s) and grantackowledgment(s)
1. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, 
et al. Acute respiratory distress syndrome: The Berlin definition. JAMA ‑ J Am 
Med Assoc. 2012;307(23):2526‑33.
2. Singer M, Deutschman CS, Seymour C, Shankar‑Hari M, Annane D, Bauer 
M, et al. The third international consensus definitions for sepsis and septic 
shock (sepsis‑3). JAMA ‑ Journal of the American Medical Association. 
2016;315(8):801‑10.
3. Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: A novel diagnostic and 
therapeutic target in sepsis. Critical Care. 2019;23(1):16.
4. Millar FR, Summers C, Griffiths MJ, Toshner MR, Proudfoot AG. The pulmo‑
nary endothelium in acute respiratory distress syndrome: Insights and 
therapeutic opportunities. Thorax. 2016;71: 462–473.
000364 
A multi‑site retrospective analysis of angiotensin II utilization 
and clinical outcomes in septic shock
S.  Choi1; A. Nagy1; R. Shata2; C. Adams2
1Pharmacy, Saint Barnabas Medical Center, Livingston, United States 
of America; 2Pharmacy, RWJ University Hospital Somerset, Somerville, 
United States of America 
Correspondence: A. Nagy
Intensive Care Medicine Experimental 2020, 8(2): 000364
Introduction: Septic shock, a form of distributive shock, is the most 
common cause of death in patients admitted into the intensive care 
unit (ICU).1 Persistent hypotension is a hallmark sign of shock and its 
resulting end-organ hypoperfusion is directly related to mortality.2 Ini-
tial management of septic shock focuses on the maintenance of mean 
arterial pressure (MAP), which includes early and adequate fluid resus-
citation and the initiation of vasopressors.3 Angiotensin II is a novel 
treatment modality for patients unresponsive to the current stand-
ard of care recommended by consensus guidelines.4 Its administra-
tion was associated with a 660% increased chance of obtaining MAP 
response when compared to placebo.5 We investigated the utility of 
angiotensin II for the treatment of patients experiencing septic shock 
in the ICU.
Objectives: To assess the clinical outcomes of patients that were 
administered angiotensin II in the ICU of two academic medical 
centers.
Methods: In this retrospective chart review, we evaluated patients 
who received angiotensin II in the ICU of two academic medical cent-
ers from July 1, 2018, to January 31, 2020. Eligible patients were at 
least 18 years of age, had vasodilatory shock, and received angiotensin 
II. Baseline characteristics included age, sex, body mass index, clinical 
markers, severity of illness scores, and prior exposure to an angioten-
sin-converting enzyme inhibitor and/or to an angiotensin receptor 
blocker. Data for evaluation included changes in MAP, vasopressor 
use prior to and during angiotensin II use, Sequential Organ Failure 
Assessment (SOFA) score change at hour 48, adverse events, and mor-
tality. All the data were analyzed using descriptive statistics.
Results: A total of 28 patients received angiotensin II during the stud-
ied period. The average baseline MAP was 60±13 mmHg. The mean 
MAP increase from baseline at hour 3 was 12±18 mmHg (24 patients) 
and at hour 48 was 17±15 mmHg (13 patients). When examining vaso-
pressor use, the specific agent(s) used varied on the patient and site, 
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however, the two most common vasopressors used before angioten-
sin II administration were norepinephrine (NE) and vasopressin. The 
baseline total NE-equivalent dose was 0.435±0.189 mcg/kg/min, at 
hour 3 was 0.406±0.184 mcg/kg/min, and at hour 48 was 0.385±0.226 
mcg/kg/min. The mean baseline SOFA score was 10±4. At hour 48, 
SOFA increased by 1±6 points. Side effects that arose included fungal 
infections (18%) and new-onset thromboembolism (4%). Mortality 
occurred in 46% of patients at hour 24, 68% of patients at day 7, and 
71% of patients at day 28.
Conclusion: Angiotensin II effectively increased MAP in patients with 
vasodilatory shock that did not respond to high doses of conventional 
vasopressors. Administration allowed the requirements of other vaso-
pressors to be reduced over time. However, the patients still showed a 
rise in their SOFA scores and had a high mortality rate. More investiga-
tion is warranted to prove utility of angiotensin II at our clinical sites.
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Introduction: Recognition of  mortality risk factors and early inter-
vention of appropriate broad-spectrum antimicrobial administration 
may significantly improve the outcome. Selective Digestive Decon-
tamination (SDD) has been associated with reduced ICU mortality and 
acquired infection rates.
Objectives: To analyze mortality risk factors in patients with nosoco-
mial infection (NI) in an ICU after 8 years of SDD.
Methods: Prospective study. Patients with NI were included from 
October 1, 2010 to September 30, 2019 in a polyvalent ICU of 30 beds. 
SDD was applied for 8 years, from October 1, 2011 to September 30, 
2019. Patients requiring mechanical ventilation for more than 48 
hours, an enteral solution and a paste with colistin, tobramycin and 
nystatin every 8 hours until discharge were applied. Also intravenous 
cefotaxime were administered during the first 4 days. Rectal and phar-
yngeal exudates were collected on admission and weekly. The cat-
egorical variables were summarized in frequencies and percentages 
and the numerical variables as means and standard deviations or in 
medians and interquartile ranges. The percentages were compared 
with the X2 test or the Fisher exact test, the means with the t-test and 
the medians with the Wilcoxon test for independent data. A multidi-
mensional logistic analysis was carried out. It was considered signifi-
cant if p≤.05.
Results: Of 8202 patients admitted, 238 (35,57%) out of 669 patients 
with NIs died. In an univariate analysis we did no find statistically sig-
nificant difference in ICU stay. Multiresistant (MR) Pseudomonas and 
MR Gram negative bacteria (GNB) were significantly higher in patients 
who died (Table 1)
. Independent mortality risk factors were: APACHE II Odd ratio 
(OR)1.060 (1.033; 1.087), renal replacement therapy OR: 4.306(2.966; 
6.251), septic shock OR: 2.636 (1.818; 3.824), parenteral nutrition OR 
1.970 (1.303; 2.979) and neoplasm OR 3.334 (1.843; 6.030). (Table 2).
Conclusion: In an ICU with SDD, factors that were independently 
associated with motality were: APACHE II, renal replacement therapy, 
septic shock, parenteral nutrition and neoplasm. MR Pseudomonas and 
MR GNB also had significantly higher mortality.
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Introduction: The most common reason for intensive care unit (ICU) 
admission for patients with severe coronavirus disease 2019 (COVID-
19) is acute respiratory failure (ARF). However, data on organ dys-
functions (OD) other than lungs remains poorly defined in this field. 
The aim of this study was to analyze the rate of various OD (acute kid-
ney injury, AKI; liver failure, LF; circulatory failure, CF; coagulopathy; 
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pancytopenia) in a cohort of COVID-19 patients admitted in a Interme-
diate Care Unit (IMCU) for ARF.
Methods: We performed a retrospective analysis, reviewing all COVID-
19 patients admitted for ARF in our IMCU from March 1st to March 
31st 2020. The inclusion criteria were age ≥ 18 years old; diagnosis 
of COVID-19 by a nasopharyngeal swab. AKI was defined by KDIGO 
criteria; LF was defined by high levels of bilirubin (> 2 mg/dL), pro-
longed prothrombin time (PT) > 18 sec; circulatory failure was defined 
by mean arterial pressure (MAP) < 65 mmHg and requiring the use of 
vasopressors; coagulopathy was defined by prolonged PT > 18 sec, 
activated partial thromboplastin time (aPTT) > 60 sec and low plate-
let count (< 150,000/microL); pancytopenia was defined by neutrophil 
count < 1800/microL; Hb < 12 g/dL for women and < 13 g/dL for men; 
platelet count < 150,000/microL. We collected the demographic char-
acteristics and the rate of the OD associated to ARF. We also reported 
the rate of COVID-19 patients affected by 2, 3 o more than 3 simulta-
neous OD.
Results: We reviewed 134 patients and 93/134 respected the inclu-
sion criteria. Demographic characteristics are shown in the Table 1. All 
patients showed ARF with a PaO2/FiO2 ratio 115 ± 78. SAPS2 score 
was 33 ± 9, SOFA score was 3 ± 1. The rate of endotracheal intuba-
tion (ETI) was 42/93 patients (45,2%). We found AKI in 19/93 patients 
(20,4%), LF in 23/93 patients (24,7%), CF in 7/93 (7,5%), coagulopathy 
in 22/93 patients (23,7%), pancytopenia 3/93 (3,2%). 45/93 (48,4%) 
showed multiple OD. In particular 22/93 patients had 2 simultane-
ous OD; 14/93 showed 3 simultaneous OD and 9 patients ≥ 3 OD (see 
figure 1)
Conclusion: In our cohort of COVID-19 patients, multiple organ dys-
funtion was a common finding with a rate close to 50% of cases.
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Introduction: Adequate utilization of vancomycin is essential for 
achieving therapeutic targets while avoiding clinical failure and devel-
opment of antimicrobial resistance, especially in critically ill patients.
Objectives: We aim to determine whether there is a difference in the 
incidence of sub-therapeutic vancomycin level between surgical and 
medical patients in a mixed intensive care unit (ICU) and identify the 
possible factors that lead to this difference.
Methods: A retrospective electronic medical chart review was done for 
all adult ICU patients who received intravenous Vancomycin between 
2012 and 2017 at our center. Patients with renal failure were excluded. 
The Vancomycin dose used in our population was 15–20 mg/kg every 
8 hours, adjusted according to each patient’s GFR. Blood Vancomycin 
trough levels below 15 mg/l before the 4th dose were reported as sub-
therapeutic. The lab studies and illness severity scores of our patients 
during their ICU stay were also collected. A descriptive data analysis 
was done followed by a multivariate analysis to study the subtherapeu-
tic Vancomycin levels between medical and surgical patients.
Results: A total of 85 patients were included in the study, divided into 
44 surgical ICU (SICU) patients and 41 medical ICU (MICU) patients. No 
difference was found in age, gender, BMI, and eGFR between the two 
groups. Subtherapeutic vancomycin levels were significantly higher 
in SICU patients as compared to MICU patients (29(66%) out of 44 vs. 
14(34%) out of 41, P=0.003). SICU patients were found to have a higher 
total volume intake, higher fluid balance, and lower Hb levels as com-
pared to MICU patients. SICU patients also had a longer stay in the ICU 
before the initiation of Vancomycin treatment and lower APACHE and 
SAPS mortality scores as compared to MICU patients. Multivariate logis-
tic regression including all the above factors associated with subthera-
peutic vancomycin showed that admission to the ICU from a surgical 
service is an independent risk factor for subtherapeutic vancomycin 
levels (P=0.001, OR=6.48, CI (2.14 – 19.59)). Further subgroup analysis 
could not be done due to the relatively small sample size.
Conclusion: Critically ill surgical patients receiving intravenous Vanco-
mycin in the ICU are inherently at a higher risk for subtherapeutic vanco-
mycin levels than medical patients. We recommend further studies with 
larger sample sizes to further investigate the factors leading to the higher 
incidence of subtherapeutic vancomycin levels in surgical patients.
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Introduction: Cardiac function is known to be negatively impacted by 
sepsis. Monitoring Cardiac Output (CO) and Stroke volume (SV) trends 
over the course of treatment may provide insight into cardiac function 
and may be used to predict patient outcome.
Objectives: The goal of this study was to explore the relationship 
between the change in cardiac output over time in septic shock.
Methods: FRESH is randomized controlled study, evaluating 
hemodynamics in critically ill patients with sepsis or septic shock 
(NCT02837731). Patients randomized to PLR guided resuscitation 
received hemodynamic monitoring for 72 or until ICU discharge, 
whichever occurred first (Starling SV, Cheetah Medical). Patients that 
exhibited an improvement in stroke volume at 12, 24, 36 and 48 hours 
were compared to those who did not exhibit improvement. Overall 
improvement in stroke volume (first SV measurement compared to 
last SV measurement) was also compared between groups.
Results: 90 patients with septic shock received hemodynamic moni-
toring over a 72 hour monitoring period. 60 % were female, and the 
average age was 61 years. Overall, 44% of assessments demonstrated 
a fluid responsive positive response after receiving initial resuscitation 
fluid of 2.3 L. Patients who exhibited improved SV at 24 and 36 hours 
exhibited a decreased fluid balance over the course of their ICU stay 
at both 24 hours (1.06 ± 3.40 vs 3.15 ± 4.38, p=0.029) and 36 hours 
(1.18 ± 2.58 vs 3.41 ± 4.52, p=0.032). Notably, patients who exhibited 
an overall improvement in SV also required less hours on vasopressors 
(34.50 ± 41.03 vs 64.28 ± 65.07, p=0.05) and decreased ICU length of 
stay (3.93 ± 3 vs 5.59 ± 5.24 days, p=0.08) (Figure 1).
Conclusion: We have previously shown that patients who improve 
SV in response to the resuscitation exhibited improved outcome. 
Trending cardiac output over the 72 hour monitoring period revealed 
additional usefulness in predicting patients with improved outcome. 
The results highlight the importance of trending hemodynamics in 
therapy.
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Introduction: Current guidelines recommend to increase mean arte-
rial pressure (MAP) in previously hypertensive septic shock patients to 
higher levels (80-85 mmHg) when tissue hypoperfusion has not been 
corrected with the initial fluid resuscitation and restoration of MAP to 
65 mmHg. The impact of incremental NE titration on cardiac function 
depend on the balance between the effects on preload, contractibility 
and afterload. As NE may both increase venous return and afterload, 
a particular concern is a potential decrease in stroke volume (SV) in 
fluid-unresponsive patients.
Objectives: Determine whether septic shock patients requiring a high 
MAP exhibit afterload dependence, defined as a decrease in stroke 
volume >10%.
Methods: We evaluated a cohort of previously hypertensive patients 
with septic shock in whom the attending physician decided to increase 
MAP from 65 to 85 mmHg because of persistent hypoperfusion after 
initial resuscitation. A comprehensive echocardiographic assessment 
was performed at baseline 1 (MAP 65 mmHg), after reaching the MAP 
target (MAP 85 mmHg), and after return to baseline 2 (MAP 65 mmHg). 
Preload, contractility and afterload variables were assessed. Statistical 
analysis was performed with Wilcoxon signed-rank test, P < 0.05 was 
considered as significant.
Results: Twelve mechanically ventilated patients (age 72± 9 yr, 
APACHE II 23±5, SOFA on admission 10 ± 3) were included in this pre-
liminary report. No significant decrease in stroke volume was shown; 
in contrast, 60% of the studied patients increased their stroke volume 
>10% despite being fluid unresponsive at baseline and with a signifi-
cant increase in afterload. Hemodynamic and echocardiography vari-
ables are shown in Table 1.
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Table 1. Hemodynamics variables and echocardiography variables
Baseline 1 MAP 85 Baseline 2
MAP, mmHg 65 [63,67] 84[83,88]* 66[62,66]† 
NE, mcg/kg/min 0.17[0.08,0.37] 0.41[0.13,0.49]* 0.28[0.06,0.37]† 
HR, beats/min 86[74,101] 88[71,100] 93[69,106] 
CVP, mmHg 10.0[6.5,12.5] 10.0[7.0,13.0] 9.0[5.5,10.5]† 
Pmsf, mmHg 18.1[15.0,20.2] 18.9[18.2,22.2]* 15.9[15.3,19.5] † 
Pvr, mmHg 7.8[6.6,9.6] 8.8[7.7,11.1]* 8.5[6.9,10.2]* † 
CO, L⋅min-1 4.9[3.4,6.2] 5.0[3.9,6.7]* 5.3[3.9,6.7]† 
RVR, 
mmHg⋅min⋅mL-1 1.60[1.49,1.99] 1.80[1.55,2.03]* 1.61[1.44,1.86] † 
SVR, 
mmHg⋅min⋅mL-1 880[679,1391] 1246[858,1552]* 890[615,1277] † 
Aortic Elastance 1.52[1.33,2.21] 1.92[1.65,2.69]* 1.42[1.28,1.77]† * 
Left Ventricle
GLS, % -15.0[-18.9,-12.1] -16.5[-17.4,-13.7] -13.4[-18.1,-11.8] 
S’ wave, cm/sec 12.6 [6.7,16.2] 14.2[6.9,18.0] 13.3[6.5,18.0] 
MPI 0.63[0.55,1.08] 0.68[0.45,10.93] 0.75[0.54,1.06] 
IVA, cm/sec2 318[172,522] 322[243,556] 394[139,776] 
VTI, cm 18.9[14.5,26.7] 20.7[15.6,27.7]* 20.1[15.8,25.4] 
VTI Descendent 
Aorta, cm 11.3[8.5,13.53]  11.9[8.9,14.0] 11.6[8.5,13.9] 
LV EF, % 66[45,75] 67[49,71] 65[52,69] 
LV EndSyst-
Elastance 1.84[0.80,2.33] 2.53[1.15,3.12]* 1.77[0.85,1.94] † 
VA coupling 1.19[063,1.79] 1.01[0.59,1.79] 0.96[0.65,1.83] 
Preload
E wave, cm/sec 67[55,96] 80[67,113]* 68[51,108]† 
DT E wave, 
cm/sec2 223[143,289] 229[139,281] 223[142,302] 
A wave, cm/sec 70[50,106] 74[54,122]* 84[59,101]
E/e’ratio 5.7[4.3,8.2] 6.7[4.9,9.1]* 5.4[4.3,10.0] 
Right Ventricle
TAPSE 20.3[17.9,23.6] 23.2[20.5,27.8]* 21.0[19.6,27.5] 
S’wave, cm/sec 13.7[12.1,18.6] 16.4[11.9,20.9] 15.6[13.4,18.6] 
MPI 0.60[0.38,0.69] 0.63[0.49,0.86] 0.64[0.49,0.77] 
PASP, mmHg 38.5[36.2,43.7] 42.9[38.4,53.63] 38.8 [31.0,46.0] 
Data are shown as median [IQR 25,75].  * p<0.05 vs. Baseline1, † p<0.05 vs. 
MAP 85.   
Conclusion: In previously hypertensive and currently fluid unrespon-
sive septic shock patients in whom MAP was increased from 65 to 
85mmHg stroke volume did not decrease despite the increased after-
load due to an increase in left ventricular contractility.
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Introduction: Introduction: The severity of microcirculatory altera-
tions is related to mortality in septic shock patients (1). Remote 
ischaemic conditioning (RIC) is a promising technique that may pro-
tect organs and tissues from the effects of further ischaemic episodes. 
Studies have shown that remote ishaemic conditioning may improve 
endothelial function,red blood cell deformability, reduce leukocyte 
adhesion and etc. These mechanisms may lead to improved micro-
circulation. RIC preserved microcirculation and prolonged survival in 
septic shock animals (2). However, RIC’s impact on microcirculation in 
septic shock patients has not been evaluated.
We hypothesize that RIC improves sublingual microcirculation in sep-
tic shock patients.
Objectives: This study aims to evaluate RIC effects on sublingual 
microcirculation in septic shock patients.
Methods: This single-center open-label trial was performed in a mixed 
ICU in a tertiary teaching hospital. We included patients with septic 
shock within the first 24 h after ICU admission. RIC procedure involved 
three cycles of 5 min brachial cuff inflation to 200 mmHg and then 
deflation to 0 mmHg for another 5 min. RIC was performed at inclusion 
and repeated 12 h and 24 h later. Sublingual microcirculatory meas-
urements were obtained before and after each RIC procedure, using 
a sidestream dark-field imaging device. Data are reported as medians 
with 25th and 75th percentiles.
Results: Twenty-six septic shock patients with a median age of 65 (57-
81) were enrolled in this study. The median APACHE II and SOFA scores 
at admission were 20 (13-23) and 10 (9-12), respectively. We found a 
significant increase in microvascular flow index compared before and 
after the first RIC procedure (p=0.003). We found no change in micro-
circulatory flow and density parameters during repeated RIC after 12 
h and 24 h.
Conclusion: The first remote ischaemic conditioning procedure 
improved microcirculatory flow, while subsequent procedures did not 
affect sublingual microcirculation in septic shock patients.
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Introduction: Severe acute pancreatitis (SAP) is associated with multi-
ple organ failure and systemic inflammatory response syndrome what 
leads to high mortality rate. Patients often require different interven-
tional measures including surgical procedures to improve outcomes.
Objectives: to describe the evolution of patients with SAP and its 
associated complications. To analyze the medical and surgical man-
agement of secondary abdominal compartment syndrome (ACS).
Methods: retrospective study including patients admitted to ICU with 
a diagnosis of SAP during the period 2013-2019. Demographic data, 
cause, severity scales, and occurrence of associated complications are 
recorded: acute renal failure (ARF), infections, ACS, need for ventilatory 
support. Treatment with continuous renal replacement techniques 
(CRRT), the need for a surgical approach and nutritional support are 
recorded. Results are expressed as mean (95% CI).
Results: 43 patients were studied, 58.1% male, age 72.1 (63.3-76.9) 
years, APACHE 16.3 (12.9-19.8), SAPS II 38.1 (31.8-44.3), SOFA 4.3 (2.9-
5.7). The cause of SAP was: lithiasic 30.2%, alcoholic 9.3%, post-ERCP 
16.3%, idiopathic 44.2%. Up to 41.9% required mechanical ventilation 
(MV) for 17.1 (6.1-28.2) days, of which 7% underwent tracheostomy. 
High-flow oxygen therapy was administered to 9.3%. The prevalence 
of ARF was 55.8%, 18.6% of patients were treated with CRRT. ACS was 
present in 18.6% of patients, and laparotomy was performed in 20.9% 
(11.6% decompressive, 4.7% necrosectomy). After decompressive 
laparotomy, the duration of the vacuum-assisted closure system (VAC) 
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was 15.2 (0.3-30.1) days with 2.3 (0.6-4) mesh replacements. Abdomi-
nal infection rate 21%, respiratory infection 23.3%, multi-resistant col-
onization 2.3%. 74.4% received nutritional support (39.5% parenteral, 
7% enteral, 27.9% mixed). ICU stay was 13.7 (7.4-20) days, hospital stay 
24.9 (22.4-27.4) days and mortality 34.9%. The absence of ARF was 
associated with less need for surgery (39% in the ARF group VS 0% in 
the group without ARF) p<0.05 (Fisher’s exact test). Surgical treatment 
did not influence stay or mortality in our sample.
Conclusion: SAP is an entity with high morbimortality, multidiscipli-
nary management may improve mortality and reduce sequels.
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Introduction: The early recognition of sepsis is one of the pillars to 
improve its prognosis. It is necessary to explore if there are symptoms 
or early clinical characteristics associated with the worse outcomes 
such as the need for Intensive Care Unit (ICU) admission or in-hospital 
mortality. This information could lead to the optimization of timely 
care protocols.
Objectives: To identify the earliest symptoms of patients with sus-
pected infection or sepsis that may be associated with the need for 
ICU admission or in-hospital mortality.
Methods: Prospective cohort study conducted between June/2019 
and March/2020 in a university hospital of Medellín, Colombia. We 
included patients older than 18 years with diagnosis of any type of 
infection or sepsis (suspected or confirmed), requiring hospitalization 
by the emergency department (ED). Previously trained researchers col-
lected symptoms and signs, by reviewing the clinical history and inter-
viewing the patient and their relatives, using standardized equipment 
and formats. The primary outcome was ICU admission or mortality. 
We did univariate logistic regression models for each one of the inde-
pendent variables. Then a multivariable adjusted logistic regression 
model was fitted to estimate the independent effect of each symptom 
on the outcome. The results are shown as OR with 95%CI.
Results: Among 965 eligible patients, 245 (25.4%) were included. The 
main causes of exclusion were use of antibiotics in the last 15 days 
(44%) and immunodeficiency (21%). The median age was 60 years 
(IQR=45-71) and 51% were male. The main comorbidities were kidney 
disease (23%), congestive heart failure (15.1%) and chronic respiratory 
disease (15.1%). The most common symptoms were general malaise 
(80.6%), subjective fever (76%) and chills (70.5%). The median SOFA 
score was 2 (IQR = 0-5) and the main foci of infection were the res-
piratory tract (29.4%), followed by skin and soft tissues (21.2%) and 
the gastrointestinal tract (19.2%). The in-hospital mortality rate was 
12.7% and 119 (48.6%) patients required admission to the ICU. In the 
univariate analysis, the symptoms significantly associated with hospi-
tal mortality or ICU admission were chills, subjective fever, productive 
cough, dyspnea and altered mental status. However, after multivariate 
adjustment of symptoms for age, SOFA and Charlson score, only dysp-
nea and altered mental status remained associated, but they were not 
longer statistically significant (OR = 2.16, 95%CI = 0.9; 5.2 and OR = 
1.51, 95%CI = 0.7; 3.2, respectively)
Conclusion: A few symptoms, easily identified in the ED by a sim-
ple interrogatory, may be early indicators of ominous prognosis in 
patients with sepsis. A prospective multicenter cohort study is war-
ranted for confirmation and external validation of our findings.
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Introduction: The initial clinical presentation of sepsis is heterogene-
ous and largely depends on the primary site of infection. This situation 
makes the early diagnosis of this condition a clinical challenge. Tools 
such as qSOFA help to assess the risk of complications in patients with 
suspected infections; however, this approach is indifferent to the site 
of infection itself. A more individualized identification would allow 
focusing on earlier targeted therapy
Objectives: To identify simple variables associated with risk of in-
hospital mortality or Intensive Care Unit (UCI) admission, according to 
infection sites
Methods: Secondary analysis of a multicenter prospective cohort. We 
included patients older than 18 years hospitalized between 2014 and 
2016 with suspected sepsis, who were admitted to Emergency Depart-
ments (ED) of three tertiary care university hospitals in Medellín, 
Colombia. Bivariate and multivariate logistic regression models were 
performed to estimate the association of widely available and clini-
cally relevant variables with in-hospital mortality or ICU admission 
according to 5 infection sites: urinary tract infection (UTI), commu-
nity acquired pneumonia (CAP), intra-abdominal infection (IAI), sep-
sis without evident source (primary) and others (soft tissue and bone 
infections, catheter-associated bacteremia, meningitis, surgical site 
infections, others). The independent effect of each variable on the 
outcome was estimated using Odds Ratio (OR) with its respective 95% 
confidence interval (CI).
Results: A total of 5,022 patients were screened, of which 2,454 
entered the primary study. In this secondary analysis, we included 
1,947 patients with confirmed diagnosis of infection. The most com-
mon sites of infection were UTI (n=586, 30%), CAP (n=585, 30%), IAI 
(n=213, 11%), primary (n=224 11.5%) and others (n=339, 17.4%) 
patients, respectively. After multivariable adjustment, the most sig-
nificant signs varied widely according to the site of infection (Table 1): 
Respiratory rate (RR), Systolic Blood Pressure (SBP) and lactate for ITU; 
Heart Rate (HR), RR and temperature < 38°C for CAP; Glasgow coma 
scale (GCS), lactate and age < 65 for IAI; SBP, GCS, lactate and tempera-
ture < 38°C for primary and RR, GCS and temperature < 38°C for others.
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Table 1. Relevant clinical variables according to infection site 
Variable (OR 
95%CI) UTI CAP IAI Primary Others 
HR > 120 1.4 (0.8 – 2.2) 
1.6 (1.0 – 
2.5)
1.6 (0.6 – 
3.9) 
1.2 (0.6 – 
2.4) 
1.6 (0.8 – 
3.0) 
RR > 22 3.0 (1.8 – 5.0)
1.9 (1.3 – 
2.8)
1.8 (0.7 – 
4.5) 
2.0 (0.9 – 
3.9) 
3.4 (1.7 – 
6.5)
SBP < 100 3.0 (2.0 – 4.4)
1.4 (0.9 – 
2.1) 
1.3 (0.7 – 
2.6) 
2.6 (1.4 – 
4.8)
1.6 (0.9 – 
2.7) 
GCS < 15 1.7 (0.9 – 3.0) 
1.3 (0.8 – 
2.2) 
9.6 (1.2 – 
80.5)
4.5 (1.7 – 
11.4)
3.0 (1.6 – 
5.8)
Lactate > 2 1.6 (1.1 – 2.4)
1.2 (0.8 – 
1.7) 
3.1 (1.6 – 
6.0)
2.0 (1.1 – 
3.9)
0.6 (0.3 – 
1.1) 
≥ 38°C Ref Ref Ref Ref Ref 
< 38°C 0.7 (0.5 – 1.0) 
2.1 (1.4 – 
3.0)
1.0 (0.5 – 
2.2) 
2.1 (1.1 – 
3.9)
2.9 (1.6 – 
5.1)
Age > 65 1.0 (0.7 – 1.5) 
0.5 (0.4 – 
0.7) 
2.3 (1.2 – 
4.5)
0.8 (0.4 – 
1.6 
1.2 (0.7 – 
2.1) 
Conclusion: Our results suggest that the best approach for sep-
sis diagnosis in clinical practice, should consider different criteria 
depending on the site of infection. More research efforts in the area 
are required to integrate these variables into a qSOFA-type tool, with 
the aim of achieving a more individualized treatment according to the 
suspicion of the infection site.
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Introduction: Sepsis is a heterogenous syndrome caused by a dys-
regulated immune response to infection. Numerous studies on 
immunomodulatory therapies have failed to improve outcome. Iden-
tification of distinct immunological phenotypes in septic patients may 
lead to more precise clinical immunomodulatory studies. Clinical dis-
tinct septic patient phenotypes have different clinical presentations, 
microbial findings and outcome1.
Objectives: To study whether four different clinical phenotypes, 
based on the presence or not of preexisting inflammatory insults, 
differed in inflammatory mediators in intensive care treated septic 
patients.
Methods: For 12 months, 276 adult patients admitted to a single ICU 
and provided with an arterial catheter were consecutively included 
in a prospective study after informed consent. Plasma was obtained 
for the first 3 days for the analyses of heparin binding protein, NGAL, 
tumor necrosis factor receptor 1 and 2, endostatin, procalcitonin, 
calprotectin and C-reactive protein. Patients were retrospectively 
grouped as either septic or non-septic according to the Sepsis-3 classi-
fication. Further, the septic patients were classified based on the pres-
ence of preexisting inflammatory insults into either primary (no prior 
insults), secondary (one recent insult) or tertiary sepsis (several recent 
insults). Independent of prior inflammatory insults, patients with 
immunosuppressive treatments or immunosuppressive diseases were 
classified as immunosuppressive sepsis.
Results: Septic patients had significantly higher plasma levels in all 
measured inflammatory mediators at admission to the ICU compared 
to non-septic patients, with the exception of procalcitonin where no 
significant difference could be noted (p=0.29). During the first 3 days, 
patients with primary sepsis had higher levels of heparin binding pro-
tein (p<0.02) than secondary, tertiary or immunosuppressive sepsis. 
Patients with primary and immunosuppressive sepsis had lower levels 
of calprotectin (p<0.01), than those with secondary or tertiary sepsis. 
No differences in plasma levels of endostatin, NGAL, procalcitonin, 
tumor necrosis factor receptor 1 or 2, were noted between the immu-
nological phenotype groups.
Conclusion: Classification of patients into inflammatory phenotypes 
based on preexisting inflammatory insults prior to sepsis, is supported 
by early differences in plasma levels of heparin binding protein and 
calprotectin. Procalcitonin performed poorly as a biomarker to distin-
guish septic patients from non-septic patients in the ICU.
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Introduction: Procalcitonin (PCT) is one of the most studied biomark-
ers regarding antibiotic stewardship1. In the critical care setting, pub-
lished studies differ greatly considering patient case-mix, the source of 
infection, the severity of the disease, exclusion criteria as well as cut-
offs and laboratory methods for PCT measurements2-4.
Objectives: PCT testing was implemented in the emergency lab of the 
Department of Laboratory Diagnostics in October 2016. As an initial 
demand management strategy, only the emergency department and 
intensive care units gained unlimited access to direct test ordering. 
The study aimed to evaluate the applicability of PCT testing in severely 
ill patients with suspected infection in a tertiary referral hospital in 
Croatia.
Methods: Patients with suspected infection were included in a pro-
spective, observational study in the medical intensive care unit (ICU) 
at the University Hospital Centre Zagreb, Croatia. Analysis of disease 
severity (APACHE II, SOFA score), microbiological cultures (blood cul-
ture (BC), urine culture (UC), endotracheal aspirate culture (ETA)), 
C-reactive protein (CRP), and PCT was performed.
Results: 129 patients were included, 83 males (63.6%) of median age 
64 (39-89). Median APACHE II was 21 (7-35) and SOFA 7 (1-13). Sepsis 
(50, 38.8%) and pneumonia (37, 28.7%) were the most common diag-
noses. Overall PCT was 1.66 ± 11.43 µg/L and CRP 102 ± 166 mg/L. 
Most patients (83,64.3%) received antibiotics before admission. No dif-
ference in PCT (1.56 ± 8 vs 1.44 ± 13, p=0.6) nor in CRP (98 ± 137 
vs 127 ± 171, p=0.5) was observed regardless of previous antibiotic 
therapy.
Infection was clinically confirmed in 106 (82.2%) patients. Micro-
biological cultures were positive in 86 (66.7%) and 81.1% of patients 
with clinically confirmed infections. PCT and CRP were significantly 
increased in patients with positive BC, the infection caused by Gram-
negative microorganism regardless of disease severity (no differ-
ence in SOFA and APACHE score) and pneumonia with complications 
(Table 1). PCT did not differ among patients with positive vs negative 
UC (4.6 ± 16 vs 1.76 ± 11.9) nor positive vs negative ETA (1.93 ± 11.4 
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vs 1.76 ± 1.11). The change of antimicrobial treatment based on PCT 
value was done in 36 patients (28%).
Table 1. Values are medians with interquartile ranges. 
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Conclusion: PCT level was not influenced by previous antibiotic expo-
sure. Patients with infection caused by gram-negative strains had a 
higher level of both CRP and PCT. The incomplete application of PCT 
guided stewardship in our patient series could be at least partially 
explained by a lack of experience in the routine clinical application of 
the studied biomarker.
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Introduction: Sepsis is a major healthcare problem which affects 
millions of people around the world each year. Despite significant 
advances in diagnostic tools and the increasing use of biomarkers, the 
early recognition of sepsis in critically ill patients could be challenging. 
Recently, it has been described that morphological changes in leuko-
cyte populations, especially the morphology and size of monocytes, 
could be used as a new biomarker for the early detection of sepsis.
Objectives: The main purpose is to determine if the monocyte distri-
bution width (MDW) could be used as a new biomarker of sepsis. The 
secondary objective is to assess if MDW could be a prognostic factor of 
mortality in septic patients.
Methods: Prospective, observational study carried out during 2019 
in the Intensive Care Unit (ICU). Critically ill patients with all kind of 
pathologies were included. It has been collected demographic vari-
ables, severity scores and ICU mortality. According to Sepsis-3 criteria, 
patients were divided into 3 groups on admission: non-infected (NI), 
sepsis (S) and septic shock (SS). MDW and traditional biomarkers were 
analyzed on admission. Statistical analysis includes qualitative vari-
ables, presented as proportions, and quantitative variables, presented 
as medians and minimum-maximum (Min-Max). Kolmogorov-Smirnov 
test was used for the assessment of normality. Kruskal-Wallis test was 
used to compare biomarkers among groups. The association between 
ICU mortality and each biomarker was performed using Mann-Whit-
ney U test. The area under the receiver operating characteristics (ROC) 
curve (AUC) was used to assess the prediction of ICU mortality. The 
study was previously approved by the Hospital Ethics Committee.
Results: A total of 188 patients were included: NI 127 (0.676), S 35 
(0.186), SS 26 (0.138). Age 56.7 years; males 0.59. Severity scores: 
APACHE II NI 15 (Min-Max: 2-58), S 16 (Min-Max: 9-41), SS 23.5 (Min-
Max: 8-45; p < 0.001); SOFA NI 6 (Min-Max: 0-17), S 8 (Min-Max: 0-17), 
SS 10.5 (Min-Max: 3-17; p < 0.001). Biomarkers on admission: MDW NI 
20.5 (Min-Max: 15,3-40.6), S 24 (Min-Max: 16.4-39.8), SS 35.5 (Min-Max: 
21-58.9; p < 0.001); CRP NI 19.8 mg/L (Min-Max: 0.8-343.7), S 106.5 
mg/L (Min-Max: 3.6-478.2), SS 249 mg/L (Min-Max: 86.7-437.6; p < 
0.001); PCT NI 0.15 ng/mL (Min-Max: 0.2-46.7), S 1.2 ng/mL (Min-Max: 
0.15-75), SS 24.5 ng/mL (Min-Max: 1.27-100; p < 0.001); lactate and 
total leukocytes were not statistically significant (pns). The ICU mor-
tality was 0.138. Association of biomarkers and mortality: MDW alive 
patients (AP) 21.1 (Min-Max: 15.3-57.7), dead patients (DP) 28.3 (Min-
Max: 17.3-58.9; p < 0.001); CRP AP 34.8 mg/L (Min-Max: 0.8-478.2), DP 
112.6 mg/L (Min-Max: 9.6-355; p = 0.007); PCT AP 0.31 ng/mL (Min-
Max: 0.02-100), DP 2.8 ng/mL (Min-Max 0.07-100; p = 0.005); lactate 
AP 1.16 mmol/L (Min-Max: 0-4.9), DP 2 mmol/L (Min-Max: 0-16.6; p= 
0.001); total leukocytes were not statistically significant (pns). Mortal-
ity prediction according to each biomarker: AUC MDW 0.74(Min-Max: 
0.63-0.85; p < 0.001); AUC CRP 0.67 (Min-Max: 0.57-0.77; p = 0.007); 
AUC lactate 0.71 (Min-Max: 0.59-0.83; p = 0.001); AUC PCT 0.69 (Min-
Max: 0.58-0.8; p=0.005).
Conclusion: MDW could be considered as a new biomarker for the 
diagnosis of sepsis. Additionally, MDW could have prognostic perfor-
mance in septic patients.
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Introduction: Septic shock and the underlying cytokine storm remain 
a major contributor to mortality in critically ill patients. The introduc-
tion of cytokine haemoadsorption techniques offer a novel approach 
to treatment of septic shock [1-3], nevertheless the efficacy of these 
devices in cytokine removal, as well as their effect on the course of dis-
ease remain to be further assessed.
Objectives: To study the effect of the Cytosorb (I) directly on the lev-
els of Interleukin-6 (IL-6), (II) on the need for vasopressors assessed 
through the Vasopressor Dependency Index (VPI) [4], and (III) on inten-
sive care unit (ICU) mortality.
Methods: We analysed 48 patients prospectively treated with a pro-
inflammatory (IL-6 ≥ 1000ng/l), therapy refractory (VPI ≥ 3) sep-
tic shock, admitted to the medical ICU of the University Hospital of 
Zurich between 2014 and 2018, with a Cytosorb coupled in series to 
a CRRT for 3 x 24 hours after septic shock diagnosis, in an “intention 
to treat” approach. A historical cohort of 437 patients admitted with 
septic shock to the same ICU between 2011 and 2018 was further ret-
rospectively constituted. To reduce biased estimation of the treatment 
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effect of Cytosorb, six matching algorithms based on the variables 
age, sex, BMI, SAPS II, SOFA, IL-6, lactate, PCT and VPI at septic shock 
diagnosis were employed and compared to determine the most bal-
anced population of control patients to the Cytosorb cohort. Finally, 
a genetic matching algorithm demonstrated its superiority regarding 
the achievement of a standardized mean difference of under 0.1 and a 
variation ratio of between 0.5 and 2.0 for all matching variables, select-
ing 48 control patients [5].
Results: After matching, all matching variables and other baseline 
characteristics were balanced between the matched cohort (MC) 
and the Cytosorb cohort (CC). Cytokine adsorption did not result in 
a greater relative decrease in IL-6 over 72 hours as compared to the 
matched control (MC: 85% [0-95] vs. CC: 54% [0-73], p = 0.09). Further, 
there was no evidence that Cytosorb use lead to an increased reduc-
tion in the VPI (MC: 88% [54-95] vs. CC: 51% [6-83], p = 0.56). Finally, 
30-day ICU mortality was more pronounced in the CC (Hazard Ratio 
1.79, CI [1.01 – 3.18], p = 0.04).
Conclusion: Our ambispective study suggested that broad adsorp-
tion of cytokines as provided by the Cytosorb may have, as compared 
to the matched control of septic shock patients, an uncertain effect 
on IL-6 kinetics and the need for vasopressors over an observation 
period of 72 hours, this with a potential deleterious effect on 30-day 
ICU survival. A large randomized controlled trial is ugently needed to 
prove the efficacy of the Cytosorb treatment in patients with septic 
shock. Awating these results its use in septic shock should be carefully 
considered.
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Introduction: Lemierre Syndrome is a a rare and potentially life 
threatening condition characterized by septic thrombophlebitis of 
the internal jugular vein (IJV). First identified in 1900, it was described 
by André Lemierre in 1936 and had a rapidly fatal course in the pre-
antibiotic era.  [1] The incidence appears to be rising with a mortality 
of 5-18% [2]
Methods: We present a case of a Lemierre Syndrome,which was 
admitted to our Intensive Care Unit following a recent history of 
Covid19.
Results: A 39 year old male presented with a 7 day history of phar-
yngitis, pyrexia and vomiting. His medical history was significant for 
seizures associated with a traumatic brain injury. The patient tested 
positive for SARS-CoV 2 infection 12 weeks previously. SARS-CoV 2 was 
not detected on multiple investigations during this presentation.
The patient developed type 1 respiratory failure. Chest X Ray and CT 
Thorax revealed a bilateral cavitating pneumonia and pleural effu-
sions. Blood cultures were positive for Fusobacterium necrophorum. He 
was also severely thrombocytopenic.
Increasing oxygen requirements necessitated mechanical ventilation. 
A subsequent CT neck revealed a left sided 3.5cm peritonsillar abscess 
with an associated internal jugular vein thrombosis.
The patient was transferred to another Intensive Care Unit with on site 
ENT support. Spontaneous rupture of the peritonsillar abscess precipi-
tated septic shock requiring debridement and washouts in the Inten-
sive Care Unit and in Theatre. Bilateral chest drains were inserted to 
facilitate oxygenation and ventilation.
The patient was weaned from vasopressors and mechanical ventila-
tion and subsequently dischargedhome on long term intravenous 
antibiotics
Conclusion: Lemierre syndrome is a rare condition precipitated by a 
bacteral pharyngitis typically caused by anaerobic organisms includ-
ing Fusobacterium necrophorum. [1] It has been previously linked with 
Epstein-Barr Virus infection. However, given the recent pandemic we 
question the impact of SARS-CoV-2 on the pathogenesis of the disease 
and psychological factors at play leading to this critical illness?
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Introduction: Coagulopathy is one of the major causes of organ 
dysfunction and death in sepsis; however, there are no standard cri-
teria for diagnosis of it. Recently, sepsis-induced coagulopathy (SIC) 
was developed as a new criterion for coagulation disorder of sepsis 
patients. It includes the sequential organ failure assessment (SOFA), 
similarly the new definition of sepsis revised in 2016 (sepsis-3 defini-
tion). Previous studies suggested that SIC score might be a prognostic 
value for patients with sepsis and coagulopathy, however, there are 
few studies about SIC of septic shock patients who are defined as a 
subset of critically ill sepsis patients.
Objectives: To evaluate the accuracy of SIC score as a prognostic 
value for both sepsis patients and septic shock patients.
Methods: Coagulation [JSEPTIC-DIC] study), which investigated 
patients with sepsis in 42 intensive care units (ICUs) from 2011 to 
2013, were analyzed. This contained information about patients’ 
backgrounds, examination results, treatments, and mortality. Primary 
outcome measure was in-hospital mortality. Firstly, we grouped sub-
jects into two (patients with vasopressor and patients without vaso-
pressor). This database didn’t contain information about vital signs, 
therefore,  we analyzed the patients needed vasopressor instead of 
septic shock patients. Seconodly,  we assessed patient characteristics 
and mortality of vasopressor groups between SIC and non-SIC, using 
χ2 test or Fisher’s test. Then, we compared the same things between 
SIC and non-SIC in no vasopressor group.  Furthermore, we analyzed 
in-hospital mortality of vasopressor group using a logistic regression 
analysis adjusted for age, gender, SIC and treatment for coagulation 
abnormality.
Results: This study included 1894 patient: 1453 in vasopressor 
group, and 441 in no vasopressor groups. In vasopressor group, 965 
(66.4%)  were diagnosed with SIC. In-hospital mortality was signifi-
cantly higher among SIC patients than non-SIC patients (35.8% vs 
27.9%, p < 0.01). Besides, ventilator free days and ICU free days were 
significantly shorter in SIC than non-SIC (mean days ± standard devia-
tions, 14.7 ± 11.4 vs 15.5 ± 11.0 p < 0.01, 12.0 ± 10.2 vs 13.2 ± 10.1 p 
< 0.01, respectively). On the other hand, 186 (42.2%) were diagnosed 
as SIC in no vasopressor group. There were no statistically significant 
differences about in-hospital mortality, ventilator free days, and ICU 
free days (15.6% vs 12.2% p =  0.33, 21.9 ± 9.8 vs 22.0 ± 9.3 p = 0.22, 
16.9 ± 9.7 vs 17.8 ± 8.6 p = 0.29, respectively). Moreover, the diagno-
sis of SIC in vasopressor group had significant association with worse 
outcome via a logistic regression analysis adjusted for factors inde-
pendently associated with mortality (odds ratio: 1.52, 95% confidence 
interval: 1.23-1.86).
Conclusion: SIC might be a good diagnostic value of fatal coagulation 
abnormally among sepsis patients who needed vasopressor.
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Introduction: While catecholamine reactivity and response are well-
documented in septic shock, those related to the apelin and related 
renin-angiotensin and kallikrein–kinin systems are mostly unknown. 
From both experimental and human standpoints, the apelin system 
(i.e., apelinergics: apelins -APLNs- and Elabela -Ela-) offers an alterna-
tive pathway for hemodynamic support with evidence of efficiency 
and protection.
Objectives: Determine the endogenous blood contents of apeliner-
gics; the related breakdown enzymatic profile; and the link with out-
comes for septic patients.
Methods: An observational cohort study in 52 subjects: 33 patients 
admitted to the intensive care unit (ICU) for sepsis/septic shock (S) and 
19 healthy volunteers (H) with early blood sampling and data record-
ing up to the outcome.
Results: The endogenous apelinergic system is reactive to S (1.5-to-
3-fold increase of APLNs and Ela blood contents, respectively, p < 
0.01). Concomitantly, lower angiotensin converting enzyme-ACE2- but 
higher angiotensin converting enzyme -ACE1-, Neprilysin -NEP-, Kal-
likrein -KLK1-, and ACE1 enzymatic activities are found in S compared 
to H (p <  0.01-to- 0.0001). Such a huge elevation of systemic ACE1:2 
ratio (16.5 [2.3-60.8] in S vs. 1.2 [0.9-1.3] in H, p=0.0004) and of related 
enzymatic breakdown activities can jeopardize endogenous apeliner-
gics with potential impacts on the outcome. Indeed: 1) S non survivors 
exhibit much higher ACE1:2 ratio than survivors (61.2 [6.3-77.9] vs. 8.8 
[0.7-27], p=0.0352), 2) exogenously added APLN-13 and Ela to plasma 
in vitro display lower stability in S, suggesting an enhanced breakdown 
environment (half-life (min): APLN-13; H: 194 ± 15, S: 143 ± 20 p = 
0.045; Ela, H: 258 ± 45, sepsis: 69 ± 12 p = 0.003). Decreased APLN-
13 half-life is significantly associated with higher NEP and KLK1 enzy-
matic activities (p=0.0116 and 0.0003, respectively). Also, increased 
ACE1/2ratio and NEP activities are significantly linked with higher cir-
culating Ang1–7 levels in S (p < 0.0001). PCA analysis showed a strong 
association between the following variables: arterial lactates, creatinine 
and cortisol circulating levels, APACHE II and SOFA scores, which alto-
gether defined a PC1 axis. A second relationship gathering circulating 
APLNs, Ela, and Ang1–7 levels as well as ACE1, KLK1, and NEP activi-
ties, defined a PC2 axis. In this illustration, sepsis non-survivors were 
widely distributed in the positive area of the PC1 and PC2 axes, sug-
gesting that worse sepsis outcomes could have been influenced by the 
profile of the apelinergic release-degradation system in the critically ill 
patients.
Conclusion: Sepsis-induced renin-angiotensin and kallikrein–kinin 
system disturbances potentiallyimpair the apelin system-driven 
hemodynamic support ability and affect the outcome in human 
patients with septic shock.
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Introduction: Critically ill patients with COVID-19 infection frequently 
exhibit a hyperinflammatory response and develop organ failures, 
however the underlying mechanisms are unclear. We investigated the 
microcirculatory, endothelial and inflammatory responses in critically 
ill COVID-19 patients and compared them to a group of patients with 
septic shock.
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Methods: Prospective observational case control study. 30 critically 
ill patients with COVID-19 were compared to 33 patients with septic 
shock. Measurements of sublingual microcirculatory flow using Inci-
dent Dark Field (IDF) video-microscopy and serial measurements of 
IL-6 and Syndecan-1 levels were performed.
Results: COVID-19 patients had significantly less vasoactive drug 
requirement and lower plasma lactate than those with septic shock. 
Microcirculatory flow was significantly worse in septic patients than 
those with COVID-19 (MFI 2.6 v 2.9 p 0.02, PPV 88 v 97% p <0.001). IL-6 
was higher in patients with septic shock than COVID-19 (1653 v 253 
pg/ml, p 0.03). IL-6 levels in COVID 19 patients were not elevated com-
pared to healthy controls except on the day of ICU admission. Synde-
can-1 levels were not different between the 2 pathological groups.
Conclusion: Compared to patients with bacterial sepsis an overt 
shock state with tissue hypoperfusion does not appear typical of 
COVID-19 infection. There was no evidence of significant sublingual 
microcirculatory impairment, widespread endothelial injury or marked 
inflammatory cytokine release in this group of critically ill COVID-19 
patients. COVID-19 may have a different pathogenesis to bacterial 
induced septic shock
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Introduction: Body temperature abnormalities including hypother-
mia occur frequently in sepsis patients and can influence the inflam-
matory response to infection [1]. However, the relationship between 
hypothermia and clinical parameters of sepsis diagnosed with modern 
definitions is still unsettled.
Objectives: To estimate the impact of hypothermia upon admission 
to the intensive care unit (ICU) on the course and outcomes of sepsis.
Methods: We performed a retrospective analysis of the ICU charts of 
all patients admitted to the 44-bed adult ICU of the City hospital #1 
of Arkhangelsk in 2018. We included for analysis all patients who was 
diagnosed with sepsis upon admission to ICU according to Sepsis-3 
definitions [2] and recorded diagnosis, body temperature, demo-
graphic, clinical and laboratory data, duration of ICU stay and mortal-
ity. We used the Student’s t-test, Mann-Whitney’s test or chi-square 
test to compare the data according to their type and distribution. The 
correlation analysis was performed using Spearman’s rho coefficient. 
The results are presented as n (%), M±SD or median (25–75 percen-
tiles). p values < 0.05 were regarded as statistically significant.
Results: Totally, 3103 ICU charts were examined. Upon admission to 
ICU, sepsis was observed in 121 patients (3.9% from all admissions, 
51.2% males and 48.8% females). The mean age was 66.5±14.7 years, 
the duration of ICU stay was 4 (1.0–7.2) days. The most common ori-
gins of sepsis were pulmonary and abdominal. The organ dysfunctions 
included septic shock (57.9% of cases), kidney injury (57.9%), delirium 
(53.7%), acute respiratory distress syndrome (50.4%), disseminated 
intravascular coagulation (28.9%), metabolic disorders (26.4%), and 
hepatic failure (23.1%). The mean SOFA score during the first 24 hrs 
of ICU stay was 9 points; the hospital mortality was 51%. The mean 
body temperature on ICU admission was 36.2 (35.9-36.7)°C. Hypother-
mia <36°C was diagnosed in 24% of cases; 67% of patients had body 
temperature within 36-38°C, and 9% were febrile (> 38°C). Among 
hypothermic patients with sepsis, 59% were postoperative. The 
patients with sepsis and hypothermia had more severe lactic acidosis 
as compared to normal or febrile body temperature: arterial pH 7.22 
(7.14-7.33) vs. 7.30 (7.20-7.41) and 7.38 (7.34-7.49) (p < 0,002), lactate 
5.0 (2.5-9.5) vs. 2.6 (1.5-4.9) and 4.1 (2.1-5.3) mmol/L, respectively (p = 
0,04). Body temperature on ICU admission correlated with mean arte-
rial pressure (rho = - 0,24, p = 0,015) and platelet count (rho = - 0,34, 
p = 0,001). Hypothermia in septic patients on ICU admission was not 
related with increased mortality or duration of ICU stay.
Conclusion: In sepsis, hypothermia <36°C on admission to ICU occurs 
in 24% of patients and is accompanied by worsening lactic acidosis. 
The relationship between hypothermia and clinical outcome of sepsis 
requires further analysis.
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Introduction: In septic patients, the piperacillin-tazobactam (Pip-
Taz) association is one of the most used antibiotics. Pharmacokinet-
ics of Pip-Taz depend mainly on distribution volume, renal clearance, 
patient’s weight and serum albuminlevel. These parameters are highly 
variable in sepsis. Predictive algorithms based on clinical and biologi-
cal parameters may help optimise dosing and improve outcome.
Objectives: To build a Bayesian model predicting optimal dosing regi-
men of Pip-Taz in septic patient. We designed the OPTAZ study with a 
60-patient construction cohort and a 30-patient validation cohort. We 
present here the pharmacokinetics in the first patients recruited.
Methods: Patients were included prospectively in 4 ICUs in France. Pip 
4g and Taz 0.5g were infused every 6 hours (group 1) or 8 hours (group 
2) according to clinician choice. Infusion time was of 3 hours. For 
patients receiving Pip-Taz every 6 hours, plasma level of Pip and Taz 
was assessed before infusion (H0) and 1.5, 3, 4, 6, 12, 24 and 48 hours 
after the beginning of the first infusion. For patient receiving Pip-Taz 
every 8 hours, plasma level of Pip and Taz was assessed at H0, H1.5, 
H4, H6, H8, H16, H24 and H48. Serum level of Pip-Taz was assessed by 
mass spectrometry. Values expressed as med [Q1-Q3]. We assessed the 
proportion of residual points over 4 times the EUCAST non-species-
related breakpoint for Pip-Taz (4mg/L).
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Results: Nineteen patients included. 14/19 (73%) men, age 54 [47-
62] years, weight 88 [76-92] kg, BMI 27.47 [23.59-33.18] kg/m2. On 
day 1, 5 (26%) received norepinephrine, 4 (21%) lactate ≥ 2mmol/L 
and urine output was 1580 [1350-2180] mL/24h. Patients received 44 
[39-52] mg/kg of Pip and 5.65 [5.28-6.54] mg/kg of Taz. Seven patients 
received the infusion every 8 hours and 12 patients every 6 hours. 
After the first infusion, the AUC of Pip was 280 [218-367] mg.h/L in 
group 1, and 437 [313-566] mg.h/L in group 2. The AUC of Taz was 22.9 
[19.4-36.8] mg.h/L in group 1, and 40.0 [27.1-46.2] mg.h/L in group 
2. After the first infusion, the residual concentration was 13.77 [5.75-
31.95]mg/L, 33% being under 16mg/L in group 1, 71% in group 2. At 
H48, these values were 37.99 [15.00-48.19] and 9.68 [6.37-100.15], 33 
% and 71 %.
Conclusion: In this prospective pilot series of patients admitted with 
sepsis and treated empirically with Pip-Taz, the blood exposure to the 
drug was consistent with the dosing interval but was highly variable, 
including values below the inferior (efficacy) target and over the supe-
rior (toxicity) target.
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Introduction: Biomarkers are essential to adequate triage and risk 
stratification of patients at hospital admission in order to provide an 
appropriate treatment.
Objectives: To compare the value as predictive biomarkers of differ-
ent analytical parameters routinely performed in these patients.
Methods: Multicenter, prospective, observational study, carried out in 
the emergency department from 7 Spanish hospitals. Epidemiological 
and analytical data including demographics, therapy, inflammatory 
and immunity parameters were collected. Patients with the diagnosis 
of COVID-19 infection were included from two groups: patients admit-
ted to the ICU and another group admitted to the hospital with less 
severity. The levels are expressed in median (IRQ).
Results: 203 patients admitted to the hospital emergency department 
with clinical symptoms and positive PCR for Covid-19 were recruited: 
59 were admitted to the ICU during its evolution, 121 patients were 
admitted to the hospital for treatment and 22 were discharged and 
treated at home. The mortality of the patients admitted to the ICU was 
42.37% and in the hospital 17%.
All Biomarkers were significantly higher (p <0.05) in the most severe 
group. Ferritin levels were significantly elevated in patients admitted 
to the ICU 1319 ng / ml compared to those admitted to the hospital 
468 ng/ml and 85 ng / ml in those discharged; the CRP levels were 
14.12 mgs / l vs 8.65 vs 0.84 mgs / L, respectively; PCT levels 0.245 vs. 
0.07 vs. 0.03 ng/ml respectively; DD 1590 vs. 806.5 vs. 632 ng / ml; LDH 
437 vs 280.5 vs 195 U / L; IL6 146 vs 14; Lactate 1.52 vs. 0.87. mOsm / 
l respectively. The lymphocyte count showed a significant decrease in 
the severity group 765 vs 1070 vs 1540 cel / µl respectively.
Regarding the relationship with gender, men predominate with 66.6% 
of those admitted to the ICU, with a lower percentage of those admit-
ted to the hospital (42.97%). Moreover, ferritin levels in men admitted 
to the hospital were significantly higher than in women at admission 
(625.5 vs 354 ng / ml; p = 0.0033) and in the highest during evolution 
(777 vs 393 ng / ml; p = 0.0007).
The ROC-AUC to predict ICU admission and the need for MV were: Fer-
ritin 0.821; PCT 0.767; DD 0.728; LDH 0.720; Lymphocyte count 0.663. 
To predict mortality, the ROC-AUC were: Ferritin at admission 0.703; 
higher value of Ferritin 0.776; PCT 0.786; LDH 0.753; DD 0.680; PCR 
0.613; Lymphocyte count 0.649. In the multivariate analysis, Ferritin 
and LDH levels at admission were predictors of mortality in patients 
with severe Covid-19 pneumonia admitted to the ICU.
Conclusion: Ferritin levels are the best marker of severity and mortal-
ity in patients infected with Covid -19 virus, with a component linked 
to male sex.
001081 
Iron admission values predict respiratory failure in patients 
with SARS‑Cov‑2
F. Valenzuela‑Sánchez1; B. Valenzuela‑Mendez2; L. Fernandez  Ruiz3; 
JF. Rodriguez‑Gutierrez4; MA. Gonzalez‑Garcia5; P. Martínez‑Garcia6; 
S. Moreno  Cano7; J. Rello8; A. Estella7
1Ciberes. unidad de cuidados intensivos, Hospital Universitario de 
Jerez, Jerez de la Frontera, Spain; 2Ginecologia, Hospital Municipal de 
Badalona, Badalona, Spain; 3Unidad de cuidados intensivos, Hospital 
San Juan de La Cruz, Úbeda, Spain; 4Hematología, Hospital Universitario 
de Jerez, Jerez de la Frontera, Spain; 5Analisis clinicos. bioquimica, Hospi‑
tal Universitario de Jerez, Jerez de la Frontera, Spain; 6Servicio medicina 
intensiva, University Hospital of Puerto Real, Puerto Real, Spain; 7University 
hospital of jerez., Intensive care unit, Jerez, Spain; 8Ciberes. vall d’hebron 
research institute, Vall d’Hebron Barcelona Hospital Campus, Barcelona, 
Spain 
Correspondence: F. Valenzuela‑Sánchez
Intensive Care Medicine Experimental 2020, 8(2): 001081
Introduction: Although iron (Fe) is essential for biological processes, 
excessive iron levels can cause tissue damage and increased infection 
susceptibility. Also the immune response to pathogens could modify 
the iron concentration.
Objectives: To relate parameters of Fe metabolism with respiratory 
failure, oxygen requirements, and the need for invasive mechanical 
ventilation in patients with Covid-19.
Methods: Multicenter,prospective, observational study, carried out 
in 7 Spanish hospitals. Epidemiological and analytical data including 
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demographics, therapy, inflammatory and immunity parameters were 
collected, including iron metabolism, and compared from two groups: 
patients admitted to the ICU and another group admitted to the hos-
pital with less severity. The levels are expressed in median (IRQ).
Results: 180 patients with clinical symptoms attended in the Emer-
gency Department, including respiratory failure, and a positive PCR 
for Covid-19 were recruited: 59 were admitted to the ICU during their 
evolution and 121 patients were admitted to the hospital. The global 
mortality rate was 17%. Mortality rate for patients admitted to the ICU 
(59) was 42.3% and 55% for patients that required mechanical ventila-
tion (47). Ferritin levels were significantly elevated (p <0.05) in patients 
admitted to the ICU 1319 ng / ml compared to those admitted to the 
plant 468 ng / ml. Iron levels were 24 µg / dl (16-44.75) in ICU patients 
µg / dl vs. 56 (28.5-82.5) µg / dl in the control group. The ROC curve 
for predicting ICU admission showed an AUC of 0.820 for Ferritin and 
0.711 for Fe levels. The ROC curve for mechanical ventilation showed 
an AUC of 0.777 for Ferritin and 0.775 for Fe levels.
In the multiple linear regression, only Fe levels were directly and sig-
nificantly associated with the worst PaO2 / FiO2 ratio (PAFI) with a r 
coefficient = 0.6688 (p < 0.0001).
Conclusion: a) Ferritin and Iron levels are related to the severity of 
respiratory failure and the need for mechanical ventilation in Covid-19 
patients
b)  Iron levels are associated with oxygenation disorders in these 
patients.
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Introduction: Multiorgan dysfunction and death in sepsis is modu-
lated by a balance between exaggerated hyperinflammation state and 
persistent immune dysfunction leading to anergy.
Objectives: To compare the state of immune dysfunction present in 
a cohort of adults with COVID-19 compared with a control group of 
influenza and predict immunophenotypes identifying need for inva-
sive mechanical ventilation (MV) and death.
Methods: Multicenter, prospective, observational cohort study, car-
ried out in the emergency department from 7 Spanish hospitals. A 
cohort of adults with confirmed PCR diagnosis of COVID-19 was com-
pared with a historical control group with confirmed H1N1pdm2009 
influenza virus admitted to the ICU. Epidemiological and analytical 
data including demographics, therapy, inflammatory and immunity 
parameters were collected. Patients were stratified depending on a) 
no need of oxygen therapy b) Oxygen requirements and c) Invasive 
mechanical ventilation. Findings were adjusted by age (65 and 80 yr). 
Mortality and progression to invasive MV were the main end-points.
Results: 203 COVID19 symptomatic adults were assessed in the emer-
gency department by positive PCR for Covid-19. The global mortal-
ity rate was 17%. Mortality rate for patients admitted to the ICU (59) 
was 42.3% and 55% for patients that required mechanical ventila-
tion (47), whereas in the 75 ICU admission adults with influenza A 
H1N1pdm2009 was 29.33%.
In comparison to immunity parameters the results were the following: 
the number of lymphocytes per µl were significantly lower in patients 
admitted to the ICU 730 (530-1150) vs. 1070 (790- 1450) at the hospi-
tal and 1470 (1030-1965) in discharged patients. This difference is at 
expense of the TCD4+  (584.17 vs. 921.42); BCD19+ (66.12 vs. 264.5) 
and NKCD56+ (69.46 vs.138.18) the number of monocytes was similar 
but HLA-DR expression in monocytes was significantly lower in those 
admitted to ICU 1323 (854.25-1739.5) vs. 4618.5 (4537- 4700) MFI.
Ferritin levels were significantly elevated in patients admitted to the 
ICU 1319 ng/ml compared to those admitted to the hospital 468 ng/
ml and 85 ng/ml in those discharged. CRP levels 14.16 mg/dl (5.23-
24.37) in ICU admitted vs. 8.58 mg/dl (3.07-15.9) in hospital admitted 
(p=0.01) vs. 0.86 mg (0.26-4) (p < 0.0001) in those discharged. PCT lev-
els 0.25 µg/l (0.1-0.62) in ICU admitted vs. 0.07 µg/l (0.04-0.08) in hos-
pital admitted vs 0.03 µg/l (0.02-0.05) (p < 0.0001) in those discharged. 
IL6 levels 146 pg/ml (32.9-1201) in ICU admitted vs. 14.56 pg/ml (7.24-
29.53) (p < 0.0014) in hospital admitted.
In survivors, the numbers of cells TCD4+ were significantly higher (921 
vs. 263) as NKCD56+ (138.18 vs. 59.91), IgM (112 vs 60) and HLA-DR 
expression in monocytes (1600 vs. 847 IMF); IL6 levels were higher in 
the non-survivors: 641.55 pg/ml (114.3-1156) vs. 81.9 pg/ml (26-1624) 
as well as Ferritin 1172 vs 500 ng / ml.
Similar findings were reported in the control group of H1N1pdm influ-
enza admitted to the ICU, which differed in a significantly (p = 0.0017) 
lower BCD19+ (9.750 vs 15.65) rates and IgM levels (72 vs. 160 mgs/dl) 
but significantly higher Ferritin median plasma levels were 1345 ng/ml 
(819.25-2124.25) vs. 558.1 ng/ml (180 - 1880).
The ROC-AUC analysis to predict ICU admission and the need for MV 
were: Ferritin 0.821; NKCD56% 0.818; CD19% 0,773; for IL6 levels 0.731; 
IgM 0.682; lymphocyte count 0.663. The ROC-AUC analysis to predict 
mortality, were: Ferritin at admission 0.703; highest value of Ferritin 
0.776; IL6 levels: 0.921; HLA-DR: 0.857; IgM: 0.755; lymphocyte count: 
0.649.
Stratification by age groups showed higher mortality in the 65-79 
age group: 21.9% compared to those under 65, 10.3%. Likewise, they 
required a greater need for MV 36.1% vs. 20.8% and treatment with 
corticosteroids. There were no differences in immunity cells levels, but 
significantly higher levels of inflammatory parameters: Ferritin, CPR, 
PCT and IL6.
Conclusion: A) Covid-19 patients showed a patent alteration in immu-
nity that worsen with disease severity, similar to what happened in 
Influenza A N1H1 pneumonia, with a marked dysfunction of lympho-
cytes TCD4+ lymphocytes BCD19+, NKCD56+ and monocytes mani-
fested by the low HLA-DR expression.
 B) Covid-19 ICU admitted patients showed an important proinflam-
matory state expressed by high levels of IL6 and Ferritin, higher than 
those showed by severe A H1N1pdm2009 Influenza patients.
 C) Both components influence the severity and poor evolution of the 
patients.
 D) After age stratification, there is a greater hyperinflammation, need 
for respiratory support and mortality in the 65-79 age group.
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Introduction: Coronavirus disease 2019 (COVID-19) may be associ-
ated with systemic hyperinflammation, with consequent increase in 
pro-inflammatory cytokines (e.g. interleukin (IL)-1, IL-6, tumor necro-
sis factors) which leads to multiple organ dysfunction and increased 
mortality. Anakinra, an interleukin-1 receptor antagonist, is a potential 
therapy in patients with severe COVID-19 and may provide clinical 
benefits.
Objectives: We aimed to investigate the effects of anakinra on inflam-
matory markers and clinical outcomes in critically ill patients with 
COVID-19.
Methods: This was a retrospective observational study at a university-
affiliated tertiary hospital during March 18th and May 9th, 2020. We 
included adult patients (≥ 18 years) with confirmed COVID-19 admit-
ted in intensive care units (ICU) and received at least one dose of anak-
inra. We compared them to a group of patients matched for age (± 2 
years), date of ICU admission (± 2 days), type of ventilatory support. 
The primary outcome was the change in c-reactive protein (CRP) 72 
hours post-treatment. The secondary outcomes were changes in white 
blood cells (WBC), D-dimer, ferritin over 72 hours, and ICU mortality. 
(NCT04408326)
Results: 21 patients (male 90.5%) received anakinra. Time from ICU 
admission to the first dose of anakinra was 8 days (interquartile range 
[IQR] 4-16). The duration of anakinra administration was 11 days (IQR 
8-12), and the median total received dose was 2600 mg (2100-3400 
mg). Compared with the control group, patients who were treated 
with anakinra had significantly higher pre-treatment CRP (32.7 (IQR 
21.1,37.3) vs. 16.9 (IQR 7.7,30.1) mg/dL; p=0.03) and D-dimer (9975 
(IQR 6390,72830) vs. 1580 (IQR 1000,7080) ng/mL; p = 0.001). Over 
72 hours, there were significant differences in post-pre CRP (-13.3 
(95% confidence interval [CI] -17.5,-9.2) vs. 0.2 (95%CI -3.8,4.3) mg/dL; 
p=0.006), WBC (1266 (95%CI -1171,3703) vs. 2717 (95%CI 280,5154) 
cells/mm3; p=0.002), and D-dimer (-10729 (95%CI -19089,-2369) vs. 
-2758 (95%CI -10441,4924) ng/mL; p=0.004), but similar changes in 
ferritin (-864 (95%CI -2903,1175) vs. -2005 (95% CI -3948,-62); p=0.25). 
ICU mortality was not different between the groups.
Table 1 Baseline characteristics between patients who received anakinra and control (n=42) 
Parameters Anakinra group (n=21) Control (n=21) P-value 
Age (years) 49.2 ± 11.4 49.6 ± 11.1 0.90 
Male sex (%) 19 (90.5) 18 (85.7) 1.00 
SOFA score 6.5 ± 2.9 6.8 ± 3.2 0.73 
Mechanical ventilation (%) 20 (95.2) 20 (95.2) 1.00 
Vasopressor (%) 10 (47.6) 8 (38.1) 0.53 
Venovenous ECMO (%) 10 (47.6) 6 (28.6) 0.20 
Conclusion: Administration of anakinra in critically ill patients with 
COVID-19 was associated with significant decrease in inflammatory 
markers.  Further clinical trials are required to confirm the effects of 
anakinra on clinical outcomes.
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Introduction: Inter-hospital transfers (IHTs) to tertiary care centers are 
commonly due to limited availability of time-critical interventions and 
resources. Transfer patients are complex often requiring organ sup-
port with treatment delays resulting in worse outcomes. In one study, 
IHT patients with severe sepsis or septic shock had significant delays 
in appropriate antibiotic and resuscitation therapy compared to non-
transferred patients, with no difference in ICU LOS or mortality. In a 
surgical population, increased complications were observed in IHTs for 
acute appendicitis versus patients that presenting directly. Weekend 
neurosurgical IHTs had worse functional outcomes with daytime IHTs 
experiencing longer length of stay (LOS). The “weekend effect” has 
been associated with higher mortality in the emergency department.
Objectives: The objective of this study was to evaluate whether the 
timing of IHTs affects outcomes in critically ill patients with sepsis.
Methods: A retrospective cohort study of IHT patients ≥18 years old, 
admitted to the critical care service with a primary sepsis diagnosis 
during 1/1/2016-12/31/2018. Data sources were merged from the 
transfer center, administrative databases, and the electronic health 
record chart review. Timing was defined as weekday (Monday 7:00 to 
Friday 17:59) vs. weekend (Friday 18:00 - Monday 06:59), and daytime 
(7:00 - 17:59) vs. nighttime (18:00 - 06:59). Evaluation included patient 
characteristics, sepsis diagnosis, therapies (days on mechanical venti-
lation (MV), dialysis, and vasopressors, and surgical procedures), and 
outcomes. Descriptive analysis included 95% confidence intervals to 
describe the data using means (SD) or median (IQR).
Results: A total of 521 patients were included of which 199 were day-
time admissions, 322 nighttime, 319 weekday and 202 weekend. Com-
paring weekday vs. weekend, the groups were similar for age (60 vs. 
61, p=0.61), sex, race, BMI and APACHE II score (25.4 (8.71) vs. 26.92 
(7.92), p=0.08). More patients received MV on the weekend (67.3% vs 
58% weekday, p=0.33), with weekend patients on MV longer (6 (3-12) 
days vs 5 (3-9), p=0.05). Vasopressors were administered in 62% with 
weekend admissions receiving more days on vasopressors (3 (2-6) 
vs. weekday 2 (1-4), p=0.03). Shorter LOS was observed in weekday 
admissions (3 (1-8) vs 5 (2-10.25) weekend, p=0.03). No difference in 
hospital LOS, mortality, or discharge disposition. Comparing daytime 
vs. nighttime, no significant differences were observed for patient 
characteristics, treatments, or outcomes. Most IHTs had sepsis with an 
unspecified organism. Mortality was ≥27%, and discharge to hospice 
was ≥30% in all groups.
Conclusion: In this cohort, IHTs were severely ill requiring life-sus-
taining therapies with increased resource use for weekend transfers. 
Contrary to previous studies, the timing of transfer did not have a sig-
nificant effect on patient survival. Clinician awareness of IHT on the 
weekend with attention on weaning vasopressors and mechanical 
ventilation as appropriate, may contribute to decreased resource utili-
zation and improved patient outcomes.
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Introduction: During sepsis, red blood cells (RBCs) rheology are 
altered (more spherical shape, decreased deformability and increased 
aggregation). Persistence of these alterations were associated with 
poor outcome [1,2]. Moreover, RBCs are physiologically protected by 
membrane surface proteins (CD35, CD55 and CD59) against the com-
plement system activation [3]. In malaria, Waitumbi et  al. reported 
links between the modification of the expression of these RBCs mem-
brane proteins and the erythrophagocytosis, a cause of anaemia in 
this disease. [4]
Objectives: We studied the time course of RBCs deformability and 
the surface IgG and regulatory proteins content in RBCs from septic 
patients (S) compared to healthy volunteers (V).
Methods: By flow cytometry technics, we measure at ICU admission, at 
day 3-5 and day 7-10, the RBC membrane expression of IgG and com-
plement proteins (CD35, 55, 59 and CD95) from S patients compared 
to RBCs from V. We assessed the RBC shape by the second moment of 
dissymetry of Pearson as already reported [1]. RBCs deformability was 
estimated by an ektacytometry technique (laser-assisted optical rota-
tional cell analyzer) for shear stress from 0.3 to 50 Pa.
Results: RBCs from 11 S patients and 21 V were included. At ICU 
admission, RBCs from S patients were more spherical than V (moment 
S  : -0.193 (-0.561; -0.033)  vs V  : -0.538 (-0.657; -0.491);  p=0.026) and 
deformability was significantly altered for all shear stress ≥ 3.07 Pa. 
However, these alterations of shape and deformability persists at Day 
3.
We observed only a significant decrease at ICU admission in CD35 
expression in S patients compared to V (9.2 (5.02-13.18) vs 23.04 
(11.39-32.57); p = 0.011). No significant changes were observed over 
time.
Conclusion: Our study suggests that a decrease in CD35 expression 
at the surface of the RBCs as well, as we have already observed (an 
increase in RBC sphericity and decrease membrane sialic acid content) 
[1], could be at the root of the accelerated aging of RBCs. This could 
contribute to the anaemia observed in septic patients.
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Introduction: Sepsis describes the condition of life-threatening organ 
dysfunction due to a dysregulated host response to infection. Early 
diagnosis and treatment can significantly reduce mortality. Microcircu-
latory dysfunction is an important pathophysiological feature of sepsis 
and may correlate with disease severity [1,2]. Infrared thermal imaging 
is a novel approach for monitoring the microcirculation via cutaneous 
temperature gradients [3]. Machine Learning shows great promise as 
a tool for medical image analysis, approaching the accuracy of clini-
cians in a growing range of tasks [4]. The combination of infrared ther-
mal imaging and machine learning classification may be a promising 
approach for the automating the diagnosis of sepsis severity.
Objectives: This study is aimed at the preliminary development 
of a machine learning technique for identification of sepsis sever-
ity utilising infrared thermal images as a means of interrogating the 
microcirculation.
Methods: Participants were recruited in to two groups based on the 
2009 sepsis definitions; early sepsis patients without organ dysfunc-
tion (n=33), and severe sepsis patients with evidence of organ dys-
function (n=34). Standardised infrared images were acquired of the 
anterior knee for each participant. A sliding window approach was 
used to extract image patches from the images. The patches were 
grouped by category and clustered with K-Means clustering. The 
Elbow method was applied to find the optimal number of clusters for 
each category. The patches were then projected onto the cluster cen-
troids. With a large number of patches for each image, the image-wise 
features were reconstructed as mean values of patch-wise features. 
A number of classifiers were trained for the binary classification task 
in the space of the extracted features. The model performance was 
evaluated by 5-fold cross-validation, where the samples were the sam-
ples were separated 5 folds, and for each fold (testing set) four other 
folds were used as training set. We accumulate the validation predic-
tions from each fold and compare them to their actual grouping for 
evaluation.
Results: The highest performing classifier found is a support vec-
tor machine with gridsearch optimized hyper-parameters. This clas-
sifier produced an accuracy of 83.58%, or error of 16.42%, for the 
binary classification of early and severe sepsis in the cross-validation 
protocol.
Conclusion: The preliminary results show that the presented tech-
nique, in this h dimensional yet low-sample setting, may be a feasible 
approach to the binary discrimination of severity for infrared thermal 
imaging monitoring of microcirculation in sepsis patients. Further 
research is required to test and develop this preliminary technique, 
while more data is required to assure that the model does not overfit.
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Introduction: Acute inflammatory processes like sepsis are often 
accompanied by a dysfunctional endothelial barrier causing hyperper-
meability and organ failure. While impaired expression of cell adhe-
sion molecules is a typical feature of barrier disruption, it is known that 
microRNAs (miRs) play an essential role in regulating these adhesion 
molecules [1]. Recently, miR-125a was found to be upregulated in the 
blood of patients with sepsis [2]. Therefore, we wanted to investigate 
whether there is a miR-125a-specific functional network controlling 
endothelial barrier in acute inflammatory conditions.
Methods: MiR-125a was transfected into primary human umbilical 
vein endothelial cells (HUVECs). After stimulation with TNF transcrip-
tome was analyzed using Next Generation Sequencing (NGS) followed 
by bioinformatics pathway analysis. NGS-results were validated via 
immunoblot and RT-PCR. To verify a direct miR-125a-3’-UTR interac-
tion, we analyzed luciferase reporter assays. We tested endothelial 
barrier function with permeability assays and with electric cell sub-
strate impedance sensing (ECIS) in HUVECs transfected with miR-125a, 
specific target siRNAs and blocking antisense miRNA (Antimir). For sta-
tistical evaluation we used student’s t-test.
Results: In response to various inflammatory stimuli (cytokines, 
hypoxia, septic serum) HUVECs significantly upregulated miR-125a 
(Fig.  1A). NGS identified the pathways, GO_regulation of cell adhesion 
and KEGG_adherens junctions, as significantly regulated by miR-125a. 
We focused on five potential targets with an in-silico predicted miR-
125a binding site: The adhesion molecules VE-Cadherin (CDH5) and 
Claudin-5 (CLDN5) as well as the protein phosphatases PTPN1, PPP1CA 
and the transcription factor ETS-1. Validation of the NGS confirmed a 
significant downregulation of RNA and protein expression (Fig. 1B-D). 
Via reporter construct analysis, we newly identified CDH5 and PTPN1 
as direct targets of miR-125a. Whereas expression of CLDN5 was 
dependent on CDH5 expression [3] and PPP1CA and ETS-1 are pub-
lished targets of miR-125a [4, 5]. MiR-125a transfected HUVECs show 
a significantly increased permeability in permeability assays and 
decreased barrier function in ECIS. Specific knock-down of each of the 
five targets in the miR-125a functional network created a compara-
ble phenotype. In contrast, hyperpermeable phenotype in the acute 
inflammation could be partially rescued by specific inhibition of miR-
125a (Fig. 1E, F).
Conclusion: MiR-125a induced by inflammatory stimulation directly 
targets the five target molecules CDH5, CLD5, PTPN1, PPP1CA and 
ETS-1 leading to increased permeability of the endothelial mon-
olayer. In acute inflammatory diseases like sepsis this newly identified 
miR-125a-specific functional network could be a novel mechanism 
involved in the pathologic loss of intravascular fluids and thus block-
ade of miR-125a may be of therapeutic interest.
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Introduction: Acute lung injury (ALI) is the leading cause of mortal-
ity in critically ill patients. Exacerbated inflammatory response is a key 
mechanism of sepsis-induced ALI, so that attenuating inflammation 
is crucial1. Previously, we showed that methotrexate (MTX) carried 
in lipid core nanoparticles (LDE) had powerful anti-inflammatory and 
anti-proliferative effects on rheumatoid arthritis2 and atherosclerotic 
lesions3 and improved left cardiac dysfunction in myocardial infarc-
tion4. When MTX is associated to LDE, the cellular uptake of the drug is 
increased several-fold, which conceivably endows MTX with increased 
therapeutic action and diminished toxicity.
Objectives: To investigate whether treatment with LDE-MTX can 
attenuate the development of inflammatory process in septic rats with 
ALI.
Methods: Sepsis was induced in Wistar rats by two I.P lipopolysac-
charide (LPS, 10mg/kg) injections administered at 24h interval. Rats 
were allocated to Control group (CT, without sepsis) and 2 groups with 
sepsis: LDE, treated with LDE only; and LDE-MTX, with LDE-MTX at a 
dose of 1mg/kg I.P. 72h after sepsis induction, the animals were eutha-
nized for protein expression analysis by Western blot of inflammatory, 
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apoptotic, antioxidant enzymes, angiogenesis, cell hypoxia, fibrosis 
and adenosine bioavailability markers in lungs.
Results: Compared to CT, the antioxidant enzymes, (catalase and 
superoxide dismutase-1) and fibrosis (collagen types 1 and 3) were 
lower in LDE and LDE-MTX groups. Although the expression of leu-
cocytes and interleukins levels were similar in all 3 groups, septic 
rats treated with LDE had higher expression of macrophage recruit-
ment marker (CD68) and tumor necrosis factor alpha, while LDE-MTX 
was able to decrease these levels, both compared to CT. Apoptotic 
markers, such as caspase 3 and b-cell associated X protein/b-cell lym-
phoma-2 ratio, were higher in LDE group. LDE-MTX treatment was able 
to lower these pro-apoptotic factors to CT levels. Regarding angiogen-
esis and cell hipoxia, protein expression of CD31 and angiostatin, pro 
and anti-angiogenesis markers, respectively, and hypoxia-inducible 
factor 2-alpha were normalized to CT levels by the treatment with 
LDE-MTX, when compared to LDE group. The increase in thebioavail-
ability of intracellular adenosine of septic animals treated with LDE-
MTX was suggested by the higher expression of A1 and A2b receptors 
in the lungs.
Conclusion: Possibly by increasing the bioavailability of intracellular 
adenosine, LDE-MTX treatment was effective in reducing the inflam-
matory process, decreasing cell death by apoptosis and normaliz-
ing angiogenesis and cell hypoxia factors in septic rats with ALI. The 
marked improvement of inflammatory response in ALI by LDE-MTX 
may pave the way for a novel strategy to treat this condition.
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Introduction: Regulatory T cells (Tregs) are a subset of CD4+ T cells 
which have an immunosuppressive function and essential for main-
taining peripheral tolerance. In critically ill patients, the risk of adverse 
outcomes (including nosocomial infections), increase with increasing 
proportion of total Tregs. We hypothesised that this increase in risk is 
secondary to increases in proportions of effector Tregs and effector 
Tregs will be higher in sepsis compared to non-sepsis critical illness. 
Our aims were to compare the proportion of total Tregs and Treg sub-
sets in critically ill patients with sepsis and without sepsis (non-sepsis) 
over the first 3-days following critical care admission.
Methods: INFECT was an observational study of critically ill adults 
admitted to ICU (n=148), involving measurement of percentage 
Tregs to predict the risk of nosocomial infection. Data from 140 criti-
cally ill adult patients were included in this post-hoc analysis. Patients 
were categorised into those admitted with sepsis (57/140 and those 
who developed nosocomial infection during their ICU stay (n=53). 
We measured total Treg proportions by CD25+ CD127- expres-
sion on CD4+ T cells. Treg subsets studied included naïve (CD4+, 
CD25+, CD127-, CD45RA+, CD15s-), effector (CD4+, CD25+, CD127-, 
CD45RA-, CD15s+), CD161+ cytokine-secreting Tregs (CD45RA-, 
CD15s-, CD161+) and CD161- non-regulatory cells (CD45RA+, 
CD15s+, CD161-).
Results: We found no significant difference in proportions of total 
Tregs (Fig. 1A), naïve Tregs (Fig.1B), CD161+ Tregs (Fig. 1D) and CD161- 
cells (Fig.  1E) in septic and non-septic patients at admission (T1) (p 
> 0.05). However, we found significantly less effector Tregs in septic 
patients versus non-septic patients at T1 (Fig.  1C, p < 0.05, Mann-
Whitney). We further categorised septic/non-septic patients according 
to the development of nosocomial infection. We found no significant 
changes in proportions of total Tregs and Treg subsets in infected and 
non-infected patients at T1 and T3 (p > 0.05, Two-way ANOVA).
Conclusion: We found lower proportions of effector Tregs in patients 
admitted to ICU with sepsis compared to other admissions. Our data 
does not suggest that total Treg and Treg subsets proportions can be 
used to predict nosocomial infection in critically ill adults admitted to 
ICU.
Reference(s) and grant ackowledgment(s)
1. The study was funded by Innovate UK (Sepsis 2: 101193), BD Biosciences 
and the National Institute for Academic Anaesthesia. Dr Conway Morris is 
supported by a Clinical Research Career Development Fellowship from the 
Welcome Trust (WT 2055214/Z/16/Z). Dr Shankar‑Hari is supported by the 
National Institute for Health Research Clinician Scientist Award (CS‑2016‑16‑
011). The views expressed in this publication are those of the author(s) and 
not necessarily those of the NHS, the National Institute for Health Research 
or the Department of Health and Social Care.
000994 
Survivin and caspases upregulation in sepsis
M. Miliaraki1; P. Briassoulis1; S. Ilia1; A. Polonifi2; M. Mantzourani2; 
E. Briassouli2; S. Nanas3; A. Pistiki4; M. Theodorakopoulou4; G. Daikos2; 
G. Briassoulis1
1Pediatric Intensive Care Unit, Medical School, University of Crete, Herak‑
lion, Greece; 2First department of internal medicine, laiko hospital, National 
and Kapodistrian University of Athens, Athens, Greece; 3First critical care 
department, National and Kapodistrian University of Athens, Athens, 
Greece; 42nd department of critical care, Attikon General University Hos‑
pital, Haidari, Greece 
Correspondence: M. Miliaraki
Intensive Care Medicine Experimental 2020, 8(2): 000994
Introduction: Sepsis is a dysregulated host response to infection, 
related to devastating outcomes. Recently, interest has been shifted 
towards apoptotic and antiapoptotic pathobiology (1). Apoptosis 
is executed through the activation of caspases (2) and regulated 
through the activation of a number of anti-apoptotic proteins, such 
as survivin, with different biological functions (pro-apoptotic or anti-
apoptotic), depending on the expression of its different splice variants 
(wild type-WT, -ΔEx3, -2B, -3B) (3). The apoptotic and antiapoptotic 
responses have not yet been elucidated in sepsis.
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Objectives: The present study seeks to ascertain whether sepsis is 
associated with an upregulation of certain apoptotic (caspases) or 
anti-apoptotic biomolecules (survivin), and also seeks to assess the 
prognostic value of survivin transcript variant expression (survivin-
WT, -ΔΕx3, -2B and -3B), in ICU patients with sepsis and non-infectious 
(trauma-related) SIRS.
Methods: This prospective observational study was performed in a 
sample of critically ill adult patients with sepsis (n= 107) or traumatic 
SIRS (n= 75), compared to healthy controls (n= 89). The expression of 
survivin transcript variants was analyzed by real-time quantitative PCR 
in peripheral blood leukocytes, whereas the apoptotic or antiapop-
totic equilibrium was specified by measuring caspases-3 and -9, along 
with survivin-WT serum protein concentrations, through enzyme-
linked immunosorbent assay (ELISA).
Results: The survivin-WT, -2B, -ΔΕx3 mRNA, survivin protein and 
caspases-3 and -9 showed an escalated increase in sepsis (Figure  1), 
compared to traumatic SIRS and controls, whereas survivin-3B was 
repressed in sepsis (p < 0.05). For discriminating sepsis, caspase-
9achieved the best receiver operating characteristic curve (AUROC) of 
0.95. In predicting mortality, caspase-9 and survivin protein achieved 
an AUROC=0.70.
Conclusion: The upregulated apoptotic and anti-apoptotic pathways 
might represent attractive targets for future research in the clarifica-
tion of sepsis. The mRNA expression of survivin variants and protein 
activity quantification of survivin and caspases could predict outcome 
and provide additional information about clinical management of 
patients suffering from sepsis.
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Introduction: Sepsis is characterized by dynamic changes of the 
immune system resulting in deregulated inflammation. In a certain 
group of patients, the robust hyperactivation of inflammation occurs 
very early. This so-called “cytokine storm” leads frequently to patient’s 
death and could be considered as a potential target group for future 
early immunotherapy. Circulating monocytes are among the first ones 
to recognize and clear pathogens and thus have an important role in 
early stages of infection and sepsis (1). Three distinct subpopulations 
of monocytes have been described: classical (CD14+ CD16-), interme-
diate (CD14+ CD16+) and non-classical (CD14lo CD16+) (2-3).
Objectives: The aim of the study was to evaluate monocyte popula-
tions in the early stages of septic shock in relation to patient mortality. 
Specifically, we focus on the group of patients with very early mortal-
ity (up to 72 hr. after ICU admission). We aim to determine whether 
specific changes in monocyte populations could be used as biomarker 
in prediction of early mortality and whether it correlates with severity 
of septic shock.
Methods: Patients admitted to the ICU with early septic shock were 
prospectively enrolled into the study. Whole blood samples and clini-
cal data were collected at within 12 hr. after admission. Peripheral 
blood monocytic cells were isolated and labelled with specific anti-
bodies. Presence of particular populations were determined by flow 
cytometry. With the use of Spearman correlation and Mann-Whitney 
test, the obtained data were related to 3-days mortality and the rela-
tionships with patient’s age, sex, number of comorbidities, SOFA, CRP 
and the need of catecholamines were estimated. The predictive poten-
tial was assessed using receiver-operating curve. Data are provided as 
median (IQR).
Results: Recruited septic shock patients (n = 41) were predominantly 
male (57.1 %) with median age 73.0 (66.5-77.0) years. All patients were 
mechanically ventilated and the SOFA score at admission were 11 (10-
14). There was no statistically significant difference in the patients’ 
comorbidities, chronic medication or age between patients who died 
in first 72 hours (early deaths) and the others. 3-day and 28-day mor-
tality rate were 14 % and 51%, respectively. Group of early deaths had 
a lower percentage of classical monocytes (57.6 (42.5-62.0) % vs. 81.6 
(65.5-90.1) %; p = 0.0098) and conversely had a higher proportion of 
intermediate (29.1 (26.2-36.1) % vs. 8.9 (4.2-19.6) %; p = 0.0005) and 
non-classical (5.4 (4.5-6.5) % vs. 3.1 (1.9-6.4) %; p = 0.1485) monocytes 
than other patients. AUC of receiver-operating curve for prediction of 
3-day mortality was 0.8357 for classical, 0.9095 for intermediate and 
0.6905 for non-classical monocytes. The ratio classical/intermediate 
shows even higher predictive potential (AUC = 0.9238). Furthermore, 
there were no statistically significant correlation between monocyte 
subsets and other characteristics (SOFA, lactate, CRP, catecholamines, 
etc.).
Conclusion: The determination of monocyte subsets frequency (espe-
cially intermediate monocytes) or its ratio can be used to predict a ful-
minant course of septic shock and to identify patients with excessive 
inflammatory response who might profit from personalized immuno-
modulatory therapy.
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Introduction: Procalcitonin (PCT) has emerged as a tool to guide anti-
biotic (ABx) therapy in bacterial pneumonia, but PCT’s role in distin-
guishing between bacterial & viral pneumonia is uncertain(1). With the 
novel SARS-CoV-2 pandemic there’s emerging interest in the role of 
this biomarker for assessing COVID-19 disease severity & progress(2). 
In COVID-19 pts, bacterial or fungal coinfection incidence is 8%, whilst 
72% of the pts have been reported to receive antimicrobial therapy(3). 
In the UK a recent guideline from NICE suggests early review of need 
for antibiotic treatment in COVID-19 on basis other than PCT(4). We 
have reviewed our institutional data in order to assess current practice 
& usefulness of using PCT as a tool for assessing disease severity, pro-
gress & for guiding ABx therapy.
Objectives: 1) Compare PCT between COVID-19 pts admitted to ICU 
and not
2) Describe how concurrent bacterial infection in ICU pts influenced 
PCT
3) Describe how PCT was associated with duration of ABx therapy.
Methods: Contemporaneous eMR records were reviewed retro-
spectively for 70 COVID-19 pts admitted to ICU vs 70 who were not. 
Evidence of concurrent bacterial infection was sought; defined as bac-
teraemia, positive sputum/tracheal aspirate culture or molecular test-
ing. Duration of ABx therapy was also collected.
Student’s t-test was used to compare mean PCT values, whilst diag-
nostic performance of PCT >0.5  μg/mL in bacterial co-infection was 
assessed. Duration of ABx was assessed in pts with PCT> & <0.5 μg/mL 
threshold.
Results: Data was available from completed 70 ICU & 70 ward admis-
sions 35/70 ward pts had PCT measured. Similarly, 17/70 ICU pts had 
PCT measured prior to ICU. PCT levels were not clinically & statisti-
cally significantly different (mean; ward 0.69mg/mL, ICU 0.57mg/mL, 
p=0.87).
Of the 70 ICU pts, PCT was tested in 6/9 pts with evidence of bacterial 
co-infection & in 39/61 pts without bacterial infection. PPV of PCT >0.5 
to indicate bacterial co-infection was found to be 21%, but on the con-
trary the NPV of PCT <0.5 to exclude was found to be 95%. There was 
no difference in median no. of ABx-days amongst pts with PCT >0.5 & 
<0.5 (9.5 vs 10 days) but amongst pts with PCT > of 2mg/ml there was 
a trend towards longer therapy (9 vs 11 days).
Conclusion: It’s not clear from this data that PCT on presentation dis-
criminates between pts with severe & non-severe COVID-19. Although 
the usual threshold PCT <0.5mg/mL was able to effectively rule out 
bacterial co-infection, its PPV was modest. This reflects limited impact 
that PCT had on duration & intensity of ABx therapy. In pts with severe 
respiratory failure clinicians may be reluctant to stop ABx, given the 
non-trivial rate of bacterial co-infection. The combination of PCT & a 
rapid, sensitive molecular test may improve antimicrobial stewardship.
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Introduction: Sepsis is a host response to infection, which when 
exaggerated can lead to multiple organ dysfunction and death. Early 
treatment of sepsis decreases mortality and early diagnosis of sepsis, 
especially in critically ill patients, is essential.
Objectives: This study aimed to analyze abnormal body temperature 
patterns in intensive care patients using the PreEmpsis™ proprietary 
algorithm developed by Medisim Ltd. and visual inspection to see if 
they could predict the subsequent diagnosis of sepsis.
Methods: This retrospective study was from January 2016 to Decem-
ber 2016. A total of 50 patients (35 male and 15 female) out of 1365 
patients admitted to the ICU were included in the study when they 
developed a temperature above 38.3°C at least 72 hours after admis-
sion to the ICU. 24 of them were subsequebtly diagnosed as septic 
and 26 were non-septic patients. Patients were individuals aged 18 
years and above (average age 58.34 years). Sepsis was diagnosed 
according to the Third International Consensus Definitions for Sepsis 
and Septic Shock (Sepsis-3, 2016) if these findings occurred 72 hours 
after admission to the ICU.
The temperature was measured non-invasively from the axillary, femo-
ral, or rectal sites with a standard continuous temperature probe con-
nected to our monitoring system. The investigators retrospectively 
screened all the temperature recordings retrieved from the electronic 
patient record of the patients admitted to the ICU during the study 
period. Patients with a temperature recorded at least once of more 
than 38.3°C were then screened for the additional criteria to determine 
the diagnosis of sepsis or not. The control group comprised those 
patients who developed temperatures above 38.3°C after 72 hours 
of admission to ICU but were not subsequently diagnosed as septic. 
Temperature curves for the 72 hours before the clinical suspicion of 
sepsis (for septic patients) and for the 72 hours before developing a 
temperature above 38.3°C (for non-septic patients) were quantitatively 
analyzed using visual inspection and the PreEmpsis™ proprietary, pre-
dictive temperature trend analysis algorithm.
Results: The mortality rate was 26% (13 out of 50). As expected, the 
mortality rate for septic patients was higher – 50% (12 out of 24) com-
pared to the control group – 3.8% (1 out of 26). We did not find any 
difference between the temperatures of the two groups by visual 
inspection alone, but the PreEmpsis™ proprietary algorithm detected 
a difference by monitoring the maximum temperature changes within 
24 hours. The maximum temperature change within 24 hours for sep-
tic patients was 1.8±0.54, and for non-septic patients was 2.0±0.39. 
In addition the algorhithm also detected differences in the patterns 
of temperature recording between the two groups – frequency and 
amplitude changes, as well as change from baseline. The accuracy of 
the temperature changes detected by thealgorithm as compared to 
clinical diagnosis of sepsis was 0.71, with a sensitivity of 0.78 and a 
specificity of 0.65.
Conclusion: The visual inspection method of temperature changes 
alone is not accurate, nor specific enough to differentiate between 
septic and non-septic patients with high temperatures. However, 
PreEmpsis™ computerised predictive trends analysis was superior to 
visual inspection. Nevertheless, we should not use the temperature 
changes alone as a sole diagnostic method for predicting the onset of 
sepsis until validated by larger studies.
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Introduction: Vitamin C’s role in the management of sepsis was first 
popularised in 2017 with the work of Marik et al1. Vitamin C is consid-
ered a safe therapy in other contexts such as management of malnu-
trition, itself shown to adversely affect outcome2. As such, we audited 
our current use of Vitamin C in sepsis.
Objectives: To investigate prescribing practice of Pabrinex (Vitamin B 
and C) in sepsis admissions to a district general hospital intensive care 
unit, and investigate its impact on mortality or requirement for organ 
support.
Methods: A retrospective analysis of prescribing practice was con-
ducted studying all admissions to critical care who met the physi-
ological parameters for Sepsis 3 during a 1 year time period. Outcomes 
including mortality and requirement for invasive organ support were 
monitored. The total dose of vitamin C prescribed during admission 
was calculated.
Results: A total of 253 patients met sepsis criteria between April 2018-
April 2019. Pabrinex was prescribed in 91 cases (36% of admissions). 
There was no uniformity in prescribing of Vitamin C. Regimes ranged 
from 1 pair a day to 3 pairs, three times a day. There was no correlation 
between severity of illness and dose of Pabrinex prescribed, nor asso-
ciation between higher doses of Vitamin C and outcomes measured. 
Total dose received during admission ranged from 0mg to 32g.
The mean age of those receiving Pabrinex was 61, with ICNARC mor-
tality predicted at 30.8%. Actual mortality was 23% (SMR 0.77). 23% 
required vasopressors, 58% required invasive ventilation and 28% 
required renal replacement therapy.
The non-Pabrinex group (64% of total admissions) had a mean age of 
55, with ICNARC mortality 23%. Actual mortality was 12% (SMR 0.5). 
59% required vasopressors, 34% required invasive ventilation and 8% 
required renal replacement therapy.
Conclusion: The survival rates in both groups were better than pre-
dicted using ICNARC Mortality calculators, indicating our centre per-
forms above expectations in the management of sepsis admissions. 
Due to the heterogeneity of the study groups we were unable to 
accurately ascertain the impact of vitamin C in modifying patient out-
comes. Vitamin C was often prescribed to older, more unwell patients, 
possibly reflecting the severity of their illness. Concurrent use of 
Pabrinex in the management of malnutrition also acts as confounding 
factor. Due to the disparities in prescribing practice we have initiated a 
standard prescription bundle for all admissions with sepsis.
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Introduction: Patients in acute circulatory failure are characterized by 
inequality between tissue oxygen demand and supply. The difference 
of carbon dioxide tension between central venous and arterial blood 
(ΔPCO2) reflects the veno-arterial CO2 concentration difference and is 
inversely related to cardiac output, tissue oxygen delivery and perfu-
sion [1]. High ΔPCO2 in sepsis and septic shock is associated with poor 
outcome [2]. However, there has not been any study yet to evaluate 
ΔPCO2 during the course of a septic episode.
Objectives: To follow and evaluate the difference of PCO2 between 
central venous and arterial blood sample (ΔPCO2), during the progress 
of a septic episode
Methods: Seventy nine (79) patients were included and were sepa-
rated into two groups. Group A included 52 patients who had sepsis 
remission while group B included 27 patients who had sepsis deterio-
ration. ΔPCO2 was calculated in septic patients on admission and at 
either deterioration or remission of the septic episode.
Results: ΔPCO2 was higher in the sepsis deterioration group on 
admission (6.47±3.03 vs. 7.71±3.07 mmHg, for group A and group B 
respectively, p=0.08), although the difference did not reach a statis-
tically significant level. In group A ΔPCO2 increased at sepsis remis-
sion (6.47±3.03 vs. 7.41±3.24 mmHg, p=0.05). In contrast, in group 
B ΔPCO2 decreased at sepsis deterioration (7.71±3.07 vs. 6.30±3.23 
mmHg, p=0.04). Group B patients were also characterized by 
increased use of vasopressors (0.532±0.315 vs. 0.258±0.166 μg/kg/
min, p < 0.001), increased lactate concentration (5.2±3.8 vs. 2.4±1.3 
mmol/l, p=0.001) and higher SOFA score (13.4±3.0 vs. 10.4±3.0, p < 
0.001) at deterioration compared to admission, as expected.
Conclusion: The higher ΔPCO2 on admission, in the group of patients 
who deteriorated compared to those who improved, might indicate 
tissue hypoperfusion occurring early in sepsis. However, at sepsis 
remission/deterioration, the results of our study probably reflect the 
different basal metabolic rate at the different stages of sepsis. Thus, 
at deterioration basal metabolic rate/mitochondrial metabolism 
decreases, leading to decreased CO2 production and low ΔPCO2. 
On the contrary, during sepsis remission, mitochondrial metabolism 
recovers and, consequently, ΔPCO2 increases[3].
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Introduction: It is known that automatic alert systems are helpful in 
early detection of sepsis, considering how important early diagnosis as 
a prognostic factor. So far, automated monitoring electronic programs 
have been used with this objective, but not based on Sepsis-3.
Objectives: The main aim of this study is to compare the 3 different 
algorithms that could define sepsis including the classic sepsis defini-
tions (Defs.) and Sepsis-3.
As secondary goals, it is described the automatic alert system itself, 
representing its sensibility (S), specificity (E), negative predictive value 
(NPV) and positive predictive value (PPV).
Besides, some of the clinical information that is provided by the pro-
gram, such as focus and source of infection and mortality rate are 
analyzed.
Methods: SEPSIS SAVER is a new electronic  software counselled by 
expert clinicians of 3 different Intensive Care Units of University Hos-
pitals in Spain.
After improvements in the software (integration of basal SOFA scale 
estimation for each patient before testing any of the algorithm) and 
a  friendly  & useful designed tool in pursuit of clinicians, during 2 
months (February and March 2020) has been implemented as a pilot 
testing in our 1063-bed University Hospital of Burgos (UHB). The pro-
spective evaluation was compared to the the Standard Sepsis Codifi-
cation System (SSCS) of our UHB.
Any patient admitted in the hospital, through Emergency Room or 
during whole stay in ward, is monitored and after evaluating the clini-
cal and lab tests results, the tool observes if patient matches any of the 
algorithms:
1. Systemic Inflammatory Response Sindrome [SIRS] 3 2 + 1 Organ Failure 
[OF].
2. Sequential Organ Failure scale [SOFA] 3 2.
3. quickSOFA [qSOFA] 3 2. The validated clinical score in Sepsis‑3 Definition.
There can be matches to any of them or to more than one. Instantly, 
the tool will inform to the clinician(by email, cell phone or checking 
the tool)=patient at increased risk of sepsis.
Results: During February-March 2020, SEPSIS SAVER 2.0 monitored 
13.584 (100%) patients. Among them, 844 (6.21%) were warned at 
risk of sepsis and 191 (prevalence[P] 1.40%) were finally confirmed as 
sepsis by members of Sepsis Team. It means a rate of 703 sepsis epi-
sodes/100.000 inhabitants per month. Instead, the  Standard Sepsis 
Codification System (SSCS)of our UHB, confirmed only 81 sepsis cases 
(P 0.60%) and a rate of 22,8 ep./100.000 inh./month the preliminary 
software used in 531-bed Doctor Peset University Hospital (SEPSIS 
SAVER 1.01).
Only 9.42% of patients of the  confirmed cases  were admitted to ICU 
due to Septic Shock. Global mortality attributable to sepsis was 11%.
SOFA was the algorithm that more sepsis cases detected with 67,53% 
of cases. SIRS+ 1 OF 31,46% and qSOFA only 16 cases (assumption 
8,40%) but these episodes were also detected at the same time by the 
other 2 algorithms.
Conclusion: SOFA is the most sensitive tool, although S improves 
implementing SIRS+OF at the same time, therefore, Sepsis-2 Defs. 
Instead, Sepsis-3 Defs where qSOFA is used, is not valuable as sepsis 
detector, launching debate about validity of the “New Sepsis Defs 
2016”.
The SSCS of our UHB vs the use of automatic alarm tool and the 
enhancements of Sepsis Saver 2.0, verifies the importance & useful-
ness of automatic alarm guided electronic tools. The upgrade of E,S, 
NPV and PPV, encourage us to continue in the design of the “future 
perfect automatic tool” in sepsis detection.
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Introduction: Underfeeding and malnutrition are known to be associ-
ated with impaired short and long-time recovery after major surgery 
inpatients admitted to ICU [1-3]. Although head and neck cancer 
(HNC) free flap surgery may have a substantial impact on normal eat-
ing, chewing and swallowing, there is a lack of studies contemplating 
the adequacy of nutrition during the immediate postoperative period 
after HNC surgery [4-5].
Objectives: The aim of the present study was to evaluate the ade-
quacy of nutrition after free flap surgery for HNC during the imme-
diate in-hospital recovery and to discover factors associated with 
inadequate nutrition delivery.
Methods: This single-center retrospective cohort study included 218 
HNC patients who underwent free flap surgery in Oulu University 
Hospital, Finland between the years 2008 and 2018. Nutrition delivery 
methods, the adequacy of nutrition and complication rates were eval-
uated during the first 10 postoperative days.
Results: A total of 131 (60.1%) patients reached nutritional adequacy 
of 60% of calculated individual demand during the follow-up period. 
According to multivariate analysis, nutrition inadequacy was asso-
ciated with higher ideal body weight (OR 1.11 [1.04-1.20]) whereas 
adequate nutrition was associated with higher number of days with 
oral food intake (OR 0.79 [0.67-0.93]). In the univariate model trache-
ostomy, bilateral neck dissection and postoperative surgical complica-
tions were associated to poor postoperative nutrition adequacy.
Conclusion: Inadequate nutrition is common after HNC free flap sur-
gery. The present results suggest that more adequate nutrition deliv-
ery might be obtained by the early initiation of oral food intake and 
close monitoring of nutrition support.
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Introduction: Aggressive muscle wasting occurs early in critical ill-
ness. It is associated with greater duration of mechanical ventilation, 
and intensive care unit (ICU) and/or hospital stays, and frequent long-
lasting functional impairment. No known interventions prevent this 
wasting.
Ketone bodies, produced by the liver from fatty acids in response to 
starvation, can act as metabolic fuels for muscle or other peripheral tis-
sues, and as signalling molecules.
Increasing ketone body production by altering nutrition composi-
tion - providing it is feasible, safe and tolerated by ICU patients - may 
mitigate early muscle loss in critical illness by acting as a more efficient 
energy source, improving related outcomes.
Objectives: To perform a randomised controlled feasibility study to 
determine whether:
i) ICU patients during early critical illness can be recruited to and 
retained in a study of ketogenic enteral feed administration, and 
whether
ii) this feed significantly raises plasma and urine ketone body levels 
while being safe and well-tolerated.
Methods: A two centre feasibility study conducted over 30 months. 
Patients will be recruited (with consultee agreement) within 48 hours 
of ICU admission and randomised to either ketogenic or standard 
enteral feed over a 10-day period. Data will be collected during the 
study period, and 3, 6 and 12 months post ICU-discharge.
Inclusion criteria: (i)>18 years old (ii) prescribed enteral nutrition (iii) 
mechanically ventilated ≥48 hours (iv) likely to remain on ICU ≥5 days 
and (v) likely to survive ≥10 days (vi) multi-organ failure (SOFA score 
>2).
Exclusion criteria: (i) existing primary neuromyopathy/significant neu-
rological impairment (ii) uni- or bilateral lower limb amputation (iii) 
requiring sole/supplemental parenteral nutrition (iv) need for special-
ist nutrition (v) patients with known inborn errors of metabolism.
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Intervention: Modular ketogenic enteral feed will be reconstituted on 
the ICU for each patient for 10 days, as prescribed by dietitians to meet 
nutritional energy targets: medium chain triglycerides (Betaquik®, 
Vitaflo) increasing from 40% to 80% during the study period, plus long 
chain triglycerides (Fresubin 5kcal®, Fresenius Kabi) to keep total fat 
at 80% of energy input; 15% protein (Renapro®, Stanningley Pharma), 
provided minimum protein requirements are met; and 5% carbo-
hydrate (Maxijul®, Nutricia). The contribution of energy from other 
sources. e.g. propofol and dextrose (including additional dextrose 
used as drug diluents) will be taken into account.
Sample size: 24 ICU patients receiving randomised feed for 10 days or 
up to ICU discharge: allowing for a 34% dropout rate, up to 37 eligible 
patients will be required. Site-specific data and past trial experience 
suggest that recruitment will take 15 months.
We will assess feasibility of patient follow-up at 3, 6 and 12 months 
post-ICU discharge, and the views of ICU nurses on study safety, practi-
cality and acceptability. Levels of ketone bodies and other metabolites 
will be determined, as well as cost-effectiveness comparisons between 
the two feed regimens.
Results: Nine patients have been recruited so far with no feed-related 
adverse effects reported.
Conclusion: If using ketogenic feed in ICU patients is shown to be safe 
and feasible, it may mitigate muscle loss in early critical illness, provid-
ing a new way to improve function and well-being in ICU survivors.
ClinicalTrials.gov NCT04101071.
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Introduction: Hypophosphatemia (HypoP) is frequent in intensive 
care unit (ICU) settings and may affect up to 35% of admissions. Severe 
hypophosphatemia is associated with organ dysfunction and mortal-
ity. Its true prevalence and its proportional relationship to refeeding 
syndrome remain largely unknown.
Objectives: The aim was to learn the point-prevalence of HypoP 
defined as blood phosphate (P) <0.8 mmol/l on one particular day 
(D-Day) at international level while gathering information about the 
internal ICU policies/guidelines for the management of HypoP among 
international ICUs.
Methods: This point-prevalence survey was conducted with Ethical 
approval by the Section of Metabolism, Endocrinology and Nutrition 
of ESICM and endorsed by ESICM, : each site had one D-Day during the 
week 11/2020: the primary endpoint was the prevalence of blood P < 
0.8 mmol/l. Data were collected on ICU (number of beds, frequency 
of P analysis, treatment strategies) and patients (collected for hypoP 
patients only): age, days in ICU, nutritional therapy, renal replacement 
therapy (CRRT)). Data are presented as number (percentage) for cat-
egorical and median [IQR1;3] for continuous variables.
Results: 59 ICUs from 23 countries participated and 4 ICUs were pae-
diatric: 40/59 ICUs were mixed medico-surgical, (see Table); 20 sites did 
measure P daily, 7 ICUs stated “never”. Out of 881 patients present on 
D-Day, 675 (76.6%) patients had P determined, and 99 (15%) presented 
hypoP, with 48 (48.5%) patients with severe hypoP < 0.65mmol/l; 50% 
of the hypoP were documented within the first 5 days in the ICU. Age 
was 62 [52;71] years. HypoP was most frequent in medical patients. 
HypoP was not associated with feeding (enteral in 52%, parenteral in 
19%), but with being on CRRT (p = 0.045)







 (>40 beds) 
ICU profile 59 20 37 2 
Mixed 40 10 28 2 
Medical 8 6 2 0 
Cardio-Surgical 11 4 7 0 
Total patients in the ICU on 
D-Day 881 156 647 78 
Total patients with P analysis 675 (77%) 102 (65%) 500 (77%) 73 (94%) 
Patients with P <0.8 mmol/l 99 (15%) 12 (12%) 75 (15%) 12 (16%) 
                      P<0.65 mmol/l 48 31 40 1 
Phosphate measure 
frequency: 
At least once daily 21 (35.5%)5 15 1 
3 x per week 21 (35.5%)7 13 1 
never 7 (12%) 4 3 0  
Conclusion: The point-prevalence survey shows that HypoP is present 
at least in 15% of ICU patients, and in half of them is observed dur-
ing the first 5 ICU days. Half of the patients had a severe hypoP. This 
number is an underestimation since systematic measurements occur 
only in ¾ of patients, while 12% of ICUs never monitor this electrolyte. 
Moreover the study was done in ICUs with metabolic interest.
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Introduction: Early provision of a high-protein nutrition improves 
the prognosis of patients in intensive care units (ICUs). However, high 
protein intake increases blood urea nitrogen (BUN). No study has 
compared outcomes according to protein intake, and the clinical sig-
nificance of changes in BUN (ΔBUN) in ICU patients is unclear. Here, we 
investigated the association of high protein intake with outcomes and 
BUN and assessed the clinical significance of ΔBUN.
Objectives: This study aimed to investigate the effect of high-protein 
provision on the outcomes and BUN, and to investigate the clinical 
significance of ΔBUN.
Methods: This was a single-center retrospective cohort study. 
Between 1 January 2016 and 30 September 2019, 295 ICU patients 
received enteral nutrition for at least 3 days while undergoing 
mechanical ventilation. After applying the exclusion criteria of an 
age of <18 years, gastrointestinal disease, maintenance dialysis, renal 
replacement therapy after admission, kidney transplantation, and 
death within 7 days of commencing enteral nutrition, 206 patients 
remained.
Participants were divided into those receiving >1.2 g/kg/day of pro-
tein (highprotein group; n = 111) and those receiving ≤1.2 g/kg/
day of protein (non-high-protein group; n  =  95). The groups were 
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balanced by propensity score matching. The primary endpoint was 
28-day mortality, and the secondary endpoints were 90-day mortality, 
length of ICU stay, number of ventilator-free days in the first 28 days, 
and ΔBUN.
Results: The high-protein group had significantly lower 28- and 90-day 
mortality and significantly greater ΔBUN, including after propensity 
score matching. ΔBUN might not be associated with outcomes.
Conclusion: Provision of >1.2 g/kg/day of protein may be associated 
with lower mortality of tube-fed and mechanically ventilated patients. 
Furthermore, while high protein intake may be associated with higher 
BUN, these changes may not be adversely associated with outcomes.
Reference(s) and grant ackowledgment(s)
1. 1. Tian F, Wang X, Gao X, et al: Effect of initial calorie intake via enteral nutri‑
tion in critical illness: a meta‑analysis of randomised controlled trials. Crit 
Care 2015; 19:180. 2. Elke G, Wang M, Weiler N, et al: Close to recommended 
caloric and protein intake by enteral nutrition is associated with better 
clinical outcome of critically ill septic patients: secondary analysis of large 
international nutrition database. Crit Care 2014; 18:R29. 3. McClave SA, 
Saad MA, Esterle M, et al: Volume‑based feeding in the critically ill patient. 
J Parenter Enteral Nutr 2015; 39:707‑712. 4. McCall M, Cahill N, Murch L, 
et al: Lessons learned from implementing a novel feeding protocol: results 
of a multicenter evaluation of educational strategies. Nutr Clin Pract 2014; 
29:510‑517. 5. Heyland DK, Cahill NE, Dhaliwal R, et al: Enhanced protein‑
energy provision via the enteral route in critically ill patients: a single center 
feasibility trial of the PEP uP protocol. Crit Care 2010; 14:R78. 6. Long CL: 
Energy balance and carbohydrate metabolism in infection and sepsis. Am 
J Clin Nutr 1977; 30:1301‑1310. 7. Jensen GL, Mirtallo J, Compher C, et al: 
Adult starvation and disease‑related malnutrition: a proposal for etiology‑
based diagnosis in the clinical practice setting from the International 
Consensus Guideline Committee. Clin Nutr 2010; 29:151‑153. 8. Allingstrup 
MJ, Esmalizadeh N, Wilkens Knudsen A, et al: Provision of protein and 
energy in relation to measured requirements in intensive care patients. 
Clin Nutr 2012; 31:462‑468. 9. McClave SA, Taylor BE, Martindale RG, et al: 
Guidelines for the provision and assessment of nutrition support therapy 
in the adult critically ill patient: Society of Critical Care Medicine (SCCM) 
and American Society for Parenteral and Enteral Nutrition (ASPEN). JPEN J 
Parenter Enteral Nutr 2016; 40:159‑211. 10. Singer P, Blaser AR, Berger MM, 
et al: ESPEN guideline on clinical nutrition in the intensive care unit. Clin 
Nutr 2019; 38:48‑79. 11. Wolfe RR, Goodenough RD, Burke JF, et al: Response 
of protein and urea kinetics in burn patients to different levels of protein 
intake. Ann Surg 1983; 197:163‑171. 12. Shaw JH, Wildbore M, Wolfe RR: 
Wole body protein kinetics in severely septic patients. The response to 
glucose infusion and total parenteral nutrition. Ann Surg 1987; 205:288‑294. 
13. Larsson J, Lennmarken C, Martensson J, et al: Nitrogen requirements 
in severely injured patients. Br J Surg 1990; 77:413‑416. 14. Ishibashi N, 
Plank LD, Sando K, et al: Optimal protein requirements during the first 2 
weeks after the onset of critical illness. Crit Care Med 1998; 26:1529‑1535. 
15. Strack van Schijndel RJ, Weijs PJ, Koopmans RH, et al: Optimal nutrition 
during the period of mechanical ventilation decreases mortality in critically 
ill, long‑term acute female patients: a prospective observational cohort 
study. Crit Care 2009; 13:R132. 16. Sevette A, Smith RC, Aslani A, et al: Does 
growth hormone allow moreefficient nitrogen sparing in postoperative 
patients requiring parenteral nutrition? A double‑blind, placebo‑controlled 
trial. Clin Nutr 2005; 24:943‑955. 17. Tamura T, Yatabe T, Yokoyama M, et al: 
Current status of studies about optimal composition of amino acid and 
protein for ICU patients: systematic review. Anaesth Intensive Care 2014; 
42:806‑807. 18. Weijs PJ, Stapel SN, de Groot SD, et al: Optimal protein and 
energy nutrition decreases mortality in mechanically ventilated, critically ill 
patients: a prospective observational cohort study. JPEN J Parenter Enteral 
Nutr 2012; 36:60‑68. 19. Dickerson RN: Estimating energy and protein 
requirements of thermally injured patients: art or science? Nutrition 2002; 
18:439‑442. 20. Frankenfield D: Energy expenditure and protein require‑
ments after traumatic injury. Nutr Clin Pract 2006; 21:430‑437. 21. Hoffer 
LJ, Bistrian BR: What is the best nutritional support for critically ill patients? 
Hepatobiliary Surg Nutr 2014; 18:701. 22. Frank H, Graf J, Amann‑Gassner U, 
et al: Effect of short‑term high‑protein compared with normal‑protein diets 
on renal hemodynamics and associated variables in healthy young men. 
Am J Clin Nutr 2009; 90:1509‑1516. 23. Arihan O, Wernly B, Lichtenauer M, 
et al: Blood urea nitrogen (BUN) is independently associated with mortality 
in critically ill patients admitted to ICU. PLoS One 2018; 13:e0191697. 24. 
Larson J, Ljljedahl SO, Schildt B, et al: Metabolic studies in multiple injured 
patients. Clinical features, routine chemical analysis and nitrogen balance. 
Acta Chir Scand 1981; 147:317‑324. 25. Schoenfeld DA, Bernard GR: Statisti‑
cal evaluation of ventilator‑free days as an efficacy measure in clinical trials 
of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 
30:1772‑1777. 26. Austin PC: An introduction to propensity score methods 
for reducing the effects of confounding in observational studies. Multivari‑
ate Behav Res 2011; 46:399‑424. 27. Stuart EA: Matching methods for causal 
inference: A review and a look forward. Stat Sci 2010; 25:1‑21. 28. Arabi YM, 
Tamim HM, Dhar GS, et al: Permissive underfeeding and intensive insulin 
therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr 
2011; 93:569‑577. 29. Krishnan JA, Parce PB, Martinez A, et al: Caloric intake 
in medical ICU patients: consistency of care with guidelines and relation‑
ship to clinical outcomes. Chest 2003; 124:297‑305. 30. Rice TW, Mogan S, 
Hays MA, et al: Randomized trial of initial trophic versus full‑energy enteral 
nutrition in mechanically ventilated patients with acute respiratory failure. 
Crit Care Med 2011; 39:967‑974. 31. Rice TW, Wheeler AP, Thompson BT, 
et al: Initial trophic vs full enteral feeding in patients with acute lung injury: 
the EDEN randomized trial. JAMA 2012; 307:795‑803. 32. Ahrens CL, Barletta 
JF, Kanji S, et al: Effect of low‑calorie parenteral nutrition on the incidence 
and severity of hyperglycemia in surgical patients: a randomized, controlled 
trial. Crit Care Med 2005; 33:2507‑2512. 33. McCowen KC, Friel C, Sternberg 
J, et al: Hypocaloric total parenteral nutrition: effectiveness in prevention of 
hyperglycemia and infectious complications: a randomized clinical trial. Crit 
Care Med 2000; 28:3606‑3611.
2. None declare
000313 
Hypermetabolism: Does it affects prognosis in critical patients? 
Indirect Calorimetry as an instrument of research
G. Sousa1; I. Mendes2; L. Tavares1; R. Carvalho2; M. Henriques1; H. Costa1
1Intensive Care, Hospital do Divino Espírito Santo, Ponta Delgada, Portu‑
gal; 2Endocrinology and nutrition, Hospital do Divino Espírito Santo, Ponta 
Delgada, Portugal 
Correspondence: G. Sousa
Intensive Care Medicine Experimental 2020, 8(2): 000313
Introduction: Energy expenditure (EE) evaluation in Intensive Care 
Unit (ICU) patients is very challenging. Critical illness is characterized 
by great variability in the EE, which is influenced by the disease itself 
and the effects of treatment. Indirect calorimetry (IC) is currently the 
gold standard to measure EE in ICU patients. However, calorimeters 
are not widely available and predictive formulas (PF) are still com-
monly used, which may lead to under or overfeeding and its del-
eterious consequences.1,2 Important metabolic changes occur and 
catabolism becomes prominent in critically ill patients.3,4 However, 
both hyper and hypometabolism are observed.5 Hypermetabolism is 
a condition mediated by the immune system, which can be affected 
by damaged tissue, pathogenic microorganisms, and the entry of their 
toxins into the bloodstream, as well as the body’s response, with hor-
mones and cytokines release. Due to this situation, hypermetabolic 
patients often have higher mortality rates compared to metabolically 
normal patients. 6,7
Objectives: To assess the incidence of hypermetabolism and to com-
pare clinical outcomes between hypermetabolic and normometabolic 
patients in ICU with EE measured by IC.
Methods: Single-centre, retrospective, observational study includ-
ing mechanically ventilated patients admitted in ICU between 
August 2018 and February 2020. EE was measured by IC. Basal Energy 
Expenditure (BEE) was estimated by the Harris-Benedict equation 
(HB). According to their metabolic state (EE/BEE × 100), patients were 
divided in hypermetabolic (≥130%) and normometabolic (<130%). To 
determine the limits of agreement between EE and BEE, we performed 
a Bland-Altman (BA) analysis. Baseline characteristics, severity criteria, 
and main diagnosis were compared. The primary outcome consid-
ered was 30-day mortality. Other outcomes were evaluated, such as 
the length of stay (LOS) in ICU, LOS in hospital, and length of invasive 
ventilation.
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Results: Of the 55 ICU patients included, median age was 62,0 [52,0-
72,0] years. BA showed a mean -411 ± 554 Kcal/d for EE and BEE. 
Seventeen patients (30,9%) were in hypermetabolic group with a sig-
nificantly higher proportion of male patients (88,2 vs 11,8%; p=0,04), 
a lower BMI (26,1 [23,0-27,7] vs 27,7 [24,7-33,8] Kg/m2; p=0,04), a 
higher proportion of patients admitted due to medical conditions 
(76,5 vs 47,4%, p = 0,04), and due pneumonia (41,2 vs 15,8%; p = 
0,04). We did not find any statistically significant difference between 
the two groups, neither in 30-day mortality nor in the other outcomes 
compared.
Conclusion: There was no statistically significant difference between 
the two groups in all the clinical outcomes considered. However, we 
concluded that hypermetabolic patients were predominantly males, 
had a lower BMI, and had a higher proportion of admissions due to 
medical conditions and pneumonia.
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Introduction: Diarrhoea is a common concern in the intensive 
care unit (ICU) and incidence varies from 2-95% in previous studies. 
This variation is due to lack of a consistent definition of diarrhoea 
and scientific inattention to this clinical problem. The prevalence, 
predisposing factors, and prognosis of diarrhoea during critical illness 
have not been well defined in prospective studies.
Objectives: To determine the incidence (using different diagnostic cri-
teria), risk factors, management modifications, and clinical outcomes 
associated with diarrhoea in critically ill adults.
Methods: Design, Setting and Participants: We prospectively 
enrolled consecutive adults admitted to 12 Intensive Care Units (ICU), 
in 4 countries, during a 10-week period. We excluded patients admit-
ted to the ICU for <24 hours.
Main Outcome: The primary outcome was diarrhoea incidence, using 
the World Health Organization (WHO) definition, and the Bristol Stool 
Chart (Bristol) and Bliss Stool Classification System (Bliss), and risk fac-
tors. Secondary outcomes included Clostriodiodes difficile-associated 
diarrhoea (CDAD), ICU and hospital length of stay and mortality.
Analysis: We used logistic regression to evaluate 12 potential risk 
factors for diarrhoea, and Cox regression to estimate the association 
between diarrhoea and morbidity and mortality. All models were 
adjusted for age, sex and APACHE II scores.
Results: Among 1109 patients age 61.4 [17.49] mean [standard devia-
tion] years, APACHE-II 18.8 [7.98], 981(88.5%) medical patients, 645 
(58.2%) mechanically ventilated, diarrhoea was common (WHO 73.8%, 
95% confidence interval [CI] 71.1-76.6; Bristol 53.5%, 95%CI 46.7-50.4; 
and Bliss 37.7%, 95%CI 34.9-40.4). Independent risk factors for diar-
rhoea (WHO Definition) included enteral nutrition (OR 2.43, 95% CI 
1.70-3.48), suppository use (OR 1.73, 95% CI 1.28-2.35) and number of 
antibiotic days (OR 1.10, 95% CI 1.05-1.14). Female sex (OR 0.71, 95% 
CI 0.52-0.95) and opioid use (OR 0.32, 95% CI 0.22-0.48) were associ-
ated with a lower risk of diarrhoea. Diarrhoea resulted in modifications 
to patient management including: enteral nutrition held or changed, 
stool softener or prokinetic held, rectal appliance used, or C. difficile 
test ordered (OR 10.9; 95% CI 5.74-21.03). CDAD prevalence in the 
ICU was 85/1109 (7.7%). Among the 99 patients with diarrhea tested 
for CDAD, 23/99 were positive, for a CDAD ICU incidence of 23/ 1109 
(2.1%). Diarrhoea was associated with a longer length of stay in the 
ICU (HR 2.62, 95% CI 2.23-3.06; p < 0.001) and hospital (HR 1.72; 95% CI 
1.46-2.01; p < 0.001) and increased hospital mortality (HR 2.12; 95% CI 
1.61-2.78; p < 0.001).
Conclusion: Diarrhoea is common during critical illness; incidence 
varies by diagnostic definition. Several risk factors are modifiable. Diar-
rhoea is associated with increased morbidity and mortality.
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Introduction: The positive influence of nutritional support is under-
recognized and nutrition is considered an adjunctive more than a pri-
mary therapy itself.
Objectives: The main aim of the present study was to evaluate the 
influence of nutritional support in outcomes in the critical care setting.
Methods: Prospective observational multicenter study. Demographic, 
comorbidities, cause of admission, nutritional evaluation, type and 
characteristics of nutritional support (during the whole nutritionalde-
livery or at least the first 14 days of nutritional support), and outcomes, 
with special attention in 28-day mortality, were registered in a data-
base. Confounders, such as disease severity, type of patient and the 
length of nutritional support among others, were considered for final 
statistical approach (NCT:03634943).
Results: 639 patients were included with a 25.6% of mortality. Non-
survivors showed older age, higher comorbidities, higher SOFA score 
(6.6±3.3vs8.4±3.7;P < 0.001) and nutritional risk (3.8±2.1vs5.2±1.7;P 
< 0.001) on admission. Nutritional support did no differ among 
groups, except a trend towards lower mean protein intake in non-
survivors. Non-survivors suffer from higher needs on vasopressor 
therapy (70.4%vs83.5%;P=0.001) and renal replacement therapy 
(12.2%vs23.2%;P=0.001). Multivariate analysis showed that older 
age (HR:1.023;95% CI:1.008-1.038;P=0.003), higher SOFA Score 
(HR:1.096;95% CI:1.036-1.160;P=0.001), higher NUTRIC Score 
(HR:1.136;95% CI:1.025-1.259;P=0.015), the need of parenteral nutri-
tion (PN) after the initiation of enteral nutrition (EN) (HR:2.368;95% 
CI:1.168-4.798;P=0.017), mean Kcal/Kg/day (HR:1.057;95% CI:1.015-
1.101;P=0.008), and mean g protein/Kg/day (HR:0.507;95% CI:0.263-
0.977;P=0.042) were factors associated with mortality.
Conclusion: Elderly, higher average of organ failure and nutritional 
risk are nutritional related factors that may be associated with higher 
mortality. Patients who need of PN after initiation of EN may represent 
a high mortality risk subgroup due to illness severity and problems in 
giving appropriate nutritional support. The mean caloric and protein 
delivery may play a key role in outcomes.
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Introduction: There is a gap between the theoretical benefits of phar-
maconutrition and the moderate benefit in clinical practice in the 
Intensive Care Unit (ICU).
Objectives: The aim of the present research was to evaluate the 
impact of immunonutrition formulas (IMN) with standard enteral for-
mulas in outcomes during the ICU stay.
Methods: National multicenter prospective observational study (37 
hospitals) from April to June 2018, conducted in ICUs throughout 
Spain (NCT Registry: 03634943). Patient characteristics, calorie-protein 
dose, life support needs and mortality were evaluated. Statistical dif-
ferences were analyzed according to the administration of IMN formu-
las and the type of patient.
Results: 525 patients who received enteral nutrition (EN) were 
included in the analysis, of which 406 (77%) received only EN. 16.57% 
of the patients received IMN formulas. The age was 61.33 ± 15.01 
years, BMI: 27.86 ± 6.06Kg / m2, the majority were medical patients 
(68%), malnutrition was 38.58% (SGA) and the mean nutritional risk 
was 4.17 ± 2.14 (NUTRIC Score). The 28-day mortality was 26.1% and 
the IMN formulas were not associated with lower mortality compared 
to the other formulas when comparing the subgroup of survivors with 
non-survivors.
However, a lower need for vasopressor support (75.6% vs. 60.66%; 
OR: 0.490; 95% CI: 0.260-0.910; P = 0.023) and continuous renal 
replacement therapies (OR: 0.130; 95% CI: 0.010-0.650; P = 0.049) was 
observed in those patients who received IMN formulas compared 
with standard formulas. The use of IMN formulas was associated with 
a higher average protein delivery during the nutritional therapy (0.74 
± 0.34vs0.9 ± 0.31g/Kg/d; OR: 6.230; 95% CI: 2.590-15.540; P < 0.001).
Conclusion: We showed lower need of vasopressors and continu-
ous renal replacement therapies during ICU stay with the use of IMN 
formulas, which may be associated with their modulatory effect over 
inflammatory response. A higher protein delivery may be provided 
with IMN formulas in the ICU.
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Introduction: Background: In critically ill patients thyroid levels have 
a significant role in terms of recovery from critical illness however, 
their replacement has not been shown to confer mortality/outcome 
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benefit in subsets with lower hormone levels. This communication 
attempts to delineate the outcomes/mortality correlations in patients 
with abnormalities of thyroid levels getting admitted to an intensive 
care unit (ICU).
Objectives: Comparison of mortality outcomes in patients of sepsis 
with abnormalthyroid levels and no underlying thyroid disorders get-
ting admitted to ICU.
Setting: 60 bedded mixed ICUs of tertiary care units.
Methods: All patients getting admitted with Sepsis from Jan 2019- till 
date were included and their baseline samples of TSH/T3/T4 were col-
lected. Data was collected with a focus on demographics, SOFA scores, 
Length of stay (LOS) and mortality. Patients with hypoalbumine-
mia, preexisting thyroid disorders and receiving Amiodarone were 
excluded. Death/discharge from ICU were considered as end points. 
Statistical analysis was done using SPSS version 23. Chi square test was 
used to delineate association with mortality.
Results: Ninety patients were included (n=90, M: F-58:32). Age of the 
cohort was 50+17 years (Range-22-85). SOFA scores were 11.8+3.2 
(Range-6-18). Length of stay was 6.9+ 4.3 days (Range-1-20) and in 
hospital mortality was 37.8%(n=34). Thyroid hormone levels were 
TSH (4.6+ 2.8[Range- 1-12.6]/Ref -0.4-4.2), T3 (1.4+ 0.57[Range-
0.6-2.5]/ Ref-0.4-2.4) and T4 (7+2.6[Range-2.2-11.8]/Ref-6.09-12.23) 
respectively. On statistical analysis in isolation both low TSH levels and 
Low T3 levels were significant predictors of mortality [0.0006P and 
0.0001P]. Combination of these variables did not improve the associa-
tion and was statistically not significant
Conclusion: Low TSH and T3 levels at baseline predict mortality in 
sepsis cohorts. However, whether the relationship would remain sac-
rosanct in patients with hypoalbuminemia and patients receiving Ami-
odarone remains to be seen. We will need bigger subsets with more 
variables to enhance our knowledge levels for the same.
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Introduction: The COVID pandemic has resulted in a high number of 
intensive care (ICU) admissions, generally The COVID pandemic has 
resulted in a high number of intensive care (ICU) admissions, gener-
ally for respiratory distress. While research has focused on respiratory 
and infectious characteristics, little is known about their metabolic and 
nutritional characteristics compared to other categories of patients.
Objectives: The aim was to compare COVID patients’ status and meta-
bolic response to persistently critically ill patients (PCI) defined as >10 
days in ICU
Methods: Prospective observational study in consecutive cohorts of 
long stay patients on mechanical ventilation and COVID-19 patients 
were analysed. Variables: demographic data, severity score (SAPS2), 
Nutritional risk screening (NRS) score, C-reactive protein (CRP). Pre-
albumin values determined on admission (adm) and D6-9 (delta 
pre-albumin was calculated between admission and D6-9 values), 
nutritional management, length of stay and outcome. Nutritional rec-
ommendations were: energy target 20 kcal/kg during first week (then 
adapted according to indirect calorimetry measurements for LSP, no 
calorimetry for COVID-19), protein 1.2 g/kg, early enteral nutrition 
privileged (time to feeding recorded). The confined dieticians worked 
remotely. Statistics: median (interquartiles), percentage.
Results: Altogether 50 LST and 54 COVID-19 mechanically ventilated 
patients were included. Characteristics are shown in Table. The two 
cohorts were similar in terms of age, gender distribution (74% men) 
and disease severity; however, COVID patients were significantly 
heavier. Median NRS was 5 in both groups, several points coming from 
reduced eating during last days in COVID patients, which was less fre-
quent in PCI cohort. Mortality did not differ. Enteral nutrition was initi-
ated earlier in COVID: on Day1 in 50% vs 20%, on Day2 87% vs 33%, 
and Day3 94% vs 53% (p < 0.0001) respectively. Combined EN and par-
enteral feeding was only required on rare occasions (<2%). Admission 
prealbumin was significantly lower in COVID vs PCI, unrelated to NRS 
score, and poorly correlated to CRP (r2=0.082). Prealbumin increase 
(delta 0.19 g/l) was significantly higher in COVID patients, but also in 
survivors of both groups, where difference over time was 0.03 (0; 0.09) 
g/l (p < 0.0001). Protein data are in prepartion.
PCI (n=50) COVID (n=54) P value 
Age (yrs) 61 (53; 73) 61 (56; 71) 0.822 
Weight 77 (63; 90) 85 (75; 98) 0,0001 
BMI (kg/m2) 25.5 (21.4; 31.7) 27.7 (25.7; 33.4) 0.0036 
SAPS2 score 41 (33; 59) 40 (33; 46) 0.703 
Length ICU stay (d) 26.1 (21.0; 38.0) 18.7 (10.4; 27.7) 0.0002 
Prealbumin Adm. g/L 0.095 (0.07; 0.14) 0.070 (0.06; 0.09) 0.014 
Delta prealbumin g/L 0.025 (0.01; 0.06) 0.19 (0.09; 0.32) <0.0001 
Mortality 20.0% 15.4% 0.541  
Conclusion: Mechanically ventilated COVID patients were heavier 
both groups presenting a similar nutritional risk. Prealbumin values 
on admission were significantly lower and reverted faster to normal 
values, which might be due to a faster clearance of inflammation and 
related catabolism, but maybe also to nutrition. Early enteral feeding 
was significantly more frequent in COVID patients, reflecting the lesser 
impact of a single respiratory organ failure on GI tract.
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Introduction: The rapid decline of muscle mass and function in 
mechanically ventilated critically ill patients is associated with poor 
outcome, and prolonged impairment in physical function. The loss of 
lean body mass (LBM) is rapid and massive being close to 20% in one 
week. Nutrition only partly attenuates muscle loss. HMB, a metabolite 
of leucine, has been shown to substantially reduce loss of muscle mass 
in older adult healthy and sick subjects but has not been tested in ICU 
patients.
Objectives: The study aimed at testing the impact of HMB on LBM 
using ultrasound assessment and on amino acid metabolism.
Methods: RCT in 37 critically ill patients (ITT), on mechanical ventila-
tion, with full treatment and a functional gastro- intestinal tract. Inter-
vention: Enteral HMB 2*1.5 g/day versus placebo from day 4 to day 30 
after admission. Primary outcome: muscle mass loss (ultrasound of 
thigh on days 4 and 15 to determine % change of skeletal muscle index 
(SMI). On days 4 and 15, amino acid metabolism was investigated with 
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the pulse administration of a mixture of stable amino acid tracers. 
Plasma enrichments were measured by LC-MS/MS, and areas under 
the curve (AUC) were calculated to determine whole body production 
and interconversions of several amino acids. Patients were separated 
in two groups at day 4 based on net protein breakdown (netPB: con-
version of phenylalanine to tyrosine): low (lower than lower limit of the 
95% CI) and high. Stats by 2 factor ANOVA (Graphpad Prism 8.4).
Results: Critically ill patients with age 65±15 years and SAPSII 47 
±12 were studied. Seven patients were studied only at day 4. SMI 
decreased significantly (p < 0.001) in both groups, without difference 
between HMB group or placebo. However, patients with a lowPB who 
received HMB had a smaller SMI loss compared to placebo (mean dif-
ference -3.98(95% CI -6.29. to -1.68; p=0.0155) and mean interaction 
difference -5.87 (95% CI -10.48 to -1.26; p=0.0148)).
Conclusion: In a heterogeneous group of severe ICU patients, HMB 
did not significantly reduced muscle loss. Although, post hoc analysis 
showed that HMB can reduce muscle loss in patients with the lowest 
netPB.
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Introduction: Patients in intensive care units (ICUs) are at high risk of 
unfavorable outcomes. Considering the role of vitamin D (Vit D) in car-
diovascular and immune functions, Vit D deficiency could affect ICU 
patients’ outcomes.
Objectives: To evaluate Vit D status and its predictive value for out-
come in ICU patients.
Methods: prospective cohort study that included all adult patients 
admitted to the medical ICU of la Rabta Hospital from January 2016 
to December 2018. Non inclusion criteria were: Sepsis, cancer, renal 
or liver failure, surgery within 3 months; immunotherapy or vitamin 
supplements within 6 months; pregnant or lactating, discharge or 
death within 48 hr of admission were the exclusion criteria. Plasma 
25-hydroxyvitamin D (25(OH)D) was assessed by immunoassay. The 
primary outcome was the occurrence of the following major adverse 
events (combined MAE): the need for a central venous catheter (CVC), 
organ failure, and septic shock. Secondary outcomes were the occur-
rence of at least one ICU-acquired infection (combined ICU-AI), septic 
shock, organ failure, other individual adverse events, and ICU mortal-
ity. Multivariate Cox regression analyses were performed to test the 
associations of low 25(OH) D levels with poor outcomes.
Results: A total of 169 ICU patients were followed during ICU stay. 
Around 75% of patients had 25(OH) D levels <12 ng/ml. During their 
ICU stay, 114 patients presented MAE, 85 patients presented an ICU-
acquired infection, and 22 patients died. The comparative distribution 
of plasma 25-hydroxyvitamin D (25(OH)D) in ICU patients according to 
selected outcomes are displayed in the attached figure.
Plasma 25(OH) D levels <12 ng/ml were associated with higher risk of 
major adverse events, Hazard ratio [95% CI], 4.47 [1.77, 11.3], p=0,020, 
and ICU-acquired infection, 2.67 [1.01, 7.42], p=0,049, but not with 
increased risk of ICU mortality.
Conclusion: Hypovitaminosis D is common in ICU patients. Results 
of the present study show that low plasma 25(OH)D levels are associ-
ated with increased risk of unfavorable outcomes. Additional research 
is needed to investigate the impact of Vit D status and effect of Vit D 
supplementation in ICU patients.
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Introduction: Vitamin D is an essential nutrient and hormone that 
plays role in calcium homeostasis and bone health. In the last two dec-
ades, vitamin D is known to promote innate and adaptive immunity. It 
may play a role in modulating the outcome of sepsis.
Objectives: This study was conducted to describe the prevalence of 
vitamin D deficiency in pediatric patients with severe sepsis or septic 
shock and to evaluate the correlation between vitamin D level and 
severity of illness.
Methods: This is cross-sectional study. Populations were children aged 
30 days to 18 years who were diagnosed with severe sepsis or septic 
shock from August 2018 to May 2019. We collected demographic data, 
principal diagnosis, 25-Hydroxyvitamin D (25-OHD) level, 1,25-Dihy-
droxyvitamin D (1,25-OHD) level, severity, and clinical outcomes of the 
disease.
Results: Nineteen patients were included. The median age was 21 
months, most of them have normal nutritional status (17/19). Source 
of infection were pneumonia (6), urinary tract infection (2), catheter 
related blood stream infection (1), and others (10). The prevalence of 
25-OHD deficiency (<30 ng/ml) and 1,25-OHD deficiency (<19.9 pg/
ml) in severe sepsis and septic shock patients were 57.9% and 10.5% 
respectively. All patients were survived. Vitamin D deficiency (25-
OHD and 1,25-OHD) was not correlated with length of stay in pedi-
atric intensive care unit (25-OHD: r = 0.076, p = 0.756; 1,25-OHD: 
r = 0.170, p = 0.486), and vasoactive inotropic score (25-OHD: r = 
0.20, p = 0.408; 1,25-OHD: r= 0.077, p = 0.755). Subgroup analysis of 
patients who did not received antibiotics before enrollment, 25-OHD 
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deficiency had higher risk of positive blood culture compare to the 
group with normal 25-OHD level (odds ratio = 2.75, 95%CI 1.26, 6.01, 
p = 0.017) and 1,25-OHD level had statistically significant inverse cor-
relation with PRISM III score (r = -0.527, p = 0.036) (figure 1).
Conclusion: Our findings suggested that there may be a correla-
tion between vitamin D deficiency and severity of illness in pediatric 
patients with severe sepsis and septic shock. Further study with larger 
sample size should be performed.
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Introduction: Obesity is defined by the World Health Organization 
as an excessive accumulation of fat in the body of people that can be 
harmful to their health, measured through a body mass index (BMI) 
≥30 kg/m2, cataloged as a chronic and identified disease in children, 
adolescents and adults, being recognized as the epidemic of the 21st 
century.
There are approximately 500 million obese adults and 42 million 
obese children under the age of five worldwide, hence the importance 
of their prevention, diagnosis and early treatment, to avoid subse-
quent comorbidities.
Obese patients present a high vital risk, since severe obesity is asso-
ciated with cardiovascular, respiratory, metabolic, osteoarticular, 
digestive pathologies and even with the increase in some types of 
malignancies.
Surgery and bariatric procedures continue to be the most effective 
sustained weight loss option for patients with morbid obesity, high-
lighting among its main objectives to maximize weight loss and main-
tain nutritional health while preventing micronutrient deficiencies and 
loss of lean body mass.
Although it is an innovative and effective procedure, it is not exempt 
from post-surgical complications. It is essential to previously exhaust 
the resources of prevention and medical treatment, although most of 
these patients are not capable of maintaining a weight loss with psy-
chological, dietary or pharmacological treatment.
Objectives: Main: To determine the profile of bariatric surgery 
patients admitted to our Intensive Care Unit (ICU) between May-2018 
and November-2019 and its post- ICU metabolic control.
Secundary: To analyze the frequency of comorbidities, preoperative 
and postoperative characteristics, analytical results, ICU evolution, 
score on risk scales (APACHE, SOFA and SAPS II). To assess the degree 
of linear correlation between the BMI and the age of the patients, with 
the scores obtained on the risk assessment scales.
Methods: Observational, descriptive, prospective and correlational 
study in bariatric postoperative patients admitted to our ICU in 18 
months, using a database of 40 patients, with medical and surgical 
history, anthropometric data, analytical results, type of surgery, post-
operative treatments, and scores on the risk scales, in addition to a 
correlational analysis to determine the degree of linear relationship 
between BMI and age, with the risk scales, as well as the comparison of 
means of its post-ICU metabolic control.
Results: Among the 40 patients, the mean age was 42 years, women 
(77.5%), with an average BMI of obesity type 3 (46.55 kgm-2). The most 
frequent type of surgery was gastric sleeve (70%). Highlighting sleep 
apnea-hypopnea syndrome (SAHS) with CPAP (62.5%), trauma pathol-
ogies (37.5%), genitourinary and digestive (both 35%), hypertension 
(30%) and anxiety/depression (27, 5%). Complications (surgical) were 
found only in 2.5% of patients, with a mortality rato of 0%.
Performing the comparison of means through T-Student for related 
samples, we obtain a statistically significant decrease during the first 
six months after discharge from the ICU in LDL (p 0.018), HbA1c (p 
<0.001) and baseline blood glucose (p <0.001).
Upon their arrival in the ICU, prophylactic antibiotherapy was per-
formed in 100% of them and anticoagulation in 75%; being 10% of 
the airway difficult. 95.1% were admitted intubated, with an extuba-
tion time of 5 hours, and a 1-day stay. Analgesia was performed with 
Remifentanil (75%), with a low incidence of complications (0.025 95% 
CI). 55% required Sugammadex, and 40% weaning was performed 
with a T-tube only, and associated with CPAP in 32.5%.
The high probability of average death is impressive: APACHE II of 
19.95, SOFA 7.58 and SAPS II 55.25. We determined the level of correla-
tion between BMI and age with the risk scales, obtaining a moderate 
correlation r=0.414 (p 0.008) between APACHE II and age; moderate 
r=0.508 (p 0.001) between SOFA and SAPS II; and low, r=0.353 (p 
0.028) between SOFA and BMI.
Conclusion: The strongest associated variables were SAHS (with 
CPAP), traumatic, genitourinary and digestive pathologies, in women, 
obese type III, with high scores on risk scales, with a favorable evolu-
tion, with a minimum incidence of complications, and an adequate 
post-ICU metabolic control (LDL, HbAc1 and baseline blood glucose), 
hence the importance that the postoperative period of these patients 
should be performed in the ICU.
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Introduction: Large burns are the cause of extensive skeletal muscle 
devastation which contributes to the risk of metabolic failure [1]. Illu-
sory movements are a relatively new method of physiotherapy, which 
through functional proprioceptive stimulation (FPS) enables the inte-
gration and networking of muscle units and has a neurotrophic effect 
on the cerebral cortex [2]. However, illusory movements haven’t been 
studied in the critically ill yet. How they influence human’s metabolism 
is not known.
Objectives: Six male patients with large deep burns (> 30 % total 
body surface area) in the late acute phase of burn disease, median age 
53 years, median day since admission 96 days, median APACHE II score 
19. They suffered from prolonged catabolism and poor healing. Their 
basal metabolic rate (BMR) was about 32 % (means) below their cal-
culated BMR.
Methods: We rehabilitated the patients with illusory movements for 
30 minutes twice a day, for 14 days, along with standard rehabilita-
tion. After two weeks, FPS was stopped, and patients received stand-
ard rehabilitation only. Nitrogen balance was calculated daily. On the 
day 1, 15, and 30, we measured BMR with indirect calorimetry, insulin 
resistance and glucose disposal, muscle strength, and diameter of m. 
rectus femoris measured with ultrasound.
Results: In all six patients, BMR increased significantly compared to 
baseline (p < 0.01), with a (non-significant) trend to improve nitro-
gen balance and muscle strength. 14 days after the end of FPS, BMR 
decreased to the level of calculated BMR, but remained significantly 
increased from baseline (p <0.05) (Tab. 1). No adverse side effects were 
observed in any patient. All of them survived and were discharged 
from the hospital.
Conclusion: Illusory movements improved decreased BMR in six 
patients with metabolic failure. It is not known whether the observed 
increase in energy expenditure is a quintessential feature of FPS, or if it 
was specific to patients with hypometabolism.
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Introduction: Diabetic ketoacidosis (DKA) is the most common life-
threatening metabolic-endocrine emergency in children. The cur-
rent criterion for the diagnosis of DKA is characterized by a triad 
of hyperglycemia (blood glucose ≥200mg/d, metabolic acidosis 
(venous pH <7.3, or serum HCO3 <15mEq/l) and ketonemia (blood 
β-hydroxybutyrate ≥3mmol/L) or moderate to large ketonuria(1). In 
DKA, β-hydroxybutyrate (BOHB) is the major ketone body and its con-
centration increased to 4-10 times.(2) Urine ketone assay has several 
potential limitations such as delayed voiding delay the diagnosis and 
unnecessarily prolonged insulin infusion because of continued excre-
tion of ketoacid in the urine.(3) The current literature strongly support 
the use of capillary blood BHOB in the establishing diagnosis as well 
as response to treatment of DKA both in children and adults. (4) (5)
There is a paucity of data available its use in the management of DKA 
in PICU. The objective of this study to assess the clinical and statistical 
correlation of capillary blood β-OHB level with the traditional standard 
acid variables like pH, HCO3, AG, and BD in the diagnosis and resolu-
tion of ketoacidosis in the management of DKA in PICU in resource 
limited settings.
Objectives: To affirm the Role of Capillary Blood Ketone Assay in Diag-
nosis and Management of DKA in PICU in resource limited settings.
Methods: We retrospectively reviewed electronic medical record of 
children (aged 2 mo-16yrs) with DKA from January 2018 to January 
2020 admitted in PICU of The Indus Hospital. All children received the 
treatment according to standard protocol. Capillary blood BOHB were 
measured on admission and q 4-6 hourly along with blood glucose. All 
parameters were recorded on a structured sheet.
Results: Among 1080 admissions, 26 patients (2.4%) were diagnosed 
as DKA. The mean age was 9.8±3.8 years and females were 54%. Half 
patients were newly diagnosed with 1DDM. Mild, moderate, and 
severe cases of DKA were 19%, 50%, and 31% respectively. The median 
time to resolution of acidosis was 17 (10-39) hours. At the time of reso-
lution of acidosis, the correlation between capillary BOHB and blood 
pH (r=0.11, p=0.56), HCO3 (r=0.37, p=0.86), AG (r=0.37, p=0.06), and 
BD (r=0.04, p=0.82) was noted. Hyperchloremia was present in 61.5%. 
Five patients (19.2%) developed AKI that recovered. There was a 
strong clinical correlation of BHOB with standard acid variables of DKA 
management.
Conclusion: Bedside capillary blood BOHB is a simple, inexpensive, 
point-of-care test that helps in the diagnosis and treatment of DKA 
especially in resource-limited settings for avoiding unnecessary delays.
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Introduction: Changes in homeostasis activate the hypothalamic-
pituitary axis and induce an adaptive hypercatabolic state (1), which 
is harmful if persistent (2). Copeptin, an equimolar indicator of serum 
antidiuretic hormone (ADH), has been associated with a higher mor-
tality of critically ill patients (3). However, alterations in copeptin levels 
over time during an acute stress are not known.
Objectives: The aim of the present study is to investigate the cor-
relation of copeptin levels with glycemic parameters in critically ill 
patients.
Methods: From June 2019 to October 2019, critically ill adult patients 
were prospectively enrolled and followed for 90 days. Plasma copeptin 
levels were quantified during the first 24 hours of intensive care unit 
(ICU) admission (T1), 24 h after the study entry (T2), and 48 h after the 
study entry (T3). Blood glucose and glycated hemoglobin (HbA1c) val-
ues were measured at study entry. ICU and hospital mortality, 30 and 
90-day mortality, need for mechanical ventilation (VM), need for renal 
replacement therapy (RRT), time on VM and on RRT, length of stay in 
the ICU and hospital, and readmission to the ICU were evaluated.
Results: A total of 104 patients admitted to the ICU were included. 
Overall mortality was 40.4% (n = 42). Weak inverse correlations were 
detected between blood glucose and copeptin T2 (r = -0.23, p = 0.03), 
and glycemic gap (r = -0.25, p = 0.03) and SHR (r = -0.24, p = 0.03) 
and copeptin T3. No associations were identified between copeptin 
values at T1 and T2 with clinical outcomes. However, copeptin values 
at T3 were significantly higher in survivors than in non-survivors at 
hospital discharge (561 pg/mL [370 to 856] vs 300 pg/mL [231 to 693], 
p = 0.015), at 30 days (581 pg/mL [387 to 865] vs 299 pg/mL [231 to 
690], p = 0.02) and at 90 days (517 pg/mL [380 to 884] vs 492 pg/mL 
[295 to 698], p = 0.03). Copeptin values at T1 and T2 were not different 
between survivors and non-survivors.
Conclusion: Weak inverse correlations were found between copep-
tin levels and glycemic parameters, suggesting that copeptin is not a 
major factor in the induction of hyperglycemia during critical illness. 
Besides, copeptin values at the third ICU day were significantly higher 
in survivors than in non-survivors.
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Introduction: Approach consideration  in DKA are  intravenous 
fluid, correction of hyperglycemia with insulin, electrolytes distur-
bances, acid base balance and treatment to precipitating condi-
tion.  Many patients with DKA were given fluid more than 2 litre in 
the initial 4 hours developed into lung edema and longer period of 
hospitalization.
Objectives: To evaluate the outcome between patients in who were 
given more than 3 litre in the initial 4 hours of treatment to patients 
who were given maintenance fluid dose in emergency room
Methods: We had 6  patients diagnosed with DKA, in their 30’s and 
40’s. They are obese type II diabetic with  oral hypoglycemia medica-
tion. Before admission, all of them reported suffered from infection: 
CAP, UTI, gastrointestinal infection. There was no sign of nausea, 
vomitus, or dehydration. All of them in mild hypotension with nor-
mal serum sodium level. There were 2 group, 1 group, the liberal fluid, 
were given more than 3 liter NaCl 0,9% (7 to 14 ml/kg/hour, with initial 
boluses 1 litre NaCl 0,9% before within an hour) in the early 4 hours 
phase of the treatment, the other only given 1 litre initial boluses NaCL 
0,9% within an hour then followed by maintenance fluid 25 - 30 ml/
kg/d NaCl 0,9%. All of them were given insulin intravenously depend 
on their glucose status hourly, then we maintained the glucose level to 
150 -200 mg/dL, deescalation antibiotics broad spectrum, continuous 
monitored hemodynamics and level of consciousness. We also docu-
mented fluid balance, urin output every hour, and acid base, electro-
lite, and ketonuric status every 12 hour. Fluid challenge test was given 
if urine output not reached target,and will be given additional fluid 
to reach normorehydration status. If there is imbalance electrolyte 
present, we corrected it with supplement potassium intravenously if 
needed.
Results: In both groups, DKA were resolved within  first  24 hours. All 
the patients regain their consciousness, the blood glucose were reach 
the target. In the liberal fluid, 1 patient developed lung edema, so we 
need to intubate him, 1 patient with positive balance without clinical 
deteoritation, and the other one recovered well. The 2nd group, none 
had lung edema, but 1 patient was given fluid challenge test once and 
responded well so we gave extra 500 ml NaCl 0,9% within 3 hours to 
total maintenance fluid. 5 out of 6 were able to be stepped down to 
the ward, while 1 patient from the liberal fluid stepped up to intensive 
care unit.
Conclusion: DKA occurred in the obese diabetic type II patient pre-
cipitated by infection, resolved well within 24 hours with deescalation 
technique on antibiotics, insulin therapy, and maintenance dose of 
fluid.
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Introduction: Analysis of glycaemia in non-critically ill patients with 
COVID-19 has suggested that hyperglycaemia is associated with poor 
outcomes in patients with and without diabetes. However, to our 
knowledge there has not been a longitudinal assessment of glycaemic 
control and mortality in critically ill patients with COVID-19.
Methods: Retrospective observational study of contemporaneous 
electronic medical records of patients admitted to our intensive care 
unit (ICU) for > 24 hours with COVID-19 during the months of March 
and April 2020. Glycaemic control was assessed relative to the tar-
get range of 4-10 mmol/L by three related metrics: estimated time in 
range 4-10mmol/L, percentage of BG measurements between 4 and 
10mmol/L, and mean BG.
Results: 54 patients met inclusion criteria, 1 patient had incomplete 
BG data and was omitted from our analysis. Median time in range 
was 86%, similar to previous studies. Hypoglycaemia was rare with 
4 patients experiencing mild hypoglycaemia (BG <4mmol/L) and 2 
patients experiencing biochemically severe hypoglycaemia (BG < 2.5 
mmol/L). In the whole cohort we did not find a difference in any glu-
cose metric between those discharged alive from ICU or those who 
died in ICU. However, we did observe an interaction between dia-
betes status and ICU outcome with respect to mean blood glucose 
(P < 0.05), suggesting that the relationship between glycaemia and 
mortality may depend on diabetes status. Indeed, the percentage of 
BG measurements in range, time in range and mean blood glucose 
were significantly different in ICU survivors and non-survivors in the 
cohort without diabetes (N= 42, P < 0.05 for all metrics) with bet-
ter glycaemic control observed in ICU survivors. In univariate logistic 
regression analyses mean BG (OR = 0.44, 95% CI 0.19 – 0.84, P = 0.02) 
and BG measurements in range (OR = 1.05, 95% CI 1.00 – 1.11, P = 
0.04) predicted discharge alive from ICU with better glycaemic con-
trol positively associating with survival. Interestingly, both mean BG 
and BG measurements in range had superior predictive ability for ICU 
mortality to BMI, steroid use, sex and cross-sectional measurements 
of CRP, Troponin and D-Dimer in univariate analyses. To determine 
the additive predictive effect of glycaemia to the dominant risk fac-
tor for COVID-19 mortality, age, we examined the effect of glycaemia 
(BG measurements in range) in a model adjusted for age. The model 
explained 22% of the variance of the data, compared to 11% forage 
alone with a similar effect size for glycaemia as was seen in the univari-
ate analysis (OR 1.05 CI: 1.00 – 1.11).
Conclusion: Here we demonstrate, for the first time, an association 
between glycaemia and mortality in critically ill non-diabetic patients 
with COVID-19. Given the high prevalence of hyperglycaemia in criti-
cally ill patients with COVID-19 further assessment of the interaction 
between hyperglycaemia and ICU outcomes in diabetic and non-dia-
betic patients is warranted.
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Introduction: International guidelines recommend the assessment of 
nutrition status before the initiation of nutritional support. NUTrition Risk 
in the Critically ill (NUTRIC) score has been proposed to quantify the risk 
of adverse outcomes that may be modified by artificial nutrition. A “mod-
ified NUTRIC score” (mNUTRIC) has been introduced without IL-6 levels.
An unprecedented number of relatively young and previously healthy 
patients has been admitted to the ICU during the recent COVID-19 out-
break. These patients often experienced a dysregulated inflammatory 
response, potentially leading to a cytochine storm and multiple organ 
damage. In this population, IL-6 has been measured to assess the inflam-
matory status, allowing the calculation of NUTRIC and mNUTRIC scores.
Objectives: To assess whether NUTRIC score is a reliable nutritional 
risk assessment tool in patients with COVID-19-related acute respira-
tory failure and to compare the prognostic performance of NUTRIC 
and mNUTRIC score.
Methods: Single centre, retrospective cohort study in critically ill 
patients with COVID-19-related acute respiratory failure. Patients with 
NUTRIC or mNUTRIC score ≥5 were considered at high nutritional 
risk. The prognostic performance of NUTRIC and mNUTRIC score were 
compared, as well as their discriminative abilities for ICU-mortality.
Results: 42 patients were enrolled: 34 (79%) males, age 62±9, BMI 
27.6±4.2. Average NUTRIC score: 2.5±1; mNUTRIC score: 2.6±1.1.
ICU mortality was 40.5%; all non-survivors had mNUTRIC score ≤4 
(low nutritional risk); only one non-survivor had a high nutritional risk 
(NUTRIC Score ≥5). Non-survivors were older (67.5±6.7 vs. 59.0±9.9 
years, p=0.0036), had higher IL-6 blood levels (152 [78; 264] vs. 53 [12; 
109], p=0.0202) and a higher NUTRIC score (3 [2; 3] vs. 2 [2; 3] points, 
p=0.0425). mNUTRIC score was not different between survivors and 
non-survivors (p=0.0743).
In multivariate logistic analysis, NUTRIC score was significantly related 
with ICU mortality (OR 2.49 [95%CI 1.02-6.10]). The discriminative abil-
ity of NUTRIC score for ICU mortality was (AUROC) 0.67 [0.525-0.826], 
while that of mNUTRIC-score was 0.66 [0.514-0.817], p=0.4109.
Conclusion: Despite a relatively low nutritional risk, NUTRIC score 
seems to identify a subpopulation of critically ill, COVID-19 patients 
who may benefit from nutritional support. The prognostic perfor-
mance of NUTRIC and mNUTRIC score is comparable in patients with 
high inflammatory status as in COVID-19.
Reference(s) and grant ackowledgment(s)
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Introduction: Survivors of critical illness experience significant skele-
tal muscle wasting that may predict clinical outcome. Ultrasound (US) 
is a noninvasive method that can measure muscle quadriceps muscle 
layer thickness (QMLT) at the bedside.
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Objectives: The objective of this study was to determine muscle wast-
ing (assessed using US) in critically ill patient over a period of 7 days 
and the relationship between loss of muscle quadriceps thickness and 
hospital survival probability in critically ill patient under mechanical 
ventilation.
Methods: The data were entered into an electronic database (Micro-
soft Excel; Microsoft, Redmond, Washington) and analyzed using SPSS 
V.26. Data collection was halted after the successful inclusion of 70 
patients. Demographic data were expressed as the means ± SD, medi-
ans and percentiles or percentages. This study involved patients ≥ 
18 years of age admitted to the intensive care unit (ICU) who needed 
mechanical ventilation for at least 48 hours. The QMLT at the two-
thirds-thigh was quantified using bedside US with a 12 MHz linear 
transducer. Measurements of the first (D1), third (D3) and seventh (D7) 
days were performed of QMLT (mean ± SD) was displayed for left and 
right legs.
Results: Ultrasound quadriceps thickness measurements were per-
formed on 74 critically ill patients. The mean age was 62.3±19.5 years, 
54.1% male, BMI 25.5±4.6 kg/m2, SAPS 3 was 55.2±17.2 and NRS 
3.2±1.0. Overall, the percentage muscle thickness declined at the right 
leg in 15% (95%CI, 10.5% to 19.4%), and 12.7% (95%CI, 9.1% to 16.3%) 
at the left leg assessed by the US occurred from the first to the seventh 
day. The decline in muscle thickness at the right leg and left leg were 
higher among non-survivors compared to survivors at all time points. 
In right leg 2.1±0.7 cm in survivor vs 1.7±0.5 cm nonsurvivor at D1, 
1.9±0.7 cm in survivor vs 1.6±0.4 cm nonsurvivor at D3, 1.8±0.6 cm 
in survivor vs 1.4±0.4 cm nonsurvivor at D7; GLM- P= 0.01. In left leg 
2.1±0.7 cm in survivor vs 1.7±0.4 cm nonsurvivor at D1, 2.0±0.8 cm 
in survivor vs 1.7±0.5 cm nonsurvivor at D3, 1.8±0.6 cm in survivor vs 
1.5±0.5 cm nonsurvivor at D7; GLM- P = 0.04. ROC analysis showed 
that a cutoff of decline in muscle thickness of less than or equal to 
1.64 cm at day 7 can predict survival, AUC=0.7 (95% CI 0,582 to 0,801). 
Thus, in cox regression after adjusting for SAPS 3 and gender, the 
probability of patients remaining in the mechanical ventilation was 
higher with ≤ 1.64 cm at day 7 of loss of thigh muscle thickness, the 
hazard was 2.1 times (95% CI 1.1–3.8) higher than their counterparts 
with p value 0.017. The same occurred ≤ 1.64 cm at day 7 of loss of 
thigh muscle thickness about ICU survival probability; HR= 3.7 (95% 
CI 1.2 to 11.5) and hospital survival probability; HR= 4.5 (95% CI 1.5 
to 13.7).
Conclusion: Among these critically ill patients, muscle wasting 
occurred during the first week of critical illness under mechanical 
ventilation. The patients who lost the most muscle was those with the 
worst survival. Decline in muscle thickness was associated with in-hos-
pital mortality. USG has a potential to identify patients at risk of worse 
in-hospital outcomes.
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Introduction: We introduced the hospital policy on the management 
of severe symptomatic hyponatraemia (SSH), with hypertonic saline 
(HS)of 1.8% and 5% saline in 2017. This is one of the few UK centres to 
offer this treatment, therefore the evidence is limited. The policy was 
based on European and American guidelines (1)(2).
Objectives: To study the adherence, and effectiveness, of this guide-
line in managing patients with SSH.
Methods: Patients were identified using the Biochemistry tracking 
system between 01/01/18 until 14/05/20. The terms - Hypona, sod, 
Hypertonic, 5%, 1.8% a were searched. The laboratory result system 
was used to identify hyponatraemic (<130 mmol/L) patients at the 
time they were logged onto the tracking system. Clinical notes were 
crossmatched for the use of 1.8% and 5% saline for those with sodium 
<130mmol/L. 12 patients were identified.
The following data was collected using hospital records: age, gender, 
location, fluid status, presentation, symptoms after HS adminsitration, 
volume and type of fluids. Sodium was recorded; prior to and dur-
ing presentation, after HS saline, at 24, 48 hours and at discharge or 
death. Cause of death (if applicable), complications of HS and lenght 
of admission after treatment were also noted. This was compared to 
the 2017 current hospital guideline
Results:
Standard 1:  11 patients had symptoms of hyponatraemia. They 
were confusion (6), somnolence (5), seizure (4), vomiting (3). Other 
sympotms included muscle twitching, fatigue and nausea. SSH 
was suspected in 2/11 patients, but it was not the primary diagno-
ses.  One patient was asymptomatic- the only patient with chronic 
hyponatraemia.
Standard 2a/b: All patients identified were treated with 1.8% saline. 
None with 5% saline.
Standard 2c:  7/12 patients overcorrected (there should be a 
<5mmol/L increase following HS). In 4/7 there was inappropriate 
application of the guideline; HS was given despite improvement of 
symptoms or after the 5mmol/L target had been achieved.
An average volume of 481ml (range 100-1250ml) HS was given over 
an average of 3h 53m. This increased sodium by mean of 6.4mmol/L 
(range 2-12) by the end of treatment with HS.
Standard 2d: 9/11 patients had atleast partial or full improvement in 
the symptoms at the end of treatment with 1.8% saline. In 2/11 whose 
symptoms were  secondary to other causes (paranoia/ hallucina-
tions), did not have improvement of symptoms after HS.
Standard 2e:  9/12 patients had HS administered as per the recom-
mended guideline calculation for rate. 2 patients were hypervolaemic 
and were treated with a slower infusion to prevent overload. 1 patient 
was treated using 100mls 1.8% saline for no clear reason.
Standard 2f:  2 patients were clinically hypervolaemic - NS was 
avoided due to risk of overload. 1 patient had a 9mmol increase after 
24 hours, (<10mmol increase advised).
Standard 3a/b: There was 7/12 who overcorrected at 24 hours, and 
5/12 at 48 hours (should be <10mmol/L and <18mmol/L, respec-
tively). The mean increase in serum sodium at 24 and 48 hours were 
12.25mmol/L (range 7-21) and 17.25mmol/L (range 10-26) respec-
tively. 11/12 patients eventually normalised (>130mmol/L) their serum 
sodium. 1 patient self discharged before this. The mean lenght of time 
to achieve this was 6.5 days.
In addition: 3 patients died. No deaths were attributed to treatment 
with 1.8% saline. Specifically, no patients developed central pontine 
myelinolysis
Conclusion:
1. Our audit showed symptomatic improvement in moderate and SSH, follow‑
ing HS use.
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2. Patients with symptoms due to other causes, did not show improvement in 
symptoms following HS. Before administrating HS, SSH should be the most 
likely diagnoses.
3. 5% Saline was not adminstered, it should be removed from the guidelines. 
1.8% can safely be used in severe and moderate cases.
4. The guideline was inappropriately followed for cases where there was over‑
correction following HS. It should be clearly stated that HS can be stopped 
once there is symptomatic improvement, even if this occurs prior to the 
5mmol/L target.
5. The increase in serum sodium at 24 hours and 48 hours should be 
<10mmol and <18mmol from baseline. This includes administeration of HS 
followed by NS.
6. No adverse events were identified from treatment with HS or from 
overcorrection.
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Introduction: Critical illness-induced weakness is prevalent and asso-
ciated with increased morbidity and mortality. Interestingly, obesity 
attenuates both muscle wasting and weakness.1,2 We here aimed 
to investigate whether the adipokine leptin mediates this protective 
effect.
Methods: In a catheterized, antibiotic-treated, fluid-resuscitated 
mouse model of sepsis, evoked by cecal ligation and puncture, impact 
of leptin availability was compared in obese and lean mice. In four 
groups of septic mice (n≥11 survivors per group) - diet induced obese 
(Ob-DIO), leptin-deficient obese (Ob-KO), placebo-treated lean (Ln) 
and leptin-treated lean (Ln-lep) mice - body composition (MRI), spe-
cific muscle force (ex vivo contractibility in mN/mm2 per mass EDL) 
and plasma markers of lipolysis and inflammation were measured.
Results: Prior to sepsis, plasma leptin was undetectable in Ob-KO, and 
higher in Ob-DIO (12.4[8.2-15.1]ng/ml) than Ln (1.8[0.9-3.0]ng/ml) (p 
< .0001). Ob-DIO and Ob-KO were similar in body weight (p = .5) but 
46% heavier than lean mice. Ob-KO (22.4 ± 2.6g) had more fat mass 
than Ob-DIO (19.3 ± 1.8g) and Ln (2.7 ± 1.2g), but less lean mass (19.3 
± 1.8g) than Ob-DIO (25.8 ± 2.2g) or Ln (24.8 ± 2.1g) (p < .0001 for all). 
After 5 days of sepsis, mortality was highest in Ob-KO (53%) (p≤.06) 
but was comparable in Ln (39%), Ln-lep (36%) and Ob-DIO (23%). 
Plasma leptin was undetectable in Ob-KO, higher in Ob-DIO (15.4[12.6-
19.4]ng/ml) and Ln-lep (34.7[14.7-135.4]ng/ml) than Ln (0.2[0.1-0.7]
ng/ml) (p < .0001). Loss of lean mass loss was 2x more pronounced in 
lean than in obese mice (p < .0005), but not affected by leptin avail-
ability in lean (Δ 4.2 ± 1.6g Ln and 3.3 ± 2.0g Ln-lep, p=.2) or obese 
(Δ 1.8 ± 1.1g Ob-DIO and 1.3 ± 1.1g Ob-KO, p=.2). Functionally, Ob-
DIO and Ob-KO mice maintained their specific muscle force (p ≥ .1) 
up to healthy levels (98.8% and 116.5% of healthy control, respec-
tively), whereas Ln and Ln-Lep mice suffered from reduced specific 
muscle force (77.9% and 65.4% of healthy control, respectively, p ≤ 
.01), again not affected by leptin availability (p≥.2). In contrast to mus-
cle, fat mass loss was 2x more pronounced in obese than in lean (p < 
.0001), greatest in Ob-DIO (Δ 4.2 ± 0.8g Ob-DIO and 3.2 ± 0.7g Ob-KO, 
p=.0002), but was not affected by leptin in lean (Δ 1.9 ± 0.5g Ln and 
2.1 ± 0.8g Ln-lep, p =.4). In accordance, both Ob-DIO and Ob-KO mice 
had increased plasma free fatty acids, glycerol and peak 3-hydroxybu-
tyrate concentrations compared to Ln and Ln-lep (p ≤ .01). Both obese 
groups showed an attenuated inflammatory response compared to 
both Ln and Ln-lep, evident by a 50% lower plasma TNFα increase (p 
< .005).
Conclusion: Not increased leptin availability, but adiposity attenuated 
critical illness induced muscle wasting and weakness. A more efficient 
mobilisation of fat stores and ketogenesis, as shown previously2, but 
also a blunted inflammatory response might play a mediating role.
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Introduction: To examine 1) inter-device, inter- and intra-observer 
variability of BIA measurements and 2) effect of fluid load on BIA 
measurements in healthy adult volunteers.
Methods: We studied two groups of ten healthy adults (women:men 
= 1:1 in each group). In the first group, three observers performed in 
each participant three tests on the right and three tests on the left side 
with two BIA devices (BioScan Touch i8 (Maltron Int. Ltd) and Nutrilab 
(Akern SRL)). In the second group, BIA tests were done in each partici-
pant before and after (immediately – 30 min – 60 min – 120 min later) 
the fluid load (i.e., drinking of 0.5L or 1L of bottled still water). TBW 
(total body water), ECW (extracellular water), ICW (intracellular water), 
ECW/ICW, BCM (body cell mass), FM (fat mass), FFM (fat-free mass), 
plasma and interstitial fluid volume, and PhA (phase angle at 50 kHz) 
were compared.
Results: 1) No significant differences between BIA parameters while 
tested by the same observer. Significant differences were seen in all 
BIA parameters between BIA devices (p < 0.001). In tests obtained with 
BioScan, no significant interobserver difference was seen, while sig-
nificant (p = 0.004) and almost significant (p = 0.091 and 0.06) differ-
ences between observers were found with Nutrilab. 2) Water load led 
to significant change in ECW, ICW, ECW/ICW, interstitial fluid, PhA (p < 
0.001) and BCM (p = 0.002) with time, which was most pronounced in 
the measurements taken as latest.
Conclusion: 1) BIA measurements show low intraobserver variability. 
With BioScan, inter-observer variability was low as well, while with 
Nutrilab it was significantly high. Various BIA devices reproduce signifi-
cantly different results. 2) After fluid load, ECW, ICW, interstitial fluid, 
PhA and BCM changed significantly with time.
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Introduction: Both physiological theory (1) and anecdotal observa-
tions (2) support the principle that most mammalian cells may sustain 
their metabolism using lactate instead of glucose. Combined hyper-
lactatemia and hypoglycemia (HLHG) may constitute a novel treat-
ment for various diseases, including cancer and malaria. However, 
induction, maintenance and reversal of HLHG may be challenging and 
leading to profound derangement of the electrolyte and acid-base 
equilibrium.
Objectives: To develop a porcine model of HLHG by extracorporeal 
administration of lactic acid (HLa) and hyperinsulinemic clamping.
Methods: Five female swine (36.0 ± 6.5 kg), received an oral dose of 
1000 mg metformin before anesthesia induction and connection to 
an extracorporeal circuit for HLa administration (3). Target lactatemia 
level was 8-10 mmol/L. Once lactatemia achieved 7.5 mmol/L, deep 
hypoglycemia (target glycaemia: 23-31 mg/dL, 1.3-1.7 mmol/L) was 
induced and maintained with hyperinsulinemic clamp, i.e. continuous 
infusion of insulin and concentrated glucose. Hypoglycemic counter-
responses were inhibited by infusion of labetalol and octreotide. Res-
piratory rate (RR) was adjusted targeting an arterial pCO2 of 40 mmHg. 
After 4 hours of stable HLHG, normal glycaemia and lactatemia were 
restored. Numerous blood samples were obtained for gas and bio-
chemistry. Data are reported as mean±standard deviation.
Results: The figure shows the time course of lactatemia and glycae-
mia. The initial target lactatemia (8.3±1.2 mmol/L) was achieved by 
infusing a total amount of 190.8±82.2 mmol of HLa over 48±22 min-
utes. Subsequently, hypoglycemia was obtained in 44±18 minutes by 
infusing 81.6±53.2 IU insulin. In this phase hyperlactatemia (8.9±1.1 
mmol/L) was maintained by infusing 267.1±41.5 mmol of HLa, while 
a total amount of 20.0±8.0 mcg octreotide and 16.2±7.9 mg labetalol 
was administered. HLHG was maintained for 260±23 minutes with a 
glycaemia of 25±4 mg/dL requiring low dose insulin continuous infu-
sion (0.4±0.5 UI/h). In order to avoid serum glucose dropping below 
18 mg/dL, 50% glucose administration was required in all animals at 
an average rate of 5.1±2.7 g/h, for a total infused dose of 23.7±10.1 g. 
Labetatol infusion was performed at a rate of 26±22 mg/h for a total 
labetalol dose 124.5±99.4 mg. After the HLHG phase, 20.7±12.1 g of 
glucose over 72±24 minutes were required to restore normoglycemia 
(>60 mg/dL). No major hemodynamic derangements occurred. A mild 
positive fluid balance was observed, but not exceeding 1 L. RR was 
increased from 20.4±3.3 bpm at baseline to a maximum of 29.8±3.8 
bpm and returned to 19.6±2.6 bpmafter restoration of normal glu-
cose and lactate levels. Minimum values of arterial pH and bicarbo-
nate were 7.25±0.09 and 19.3±3.4 mmol/L, respectively. Biomarkers 
of hepatic, renal and myocardial damage did not increase throughout 
the experimental procedures.
Conclusion: In a large mammal model, induction, maintenance and 
reversal of HLHG was feasible and without major hemodynamic or 
metabolic derangements. Further studies will be required to evaluate 
safety and possible therapeutic effects of HLHG.
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Introduction: Skeletal muscle atrophy is common in critically ill 
patients. Although monitoring of muscle mass is important, biomark-
ers associated with muscle atrophy have not been reliably identified. 
Titin is a spring-like protein in muscle, and has become measurable 
as a marker of muscle breakdown. We hypothesized that urinary titin 
is a useful biomarker for monitoring muscle atrophy in critically ill 
patients.
Objectives: We conducted a two-center prospective observational 
study to investigate titin level and its association with muscle atrophy 
in critically ill patients.
Methods: We recruited adult patients who were expected to remain in 
the intensive care unit (ICU) for more than 5 days. We excluded post-
operative patients due to the increased titin level by surgery. Urine 
sample was collected on days 1, 2, 3, 5, and 7. The urinary N-terminal 
fragment of titin was measured using an enzyme-linked immunosorb-
ent assay (ELISA) kit. We corrected titin with urinary creatinine (nor-
mal range: 1–3 pmol/mg Cr). In order to assess muscle atrophy, rectus 
femoris cross-sectional area and diaphragm thickness were measured 
with ultrasound on days 1, 3, 5, and 7. The primary outcome was the 
relationship between cumulative titin level and the atrophy rate of 
rectus femoris muscle. Secondary outcomes included the relationship 
between urinary titin level and the change of diaphragm thickness, 
the incidence of ICU-acquired weakness (ICU-AW), ICU mobility scale 
(IMS), and mortality in the ICU.
Results: Fifty-six patients (33 males and 23 females; mean age, 72 
± 13 years) were included at 232 titin measurements. The APACHE II 
score was 25 (19–29) and the length of ICU stay was 6 (4–9) days. The 
titin level was 27.9 (16.8–59.6), 47.6 (23.5–82.4), 46.6 (24.4–97.6), 38.4 
(23.6–83.0), and 49.3 (27.4–92.6) pmol/mg Cr on days 1, 2, 3, 5, and 
7, respectively. The cumulative titin level was significantly associated 
with the atrophy of rectus femoris muscle on day 3 (P <.01), day 5 (P 
<.01), and day 7 (P =.03), although titin was not associated with the 
change of diaphragm thickness (P = 0.54). Furthermore, the cumula-
tive titin level was associated with ICU-AW (P = 0.01) and mortality in 
the ICU (P = 0.02), but not with IMS (P = 0.18).
Conclusion: In non-surgical critically ill patients, the urinary titin 
level was increased approximately 10-30 times the normal level. The 
increased titin level was associated with lower limb muscle atrophy, 
incidence of ICU-AW, and ICU mortality.
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Introduction: Diabetes Mellitus(DM) is a chronic disease, which is 
associated with a marked increase in cardiovascular morbidity and 
mortality
Objectives: Our aim was to analyze the clinical and metabolic control, 
as well as the degree of systemic affection in this group of patients (p)
Methods: An observational analytical prospective study including 
161diabetic patients, consecutively admitted to the Intensive Care 
Unit with acute coronary syndrome (ACS).
Results: Mean age at diagnosis:69.1 years ± 9.2.Male:63,2%.Years 
of evolution of DM 11.9 ± 2.3. Ambulatory treatment:23 p(14.3%)
diet; 44p(27.3%)oral antidiabetic(OAD)monotherapy,32p(19.9%)
combined OAD,24p (14.9%)OAD+insulin and 38 p(23.6 %),insu-
lin. Average weekly controls: 7 ± 3.Monitoring was performed by 
72% general practioner; Endocrinology 13%, 8% without follow-
up and 6.8% by other specialists;with 2 annual reviews of average.
During their hospitalization, the mean glycemic level was: before 
breakfast:115.8±37mg/dl; before lunch:209.2±63mg/dl and before 
dinner:187±70mg/dl.Mean Glycosylated hemoglobin level was 7.5%.
Regarding macrovascular affection:previous heart disease:74.5% 
(22.9% type angina, 37.9% acute myocardial infarction,other heart 
disease 13.7%).Previous stroke:17p (10.5%).37p intermittent claudica-
tion (23.5 %).Pedal pulses present in 43.5%,weak in 42,8% and absent 
in 13.6%.Microvascular affection:retinopathy 32p(19.8%).Nephropathy 
39p (24.2%).Neuropathy in 34p (21.1%).History of lower limb ulcers in 
15p (9.3%). Monofilament examination:sensitivity 6/6 in 56.5%,5/6 in 
11.1%, 4/6 in 8.7%, 3/6 in 13.6%, 2/6 in 4.9%, 1/6 in 2.5%, 0/6 in 3.1%.
Conclusion: The clinical profile of diabetic patients admitted in our 
Unit corresponds to a middle-aged man, with insulin regimen and 
improvable metabolic control.Cardiovascular complications were 
found in a remarkable percentage.Therefore,it must be highlighted 
the importance of a strict control of blood glucose levels in these 
patients to slow the progression of the disease.
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Introduction: Rapid crystalloid fluid loading in ketoacidosis is essen-
tial to restore the patient to normal metabolic state. The main objec-
tive of the CIT is to identify triggers and to fix it as soon as possible.
Objectives: To evaluate DKA’s triggers; to appreciate the role of early 
VT with NaCl 0.9% vs Ringer lactate on acid-base balance values and 
time spent in ICU for patients with DKA.
Methods: A retrospective study (conducted in the hospital “Sfanta 
Treime”, Chisinau, during the 2018-2019 years) based on 64 critical ill 
patients (mean of age 35.68±3.45 years, P=0.204) who needed VT, 
mechanical ventilation (MV), acid-base balance and glycemic correc-
tion in 24 hours. Patients were divided in 2 groups. Group I (n=34) – 
patients received NaCl 0.9% and group II (n=30) – Ringer lactate as VT. 
In these patients were appreciated clinical manifestation, BP (blood 
pressure), HR (heart rate), PICCO parameters, acid-base balance (ABB), 
glycemia, lactate, anionic gap (AnGap), blood osmolarity.
Results: According to this study triggers for DKA were: neglected insu-
lin therapy regimen n=28 (43,75%), wrong diet n=6 (9,37%), inflam-
matory process n = 30 (46,87%). At admission in ICU in group I were 
found a higher APACHE II and SOFA score (group I – APACHE II 16p±2.1, 
SOFA 14p±1.9 vs group II – APACHE II 14 p±2.3, SOFA 12± 2.0) and at 
the end of the treatment – a shorter hospital stay (group I-3.4 days vs 
group II-4.8 days). Also, in the group I was observed a faster improve-
ment of the ABB values (lactate = 8.2-3.5mmol/l, glycemia = 31-16 
mmol/l, blood osmolarity – 275-290 mmol/kg, AnGap 12-16mmol/l) 
vs group II (lactate = 8.2-4.5mmol/l, glycemia =30-18mmol/l, blood 
osmolarity – 285-900mmol/kg, AnGap 14-18mmol/l). Mortality in 
group I was 5.88%; P = 0,012 vs. group II-6.66%; P = 0,023.
Conclusion: Clear identifying of the DKA’s triggers and early VT with 
NaCl 0.9% given to critical ill patients showed a faster improvement in 
ABB values, shorter hospital stay and reduced mortality rate.
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Introduction: Oropharyngeal dysphagia and its consequences are 
problems that seem frequent among critically ill patients, although 
this question has yet to be resolved, since its incidence in this patient 
profile is not clearly known.
Objectives: To study the perception of dysphagia among ICU phy-
sians and nurses.
Methods: Cross-sectional, prospective, descriptive and quantitative 
study through a personal, self-administered survey, which has been 
translated from a reference work and adapted to our environment.
Results: 102 questionnaires were fullfiled. Almost 80% of ICU profes-
sionals consider dysphagia as a problema. In addition, more than 60% 
of the interviewees believe that dysphagia prolongs the length of 
stay in the ICU of the patients and almost half believe that dysphagia 
increases morbidity and mortality (46.1%). However, no screening is 
done (65.7%), but when this is accomplished, it is through a test meal 
(38.2%).
On the other hand, they believe that the main risk factors for develop-
ing dysphagia during admission are prolonged intubation, ICU admis-
sion for acute or pre-existing neurological disease. Finally, regarding 
the complications produced by dysphagia, a large majority of profes-
sionals point to aspiration pneumonia as the main one.
Conclusion: The staff perceive that dysphagia is a problem, although 
it is not very frequent, it can have an impact on the patient’s morbidity 
and mortality. Furthermore, being determined of the need to improve 
their level of awareness, we believe that it is necessary to implement 
standardized screening protocols, guided by experts from multidisci-
plinary areas and focused on early suspicion, diagnosis and treatment 
of dysphagia.
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Introduction: Although several devices were tested in randomized 
controlled trials and are in use currently, the role of artificial and bio-
artificial liver support systems (ALSS) in acute-on-chronic liver failure 
(ACLF) is still controversial. There is a lack of evidence for survival ben-
efit, therefore most international societies do not advise the routine 
use of these devices in ACLF. Network meta-analyses enable indirect 
comparison of interventions without the need for head-to-head trials, 
therefore may produce additional evidence.
Objectives: Our aim was to perform the first network meta-analysis 
comparing different liver support systems to each other and to stand-
ard medical therapy (SMT) in patients with ACLF.
Methods: The protocol was registered with PROSPERO 
(CRD42020155850). The systematic search was conducted in MED-
LINE, CENTRAL, Scopus, Embase and Web of Science databases. Selec-
tion and data extraction was performed in duplicate and a Bayesian 
network meta-analysis of randomized controlled trials was conducted. 
Risk ratios and 95% credible intervals (CrI) were calculated and inter-
ventions were ranked by their posterior probability via calculating the 
surface under cumulative ranking (SUCRA) curve values. SUCRA values 
range from 0 to 100%. The higher the SUCRA value, and the closer to 
100%, the higher the likelihood that a therapy is in the top rank or one 
of the top ranks. Version 2 of the Cochrane risk-of-bias tool for rand-
omized trials (RoB 2) and a modified GRADE approach were used for 
the assessment of risk of bias and quality of evidence.
Results: The systematic search yielded 2774 records. Twenty-three 
studies were included in the qualitative synthesis from which sixteen 
were incorporated in the meta-analysis, using MARS®, Prometheus®, 
ELAD®, plasma exchange (PE) and BioLogicDT®. Overall (OS) and trans-
plant-free (TFS) survival were assessed at 1 and 3 months. PE signifi-
cantly improved 3-month OS compared to SMT (RR 0.74, CrI: 0.6–0.94) 
and ranked first on the cumulative ranking curves in three out of four 
outcomes. Other comparisons did not reach statistical significance. 
ELAD ranked first before PE for 1-month TFS. MARS performed better 
in the analyses for OS than for TFS. Quality of evidence was very low 
except for PE considering 1 month OS and both TFS outcomes with 
moderate certainty. Hepatic encephalopathy, laboratory parameters 
and safety were assessed in the systematic review.
Conclusion: This is the first network meta-analysis evaluating the 
effects of all available and tested artificial and bioartificial liver support 
therapies on survival in ACLF.Plasma exchange seemed to be the most 
beneficial for this patient population at present, but based on the low 
quality of evidence more and better-designed trials are needed refin-
ing evidence for already existing options and introducing new devices.
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Introduction: Chronic liver failure is frequently a terminal event 
unless there is a specific and potentially reversible precipitant such as 
variceal haemorrhage. Increasing organ failure carries a poor progno-
sis with renal failure having a “particularly high mortality”.
It has also been well-established that patients with or without a spe-
cific and potentially reversible precipitant have a mortality in excess of 
89% when three or more organs (including the liver) have failed. Most 
available literature is from tertiary liver centres (1).
Objectives:
1. Investigate the ICU‑mortality of patients with liver cirrhosis referred to ICU 
in a district general hospital
2. Assess the mortality within one year
Methods: Data was collected over a one year period from 1st April 
2018 to 31st March 2019 by retrospectively reviewing patient notes, 
Wardwatcher®, and ICU referrals audit data.
Patients were classed as having liver cirrhosis if they had documented 
biopsy or radiological evidence of liver cirrhosis before referral to ICU 
and had been reviewed in a hepatology clinic for management of 
chronic liver disease.
Results: 39 patients were referred to ICU with liver cirrhosis: 21 were 
admitted to ICU, 7 improved following an endoscopy, 2 were trans-
ferred to a specialist centre, 7 required level 1 care and 1 required end 
of life care.
15 patients were admitted to ICU due to decompensated liver cirrho-
sis, 6 were admitted for other reasons (e.g pneumonia). ICU mortality 
was 87% in the decompensated liver disease group and 93% at 1 year. 
All patients with cirrhosis admitted to ICU for other reasons survived 
ICU however 1-year mortality was 33%. 1-year mortality was 19% in 
the patients not admitted to ICU.
Conclusion: Patients with liver cirrhosis have a high mortality regard-
less of the reason for ICU admission. Most patients admitted to ICU 
with decompensated liver cirrhosis as their main problem died; no 
patients with liver cirrhosis died in ICU if their primary reason for 
admission was not related to liver cirrhosis.
We recommend that patients with liver cirrhosis should be assessed 
on an individual basis and be considered for ICU admission if there is 
a potentially reversible cause for their presentation. We advise ward-
based teams to discuss with regional specialist centres at an early 
stage to assess whether an episode of decompensation is reversible 
(e.g. Transjugular Intrahepatic Portosystemic Shunt). Daily consult-
ant reviews of patients could avoid late referrals, improve the rate of 
timely interventions and avoid the need for critical care.
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Introduction: CytoSorb (CytoSorbents, USA) is a relatively new extra-
corporeal blood purification device. It was primarily used in septic 
shock and other hyperinflammatory conditions for removing inflam-
matory mediators, preventing the harmful effects of cytokine storm. 
Acute liver failure is a severe, devastating condition that usually neces-
sitates intensive care. Data from the International CytoSorb Registry 
shows that Cytosorb is often used in liver failure to prevent the devel-
opment of multiple organ failure.
Objectives: We report on the biggest case-series to date on Cyto-
Sorb use in liver failure as a subgroup from the International Cytosorb 
Registry.
Methods: The International CytoSorb Registry (NCT02312024) pro-
spectively collects data from adult patients who underwent CytoSorb 
treatment. No exclusion criteria are defined. Data was recorded at 
baseline, up to 24 hours before treatment (T1), up to 24 hours after the 
last CytoSorb therapy (T2) and at discharge from hospital or mortality 
onelectronic case report forms. Descriptive statistical methods were 
used. Changes were calculated form T1 and T2 values using t-test as 
well as a linear model for selected variables. 95% confidence intervals 
(CI) were provided.
Results: From May 2015 until November 2019, 930 patients were 
entered into the Registry from 9 countries by 42 centres. In 89 cases 
the stated indication for therapy was liver failure, being the third most 
frequent indication after sepsis and pre-emptive use during cardiac 
surgery. In this subgroup the mean age was 48.2 years and the major-
ity of patients were male (56.2%). Patients received a median of 2 treat-
ments (i.e.: 2 adsorbers), with a median overall treatment duration of 
43 hours. The median time of use per adsorber was one day and time 
between treatments was less than 1 hour (median).
More than 90% of patients were alive at the termination of CytoSorb 
therapy. Forty-seven patients died in the ICU and 3 more during hospi-
talization, which corresponds to a 57.5 % in-hospital mortality. Attend-
ing physicians observed improvement in 62 cases (70.4%). No change 
was registered in 15 cases (17%) and in 4 patients the condition wors-
ened. SOFA scores hardly changed (T2-T1). Changes in CRP and PCT 
were not significant. Serum total bilirubin (TBIL) showed a significant 
reduction (T2-T1; mean [CI]: -61.7 [-92.7 to -30.8]). Regarding safety, 
device-related serious adverse events were not reported.
Conclusion: We report on the largest case series on CytoSorb applica-
tion in patients with liver failure. The therapy proved safe, reduced TBIL 
significantly and resulted in subjective improvement in the patient’s 
condition due to CytoSorb treatment in 70% of the cases. These 
encouraging results underline the need for randomized controlled tri-
als assessing CytoSorb in liver failure.
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Introduction: Several studies have identified abnormal liver function 
tests (ALFT) during the clinical course of Covid-19. [1, 2] Acute liver 
injury (ALI) in Covid-19 patients may be caused by direct viral effects, 
systemic inflammatory response, drug toxicity or haemodynamic fac-
tors. There is currently no literature comparing incidences and char-
acteristics of liver dysfunction between critically ill patients with and 
without Covid-19.
Objectives: To assess whether infection with Covid-19 has any impact 
on liver function in critically ill patients with respiratory failure who are 
infected with Covid-19 and is relevance for clinical outcomes.
Methods: This is retrospective cohort study of patients admitted to 
an intensive care unit (ICU) over 5 months. Laboratory data related to 
liver pathology and function (Alanine transferase (ALT), alkaline phos-
phatase (ALP), bilirubin, albumin, prothrombin time) was collected 
at day 1, 7 and 14 of admission. ALFT are defined as a rise in ALT/ALP 
greater than the normal limit, whereas ALI is defined as a rise in ALT/
ALP by ≥3 times the upper limit of normal. Any ALFT or ALI cases were 
classified into hepatocellular, cholestatic, or mixed liver injury. Cat-
egorical data was assessed with χ2 test and odds ratio (OR). The Mann-
Whitney U test was used to assess continuous variables between 
patients infected with Covid-19 (as confirmed by positive viral PCR 
swab) and those who were not. P values lower than .05 were consid-
ered statistically significant.
Results: There were 256 admissions into intensive care during the 
study period. 132 (51.6%) was infected with Covid-19. ALFT was pre-
sent in 80 (60.6%) of Covid-19 patients; 90% had a hepatocellular 
pattern, 10% had a mixed pattern and 2% was cholestatic. ALFT was 
present in 55 (44.4%) non-Covid-19 patients (p = .009, OR 1.9, 95% CI 
1.2, 3.2). ALI was observed in 10.1% of non-Covid patients and 10.7% 
of Covid patients (p = .87). At day 1 of admission, Covid-19 patients 
had a median ALT of 44 (28, 78) compared to non-Covid-19 patients 
with a median of 29 (18, 58; p < .001). At day 7, Covid-19 patients had 
a median albumin of 17 (14-19) compared to 19.5 (16, 24, p = .01) in 
non-Covid-19 patients. On day 14, there was no significant differences 
in distribution of liver biochemistry or prothrombin time between the 
two cohorts. Within the Covid-19 group, there are no significant differ-
ences between patients with or without ALFT or ALI in 28-day mortal-
ity, requirement of renal replacement therapy, duration of mechanical 
ventilation or duration of vasoactive support
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Conclusion: ALFT is more prevalent in Covid-19 patients compared 
to other patients with respiratory failure, and mainly with a hepato-
cellular pattern. Covid-19 patients may display poorer liver synthetic 
function in early stages of the disease (<14 days). There is no impact 
on clinical outcomes.
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Introduction: Acute-on-chronic liver failure (ACLF) was defined in the 
CANONIC study by acute development of one or more major compli-
cation of decompensated liver cirrhosis, plus organ failure and high 
risk of short-term mortality. ACLF is common, affecting approximately 
30% of hospitalised cirrhotic patients and may develop in patients 
without previousdecompensation. Precipitants include infection, 
alcoholic hepatitis and surgery, but in more than 40% of patients no 
precipitating event is identified. Clinical management focuses on 
treatment of a precipitant, whilst addressing the characteristic sys-
temic inflammation and physiological disturbance of the critically ill 
patient with liver disease. Given the high risk of short-term mortality, 
much of the literature relates to the use of prognostic scores to con-
textualise  the degree of ALCF organ failure and arguably the utility 
of critical care admission; with the CLIF-C ACLF score shown to have 
greater predictive accuracy in ACLF than other cirrhotic liver disease 
scoring systems.
Objectives: This study retrospectively identified patients with ACLF, 
admitted to our general adult critical care service (ICU), in order to 
review their admitting aetiology, level of organ support and survival. 
In addition, we sought to apply a range of available prognostic scores 
for cirrhotic liver failure to determine their efficacy.
Methods: The Intensive Care National Audit and Research Centre 
(ICNARC) database was searched for patients admitted to ICU at 
Oxford University Hospitals (OUH), between 1st April and 31st Decem-
ber 2019, with a diagnosis code of: liver cirrhosis, acute alcoholic hepa-
titis, encephalopathy, portal hypertension, or gastrointestinal/variceal 
haemorrhage. Also identified were cirrhotic patients with sepsis or 
acute renal failure by necessary association with these codes.
Review of these patient records identified patients with ACLF; includ-
ing their clinical data, admission reason, survival to unit and hospital 
discharge, and 28- and 90-day mortality. CLIF-C organ failure, UKELD 
and Child-Pugh scores were calculated for time of critical care admis-
sion and, given their association with predicted mortality for a given 
score, compared between survivors and non-survivors with the aim of 
comparing prognostic ability. CLIF-C was also calculated with 48 hours 
post-admission data, to give delta-CLIF scores.
Results: 21 patients (M:F/13:8, median age 51 [38-76] years), were 
admitted to ICU due to ACLF – though this specific diagnosis was 
rarely made.
Stated admission cause included: remaining intubated post-endos-
copy for upper gastrointestinal (UGI) haemorrhage (9/21, 43%), 
vasopressor treatment (5/21, 24%), invasive monitoring (4/21, 19%), 
reduced conscious level (2/21, 9.5%), palliative care (1/21, 4.5%). Com-
monest aetiology was gastrointestinal (GI) bleeding; variceal (7/21, 
33%), non-variceal (1/21, 4.5%), lower GI (2/21, 9.5%). Other causes 
included bacterial infection (3/21, 14%), acute alcoholic hepatitis 
(3/21, 14%),  ischaemic bowel (1/21, 4.5%). In four cases, no clear pre-
cipitant for ACLF was identified (4/21, 19%).
81% (17/21) were admitted with CLIF-C ACLF grade 3, 19% (4/21) 
admitted with ACLF grade 2; giving a median CLIF-C ACLF prognostic 
score of 68 [IQR 11.5], which, for the median age of 51 years, would 
convey 85% predicted mortality at 1 month and 95% at 3 months.
Actual mortality at 48-hours was 48% (10/21), at ICU discharge, 67% 
(14/21), and hospital discharge, 28 day- and 90-day mortality rates 
were the same at 71% (15/21). Of 11/21 patients alive at 48 hours, 
median delta-CLIF organ failure score was 0 [IQR 2].
Median CLIF organ failure, UKELD and Childs-Pugh scores were com-
pared between those patients alive at 28/90 days and those who had 
died: CLIF, 13 vs. 15 (P=.31); UKELD, 58 vs. 59 (P=.33); Childs-Pugh, 11 
vs. 12 (P=.15).
Conclusion: Studied mortality was lower than predicted by the most 
well-validated prognostic score available in this context (CLIF-C ACLF). 
Possibly due to small sample size, the difference in severity between 
prognostic scores in survivors and non-survivors was not statistically 
significant – nor was the CLIF-C score shown to have superior prog-
nostic ability. Unchanged average delta-CLIF scores was likely a result 
of the advanced degree of organ failure on admission, which is rec-
ognised to correlate with slower improvement in this context. Fur-
ther prospective study of ACLF scores and outcomes, ideally in both 
referrals and admissions to critical care, are needed in order to under-
stand the potential role for prognostic scoring in guiding critical care 
intervention.
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Introduction: Spontaneous subarachnoid hemorrhage (SAH) is one 
of the significant aetiologies for stroke. SAH causes higher morbid-
ity, mortality with loss of productivity resulting in increased disease 
burden. A few studies about SAH are from the region and the epide-
miological features of SAH and aneurysmal subarachnoid hemorrhage 
(aSAH) have not been comprehensively studied before in Qatar.
Objectives: Aim of our study was to describe the epidemiological pro-
file of patients with SAH and aSAH in the State of Qatar
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Methods: A retrospective chart review was performed for all sponta-
neous subarachnoid hemorrhage and/or ruptured aneurysm cases 
that were consecutively admitted to Hamad General Hospital (600 
bedded tertiary care facility) during the period January 1, 2007 until 
December 31, 2016. A quantitative analysis of demographics, clinical 
characteristics, diagnostic findings, interventions and overall mortal-
ity was done. Data was entered in SPSS version 18. Chi square and 
student t tests were used to compare between the groups. P value of 
<0.05 was considered stastically significant.
Results: A total of 323 patients were included in the study composed 
of both aneurysmal and non-aneurysmal subarachnoid hemorrhage. 
Mean age at presentation was 47.4±12.2 years. Men comprised 68.7% 
of the cases. 86.6% of the patients presented with acute onset head-
ache. 217 patients had 1 aneurysm and 32 patients had multiple aneu-
rysms. ACOMA (Anterior communicating artery) aneurysm was the 
most common aneurysm. Non Aneurysmal Subarachnoid hemorrhage 
occurred in 74 patients (22.9%) and was more common in men. 23.7% 
of the patients underwent microsurgical clipping of the aneurysm and 
52.6% of the patients underwent coiling of the aneurysm. Overall mor-
tality was less in WFNS 1 and 2 SAH than in higher grades (28.6% vs 
71.4%). 69 out of a total of 323 patients died within 1 month post ictus, 
accounting for an overall mortality rate of 21.2% in our study.
Conclusion: The annual incidence of aneurysmal SAH in Qatar is on 
the rise. Males had a higher incidence of aSAH. ICA aneurysms have 
been found to be more common in Qatari women which may have a 
genetic basis. Lower WFNS grades of aSAH was associated with bet-
ter prognosis. The overall mortality associated with aSAH in Qatar has 
declined over the last 3 years.
Reference(s) and grant ackowledgment(s)
1. Nogueira G. J. Spontaneous Subaraehnoid Haemorrhage and Ruptured 
Aneurysms in the Middle East. A Myth Revisited. ActaNeurochir (Wien) 
(1992): 114:20‑25
2. Donkor ES. Stroke in the Century: A Snapshot of the Burden, Epidemiology, 
and Quality of Life. Stroke Research and Treatment 2018; 2018: 1‑10
3. None
000034 
Status epilepticus: a retrospective observational study of current 
practice and outcomes at a single UK tertiary centre neurocritical 
care unit
B. Scally1; A. Boyle1; M. Blackstock1
1Intensive care unit, western general hospital, NHS Lothian, Edinburgh, 
United Kingdom 
Correspondence: B. Scally
Intensive Care Medicine Experimental 2020, 8(2): 000034
Introduction: Evidence for the treatment of refractory and super-
refractory status epilepticus in intensive care is mostly based on case 
reports and small case series; there is a strong imperative to publish 
larger cohorts and share data on clinical outcomes.
Objectives: To describe the demographics, management, and out-
comes of patients with status epilepticus requiring critical care sup-
port at a single UK tertiary centre neurocritical care unit.
Methods: A retrospective observational study of all consecutive 
patients admitted with status epilepticus to intensive care for level 
two or level three organ support at the Western General Hospital, 
Edinburgh over a five year period (Jan 1st 2014 - Dec 31st 2019).
Results: During the study period, there were 141 admissions to inten-
sive care from 133 unique patients with a confirmed diagnosis of 
status epilepticus. 56% of patients were male; mean average age at 
admission was 51 years; and mean average length of stay was nine 
days. The mean average APACHE II score for the study population was 
16 corresponding to a predicted non-operative mortality of 25%. The 
actual observed mortality in our study population was only 15%. Mor-
tality was higher among patients admitted following out-of-hospital 
cardiac arrest or neurosurgical procedures and lower for patients with 
a pre-existing diagnosis of any epilepsy syndrome. The drug treat-
ments most frequently prescribed for each step of management were 
as follows: (1) benzodiazepines; (2) phenytoin; (3) levetiracetam; (4) 
midazolam infusion; and (5) phenobarbitone or thiopentone coma. 
Overall, 74% of patients required general anaesthesia and mechanical 
ventilation. 46% of patients received formal EEG testing and 10% were 
diagnosed with super-refractory status epilepticus treated with formal 
burst suppression. The observed mortality among patients with super-
refractory status epilepticus was 29%.
Conclusion: Mortality in patients admitted to intensive care with sta-
tus epilepticus is higher following out-of-hospital cardiac arrest and 
neurosurgical procedures. More than 70% of patients in super-refrac-
tory status epilepticus at our site survived to hospital discharge.
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Introduction: Delayed cerebral ischemia (DCI) constitutes a major 
complication following subarachnoid hemorrhage (SAH) and is partly 
associated with vasospasm (VS) and impaired cerebral autoregula-
tion. Different surrogate markers of cerebral blood flow (CBF), such as 
non-invasive transcranial doppler (TCD), are frequently used to moni-
tor development of VS, as well as integrity of autoregulation. In this 
respect, different physiological parameters can be estimated, such the 
dynamic index of autoregulation Mxa, which is a moving correlation 
coefficient between spontaneous fluctuations of cerebral blood flow 
velocity (CBFV) and arterial blood pressure (ABP). A positive correla-
tion signals disturbed autoregulation. Other indices include cerebral 
arterial time constant (tau) that reflects arterial filling time distal to 
insonation vessel and critical closing pressure (CrCP), which estimates 
the theoretical lowest value of ABP that is needed for maintaining CBF.
Objectives: We investigated how VS affects different TCD-derived 
indices of cerebrovascular dynamics in patients suffering from SAH. 
Secondarily, we explored the potential differences of such VS-associ-
ated changes between subgroups of patients with and without DCI, in 
both temporal and spatial settings.
Methods: A retrospective analysis was performed using record-
ings from 32 SAH patients, admitted to the Neurocritical Care Unit 
at Addenbrooke’s Hospital, in Cambridge, UK, diagnosed with VS 
through bilateral TCD measurements. Patients were divided in 2 
groups, depending on development of DCI (DCI group, N=19 vs non-
DCI group, N=13). Cerebral autoregulation was estimated using the 
index Mxa. We also measured tau as the product of arterial resistance 
(Ra) and compliance (Ca) and estimated CrCP, as the intercept point of 
a regression line between systolic and diastolic ABP plotted along the 
x axis and systolic and diastolic CBFV plotted along the y axis.
Results: In the whole population, VS caused shortening of tau (ipsilat-
eral to spasm: 0.17 ± 0.08 vs before spasm: 0.25 ± 0.17 sec, p = 0.04), 
decrease in CrCP (ipsilateral to spasm: 9.69 ± 23.28 vs before: 27.23 ± 
23.31 mmHg, p = 0.01) and interhemispheric asymmetry with lower 
values on ipsilateral side (p < 0.01). Ipsilateral CrCP during VS was neg-
atively correlated with Mxa (r =-0.43, p=0.01) and positively correlated 
with tau (r=0.74, p < 0.001). In patients with DCI, VS caused increase in 
Mxa (ipsilateral to spasm: 0.36 ± 0.18 vs before: 0.26 ± 0.23, p = 0.04), 
decrease in CrCP (ipsilateral to spasm: 6.61 ± 24.5 vs before: 17.24 ± 
19.4 mmHg, p = 0.04) and lower values on ipsilateral side (p < 0.01).
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Conclusion: VS was associated with reduced tau and CrCP in both 
temporal and spatial assessments, in all patients with SAH. Impaired 
autoregulation and shortened tau correlated with decreased CrCP. VS 
in patients who developed DCI, reduced CrCP (temporal and spatial 
effect) signifying vasodilatation, and increased Mxa, reflecting dis-
turbed autoregulation.
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Introduction: High cervical spinal cord-injured (C-SCI) patients expe-
rience severe disability and are at risk of ventilator-dependency and 
tracheostomy(1,2). In the acute phase, they need invasive ventilator 
support. Conventional weaning parameters such as P 0-1, pressure 
muscleindex (PMI)(3) and negative inspiratory force (NIF) are not 
always informative in C-SCI, because most of them will not match the 
conventional targets and still undergo successful weaning. The global 
incidence of tracheostomy in C-SCI varies widely among the different 
studies, and is described up to 60%, with a higher risk in males, AIS 
A grade, upper C-SCI, high injury severity score (ISS), GCS≤8, thoracic 
injury, and patients with respiratory complications(4). Some studies 
suggest that the use of non-invasive mechanical ventilation (NIMV) 
and mechanically cough assist (MAC) can allow extubation without 
further complications(5).
Objectives: To retrospectively assess the safety and efficacy of an 
aggressive respiratory approach with early extubation coupled with 
NIMV, MAC, and intensive nursing assistance on C-SCI patients (C3 to 
C6 SCI).
Methods: This was a single-center retrospective study. Clinical records 
of the patients with spinal cord injury from January 2018 to December 
2019 were revised. All the patients with cervical spinal cord injury were 
included, with no limits of age or comorbidities.
Standard management of quadriplegic patients in our department is 
based on aggressive respiratory management, early extubation, NIMV 
and MAC performed regularly at least 4 times a day; the clearance of 
respiratory secretions is also facilitated by alternated side positioning.
Results: Twenty-five patients with acute cervical spinal cord injury 
were admitted to our department in the study period. Age was 39 ±17 
years and 72% of them were male. Full data of the initial population 
are shown in Table 1. Twenty-four of them were traumatic, 1 ischemic. 
Median ISS in traumatized patients was 25 and most of the patients 
(80%) were isolated cervical traumas. The full data of the initial popula-
tion are shown in table 1.
All patients except 2, were intubated, only 3 patients (12%) were tra-
cheostomized. Five patients (20%) failed an extubation trial, only 1 
of them underwent a tracheostomy. In one of the tracheostomized 
patients, our protocol was not applicable because it came from 
another hospital three months after the trauma. Among patients 
who failed the extubation trial, 3 came from other hospitals, 2 were 
treated in our institution from the beginning. The extubation failure 
rate in patients admitted to our institution first was 8%. One patient 
was diagnosed with pneumonia, while another patient experienced 
complete atelectasis of a pulmonary lobe, treated with bronchoscopy.
The incidence of tracheostomy was different according to the level of 
lesion, being (50%) in C3 lesion, 28% in C4 lesion and 0 in the lower 
levels. ASIA A patients underwent tracheostomy in the 8% of cases, 
ASIA B in the 28%, while no ASIA C patient received a tracheostomy. At 
1-year follow-up (when available) no new tracheostomy has been per-
formed, no urgent re-admission to ICU occurred for any reason. The 
intubation rate at admission was 23/25 (92%). An extubation trial was 
performed in 21/25 patients (84%).
Table 1. Demographic data. Data are presented as N(%) or mean ±standard deviation where 
appropriate. 










Traumatic injury   24 (96%) 
ISS   27±4.5 
List of abbreviations. ASIA: Americal Spinal Injury Association – ISS: Injury Severity Score.  
Conclusion: We present a C-SCI group of patients, with a lower rate 
of tracheostomy compared to current evidence(1,4,6,7), and a low rate 
of respiratory complications, such as pneumonia or atelectasis. Our 
data suggest that an aggressive weaning program tailored to specific 
patient’s needs could lead to a higher rate of respiratory autonomy 
without side effects.
Reference(s) and grant ackowledgment(s)
1. 1. Childs BR, Moore TA, Como JJ, Vallier HA. American Spinal Injury Associa‑
tion Impairment Scale Predicts the Need for Tracheostomy After Cervical 
Spinal Cord Injury. Spine 2015;40(18):1407–13.
2. 2. Selvarajah S, Hammond ER, Haider AH, et al. The burden of acute 
traumatic spinal cord injury among adults in the united states: an update. J 
Neurotrauma 2014;31(3):228–38.
3. 3. Foti G, Cereda M, Banfi G, Pelosi P, Fumagalli R, Pesenti A. End‑inspiratory 
airway occlusion: a method to assess the pressure developed by inspiratory 
muscles in patients with acute lung injury undergoing pressure support. 
Am J Respir Crit Care Med 1997;156(4 Pt 1):1210–6.
4. 4. Wang Y, Guo Z, Fan D, et al. A Meta‑Analysis of the Influencing Fac‑
tors for Tracheostomy after Cervical Spinal Cord Injury. Biomed Res Int 
2018;2018:5895830.
5. 5. Bach JR, Gonçalves MR, Hamdani I, Winck JC. Extubation of patients 
with neuromuscular weakness: a new management paradigm. Chest 
2010;137(5):1033–9.
6. 6. Flanagan CD, Childs BR, Moore TA, Vallier HA. Early Tracheostomy in 
Patients With Traumatic Cervical Spinal Cord Injury Appears Safe and May 
Improve Outcomes. Spine 2018;43(16):1110–6.
7. 7. Higashi T, Eguchi H, Wakayama Y, Sumi M, Saito T, Inaba Y. Analysis of the 
risk factors for tracheostomy and decannulation after traumatic cervical 
spinal cord injury in an aging population. Spinal Cord 2019;57(10):843–9.
000147 
Comparative analysis of serum iron in patients with favorable 
and unfavorable outcomes of the treatment of traumatic brain 
injury
D. Markevich1
1Department of Anesthesiology and Resuscitation, Mogilev City Emer‑
gency Hospital, Mogilev, Belarus 
Correspondence: D. Markevich
Intensive Care Medicine Experimental 2020, 8(2): 000147
Introduction: TraumaTraumatic brain injury (TBI) is considered as a 
generalized process in which a systemic inflammatory response syn-
drome often develops [1]. Iron is a co-factor of metalloproteases and 
its metabolism is actively changing with multiple organ dysfunction 
[2,3]. Monitoring changes of serum iron is very interesting as a prog-
nostic criterion of treatment outcome in patients with head injury [4].
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Objectives: To study the dynamics of serum iron in patients with head 
injury in the postoperative time and its potential in predicting treat-
ment outcome.
Methods: A prospective study was hold from 01.05.2018 to 
31.12.2019. The ethics committee received permission for this study. 
76 adult patients(13 women and 63 men) who needed surgical treat-
ment of traumatic brain injury wereincluded the study. The age of 
the patients was 54 (43.5; 60) years. 45 patients underwent general 
anesthesia, and 31 patients underwent combined general anesthe-
sia and scalp block with using small volumes (0.5-1 ml for one nerve) 
0.75% ropivacaine. General anesthesia was total intravenous anesthe-
sia using propofol and fentanyl. In 3–6 months after craniotomy the 
Glasgow Outcome Scale (GOS) was taken for rating the outcome of 
treatment in patients with head injury. The treatment outcome was 
unfavorable 1-3 points by GOS(1 - patient’s death, 2 - vegetative state, 
3 - severe disability).The treatment outcome was favorable at 4 or 
5 points by GOS(4 - the possibility of self-care, 5 - full recovery). Two 
groups of patients were formed. Group 1 included 46 patients with 
a favorable outcome, and group 2 included 30 patients (of whom 17 
patients (56.7%) died) patients with an unfavorable outcome.
The groups of patients did not differ in age, weight, sex, method of 
anesthesia. Patients of groups 1 and 2 significantly reliably differed 
at the volume of intracranial hematomas, the intraoperative bleeding 
and estimated Glasgow Coma Scale (in group 1 - 14 (11; 15) in group 
2 - 7 (6; 10)), p <0.05.
Serum iron was compared between groups 1 and 2. A BA 400 Biosys-
tems biochemistry analyzer (Spain) was used for analysis of serum 
iron. The reference values of serum iron was 11.6-31.3 μmol/l. Blood 
sampling was performed 1-2 hours before the operation, and further 
in 11 (6; 17) hours on the 1st day after the operation, then in 35 (29; 40) 
hours on the 2nd day, in 60 (52; 65) hours on 3 day, after 108 (100; 113) 
hours on the 5th day, in 155 (148; 161) hours on the 7th day and in 226 
(220; 233) hours on the 10th day after craniotomy.
Statistical analysis was performed by Statistica 8.0 and Microsoft Excel 
2007. The normal distribution was checked using the Shapiro-Wilk`s 
test. Nonparametric methods were used to test the significance of sta-
tistical hypotheses. Descriptive statistics are presented as medians and 
lower and upper quartiles Me (LQ; UQ). The hypothesis of a statistically 
significant difference in the independent groups was tested using the 
Mann-Whitney test. The determination of serum iron as an unfavora-
ble classifier of outcome was evaluated using logistic regression with 
the construction of ROC-curves and calculating the area(AUC), sensi-
tivity (Se) and specificity (Sp).
Results: Significant differences in the serum iron between patients of 
groups 1 and 2 were revealed on the 5th, 7th and 10th days after the 
operation. Before surgery, the serum iron in patients of group 1 was 
13.5 (5; 17) μmol/l, in group 2 it was 7.7 (6.5; 14.3) μmol/l, p = 0.82. 
On the 1st day after the operation, in group 1 the iron was 6.6 (4.2; 
13.7), and in group 2 it was 7.5 (5.5; 13.2) μmol/l, p = 0.48; on 2th day 
after surgery in group 1 - 3.9 (2.8; 6.6), and in group 2 - 4.9 (2.8; 8.1) 
μmol/l, p = 0.61; on 3th day in group 1 - 5.1 (2.7; 7.6), and in group 2 - 
3.1 (2.3; 5.6) μmol/l, p = 0.12; on 5th day after surgery in group 1 - 6.1 
(2.6; 14.5), and in group 2 - 2.5 (1.9; 5.2) μmol/l, p = 0.02; on 7th day 
in group 1 - 7.3 (4; 13.5) μmol/l, p = 0.02; on the 10th day after crani-
otomy in group 1 the iron was 7.3 (3.6; 12.3), and in group 2 - 3.6 (1.9; 
5.7) μmol/l, p=0.03.
Using logistic regression, a statistically significant difference was 
revealed between patients of groups 1 and 2 in serum iron on 5th and 
10thdays after the operation for an unfavorable outcome. On 5th day: 
AUC 0.71, sensitivity (Se) 70.6%, specificity (Sp) - 65.2%. On 10th day: 
AUC 0.73, Se 75%, Sp - 60%.
Conclusion: 1. Patients with an unfavorable outcome of treatment’s 
TBI on the 5th, 7th and 10th days after craniotomy revealed sig-
nificantly lower level of serum iron than in patients with a favorable 
outcome.
2. Lower value serum iron starting 5th day after craniotomy can be 
considered a predictor of an unfavorable outcome in the treatment of 
patients with TBI.
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Introduction: It is known that patients with ischemic stroke may have 
nutritional deficiency. However, the frequency of its occurrence, pri-
marily at the beginning of the disease and the possible connection 
with mortality remain issues of discussion.
Objectives: To assess the incidence of malnutrition in patients with 
ischemic stroke at the beginning of the disease and its relationship 
with mortality in these patients.
Methods: An observational study was conducted of patients with IS 
admitted to the NICU within 1 randomly selected month. The criterion 
for exclusion from the study was the presence of a terminal stage of 
cancer. A total of 84 patients were included in the study, of which 61 
(73%) were women and 23 (27%) were men. The age of the patients 
is 71.5 [68.0; 80.8] years. All patients on admission were evaluated on 
the Nutritional Risk Screening (NRS) scale. Estimated height, weight 
of patients, calculated body mass index  (BMI). Data are presented as 
median and 25% and 75%. Statistical analysis was performed using 
the χ2 criterion.
Results: The weight of patients at admission was 76.5 [66.3; 88.0] kg, 
body mass index (BMI) - 27.5 [26.8; 28.5]. When assessing the presence 
of risk factors for malnutrition according to the NRS 2002, the only risk 
factor was hospitalization in the intensive care unit. In the final assess-
ment, in 57 (68%) patients, the total score was more than 3 due to the 
following parameters - age over 70 years and the presence on the 
APACHE II scale of more than 10 points. From these 16 (19%) patients 
were diagnosed with mild malnutrition due to a decrease in the abso-
lute number of lymphocytes. Moderate and severe malnutrition were 
not diagnosed in these patients.
12 (14.3%) patients died. Of these, 7 (43.8%) patients died in the group 
of patients with mild malnutrition. It is significantly higher than in the 
group of patients without malnutrition (χ2 = 14.013, p = 0.001).
Conclusion: Patients with ischemic stroke have at admission a low risk 
of malnutrition assessed according to the INR 2002. The presence of 
mild malnutrition in patients with IS is due to the age of patients older 
than 70 years and the presence of an APACHE II score of more than 
10 points. Mortality in patients with mild malnutrition is significantly 
higher than in patients without malnutrition.
Reference(s) and grant ackowledgment(s)
1. No
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Introduction: Acute Ischaemic Stroke (AIS) remains a significant cause 
of morbidity and mortality worldwide. With increasingly advanced 
techniques for reperfusion and prevention of secondary injury, the 
role of intensive care management in AIS is expanding. Beaumont 
Hospital, Dublin is the national neurosurgical and interventional neu-
roradiology referral centre in the Republic of Ireland with 17 Intensive 
Care beds. There were 2531 ICU admissions across all categories dur-
ing this time period.
Objectives: The study sought to review the number and nature of 
admissions, baseline characteristics, interventions and outcomes of 
patients with AIS and compare these to international data.
Methods: A retrospective review of admissions from January 2017 
to July 2019 was performed using standard data points collected by 
the National Office of Clinical Audit (NOCA). Approval for retrieval and 
assessment of data was granted by NOCA. Patients with a primary 
admission diagnosis of AIS were included. Other causes of cerebrovas-
cular accident including subarachnoid haemorrhage were excluded. 
Eighty-seven pre-determined data points were examined. Statistical 
analysis was performed in RStudio, Verision 1.1.456. Results are pre-
sented as percentages, mean/median and 95% Confidence Interval as 
appropriate.
Results: 68 patients were admitted in this period with a primary diag-
nosis of AIS. 34% were female. Mean age was 60 years (95% CI 58.8-
61.2). The MCA territory was implicated in 38% cases.
16% of patients presented locally. Referring hospitals ranged from 5.6 
to 243 kilometres in distance from our centre.
Thrombectomy was performed in 36 patients (52%). The majority of 
patients (89.7%) were mechanically ventilated. The median mechani-
cal ventilation days was 4 (range 1-22 days). Tracheostomy was per-
formed in seven patients. The majority of patients in this group had 
posterior circulation involvement. 43% of patients were treated for 
hyperglycaemia.
Median Intensive Care length of stay was 6 days (range 1-26 days). 63% 
of patients survived to ICU discharge. Middle Cerebral Artery decom-
pression was performed in 16 patients (24%). This group of patients 
had a lower median age, higher rates of stroke-associated pneumonia 
and a similar survival to ICU discharge. Increasing age was associated 
with reduced survival to ICU discharge (OR 0.94; CI 0.90-0.99; P =0.02). 
Other variables such as body mass index, hyperglycaemia, mechanical 
ventilation days and ICU length of stay did not reach statistical signifi-
cance. This may be reflective of the relatively small study numbers.
Conclusion: This data confirms the high acuity and treatment burden 
posed by this evolving group of patient. Rates of mechanical ventila-
tion, pneumonia and ICU mortality were similar to data previously 
reported (1). Increasing age was predictive of ICU mortality.
Reference(s) and grant ackowledgment(s)
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Introduction: We study the possibility of predicting the onset of 
death with the help of various hormonal and metabolic indicators in 
the acute period of cerebral stroke.
Methods: In 626 adult patients in the acute period of cerebral stroke 
(regardless of its type, variant, etc.) who were treated in the intensive 
care unit, along with generally accepted instrumental and laboratory 
tests, in cerebrospinal fluid and venous blood samples colorimetric 
determination of adenine, guanine, hypoxanthine, xanthine, uric acid, 
magnesium was carried out, enzyme-linked immunosorbent assay for 
cortisol and dehydroepiandrosterone, thyroid-stimulating hormone, 
thyroxine and triiodothyronine.
Results: The most specific factors were: increased concentration of 
uric acid in the blood serum on the 1st and 3rd day of stroke (0.89 
and 0.98), combination of an increased content of uric acid in blood 
serum and cerebrospinal fluid on the 1st and 3rd day of a stroke (0.90 
and 0.97); reduced guanine in cerebrospinal fluid (0.84) on the 3rd day 
of stroke; increased content of free fractions of triiodothyronine and 
thyroxine on the 1st day of stroke (0.86 and 0.76). The relative risk of a 
fatal outcome is high when a stroke of increased concentration in the 
blood serum of cortisol is detected on the 1st and 3rd day (3.25 and 
7.39); increased content of hypoxanthine (2.49), xanthine (2.49) and 
uric acid (3.53) on the 3rd day of stroke, a combination of increased 
serum uric acid and cerebrospinal fluid (2.71). The highest chances of a 
fatal outcome when a stroke is detected on the 1st day of a stroke are 
elevated concentrations of cortisol and free thyroxine in blood serum 
(OR 4.98 and 2.59, respectively), uric acid in cerebrospinal fluid (OR 
2.79); when a stroke concentration of adenine (OR 2.61), guanine (OR 
3.75), hypoxanthine (OR 4.55), xanthine (OR 3.60), urine is detected in 
the blood serum on the 3rd day of a stroke acid (OR 20.0), cortisol (OR 
10.4), a combination of high uric acid in blood serum and cerebrospi-
nal fluid (OR 23.3).
Conclusion: In patients in the acute period of cerebral stroke (regard-
less of its type), indicators of the purine spectrum, stress-adaptive 
hormonal status are highly informative factors in predicting the onset 
of a fatal outcome. The most prognostically “powerful” of the studied 
parameters is the blood level of uric acid.
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Introduction: We study the possibility of predicting the onset of a 
fatal outcome using various hormonal and metabolic parameters in 
acute cerebral ischemia.
Methods: In 402 adult patients in the acute period of cerebral 
ischemic stroke, who were treated in the intensive care unit and 
intensive care unit of the angioeurological department, along with 
generally accepted instrumental and laboratory tests, colorimetric 
measurements of adenine, guanine, hypoxanthine, xanthan were car-
ried out in samples of cerebrospinal fluid and venous blood uric acid, 
magnesium, malondialdehyde. Based on the concentration ratio of 
uric acid / xanthine, xanthine / hypoxanthine, uric acid / hypoxanthine, 
the activity of the first and second stages of the xanthine oxidase reac-
tion and the total xanthine oxidase activity were calculated. Enzyme 
immunoassays examined the levels of cortisol and dehydroepiandros-
terone, thyroid stimulating hormone, thyroxine and triiodothyronine.
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Results: The most sensitive predictors of lethal outcome of ischemic 
stroke were: increased xanthine concentration on the 1st and 3rd day 
of stroke (0.83 and 0.76), reduced xanthine oxidase activity (in the sec-
ond stage of the xanthine oxidase reaction - 0.61). Among the most 
specific such factors: an increased concentration of uric acid in the 
blood serum on the 1st and 3rd day of a stroke (0.91 and 0.98), a com-
bination of an increased content of uric acid in the blood serum and 
cerebrospinal fluid on the 1st day of a stroke (0.93). The relative risk of 
death is highest when a stroke concentration of uric acid in the blood 
serum is detected on the 3rd day (3.93). The highest chances of a fatal 
outcome when a stroke is detected on the 3rd day of an elevated 
blood serum uric acid (OR 21.5), adenine (OR 3.55), guanine (OR 3.27); 
a combination of increased serum uric acid and cerebrospinal fluid (OR 
3.37), increased serum uric acid (OR 2.87), decreased xanthine oxidase 
activity in the second stage of the xanthine oxidase reaction on the 1st 
day of stroke (OR 2,67).
Conclusion: In patients with acute cerebral ischemia in the acute 
period of cerebral ischemic stroke, the most prognostically “powerful” 
lethal outcome factors are uric acid level and xanthine oxidase activity.
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Introduction: Subarachnoid Hemorrhage (SAH) is a medical emer-
gency and the most frequent etiology is a ruptured aneurysm. It 
remains a major cause of morbidity and mortality due to the initial 
insult but mainly as a result of secondary brain injury (SBI). Multimodal 
Monitoring provides an individualized care at bedside, giving tools to 
guide therapeutic interventions, preventing or minimizing SBI.
Objectives: To identify possible factors with impact in outcome in 
patients admitted with spontaneous SAH.
Methods: A retrospective case-series study that included all patients 
with SAH admitted to a Neurocritical Unit (NCCU) of a tertiary hospi-
tal at intensive care level between the first january 2018 and the 30th 
june 2019. Primary outcome was defined by Glasgow Outcome Scale 
at discharge from NCCU and at 28, 90 and 180 days after the event.
Results: Forty-six patients (29 females) were included. Median age 
was 55.5 years (50.0-63.3). In 41 patients an aneurysm was identified. 
The most frequent aneurysm locations were Anterior Communicating 
Artery and Middle Cerebral Artery, in 11 (23.9%) and 9 (19.6%) cases, 
respectively. The median length of stay in the NCCU at intensive care 
level was 20.5 (4.8-31.0)days. Fourteen (30.4%) patients were submit-
ted to neuroradiology procedure. No patient submitted to neurora-
diology procedure had a bad outcome at six months. At all moments 
of follow-up, Glasgow Coma scale (GCS) at admission, Hunt & Hess 
(H&H)  scale, duration of invasive ventilation (IMV) and delayed cer-
ebral ischemia (DCI) had an association with patients’ outcome (p < 
0.05). The three deaths (6.5%) recorded occurred during NCCU stay: 
two patients with severe SAH (GCS of 3, Fisher scale of 4 and H&H scale 
of V) and a third patient who developed many complications (hydro-
cephalus, re-bleeding and vasospasm requiring intra-arterial adminis-
tration of verapamil), despite admission with GCS of 15, Fisher scale of 
4 and H&H of II.
Association between variables and outcome 
At Discharge 
from NCCU (p 
value) 
At the 28th 
day (p 
value) 







Age(>55years) 0.001 0.011 0.053 0.25 
Arterial 
Hypertension 0.42 0.13 0.298 0.65 
GCS(admission) 0.003 <0.001 0.002 0.007
Fisher scale 0.001 0.001 0.08 0.138 
H&H scale <0.001 <0.001 0.005 0.008
Hemoglobin 
(admission) 0.007 0.019 0.204 0.78 
Days with IMV <0.001 <0.001 <0.001 0.04
DCI 0.03 0.039 0.006 0.012
Vasospasm 0.02 0.033 0.027 0.628 
Hydrocephalus 0.006 <0.001 0.056 0.065 
Re-bleeding 0.005 0.006 0.086 0.028
Type of 













(GOS 1, 2 and 
3) 
25 (54.3%) 25 (55.6%) 13 (32.5%) 6 (23.1%) 
Good Outcome 




46 (100.0%) 45 (100.0%) 40 (100.0%) 26 (100.0%) 
Conclusion: SAH related complications were common and associ-
ated with worse outcomes, therefore treatment approach should be 
focused on its avoidance and prompt resolution. Endovascular treat-
ment had better outcomes at six months than surgical intervention.
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Introduction: Chronic hydrocephalus (CH) is a common and poten-
tially modifiable complication of spontaneous subarachnoid hemor-
rhage (SAH) requiring prompt treatment for optimal outcomes. Risk 
factors for CH have been extensively investigated, but reliable scores 
to predict shunt dependency after aneurysmal SAH (aSAH) are scarce. 
A newly developed shunt dependency in aSAH (SDASH) score based 
on the combination of acute hydrocephalus (aHP), Hunt and Hess 
grade, and Barrow Neurological Institute (BNI) score was found to be 
a reliable tool for predicting shunt-dependent hydrocephalus (SDHC). 
This prediction model, however, was based on a single-center retro-
spective population.
Objectives: The present study was designed to validate the SDASH 
score in an external cohort of aSAH patients.
Methods: The study population included 214 of 249 (85.9%) patients 
with aSAH admitted to our hospital (2016-2019). In each patient, the 
SDASH score, the Hijdra score, the BNI score, the chronic hydroceph-
alus ensuing from SAH score (CHESS), the Graeb, and the modified 
Graeb score (mGS) were calculated, and the reliability of these mod-
els were compared. Logistic regression analysis was used to determine 
the reliability of the SDASH score, and the area under the receiver 
operating characteristics (ROC) curve (AUC) to assess the discrimina-
tion capacity of the model.
Results: 40 patients (18.7%) developed SDHC. Older age, high Hunt 
and Hess grade, high grade of the WFNS classification scale, EVD place-
ment, ventricular hemorrhage, CSF daily output and higher bicaudate 
index, correlated significantly with an increased rate of ventriculo-
peritoneal shunt insertion. The AUC for SDASH score was 0.816. The 
SDASH score reliably predicted SDHC in aSAH (odds ratio of 2.93; 95% 
confidence interval 1.99-4.31; p < 0.001). No statistically significant dif-
ferences were found between SDASH score and the other predictive 
scores.
Conclusion: The SDASH score was found to be a reliable tool for pre-
dicting SDHC and could be used in daily practice. The SDASH score 
may be added to the list of other scores such as CHESS, Graeb, or mGS 
which may help to early management of hydrocephalus in aSAH.
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Introduction: Delayed cerebral ischemia (DCI) is a major contributor 
to the high fatality and morbidity case rates of aneurysmal subarach-
noid hemorrhage (SAH). About 30% of the SAH patients develop DCI 
but it is difficult to predict which patients will develop it.
Objectives: To assess the development of DCI risk factors in patients 
with SAH, admitted in a Neurotraumatic ICU.
Methods: Prospectively collected data of patients admitted from 
October, 2013 to December 2019 to a 10-bed Neurotraumatic ICU. We 
analyzed: main diagnosis at admission; demographic data including 
sex and race; neurological data (clinical examination, pupils reactivity 
and size, and Glasgow Coma Score: GCS; localization and aneurysm 
size; presence of intracranial hematoma (ICH); presence and volume 
of intraventricular bleeding; days to develop vasoespam; develop-
ment of DCI; Fisher scale, Modified Fisher scale (MFS), Hunt and Hess 
scale (HHS), Word Federation of Neurosurgeons (WFNS) scale; pres-
ence of vasoespasm in doppler orarteriography; delayed of admis-
sion in ICU; treatment of the aneurysm; complications, including 
infections; Glasgow Outcome Scale (GOS) at ICU discharge and 6 
months after ICU discharge and several other risk factors. A univari-
ate analysis of DCI was performed. To obtain a predictive rule for the 
DCI, a model for the prediction was obtained using the classification 
and regression trees (CART) procedure [1]. CART classifies data using 
a sequence of if–then rules. The basis of the decision tree algorithms 
is the binary recursive partitioning of the data. The most discrimina-
tive variable is first selected to partition the data set into child nodes. 
The splitting continues until some stopping criterion is reached. At 
each terminal node, the probability of DCI was estimated as the pro-
portion of patients belonging to that node that developed the event. 
The tree was constructed according to the following algorithm: in the 
first stage, the tree grows until all cases are correctly classified, and in 
the second stage, we used the tenfold cross-validation method of suc-
cessive pruning [1]. Finally, the tree that minimized the error measure-
ment (deviance) was chosen. For this predictor the corresponding ROC 
curve was obtained and the AUC was estimated by means of a 95 % CI.
Results: One hundred forty two SAH patients were collected, 32 
(22,5%) of them developed DCI. Demographic data and types of 
admission are shown in Table 1a and 1b.
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Anterior communicating (Aco) artery aneurysms were the most fre-
quently found and most of them were located in the left side. . The 
most frequent DCI patient complications were stroke 24 (75%) and 
hydrocephalus 18 (56.2%). GOS at ICU discharge was 4 and, six months 
after ICU discharge, was 5 in patients with SAH. Patients who devel-
oped DCI had GOS at ICU discharge of 4 and it was also 4 six months 
later. Also 19 (59,37%) had GOS > 3 at ICU discharge. Thirty two 
(22.9%) SAH patients died. Seven (22.6 %) DCI patients died. There was 
not statistical significant difference in mortality in DCI vs SAH patients.
Classification tree showed:HHS 1 has a high probability of not having 
DCI.MFS >3 and HHS >1 have probabilities of around 30% of DCI.
Conclusion: Our data show 22,5 % of our studied patients had DCI. 
GOS reflected low disability of DCI patients both at ICU discharge and 
six months later. Classification tree showed: HHS 1 has a high probabil-
ity of not having DCI. MFS >3 and HHS >1 have probabilities of around 
30% of DCI. Finally, mortality was not significantly greater in the stud-
ied patients.
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Introduction: Aneurysmal subarachnoid hemorrhage (SAH) is a 
worldwide health burden with serious outcomes such as permanent 
disability. It is important to learn the disability risk factors and identify 
those potentially preventable, to reduce them.
Objectives: To assess disability risk factors in patients admitted with 
subarachnoid hemorrhage (SAH), admitted in a neurotraumatic ICU.
Methods: Prospectively collected data of patients admitted from 
October, 2013 to December 2019 to a 10-bed Neurotraumatic ICU. We 
analyzed: main diagnosis at admission; demographic data, including 
sex and race; neurological data (clinical examination, pupils reactiv-
ity and size, and Glasgow Coma Score (GCS); location and aneurysm 
size; presence of intracranial hematoma (ICH); presence and volume 
of intraventricular bleeding; days to develop vasoespam; develop-
ment of delayed cerebral ischemia (DCI); Fisher scale, modified Fisher 
scale, Hunt and Hess scale, Word Federation of Neurosurgeons (WFNS) 
scale; presence of vasoespasm in doppler or arteriography; delayed of 
admission in ICU; treatment of the aneurysm; complications, includ-
ing infections; Glasgow Outcome Scale (GOS) at ICU discharge and 6 
months after ICU discharge and several other risk factors.  Disability 
was defined as GOS ≤ 3. In order to identify those factors that main-
tain independent association with disability, a multivariate logistic 
regression analysis were performed. It was considered significant if p 
≤.05.
Results: Among 152 SAH admitted patients, 58 (38.15%) out of 94 
patients had GOS ≤ 3. Univariate analysis is shown in Table 1a and 1b
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Twenty four SAH patients (16.1%) died at ICU discharge. Decompre-
sive craniectomy was performed in 7 (4.7 %) SAH patients, all of them 
with GOS ≤ 3. The independent risk factors associated with disability 
(GOS≤3) were: Apache II at ICU admission per unit OR (95% CI) 1.547 
(1.229; 1.948); number of platelets x 103 at ICU admission OR : 112 (5.4; 
2304); SDD OR: 0.064 (0.008; 0.538); stupor OR: 6.479 (1.223; 34.336); 
isochoric pupils OR: 0.05 (0.004; 0.652); hydrocephalus OR: 6.708 
(1.359; 33.103) and MV> 7 days OR: 36.861 (3.90; 340.497) (Table 2).
Conclusion: In SAH patients admitted to a neurotraumatic ICU, risk 
factors that were independently associated with disability were: 
Apache II at ICU admission per unit, number of platelets at ICU admis-
sion, SDD, stupor, isochoric pupils, hydrocephalus and MV> 7 days.
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Introduction: Second level therapeuticactions for controlling intrac-
ranial hypertension (ICH) proposed by the European Brain Injury 
Foundation include barbiturates, moderate hypothermia and decom-
pressive craniectomy (DC), but outcomes are controversial. Our aim 
was to evaluate the factors associated with disability and mortality 
after ICU discharge in patients undergoing DC.
Objectives: To assess the factors associated with disability and mor-
tality, after ICU discharge, in DC patients after 7 years.
Methods: Prospective study of patients admitted from January 1, 
2013 to March 2020 who required DC. DC was performed due ICH 
refractory to medical treatment. We analyzed: main admission diag-
nosis; demographic data; neurological data (clinical examination and 
Glasgow Coma Score: GCS); hypotension type of craniectomy and DC 
complications; Rankin scale, and Glasgow outcome scale (GOS) at 30, 
60 days after ICU admission, at ICU discharge and 6 months after ICU 
discharge; preoperative serum lactate levels; hypo and hyperglycemia; 
application of mannitol or hypertonic saline solution before and after 
DC; leukocytes and platelets previous and after DC and other factors 
related to prognosis. Univariate analysis of disability (Rankin > 3) and 
mortality in ICU, 60 days after ICU admission and 6 months after ICU 
discharge were performed. Statistical significance was set at p ≤ 0.05.
Results: Thirty five DC patients were collected. Demographic data and 
types of admission are shown in Table 1
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Most DC were subarachnoid hemorrhages (SAH) 17 (48.6%) and 75% 
of them were hemicranial. The most frequent complications were 
reoperation due to complications (42,9% of them) and hydrocephalus 
(42,9%). Six patients died at ICU discharge (17,1%), 4 (66,6%) of them 
were SAH. Rankin score at ICU discharge was 4 and GOS was 3. Rankin 
score at 6 months after ICU discharge was 4,5 and GOS was 3. Oblitera-
tion of basal cisterns was found to be a significant risk factor associ-
ated with disability, six months after ICU discharge (Table 2)
Mortality 6 months after discharge was significantly associated with 
bilateral pupillary reactivity prior to DC, female sex and the presence 
of focal contusion with edema and expansivity (Table 3).
Conclusion: DC patients showed low ICU mortality (17,14%) Rankin 
and GOS reflected moderate / severe disability of these patients, at 
ICU discharge. Rankin and GOS also showed disability, sixty days and 
6 months after ICU discharge. Obliteration of basal cisterns was signifi-
cantly associated with disability 6 months after ICU discharge. Mortal-
ity, 6 months after discharge, was significantly associated with female 
sex, bilateral pupillary reactivity prior DC and presence of focal contu-
sion with edema and expansivity.
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Introduction: Cerebral vasospasm continues to account for high mor-
bidity and mortality in patients following aneurysmal subarachnoid 
haemorrhage (SAH).[1] Recent advances in neuroimaging have led 
to improved detection of vasospasm in this cohort but, despite many 
years of research, choice of hypertensive therapies remains highly var-
iable between neurosurgical centres.[2]
Objectives: Demonstrate the morbidity caused by vasospasm in 
patients admitted to Beaumont Hospital, the national neurosurgical 
centre in Ireland, following aneurysmal SAH.
-Examine current practices and outcomes in treatment of vasospasm 
in the national centre.
Methods: We identified all patients admitted with aneurysmal SAH 
over a three year period from February 2016 to February 2019. We con-
ducted a retrospective chart analysis examining demographics, clini-
cal features and outcome data. A subgroup who developed clinically 
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significant vasospasm was further analysed to examine management 
and outcomes.
Results: 532 patients with aneurysmal SAH were identified, of which 
68 developed significant vasospasm. Patients who presented with a 
higher Fisher grade were more likely to develop vasospasm (p < 0.05). 
A significant increase in morbidity was shown in patients who devel-
oped cerebral vasospasm versus those who did not, with median Glas-
gow Outcome Score (GOS) at three months of 3 versus 4, respectively 
(p < 0.05). The 68 patients with vasospasm stayed a combined 783 
days in ICU, with mean LOS of 11.5 days (range 1-38 days).
Regarding hypertensive treatment of vasospasm, 27 patients (39.7%) 
were treated with noradrenaline (NA) alone and 35 (51.5%) with NA 
plus vasopressin. There was no difference between the two groups 
in grade of presentation (Fisher or WFNS), MAP targets set or the per-
centage of days MAP targets were met. Of note however, worse GOS at 
three months occurred in those who received double agent hyperten-
sive therapy vrs NA alone (p < 0.05). In addition, of those treated with 
NA plus vasopressin, 28/35 (80%) developed hyponatraemia, versus 
8/27 (<30%) of those treated with NA alone (p < 0.01).
Conclusion: Cerebral vasospasm after SAH is a significant cause of 
morbidity for patients in the national neurosurgical centre in Ireland. 
Vasospasm also causes a significant burden due to duration of ICU 
stay. Hypertensive therapies used in vasospasm are not benign treat-
ments. Despite equal MAP control in both groups, patients treated 
with NA and vasopressin had significantly worse outcomes than 
those treated with NA alone, with associated high rates of severe 
hyponatraemia. This may call into question the benefit of the addi-
tion of vasopressin in this cohort. There are no consensus guidelines 
regarding treatment of vasospasm. Ideally, well designed, multicentre 
randomised control trials are required to evaluate the optimal treat-
ment of this patient cohort.
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Introduction: The ultimate goal of therapy of spontaneous Subarach-
noid Hemorrhage (sSAH), after acute phase, is to prevent secondary 
cerebral injury. Induced hypertension, hypervolemia and hemodi-
lution (triple H) therapy have been used to increase cerebral blood 
flow. Recently, the physiological effects of components of triple-H 
therapy have been questioned. Hypervolemia may result in potentially 
life-threatening complications, like pulmonary and cerebral edema. 
Optimal fluid management after sSAH is variable throughout differ-
ent centers but maintaining euvolemia is what is recommended by 
ESICM consensus 2018, through vigilant assessment of fluid balance 
(FB) along with arterial blood pressure. A positive FB has been associ-
ated with worse functional outcomes at 3 months but has not been 
widelyassessed during the critical period when patients are most likely 
to develop symptomatic vasospasm.
Objectives: To assess the impact of early FB in the occurrence of 
vasospasm in patients (pts) with sSAH.
Methods: Retrospective single-center study that includes pts admit-
ted in a neuro-ICU with sSAH, during a period of 2 years. Data were 
collected during the first 10-days of ICU. We hypothesized that an 
early more positive FB, particularly at 48 hours, may influence the 
development of vasospasm in the following days. All reported p values 
are two-tailed, with a p value of 0.05 indicating statistical significance. 
Receiver operating characteristic (ROC) curve and area under curve 
(AUC) were calculated, a cutoff point of the cumulative fluid balance at 
day 2 was identified and two groups were formed: (i) pts with cumu-
lative FB at day 2 >1.5 Litres (L) and (ii) pts with FB ≤ 1.5L. Multivari-
able logistic regression was used to adjust for potential confounders. 
Analyses were performed with the use of SPSS® software v22 and 
MedCalc® v19.2.3.
Results: A total of 83 pts were included, 57% male, with a mean age of 
56±12.1 years. Hunt-Hess was IV-V in 21 pts (25%) and Modified Fisher 
scale was III-IV in 70 pts (84%). Only 7 (8,4%) did not developed sono-
graphic vasospasm criteria during the 10-day period. The mean FB at 
day 2 was 1.6±1.3 L and it was significantly higher in pts who devel-
oped vasospasm after 2nd day (vasospasm: 1.8L [IQR 1.2]; no vasos-
pasm: 1.1L [IQR 1.5]; p=0.007). A ROC curve was calculated (Fig. A) and 
the AUC was 0.675 (p=0.007; CI 95% 0.1-0.8). Kaplan-Meier curve (Fig. 
B) demonstrated that pts with less positive FB on 2nd day had lower 
occurrence of vasospasm. A cumulative FB at 2nd day >1.5L was asso-
ciated with increased odds of vasospasm occurrence from the 4th to 
the 7th day. After adjustment for possible confounders, FB >1,5L on 
the 2nd day remains an independent predictor of vasospasm occur-
rence from 4th to 6th-day [day 4: adjusted (adj) OR 5.3, 95% CI 1.4-19.9; 
day5: adj OR 6.9, 95% CI 1.7-28.4; day 6: adj OR 6.1, 95% CI 1.5-24.0].
Conclusion: The main finding of this study is that a high FB in sSAH 
pts, in the first 48 hours after admission, is an independent predictor 
of vasospasm occurrence.
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Introduction: Cerebral blood flow is compromised following spon-
taneous subarachnoid hemorrhage (sSAH), not only due to the early 
consequences of the acute bleeding, namely intracranial hyperten-
sion, but also due to late complications such vasospasm and vasore-
activity impairment in response to acute changes either in oxygen or 
carbon dioxide levels.
Objectives: To assess the vasoreactivity response to oxygen and car-
bon dioxide after sSAH and its impact on neurological outcome.
Methods: Retrospective single-center study that includes patients 
(pts) admitted in a neuro-ICU with sSAH diagnosis, from January 2017 
to December 2018. Patients’ demographics, clinical grading of SAH, 
Glasgow Coma Scale (GCS) at admission and at hospital discharge, 
Glasgow Outcome Scale (GOS) at 6 months and gasometric param-
eters during the first 10 days were recorded. Categorical variables are 
presented as frequencies and percentages and were compared with 
the use of Fisher’s exact test or chi-square test. Continuous variables 
were expressed as means and standard deviations, or medians (Mdn) 
and interquartile ranges (IQR) and compared with the use of Student’s 
t-test or Mann-Whitney U-test. All reported p values are two-tailed, 
with a p value of 0.05 indicating statistical significance. Multivariable 
logistic regression was used to adjust for potential confounders. Analy-
ses were performed with the use of SPSS® software v22.
Results: A total of 83 pts with sSAH were included, 57% male, with 
a mean age of 56±12 years. At admission, mean GCS was 12±4 but 
with 18,6% (n=16) of pts presented GCS 3-8; at hospital discharge the 
mean of GCS was 14±3 with a decrease in number of patients with 
GCS ≤ 8 (n=6, 7%). The difference between GCS at the discharge and 
at admission was 1.3±3.5 and each increase in 1 mmHg in PaO2 was 
associated with an increase of 0.31 points in that difference. About 
55% of pts (n=47) had GOS 5 at 6 months, 17 pts (19,8%) had poor 
neurologic outcome (GOS 1-3) and 5 pts died.
During the first ten days, median of PaCO2 and PaO2 are significantly 
higher in the group of pts with GOS 1-3 at 6 months (PaCO2: 40.3, IQR 
4.2; PaO2: 143.9, IQR 52.8) than in pts with GOS 4-5 (PaCO2:35.8, IQR 
4.0; PaO2 103.1, IQR 44.1) (PaCO2: p < 0.001; PaO2: p=0.017). Each 
additional increment of 1 mmHg in PaCO2 was associated with a 49% 
(95% CI 1.2-1.9) increase in the odds of having a GOS 1-3. After adjust-
ment for potential confounders (Fig. 1), PaCO2 (adjusted OR 1.99, 95% 
CI 1.17-3.37), but not PaO2, remains an independent predictor of poor 
neurologic outcome.
Conclusion: In our study PaCO2 was an independent predictor of 
poor neurologic outcomes in patients with sSAH with significantly 
higher levels in pts with GOS 1-3 at 6 months. PaO2 was associated 
with an increase in the difference between GCS at the discharge and 
at admission.
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Introduction: The usefulness of Decompressive Craniotomy (DC) after 
a Traumatic Brain Injury (TBI) is not clear, so it is impossible to prepare 
Guidelines with adequate evidence. Furthermore, there are no early 
clinical or radiological findings before the development of refractory 
Intracranial Hypertension that appropriately indicate a DC surgery.
Objectives: To perform a score with early clinical and radiological 
findings after a TBI that identify the patients who in their subsequent 
evolution are going to undergo DC.
Methods: Observational study of a retrospective cohorts of patients 
who, after a TBI, enter the Neurocritical Section of the Intensive Care 
Unit of our hospital for a period of 5 years (2014-2018). Main event 
of the study: DC. Detection of clinical (GCS, mydriasis, shock) and 
radiological (CT) criteria and generation of all possible models with 
significant, clinically relevant and easy to detect early variables. Selec-
tion of the one with the lowest Bayesian Information Criterion (BIC) 
and Akaike Information Criterion (AIC) values  for the creation of the 
score. Calibration and internal validation of the score using the Hos-
mer-Lemeshow and a bootstrapping analysis with 1,000 re-samples 
respectively.
Results: 37 DC were performed in 153 patients who were admitted 
after a TBI. The resulting final model was:
Dependent variable: CD Odds Ratio p 95% CI 
Cerebral Midline Deviation  6,35  0,0001 2,37-17,04 
TCE according to GCS (mild/moderate-
severe)) 4,32  0,025 1,20-15,50 
Ventricular collapse 5,27   0,002 1,89-14,74 
Area under ROC Curve: 0.84 (95% IC 0.78-0.91). Hosmer-lemeshow 
p=0.71. A value of 1 was assigned to each of the factors. A score value 
of 2 had a very high Sensitivity and Specificity (greater than 78%) with 
acceptable Positive and Negative Predictive Value to detect patients 
who were going to need a DC. The developed score detected well 
those patients who were going to need an early (primary) DC after 
a TBI (2.5+/-0.5) but not those who would need it in a later stage of 
their disease (secondary) (1.7 +/- 0.8). However, it seems to advice us 
about the patients who, although not requiring a primary DC are likely 
to need it later in their evolution (secondary DC vs do not require DC 
1.7+/-0.8 vs 1+/-0.7; p=0.002).
Conclusion: We have developed a prognostic score using early clini-
cal-radiological criteria that, in our environment, detects with good 
Page 377 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
sensitivity and specificity those patients who, after a TBI, will require 
a DC.
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Introduction: The risk of intracranial hemorrhage (ICH) in patients 
with left ventricular assist devices is high. Surgical intervention and 
reversal of anticoagulation is not without risk. There is limited, pub-
lished information regarding the surgical management of LVAD 
patients and often decision making is difficult, requiring a multidisci-
plinary approach.
Objectives: We aim to review the relevant literature regarding surgical 
and medical management of intracranial hemorrhage in patients with 
LVAD and present a case from our ICU.
Methods: A systematic review of the literature was undertaken using 
the key words “intracranial hemorrhage” and “left ventricular assist 
device” in the Scopus, PubMed, and Google Scholar databases. Pub-
lished case reports and series written in English were included with 
adult patients. Abstracts were not included in the review. Data was 
extracted regarding the number of surgical interventions performed 
to total number of patients reported, and the type of ICH and surgi-
cal procedures performed. Data was also extracted regarding preop-
erative and postoperative anticoagulation as well as the outcome of 
the surgical patients. A case of a young patient from our ICU is also 
presented.
Results: In total 9 studies (7 case series, 2 case reports) were included 
in our review regarding a total of 292 patients with intracranial bleed-
ing. Surgery was undertaken in 49 (16.7%) patients with surgery 
ranging between 5.7% and 40% in the case series patients. Type of 
bleeding, surgery performed, anticoagulation and outcome param-
eters are summarized in Table  1. Spontaneous intraparenchymal 
hematomas (IPH) were more common and presented with the worst 
outcomes throughout all the included studies. No significant corre-
lation was established between elevated INR and the incidence nor 
severity of ICH. Immediate thromboembolic events were not encoun-
tered in any patients. Interestingly decision for surgical treatment was 
not specified in most studies. Three studies indicated that surgical 
intervention provided no improvement in outcome although it was 
not linked to increased mortality. Several limitations exist due to the 
heterogeneity of data provided and the fact that often little data was 
given regarding surgical intervention patients.
A 29-year-old female, with LVAD placement one-month prior was 
admitted to our ICU due to a spontaneous large left sided IPH. The 
patient’s INR upon admission was 1.6. Immediate extensive left side 
craniectomy and hematoma removal was performed. Re initiation of 
anticoagulation commenced 5 days after craniectomy following stable 
CT scan imaging of the hematoma with argatroban infusion due to a 
history of HIT. APTT values of 1.5 to 2 times initial aPTT were aimed 
(45 to 60 seconds). The patient was successfully discharged from the 
hospital 2 months after ICU admission with a GOS of 4, on warfarin, to 
a rehabilitation center.
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Conclusion: Early surgical treatment with craniectomy in large IPH 
that present a midline shift and large volumes may be lifesaving. Med-
ical anticoagulation may be withheld from patients with LVAD treat-
ment for a certain period without thromboembolic events. A possible 
bridge to re-initiation of warfarin in patients presenting with HIT or 
heparin resistance may be achieved with argatroban infusion with set 
aPTT levels of 1.5 to 2 times initial values according to our experience. 
The current literature is lacking regarding effective surgical and medi-
cal management and further research is of great necessity.
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Introduction: Patients with large vessel occlusion stroke (LVOS) eligi-
ble for mechanical thrombectomy (MT) are at risk for stroke- and non-
stroke related complications resulting in the need for tracheostomy 
(1). Evidence suggest that early tracheostomy might exhibit distinct 
advantages over continued orotracheal intubation, ventilation and 
sedation (2).
Objectives: To investigate clinical-, periinterventional- and imaging 
factors to predict the need for tracheostomy in major stroke patients 
undergoing MT.
Methods: Prospectively derived data from patients with LVOS and MT 
being treated in a large, academic neuro-ICU between 2014 and 2018 
were analyzed in this monocentric study. Predictive value of peri- and 
postinterventional factors, stroke imaging and pre-stroke medical his-
tory were investigated for their potential to predict tracheostomy dur-
ing ICU-stay using logistic regression models.
Results: From 635 LVOS-patients treated with MT, 40 (6.3%) under-
went tracheostomy during their neuro-ICU stay. Patients receiving 
tracheostomy were younger (71 (62-75) vs. 77 (66-83), p<0.001), had 
a higher National Institute of Health Stroke Scale (NIHSS) at baseline 
(18 (15-20) vs. 15 (10-19), p=0.009) as well as higher rates of hospital 
acquired pneumonia (HAP) (39 (97.5%) vs 224 (37.6%), p<0.001), faile-
dextubation (15 (37.5%) vs 19 (3.2%), p<0.001), sepsis (11 (27.5%) vs. 
16 (2.7%), p<0.001), symptomatic intracerebral hemorrhage (sICH) 
(5 (12.5%) vs. 22 (3.9%), p=0.026) and decompressive hemicraniec-
tomy (DH) (19 (51.4%) vs. 21 (3.8%), p<0.001). In multivariate logistic 
regression analysis, HAP (OR 21.1 (CI, 2.7-163.3), p<0.003), Sepsis (OR 
5.6 (1.8-18), p=0.003), failed extubation (OR 8.9 (3.2-24.5), p<0.001) 
and DH (OR 9.1 (3.5-23.3), p<0.001) remained as strongest predictors 
for tracheostomy. Patients with later timepoint of tracheostomy had 
longer ICU length of stay (r=0.384, p=0.030). There was no association 
between time to tracheostomy and clinical outcome (NIHSS at dis-
charge: r=0.125, p=0.461; mRS at 90 days: r=-0.179, p=0.403).
Conclusion: Patients with LVOS undergoing MT are at high risk to 
require tracheostomy if extubation after the intervention fails, DH is 
needed and severe infectious complications occur in the acute phase 
after ischemic stroke. These factors are likely to be useful for the indi-
cation and timing of tracheostomy to reduce overall sedation and 
shorten ICU length of stay.
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Introduction: EEG slowing (a relative increase of slow frequency and 
decrease of high-frequency power) is a common feature associated 
with loss of consciousness. We previously described how the EEG 
power spectrum slope (1/f decay) is steeper when consciousness is 
lost (e.g. during propofol and xenon anesthesia) and flatter when con-
sciousness is preserved despite similar behavioral unresponsiveness 
(e.g. during ketamine anesthesia). The Spectral Exponent β describes 
how steep is the decay of the power spectral density over frequencies 
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(PSD=f-β, i.e. the EEG slowing)1. Similarly to both sleep and phar-
macologically induced conditions, coma due to acute brain injury 
is typically associated with EEG slowing, whereas exit from a coma is 
associated with a recovery of fast frequencies and low amplitude EEG 
activity typical of normal wakefulness.
Objectives: We tested the hypothesis that the recovery of conscious-
ness after acute brain injury is paralleled by a progressive flattening of 
the PSD decay.
Methods: We collected 107 longitudinal EEG at different days from 
injury from 22 patients (mean 4,6 EEG for each patient, IQR 3 – 6) with 
acute brain injury with transient loss of consciousness and good recov-
ery (functional communication at discherge). Patients are divided into 
two subgroups based on etiology: post anoxic groups (n=14) and 
generic acute brain injuries (different etiologies but post anoxic, n=8). 
Recordings with any anesthetics or status epilepticus were excluded. 
We obtained the Spectral Exponent (SE) for each EEG. We then esti-
mated if the modifications of the β values were linearly predictable 
by two variables: time form injury and a clinical feature expressed by 
the Glasgow Coma Scale (GCS). A mixed-model effect was used to 
estimate whether the variation of β was dependent across subjects 
to either time post injury or the GCS, beyond the effects observable 
within each subject.
Results: For both groups we found a significant effect of the two inde-
pendents variables on the Spectral Exponent β: β decreases signifi-
cantly as a function of the time after injury (p<0.005 for both groups) 
and as a function of GCS (p<0.0001 for both groups).
Figure: each coloured dot represents the value of the spectral expo-
nent colour-coded for patients who recovered from coma (acute brain 
injury, Group 1; post anoxic, group 2). Regression lines are represented 
with colour coding for patients. Bold black line represents the mixed 
model effects: slope, F Fischer and p value are reported for the two 
variables of each group.
Conclusion: Together with the traditional clinical evaluation, the 
Spectral Exponent β seems to be a reliable measure for tracking brain 
state transitions leading to the recovery of consciousness after acute 
brain injury. The theoretical background about the genesis of the 
slow rhythms in disorders of consciousness provides a framework 
for the clinical use of the spontaneous EEG in objectively monitoring 
brain states behind clinical signs. The Spectral Exponent may help clini-
cians to identify the underlying brain processes that steer from slow 
rhythms to a recovery of more balanced EEG activity patterns able to 
support consciousness.
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Introduction: The value of serial lactate measurements in patients 
after SAH has not been well studied. The aim of this study was to 
assess the prognostic role of serial lactate measurements on survival 
and neurological outcomes in aneurysmal subarachnoid hemorrhage 
(aSAH) patients.
Methods: We reviewed data of all patients admitted to our Depart-
ment with the diagnosis of aSAH from January 01, 2007 to March 31, 
2019. Arterial blood lactate levels were routinely obtained at least 
once a day. We collected the highest lactate level daily during the first 
5 days. We reported hospital mortality and 3-month unfavorable neu-
rological outcome (UO) defined as a Glasgow Outcome Scale of 1-3.
Results: Of a total of 456 patients, 64% were female, with a median 
age of 54 [46-63] years. Hospital mortality occurred in 158 (35%) 
patients and UO in 209 (46%) patients. The highest lactate level was 
on admission (2.1 [1.2-3.4] mmol/L) and then progressively decreased 
until day 5. Patients with UO had significantly higherlactate levels over 
time than the other patients, in particular on the day of admission (2.9 
[1.9-4.1] vs. 1.5 [0.9-2.6] mmol/L; p<0.01). In a multivariable analysis, 
lactate levels measured on admission were significantly associated 
with UO (OR 1.25 [CI95% 1.0-1.6]; p=0.049).
Conclusion: Initial lactate levels have prognostic implications in SAH 
patients; their value in conjunction with other variables should be 
evaluated in larger cohorts.
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Introduction: Refractory and super-refractory status epilepticus (SE) 
in children are associated with high morbidity and mortality. Refrac-
tory SE (RSE) is defined as persistent seizures that fail to respond to 
antiepileptics and is only controlled with continuous infusions of 
anesthetic solutions, while super-refractory SE (SRSE) persists after 
induction of anaesthetics or leads to rebounds after withdrawal of 
anaesthesia (1,2). Thorough imaging, metabolic, immunological and 
genetic investigations are often necessary to identify the cause.
Objectives: The present study aims to describe characteristics of sta-
tus epilepticus in children and adolescents, focusing on RSE and SRSE.
Methods: This is a retrospective, single-centre study of SE, RSE, and 
SRSE cases treated in the pediatric ICU of the University Hospital of 
Heraklion from 2009 to 2019.
Results: A total of 93 hospitalisations for SE, concerning 86 patients 
(50% females), were included in the study. The median age of the 
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patients at first SE was 5 years (IQR 1.86-9.5). 63 admissions (67.7%) 
were due to RSE and 15 to SRSE (16.1%). Compared to idiopathic SE 
(53,8%), which predominated in the new-onset RSE (NORSE) (p<0.001), 
acute symptomatic (60%) and febrile infection-related Epilepsy Syn-
drome (FIRES) (88.9%) more often evolved to SRSE (p=0.04). The likeli-
hood of abnormal EEG or CT did not differ between SE, RSE, and SRSE, 
while abnormal MRI findings were most commonly observed in the 
group of SRSE (p=0.023). When the initial investigation was incon-
clusive, a definitive diagnosis was reached by genetic testing (7.5%), 
or brain biopsy, followed by viral detection with PCR (7.7%).Higher 
incidence of autoimmune, mitochondrial diseases, and FIRES charac-
terized SRSE compared to SE or RSE (p=0.017). NORSE or FIRES were 
diagnosed in 25% of cases, most commonly presenting as SRSE (53%) 
rather than RSE (24%) or SE (0%) (p<0.001). In RSE/SRSE, immunomod-
ulatory treatments (p=0.05) and ketogenic diet (p=0.005) were more 
frequently used. Also, in RSE/SRSE, weaning off of anaesthetics was 
prolonged (p<0.001), and mechanical ventilation duration and ICU/
hospital length of stay (p<0.001) were increased. Mortality was 3.2% 
and concerned younger patients <5years (p=0.013). The prognosis 
was particularly poor in patients with NORSE or FIRES or with acute 
symptomatic SE and progressive encephalopathy (p<0.001).
Conclusion: A high percentage of pediatric SE episodes evolve to RSE 
or SRSE, which is characterized by a high incidence of FIRES, NORSE, 
autoimmune and mitochondrial diseases. Further research in this area 
is necessary and evidence-based protocols for the management of 
SRSE need to be established.
Reference(s) and grant ackowledgment(s)
1. 1. Vasquez, A., Farias‑Moeller, R. & Tatum, W. Pediatric refractory and super‑
refractory status epilepticus. Seizure 68, 62–71 (2019).
2. 2. Dubey, D., Kalita, J. & Misra, U. K. Status epilepticus: Refractory and super‑
refractory. Neurol. India 65, S12–S17 (2017).
000990 
Delay in treatment and incidence of complications in patients 
with subarachnoid hemorrhague
A. Fuentes  Calatayud1; F. Pino  Sanchez2; F. Villagran  Ramirez2; LF. Guerrero3
1Intensive care, University Hospital Complex of Granada, Granada, Spain; 
2Intensive care unit, Hospital Virgen de las Nieves, Granada, Spain; 3Neuro‑
critical and trauma intensive care unit, University Hospital Complex of Gra‑
nada, Granada, Spain 
Correspondence: A. Fuentes Calatayud
Intensive Care Medicine Experimental 2020, 8(2): 000990
Introduction: Subarachnoid hemorrhage treatment has been 
changed over the last years because of the improvement of Interven-
tionist Radiologist technology, but has it changes the mortality and 
the incidence of complications?
Objectives: To study the differences in complications, mortality and 
hospital stay between the patients admitted in ICU suffering suba-
rachnoid hemorrhage (SAH) before and after the Interventionist Radi-
ologist team 24 h disponibility started.
Methods: We performed a cohorts study including all patients admit-
ted to ICU because of SAH since 1996 until 2019. We divided them into 
two groups (group 1: before; group 2: after the team started), since 
the admission to ICU until hospital discharge. We took sex, age, initial 
symptoms (GSC, H&H, Fisher, WFNS), APACHE II. We studied location 
of aneurysm, type of treatment and delay, hospital length of stay and 
mortality.
Statistical analysis: basic descriptive statistics. Mann-Whitney U test 
and T-student for continuous variables between groups, as appropri-
ate; chi-square for qualitative variables. We considered statistically sig-
nification p < 0.05.
Results: 1233 patients were analyzed, 59.1 % women. 1111 in group 
1 and 122 in group 2. There were not significants differences between 
groups in sex, age (56,2 ± 14,5), APACHE II (13.1 ± 8,6), location of 
aneurysm or initial symptoms (measured by GSC, H&H and WFNS). 
Delay in treatment, either endovascular or surgical, has been sig-
nificantly reduced in group 2 (6,05 ± 9,3 vs 1,34 ± 1,86), as well as 
incidence of rebleeding and brain stroke. It has been shown a trend to 
reduce the incidence of vasospasm. There have been no significantly 
differences in mortality or hospital length of stay.
Conclusion: After the start of a specific program for endovascular 
treatment disponibility, delay on treatment and incidence of compli-
cations have been reduced, even though we have not found differ-
ences in mortality and hospital length of stay yet.
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Introduction: Aneurysmal subarachnoid hemorrhage (ASAH) is a sud-
den and infrequent acute brain injury. Despite fatality rates tending to 
improve in the last years, preventing or minimizing secondary brain 
lesion remains a challenge with significant impact on outcomes.
Objectives: Characterization of the ASAH population and identifica-
tion of clinicaland therapeutic predictors of outcome.
Methods: Retrospective analysis of all adult patients admitted from 
1st January 2018 to 31st December 2019 at a Neurocritical Care Unit of 
an University Hospital in Portugal, who underwent treatment for rup-
tured cerebral aneurysms (endovascular coil embolization or surgical 
clip intervention). The primary outcome was unfavorable functional 
outcome defined by Glasgow Outcome Scale (GOS) of 1, 2 or 3 at 28th 
day, 3rd and 6th month of follow-up.
Results: Sixty-five patients were included, 43 females (66.2%), with 
a median age of 55 (47.5-66.5) years, 35 (53.8%) had pre-ictus hyper-
tension and 19 smoking habits (29.2%). All except two patients had a 
previous Modified Rankin Score (mRS) of 0 or 1. Initial Glasgow Coma 
Score (GCS) inferior to 8 points was observed in 14 (21.5%), Hunt 
and Hess score of 4 or 5 in 25 (38.5%) and Fisher score of 3 or 4 in 58 
(89.2%). Forty-two patients (64.6%) were submitted to surgical clip-
ping and 23 (35.4%) underwent endovascular coiling, with similar clin-
ical severity in both groups. Regarding complications associated with 
ASAH, 42 (64.6%) had Doppler documented vasospasm (66.7% sub-
mitted to intra-arterial infusion of verapamil), 26 (40.0%) developed 
delayed cerebral ischemia, 23 (35.4%) hydrocephalus and 7 (10,8%) 
rebleeding. ICU-mortality was 10,8%. Among the patients with a reg-
istered medical follow-up, mortality was 9.4% (6 of 64) at 28th day, 
14.0% (8 of 57) at 3rd month and 16.7% (8 of 48) at 6th month. Ana-
lyzing the patients with a previous mRS of 0 or 1, an unfavorable GOS 
was observed in 53.2% (33 of 62) at 28th day, in 36.4% (20 of 55) at 3rd 
month and in 26.1% (12 of 46) at 6th month. At 3rd month there was 
a significant difference in patient’s outcome comparing the two thera-
peutic approaches (45.9% vs. 16.7%, p=0,03), favoring endovascular 
coiling, but it was not observed at 28th day and 6th month. In final 
multivariate logistic regression models, adjusted for age, two inde-
pendent predictors of unfavorable functional outcome were identi-
fied at the 3 follow-up periods considered: lower initial GCS (28th day: 
OR 0.49, 95% CI 0.21-0.76; 3rd month: OR 0.76, 95% CI 0.61-0.92; 6th 
month: OR 0.67, 95% CI 0.48-0.94) and development of delayed cer-
ebral ischemia (28th day: OR 14.75, 95% CI 2.28-95.38; 3rd month: OR 
16.08, 95% CI 2.82-91.83; 6th month: OR 91.38, 95% CI 3.26-2564.56); 
hydrocephalus was also a predictor of poor outcome at 28th day (OR 
10.60, 95% CI 1.37-82.11), no other variables persisted in the models 
after adjustment.
Conclusion: ASAH mortality rates remain high. In this non-selec-
tive ASAH location, surgical or endovascular methods had similar 
outcomes at 28th day and 6th month of follow-up. Lower GCS and 
delayed cerebral ischemia are independent predictors of unfavorable 
functional outcome.
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Introduction: On the frontline of the battle against coronavirus dis-
ease 2019 (COVID-19) the importance of identifying symptoms early 
and understanding their clinical relevance is crucial. Up to 36% of 
Covid 19 patients exhibit some form of neurological symptoms, such 
as anosmia and headaches on presentation (1, 2). However, it is not 
known whether patients presenting with neurological symptoms are 
at higher risk of neurological complications in an intensive care unit 
(ICU).
Objectives: This study aims to assess whether critically ill patients pre-
senting with neurological symptoms are at higher risk of subsequent 
neurological sequelae in critically ill patients infected with Covid-19.
Methods: This is a retrospective observational study of PCR posi-
tive Covid-19 patients admitted to ICU in a single tertiary hospital. 
Anosmia and headache were considered neurological symptoms at 
presentation (3). Neurological complications, including stroke and 
intracranial bleeding, were diagnosed using a combination of clini-
cal evidence and consultant level neuroradiology review of computer 
tomography (CT) imaging (4). Chi-square statistic with risk estimation 
was used to assess association between categorical variables. P values 
lower than 0.05 were considered significant.
Results: 132 patients were included in the study. 14 (10.6%) presented 
with headache and 11 (8.3%) with anosmia. In terms of complica-
tions, 21(15.9%) had a intracranial haemorrhage, and 3 (2.3%) also had 
a stroke. Among 21 patients who had neurological complications in 
ICU, 3 patients presented with headache (21.4%) and 2 patients had 
anosmia on presentation (18.2%). These associations are neither sig-
nificant for headache (p = 0.55, OR 1.5, 95% CI 0.4, 6.0) nor for anosmia 
(p= 0.83).
Conclusion: Anosmia or headache at presentation is not associated 
with higher incidence of neurological complications in critically ill 
patients infected with Covid-19.
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Introduction: The determinants of decisions to limit life support 
(withholding or withdrawal) in ventilated stroke patients have been 
poorly investigated.
Objectives: We sought to describe the incidence, timing, and fac-
tors associated with life support limitation in critically ill patients, 
with either ischemic or hemorrhagic stroke, requiring mechanical 
ventilation.
Methods: In a prospective multicenter observational cohort (2005-
2016), we evaluated limitation of life support in ventilated stroke 
patients and in a non-brain-injured population and identified factors 
associated with this limitation using Fine and Gray competing risk 
models.
Results: We identified 373 stroke patients (ischemic, n=167 (45%); 
hemorrhagic, n=206 (55%)), and 5683 non-brain-injured patients. 
Decisions to limit life support were taken in 41% of ischemic stroke 
cases (vs. non-brain-injured patients, sHR 3.59 [95% CI 2.78-4.65]) and 
in 33% of hemorrhagic stroke cases (vs. non-brain-injured patients, 
sHR 3.9 [95% CI 2.97-5.11]). Time from ICU admission to the first limita-
tion was longer in ischemic than in hemorrhagic stroke (5 [3 - 9] vs 2 [1 
- 6] days, p<0.01). Limitation of life support preceded ICU death in 70% 
of ischemic strokes and 45% of hemorrhagic strokes (p<0.01). Life sup-
port limitation in ischemic stroke was associated with a vertebrobasi-
lar location (vs. anterior circulation, sHR, 1.61 [95% CI 1.01 - 2.59]) and 
in hemorrhagic stroke, it was associated with an age>70 years (2.29 
[1.43 - 3.69]), a Glasgow score<8 (2.15 [1.08 - 4.3]) and a lower non-
neurologic admission SOFA score (per point, 0.89 [0.82 - 0.97]).
Conclusion: In ventilated stroke patients, decisions to limit life sup-
port are more than 3 times more frequent than in non-brain injured 
patients, with different timing and associated risk factors between 
ischemic and hemorrhagic strokes.
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Introduction: Pharmacological thromboprophylaxis (PT) may be 
effective in reducing the incidence of DVT following TBI (Carney et al., 
2017). However, there is a reluctance to commence it due to concerns 
about the risk of intracranial haematoma (ICH) expansion and contu-
sion enlargement (Geerts et al., 1996). PT is therefore often delayed, 
exposing patients to potential risks and complications of DVT. Appro-
priate timing to start pharmacological thromboprophylaxis (PTP) in TBI 
patients is unclear. Our aim is to conduct a systematic review to assess 
the safety of PTP administration before and after 72 hours.
Objectives: 1 -To produce an updated systematic review on the safety 
and efficacy of early verses late PTP in TBI.
2-To explore the feasibility of a rapid low-cost systematic review pro-
cess, “systemic review lite” used to direct future research efforts.
Methods: This project was undertaken by medical students over 
a 10-week student selected module. PubMed and Embase were 
searched for cohort studies or randomised control trials compar-
ing early versus late administration of PTP in TBI patients. “Early” was 
defined as < 72 hours and “late” as ≥ 72 hours. Primary outcomes 
were defined as VTE diagnosis and ICH progression.
In the first filter studies were excluded if full text or English transla-
tion were not available. Non-human studies and studies on neonates 
and children were excluded. Authors were not contacted for missing 
data and individual references were not individually hand searched 
and cross checked for relevant publications. In the second filter full 
text articles were assessed and excluded if they included alternat 
time frames or lacked appropriate comparators. Data was extracted 
to Review manager 5.3 (Cochrane Collaboration 2014). Quality was 
assessed by 2 independent reviewers using the Newcastle-Ottawa 
Scale.
Results: After the second pass filter full text articles were reduced to 
10 after alternate time frames and lack of appropriate comparators 
were considered.
Meta-analysis revealed no statistically significant difference in either 
VTE diagnosis (Odds ratio 0.74 [95% CI 0.52, 1.05]) or ICH progression 
(Odds ratio 0.85 [95% CI 0.38, 1.89]) for early verses late PTP. Subgroup 
analysis of high-quality studies demonstrated a decrease in VTE diag-
nosis with early PTP (Odds ratio 0.63 [95% CI 0.42, 0.95] p=0.03). In 
studies of severely injured patients (GCS<=8 or AIS>=3), early PTP 
was associated with a decrease in VTE incidence (Odds ratio 0.53 [95% 
CI 0.39, 0.71] p=<0.0001. Mortality risk showed no difference between 
early and late groups.
Conclusion: This review suggests that early PTP can reduce the risk of 
VTE. However, possible the confounding effect of only administering 
early PTP to patients with stable brain injuries cannot be discounted.
This systemic review lite format proved to be feasible, the student 
group delivering clear results in a short time frame that serves as a 
useful update to previous reviews (Chelladurai et al., 2013; Jamjoom 
and Jamjoom, 2013).
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Introduction: Patients with traumatic brain injury (TBI) may pre-
sent with several clotting abnormalities, both pro and anticoagulant, 
involving complex mechanisms such as the acute traumatic coagu-
lopathy (ATC) and delayed coagulopathy secondary to hemodilution 
(Brohi et al., 2003; Maegele et al., 2017).
Viscoelastic testing of coagulation allows near patient assessment of 
coagulation profiles. However, there is a paucity of data specifically in 
patients with traumatic brain injury.
Methods: TARDIS is a prospective, multi centre, observational pilot 
study to investigate the incidence of deep venous thrombosis (DVT) 
after TBI, using compression ultrasound. Patients admitted to an inten-
sive care unit within 72 hours of injury are eligible. As an additional sub 
study, viscoelastic testing performed using ether rotational thromboe-
lastometry (ROTEM) or thromboelastography (TEG) as per the manu-
facturers’ instructions. These results were compared with conventional 
laboratory coagulation testing from the same day.
Data is described as mean (standard error of the mean) and median 
(interquartile range). Proportions were analysed by Chi square, p<0.05 
being considered significant.
Results: 21 patients with moderate to severe TBI (mean GCS 6.2 SEM 
0.6) had ROTEM INTEM (n=8) or TEG (n=13) data available. The mean 
age was 52.9 years (SEM 4.8). The majority were male (N=16, 76%). 
Marshal scores were 1, n= 1 (4.8%), 2, n=9 (42.9%), 3, n=1 (4.8%), 4, 
n=4 (19.1%), 5, n=5 (23.8%) and 6, n=1 (4.8%). Three (14.3%) patients 
were taking anticoagulant medication prior to injury. Two (9.5%) 
received coagulation factors and 8 (38.1%) were given Tranexamic 
acid.
The mean activated partial thromboplastin time was 31.8 seconds 
(SEM 1.1), within our normal laboratory range (26 - 36 seconds). 
Median prothrombin time (PT) was slightly prolonged at 14.8 seconds 
(IQR 14.0 – 16.1) compared with the laboratory range (10.5 - 13.5 sec-
onds). Similarly, the fibrinogen concentration was slightly increased at 
4.6 g/l (SEM 0.3) compared to the reference range (1.5-4.0 g/l).
We found evidence of abnormal viscoelastic parameters in 7 or 21 
patients. Three (14.3%) had a Clotting Time/R prolonged and 6 (29.0%) 
had a prolonged clot formation time/K. Alpha angle was reduced in 4 
(19.1%) and maximum clot firmness/maximum amplitude reduced in 
3 (14.3%). None of the patients with ROTEM/TEG abnormalities where 
taking anticoagulants prior to injury. Two had been given Tranexamic 
acid and 2 coagulation factors. Comparing laboratory PT with viscoe-
lastic parameters significantly more patients had a PT greater than 
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reference range than had an abnormal ROTEM or TEG profile, 18 
(86.0%) versus 7 (33.3%) p=0.002.
Conclusion: Within 72 hours of TBI we found evidence of impairment 
of coagulation in conventional and a near patient viscoelastic tests 
of coagulation function. This abnormality was significantly more fre-
quent in the PT than ROTEM/TEG profiles.
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Introduction: Electrolyte disturbances, such as dysnatremia, hypoka-
lemia and hypomagnesemia, are frequently observed during the acute 
period after spontaneous subarachnoid hemorrhage (sSAH). However, 
the data concerning hypophosphatemia after sSAH are scarce.
Objectives: To analyze the frequency of phosphate disturbance in 
sSAH patients (pts), daily phosphate repletion and to acess the influ-
ence on the outcomes comparing with pts with no sSAH.
Methods: All pts with sSAH admitted from January 2017 to December 
2018 in the Neurocritical Care Unit were enrolled in our cohort. Control 
group includes critically ill non-neurologic pts admitted in a general 
ICU in the same ICU Department. Serum phosphate levels and daily 
phosphate repletion were collected on the first 10 days after admis-
sion. The primary endpoint was neurologic outcome, using Glasgow 
Outcome Scale at 6 months (GOS-6M) and Glasgow Coma Scale at 
ICU discharge (GCS-ICUd). Outcomes analysis were made using mean 
phosphate level during the first 10 days. We performed multiple linear 
regression, adjusted for age, GCS at admission, APACHE II, phosphate 
repletion (and Hunt-Hess and Modified Fisher scale for sSAH group) 
to assess the effect of phosphatemia in outcomes. Analysis were per-
formed with SPSS® software v22.
Results:
83 pts with sSAH and 92 controls, with mean age of 56±12.1 and 
64±13.1 years, respectively. Pts with sSAH had increased odds of hav-
ing hypophosphatemia at admission as compared with controls (OR 
3.2, 95% CI 1.1-8.9, p=0.029) and none presented with hyperphos-
phatemia. Mean phosphate level was lower in sSAH patients com-
pared to controls (3.1±0.4 vs 3.9±1.3, p<0.001) as well as daily levels. 
Hypophosphatemia was more frequent in sSAH pts, mostly in the first 
4 days (figure 1) and 52 pts (63%) had at least one day with hypophos-
phatemia (35 in control group, p<0.002). Median phosphate dose 
repletion was higher in sSAH pts [696 (1045) vs 100 (284), p<0.001].
In sSAH pts, phosphate level and phosphate repletion (table 1) were 
independently associated with GCS-ICUd  (R2 58%,  R2 adj 54%); pts 
with hypophosphatemia at admission had lower GCS-ICUd compared 
with pts with normophosphatemia (12.1±3.4 vs 14.1±2.4, p=0.005). 
sSAH pts with lower GOS-6M had hypophosphatemia at admission 
and those who died had lower mean phosphate level (2.8±0.8 vs 
3.1±0.4).
In multivariable analysis, phosphate repletion was significantly associ-
ated (β 0.21, 95% CI 0.000-0.001) with GOS-6M  (R2 52%,  R2 adj 47%), 
but not mean phosphate level (table 1). In control group, lower mean 
phosphate level was associated with higher GOS-6M  (R2 27%,  R2 adj 
22%) and higher GCS-ICUd  (R2 25%,  R2 adj  21%); there was not an 
association between phosphate repletion and outcomes (Table 2).
Conclusion: Pts with sSAH had lower mean phosphate levels and 
required a significantly higher daily phosphate replacement to 
achieve normal values, compared with non-neurologic critically ill pts. 
sSAH pts need cautious phosphate repletion, as hypophosphatemia 
may be associated with poor neurologic outcomes. Further studies are 
warranted to better understand the role of phosphorus in the patho-
physiology of sSAH, namely regarding brain metabolism, kidney-brain 
links and outcomes.
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Introduction: In developed countries, ischemic stroke is one of the 
leading causes of disability and the second leading cause of death, 
85% of them being of cardioembolic or atherothrombotic origin. In 
recent years, endovascular treatment in this type of patient has shown 
superiority over systemic fibrinolysis.
Objectives: The objective of this study is to analyze the results and 
associated complications after endovascular treatment in patients 
with acute ischemic stroke admitted to our Reanimation Unit.
Methods: An observational retrospective study was carried out. 
All patients with acute ischemic stroke undergoing mechanical 
thrombectomy who were admitted to the Reanimation Unit in Febru-
ary 2015 and December 2018 were included. The following variables 
were selected as study variables: demographic (age and sex), clinics 
(NIHSS at admission, cardiovascular risk), type of anesthesia performed 
(general or sedation), neurological complications during your stay, and 
infectious complications (respiratory and urinary). Statistical analysis 
was performed using the SPSS 25.0 program. Continuous variables 
were described using the mean. Categorical variables are described by 
absolute and relative frequencies.
Results: A total of 224 patients were collected. 90% of the patients 
who underwent endovascular treatment remained admitted to the 
Reanimation Unit. The mean age was 69.3%. 43.3% were men and 
56.7% women. Cardiovascular risk factors: Hypertension described 
in 73%, diabetes mellitus 32%, dyslipidemia 45%, personal history of 
ischemic heart disease 13.6%, intermittent claudication 5.7%, tobacco 
use 19%, history of SAHS 5%. 27.4% consumed oral anticoagulants and 
28.1% had AF among their antecedents, de novo arrhythmia was diag-
nosed in the emergency room in 11%. In 91% of the cases described, 
there was no previous stroke. Stroke mechanism: cardioembolic 71%, 
atherothrombotic 22.8%, undetermined origin 22.3%, infrequent 
6.7%. In 36% of cases, the artery predominantly affected was the mid-
dle cerebral artery in segment M1. The least frequently affected artery 
is the vertebral artery, with 2.3% of cases. The median time from clini-
cal presentation to the start of endovascular treatment was 160 min-
utes. Neurological assessment was performed using the NIHSS scale: 
on arrival at the Emergency Department, the mean was 17 points, with 
no variations after the procedure. After 24 hours it is at 8 points. The 
mean at discharge was 9 points. The type of anesthesia performed was 
general in 96% while sedoanalgesia was performed in 4%. VTE was 
indicated for failure of fibrinolysis with IVr-t-PA in 8 patients (13.3%). 
Infectious complications: 38% of patients develop urinary tract infec-
tion; in 43% respiratory infections (pneumonia associated with 
mechanical ventilation, nosocomial pneumonia, tracheobronchitis). 
Percutaneous tracheostomy was required in 13%. The average stay in 
our unit is 3 days.
Conclusion: Ischemic stroke is a medical emergency that requires 
urgent intensive treatment and strict postoperative control. Bladder 
catheterization or orotracheal intubation prior to the procedure can 
be risk factors for the development of serious infections that can com-
promise the patient’s life. Performing sedoanalgesia as an anesthetic 
procedure can be useful in minimizing these risks, reducing hospital 
stay, reducing costs and improving the patient’s prognosis.
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Introduction: Both acute myocardial infarction (AMI) and atrial fibril-
lation (AF) are risks for stroke. The risk of stroke after AMI may be 
different in patients with or without AF. The aim of this study was to 
evaluate the impact of AF on stroke in patients after first AMI.
Methods: SettingRetrospective nationwide cohortstudy.
ParticipantsA total of 170,472 patients who had the primary diag-
nosis of first AMI between 2000 and 2012. Among them, 8,530 with 
AF was identified. Propensity score matching technique was used to 
match 8,530 patients without AF with similar ages and genders.
Primary and secondary outcome measuresAll patients were fol-
lowed until stroke or 31 December 2012, whichever occurred first.
Kaplan–Meier cumulative survival curves were constructed to com-
pare stroke between AMI patients with and without AF.
Results: Overall, 12-year stroke rate was higher in patients with AF 
than without AF (log rank P-value < 0.001), including in different gen-
ders, agesor intervention subgroups. In patients with AF,those with-
preexisted AF have higherstroke rates in male gender, agebelow65 
years, and with interventionsubgroups thanthose with new-onset AF. 
In cox proportional-hazard regression analysis, AF was an independ-
ent risk factor for stroke after first AMI (hazard ratio, 1.67; 95% confi-
dence interval, 1.5-1.87).
Conclusion: AF significantly increased stroke risks after first AMI.In 
patients with AF, those with preexisting AF have higher stroke risks in 
male genders, ages below 65 years, and with interventions than those 
with new-onset AF.
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Introduction: Ischemic stroke can occur in 20-55% of patients with 
infective endocarditis (IE) with 75% occurring during the first 2 weeks 
of treatment. CT or MRI brain can diagnose the sequelae of stroke but 
transcranial Doppler (TCD) can document active embolization. We 
undertook a retrospective review of our patient cohort and a system-
atic review of literature to assess the role of TCD in early diagnosis and 
management of ischemic stroke in IE.
Methods: Retrospective chart review and literature review.
Results: We found 89 patients with stroke caused by IE at our institu-
tion from December 2011 to April 2018. TCDs were obtained on 26 
patients; 16 were abnormal for cerebrovascular abnormalities. Only 4 
patients had 30-minute emboli monitoring performed, of which one 
revealed emboli. We found 3 studies investigating the role of TCDs 
in IE that showed promise in its use as a predictive tool in stroke risk 
stratification.
Conclusion: Presence of embolization in the form of high intensity 
transient signals (HITS) detected on TCDs can be used for early diag-
nosis of IE, assessing efficacy of antibiotic therapy, and stratification of 
stroke risk in IE. This can aid further research into testing preventative 
interventions for reducing stroke burden in IE, such as earlier valvular 
surgery or vacuum-assisted vegetation extraction.
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Introduction: Neurocritical care is a subspecialty of critical care medi-
cine that focusses on the evaluation, diagnosis, and management of 
patients with acute life-threatening central nervous system diseases.
(1,2) Because of their complexity, neurocritical patients needs specific 
continuous monitorization, to allow their recovery.
Objectives: 1. Characterize neurocritical Intensive Care Unit (ICU) 
patients admitted in 2019 and to correlate neurocritical care variables 
with Glasgow outcome Scale at ICU discharge  and 6 months after 
discharge.
2. Finding the most significative variables in order to build a model 
that best predict outcome.
Methods:
An observational retrospective study included 105 neurocritical 
patients in our intensive care unit (ICU) during the year of 2019. Col-
lected variables included age, gender, diagnoses, severity scores 
(APACHE, SAPS, initial SOFA), in local Glasgow coma score (GCS), hos-
pital admission GCS, Marshall, Hunt & Hess scale, Fisher scale, National 
institute of Health stroke scale (NIHSS), intracranial pressure (ICP) at 
ICU admission, time with ICP>24 in the first 72h after ICU admission, 
mean ICP during ICU stay, doppler variables in the first 24h of ICU stay 
(middle cerebral artery (MCA) blood velocity and pulsatility index) and 
Glasgow Outcome Scale (GOS) at ICU discharge and 6 months after 
discharge.We included also the time (minutes) between local to emer-
gency departement (ED) admission and time between ED and ICU.
We performed a Multiple Regression Analysis using Akaike´s Informa-
tion Criterion (AIC) to identify the most relevant variables that best 
explain outcome.
Results: One hundred and five neurocritical patients were included: 
traumatic brain injury (TBI) (61), aneurism (31) of which 27 had suba-
rachnoid haemorrage, stroke (11) and arteriovenous malformation (2).
In patients with TBI 84,8 % were male, mean age of 45,7 years, 80,4 % 
present moderate to severe TBI, 68,4% present Marshall scores of 3 
and above. 52% with inital sofa score of 7 and above.
In patients with aneurism, 72,4 were female, mean age of 57,8 years, 
mean hospital admision GCS of 10, 42% hunt&hess of 2 and above, 47 
% with initial sofa score of 7 and above.
The best model for predicting GOS at ICU discharge included 5 vari-
ables: Sex, Age, initial SOFA Score (at admission), admition GCS, and 
Time between ED and ICU:
-Associated with best outcome : male sex, younger age, higher admi-
tion GCS, more Time ED-ICU.
-Associated with worse outcome :female sex, older age, lower admi-
tion GCS, high SOFA score.
The adjusted R 2 for this model was 40 % (accounts for 40% of varia-
tion in outcome)with a p- value < 1.6 x 10^9.
Conclusion: It was not surprise for us that high admition GCS and 
younger age were associated with best outcome. However we were 
not expected that more time between ED-ICU leads to better out-
come. The male sex appears to preform better than female sex. Those 
facts will be a good discussion points.
The focus of this work was characterization of our neurocritical care 
population. The identification of a new predictive model presents an 
interesting hypothesis for future validation.
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Introduction: Reductions in heart rate variability (HRV) are associ-
ated with poor outcomes in patients with severe acute brain injury. 
However, it is unknown if the changes in HRV precede neurological 
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deterioration in such patients, as an early indicator of brain-heart net-
work dysfunction.
Objectives: We examined the changes in HRV measured by electro-
cardiography (ECG) in patients who experienced neurological dete-
rioration after severe acute brain injuries, and analyzed the correlation 
between HRV and the qualitative and quantitative variables of electro-
encephalography (EEG).
Methods: Thirteen EEG channels and one channel of simultaneously-
acquired ECG were segmented in 120 s epochs and used to calculate 
ten HRV features (standard deviation of the normal-normal intervals, 
root mean square of the difference in successive intervals, very low 
frequency power, low frequency power, high frequency power, low 
frequency/high frequency power ratio, SD along the transverse axis of 
the Poincaré plot [SD1], SD along the longitudinal axis of the Poincaré 
plot [SD2], SD2/SD1 ratio, and approximate entropy) and three quan-
titative EEG features (suppression ratio, asymmetry index, and alpha/
delta band power ratio). Raw EEGs of epochs were also reviewed using 
standardized terminology and graded according to its background 
activities and ictal-interictal continuum patterns.
Results: The neurophysiological features of 25 patients with severe 
acute brain injury due to various causes were analyzed. The HRV 
and EEG features showed progressive and significant changes in the 
48-hour period prior to neurological deterioration. Notably, the sup-
pression ratio and background severity grade of the EEG showed sig-
nificantly negative correlations with all HRV features.
Conclusion: Integration of HRV monitoring with continuous EEG 
monitoring may enable timely identification of progressive secondary 
brain injury before the development of irreversible injury.
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Introduction: Increased intracranial pressure (ICP) is one of the major 
clinical complications of acute brain injuries (ABIs) and correlates 
with poor outcome. ICP monitoring (ICPm) is the most common neu-
romonitoring modality used in intensive care units (ICUs). However, no 
evidence-based recommendations on ICP management are present in 
the current literature. Practice about indications of ICPm is variable in 
high- (HICs) and in low-middle-income countries (LMICs), where data 
is scarce or inconsistent.
Objectives: Aim is to quantify practice variations in ICPm in HICs and 
LMICs and in TBI and non-TBI patients.
Methods: The SYNAPSE-ICU is a prospective, observational, inter-
national cohort study (NCT03257904) focused on describe the 
current practice of ICPm using a worldwide sample. Centre Data 
Characteristics Form has been submitted to each center enrolled in 
the study to assess the standard intensive care practice in ABI patients. 
Information about the institution and ICP monitoring and manage-
ment were indicated.
Results: Worldwide, 156 sites distributed in 41 countries participated 
in the study. The Center Form was completed by 97.4% of sites. Based 
on World Bank List of Economies Classification (2019-2020), 110 
(72.4%) of centers were localized in HICs and 42 (27.6%) in LMICs. Over 
two thirds of the centers have an academic affiliation (69.7%). A spe-
cialist neurocritical ICU was available in 31.6% of centers, whereas in 
the majority of them (68.4%) ABI patientswere admitted to other ICUs 
(mixed, surgical, medical). In 99.3% of sites patients were monitored 
24/7 by medical staff, and the most represented nurse:patient ratio 
was 1:2 (54.0%).
Overall, 72.4% of centers routinely used ICPm in TBI patients, and 
approximately half of them routinely monitored ICP in SAH and ICH. A 
protocol/policy for ICP treatment in TBI, SAH and ICH was available in 
63.8%, 49.3% and 48.0% of centers, respectively.
Regarding the availability of neuromonitoring devices, 95.4% of ICUs 
declared to have an intracranial catheter to monitor ICP. At least one 
additional non-invasive neuromonitoring technique (transcranial 
doppler, optic nerve sheath diameter ultrasound, EEG, pupillometry 
and NIRS) was available in most of centers both in HICs (91.8%) and 
in LMICs (90.5%), whereas an additional invasive neuromonitoring 
device (brain tissue oxygen and temperature, cerebral microdialysis, 
regional cerebral blood flow, deep/cortical EEG electrodes) was usable 
in 49.1% of HIC and in 26.2% of LMIC centers.
Neuroimaging modality most frequently used was CT scan (98.6% of 
ICUs), while an advanced technique (MRI, CT angiography, CT perfu-
sion, and PET) was available in 59.3% of centers.
Conclusion: A great center variability in ICPm of ABI patients was 
observed worldwide. The results stress the need of evidence-based 
recommendations regarding ICPm, in particular in LMICs, where 
resource limitation may preclude ICPm utilization.
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Introduction: Does near-infrared spectroscopy (NIRS) is a reliable 
index of brain oxygenation? NIRS is generally used as a non-invasive 
tool to assess regional cerebral oxygen saturation (rSO2) to prevent 
ischemic brain damage. Albeit its use is widespread in the neurocriti-
cal care field[1], its real role in accurately detect ischemic insults and 
low cerebral flow is still a matter of debate mainly because of a lack of 
information on the NIRS algorithm utilized by each manufacturer and 
the low-resolution depth of the elliptical path of the optical spectro-
photometry [2–4,6].
Objectives: Our purpose is to detect the cerebral oxygen saturation of 
the forehead in a clinical model of a diffuse ischemic brain injury, such 
as brain-dead patients.
Methods: We retrospectively analyzed adult neurocritical care 
patients who evolved into brain death between January 2019 and 
March 2020. NIRS was sampled with the O3™ (Masimo, Irvine, CA) 
and SensmartTM X-100 (Nonin Medical, Inc., Plymouth, Minnesota, 
US) system for the total duration of 20 minutes after the patient had 
been declared brain dead, according to the Italian national criteria/
guidelines.
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Results: A total of 40 brain dead patients were studied (median age 72 
IQR[55-79], 35% intracranial hemorrhage, 35% traumatic brain injury, 
15% ischemic stroke, 7% hypoxic brain injury post-cardiac arrest, 3% 
subarachnoid hemorrhage from brain aneurysm rupture, 5% others). 
Among them, despite the presence of clinical, neurophysiological 
and neuroradiological criteria of brain death (assessed with brainstem 
reflexes, electroencephalography, and CT angiography), we recorded 
a median rSO2 value of 72% (IQR [63-75]). The 90% of the total series 
(36/40) have experienced a normal rSO2 values (i.e., rSO2 >50%) and 
only 10 % (4 patients) showed rSO2 values below 50%, among whom 
two patients presented concomitant severe cardiac dysfunction. A 
left-sided decompressive craniectomy was performed in two patients, 
in which we observed the left rSO2 value much higher than contralat-
eral (i.e., both with delta rSO2>20). Moreover linear correlation was 
found between rSO2 and SaO2 (r = - 0,393; p<0,02).
Conclusion: In the experimental model of global brain ischemia such 
as brain death, the current NIRS technology does not mirror the real 
state of the brain oxygenation; indeed a normal rSO2 values were 
found in our analysis (72%, IQR[63-75]) These data sustain the low 
sensitivity of the NIRS monitoring in measure faithfully the correct oxy-
genation status beyond the forehead[5, 6]. More studies are needed 
to better understand the limits and reliability of NIRS algorithms in 
detecting brain ischemia.
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Introduction: Echography is becoming a diffuse, economic and non-
invasive tool used in general ICU (Intensive care unit) while is less uti-
lized for exploring the brain, protected by the skull. However, it could 
have multiple applications in the study of cerebral vessels anatomy 
and from its important role in the diagnosis of acute intracranial 
pathologies (1). Skills to be acquired have been recently described in 
a Consensus (2). No information about the utility of practical training 
are available.
Objectives: The aim of this project is to evaluate the improvement 
in the use of ultrasonography and TCCD (transcranial colour-coded 
duplex) diagnostic methods after a dedicated training course.
Methods: In December 2019, 31 participants (3 intensivists and 28 
residents) naïve to the technique attended for two days the SONIC 
(Sonography in Neuro-Intensive Care) theoretical-practical course at 
University of Piemonte Orientale. Specialists in this field described the 
use of ultrasonography and TCCD in a large spectrum of clinical con-
ditions, followed by practical hands-on sessions on volunteers and in 
ICU.
Before and after the training, all participants answered to a 51 multi-
ple-choice online questionnaire and were required to evaluate a set of 
brain echographic images. A paired t-test was applied to evaluate the 
improvement.
Results: The median score obtained in the multiple-choice ques-
tion was respectively 27 (pre) and 36 (post).
The paired t-test applied, showed a significant difference between 
the mean performance scores pre and post training course (p <0.001). 
The mean difference, between pre and post scores, was equal to 10.19 
points (95% confidence interval = 7.95-12.43).
The median score obtained in the images’ evaluation was 4 (maximum 
score of 5).
Conclusion: The analysis conducted on the scores obtained before 
and after the theoretical-practical course showed how useful could 
be a targeted approach to the correct use of TCD ultrasonography 
improving personal skills about it.
According to the Consensus (2) we could consider an upgrade of the 
participants’ level to basic-plus/pre-advance.
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Introduction: Optimal management and monitoring of traumatic 
brain injury (TBI) remains uncertain. Intracranial pressure (ICP) moni-
toring lacks high quality evidence and does not prevent cerebral 
hypoxia (Stiefel et al., 2006; Carney et al., 2017) . Robust evidence for 
the use of brain oxygen tension (PbtO2) monitoring is also lacking, 
but preliminary work is promising and suggests it may improve out-
comes. In a prior study, we found that early PbtO2 improvement, or 
low hypoxic load over the first 24 hours, were associated with ICU sur-
vival (Rhodes, Chandrasekaran and Andrews, 2016).
Objectives: In a second independent cohort of patients with moder-
ate to severe TBI, to validate the observation that exceedingly early 
changes in PbtO2 are associated with ICU survival.
Methods: A retrospective analysis was performed on prospectively 
collected data from a cohort of 60 TBI patients at a single centre focus-
ing on the first 24 hours of monitoring. Minute-to-minute ICP, cerebral 
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perfusion pressure (CPP) and PbtO2 values were recorded via an inva-
sive cerebral monitor on to a bedside laptop running ICU pilot soft-
ware (CMA, Sweden). The relationship of PbtO2 vs. time was described 
as a Spearman correlation coefficient for each patient. The percentage 
of time that PbtO2 was <20mmHg was calculated. Demographic and 
baseline characteristics were collected. The primary outcome was ICU 
survival.
Comparisons were made using paired or unpaired T tests and Wil-
coxon signed rank test or Mann-Whitney U test. ICU survival was ana-
lysed using logistic regression.
Results: Demographics were well matched, except age, which was 
significantly higher in non-survivors (43 years [IQR 26.3 – 555.0] vs. 
60 years [IQR 49.3 – 72.8] p=0.01). Survivors demonstrated significant 
increases in PbtO2 over the first 24 hours, (18.9mmHg [IRQ 12.8 to 
23.1] vs. 25.6mmHg [21.6 to 30.6], p<0.001, which was not seen in non-
survivors (16.3 mmHg [IRQ 8.5 to 32.3] vs. 18.3 mmHg [16.9 to 21.8], 
p=0.898. Survivors experienced a significantly higher PbtO2 over 24 
hours than non-survivors (25.3mmHg [22.1 to 26.4] vs. 18.4mmHg 
[17.3 to 20], p<0.001). Age (odds ratio 0.95, [ 95% CI 0.90 to 1.00] 
p=0.032), the correlation coefficient between PbtO2 and time (odds 
ratio 5.24 [95% CI 1.02 to 26.96] p=0.047) and percentage hypoxia in 
the first 24 hours (odds ratio 0.98 [95% CI 0.96 to 1.00] p=0.033 were 
significantly associated with ICU survival. When the data from this 
cohort were combined with the original cohort (n=25), these findings 
were preserved.
Conclusion: In patients with moderate to severe TBI undergoing inva-
sive multimodality monitoring, data from PbtO2 monitoring as early as 
the first 24 hours of monitoring is associated with survival. An improv-
ing PbtO2 with time and low cumulative hypoxia were significantly 
associated with ICU outcome. The findings of the original observa-
tional study are upheld. What remains unclear is if this association with 
survival occurs spontaneously or is the result of goal directed therapy.
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Introduction: Fewstudies report the relation between functional 
brain alterations during and after ICU stay and abnormalities of CBF 
displayed on TCD. Using VTI as hemodynamic parameter is unusual for 
evaluation of CBF(1).
Objectives:
The purpose of this preliminary study is to compare the values of VTI 
of healthy Controls (C) versus ICU (P) with usual parameters (i,e systolic 
(Vs), diastolic (Vd) and mean velocities (Vm), resistance (RI) and pulsa-
tility (PI) indexes.(2).
Methods: 50 C and 160 P were consecutively included during a 6 
months period (August 2019 to May 2020). Velocities and VTIMCA 
were sampled using TCD at the middle cerebral artery (MCA, M1 
segment). Left ventricular outflow (VTIAo) was assessed by transtho-
racic echocardiography.
Demographic data, reasons for admission in ICU, SAPS, sedative, vaso-
pressor use and ventilator support were recorded as well MAP, Vs, Vd, 
Vm, PI, RI.
Data are shown as medians (interquartile:25-75).Ttest or non-paramet-
ric test (if appropriate) were use. P<0,05 was considered as significant.
Results: Sex ratio(M/F): 2,5 in P with SAPS II: 57 (41-69) and 1 in C. Age: 
58 years (51-69) in P vs 40 years (30-52) in C.
Reasons for admission were sepsis: 71 (47 septic shocks), cardiac 
arrests: 19 cardiogenic shocks: 11, neurologic disorders: 12, others: 27.
210 measurements were realized respectively under: mechanical ven-
tilation: 183, vasopressor support: 101 and sedative drugs: 116.Table1 
shows relevant data.
  C (n=50) P (n=160) p 
MAP mmHg 95,00 (89,00-98,00) 80,00 (73,00-92,00) <0,001 
VTIAo cm 21,50 (19,50-30,00) 18,00 (15,00-21,50) <0,001 
VTIMCA cm 51,75 (44,00-58) 34,80 (26,40-42,00) <0,001 
Vd cm/s 40,30, (35,38-46,20) 32,06 (23,52-44,00) <0,015 
Vm cm/s 58,50 (54,70-66,15) 52,00 (40,65-65,90) <0,007 
RI 0,55 (0,50-0,59) 0,63 (0,52-0,69) <0,001 
PI 0,86 (0,73-1,01) 1,09 (0,84-1,30) <0,001 
VTIMCA/VTIAo 2,52 (2,15-3,09) 1,90 (1,43-2,44) <0,001 
HF*VTIMCA/BSA 1876 (1712-2219) 1542 (1229.9-2044.4) <0,001 
HF*VTIAo/BSA 759 (682-919) 817 (639-1016) NS 
HF= Heart Frequency. BSA=Body Surface Area 
There was a weak correlation between VTIMCA and VTIAo in P (not 
found in C).
However, VTIMCA and VTIAo were markedly dependent when 
VTIAMCA/ VTIAo ratio was <1,5 in P with marked PI and Vd abnormali-
ties. (Spearman, r=0,82, p<0,001).
This ratio highlighted the coupling between VTIMCA and VTIAo. Low 
VTIAo correlated to low VTIMCA. P with vasopressors had higher 
VTIAMCA/ VTIAo ratio.
In addition, VTIMCA<35cm was more accurate than PI>1.3 and 
VD<25cm/s for the detection of abnormal neuropsychological behav-
ior (respectively AUC: 0.81; 0.541;0.345)
Conclusion: CBF could be estimate using VTIMCA and a hemody-
namic index as HF*VTIMCA/BSA. The VTIMCA/ VTIAo ratio could be a 
tool to detect coupling. Low VTIMCA should do assess a VTIAo meas-
urement. Further studies are needed to evaluate the clinical perti-
nence of the TCD in general ICUs.
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Introduction: Electroencephalography (EEG) is one of the most 
used non-invasive monitoring methods in critically ill patients. How-
ever, EEG interpretation requires the presence of an experienced 
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neurophysiologist and is time-consuming. The aim of this study was 
to evaluate whether automated pupillometer (AP)-derived variables 
might help to assess the degree of cerebral dysfunction in critically ill 
patients.
Methods: Prospective study conducted in the Department of Inten-
sive Care of Hôpital Erasme in Brussels. Pupillary assessments were 
done using the AP in three subgroups of patients concomitantly 
monitored with continuous EEG: 1) Post-anoxic brain injury; 2) Pri-
mary brain injury; 3) Others (i.e. sepsis, liver failure …). An independ-
ent neurologist blinded to patient’s history and AP results scored the 
degree of encephalopathy and reactivity on EEG using a standardized 
scale. The mean value of Neurologic Pupil Index (NPi), pupillary size, 
constriction rate, constriction and dilation velocity (CV and DV) and 
latency for both eyes were reported using the NPi®-200 (Neuroptics, 
Laguna Hills, CA, USA).
Results: We included 214 patients (mean age 60 years, 55% male). EEG 
tracings were categorized in: mild (n=111, 52%), moderate (n=65, 
30%) or severe (n=16, 8%) encephalopathy; burst/suppression (n=19, 
9%) or suppression (n=3, 1%). A total of 38 (18%) EEG were classi-
fied as unreactive. We found a significant difference in all pupillom-
etry variables among different EEG categories; an unreactive EEG was 
associated with lower NPi, pupil size, pupillary reactivity, CV and DV 
and a higher latency than reactive recordings. DV and sedation were 
independently predictors of unreactive EEG (OR 47.68 [5.65-402.76]; 
p<0.01 and 6.67 [2.49-17.86]; p<0.01, respectively). In particular, DV 
values had an AUC of 0.85 [0.78 – 0.91; p<0.05] to predict the pres-
ence of unreactive EEG; in subgroups analyses, area under the curve 
(AUC) of DV to predict unreactive EEG was 0.70 [0.55-0.86; p<0.01], 
0.91 [0.82-1.00; p < 0.01] and 0.95 [0.88-1.00; p<0.01] for post-anoxic, 
primary brain injury and others, respectively.
Conclusion: This study suggests that DV assessment via the AP might 
effectively identify unreactive EEG background, in particular in non-
anoxic critically ill patients.
001162 
PBtO2 vs pBtO2/paO2 ratio. Which is the best predictor 
of outcome in patients with acute brain injury?
T. Schizodimos1; E. Siomos1; P. Ioannidis1; I. Karageorgiou1; P. Poulios1; 
N. Kapravelos1; C. Iasonidou1
1B icu, General Hospital “G. Papanikolaou”, Thessaloniki, Greece 
Correspondence: T. Schizodimos
Intensive Care Medicine Experimental 2020, 8(2): 001162
Introduction: Neurocritical care patients with acute brain injury (ABI) 
are at risk of developing intracranial hypertension which is associated 
with poor outcome. Monitoring of intracranial pressure (ICP) and other 
additional parameters, such as brain tissue pO2 (PbtO2), and brain 
oxygenation ratio (PbtO2/PaO2 ratio), can assess the severity of ABI 
and guide treatment. Thus, it may help predict and improve outcomes 
of these patients.
Objectives: To investigate the relationship between the type of out-
come and parameters measured using an intraparenchymal monitor-
ing catheter (PbtO2 and PbtO2/PaO2 ratio) in patients with ABI.
Methods: An observational study was performed in a Greek ICU from 
July 2018 to May 2020, including 34 patients with ABI (13 Traumatic 
brain injury, 14 Subarachnoid hemorrhage, 5 Intracerebral hemor-
rhage, 2 Ischemic stroke) and ICP/PbtO2 monitoring. GCS on admis-
sion, APACHE II score, ICP, PbtO2 and PbtO2/PaO2 ratio during the 
first 24 hours were recorded. We ensured normal ICP (< 22 mmHg) 
with appropriate treatment measures in all patients. We considered 
as critical thresholds of PbtO2 < 15 mmHg and PbtO2/PaO2 ratio < 
0.15. Patient outcome was determined as favorable (patient had good 
recovery or moderate disability) or unfavorable (patient died, or was 
in a vegetative state or had severe disability) using the Extended Glas-
gow Outcome Scale (GOS-E) at 6 months after ABI. Simple logistic 
regression models were fittedto the data.
Results: Included 34 patients had a median age of 57 (IQR 15) years, 
median ICU admission GCS 7 (IQR 4.75) and mean APACHE II score 
16.91 (SD ± 5.25). An external ventricular drain was inserted in 19 
patients (55.9%) and surgery before ICU admission occurred in 20 
patients (58.8%). A positive association of mean PbtO2 on day 1 with 
type of outcome is detected. The odds for favorable outcome are 1.06 
times higher or 6% increased for every mmHg that PbtO2 is increased 
but this is not significant (p = 0.149, p > 0.05, 95%CI is 0.98-1.15 and 
includes 1) (Table 1). In our small sample, natural logarithm of mean 
PbtO2/PaO2 ratio on day 1 is positively related with type of outcome. 
Regarding 0.1 increments in natural logarithm of PbtO2/PaO2 ratio 
the odds for favorable outcome are 1.045 times or 4.5% higher. This 
relationship is not significant though (p = 0.296, p > 0.05, 95%CI is 
0.68-3.55 and includes 1) (Table 1). Mean PbtO2 and PbtO2/PaO2 ratio 
values for favorable and unfavorable outcome are recorded in Table 2.
Table 1. Association of outcome with catheter-based monitoring parameters. 
Variable OR (95% CI) p-value
Mean PbtO2 on day 1 1.06 (0.98, 1.15) 0.149, >0.05 
Mean PbtO2/PaO2 on day 1 1.55 (0.68-3.55) 0.296, >0.05 
stnemercni1.0rof540.1
Table 2. Means of catheter-based monitoring parameters according to outcome. 
Variable Favorable outcome Unfavorable outcome
Mean PbtO2 on day 1 18.6 12.58 
Mean PbtO2/PaO2 on day 1 0.158 0.112  
Conclusion: In addition to ICP, monitoring and normalizing param-
eters, such as PbtO2 and PbtO2/PaO2 ratio could help improve out-
come in patients with ABI. Mean PbtO2 and PbtO2/PaO2 ratio on day 
1 had similar performance in these patients but PbtO2/PaO2 ratio was 
inferior to PbtO2 alone in our small sample. There remains a need for 
more, high quality trials in patients with ABI.
Reference(s) and grant ackowledgment(s)
1. 1. Roh D, Park S. Brain Multimodality Monitoring: Updated Perspectives. Curr 
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traumatic brain injury and clinical utility of a novel brain oxygenation ratio. J 
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Introduction: The Barking, Havering, Redbridge University Trust 
(BHRUT) simulation team, ITU team and transfusion team collaborated 
in an attempt to improve knowledge among ITU nurses around local 
Massive Haemorrhage (MH) guidelines [1] through simulation, to great 
effect in a mere 1-hour whilst on ITU.
Methods: The simulation team ran a high-fidelity in-situ simulation of 
an unexpected massive haemorrhage in an ITU patient, on the inte-
sive care unit. The doctor in the scenario managed the patient’s air-
way during the ongoing massive haematemesis. The transfusion team 
were aware of the simulation and attended, when called, to simulate 
real life.
Questionnaires were administered pre and post simulation to gauge:
1. Knowledge about MH protocols in general [2]
2. Confidence levels with regards to MH guidelines specific to the Trust
3. Confidence levels around what constitutes a MH
4. Confidence levels around the key initial steps in escalating a patient with a 
MH
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Results: A 5-point Likert scale was used to assess the key learning 
objectives for the session, where 5 was the most positive outcome and 
1 was the least positive outcome:
1. Prior to simulation, ITU nurses had an average score 2.0 when asked about 
their general knowledge on Massive Haemorrhage protocols, this improved 
to 4.3 after simulation.
2. Perceived confidence levels with regards to following the Trusts’ flow dia‑
gram on managing a MH improved from an average score of 1.8 to 4.0 after 
participants were involved in simulation.
3. ITU nurses felt much more confident in identifying a MH as a result of 
partaking in the scenario; 100% of nurses were able to identify a MH after 
simulation, compared with only 25% being able to name one parameter 
that constitutes a MH prior to the simulation.
4. 100% of nurses knew the two most important steps to take in the event of 
a MH before simulation, but valued the opportunity to take those steps in 
real‑time during the simulation.
Conclusion: Haemorrhage following trauma is the leading cause of 
death in young adults in the UK [3], haemorrhage following child-
birth remains the third leading cause of direct maternal death in the 
UK [4] and acute upper gastrointestinal bleeds (AUGIB), a common 
in-hospital emergency, and has a case mortality of 10%, according to 
the Joint UK Blood Transfusion and Tissue transplant Services [5]. Thus, 
it’s not uncommon for our ITU staff to be faced with massive haemor-
rhage and hence it made this particular emergency an important tar-
get for simulation.
A mere 1-hour of in-situ simulation, centred around very specific mas-
sive haemorrhage learning objectives, proved an extremely effective 
way to impart learning during working hours to prepare ITU nurses for 
the inevitable day when they are faced with a real major bleed. Here 
we have demonstrated considerable improvements in knowledge and 
confidence with regards to management of massive haemorrhage fol-
lowing only 60 minutes of simulation.
Reference(s) and grant ackowledgment(s)
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Introduction: Many adult critical ill patients have central access 
devices (CAD) that includes central venous catheter (CVC), continuous 
renal replacement therapy (CRRT) catheter, or femoral arterial line dur-
ing their acute phase of illness in the intensive care unit (ICU) for inva-
sive monitoringof physiological status and treatment responsiveness. 
Bleeding is the most likely complication to occur after removal of the 
CAD when applied direct pressure to the puncture site is not adequate 
to achieve haemostasis. This kind of complication can be fatal espe-
cially if the larger size (such as 13FR) CRRT catheters are used.
Therefore, a Continuous Quality Improvement team has developed a 
removal of central access devices label aimed to provide quick clinical 
guide to bedside ICU nurses for the removal of CAD.
Objectives:
1. To deliver safe and standardize care to ICU patients during the removal of 
CAD
2. To prevent bleeding after removal of CAD
Methods: Wide staff consultations were made about the various kinds 
of method used to remind nurses on important clinical steps of the 
removal of CAD. Finally, a removal of central access device label was 
developed. The label reinforced the following critical actions for the 
removal of these line / catheter: 1. Application of direct pressure to 
the CAD exit site after the line has been removed for at least 10 min-
utes, 2. Re-checking of the removal site 5 minutes later after direct 
pressure was stopped for any bleeding / haematoma, 3. Removal of 
all central venous & arterial lines as early as possible while the patient 
was waiting to transfer out to general ward, 4. Checking the integrity 
of removed lines to avoid any retention of lines material, 5. Enhance-
ment of nursing clinical handover through standardization of nursing 
documentation
Promotion of the project: 1. Staff education during briefing, 2. Eye 
catching smart point posted in the common staff areas of the unit, 3. 
Ad hoc compliance check during daily round
Results: The project was implemented in May 2016. Every year, the 
Intensive Care Unit of Prince of Wales Hospital has around 1800 admis-
sions of which 450 CVC lines and CRRT catheters were removed. A reg-
ular surprise audit on removal of CAD and implementation of the label 
was 100% compliance. Moreover, there were no incidences of immedi-
ate bleeding.
However, there were 2 reported cases of delay bleeding after removal 
of CRRT catheters due to the patient’s underlying illness in 2018. 
Therefore, a second check was made 15 to 30 minutes after direct 
pressure was stopped in order to close this loophole. As of December 
2019, there were no immediate or delay bleeding cases reported.
To evaluate the effectiveness of the project, a staff survey was also 
conducted with questionnaires distributed to 80 ICU nurses (76%). 
Totally, 65 (81%) completed questionnaires were returned with the 
result analysed as follows:
Table 1. Result of the staff survey 
Questions Strongly Agree Agree Neutral Disagree
Strongly 
Disagree 
Q1. The removal of CAD label 
can provide quick clinical 
guide to prevent bleeing 
complication after removal of 
CAD 
18.6% 69.5% 8.5% 3.4% 0% 
Q2. The removal of CAD label 
can remind you to prevent 
bleeding complication after 
removal of CAD 
18.6% 67.8% 10.2% 3.4% 0% 
Q3. The removal of CAD label 
can help the prevention of 
bleeding complication 
15.3% 55.9% 22.0% 6.8% 0% 
Q4. The removal of CAD label 
can facilitate your 30.5% 62.7% 5.1% 1.7% 0% 
documentation and clinical 
handover to nurses of next 
shift and general ward nurses 
Data in Table 1 shows that there was positive response on the project 
from the staff survey. Although there was 71.2% of the staff stated 
agree and strongly agree on the label which can help the preven-
tion of bleeding complication, over 80% of the staff (88.1%, 86.4% 
and 93.2% respectively) agreed that the label can provide quick 
clinical guide and remind nurses to prevent bleeding complication 
after removal of CAD and also can facilitate their documentation 
and clinical handover. Hence, the result of staff survey showed that 
the removal of CAD label can provide quick clinical guide to prevent 
bleeding complication after removal of CAD.
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Conclusion: Development of a removal of central access devices label 
has demonstrated its’ effectiveness in preventing post removal bleed-
ing complication in ICU. Nurses also feedback to enhance clinical doc-
umentation and handover as a biproduct of the project.
Reference(s) and grant ackowledgment(s)
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Introduction: More data has been recently acquired about effec-
tiveness of early rehabilitation in the Intensive Care Unit. However, 
the data on the safety of this technique for patients with acute brain 
impairment (ABI) is still being discussed [1, 2].
Objectives:
To assess the effectiveness and safety of early rehabilitation of ABI 
patients in the Intensive Care Unit (ICU).
Methods: The inclusion criteria were ABI following a brain infarc-
tion, intracerebral hematoma, or subarachnoid hemorrhage. Criteria 
of an exclusion were a short rehabilitation course (≤ 7 days), deeply 
decreased level of consciousness (≤ 7 points on Glasgow coma 
scale), multi organ decompensated failure. All patients (n = 42) were 
assigned to the Early Rehabilitation Group (ERG) if it started 1-2 day 
from ABI onset, or to the Delayed Rehabilitation Group (DRG) if it 
started after 2nd day. All patients were given a daily mobilization com-
plex taking into consideration their mobility and tolerance of physical 
activity. Clinical and laboratory indicators were analyzed, including the 
frequency of depression and deliria, the length of hospital stay and the 
time of mechanical ventilation. The development of serious complica-
tions during mobilization and mortality were also recorded. The data 
is presented as absolute values (frequency in percent), average (stand-
ard deviation), or median (25-75th percentile) depending on the type 
and allocation of the data.
Results: In group ERG (n = 15) mobilization started on 2nd (1-2) day 
on average, while in group DRG (n = 27) only on 7th (4-12) day (p < 
0.001). The groups were comparable in degree of consciousness dis-
order and organ dysfunction. All patients had severe disabilities (≥4 
points on the modified Renkin scale). No differences in groups were 
found as for the duration of mechanical ventilation, hospital admis-
sions and mortality. The frequency of both delirium (p = 0.024) and 
depression (p = 0.040) was lower in the ERG group. The length of hos-
pital stay in the Intensive Care Unit was higher in the DRG group than 
in the ERG group (27 (21-34) and 19 (10-27), respectively; p=0,042). 
At the time of discharge, the incidence of severe disability decreased 
in both groups (to 87% in group ERG and to 78% in group DRG, p = 
0.482). There were no serious complications during mobilization in 
both groups.
Conclusion: Early rehabilitation can be effectively and safely applied 
for patients with ABI. The use of early rehabilitation for patients with 
acute cerebral deficiency reduces the frequency of mental disorders 
and the time in the Intensive Care Unit, which creates the basis for 
favorable long-term outcomes.
Reference(s) and grant ackowledgment(s)
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Introduction: Italy was one of the most affected country at the begin-
ning of COVID-19 pandemic with the highest number of deaths in 
Europe mostly concentrated in the Lombardy region. Critically ill 
patients with COVID-19 required intensive care unit (ICU) admis-
sion due to the development of acute respiratory distress syndrome 
(ARDS). Prone positioning as rescue therapy can support respiratory 
function in patients with severe ARDS although the feasibility of the 
extensive use depends from the personnel expertise.
Objectives: To report the experience with the respiratory manage-
ment and extensive use of prone positioning in COVID-19 patients 
admitted to the ICU hub of a tertiary-level hospital in Lombardy 
region.
Methods: All patients with laboratory-confirmed SARS-CoV-2 infec-
tion and subsequently admitted to ICU of Foundation IRCCS Ca’ 
Granda Ospedale Maggiore Policlinico (Milan), between February 
23 and May 31, 2020, were enrolled in this retrospective consecutive 
case-series study. The recorded date included: age, sex, mode of res-
piratory support (non-invasive or invasive mechanical ventilation), use 
of prone positioning, mortality and ICU discharge.
Results: Of the 128 patients included, 121 required endotracheal intu-
bation and prone positioning was used in 46% (59/128) as rescue ther-
apy. The other results are summarized in the table.
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Conclusion: Prone positioning is part of the strategies available to 
intensive medicine for ARDS treatment in COVID-19 patients. During 
COVID-19 pandemic era, extensive use of prone positioning as rescue 
therapy can be applied using a specific protocol to support the staff 
decisions, limit the occurence of complications and avoid excessive 
nursing staff workload.
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Introduction: One output from the INACTIC collaboration (1) is a set 
of core competencies for advanced practice ICU nurses across Europe. 
Some European countries, such as the UK (2), have identified such 
competencies, however these roles are rare across the rest of Europe. 
The INACTIC competencies were developed with an expert panel of 
184 ICU nurses from 20 countries; however it is important to verify 
these with patients and family members with experience of intensive 
care.
Objectives: The aim of the study was to examine the views of 
recovered ICU patients and relatives regarding the INACTIC core 
competencies.
Methods: Three Focus Groups were conducted in the UK (n=12 par-
ticipants) and Greece (n=5 participants) to discuss a lay version of the 
competencies.
Results: The feedback from across the focus groups confirmed the 
inclusion of statements about personal attributes, such as ‘patient 
advocacy’ or ‘having the confidence to defend your opinion about 
a patients’ care’ and described this as the ‘essence of the expert role’. 
There was a cultural difference with the Greek focus group: because of 
very restricted family visiting relatives felt encouraging their participa-
tion in patient care was not possible.
Conclusion: The perspectives of patients and family members largely 
aligned with the professional consensus of the expert panel, in par-
ticular related to personal attributes of the expert ICU nurse. Cultural 
differences in ICU experience highlight the changes that some ICUs 
would need to make for the competencies to be embedded.
Reference(s) and grant ackowledgment(s)
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Introduction: To provide insights into visiting policies of Intensive 
Care Units (ICUs), especially for children and adolescents, and family-
centred care in German-speaking countries (Austria, Germany, Luxem-
bourg and the German-speaking part of Switzerland).
Methods: Online survey with leading clinicians from all adult, age-
mixed, or paediatric ICUs from German-speaking countries (n=1,943).
Results: In total, maximal 19.8% (n=385) of clinicians answered the 
survey. Most respondents were physicians (n=213, 57.3%). Open 
visiting times were reported by 36.3% (n=117), with significant differ-
ences between paediatric ICUs (79.2%), adult (21.3%), and age-mixed 
ICUs (41.2%) ICUs (p<001). More than two thirds of clinicians stated 
that their ICUs had no age restrictions for children as visitors (n=221, 
68.4%). Most frequently implemented family-centred care activities 
were open visitation times and information’ dissemination. Clinicians 
reported concerns about children’s traumatization, risk of infection, 
and workload as major barriers. Arguments for family-centred care 
were evidence, education, and communication.
Conclusion: One third of participating clinicians reported providing 
open visiting policies in their ICUs. Two thirds of the respondents’ ICUs 
allow children as visitors without age restrictions, with even higher 
proportions in paediatric ICUs. The majority of respondents reported 
to offer family-centred care in their ICUs, although they stated con-
cerns about risks and debatable benefits.
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Introduction: APRV is a pressure controlled mode of ventilation 
that delivers an almost continuous positive pressure with intermit-
tent, time-cycled, short releases at a lower pressure while spontane-
ous breathing is encouraged. It is based on the open lung approach 
(Stock and Down 1987). Few UK ICUs have a consistent experience of 
APRV as it is primarily used as a rescue mode of ventilation where oth-
ers modes have failed (Zhou et al 2017; Swindon et al 2020). On our 
ICU APRV use has increased over the past 5 years, with a significant 
increase since 2017.
Critical care nurses play a vital role in the care and management of 
patients requiring mechanical ventilation. The Nursing and Midwifery 
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code of conduct specifies nurses must work within the limits of their 
competence and that the necessary training should be completed 
before carrying out any new role. Our ICU currently has no teaching 
package or written guideline for the setup and management of APRV.
Methods: A MDT working group was established to deliver the pro-
ject. 5 ICU’s around the region were surveyed and no unit had an 
APRV teaching package. A questionnaire regarding knowledge and 
confidence in the use of APRV was sent out to all members of nurs-
ing staff. A teaching package was designed starting with small pilots 
of teaching to a multi-disciplinary team on an adhoc basis. The teach-
ing package will be cascaded via the Bath University Hospital Tea 
Trolley Teaching method (Hawkes 2018), enabling larger numbers of 
staff to be educated in a timelier manner. The efficacy of the teaching 
program will be assessed by a further questionnaire sent out after the 
teaching has been attended.
Results: The baseline questionnaire was sent to 77 members of staff 
and generated 46 responses (58.4%). 91% of staff completing had 
cared for a patient receiving APRV and 66% of those report no prior 
knowledge of APRV. Of the 46 responses 45 expressed the need for 
education in the free text section. 20 members of staff received teach-
ing as part of the pilot, achieving 14 post teaching questionnaire 
responses (70%).
Conclusion: APRV use is increasing and the first survey showed a 
lack of knowledge or experience/confidence in its use. This has been 
addressed by the creation of a teaching package, and the pilot data 
has shown a positive outcome to both the delivery and content.
Staff confidence/knowledge of APRV will be re-evaluated again once 
the teaching package has been delivered. The results of this will be 
available for presentation at the conference.
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Introduction: Advanced Critical Care Practitioners (ACCPs) are 
now well integrated within critical care (CC) workforces across Eng-
land, Scotland and Wales. As such, ACCPs have been acknowledged 
within landmark publications for their contribution to the delivery of 
CC services1-3. There have been numerous key initiatives that have 
advanced the development of the role, including national curricu-
lums/pathways for training and continued professional development 
4-6. Despite now being well embedded within the CC workforce, only 
local quality-assurance datasets that have evaluated the perceived 
effectiveness and/or safety perceptions surrounding the introduction 
of the ACCP role have been published7-10.
Objectives: The study had several objectives: 1) Evaluate perceptions 
surrounding the ACCP role within the CC workforce; 2) Assess the 
level at which current qualified ACCPs were perceived to be working 
towards the expectations of the role described by the Department of 
Health (DoH) and the Faculty of Intensive Care Medicine (FICM)4-5; 
3) Evaluate whether the introduction of the ACCP role had any nega-
tive impact on Medical, Nursing and/or Allied Healthcare Professional 
(AHP) training; 4) Identify areas of concerns regarding interprofes-
sional working and 5) Assess the scope for further development of the 
role.
Methods: Previous work conducted at a local level informed the 
objective and design of this study7. We designed and distributed an 
online anonymous electronic survey via OnlineSurveys.com to mul-
tiple centres within England, Scotland and Wales via multiple CC 
networks. A link to the survey was hosted on the FICM website. All pro-
fessional groups that had experience of workingdirectly with ACCPs 
were eligible to take part in the survey. ACCPs were excluded from 
participating. Institutional ethical decision tools did not deem this pro-
ject to require independent peer review.
Results: 591 clinicians responded to the survey during the 6-week 
period study period. The majority of respondents (n = 150, 25%) 
were Medical Consultants, followed closely by Staff Nurses (n = 141, 
23.9%). Respondents ranged across all regions in which ACCPs are cur-
rently known to be in post. Results demonstrated overall positive out-
comes for all objectives (Fig. 1). Qualitative analysis of free text data is 
ongoing, however initial thematic analysis identified several themes; 
improved workforce stability, enhanced patient safety, variations in 
level of training, deskill in other members of the workforce, limited 
career progression.
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Conclusion: The ACCP role continues to develop across England, 
Scotland and Wales. This survey has identified that overall respond-
ents perceive the introduction of the ACCP role to be positive and that 
current qualified ACCPs meet the expectations set by the DoH and the 
FICM, and should be given scope to develop their roles further. How-
ever, a number of areas have been identified amongst respondents 
which warrants further exploration to inform effective and sustainable 
future development of the ACCP role.
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Introduction: The success of advanced nurse practitioners in inten-
sive care is widely documented. Advanced Clinical practitioners (ACP) 
are highly skilled, experienced and competent practitioners. In Inten-
sive Care (ICU) there is not only a need for university qualification and 
achievment but a specialist training program specific to ICU to run 
alongside. The ACPs on this CICU have set up an innovative program 
for training; obtaining and documenting competency and supporting 
trainee nurse practitioners. The ‘specialist core training’ program. This 
program runs paralel to university education, complimenting learning 
but focusing on core ICU skills and development. Core training can 
be individualised to learner needs but has central achievment stages 
throughout the 3 year training period. This specialist core training 
includes; speciality skills and education, involvment in providing MDT 
teaching, leadership skills, research focus groups and competency/
pathway document. The aim is to enhance care delivery, specialise 
ICU training, complement foraml university training, cover the 4 pil-
lars of ACP and support/improve the transition from training into ACP 
roles. Ultimatly the goal, on completion of this specialist program, is a 
trainee who can function successfully as an ACP on a medical rotation, 
initiate and lead change projects, be innovative and forward focused.
Objectives: The aim of this PICU specialty core training is to compli-
ment general ACP training and allow PICU ACPs to have a sound 
foundation, knowledge and competence in their chosen specialist 
area. Our hypothesis is that the trainee experience, multidisciplinary 
team (MDT) experience and patient care and safety will be enhanced. 
We would consider this comprehensive program to be reproducible 
within other PICU environments.
Methods: PICU requires specialist knowledge and competence these 
skills can be taught alongside ACP training. Developing PICU specialist 
core training has required MDT collaboration including; trainee ACPs, 
anaesthetic consultants, ICU consultants, established ACPs and con-
sideration of national guidance. We have developed a comprehensive 
program that runs alongside the formal ACP program that will map 
career progression from induction through to qualification. Thus pro-
viding a transparent vision/expectation as to how their career should 
progress.
Results: The project has been very successful. Feedback from current 
trainee ACPs highlights that this more robust program will help with 
training into such specialty ACP roles. The program covers 4 pillars of 
ACP, specialist skills, specialist education, MDT learning and clinical 
leadership and managment training.
Trainee Feedback ‘The specialist training I would say is extensive, we 
have to be able to prove we can make reliable and safe judgements, 
planning our own caseloads and are also able to adapt swiftly to 
changing situations.’
Conclusion: This program has enhanced the training our trainee 
ACPs recieve and supports the formal university learning. Has already 
enhanced the trainee ACP, MDT and patient experience. We would like 
to consider a national application for this program across UK PICU.
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Introduction: Intensive care nurses develop specialized and specific 
care for which extensive and continuous training is necessary(1).Sev-
eral scientific associations have developed different tools to stand-
ardize minimum training requirements. The European Federation of 
Critical Care association has developed a series of areas where the dif-
ferent competences of nurses are developed, these areas are: clinical, 
professional, management, educational and development (2).These 
competences, as different authors name, must be developed through 
specific training that must focus on the own needs of nurses through-
out their professional continuum and the healthcare organization 
requires (3).
Objectives: Identify the different dimensions focused on the training 
needs of intensive care nurses in Spain and the nurses’ perception of 
them.
Methods: Descriptive cross-sectional study by means of an electronic 
questionnaire to 84 intensive care units. The questionnaire was pre-
viously validated by a brain trust.  The survey consisted of 66 items 
using a Likert scale from 1 to 10. Statistical analysis was performed by 
exploratory factor analysis (EFA) through polychoric correlations with 
the Factor Analysis 10.9.02 program and inferential statistics with the 
spss 20.0 program.
Results: The sample consisted of 568 nurses. The EFA determined 13 
dimensions of care, which explains a total percentage of explained 
variance of 64,219 and a Cronbach’s alpha of 0.934. The dimensions 
detected were: Skills in critical patient care, Communication and clini-
cal safety, Nursing knowledge and clinical reasoning, Reception plans 
for novice nurses, Specific and continuous training of staff nurses, 
Excellence in care, Evaluation of critical patient, tools and technology, 
health management, application of support measures, decision-mak-
ing and coping at the end of life, measures to improve care, motivation 
to continue training, impact of training.
Significant differences were found in the assessment of these train-
ing needs among the nurses with the longest years of experience as 
a nurse (p = 0.004) as an ICU nurse (p = 0.021), the nurses with official 
postgraduate degree (p = 0.001) and the rest of the nurses.
Nurses with a higher academic degree and greater work experience as 
nurses value more positively the training needs and the need to have 
previous training requirements as the Jonckheere tepstra test (p = 
0.035) and Chi-Square (p = 0.016) demonstrate.
Nurses from smaller hospital also value more positively 6 of the dimen-
sions detected with p values  between 0.002-0.036 compared to ICU 
nurses from large centers (> 500 beds).
Conclusion: The perception of the training needs of nurses are influ-
enced by intrinsic and extrinsic factors. Among the intrinsic factors 
the following stand out: the total work experience and in the ICU as 
a nurses and their own academic degree. Within external factors, the 
size of the hospital center influences more than the size of the inten-
sive care unit itself.
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Introduction: Occlusions of intravenous (IV) tubing can prevent vital 
and time-critical medication or solutions from being delivered into 
the bloodstream of patients receiving IV therapy. At low flow rates (≤1 
ml/h) the alarm delay (time to an alert to the user) can be up to 2 hours 
using conventional pressure threshold algorithms. In order to reduce 
alarm delays we developed and evaluated the performance of three 
new real-time occlusion detection algorithms that exploit the trend in 
pressure changes.
Methods: Bench-tested experimental runs were recorded in triplicate 
at rates of 1, 2, 4, 8, 16, and 32 ml/h. Each run consisted of 10 minutes 
of non-occluded infusion followed by a period of occluded infusion 
of 10 minutes or until an occlusion alarm. The first algorithm based 
on binary logistic regression tried to detect occlusions based on the 
pump’s administration rate (Q(t)) and pressure sensor readings (P(t)). 
The second algorithm continuously checked whether the actual vari-
ation in the pressure (P-SD-actual) exceeded a threshold of 2 standard 
deviations (SD) above the baseline pressure. When a pump detected 
an occlusion using either the regression or SD algorithm, a third algo-
rithm correlated the pressures of multiple pumps to detect the pres-
ence of a shared occlusion. The algorithms were evaluated using the 
six bench-tested single-pump occlusion scenarios and seven multi-
pump co-occlusion scenarios (i.e. with flow rates of 1+1, 1+2, 1+4, 
1+8, 1+16, and 1+32 ml/h respectively). Alarm delay (minutes) was 
the primary performance measures.
Results: In the single-pump occlusion scenarios the overall mean ±SD 
alarm delay of the regression and SD algorithms were (1.8 ±0.8 min) 
and (0.4 ±0.2 min), respectively. Compared to our local alarm thresh-
old of 400 mmHg (7.4 ±7.5 min) this corresponds to a mean time 
reduction of 52 ±34% (p =0.003) and 90 ±6% (p =0.001), respectively.
In the multi-pump scenarios a correlation >0.8 between multiple 
pump pressures after initial occlusion detection by the regression or 
SD algorithms had a mean ±SD alarm delay of 0.4 ±0.2 min. No occlu-
sions were missed in the single-pump and multi-pump scenarios by 
any of the algorithms.
Conclusion: Both the regression and SD algorithms were able to sig-
nificantly reduce alarm delays compared to conventional pressure 
limit based detection. Coupled with a correlation algorithm co-occlu-
sions could reliably be detected far more rapidly than with the con-
ventional technique. The latter may be used to localize the segment of 
tubing in which the occlusion occurs.
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Introduction: Delirium is a common complication in patients on 
Intensive Care Units (ICU). Intervetions such as mobilization are effec-
tive in prevention and treatment of delirium, but recommended dur-
ing daytime.
Objectives: The objective of this study was to prove the effect of 
mobilization in the evening to prevent and reat ICU patients from 
delirium
Methods: The design was a multicentric, randomized, controlled trial 
in 5 mixed ICUs over a period of 2 weeks. Patients in the intervention-
group were mobilized onto the edge of the bed or more between 
9:00-11:00 p.m. Patients in the control group received usual care. Pri-
mary outcome parameter was the duration of a delirium. Secondary 
parameters were delirium incidence, mortality, duration of mechanical 
ventilation (MV) and stay for 28 days follow-up, feasibility, and safety
Results: In summary, n=69 patients could be analysed (intervention 
n=36, control n=33). Mobilization in the evening did reduce dura-
tion of existing delirium (Median (Interquartil Range) 1.5 (1-2.7) vs. 2 
(1-2) days,  albeit not statistically significant.  Length of MV or days in 
ICU and hospital, and mortality were not significantly different. In an 
unplanned post-hoc analysis, mobilization in the evening prevented 
patients from delirium in the first four days (n=6 (16.7%) vs. n=13 
(39.4%), p=0.032), with a number needed to treat of 5. The interven-
tion was feasible in 71.7% of eligible patients, with 13.6% mobiliza-
tion-related safety events.
Conclusion: In a mixed ICU population, mobilization in the evening 
did not show a reduction in duration of delirium, MV or length of stay, 
but a possible reduction in the incidence of early onset delirium.
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Introduction: The perspective of training needs is an element focused 
on daily clinical practice.The difficulties and opportunities detected in 
the day to day can be useful to assess and evaluate which elements of 
improvement are applicable.It is necessary to extract the experiences 
of nursing professionals in a field as specific as intensive care, to later 
develop elements that can help us generate training that provides 
safe and quality care by ICU nurses.
Objectives: Generate a questionnaire to analyze the training needs of 
nurses in the ICU.
Methods: Delphi technique modified with an extensive semi-struc-
tured pre-interview based on the recommendations of the European 
Federation of critical care nurse association and digitally recorded.
The panel of experts consisted of 15 nurses with three or more years 
of experience as an ICU nurse in a polyvalent adult unit of the Com-
plejo Hospitalario Insular Materno-Infantil. It took three rounds for the 
expert group to reach a consensus.
The scale used for its evaluation was a Likert of 10 points, where 1 were 
always unimportant values  and 10 were very important values.Items 
with a mean score greater than or equal to 6.1 and a median greater 
than 7 were included.The diffusion of the questionnaire was telematic 
with a period of 15 days for each of the phases.
Statistical analysis was performed using the SPSS statistical program 
version 20.0
Results: In the preparatory round, 92 questions were developed by 
the research team from the interviews previously carried out with the 
expert panel.
In addition, text-type comments were allowed to assess the questions 
asked by the experts.
In the first phase, the 92 questions were sent and due to the experts’ 
assessment, 14 items were withdrawn, leaving the assessment docu-
ment at 78 items. In the second phase the 78 items were sent, and the 
text comments made in phase 1. In this second phase, text comments 
were not received on the questions or related to their drafting.
The questionnaire with 66 questions was forwarded for evaluation in 
the third phase.This questionnaire was distributed as follows: clinical 
setting (18 items), professional setting (14 items), management setting 
(16 items), educational and development setting (6 items), and train-
ing activities (12 items).
The third round was evaluated by experts and subsequently ana-
lyzed to assess the generated construct.The reliability of the scale was 
assessed by Cronbach’s alpha, whose result was 0.908
Conclusion: The questionnaire generated following the steps of the 
Delphi technique allows us to reliably explore the training needs of 
nurses in the ICU. The experts included a large amount of care distrib-
uted throughout the questionnaire. The expertsespecially included 
questions aimed at maintaining a continuous and permanent training 
program
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Introduction: The recovery from prolonged Intensive Care Unit (ICU) 
hospitalization involves physical and psychological sequela that influ-
ence patients’ recovery from complicated illness. Patients and families 
deal with the transition from high dependency care of the ICU to a less 
intense environment of the regular ward where nurses cope with mul-
tiple complicated patients. A new function was suggested and imple-
mented, dealing with the need for continuity of care for such patients. 
The function, “Follow up ICU” was implemented in various hospitals, 
each including varying specific roles and responsibilities. I discuss the 
implementation of immediate intrinsic follow up (during hospitaliza-
tion) in Israel, addressing specific characteristics of the unique hospital 
environment and role distribution between the different wards. Spe-
cial attention was given to patient-family centered care for the post 
ICU patient. Utilization and benefits were evaluated using surveys with 
medical stuff
Objectives: Evaluate utility and gain from establishing intrinsic ICU 
follow up in an Israeli hospital, as implemented by a dedicated nursing 
function assisted with other medical services.
Methods: During 2019 – 2020 follow-up nursing was implemented, 
with additional medical support functions. A survey comparing pre 
and post-prior assessment of the quality of care by ward nurses was 
conducted. services in hospital adopting the patient-family centered 
care for improving recovery from acute illness.
Results: ICU follow-up team, led by a nurse and assisted by a dietician, 
social worker, physiotherapist, and a physician created a patient-spe-
cific plan of care. The plan was implemented starting before releasing 
from ICU and continuing as the patient was transferred to the ward. 
During 2019 the process was implemented in support of 200 patients. 
A mean per-patient number of post ICU hospitalization was 3.5. 44% of 
the visits involved respiratory assessments, 34% involved mobility and 
wound care, and 39% post ICU syndrome caregiver-patient conversa-
tions. Survey with ward nurses indicated mainly that: post-ICU follow 
up support led to improved critical thinking and improved quality 
of care for post-ICU patients, as special attention was dedicated to 
unique treatment aspects. Dedicated guidance and support for the 
ward nurses led to significant improvement of specific needed nursing 
skills which in turn assist in increased quality of care. Two prominent 
examples include: care for tracheostomy patients and dealing with 
post-ICU syndrome. Overall 90% of interviews indicated high benefit 
due to improved communication between the ICU unit and the ward.
Conclusion: Following the establishment of an intrinsic post-ICU fol-
lowup unit quality of care as evaluated by ward nurses improved 
significantly.
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Introduction: The application of physical restraints remains a com-
mon and unchallenged practice in the Intensive Care Units (ICUs) in 
many countries worldwide. However, if on the one hand nurses con-
sider physical restraints as an unavoidable practice in ICU, on the other 
some physical adverse effects, such as skin breakdown and functional 
decline, and psychological outcomes, such as delirium and post-trau-
matic stress disorders, have been documented. To date, there is little 
understanding of physical restraint use from the perspective of ICU 
nurses in Italy.
Objectives: To assess the knowledge, the attitudes, and the practice 
of intensive care nurses about physical restraints use.
Methods: A qualitative study following a phenomenological approach 
was carried out between September and October 2019. Semi-struc-
tured face-to-face and audio-recorded interviews were carried out 
in three general Italian ICUs. All interviews were audio-recorded and 
transcribed verbatim. Each interview lasted approximately 20 minutes. 
Data were analysed with a content analysis method.
Results: 11 nurses were interviewed, mainly female (n=6, 63.6%) and 
with an average age of 36 years. A preliminary data analysis produced 
53 initial categories, 11 subthemes, and 3 main themes. The main 
themes included: a) The decision-making process (patients’ charac-
teristics, organizational features, decision maker’s role, and nurses-
specific factors); b) The use of physical restraints (rationale, methods, 
outcomes, and alternative approaches); and c) The experiences of 
nurses (nurses’ lived experiences, and ethical dilemmas).
Conclusion: According to the findings, the antecedent for an almost 
routine use of physical restraints in ICUs is the need to ensure patient 
safety. Although known by nurses, the alternative approaches to limit 
this practice were not implemented.
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Introduction: King’s College Hospital in South East London was one 
of the acute hospitals most affected by the SARS-CoV2 pandemic. 
The institution treated more than 2000 patients with COVID 19 pneu-
monitis, 192 of whom required a critical care admission. The hospital 
expanded its critical care capacity from 69 to 196 ICU beds during the 
peak of the outbreak and was one the busiest critical care services in 
the UK with COVID 19 critical illness. Patients in our institution also 
had high severity COVID 19 due to the high prevalence of acute renal 
failure in 50% of our ICU admissions.
A key component of the response of King’s Critical Care was provided 
by the Advanced Critical Care Practitioners (ACCPs). The ACCP pro-
gram, within King’s Critical Care, was launched in 2017 using the Fac-
ulty of Intensive Care Medicine curriculum delivered over two years 
(FICM, 2008). This first cohort consisted of seven intensive care nurses, 
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two critical care paramedics, and two intensive care physiotherapists, 
with a combined total of over 100 years of intensive care unit (ICU) 
experience. 2 ACCPs were provided on each 12 hour shift. Here, we 
assess the contribution, performance and effectiveness of this team 
to the COVID 19 response through use of the Critical Care Informatics 
System and database. Specifically, the contribution of ACCPs to inva-
sive interventions, proning (Gattinoni, 2020) and intra-hospital trans-
fer were examined.
Objectives: To assess the utilisation and effectiveness of the ACCP 
group during the COVID 19 pandemic in a critical care service at the 
epicentre of the United Kingdom Outbreak.
Methods: Appropriate service improvement approvals were gained. 
The ICCA (Intellivue Critical Care & Anaesthesia, Philips HealthCare) 
database was queried for ACCP interventions (lines, intubations, pron-
ing procedures) during the COVID 19 pandemic. (Microsoft SQL Server 
Management Studio 17). The ICCA complications audit table was also 
queried. The ACCP active directory role was queried to ensure anonim-
ity of healthcare professionals and no patient identifiers are reported.
Results: Within the ICCA dataset, the ACCP group were involved in 
the assessment and management of 177/192 patients admitted with 
COVID 19. They performed 86 central lines; 74 arterial lines; 29 vas-
caths and assisted 59 intubations across the Emergency Department; 
Critical Care and acute medical wards within our institution during 
the pandemic response. Additionally the ACCP group were the main 
providers of PICC line insertion. No immediate adverse events were 
reported. The ACCP group were tasked with the challenge of setting 
up and delivering a prone service for patients with oxygenation fail-
ure due to ARDS. Throughout their training they had been signed off 
as airway competent and able to perform stable intubated transfers, 
empowering them to lead and orchestrate in total 64 prone posi-
tions with only 2 adverse events and zero events leading to imme-
diate patient harm. The ACCP team independently performed 56 
intra-hospital patient transfers, with only two adverse events and 
no direct patient harm. The interventional procedures performed by 
ACCPs had less complications recorded than those performed by phy-
sicians and higher documentation compliance (eg seldinger wire out 
confirmation/use of check-lists). Finally, the ACCPs played a key role 
in developing and delivering simulation training for the resuscitation 
(including rapid-sequence intubation, transfer and proning) of criti-
cally ill patients with COVID 19.
Conclusion: The 2020 COVID 19 pandemic confirmed the critical role 
that the ACCP group play within the critical care service at our insti-
tution. The inherent strengths of the ACCP team, such as geopolitical 
awareness; awareness of protocols; a willingness to follow protocols; 
longevity as a team (no rotation); high technical skills led to the ability 
of this team to rapidly adapt at a time of unprecedented operational 
and clinical strain. Specifically, the ACCP group were able to bridge the 
communications between strained medical and nursing teams, ena-
bling structured and systematic task-based management of patients 
with severe COVID 19 illness in very difficult clinical settings with ad 
hoc organ support systems and critical supply chain pressures. Further 
work is planned, to use these operational and clinical observations 
from the ACCP response during the COVID 19 pandemic, to further 
develop this service. One key goal will be to explore independent 
working from ACCPs.
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Introduction: COVID-19 can cause acute critical illness requiring intu-
bation and mechanical ventilation. Early rehabilitation in the Intensive 
care unit (ICU) may prevent some complications of critical illness such 
as ICU-Acquired Weakness (ICU-AW) and may lead to improved func-
tional status[1]. In the United Kingdom (UK), tracheostomy for patients 
with COVID-19, is recommended to be considered 10-14 days after tra-
cheal intubation[2]. However, earlier tracheostomy may be associated 
with reduced sedation, early rehabilitation and therefore improved 
functional outcomes[3].
Objectives: To assess whether rehabilitation outcomes were affected 
by early tracheostomy in patients with COVID-19 admitted to an ICU.
Methods: A retrospective review of all adults admitted in a single cen-
tre district general ICU in the UK with a diagnosis of COVID-19 who 
were mechanically ventilated and had a tracheostomy. Patients were 
excluded who were transferred to other institutions for ICU capacity 
reasons or who died during their ICU admission.
Data was collected from patient records and physical morbidity meas-
ured using a modified Chelsea Critical Care Physical Assessment Tool 
(CPAx) score[4]. This was calculated for each patient at the time of tra-
cheostomy, when active rehabilitation commenced and on discharge 
to the ward and home.
A 2-tailed Mann-Whitney U test statistic assuming an alpha value 
of 0.05 was then calculated and data for tracheostomies performed 
before and after 7 days compared.
Results: Tracheostomies were performed on 11 mechanically venti-
lated patients within a median 5 days (IQR range 3.5-8.5). Median time 
to start active rehabilitation was 4 days (3.5-8.5) after tracheostomy. 
The median modified CPAx score on the first day of active rehabilita-
tion was 9/45 (8.5-10.5); on step-down to a ward it was 28/45 (15-35); 
and on discharge it was 45/45 (44-45). 10 patients (91%) were dis-
charged from hospital directly to their home.
When comparing tracheostomies performed before and after 7 days, 
there was a statistically significant difference (p<0.05) in: length of crit-
ical care admission (median 17 vs 31 days); days on sedation (median 
5 vs 21.5 days); days on controlled ventilation (median 6 vs 23 days); 
total hospital length of stay (median 27 vs 53 days); and modified CPAx 
score on step down to the ward (median 34/45 vs 12/45).
Conclusion: In this single centre case series early tracheostomy in 
COVID-19 patients who survived their ITU admission was associated 
with improved modified CPAx scores and functional outcomes.
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Introduction: Extubation failure is associated with 42% increase in 
mortality and doubles Intensive Care Unit (ICU) length of stay (Menon 
et al 2012). There is a 10-20% re-intubation rate despite a spontaneous 
breathing trial (Thille et  al 2013). The current evidence base outlines 
key factors that predict risk of extubation failure, such as; rapid shallow 
breathing Index (Yang and Tobin 1991), suction frequency (Miu 2013)
and respiratory secretion abundance (Salam et  al 2004). Currently at 
a large West Midlands teaching hospital, physiotherapists are not 
involved in the decision making process for extubation readiness on 
ICU.
Objectives: 1. To evaluate if newly developed evidence based tool 
predicts extubation readiness
2. To evaluate risk factors that predict extubation failure.
Methods: Data was collected for all patients admitted to the adult ICU 
due for extubation from February 2019 until September 2019. Exclu-
sion criteria were palliative patients and patients tracheotomised with 
no trial for extubation. Data was collected within one hour prior to 
extubation using an extubation readiness tool. This was devised using 
evidence based key factors that can help predict success or failure. 
Extubation failure was defined by the requirement for reintubation 
within one week or if the patient died.
Each risk factor from the assessment tool was categorised as high or 
low risk for extubation failure for each patient. Pass and failure rates 
for each risk factor were established. Data was analysed using the 
Fisher exact test.
Results: A total of 18 patients met inclusion criteria and were included 
in the analysis, of which 7 were scored as high risk based on the assess-
ment tool. Patients deemed high risk were significantly more likely to 
fail extubation (43% vs 0%, p<0.05), with no patients deemed low risk 
requiring reintubation. The most common risk factors associated with 
failure were respiratory rate, secretion load, MIP and Po1:MIP ratio. 
(See Table 1)
Table 1: Results of significant risk factors 
Risk Factors N -number Low risk (actual failure)
High risk (actual 
failure)
Ventilator days 18 9  (1) 9  (2) 
Trauma 18 4  (1) 14  (2) 
Respiratory rate 18 6  (0) 12  (3)




18 15  (1) 3  (2) 




18 12  (0) 6  (3)
P01:MIP ratio 18 9  (0) 9  (3)
Peak cough flow 18 8  (1) 10  (2) 
White blood cells 18 10  (1) 8  (2) 
CRP 18 1  (0) 17  (3) 
Pneumonia 18 14  (1) 4  (2) 
Conclusion: The extubation readiness tool was effective in identify-
ing patients at high risk for extubation failure. The tool demonstrated 
100% successful extubation in patients identified as being in the low 
risk category. The four most significant risk factors that predict extuba-
tion success or failure are respiratory rate, secretion volume, maximal 
inspiratory pressure and P01:MIP.
Future projects will aim to recreate the tool using the factors that were 
deemed most significant and effective in predicting success or failure, 
and increasing the sample size. Limitations of this study were that the 
trial took a long period of time to recruit to secondary to balancing a 
clinical caseload alongside non-clinical work and difficulties in consist-
ently identifying with the medical team which were the planned extu-
bations each day.
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Introduction: CoVID-19 has severely challenged communication 
between intensive care unit (ICU) staff and patients’ families, limiting 
information sharing, whilst also denying patients and their loved ones 
mutually supportive interaction.[1-3] Consequential reliance on less-
effective telephone, video or e-mail communication.[2] is complicated 
by personal protective equipment and infection control requirements 
within clinical areas. Concurrently, many staff have been required to 
step back from direct patient contact due to risk to their own health.
[4] Addressing these issues, our ICU introduced a new family liaison 
(FL) role. Two team members shielding from direct patient contact 
were utilized to establish this new service aimed at ensuring ongo-
ing family centeredcare through regular, consistent contact between 
relatives, clinicians, and patients[3-5] and relieving pressures on direct 
care staff through reducing time burdens of family communication 
and associated administration. Key activities include facilitating video-
calls, collating personal ‘This is Me’ information for new admissions, 
family updates and ‘check-ins,’ organizing ‘garden visits’ with a rela-
tive and coordinating bereavement support.
Objectives: To evaluate the impact and possible longer-term ben-
efit of the reallocation of staff to a new family liaison role during the 
CoVID-19 pandemic.
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Methods: We conducted a retrospective audit of documented family 
phone communications, direct visits and video-calls, for all patients 
on ICU for one week periods in February (prior to CoVID restrictions), 
March (during restriction, before FL introduction) and May (restriction 
in place, FL established). A web-based survey of was also conducted 
utilizing scaled, multiple-choice responses and free text comments.
Results: Of 109 ICU staff invited, 50 (45.9%) responded to the survey 
to date. 100% (n=50) indicated FL has improved consistency of family 
communication, 94% (n=47) reported it as helpful during end-of-life 
care and 84% (n=42) that FL reduced stress of communication. 54% 
(n=27) reported less telephone time and 98% (n=49) that video calls 
improved patient and family care. 42% (n=20) found FL made it easier 
to build relationships with families, 35% (n=17) no change, and 23% 
(n=11) found it harder (2 non-respondents). 84% (n=42) thought it 
would be valuable to continue the FL role beyond the current pan-
demic situation. The survey generated 137 comments (mean 15.2 per 
question) for further analysis.
Conclusion: Innovative use of staff at risk from direct patient to cre-
ate a FL role appears to have increased volume of documented phone 
and video contacts with patients’ families. FL has been well received 
by colleagues, improving consistency of communication, helping end-
of-life care, reducing stress and time on the phone. We hope to pre-
sent further insight regarding impact and interest in continuing the 
FL through analysis of comments and further examination of evolving 
functions since the roles’ introduction.
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Introduction: Neonatal late-onset-sepsis occurs after 72 hours of life 
(1,2). The relationship between late-onset-sepsis and mortality can be 
confounded by other events that are part of NICU journey, thus the 
true effect on mortality of this complication is difficult to assess (3).
Objectives: The aim of this study was to assess the impact of late-
onset-sepsis on mortality in critically ill infants.
Methods: Single-centre retrospective cohort study of neonates admit-
ted to the NICU for ≥72 hours in a 10-year period (2002-2011). Late-
onset-sepsis is defined according to National Institute of Child Health 
and Human Development criteria (2). Multivariate logistic regression 
analysis was used to assess risk factors for mortality.
Results: Of all admissions, 6.9% developed late-onset-sepsis (Table 1). 
Infants with late-onset-sepsis had higher mortality, lower gesta-
tional age, lower birthweight, longer NICU stay, spent more days 
mechanically ventilated and on parenteral nutrition. Furthermore, ini-
tiation of enteral nutrition was delayed by 7 days in infants who had 
late-onset-sepsis.
Independent risk factors for mortality included gestational age<=28 
weeks (OR=9.2, CI 3.8-22.3), periventricular leukomalacia (OR=4.3, CI 
2.7-6.98), late-onset-sepsis (OR=2.6, CI 1.5-4.2), abdominal surgery 
(OR=2.3, CI 1.1-4.7) and chronic lung disease (OR 1.97, CI 0.966-4.0).
Conclusion: Infants who developed late-onset-sepsis had a higher 
mortality and a longer, more eventful NICU stay. After adjustment for 
major risk factors, late-onset-sepsis appeared an independent risk fac-
tor for mortality.
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Introduction: It is well recognized that the transfer from Intensive 
Care Units (ICU) to the ward is a highrisk transition which causes chal-
lenges for staff and anxiety for patients (1). National Guidance for reha-
bilitation after critical illness (2), recommends a structured handover 
process for patients and appropriate multidisciplinary follow-up on 
transition from ICU to the ward. A previous project identified ongo-
ing rehabilitation on the ward is often inconsistent leading to delays 
in ongoing recovery.
Objectives: To assess the feasibility of a physiotherapy follow-up ser-
vice for patients transitioning from ICU to the ward.
Methods: Patients admitted to a large UK based ICU between Decem-
ber 2018 and February 2019 were recruited to the study. Inclusion 
criteria included patients under the care of a specialist critical care 
rehabilitation team, discharged from ICU with a Manchester Mobility 
Score (MMS) of less than 5 (i.e. unable to mobilise) and considered to 
have rehab potential.
On transfer to the ward, patients were continued to be reviewed daily 
by the ICU physiotherapy team for one week. The physiotherapists 
provided ongoing structured rehabilitation and communication with 
the patient, their relatives and facilitated a gradual handover to the 
receiving ward therapy team during this transition period. Primary 
outcome was changes in MMS, with secondary measures of patient 
and staff satisfaction.
Results: 13 patients were included in the pilot. Rehabilitation was 
delivered consistently during the trial period, with patients reviewed 
by the ICU physiotherapy team for a mean of 6 days on transition to 
the ward.
During this time, the median MMS scores increased from 4 (i.e. able to 
stand with assistance) at ICU discharge, to 6 (i.e. mobilising up to 30 
metres).
Patient feedback was extremely positive. Patients valued the continu-
ity of care and felt supported during the step down in care from ICU. 
Positive feedback was also received from ward staff who felt more 
supported in the handover process and able to deliver seamless care. 
However, as the follow-up team was based in ICU, they did face prac-
tical challenges during the pilot; including coordination of rehabilita-
tion sessions and communication across multiple wards.
Conclusion: Although a small pilot study, the results demonstrate that 
the physiotherapy ward follow-up service was feasible to introduce. 
The pilot study demonstrated an improvement in mobility scores 
with ongoing structured, physiotherapy rehabilitation. Patient and 
staff feedback was positive, although the service requires good lines 
of communication to support timetabling of rehabilitation and team 
working.
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Introduction: Providing a patient with a reliable venous access device 
is a key factor determining the effectiveness of therapy in pediatric 
oncology, hematology and immunology. In practice nurses resolve 
issues related to the usage of central venous access devices.
Objectives: The aim of the study was to determine the impact of 
implementation of central venous access devices (CVAD) guidelines 
combined with simulation training of nursing staff  on the change in 
the numbers of infectious and occlusal complications in patients with 
central vascular access.
Methods: There was a retrospective and prospective analysis of the 
operational peculiarities of 3357 venous access devices installed to 
2453 patients (1336 males, 1117 females) aged from 1 month to 18 
years over a January 2018 to December 2020 period.
In 2017 the National Research Center of Pediatric Hematology, Oncol-
ogy and Immunology approved and implemented guidelines for the 
operation of central venous access devices. In 2018 the record of all 
complications during the operation of central venous access devices 
was started. In 2019 simulation training for nurses was introduced; 
by the end of 2019 106 people had been trained. The main outcomes 
were the assessment of complications during the operation of vascu-
lar devices.
Results: In 2018 1618 central venous catheters were installed, in 2019 
- 1739 ones. During the year after the implementation of the CVAD 
guidelines the following issues were recorded: infectious complica-
tions – 3.2% (n=52), lumen occlusion unrelated to thrombosis – 1.8% 
(n=30), catheter-related thrombosis – 12.2% (n=199), which in 7.4% 
(n=121) of patients led to catheter damage during attempts to restore 
patency. In 2019 given the additional simulation training the follow-
ing issues were revealed: infectious complications – 2.6% (n=46), 
lumen occlusion unrelated to thrombosis – 1.72% (n=30), catheter-
related thrombosis – 13.7% (n=239), catheter damage – 4.6% (n=81) 
of patients.
In the group of patients where the guidelines and simulation training 
were used, the frequency of catheter damage was statistically signifi-
cantly lower, Pearson’s chi-square test showed 11.791, p < 0.001, OR 
1.654 95%, CI 1.238-2.211.
A total of 120,059 catheter-wearing days were recorded in 1203 
patients in 2018, and 148.327 catheter-wearing days in 1250 patients 
in 2019.
Conclusion: An analysis of the data showed that the simulation train-
ing of nurses in conditions of compliance with the guidelines does not 
practically affect the frequency of thrombotic and infectious compli-
cations, which is most likely related to many additional factors in the 
pathogenesis of these complications. However due to the simulation 
training under our conditions the number of catheter damages when 
restoring catheter patency during the development of intraluminal 
thrombosis decreased.
The experience of the National Research Center of Pediatric Hematol-
ogy, Oncology and Immunology has shown that the implementation 
of simulation training in addition to the usage of the guidelines had 
reliably reduced the number of damages of central venous access 
devices.
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Introduction: Gastrointestinal motility disorders are frequent events 
in Intensive Care Unit (ICU). A number of factors increase the fre-
quency of diarrhoea and constipation among critically ill patients, and 
a number of interventions can prevent them. Given the relevance of 
these two phenomena, further epidemiological studies areneeded.
Objectives: To determine the incidence of diarrhoea and constipation 
among critically ill patients in ICU.
Methods: An observational study was carried out in three general 
Italian ICUs with a total if 28 beds. The present investigation was pro-
spective in design, with the analysis of medical records and the direct 
observation of patients admitted during the period from September 
and October 2019. Chi-squared and Wilcoxon tests were used to com-
pare factors associated with diarrhoea and constipation. Statistical 
analysis was performed using the SAS® software. The study protocol 
was endorsed by the Regional Ethics Committee of the Friuli Venezia 
Giulia region (CEUR-2019-Os-170).
Results: Fifty-three patients were enrolled in the study, mostly males 
(n=37; 69.8%), with an average age of 66.6 years (SD 13.4) and a BMI 
of 26.8. For about a half of the sample (n=29; 54.7%) the main diagno-
sis reported at time of admission was organ failure (especially respira-
tory). Diarrhoea affected the patients in 10/53 (18.9%) cases within 72 
hours after admission in ICU, and in 19/53 (35.8%) during the whole 
ICU-stay period. The incidence of diarrhoea in patients who received 
antibiotics and prokinetics was 18% and 37.5% respectively, with no 
differences with patients who received no antibiotics (p=0.37) and 
no prokinetics (p=0.78). Among patients who received laxatives, the 
incidence of diarrhoea was 100%, compared with those received no 
laxatives (13.6%; p=0.001). Against, constipation occurred in 26/53 
(49.1%) patients within 72 hours after admission in ICU, and in 4/27 
(14.8%) on the sixth day. There was no difference between consti-
pated and no constipated patients in terms of opiate and curare use, 
mechanical ventilation, and hypotension. Remifentanil administration 
was associated with increased constipation (p=0.001).
Conclusion: Diarrhoea and constipation are very common among 
critically ill patients in ICU. Diarrhoea was associated with the use of 
laxatives, and constipation was associated with the use of remifentanil.
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Introduction: The handover/handoff process takes place on a daily 
basis in all health care institutions, accounting for a significant portion 
of the work time of health professionals, moments and processes that 
are sometimes neglected and undervalued, although they are consid-
ered critical to patient safety.
Objectives: • Introduce a semi-structured approach, evidence-based, 
in the Nursing handover in a level III ICU.
Methods: Running between December 2017 and March 2018 in a 
level III UCI, based on project work methodology (1), a semi-structured 
evidenced-based approach was introduced, adapted to the context 
combining the ISBAR (Identification, Situation, Background, Assess-
ment, Recommendations) with the primary approach of the critical 
patient ABCDE (Airway, Breathing, Circulation, Disability and Exposi-
tion). It was divided into mandatory items, mandatory reference in all 
handover moments, and optional items related to the specific clinical 
situation.
This strategy was assessed through direct observation of the Nursing 
Handover, with prior obtaining an informed consent, and applying a 
questionnaire to assess the perception of the Nursing team, after the 
implementation of the semi-structured evidenced-based approach, 
with regard to knowledge held on patient safety and the usefulness, 
satisfaction and sensitive and specific gains to the form.
Results: 100 Handover moments were observed. All nurses gave their 
consent for observation and records made during these moments. 
Conformity related to the items referring to the ISBAR mnemonic at 
the observed times was 89.5%, ranging from 100% (Identification 
and Evaluation) to 70% (Situation). The compliance related to items 
referring to the primary ABCDE assessment at the time observed var-
ied from 84% (exposure) and 99% (Airway and Ventilation), with an 
average of 92.25%. An average of 75.65% of mandatory items was 
referenced, ranging from 50% (fluid balance) to 94% (Mechanical Ven-
tilation/Oxigen setings)
With regard to the questionnaire, using a Likert Scale (1-10), a high 
perception of better organization and systematization (7,67) of the 
Nurse’s Handover is notorious, more efficient (7,5) and of better quality 
(7,16), with the constructed semi-structured instrument being consid-
ered useful (7,7), contributing to the increase of satisfaction (7,4) of the 
Nursing team at this fundamental moment to providing excellent care. 
These results are transversal to the literature found, with regard to 
organization and systematization (2-4) efficiency and quality (3,5) and, 
finally, related to the global satisfaction and usefulness of structuring 
the care transition (3, 6-7).
Conclusion: There was little knowledge about the subject of patient 
safety, effected by a relative lack of knowledge in relation to the essen-
tial documents that guide this subject, highlighting the improvement 
of this knowledge after implementation. There was a high rate of com-
pliance, based on the semi-structured tool built for this purpose, in 
relation to the mandatory reference items, the contents contained in 
the ISBAR mnemonic and included in the primary assessment, using 
the ABCDE approach. It is also clear a high perception on the part of 
the Nursing team, after the use of the semi-structured tool, with regard 
to improving the organization, systematization, efficiency, quality and 
satisfaction with the passage of the Nursing shift, with agreement on 
the part of the referred team the usefulness of the tool created and 
adapted.
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Introduction: It has been reported that the vasoactive ventilation 
renal (VVR) score predicts the outcomes of cardiac surgery in children.
Objectives: We investigated whether the VVR score on admission pre-
dicts the length of stay (LOS) in the pediatric intensive care unit (PICU) 
in children diagnosed with heart failure (HF).
Methods: Medical records were reviewed for 96 pediatric HF cases 
between January 2010 and December 2016. A prolonged LOS (PLOS) 
was defined by a longer stay than the median duration for the surviv-
ing cases.
Results: The median LOS in our current patient series was 12 days. The 
VIS (14.1 [7.4, 24.3] vs 8.5 [5.0, 18.3], p=0.018), VVR (27.8 [11.6, 36.2] vs 
11.1 [5.5, 20.7], p<0.001), lactic acid level (mmol/L) (2.8 [1.2, 5.3] vs 1.8 
[1.1, 2.5], p=0.020), and B-type natriuretic peptide concentration (BNP, 
pg/mL) (2340.0 [1234.8, 6836.8] vs 1478.5 [529.8, 4532.8], p=0.036) 
were significantly different between the prolonged LOS versus the 
control group. The use of a mechanical ventilator and extracorporeal 
membrane oxygenation (ECMO) were associated with PLOS (odds 
ratios: 10.82 and 3.61, respectively). The AUCs of the VIS, VVR score, lac-
tic acid level, and BNP for evaluating the association with mechanical 
ventilator or ECMO use were 0.682 (p=0.006), 0.823 (p=0.000), 0.683 
(p=0.006), and 0.783 (p=0.000), respectively. In multivariable logistic 
regression analysis, the VVR score was the only parameter that was sig-
nificant for predicting PLOS.
Conclusion: The VVR score on admission to the PICU is predictive for 
mechanical ventilator or ECMO use, which correlates with a PLOS. The 
VVR score at PICU admission in children with HF is therefore a useful 
LOS marker.
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Introduction: Young children with viral diarrhea lose their body 
weight very quickly, and consequently their anthropometric indicators 
sharply decrease, and malnutrition increases up to cachexia. Thereby, 
it is necessary to perform a short-term assessment of the nutritional 
status of the child, in order to select nutritional supportrationally. The 
purpose of our study was to assess the nutritional disorder in children 
on the first year of life with moderate to severe acute intestinal infec-
tion of viral etiology based on anthropometric research methods.
Methods: We examined 12 children with moderate to severe acute 
intestinal infection of viral etiology. Anthropometric methods for 
assessing nutritional status were used: mass-growth indicators, cali-
perometry with an assessment of the skin-fat fold of the triceps at 
baseline and a week after admission. Evaluation of the indicators was 
carried out according to the calculation formula: body mass index 
(BMI = Weight / Height2 (kg / m2)), centile tables. Used tools: caliper, 
centimeter tape, table scales.
Results: The analysis of the data revealed that by the time of admis-
sion to the hospital 5 (41%) of 12 children showed a decrease in BMI 
by 10%, and 3 (25%) children showed a decrease in BMI by 20%. One 
week later BMI was restored to normal. When assessing the skin-fat 
fold of the triceps, it decrease was found to be 1-2 mm from the norm 
in all studied children (100%), and was regarded as a mild degree of 
malnutrition due to indicators less than the 50-th percentile. By the 
5th day of the ongoing nutritional support, the fold was restored to 
the physiological norm (50th percentile).
Conclusion: Anthropometric methods for assessing nutritional status 
in children with viral diarrhea on the first year of life is found to be easy 
and helpfully.
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Introduction: Underweight on admission to the pediatric inten-
sive care unit (PICU) has been associated with outcome. The Pedi-
atric Sequential Organ Failure Assessment (pSOFA) score has been 
reported as predictor of outcome in critically ill children.
Objectives: The study aim was to assess the effect of organ dysfunc-
tion and nutritional status on outcomes of children admitted to PICU.
Methods: Retrospective study of children admitted to the PICU at 
Texas Children’s Hospital (Jan-Dec 2016) with a length of stay (LOS) 
≥ 3 days; nutritional status assessed by weight for age (WFA: under-
weight), z-scores by WHO and CDC. Malnutrition (MAL) defined as 
mild, and moderate-severe if z-scores were < -1, <-2, respectively. 
Hospital and PICU LOS, risk of mortality (ROM) by PIM2, need of 
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mechanical ventilation (MV) on admission to PICU, and mortality col-
lected. Organ dysfunction (OD) was defined as a pSOFA score > 5, and 
collected on days 1 & 3.
Results: A total of 638 children (367 M/271 F) were included; age 2.8 
yr. (0.6-11; median (25-75th IQR)). 513 (80.4%) children required MV 
on admission, had PIM2 ROM (%), 3.1 (0.9-4.7), PICU LOS, 6.4 days (4.4-
11), Hospital LOS, 17 days (10-31); and PSOFA score on days 1 & 3 of 5 
(4-7) and 5 (3-6) (p < 0.0001, Wilcoxon Signed Rank Test) for a preva-
lence of organ dysfunction of 45% and 38%, respectively. WFA z-score 
of -0.63±1.97 (SD) and the prevalence of underweight was 35.6%; 
moderate to severe underweight was associated with organ dysfunc-
tion; odds ratio (OR) (95% CI) 1.62 (1.10-2.39) (p <0.05). Children with 
malnutrition or OD and children with malnutrition and OD vs. normal 
children were associated with need of MV on admission to the PICU 
and with mortality; 2.29 (1.51-3.47) (p <0.0001), 7.26 (3.04-17.35) 
(p<0.0001); respectively; and 5.04 (1.73-14.69) (p <0.005), 4.02 (1.15-
14.04) (p < 0.05); respectively. A total of 36 children died for a hospital 
ortality rate of 5.64%.
PIM2 ROM (%) PICU LOS Days Hospital LOS Days 
Normal (n=229) 1.40 (0.80-4.07) 5.60 (3.87-8.82) 15 (10-27) 
MAL or OD 
(n=304) 3.18 (0.91-4.98) 6.97 (4.72-11.2) 17 (11-34) 
MAL + OD (n=105) 3.81 (1.19- 7.87 (4.92- 21(11-39)** 
6.39)* 12.1)* 
Values are median (25th-75th IQR); * p < 0.0001, ** p < 0.05 by Kruskal-Wallis  
Conclusion: Organ dysfunction and underweight were commonly 
found on children admitted to the PICU. The presence of either or 
both conditions was associated with higher risk of mortality, need of 
ventilatory support, longer PICU and hospital LOS, and mortality.
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Introduction: A genome-wide DNA-methylation study previously 
identified de novo alterations in leukocyte DNA of critically ill children 
at paediatric intensive care unit (PICU) discharge, which offered a 
biological basis for the impaired long-term neurocognitive develop-
ment of these patients.1 Early use of parenteral nutrition (early-PN) 
in the PICU, as compared with omitting PN in the first week (late-PN), 
explained the differential methylation of 23% of the affected CpG-
sites. It remained unclear how fast these changes in DNA-methylation 
took place and how they evolved over time in PICU.
Objectives: We documented the time course of altered DNA-methyl-
ation in PICU and the impact hereon of early nutritional management.
Methods: We selected 36 early-PN and 36 late-PN patients, matched 
for age, type (admission diagnosis) and severity of illness (PeLOD 
score), infection upon admission, gender, height, weight and educa-
tional level of the parents and 42 age and gender matched healthy 
children. We quantified DNA-methylation on day 3, 5 and 7 for the 147 
CpG-sites of which methylation was normal upon PICU admission in 
this subset, and altered by critical illness at PICU discharge (EPIC Bead-
Chip). For each time point, we determined how many of the CpG-sites 
were differentially methylated in critically ill as compared with healthy 
children, applying ANOVA and FDR 0.05. Next, for each CpG-site, we 
performed within-patients time course analyses of the methylation 
status, to identify any patterns within the time series based on paired 
t-test p-value and direction of change from admission to day 3 and 
beyond. For the CpG-sites affected by early-PN on the last PICU day, 
earlier changes in DNA methylation status -and patterns hereof- were 
compared for early-PN and late-PN patients.
Results: Methylation in patients differed from healthy children for 
64.6% of the 147 CpG-sites on day 3, for 72.8% on day 5 and for 90.5% 
on day 7. Rapid demethylation from admission to day 3 occurred 
for 76.2% of the CpG-sites, of which 67.9% remained equally dem-
ethylated or partially remethylated and 32.1% further demethyl-
ated beyond day 3. From admission to day 3, 19.7% of the CpG-sites 
became hypermethylated, of which, beyond day 3, 34.5% remained 
equally hypermethylated or partially demethylated again and 65.5% 
further hypermethylated. For 4.1% of the CpG-sites, changes only 
appeared beyond day 3. Of the CpG-sites affected by early-PN versus 
late-PN at PICU discharge, 38.9% were already differentially methyl-
ated by day 3, another 25.0% by day 5 and another 13.9% by day 7.
Conclusion: Critical illness- and early-PN-induced changes in DNA-
methylation occurred mainly within 3 days. Most abnormalities were 
at least partially maintained or got worse with longer time in PICU. 
Interventions targeting aberrant DNA-methylation changes should be 
initiated early.
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Introduction: Esophageal atresia (EA) with or without trachea-esoph-
ageal fistula is a common neonatal emergency which may be associ-
ated with major life incompatible cardiac abnormalities1. Survival of 
such neonate depends on stabilization and proper resuscitation fol-
lowed by postoperative care.
Objectives: Keywords- Esophageal atresia, trachea-esophageal fistula, 
single ventricle, PDA, VSD
Methods: Case Report:
We came across a 4 days old male baby, with diagnosis of EA and dis-
tal TEF, posted for right thoracotomy with primary repair under GA. On 
preoperative evaluation baby had respiratory distress, frothing from 
mouth & was hemodynamically unstable on dopamine with oxygen 
saturation (SpO2) of 85% on room air. Intraoperatively surgery was 
uneventful but baby not able to maintain SpO2 even after ligation of 
fistula. At time of reversal of neuromuscular blockade, he had active 
movements, was maintaining SpO2 of 88% with 100% O2 & on dopa-
mine. After extubation he maintained SpO2 of 85% on nasal prongs 
when shifted to PACU. But after 3 hours of surgery, his SpO2 started 
falling & developed persistent cyanosis, so trachea was intubated with 
chest tube insertion on right side done suspecting pneumothorax or 
hemothorax or pleural effusion which were subsequently ruled out, 
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emergency 2 D echocardiography showed large VSD, pulmonary atre-
sia, PDA, single ventricle with Tetrology of Fallot. He was started on 
PGE1, Alprostadil & dobutamine because of worsening hemodynamic 
instability shifted to NICU but was not able to maintain SpO2>75% 
with mechanical ventilation. His general physical condition deterio-
rated over next 2 days and died due to respiratory failure and cardiac 
arrest.
Results: Discussion and Conclusion:
EA- TEF is a major congenital anomaly and when it is associated with 
life incompatible anomalies like single ventricle along with PDA, VSD 
and Pulmonary atresia,it becomes a nightmare and a real challenge 
to both pediatric surgeon andanaesthesiologis1,4.Success in survival 
of neonate with EA-TEF is attributed to improved neonatal care, anes-
thesia and better understanding of neonatal physiology.But unfortu-
nately our institution is not well equipped with emergency cardiac 
back up which if would have been there, then after successful ligation 
of trachea-esophageal fistula, our 4 days old neonate could have been 
saved, who died of respiratory failure and cardiac arrest.
Conclusion: This case emphasizes the importance of considering 
headache &/or visual changes developing during postpartum period 
- a prodrome for LPE even in normotensive patients. Early diagnosis 
with subsequent initiation of anticonvulsants & antihypertensive can 
prevent severe complications.
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Introduction: Longitudinal data on isolated pathogens and trends of 
antimicrobial resistance (AMR) in pediatric intensive care units (PICUs) 
are worldwide limited.
Objectives: To determine the most common microorganisms cul-
tured from biological samples along with AMR trends over the years 
2008-2019 in a university PICU.
Methods: Data from the Infection Control Committee electronic data-
base were retrospectively exported and analyzed.
Results: Out of 2,127 positive cultures, 1,598 were analyzed (529 
duplicates). Overall, Gram (-) microorganisms (972, 60.8%) predomi-
nated, mainly represented by Pseudomonas aeruginosa (365, 37.6%). 
Out of Gram (+) pathogens (475, 29.7%) coagulase-negative Staphylo-
cocci (CoNS) (280, 58.9%) were most commonly found. Fungal positive 
cultures were infrequently reported (151, 9.5%). CoNS increased mark-
edly over the years, compared to other Gram (+) pathogens (p=0.003) 
and were the most consistently identified isolates in blood cultures 
(p<0.001). Gram (-) bacteria resistance rates are shown in Table 1.
Conclusion: Gram-negative bacteria were the most commonly cul-
tured pathogens, mainly represented by P.aeruginosa. Although their 
incidence did not change over a decade, the high carbapenem and 
third-generation cephalosporin resistance rates stress the need for 
strict implementation of infection control bundles and AMR steward-
ship interventions.
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Introduction: There is some evidence supporting the manipulation 
of DA patency in newborns affected by pulmonary hypertension, but 
choosing the appropriate timing for PDA closure is still a challenge.
Objectives: Aim of our study was to evaluate the haemodynamic 
effects of PDA closure during vv-ECMO support.
Methods: We evaluated newborns affected by severe acute respira-
tory failure secondary to pulmonary hypertension on vv-ECMO and 
with PDA, admitted to our ICU between May 2017 and July 2018. We 
collected haemodynamic parameters (MAP, HR, SpO2, NIRS, urinary 
output), blood gasanalysis, biochemical data, respiratory and inotropic 
support at 24 hours pre and 48 hours post-PDA closure (documented 
by echocardiography).
Results: We analyzed 7 newborns (2 males and 5 females), with mean 
gestational age of 36.4 weeks and mean body weight of 2.9 kg. 5 
out of 7 patients were affected by congenital diaphragmatic hernia, 
1 by meconium aspiration syndrome and 1 by hemolytic disease of 
the newborn with hydrops. In 3 cases we obtained pharmacological 
PDA closure (with ibuprofen iv),while 4 patients underwent surgical 
approach. Comparing post vs pre-PDA closure parameters, we found 
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a significant reduction (p< 0.05) in lactate levels (14±7.8 vs 20.5±13 
mg/dl) and epinephrine dose (0.05±0.1 vs 0.08±0.1 mcg/kg/min). We 
also detected a trend in increasing of MAP (58.7±11.8 vs 53.3±15.2 
mmHg) and decreasing of milrinone (0.4±0.33 vs 0.44±0.32 mcg/kg/
min) and iNO (9.3±6.1 vs 12.2±6.9 ppm) support, but with no statisti-
cal significance. There were no differences, instead, in SpO2 (95.6±2.1 
vs 92.4±9.7 %), NIRS (61.8±9.1 vs 61.9±8.1 %) and urinary output 
(6.3±2.7 vs 7±4 ml/kg/h).
Conclusion: During the early phase of severe pulmonary hyperten-
sion, PDA is important to ensure the unloading of right ventricle and a 
better systemic perfusion. With the progressive lowering of pulmonary 
vascular resistances, instead, PDA closure leads to an improvement 
of systemic perfusion indexes (lactates) and a reduction of inotropic 
drugs.
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Introduction: Stroke after coronary artery bypass surgery (CABG), is a 
serious complication with an incidence of 1.3% and a reported mor-
tality of 20%. Identification of intraoperative and early postoperative 
pathogenetic mechanisms is important for developing preventive 
strategies
Objectives: To evaluate perioperative factors related to postoperative 
stroke in coronary artery bypass surgery (CABG
Methods: All patients who underwent CABG procedure with the use 
of cardiopulmonary bypass from June 2012 to February 2020 and 
were complicated with postoperative ischemic stroke, were retro-
spectively evaluated. The following perioperative factors were com-
pared between stroke patients-Group A, and control group B: Female 
gender, history of stroke, current smoking, asymptomatic carotid 
disease(>50% stenosis), diabetes mellitus, cardiopulmonary bypass 
time(CPB),low cardiac output syndrome(LCOS) and postoperative 
atrial fibrillation
Chi square test was used for statistical analysis
Results: From a total of 2339 CABG patients (37 off pump procedures 
were excluded), 43 were complicated with postop ischemic stroke






Age 65,6±9 64,9±9.5  
Female (n,%) 11(25,6%) 320(13,9%) 0,04 
History of stroke  8(18,6%) 214(9,3%) 0,06 
Smoking 12(27,9%) 834(36,5%) 0,28 
Carotid disease 10(23,7%) 286(12,5%) 0,04 
Diabetes 22(51,2%) 889 (38,7%) 0,11 
CPB>120 min 13(30,2%) 406(17,7%) 0,03 
LCOS 7(16,3%) 142(6,1%) 0,03 
Post-op AF 24(55,8%) 670(29,2%) <0,01 
Conclusion: Female gender, carotid disease, CPB time > 120 min, 
LCOS and postoperative atrial fibrillation are factors with statistical 
significant relationship with postoperative ischemic stroke after CABG
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Introduction: Surgical revascularization is the only therapeutic choice 
in many patients with coronary artery disease. The optimal timing of 
coronary artery bypass grafting(CABG) after myocardial infarction (MI) 
remains unclear
Objectives: To investigate if time interval between myocardial infarc-
tion and elective CABG has any impact on early postoperative morbid-
ity and mortality
Methods: All patients with a history of myocardial infarction, who 
underwent CABG procedure with the use of cardiopulmonary bypass 
from June 2012 to February 2020, were retrospectively evaluated. 
Exclusion criteria were : Rescue CABG and off pump procedures. Based 
on time distance from myocardial infarction(MI) patients were divided 
in : MI < 1 month (Group Α) and MI > 1 month (Group Β) The following 
factors were compared between the groups: post-op use of Intra-aor-
tic Balloon Pump (ΙΑΒΡ), use of Levosimedan for inotropic support, 
atrial fibrillation (AF), acute kidney injury(AKI), prolonged mechani-
cal ventilation (>24 hours), perioperative myocardial infarction (PMI) 
and mortality. We also compared patients with MI < 1week (Group C) 
with the rest of the cohort (Group D). Age, gender, Euro score II were 
similar between the groups. Chi square test was used for the statistical 
analysis






Use of ΙΑΒΡ (n,%) 57 (12,2%) 45 (7,1%) 0,004 
Levosimendan (n,%) 49 (10,5%) 43 (6,8%) 0,03 
AF(n,%) 150 (32,1%) 201 (31,7%) 0,87 
AKI(n,%) 50 (10,7%) 94 (14,6%) 0,1 
Prolonged ventilation 
(n,%) 
17 (3,6%) 20 (3,1%) 0,65 
PMI(n,%) 5 (1,1%) 8 (1,3%) 0,8 
Mortality (n,%) 13 (2,8%) 8(1,3%) 0,07 






Use of  ΙΑΒΡ (n,%) 14 (17,3%) 88 (8,6%) 0,01 
Levosimendan(n,%) 11(13,6%) 81 (7,9%) 0,08 
Prolonged vent 
(n,%) 
9 (11,1%) 28 (2,7%) <0,01 
PMI(n,%) 4 (4,9%) 9 (0,9%) 0,01 
Mortality (n,%) 4 (4,9%) 17(1,7%) 0,04 
Conclusion: In patients who underwent CABG during the first month 
from myocardial infarction ΙΑΒΡ and Levosimendan were more com-
mon required. Patients with time interval of 1 week had higher mor-
tality, while use of ΙΑΒΡ was more frequent. Perioperative myocardial 
infarction and prolonged mechanical ventilation were also more 
frequent
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Introduction: Postoperative atelectasis after cardiac surgery with 
median sternotomy, occurring 32 to 68% [1] [2] [3], is commonly 
considered as a cause of postoperative hypoxia. On the other hand, 
re-expansion pulmonary edema (RPE), rather than atelectasis, is fre-
quently considered as a cause of postoperative hypoxia after mini-
mally invasive cardiac surgery (MICS) with right mini-thoracotomy 
although the reported incidence of RPE is only 2.1% [4]. There is no 
previous study reporting the incidence of postoperative atelectasis in 
patients who had MICS with right mini-thoracotomy.
Objectives: The aim of this study is to assess the incidence rate of 
postoperative atelectasis in patients who underwent a right mini-thor-
acotomy MICS.
Methods: We retrospectively investigated the incidence rate of 
postoperative atelectasis in patients who underwent a right mini-
thoracotomy MICS between January 2017 and December 2018 in our 
hospital. Postoperative chest X-rays were reviewed by two independ-
ent doctors and diagnosis of atelectasis was made only when two 
doctors agreed. We included only atelectasis defined by collapse or 
incomplete expansion of the right lung or part of the right lung and 
excluded pulmonary edema without volume loss of the lung field.
Results: One hundred fifty patients underwent right mini-thoracot-
omy MICS during the period. We excluded 3 patients who had reop-
eration on the same day because of complications of the first surgery 
and we included total of 147 patients. The mean age was 59.1 years 
and 57% were male. 48 patients (32.7%) were diagnosed with atelecta-
sis on the operated side. Cohen’s kappa inter-evaluator reliability was 
0.637. Most conducted surgery was mitral valve surgery (82 patients, 
55.8%). RPE was detected only in six patients (4.1%).
Patients with postoperative atelectasis were older (mean age; 64.8 vs 
58.9, P = 0.035) than patients without postoperative atelectasis. There 
was no statistical difference in the incidence of atelectasis between 
aortic valve surgery and mitral valve surgery (37.2% vs 30.5%, P = 
0.29).
Conclusion: We detected about 30% postoperative atelectasis on 
the operated side after right mini-thoracotomy MICS. Atelectasis is a 
common postoperative complication not only in cardiac surgery with 
median sternotomy but also in MICS with right mini-thoracotomy. 
Atelectasis should be included in the differential diagnosis for post-
operative hypoxemia after MICS with right mini-thoracotomy because 
postoperative atelectasis can be rapidly improved with active physical 
therapy.
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Introduction: The literature, qualitative feedback and personal expe-
rience tells us that simulation provides a highly effective platform for 
learning owed to its’ fully immersive design which aims to replicates 
substantial aspects of real life for a medical professional [1] but with-
out putting patients at risk. Yet it is hard to quantify if it is more effec-
tive than the traditional didactic equivalents and if it is, as we suspect 
it is, to what degree [2]. Secondly, it remains almost impossible to 
evaluate whether the clear technical and non-technical learnings, that 
take place during a full day of simulation, are put in to practice upon 
an individual’s return to work.
Here we describe a simulation design which enable the learning from 
simulation and the simulation debrief to be put into practice immedi-
ately within an individuals’ workplace, with their usual colleagues, in 
the same morning. This is likely to be a superior model for in-situ simu-
lation going forward. Barking, Havering and Redbridge University Trust 
(BHRUT) hold anaesthetic and theatre clinical governance meetings on 
a monthly basis and thus, all theatre activity is stopped across site for 
an entire morning. On these mornings theatre staff are asked to come 
in as normal and hence this presents a perfect opportunity for training.
Objectives: We aim to demonstrate that learning and knowledge 
through the proposed SIM, RECORD, REPLAY, REPEAT process is more 
likely to be retained as a result of making errors and correcting errors 
in consecutive simulations, respectively, within their work environ-
ment and with their usual team.
Methods: The simulation team, the junior on-call anaesthetist, the 
consultant anaesthetist on-call and a full cohort of theatre staff includ-
ing, ODPs, scrubs nurses and anaesthetic nurses were involved in an 
in-situ simulation scenario of anaphylaxis on induction.
The simulation was recorded on the ‘SMOTS™ In-Situ System’ cameras 
with playback SMOTS technology [3]. The simulation ran for 10-min-
utes in a functional theatre and the debrief that followed took place 
immediately afterwards in the neighbouring empty theatre. Staff 
first watched their performance back and then debriefed their per-
formance, stating which technical and non-technical factors they felt 
they underperformed in and how these could be corrected. Staff were 
then given the opportunity to take part in an identical simulation, 
retaining the same roles, in an endeavour to improve aspects of their 
performance that they identified as suboptimal.
Results: Result collection is ongoing at time of writing: Through this 
work we hope to demonstrate that a second playback and debrief of 
a second consecutive identical in-situ simulation will provide evidence 
of significant improvements in performance. More importantly, we 
hope to demonstrate that learning and knowledge through this pro-
cess is more likely to be retained as a result of making errors and cor-
recting errors in consecutive simulations, respectively.
Conclusion: We put the ‘SIM, RECORD, REPLAY, REPEAT’ process 
described here forward as a superior model for in-situ simulation train-
ing because of the obvious advantages of the conditions (no theatre lists, 
same workplace, same team) together with being able to action both 
technical and non-technical learnings with immediate effect. We postu-
late that learnings in these conditions are more likely to make it into the 
working environment as a result of the usual team being involved and 
bearing witness to improvements over a short period of time.
We believe this model can be extrapolated to ITU and other areas 
of medicine and  we would encourage staff and managers to look to 
create space for this model of learning owed to the clear benefits for 
patient safety.
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Introduction: Vitamin C has been investigated for a wide variety of 
uses within intensive care due to its anti-oxidative properties (1, 2, 3). 
Research regarding its potential for the prevention of postoperative 
atrial fibrillation (POAF) after cardiac surgery is ongoing but results 
remain inconsistent (4, 5, 6). Due to a broad intracellular anti-oxidant 
effect, several postoperative pathological effects might be mitigated. 
Taking into account the low cost of vitamin C, it might be more valu-
able to investigate a pharmaco-economic benefit in addition to an 
effect on POAF.
Objectives: Our primary goal was to investigate the pharmaco-eco-
nomic impact of perioperative supplementary oral ascorbic acid intake 
in patients undergoing coronary artery bypass graft surgery (CABG). 
Secondary endpoints were the effects on the length of stay in both the 
intensive care unit (ICU) and the hospital and the incidence of POAF.
Methods: After IRB approval, patients planned for CABG who met the 
inclusion criteria (in cardiac sinus rhythm preoperatively and not tak-
ing supplementary vitamin C independently) were randomized into a 
placebo group and an intervention group. The medication was given 
orally, 1 gram twice a day, starting from 5 days preoperatively until 10 
days postoperatively. The used medication, length of hospital and ICU 
stay and development of POAF in ICU were recorded. We report the 
preliminary results with a calculated target sample size of 75 patients. 
Significant differences were assessed using an independent T-test and 
a Mann-Whitney U test.
Results: Of the 119 screened patients, 68 patients completed the 
study. Except for BMI (p=0.029), there was no statistically significant 
difference in baseline characteristics. (Table 1) The median pharmaco- 
economic cost was significantly lower (P=0.009) in the vitamin C 
group (€ 1636) than in the placebo group (€1687). There was no sig-
nificant difference in the incidence of POAF or length of stay. (Table 2)
Table 1. Demographics 
Vitamin C Placebo 
Age (Mean; Standard Deviation) 66 (10) 66 (8) 
Male/Female (Count) 24/6 31/7 
BMI (Mean; Standard Deviation) 25,9 (3,1) 28,0 (4,5) 
Table 2. Results 





(€ 1299- € 
3662) 
€ 1636 
(€ 663 -€ 
1892) 
0.009 
Length of hospital 
stay (days) (Median; 
min-max) 
7 (5-14) 7(5-9) >0.05 
Length of ICU stay 
(hours) (Median; min-
max) 
36 (8-93) 28 (21-68) 
>0.05 
POAF incidence 7/38 (18.4%) 7/30 (23.3%) >0.05 
Conclusion: In this preliminary analysis, Vitamin C had a small phar-
maco-economic benefit when used in the perioperative period of 
CABG surgery. No effect was found on the length of stay or the inci-
dence of POAF. However, we should acknowledge the fact this is pre-
liminary data and further inclusion is warranted. Potential benefits in 
other types of cardiac surgeries should also be investigated.
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Introduction: Cardiac surgery patients receive large amounts of fluid 
perioperatively. Some studies demonstrated that an intraoperative lib-
eral infusion of fluids was associated with increased morbidity.
Objectives: The aim of this study was to evaluate the impact of intra-
operative excessive fluid balance in relation to early acute kidney 
injury and mortality in patients undergoing off-pump coronary artery 
bypass graft surgery.
Methods: A prospective cohort study during 1 year in two tertiary 
hospitals. The study included consecutively patients aged 18 years 
or more who required postoperative ICU after undergoing off-pump 
coronary artery bypass graft surgery. Patients were compared intra-
operatively to those who received excessive fluid balance (EFB) or not 
(non-EFB). The primary endpoint was early acute kidney injury.
Results: After matching, 180 patients remained in each group. The 
percentage of acute kidney injury was 31.7%. The intraoperative fluid 
balance from non-survivors was higher. Patients with fluid balance 
above 2500 mL intraoperatively had a higher incidence postopera-
tively of composite cardiovascular complications, intra-aortic balloon 
pump requirement and mortality, but not early acute kidney injury.
During the study period, 586 surgical patients were enrolled (329 
excessive fluid balance and 257 non-excessive fluid balance)
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The postoperative complications are shown Table 1. Although no dif-
ferences were observed in acute kidney injury between the EFB and 
non-EFB (P = 0.36), the cardiovascular complications postoperatively 
were higher in EFB group. Also, mortality rates were statistically differ-
ent in EFB (10%) and in non-EFB (3.9%) groups P =0.02.
Table 1. Postoperative outcomes 



















12(2,2%) 39(6.6%) 0.003(1.7%) 11(6.1%) 0.02  
Acute kidney 




2 (1-4) 2 (1-4) 0.593 (1 – 4) 2 (1 – 4) 0.29  
Hospital LOS 
(d), median (IQ 
25–75) 
17 (11-26) 16 (9-25) 0.3015 (9 - 23.75) 
22 (13 - 
30.75) 0.01  
Hospital 
mortality rate 53(9,0%) 66(12%) 0.107(3.9%) 18(10.0%) 0.02  
Legends: EFB - Excessive fluid balance. ICU – intensive care unit. All values between 
parentheses represent percentile 25-75 values observed.  
Conclusion: Patients undergoing off-pump coronary artery bypass 
with excessive intraoperative fluid balance have more complications 
and higher hospital mortality, but the same incidence of early acute 
kidney injury.
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Introduction: Acute kidney injury (AKI) is a significant complication 
in the care of patients with end-stage liver disease (ESLD) after liver 
transplantation (LT). In the present study, we addressed the question 
of whether those with AKI had a greater difference (deficit) between 
premorbid and within-ICU hemodynamic pressure-related parameters 
compared to those without AKI.
Methods: Prospective observational study including all patients 
admitted to the ICU after liver transplantation over a 3-years study 
period. Demographic variables (sex, age, cause of transplantation and 
severity scores), hemodynamic variables, and those related to graft 
function and postoperative complications were recorded. Patients 
were classified according to the development of AKI.
We obtained premorbid and ICU, time-weighted average values for 
hemodynamic pressure-related parameters (systolic [SAP], diastolic 
[DAP], and mean arterial pressure [MAP];central venous pressure 
[CVP], mean perfusion pressure [MPP], and diastolic perfusion pressure 
[DPP]) and calculated deficits in those values.
Data statistical analysis was done using SPSS software. Quantitative 
variables are expressed as mean with standard deviation (SD) and 
qualitative variables as absolute and relative frequencies. The statisti-
cal significance of the proportion comparison was addressed by the 
chi-square test, Mann Whitney U test or Student ́s t-Test with a statisti-
cal significance p < 0.05.
Results: During the study period, 100 patients were admitted to the 
ICU after a liver transplantation (80% male) with a median age of 56 
(IQR 50-61). The main causes of the liver transplant were alcoholism 
(58%), hepatocellular carcinoma (45%) and hepatitis C virus infection 
(43%). Median MELD score was 13 (IQR 9-19); Median ICU stay was 5 
days (IQR 4-9), with an overall ICU mortality of 8%.
Fifty nine patients presented AKI, which was associated with a signifi-
cantly higher ICU stay (4 vs 6, p=0.005), higher hospital stay (13 vs 20, 
p=0.005) and higher ICU mortality (0 vs 8, p=0.001) .
All achieved pressure-related values were similar between patients 
with or without AKI progression. However,  a significantly greater 
increase in CVP was observed in patients with AKI (0 vs 27%, p=0,039).
Conclusion: Acute Kidney Injury after liver transplantation is a fre-
cuent complication wich is associated with worse outcomes. The 
hypervolemia defined as an early  increase in CVP could be a modifi-
able factor.
Reference(s) and grant ackowledgment(s)
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Introduction:
Nutritional status influences periorperative outcomes in patients with 
heart failure and cardiac surgery
Objectives: The aim of our study was to assess the influence of nutri-
tional status on the results and prognosis of patients undergoing car-
diac surgery.
Methods:
Prospective observational study from 2011 to 2015. Preoperative 
nutritional status was assessed using the Prognosis Nutritional Index 
(PNI). PNI was calculated as 10 x serum albumin (g/dL) + 0.005 x total 
lymphocyte count (per mm3).Preoperative and intraoperative vari-
ables, postoperative complications, and hospital and long-term mor-
tality were collected in a local database.
Results: 1279 patients were included: mean age 67 (59-73.43) years; 
68.49% (876) were men; BMI: 27.3 (24.9-30) Kg/m2; APACHE II: 12 
(9-15). 54.03% (691) were valve surgeries and 40.27% (515) bypass 
surgeries. Hospital mortality was 6.8% (87). The patients were classi-
fied according to the nutritional status based on PNI values in three 
subgroups:
Normal 64.8% (829), Moderate 20% (256) and Severe 15.2% (194).
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Univariate analysis between subgroups identified higher postopera-
tive complications and mortality in the subgroups with the worst PNI. 
The multivariate analysis showed a longer mean hospital stay (24 (16-
33) vs 29.5 (21.75-41) days; OR: 1.015; 95% CI: 1.006-1.024; P=0.001) in 
the moderate subgroup when compared to the normal one. Likewise, 
a higher
degree of renal dysfunction was observed (93 (77-115) vs 113 (83-
169) umol/L of creatinine; OR: 1.003; 95% CI: 1.001-1.005; P=0.005), a 
greater mean hospital stay (24 (16-33) vs 33 (24-49) days; OR: 1.022; 
95% CI:1.009-1.034; P<0.001)and a longer time in mechanical ven-
tilation (14 (8-20) vs 18 (10-68) hours; OR: 0.998; 95% CI: 0.996-0.999; 
P=0.01) in the subgroup of patients with severe PNI compared to the 
normal subgroup.
Conclusion: A higher PNI may be associated with greater postopera-
tive complications (i.e., renal and respiratory) after cardiac surgery, as 
well as a longer hospital stay in our population.
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Introduction: Signs of inadequate cardiac output in the post-oper-
ative phase after major surgery is often treated with fluid in order to 
optimize preload [1]. Given that overly aggressive fluid treatment 
is likely to worsen outcome, prediction of fluid responsiveness by 
dynamic indices should be used in patients with circulatory instability 
to identify those likely to respond to fluid therapy with an increase in 
cardiac output [2]. However, preload is dependent not only on blood 
volume but also on venous tone meaning that fluid responsiveness 
may be related to a lower than normal venous tone rather than hypo-
volemia [3]. If so, this could imply that a pharmacological increase in 
venous tone can be a more rational approach to increase preload in 
some preload responsive patients.
Objectives: To assess the prevalence of hypovolemia in a cohort of 
patients likely to be preload responsive.
Methods: Data from the randomized controlled trial AIR was analyzed 
[4]. The AIR trial included post-operative patients after major abdomi-
nal surgery and was approved by the regional ethical vetting board in 
Lund, Sweden.
Inclusion criteria for the present analysis were post-operative patients 
with signs of hypoperfusion: a) ScvO2 < 70%, b) lactate >2 mmol/L, c) 
urine output <0,5 ml/kg in the hour prior to inclusion or d) systolic BP 
<100 mmHg or MAP < 55 mmHg. In spontaneously breathing post-
operative patients the passive leg raising test appear to be the most 
useful predictor of preload responsiveness [5,6]. A positive passive leg 
raising test was used to identify patients likely to be preload respon-
sive and was defined as an increase in pulse pressure (ΔPP) of > 9%, 
measured through an arterial line [7].
Plasma volume(measured using 125I-albumin) and hematocrit (meas-
ured spectrophotometrically) was used to calculate blood volume 
(BV). Normal BV was estimated based on length, weight and gender 
[8,9]. Patients were considered hypovolemic if the measured BV was at 
least 10% lower than the predicted normal BV, as previously defined 
[10]. We defined hypervolemia as at least 10% higher BV than the 
predicted normal value. Data are presented as median (interquartile 
range) or as proportions.
Results: A total of 40 patients were included in the analysis. Baseline 
characteristics can be seen in Table 1.
Median blood volume in the cohort was 4051 (3373-5275) ml or 55 
(49-64) ml/kg. A total of 43% (17/40) of the patients were hypovolemic, 
32% (13/40) were euvolemic and 25% (10/40) were hypervolemic (Fig-
ure  1). A correlation analysis showed no correlation between blood 
volume and ΔPP after PLR (Spearman, R = -0.109 [95% CI -0.414-0.219, 
P=0.505).
Table 1 - Patient demographics 
Age, yrs 67 (54-73) 
Weight, kg 71 (62-85) 
Height, cm 167 (163-176) 
2ASA (2-3) 
POSSUM physiology score 15 (13-17) 
Revised Cardiac Index Score 1 (1-1) 
Duration of surgery, min 402 (329-480) 
Duration of anesthesia, min 506 (439-585) 
Peroperative bleeding, ml 600 (263-1000) 
Peroperative diuresis, ml/kg/h 0.6 (0.4-1.0) 
Peroperative crystalloids, ml 4325 (3963-5250) 
Peroperative colloid, ml 725 (500-1000) 
Conclusion: A large fraction of hemodynamically unstable post-oper-
ative patients likely to be preload responsive are not hypovolemic and 
in these patients a pharmacological increase in venous tone may be a 
more rational approach to increase preload than further intravenous 
fluid administration.
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Introduction: Most important problem of early post- operative 
period post major abdominal surgeries is Intestinal Failure (IF) which 
if unmanaged properly might lead to Abdominal Compartment Syn-
drome, ultimately causing Multiorgan Failure. Postoperative IF is sup-
pression of motor-evacuation function, alteration of small bowel 
digestive, food intake capability, developing critical water-electrolyte 
imbalance, circulatory hypoxia of bowel wall, dysbacteriosis with prox-
imal microbial colonization of bowels, accompanied by changes in 
acid-base balance. Main reason is inadequate infusion therapy during 
perioperative period. Liberal infusion therapy might aggravate visceral 
edema of ischemic bowels, while as insufficient infusion therapy might 
aggravate splanchnic ischemia
Objectives: Improving result of surgical treatment of patients post 
emergency abdominal surgery with selection of perioperative infusion 
therapy strategies, optimal for postoperative restoration of intestinal 
function
Methods: Research work included 60 patients (28 male, 32 female, 
average age 56.5 ± 14 years) post emergent abdominal surgeries, 
divided into 2 groups. In group 1 (n=29) perioperative infusion ther-
apy included balanced ionic solutions. 2nd group (n=31) balanced 
ionic solutions was combined with synthetic colloids. For investigation 
of intestinal function in postoperative period, complex assessment 
of gastrointestinal tract condition, including physical examination, 
measuring of intra-abdominal pressure (IAP), ultrasound visualization 
of condition of intestinal wall as well as absorptive function of gastro-
intestinal tract, laboratory monitoring, perioperative infusion therapy 
was recorded, monitoring of vital functions
Results: The correlation reviewed was strong significant (r= 1.000, 
p=0.01) between the amount of infusion therapy and stage of IF. Day 1 
& subsequent two days, patients in both groups showed IF 3rd stage. 
Signs of bowel function recovery were observed by Day 4. Correlation 
analysis, strong significant correlation between stage of IF and lumen 
diameter of small bowel (r=0.931), intestinal wall thickness (r=0.940), 
IAP (r=0.998, P=0.01). The IAP as parameter with highest r compared to 
other parameters was considered prognostic index for the IF dynam-
ics, used to determine tactics of infusion therapy. In group 2, signifi-
cant correlation was found between intraoperative infusion volume 
and IAP (r=0.417), demonstrating that both excessive & insufficient 
infusion load results in increased IAP on Day 1. Investigation of influ-
ence of infusion therapy quality on intestinal failure stage discovered 
that inclusion of a third generation hydroxyethyl starch infusion solu-
tion (patients of group 2) lowered infusion therapy influence on the 
bowels condition. Analysis of influence of infusion therapy quality on 
IAF and IF severity did not find significant differences between use and 
non-use of colloids as a part of infusion therapy; nevertheless, a trend 
towards more favorable course of IF in patients of group 2 was noted. 
Hence, the presence of colloids as a part of infusion therapy can be 
considered influence on IF severity
Conclusion: The amount of intraoperative infusion therapy has direct 
effect on postoperative intestinal function. Optimization and adminis-
tration of oriented infusion therapy in postoperative periods leads to 
early regression of intestinal failure
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Introduction: Arterial hypotension following spinal anaesthesia is a 
common issue in clinical practice, possibly leading to major compli-
cations in emergency settings [1]. To prevent this, standard adminis-
tration of intravenous fluids is usually performed. Inferior vena cava 
(IVC) ultrasound [2] and passive leg raising test (PLRT) [3] are effective 
methods in guiding fluid therapy in non-critical patients.
Objectives: Aim of the study was to evaluate IVC ultrasound and 
PLRT guided volaemic optimisation compared to standard of care in 
patients undergoing spinal anaesthesia, in order to decrease post-
anaesthesia hypotension rate and excessive fluid administration.
Methods: This prospective, controlled, randomised trial included 474 
consecutive patients, allocated in a block of six into a  control group, 
an IVC-ultrasound group and a PLRT group. Inclusion criteria were adult 
patients of both sexes,  evaluated as American Society of Anaesthe-
siology (ASA)-risk class I to III  4, undergoing an  elective intervention 
under spinal anaesthesia. Patients from the three groups received the 
same standard non-invasive monitoring.
 Control group:  According to standard of care, volaemic filling 
status was not checked prior to the procedure. Post-spinal anaes-
thesia hypotensive patients were treated according to standard 
protocol and clinical situation with crystalloid replacement and 
vasoactive drugs.
 IVC-ultrasound group:  IVC collapsibility index (IVC-CI) of 
36%5  was chosen as the cut-off level to differentiate  respon-
sive (with IVC-CI >36%) or unresponsive patients (IVC-CI <36%) 
to fluid administration. In case of  responsive  pattern, 500 ml of 
crystalloid infusion over 20 minutes was administered.
 PLRT group: Before and after the PLRT, etCO2 analysis was per-
formed; patients with an etCO2 increasing more than 12% from 
baseline were interpreted as responsive3 and received crystalloid 
infusion.
Primary outcome was the hypotension rate reduction after spinal 
anaesthesia. Secondary outcomes were fluid amount administered, 
the amount of vasoactive drug used and the time needed to perform 
the whole anaesthetic procedure.
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Results: An 11% reduction rate in hypotension (p = 0.047) was 
observed between the  IVCUS group  and the control group. A 2% 
reduction rate in hypotension (p = 0.428) was observed between 
the PLRT and the control group. Total fluid amount administered was 
greater in the IVCUS than in the control group (593 ml versus 453 ml, 
p = 0.014), but selectively administered, according to patient’s volae-
mic status. Total amine consumption was 36% in control group, 16% 
in IVCUS group and 22% in PLRT group. Procedure time was increased 
in the IVCUS group (48 min) compared to control group (46 min) and 
PTLR group (40 min), p = 0.35.
Conclusion: IVCUS-guided fluid replacement was a method able to 
generate a significant reduction in post-spinal arterial hypotension 
rate.
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Introduction: Conventional goal-directed therapy(GDT) as used in 
perioperative & critical care to optimize resuscitation, has had mixed 
outcomes. (Gelman 2020) The venous-to-arterial partial pressure of 
CO2  difference (DCO2) reflects oxygen supply to demand adequacy 
and has been suggested to improve resuscitation in sepsis. (Mallat 
et  al. 2016)(Nassar and Mallat 2019) We hypothesized that a DCO2 
guided GDT protocol would decrease morbidity after major surgeries.
Objectives: To compare the incidence of postoperative organ dys-
function, length of ICU, and hospital stay in patients undergoing major 
surgeries when managed by a goal-directed DCO2 aided protocol ver-
sus usual care.
Methods: This was a double-blind randomized controlled trial (RCT), 
permitted by the institutional ethical committee and registered pro-
spectively (CTRI/2018/07/014987). Conducted from July 2018 to May 
2020 in an 800 bedded university teaching center with 16 multispe-
cialty theatres and 14 bedded intensive care unit. 100 ASA1/2 patients 
undergoing elective major surgeries and planned for arterial and cen-
tral venous catheters were randomized (computer-generated random 
numbers) and allocated (sealed opaque envelopes). In both groups, 
arterial and venous blood samples were collected second hourly (or 
earlier in the intervention group (I) if changes were made). Fluid man-
agement was based on a prespecified protocol that used pulse pres-
sure variation (PPV), central venous saturation (SCVO2), hemoglobin 
(Hb), and DCO2 levels to guide GDT in group I. Dobutamine infusion 
was started if DCO2 was > 6mmHg, other parameters being normal. 
(Figure1). Control group C was provided care as per unit protocols. 
Patient demographics, details of the surgery, duration, hemodynam-
ics, fluid balance, vasopressors and inotropes used, blood gas reports, 
and ICU parameters like APACHE and S071OFA scores were noted for 
48 hrs after surgery. Organ dysfunction was defined as an increase in 
SOFA score from the preoperative value. Appropriate statistical tests 
were applied for sample size calculation and comparing the outcomes.
Results: Data were analyzed from 44 patients in each group. Patients 
were similar between the groups. The majority of the patients under-
went oncosurgery (64%), followed by neurosurgery (16%) and uro-
surgery (10%). Length of ICU stay in group I (M= 1.52, SD 0.82) was 
significantly less than group C (M= 2.18, SD= 1.08, t= 3.21, p= .002).
The incidence of complications and the length of hospital stay were 
comparable between the groups.
Conclusion: Conclusion- In this RCT a protocolized approach of DCO2 
guided goal-directed therapy in patients undergoing elective major 
surgery, resulted in a significantly decreased length of ICU stay. The 
concept of using DCO2 seems both elegant and cost-effective in major 
surgeries (where arterial and central lines are already planned) and 
may prove of benefit in the era of enhanced recovery after surgery. 
Better powered multicentric studies in patients with comorbidities 
may demonstrate a difference in organ dysfunction and other out-
comes in the future.
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Introduction: MDR colonization is a major issue for perioperative 
and intensive care medicine frequently resulting in life-threatening 
infections.
Objectives: Within our ICU admissions, the aim of this study was to 
evaluate MDR colonized patients undergoing surgery and their post-
operative course compared to non colonized patients.
Methods: We retrospectively analyzed all consecutive patients under-
going surgery in our hospital for a period of 21 months (July 2017-
April 2019) that required ICU admission on POD 0. We then compared 
MDR colonized (rectal and/or pharyngeal swab) patients (MDR+) to 
non colonized patients (MDR-) for post operative complications, ICU 
and hospital LOS and mortality. We also investigated the impact of tar-
geted perioperative antibiotic therapy compared to empiric antibiotic 
prophylaxis (https://www.save.veneto.it/home-sanitari/).
Results: 540 patients were included in the study (352 men, 65%), 
mean age 68±12 years; they underwent either elective (n=477, 88%) 
or emergency (n=63, 12%) surgery; 234 (44%) were submitted to 
pancreatic surgery, 137 (25%) to hepato-biliary surgery, 100 (19%), to 
intestinal resection and the rest to other abdominal/vascular surgery; 
they were admitted to ICU on POD 0 for scheduled (n =461, 85%) or 
unscheduled intensive PO monitoring.
143 pts were pre operatively MDR+ (27%), 54 (38%) of whom were 
either Klebsiella Pneumoniae Carbapenemasis Producer or Enterococ-
cus Faecium VRE colonized and 115 (80%) were ESBL colonized. ICU 
LOS was significantly higher in MDR+ compared to MDR- (8.02±13.8 
vs 2.39±3.4 days, p <0.05). Hospital mortality occured in - patients, - 
were MDR+, - of them in the ICU. Complication rate and type were sig-
nificantly higher in MDR+ patients (97, 68%) compared to MDR- (118, 
30%).
88 MDR+ patients (52%) received targeted pre-operative antibiotic 
therapy compared to standard prophylaxis but, despite a trend, this 
did not influence their outcome significantly.
Conclusion: Pre-operative surveillance swab positivity correlates with 
both ICU LOS and post-operative mortality. Targeted perioperative 
antibiotic prophylaxis may modify patient’s outcome and this should 
be routinely evaluated. More studies are needed to further investi-
gate the possibile therapeutic options in MDR+ patients undergoing 
surgery.
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Introduction: Orthotopic liver transplantation (OLT) is the only effec-
tive treatment for end stage liver disease (ESLD) [1]. Advanced liver cir-
rhosis has numerous pathophysiological consequences that leads to 
difficulty in controlling fluid balance. The OLT procedure also has sig-
nificant haemodynamic consequences [2]. Goal-directed fluid therapy 
(GDFT) has been shown to reduce postoperative complications in the 
general surgical population [3] but the value of post-operative GDFT 
has not been established in patients with liver cirrhosis undergoing 
OLT.
Methods: A systematic review was conducted on GDFT post OLT by 
searching EMBASE, MEDLINE and PubMed databases. Human stud-
ies from 01/01/1980 to 10/06/2020 investigating goal directed fluid 
therapy in the post-operative period after OLT were included. We 
excluded animal experimental studies, those not reported in English 
language, and non-OLT studies (eg living donor hepatectomy) and 
studies that did not directly investigate a haemodynamic variable.
Results: Of the 533 studies identified by the search terms 522 were 
excluded for lack of relevance or were duplicates. Of the remaining 
11, 9 were excluded (non-OLT surgery (1), no haemodynamic variable 
monitored (7) and one transfusion study). One RCT and one cohort 
analysis evaluated GDFT in the immediate (0-72 hours) postoperative 
setting of liver transplantation (110 participants).
Of the two studies Martin et  al (2019) reported a randomised, con-
trolled feasibility trial of GDFT post OLT. In this study GDFT was based 
on SV optimisation in the first 12 hours post operatively. Controls 
received standard of care without the use of cardiac output measure-
ment.  SV optimisation was achieved by repeated boluses of 250ml 
crystalloid until a <10% increase in SV was seen. It was demonstrated 
that delivering GDFT immediately post-OLT is safe and feasible. The 
GDFT group had significantly higher volumes of crystalloid infusion. 
Although there were signals of reduced length of ICU and hospital 
stay thestudy was not powered to demonstrate a clinical benefit. [4]
Reydellet et  al (2014) conducted a retrospective analysis of patients 
undergoing OLT before and after introduction of a GDFT protocol. 
The GDFT protocol was based on several haemodynamic parameters. 
Haemodynamic optimisation intraoperatively and in the first 48 hours 
postoperatively was achieved with drugs or fluids. A transfusion pro-
tocol with Hb >8 g/dl or ScvO2 >70 % as the targets was also used. 
The control was physician guided fluid therapy prior to introduction 
of the protocol. Contrary to the COLT study, the protocol group in this 
cohort received significantly less crystalloid volume. The study also 
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demonstrated a significant reduction in post-operative ileus and dura-
tion of mechanical ventilation in the protocol group. [5]
Conclusion: The two studies suggest clinical benefit but were not 
adequately powered to demonstrate efficacy. An adequately powered 
effectiveness study of GDFT following liver transplant is required.
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Introduction: The management and safety of the airway during 
general anesthesia or in a critical environment is one of the most 
important skills of an anesthesiologist  or an intensive care physi-
cian. Inadequate airway protection or insufficient oxygenation of the 
patient is associated with an overall increase in mortality and mor-
bidity. The primary goal is  the early  identification of  the Difficult Air-
ways (DA) to reduce or eliminate potential risks linked to incorrect 
management. The identification of DA is, generally, based on clinical-
anamnestic evaluation with low sensitivity and specificity. Ultrasound 
evaluation has been recently proposed as a useful, non-invasive, and 
cost-effective tool.  Many ultrasonographic parameters have been 
studied to identify a diagnostic tool to predict difficult laryngoscopy, 
but no useful cut-off range was at present validated to define a stand-
ard parameter, mainly due to the lack of a systematic scan approach 
in ultrasound neck examination. Among sonographic parameters, the 
increased thickness of soft tissues anterior to the epiglottis (STTe) was 
emerging as one of the most reliable independent predictors of dif-
ficult laryngoscopy and mask ventilation. In our usual clinical practice, 
we have highlighted that the anteroposterior and longitudinal scan-
ning allows us to obtain a systematically standardized and reproduc-
ible measurement of STTe.
Objectives: This study aimed to analyze the use of a standardized 
ultrasound approach to identify a DA with specific research of pre-
dictive parameters of difficult intubation (DI) and difficult ventilation 
(DV)  combined with clinical-anamnestic evaluation. The aim was, 
therefore, to verify whether these parameters are useful in order to 
help creating an airway plan in the operating room, but also a critical 
care setting. Another possible use of these tools could be the selection 
of patients who need a protection extubation.
Methods: Prospective, observational, cohort, single-blind study. The 
study was conducted at the University of Bologna S.Orsola-Malpighi 
Hospital and approved by the Independent Ethics Committee. Eligibil-
ity criteria were consenting adult patients requiring general anesthesia 
and orotracheal intubation. The patients were consecutively enrolled 
(from September 2017 to October 2018) during the preoperative 
anesthesia evaluation. Exclusion criteria were emergency  surger-
ies, rapid-sequence induction,  uncooperative or pregnant patients, 
patients with a history of difficult intubation, or with difficult laryn-
goscopy  and/or with indication to bronchoscopy. The clinical design 
is divided into two  different  phases: the preoperative phase (phase 
1) and the intraoperative phase (phase 2). Evaluations  carried out in 
phase 1 and in phase 2 were performed by different anesthesiologists 
at different times (blinded study). In phase 1 clinical-anamnestic evalu-
ation and ultrasound were performed. The  intraoperative  phase was 
conducted by expert anesthesiologists (more than 5 years of experi-
ence). General anesthesia was conducted according to a standard pro-
tocol. DI was evaluated using the Cormack-Lehane score.
Results: As statistical estimation, 253 patients were enrolled (50% 
male, range 18-88 years old). Direct laryngoscopy was classified as 
difficult (CL >3) in 15 patients (6%), 10 were predicted by the preop-
erative clinical evaluation, while the remaining 5 cases (2,1%) had not 
been anticipated. The ultrasound parameter predictive of DI was the 
thickness of the soft tissues anterior to the epiglottis in hyperexten-
sion of the head and protrusion of the tongue (STTep). The ROC curve 
analysis identified a cut off of STTep equal to a value of 2.50 cm above 
which we can predict difficulties in intubation (specificity 55.9%, sen-
sitivity 73.3%; AUC 0.649, CI 0.537 - 0.762; p=0.05). This cut-off value 
is confirmed even better in the group of patients with difficult laryn-
goscopy (Cormack-Lehane ≥ 3 even after BURP) in which it results 
the same specificity (55.9%) but greater sensitivity (87.5%; AUC 0.726; 
p=0.03). In addition, we verified the predictive role of the US in iden-
tifying the borderline difficult laryngoscopy (CL 2e). We found 23 hav-
ing a CL 2e: STTep was verified both before (p= 0.001) and after BURP 
(p=0.001). No statistically significant differences were found between 
the two groups (easy vs difficult) for other US parameters for DI. STTep 
was, also, the best predictor for DV.
Conclusion: The use of ultrasound has found in recent decades a wide 
application as a diagnostic and a therapeutic tool, specifically at pre-
sent  airways ultrasound evaluation is an important tool to predict a 
DI. Standardized ultrasound assessment of  the STTep may be useful 
to predict “complex difficult” direct laryngoscopy and difficult intu-
bation  and to identify a DI not foreseen by the conventional clinical 
parameters (clinically unexpected or unexpected DI). Preoperative 
identification of DA permit to better organize patient’s management 
in the perioperative and the pre-procedure identification of DA permit 
to better choose the airway strategy. Further studies are necessary to 
validate the parameters found and correlate them to the preoperative 
clinical evaluation, improving patient safety, and allowing the best use 
ofresources. US airway evaluation could find a place in scores for DA 
prediction.
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Introduction: In patients who have undergone a radical cystectomy, 
delayed return of bowel function is to be expected. However, a cohort 
of patients (10-40%1) go on to develop the complication of post-oper-
ative paralytic ileus (POI), which can negatively impact outcomes2. 
Although the causative factors of POI are often complex3, identifica-
tion of potential risk factors could prove useful in the management of 
these patients in order to improve patient outcomes.
Objectives: To:
* establish the incidence of ileus in patients having radical cystecto-
mies
* compare length of stay and mortality between those that had and 
did not have ileus
* identify features that correlate with developing ileus.
Methods: This was a single-centre retrospective, observational study 
carried out at the Royal Surrey County Hospital. We reviewed the elec-
tronic and paper medical records, drug charts, anaesthetic charts and 
operative notes of all patients who had radical cystectomies and ileal 
conduits in 2018.
Results: 72 patients were identified from a surgical registry. The inci-
dence of ileus was 34% (24/72). Full notes including intra-operative 
notes were only available for 61 patients.
Delayed return 








Hospital length of stay 8.5 (6 – 21) 6 (5-7) p<0.0001 
Mortality n (%) 6/24 (25%) 0/47 (0%) p<0.0001 
Intrathecal diamorphine 
(mcg) 700 (500-1000) 800 (500 – 800) p=n.s. 
First 48 hrs post-op po 
morphine equivalent dose 
(mg) 
61 (37-108) 45 (25-114) p=n.s. 
Intra-operative iv fluids 
(ml) 
2000 (2000 – 
2500) 
2000 (1688 – 
2500) p=n.s. 
Highest intra-operative 
lactate (mmol/L) 2.75 (1.7 – 4.1) 2.1 (1.7 – 3.15) p=n.s. 
Parenteral nutrition, n 
(%) 6/24 (25%) 0/47 (0%) p<0.0001  
Conclusion: Delay to return to normal bowel function including post-
operative ileus was associated with a significant increase in hospital 
length of stay, increased requirement for parenteral nutrition and 
significantly increased mortality rates. This is a complex, multifacto-
rial post-operative complication and we were unable to find any fac-
tors that were associated with ileus in this study. Further prospective 
research is required to establish if there are causative factors which 
may be optimised to prevent this post-operative complication.
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Introduction: Major changes occur in central hemodynamic during 
early postpartum period: redistribution of fluid from the interstitial 
space into the bloodstream, which increases the blood volume circu-
lating and cardiac output. All these changes are aimed at stabilizing 
the patient in the postpartum period with blood loss. However, blood 
volume circulating during pregnancy and postpartum period remains 
unknown and studies on its results come to the conclusion about its 
great variability. The aim of this study was to evaluate the postpartum 
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volume status of puerperas with blood loss 10-20% of blood volume 
circulating.
Methods: Thirty puerperas after a elective cesarean section with spi-
nal anesthesia, underwent ultrasound evaluation of the heart andinfe-
rior vena cava immediately after surgery, 3 and 6 hours.
Results: The volume of blood loss measured by the gravimetric 
method was 914 ± 410 ml, which amounted to 10 to 20% of the blood 
volume circulating, calculated by the formula 100 ml * weight before 
pregnancy (kg). The ejection fraction of the left ventricle, measured 
immediately after surgery, 3 and 6 hours, was 55.5% (95% confidence 
interval 51.9 - 61.6), 58.2% (95% CI 59.4 - 61.2) and 55.4% (95% CI 53.5 
- 59.9), respectively. The Friedman test (χ2) showed the absence of a 
statistically significant difference of the ejection fraction (p = 0.692). 
Inferior vena cava collapsibility index showed a statistically signifi-
cant decrease in the measurement periods: 35.5% (95% CI 22.5 - 44.8), 
20.5% (95% CI 14.6 - 28.5), 14.4% (95% CI 12.2 - 25.6), respectively, the 
Friedman test (χ2) p = 0.036. A statistically significant increase of the 
end-diastolic volume of the left ventricle was also noted: 73.0 ml (95% 
CI 66.3 - 76.7), 81.2 ml (95% CI 72.9 - 87.3), 89.8 ml (95% CI 80.4 - 96.7), 
respectively, the Friedman test (χ2) p = 0.021.
Conclusion: Blood loss 10-20% of blood volume circulating or more 
than 1000 ml does not always require replacement fluid management, 
redistribution of fluid volume from the interstitial space increases 
blood volume circulating within 3-6 hours after delivery. Further stud-
ies of the volume status are needed.
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Introduction: Fluid responsiveness assessment is the cornerstone of 
fluid therapy in both the ICU and the operating room (1,2).The use of 
dynamic indices (fluid challenge or the cardiopulmonary interaction) 
has proved to be the most effective method and these tests have been 
included in guidelines (3).Nevertheless, fluid responsiveness in car-
diac surgery (CS) patients is weakly investigated. A recent study has 
reported that in ICU patients the repiratory variability of the superior 
vena cava (SVC) performed better than other tests (4).
Objectives: The routine use of a TEE probe in all our CS patients 
allowed us to investigate in a prospective observational study the per-
formance of the respiratory variation of the VCS (Delta VCS) and mini 
fluid challenge (FC100) as a predictive indice for fluid response.
Methods: All patients were included after CPB and chest closure while 
still under general anesthesia. A fluid infusion was performed in all 
patients by infusion of the CPB residual volume treated by a cell saver 
(500–600 ml;hematocrit>50%). The cell saver bag was infused sequen-
tially and hemodynamic measures were obtained after 100 ml (FC 
100), 250 ml (FC250) and 500 ml (FC 500). We recorded demographic 
and procedural data. At baseline and at each stage of the FC we 
recorded  : SV, VTI, HR, BP, E/A ratio, E/E’ ratio, S’Ann wave, the diam-
eter of SVC during inspiration and expiration. SVC diameter was meas-
ured during QRS and T wave of the ECG. We calculated the respiratory 
variation index (%) of SVC as (Exp VCS Diam – Insp VCS Diam)/ Exp VCS 
Diam for QRS wave, T wave and absolute variation. Patients were clas-
sified as Fluid responders(RESP) if SV increased by +15% after FC500 
or Non Responders (NRESP). Groups were compared by KHI2 and Stu-
dent t tests. ROC curves were built for FC 100, Delta VCS QRS, Delta 
VCS T and Delta VCS absolute (p<0.05).
Results:
49 patients were included  : M 39 (79.6%), CABG 51%, AVR 27%, MVR 
8%, Other 14%; mean age 67 +/- 11.5; mean Euroscore 2 3.48 / 3.16%; 
mean LVEF 53.9 +/- 11,4. 31 patients (63,3%) were NRESP and 18 
(36,7%) were RESP. There was no difference for RESP / NRESP groups 
for LVEF (RESP : 51.2% vs NRES : 56.6%) CPB duration (RESP : 71.2min 
vs NRES : 68.6min), Cross clamp time (RESP : 57min vs NRES : 54.4min), 
baseline E/A (RESP  : 1.49+/-0.24 vs NRES  : 1.19+/-0.19), baseline E/e’ 
(RESP  : 7.86+/-1.28 vs NRES  : 8.54+/-1.37). Delta SVC QRS and delta 
SVC T were higher in the RESP group but the difference did not reach 
significance  : (RESP  : 13.67% vs NRES  : 7.84% and RESP  : 13.89% vs 
NRES : 9.91% respectively). Groups were significantly different only for 
delta SV after FC100 (RESP : 11.4+/-3.08% vs NRES : 2.54+/-0.57%; 95CI 
0.05918 to 0.21458). ROC curves are shown in fig 1. The highest AUC is 
obtained by FC100 (AUC 0.829; 95CI 0.677 to 0.929) and significantly 
higher than the SVC derived indices (p<0.036).
Conclusion: The main findings of our study are : First, in CS up to 63% 
of the patients may be unresponsive to FC and this is similar septic 
shock patients. Second, the SVC derived indices perform poorly in pre-
dicting fluid responsiveness and that is not consistent with the results 
obtained in shock patients (4). The influence of the specificities of CS 
patients (type of anesthesia, cardioplegia and CPB, chest drainage sys-
tem) are discussed. Third, the good performance of the mini fluid chal-
lenge (FC100) makes it a method of choice in post CPB CS patients.
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Introduction: It has been demonstrated that persistently decreased 
microvascular blood flow is associated with mortality in the critical 
care population.1,2  Microvascular blood flow is a potentially impor-
tant therapeutic target, that may diverge from macrovascular param-
eters leading to a loss of haemodynamic coherence.3 In our centre we 
use a low central venous pressure (CVP) anaesthetic for liver resec-
tion surgery to decrease intra-operative blood loss 4  with subse-
quent goal-directed fluid therapy (GDFT). This can be considered as 
a model of shock and resuscitation.  These  patients were studied to 
assess peri-operative microvascular flow and relation to macrovascular 
parameters.
Objectives: To establish:
• changes in microvascular blood flow peri-operatively in liver 
resection surgery
• relationship between microvascular blood flow and macrovascu-
lar parameters
• relationship between microvascular blood flow following GDFT 
to post-operative complications
Methods: This was a single-centre prospective observational study 
(REC  14/NE/1150) enrolling patients undergoing elective liver resec-
tion surgery. Microvascular blood flow, measured using the MicroScan 
device (MicroVision Medical, Amsterdam) and physiological meas-
urements were taken at pre-specified time points throughout the 
peri-operative period (T1, awake on day of surgery pre-operatively, 
T2 following induction of anaesthesia, T3 on exposure of the liver, T4 
completion of liver resection prior to fluid resuscitation, T5 arrival at 
ICU, T6 completion of goal directed fluid therapy (GDFT)). Mortality 
rates, post-operative morbidity survey (POMS) and Clavien-dindo clas-
sification were used to assess post-operative complications.
Results: A total of 55 data sets were included in the analyses, 28 male 
and 27 female, mean age was 58 years (S.D. 13) and BMI 28.1 kg/
m2 (S.D. 5.4), 18% were smokers, 13% were diabetic and 76% had neo-
adjuvant chemotherapy.
CVP was decreased successfully during anaesthesia from 7mmHg (IQR 
4.7-10) at T2 to 3 mmHg (IQR 0.7-5) at T4 (p<0.0001). There was a statis-
tically significant decrease in mean arterial pressure (MAP); 74 mmHg 
(IQR 65 – 88) at T2 to 64 mmHg (58 – 74) at T4 (p=0.0002). This was 
accompanied by a rise in heart rate from a median of 67 bpm (IQR 
60-77) to 73 bpm (IQR 64-87) at T4 (p=0.013). A subset of 18 patients 
had records of cardiac output measured by oesophageal doppler, this 
was not suitable for use in awake patients so was only recorded at T2, 
T3 and T4. There was no significant difference between cardiac index 
(CI) at time 2 and time 4; median CI 2.55 L/min/m2  (1.88 – 3.48) and 
2.00 L/min/m2 (1.80 – 2.30) respectively.
Following completion of GDFT (T6) there was no significant difference 
in heart rate compared to baseline (T1). However, MAP at T6 remained 
significantly lower than baseline (T1); 100mmHg (88-110) vs 77 (73-
89), p<0.0001.
Microvascular flow measurements decreased post-operatively and this 
fall was sustained after completion of GDFT as detailed below.
Table 1 – Microvascular flow (results displayed as median (IQR), Kruskal-Wallis was used to 
determine significance of variation between groups) 
























There was an increase in proportion of perfused large blood vessels 
(lPPV); 66.7 (34.1-90.9) at T1 vs 99 (91-100) at T6, p<0.0001 density 
(tPVD).
There was no significant correlation between MAP and the microvas-
cular parameters MFI, sPPV or sPVD at any time point using Pearson 
and Spearman correlation coefficients as appropriate. There was no 
association with microvascular flow and post-operative morbidity or 
mortality.
Conclusion: Microvascular blood flow decreased post-operatively 
and this was sustained despite completion of GDFT and restitution 
of macrovascular parameters. There was evidence of shunting with a 
decrease in small perfused blood vessel density and increase in large 
perfused blood vessel density from baseline to completion of GDFT. 
GDFT was insufficient to restore post-operative sublingual microvas-
cular perfusion.
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Introduction: High blood glucose levels are frequently shown in 
patients post-cardiac surgery patients that might affect prognosis.
Objectives: To evaluate postoperative blood glucose trend levels and 
predisposing risk factors in cardiac surgery patients, during their stay 
in intensive care unit (ICU).
Methods: 210 consecutive post-cardiac surgery patients, admitted 
to ICU, participated in this prospective clinical study. Blood glucose 
levels were measured by patients’ admittance to ICU and afterwards 
every 2-3 hours daily, until their discharge or for up to seven days (if 
discharged later). An existing ICU protocol for blood glucose control 
was applied. Patients were classified by mean blood glucose level dur-
ing their stay in ICU.
Results: 56% of the patients had mean blood glucose levels 140 – 
180mg/dl, 25% above 180mg/dl and 19% below 140mg/dl. 36% of the 
participants had mean blood glucose levels above 180mg/dl during 
the first and second day of ICU treatment and 30% during the third 
day. Multivariate logarithmic regression analysis has shown history 
of Diabetes mellitus, Euroscore II and pre-operative white blood cells 
count as independent predictors of post-cardiac surgery mean blood 
glucose levels above 180mg/dl. Patients with mean blood glucose 
levels above 180mg/dl post-cardiac surgery had greater duration of 
mechanical ventilation support (p=0.019).
Conclusion: According to our study, a high percentage of cardiac sur-
gery patients admitted to ICU exhibit blood glucose levels >180mg/
dl, at the immediate postoperative period despite standard treatment 
protocol. Diabetes mellitus, Euroscore II and pre-operative white blood 
cells count were independent predictors of hyperglycemia. Appliance 
of a further bundle for optimization of blood glucose levels is deemed 
necessary.
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Introduction: Neurological sequelae after carbon monoxide (CO) 
poisoning has recently become a critical issue.  Epidemiologic data 
of delayed neurological sequelae such as incidence, time of develop-
ment, and duration vary widely in the literature.
Objectives: We aim at analyzing nationwide claims data from South 
Korea for incidence patterns of neurological disorders in survivors of 
carbon dioxide poisoning.
Methods: A national cohort was abstracted from database that 
includes the patients diagnosed with carbon monoxide poisoning 
from January 1st, 2007 to December 31st, 2018. We investigated the 
whole diagnostic codes for nervous system diseases. The codes were 
retrieved from the claims data generated during the patients’ initial 
visits to an inpatient or an outpatient after the diagnosis of T58, car-
bon monoxide poisoning.
Results: Among the total of 26,778 patients, 18,720 (69.9%) patients 
were diagnosed with nervous system diseases after the carbon mon-
oxide poisoning. The most common disease was disorders of sleep 
initiating and maintaining (n = 701, 3.74%), followed by tension-type 
headache (n = 477, 2.55%), and anoxic brain injury (n = 406, 2.17%). 
Admission to the intensive care unit after carbon monoxide poison-
ing was associated with subsequent development of nervous system 
diseases. The cumulative hazard ratio was 2.25 (95% CI, 2.07 to 2.44, 
p<0.05).
Conclusion: In poisoned patients with carbon monoxide, it needs to 
consider that nervous system diseases followed after carbon monox-
ide poisoning have relatively early peak incidence patterns.  Nervous 
system diseases after carbon monoxide poisoning had different pat-
terns of incidence depending on whether the patient had been admit-
ted to intensive care unit or not.
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Introduction: Arsenic, a group 1 carcinogen classified by International 
Agency for Research on Cancer, is a major environmental toxicant 
and pollutant, which has caused health concern all over the world. 
The Agency for Toxic Substances and Disease Registry also enlisted 
arsenic as number one in their ranking of substance priority list 2017. 
Neutrophils are the vanguard of host innate immune system against 
invading microbial pathogens and several diseases. Neutrophil extra-
cellular traps (NETs) have been disclosed as an essential aspect of 
human innate immunity. NETs are comprised of meshwork of chroma-
tin fibers decorated with antimicrobial proteins like myeloperoxidase 
(MPO), neutrophil elastase (NE) and cathepsin G [1]. The function of 
NETs is to capture, immobilize and kill intruding gram negative and 
gram positive bacteria, fungi, parasites as well as invading microor-
ganisms extracellularly [1]. The influence of arsenic on human NET for-
mation, however, was not well established.
Objectives: This study aimed to evaluate the effects of acute low dose 
(20 ng/ml) NaAsO2 exposure on innate defense mechanisms regard-
ing NETs and phagocytosis in vitro.
Methods: Isolated polymorphonuclear  neutrophils (PMN) from 
peripheral blood of healthy human volunteers were incubated with 
NaAsO2 for 12 h and phorbol myristate acetate was used to induce 
NET formation. Effect of arsenic exposure on PMN functions includ-
ing NETs release, phagocytosis, bacterial killing and reactive oxygen 
species (ROS) production were assessed. NETs formation was quanti-
fied by measuring cell-free extracellular DNA (cf-DNA), MPO-DNA and 
NE-DNA which are characteristic of NET. Cell-free DNA (cf-DNA) was 
measured using the Quant-iT PicoGreen dsDNA assay kit. MPO- and 
NE-DNA were measured by sandwich ELISA. ROS production was 
measured in live cells by a technique that converts 2’, 7’–dichloro-
fluorescin diacetate which was oxidized to a fluorescence dye 2’, 
7’–dichlorofluorescein. Extracellular killing of bacteria by NETs was 
evaluated by co-culture of Escherichia coli and neutrophils in the pres-
ence of a phagocytic inhibitor cytochalasin D.
Results: In vitro inorganic arsenic exposure to human PMN signifi-
cantly dampens the release of cf-DNA, MPO-DNA and NE-DNA which 
are the main components of NETs. Either capacity of phagocytosis and 
bacterial killing were also reduced after acute arsenic exposure.
Conclusion: We conclude that low dose of inorganic arsenic will dis-
turb PMN function including NETs and phagocytosis. Our results open 
new doors for understanding the detailed mechanisms of arsenic 
intoxication on human innate immunity.
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Introduction: An effective treatment for carbon monoxide poisoning 
is the elimination of blood carbon monoxide by the administration 
of high oxygen concentration. Hyperbaric oxygenation therapy has 
the highest concentration of oxygen; however, medical institutions 
without hyperbaric oxygenation chambers also often treat patients 
with carbon monoxide poisoning. If hyperbaric oxygenation therapy 
is unavailable, the first-line treatment is a 100% oxygen mask; of late, 
another oxygen administration method in use is the nasal high-flow 
(NHF) therapy. However, no previous study has verified the type 
of oxygen administration method that can deliver higher oxygen 
concentration to the body. Here, we present a comparison of 100% 
intratracheal oxygen administration by oxygen mask or by NHF, using 
an original tracheal oxygen concentration measuring model.
Objectives: To compare the tracheal oxygen concentration of 100% 
oxygen administered by mask or by NHF using a special intratracheal 
oxygen measuring model.
Methods: A Michigan Instruments artificial lung was connected to a 
Hamilton ventilator C1 and a human model of intubation practice. The 
measuring device of oxygen concentration with INOflo, manufactured 
by Mallinckrodt pharmaceuticals, was inserted into the trachea of the 
human model to measure the oxygen concentration. The lung tidal 
volume and the minute volume were adjusted by the Hamilton C1. 
The minute volume was set to 5 L and 10 L; the flow rate of the oxygen 
mask was set to 6 L, 10 L, and 15 L; and the flow rate of the NHF was 
set to 10 L, 20 L, and 40 L. For each of these, the measurement was 
performed four times.
Results: The model tracheal oxygen concentration results were as fol-
lows. Under the 100% oxygen by mask and 5L of minute ventilation 
conditions, when the oxygen flow rates were set to6L, 10L, and 15L, 
the average oxygen concentrations were 58.75%, 63.75%, and 68.75%, 
respectively. When the minute ventilation was set to 10 L, these values 
were 39.75%, 46.5%, and 53.75%, respectively. In NHF, 5L of minute 
ventilation, when the oxygen flow was 10L, 20L, and 30L, the average 
oxygen concentrations were 96.5%, 97%, and 97.5%, respectively; and 
for the 10L of minute ventilation, for the 10 L, 20 L, and 30 L flow rates, 
the average values were 91.75%, 95%, and 97%, respectively.
Conclusion: The oxygen concentration in the human model’s trachea 
was higher with NHF oxygen administration, regardless of the venti-
lation minute volume and oxygen flow rate. These results suggested 
that for patients with carbon monoxide poisoning, NHF may reduce 
carbon monoxide in a shorter time than oxygen administration via a 
mask.
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Introduction: Carbon monoxide (CO) is a colorless, odorless toxic gas 
produced by incomplete combustion of carbon-based fuel and mate-
rial. Because of these characteristics, many patients cannot recognize 
that they are poisoned and in mild cases, diagnosis and treatment 
are often delayed because symptoms do not appear immediately. In 
CO poisoning, the brain and heart which are vulnerable to ischemia 
are damaged due to the decline of oxygen transport. Development 
of delayed neurological sequelae (DNS) defined as any neurological 
symptoms that newly developed within 6 weeks after CO poisoning. 
Preventing DNS is a major goal of treating acute CO poisoning, but to 
our knowledge there are no reliable tools for assessing the probability 
of these sequelae.
Objectives: To find out whether acute brain lesions on diffusion-
weighted imaging are relevant to subsequent development of DNS 
after acute CO poisoning.
Methods: This registry-based observational study was conducted at 
a university hospital in Korea, between January 1, 2017, and Decem-
ber 31, 2018. Of 254 patients (aged≥18) with acute CO poisoning, 154 
patients (60.63%) who underwent diffusion-weighted imaging were 
considered for the study. Patients who refuse magnetic resonance 
imaging (MRI) (n=40), discharge against medical advice (n=6), follow 
up loss (n=32), persistent neurological symptoms at discharge (n=8) 
and refuse hyperbaric oxygen therapy (n=14) were excluded. Patients 
were scheduled for MRI within 2 days of visiting hospital. If two or 
more of the univariate factors retained in the multivariate analysis 
were highly correlated, then only one factor was selected for further 
modeling to avoid collinearity before modeling. (Table 1).
Table 1. Factors associated with the development of delayed neurologic sequelae 
Univariable 
analysis Multivariable analysis













Headache 0.438(0.096-1.992 0.285         
CRP 1.055(0.964-1.155) 0.245         
Troponin I 1.164(0.894- 0.259   
1.516) 























26.516) 0.001     
6.741(1.843-
24.660) 0.004 
OR, odds ratio; CI, confidence interval; CRP, C-reactive protein; GCS, glasgow coma scale; MRI, 
magnetic resonance imaging 
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Results: Of the 154 included patients, acute brain lesions on diffusion-
weighted imaging were observed in 49 patients (31.8%). Among 154 
patients, DNS occurred in 30 patients (19.5%). In the multivariable 
logistic regression analysis, abnormal MRI was associated with DNS 
in model 1 (odds ratio [OR], 2.24; 95% Confidence interval [CI]), 0.864-
5.821; P = 0.097). In model 2, the acute brain lesions on MRI in white 
matter was notably associated with development of DNS (OR, 6.741; 
95% CI, 1.843-24.660; P = 0.004). And Glasgow coma scale and expo-
sure time were also related to subsequent development of DNS after 
CO poisoning in model 1, 2.
Conclusion: Acute brain lesions on MRI in white matter was notably 
associated with the development of DNS. Diffusion-weighted imaging 
during the acute phase of CO poisoning may predict the risk of devel-
oping subsequent neurologic deficit.
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Introduction: Selenium, an essential micronutrient incorporated into 
antioxidant ‘selenoproteins’, has been extensively trialled as a putative 
therapy in critical illnesses. However, when administered in its oxidised 
form, selenite, it exhibits varying degrees of success [1]. Importantly, 
the ability of any molecule to undergo ‘redox’ reactions depends on its 
oxidation status. We previously showed that the reduced form of sele-
nium, selenide, acts both as an antioxidant and a metabolic modula-
tor via transient inhibition of mitochondrial cytochrome C oxidase [2]. 
Here we assessed the effects of a basic selenide salt (NaHSe) against 
oxidative stress in human hepatocytes.
Methods: HepG2 human hepatocytes were grown to 80% confluence 
under standard cell culture conditions. Sodium hydrogen selenide 
(NaHSe) was synthesized as described [3]. Cells were incubated with 
0.3 or 1 μM NaHSe (as therapeutic concentrations) for 1 hour. Oxida-
tive stress was initiated by addition of hydrogen peroxide (H2O2; 500 
μM); cells were incubated for a further 24 hours. Cell viability (in tetra-
zolium chloride [1% w/v] stained cells) or mitochondrial membrane 
potential (MMP; in tetramethylrhodamine methyl ester [TMRM] incu-
bated [25 nM for 30 min] cells) were measured using spectrophotom-
etry and flow cytometry, respectively.
Results: H2O2 decreased cell viability and mitochondrial membrane 
potential and these could be reversed by NaHSe treatment (Fig 1).
Conclusion: Treatment withthe reduced form of selenium, hydrogen 
selenide, protected against oxidative stress in human hepatocytes. 
This was associated with a clear elevation in mitochondrial membrane 
potential. The ability of selenide to confer protection against oxidative 
pathologies via a mitochondrial mechanism of action (and the impor-
tance of its oxidation status) will be subject to further investigation.
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Introduction: Selenium, an essential micronutrient, is incorporated 
into numerous ‘selenoprotein’ oxidoreductase enzymes that impact 
on cellular redox status in health and disease. As a putative antioxi-
dant therapy in critical illness states, selenium has been administered 
solely as the oxidised form, selenite, with varying success [1]. However, 
the ability of any molecule to undergo ‘redox’ reactions depends on its 
oxidation status, and this may impact on its utility as a therapy [2]. We 
assessed the ability of both the oxidized selenium product, selenite, 
and the reduced form, selenide, to modify selenoprotein expression in 
human hepatocytes.
Methods: HepG2 human hepatocytes were grown to 80% conflu-
ence under standard cell culture conditions. Cells were plated and 
incubated with either sodium hydrogen selenide (NaHSe; 30 nM, 
synthesized as described [3]), sodium selenite  (Na2SeO3; 30 nM) or no 
treatment (cell medium) for 24 hours. L-cysteine (0.1 mM) was used 
as a positive control (to decrease selenoprotein synthesis) as it inter-
feres with selenocysteine, a crucial intermediate. Protein expression of 
glutathione peroxidase-1 (GPX-1) and thioredoxin reductase-1 (TxR-1) 
was determined by Western blot analysis. These selenoproteins were 
chosen as they are ubiquitously expressed, readily abundant, and 
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crucially involved in the detoxification of inorganic and organic perox-
ides, respectively.
Results: The oxidized selenium form, selenite, used in critically ill 
patients as an antioxidant therapy, negatively impacted on antioxi-
dant selenoprotein expression (Fig  1). By contrast, exposure to the 
reduced form, selenide, showed increased abundance of the two 
enzymes studied.
Conclusion: The oxidation status of selenium-based therapies on 
selenoprotein expression revealed divergent results. This demon-
strates that oxidation status can impact on efficacy, and suggests that 
targeted administration of reduced selenium forms may yield more 
favourable results.
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Introduction: 3-14% ICU admissions are due to poisonings. The 
mortality rate is 2,1%. The treatment for acute poisonings requires: 
precociousness, vital functions support, metabolic support and symp-
tomatic treatment, reducing or stopping the absorption of the poison, 
an antidote-based treatment and measures to increase the elimina-
tion of the toxic (intestinal and renal excretion as well as extracorpor-
eal techniques).
Objectives: The aim of this review is to establish the organ and system 
substitution techniques currently available and how they were used to 
treat poisonings in our ICU during the 2015-2018 period.
Methods: Study authorized by the ethics committee in the centre. 
In the 2015-2018 period there were 7941 admissions to the ICU. 31 
of these were poisonings (0,39%). The organ and system substitution 
techniques consist in: 1. Renal replacement techniques (hemodialy-
sis, continuous renal replacement techniques and peritoneal dialysis), 
2. Plasmapheresis and plasma exchange, 3. Hemoperfusion and 4. 
Exchange transfusion. The following extracorporeal organ support 
techniques are also available: 1. Extracorporeal liver support (MARS: 
molecular adsorbent recirculating system), and 2. Extracorporeal 
membrane oxygenation (ECMO).
Results: In our series, 64% were men and the average age was 44 
years old. The most common cause was medication-related poisoning 
(benzodiazepines). Ethanol was the main addictive drug. The meas-
ures taken in our ICU have been continuous renal replacement ther-
apy in one occasion (lithium poisoning).
Conclusion: In spite of the fact that the ICU admissions rate is low, it is 
necessary to be familiar with the organ and system substitution tech-
niques in order to apply the best one in each case. It is equally impor-
tant to know about the pharmacokinetic characteristics of those toxics 
that can be expelled using these extracorporeal techniques.
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Introduction: Naloxone, an opioid antagonist, is used for the manage-
ment of opioid toxicity, presenting with respiratory depression, miosis 
and/or decreased consciousness. This is a medical emergency occur-
ring in different settings: theatre recovery, maternity or general surgi-
cal wards. Urgent naloxoneadministration is vital and can be given IV, 
SC or IM at an initial dose of 400mcg(1). Naloxone is initially given as 
a push bolus, and locally is prepared as 400mcg in 1ml ampoules (2).
We recognised that familiarity with naloxone at our institution was 
low. Lack of knowledge and familiarity is a known contributor to drug 
error(3). Use of cognitive aids can facilitate timely implementation of 
treatment in emergencies such as opioid toxicity(4).
Objectives:
• To assess staff familiarity and confidence with naloxone.
• To assess knowledge regarding naloxone administration.
Methods: An anonymous staff survey was designed to assess familiar-
ity and confidence with naloxone use and was distributed to theatre 
recovery, surgical wards and maternity. Later a poster (Figure  1) was 
designed and placed on control drug (CD) cupboards to serve as an 
accessible cognitive aid in an emergency. A safety alert was emailed 
to guide staff on how to manage suspected opiate toxicity. We re-sur-
veyed to assess improvement in knowledge and confidence of nalox-
one use.
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Results: Our initial survey found low confidence in naloxone adminis-
tration with 79% of respondents either unwilling or needing a nomo-
gram to administer it. This was unsurprising as most had not used 
naloxone in the preceding year. On re-survey, we found improved con-
fidence, with an increase in those either confident or very confident 
from 20% to 40% and fewer people unwilling to use naloxone (17% to 
12%). Staff selecting the correct dose as per trust protocol increased 
by 31%, from 41% to 72% (p=0.02 CI 4.5%-51.9%).
Conclusion: Use of naloxone is rare and staff at our institution are 
unfamiliar with it, demonstrated here by a lack of confidence and 
knowledge of correct dose. 30% of medication errors relate to gaps in 
knowledge or application of knowledge of a drug(3). However, in opi-
ate toxicity, prompt, accurate administration of naloxone is imperative, 
yet human factors such as stress and communication breakdown in an 
emergency scenario may further inhibit ability to correctly administer 
treatment.
A simple and low-cost cognitive aid positioned on CD cupboards com-
bined with a safety alert via email improved accuracy and confidence 
with naloxone use.
In critical care, doctors drill for rare emergencies though simulation 
(sim), but key members of the MDT such as nurses and midwives 
receive less sim-based training. We have demonstrated an increase 
in confidence and accuracy of naloxone administration with simple, 
cost-effective measures. Further work could examine the sustainability 
of these improvements and implement sim-based training to further 
improve MDT performance.
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Introduction: Patients admitted to an intensive care unit (ICU) have a 
potentially fatal physical condition which also has an intense psycho-
logical impact
The emotional impact of this experience can have negative reper-
cussions during the patient’s recovery, as evidenced by the fact that 
anxiety, depression and post-traumatic symptoms are more prevalent 
among critical care survivors than in the general population.
The use of analgesia-based sedation, or analgosedation, is therefore 
a common and necessary practice in ICUs, the aim being to achieve 
an optimum level of comfort and pain relief for patients, to reduce 
their anxiety and disorientation, and to allow them to rest and sleep 
without interfering with medical and nursing care. However, the use 
of analgosedation is not free of complications, not least as its over-
use can hamper the conscious processing of events experienced in 
the ICU. In addition, patients who undergo prolonged sedation may 
become difficult to sedate and require increasing doses, a scenario 
that has been associated with longer ICU stays and more complica-
tions during admission. In this respect, analgosedation may increase 
the likelihood of severe psychological sequelae among critical care 
survivors. Moreover, patients who prove difficult to sedate during an 
ICU admission experience more periods of over- and under-sedation 
as it is a challenge to keep them within the target range of conscious 
sedation (Richmond Agitation-Sedation Scale score of -2, -1, 0).
Objectives: The aim of the present study was to determine the inci-
dence of anxiety, depression and PTSD among critical care survivors 
and to explore the impact of difficult sedation on the frequency and 
intensity of these symptoms.
Methods: Descriptive and prospective analysis of analgosedation and 
psychological symptoms in patients who required >24 h of mechani-
cal ventilation during their ICU admission. We compared complica-
tions, clinical outcomes and psychological sequelae according to 
whether or not patients had been difficult to sedate. Descriptive analy-
sis and multivariate logistic regression were performed.
Results: Data were obtained for 195 patients, of whom 30% expe-
rienced difficult sedation. Difficult to sedate patients were younger 
(52.2±16.4 vs. 61.4±14.1 years; p=.001), less critically ill (APACHE 
II score 22.1±9.9 vs. 26.4±8.7; p=.002) and more likely to engage 
in harmful use of alcohol (p=.001) and to have used psychoactive/
psychotropic drugs during the previous three months. They also 
spent longer in the ICU (28.1±25.8 vs. 17.6±15.4 days; p=.001) and a 
greater percentage of time on mechanical ventilation (61.1±15.4 vs. 
51.4±18.8; p=.001). At 1-month follow up, 87.7% of difficult-to-sedate 
patients reported anxiety (vs. 45.4%; p=.001), with the corresponding 
figures at 3 and 6 months being 75.4% (vs. 29%; p=.001) and 70.8% 
(vs. 23.7%; p=.001). Depression was reported by 82.4% (vs. 43.1%; 
p=.001), 66% (vs. 33.9%; p=.001) and 60.4% (vs. 27.2%; p=.001) of dif-
ficult-to-sedate patients at 1, 3 and 6 months, respectively. At I month, 
28.1% of these patients (vs. 11.5%; p=.007) reported symptoms of 
PTSD.
Conclusion: Critical care patients who undergo prolonged analgose-
dation may become difficult to sedate, and this can have a negative 
impact on their subsequent emotional wellbeing. It is therefore cru-
cial to implement multidisciplinary sedation protocols based on 
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algorithms that encourage collaborative sedation and weaning. The 
early identification of patients who are likely to experience difficult 
sedation, coupled with strategies for preventing it, are essential for 
minimizing the impact of this complication, both in the short and long 
term. It is also important to ensure that adequate attention is paid not 
only to the physical but also the psychological needs of critical care 
patients, since both aspects will impact their subsequent recovery 
process.
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Introduction: Cardiac surgery requiring cardiopulmonary bypass 
(CPB) has been associated with neurocognitive impairment, called the 
postperfusion syndrome. Delirium is the most common form of neu-
rocognitive impairment and has been linked with increased morbid-
ity and mortality. It has been suggested that micro-emboli during CPB 
cause this postperfusion syndrome
Objectives: We aimed to assess whether the duration of CPB is the 
major factor in delirium after cardiac surgery.
Methods: This single centre retrospective study included 235 patients, 
admitted to the ICU after cardiac surgery with CPB between 01-01-
2019 and 31-12-2019. Delirium was defined as patients having been 
administered the antipsychotic drugs haloperidol or quetiapine, either 
intravenously or orally, at least once during ICU-stay. Patient charac-
teristics and drugs were retrieved directly from the electronic medical 
records. Risk factors for delirium after cardiac surgery were analysed: 
age, type of surgery, Euroscore, APACHE-II score. Data were presented 
as median and IQR.
Results: Patients underwent arcus (n=10), CABG (n=85), CABG/valve 
(n=36), valve (n=51), mitral valve (n=44) and multiple valve surgery 
(n=9). 24/235 (10%) received antipsychotics during ICU-stay. ICU-stay 
and hospital stay were longer in patients with delirium (median 5, IQR 
4-7.5 and median 17.5, IQR 11-40.5)than in patients without (median 3, 
IQR 3-5 and median 11, IQR 9-17)(both p<0.004). Median duration of 
CPB did not differ between patients with delirium (135.5, IQR 105.75-
203) and those without (150,IQR 115-193)(p=0.90). Age, type of sur-
gery, Euroscore, APACHE-II score also did not differ between patients 
with or without delirium.
Conclusion: In our centre, duration of CPB was not associated with 
incidence of delirium.However, both length of stay at the ICU and in 
the hospital were significant prolonged in cardiac surgery patients 
with delirium. This findings underline the clinical importance of delir-
ium both on short term and long term outcome.
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Introduction: Critically ill patients experience pain during Intensive 
Care Unit (ICU) stay, which must be assessed by valid scales since it 
affects various outcomes.
Objectives: To evaluate painful procedures in critically ill patients 
and to investigate their effect as well as the role of analgesia in the 
outcome.
Methods: We included 28 mechanically ventilated patients who 
were subjected to 5.71 ± 4.29 painful (turning, endotracheal suction, 
physiotherapy, central venous catheter placement) and non-painful 
(oral care, dressing change) procedures. We measured their pain 
level before, during and after the stimuli by using the Behavioral Pain 
Scale (BPS) and the Critical care Pain Observation Tool (CPOT). We also 
recorded their vital signs (systolic and mean blood pressure, heart rate 
and respiratory rate) at the same timepoints. We analyzed the correla-
tion of our measurements as well as the use of bolus analgesia with 
the duration of mechanical ventilation, the ICU stay and the survival 
of the patients.
Results: There were statistically significant differences in the pain 
scores and vital signs between the different timepoints (before-during 
and during-after) for all procedures. The differences in the values of 
BPS and CPOT scales in the aforementioned timepoints were signifi-
cantly correlated with the respective differences in the values of vital 
signs. Regarding the type of the procedure, it was shown that physi-
otherapy influenced more than the others the change of both pain 
scales. The use of bolus analgesia during the procedure compared to 
the non-use predicted both less days of mechanical ventilation (17.94 
± 12.73 vs 25.02 ± 21.19, p = 0.015) and less days of ICU stay (18.54 
± 12.82 vs 25.56 ± 20.92, p = 0.016). The higher difference in the 
BPS before and during the stimuli was correlated with more days of 
mechanical ventilation [B (95%CI) = 3.640 (1.001 – 6.280), p = 0.007] 
and more days of ICU stay [B (95%CI) = 3.645 (1.035 – 6.254), p = 
0.006]. As far as the outcome, the higher difference in the CPOT dur-
ing and after the stimuli and the non-use of bolus analgesia related 
to increased chance of death [OR (95%CI) = 1.492 (1.107 – 2.011), p = 
0.009 and OR (95%CI) = 2.626 (1.013 – 6.806), p = 0.047 respectively].
Conclusion: Increased level of patients’ pain during various proce-
dures in the ICU, as assessed by the BPS and CPOT scales, is related to 
worse outcomes while the use of bolus analgesia during these proce-
dures might improves the outcomes.
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Introduction: While procedures and treatments are performed, seda-
tion is undergone not only for reducing patient’s anxiety and pain but 
also for facilitating the performance. Although there are various seda-
tives in pediatrics, most of them are not officially approved. The choice 
and doses of drugs are different case by case and also the responses 
of them are inconsistentwith expectation. For this reason, careful 
management are particularly necessary. Usually, until the early recov-
ery period in post-anesthetic care unit (PACU) after sedation, adverse 
events can be observed through careful monitoring. However, it is 
difficult to identify delayed complications (after 2hours) and also few 
studies introduced.
Objectives: In this study, we investigated the delayed adverse events 
that may occur in pediatrics after sedation. We would like to find out 
the most common adverse reactions and their period. And based on 
these evidences, how to deal with delayed responses takes a message 
in the future.
Methods: The subjects were pediatric patients (3 to 18 year-old) who 
had undergone sedation for procedures related to hemato-oncology 
examinations such as bone marrow biopsy, aspiration, spinal tap or 
both. The adverse events ere consisted of 20 categories and they were 
recorded after sedation by their parents. Patients were divided in two 
groups; patients who were visited to day care center (DCC) (group A) 
and admitted in ward (group B). They had repeated these procedures 
periodically. With Fentanyl 1.5mcg kg-1 as analgesics, three type seda-
tives were used in order; propofol: ketamine 3:1 combination (type A), 
4:1 combination (type B) and propofol single use 1.5mg kg-1 (type C). 
The occurrence time interval was set at two hour intervals including 
30 minutes recovery room period as session one, total 13 sessions. 
The beginning and ending time of adverse events were also recorded. 
These categories were based on adverse event of sedative drugs and 
others specific events were recorded separately.
Results: A total of 168 Patients were participated, group A was 103 
patients and group B was 65 patients. Adverse symptoms were 
showed mostly within 24 hour; group A was 34.95% (36/103) and 
group B was 51.56% (33/64). Among 20 items, most common adverse 
events were nausea (13.59%, 14/103) in group A and drowsiness 
(26.56%; 17/64) and dizziness (23.44%; 15/64) in group B. The inci-
dence was not related to the type of procedure or the combination 
of sedatives. For hemostasis and intrathecal chemotherapy, during 
this time, patients were lying down on recovery and intensively moni-
tored, adverse events in group A were showed distribution of various 
time session (32.8%; 21/64 in recovery room) but those of group B 
were mostly occupied in this period (74.4%; 32/43). More than 50% of 
adverse events occurred within 6 hours. In particular, group B rarely 
occurred after 12 hours (2%; 1/43). Adverse events were disappeared 
within a day except four cases in group A (6%; 4/64). All adverse events 
were not required any treatment, refusal of next sedation or need for 
change of sedatives.
Conclusion: Although there are various sedatives in pediatrics, most 
of them are not officially approved. The choice and doses of drugs are 
different case by case and also the responses of them are inconsistent 
with expectation. The overall trend and degree of risk could be pre-
dicted through this study on delayed adverse reactions to sedatives. 
Though various adverse responses were developed, most of them dis-
appeared within 24 hours spontaneously.
Based on these results, we could consider that sedation with propofol 
and ketamine should be safe sedatives to reduce anxiety and facili-
tate sedation safely even when continuous intensive monitoring and 
management is impossible. Apart from studies of delayed adverse 
responses in pediatric patients, future studies seek to identify and 
address how to reduce the adverse reactions and related variables.
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Introduction: Delirium is a severe neuropsychiatric disorder of 
organic origin characterized by the appearance of alterations in both 
consciousness and cognitive functions. The development of delirium 
is associated with multiple complications: increased mortality, longer 
duration of mechanical ventilation, higher rate of reintubation, and 
increased hospital stay. Since effective treatment has proven trouble-
some, prophylactic strategies become paramount.
Objectives: Analysis of the risk factors associated with the develop-
ment of delirium in a polyvalent ICU.
Methods: Prospective observational study on a cohort of ICU patients 
admitted from 1/10/2016 to 1/05/2019; those requiring transfer 
to another centre were excluded. Patients were classified into two 
groups, according to whether they developed delirium or not, and the 
following variables were analysed: sex, age, frailty, reason for admis-
sion, comorbidities, SAPS 3, SOFA, specific management measures and 
development of organic failure(s) (OF). Statistical analysis between 
subgroups was carried out: Pearson’s Chi-square test or Mann-Whit-
ney’s U to find significant differences, and uni- and multivariate logis-
tic regression analysis to quantify existing associations.
Results: 1534 patients were admitted during the indicated time, 
72 excluded. Ninety-three developed delirium (incidence 6.3%). 
After obtaining the initial data, we performed a multivariate analysis 
(table 1) including significant variables of the univariate analysis (with 
p<0.1), and finally, recursive partitioning using Chaid tree, observing 
(a) a higher incidence of delirium in patients who presented more than 
2 OF (20.4%) and, (b) in patients with less than 2 OF, higher incidence 
in patients above 74 years (8.6%). Patients who developed delirium 
had longer ICU and hospital length-of-stays and a higher rate of read-
mission, without differences in mortality.
Table 1. Multivariate analysis 
VARIABLE OR (CI 95%) 
Age (>74) 2,1 (1,3-3,5) 
Coma as reason for admission 2,5 (1,07-5,8) 
More tan 2 OF 4,9 (2,9-8,2) 
Invasive mechanical ventilation 1,9 (1,1-3,3) 
Confirmed isolation 2,4 (1,2-4,6) 
Continuous neuromuscular blockade 7,2 (2-26,3)  
Conclusion: The highest risk observed for developing delirium clus-
tered in patients who presented more than 2 OF and patients over 74 
years old. The detection of patients at high risk for developing delirium 
could imply a change in management and an improvement in the 
quality of care.
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Introduction: Delirium is a common often misdiagnosed, unrecog-
nised and misunderstood condition in the critical care setting (Page 
et al,2009) that has been associated with increased mortality, morbid-
ity and cognitive dysfunction (Leutz et al, 2010) . Delirium has implica-
tions for increasing cost to the National Health Service as it is linked 
to prolonged ventilation, and ICU stay which exposes the patient to 
associated risks as well as increased hospital stay (Mehta et  al, 2015, 
Zhang et al, 2013, Gleason et al 2015).
Objectives: The aim of this study was to identify our prevalence of 
delirium in our critically ill patient population and assess our compli-
ance with using CAM-ICU (Confusion Assessment Method for the 
Intensive Care Unit), the gold standard screening tool for identifying 
patients with delirium in the critical care setting (Gelinas et  al, 2018, 
NICE, 2010).
Methods: A prospective cohort study was undertaken in a 75 bedded 
UK critical care unit, between August 2018 to December 2018. Patients 
were reviewed consecutively for 2 weeks between 14:00 and 16:00hrs 
in which a Richmond Agitation and Sedation Score (RASS) was com-
pleted. For patients that were found to have a RASS score > -1, CAM-
ICU was completed. 106 Patients were excluded (106 patients) due to 
a length of stay less than 2 days, a previous known cognitive dysfunc-
tion, non-English speaking or were <18 years old.
Results: 217 patients were identified in the 2 week period. A RASS 
score was completed on 111 patients, of which 24 percent of patients 
were found to be CAM-ICU positive at least once during their critical 
care stay, 61% were had a negative CAM-ICU and 14% were unable to 
be assessed for delirium as remained with a RASS <1 throughout the 
study. Higher rates of CAM-ICU positive were found in patients admit-
ted to the neuro and cardiothoracic speciality areas, 50% and 32% 
respectively. CAM positive score were more likely to be seen in males 
and in emergency admissions. No differences in ICNARC or APACHE 
II scores were identified between the 2 groups. The compliance with 
CAM-ICU was poor, out of 311 opportunities identified; CAM-ICU was 
only completed on 52 occasions (19%). Of the CAM positive group, 
only 14 percent had been screened for delirium. Patients that were 
found to be CAM-ICU positive had long lengths of ITU stay and longer 
lengths of hospital stay. This cohort was less likely to be discharge 
back to their usual place of residence.
Conclusion: Delirium in critical care is effecting a quarter of our 
patients yet continues to be under diagnosed. Further work is required 
to increase compliance with CAM-ICU screening in an effort to identify 
patients at risk and implement intervention to minimise the long-term 
effects associated with ICU delirium.
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Introduction: Delirium is a common condition in the intensive care 
unit (ICU), notably among the elderly, and is associated with poor out-
comes. Pharmacological therapy is often used for its treatment, how-
ever, its efficacy has not yet been established.
Objectives: To investigate whether pharmacological therapy is effec-
tive in reducing delirium-related outcomes among ICU adult pacients.
Methods: A systematic review of randomized clinical trials was con-
ducted. For the review of literature, we searched MEDLINE and EMBASE 
from January 1st 1980 through February 4th 2020 for parallel-group 
clinical trials testing pharmacological treatment for delirium. Inclusion 
criteria were randomized clinical trials of adult participants with delir-
ium in the ICU. The exclusion criterion was trials including patients on 
antipsychotic treatment for pre-existing disorder. Title/abstract screen-
ing and full-text screening were independently conducted by two 
authors. In case of disagreement, a third reviewer was consulted. The 
primary outcome was the number of days with delirium. Secondary 
outcomes were delirium-free days, reduction in delirium scale scores, 
ICU and hospital length of stay, ICU and hospital mortality, mortality in 
longest period reported, mechanical ventilation-free days, incidence 
of coma, coma-free days and adverse outcomes. Quality assessment 
and data extraction were performed by two authors. Meta-analysis 
was not conducted due to between-study heterogeneity.
Results: From 1055 articles identified by the search strategy, seven 
fulfilled the inclusion criteria and were analyzed, comprising 1244 
patients. The following drugs were analyzed: haloperidol, morphine 
sulfate, quetiapine, olanzapine, rivastigmine and dexmedetomidine. 
Significantly shorter duration of delirium in the intervention group 
was found in two studies (28.6%). Greater reduction in delirium 
severity among patients receiving intervention was found in one 
study (14,3%). More ventilator-free days in the intervention group 
was reported in one study (14,3%). Also, longer ICU length of stay in 
patients receiving intervention was found in one study (14,3%), and 
higher mortality in the intervention group was reported in one study 
(14,3%), although not significant (RR: 2.78 IC 95%, 0.958-8.051). Four 
studies (57,1%) reported the number of patients with adverse effects. 
See the attached figures for detailed data.
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Conclusion: This systematic review concluded that pharmacological 
approach to delirium in the ICU may reduce duration of delirium. How-
ever, high heterogeneity between studies and their risk of bias com-
promise quality of evidence and analysis. Future assessment by more 
homogeneous trials with lower bias are required for solid conclusions.
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Introduction: Psychoactive drugs such as benzodiazepine/non-ben-
zodiazepine sedatives and antipsychotics are routinely prescribed 
for sedation, agitation, and delirium in the intensive care unit (ICU). 
Although intended for short-term use, recent studies suggest these 
drugs may not be stopped on ICU discharge and continued at hospital 
discharge in some patients.
Objectives: Among ICU patients discharged alive, 1) determine if 
invasive mechanical ventilation (iMV) ≥48 hours is associated with 
new (i.e. initiated in the ICU) psychoactive drug use on hospital dis-
charge; 2) to identify factors predicting the number of new psychoac-
tive drugs, adjusting for potential confounders and clustering by site.
Methods: We conducted a multicentre retrospective cohort study of 
adult patients admitted to 3 academic ICUs during one year to char-
acterize continuation of psychoactive drugs initiated in the ICU at 
hospital discharge. Data collected included demographics, severity of 
illness, clinical management, and drug exposures. Multivariable logis-
tic and Poisson models were constructed to address primary and sec-
ondary objectives, respectively.
Results: Data collection has been completed for 1111 ICU patients 
that survived to hospital discharge. At discharge, 12.3% were dis-
charged on one, 3.3% two, and <1% on three new psychoactive drugs; 
83.5% were discharged without a new psychoactive drug. Psychoac-
tive drug use prior to hospital admission and iMV ≥48 hours increased 
the odds of continuing a newly initiated psychoactive drug in the ICU 
on hospital discharge (adjusted odds ratio (aOR) 1.5, 95% confidence 
interval (CI) 1.0,2.1 and aOR 2.4, 95% CI 1.6,3.4 respectively) while 
female sex decreased the odds (aOR 0.7, 95% CI 0.5,0.9). We found 
females were discharged on fewer new psychoactive drugs (adjusted 
rate ratio (aRR) 0.7, 95% CI 0.5,0.9) whereas patients started on antip-
sychotics or non-benzodiazepine sedatives while in the ICU were dis-
charged on a greater number of psychoactive drugs (aRR 2.5, 95% CI 
1.9,3.3 and aRR 1.7, 95% CI 1.2,2.5 respectively).
Association between iMV and new psychoactive drug prescription on 
hospital discharge 
Predictor Adjusted OR (95% CI) p-value 
iMV ≥48 hours (ref = <48 hours) 2.37 (1.64, 3.42) < 0.001 
Age  1.0 (0.99, 1.01) 0.819 
Female sex (ref = male) 0.66 (0.47, 0.94) 0.02 
Any psychiatric history (ref = no) 1.33 (0.88, 2.01) 0.176 
Association between iMV and new psychoactive drug prescription on 
hospital discharge 
Predictor Adjusted OR (95% CI) p-value 
Alcohol use disorder (ref = no) 1.04 (0.63, 1.74) 0.861 
Illicit drug use disorder (ref = no) 1.32 (0.71, 2.43) 0.378 
Smoker (ref = no) 1.04 (0.69, 1.55) 0.863 
Psychoactive drug PTA (ref = no) 1.47 (1.0, 2.14) 0.047 
Admission category (ref = medical) 0.97 (0.68, 1.4) 0.848 
SOFA score 1.0 (0.95, 1.05) 0.995 
Abbreviations: OR = odds ratio; CI = confidence interval, iMV = invasive mechanical ventilation; 
ref = reference; PTA = prior to admission; SOFA = sequential organ failure assessment.   
Conclusion: Preliminary analyses suggest iMV ≥48 hours and psy-
choactive drug use prior to hospitalization are associated with con-
tinuation of an ICU-initiated psychoactive drug at hospital discharge. 
Furthermore, antipsychotics and non-benzodiazepine sedatives initi-
ated in the ICU impact the number of prescribed psychoactive drugs 
on discharge. The final results will be used to inform the development 
of a quality improvement initiative to optimize medication reconcilia-
tion of psychoactive drugs initiated in critically ill patients.
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Introduction: Postoperative delirium is one of a common complica-
tion after major surgeries and associated with increased morbidity and 
mortality, prolonged mechanical ventilation, longer lengths of ICU 
or hospital stays, increased cost of care, and worse long-term cogni-
tive function. Therefore, pharmacologic intervention to prevent post-
operative delirium is of particular importance for surgical patients. 
Acetaminophen is commonly used to as adjuvant analgesics in sur-
geries and may reduce inflammatory response and decrease opioid 
consumption in surgical patients. Previous studies demonstrated that 
acetaminophen analgesia may decrease the incidence of postopera-
tive delirium.
Objectives: The aim of this study was to determine the effects of 
adjunctive acetaminophen analgesia on postoperative delirium.
Methods: We searched randomized controlled trials (RCTs) in data-
bases including MEDLINE, EMBASE, Cochrane Library, the National 
Institute of Health Clinical Trials Register, the World Health Organi-
zation International Clinical Trials Registry Platform, and the refer-
ence lists of retrieved articles from inception date to March 2020. 
The primary outcome was the incidence of postoperative delirium. 
The protocol has been registered with the International Prospec-
tive Register of Systematic Reviews (PROSPERO) registration number 
CRD42019145666.
Results: Out of 840 reports, 29 RCTs met the inclusion criteria and 
were appropriate for our meta-analysis. Of 29 RCTs, only 3 RCTs 
reported the primary outcome. The pooled results of included clini-
cal trials indicated that acetaminophen significantly decreased the 
incidence of postoperative delirium: pooled risk ratio was 0.38 [95% 
confidence interval (CI) 0.18–0.80; I2 = 0%; n = 263]. The certainty 
of the body of evidence was judged as moderate using the GRADE 
methodology.
Conclusion: The results of this systematic review and meta-analysis 
indicated that administration of acetaminophen was associated with 
decreased incidence of postoperative delirium.
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Introduction: Delirium has paramount morbidityand mortality bur-
den; and requires early diagnosis and prompt treatment.
Objectives: We introduced a delirium tool including RASS scoring sys-
tem first time in our trust in 2016 based on an audit at that time, best 
practice and NICE recommendations. To ensure the effective usage of 




• Time Frame: 4 months
• Data Collection: A questionnaire designed according to NICE 
recommendations that collected data regarding risk factors, 
indicators, preventive measures and diagnosis using RASS and 
CAM-ICU.
• Data Source: Information from patients, nursing staff, patients’ 
notes, and nursing sheets.
Results: Results were analyzed according to NICE guidelines.
• Risk factor assessment: 91% of patients were at high risk for delir-
ium on admission to ITU.
• Indicators of Delirium: Out of 4 major indicators of delirium 
defined by NICE, 77% of the patients had at least 1 of these indi-
cators present.
• Interventions to prevent Delirium:
• To prevent cognitive dysfunction, not a single patient had all 
the simple preventive measures that are recommended by 
NICE.
• Mobilization was done only in 44% of the patients and out of 
this only 17% had walking mobilization (ventilated patients 
were excluded).
• Pain scores were recorded only in 37% patients. 2 patients were 
currently in pain, but pain scores were not documented.
• Sleep disturbance was found in 55% of the patients.
• RASS score hourly and CAM ICU once a shift is the key to diag-
nose delirium according to NICE. Results showed that hourly 
RASS was done only in 28% and CAM ICU only in 14%.
Conclusion: Delirium has paramount morbidity and mortality issues. 
Our audit highlighted several areas of potential improvement. As 
part of an action plan, formal and informal teaching sessions were 
arranged that showed positive feedback. Next step is to reaudit to 
assess quality improvement.
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Introduction: To investigate de efficacy of enteral methadone (MET) 
to control difficult sedoanalgesia in critical ill patients ventilated due 
to ARDS in SARS-CoV-2 infection.
Methods: We analyze retrospectively case reports who received MET 
during the Pandemia. Descriptive analyses were used to describe 
demographic, clinical and evolutionary trends of the patients and sed-
ative, analgesic and neuromuscular blockade doses five days before 
and after MET. Adverse effects were also described. Difficult sedoan-
algesia was defined as difficulties to weaning from mechanical ventila-
tion (MV) due to agitation and delirium while reducing sedatives and/
or analgesics (group A); pain due to opiate withdrawal (group B) or 
nonoptimal patient ventilator interaction despite high dose of seda-
tives/analgesics (group C).
Results: 13 patients met the inclusion criteria and constituted 
the study population. Median age was 64 ± 9 years and 12 were 
male. With a median of VM of 49 ± 16 days from the first MET dose, 
7 patients were included as group A, 3 group B and 3 group C, 
respectively.
Five days before starting MET, all the patients had a median cumula-
tive IV morfine dose of 589 ± 332 mg. 11 patients were receiving 
propofol with a median dose 15.443 ± 11.189 mg. 5 patients were 
also receiving midazolam (median dose 589 ± 261 mg) and 5 patients 
needed cisatracurium (median 1.753 mg ± 1.706 mg) too.
MET initial dose (enteral route) was 45 ± 23 mg.
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Five days after MET treatment, 9 patients could reduce opiate treat-
ment in a 68% ± 17% of the initial dose. 4 patients could also decrease 
propofol in a 68% ± 27%. 3 of 5 patients that were taking midazolam 
reduced 51 ± 31% the initial dose. All patients that were receiving cis-
tracurium decreased doses in 43 ± 31%.
Regarding difficult sedoanalgesia, 3 patients of group A could pro-
gress in the weaning from MV, the other 4 patients could reduce 
sedatives and analgesics but couldn’t progress from MV because of 
respiratory conditions. All group B patients could control the pain and 
all patients in group C reached optimal patient ventilator interaction 
while reducing analgesics and sedatives.
Hypotension was observed in 3 patients after the first MET dose and 
crystalloids and vasoactive were needed. No other adverse effects 
were reported.
Conclusion: We concluded that in patients with difficult sedoanalge-
sia, methadone is effective to reduce doses of sedatives and analgesics 
and help weaning from MV.
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Introduction: Critical illness is often related to the development of 
brain disfunction, which can present itself in several ways, either on 
the short or the long term.
Up to 80% of the critical illness survivors present with some form of 
brain disfunction either during the acute episode or when evaluated 
soon after hospital discharge, and in some patients even years after 
the acute episode.
Evidence points to the possible improvement in cognitive prognosis 
when a2 adrenergic agonists are used in the critically ill. The seda-
tion pattern of these agents is quite different from other sedatives, in 
which patients can easily be aroused and their cognitive performance 
in psychometric tests is usually preserved.
The main purpose of this work was to investigate the relationship 
between the use of dexmedetomidine in the critically ill and some 
dimensions of the post intensive care syndrome.
Methods: Data was collected retrospectively from the individual 
medical records of patients admitted to a Mixed Intensive Care Unit 
(ICU) during the year of 2017. Collected data focused on the results 
of the inquiries done during the follow-up outpatient clinic usually 
held between the third and sixth months after hospital discharge. The 
applied formularies were the Anxiety and Depression Scale, the ICU 
– Post Traumatic Stress Syndrome (PTSS) questionnaire and the ICU 
Memories questionnaire.
Results: A total of 318 patients were admitted to the ICU, 64% were 
male. Most of the patients (72%) were admitted for medical reasons 
and 64% received mechanical ventilation. The mortality rate was 26%. 
Dexmedetomidine was used in 26% of the patients, usually as part of 
a combined sedation strategy. Only 123 patients (39%) attended the 
follow-up outpatient clinic.
No significative difference was found in the group of patients under 
dexmedetomidine when considering the Anxiety and Depression 
Scale or the ICU – PTSS questionnaire. When the ICU Memories ques-
tionnaire was applied, we observed that patients seemed prone 
torecall more memories when under the use of dexmedetomidine, 
interestingly both pleasant and unpleasant ones.
Conclusion: Our study has some limitations, namely the fact that only 
a moderate percentage of patients attended the outpatient clinic, 
possibly explained by the fact that our ICU population assists many 
foreigners as it is located in a touristic region. Still it allows us to con-
clude that patients who receive dexmedetomidine are more aware of 
their surrounding environment, more cooperative and less susceptible 
to some adverse effects from the sedative medications.
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Introduction: Deep sedation can have negative consequences 
for Intensive Care Unit (ICU) patients such as delirium, prolonged 
mechanical ventilation, and longer ICU and hospital stay.
Objectives: To compare the level and duration of sedation, sedative 
agents, and clinical outcomes of ICU patients before and after imple-
mentation of Pain, Agitation, and Delirium (PAD) guideline.
Methods: A before and after study design. Eligible patients were 
mechanically ventilated, 18 years and older, with 24 hours or longer 
ICU stay, of mixed ICU patient population in two, single-center ICUs. 
Data were collected over six weeks, from 1st December 2017 – 12th 
January 2018, before the PAD implementation and over six weeks, 
from 1st May – 15th June 2019, four months after completion of the 
PAD implementation. The sedation level was measured for the first 
three days of the patients’ stay with the Richmond Agitation Sedation 
Scale (RASS). Sedation duration and types of sedation agents were col-
lected through the patients’ stay. 
Results: There were 101 patients included, 52 in the before group 
and 49 in the after group. The two groups were comparable in age, 
gender, and reason for ICU admission. The after group had a lower 
APACHE II score compared to the before group (p=0.01). The level of 
sedation was -3 (median) on the RASS scale in both groups the first 
three days of the ICU stay (p=0.18). Patients in the before group were 
sedated 41 hours vs. 20 hours (median) in the after group, without dif-
ference between the groups after adjusting for background variables 
(p=0.22). Seven types of analgesia and morphine-based continuous 
sedation were used, in various combinations, from none to six in the 
before group and the after group. Propofol was the most common 
sedative in both groups (92% vs. 90%, p=0.66), and the duration of 
propofol sedation was shorter in after group (30 vs.16 hours, p=0.04). 
More patients in the after group were sedated with one drug com-
pared to patients in the before group (37% vs. 17%, p=0.03) and fewer 
patients in the after group were sedated with a combination of two 
drugs than patients in the before group (12% vs. 29%, p=0.04). The 
difference between the groups in duration of mechanical ventilation 
(median, 36 vs. 16 hours, p=0.44), and length of ICU stay (median, 6.2 
vs. 4.9 days, p=0.44), and hospital stay (median, 12.6 vs. 10.3 days, 
p=0.46) stay was not significant.
Conclusion: The level of sedation was moderate (RASS -3) before and 
after the PAD guideline implementation without a difference in seda-
tion duration. The depth of sedation, the number of sedation agents 
administered, and the PAD guideline implementation needs further 
investigation.
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Introduction: Delirium is a disturbance of consciousness with 
changes in cognition. It manifests as a constellation of symptoms with 
acute onset and a fluctuating course. Delirium is extremely common in 
the ICU especially amongst mechanically ventilated patients and it has 
prognostic implications (2.5 fold increase in short term mortality and 
3.2 in 6months). Three subtypes have been recognized: hyperactive, 
hypoactive, and mixed. It is frequently undiagnosed unless specific 
diagnostic instruments are used. The CAM-ICU is the most studied and 
validated diagnostic tool.
Objectives: - To calculate the incidence of delirium during the first 72 
hours of ICU admission.
- To use Confusion Assessment Method Scale (CAM- ICU) to diagnosed 
delirium in the ICU.
- To describe the main features and causes of admission in the ICU of 
the patients that developed delirium in the ICU, compared to the ones 
that didn´t.
Methods: Observational, prospective and descriptive study that 
includes patients that entered the UCI between October 15th and 
November 15th, 2019. We performed the CAM-ICU scale at the admis-
sion and daily for the first 72 hours or until they were discharged to 
hospitalization ward, required orotracheal intubation or died. We 
excluded patients that required orotracheal intubation at admission 
and those who had mental disorders or central nervous system disor-
ders that made impossible to evaluate delirium with CAM-ICU scale. 
The collected data was analyzed with SPSS and evaluated in terms of 
descriptive statistics. We used the mean and standard deviation for 
quantitative variables and absolute and relative frequencies for quali-
tative variables.
Results: 102 patients were included, the mean age was 68 (± 14 
years), 39 (38.9%) patients were previously at the hospitalization ward. 
The incidence of delirium of those patients that werepreviously in the 
hospitalization ward was 64.10% (25 patients). The global incidence 
of delirium in the first 72 hours in the ICU was 28.4%, during the first 
day in the ICU the incidence was 15.69%, during the second day was 
22.56%, and the third day was 11.76%. The disorders that were more 
strongly related with the development of delirium in the ICU were: 
Acute coronary syndrome (50%), decompensated cirrhosis (19%), 
sepsis (16%), upper gastrointestinal bleeding (7%)) and patients with 
transcatheter aortic-valve implantation (5%).
Conclusion: - Delirium is a frequent complication in the ICU, even in 
the first 72 hours, and without the presence of another factors related 
with delirium such as illness severity, mechanical ventilation and 
sedation.
- The incidence of delirium in this study is higher (28 cases per 100 
patients) than the one described in other studies (11 cases per 100 
patients).
- The disease that was most associated with the presence of delirium 
was acute coronary syndrome. This suggest the need of performing 
studies that include patients earlier and with less stay in the ICU.
- The use of a specific scale to diagnosed delirium in the ICU is a useful 
tool to diagnosed it in the ICU.
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Introduction: Delirium is a condition characterized by an acute cogni-
tive decline, a fluctuating mental status, disturbance of consciousness, 
inattention, or disorganized thinking. It is a well–recognized adverse 
prognostic index in Intensive Care Unit patients that is associated with 
increased morbidity, mortality, and the development of long–term 
neurocognitive deficits.
Objectives: To evaluate the presence of delirium, using a well vali-
dated scale the “Confusion Assessment Method for the ICU”, in post-
cardiac surgery patients and to identify possible risk factors which 
contribute in the development of delirium.
Methods: Our cohort consisted of 202 consecutive post-cardiac sur-
gery patients admitted to ICU. All patients were evaluated for delirium 
using the CAM-ICU scale. According to this scale, patients developed 
an acute onset of cognitive decline or a fluctuating mental status, dis-
turbance of consciousness, inattention, or disorganized thinking were 
diagnosed with delirium.
Results: Patients (mean age:66±13 years old) had a prevalence of 
delirium of 29.2%. Patients with delirium were 4 years older than non-
delirium subjects (p=0.002), while there were no gender differences 
between the two groups.
Prevalence of chronic kidney disease in study cohort was significantly 
higher in delirium patients (12%) compare to non-delirium subjects 
(4%) (p=0.040).
The in-hospital mortality risk using Euroscore II score was 1,67% in the 
study cohort, while patients with delirium scored significantly higher 
Euroscore II compared with the non-delirium ones (2.32% versus 
1.38%, respectively, p<0.001).
The median duration of anesthesia-sedation was 360 minutes, while 
patients presented with delirium had prolonged anesthesia-sedation 
duration compared to no delirium patients (p<0.001).
These patients had also prolonged mechanical ventilation (median 
duration in patients with delirium was 1230 minutes versus 717 
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minutes in non-delirium patients, p<0.001) and a longer ICU stay 
(3210 versus 1440 minutes, p<0.001).
According to ROC curve analysis, variables that predicted delirium 
were duration of anesthesia-sedation, age, Euroscore II, urea, lactic 
acid and intravenous vasoactive medications.
Moreover, in a multivariate logistic regression analysis it was shown 
that age, Euroscore II and duration of anesthesia-sedation were all 
independent predictors of delirium.
Conclusion: According to our study the prevalence of delirium in ICU 
after cardiac surgery was high. Age, prolonged duration of anesthesia 
and Euroscore II score represent independent risk factors of delirium. 
Delirium was associated with prolonged mechanical ventilation and 
ICU stay.
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Introduction: There is evidence of the muscle/brain interaction in sev-
eral cognitive disorders due to the neurotrophic factors released by 
muscle endocrine, paracrine and autocrine activity. We didn´t found 
any research on this topic in Post Intensive Care Syndrome (PICS).
Objectives: Our hypothesis was to determinate if there is any relation-
ship between cognitive impairment after critical illness (CIACI) and ICU 
Acquired Weakness (ICUAW).
Methods: Setting: teaching hospital, medical and surgical ICU. Mai-
monides Universty ethic commitee aproved the protocl and waived 
informed consent. Inclusion criteria: >18yo, ARDS, sepsis or septic 
shock, APACHEII > 14, Clinical Frailty Scale, Delirium >48h, mechanical 
ventilation >4d, ICU stay >7 days, use of NMB or steroids, vasopres-
sors. CAM-ICU and RASS (daily), Medical Research Council (MRC) scale 
and Spanish version of Montreal Cognitive Assessment (MoCA) were 
the evaluation tools. MRC <18 diagnoses ICUAW and MoCA>26 CIACI. 
Statistical analysis: IBM SPSS Macintosh 25.0. Descriptive statistics. Chi 
squared or Fischer exact test.
Results: From April 1st to September 30th, 92 patients were admitted. 
Of them 28 fulfilled IC. 13 (53.6%) were female, mean age (), in table 1 
mean values are expressed. 75% presented delirium. At ICU discharge 
64,3% presented ICUAW and 60.7 CIACI. There was a significant associ-
ation between ICUAW and CIACI (Chi Squared test p 0.03) as is shown 
in figure 1.
Conclusion: There was a significative association between ICUAW and 
CIACI in this PICS population. According to our pathophysiological 
hypothesis our data opens a window for myokines and neurotrophic 
factors measurements and for the evaluation of the efficacy of multi-
modal neurotrophic factors preparations.
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Introduction: Muscle weakness is a frequent entity in patients admit-
ted to the ICU. Its most common presentations are polyneuropathy 
and critical patient myopathy, or a combination of the two. In addi-
tion, SARS COV-2 requires prolonged invasive ventilatory support and 
the use of neuromuscular blockers, favoring its appearance. Preven-
tion has an important role in reducing the loss of functionality at ICU 
discharge.
Objectives: 1-Value the degree of functionality and independence of 
patients admitted for SARS COV-2 at ICU discharge.
2- Identify the risk factors associated with the loss of functionality and 
independence during admission.
Methods: Retrospective observational study conducted in a multipur-
pose ICU with 30 beds. All the patients admitted for hypoxemic res-
piratory failure secondary to SARS-COV-2 during the months of March 
- May 2020 were collected. Demographic data, days of stay in the ICU 
and risk factors associated with acquired ICU weakness were recorded, 
including the time of start of physical therapy after admission. The Bar-
thel index was used to calculate the functionality and degree of inde-
pendence of all patients, both at admission and at discharge from the 
ICU. In the statistical analysis, the Pearson correlation coefficient was 
used for the quantitative variables and the mean comparison test for 
qualitative variables.
Results: During the study period, 27 patients were admitted due 
to SARS COV-2 infection, of which 5 (18.51%) were exitus, for which 
a total of 22 patients were included in the study. All entered with 
a score on the Barthel index of 100 points, while the mean score on 
the Barthel index at discharge was 37.05 ± 16.67. In the association 
test carried out, we found a high correlation of the loss of functional-
ity at discharge from the ICU with the variables: Days of admission to 
the ICU (p = 0.000), Days of mechanical ventilation: (p =: 0.000), Days 
with sedoanalgesia and neuromuscular block: (p =: 0.000), Days with 
delirium: (p =: 0.000), Physiotherapy during the ICU stay: (p = 0.000), 
Days of initiation of physical therapy: (p = 0.000).








DAYS IN ICU --- --- 
-0,811 
(0,000)













DAYS WITH BZD --- --- 
-0,820 
(0,000)
DAYS WITH PROPOFOL --- --- 
-0,583 
(0,004)
DAYS WITH OPIATES --- --- 
-0,833 
(0,000)
NEUROMUSCULAR BLOCKERS: 63,00 6,71 --- 7,690 
Yes
No
29,41 8,99 (0,000) 
DAYS WITH NEUROMUSCULAR 
BLOCKERS: --- --- 
-0,796 
(0,000)

















Conclusion: -Patients admitted to the ICU due to SARS COV-2 infec-
tion present a significant functional loss upon discharge from the ICU.
-The delay in the start of physiotherapy adds to the risk factors already 
known for the appearance of weakness and loss of autonomy at dis-
charge from the ICU. An early mobilization strategy for the critically ill 
patient could mitigate these consequences.
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Introduction: The incidence of delirium in patients admitted to ICU 
due to SARS COV-2 infection is very high according to the different 
registers. The use of validated scores such as Predeliric and E-predeliric 
that predict the likelihood of delirium development in different 
patients can help in setting priorities with regard to the use of delirium 
preventive measures, especially in situations of limited resources such 
as COVID infection.
Objectives: 1.Evaluate the correlation between the E-Predeliric and 
Predeliric values  when they are recoded into four categories of risk of 
developing delirium (very low, low, moderate and high risk).
2.Evaluate the correlation between the predicted probability of delirium 
according to the E-Predeliric and Predeliric models with the actual rate 
of delirium developed in patients admitted to the ICU for SARS COV 2.
Methods: Retrospective observational study carried out in a multipur-
pose ICU with 30 beds. All patients admitted for SARS COV2 infection 
were collected during the months of March to May 2020. The E-PRE-
DELIRIC was calculated in all patients at the time of ICU admission and 
the PRE-DELIRICa24 hours after admission, classifying patients into 
four risk groups according to the result (very low, low, moderate and 
high risk). We quantified the incidence of delirium after sedation was 
removed. The presence of agitation, maladjustment (in the absence 
of pain or ventilatory problems) and the need for administration of 
dexmedetomidine or an antipsychotic drug was considered delirium. 
And finally the results were compared with the actual rate of delirium 
observed in these patients.
Results: During the period from March to May 2020, a total of 27 
patients were admitted to our service with the diagnosis of SARS-
COV 2, with an average age of 65.81 ± 9.72. There is a high correla-
tion between the percentage values  of E-Predeliric and Predeliric (r = 
0.608, p = 0.01). This result is corroborated with the association test 
between both variables when they are recoded in four categories. 
There were no statistically significant differences in the percentage 
value of E-Predeliric and the patient’s state of real delirium (t = 1,481, 
p = 0.151). Their mean values  are very similar (38.95% and 33.50% for 
the patients who suffered delirium versus those who did not, respec-
tively). The opposite occurs with Predeliric (t = 5,460, p = 0.00), with 
the mean values  being 85.68% and 41.00%. These results are corrobo-
rated with the association test performed between the patient’s actual 
state of delirium and these two scales coded in its four states.
Conclusion: 1.The E-Predeliric and Predeliricscores allow patients to 
be classified according to the risk of developing delirium in 4 groups, 
in a homogeneous manner, regardless of the score used.
2.The predicted risk at admission according to the E-Predeliric, in rela-
tion to the observed delirium rate, shows that the risk of delirium is 
underestimated, while the24h after admission calculatedPredeliric is 
better correlated with the actual incidence observed.
001148 
Analysis of patients suffering critical care delirium in an Intensive 
Care Unit in the North West of England
J.  Manalayil1; AN. Thomas1
1Critical Care, Salford Royal NHS Foundation Trust (Formerly Hope Hospi‑
tal), Manchester, United Kingdom 
Correspondence: J. Manalayil
Intensive Care Medicine Experimental 2020, 8(2): 001148
Introduction: Identifying patients with delirium is essential for the 
prevention, treatment and management of the condition; this requires 
a structured assessment that can be done using the CAM-ICU method-
ology (Miranda et al 2018). We set a standard of recording twice daily 
CAM-ICU assessments in patients’ electronic records (EPR). Access to 
these records has allowed us to audit compliance to our standards and 
to review outcomes of different types of delirium and review the fre-
quency with which patients meet different stages of the assessment.
Objectives: To retrospectively assess 1-year mortality of patients with 
hyperactive and hypoactive delirium, to assess compliance with delir-
ium assessments and to review the frequency with which patients met 
different components of theCAM-ICU.
Methods: The review was conducted in a 32 bedded general and neu-
rosciences unit. EPR records (Sunrise Clinical Manager) of the CAM-
ICU assessments from August 2018-August 2019 were exported to 
Excel files. Patients were categorised as who were delirium positive 
(with or without agitation), or negative but with or without cognitive 
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impairment. Cognitive impairment was defined as an acute change 
from a patient’s normal mental state. These patients can then be dived 
into those with inattention errors using the Letters Attention Test, or 
with disorganized thinking using straightforward Yes/No questions 
and commands to follow.
Records were linked to the patients’ Intensive Care National Audit and 
Research Centre (ICNARC) records to investigate reason for admis-
sion, co-morbidities, social history, length of stay and outcome. On 
six occasions we provided feedback to nurses about the number of 
assessments by individual nurses and with information about the 
assessments.
Results: There were a total of 2728 admissions (2408 total patients, 57% 
male, mean age 57 (SD 18 years)) in the ICNARC records. 1358 patients 
had 10,530 recorded CAM-ICU assessments, of these 1191 had full 
ICNARC records and were reviewed in more detail (6 patients with delir-
ium had ICNARC details filled out from EPR). 214 (18%) had at least one 
positive assessment, of the remaining 977 patients, 82 had with cogni-
tive impairment and 895 had no cognitive impairment, the remaining 
167 remained in a coma. Of 10,530 assessments, 66 were excluded as 
incomplete, 7,243 were not deeply sedated. 989 had an acute change 
from their baseline mental state, out of which 775 had >2 inattention 
errors on assessment (CAM-ICU positive). The remaining 199 patients 
had 0-2 inattention errors (CAM-ICU negative). Of the 775, 246 were 
calm and alert; 199 had 2 or more points for disordered thinking.
Patients with delirium had a longer length of hospital and ICU stay 
(LoS) compared to those without delirium (median (IQR) ICU LoS: 
CAM-ICU positive 9 (4-18) days, negative with cognitive impairment 4 
(2-8) days, without 3 (2-6) days. Patients with delirium required more 
organ support, had a higher mortality (ICU: 14% vs 7% vs 9%) and 
were more likely to be male, their mortality rate increased from 13% at 
30 days to 22% at one year . Those that died were older, had more co-
morbidities and had worse functional status than those that survived.
In all patients, 23% had an assessment completed once per shift and 
62 % once per day. In patients with a positive assessment, 65% had 
investigations to identify a cause, 42% required some form or restraint 
and 65% had cognitive impairment at unit discharge. Those suffering 
from hypoactive delirium were older (mean 60 years, SD 18 years) and 
more likely to die (1-year mortality of 26%).
Conclusion: Electronic records of delirium assessments can be used 
to audit compliance with standards for delirium management. Even 
with staff feedback, only 62% of patients had daily assessments. The 
study provides further evidence that patients with delirium are more 
likely to be male, have a higher mortality (particularly with hypoactive 
delirium), need more support, and continue to die in the 12 months 
after their ICU stay.
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Introduction: Pupilometry is a simple and non invasive technique 
that allows to asses nociceptive responds to stimulus through pupil-
lary dilation reflex (PDR) objective measurement.
Objectives: To evaluate diagnostic efficacy of PDR compared to BPS 
scale.
Methods: ICU patients over 18 years, under intravenous sedoanal-
gesic drugs,  mechanically ventilated,  basal BPS of 3, RASS between 
-1 and -4. Exclusion criteria: use of paralyzing drugs, neuromuscu-
lar diseases, polyneuropathy, pupillary damage, GCS <6, clonidine, 
dexmedetomidine, tramadol, ketamine, adrenalin, calcioantagonist, 
noradrenaline > 0.6 or dobutamine > 10 mg/kg/min. It will be assessed 
pain response with BPS and PDR in pain absence, pain stimulus of 
10,20 30 and 40 mA and with tracheal aspiration. PDR measurements 
: Pupilometer AlgiScan®. Presence of pain was considered as BPS>3. It 
will be preformed a diagnostic PDR test vs BPS globally and separated 
for each painful stimulus or not. Significance as p < 0.05. Approved by 
Basque Ethics Committee (CEIm-E).
Results: We obtained an AUC of 0,885 (IC 0,830-0,940). PDR value of 
best diagnostic efficiency was  11,5%,  with a sensitivity of 89,8% (CI 
95% 78,2-95,6) and specificity of 78,4% (CI 95% 70,6-84,5) (Table 1).
Table 1. Diagnostic efficiency of different PDR cut points (global measurements). 





















































Odds ratio 31,8 (11,5-87,6) 14,7 (5,5-39,7) 16,2 (4,8-54,9) 14,4 (3,3-62,0) 
PPC 4,15 (2,9-5,8) 2,4 (1,9-3,06) 1,9 (1,6-2,3) 1,6 (1,4-1,8) 
NPC 0,13 (0,06-0,3) 0,16 (0,07-0,4) 0,12 (0,04-0,3) 0,1 (0-0,4) 
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In 20 mA stimulus we found the best results on efficiency diagnostic 
parameters, with an AUC of 0,853 (0,7-1,0) and a sensitivity of 100% 
(34,2-100) and a specificity of 75,9% (57,9-87,8) for the cut point of 
PDR=11,5% (Table 2).
Conclusion: PDR valuesover 11,5% indicate pain with a 90% of sensi-
tivity and 80% of specificity.
A pupillary response over 11,5% during 20mA stimulus could predict 
the need of analgesics during tracheal aspiration. Further studies will 
be needed to confirm.
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Introduction: Pain assessment in the non-communicative patient in 
critical care units remains under continuous evaluation. Clinical com-
plexity of the critically ill patient could establish behavior responsive-
ness to pain.
Objectives: To determine the pain response in critically ill patients by 
comparing two tools: the behavior pain scale (BPS) and the pupillary 
dilation reflex (PDR), establishing the demographic (age) and clinical 
factors (severity level-APACHE II, and sedation level-Bispectral Index 
scale-BIS) which may interfere with their response.
Methods: ICU patients over 18 years, under intravenous sedoanalgesic 
drugs,  mechanically ventilated, basal BPS of 3, RASS between -1 and 
-4. Exclusion criteria: use of paralyzing drugs, neuromuscular diseases, 
polyneuropathy, pupillary damage, GCS <6, clonidine, dexmedetomi-
dine, tramadol, ketamine, adrenalin, calcioantagonist, noradrenaline > 
0.6 or dobutamine > 10 mg/kg/min. It will be assessed pain response 
with BPS and PDR in pain absence, pain stimulus of 10,20 30 and 40 
mA and with tracheal aspiration (TA) PDR measurements: Pupilometer 
AlgiScan®. Presence of pain was considered as BPS>3. Categorical vari-
ables as percentages % and compared using X2 o Fisher, continuous 
variables median IQR and compared using two samples T-test. Mul-
tivariate analysis was performed using a logistic regression model 
showed as odds ratios (OR) and 95% confidence intervals (CI). P<,05. 
Approved by Basque Ethics Committee (CEIm-E)
Results: 183 measurements on 31 patients. Demographic characteris-
tics;  mean±SD: age 62,4±17,1; APACHE II 21±8,3; BIS 63±19,5; RASS 
-3,4±1,8.  Percentage: Female 38,7; Admission: ARF 25,8; Post-surgery 
32,2; Sepsis 29,1; Trauma 12,9.
Only in 49 measurements (26.7%) of them presented pain (BPS ≥4), 
with median of PDR of 28% (17-48), vs 134 where not experience pain 
(BPS<4) with a median of 5% (2-11) (p <0.001).
In the bivariate analysis, an age over 65, a higher level of severity 
(APACHE II >20) or a higher level of sedation (BIS ≤  40) did not pre-
dict a lower likelihood of having pain measured for BPS (BPS  ≥4) 
(Table 1). Similarly, age above 65 was not related to lower PDR. In con-
trast, BIS ≤ 40 and APACHE>20 were both significantly associated with 
lower PDR (Table 2).
Table 1. Behavior of BPS according to level of BIS, age and APACHE II. 
BPS<4 BPS≥4
n % n % p
BIS ≤40 20 14,9% 5 10,2% 
0,41 
BIS >40 114 85,1% 44 89,8% 
Edad≤65 70 52,2% 25 51% 
0,884 
Edad>65 64 47,8% 24 49% 
APACHE≤20 57 45,2% 26 57.8% 
0,149 
APACHE>20 69 54.8% 19 42.2% 
APACHE>20 88 6,5 (3-17) 
Table 2:  Behavior of PDR according level of BIS, age and APACHE II. 
PDR
n P50 (P25-P75) p
BIS ≤40 25 3 (2-10,5) 
0,020 
BIS >40 158 9 (3,75-21) 
Edad≤65 95 9 (3-22) 
0,242 
Edad>65 88 7 (3-19) 
APACHE≤20 83 11 (4-29) 0,029 
In the multivariate analysis adjusted by APACHE and BIS the OR in 
adjusted and non adjusted model was 1,095 (1,062-1,130) (p<0,001).
Conclusion: Higher PDR values  are related to painful response accord-
ing to BPS.
The response to pain is independent of the level of sedation, age and 
severity of the patients.
Reference(s) and grant ackowledgment(s)
1. Rouche O, Wolak‑Thierry A, et al. Evaluation of the depth of sedation in an 
intensive care unit based on the photo motor reflex variations measured by 
video pupillometry. Ann Intensive Care. 2013;3(1):5.
2. Li D, Miaskowski C, Burkhardt D, et al. Evaluations of physiologic reactivity 
and reflexive behaviors during noxious procedures in sedated critically ill 
patients. J Crit Care. 2009;24(3):472.e9‑13.
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Introduction: We report a patient who presented with pulmonary 
oedema, hypertension and progressive renal failure. Recent investiga-
tions for systemic sclerosis had been performed but results were still 
awaited on admission. Systemic Sclerosis is a rare disease with an inci-
dence of two to ten cases per million of the population. Scleroderma 
Renal Crisis, with an incidence of 5% in patients with diffuse disease, is 
a rare complication of a rare disease.
Methods: This 70-year-old lady presented with pulmonary oedema 
and acute kidney injury. A diagnosis of Systemic Scleroderma was con-
sidered due to presence of dermatological changes (fig.1), hyperten-
sion, presence of right heart strain on transthoracic echocardiography 
and rapidly progressive renal failure. Scleroderma renal crisis became 
the primary diagnosis following positive biochemical tests.
After immediate resuscitation and initiation oftreatment with the 
angiotensin converting enzyme inhibitor, Captopril, the patient was 
transferred to the regional renal unit for continued management. 
The patient’s renal failure worsened and she became dialysis depend-
ant. She also developed left ventricular failure and worsening pul-
monary hypertension. Despite prompt diagnosis of a rare condition 
and aggressive resuscitation, the patient did not survive her hospital 
admission.
Results: An immunological screen was sent with key positive find-
ings including positive CENP B, PM-Scl100, anti-nuclear AB screen and 
P-ANCA screen pattern. Echocardiogram demonstrated left ventricular 
hypokinesia with an ejection fraction of 35% and  moderate pulmo-
nary hypertension. Urine dipstick showed protein +++, blood +++.
Conclusion: Acute renal failure is not always secondary to septic shock 
in a patient with sepsis. This case demonstrates the importance of con-
sidering rare causes of acute renal failure in the intensive care setting.
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Introduction: Sarcoidosis is a mutisystemic granulomatous disorder 
of unknown etiology that most commonly affects the lung and lym-
phatic system. It is characterized pathologically by the presence of 
noncaseating granulomas in involved organs. The estimated preva-
lence is 10 to 20 per 100,000 population. In approximately on-half the 
disease is detected incidentally by radiographic abnormalities prior to 
the development of symptoms, which includes fever, cough, dyspnea 
and chest pain.
Objectives: We present two cases of Sarcoidosis which had lately 
diagnosed because of their debut as acute respiratory distress syn-
drome (ARDS).
Methods: A 52 year old man and a 62 year old woman, both pre-
sented as fever and dyspnea of approximately two weeks of evolution, 
the chest radiography at presentation revealed extensive bilateral 
intersticial infiltrates. On physical examination: tachypnea with normal 
skin coloration and fever, no skin, eye or joint lesions. Severe hypox-
emia and on auscultation “velcro-like” crackles in bibasilar areas.
Results: Complete blood count, electrolytes and rena and liver test 
were within normal limits. At day +6 and +4 of adminission, respec-
tivelly, they both presented poor respiratory income and required 
both orothraqueal intubation and connection to mechanic ventilation. 
Both thoracic CT showed with bilateral extensive multifocal infiltrates 
with significant mediastinal and bilateral hiliar lymphadenopathy. 
Empirical treatment with intravenous antiobiotics and, in the first case, 
antituberculostatic treatment, was started, because of the appearance 
of positive Mantoux test. Fibreoptic bronchoscopy with bronchoalve-
olar lavage (BAL) were performed in both cases and revealed no evi-
dence of PCP, acid fast bacilli, fungi, or malignancy. No other causes 
were found.
Conclusion: Due to this results, initiation of corticosteroids and pul-
monary biopsy was performed in both cases. In the first case, endo-
scopic ultrasound guided needle aspiration was performed and in the 
second case transbronchial lung biopsy. Histopathologic detection 
of noncaseating granulomas, compatibility clinical and radiographic 
manifestations and exclusion of other diseases, concluded in the diag-
nosis of pulmonary sarcoidosis. By days +2 and +4 of initiation with 
corticosteroids, they both presented notably improvement in respira-
tory status and radiograph images.
Reference(s) and grant ackowledgment(s)
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4. F Sabbagh, C Gibbs, L S Efferen. Pulmonary sarcoidosis and the acute 
respiratory distress syndrome (ARDS). Thorax 2002;57:655–656
000890 
Study of three clinical variables as a grading prognosis for acute 
severe pancreatitis
A. Muñoz‑Cantero1; D. Pérez‑Civantos1; JD. Jiménez‑Delgado2; 
M. Cidoncha‑Gallego2; P. Nieto‑Sánchez1; J. Pérez‑Bazaga1
1Critical Care Unit, Complejo Hospitalario Universitario de Badajoz, Bada‑
joz, Spain; 2Critical care unit, Don Benito‑Villanueva Hospital, Don Benito, 
Spain 
Correspondence: A. Muñoz‑Cantero
Intensive Care Medicine Experimental 2020, 8(2): 000890
Introduction: The assessment of severity at the initial medical exami-
nation of serious acute pancreatitis plays an important role in intro-
ducing adequate early treatment and the transfer of patients to the 
ICU. Different early prognostic scores have been proposed but many 
are not sharply enough for many practitioners.
Objectives: To study the correlation of imaging using TC severity 
score against SOFA score plus serum lactate and the first 24 hours fluid 
balance as a predictor score for severe acute pancreatitis.
Methods: A lineal retrospective, two centers study was carried out. We 
enrolled all consecutive patients with acute pancreatitis admitted to 
the ICU of two Hospitals (a teaching tertiary center and a small county 
Hospital).
Univariate analysis was performed to identify the parameters which 
showed some correlation with the mortality. We used a square-Chi 
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model for qualitative parameters and T-Student for quantitative. We 
also performed a multivariate analysis using independent significant 
(p ˂ 0.05) parameters in univariate analysis.
We evaluated the area under the ROC curve (AUC) for significant sin-
gles parameters in a logistic regression model. Finally, we constructed 
a model using the analysis of three parameters altogether like an early 
predictor of the severity of acute pancreatitis. To assess the diagnos-
tic performance of the model, we compared the AUC-ROC with each 
selected single parameter. The SPSS 22.0 program was used for statisti-
cal analysis.
Results: 64 patients were enrolled in the study. All data expressed 
as median and standard deviation. Age was 60,4 +/- 14. Sequential 
Organ Failure Assessment (SOFA) score at ICU admission was 3.3 +/- 
3.1, Acute Physiology and Chronic Health Evaluation (APACHE-II) score 
were 11.6 +/- 5.8. We also analyze parameters like Fluid Balance dur-
ing the first 34 hours, 3.2 +/- 2.5 litres, and serum lactate 2.0 +/- 1.4 
mmol/l. The aetiology of acute pancreatitis was: gallstones (60.9%), 
alcoholism (14.0%), TGC (1.6%), and other causes (20.4%). ICU Mortal-
ity was 30.2%. Ten patients required surgical treatment and we found 
a significant correlation between mortality and the need for surgery (p 
˂0.001). In the same case SOFA score (p ˂ 0.0001), serum lactate, initial 
fluid balance, ICTS and the sum of SOFA Score + Lactic + Fluid Balance 
were significantly associated with ICU mortality. For the early predic-
tion of the severity, we used a three feet analysis model that was con-
structed using the SOFA score, Fluid Balance, and serum lactate on the 
first 24 hours of ICU admission. Our model showed a trend of a higher 
AUC (0.8892) than that of every single parameter (SOFA score, 0.766; 
Fluid Balance, 0.822; lactate, 0.852, ICTS, 0.447).
Conclusion: We can conclude saying that probably the sum of three 
clinical parameters like initial Fluid Balance plus Serum Lactate plus 
SOFA score is superior to TC severity score as an early prediction of 
mortality for severe pancreatitis. These preliminary results should need 
to be confirmed in further studies with a larger number of patients.
Reference(s) and grant ackowledgment(s)
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puted To‑mography Severity Index Is an EarlyPrognostic Tool for Acute 
Pancreatitis. J Am Coll Surg 2005;201:497–502.
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Introduction: Immunosuppressed Covid-19 patients were predicted 
to have poorer outcomes (1-3), however what contributes to these 
worse outcomes remain unknown.
Objectives: To assess whether immunosuppression on presentation 
is a predictor of poor outcomes in critically ill patients admitted with 
Covid-19 infection in an intensive care unit (ICU) and to identify princi-
ple determinants of the poorer outcomes.
Methods: Immunosuppressed patients were defined as patients 
on regular immunosuppressive treatments. PCR positive Covid-19 
patients at St George’s Hospital ICU from 01/03/20 to 15/05/20 were 
included in this observational study. Primary outcome was the odds 
ratio (OR) of mortality at 28-days after ICU admission. Disease severity 
was assessed as secondary end points, such as ICU length of stay (LOS), 
duration of mechanical ventilation (MV), duration of cardiovascular 
(CV) support, and the need for renal replacement therapy (RRT). A uni-
variate analysis was performed with Chi square statistic, and a logistic 
and linear regression model was used for the multivariable analysis. 
Medians were compared with Mann-Whitney U test. P values greater 
that 0.05 were considered significant.
Results: A total of 132 adult Covid-19 patients were included in the 
study, out of which 15 (11.4%) were immunosuppressed. 6 (40%) of 
immunosuppressed patients died at 28 days (Figure1), compared to 64 
(54.7%) in the immunocompetent group (OR 1.8; 95% CI 0.6, 5.4; p = 
0.28.). Immunosuppression in Covid-19 patients did not affect LOS (12 
days in immunosuppressed group (5, 22) vs 11 days (5,17) p = 0.8), the 
requirement of RRT (26.7% vs 37.6%, OR 1.6, 95% CI 0.48, 5.5, p = 0.4) 
length of MV (6 days (0, 22) vs 9 days (3, 16), p = 0.8) or duration of CV 
support (1.5 days (0, 8.5) vs. 4 days (0, 9), p = 0.3).
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Conclusion: Immunosuppression on presentation neither increases 
28-day mortality nor pre-disposes patients to severe Covid-19 
complications.
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Introduction: Diabetes is a risk factor for various postoperative com-
plications. One of the most serious of these complications is throm-
boembolism such as myocardial infarction and cerebral infarction, 
in which enhanced platelet α2-adrenoceptor function may play a 
key role (Ref. 1). Currently, many patients admitted to the postop-
erative intensive care unit (ICU) are sedated long-term by continuous 
intravenous infusion of the α2-adrenoceptor sedative dexmedeto-
midine. Therefore, it is extremely important to examine changes in 
platelet functions in patients with diabetes due to differences in 
anesthetics and sedatives, and to establish an optimal approach to 
perioperative management for prevention of postoperative bleeding 
and thromboembolism.
Objectives: The aim of this study is to analyze the effects of dexme-
detomidine on expression of P-selectin, a platelet activation marker, 
by flow cytometry using peripheral blood samples collected before 
and after surgery from patients with and without diabetes who were 
admitted to the ICU after major surgery.
Methods: Informed consent was obtained from subjects and the pro-
tocol was approved by the ethics committee (R1109). The subjects 
were patients with (n=5) and without (n=4) diabetes who entered the 
ICU after subtotal esophagectomy or pancreatectomy. The exclusion 
criteria were age <20 years; abnormal platelet count, platelet func-
tion, or coagulation ability before surgery; treatment with antiplatelet 
drugs or anticoagulants up to 2 weeks before surgery; intraoperative 
blood transfusion, and intraoperative treatment with drugs that might 
affect platelet function. Blood samples were collected from arterial 
pressure lines before the start of surgery and immediately after admis-
sion to the ICU after surgery. Platelet-rich plasma was stimulated by 
ADP with dexmedetomidine (0-100 ng/ml) at room temperature for 
30 min. Samples were coincubated with PerCP-labeled anti-CD61 anti-
body and PE-labeled anti-CD62P (P-selectin) antibody, and P-selectin 
expression levels were assessed by flow cytometry. Data from before 
to after surgery were compared by t-test. All other data were com-
pared by one-way ANOVA, followed by a Dunnett post hoc test. P<0.05 
was considered to indicate significance in all analyses.
Results: In patients without diabetes, dexmedetomidine increased 
P-selectin expression in a dose-dependent manner, with no significant 
difference between pre- and postoperative data (Fig.  1). In patients 
with diabetes, P-selectin expression was higher than in patients with-
out diabetes at all concentrations of dexmedetomidine before and 
after surgery (Fig.  2). P-selectin expression in patients with diabetes 
was enhanced in a dexmedetomidine dose-dependent manner, simi-
larly to patients without diabetes, but was significantly higher after 
surgery than before surgery.
These results show that the P-selectin expression level in patients 
with diabetes is higher before and after surgery, compared to that in 
patients without diabetes, which indicates that platelets from patients 
with diabetes are activated and have a tendency for thrombosis. Our 
previous studies on healthy individuals showed that dexmedetomi-
dine enhanced P-selectin expression in a concentration-dependent 
manner (Ref. 2). This is consistent with the results of this study and 
indicates that this tendency does not change after surgical invasion. 
In patients without diabetes, dexmedetomidine had similar levels of 
platelet activation before and after surgery, whereas patients with 
diabetes had significantly increased P-selectin expression after sur-
gery. This suggests that the sensitivity of α2-adrenoceptors may be 
enhanced or the number of α2-adrenoceptors may increase due to 
surgical invasion in platelets of patients with diabetes.
Conclusion: The function of  platelet α2-adrenoceptor  may 
be  enhanced postoperatively and platelets may be activated more 
strongly by dexmedetomidine  in patients  with diabetes compared 
to patients without diabetes.
Reference(s) and grant ackowledgment(s)
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Introduction: Coronavirus disease 2019 (COVID-19 is associated with 
coagulation abnormalities leading to numerous thromboembolic 
complications. Conventional coagulation tests show trends of coagu-
lopathy, but reflect only limited parts of the coagulation cascade. 
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Rotational thromboelastrometry (ROTEM®) is a digitized modification 
of thromoboelastography reported to be useful in identifying hyper-
coagulable conditions.
Objectives: The aim of this study was to evaluate ROTEM® profiles of 
COVID-19 patients in identifying hypercoagulable states.
Methods: Patients admitted to the Intensive Care Unit with COVID-19 
were included in this prospective observational study. Blood samples 
were collected for ROTEM® thomboelastometry. Coagulation patterns 
were analyzed using extrinsic and intrinsic rotational thromboelasto-
metry activators (respectively EXTEM and INTEM). The following varia-
bles were recorded and analyzed: clotting time (CT), clotting formation 
time (CFT), clot firmness’ amplitude after 5 minutes (A5) and after 10 
minutes (A10), and maximum clot firmness (MCF). The ROTEM® results 
were compared with conventional coagulation parameters, which 
were collected as part of standard clinical care. Hypercoagulability was 
defined as a reduction in CFT and increase in MCF.
Results: Forty-seven COVID-19 patients were included, of which 
81% were male. The median age was 63 years (range 29-79), and the 
median BMI was 28.8 kg/m2 (range 24.4-48.4). The median length of 
stay at the ICU at the time of blood sampling for ROTEM® was 8 days 
(range 1-25). All patients required mechanical ventilation.
Mean ROTEM® clot formation time (CFT) was shortened in EXTEM 
(45.3 s; normal 46-149 s) and INTEM (45.6 s, normal 62-130 s). Mean 
maximum clot firmness (MCF) was increased with all three activators 
(EXTEM, 77.3 mm, normal 55-72 mm; INTEM 72.9 mm, normal 51-69 
mm; FIBTEM 32.9 mm, 6-21 mm).
Conventional coagulation analyses showed the typical coagulopathy 
pattern with increased fibrinogen (mean 7.2 g/L, SD 1.5 g/L), pro-
longed PT (15.3 s, SD 2.0 s), and prolonged APTT (34.7 s, SD 8.7 s). 
Mean platelet count was slightly increased (404 109/L, SD 154 109/L).
Conclusion: ROTEM® confirmed an overall hypercoagulable state of 
COVID-19 patients admitted to the ICU.
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Introduction: Therapeutic plasma exchange (TPE), the use of which 
has been expanding in recent years, is a nonspecific extracorporeal 
treatment method and is used in many immunological and toxicologi-
cal diseases.
Objectives: The aim of this study is to determine demographic and 
clinical characteristics of critically ill patients in the intensive care unit 
(ICU) with TPE
Methods: : This study was performed prospectively in ICU. Patients 
in need of ICU, bigger than 18 years old and with TPE indication were 
included in the study.
Results: We enrolled 31 patients. A total of 207 sessions of TPE were 
performed. The mean age was 46 ± 18 years. The median APACHE II 
score was 20 (min:5- max:40). The most common reason for ICU admis-
sion were 56% microangiopathic hemolytic anemia (MAHA), 13% 
Crimean-Congo Hemorrhagic Fever (CCHF) and 10% Guillain-Barre 
Syndrome, respectively. There were significant difference between 
survivors and non survivors APACHE II (survivors 17±7, non survivors 
25±9, p=0.02) and GC score (survivors:12 (min:3-max:15), non survi-
vors:8 (min:3-max:15), p=0.08). Length of ICU stay was 12 (min-max: 
1-86) days. ICU mortality was 48%.
Conclusion: As a result of this study, the most common TPE indication 
was determined as MAHA in the ICU. The mean age of patients under-
going TPE was lower than the general ICU patient profile. Nearly half 
of the patients died. Scoring systems such as APACHE II score and GKS 
maybe effective in determining the mortality of these patients.
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Introduction: COVID-19 is a novel Coronavirus that is currently 
responsible for the Global Pandemic of 2019-2020. It has been 
reported that up to 25%(1) of hospitalized patients with COVID-19 
develop VTE (Venous Thromboembolism) and this figure can be as 
high as 31% in ICU patients with COVID-19(2). We aimed to establish 
theincidence rate of VTE in COVID-19 patients admitted to ICU com-
pared to patients admitted with Seasonal Influenza and mechanically 
ventilated without both influenza and COVID-19.
Methods: We included 38 patients that were admitted to the ICU 
at SJH with COVID between the 31/03/2020 – 13/04/2020. We also 
included the last 38 patients that had been admitted to ICU with Sea-
sonal Influenza, as a comparison group. These patients were admit-
ted between 06/02/2016 – 22/03/2020, as there were fewer cases per 
year. We used a control group consisting of the last 37 patients that 
had been admitted to the ICU and required Mechanical Ventilation for 
greater than 48 hrs for a non-respiratory reason.
Each patient’s Electronic Patient Record was reviewed retrospectively. 
We recorded each patient’s background and co-morbidities, whether 
they developed VTE or not and reviewed the radiological evidence. 
We also looked at each patient’s Coagulation profile on admission and 
how they were anticoagulated in ICU. We used SPSS 26.0 to analyse 
the data.
Results: SAPSII scores and SOFA scores were significantly higher in 
patients without both influenza and COVID-19 compared to influenza 
and COVID-19 respectively (Table  1)The incidence rate of VTE in the 
COVID group was 13.2% (DVT 5.3%, PE 10.5%). The Rate of VTE in the 
Seasonal Influenza group was 15.8% (DVT 13.2%, PE 2.6%). The Rate of 
VTE in the Non-respiratory Group was 8.1% (DVT 8.1%, PE 2.7%). There 
was no significant difference between the groups (p 0.5).
All patients that went on to develop VTE had received prophylactic 
anticoagulation before diagnosis, and all received therapeutic antico-
agulation thereafter.






















Sex (M:F) 28:10 20:18 26:11  0.1
SAPS II 49 (18.1) 56.8 (17.5) 61.5 (16.4) 0.009
SOFA 6 (4.1) 8.8(3.9) 9.2(3.3) 0.001
Age (years) 57.9 [14.8] 61.0 [17.4] 58.4 [18.2]  0.7
Diabetes (%) 9 (23.7) 6 (15.8) 4 (10.8)  0.3
Heart Disease 
(%) 6 (15.8) 18 (47.4) 12 (32.4)  0.01
COPD (%) 5 (13.2) 14(36.8) 8(21.6)  0.04
Active Smoker 
(%) 2 (5.3) 7(18.4) 9(24.3)  0.06
CKD (%) 3 (7.9) 1(2.6) 0  0.1
BMI (kg/m2) 25.7 [5.4] 27.5 [9.2] 26.4 [6.4]  0.5
SAPSII 49.0 [18.2] 56.8 [17.5] 61.5 [16.4] 0.009
SOFA 6.0 [4.2] 8.8 [3.9] 9.2 [3.3] 0.001




36.0 30.9 [3.7] 16.8 [12.9] 15.2 [4.1] <0.001
Fibrinogen  
(g/L) 1.9 – 3.5 6.2 [ 1.6] 34.6 [14.0] 30.8 [5.0] <0.001
Platelets 





CRP (mg/L) <10 171.0 [107.5] 186.7 [105.7]
233.5 
[156.0] 0.8
LDH (IU/L) 135 - 250 431.2 [237.8] 101.5 [84.6] 92.9 [108.6] <0.001
VTE (%) 5(13.2) 6(15.8) 3(8.1) 0.5
PE (%) 4(10.5) 1(2.6) 1(2.7) 0.2
DVT (%) 2(5.3) 5(13.2) 3(8.1) 0.4
Conclusion: There was no significant difference in the rates of VTE 
between ICU patients with COVID-19 compared to Influenza, in our 
cohort. Yet, VTE still occurred despite prophylactic anticoagulation and 
remains a pertinent differential to keep in mind.
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Introduction: Since its emergence in December 2019, the coronavi-
rus disease 2019 (COVID-19) epidemic rapidly progressed into a pan-
demic. A noticeable observation in critically ill patients affected by 
COVID-19 pneumonia is the high incidence of thrombotic complica-
tions, especially that of pulmonary embolism. Importantly, the major-
ity of patients admitted to the ICU receive a central venous catheter 
of which a considerable proportion develops catheter-related throm-
bosis.  When considering COVID-19 coagulopathy to cause an over-
all hypercoagulable state rather than mainly a local pro-thrombotic 
state in the pulmonary circulation, the prevalence of catheter-related 
thrombosis is presumably higher in COVID-19 patients than in non-
COVID-19 patients with a central venous catheter.
Objectives: The aim of this study was to investigate whether COVID-
19 is associated with catheter-related thrombosis.
Methods: This was a multicenter case-control study conducted at 
four intensive care units. Adult critically ill patients with an indwelling 
central venous catheter of the internal jugular, subclavian or femoral 
vein were included. Patients were excluded if catheter indwelling-
time was less than 48 hours. All patients underwent a compression 
and duplex ultrasound examination of the cannulated vein. Cases and 
controls were patients with and without catheter-related thrombosis, 
respectively. Primary outcome was the association of COVID-19 with 
catheter-related thrombosis. Patients were considered to have COVID-
19 pneumonia if they had a positive polymerase chain reaction assay 
for SARS-CoV-2 and had corresponding abnormalities on thoracic 
imaging.
Results: Ultrasound examination was performed in 87 intensive care 
unit patients. Catheter indwelling-time was less than two days or was 
unknown in five patients. A total of 82 patients were included in the 
analysis, of whom 18 were diagnosed with catheter-related throm-
bosis (22%). The majority was male (80.5%) and median age was 63.0 
[IQR: 54.5, 70.0] years. The overall prevalence of COVID-19 was 76% 
(62/82) and 94% (17/18) among the cases. The crude odds ratio for 
catheter-related thrombosis in patients with COVID-19 versus controls 
was 7.2 (95% CI: 1.32, 130). The odds ratio for catheter-related throm-
bosis adjusted for anticoagulation dosage and catheter indwelling-
time in critically ill COVID-19 patients was 18.3 (95% CI: 2.31, 410).
Conclusion: COVID-19 is highly associated with catheter-related 
thrombosis, suggesting a diffuse hypercoagulable state rather than 
mainly a local pro-thrombotic state in the pulmonary circulation lead-
ing to pulmonary immunothrombosis.
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Introduction: The use of cardio-pulmonary bypass (CPB) during car-
diac surgery is associated with bleeding complications. Alterations in 
platelet function has bearing on the risk of bleeding. The effect of CPB 
on the actual number and function of platelets is not fully understood.
Objectives: The aim of this study was to analyse the kinetics and func-
tion of platelets during and immediately after weaning from CPB.
Methods: Thirty-nine elective coronary artery bypass grafting (CABG) 
patients were studied with impedance aggregometry (Multiplate) and 
blood count. Samples were taken before anaesthetic induction (Base-
line), 30 minutes after start of CPB (22 of the patients) (CPB30), after 
weaning from CPB before protamine administration (EndCPB) and five 
minutes after protamine (After Protamine). Adenosine diphosphate 
(ADP) was used as activator and aggregation was expressed as the 
area under the curve (AUC). The number of platelets was corrected 
for haemodilution by using haemoglobin as marker and expressed as 
number of platelets  (x109/L) divided by haemoglobin concentration 
(g/L). Statistics used were paired t-test followed by Bonferroni correc-
tion for multiple comparisons. Data are expressed as mean ± standard 
deviation.
Results: Mean CPB time was 85.1±21.3 minutes (range 46-138 min-
utes). The number of platelets corrected for dilution was not reduced 
during CPB. Mean number of platelets divided by concentration of 
haemoglobin was at baseline 1.7±0.4 *109/g. At 30 min of CPB it 
was almost identical at 1.7±0.3 *109/g and after weaning from CPB 
increased to 1.9±0.4 *109/g (p<0.05). Five minutes after protamine it 
decreased to 1.7±0.5 *109/g compared to before protamine (p<0.001). 
With impedance aggregometry, mean AUC for platelets activated 
with ADP was 77.1±26.3 at baseline. After 30 minutes of CPB, AUC 
was reduced to 49.3±24.7 (p<0.001). After weaning from CPB, mean 
AUC had increased to 68.5±28.4. Five minutes after protamine, AUC 
decreased to 58.9±29.3 (p<0.05 compared to before protamine).
Conclusion: Platelet numbers corrected for dilution were not 
decreased and platelets were not consumed during CPB. Initially dur-
ing CPB platelet aggregability was reduced but returned to baseline 
levels at the end of CPB. After administration of protamine platelets 
were consumed as expected. The reversal of heparin with protamine 
seems however to impair platelet function. These effects of CPB and 
protamine on platelet function can be of significance for the bleeding 
problems seen in cardiac surgery.
000924 
Targeted anticoagulation in Covid 19 patients based on d 
dimers: a retrospective study of Anti Xa versus APTTr monitoring 
in patients on systemic heparin infusions to establish superiority 
and patient outcomes
K.  Bhalsod1; J. Husselbee1; R. Matthews1; R. Carroll1; R. Stumpfle1
1Intensive care, Hammersmith Hospital, London, United Kingdom 
Correspondence: K. Bhalsod
Intensive Care Medicine Experimental 2020, 8(2): 000924
Introduction: COVID-19 patients with elevated d dimers have a higher 
mortality rate(1), which is reduced when treated with heparin(2), 
resulting in its recommendation for hospitalised patients.(3) However 
the type and dose of heparin and heparin infusion monitoring (Anti Xa 
versus APTTr (Activated Partial Thromboplastin Time Ratio)) remains 
under discussion (3,4,5).
Methods: We undertook a single centre, retrospective observational 
service evaluation examining COVID-19 positive critical care admis-
sions receiving heparin infusions (based on d dimer > 3000ng/ml). 
Two groups of patients were identified: the first group had heparin 
monitoring via APTTr whilst the second by Anti Xa. We compared the 
two groups over 2 separate 10 day periods, assessing whether either 
method of heparin monitoring would affect the following endpoints:
1. The mean rate of heparin infusion
2. Number of monitoring blood tests sent (Anti Xa assay or APTTr)
3. Number of infusion changes made, as a surrogate marker for nursing 
interventions
4. The mean Anti Xa and APTTr values as a surrogate marker for adequate 
anticoagulation
5. Clotting and bleeding episodes.
Results:
Our sample groups comprised 18 patients monitored with APTTR and 
21 patients monitored with Anti Xa. The table below describes results 
obtained.
Table 1: To compare Anti Xa vs APTTr monitoring in 2 separate defined 10 day periods 
Variable Anti Xa group APTTr group P-Value *
Total number of 




18.46 16.31 0.09 
Mean number of 
monitoring blood 







Mean number of 
heparin infusion 
adjustments per 











Total number of 
patients in each group 
on RRT (CVVHDF) 
12 15 - 
Mean number of RRT 







Mean RRT filter 






Total number of VTE 
*** 1 2 0.47 
Total number of 
bleeding 
complications *** 
2 0 0.19 
Conclusion: Overall, Anti Xa monitoring is at least comparable to 
APTTr monitoring in critically unwell COVID-19 patients. Our data sug-
gests that Anti Xa monitoring may be more favourable (improved filter 
lifespan, less labour intensive and less blood test monitoring), how-
ever this needs further investigation.
Heparin remains the mainstay of treatment of covid-19 patients and 
given the ongoing pandemic, urgent studies are required to establish 
the optimum method of heparin monitoring in critical care patients.
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Introduction: COVID-19 patientstypically have a prothrombotic sta-
tus and acute pulmonary embolism (PE) may be a cause of persistent 
hypoxemia or sudden death. However, the incidence of PE has not 
been well reported.
Methods: Prospective institutional database of critically ill adult 
mechanically ventilated COVID-19 patients, conducted between 
March 10 and April 20, 2020. Patients were eligible if they underwent 
a computed tomography pulmonary scanner angiography (CTPA), 
as part of the routine management in case of persistent hypoxemia 
or respiratory deterioration. The primary endpoint of this study was 
the occurrence of PE; the impact of standard thromboprophylaxis 
(i.e. subcutaneous enoxaparin 4000 IU once daily) or high-regimen 
thromboprophylaxis (i.e. subcutaneous enoxaparin 4000 IU twice 
daily or therapeutic unfractioned heparin) on PE occurrence was also 
analyzed.
Results: Of 42 mechanically ventilated COVID-19, 36 underwent CTPA 
after a median of 7 [4-9] days since ICU admission and 13 [10-16] days 
since the onset of symptoms. Twelve (33%) patients were diagnosed 
of PE, which was bilateral in 5 patients and localized in the right lung 
in 7 patients. Ten of the patients with PE (83%) and 11 of the other 24 
patients (46%) received standard thromboprophylaxis (OR 3.57 [1.09-
13.47]; p=0.04). D-dimers on the day of CTPA had a predictive accu-
racy of 0.90 (95% CIs 0.78-1.00) for APE. Two patients with PE (17%) 
and 10 patients without PE (43%) died at ICU discharge (OR 0.28 [0.05-
1.35]; p=0.26).
Conclusion: One third of COVID-19 mechanically ventilated patients 
have a pulmonary embolism visible on CTPA. Optimal diagnostic and 
prophylaxis strategies need to be further assessed. 
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Introduction: As the cycling population grows, lack of public aware-
ness of cycling while under the influence of alcohol has become an 
issue. The purpose of this study was to investigate the association 
between alcohol consumption and bicycle-related injuries such as 
traumatic brain injuries and EMR-ISS.
Methods: We conducted a retrospective analysis using data col-
lected from the Korean Emergency Department-based Injury In-depth 
Surveillance (EDIIS) database from 20 emergency departments during 
2011–2016. Study subjects had sustained bicycle-related injuries at 
the age of over 18 years. Covariates included mechanism, place, and 
time of injury. Outcomes were traumatic brain injury (TBI) incidence 
and severe trauma EMR-ISS325. Effects of alcohol consumption on 
these outcomes were analyzed, and differences in effects were deter-
mined using logistic regression.
Results: Of 24,297 individuals, 1,912 had alcohol-related bicycle inju-
ries, which led to a higher proportion of single-vehicle injury incidents 
(alcohol 63.7% vs. non-alcohol 46.4%, p < 0.001). The alcohol group 
had a higher rate of TBI (alcohol 11.5% vs. non-alcohol 4.6%, p < 0.001) 
and severe EMR-ISS (alcohol 23.1% vs. non-alcohol 11.7%, p < 0.001). 
TBI (odds ratio [OR], 2.72; 95% confidence interval [CI], 2.33–3.16) and 
EMR-ISS (OR, 2.26; 95% CI, 2.01-2.53) showed a significant association 
with alcohol. Head and neck injuries were higher in the alcohol group 
(alcohol 73.7% vs. non-alcohol 40.0%, p < 0.001).
Conclusion: Our study showed an association of alcohol consump-
tion with higher incidence of traumatic brain injuries and severe EMR-
ISS. Education should focus more on the association between cycling 
under alcohol influence and injury severity.
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Introduction: Traumatic coagulopathy is often observed in patients 
with severe traumatic brain injury (sTBI). The association between TBI 
and coagulopathy is well established. Earlier transfusion with high 
blood product ratios is recommended for severely injured patients, 
and fibrinogen is known as one of the most important coagulation 
factor in the trauma field. Fibrinogen concentrate (FC) is widely used 
for severe trauma patient and its effectiveness is gradually recognized. 
However, FC for sTBI is less reported and usage criteria is not estab-
lished. We started to use FC since 2019 after approval of clinical ethics 
committee and aggressively administer to multiple trauma patients. 
We aimed to identify predicting factors of fibrinogen declining in 
order to set the criteria of FC usage for sTBI.
Methods: We retrospectively reviewed successive adults sTBI in our 
hospital between January 2017 and December 2019. We compared 
factors between two groups (high fibrinogen group: fibrinogen value 
is less than 150mg/dL 3-6 hours after arrival, and low fibrinogen 
group: fibrinogen value is 150mg/dL or more 3-6 hours after arrival). 
We researched vital signs, labolatory data, findings of computed 
tomography(CT) and analyze predictingfactor.
Results: 50 patients were enrolled. 35 patients archieved fibrinogen-
value 150 or more, and 15 patients did not. D-dimer on arrival above 
50μg/mL, skull fracture and depressive skull fracture were strong pre-
dicting factors of low fibrinogen group.
Conclusion: Low fibrinogen group should be administered FC. Some 
labolatory data of Coagulation abnormality demonstrated low fibrino-
gen as reported. Likewise, skull fracture and especially depressive skull 
fracture reflect severe coagulopathy in this study and patients with-
out skull fracture is enough treated by using only fresh frozen plasma. 
Skull fracture has possitility of provoking tissue factors and predicting 
sevrere coagulopathy.
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Introduction: Pulmonary embolism (PE) is a major complication and 
crucial disease in patients with trauma. Previous studies have been 
scarce to investigate risk factors for PE in patients with trauma.
Objectives: Our aim was to investigate risk factors for PE among 
patients with trauma.
Methods: This is a nested case-control study using the Japan Trauma 
Data Bank (JTDB) from 2004 to 2017. The JTDB is a nationwide trauma 
registry in Japan. We included patients who had blunt or penetrate 
trauma; aged ≥16 years old; had Injury Severity Scores (ISSs) ≥ 9; 
and survived for more than 2 days after hospital admission. A nested 
case-control study (1:5) was conducted using propensity score (PS) 
matching. The variables included in the PS matching were age, gender, 
mechanism of injury, vital signs at emergency department, ISSs, and 
ward type. Then, we conducted a conditional logistic regression anal-
ysis to identify risk factors for PE in the matched cohort. The primary 
outcome was occurrence of PE during hospital stay. The explanatory 
variables were selected based on prior studies and univariate analysis, 
such as comorbidities, abbreviated injury scale (AIS), transfusion, cen-
tral vein catheter placement, and surgical procedures.
Results: Of those who were registered in the JTDB database, 719 
patients with PE and 3,595 patients without PE were selected by PS 
matching. The median age was 73 (interquartile range (IQR): 55–84), 
and 57% was female. The mean ISSs was 10 (IQR: 9–19). Patients with 
PE had upper and lower extremity open fracture more frequently than 
those without PE (7.9 vs. 4.6% [p <0.001], 27.7 vs. 7.7% [p <0.001], 
respectively). Patients with PE had central vein catheter placement 
and surgical procedure more frequently than those without PE (7.0 
vs. 2.9% [p <0.001], 86.6 vs. 57.1% [p <0.001], respectively). In-hospital 
mortality was higher in patients with PE than in those without PE (5.8 
vs. 3.4% [p =0.003]).
In the multivariate logistic regression model, lower extremity open 
fracture (odds ratio (OR) [95% confidence interval (CI)], 3.42 [2.65–
4.41]), central vein catheter placement (OR [95% CI], 2.41 [1.55–3.73]), 
and surgical procedure (OR [95% CI], 5.34 [4.04–7.06]) were indepen-
dently associated with PE.
Conclusion: Patients with trauma complicated with PE had high in-
hospital mortality. Lower extremity open fracture, central vein cath-
eter placement, and surgical procedures could be risk factors for PE 
among patients with trauma.
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Introduction: In critically ill patients after trauma, the intestine can 
remain a vulnerable organ. Gastrointestinal system dysfunction is 
common in these patients. Intestinal damage occurs in about 50% of 
critical patients.
Objectives: In this study, it was aimed to investigate the intestinal 
barrier functions in adult critical patients who were followed up in the 
intensive care unit (ICU) due to trauma.
Methods: This study was performed prospectively. The study included 
29 critical patients bigger than 18 age who were admitted to the ICU 
for 5 days or more due to trauma, and 18 healthy people of similar 
age and gender as the control group. Claudin, occludin, tricellulin and 
junctional adhesion molecule 1 (JAM-1) levels in the protein structure 
of the blood samples taken from patients to evaluate the intestinal 
barrier functions were measured using ELISA kits.
Results: The median age of patients was 35 (min:18- max:66) years. 
The GCS of the patients was 11 (min:3-max:15), and the APACHE II 
score was 11±1. The most common reason for ICU admission was 
traffic accidents (75%). A statistically significant difference was found 
between the baseline, 2nd day, 5th day, and 10th day plasma levels 
between patients with claudin, occludin and tricellulin levels (p<0.001, 
p<0.001, p<0.05 respectively). An increase in claudin and occludin 
levels was found in patients’ baseline plasma samples compared to 
controls (p<0.01). This increase in plasma claudin levels of patients 
decreased gradually on the 2nd day, 5th day and 10th day (p<0.01). 
However, plasma occludin levels of patients increased on the 2nd 
and 5th days (p<0.01) then decreased on the 10th day (p<0.01). The 
plasma tricellulin levels of the patients increased on the 2nd and 5th 
days compared to baseline (p<0.01 and p<0.05, respectively), then 
decreased on the 10th day (p<0.05). Length of ICU stay was 15 (min:5-
max:39) days. ICU mortality was 13%.
Conclusion: As a result, it was determined that gut barrier functions 
were impaired in adult critical patients who were followed up in the 
ICU due to trauma. We can suggest that claudin and occludin protein 
levels can be used as markers in these patients.
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Introduction: Systolic arterial blood pressure (SBP) increases with age. 
We aimed at testing the combination of SBP and age on mortality after 
trauma.
Methods: This retrospective Real World Evidence (RWE) monocentric 
study included all adult patients from a French level-1 trauma center. 
A Generalized Additive Model (GAM) was created to predict 30 day-
mortality based on age and SBP. The gray zone technique served to 
determine SBP thresholds. Subgroup analysis focused on Injury Sever-
ity Score (ISS).
Results: Among 2655 patients, 717 (27%) were older than 50 yo. 
Median ISS was 13 [6 - 25], average mortality was 11.5% [10.3%; 
12.7%]. Older patients had higher ISS, higher mortality (22% vs. 7%, 
p < 0.001); more so when ISS ≥ 26. Threshold effects on mortality 
appeared as SBP ≤ 90 mmHg, but none specific to ISS subsets. Risk 
appeared as SBP ≥ 130 mmHg, increased when combined with ISS 
≥ 26, reduced with ISS ≤ 15. Computation led to no SBP threshold 
depending on age; in particular not 110 mmHg for 50 yo.
Conclusion: We confirmed the threshold of SBP below 90 mmHg, and 
effects above 130 mmHg with severe ISS. Older age and lower SBP 
combined increased mortality. Computation did not prove 110 mmHg 
should be used as a threshold for patients older than 50 yo.
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Introduction: Frailty can be defined as a multidimensional syndrome 
characterized by organic and functional impairments associated with 
a decrease in physiological reserves. Current evidence suggests that 
frailty is associated with unfavourable outcome among the geriatric 
population exposed to a stressor event. No information is available 
about the impact of frailty on long term outcomes in the subpopula-
tion of TBI patients.
Objectives: The aim of our study is to create a reliable index to 
describe frailty among patients admitted to ICU with a diagnosis of TBI 
and to assess its association with the 6 months neurological outcome 
expressed in terms of Extended Glasgow Outcome Scale (GOSE<5) 
and mortality at 6 months.
Methods: The study was conducted using the data extracted from the 
CENTER-TBI database v2.1 with Neurobot v2.6. Patients’ information 
were collected at ICU admission and used to build a frailty index (FI) 
as a compound of accumulated deficits. Thirty-five variables assessing 
health status at baseline were used to develop the FI. These features 
included chronic medical conditions, previous TBI, laboratory findings, 
number and type of drugs, alcohol or toxic agents abuse. For any sub-
ject, the FI was calculated as the sum of the reported deficits divided 
by the totality of evaluated items, expressed in percentage; FI (%) is 
related to an incremental factor of ≅2 points.
A Logistic regression model was performed to estimate the contribu-
tion of the FI to explain the 6-month outcomes and it was adjusted for 
the IMPACT core variables (i.e. age, pupillary reactivity and GCS motor). 
The model was also performed on the group of elderly subjects (≥ 65 
years old).
Results: 1754 participants were included in this study (n= 425 sub-
jects ≥65 years old). The median age was 49 [IQR: 29; 65.75] and sex 
prevalence of males (72.6%). The median baseline value of the FI over-
all was 8.82 (I-III quartiles 3.44-14.71; range 0.00 to 54.54) and 14.82 
(I-III quartiles 9.09- 23.33; range 0.00 to 42.8) considering the subset of 
elderly subjects.
Frailty significantly increased the risk of unfavourable GOSE at 6 
months, with an odds ratio (OR) of 1.03 (95% CI 1.01–1.04, p-value 
<0.001) and also the risk of mortality, with an OR of 1.004 (95% CI 
1.002-1.006, p-value =0.001). Considering only elderly subjects, there 
was no evidence that frailty increased the risk of unfavourable out-
come (OR =1.03, 95% CI =0.99 - 1.08, p-value= 0.204) and mortality 
(OR = 1.001, 95% CI =0.997-1.006, p-value=0.541).
Conclusion: In this study we developed a FI for the specific applica-
tion on TBI patients. This index was built from data collected from a 
large cohort of TBI patients characterized by a wide age spectrum. 
Our results indicated a significant increased risk of unfavourable neu-
rologic outcomes in patients with high FI score, regardless of age and 
other IMPACT variables.
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Introduction: Tranexamic Acid (TXA) is used for a number of indica-
tions, including trauma, based on evidence that it decreases bleeding 
and improves survival. Its role in acute traumatic brain injury (TBI) is 
less certain, although a recent large randomized controlled trial (RCT) 
suggested it may improve head-injury related deaths. We conducted 
a systematic review and meta-analysis, including this latest RCT, to 
investigate the efficacy and safety of TXA in acute TBI.
Methods: We performed a comprehensive search of MEDLINE, Pub-
Med, EMBASE, CINHAL, ACPJC, Google Scholar, and unpublished 
sources from inception until June 24th, 2020 for randomized con-
trolled trials (RCTs) examining the role of TXA in adults with acute 
TBI. We pooled data using the inverse variance method and random 
effect model and report summary estimates using relative risk (RR) for 
dichotomous outcomes and mean difference (MD) for continuous out-
comes, both with corresponding 95% confidence intervals (CIs). For 
outcomes reported at multiple end-points, we used the longest dura-
tion of follow-up for analysis. We assessed individual study risk of bias 
using a modified Cochrane risk of bias tool and certainty of evidence 
using GRADE methodology.
Results: We included nine RCTs (n= 14,846 patients). Pooled results 
demonstrate that TXA has no effect on mortality (RR 0.95; 95% CI 
0.88 to 1.02; absolute risk reduction [ARR] 1.0%; 95% CI 2.4% reduc-
tion to 0.4% increase, moderate certainty), no difference in disability 
as assessed by the Glasgow Outcome Scale (GOS) (MD, -0.16 points; 
95% CI -0.57 to 0.25; moderate certainty) or disability based on pro-
portion of patients with a GOS score 3 4 (RR 0.87; 95% CI, 0.57 to 1.32; 
0.4% ARR; 95% CI 1.3% reduction to 1.0% increase; very low certainty) 
compared to those that did not receive TXA. TXA may reduce hema-
toma expansion on subsequent imaging (RR 0.78; 95% CI 0.59 to 1.04, 
ARR 3.2%, 95% CI 6.0% reduction to 0.6% increase); however, this 
was based on low certainty evidence, limited by imprecision. Risks of 
adverse events including pulmonary embolism, deep vein thrombo-
sis, stroke, and seizure (all moderate certainty) were similar between 
those receiving and those not receiving TXA.
Conclusion: In patients with acute TBI, TXA probably has no effect on 
mortality or disability. TXA may decrease hematoma expansion on 
subsequent imaging; however, this outcome is of unclear benefit to 
patients. Use of TXA is probably not associated with an increased risk 
of adverse events.
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Introduction: CPR related injuries were not properly observed since 
were established new guidlines for resuscitation (CPR) 2015 with 
stronger recomandation for bystader and topless CPR. Data were not 
objectivised by any scale in effort to establish seriousness of injury.
Objectives: To determine impact of trauma associated with resuscita-
tion, describe their frequency and seriousness and their influence on 
morbidity and mortality of patients after OHCA (Out of Hospitals Car-
diac Arrest).
Methods: Analyse of data from prospective registry of OHCA from 
regional Cardiac Arrest Center (CAC). Trama patients were identified 
with clinical suspection and subsequently with imagine methods 
(CT, X ray, sonography), trauma as cause of arrest was no included. 
To determine seriousness we used Abbreviated injury scale (AIS) and 
summary of all injuries with New injury severity score (NISS).
Results: In study were included 231 patients after OHCA admitted 
to ICU. 30 (13%) had relevant CPR related trauma established with 
clinical suspection and confirmed with imagine methods. In base-
line characteristics was no difference in gender (76,7% of men in 
TRAUMA group vs. 78,1% in nonTRAUMA group, p=0,82), no differ-
ence in age (65±13 years in TRAUMA group vs. 62±13 years in non-
TRAUMA group, p=0,38), no difference in inicial shockable rythm 
(57% in TRAUMA group vs. 73,1% in nonTRAUMA group,p=0,08) and 
no difference in witnessed arrest (83% in TRAUMA group vs. 87% in 
nonTRAUMA group, p=0,58). There was no differences in duration 
of bystander CPR (9,3±4,4 min in TRAUMA group vs. median 10 min, 
IQR 25-75:5-10 in nonTRAUMA group,p=0,77), but total duration of 
CPR untill ROSC was signifficant longer in TRAUMA group (median 25, 
IQR 25-75:14,5-30 min in TRAUMA group vs. median 18, IQR 25-75:10-
25 min in nonTRAUMA group, p=0,03). There was no differences in 
ventilation days (mean 6±5 days in TRAUMA group vs. median 4,IQR 
25-75:1-7 days in nonTRAUMA group, p=0,35) and ICU stay (median 
6, IQR 25-75:1-15 days in TRAUMA group vs. median 7, IQR 25-75:3-12 
days in nonTRAUMA group,p=0,84). Cardiac cause of arrest was signif-
ficant higher in nonTRAUMA group (37% in TRAUMA group vs. 71% in 
nonTRAUMA group, p=0,0003) and also coronarography was provided 
more frequent in nonTRAUMA group (37% in TRAUMA group vs. 64% 
in nonTRAUMA group.p=0,005), but without difeerence in frequency 
of revascularisation (28% in TRAUMA group vs. 43% in nonTRAUMA 
group, p=0,11). 30 days mortality was signifficant worse in TRAUMA 
group (66% in TRAUMA group vs. 38% in nonTRAUMA group, p=0,005, 
RR 2,76, 95%CI 1,4-5,6) and 30 days good neurological outcome (CPC 
1,2) also worse in TRAUMA group (vs. 56% in nonTRAUMA group, 
p=0,0014, RR 3,5,95%CI 1,6-7,7). In TRAUMA group was lung contusion 
present by 16,7%, pneumothorax by 36,7%, liver injury by 13,3% and 
spleen injury by 6,7%of patients. Ribs fractures were presented by 60% 
and sternum fractures by 20% of patients. Mean of fracutred ribs was 
9± 5,2 ribs. Median of AIS was 3 (IQR 25-75) 2-4. Median of NISS was 
11,5 (IQR 25-75) 7-19,25.
Conclusion: Trauma is present by 13% of OHCA patients with ROSC. 
There is no difference in age, gender, initial shockable rythm and 
bystander CPR between TRAUMA and nonTRAUMA group, but resus-
citation is signifficant longer in TRAUMA group. In TRAUMA group 
we have observed worse 30-days mortality and good neurological 
outcome.
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Introduction: Massive hemorrhage in trauma is a diagnostic and ther-
apeutic challenge. An early approach to hemorrhagic shock by trans-
fusion of blood products and damage-control resuscitation is essential 
to avoid lethal pentad and death.
Objectives: To assess the quality of care in traumatic massive bleed-
ing in a Level 1 Trauma Centre by analyzing two indicators: early 
activation of the massive transfusion protocol (MTP) and optimal 
transfusion of packed red blood cells (pRBC).
Methods: A retrospective single-center cohort study was obtained 
from two prospective databases of University Hospital 12 de Octubre 
(Madrid): the Severe Traumatic Disease registry and the MTP database 
in a 6-year period of time (2013-2019).
Study subjects: Traumatic patients who were admitted in the ICU and 
required transfusion of ten or more pRBC in the first 24 hours of admis-
sion (defining criteria of massive hemorrhage, MH).
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Variables of interest:
- Early diagnostic sensitivity (S): Percentage of activation of MTP in 
patients with traumatic MH. TheTrauma-Associated-Severe-Haemor-
rhage (TASH) Score, the Injury-Severity-Score (ISS) and the percent-
age of FAST were retrospectively calculated in the false-negative (FN) 
subgroup.
- Optimal transfusion of pRBC: According to scientific literature, three 
cohorts were described according to hemoglobin (Hb) at 24 hours of 
admission. Thepercentage of under-transfusion (UT) (Hb <8mg / dl) 
and over-transfusion (OT) (Hb> 11.9mg / dl) was studied.
Data analysis: SPSS Statistics 24.0.0. Variable expression: mean and 
standard deviation.
Results: Descriptive statistics
First, a descriptive analysis of the MH cohort (n = 145) was performed.
The mean age was 40.7 ± 17 years, with male predominance (76.6%).
The mean ISS was 42.8 ± 16, highlighting a 72.4% prevalence of hem-
orrhagic shock coagulopathy and an overall mortality of 43.4%.
Deaths were due to exsanguination (38%, n = 24), intracranial hyper-
tension (36.5%, n = 23), multiple organ dysfunction syndrome (12.7%, 
n = 8) and limitation of therapeutic effort (6.3%, n = 4).
Regarding the mechanisms involved, the most relevant were precipi-
tation (n = 45), sharp objects injury (n = 23), automobile accident (n = 
21), motorcycle accident (n = 17) and pedestrian injury (n = 16).
FAST was performed in 71.7% of the cases. Therapeutic arteriography 
was performed in 28.8% of the cases. 81.3% underwent damage con-
trol surgery.
Diagnostic sensitivity
MTP was activated in 135 out of the 145 patients with MH criteria (S = 
93.1%).
In FN (n = 10), the mean TASH score was 12.4 ± 3 and the mean ISS 
was 31.7 ± 12.
30% (n = 3) presented a TASH score <= 9 (MH pre-test probability 
<5%), all presenting with bleeding during damage control surgery 
requiring intraoperative transfusion > 6 pRBC.
In the remaining cases (n = 7) the TASH score was > 13 (MH pre-test 
probability range 28-35%), with FAST being performed in 57% of cases 
(n = 4).
Transfusion quality
68.7% of patients were in the optimal transfusion cohort, while 8.9% 
were in the UT cohort and 22.5% in the OT cohort. Mortality was 
respectively 25.6%, 50% and 24%, without statistically significant dif-
ferences in subgroup analysis (p = 0.243).
Conclusion: The diagnostic sensitivity was similar to that achieved by 
the MH prediction scores, considered the gold-standard. Nonetheless, 
FN analysis shows the need to optimize early identification.
The transfusion target was suboptimal in one third of patients. Specific 
transfusion protocols need to be created for severe traumatic disease 
with intermediate pre-test probability of MH.
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Introduction: Trauma remains the leading cause of death all over the 
world. To better exploit the trauma care system, precise diagnosis of 
the injury site and prompt control of bleeding are essential. Here, we 
created a nursing protocol for initial medical care for trauma.
Objectives: The aim of this study was to evaluate the impact of pro-
tocoled nursing care for trauma on measures of quality performance.  
Methods: This was a retrospective historical control study, consisted 
of consecutive severe trauma patients (Injury Severity Score >16). Peo-
ple were divided into two groups: protocoled group (from April 2017 
to March 2019) and control group (from April 2014 to March 2017). 
We set the primary endpoint as mortality for bleeding. The second-
ary endpoints included time allotted from arrival to start of CT scan 
and surgery, administration rate of several drugs (sedations, painkill-
ers, preoperative antibiotics, and tranexamic acid). For the statistical 
analysis, continuous variables were expressed as median (interquartile 
range) and were compared by Wilcoxon rank sum tests given a non-
normal distribution of the data.
Results: We included 152 patients in the study: 84 in the control group 
before the introduction of the protocol, 68 in the protocoled group. 
As a primary endpoint, the mortality for bleeding was similar between 
two groups (5% in the control group and 5% in the protocoled group). 
As a secondary endpoint, the time to CT initiation [Group A 11 (7-16) 
min vs Group B 7 (5-10) min; p <0.001], and emergency procedure 
[Group A 41 (33-56) min vs group B 29(25-43); p <0.001] were short-
ened by the protocol introduction. Furthermore, the administration 
rates of sedations, painkillers, preoperative antibiotics, and tranexamic 
acid were increased in the protocoled group compared with the con-
trol group.
Conclusion: Although the mortality as a patient-oriented outcome 
was not affected, improved quality of medical care by nursing proto-
col introduction may be suggested in this analysis.
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Introduction: care at the end of life of patients who die; includes 
the shared decision-making between health professionals and family 
members, the communication and registration of agreements.
Objectives: to analyze the LLST procedure from 1-1-2004 to 12-31-
2019 (16 years), the evolution of recommendations and improvement 
actions.
Methods: retrospective descriptive study
Results: During the analyzed period, 12422 patients were admit-
ted to the ICU, 1329 of whom died (10.69% mortality). LLST has been 
agreed in 10% of the admitted patients and in 81’46% of the deceased 
(range 73-94%). The opinion of the nursing staff evaluated through 
a survey detected training needs and interest in participating in 
decision-making and information for family members. The few con-
flicts registered have been resolved by postponing the decision and 
encouraging the participation of other specialists involved. The proce-
dure has improved with: a) the use of a specific sheet of medical orders 
on LLST b) its subsequent computerization to be recorded in the elec-
tronic medical record c) Terminal Extubation procedure d) continuing 
training on Bioethics and LLST of health personnel. The opinion of 
the patients’ relatives who died after LLST is collected through semi-
structured interviews (in the study phase). The LLST experience facili-
tated the launch of the Controlled Asystole Donation procedure. More 
than 100 training and outreach sessions have been held, not only for 
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healthcare personnel but also forpatient associations. Care and treat-
ment planning (Advance Directives) have been promoted to try to 
improve decision-making through specific programs for the chroni-
cally ill, interviewing more than 500 patients and family members.
Conclusion: LLST is a common procedure, with established, published 
and improved recommendations. It allows palliative care to be inte-
grated into the field of intensive medicine.
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Introduction: Sedation with morphine and midazolam (M&M) is 
often used at the end of life (EoL) to relieve symptoms during the 
terminal phase of a patient’s illness. While the medications used can 
control these symptoms, excessive doses hasten death. Therefore, 
doses should be titrated carefully, based on the patient’s condition. 
In Medical High Dependency Unit (MHDU), a prescription for Intrave-
nous (IV) infusion of M&M would be written for a patient approaching 
EoL and nursing staff would titrate dosing independently based on 
their clinical judgment. Only 33% of nursing staff always felt comfort-
able titrating the infusion rate and 67% wanted more guidance on 
dose titration. It was also felt that a patient’s infusion rate could vary 
dependent on the nurse looking after them.
Objectives: The aim was to implement clear guidance for IV M&M 
infusions into MHDU by February 2020 and for it to be used in 90% of 
IV M&M infusions. This would;
•provide guidance for nursing staff to tailor the infusion rate to the 
individual
•protect nursing staff from any legal uncertainty.
Methods: Existing practice was reviewed by surveying nursing staff 
and collecting data from the last 10 patients who received an IV M&M 
infusion from May to July 2019. A guideline was created for MHDU 
using the Respiratory Distress Observation Scale(1) and the Critical 
Care Pain Observation Tool(2) to provide a validated scoring system 
to guide dose titration. Small group teaching with both nursing and 
medical staff was organised for education. Data was then collected for 
10 subsequent patients from October 2019 to February 2020 and ana-
lysed. Qualitative data via anonymous feedback forms was collected 
from staff after implementation.
Results: All patients received IV M&M infusions according to the 
guideline (n=10). The average maximum dose infused was reduced 
(morphine: pre-intervention 4.75mls/hr, post-intervention 2.40mls/hr; 
midazolam: pre-intervention 4.75mls/hr, post-intervention 3.20mls/
hr). The average rate of infusion was reduced (morphine: pre-interven-
tion 3.87mls/hr, post-intervention 2.28mls/hr; midazolam: pre-inter-
vention 3.87mls/hr, post-intervention 2.33mls/hr). The average time 
between starting IV M&M and death was not significant (pre-interven-
tion 3.09hrs, post-intervention 2.99hrs). Documented reasons behind 
dose adjustments increased from 6% to 81%. All staff felt more com-
fortable titrating M&M when using the guideline (n=10). In one case, 
the scoring system within the guideline led to a patient not receiving 
any IV M&M and subsequently surviving to discharge.
Conclusion: The guideline was widely appreciated by the nursing staff 
and therefore used in all patients who required IV M&M. Using the 
guideline showed a reduction in the dose of M&M administered, with-
out affecting the time to death. The guideline gave more confidence 
behind titrating dose to patient symptoms and the results also gave 
reassurance that the doctrine of double effect was not being taken 
advantage of via administration of these drugs.
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Introduction: Normothermic regional perfusion (NRP) in controlled 
donation after circulatory death is becoming a popular method due to 
the favorable results of the grafts procured under this technique.
Objectives: To study the differences between livers suitable vs. liv-
ers discarded for transplantation obtained from controlled circulatory 
death donors (cDCD) managed with NRP.
Methods: Retrospective study (February 2017/December 2019).  We 
studied all cDCD managed by the mobile NRP team of the Autono-
mous Community of Madrid (Spain) in which the liver was evalu-
ated for transplantation. The following data were recovered: 1) cDCD 
demographics: age, sex, ICU length of stay and reason for limitation 
of life sustain therapies (LLST); 2) warm ischemia times (WIT) defined 
as the interval between systolic arterial pressure < 60 mmHg to com-
mencement of NRP; 3) NRP duration and 4) biochemical parameters 
(Figure  1) at the start and end of NRP together with the differences 
between final – initial NRP values.
Results: During the period studied the  mobile  NRP team assisted in 
the management of 55 cDCD. Liver evaluation was performed in 32 
(58.2%) cases. The liver was deemed suitable for transplantation in 19 
(59.4%) and discarded 13 (40.6%). We found no differences between 
suitable vs. discarded livers regarding: age [60(48–64) vs. 63(55–65) 
years], sex [9(47.4%) vs. 5(38.5%) males], ICU length of stay [8(4–14) 
vs. 6(4–13.5) days] or main reason for LLST [catastrophic brain injury: 
19(100%) vs. 11(84.6%)]. Suitablelivers had lower WIT [11(7–15) vs. 
15.5(12–19) min;p<0.03] and longer NRP times [90(73–110) vs. 63(31–
89) min;p<0.02]. We found no differences in the biochemical param-
eters analyzed (Figure 1). The main reason for organ rejection was the 
existence of an unfavourable  visual assessment  (n=12; 92.3%).  One 
liver was rejected after a renal carcinoma was found during the 
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laparotomy. None of the livers were discarded due to a transaminase 
elevation during NRP.
Conclusion: In our series we found no differences between suitable 
vs. discarded livers in cDCD managed with NRP. An unfavourable vis-
ual assessment  was the main reason for organ rejection. In order to 
improve the ratio of suitable livers coming from cDCD and managed 
with NRP, it might be necessary to search for more objective strate-
gies that might include a microscopical evaluation of the organ and/or 
newer biochemical markers.
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Introduction: Controlled donation after circulatory death (cDCD) 
occurs after a decision to withdraw life-sustaining treatment (WLST) 
and subsequent family approach and approval for donation. We cur-
rently lack data on factors that impact the decision-making process on 
WLST and whether time from admission to family approach, influences 
family consent rates. Such insights could be important in improving 
the clinical practice of potential cDCD donors.
Objectives: The main aim of our study was to assess timing and 
patient characteristics that are associated with the decision-making 
process leading to the initiation of end-of-life care, in a large multi-
center prospective study of potential cDCD donors. A second objec-
tive was to explore the influence of this timing in family approach on 
consent to organ donation.
Methods: In a prospective multicenter observational study, we evalu-
ated the impact of timing and of the clinical factors during the end-of-
life decision-making process in potential cDCD donors. Characteristics 
and medication use, of 409 potential cDCD donors admitted to the 
intensive care units (ICU), were assessed.
Results: End-of-life decision-making was made after a mean time of 
97 h after ICU admission and mostly during the day. Intracranial hem-
orrhage or ischemic stroke and a high APACHE IV score were associ-
ated with a short decision-making process. Preserved brainstem 
reflexes, high Glasgow Coma Scale scores or cerebral infections were 
associated with longer time to decision-making. Our data also suggest 
that the organ donation request could be made shortly after the deci-
sion to stop active treatment and consent rates were not influenced by 
day- or nighttime or by the duration of the ICU stay.
Conclusion: In summary, our data  provide valuable insights on the 
largely overlooked topic of end-of-life decision-making in potential 
organ donors and show that early prognostication occurs in certain 
patient categories more often. Although prognostication is more 
difficult in the acute setting, our data show that if the treating team 
believes decision-making about WLST is possible early after hospital 
admission, this will not necessarily have a negative effect on the con-
sent rates to organ donation.
000867 
Organ Donation within an Intensive Care Unit in Portugal
C.  Roriz1; D. Castro1; F. Sequeira1; H. Fernando1; O. Gomes1; L. Pereira1
1Serviço de medicina intensiva, Centro Hospitalar de Leiria, Leiria, Portugal 
Correspondence: C. Roriz
Intensive Care Medicine Experimental 2020, 8(2): 000867
Introduction: Organ and tissue transplantation is often the only treat-
ment for end stage organ failure. In 2017, Portugal ranked second 
among 82 member states which reported to the global observatory 
on donation and transplantation with 34.1 donors per million inhab-
itants. The development of organ support systems in recent decades 
led to the ability to artificially maintain organ viability, leading to the 
concept of brain death. Brain death is the irreversible cessation of cer-
ebral and brain stem function; characterized by the absence of electri-
cal activity in the brain, blood flow to the brain, and brain function as 
determined by clinical assessment of responses. The brain death diag-
nosis and organ donor treatment are primordial given the importance 
of achieving a better quality of organs available for transplant. Organ 
donor treatment represents a crucial part of the donation process 
being the ultimate goal to obtain as many viable organs as possible 
by donor.
Objectives: The purpose of this study is to characterize potential 
organ donors admitted to a 10-bed combined medical-surgical inten-
sive care unit of a Portuguese hospital, identify reasons for non-dona-
tion, length of stay in the intensive care unit and to determine the 
number and type of donated organs.
Methods: A retrospective cohort study of all the potential organ 
donor admissions in a 10-bed combined medical-surgical intensive 
care unit of a Portuguese hospital between January 2018 and May 
2020 and characterize demographic and clinical variables as well as 
the number of harvest organs.
Results: In the period of 2 years and 5 months 26 potential organ 
donors of whom 15 were effective donors, were identified and admit-
ted to the intensive care unit, representing 3.7% of all intensive care 
unit admissions. Among potential donors the mean age was 60.6 and 
the majority were men (61.5%). With respect to the effective donors, 
the mean age was 59.5 and 73.3% were men. Hemorrhagic stroke 
accounted for 73% of brain deaths, anoxia and ischemic stroke were 
the cause of brain death in 26% of the patients (13.5% each type of 
lesion). Among the non-effective donors, the reasons for non-dona-
tion were refusal by the national coordination transplantation related 
with patient comorbidities in 4 patients, non-evolution to brain death 
in 2 patients and evidence of sepsis in 5 patients. The most common 
comorbidity of the potential donors was arterial hypertension (69.2%). 
The mean time from ICU admission to the diagnosis of brain was 56 
hours, and the mean time from ICU admission to organ harvesting 
was 66 hours. The most frequently collected organs were the kidneys 
(93.3%) followed by the liver (66.7%) and the most common collected 
tissue was cornea in 53.3% of the patients.
Conclusion: At the time of the study, potential organ donors were 
mostly men, over fifty years old, had arterial hypertension as comor-
bidity and died of brain death follow hemorrhagic stroke. The kidneys 
and liver were harvested in most cases.
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Introduction: In the ICU, hypotension is one of the most critical 
event to reduce patient mortality If we can predict the hypotension 
early, patient can take safer medical care. We developed the machine 
learning model for hypotension predictor(systolic blood pressure 
<60) (5hours later) from the ICU data of 1968 patients between Janu-
ary and December 2018 in veterans’ health service medical center at 
South Korea. In the ICU, hypotension is one of the most critical event 
to reduce patient mortality If we can predict the hypotension early, 
patient can take safer medical care. We developed the machine learn-
ing model for hypotension predictor(systolic blood pressure <60) 
(5hours later) from the ICU data of 1968 patients between January and 
December 2018 in veterans’ health service medical center at South 
Korea.
Objectives: To develop the novel technique to predict short term 
hypotension event predictor in ICU with machine learning analysis
Methods: A total of 1968 patient stayed in ICU of veterans’ health 
service medical center between January and December 2018 were 
enrolled and their electrical medical data including hourly recorded 
vital signs, clinical manifestations, demographic features were col-
lected for analysis. Keras (version 1.2.0, backend engine: tensorflow 
1.0) was used to generate multi perceptron neural networking model 
for modelling.
Results: Multi perceptron neuronal model with Keras was success-
fully generated from patient’s data. The prediction rate of the model 
was 97.4% and no overfitting was observed during model generation. 
The AUC value from ROC curve was 0.996 for the generated model. To 
compile multi perceptron learning model, adam optimizer was used
Conclusion: Multi perceptron learning algorithm could be very useful 
to develop new hypotension prediction model. Further study is neces-
sary to evaluate the validity of new short-term hypotension prediction 
model.
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Introduction: Fluid overload resulting from suboptimal fluid manage-
ment is common in critically ill patients and associated with adverse 
outcomes. Appropriate fluid management strategies to relieve fluid 
overload following the initial resuscitation period (the “deresuscita-
tion phase”) are largely variable in clinical practice - potentially as 
a result of the heterogeneity in disease progression and numerous 
other factors, such as age and premorbidities. There is a need to bet-
ter understand patients’ progression in the deresuscitation phase and 
to accurately predict strategies in fluid balance management with the 
goal of guiding fluid therapy to achieve optimal fluid balance.
Objectives: We extracted fluid balance and physiological factors in 
the deresuscitation phase from a large cohort of patients with sepsis in 
a retrospective electronic health records database and built a machine 
learning model to predict fluid balance change periodically after 
patients had been stabilized.
Methods: We used MIMIC-III, a publicly available critical care dataset 
from Beth Israel Deaconess Medical Center, Boston, MA. Our cohort 
consisted of adult ICU patients with sepsis (based on the Sepsis-III 
criteria) who received vasopressors and/or inotropes during resuscita-
tion. We excluded patients with Do Not Resuscitate status, cardiac sur-
gery and burn patients. End of resuscitation phase was defined as the 
time of last vasopressor/ inotrope administration. Clinical data includ-
ing, demographics, vitals, labs, fluid inputs and outputs, interventions 
and medications were extracted for the time period starting from end 
of resuscitation to ICU discharge. Data was segmented into 4-hour 
blocks. Fluid balance was calculated for each block and the change 
(increase, no change or decrease) within a block evaluated. We trained 
a 3-class logistic regression model to predict the change of fluid bal-
ance in the next block using the extracted clinical data in the current 
block. Model was evaluated using 6-fold cross validation and top pre-
dictors were calculated.
Results: A total of 2,565 ICU admissions were included in our cohort 
which was divided into 62,465 4-hour blocks. The mean area under 
receiver operator curve (AUROC) for predicting fluid balance increase 
was 0.78, mean AUROC for predicting no change in fluid balance was 
0.71 and mean AUROC for predicting fluid balance decrease was 0.77.
Conclusion: We trained a model to predict fluid balance change dur-
ing deresuscitation in our cohort. The model performs reasonably well 
in distinguish patients with no change in fluid balance, a decrease, and 
an increase in fluid balance. Additionally, we identified top predictors 
for fluid balance change, which agree with known physiology. The top 
positive correlates for fluid balance decrease are being on CRRT and 
cumulative output. Conversely, being on CRRT is a negatively corre-
lated with fluid balance increase. Therefore our model uses clinically 
meaningful features to distinguish between the different classes.
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Introduction: PaO2 to FiO2 ratio (P/F) is used to assess the degree 
of hypoxemia adjusted for oxygen requirements. The Berlin defini-
tion of Acute Respiratory Distress Syndrome (ARDS) includes P/F as a 
diagnostic criterion. P/F is invasive and cost-prohibitive for resource-
limited settings. Pulse Oximetric Saturation (SpO2) is noninvasive, con-
tinuous, and pervasive. Previous work suggests that SpO2 to FiO2 ratio 
(S/F) correlates with P/F and can be used as a surrogate in ARDS (1). 
It is unclear whether S/F can be used to identify intensive care (ICU) 
patients that are at high risk (2). We hypothesize that S/F is non-infe-
rior to P/F as a predictive feature in the critically ill.
Objectives: To demonstrate the non-inferiority of S/F to P/F in the 
prediction of ICU mortality.
Methods: We extracted data from the eICU Collaborative Research 
Database. The dataset included seven variables (6 independent and 1 
dependent) and 141,535 values (Table  1). Mortality was the depend-
ent variable for our prediction models. Exploratory data analysis was 
performed in Python. Missing data was imputed with Sklearn Iterative 
Imputer. We split the six independent variables into a train and test set 
with an 80/20 distribution. We scaled the data using the Sklearn Min_
Max Scaler. The mortality outcome (death) was rare (136,451 alive ver-
sus 8,184 died). We used a Gradient boosting decision tree algorithm 
variant called LightGBM as our model. We used AUC as our metric 
for model performance. Feature importance assessed using ELI5 and 
SHAP Python libraries. SHAP values reflect the contribution of the fea-
ture in the reduction of prediction error (3). ELI5 uses the permutation 
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of featurevalues and calculates the change in error. Feature value per-
mutation leads to a large rise in prediction error.
Results: LightGBM demonstrates good classification performance 
with a AUC of 0.782 (Figure 1). S/F had the strongest average contri-
bution to predicting mortality based upon the mean calculated SHAP 
value (Figure 2). S/F value permutation had the largest increase in pre-









Conclusion: S/F was a stronger predictor of mortality as compared to 
P/F based upon feature importance evaluation of our data. Our study 
is hypothesis-generating and a prospective evaluation is warranted.
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Introduction: SARS COV 2 pandemic infection has led to an increase 
in hospital admissions and in particular in Intensive Care Units (ICU) in 
last months.
Objectives: To report epidemiological characteristics and medical 
history of patients admitted in ICU with SARS COV 2 infection, and to 
describe clinical features and outcome of these patients.
Methods: Retrospective, single-center case series of consecutive 
critically ill patients admitted in ICU of a community hospital with 
severe  pneumonia caused by SARS COV 2.  Origin prior admission in 
ICU, APACHE II and SOFA at admission, medical history, age, gender, 
invasive mechanical ventilation requirement, time of mechanical 
ventilation, ICU length of stay, radiological pattern, procalcitonin and 
C-reactive protein levels, and mortality were collected. Statistical anal-
ysis: Data were analyzed by SPSS 18 and quantitative variables were 
expressed as a mean ± standard deviation.
Results: A total of twenty patients were admitted within a monthin an 
ICU with 17 beds; a capacity that had to be increased. At present three 
patients are currently  still  admitted to ICU.  Mortality was 30%. 15% 
were admitted from  the  Emergency room, 15% from other hospital-
sand 70% from a medical ward. 80% required mechanical ventilation 
and most of these patients were ventilated in prone position at admis-
sion, 93,75%.  Haemofiltration was indicated in 20%  and was related 
with  higher  mortality.  Hypertension was the most common  pre-
existing  medical  condition, 50 % in deceased  patients and 28,6% in 
survivors.
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Table shows clinical characteristics based on mortality. 
SARS COV 2 
Respiratory Infection
Survival n:14 Exitus n:6
Age (years)  60±8,4 65,67±6,86 
Gender (male/female) 64,3/35,7 66,6%/33,3% 
Body mass index 28,14±4,71 31,64±5,53 
Time from onset symptoms 
to ICU admission (days) 
9,64±4,74 12±5,6 
APACHE II at admission 10±4,85 11±2,36 
SOFA at admission 3,21±2,11 4±1,09 
ICU lenght of stay (days) 13,7±10,78 20,17±10,3 
Creatinine/Urea at ICU 
admission (mg/dl) 
0,84±0,28/44±44 1,25±0,24/86,3±50,02 
PCR (mg/l)/PCT (ng/ml) 154,64±190,02/0,47±0,64 183,2±157/0,45±0,34 
Fibrinogen mg/dl 641±280,9 685 
D Dimer ng/ml 4397,36±8870 1068±596  
CONCLUSION. Obesity and hypertension were risk factors associated with severe cases of 
SARS COV 2 infection. 
Renal failure, and the need for haemofiltration and mechanical ventilation were associated 
with anincreased mortality.  
Conclusion: Obesity  and hypertension were  risk factors  associated 
with severe cases of SARS COV 2 infection.
Renal failure, and the need for haemofiltration and mechanical ventila-
tion were associated with anincreased mortality.
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Introduction: Several randomized clinical trials have suggested that 
different patient populations, such as medical or surgical critically ill 
patients, may benefit from different glucose targets [1,2]. While nor-
moglycemia is often preferred in neuro-critically ill patients, the effects 
of hyper- and hypoglycemia on these patients is less clearly defined 
and optimal glycemic targets remain uncertain.
Objectives: We hypothesize that glycemic fluctuations may be associ-
ated with higher mortality amongst all neurocritically-ill patients, and 
set out to answer this question using an observational ICU dataset.
Methods: This analysis utilized the eICU Collaborative Research Data-
base (eICU-CRD) [3]. For the 13448 adult  patients diagnosed with 
primary central neurological  disease, the following features were 
extracted: blood glucose measurements (finger-stick glucometer and 
serum values), age, diabetes status, and Acute Physiology And Chronic 
Health Evaluation (APACHE) IV score. Logistic regression (LR) was esti-
mated to predict mortality during the first 24 hours of admission.
Results: When comparing characteristics for patients who survived 
versus those who expired(1,302,9.7%), survivers were younger (61.5y 
vs 65.8y; p<0.001), were more likely to have a surgical admission 
(14.4% vs 9.2%; p<0.001), and have lower APACHE IV scores (48.7 vs 
80.0; p<0.001). Additionally, survivors had lower mean glucose values 
(134.3 mg/dL vs 155.2 mg/dL; p<0.001) and a lower glucose variability 
(-1.8 vs -4.0; p=0.001).












APACHE score (per point increase) 9.14 8.62 - 9.70 < 0.001 
Diabetes 0.64 0.61 - 0.67 < 0.001 
Mean glucose (per mg/dL increase) 2.48 2.35 - 2.62 < 0.001 
Mean Δ glucose (per mg/dL 
increase) 0.82 0.79 - 0.86 < 0.001 
The LR model achieved AUROC of 0.84 in predicting mortality by day 1 
of ICU admission(Table 1). Predictor variables include diabetes status, 
APACHE IV score, mean glucose levels and change in glucose levels 
within the first 24 hours of admission.
Conclusion: Older age, higher APACHE IV score, lack of diabetes, 
higher mean glucose levels and greater decrease in glucose levels 
were associated with higher mortality within 24 hours of ICU admis-
sion in neurocritically-ill patients.
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Introduction: We were to investigate the errors of death certificate 
(DC) issued after death associated with poisoning and compare the 
errors of DCs depending on the place of issue between the emergency 
department (ED) and beyond ED
Methods: We reviewed the DC related to poisoning issued in one 
training hospital for 9 years. The errors of DCs were categorized into 
major and minor errors depending on the influence for process of 
choosing the cause of death.
Results: Seventy-nine DCs related to poisoning were reviewed. 
Fourty-three DCs were issued in emergency department (ED) and 
thirty-six in beyond ED. Total number of errors of the DCs were 3.7 
with 0.4 for major errors and 3.3 for minor errors. The errors of DCs 
issued at the ED are less than beyond ED (3.3 vs 4.4). Incorrect man-
ner of death, unacceptable cause of death and mode of dying as an 
underlying cause of death were common major errors. Incorrect time 
interval from date of onset to death, incorrect other significant condi-
tions and no record for date of onset were common minor errors.
Conclusion: The total number of errors was less in DCs issued in ED 
than beyond ED. The most common major error and minor error of 
DCs related to poisoning were incorrect manner of death and incor-
rect time interval from date of onset to death.
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Introduction: One of the challenges of the COVID-19 pandemic is the 
lack of experience with the disease and its clinical courses in intensive 
care patients. Based on first data, specific models have been devel-
oped to predict lethal courses in COVID-19 intensive care patients 
(1). However, it is yet unclear whether lethal courses of COVID-19 
patients actually differ from lethal courses in patients with other viral 
pneumonia.
Objectives: The objective of this project was to analyze whether a 
machine learning system trained on data of intensive care patients 
with non-COVID-19 viral pneumonia is also able to predict lethal 
courses in intensive care patients with COVID-19.
Methods: After approval by the local ethics committee, we trained 
a machine learning system to predict lethal courses in intensive care 
patients with non-COVID-19 viral pneumonia. To focus on predictions 
early enough to allow for adjusting treatment, we based the model on 
clinical data that was available at the time window of 96h-120h before 
the death of patients in contrast to patients without a lethal course 
at time windows matched in regard to duration since ICU admission. 
Therefore, we analyzed all data available in the electronic databases 
of Charité – Universitätsmedizin Berlin for 463 intensive care patients 
(including 193 lethal courses) with non-COVID-19 viral pneumonia. 
From these data, we extracted 163 clinical parameters of which we 
selected 10 parameters, based on clinical expertise supported by uni-
variate analyses and bivariate covariance matrices. Using the data of 
the 10 selected parameters, we trained a gradient-boosted decision 
tree models by supervised learning using the open source software 
library XGBoost. Then we applied the resulting prediction model to 
predict lethal courses in 94 COVID-19 intensive care patients (includ-
ing 34 lethal courses) and compared the predictive performance of 
our model with that of established clinical scores.
Results: The ROC-AUC to predict lethal courses in COVID-19 patients 
based on our model trained on non-COVID-19 patients was 0.86 [95%-
CI: 0.78-0.94] and thus outperforms the established clinical scores 
SOFA (0.80 [95%-CI: 0.71-0.89]), SAPS2 (0.73 [95%-CI: 0.62-0.84]) and 
APACHE2 (0.61 [95%-CI: 0.49-0.73]).
Conclusion: Our machine learning system trained on data of inten-
sive care patients with non-COVID-19 viral pneumonia shows a good 
performance for the prediction of lethal courses in COVID-19 intensive 
care patients. This suggests that despite all extraordinary features of 
COVID-19 intensive care patients the clinical parameters that indi-
cate lethal courses widely match those of patients with other viral 
pneumonia.
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Introduction: Main feature of the COVID-19 outbreak is an acute res-
piratory failure linked with diffuse alveolar damages. There are reports 
of increased rates of acute kidney injury (AKI) ranging widely from 5% 
to 36% of hospitalized patients and rised up to 52.2% in ventilated 
ICU patients. Mechanism, risk factors and outcome of AKI related to 
COVID-19 are not fully understood.
Methods: We conducted a observational study to assess risk factors of 
AKI in patients admitted in ICU for COVID-19. All patients adults admit-
ted in our ICU with COVID-19 confirmed by positive SARS-CoV2 RT-
PCR or COVID-19 serology between 01/03/2020 and 30/04/2020 were 
included. We collected all clinical and biological data within the 14 
first days following admission in ICU. Primary outcome was severe AKI 
was defined by stage ≥ 2 according the KDIGO definition. Statistical 
analysis was carried out by using a multivariate time-dependent Cox 
cause-specific proportional hazard model. Missing values of covariates 
in the multivariable model were handled bymultiple imputations with 
chained equations. All tests were two‐sided, with  P  values of 0.05 or 
less denoting statistical significance.
Results: Forty-nine patients were included in the study popula-
tion and represented of 442 daily measurement points. Median age 
of patients was 70 [58-74] including 40 (81.6%) men and 9 (18.4%) 
women. Invasive mechanical ventilation were realized in 43 (87.8%) 
patients and vasopressors used in 37 (75.5%) patients. AKI occurred 
in 19 (38.8%) patients in a median time of 6 [3-8] days following ICU 
admission. Time-dependant Cox cause specific model showed that 
hemodynamic SOFA score (CSH = 1.52 [1.06-2.16], p = 0.02), arterial 
pCO2 (1.27 [1.06-1.53] per increase of 5 cm d’H2O) and arterial base 
excess (0.88 [0.78-0.97] per increase of 1 mmol/L) was associated with 
AKI. A statistical trend was observed with expiratory positive pressure 
(1.15 [0.99-1.34] per increase of 1 cm d’H2O, p = 0.05).
Conclusion: Our findings show that severe AKI in a common compli-
cation observed in ICU patients admitted for COVID-19. Respiratory 
status with EPP levels, hypercapnia, metabolic acidemia and hemo-
dynamic deficiency are associated with higher risk of AKI in COVID-19 
patients. Impact of mechanical ventilation, with EPP levels, and sever-
ity of patient’s respiratory state, highlighted by respiratory acidosis, are 
novel risk factors of AKI in ICU patients. Further studies are needed to 
confirm those findings and understand underlying mechanism of this 
pulmonary-kidney interaction.
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Introduction: In December 2019,  coronavirus  disease 2019 (COVID-
19) emerged in Whuan, China and had rapidly  spreading worldwide, 
to  become the most global health issue nowadays.  Kidneys  are 
one of the extra pulmonary organs frequently affected by this 
infection.  Acute kidney injury  (AKI) is a well-recognized risk factor 
which increased the mortality rate in critically ill patients with sepsis.
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Objectives: The aim of this study was to determine the frequency and 
risk factors of AKI in COVID-19 critically ill patients as well as to estab-
lish clinical and prognosis profile.
Methods: We retrospectively reviewed the charts of consecutive criti-
cally ill patients with confirmed COVID-19 infection between Mars 
11 and Mai 15, 2020 in Valenciennes regional hospital. The study col-
lected clinical features at admission, severity of illness, ICU course, the 
occurrence and management of AKI. The diagnosis of AKI was based 
on kidney disease improving global outcomes (KDIGO) classification. 
Univariate and multivariate regression analyses were performed to 
identify factors independently associated with AKI, and to determine 
the risk of mortality secondary to AKI
Results: A total of 77 confirmed COVID-19 patients were admitted to 
the ICU during the study period. Among them 37(48.05%) presented 
an acute renal failure. Their main characteristics were: mean age, 
64.67±11.02; male, 29(78.4%); mean BMI, 31.97±6.7 kg/m2; mean 
Charlson index, 3.03±1.99; 4 (10.8%) patients with medical history of 
chronic kidney disease; mean SAPSII score, 39.78± 11.28; mean SOFA 
score, 5.56±  2.93; invasive mechanical ventilation, 32(86.5%); vaso-
pressors, 33(89.2%); hydrocortisone, 14(37.8%). Renal replacement 
therapy (RRT) was required in 24(64.9%) patients and the most used 
modality was an intermittent hemodialysis in  10 patients (41.7%). 
Continuous veno-venous hemodialysis was used in 3(12.5%) patients 
and 9(37.5%) patients had received both modalities of hemodialysis. 
Mortality rate was 21(56.8%) and the mean length of ICU stay was 
19.46±17.72 days. For ICU survivors, only 4 patients had their ad inte-
grum renal function restored and no patient need dialysis after hospi-
tal discharge.
Univariate  then  multivariate regression  analysis  identified the AKI  as 
an independent risk factor for mortality in COVID-19 patients (OR, 
17.74; 95%CI[4.22-74.52], p 0.000),  and  yielded the following vari-
ables  as  independently associated to AKI:  age> 65  years  (OR, 3.77; 
95% CI[1.19-11.91], p 0.024), septic shock (OR, 5.54; 95% CI[1.49-20.5], 
p 0.01) and the use of muscles blocker agents (OR, 4.26; 95% CI[1.34-
13.5], p 0.014).
Conclusion: The present study among COVID-19 critically ill patients 
identified acute kidney injury  as independent factor associated with 
mortality and showed that the incidence of acute renal failure, increas-
ing in patients aged more than 65 years, presented septic shock and 
had received muscle blocker agents during their ICU stay.
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Introduction: The cause of acute renal failure is often multifactorial 
with pre-existing co-morbidities further increasing the risk.
Objectives: To analyze the risk factors related to acute renal failure 
(ARF) in critically ill patient.
Methods: Prospective, observational study performed on patients 
admitted to ICU of HGU Gregorio Marañón between November-
December 2019. Epidemiological data, ARF risk factors, patient clini-
cal characteristics and renal function data, were collected. ARF was 
defined according to AKIN, RIFLE and KDIGO scores.
Descriptive data were reported as means with standard deviation (SD) 
for normally distributed continuous variables, medians with interquar-
tile range (IQR) for non-normally distributed variables, and as percent-
ages for categorical data. Univariate analysis was performed by means 
of Chi-square (RR) for the qualitative variables, and simple logistic 
regression (OR) for the quantitative variables. The risk factors related 
to acute renal failure were obtained by means of a multiple logistic 
regression analysis.
Results: Ninety-five patients included. 56% were male, mean age 
was 60±17 years and Charlson comorbidity index 2 points (1-4). 
The main risk factors for ARF were hypertension 45%, dyslipidae-
mia 41%, peripheral vascular disease 34%, chronic heart failure 18%, 
diabetes mellitus 16% and arrhythmias 13%. Reasons for admis-
sion: neurological 30%, respiratory 26% and 20% infectious pathol-
ogy. Severity scores: APACHE II 19±8, SOFA 7±4, the 52% of patients 
needed mechanical ventilation and 51% vasoactive therapy. 34% of 
patients developed ARF during admission, according to the follow-
ing scales: 14% stage I/risk, 8% stage II/damage, 12% stage III/failure. 
33% of patients with ARF required renal replacement therapy. The In-
hospital mortality was 29%, with an average of 11 days of hospital stay 
(6-29).
In the univariate analysis, the variables related to ARF were: age (OR 
1.05; 95% CI 1.01-1.08), diabetes (RR 5.27; 95% CI 1.62-17.17), chronic 
heart failure (RR 3.64; 95% CI 1.23-10.76), arrhythmias (RR 4.92; 95% 
CI 1.35-17.87), infectious pathology (RR 4.80; 95% CI 1.66-13.89), 
APACHE II (OR 1.21; 95% CI 1.12-1.32), SOFA (OR 1.58; 95% CI 1.29-
1.94) and vasoactive therapy (RR 3.98; 95% CI 1.54-10.29).
In the multivariate analysis, on a maximum model including the pre-
viously described, diabetes (OR 14.90; 95% CI 2.95‑75.28) and SOFA 
(OR 1.45; 95% CI 1.13‑1.86) were the only variables independently 
associated with acute renal failure.
Conclusion: There is a high incidence of acute renal failure in critically 
ill patients.The only factors independently associated with the devel-
opment of acute renal failure were diabetes and SOFA.
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Introduction: Acute kidney injury is frequently observed in trauma 
patients. A rise in serum creatinine and a fall in urine output are con-
sequences of much earlier injury to the most sensitive part of tubular 
cells located at the proximal tubule. The G1 cell cycle inhibitors tissue 
inhibitor metalloproteinase-2 (TIMP-2) and insulin-like growth factor-
binding protein 7 (IGFBP7) have been identified as novel biomarkers 
for the prediction of moderate to severe acute kidney injury (AKI) risk.
Objectives: The aim of the present study was to investigate the 
course of two cell-cycle arrest urinary biomarkers compared to serum 
creatinine in trauma patients.
Methods: A bedside test known as NephroCheck measures two uri-
nary parameters: IGFBP7 and TIMP-2. The test is based on a sandwich 
immunoassay technique. The final test output, labeled AKIRisk, is 
shown as a numeric result. We conducted a cohort study, measuring 
[TIMP2]•[IGFBP7] levels in trauma patients admitted to the ICU and 
classified the patients as NephroCheck (NC) (+) or NC (-) according to 
[TIMP-2]•[IGFBP7] values and AKI (+) or AKI (-) according to Kidney Dis-
ease: Improving Global Outcomes (KDIGO) criteria
Results: 45 patients developed AKI (29.4%.) 29 patients (19.9%) devel-
oped stage 1 AKI, 16 patients (10.5%) stage 2-3 AKI. RRT was used in 
5 patients. In patients with no AKI at admission, AKI at 24h was asso-
ciated with higher nephrocheck values at admission (median AKIrisk 
3.49 (2.33-3.73) in stage 2-3 AKI vs 0.35 (0.14-0.82) in no AKI, p=0.011) 
but not with creatinine values at admission (0.99 mg/dl (0.9-1.03) in 
stage 2-3 AKI vs 0.79 mg/dl (0.66-0.99)). There was no difference in 
nephrocheck values at admission or creatinine values at admission in 
patients with AKI was present at ICU admission. In patients with AKI, 
there was no association between Nephrocheck and progression or 
regression of AKI (p 0.4 for progression and p=0.2 for regression of 
AKI).We defined 4 groups according to levels of biological and func-
tional markers
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Conclusion: Markers of acute tubular stress/damage such as TIMP-2 
and IGFBP7 (cell cycle arrest biomarkers identified as NC are use-
ful in the risk assessment for AKI with high ability to identify patients 
likely to develop stage 2/3 AKI within 24 hrs. NC may help to identify 
patients with tubular damage in trauma patients that may or may not 
evolve into a clinically manifest syndrome
Reference(s) and grant ackowledgment(s)
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Introduction: Diffuse alveolar damage and acute respiratory fail-
ure are the main features of COVID-19 patients admitted to the ICU, 
although it may also cause damage to other organs such as the kid-
neys. Many of these patients with SARS CoV2 infection develop acute 
renal failure, and their prognostic results are worse than in those who 
do not develop it. More attention should be paid to comorbidities in 
these patients, that can be related to the infection course.
Objectives: - To analyze renal support therapies and the need of other 
support devices used in patients admitted to the ICU with the diagno-
sis of SARS-CoV-2 infection who develop renal dysfunction.
- To study the association of this organic failure with morbidity and 
mortality.
Methods: This retrospective observational study was conducted in the 
medico-surgical Intensive Care Unit of Jerez de la Frontera Hospital. All 
the patients admitted to the ICU, with the diagnosis of SARS-CoV-2 
infection, during the study period (March-June 2020) were included. 
Personal history, demographic, analytical and clinical variables, as well 
as severity and mortality scores were collected. Statistical analyses 
were performed using SPSSv22 software.
Results: Eleven patients, predominantly male (72.7%), with a mean 
age of 63.55 ± 7.53 SD, were included. With regard to the severity 
scales, mean SOFA value at admission was 4.27 points ± 2 SD and 
APACHE II 11.45 points ± 4.2 SD, with SOFA mean value on the day of 
the diagnosis of ARF of 9.1 points ± 3.2 DS. When analyzing CVRF, it 
should be noted that these patients had a high BMI with mean values 
of 31.93 ± 4.68 SD cm / m2. These patients required IMV and prone 
position in 100% of the cases, requiring 81.8% to perform a tracheos-
tomy and 90.9% hemodynamic support with norepinephrine. 63.7% 
(7) required CRRT, being CVVH the predominant modality of choice 
(100%). With regard to the indications of renal support, the most fre-
quent was oligoanuria 57.1% (4) followed by metabolic or ionic altera-
tions in 28.6% (2) and refractory shock 14.3% (1). The most frequently 
venous access used was the right femoral one (42.9%) compared to 
the right jugular venous access used in 28.6% of cases (2). Heparin 
sodium was the anticoagulant of choice in 100% of the patients who 
required CRRT. When analyzing the scales of renal damage, we found 
that the day the ARF was diagnosed they presented: AKIN I 45.5%, II 
18.2%, III 36.4%; RIFLE R 45.5%, I 9%, F 45.5%. Mortality was very high, 
reaching 63.7% (7) (p <0.05) and in those who required CRRT was 
100% (p <0.05), despite of improving renal function according to cre-
atinine criteria in 71.4% (5).
Conclusion: - In our series of cases, renal failure and the use of CRRT 
were independently associated with worst prognostic results.
- Those who developed ARF had a significantly higher BMI and 
required more organic support than those who did not develop it.
001415 
Incidence of renal failure in patients with SARS_CoV 2 infection 
admitted to the ICU
JM. Martín  Cano1; M. Pérez  Ruiz1; B. Diez Del  Corral1; J. Villegas1
1University hospital of jerez., Intensive care unit, Jerez, Spain 
Correspondence: B. Diez Del Corral
Intensive Care Medicine Experimental 2020, 8(2): 001415
Introduction: COVID-19 disease is mainly characterized by acute 
respiratory failure and diffuse alveolar damage, but it may also cause 
damage to other organs such as the kidneys. Many of these patients 
develop acute renal failure, and may have a worseprognosis.
Objectives: - To look-over the incidence of kidney failure in COVID-19 
patients admitted to the ICU of a second-level hospital.
- To analyze if there are differences between patients with kidney fail-
ure and those who do not develop this complication.
- To determine whether the development of renal failure is related to 
mortality.
Methods: This retrospective observational study was conducted in a 
medico-surgical Intensive Care Unit of a second-level hospital. All the 
patients, with positive PCR for SARS-CoV2, admitted to the ICU dur-
ing the study period (March-June 2020) were included. Personal his-
tory, demographic, analytical and clinical variables, as well as severity 
and mortality scores were collected. Statistical analyses were performed 
using SPSSv22 software.
Results: Twenty patients, predominantly male, 63% (13), with a mean 
age of 61.8 ± 8.2 SD and BMI 28.9 cm / m2 ± 4.9 SD, were included. 
With regard to the severity scales, we found a mean SOFA value at 
admission of 3.6 points ± 2.1 SD and APCHE II 10.25 ± 4.1 SD. The 
most prevalent comorbidities were HTN 45% (9); DLP 40% (8); DM 20% 
(4). The average ICU stay was 23.5 days. 55% (11) of the patients devel-
oped renal failure with a mean ICU stay of 7.8 days. 63.7% (7) required 
CRRT. The average SOFA on the day of the diagnosis of ARF was 9.1 
points ± 3.2DS, presenting AKIN I 45.5%, II 18.2%, III 36.4%; RIFLE R 
45.5%, I 9%, F 45.5%. We found significant differences, between the 
total series and the patients who developed renal failure, in the follow-
ing variables: BMI (31.9 cm / m2 vs 25.2 cm / m2), Creatinine (1.2mg / 
dl vs 0.8mg / dl), pH (7.03 vs 7.31), bicarbonate (19.7 mmol / L vs 25.3 
mmol / L) at admission or during the ICU stay (p <0.05). With regard to 
the mortality, we found that patients who developed ARF had a much 
higher mortality, 63.7% (7), compared to those who did not have this 
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organic failure (35%) (p <0.05). Those who required CRRT had a mortal-
ity of 100% (7) (p <0.05).
Conclusion: - Patients admitted to our unit, infected with SARS-CoV 2, 
developed kidney failure in a high percentage.
- The presence of ARF is associated with a higher mortality compared 
to those who do not develop it.
- Renal failure in COVID-19 patients who require continuous renal 
replacement therapies reach 100% mortality in our series.
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Introduction: A novel coronavirus (SARS-CoV-2) caused a worldwide 
pandemic and human health emergency. Worldwide coronavirus dis-
ease 2019 (COVID-19) has led to a large number of hospital and ICU 
admissions. Critically ill patients with COVID-19 suffer from high mor-
bidity and mortality. About 20% of critically ill COVID-19 patients need 
renal replacement therapy (RRT). Data on early prediction of acute 
kidney injury and RRT requirement are lacking. Mid-regional pro-adre-
nomedullin (MR-proADM), is an early marker of endothelial dysfunc-
tion predicting organ dysfunction in septic shock.
Objectives: The aim of this study was to investigate MR-proADM for 
prediction of RRT in critically ill patients with COVID-19.
Methods: We conducted a single-center observational study and 
consecutively included all adult patients with microbiologically con-
firmed COVID-19 treated at our department of intensive care medi-
cine. Patient characteristics, severity of disease, course of the disease 
and ICU mortality were assessed. MR-proADM together with other bio-
markers of inflammation was measured as part of clinical routine.
Results: Overall we could identify 64 critically ill patients with COVID-
19. 49 patients (77%) were male, median age was 62.5 (54 – 73) years. 
47 (73%) patients required mechanical ventilation. 25 (39%) patients 
had severe ARDS, and veno-venous extracorporeal membrane oxy-
genation was established in 10 patients. 50 (78%) patients needed 
vasopressor therapy. 29 (45%) patients required RRT during the ICU-
stay. The median time from admission on ICU to start of RRT was 2 (1 – 
9) days. MR-proADM on admission was significantly higher in patients 
requiring RRT (2.491 vs. 1.230 nmol/l; p = 0.002). ROC curve analysis 
showed that MR-proADM served as predictor of requirement for RRT 
with an AUC of 0.68 (95% CI: 0.54 – 0.81; p = 0.02). Multivariate logis-
tic regression showed that MR-proADM was an independent predictor 
(OR: 4.02, 95% CI 1.13 to 14.27, p < 0.05) for the requirement of RRT.
Conclusion: MR-proADM was able to independently predict RRT-
requirement in critically ill patients with COVID-19 upon admission to 
the ICU.
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Introduction: Acute kidney injury (AKI) is one of the most common 
complication observed in ICU patients. Besides classical risk factors 
associated with AKI occurrence, several studies have found a protec-
tive renal effect favoring the use of balanced solution. This could have 
been explained by the deleterious effects of hyperchloremia acidosis 
induced by the administration of a highly concentrated solution in 
chlorine.
Objectives: We aimed to assess the association of chloremia [Cl] with 
AKI occurrence.
Methods: We included all adults patients admitted to a tertiaty ICU 
between June 1st2006 and June 13th2019. AKI was defined by KDIGO 
stage ≥ 2. Hypo and hyperchloremia were defined as [Cl] < 95mmol/L 
and > 110 mmol/L, respectively. We assessed the relationship between 
chloremia and AKI occurrence within ICU stay as follows: Cox cause 
specific model using the first chloremia at ICU admission and time-
dependant Cox cause specific model using all chloremia recorded 
within ICU stay before AKI occurrence.
Results: We included 4,908 patients. Median age was 65 [51-76] years 
with mostly males (58.1%). At ICU admission, sepsis was observed 
in 63.2%, acute respiratory failure in 47.2% and shock in 37.5%. AKI 
occurred in 896 (18.2%) patients in a median time of 4 [2-9] days. 388 
(7.9%) patients died in ICU without AKI. Using first chloremia at ICU 
admission, hypochloremia and hyperchloremia were both associated 
with AKI with Cox cause specific hazard ratio (CSH) of respectively 1.40 
(95%CI [1.07-1.09], p = 0.01) and 1.60 (95%CI [1.09-2.39], p = 0.002). 
Considering all chloremias before AKI as time dependent covariate, 
the statistical association was still observed but stronger with hyper-
chloremia (CSH = 2.39 [1.75-3.27], p < 0.001) than hypochloremia (CSH 
= 1.86 [1.49-2.33], p = 0.02).
Conclusion: Abnormal chlore levels was associated with AKI occur-
rence in a large cohort of ICU patients. While both hypochloremia and 
hyperchloremia were associated with AKI, hyperchloremia seemed to 
be strongly associated with renal outcome.
Reference(s) and grantackowledgment(s)
1. MJ was granted by OpenHealth Institute
001555 
D‑dimer as a Predictor of Acute Kidney Injury in the Covid‑19 
Patient Cohort
A.  Sangam1; HD. Aya2; S. Leaver3; A. Rhodes4; M. Hamilton2
1Critical Care Medicine, St George’s Hospital, London, United Kingdom; 
2General intensive care unit, St George’s Hospital, London, United King‑
dom; 3Research lead critical care directorate, St George’s Hospital, London, 
United Kingdom; 4Intensive care unit, St George’s Hospital, London, United 
Kingdom 
Correspondence: A. Sangam
Intensive Care Medicine Experimental 2020, 8(2): 001555
Introduction: From the Covid-19 pandemic of 2020 it is evident that 
this new condition, which largely presents to critical care as respiratory 
failure is, in fact, a multisystem entity (1,2,). Although data interpreta-
tion thus far has identified clinical indices, such as elevated D-dimer, 
that are associated with increased likelihood of critical care admission 
or an increased mortality (3), less is currently understood about how 
such markers can prognosticate specific organ failures such as acute 
kidney injury, and the need for specific critical care interventions such 
as renal replacement therapy.
Objectives: Our aim was to assess whether a persistently elevated 
D-Dimer is predictor of acute kidney injury (AKI) in critically ill patients 
admitted with Covid-19 infection.
Methods: This is a retrospective, observational study examining the 
medical records of all adult patients admitted to critical care at St 
George’s Hospital in South London between 1st March 2020 and 31st 
May 2020. The D-dimer level was recorded at critical care admission, 
at day 7 and day 14. AKI was defined as per the AKIN guidelines(4). 
Requirement of renal replacement therapy (RRT) and mortality after 
28 days of admission were secondary outcomes. Proportions were 
compared using chi-squared statistic, and odds ratios are reported 
with 95% confidence interval (CI).
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Results: From 132 patients, D-Dimer was measured in 95 (72%), with 
a median value of 1294 (503, 5520). 24.2% had a normal D-Dimer on 
admission, 49.5 % had a D-Dimer between 500 – 6000, 26.3% had 
a D-Dimer greater than 6000 (the maximum laboratory value). 16 
(69.6%) patients with a normal D-Dimer on admission had AKI com-
pared to 63 (87.5%) patient with elevated D-Dimer (p= 0.045, OR 2.4, 
95% CI 1.02, 5.8). 9 (39%) patients with a normal D-Dimer on admission 
required RRT compared to 25 (34.7%) patients with elevated D-Dimer 
(p = 0.7). 9 (39%) patients with normal D-Dimer on admission died, 
compared to 43 (60%) in the group of elevated D-Dimer (p =0.084). At 
day 7, 71 patients remained in the ICU: 2 of 5 (40%) patients with nor-
mal D-Dimer had AKI, compared with 51 of 66 (77.3%) with elevated 
D-Dimer (p = 0.065). At day 14, 51 patients remained in the ICU: 1 of 
4 (25%) patients with normal D-Dimer had AKI compared to 31 of 47 
(66%) with elevated D-Dimer (p = 0.10)
Conclusion: An elevated D-dimer on admission, but not a persistent 
elevation, is a predictor of AKI in critically ill patients with Covid-19.
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hospital mortality in patients with Covid‑19. J Thromb Haemost, 2020;18(6): 
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3. 2. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associ‑
ated with poor prognosis in patients with novel coronavirus pneumonia. J 
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4. 1. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 
2019 in China. N Engl J Med. 2020.
001615 
Early diagnosis of Acute Kidney Injury in Critically Ill patients
D.  Paz1
1Intensive Care Unit, Coyoacan, Mexico City, CDMX, Mexico, Mexico 
Correspondence: D. Paz
Intensive Care Medicine Experimental 2020, 8(2): 001615
Introduction: The incidence of acute kidney injury in critically ill 
patients is gradually increasing, it indicates a poor prognosis with 
higher morbidity and mortality. Failure on acute diagnosis may delay 
the onset of an adequate therapy which may cause an unfavorable 
outcome, such as the need for renal replacement therapy, generat-
ing high costs to the health system. The validation of new methods 
that identify the presence of acute kidney injury in its early stages is 
needed.
Objectives: To demonstrate which is the earliest marker for the diag-
nosis of acute kidney injury in critically ill patients, including creati-
nine, cystatin C, urinary sediment and N- GAL.
Methods: A prospective, longitudinal and descriptive study is pre-
sented, with data obtained from patients over 18 years of age admit-
ted to Angeles Lomas Hospital Intensive Care Unit, between October 
2019 and July 2020.
Results: Serum creatinine and cylinders in urine had similar capacity 
to detect cases of AKI (baseline sensitivity 57.1%, specificity 100% and 
sensitivity 41.7%, specificity 100%, 24 hours sensitivity 58.3%, specific-
ity 100% and sensitivity 57.1%, specificity 100% respectively).
Cystatin C clearance showed better sensitivity (75% and 78.6%) but its 
specificity was reduced when detecting the mild and moderate cases 
of AKI (62.5% and 83.3%). N-GAL showed the best sensitivity (83.3% 
and 85.7%) and specificity (100% in both scenarios).
Conclusion: In this study we found that N-GAL is the most reliable 
biomarker for the diagnosis and prognosis of acute kidney injury in 
critically ill patients, compared to serum creatinine, cystatin C clear-
ance and urinary sediment. Therefore, NGAL should be considered for 
the assesment on critically ill patients with or at risk of AKI. Future pro-
spective and larger studies are required to validate its clinical utility as 
an early and accurate predictor of AKI.
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Introduction: Since February 2020, an outbreak of Novel Coronavirus 
disease (COVID-19) developed in Lombardy, Italy. COVID-19 primarily 
manifest as acute respiratory illness with bilateral interstitial pneu-
monia, however it can affect several organs, including the kidney. 
The exact mechanism of kidney involvement is unclear, and may be 
related with cytokine storm, direct cellular damage due to the virus, or 
prerenal AKI due to dehydration. The incidence and characteristics of 
AKI in acutely ill patients are not known.
Objectives: To assess the incidence and characteristics of AKI in 
acutely ill patients admitted to general wards in a large teaching 
hospital
Methods: We retrospectively collected data from all patients admit-
ted to Humanitas Research Hospital for COVID19 infection, from Feb-
ruary 2020,22 to April 2020. Study obtained IRB approval. Data were 
anonymized at extraction from EHR. AKI was defined according to 
KDIGO criteria, using both urinary output and creatinine values. When 
baseline creatinine values were not available, the lowest intra-hospital 
creatinine value was used as baseline. Data are described as median-
IQR or frequency-percentage. Chi square test or Kruskal-Wallis test are 
used for comparison.
Results: A total of 544 patients were included in the analysis, with a 
median age of 66 (IQR 53-76, range 22-93). 353/544 (64.9%) patients 
were male. 219/544 patients (40.2%) developed AKI during hospital 
stay according to KDIGO criteria, with 78/544 patients (14.3% reaching 
stage 2-3 AKI) 
Patients with AKI were older than patients without AKI. (71 (62-79 
years) vs 61 (49-72) years, p<0.001)Patients with AKI had a two-fold 
increase in the risk of death (66 patients (30.1%) vs 47 patients (14.5%), 
p<0.001). Median LOS in the total population was 8 days (IQR 5-14). 
LOS increased according to AKI stage from 0 (3-10) days in patients 
with no AKI, to 12 (8-20) in patients with AKI stage 1, to 18 (11-26) days 
in stage 2-3 (p<0.001 in each comparison).
Stages of AKI according to hospital admission day are reported in
 
The cumulative percentage of AKI, according to hospital admission 
day, is reported in 3.
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Conclusion: AKI is frequent in acutely ill patients with COVID-19 infec-
tion admitted to hospital, and leads to worse outcome, including 
increased mortality and prolonged hospital stay.
Reference(s) and grant ackowledgment(s)
1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury 
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2. Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavi‑
rus 2019 epidemic and kidneys. Kidney Int. 2020;97(5):824‑828.
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Introduction: Patients with COVID-19 who need renal replace-
ment therapy (RRT) have higher mortality[1]. Acute kidney injury is 
multi-factorial[2], in the early stages inflammatory mediators reduce 
systemic and peripheral vascular resistance, in the later stages multi-
system involvement due to micro-emboli and venous congestion are 
injurious. We hypothesize a hyperdynamic RV or a dilated RV could be 
seen, respectively, on echocardiography during these stages.
Objectives: To determine if there a hyperdynamic RV, of RV dilatation 
is associated with RRT in critically ill COVID-19 patients.
Methods: We performed an observational study of patients admitted 
to intensive care unit (ICU) in a tertiary hospital across a three-week 
period. Only patients with 2 swab PCR confirmed COVID-19 were 
included in the study. RV function was assessed using tricuspid annu-
lar plane systolic excursion (TAPSE) and right ventricular S prime (RV 
S’) during their admission. RV was recorded as normal or dilated by 
qualitative method. We used fisher’s exact test and odds ratio (OR) to 
determine the association between these variables and the need for 
RRT. ROC curve analysis was used to determine the best cut-off for 
continuous variables.P-Value of less than 0.05 is considered statistically 
significant.
Results: A total of 49 COVID-19 positive patients were included. Of 
these patients 36% (n=18) required RRT during their admission.
TAPSE readings were available for 46 / 49 patients, including all 18 RRT 
patients. Using a cut-off of 26mm or more, 9 out of 20 patients (45%) 
needed RRT. 17 out of 26 patients (65.4%) with a TAPSE < 26mm did 
not need RRT. There was no significant association between TAPSE and 
RRT (p=0.47).
RVS’ readings were available for 44/49 patients, including 16/18 
RRT patients. Using a cut off of 16mm or more, 14 patients out of 30 
patients (46.7%) needed RRT. 12 out of 14 patients (85.7%) with an RV 
S’ < 16mm did not need RRT. P-value = 0.049. OR 5.25 (1.00 – 27.61).
Assessment on RV dilatation was recorded on all 49 patients. 38 of 
49 patients (78%) had severe RV dilatation of whom 17 required RRT. 
10 out 11 patients (90.9%) with a normal size RV did not need RRT. 
(p<0.038) OR 8.1 (0.94 – 69.69).
Conclusion: In ICU patients with Covi19 pneumonitis, a patient with 
a severely dilated RV or an RVS’ greater than 16mm on echocardiogra-
phy is more likely to need Renal Replacement therapy.
Reference(s) and grant ackowledgment(s)
1. Intensive Care National Audit and research Centre ‘ICNARC report on 
COVID‑19 in critical care 24 July 2020’ www.icnarc.org
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Introduction: Difficulties associated with the evaluation and monitor-
ing of glomerular filtration rate in critically ill patients are well known.
Objectives: To analyse the concordance between the estimated glo-
merular filtration rate (GFR) obtained by means of the application of 
formulas according to serum creatinine, compare to those according 
to serum cystatin.
Methods: Prospective, observational study carried out in ICU admit-
ted patients, during the months of November-December 2019. Gen-
eral data and renal function analysis data were collected: creatinine 
(Cr) and glomerular filtration rate were estimated by MDRD 4-IMDS 
(GFRCr); Cystatin (Cs) and glomerular filtration rate were estimated by 
CKD-EPI (GFRCs).
Quantitative variables were expressed as mean (SD) or median (IQR) 
and qualitative variables as percentages. The concordance between 
the GFR values obtained by both methods was estimated by the inter-
class correlation coefficients (ICCs < 0.5 bad, ICCs 0.51-0.70 moderate, 
ICCs 0.71-0.90 good and ICCs > 0.90 excellent) and by Bland Altman 
plot (quantification of the mean difference between the two methods 
with 2DS with 95% CI). In view of the lower reliability of the MDRD 
method for high GFR, we performed a general analysis and another for 
low GFR (GFR < 60 ml/min).
Results: Eighty-five pairs of measurements were obtained in 95 ICU 
admitted patients. General data: male 56%, age 64±14 years, weight 
73±18 Kg, height 166±9 cm, 90% white race. Renal function values: 
Cr 1.26±1.47 mg/dl; GFRCr 93.07±55.72 ml/min, Cs 1.32±0.76 mg/l; 
GFRCs 67.90±32.33 ml/min; 29% of patients had GFRCr < 60 ml/min 
and 39% GFRCs < 60 ml/min.
In the general analysis of data, a moderate agreement was obtained 
between the two methods of GFR (ICCs 0.54; 95% CI 0.19-0.73), with a 
significant difference between the means (24.32; 95% CI 11.86-36.78; p 
< 0,001) (Figure 1)
Performing the same analysis when GFR < 60 ml/min, a good concord-
ance between the two methods was obtained (ICCs 0.78; 95% CI 0.38-
0.92), with a non-significant mean difference (-5.91; 95% CI-14.57-2.74; 
p=0.13) (Figure 2).
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Conclusion: Waiting to determine its clinical application, our study 
showed a good agreement between the values of glomerular filtration 
estimated by creatinine and cystatin when there is impairment renal 
function.
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Introduction: To assess in admitted patients to the ICU by coronavi-
rus the influence on mortality and also at the development of multi-
organ failure of renal function evaluated with the numbers of urea 
at the moment of admission to assess how coronavirus influence to 
the patients admitted by this ill at ICU on mortalityand also on the 
development.
Methods: Prospective cohort study of patients with coronavirus 
admitted to the ICU at theHospital Universitario de Jaén, Hospital San 
Agustín de Linares and the Hospital InfantaMargarita de Cabra.Contin-
uous variables are expressed as median (25th percentile, 75th percen-
tile) andqualitative variables with absolute and relative frequencies. U 
Mann Whitney was usedfor comparison of continuous variables and 
X2 for qualitative variables. P &lt;0.05 wasconsidered as statistically 
significant.
Results: We have studied 63 admitted patients AT ICU by coronavi-
rus INFECTION, 43 of themAT Jaén hospital ICU, 11 at Cabra hospital 
and 8 at Linares hospital.The average age was 58 (37,62). The evalu-
ated severity with APACHE II was 12 (9,17) pointsand the same evalu-
ation but using SOFA was 6 (4,8) points at the first day. 63,5% (n=40)
required tracheal intubation on their first day and 82,5% (n=52) dur-
ing the entire ICU stay.Mortality in the ICU was a percent of 38 and 
(meanwhile) at the hospital was 39,7Those patients who deceased 
were older than the survivors, 64 (60,72) vs 60 (52,70) years old,but 
the differences weren’t statistically significant (e.s) (p=0.16.). These 
ones also showedmost acutely according to Apache II, 18 (14,23) vs 14 
(12,18) pointa (p < 0,005), and a higherSOFA at the admission 7 (4,8) vs 
6 (3,8) points, but without being statistically significant(p=0.09).
The Who died show higher urea at the admission 63(34,59) vs 
45(34,59) mg, (p=0.051) although the differences weren’t s.s. Then, we 
classified the patientsaccording to whether the urea was higher than 
70 upon admission to the ICU and his relationto the mortality. The 
46 patients (73%) whose urea were less than 70 showed a mortality 
of30.43% and those that had a higher or equal urea than 70 (n=17, 
26.98%) the mortality was64.70%, (p=0.003)
On the third day, we evaluated the severity with SOFA and observed 
that the patients whodied presented a higher SOFA 8 (7.9) vs 6 (3.8) 
points, (p = 0.021).When The relation between SOFA at the moment of 
the admission and SOFA on the third daywas evaluated we could see 
that a correlation existed (r=0.588, p < 0.001). SOFA on the thirdday 
was higher in patients with Urea greater than 70 9 (8.12) vs 8 (7.11), (p 
= 0.007).
When SOFA on the third day of the admission was studied using multi-
ple linear regression itwas noticed that there was a relation with both 
SOFA at the day of admission (B=0.548±0.126, p < 0.001) and urea at 
the moment of the admission(B=0.019+0.003, p=0.033), R=0.629.
Cuando se estudio con Regresión lineal múltiple el SOFA al tercer día 
se relacionó con el SOFAal ingreso (B=0.548+0.126, p < 0.001) y con la 
Urea al ingreso (B=0.019+0.003, p=0.033),R=0.629.
Conclusion: In ICU patients admitted for coronavirus infection, a 
higher urea at the admission is related tothe mortality and is linked to 
a later worsening., as it&#39;s showed by an increase in theSOFA score 
on the third day compared to that which they had at admission in 
those patientswith higher Urea numbers.
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Introduction: Critically ill patients with COVID-19 infection frequently 
have kidney involvement with clinical presentation ranging from mild 
renal failure to progressive acute kidney injury (AKI) necessitating 
renal replacement therapy (RRT). We describe our experience during 
the peak of the COVID-19 pandemic.
Methods: Retrospective cohort study of patients suffering from 
COVID-19 infection admitted to the ICU during the peak of COVID-19 
pandemic from March to June 2020. We collected data from electronic 
medical records on demographics, Simplified Acute Physiology Score 
III (SAPS III), comorbidities, treatments received, need for RRT, use of 
low molecular weight heparin, length of ICU admission and mortality 
in ICU.
Results: 82 patients diagnosed with COVID-19 admitted to ICU. Mean 
age was 63.06 (+/- 10.036) and the majority (76.8%) were men. 68.3% 
patients (56) suffered AKI and 18 of those (32.1%) required RRT, the 
majority of them through continuous therapy (94.4%).
Comorbidities included hypertension (48.2%), diabetes (37.5%), 
chronic respiratory condition (asthma or COPD) 17.9%, obesity 
(defined by BMI > 30) 21.4%, ischaemic miocardiopathy 9.1% and 
5.4% patients with some level of immunosuppression (all causes). No 
patients with autoimmune disorders within our population.
Patients with AKI received the following COVID-specific treatment 
according to our Hospital protocol: 98.2% of patients received Hidrox-
ycloroquine, 91.1% Lopinavir/Ritonavir, 73.2% steroids (Metilpreniso-
lone or Dexametasone), 58.9% Tocilizumab, 33.9% Beta-Interferon, 
10.7% Baricitinib and 3.6% Anakinra.
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Mean SAPS III score was 57.96 (+/- 8.6). Mean ICU length stay was 
23.06 days (+/- 21.46) and mortality 71.4%, (OR 1.471; 1.022-2.117, p 
0.018) against 41% mortality of patients without renal failure.
Conclusion: The proportion of critically ill patients with COVID-19 suf-
fering from AKI was significantly higher in our population (68.3%) than 
figures published in the literature (20 to 40%). AKI has been consid-
ered a marker of disease severity and a negative prognostic factor for 
survival. In our cohort, mortality rate in patients with AKI was consider-
ably higher than mortality in patients without AKI. RRT rate, however, 
was similar to the literature published (21,9%). Even though comor-
bidities were more frequently found in the AKI group of patients, 
multivariate logistic regression analysis failed to reveal an associa-
tion. Furthermore, no association was found between AKI and COVID 
19-specific treatment received.
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Introduction: The novel severe acute respiratory coronavirus 2 (SARS-
CoV-2) is the cause of COVID-19 disease. COVID-19 disease has a 
wide spectrum of manifestations, from asymptomatic individuals, to 
acute illness with respiratory failure requiring hospitalization, to criti-
cal illness requiring ICU admission and mechanical ventilation. While 
COVID-19 disease mostly affects the lung, Acute Kidney Injury (AKI) is 
frequent in patients with SARS-CoV-2 infection, specifically in patients 
admitted to critical care.
Immunoassay test based on the urinary concentration of two biomark-
ers, tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like 
growth factor-binding protein-7 (IFGBP7), have been proposed and 
validated for AKI in other settings. No data are available on TIMP-2 and 
IFGBP7 urinary concentration in COVID-19 patients with critical illness.
Objectives: To investigate whether TIMP-2 and IGFB7P urinary bio-
markers at ICU admission are related with the risk of AKI in patients 
admitted to ICU for COVID-19 disease
Methods: We conducted a preliminary prospective cohort study, 
enrolling subsequent patients admitted to COVID-ICU in Humani-
tas Research Hospital, due to COVID-19 disease. Study obtained IRB 
approval. Informed consent was obtained according to local regula-
tions. Urinary levels of TIMP-2 and IGFB7P biomarkers were measured 
at ICU admission (AKIrisk score by NephroCheck® Test), and after 12h, 
24h and 48h from ICU admission. AKI was defined according to KDIGO 
criteria.
Data are described as median-IQR or frequency-percentage. Chi 
square test or Kruskal-Wallis test are used for comparison.
Results: A total of 13 patients were included in the study. Patients 
were mostly male (11/13, 83%), with a median age of 59 (IQR 45-67). 
5 patients (38%) had no previous disease, while the most frequent 
comorbidity was diabetes (3 patients, 23).11 patients underwent 
mechanical ventilation (84.6%).
A total of 9 patients developed AKI stage 2/3 (69%). 78% of patients 
needed diuretics during ICU stay, but none of these 13 patients under-
went CRRT.
Urinary biomarkers (AKIrisk) values according to time of measurement 
are reported in Figure 1
AKIrisk values according to AKI stage and time of measurement are 
reported in figure 2. .Only AKIrisk value at 12h were significantly asso-
ciated with AKI stage 2-3 (p=0.03)
Conclusion: In this pilot study, TIMP-2 and IGFB7P are generally ele-
vated in patients admitted to ICU for COVID-19 disease, and present 
wide variability. This may be partly explained by the large variability 
in ICU admission time, according to the onset of symptoms and to the 
first day of hospitalization. Only TIMP2-IGFB7P urinary values at 12h 
from ICU admission were correlated with AKI stage 2-3.
Reference(s) and grant ackowledgment(s)
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Introduction: Approximately 29% of all critically ill COVID-19 patients 
in Scotland required renal replacement therapy (RRT), and require-
ment for RRT is associated with greater mortality(1). Usual local pro-
tocol for anticoagulation to facilitate continuous RRT uses citrate, 
allowing anticoagulation of the filter circuit only without systemic 
anticoagulation of the patient. However, early in the pandemic it was 
noted that filtration circuits were clotting unusually quickly, perhaps 
related to the well documented procoagulant state of severe COVID-
19. Therefore, a new protocol was devised using systemic unfraction-
ated heparin. Ordinary monitoring of this would be activated partial 
thromboplastin time (APTT), however this was altered due to inter-
national evidence that it is unrepresentative of true coagulation state 
among COVID-19 patients(2,3). Therefore, anti-Xa activity monitoring 
was used, targeting a range of 0.3-0.7 initially, increased to 0.5-0.7 later.
Objectives:
1. To assess the impact of different forms of anticoagulation on continuous 
haemodiafiltration filter set longevity among COVID‑19 patients, with 
particular attention paid to the effect of anti‑Xa activity levels on longevity.
2. To assess the frequency of adverse events associated with systemic unfrac‑
tionated heparin.
Methods: Patients admitted to our ICU whose primary diagnosis was 
‘COVID-19 confirmed/suspected’ and who underwent at least one day 
of RRT were identified. Data were collected retrospectively regarding 
filter set longevity, the reason for stopping/changing filter set, method of 
anticoagulation, anti-Xa activity along with patient-level data on length 
of stay, mortality and adverse events. The data were analysed with 
regard to whether systemic heparinisation was associated with longev-
ity, whether anti-Xa monitoring affected this and frequency of recorded 
adverse events related to heparin. Data were also analysed to identify 
any association between filter set longevity and patient outcome.
Results: In total, 144 filter sets were used in 21 COVID-19 patients. Cit-
rate anticoagulation was used in 27 (19%) and heparin in the remain-
ing 117. The reason for stopping/changing filter set was clotting of the 
set in 88 of these (61.1%). Median longevity in sets that clotted was 10 
hours (range 0-87) and very positively skewed. No statistically signifi-
cant difference in longevity was observed when comparing sets using 
citrate to all sets using heparin anticoagulation (median 9 vs 10 hours, 
p  =  0.27). We then compared three groups: citrate, heparin with no 
anti-Xa levels/first anti-Xa level less than 0.3, and heparin with the first 
anti-Xa level greater than 0.3. There was significantly greater longevity 
in sets with the first anti-Xa greater than 0.3 compared to the other two 
groups (median 30 hours vs 10 hours vs 9 hours, p = 0.012). When ana-
lysing for an anti-Xa target range greater than 0.5, the median longevity 
was 35 hours, a further significant improvement (p = 0.022, see chart).
.
A significant positive correlation was observed within filter sets 
between the percentage time spent with anti-Xa levels >0.3 and lon-
gevity (p = 0.007). Two adverse events related to heparin (i.e. bleed-
ing) were recorded, one fatal. Both occurred while anti-Xa levels were 
within the range 0.3-0.7. No significant association was seen between 
patients’ average filter set longevity and their outcomes or severity 
scoring on admission to ICU.
Conclusion: This study provides evidence that the use of anti-Xa activ-
ity monitoring is useful in improving filter set lifespan among COVID-
19 patients undergoing continuous RRT, while using unfractionated 
heparin without anti-Xa monitoring is no better than citrate antico-
agulation. The effect is best seen with anti-Xa levels at a level greater 
than 0.5. However, the risk of adverse bleeding events related to hepa-
rin is a significant one and anti-Xa monitoring does not appear to be 
protective against this in our cohort.
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Introduction: Sepsis and septic shock in patients with primary brain 
injury can lead to or aggravate the existing neurologic symptoms due 
to cytokine release impairing the hematoencephalic barrier. For such 
patients standard therapy may be insufficient for fast multiorgan fail-
ure (MOF) regress and hemodynamic instability correction. Blood 
purification is a potentially reasonable option for patients with septic 
shock not responding to standard therapy.
Objectives: The objective of the present study is to evaluate the effec-
tiveness of the combined blood purification (CBP) in neurosurgical 
patients with septic shock.
Methods: We present 6 neurosurgical patients 29-82 y.o. with septic 
shock. All of them received standard therapy according to the Surviv-
ing Sepsis Campaign guidelines. CBP therapy was started within 10 
hours after septic shock diagnosis in 4 patients and within 20 hours 
– in the other 2 patients. The procedure description: CVVHDF mode 
on Gambro Prismaflex. Increased adsorption capacity filters (AN69ST 
(5 patients) and Oxiris (1 patient)) action was amplified by CytoSorb 
adsorber for all patients. Systemic anticoagulation was performed 
with heparin in 2 patients, regional citrate anticoagulation – in 3 
patients; 1 patient was not anticoagulated. The duration of the proce-
dure was 24 hours.
We observed the procedure’s influence on the vasopressor require-
ments, MOF (by SOFA score), PCT, CRP, IL-6 and lactate levels.
Results: In the course of CBP we observed clinical improvement in all 
patients. In 3 patients clinical improvement (MOF regress and lactate 
level decrease) was stable; in other 3 patients - transient.
Median NE demand for all patients reduced from 0,885  µg/kg/min 
(0,18–2,13) before CBP to 0,19 µg/kg/min (0–1,64) in 24 hours and to 
0,16  µg/kg/min (0–3,6) in 72 hours after CBP initiation (Figure  1). At 
the same time, we observed lactate level reduction from 3,25 mmol/l 
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(2–9,8) before CBP to 2,05 mmol/l (1,8–7,9) in 24 hours (p < 0,05) and 
to 1,8 mmol/l (0,7–5,8) in 72 hours after CBP initiation (Figure 2).
Mean SOFA score decreased from 14 (11–18) before CBP to 11 (4–17) 
in 24 hours (p < 0,05) and to 9 (4–18) in 72 hours after CBP initiation 
(Figure 3).
Mean PCT level decreased from 97.77 ng/ml (5.32 - >200) before CBP 
to 25.93 ng/ml (1.43–86.62) in 24 hours (p < 0,05) and to 22.8 ng/ml 
(3.1-101.45) in 72 hours after CBP initiation (Figure 4). Mean CRP level 
decreased from 138,5  mg/l (34,7–257,3) before CBP to 102,2  mg/l 
(35,4–254,4) in 48 hours and to 68 mg/l (28,2 –298,1) in 72 hours after 
CBP initiation (Figure  5). Mean IL-6 level decreased from 896  pg/ml 
(56–32280) before CBP to 249  pg/ml (19.46-9142) in 6 hours and to 
80.5 pg/ml (20.98- 6352) in 24 hours after CBP initiation (both p < 0,05) 
(Figure 6).
3 patients with stable clinical improvement had shock reversal; in 2 of 
them we observed consciousness level increase. 2 Patients with tran-
sient clinical improvement died in 72 and 74 hours after CBP initiation 
due to cerebral herniation in the setting of malignant brain oedema, 1 
patient died at 26 hours after the procedure start due to cardiac insuf-
ficiency progress after pulmonary embolism.
Conclusion: We observed that CBP in combination with standard 
intensive care contributed to overall clinical improvement in all 
patients (stable or transient). Among the key changes were the sig-
nificant MOF regress, lactate, PCT and IL-6 level decrease and not 
statistically significant vasopressor demand reduction. The use of 
CBP in septic shock patients after neurosurgical interventions may be 
rational. Further studies on the method efficacy and safety in neuro-
surgical patients with septic shock are required.
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Introduction: Acute kidney injury (AKI) complicates sepsis in 40-50% 
of cases and often necessitates introduction of continuous renal 
replacement therapy (CRRT) which significantly affects pharmacoki-
netics of multiple medications commonly used in the intensive care 
unit. Association between use of CRRT and fentanyl concentration, 
particularly in the critical care setting, has not been well described yet.
Objectives: To compare concentrations of fentanyl before and during 
continuous veno-venous hemodialysis with regional citrate anticoag-
ulation (RCA-CVVHD) in septic patients with AKI.
Methods: We enrolled patients at the of > 35 and < 85  years with 
severe sepsis or septic shock and clinical indications for CRRT due to 
AKI, according to KDIGO recommendations. RCA-CVVHD was initiated 
according to the local practice. It was performed using commercially 
available equipment and solution, with anticoagulation performed 
using 4% trisodium citrate and CaCl2 solution. All CRRT settings were 
identical for every participant at the beginning of procedure and were 
subsequently adapted based on the patient’s clinical status. Fentanyl 
was administered via a continuous intravenous infusion with a dos-
age equal to 100 µg/h. The dosing of fentanyl was not changed after 
RCA-CVVHD was initiated. Fentanyl concentrations were measured in 
seven predefined timepoints both before and after the initiation of 
RCA-CVVHD with the use of high-pressure liquid chromatography – 
tandem mass spectrometry with an electrospray ionization source.
Results: Fourteen patients at the median age of 59.5 (IQR 45.0-64.0) 
years, among whom 9 were males (64.3%), were enrolled in the study. 
The concentration of fentanyl was similar before and after initiation 
of RCA-CVVHD in the entire cohort (0.535 vs 0.581 [ng/ml], p = 0.14) 
as well as in the subgroups of patients with residual diuresis (0.729 vs. 
0.804 [ng/ml], p = 0.50) and in patients without residual diuresis (0.430 
vs. 0.559 [ng/ml], p = 0.21).
Conclusion: There were no significant differences in fentanyl levels 
before and after initiation of RCA-CVVHD, irrespective of residual diu-
resis status. Results of presented study suggest a limited usefulness of 
fentanyl concentration monitoring in this population.
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Introduction: The use of continuous renal replacement therapy with 
hemoadsorption  (Oxiris®) in patients with severe acute respiratory 
failure due to COVID-19 and associated renal failure, may modify the 
systemic inflammatory response associated with this disease based on 
cytokine clearance.
Objectives: Describe the characteristics of our serie, the therapy 
applied, and assess the impact of hemoadsorption on the outcomes 
of our patients.
Methods: Prospective, unicentric, observational study in patients 
admitted to the ICU from march to april 2020 due to SARS-CoV-2 infec-
tion with acute kidney injury (AKI) and need for Continuous Renal 
Replacement Therapy (CRRT) in which hemoadsorption with  Oxiris® 
membrane is set up. We analyze epidemiology, severity scores, respira-
tory status and inflammatory markers before and after therapy, dose 
and complications of CRRT, ICU lenght of stay and mortality. Statistical 
analysis is performed with SPSS system.
Results: 128 patients were analized; 33% of them presented acute 
kidney injury, 18% required CRRT and in 11% (14 patients) was asso-
ciated with hemoadsorption: median age of 62  years and male pre-
dominance (86%) were included, 57% of them were hypertensive, 
43% obese and 21% chronic pneumopaths. The worst SOFA at 24  h 
of admission was 5 (IQR: 4-7), the worst PaFi was 105 (IQR: 66-120) 
and the worst compliance was 45  ml/cmH2O (IQR: 40-52). Neuro-
muscular blockade and prone position were used in 93% of them, 
and veno-venous ECMO was applied in one case. The main indication 
of CRRT was homeostasis (78%) and fluid balance (14%). The initial 
dose employed was 35 ml/kg (IQR: 35-40), final 30 ml/kg (IQR 30-45) 
and median duration of 72  h. The anticoagulation system used was: 
86% citrate, 9% nothing and 5% heparin, without any case of citrate 
accumulation. We detected several complications, all of them in mild 
degree: persistence of metabolic acidosis 86%, hypothermia 50%, 
hyperkalemia 23%, metabolic alkalosis 14%, hypophosphoremia 9% 
hypomagnesemia and hypokalemia 5%. No statistically significant dif-
ferences were found between inflammatory markers (PCR, PCT, ferri-
tin, lymphocytes, fibrinogen), SOFA or PaFi pre and post-CRRT due to 
the small sample size, althought they were found between pre and 
post-CRRT D-dimer (p < 0.05). ICU lenght of stay was 12 days (IQR 6-18) 
and ICU mortality rate was 50%.
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Conclusion: In our serie, CRRT with associated hemoadsorption has 
been useful and safe technique in the management of acute renal fail-
ure in COVID-19 patients. This therapy could lower D-dimer levels.
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Introduction: The optimal treatment modality for a metformin lac-
tate acidosis (MALA) remains controversial [1]. Though intermittent 
haemodialysis (IHD) is considered superior in correcting acidemia and 
clearing metformin, continuous renal replacement therapy (CRRT) is 
still used frequently due to a proposed better hemodynamic tolerabil-
ity and less logistic implications [1-4].
Objectives: Does the fear of an increased risk of hemodynamic pertur-
bation outweighs the proven benefit of a more effective clearance? In 
this paper we illustrate a significant difference in clearance between 
both modalities of RRT with a pharmacokinetic time course of met-
formin levels.
Methods: This trial is a retrospective, observational study. From July 
2019 to December 2019, we identified all patients who were admit-
ted to the ICU of the Sint-Jan Hospital in Bruges with the diagnosis of 
severe MALA requiring RRT. The metformin plasma levels where moni-
tored with an interval of three hours. RRT was discontinued as soon as 
the clinical condition and renal function improved sustainably.
Results: Our trial population consists of 2 patients. The first patient 
underwent IHD (Qb 345  ml/min, Qd 500  ml/min) during 4  h after 
which CVVH (Qb 120  ml/min, Qe 40  mL/kg/h, 50% pre-dilution and 
50% post-dilution with Hemosol BO replacement fluid) was started. 
Metformin concentrations were dramatically reduced in the first 4  h 
and metabolic acidosis was corrected. The mean rate of metformin 
elimination was 12%/h with IHD and 5%/h with CVVH (Fig. 1).
The other patient immediately received CVVHDF (Qb 120 ml/min, Qe 
55 ml/kg/h, 66% pre-dilution and 33% post-dilution with Hemosol BO 
replacement fluid, Qd of 2000  ml/h) with a gradual normalisation of 
the metabolic acidosis and metformin concentrations in the first 24 h. 
The mean rate of metformin elimination was 2.4%/h (Fig. 2).
The IHD was hemodynamically well tolerated, while the second 
patient was highly vasopressor dependent during the first 20  h of 
CVVHDF. Both our patients had a favourable outcome (Table 1).
Conclusion: CRRT and IHD are equivalent dialysis strategies regard-
ing outcome for the ICU patient with AKI [5]. Arguments in favor of 
CRRT are a presumed better hemodynamic tolerability and its poten-
tial for gradual fluid removal. On the other hand, IHD is more flexible 
and cost-effective, offers the possibility to minimize anticoagulation 
and removes small solutes more efficiently [5]. Our study illustrates 
that IHD was more efficient to restore the metabolic homeostasis and 
eliminate metformin. It’s our opinion that IHD is the preferred modal-
ity of RRT in MALA, despite the presence of hypotension. There is no 
need for net ultrafiltration and the hemodynamic instability is most 
likely induced by the extreme metabolic derangements related to 
metformin [5-6]. However, further studies are needed to determine 
the indication, timing and modalities of RRT and the potential role 
of hybrid therapies such as sustained low-efficiency daily dialysis in 
patients with MALA.
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Introduction: On-line databases have grown as an alternative method 
for storing and analysing scientific data, respecting confidentiality, 
providing security and simplicity of use. Based on the use of an inter-
national database, initial evaluation of an on-line database for the fol-
lowup of renal depuration techniques is presented.
Objectives: Analize the initial results in a multicenter register which 
allows a continuos follow up of the patients with Continuous Renal 
Replacement Therapy (CRRT) with the objective of detect and solve 
the problems in their implementation.
Methods: Observational, prospective, multicenter and descriptive 
studio, by the database DialyReg, which one has the caractheristic of 
a database with a little number of variables, making it easier to fill. 
REDCap is an on-line database which has the legal garantees regard-
ing security and confidentiality, feasibility and an easy access, with a 
possibility of data analize in real time. Statistical analysis is performed 
with SPSS system and it has got the bioethical approve.
Results: In 2019, 159 patients has been included with the main admis-
sion diagnosis of medical illness(47%), postoperative (26%), sepsis 
(24%) and trauma (5%). The principal indication for the theraphy was 
internal homeostasis (43%), oliguria (24%), hemodynamics (16%) and 
hydric disbalance (15%). The median of the number of catheter per 
patient was 1 (IQR1-1) with a median of duration by 6 days (IQR 3-9). 
The 82% of the catheters were coaxial dual lumen, and the preferen-
tial vascular acces was internal femoral vein (58%). The main com-
plications derived by the theraphy were hematoma (2%), infection 
(2%) and trombosis (1%). Median of the hemodialysis sets was 3 (IQR 
2-6), with a median of therapy set by 22 hours (IQR 12-48 h). The inti-
tial theraphy dosis was set in 30  ml per kilogram (IQR 20-40  ml) and 
dynamic adjustment was perform in the 68% of the sample. The main 
motive for discontinuation of the theraphy was recovery (58%), exitus 
(29%) and intermittent renal replacement (8%). Discontinuation was: 
planned (37%),end of the treatment (18%) or a dyalisis set coagu-
lation (36%). The main complications derived by the therapy were 
hypophosphoraemia(15%), hypotermia(12%), metabolic acidosis, 
hypokalemia and hypocalcemia (6% respectively). 53% of the patients 
were discharged from the hospital while 40% died in the ICU and 6.5% 
during hospitalization.
Conclusion: The DialyReg register is a feasible tool, affordable for 
a real time control of the results of dyalisis theraphy in our units. It 
could be usefull for the maintenance of security programs in these 
thecniques.
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Introduction: Citrate-based renal purification therapy is increasing 
its use over other conventional anticoagulation modalities, providing 
evidence of a safe and effective alternative. For this purpose we would 
like to analyse the impact of complications due to the use of citrate 
versus other anticoagulation modalities in Continuous Renal Replace-
ment Therapy (CRRT).
Objectives: Comparison between citrate anticoagulation with other 
modalities in terms of efficacy and safety.
Methods: Prospective multicenter observational cohort study based 
on the DialyReg registry, with the Clinical research ethics committee 
(CEIC) approval from both hospitals. We compare therapy doses, clot 
filter loss and common complications in patients undergoing Continu-
ous Renal Replacement Therapy (CRRT) in 2019. Statistical analysis is 
performed with SPSS system.
Results: Data from 159 patients corresponding to 690 haemofilters 
are analysed. The distribution in anticoagulation systems was: heparin 
(35.8%), citrate (29%), and without anticoagulation (44.5%). The initial 
dose of therapy was similar in citrate group (30 ml/kg, IQR 25-35) with 
respect to the heparin and without anticoagulation groups. Dynamic 
adjustment was performed more frequenty in the citrate group (84%) 
than in heparin (69%) and without anticoagulation groups (66%) 
(p  <  0.05). The final therapy dose was lower with citrate (20  ml/kg, 
IQR 20-30) versus heparin (30  ml/kg, IQR 20-35) and without antico-
agulation (25 ml/kg, IQR 15-35), (p < 0.05). Median duration of the set 
was higher in citrate group (55 h, IQR 24-72) versus 23 h in heparine 
group (IQR 12-48) and 12  h in no anticoagulation group (IQR 12-31) 
(p < 0.05). Coagulation of the system had a higher incidence with hep-
arin (46.7%) than with citrate (29.5%) (p < 0.05). Complications associ-
ated with the technique were observed: hypothermia (19% citrate vs 
9% rest), hypokalemia (18% citrate vs 3% rest) and hypomagnesemia 
(6.6% citrate vs 2% rest) (p < 0.05); although these findings observed 
in higher proportion in citrate group are attributable to the learn-
ing curve of one of the participating hospitals. Following proper use 
of the technique and the use of phosphate dialysis fluids, complica-
tions are similar to the other types of therapy. Citrate anticoagula-
tion was also analyzed in the subgroup of hepatopathic patients (27 
patients:52% cirrhosis, 37% liver transplantation, 7% acute liver failure, 
and 4% acute-on-chronic failure). Heparin was used in 39%, citrate in 
21%, and no anticoagulation was used in 38% of the sample. No sta-
tistically significant differences were found in terms of complications 
due to therapy, however there was a lower frequency of citrate use in 
hepatopathic patients than in non -hepatopathic ones (19% vs. 35%) 
(p < 0.05).
Conclusion: Citrate anticoagulation increases the duration of the 
haemofilters and allows better adjustment of the therapy dose in our 
series, possibly being more cost-effective. It is a safe anticoagulation 
system once the learning curve is covered.
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Introduction: The global COVID-19 pandemic resulted in a signifi-
cant proportion of hospitalised patients developing ARDS requiring 
mechanical ventilation(1). Prominent features of COVID-19 are a large 
inflammatory response with significant pyrexia and moderate-severe 
ARDS often requiring prolonged ventilation(2). Our unit uses an evi-
denced based protocol to manage patients with ARDS which includes 
lung protective ventilation, prone positioning and paralysis with 
neuromuscular blockade(3). Our clinical experience using this proto-
col to manage COVID-19 patients was that we encountered multiple 
episodes of failure to wean paralysis after an initial apparent improve-
ment in oxygenation and respiratory mechanics. We hypothesised 
that this failure may be more likely if there was evidence of significant 
ongoing inflammatory response. We sought to analyse if ongoing sig-
nificant inflammation as determined by pyrexia and rising CRP was 
associated with failure to wean paralysis.
Methods: Data was collected on ventilated patients admitted with 
COVID-19 pneumonia from March to May 2020. For each patient on 
each day ventilated we collected P/F ratio, mandatory vs spontaneous 
ventilation, whether paralysis was weaned successfully, peak tempera-
ture and CRP. Pyrexia was defined as temperature >38oC, CRP was 
compared to the previous 24 hour’s result to determine trajectory. 
We routinely use continuous atracurium infusions titrated to effect for 
paralysis. Statistical analysis was performed on Real Stats for Excel.
Results: Over the time period; 51 patients with COVID-19 pneumo-
nia were ventilated in our ICU. We excluded patients whose medical 
records were unavailable (n = 1) or those who didn’t complete their 
entire ventilated stay in our ICU (n = 7). All were followed up until ICU 
discharge. As of June 17th 2020, 4 patients remained in hospital with 
59% of patients (44) discharged home. Over the study period, there 
were 125 attempts at weaning paralysis of which 32 were success-
ful. The median number of days receiving paralysis was 6. In pyrexial 
patients with rising CRP, 11% of attempts to wean were successful 
compared to 34% of attempts in apyrexial patients with falling CRP 
(p = 0.048).
Conclusion: To our knowledge there are no other reports of neuro-
muscular blockade management during the COVID-19 pandemic. We 
have seen high rates of failure weaning paralysis in our patient cohort, 
but improved success rates when there is evidence of improving 
inflammatory response.
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Introduction: Although there are few previous published observa-
tional studies examining the incidence and mortality of patients with 
acute respiratory failure and ARDS, there are no studies specifically 
assessing the epidemiological characteristics, patterns of ventilation 
and clinical outcomes in patients with acute hypoxemic respiratory 
failure (AHRF) in the current era of lung protective ventilation. Under-
standing the factors associated with AHRF outcomes could lead to 
development of effective interventions and improvement of patient 
care.
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Objectives: The aim of the study was to identify the intensive care 
unit (ICU) mortality for patients suffering from AHRF. Secondary aim 
was analysis of factors influencing patient mortality and investigation 
of the parameters of ventilatory management as well as the use of res-
cue therapies for hypoxemia.
Methods: This was a multi-centre prospective study carried out in nine 
hospitals in Wales, UK, over two 2-month periods. All patients admit-
ted to ICU were screened for AHRF and followed-up until discharge 
from the ICU or hospital. Data was collected from patient charts on 
patient demographics, reason for ICU admission, methods of AHRF 
diagnosis, physiological and laboratory results, treating team manage-
ment and complications during the ICU stay.
Results: We recruited 197 patients in our study. Fifty-nine (29.9%) 
were non-survivors, 101 (51.3%) were survivors and data was missing 
for 37 (18.8%). Inotropic support (p = 0.03), re-intubation (p = 0.04), 
pneumonia (p = 0.002) and increased SOFA score (p = 0.04) were asso-
ciated with mortality. The majority of patients (87.8%) did not receive 
the optimal tidal volumes of ventilation (VT), recommended as 6-7 ml/
kg predicted body weight (PBW), with only 13.35% of all VTmax and 
27.98% of VTmin measurements within the optimal range. 77.90% 
VTmax and 23.69% VTmin measurements had values above 7  ml/
kg PBW. Rescue therapies were not used in the vast majority of the 
patients. Muscle paralysis was used only for 21.3% and recruitment 
manoeuvres for 17.8% of patients, whereas prone positioning and 
more invasive technologies such as ECMO were used in less than 1% 
of patients.
Conclusion: AHRF is associated with high mortality despite increased 
awareness and recognition of this condition. Despite advances of care, 
mechanical ventilation and use of adjunctive measures is still not opti-
mal for the vast majority of patients.
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Introduction: The global pandemic of SARS-CoV-2 resulted in a large 
cohort of patients requiring critical care support for severe respiratory 
failure (SRF) (1). Prone positioning (PP) is a well-established technique 
for improving oxygenation in patients with SRF (2).
Objectives: To describe our experience of PP as a management strat-
egy for patients with hypoxaemia admitted to the intensive care unit 
(ICU) in Aberdeen Royal Infirmary (ARI) with SRF due to SARS-CoV-2 
infection.
Methods: Patients admitted to the ARI ICU between March and May 
2020 with respiratory failure and confirmed SARS-CoV-2 infection 
were identified. Retrospective clinical and demographic data were 
gathered from electronic notes, observation charts and the local inci-
dent reporting system. Pa02/Fi02 ratio (P/F) change was calculated 
using the last value prior to PP and the maximum value during PP.
Results: 46 patients with confirmed SARS-CoV-2 infection were iden-
tified. 16 patients underwent proning during their ICU admission. 
Demographic data is shown in table 1. There were 52 discrete proning 
episodes; the maximum number of times a single patient was proned 
was 12. In 33 episodes the P:F ratio prior to proning placed the patient 
in the category of severe ARDS. The mean time from admission to 
first PP was 4.1 days (0-11). Average prone episode duration was 14.6 
hours (2-19.5). All prone episodes bar one involved invasive mechani-
cal ventilation via an endotracheal tube or tracheostomy. Mode of 
ventilation when prone comprised 56% volume control and 44% pres-
sure control. Average P/F ratio prior to PP was 13.4 kPa compared to 
24.5 kPa during PP. In all proning episodes the P/F ratio improved with 
a mean percentage increase of 86% (8.7-197.5) (figure 1). The percent-
age increase for prone episodes involving volume control ventilation 
was 89% compared to 84% for those involving pressure control ven-
tilation. Complications associated with PP included cardiac arrest on 
proning (2 cases), brachial plexus injury (1 case) and facial pressure 
injury (3 cases). ICU mortality was 37.5% for those with prone episodes 
and 30% in those patients not proned.
Table 1 Demographic data for PP patients and those not proned. Values 
expressed as mean unless otherwise stated. 
Proned Not proned P value
Age, years 61.5 55 0.06 
BMI 29.4 28.6 0.60 
Comorbidity (%) 
Hypertension 50 40.7 0.44 
Diabetes Mellitus 43.8 14.8 0.03 
ICU LOS, days 20.6 6.7 0.0004 
Mortality (%) 37.5 30 0.60 
.
Conclusion: Based on our experience, for patients with moderate to 
SRF secondary to SARS-CoV-2, PP appears to improve oxygenation. 
The mode of ventilation does not seem to influence change in oxygen-
ation. PP may be associated with increased risk of pressure damage, 
nerve injury and haemodynamic instability including cardiac arrest.
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Introduction: Acute respiratory distress syndrome (ARDS) is a form 
of acute, inflammatory lung injury with increased vascular perme-
ability that results in respiratory failure (1). The outbreak of coronavi-
rus disease 2019 (COVID-19) caused by the severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) has triggered a rapid increase 
in the number of ARDS cases worldwide. The current best practice for 
management of ARDS includes low tidal volume ventilation (2) and 
prone positioning where appropriate. Iloprost is a prostacyclin which, 
in nebulised form, is licensed for treatment of primary pulmonary 
hypertension (3); its actions have been hypothesised to reduce V/Q 
mismatch in ARDS.
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Objectives: This study aims to observe the current practice of using 
inhaled iloprost in patients with refractory ARDS at the Royal Free Hos-
pital Intensive Care Unit, and evaluate its use in mechanically venti-
lated patients with COVID-19 related ARDS.
Methods: Ten COVID-19 positive patients with confirmed severe ARDS 
as per the Berlin criteria (1), and multi-organ failure were observed. 
Iloprost nebuliser solution was given every 4 hours at a dose of 5 
micrograms initially, with stepwise increments of 5 micrograms to a 
maximum of 20 micrograms. Changes in oxygenation were monitored 
using the PaO2/FiO2 ratio (P/F ratio) from arterial blood gas (ABG) 
measurements. Measurements were recorded from 24 hours prior to 
the first dose to 24 hours after the last dose was administered. Data 
were analysed with linear regression and Pearson’s r correlation coeffi-
cient using SPSS. Mean arterial pressure was used to monitor for safety.
Results: Ten patients were followed (table 1). Iloprost treatment was 
given for 3  days on average. The average follow-up time was 106 
hours per patient with 303 time points sampled. The correlation in the 
24 hours prior to initiating iloprost was -0.225 (p = 0.67) (figure 1). The 
correlation between P/F ratio and time in the first 24 hours after ilo-
prost was started was 0.146 (p = 0.2) (figure 2). No adverse drug reac-
tions were reported. Two patients died during the study and four died 
in the days after iloprost was stopped.
.
Conclusion: The overall effect of nebulised iloprost was inconclusive. 
There were possible short-term improvements in oxygenation during 
treatment but there was no evidence that inhaled iloprost conferred 
a survival benefit. Inhaled iloprost was well tolerated with no safety 
concerns. The findings reported are in keeping with current literature 
however the study lacked statistical power to draw conclusions that 
may influence practice (4,5). Inhaled iloprost may offer a potentially 
useful treatment intervention in the management of COVID-19 related 
ARDS and appears to be safe even in patients with multiple co-mor-
bidities. Further, more powerful studies are needed to determine the 
precise clinical value of iloprost in ARDS and COVID-19 related ARDS.
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Introduction: Laboratory parameters in COVID-19 regarding disease 
severity have been extensively evaluated [1, 2]. However, duration of 
their normalization is unknown.
Objectives: To determine the normalization time and sequence of 
laboratory parameters in critically-ill COVID-19 survivors.
Methods: Medical records of COVID-19 patients, admitted to ICU 
between March 29th and June 1st 2020 and discharged till July 18th 
2020 were examined. For each laboratory parameter, normalization 
date was accepted as the first day of the normal laboratory result 
series following two or more abnormal consecutive results. PaO2/FiO2 
(P/F) of ≥ 200 mmHg was accepted as improved value for oxygenation.
Results: A total of 21 patients were enrolled in the study. Patient char-
acteristics, normalization and treatment details are demonstrated in 
table. P/F improved first, and D-dimer normalized last. The sequence 
of normalization is demonstrated in figure.























































































































































































































































*: number of patients (%), others median days [25th and 75th percentiles]; §: No 75th percentile, 
due to low number of cases; Day 0 is ICU admission day; SOFA: sequential organ failure 
assessment; P/F: PaO2/FiO2 ratio, LYM: lymphocyte count, NLR: neutrophil/lymphocyte ratio, 
LDH: lactate dehydrogenase, CRP: C-reactive protein, LPV/r: Lopinavir/Ritonavir, AZT: 
Azithromycin, HQ: Hydroxychloroquine, FAV: Favipiravir, IVIG: Intravenous Immunoglobulin, 
CP: Convalescent Plasma 
.
Conclusion: In critically-ill COVID-19 survivors, oxygenation improves 
before inflammatory parameters, and D-Dimer normalizes last, sug-
gesting prolonged coagulopathy.
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Introduction: Patients with COVID-19 pneumonia are at major risk for 
acute respiratory distress syndrome (ARDS). Prone positioning (PP) has 
many benefical effects on pulmonary physiology and improves oxy-
genation in patients with ARDS.
Objectives: We aimed to investigate the effects of PP in non-intu-
bated patients with COVID-19 related pneumonia.
Methods: In this retrospective, single-center, before-after study we 
enrolled spontaneously breathing patients with confirmed diagnosis 
of COVID-19 pneumonia who received PP between March 21th and 
July 5th, 2020. We collected baseline data of demographic variables, 
SOFA score, APACHE II Score, oxygen therapy methods (as nasal can-
nula, simple face mask, non-rebreather mask) and non-invasive ven-
tilation. We compared PaO2, SpO2, FiO2, PaO2/FiO2, SpO2/FiO2, 
respiratory rate (RR) before PP, during PP and 1 hour after return to 
supine position. The main outcome is improvement in oxygenation. 
For statistical analysis of related repeated measures the Friedman test 
was used. Results are expressed as median (IQR).
Results: Fifteen patients (13 males) were enrolled in the study. Age 
was 67 (59-75), APACHE II and SOFA Scores were 15 (12-19) and 3 (3-5). 
As seen in Table PaO2, SpO2, FiO2, SpO2/FiO2 and RR improved dur-
ing PP compared to baseline. Overall 3 patients were intubated in 
whom PaO2/FiO2 improved less than 15% during PP. Six of 12 patients 
had > 15% improvement in PaO2/FiO2 during PP. There was not any 
improvement in PaO2/FiO2 after PP except 1 patient. Two intubated 
patients died.
n=15 before PP during PP after PP p value
PaO2, mmHg 63.9 (11.4) 73.9 (13.6) 66.4 (19.2) 0.02 
SpO2, % 91 (1.9) 93.9 (2.3) 91.4 (1.5) <0.0001 
FiO2, % 43.6 (18.2) 41.7 (17.7) 40 (14.3) 0.032 
PaO2/FiO2, mmHg 179.9 (56.3) 197.5 (64.1) 167 (46.7) 0.06 
SpO2/FiO2, % 236.6 (73) 251 (72.4) 248.6 (65.2) <0.0001 
RR, breaths per min 30.8 (5.4) 25.5 (4.5) 25.6 (6.1) <0.0001 
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Conclusion: PP improves oxygenation and RR in patients with COVID-
19 pneumonia.
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Introduction: Previous studies have described the respiratory 
mechanics of Covid-19 related acute respiratory distress syndrome 
(ARDS) and different phenotypes. However, their characteristics 
regarding transpulmonary thermodilution variables, such as extravas-
cular lung water (EVLW) and pulmonary vascular permeability, have 
been rarely described. Considering these parameters are important 
to fluid management strategy, our study aimed to describe EVLW and 
pulmonary vascular permeability in Covid-19-related ARDS and com-
pared them with a historical control group of patients with non Covid-
19 ARDS.
Objectives: To describe the characteristics of extravascular lung water 
index (EVLWi) and pulmonary vascular permeability index (PVPI) in 
Covid-19 ARDS patients. To investigate the relationship of EVLWi 
and PVPI with mortality and to compare these patients to a historical 
cohort of patients with non-Covid-19 ARDS.
Methods: In this observational multicentre study performed in three 
ICUs, we included patients with mild to severe Covid-19 ARDS and 
monitored by transpulmonary thermodilution. Demographic and rel-
evant clinical data were collected. Transpulmonary thermodilution 
variables were collected at least once a day for a maximum of 14 days. 
We selected values corresponding to the maximum value of EVLWi 
(EVLWimax) and of PVPI (PVPImax) per day. Other hemodynamic val-
ues, the ratio of arterial partial pressure of oxygen (PaO2) over FiO2 
(PaO2/FiO2) and other respiratory parameters were recorded at the 
time when the transpulmonary thermodilution values of interest were 
assessed.
Results: From March 13th to May 10th, 45 ARDS patients with con-
firmed Covid-19, monitored by transpulmonary thermodilution were 
included. On day 1, EVLWi was 17 (13-19) mL/kg and PVPI was 3.4 (2.6-
4.2). EVLWimax and PVPImax was reached on 3 (1-4) and 2 (1-3) days, 
respectively. EVLWimax was higher in non-survivors than in survivors 
(24 (19-28) vs. 18 (16-25) mL/kg, respectively, p = 0.03). PVPImax was 
also elevated in non-survivors than in survivors (4.9 (3.9-6.0 vs. 3.8 (3.4-
4.7), respectively, p = 0.03). Nevertheless, 4 of 27 patients with PaO2/
FiO2 ≤ 100  mmHg exhibited moderately increased EVLWi (≤ 15  mL/
kg) and PVPI ( < 4). Compared to non Covid-19 ARDS patients, Covid-
19 patients had similar values of EVLWimax (22 (17-27) vs. 20 (14-26), 
respectively) and PVPImax (4.5 (3.6-5.4) vs. 3.9 (3.0-5.5), respectively). 
At multivariate analysis of the merged cohorts of ARDS patients with 
and without Covid-19, EVLWimax (odds ratio (OR) =  1.06, 95% confi-
dence interval (CI) [1.01-1.10]), PVPImax (OR = 1.23, 95% CI [1.01-1.49]), 
and the Covid-19 status (OR = 2.73, 95% CI [1.17-6.37]), were inde-
pendent factors of 28-day mortality.
Conclusion: Covid-19 ARDS is characterized by elevated EVLWi and 
PVPI, which do not differ from non-Covid-19 ARDS. The maximal val-
ues of these variables are associated with the outcome. Covid-19 ARDS 
seems to be an independent risk factor for mortality.
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Introduction: An acute respiratory disease, caused by a novel coro-
navirus (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) has 
spread throughout the world. COVID-19 induces a severe inflamma-
tory response causing acute respiratory distress syndrome (ARDS) and 
respiratory failure. The management of ARDS is primarily supportive 
which includes ventilatory and non-ventilatory management. Due to 
acute lung parenchymal injury, ventilation often proves difficult and 
rescue measures are required, which include prone position ventila-
tion. In previous studies, prone position ventilation has shown dra-
matic improvement in oxygenation and ventilation but no statistically 
significant difference in mortality and ICU length of stay.
Objectives: To Assess the effects of prone positioning on ventilation 
and oxygenation of patients with COVID-19 ARDS.
Methods: Following ethical approval, data was collected from both 
written and electronic records (IntelliSpace Critical Care and Anaes-
thesia information system). All patients admitted to Tallaght University 
Hospital’s Intensive Care Unit (ICU) over a four month period between 
February 2020 to June 2020 with a Covid19 positive viral PCR and who 
were subsequently intubated, ventilated and proned were included in 
this study. Self proning, non-intubated patients were excluded. Clini-
cal data was extracted at four periods around each proning session; 
immediately prior to prone positioning (R1), two hours post prone 
positioning (R2), one hour pre-supination (R3) and one hour post supi-
nation (R4).
Data was collected and analysed using Microsoft Excel.
Results: In total, 16 patients (4F,12M) were intubated and proned. 
Five patients were of Asian origin, three of African Origin and eight 
were Caucasian. The mean age was 51 and the median body mass 
index (BMI) was 31.5 kg/m2. 14 patients (87.5%) survived and were dis-
charged from ICU. Significant cardiovascular comorbidities were pre-
sent in the two non-surviving patients. 77 proning session took place 
in total. The mean day of proning post intubation was day 2, with an 
average of 4.8 sessions per patient, lasting a mean of 17.1 hours. The 
mean PaO2/ FiO2 ratio (PFR) prior to the first proning session was 17 
(11-29) versus the mean PFR after the patient’s final proning session 
of 26 (15-46).
A PFR increase of >30% was present in 44% (34/77) of sessions 
immediately post proning (R1 vs R2) vs 64% (49/77) found after a full 
proning session (R1 vs R3), suggesting an improvement in oxygena-
tion with time. Comparing the PFR in the supine position pre and 
post proning sessions, an improvement was present in 68% of cases 
(R1vsR4).
Where end tidal C02 levels were accurately recorded, a reduction 
in the End tidal-Arterial CO2 gradient was present in 68% (45/66) of 
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sessions after proning (R1 vs R3) with a median change of -0.3  kPa, 
suggesting a reduction alveolar dead space.
Conclusion: Prone positioning of patients with ARDS caused by 
COVID-19 appears to improve the oxygenation and ventilation in a 
similar manner compared to ARDS attributed to other causes.
Reference(s) and grant ackowledgment(s)
1. 7. Mure M, Martling CR, Lindahl SG. Dramatic effect on oxygenation in 
patients with severe acute lung insufficiency treated in the prone position. 
Crit Care Med 1997;25:1539‑44. [Crossref ] [PubMed].
2. 6. Guérin C, Reignier J, Richard JC, et al. Prone positioning in severe acute 
respiratory distress syndrome. N Engl J Med 2013;368:2159‑68. [Crossref ] 
[PubMed].
3. 5. Mancebo J, Fernandez R, Blanch L, et al. A multicenter trial of prolonged 
prone ventilation in severe acute respiratory distress syndrome. Am J Respir 
Crit Care Med 2006;173:1233‑9. [Crossref ] [PubMed].
4. 4. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone 
positioning in hypoxemic acute respiratory failure. JAMA 2004;292:2379‑87. 
[Crossref ] [PubMed].
5. 3. Richter T, Bellani G, Scott Harris R, et al. Effect of prone position on 
regional shunt, aeration, and perfusion in experimental acute lung injury. 
Am J Respir Crit Care Med 2005;172:480‑7. [Crossref ] [PubMed].
6. 2. Gattinoni L, Pelosi P, Vitale G, et al. Body position changes redistribute 
lung computed‑tomographic density in patients with acute respiratory 
failure. Anesthesiology 1991;74:15‑23. [Crossref ] [PubMed].
7. 1. Cornejo RA, Diaz JC, Tobar EA, et al. Effects of prone positioning on lung 
protection in patients with acute respiratory distress syndrome. Am J Respir 
Crit Care Med 2013;188:440‑8. [Crossref ] [PubMed].
8. Nil.
001338 
Covid‑19 Critical ill patients in Santiago de Compostela. Case 
series
B.  Lence1; C.  Rivero1
1Intensive Care Unit, Santiago Clinic Hospital, Santiago de Compostela, 
Spain 
Correspondence: B. Lence
Intensive Care Medicine Experimental 2020, 8(2): 001338
Introduction: Our experience with Covid-19 critical ill patients in San-
tiago de Compostela during spring 2020.
Objectives: To learn about what we did and how we did it, getting 
new perspectives and ideas as next steps to improve.
Methods: We identified 23 patients with severe acute respiratory 
syndrome that needed ICU admission. Clinical data were reviewed of 
medical records. The data reported here are those through March 12 
to June 26. Each patient had the whole hospital stay of follow-up.
Results: We admitted 23 patients with SARS-CoV19 in ICU. The aver-
age age was 65  years old, being the youngest 42  years old and the 
oldest 80  years old. 19 of those patients were men and only 4 were 
female.
All patients reported were admitted for respiratory failure, 35% 
needed mechanical ventilation in the admission moment, finally 
requiring the 80% of the patients mechanical ventilation (during the 
ICU stay). The initial approach for 52% (12) of the patients were high 
flow nasal cannulas, failing to meet the oxygen needs and requiring 
in 10 of them to iniciate mecanichal ventilation. In 14 patients (78%) 
prono theraphy brought benefits. The maximum time on mecanichal 
ventilation was 43  days, with and average amount of 14  days, being 
the longest 53 days. Most of the initial chest x-ray during the hospital 
admission showed consolidation in 4/4 lung fields, whilst those x-rays 
that initially showed diffuse infiltration and only consolidation in 1/4 
or 2/4 lung fields deteriorated quickly on the following hours. The ini-
tial chest x-ray affectation at the ICU admission was not related to the 
oxygen support needed.
Concerning the treatment:
– All of the patients in this ICU were treated with hydroxychlo-
roquine and lopinavir/ritonavir, with disparities on how long 
were administered (between 5 and 15 days).
– Only 1 patient had hypotension and needed vasopressors dur-
ing the ICU admission.
– 87% (20) of the patients received corticosteroid therapy. 9 with 
dexametasone, 10 with methylprednisolone and 1 with hydro-
cortisone.
– Regarding anticoagulant therapy, all the 23 patients received 
Low-Molecular-Weiht-Heparin in different doses (0.5  mg/kg/
day; 1 mg/kg/day; -1,5 mg/kg/day; 1 mg/kg/12 h). More infor-
mation must be addressed to determine an accurate dosing.
– 56% of the patients received tocilizumab when IL-6 levels 
exceeded 40 UI/L.
– Only 21% of them required continuous renal replacement ther-
apy.
Futhermore, the highest ICU occupancy rates were on the first week of 
April, yet mantaining capacity to admitt more patients.
Conclusion: During the SARS-CoV19 pandemic, 23 patients were 
admitted to ICU with the common admission criteria of hypoxemic 
respiratory failure leading to mechanichal ventilation. Most of this 
patients received corticosteroid therapy and this could play a signifi-
cant role regarding to mortality: 83% of our patients survived.
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Introduction: In the face of the SARS-COV-2 pandemic, the intensive 
care units (ICU) have been involved in a dynamic of hard work by a 
little known disease, but which has caused serious illness and has 
involved the use of many health resources. The aim of this study is to 
show our experience with this kind of patients.
Objectives: The objective of this study is to analyse demographics, 
clinical and analytical characteristics, complications and health care 
resources consumption in a cohort of patients with a diagnosis of 
severe COVID-19 infection admitted to an ICU of a University Hospital. 
Secondary objective is to analyse factors related with mortality in his 
group of patients.
Methods: This is a retrospective observational study including all 
the critically ill patients admitted to ICU with COVID-19 severe infec-
tion. Patients were included during the COVID-19 pandemic, starting 
in March 2020. The analyzed demographic variables included age, 
sex, comorbidities and severity at admission measured by APACHE 
II and SOFA scores. Analytic variables studied were those related to 
prognosis in other studies such as lactate dehydrogenase (LDH), 
creatine kinase (CK), Ferritine, D-Dimer, C-reactive protein (CRP) or 
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procalcitonin (PCT). Health care resource consumption was measured 
by the days of mechanical ventilation and ICU stay. Quantitative vari-
ables are expressed as mean ± standard deviation and the qualitative 
ones as absolute and relative frequencies. The comparison between 
quantitative variables was made by student-t test and qualitative vari-
ables by chi squared test for a 95% confidence interval.
Results: A total of 60 patients were admitted to our department for 
severe pneumonia due to SARS-COV-2 and 43 of them (72%) were 
male. The average age has been 66.5  years, indeed, age has been 
mortality related factor. Each patient has been admitted to the ICU 
for 23  days on average. Among all the patients, 82% were intubated 
and connected to mechanical ventilation (MV) at admission, and this 
MV has gone on for 19+-11  days, increasing morbidity and mortal-
ity, and resource consumption. Overall mortality has been 23.3%, 
especially up to the age of 60 (under the age of 60, only one patient 
died amongst 16). High blood pressure (p  =  0.03), obesity (p < 0.01), 
APACHE at admission (p  =  0.04) and SOFA at admission (p = 0.02) have 
been related to higher mortality as well. Although they have not been 
statistically significant, it seems that the elevation of LDH, CRP, PCT, fer-
ritin and D-dimer are associated with greater death rate.
Univariate analysis of mortality 
  Dead (%) Survivors (%) p 
APACHE score 14,2 11,3 0,04 
SOFA score 6,4 4,7 0,02 
CRP at admission 209,9 190,6 0,56 
PCT at admission 0,6 0,37 0,08 
LDH / D dimer / 
ferritine 
625 / 2786 / 
3061 
478 / 5837 / 
1750 





Sex: Male, Female (%) 43(72%) /17 (28%) 
ICU stay in days [p25-p75] 23 [14,5  30,75] 
Mortality (%) 
<50 (n=7) 








MV at admission n (%) 49 (82%) 
APACHE score / SOFA score 12 ± 4,6 / 5,1 ± 2,5 
11±91syadVM
.
Conclusion: Patients admitted to ICU with severe COVID-19 infection 
have a great mortality with an important health care resource con-
sumption. In this group of patients age, high blood pressure and obe-
sity have been associated with mortality. LDH, ferritine,….. are higher 
at admission in patients who died.
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Introduction: COVID-19 has emerged as a rapidly spreading com-
municable disease affecting people worldwide. A particular con-
cern exists regarding the vulnerability of patients who have been 
immunosuppressed prior or during this pandemic. Data on COVID 19 
in solid organ transplantation (SOT) that required intensive care are 
scarce.
Objectives: Describe our mortality in SOT recipients that have been 
infected with COVID-19 and have required intensive care.
Methods: Case series of adults (age > 18  years) SOT recipients from 
the Intensive Care Unit (ICU) of a third level hospital in southern 
Spain with a positive test for COVID-19 between March 24, 2020 and 
May 29, 2020. The data were extracted from a database of 42 patients 
that have required admission in our ICU with a positive reversed-tran-
scriptase PCR of COVID-19.
Results: 3 patients were admitted with a median age of 53 years. Our 
patients were a kidney-pancreas recipient, a kidney recipient, and a 
lung recipient. They had a median APACHE score of 14, SOFA score 
of 9, and a Brescia scale of 8. The most frequently found comorbidity 
was chronic kidney failure. Two patients were in treatment with domi-
ciliary corticoids, two patients with mycophenolate, and three patients 
with tacrolimus. At the admission time they had a leukocyte median of 
2640 mm3, a lymphocyte median of 430 mm3, a CD4 median of 440 
mm3, a IgG median of 438  mg/dL, a IL-6 median 46.2  pg/mL, and a 
C-Reactive Protein median of 100.7  mg/dL. In all of these patients 
airway isolation were required, with a median of invasive mechani-
cal ventilation (IMV) of 8 days. One patient received High Flow Nasal 
Cannula (HFNC) support that failed. Two patients suffered renal graft 
dysfunction, one of them required renal replacement therapies. Three 
patients received Hydroxychloroquine, two patients received Lopina-
vir/Ritonavir, one patient received Interferon and one patient received 
Immunoglobulin. In all of these patients, mycophenolate and tacroli-
mus were discontinued, maintaining methylprednisolone at 1 mg/kg. 
One patient was co-infected with CMV and received empirical antibio-
therapy. One patient had secondary bacterial infections during the ICU 
stay, one Ventilator-Associated Pneumonia and one Catheter-Associ-
ated Bacteremia. The three patients were alive at the ICU discharge, 
and at the hospital discharge. The mean of ICU stay was 10 days, and 
hospital stay of 26 days.
Conclusion: In our setting, all patients with COVID-19 and TOS sur-
vived. These data suggest that the prognosis associated with critical 
illness due to COVID-19 in SOT recipients may not be as poor as previ-
ously reported, and that being a SOT recipient does not indicate worse 
mortality.
Reference(s) and grant ackowledgment(s)
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Introduction: The COVID-19 pandemic has led to rapidly saturation of 
resources and the availability of ICU bed. Prone positioning is strongly 
recommended in intubated patients with severe acute respiratory 
distress syndrome. Recently, small case series showed feasibility and 
improvement in oxygenation in awake COVID-19 patients placed in 
the prone position with noninvasive ventilation (NIV). It is unknown if 
the proning with NIV can reduce the rate of intubation.
Objectives: To evaluate the feasibility, the safety and efficacy of prone 
positioning with continuous positive airway pressure (CPAP) in COVID-
19 patients with acute hypoxemic respiratory failure.
Methods: This prospective observational cohort study was con-
ducted, from Mars 25, 2020, to September 24, 2020, in King Fahad 
armed forces hospital, Kingdom of Saudi Arabia. All adult patients with 
confirmed COVID-19 pneumonia and developed acute hypoxemic 
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respiratory failure defined by PaO2/FiO2 less than 200  mmHg, and 
required CPAP, were included in this trial, if they fulfill the inclusions 
criteria. Demographic, clinical, laboratory, radiological, ventilation 
setting, and treatment data were collected and analyzed. The patient 
will be included in one of the two groups, CPAP with proning (prone 
group) or CPAP without proning (supine group). The supine group 
included either patient refused proning or who used CPAP in the 
ward. The primary outcome was the rate of tracheal intubation. The 
secondary outcomes were, the rate of ICU mortality, the length of stay, 
and the rate of health care workers (HCWs) infected by SARS-CoV2.
Results: In this preliminary analysis, a total of 79 COVID-19 patients were 
included, 31 patients in the prone group and 48 patients in the supine 
group. The two groups were similar on term of baseline characteristics, 
general management and ventilatory support. In the prone group there 
was significant increase of PaO2/FiO2 during proning compared to supine 
setting. The general acceptance of proning was from moderate to well and 
no complications or events were observed during proning periods. The 
rate of intubation was 6.5% (2 patients) in the prone group and 25% (12 
patients) in the supine group (P = 0.035). Five patients died in the supine 
group versus one patient in the prone group (P  =  0.395). One nurse caring 
for a patient in the supine group was infected with SARS-CoV2.
Conclusion: In COVID-19 patients with acute hypoxemic respiratory 
failure, the use of prone position combined with CPAP, is feasible, safe 
and decrease the rate of tracheal intubation.
Reference(s) and grant ackowledgment(s)
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Introduction: Although respiratory virus infections are generally self-
limiting, they are one of the leading causes of community-acquired 
pneumonia, acute respiratory failure (ARF), sepsis and death as we 
have experienced from miserable pandemics in the last two decades.
Objectives: To compare the clinical characteristics and prognosis of 
COVID-19 and influenza patients with ARF admitted to intensive care 
unit (ICU).
Methods: Patients with laboratory confirmed COVID-19 who were 
admitted due to ARF to our ICU between 20th March and 23th June 
2020 and patients with laboratory confirmed influenza who were 
admitted due to ARF between 1st January 2015 and 1st March 2020 
were retrospectively evaluated. Clinical characteristics and outcomes 
of patients were compared.
Results: 36 COVID-19 patients and 59 influenza patients were evalu-
ated and 34 COVID-19 and 55 influenza patients who presented with 
ARF due to viral pneuomonia were included in this study. Age, gender, 
SOFA scores, duration of symptom onset to hospital and ICU admis-
sion were similar between two groups. Diabetes, chronic lung disease 
and cardiac diseases were more frequent in influenza patients. ECOG, 
Clinical Frailty Scale© (CFS), APACHE II score of influenza patients 
were worse than COVID-19 patients. Invasive mechanical ventilation 
requirement was higher in influenza group, while admission PaO2/
FiO2 ratio was similar. Frequency of ARDS on admission was higher 
in COVID-19 patients, but mild ARDS was seen more in COVID-19 
patients. Prone positioning was utilized more in COVID-19 patients. 
Bacterial co- and superinfection, sepsis and acute kidney injury (AKI) 
were encountered more in influenza group. ICU and hospital mortality 
in COVID-19 patients were significantly lower than patients with influ-
enza (24% vs 47%, p = 0.025) (Table).
Table: Clinical Characteristics and Outcomes of Critically-Ill COVID-19 and Influenza
Patients
All (n=89) COVID (n=34)
Influenza 
(n=55) p value
Age* (years) 63 (55-77) 63 (55-76) 62 (51-77) 0.970 






Chronic lung disease 

























ECOG* 2 (1-3) 1 (0-2) 2 (1-3) 0.002
CFS©* 4 (3-6) 3 (1-5) 5 (3-7) <0.001






180 (102-250) 0.670 
ARDS, n (%)†









IMV, n (%) 51 (57) 15 (44) 36 (66) 0.048
Prone position, n (%) 19 (21) 16 (47) 3 (6) <0.001
Co-infection, n (%) 27 (30) 6 (18) 21 (38) 0.041
Superinfection, n (%) 44 (49) 10 (29) 34 (62) 0.003
Sepsis, n (%) † 30 (34) 6 (18) 24 (44) 0.012
AKI, n (%)† 49 (55) 13 (38) 36 (66) 0.012
28th day mortality, n (%) 25 (28) 6 (18) 19 (35) 0.085 
ICU and Hospital 
mortality, n (%)
34 (38) 8 (24) 26 (47) 0.025
ICU LOS* (days) 12 (6-26) 14 (6-24) 13 (7-32) 0.720 
Hospital LOS* (days) 23 (13-39) 22 (13-37) 24 (13-42) 0.571 
*median[IQR], † On admission, Text in bold in p value indicated statistical significance.  
Conclusion: The prognosis of influenza patients with ARF followed in 
ICU seems to be worse than COVID-19 patients.
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Introduction: Northwick Park Hospital supplies a diverse population 
of at least 40% black, Asian and minority ethnic groups (BAME). Dur-
ing the COVID19 pandemic, the Intensive Care Unit (ICU) experienced 
an unprecedented demand for beds, leading to the declaration of 
a critical incident on 19th March demanding a rapid expansion and 
restructure.
Recent analyses of COVID19 transmission and susceptibility have 
shown that the BAME population is disproportionately affected by 
both a high infection rate and increased mortality from COVID19. 
These inferences have been attributed to both socioeconomic dispar-
ity and occupational hazard. Similarly, an association has been found 
between the male sex and the severity of COVID19 infection.
Page 471 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
This study investigates these associations. The large sample size pro-
vided within a single clinical setting provides valuable insights into 
BAME disparity in order to optimise future treatment of COVID19.
Methods: We performed a retrospective cohort study of all the 
patients admitted to ICU at NWP with COVID19 between 01/03/2020 
and 31/05/2020. Data were collected from patient notes, local histopa-
thology databases and the ICNARC database. These included baseline 
characteristics (ethnicity, date of birth, sex and comorbidities), base-
line P/F ratio (PaO2/FiO2), organ support requirements and mortality. 
Statistical analyses were performed in R. We used logistic regression to 
determine predictors of mortality and differences between BAME and 
white patients.
Results: 264 patients were admitted to the ICU with COVID19, of 
which 83.3% of these identified as BAME. 80.3% of patients were male.
Stepwise regression showed that increasing age, and male sex, were 
the significant predictors of low P/F at admission. Logistic regression 
analyses showed that pre-morbid state (OR 1.67, 95% CI 1.22-2.32), 
BAME (OR 4.92, 95% CI 1.77-17.70) and age (OR 1.04, 95% CI 1.01-
1.06) were significantly associated with requiring haemodialysis, but 
as expected, only P/F on admission was significantly associated with 
likelihood of intubation (OR 0.96, 95% CI 0.94-0.99). Regression analy-
ses on admission parameters demonstrated that age (OR 1.05, 95% CI 
1.02-1.08), pre-morbid state (OR 1.47, 95% CI 1.07-2.05), and low PF 
(OR 0.97, 95% CI 0.94-0.99) were significantly associated with death. 
Adjusting regression for intra-ICU parameters showed that age (OR 
1.05, 95% CI 1.02-1.08) and haemodialysis (OR 3.00, 95% CI 1.67-5.44) 
were the statistically significant predictors of death. Ethnicity was not 
associated with mortality in the ICU.
Conclusion: While BAME patients are over-represented in ICU admis-
sions for COVID19, the BAME population had parity in severity of ARDS 
on admission and mortality. Pulmonary capacity at admission was 
negatively affected by being male and by increasing age, in keeping 
with national and international data.
Being of BAME ethnicity was significantly associated with haemodialy-
sis requirement on ICU, which is something to be considered during a 
second wave of the pandemic.
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Introduction: Coronavirus disease 2019 (COVID19) is caused by severe 
acute respiratory syndrome coronavirus 2 (SARS-COV2) and represents 
the causative agent of potentially fatal disease that is of great global 
public health concern. About 5% are critical infections characterized 
by acute respiratory distress syndrome (ARDS). There is scare informa-
tion about clinical characteristics and prognosis in these patients.
Objectives: The aims of this study are: (I) compare demographic and 
clinical characteristics of COVID19 versus others respiratory virus. (II) 
Analyze outcome.
Methods: Retrospective cohort study of all adults admitted to Tertiary 
Hospital in Spain from October 2018 to 15th June 2020. We evaluated 
all adults admitted to Intensive Care Unit (ICU) with confirmed SARS-
COV-2 virus infection and other respiratory virus with acute respira-
tory failure. Main variable was COVID19 aetiology. We evaluate overall 
mortality in ICU and at 60 day of admission. Exposure variables were: 
demographics, previous conditions, clinical characteristics, severity of 
illness, pharmacologic, support therapy and outcome. For categorical 
variables we applied chi square test (fisher when needed) and for con-
tinuous t de student or U Mann-Whitney test when needed. We allied 
Kaplan Meier Survival analysis and log rank test for overall 60 day mor-
tality and aetiology.
Results: During the study period there were included a total of 82 
patients: 42 patients with confirmed COVID19 versus 40 patients with 
other respiratory virus infection and acute respiratory failure. Clinical 
characteristics of COVID19 cohort were: median age was 60.6, major-
ity were males 64%. The most frequent comorbidity was hypertension 
(54%), followed by obesity (33%). 3 Patients with solid organ trasplan-
tation were included. 64% of patients with COVID19 needed mechani-
cal ventilation and 21% renal replacement therapy. In comparison with 
those with other respiratory virus infection, COVID19 patients had less 
severity of illness, SOFA at admission (5 vs 7, p = 0.04), APACHE II (12.7 
vs 20, p =  0.001). Mortality at 60 days was 26.1% (11) in COVID19 and 
22.5 in other respiratory virus infection. Survival Kaplan Meier analysis 
of overall mortality at 60  days and unfavorable did not showed dif-
ferences between COVID19 and no COVID19 cohort (p = 0.74); at this 
time there were still admitted in ICU 7% of COVI19 patients.
Conclusion: COVID19 patients had more age and less APACHEII and 
SOFA at admission in ICU than those with other respiratory virus infec-
tion. Overall mortality at 60 day was not statiscally higher in COVID19 
(log rank p = 0.74). Taking into account that 7% of COVID19 were still 
admitted, prognosis variables at longer time (ej.: overall motality at 
6  months) may be more precise to evaluate prognosis in COVID-19 
patients.
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Introduction: It has been suggested that COVID-19-associated severe 
respiratory failure (CARDS) might differ from usual acute respiratory 
distress syndrome (ARDS) due to failing auto-regulation of pulmonary 
vessels and higher shunt.
Objectives: To investigate pulmonary hemodynamics in patients with 
CARDS compared to patients with ARDS due to other causes.
Methods: Retrospective analysis of ten CARDS patients treated on our 
ICU in 04/2020 and comparison of the data to matched controls with 
ARDS (n  =  10) that were treated on our ICU from 01/2014 to 08/2019 
and for whom pulmonary artery catheter data were available.
Results: COVID-19 patients had similar ventilation characteristics and 
showed similar PO2/FiO2 ratio at a higher degree of hypercapnia as 
compared to ARDS patients as the estimated CO2 production was sig-
nificantly higher (p  <  0.05). Cardiac output was higher in CARDS vs 
ARDS patients (mean 8.1 ± 1.7 L/min vs. 5.4 ± 1.5 L/min; p  <  0.05). 
COVID-19 patients had similar pulmonary artery pressure but signifi-
cantly lower pulmonary vascular resistance. Shunt fraction was simi-
lar in CARDS compared to ARDS (mean 26% ± 13% vs. 23% ± 15%, 
p > 0.05) and was in both groups correlated with hypoxemia, as 
was VD/VT (CARDS 46% ± 20% vs. ARDS 43% ± 18%; p > 0.05). The 
arterio-venous pCO2 difference (DpCO2) was elevated (CARDS 5.5 ± 
2.8 mmHg vs. 4.7 ± 1.1 mmHg; p > 0.05) as was venous–arterial CO2 
gap to arterial-venous oxygen content difference (P(v-a)CO2/C(a-v)O2) 
ratio (CARDS mean 2.2 ± 1.5 vs. ARDS 1.7 ± 0.8; p > 0.05), indicating 
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global microcirculatory dysfunction in CARDS. AaDO2 was similar in 
both groups (p > 0.05).
Conclusion: Respiratory failure in COVID-19 patients differs only 
slightly from ARDS in ventilation characteristics and pulmonary hemo-
dynamics mainly due to increased CO2 production. Our data indicate 
microcirculatory dysfunction. More data needs to be collected to 
assure these findings and gain more pathophysiological insights in 
COVID-19 and respiratory failure.
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Introduction: Pathogenesis of severe acute respiratory syndrome cor-
onavirus 2 (SARS-CoV-2) is poorly understood. Neutrophil extracellular 
traps (NETs) have been involved in infection-related acute respiratory 
distress syndrome. The role of NETs in SARS-CoV-2 related pneumonia 
in unknown.
Objectives: Investigate the association between the quantification 
of blood NETs at ICU admission and the respiratory failure evolution 
towards refractory hypoxemia in ICU patients with SARS-COV2 related 
pneumonia.
Methods: Prospective bicentric study including consecutive patients 
with SARS-CoV2 related pneumonia admitted in intensive care unit. 
NETs blood levels were quantified in blood samples at day-1 and day-3 
by flow cytometry (using myeloperoxidase [MPO] and citrullinated 
histones [Cit-H3] markers). The primary outcome was the association 
between the day-1 blood level of NETs and the number of days with 
refractory hypoxemia defined by a PaO2/FiO2 ratio  <  100 mmHg.
Results: 58 patients (median age 62 [54, 69], mostly male (75.9%)) 
were included in the analysis. The median number of days with severe 
hypoxemia (PaO2/FiO2  <  100  mmHg) was 4 [2, 6] days and day-28 
mortality was 27.6% (n = 16). In multivariable negative binomial 
regression, MPO+ NETs were negatively associated with the number 
of days with severe hypoxemia within 7 days (0.84 [0.73, 0.97]), while 
neither single positive Cit-H3+ NETS nor double-positive NETS were 
significantly associated with the primary outcome. The blood level of 
NETS was lower at day-1 than at day-3 in patients who died (32.6 [22.3, 
70.3] vs. 56.7 [23.3, 105.6] p < 0.001, 0.37 [0.0, 1.45] vs. 2.2 [0.0, 4.3] 
p < 0.001 and 4 [1.2, 7.6] vs. 6.8 [1.8, 15.0] p < 0.001 for MPO+, Cit-H3+ 
and double-positive NETS, respectively).
Conclusion: The blood level of NETs at day-1 was negatively asso-
ciated with the number of days with severe hypoxemia in patients 
admitted to the intensive care unit for SARS-CoV2 related pneumonia. 
This could suggest a functional deficit of neutrophils in these patients 
that require further investigation.
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Introduction: Understanding the behaviour of Severe Acute Res-
piratory Syndrome CoronaVirus 2 (SARS-CoV-2) in precipitating the 
spectrum of Coronavirus disease (COVID-19) has been the scientific 
challenge of 2020. Genomewide association analysis has suggested 
an association with the ABO blood-group system; with blood group A 
being more susceptible, while blood group O seemingly conferring a 
protective effect in the development COVID-19.
Objectives:
1. To compare the ABO blood‑group of patients admitted with COVID‑19 to 
that of the general population in the UK.
2. To investigate whether any ABO blood groups correlated with more severe 
illness.
Methods: Contemporaneously recorded data from our electronic 
medical record system  (Epic®, WI, USA) was used to retrospectively 
analyse ABO and clinical data of patients admitted to our hospital with 
PCR positive SARS-CoV-2 for a 6 week period starting April 2020. Data 
included APACHE II calculations, whether patients received mechani-
cal ventilation, renal replacement therapy or developed thrombotic 
complications. The peak sustained FiO2 in ICU patients was deemed if 
stable for 2 or more hours.
Results: Blood group data was available in 92 hospital patients, 52 
of whom went to ICU. The distribution of blood groups was similar to 
that seen in the background population (Table  1). Overall mortality 
was non-significantly lower in patients with blood group O compared 
to patients with blood group A; 16% (95% CI 6-35%) vs 39% (95% CI 
20-61%) p = 0.09 by chi-squared. Comparison of illness severity mark-
ers between the two largest groups (A & O) in ICU did not reveal any 
obvious indication that blood group A patients had greater severity of 
illness to explain their apparent worse outcomes (Table 2).
Table 1: Distribution of blood groups amongst COVID-19 patients admitted 











and ICU patients 
(n=92) 
Background 
population rate  
A 18 (35%) 13 (33%) 31 (34%) 38% 
B 7 (13%) 4 (10%) 11 (12%) 10% 
O 25 (48%) 23 (58%) 48 (52%) 48% 
AB 2 (4%) 0 (0%) 2 (2%) 3% 
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Table 2: Severity of illness markers amongst blood group A and O ICU 
patients 
Parameter A (n=18) O (n=25) 
Median APACHE II score (range) 14 (3-21) 15 (6-30) 
Median age (range) 63 (34-77) 64 (17-83) 
Median peak sustained FiO2 (range) 0.72 (36-100%) 0.70 (35-100%) 
% Mechanically ventilated (95% CI) 78% (55-91%) 84% (65-94%) 
% Received renal replacement 44% (25-66%) 40% (23-59%) 
% Developed DVT/PE 6% (1-26%) 16% (6-35%) 
Conclusion: ABO blood groups in our population were similar to the 
background population in the UK and did not appear to predict ICU 
admission. There was a trend towards increased mortality in patients 
with blood group A amongst those admitted to ICU but this was not 
associated with the severity of illness markers examined. The finding 
of increased mortality in patients with blood group A is consistent 
with a recent large genome-wide association study; the mechanism of 
this increase in mortality, and implications are currently unclear.
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Introduction: Severe ARDS due to SARS-CoV-2 infection has been 
a huge challenge to the health systems. Many coadjuvant therapies 
have been proposed to manage the disease, such as antivirals to 
reduce viral load, interleukin inhibitors, and early steroids to decrease 
the inflammatory response, or the use of convalescent plasma to 
enhance the immune system. Since the evidence of the use of these 
treatments was scarce, and the pharmacology availability was lim-
ited, we decided to apply our standard ARDS protocol, based on the 
limitation of tidal volume, best PEEP titration, sequential application of 
neuromuscular blockade and prone positioning, and fluid restriction, 
leaving extracorporeal oxygenation as rescue therapy for refractory 
hypoxemia and to administer selected therapies according to different 
patient profiles: thrombotic or inflammatory profile, based on clinical 
and laboratory results.
Objectives: To present the results of a protocol on severe respiratory 
failure due to COVID-19 in the management of patients with severe 
and critical pneumonia, with selective use of novel therapies.
Methods: Observational clinical study. We analyzed prospectively 
from March 21st to July 21st, 2020 all patients admitted with severe 
and critical COVID-19. We describe demographic, clinical, and labora-
tory characteristics. The main outcomes were hospital stay and hospi-
tal mortality. Data were analyzed by descriptive statistics, distribution 
was evaluated according to the Shapiro-Wilk test, and were expressed 
according to mean ± SD and/or median and p25-75, as appropriate.
Results: Hundred thirty-eight patients were included (age 55  years 
±13.8, 60 women (43.5%), PaO2/FiO2 at admission was 148 ± 34,8. 
The number of symptomatic days before hospitalization was 7.8 ± 3,9. 
SARS-CoV-2 virus was identified in all patients. Mechanical ventilation 
in 128 patients. Of them, 66,4% received NMB, prone positioning in 67 
(52%). Use of high-dose steroids for a high inflammatory profile in 6 
patients. 21 patients were fully anticoagulated due to a high throm-
botic profile. No other pharmacological therapies were used, and no 
patients were connected to ECMO. Tracheostomy use in 13%. The 
median time in MV and ICU were 12 [9 - 17] and 15 [10 - 20] days, 
respectively. In hospital and 28-days mortality was 9,4%.
Conclusion: A protocolized management of acute respiratory failure 
using validated and easy to implement therapies allows satisfactory 
outcomes. The use of standardized protocols on severe patients and 
health policies to control infection spreading may act synergistically in 
the care of communities during pandemics.
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Introduction: Previous studies have proven that prone position-
ing optimizes lung recruitment and ventilation-perfusion matching, 
resulting in an improvement of gas exchange. However, reliable pre-
dictors of prone positioning response and the effect on ARDS morbid-
ity and mortality remains to be determined.
Objectives: Evaluate the outcome of patients with ARDS with prone 
positioning.
Methods: Observational retrospective study on Acute Respiratory 
Distress Syndrome patients, according to Berlin criteria, mechani-
cally ventilated from January 2017 to December 2019. Patients were 
divided into those who underwent prone positioning (n = 54) and 
those who did not (n = 35). Data were extracted from medical records.
Results: 89 ARDS patients were included (mean age of 
60,1 ± 13,7 years, 62 male/27 female). Severity scores were calculated 
at admission and mean results were 20,3 ± 7,06 for Acute Physiology, 
Age, Chronic Health Evaluation (APACHE) II, 47,2 ± 12,7 for Simplified 
Acute Physiology Score (SAPS) II, and 9,46 ± 3,26 for inicial Sequencial 
Organ Failure Assessment (SOFA). No statistically significant differences 
in background characteristics were observed. The main cause of ARDS 
was pneumonia (n = 57 cases, 64,0%). Moderate ARDS in 47,1% of the 
cases and severe ARDS in 32,6%.
We found a mean improvement in partial pressure of oxygen to 
inspired fraction of oxygen in the prone group of 14% vs supine group 
(p < 0,001). After adjustment for other covariates: the severity of ARDS, 
primary or secondary ARDS, the length of stay in the ICU and the 
length of hospital stay we did not find a significantly difference in mor-
tality between the two groups. The mortality of patients with severe 
ARDS at the time of discharge from the intensive care unit, was 34,9% 
in the prone and 28,6% in the supine group (RR, 0,75; 95% CI, 0,121-
4,701: P = 0,571), while their 60-days mortality was 46,8% and 28,6%, 
respectively (RR, 1,06; 95% CI 0,31-13,1: P = 0,670).
Conclusion: Although limited by its retrospective nature, small sam-
ple size and heterogeneous ARDS etiologies: our study shows that 
prone positioning contributed to improve the blood oxygenation in 
patients with moderate and severe hypoxemia, however, does not 
improve survival in patients with ARDS.
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Introduction: Coronavirus disease 2019 (COVID-19) is an emerg-
ing disease that frequently has a selflimited course, but 15% patients 
develop pneumonia that requires supplemental oxygen and 5% pro-
gress to critical illness with respiratory and organ dysfunctions (1).
Objectives: To describe the characteristics and outcomes of COVID-19 
patients admitted to an Infectious Diseases Intensive Care Unit (ICU) in 
Porto, Portugal.
Methods: Adults with confirmed SARS-CoV-2 infection admitted to 
the Infectious Diseases ICU of Hospital São João, between March 13 
and July 28/2020 and treated with oxygen supplementation or inva-
sive mechanical ventilation (IMV) were included. Demographic and 
clinical data were collected.
Results: Fifty-seven patients were included (median age 72  years 
[IQR, 55-78], 63.2% male). One patient still remains in the ICU, 7 were 
transferred to other ICUs after intubation for IMV and 39 were dis-
charged. Comorbidities were identified in 53 (93%) cases, most fre-
quently hypertension (63.2%) and diabetes mellitus (35.1%). Median 
time from symptoms onset to admission was 8  days (IQR, 4-12) and 
the most common were fever (78.9%), dyspnea (57.9%) and dry 
cough (56.1%). Thirty-one (54.4%) patients received IMV while 18 
(69.2%) of the remaining were treated with high flow nasal cannula. 
Between IMV and non-IMV patients no significant differences were 
seen in age, sex, comorbidities or respiratory symptoms. Differences 
between IMV and non-IMV patients lymphocytes, AST, ferritin and 
D-dimers mean values were -397x10^6/l (95% CI -619;-208), 59 U/l 
(95% CI 28;84), 1095.3  ng/ml (95% CI 383.9;2029) and 3.1 ug/ml (CI 
95% 1.86;5.33), respectively. The mean lowest PaO2/FiO2 ratio was 
94.09 (95% CI 80.33;107.85) in IMV and 180.84 (95% CI 136.77;224.91) 
in non-IMV patients. IMV parameters, mean (±SD), included compli-
ance 39.87±15.09 ml/cmH20, PEEP 12.48±2.27 cmH2O, plateau pres-
sure 25.3±4.1 cmH2O and driving pressure 13.61±3.87 cmH2O. IMV 
duration was 17±9.03 days, eighteen (78.2%) patients needed prone 
positioning, two CVVHF and two other ECMO-VV. Besides respiratory 
failure, cardiovascular (40%) and renal (26%) were the most common 
dysfunctions, and nineteen (38%) patients had bacterial superinfec-
tion. Cardiovascular dysfunction and bacterial superinfection were 
significantly different between the two groups (p < 0.001). Hydroxy-
chloroquine (HCQ) was given in 23 cases (46%) and HCQ plus azithro-
mycin in 15 cases (30%), with no side effects. Eleven patients (22%) 
were given corticoids, one tocilizumab and two remdesivir. Overall 
mortality was 20% (10 patients), including five IMV patients (20.8%) 
and five with no indication to escalate intensive care due to subjacent 
condition. No readmissions were registered.
Conclusion: Although COVID-19 is a new disease that remains largely 
unknown, critically ill patients may potentially recover if early and 
appropriate intensive care is provided. Our cohort allowed us to offer 
medical and human support to all patients admitted.
Reference(s) and grant ackowledgment(s)
1. (1) Phua J, Weng L, Ling L, et al. Intensive care management of coronavi‑
rus disease 2019 (COVID‑19): challenges and recommendations. Lancet 
Respir Med 2020; published online April 6. https ://doi.org/10.1016/S2213 
‑2600(20)30161 ‑2 .
001564 
Plasma lipid mediator concentrations are linked with disease 
severity in COVID‑19 patients
J.  Clarke1; F.  Palmas2; E.  Cifuentes2; R.  Colas2; A.  Keogh1; G.  Curley1; J.  Dalli2
1Department of anaesthesia and critical care medicine, Royal College 
of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland; 2Lipid mediator 
unit, Queen Mary University of London, London, United Kingdom 
Correspondence: J. Clarke
Intensive Care Medicine Experimental 2020, 8(2): 001564
Introduction: The factors that lead to critical illness in individuals 
infected with SARS-CoV-2 are not completely understood and the 
development of severe disease does not seem to be solely related to 
viral load and could involve an excessive inflammatory response. One 
aspect of the immune response that has, to date, been greatly under-
studied in COVID-19 patients is whether lipid mediator production is 
dysregulated with increasing disease severity. These molecules, which 
are produced from essential fatty acids, constitute a central part of the 
immune regulatory mechanisms activated during infections and are 
responsible for initiating and amplifying inflammation as well as for its 
termination.
Objectives: We objected to characterise the profile of lipid mediators 
in patients with COVID-19 in order to identify whether lipid media-
tor production is dysregulated with increasing disease severity and 
identifying the pathways that may become disrupted in COVID-19 
infections.
Methods: We collected plasma from 41 patients with polymerase 
chain reaction confirmed SARS-CoV 2 infection that were admitted to 
Beaumont Hospital, Ireland between the 16th of March and the 1st of 
May 2020. We categorized the patients into two main groups, severe 
and non-severe disease. Patients were categorized as severe if they 
required invasive mechanical ventilation in the intensive care unit. We 
defined non-severe as those who were managed at ward level with 
supplemental oxygen or non-invasive ventilation. Employing a liq-
uid chromatography tandem-mass spectrometry-based approach we 
then quantified lipid mediators from the four main bioactive metabo-
lomes that include the classic eicosanoids and the omega-3 fatty acid-
derived pro-resolving mediators. These molecules were identified and 
quantified in accordance with established criteria.
Results: Eight samples were excluded as they did not meet quality 
control criteria. Using partial least square discriminant analysis we 
found that overall plasma lipid mediator concentrations were dis-
tinct between the severe group when compared with the non-severe 
group. Further analysis demonstrated that mediators from the leukot-
riene (LT) metabolome, including the potent chemoattractants LTD4 
and LTB4, as well as the pro-resolving mediator Resolvin D1 (RvD1) 
were upregulated with patients with non-severe disease when com-
pared with those with severe disease. Statistical assessment of lipid 
mediator concentrations demonstrated a significant downregulation 
of mediators from the LT metabolome in plasma from patients in the 
non-severe group when compared with those in the severe group. 
We also found that the concentrations of the 22-hydroxy-Maresin 1 
(22-OH-MaR1), the further metabolite of the pro-resolving mediator 
Maresin 1, were significantly upregulated in plasma from patients in 
the severe group. Notably, we did not observe significant differences 
in plasma prostaglandin concentrations, including PGE2 and PGD2, 
between the two groups. This observation can be attributed to the 
fact that all patients received paracetamol. We observed an increase, 
albeit not reaching statistical significance of the Thromboxane B2 in 
patients in the severe group which is in line with the increased inci-
dence of thrombosis in these patients. In order to designate the best 
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subset of lipid mediators as predictors of disease severity, least abso-
lute shrinkage and selection operator regression analysis was used. 
This analysis identified 4 lipid mediators, LTD4, 20-OH-LTB4, RvD1 and 
22-OH-MaR1 that gave the strongest predictive value.
Conclusion: These results indicate that increased disease severity 
in patients with COVID-19 was linked with a failure to engage lipid 
mediator biosynthesis. They also suggest that the use of therapeutics 
that interfere with lipid mediator production and /or actions should be 
considered with caution given that it may exacerbate disease sever-
ity. The present study was limited to one hospital and evaluated lipid 
mediator concentrations in 33 patients. Despite these limitations the 
present findings suggest that plasma lipid mediator concentrations 
may also be useful markers for evaluating the efficacy of therapeutics 
in rectifying host immune responses during COVID-19 infections.
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Introduction: COVID-19 outbreak has led to an unprecedented need 
for mechanical ventilation (MV). Tracheostomy might help ease airway 
management and early weaning of the patients. However, it has not 
been widely used since it exposes physicians at high risk of contract-
ing COVID-19 infection.
Objectives: We aim to describe the cohort of the 46 patients who 
underwent percutaneous tracheostomy during ICU-stay at our unit.
Methods: We retrieved from the electronic medical records data from 
all COVID-19 patients undergoing tracheostomy during ICU admission 
at the Rimini Hospital in the period 2/3/2020-29/4/2020.
Results: Among the 68 patients that received MV and admitted to the 
ICU, tracheostomy was performed in 46 patients (66%). 76% (n = 35) 
were males and the median age was 68 (range 32-80). Median SOFA 
score at admission was 7 (3-18). All tracheostomy were percutaneous 
(Griggs or percutwist). Median ICU length of stay at the day of trache-
ostomy was 11 days (1-22) and the median P/F ratio before procedure 
was 172 (67-298). Five complications were recorded, none during the 
procedure, two bleeding from the stoma, two stoma infections, and 
one patient experienced accidental decannulation with subsequent 
cardiac arrest. All complications were treated successfully includ-
ing the patient with accidental decannulation that survived and was 
discharged from ICU. ICU-mortality rate was 32.6% (n  =  15) with a 
median ICU length of stay of 23 (7-108). Decannulation was performed 
before ICU discharge in all of ICU survivors and the median length of 
open tracheostomy was 17 (3-78). Only one patient was still admitted 
to the ICU at the 30/07/2020 after 132 days of ICU admission. By fol-
lowing the ICU safety protocol, no healthcare worker involved in the 
procedures has been infected.
Conclusion: Our results showed that percutaneous tracheostomy may 
be safely performed in severe COVID-19 patients allowing a better air-
ways management in patients that require long ICU stay.
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Introduction: Awake Prone Positioning is an increasingly widespread 
treatment modality for hypoxaemic respiratory failure in patients 
with COVID-19. We sought to evaluate whether this technique could 
improve ROX index – a non-invasive composite measure of oxygena-
tion and work of breathing shown to predict need for intubation in 
patients with acute respiratory distress syndrome (ARDS).
Methods: In this prospective cohort study, adult patients with COVID-
19 pneumonia requiring supplemental oxygen were recruited at a 
district general hospital in London. Baseline characteristics were col-
lected and ROX index calculated as the peripheral oxygen satura-
tion (SpO2) divided by the product of the fractional concentration 
of inspired oxygen (FiO2) and the respiratory rate (RR). Patients were 
instructed or assisted into prone position and ROX index recalculated 
at 15 to 60 minutes and again at 120 to 240 minutes where tolerated.
Results: In a cohort of 12 patients, ROX index improved significantly 
from a median of 3.61 (IQR 3.00 – 5.16) to 4.58 (IQR 3.83 – 5.77) after 
15 to 60 minutes (p = 0.012) and in the seven patients that maintained 
prone position, they experienced a further increase in ROX index to 
8.00 (IQR 4.86 – 11.73) at 120 to 240 minutes (p = 0.028).
Conclusion: Awake prone positioning was feasible and significantly 
improved ROX index, which has previously been shown to predict 
need for intubation in ARDS. Safe avoidance of intubation of COVID-
19 patients would be beneficial to avoid harms from invasive ventila-
tion and to optimize usage of scarce hospital resources in both high 
and low income countries. ROX Index is a simple composite measure 
of respiratory parameters that may be valuable in assessing patients 
when access to blood gas analysis is limited by availability or by 
patient numbers. Further work is needed to delineate potential risks 
and outcome benefits of this technique and to clarify its optimal mode 
of delivery, and to establish whether changes in ROX Index in COVID-
19 are associated with patient relevant outcomes.
Reference(s) and grant ackowledgment(s)
1. Sartini C, Tresoldi M, Scarpellini P, et al. Respiratory Parameters in Patients 
With COVID‑19 After Using Noninvasive Ventilation in the Prone Position 
Outside the Intensive Care Unit. JAMA Published Online First: 15 May 2020. 
https ://doi.org/10.1001/jama.2020.7861.
2. Elharrar X, Trigui Y, Dols A‑M, et al. Use of Prone Positioning in Nonintu‑
bated Patients With COVID‑19 and Hypoxemic Acute Respiratory Failure. 
JAMA Published Online First: 15 May 2020. https ://doi.org/10.1001/
jama.2020.8255.
3. Roca O, Caralt B, Messika J, et al. An index combining respiratory rate 
and oxygenation to predict outcome of nasal high‑flow therapy. Am J 
Respir Crit Care Med Published Online First: 2019. https ://doi.org/10.1164/
rccm.20180 3‑0589o c.
Page 476 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
001628 
Viral respiratory infections and ARDS in the pre‑Covid19 age, 
a small case series
R.  Amaral1; C.  Carvalho1; B.  Costa1; H.  Santos1; A.  Pais1; J.  Carvalho1
1Intensive Medicine, Centro Hospitalar De Trás‑Os‑Montes E Alto Douro, 
E.P.E., Vila Real, Portugal 
Correspondence: R. Amaral
Intensive Care Medicine Experimental 2020, 8(2): 001628
Introduction: Acute Respiratory Disease Syndrome has one of the 
core topics of intensive medicine due to its relative high incidence, and 
important morbidity and mortality. Since Covid19 disease emerged all 
literature is focusing on this new entity. Through discussions about 
this respiratory disease some have questioned although Berlin criteria 
for ARDS are met and because the lung compliance is not the most 
common in usual ARDS if this not truly ARDS.
Objectives: To report on our experience with viral respiratory infec-
tions causing ARDS in 2019, pre-covid19.
Methods: Retrospective analysis of the clinical information of patients 
admitted in intensive care with diagnosis of ARDS according to Berlin 
criteria, and laboratory specimens of viral colonization of airway.
Results: We obtained 7 patients with diagnosis of ARDS due to viral 
pneumonia. Most of the patients were male (n = 4), median age 62 
(first quartile (1Q) 52 and third quartile (3Q) 74). Severe ARDS was 
diagnosed in 2 patients median partial arterial oxygen pressure 
inspired oxygen fraction quotient (PaO2/FiO2) of 80,5 (1Q 77,75 and 
3Q 83,25); moderate ARDS in 3 patients median PaO2/FiO2 142 (1Q 
136,5 and 3Q 149); mild ARDS in 2 patients median PaO2/FiO2 226 
(1Q 214 and 3Q 238). Invasive mechanical ventilation was necessary 
in 42,9% of patients (n = 3), the other 4 patients were managed exclu-
sively with non-invasive ventilation. Median days of mechanical venti-
lation were 11 (1Q 6 and 3Q 15,5) in invasive and 3 (1Q 1 and 3Q 8,75) 
in non-invasive ventilation. Median positive end expiratory pressure 
was 8 (1Q 8 and 3Q 10). The 2 patients with severe ARDS were manged 
with invasive mechanical ventilation and prone positioning. Identi-
fied respiratory virus were: rinovirus, adenovirus, influenzae A and B, 
parainfluenzae, coronavirus 229 and metapneumovirus. Co-bacterial-
infection was observed in 1 patient, identified agents were Moraxella 
and Haemophilus. Antibiotics were administered to all patients (n = 7) 
and 58,7% (n = 6) were treated with anti-virals. Corticosteroids were 
administered to 5 patients (71,4%). Severity scores were: APACHE II 21 
(1Q 16 and 3Q 22,5); SAPS II 40 (1Q 36,5 and 3Q 40,4); SAPS 3 59 (1Q 
59 and 3Q 70); SOFA at admission 7 (1Q 6,5 and 3Q 8). Mean length of 
stay in intensive care was 11 (1Q 5,5 and 3Q 13) days and in hospital 
was 21 (1Q 13 and 3Q 21,5) days. Hospital mortality was the same of 
net mortality: 2 patients (28,6%) - with severe ARDS.
Conclusion: Although with limitations due to its retrospective 
nature, this study presents our reality and exposure to ARDS due to 
viral pneumoniae. All our patients were medicated with antibiotics, 
although only 1 patient had confirmed bacterial infection. The major-
ity of patients received corticosteroids. Outcome was linked to disease 
severity and comorbidities. Applied PEEP levels were lower than does 
presented by ARDSnet suggesting normal compliance.
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Introduction: Covid-19 pneumonitis has caused a pandemic surge in 
Europacross the globe, with almost 700,000 dead at the time of writing 
[1]. Current diagnosis of Covid-19 is based on PCR detection of surface 
antigens [2], however radiological features of Covid-19 infection have 
been reported and use as adjuvant diagnostic tool [3]. We hypothesise 
that lung ussultrasound (LUS) can also identify a characteristic pattern 
associated with Covid-19 infection.
Objectives: We aimed to assess and describe a lung ultrasound pat-
tern associated with COVID-19 pneumonitis.
Methods: We performed a prospective observational study on 
patients admitted to the ICU in a tertiary hospital during a three-week 
period. A 6-point Lung ultrasound assessment on all new admissions, 
scoring each region 0 to 3 (as per FUSIC guidance [4]). The primary 
outcome was the likelihood ratio (LR) of cumulative lung scores at 
admission to ICU with COVID-19 diagnosis, confirmed by at least two 
COVID-19 antigen-positive swabs, using fishers exact test. ROC curve 
analysis will be used to establish best threshold for continuous vari-
ables. P-Value of less than 0.05 is considered statistically significant.
Results: From 69 patients admitted during the study period, 61 were 
included with a complete US assessment. 43/61 (62%) had a positive 
antigen COVID-19. Cumulative scores ranged from 0 to 14 to both 
groups. A cut off of > 6 was used to discriminate the two populations. 
34/43 patients (79%) who had a score > 6 were diagnosis of COVID-
19. 17/18 patients (94.4%) who scored 6 of under were negative for 
COVID-19. Positive Predictive Value 0.97 (0.85 – 0.99). Negative Predic-
tive Value 0.65 (0.46 – 0.81). Accuracy 0.84. Area under the Curve 0.87. 
OR 64.2 (7.51 – 549.4). Sensitivity 79% (0.65 – 0.89) specificity 94% 
(0.74 – 0.99).
Conclusion: A cumulative score greater than 6 on 6-point Lung Ultra-
sound is a useful screening tool for COVID-19 pneumonitis.
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Introduction: Adequate ventilation strategy is crucial in patients 
affected by COVID-19. The Brixia score could help categorizing 
patients.
Objectives: Our purpose was to observe Brixia score values and the 
outcome of different ventilation strategies.
Methods: Hospitalized COVID-19 patients at Rimini Hospital requiring 
noninvasive ventilation (NIV) or invasive mechanical ventilation (IMV) 
between February 26 and April 18, 2020 were enrolled in this obser-
vational cohort study and followed up to 60 days after hospital admis-
sion. The Brixia-score assesses the extent of lung damage in COVID 
patients dividing each lung into 3 sectors on the transverse plane; to 
each of the obtained six sectors a score is assigned, ranging from 0 (no 
alteration) to 3 (interstitial-alveolar infiltrates). The overall score may 
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range from 0 to 18 and it was reported by the radiologist at the time 
of the chest x-ray.
Results: 112 patients were treated with NIV and/or IMV. Among those, 
46 (41.1%) were treated only with NIV, 25 (22.3%) underwent IMV after 
a NIV trial, and 41 (36.6%) were treated only with IMV. The Brixia score 
among patients with a successful NIV trial was higher than among 
patients that failed it although it did not reach the statistical signifi-
cance (12.1 ± 2.6 vs 10.9 ± 3.7, p-value 0.12). Brixia score was obtained 
at the time of endotracheal intubation among patients that failed a 
NIV trial and among patients that were treated with IMV without a NIV 
(13.8 ± 2.8 vs 13.8 ± 2.5, p-value 0.99). Patients who failed the NIV trial 
had a Brixia score of 10.8 ± 3.5 before the NIV which worsened to 13.6 
± 2.7 (p  =  0.002) when tracheal intubation was performed.
Conclusion: Although the Brixia score was able to identify patients 
with a more severe degree of interstitial-alveolar infiltrates it has some 
limitation when used to guide the decision of the ventilatory strategy 
to adopt with COVID-19 patients.
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Introduction: decannulation is an importan step for our critical 
patients with a tracheostomy during the weaing process and it’s fail-
ure suposes a higher morbility, mostly in terms of bronchoaspiration, 
specially in the time of isolation during Covid-19 pandemia, where the 
reponse to an emergency inside the box could be prolonged.
Objectives: First, to analyze the use of tracheal button during an 
artificial airway removal protocol in patients with tracheostomy and 
isolation with Covid-19 pneumonia in ICU. Second, to describe our 
complications, if present.
Methods: A prospective 3 month-study of all patients admitted to our 
ICU, which reconverted from usual 20 to a 40-bed unit, with COVID-
19 pneumonia who needed invasive mechanical ventilation (IMV), a 
percutaneous tracheostomy and a tracheal button during a maximum 
of 24 hours inmediately after decanulating. Variables analyzed: Patient 
data (sex, age, SAPS II), complications of tracheal button, and from all 
patients (mean days of IMV, mean time of ICU stay and ICU mortality 
rate).
Results: We treated 49 patients with COVID-19 pneumoniae: men 35 
(71%). Mean age 60,2 years (32-78). SAPS II of 50,8 (39-68). 44 patients 
underwent IMV (89%), 28 (63%) needed a percutaneous tracheostomy 
for weaning (22 (78%) men). In 9 patients (32%) we applied a tracheal 
button. Mean time of MV of 21,3  days (17-36). Global mortality rate 
Covid-19 patients in ICU 20%(10 patients), all mechanically ventilated: 
6 as a limitation of therapeutic effort and 4 as multiple organ disfunc-
tion/septic shock, none after removing artificial airway. Complication 
of tracheal button was mostly discomfort which needed removing it 
before 16 hours in 2 patients (25%).
Conclusion: The aplication of tracheal button is a safe technique 
of removing defenitively artificial airway in isolated patients with 
Covid-19 infection. Discomfort was seen in 25% and needed an early 
removal. No serious complication was seen, although our sample is 
small.
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Introduction: Percutaneous tracheostomy is an essential procedure 
for weaning in patients with SARS and invasive mechanical ventilation 
specially to minimize complications due to weakness of prolonged 
ventilation.
Objectives: First, to describe the caracteristics of all percutaneous tra-
cheostomies performed in our patients with new Covid-19 infection 
admitted to our ICU and performed by intensive care physicians. Sec-
ond, to analyze the infection rate of the ICU workers after implement-
ing these technique.
Methods: A prospective 3 month-study of all patients admitted to our 
ICU, which reconverted from usual 20 to a 40-bed unit, with COVID-19 
pneumonia who needed invasive mechanical ventilation (IMV) and a 
percutaneous tracheostomy for weaning. All tracheostomies were per-
formed by 2 intensive care physicians and 1 nurse, all with a “personal 
protection equipment” (PPE) and a percutaneous tracheostomy kit. 
Variables analyzed: patient data (sex, age, SAPS II), mean days of IMV, 
number of tracheostomies and the day it was performed, complica-
tions, mean time of ICU stay, mortality rate. Secondly, describe our ICU 
staff infection rate before and after initiating tracheostomies.
Results: We treated 49 patients with COVID-19 pneumoniae: men 35 
(71%). Mean age 60,2 years (32-78). SAPS II of 50,8 (39-68). 44 patients 
underwent IMV (89%), 28 (63%) needed a percutaneous tracheostomy 
for weaning (22 (78%) men). Mean day of tracheostomy 11 (6-16). Mild 
haemorrage as complication in 4 (14%). Global mortality rate Covid-
19 patients in ICU 20%(10 patients), all mechanically ventilated: 6 as 
a limitation of therapeutic effort and 4 as multiple organ disfunction/
septic shock. Mean time of ICU stay in ventilated patients, 20,8  days 
(5-43). Global mortality rate in ICU 19,6%(10 patients). None of the 
staff was infected after initiating this technique. Infection rate during 
first period: 8 workers from a total of 135 (6%): 3 doctors, 5 nurses.
Conclusion: A percutanoeus tracheostomy in ICU during covid-19 
infection can be performed safely for the patient and our workers with 
only 6% of infection rate in workers and none after initiating the tech-
nique. 64% needed tracheostomy as a weaing protocol with a mean 
day of perform of 11 days. Our ICU mortality rate was 19%.
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Introduction: Percutaneous Tracheostomy on Intensive Care is an 
established practice [1]. Timing of Tracheostomy with regards to the 
duration of ICU stay is well researched [2]. But the optimal timing of 
Tracheostomy with regards to the degree of ventilatory support is not 
well researched. The French Tracheostomy guidelines [3], suggest that 
the patients that are severely hypoxemic (PaO2/FiO2  < 13.3 Kpa with a 
PEEP of >10 cm H2O) are not suitable for an airway procedure as this 
can significantly worsen their clinical situation. The general consensus 
among the ICU clinicians is that it is safe to perform a Tracheostomy 
when FiO2 is  < 50% with a PEEP  < 10 cm H2O.
Objectives: Our aim was to determine the optimal time of Tracheos-
tomy in relation to the degree of ventilatory support. It was observed 
that patients have suffered episodes of desaturation and increased 
ventilatory requirements following the procedure, demanding a 
review into the clinical practice. We reviewed the pre-procedural venti-
latory requirements and post procedural ventilatory requirements at 6, 
12, 24 and 48 hours after the procedure.
Methods: We performed a retrospective analysis of the mechanical 
ventilation data in a university hospital adult intensive care unit and a 
major trauma centre over a 3-month period. The review is performed 
using the electronic notes of patients that underwent a percutaneous 
tracheostomy.
Results: A total of 51 patients were eligible to be reviewed. The mean 
age is 59 years with an age range of 20-81 years. Out of hospital car-
diac arrest, Community Acquired Pneumonia, Traumatic Brain Injury 
were the three main admission diagnoses. Poor neurological recovery 
and facilitation of respiratory weaning were the two main indications 
for Tracheostomy. The mean day for insertion was day 9 of mechanical 
ventilation.
24 hours prior to tracheostomy insertion the mean PEEP among 51 
patients was 7 and the mean PF ratio was 32 Kpa. There were devia-
tions from the general safety consensus e.g.: one patient with a PEEP 
of 14 and another patient with a PF ratio of 17kpa at the time of 
procedure.
Following tracheostomy, ventilator settings and oxygenation were 
reviewed at 6 hours, 12 hours, 24 hours and 48 hours. There was no 
significant deterioration in the PF ratios and the degree of ventilatory 
support among our patients at 6 hours, 12 hours, 24 hours and 48 
hours after the procedure. Although, several episodes of short-lasting 
hypoxia and mucus plugging were noticed.
Conclusion: The retrospective analysis of the ventilatory data in a 
population of 51 mechanically ventilated patients revealed that percu-
taneous tracheostomy is reasonably safe with a PEEP of  < 10 cm H2O 
and FiO2 of  < 50%, when performed by experienced clinicians.
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Introduction: Tracheostomy is often performed to aid weaning from 
mechanical ventilation but the timing of tracheostomy has not been 
shown to confer a mortality benefit [1]. As practice in our department 
tends towards conventionally late tracheostomies, we aimed to deter-
mine whether there was a difference in outcomes for patients venti-
lated for > 14 days, who i) underwent tracheostomy on or before day 
14 of their ICU admission; ii) underwent tracheostomy after 14 days; or 
iii) had prolonged intubation without tracheostomy.
Methods: We retrospectively reviewed the notes of patients admit-
ted to the Royal Liverpool University Hospital ICU who were mechani-
cally ventilated for > 14 days between January 2015 and January 2020. 
Patients admitted with a tracheostomy already in situ were excluded. 
Data collected included demographic information, APACHE II score, 
ICU length of stay (LOS), day of tracheostomy, and mortality on ICU 
and hospital discharge. The primary outcome was survival to hospital 
discharge. Patients who had a tracheostomy on or before day 14 are 
referred to as the ‘earlier’ group, whilst patients who had a tracheos-
tomy after day 14 are referred to as the ‘later’ group. Statistical analy-
sis was performed in IBM SPSS 25.0 using X2 tests (Fisher’s Exact Test 
where appropriate), Kruskal-Wallis or Mann-Whitney U tests.
Results: In total 246 patients were ventilated for >14  days. Of these 
patients, 91 (37.0%) had an earlier tracheostomy, 66 (26.8%) under-
went later tracheostomy and 89 patients (36.2%) were not tracheos-
tomised. Median day of tracheostomy in the earlier group was day 11 
(IQR 8-13) and in the later group day 18.5 (IQR 16.0-21.3, p < 0.001). 
There was no difference in age or APACHE II scores between the two 
tracheostomy groups. Patients with a later tracheostomy had a longer 
LOS (later tracheostomy median LOS 35.8 days [IQR 30.8-48.0] vs ear-
lier tracheostomy median LOS 28.0  days [IQR 22.5-42.30] vs no tra-
cheostomy median LOS 23.6 days [IQR 18.5-29.2], p < 0.001) and more 
days of mechanical ventilation (later tracheostomy median 31  days 
[IQR 24.0-41.3] vs earlier tracheostomy 25  days [IQR 19.0-34.0] vs no 
tracheostomy 19 days [IQR 16.0-23.5], p < 0.001). In the earlier trache-
ostomy group, 73 patients (80.2%) survived to hospital discharge; in 
the later group, 41 patients (62.1%) survived; and of those who did not 
undergo tracheostomy, 48 patients (53.9%) survived (p < 0.001).
Conclusion: Patients who were ventilated for >14  days had a better 
rate of survival to hospital discharge when a tracheostomy was per-
formed within the initial 14 days of their ICU admission compared to 
later during their admission or not at all. Our study is limited by its 
retrospective nature and there may be confounding factors influenc-
ing the poorer outcomes in those patients who were tracheostomised 
after 14 days, not represented by the data collected. Further research 
is indicated to assess the impact of earlier tracheostomy on patient-
focused outcomes such as ability to engage in rehabilitation.
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Introduction: Data on the functional outcomes of patients surviving 
an intensive care unit (ICU) admission for COVID-19 is sparse [1]. It is 
widely recognised that Speech and Language Therapists (SLT) have an 
essential role within ICU to support patients achieving optimal com-
munication and swallowing function post critical care [2]. Patients 
diagnosed with COVID-19 were intubated and ventilated for pro-
longed periods, increasing their risk of post-extubation dysphagia [1].
Objectives: To evaluate the mean and median duration of com-
mencing a normal diet in patients with COVID-19 who were tracheos-
tomised and to compare this with data collected on tracheostomised 
patients referred to SLT in 2018, who were admitted to the same inten-
sive care unit at a Tertiary Specialist Cardiothoracic centre.
Methods: During the period March to June 2020 (inclusive), SLT was 
referred and provided intervention to 30 tracheostomised COVID-19 
patients. Data was contemporaneously collected regarding intuba-
tion, extubation, tracheostomy insertion and every SLT intervention, 
including diet changes.
This data was compared to data collected over a 5-month period 
in 2018, in which 31 cardiothoracic or cardio-respiratory tracheos-
tomised patients were referred and seen by SLT.
This data was analysed retrospectively, in terms of the time taken to 
resume a normal diet post tracheostomy insertion.
Results: A total of 25 COVID-19 patients were seen for dysphagia 
intervention, by SLT, post tracheostomy. There were 22 male and mean 
age was 52. The mean time taken for tracheostomy patients to com-
mence a normal diet was 13.2 days (Median 13.5).
This was compared to data from 2019, when 21 patients were seen 
for dysphagia intervention post tracheostomy insertion, by SLT. There 
were 8 males and the mean age was 61. These patients had a mean 
time to commence a normal diet of 14 days (Median 13.1).
Conclusion: These are small but comparable patient samples, that 
show that there does not appear to be a significant difference in the 
length of time taken to commence a normal diet in tracheostomised 
patients with COVID-19 patients, when compared to the “normal” 
cohort of patients seen at a Tertiary Cardiothoracic Centre in London, 
despite the differences in the mean age of the sample groups.
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Introduction: Guidelines for long–term ventilation agree that trache-
otomy has several benefits for patient treatment [1]. However, during 
the coronavirus disease-19 (COVID-19) pandemic it is widely seen as 
an unsafe procedure with a high risk of infection [2,3]. However, as 
mentioned by Piccin et  al., theoretical considerations might speak in 
favour of early tracheotomies also in COVID-19 patients, such as ear-
lier and safer weaning in order to free ICU capacity as soon as possible 
and a reduced need for analgosedation, the drugs which were running 
out in many regions, including ours [4]. Most of these considerations 
are of theoretical nature, little clinical data is available on tracheotomy 
in COVID–19 patients. In our retrospective study, we evaluated tra-
cheotomies performed on 16 COVID–19 patients to assess the risk of 
infection for HCWs, adverse events and the time, patients spend on a 
ventilator.
Methods: We evaluated tracheotomies performed on 16 COVID–19 
patients as there is considerable disagreement if and how to imple-
ment tracheotomies in COVID–19 patients. All tracheotomies were 
performed bedside according to our standard protocol for dilatation 
tracheotomy. Tracheotomies were performed by experienced ICU phy-
sicians and trainees under supervision. Four Patients were on ECMO 
support during tracheotomy. Personal protective equipment (PPE) 
consisting of a protective gown, a N95 (FFP3) facial mask, goggles, 
visor and double layer of gloves was used in all procedures. Patients or 
legal representatives gave informed consent to the procedure. Infec-
tions on HCW were monitored by frequent nasopharyngeal swabs.
Results: Patients were in mean 61 years old (median age 60 ± 7 years; 
15/16 male), mean BMI was 31.3  kg/m2 (median 29.6 ± 6.9  kg/m2). 
Most frequent pre-existing medical condition was arterial hyperten-
sion. All procedures were percutaneous dilatation tracheotomies 
(PDT). Mean time between intubation and tracheotomy was 8.35 days, 
(median 7.5 ± 5 days). Mean time of mechanical ventilation after tra-
cheotomy was 30  days (median; SD 24.5 ± 15.9  days). There was no 
procedure related complication or death due to tracheotomy. Mor-
tality in COVID–19 patients undergoing tracheotomy was 6 out of 16 
(37.5%). No SARS-CoV2 infections were recorded in tracheotomy-per-
forming healthcare workers (HCW) or other team members.
Conclusion: Tracheotomy in COVID–19 patients is almost identical to 
patients without COVID–19. The only difference is the PPE during the 
intervention. Tracheotomy is a safe procedure in COVID-19 for both 
patients and HCW under PPE. Given the shortness in ventilators and 
medication that are reported from some areas, it might be feasible for 
safe and forward patient management during COVID–19.
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Introduction: During the Covid-19 pandemic an unprecedented 
number of patients have required intensive care unit (ICU) admission 
and prolonged ventilation, posing a significant threat to availability 
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of resources. Early tracheostomy could benefit this cohort in terms 
of reduction of duration of mechanical ventilation, length of ICU stay 
(LOS), delirium and laryngeal injury [1]. However, professional soci-
eties advocated the delay of tracheostomies or discouraged them 
altogether given the expected increase in risk of aerosol-generating 
procedures (AGP) [2-3]. We performed tracheostomy in an effort to 
deal with predicted pandemic related resource shortages and to 
reduce ICU weakness and hospital stay.
Objectives: To compare patient characteristics, tracheostomy compli-
cations and evidence of viral transmission to staff.
Methods: Prospective, single centre, service evaluation project. We 
set out a multidisciplinary approach to tracheostomy insertion, both 
surgical and percutaneous, the principal aim of which was staff safety. 
Selection for tracheostomy criteria were defined as: FiO2 ≤ 50%, posi-
tive end-expiratory pressure (PEEP) ≤ 10 for at least 24hrs prior to pro-
cedure, unready for trial of extubation and likely need for prolonged 
ventilation. We performed modified surgical and percutaneous tra-
cheostomies aiming to reduce aerosolisation. This involved personal 
protective equipment (PPE) as per Public Health England (PHE) guide-
lines with sterile gown and gloves donned over the PPE. The modified 
percutaneous technique included using 3 drapes and use of muscle 
relaxation/paralysis and ventilation pauses. Following tracheostomy, 
we documented complications and outcomes. We surveyed the opera-
tors regarding evidence of infection.
Results: Tracheostomy was performed in 33 out of the 74 patients 
that were admitted in our ICU. 14 were percutaneous and 19 were 
surgical. Patients were predominantly male (63.6%), median age was 
64 (IQR:58-68). Tracheostomy was performed after 7.5  days (median, 
IQR:5-12) from intubation and after 10  days (median IQR:7-14) of 
symptoms prior to ITU admission. We have not seen a significant dif-
ference in tracheostomy cuff leak nor wound infection/breakdown 
associated with either insertion technique. There was an increase in 
PaO2:FiO2 ratio from 23.1 (median, IQR:19-26) prior to the procedure 
to 26 (median, IQR: 19-35) after. Mortality was 20.6% (7 patients). 26 
patients (78.8%) have been discharged home. There were no episodes 
of absence of staff with COVID-19 like illness and operators performing 
tracheostomy all had negative antibodies.
Conclusion: We have demonstrated that earlier tracheostomy in 
stable COVID-19 pneumonitis patients, with modifications to inser-
tion technique, is feasible. We have not seen increased complication 
rates or instances of staff infection with COVID-19 during the study 
period. Earlier insertion during the pandemic may allow for improved 
resource allocation and reduction in upper airway complications 
related to prolonged oro-tracheal intubation.
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Introduction: The Covid-19 pandemic has placed an extraordinary 
burden on critical care medicine globally. Supportive care continues to 
be mainstay of treatment.1 At the time of the study two thirds of Covid 
-19 patients who required critical care in the UK had mechanical ven-
tilation within 24 hrs of admission.2 Due to changing guidelines,there 
was little evidence on the appropriate mode (surgical vs bedside) of 
tracheostomy for patients admitted to Intensive care unit .Some stud-
ies suggested that early tracheostomy was associated with better out-
comes3 than late tracheostomy.4.
Objectives: This is a prospective observational study looking at pos-
sibility of doing percutaneous tracheostomy in Covid19 patients 
admitted in a tertiary hospital intensive care unit requiring invasive 
mechanical ventilation.
Methods: The present study involved review of covid-19 patients who 
underwent tracheostomy during their stay in our intensive care unit 
from 18th of March 2020 to 29 th of April 2020.(6 weeks). Data related 
to demographic parameters, duration of ventilation with Endotracheal 
tube, day and type of tracheostomy from time of ICU admission and 
outcome were reviewed.
Results: 20 patients underwent planned tracheostomy during the 
study duration with 15 males (75%) and 5 female patients (25%). 
The overall mean age was 55.1yrs; for males 57.13 and for females 
49.20% had normal BMI, 20% pre obese and 60% were obese. Mean 
days of ventilation with ET tube was 13.15 +/- 6.53. Earliest tracheos-
tomy was done on day 8 of ICU admission and latest was on day 30 
of ICU admission. Median day of tracheostomy was Day 14. 11 (55%)
patients underwent percutaneous tracheostomy in the ICU while 9 
(45%) patients underwent surgical tracheostomy in operation theatre . 
Of the 9 surgical tracheostomy patients, 2 were difficult percutaneous 
tracheostomy that were subjected to surgical tracheostomy.8 patients 
were discharged to ward, 9 patients continue to be ventilated and 3 
patients died during the study.
Conclusion: This study shows that percutaneous tracheostomy can 
be safely done on Covid 19 patients in an Intensive care unit with 
adequate planning and preparation. Nevertheless, a surgical tracheos-
tomy should be considered when necessary.
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Introduction: Fluid overload has been associated with increased mor-
bidity and mortality in critically ill patients.
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Objectives: To assess the efficacy and tolerance of a rationalized diu-
retic strategy to treat fluid overload after shock in patients undergoing 
mechanical ventilation.
Methods: The IRIHS study (NCT 02345681) was a single-blind, rand-
omized-controlled study performed in 4 intensive care units (ICUs) in 
France, from May 5th 2015 to February 2nd 2019. Patients were eligi-
ble in case of fluid overload defined as in-ICU weight increase ≥ 3%, 
mechanical ventilation ≥ 24 hours, and hemodynamic stabilization 
(vasopressors drugs discontinuation > 6 hours; dobutamine ≤ 10 μg.
kg-1.mn-1). Patients were randomized into diuretic group (intra-
venous furosemide, twice a day, maximum daily dose of 250 mg from 
randomization until successful extubation), or a control group with-
out furosemide. The primary outcome was the fluid balance, defined 
as weight variation, from randomization to successful extubation. The 
main secondary outcome was the safety of diuretic.
Results: 171 patients were randomized, 5 patients who did not sat-
isfy the inclusion criteria were excluded and thus, 166 included in 
analysis: 77 in the diuretic and 89 in the control group. The primary 
outcome was available in 144 (84.2%) patients. In the complete cases 
analysis, fluid balance was 1.4 [-2.5;4.5] kg in the diuretic group and 6.4 
[0.5;11.2] kg in the control group (p < 0.001). In the multiple imputa-
tion analysis, fluid balance was significantly decreased in the diuretic 
group (β  =  -4.8 95%CI [-7.3;-2.5], p  <  0.001). Eleven (14%) patients 
died in ICU in the diuretic group, and 16 (18%) patients in the control 
group (p = 0.5). The rates of kidney failure were respectively 55 (63.2%) 
and 55 (73.3%) in the diuretic and the control group (p = 0.2).
Conclusion: In this multicenter randomized-controlled study, diuretics 
decreased the fluid overload of critically ill patients as compared to a 
no-diuretic policy.
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Introduction: Lung protective ventilation is the cornerstone of the 
ventilatory management of COVID-29 related ARDS (C-ARDS). Lung 
recruitment maneuvers (RM) and their related optimum PEEP setting 
are frequently used as adjuvant interventions. However, as lung col-
lapse does not seem to be an important pathophysiologic component, 
these interventions may be less effective in C-ARDS.
Objectives: To study the role of RM and individualized PEEP settings 
as adjuvant lung protective interventions in the management of ven-
tilated C-ARDS patients. We specifically analyzed the obtained PEEP 
levels and the effects on lung mechanics.
Methods: Retrospective analysis of all registered RM followed by a 
decremental PEEP titration performed in C-ARDS patients performed 
during the peak of the COVID pandemia in a teaching tertiary hospi-
tal ICU. Maneuvers were registered either by electrical impedance 
tomography (EIT- Enlight 1800,Timpel) or a sequential automated 
recruitment maneuver (Servo-u, Maquet CC). We compared individual 
PEEP levels determined during a decremental PEEP trial by global (Cg) 
or regional (Creg) compliance. Cg was defined by the maximal global 
compliance and Creg by the point of minimum overdistension and 
collapse as measured by EIT(1). We also analyzed differences in PEEP 
individualization between supine and prone positioning. After check-
ing for normality of the data distributions means were compared 
using t-test for independent variables.
Results: The analysis includes a total of 90 registered RM-PEEP titra-
tions (60 in supine and 30 in prone) in 19 patients (4.6 RM per patient). 
Recruitment pressures (mean  ±  SD) were 48 ± 4/33 ± 4 cmH2O 
(inspiratory pressure/PEEP). Obtained individualized PEEP levels were 
10.5±2.2 cmH2O for Cg and 8.8 ± 2,3 cmH2O for Creg (p < 0.05).
Respiratory system compliance, plateau and driving pressures 
improved after RM and PEEP setting from 37.1 ± 14.2 to 42.5 ± 13.8 ml/
cmH2O p <  0.001; 24.9 ± 3.6 to 22.7 ± 3.1 cmH2O p  <  0.001 and 
13.8±3.1 to 11.5 ± 2.8 cmH2O p < 0.01, respectively. There were no dif-
ferences between supine and prone position in individualized PEEP 
levels (Cg 10.6 ± 3.2 vs 10.2 ± 3.33 and Creg 8.9 ± 3.1 vs 8.6 ± 3.6) and 
respiratory system compliance was better in supine than in prone 
(41.9 ± 13.8 vs 42.8 ± 16.8 p  < 0.05) respectively. At the determined 
Cg and Creg PEEP levels lung protective ventilation resulted in a per-
centage overdistension of 10 ± 7.9 and 4.5 ± 3.4% and collapse of y 
3.4±3.6 and 4.5±2,5% of the total lung respectively as measured by 
EIT. Small changes in the applied PEEP levels resulted in important 
changes in the percentage overdistension and/or collapse.
Conclusion: Lung recruitment and individualized PEEP titration was 
an effective adjuvant lung protective intervention. It allowed to adjust 
and minimize PEEP in each individual patient and at different stages 
during the evolution. The individualized PEEP levels according to Creg 
were lower with less overdistension but more collapse than the ones 
according to Cg.
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Introduction: In line with NHS England guidance [1], during the 
first wave of the COVID-19 pandemic where appropriate all patients 
admitted to hospital, irrespective of COVID-19 status, were assessed 
for frailty, using the Rockwood Frailty Scale as part of a holistic 
assessment.
In this retrospective cohort study, we aimed to assess the impact of 
frailty, age and comorbidities in patients with COVID-19 requiring 
invasive ventilation.
Methods: We retrospectively reviewed case notes of all patients 
admitted to the Royal Liverpool University Hospital Accident and 
Emergency (A&E) Department, between March 23rd and April 23rd 
2020 with a positive COVID-19 RT-PCR result. Routine data, including 
demographic data, comorbidity data and Rockwood Frailty Score, 
were extracted. We assessed the predictive value of age, comorbidities 
and Rockwood Frailty Scores for disease progression to requiring inva-
sive ventilation. Receiver operating curves were generated to illustrate 
sensitivity and specifity for each variable to predict the need for inva-
sive ventilation.
Results: Patients with a diagnosis of COVID-19 who progressed to 
invasive ventilation were younger with a median age of 58.5 [53.23; 
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59.81] years compared to 72 [58.25; 81] years (p < 0.001). The major-
ity of patients invasively ventilated had a Rockwood Frailty Score  < 3 
(85%). Patients who required invasive ventilation were less likely to 
suffer from comorbidities including COPD, asthma, hypertension, 
chronic kidney disease, hepatic disease, diabetes mellitus, atrial fibril-
lation, malignancy or hypercholesteraemia and were less likely to have 
a history of myocardial infarction or stroke (p < 0.01).
Area under the curve for age was 74.2%, and 87.1% for Rockwood 
Frailty Score. For comorbidities, AUCs were between 47% and 59%, 
indicating a low predictive value.
Conclusion: Patients presenting to our A&E Department with a higher 
Rockwood Frailty Score were less likely to be admitted to ICU and 
to be invasively ventilated. Similarly, the age of patients on ICU was 
significantly lower than for patients presenting to A&E who had con-
firmed COVID-19. Our results are in line with large databases [2] that 
demonstrate that during the COVID-19 pandemic frail patients and 
those requiring support in their activities of daily living have been less 
frequently admitted to ICU compared to patients with viral pneumo-
nia in non-pandemic situations. During pandemics, shortness of venti-
lators may become a reality, supporting the need for careful planning 
and triaging of patients requiring invasive ventilation to identify those 
who will need scarce resources early during their hospital admission.
Reference(s) and grant ackowledgment(s)
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Introduction: The surge of patients with COVID19 severe acute hypox-
emic respiratory failure has put resources at their limits.
Objectives: To describe how severely hypoxemic patients were man-
aged with noninvasive and invasive respiratory support in the Catalan 
ICU network between 15 March and 15 April.
Methods: Consecutive patients admitted between 15 March and 15 
April in 26 ICUs, who tested positive for SARS-Cov-2 (RT-PCR in a naso-
pharingeal swab) and had severe acute hypoxemic respiratory failure, 
presenting with bilateral infiltrates in the chestX-ray and requiring 
invasive mechanical ventilation. Follow-up time was til ICU discharge.
Study was approved by the Ethics Committee of the coordinating 
center (HospitalUniversitari Sant Pau, Barcelona).
Results: A total of 1388 patients required invasive mechanical venti-
lation and overall mortality rate was 35% (491/1388). Most common 
single modes of oxygenation before intubation were facemask with 
oxygen reservoir in 39% patients (538/1388), of whom 182 died (34%), 
and high flow nasal cannula in 22% patients (308/1388), of whom 88 
died (29%); p = 0.12 for mortality differences.
Once intubated, the most frequent ventilator mode was volume assist-
control ventilation and was used in 1236/1388 patients (89%). The 
most frequently used ventilators were conventional ICU machines in 
66% patients (915/1388), and anesthesia machines in 12% patients 
(169/1388). The anesthesia machines were used when conventional 
ICU ventilators were lacking. Patients ventilated with ICU machines 
had an ICU mortality of 34% (308/915) whereas those ventilated with 
anesthesia machines had a 47% mortality (79/169), p = 0.002. ECMO 
was employed in 31 patients (2,2%), 28 ECMO VV and 3 ECMO VA. Tra-
cheostomies were performed in 28% patients (524/1388), of whom 
26% (137/524) died.








Hospital stay pre-ICU, 
days 
2.38±3.5 2.25±3.2 2.62±3.8 ns 
ICU stay, days 20.1±14.9 22.2±15.5 16.4±12.7 <0.001
Hospital admission to 
intubation, days 
2.74±3.5 2.6±3.2 3.02±3.97 <0.05 
ICU admission to 
intubation, days 
0.47±1.2 0.48±1.07 0.43±1.51 ns 
Duration of mechanical 
ventilation, days 
17.5±13.8 18.3±14.2 16.02±12.7 0.003 
Intubation to 
tracheostomy, days 
13.8±6* 13.5±6.1** 14.5±5.7*** ns 
*n=524, **n=387, ***n=137  
Conclusion: COVID19 mechanically ventilated patients consumed 
a substantial amount of resources, were often tracheostomized and 
their ICU length of stay was prolonged.
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Introduction: SARS-CoV-2 infection leads in the most severe cases to 
a profound respiratory failure that requires admission to the intensive 
care unit (ICU) and mechanical ventilation. Two different phenotypes 
have been proposed: H (HIGH elastance-right to left shunt ratio-lung 
weight-recruitability) and L (LOW elastance-VA/Q ratio-lung weight-
recruitability) (ref 1. Gattinoni).
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Objectives: To describe the incidence, clinical differences and out-
comes of phenotype H and L patients with SARS-CoV-2 infection 
(COVID-19) who are admitted in an ICU of a third-level hospital with 
extracorporeal membrane oxygenation (ECMO) support capacity.
Methods: We retrospectively collected and analysed data from all 
COVID-19 confirmed patients, admitted to the ICU of a third-level 
hospital in Spain between 15th February and 15th June 2020. We cat-
egorised patients into two phenotypes, L and H, and compared their 
clinical and epidemiological variables as well as ventilation related 
parameters. The data are expressed as mean  ±  standard deviation, 
median ± interquartile range, and compared using T-test, Wilcoxon 
rank test, Chi-square test and Fisher´s exact test as appropriate.
Results: A total of 87 COVID-19 confirmed patients were included 
out of which 79 (93%) received invasive mechanical ventilation. 77% 
males, mean age 60±12, median BMI 27 Kg/m2 (IQR 25-32), mean 
APACHE-II 17 ± 6. 13 patients needed VV-ECMO support (61% survival). 
Overall hospital mortality was 38%. Comorbidities: hypertension 30%, 
diabetes 14%, ischemic heart disease 5%, asthma 8%, COPD 3%.
The incidence of H phenotype was 40%, L phenotype 32% and in 
28% of the patients it was not possible to determine. Comparison of 








(mean ± sd) 
(median, IQR)
p
PaO2/FiO2 day 1 171 (114, 216) 161 (134, 209) >0.05 
PaO2/FiO2 day 3 195 (146, 263) 200 (144, 236) >0.05 
PaO2/FiO2 day 5 176 (156, 240) 189 (142, 218) >0.05 
PaO2/FiO2 day 10 184 ± 68 217 ± 73 >0.05 
PEEP day 1 (cmH2O) 15 ± 3 11 ± 2 <0.01
PEEP day 5 (cmH2O) 10 ± 3 11 ± 2   
Days of mechanical 
ventilation
15 (8, 30) 11 (6, 24) >0.05 
Tidal volume/ideal weight 
day 1 (ml/kg)
7 (6, 7) 7 /6, 7) >0.05 
Tidal volume/ideal weight 
day 10 (ml/kg)
7 (6, 8) 8 (7, 8) <0.05
Use of prone position (%) 68 60 > 0.05 
Number of prone sessions 2.6 ± 2 2.8 ± 1 >0.05 
Mortality ICU (%) 33 29 >0.05  
Conclusion: Out of all admitted patients, only 72% of them could be 
classified into one of the proposed phenotypes.
Patients with H phenotype were treated with a higher PEEP level on 
the first day of mechanical ventilation, but with a similar tidal volume. 
Tidal volume was significantly higher in L phenotype patients on day 
10.
No differences in PaO2/FiO2 ratio, days of mechanical ventilation and 
the use of prone position was observed between groups.
Reference(s) and grant ackowledgment(s)
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Introduction: COVID-29 related ARDS (C-ARDS) has specific patho-
physiologic features that include a relatively higher compliance as 
non C-ARDS of similar severity and a pulmonary vascular thrombosis 
diathesis together with a severe early hypoxemia. Given these features 
inhaled nitric oxide (iNO) could have a potential adjuvant role in the 
ventilatory management of C-ARDS.
Objectives: To study the effects of iNO on the relative change in pul-
monary perfusion and on gas exchange in C-ARDS.
Methods: Retrospective analysis C-ARDS patients with severe ARDS 
treated with iNO delivered via the SoKINOXTM device (Air Liquide). 
The relative distribution of pulmonary blood flow before and after the 
administration of iNO was determined by EIT (Enlight, 1800 Timpel). 
Perfusion data were obtained by means of a bolus infusion of 10  ml 
of hypertonic (7.6%) Saline solution during a brief apnea period main-
taining the same PEEP level(1). Ventilator settings before and after iNO 
were maintained unchanged so that no changes in the regional distri-
bution of ventilation were expected. At least one blood gas before and 
after iNO, although at different time periods in relation to the start of 
iNO therapy, were obtained. Due to the low number of patients and 
measurments no statistical analysis was performed in this descriptive 
study.
Results: A total of 8 patients were included in the analysis. After a 
few dose response trials performed in the first patients average low-
est iNO dose resulting in the maximum change in perfusion was 
15 ppm. Changes in the relative distribution of ventilation were  < 1% 
for all studied regions. The response to iNO was very variable both in 
terms of the distribution of perfusion and gas exchange with no clear 
defined pattern. Only four patients responded according to oxygena-
tion with an average increase in PaO2/FiO2 of 40.5  ±  17.7%. When 
analyzing the changes in the distribution of perfusion in vertical 
gravitational axis, iNO predominantly shifted perfusion to the ventral 
(non-dependent) lung half in 3 patients (13  ±  6.95% shift) and to the 
dorsal (dependent) lung half in 5 patients (8.4 ± 4.1% shift). This cor-
responded to a decrease of 5.5 ± 4.4% in PaO2/FiO2 and an increase 
of 13.7 ± 17.7% in PaCO2 and an increase of 29.9 ± 28.3% in PaO2/FiO2 
and a decrease of 2.3 ± 14.5% in PaCO2 in those predominantly shift-
ing perfusion to ventral and to dorsal regions respectively.
Conclusion: The response to iNO in C-ARDS patients was highly vari-
able and required higher than usual doses. In responding patients 
iNO caused a redistribution of pulmonary blood flow to dorsal non-
dependent regions.
Reference(s) and grant ackowledgment(s)
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Introduction: Patients with the most severe forms of SARS-CoV-2 
infection develop a profound respiratory failure that, during the 
global pandemic, has forced hospitals to increase their ICU-bed capac-
ity. Spaces with ICU-level monitoring, such as post-anesthesia care 
units or operating rooms have been used as temporary ICU beds 
(extended-ICU). Moreover, collaboration between professionals in the 
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departments of critical care, anesthesiology and other medical special-
ties has been necessary in order to attend all critical care patients. (ref. 
1, 2).
Objectives: We aim to determine the differences in ventilation related 
variables between patients admitted to the ICU and patients admitted 
to the extended-ICU in a third-level hospital in Spain between 15th 
February and 15th June 2020.
Methods: We retrospectively collected and analysed data from all 
COVID-19 confirmed patients admitted to a third-level hospital in 
Spain and needed intensive cares, between 15th February and 15th 
June 2020. We categorised the patients into two groups: admitted to 
ICU and admitted to extended-ICU. We compared ventilation related 
parameters between groups. The data are expressed as mean  ±  stand-
ard deviation, median  ±  interquartile range, and compared using 
T-test, Wilcoxon rank test, Chi-square test and Fisher´s exact test as 
appropriate.
Results: A total of 87 COVID patients are included, out of which 79 
(93%) received invasive mechanical ventilation. 77% males, aged 
60 ± 12, BMI 27 Kg/m2 (IQR 25-32). Mean APACHE-II 17  ±  6. 13 patients 
needed VV-ECMO support (61% survival). Overall hospital mortality 
was 38%. Comorbidities: hypertension 30%, diabetes 14%, Ischemic 
heart disease 5%, asthma 8%, COPD 3%.










1 (0, 4) 0 (0, 2) <0.05
Tidal volume/ideal body 
weight day 1 (ml/kg)
7 (6, 8) 7 (6, 8) >0.05 
Tidal volume/ideal body 
weight day 5 (ml/kg)
7 (6, 8) 7 (6, 8) >0.05 
Tidal volume/ideal body 8 (7, 8) 7 (6, 8) >0.05 
weight day 10 (ml/kg)
PaO2/FiO2 day 1 167 (109, 221) 185 (142, 222) >0.05 
PaO2/FiO2 day 5 183 (128, 240) 190 (147, 232) >0.05 
PaO2/FiO2 day 10 205 ± 79 167 ± 69 <0.05
Driving pressure day 1 
(cmH2O)
12 (10, 14) 14 (12, 20) <0.05
Driving pressure day 5 
(cmH2O)
12 ± 3 15 ± 4 <0.05
Driving pressure day 10 
(cmH2O)
12 (10, 14) 14 (12, 20) >0.05 
Plateau pressure day 1 
(cmH2O)
23 ± 3 26 ± 4 <0.05
Plateau pressure day 5 
(cmH2O)
23 ± 3 25 ± 3 >0.05 
Plateau pressure day 10 
(cmH2O)
22 ± 4 23 ± 7 >0.05 
Use of pre-intubation non-
invasive ventilation (%)
17 23 >0.05 
Extubation failure (%) 5 7 >0.05  
Conclusion: Patients admitted to the extended-ICU had less mechani-
cal ventilation free days.
Patients treated in extended-ICU had worse oxygenation, expressed as 
PaO2/FiO2 ratio than patients treated in ICU.
Patients admitted to extended-ICU had higher driving pressure and 
higher plateau pressure during the first days of treatment, when com-
pared to patients admitted to ICU.
There were no differences between groups in the use of pre-intuba-
tion non-invasive ventilation or in the extubation failure.
Reference(s) and grant ackowledgment(s)
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Introduction: Approximately 5% of coronavirus disease 2019 (COVID-
19) are admitted to intensive care unit (ICU) for acute hypoxemic res-
piratory failure (AHRF). Whether invasive mechanical ventilation (IMV) 
should be used as first line therapy over non-invasive ventilation (NIV), 
high flow nasal cannula (HFNC), continuous positive airway pressure 
(CPAP) and oxygen by mask, is debated.
Objectives: The aim of the study was to assess a non-biased effect of 
Early-IMV in COVID induced AHRF on day-60 mortality.
Methods: Data from consecutive COVID-19 patients admitted in 11 
ICUs of the French OutcomeReaTM network were prospectively col-
lected. Patients with AHRF (PaO2/FiO2  <  300 mmHg) within 2 days of 
ICU admission and not referred from another ICU were included. The 
study compared day-60 mortality between patients who were admin-
istered IMV within 48 hours of ICU admission (Early IMV group) and 
patients who did not (non-Early IMV group). We used a Cox propor-
tional-hazard model with ponderation with inverse probability of Early 
IMV weighting (IPTW) to model the risk of death at day 60 (HR > 1 in 
favor of death).
Results: Of the 306 included patients, the median age (IQR) age was 
of 61 (52-69) years, 241 were males (78.8%), 175 (57.2%) had at least 
one comorbidity; the median SAPSII and PaO2/FiO2 were 33 (25-44) 
and 133 (96-186) mmHg, repsectively. On admission, 105 (34.4%) 
patients received IMV, 26 (8.4%) NIV, 122 (39.8%) HNFC, 21 (6.8%) CPAP, 
and 32 (10.4%) oxygen by mask. Ultimately, the Early and non-Early 
IMV groups included 149 and 157 patients; and Day-60 mortality was 
40.9% and 22.9%, respectively. Between the Early and non Early IMV 
group the rates of ICU-acquired pneumonia and bacteremia were 71 
vs 29 (P < 0.01) and 15 vs 8 (P < 0.01); the median ICU length of stay 15 
(10-22) vs 8 (5-15) days (P < 0.01), respectively. In the IPTW analysis, 
day-60 mortality remained higher in the Early than in the non-Early 
IMV group (IPTWsHR = 1.78, CI 95%, 1.16 to 2.71, p < 0.01). Similar 
results were observed in a sensitive analysis using Multivariate Cox 
survival model (Table).
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Conclusion: In ICU patients admitted with COVID-19 -induced acute 
hypoxemic respiratory failure, Early-IMV increases day-60 mortality 
and should not be used as first line respiratory support.
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Introduction: Expiratory muscle weakness leads to difficult ventilator 
weaning. Maintaining their activity with functional electrical stimula-
tion (FES) may therefore improve outcome. We studied feasibility and 
efficacy of breath-synchronized expiratory muscle FES in a mixed ICU 
(“Holland study”) and pooled data with our previous work [1] (“Aus-
tralian study”) to analyze effects in a larger and more heterogeneous 
group.
Methods: Holland: Twenty patients with contractile response to FES 
received active or sham expiratory muscle FES (30-min, twice-daily, 
five days/week until weaned). Endpoints were respiratory muscle 
thickness, feasibility, and ventilation duration. Pooled: Data on clini-
cal endpoints from the Holland and Australian studies were combined 
(N = 40), including ventilation duration and ICU length-of-stay. Plasma 
cytokines (day 0, 3) were analyzed to study the effects of expiratory 
muscle FES on systemic inflammation.
Results: Holland: 272 sessions were performed (sham/active: 103/169, 
compliance: 91.1%). No FES-related serious adverse events were 
reported. Respiratory muscle thickness was not different over time 
and between groups. Pooled: At day 3, there was a between-group dif-
ference in total expiratory muscle thickness favoring the active group 
(treatment difference (95% confidence interval); 2.25 (0.34, 4.16) mm, 
P = 0.02). Plasma cytokine levels indicated that early FES did not 
induce systemic inflammation. Median ventilation duration and ICU 
length-of-stay were 10 vs. 52 (P = 0.07), and 12 vs. 54 (P = 0.03) days 
for the active vs. sham group. 3/20 patients died in the active group, 
vs. 9/20 in the sham group (P = 0.08).
Conclusion: Expiratory muscle FES is feasible in selected ICU patients. 
This might be a promising intervention within a respiratory muscle-
protective ventilation strategy. A next step would be to test whether 
this approach could improve weaning outcome.
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Introduction: Optimized external expiratory resistances improve lung 
mechanics, reduce tidal expiratory flow limitation (EFL) and prevent 
expiratory lung collapse in injured lungs (1).
EFL is associated with an increased mortality in acute respiratory dis-
tress syndrome (ARDS) patients (2, 3). To detect and avoid EFL can 
have important consequences on patients outcome.
Whether EFL can be detected by electrical impedance tomography is 
still unknown.
Objectives: EFL is expected to affect regional expiratory flow and con-
sequently regional variation of expiratory electrical impedance. We 
hypothesized that changes in regional expiratory flow and EFL, con-
sequent to different expiratory resistances and positive end-expiratory 
pressure (PEEP) levels, can be detected as changes in expiratory elec-
trical impedance of the thorax.
Methods: Ten anesthetized and mechanically ventilated pigs under-
went lung lavages to reach mild ARDS with a PO2/FIO2 ratio of 
250  mmHg at PEEP of 5 cmH2O. During the experiment the pigs 
breathed spontaneously during continue positive airway pressure. 
Three PEEP levels (12, 3 and 0 cmH2O) and four external expiratory 
resistances were tested (labeled as R0, R1, R2, R3). The electrical imped-
ance signal was simultaneously acquired. The impedance signal was 
analyzed breath-by-breath at 5 time-points of the expiratory phase 
(end-inspiration, first, second, third and fourth quartile of the expira-
tion) and separately for dependent and not-dependent lung regions.
Results: In absence of additional expiratory resistance (R0), a signifi-
cant difference in electrical impedance was observed in non-depend-
ent lung regions at different PEEP levels. High PEEP corresponded to a 
slower decrease in impedance throughout expiration.
Applying additional expiratory resistances (R1-R3), the differences in 
electrical impedance related to PEEP disappeared and showed a trend 
closer to the one observed at high PEEP and R0.
Conclusion: A change in the time course of the expiratory impedance 
at PEEP 0 cmH2O was interpreted as sign of expiratory flow limitation. 
Addition of expiratory resistances contrasts the appearance of this 
pattern. Electrical impedance tomography can indirectly detect phe-
nomena of expiratory flow limitation in injured lungs during sponta-
neously breathing ventilation.
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Introduction: During surges in demand for ventilator capacity, 
demand may outstrip supply. Split ventilation has been suggested as a 
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temporising measure for individual hospitals to cope with such surges 
in demand. Optimising split ventilation may be important in the on-
going pandemic of SARS-CoV-2 and the associated high prevalence 
of acute respiratory distress syndrome. We developed a low cost elec-
tronically controlled system for delivering split ventilation, provision-
ally termed the Combiventilate system.
Objectives: 1) To demonstrate that an electronically controlled split 
ventilation system could be used to delivery independent volume-
controlled ventilation to two test lungs under conditions of varying 
resistance, compliance and leak. 2) To demonstrate that in a porcine 
model of acute respiratory distress syndrome, the Combiventilate 
system could deliver independent modified lung protective ventila-
tion. 3) To show that in a porcine model of ARDS, markers of ventilator 
induced lung injury were similar in Cobiventilate ventilated animals 
and single ventilated animals. 4) To demonstrate that with minimal 
training, critical care staff could independently operate the Combiven-
tilate system in simulated clinical scenarios.
Methods: We performed benchtop testing of the Combiventilate sys-
tem using linear test lungs to ensure it’s ability to provide differential 
ventilation and accommodate for changes in respiratory mechanics. 
We established a porcine model of acute respiratory distress syndrome 
by administering intrabronchial hydrochloric acid. We compared ven-
tilation using the Combiventialte system to traditional individual ven-
tilation in both injured and uninjured animals (n = 30). Groups were; 
individually ventilated uninjured (n = 5), individually ventilated injured 
(n = 5), Combiventilate managed uninjured (n = 10) and Combiventi-
late managed injured (n = 10).
We compared between group differences in the ability to deliver lung 
protective ventilation and meet gas exchange targets over a period of 
6 hours of mechanical ventilation. We also compared immunological 
and histological markers of ventilator induced lung injury between 
groups. We performed benchtop simulations of clinical scenarios to 
verify that, with minimal training, clinical staff could set up and oper-
ate the Combiventilate system under conditions simulating common 
clinical scenarios.
Results: The Combiventilate system was able to deliver individualised 
volume-controlled ventilation in benchtop testing with linear test 
lungs. In a porcine model of ARDS, the Combiventilate system was 
able to facilitate similar adherence to modified lung protective ventila-
tion as compared to individual traditional ventilation. Immunological 
and histological markers of ventilator induced lung injury were similar 
in the Combiventilate managed groups compared to the traditionally 
ventilated groups. In benchtop simulations, clinical staff were able to 
set up and operate the Combiventilate system with minimal training.
Conclusion: Performance of the Combiventilate system in benchtop 
testing and in a large animal model of ARDS supports the ability to 
deliver modified lung protective ventilation. Similar degrees of venti-
lator induced lung injury as observed in the Combiventilate group as 
compared to the individually ventilated group. These data are prom-
ising and support further efforts to develop and investigate this sys-
tem for use in humans as a temporising measure when surge demand 
exceeds capacity for indivualised ventilation.
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Introduction: Elevated Plateau Pressures in mechanically ventilated 
patients with ARDS have previously been shown to increase the 
time needed for liberation from mechaincal ventilation, increase the 
lenght of ICU stay and increase hospital mortality (1,2). International 
guidelines for the management of ARDS, including ARDS secondary to 
COVID-19, reflect these findings and recommend maintaining plateau 
pressures of less than 30 cmH2O (3).
Objectives: 1. To assess how frequently Plateau Pressures were 
recorded in mechanically ventilated patients admitted with ARDS sec-
ondary to COVID-19.
2. To investigate the incidence of elevated plateau pressures in 
mechanically ventilated patients with ARDS secondary to COVID-19.
Methods: This was a retrospective audit of all patients with ARDS sec-
ondary to COVID-19 admitted to the ICU over a three month period 
(06/03/2020 - 06/06/2020) who required intubation and mechanical 
ventilation. Data was collected from patient’s medical notes, includ-
ing both paper charts as well as digital documentation. Data was also 
collected from patient’s flow charts. Data was only collected on days 
during which the patient was mechanically ventilated on a Pressure 
Regulated Volume Control (PRVC), Pressure Control (PC) or Volume 
control (VC) mode of ventilation. Elevated plateau pressures were 
defined as a pressure greater than or equal to 30 cmH2O.
Results: 24 patients were admitted to the ICU with ARDS secondary 
to COVID-19 during this time period. They spent a cumulative total of 
428  days intubated and ventilated in ICU during this time. The total 
number of days spent on a PRVC, PC or VC mode of ventilation was 
262. This was broken down as 250  days on PRVC, 8  days on PC and 
4 days on VC. In total, plateau pressures were recorded on 47% of days 
while on a PRVC, PC or VC mode of ventilation (124 of the 262 days). 
There was a documented contraindication to recording plateau 
pressures on 2 out of the 262  days. Of the recorded plateau pres-
sures, 29.8% were greater than or equal to 30 cmH20 (37 of the 124 
measurements).
Conclusion: We found that for mechanically ventilated patients with 
ARDS secondary to COVID-19, plateau pressures were not being meas-
ured routinely and were frequently found to be above the threshold 
limit recommended by international guidelines. This could have impli-
cations for patient’s length of ICU stay, duration of mechanical ventila-
tion as well as hospital mortality.
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Introduction: Flexible fiberoptic bronchoscopy (FOB) has become an 
important tool for the diagnostic and management of complications 
in critically ill ventilated patients, specially since ICU physicians can 
performe this technique with low incidence of complications.
Objectives: First, to describe the etiology and complications of per-
forming a flexible fiberoptic bronchoscopy (FOB) by intensive care 
physicians in patients under invasive mechanical ventilation (IMV) in 
our intensive care unit. Secondly, to check whether there was a signifi-
cant modification of treatment due to the results of FOB.
Methods: Retrospective study in a 24  month period (from january 
2018 until december 2019) of all FOB performed by intensive care phy-
sicians in our patients under IMV. Variables analyzed: data of patients 
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(sex, age, APACHE II), cause for IMV (primary respiratory, septic shock, 
cardiovascular, neurological), cause for implementing the bronchos-
copy (atelectasis in US, suspected orotracheal tube obstruction, evalu-
ation of tracheostomy, suspected tumor, diagnostic bronchoalveolar 
lavage), complications, change in treatment.
Results: In 24  months we performed 167 FOB in 397 patients under 
IMV. Male 55%. Mean age 58 ± 16,3 y. Mean APACHE II 19 ± 8. Cause 
of IMV: primary respiratory 135 (34%), septic shock 118 (30%), neuro-
logical 45 (11,3%), cardiovascular 44 (10%), other 55 (13,7%). Causes: 
atelectasis 48 (28,7%), orotracheal tube obstruction 11 (6,6%), evalu-
ation of tracheostomy 25 (15%), suspected tumor 7 (4,2%), diagnostic 
BAL 76 (45,5%). Complications: mild haemorrage 16 (9,6%), supraven-
tricular tachicardya 8 (4,8%), transient hypoxemia 12 (7%), transient 
bronchospasm 8 (4,8%). A significative change in treatment was 
implemented in 56 (33%). No mortality related to FOB.
Conclusion: The performing of flexible bronchoscopy in patients 
under IMV by intensive care physicians is a safe technic in our units. 
Complications are mild and in aproximately 25% of patients. A change 
in treatment was made in 33%, mostly due to microbiological findings 
in BAL, diagnostic of tumors and limitation of therapeutic effort.
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Introduction: Inhaled Nitric oxide (iNO) is used during mechanical 
ventilation as salvage therapy for refractory hypoxemia in ARDS, as 
(selective) pulmonary vasodilator in pulmonary hypertension and 
in right heart failure. At therapeutic levels for adults (up to 30  ppm) 
residual NO and its metabolite NO2 are released in the surrounding 
from the ventilator expiratory port and must be scavenged. With pro-
longed use (> 12  h) dedicated NO/NO2 scavenger filter causes addi-
tional resistance due to moisture accumulation and leads to expiratory 
flow limitation. Sevoflurane demonstrates numerous advantages over 
intravenous sedation and is preferred sedation agent in our ICU.
Objectives: Since volatile agents used for sedation in ICU also require 
scavenging we tested NO scavenging capacity of commonly used 
 Contrafluran® filter.
Methods: Breathing circuit (Elisa 800VIT, Löwenstein Medical, Ger-
many) with NO delivery/measurement system (NO-A, EKU Elektron-
ikm GmbH), Anaconda (Sedana Medical, Sweden) and Contrafluran 
(ZeoSys Medical, GmbH) was assembled according to manufacturer’s 
recommendation and hospital standards. All measurements were per-
formed during volume control ventilation (Vt 450 mL, FiO2 0.5, PEEP 
10, RR 20/min) first without sevoflurane co-administration and then 
with sevoflurane at a rate of 10  mL/h. In 20 benchmark tests con-
centrations of NO and NO2 were measured in different parts of the 
breathing circuit (Figure  1). Statistical analysis was performed using 
Student t-test (Numbers, MacIntosh).
Results: In table:
.
Conclusion: iNO concentration varies within the breathing circuit as 
a consequence of a Flow-by, mixture of inspired and expired gasses 
at Y piece and scavenging effect of Anaconda. Special caution must 
be practiced when interpreting the results of measured iNO values. 
Addition of sevoflurane does not interfere with NO/NO2 measure-
ments. Contrafluran filter is an excellent alternative to standard scav-
enger filter for NO/NO2, scavenging >99.91% NO and 100% NO2 at 10 
and 20 ppm respectively. There was no increase in respiratory system 
resistance and intrinsic PEEP formation over time, while using Contra-
fluran filter.
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Introduction: Lung protective ventilation (LPV) strategies should 
guide ventilatory care throughout the ICU stay. We evaluated 
whether mechanical ventilation followed LPV guidelines through-
out the mechanical ventilation period, with emphasis on the driving 
pressure(ΔP) and their association with 28 and 90 day mortality.
Methods: Retrospective study included 124 patients admitted to ICU 
in the Lady Davis Carmel medical center, Haifa, Israel, during 2019, 
who were mechanically ventilated for at least 48 hours. Ventilatory 
data was collected every 10 minutes for up to 28 days of mechanical 
ventilation in the ICU. We investigated the degree of compliance with 
the LPV guidelines and its association with mortality at 28 and 90 day 
post discharge.
Results: Analysis of the data per patient (mean   ±   SD) revealed ΔP 
of 15.5 ± 3.6 cmH2O, Vt of 7.6 ± 1.4  ml/kgpbw and end inspiratory 
pressure of 23.2 ± 4.5 cmH2O. The median prevalence per patient of 
ΔP > 14 cmH2O was 58% of their ventilation period, Vt > 8 ml/Kgpbw 
was 38% and of end inspiratory pressure > 30 cmH2O was 2% of the 
ventilation period. Fifty-one patients (41%) died within 28 day and 56 
patients (45.2%) within 90 day post discharge. Mean ΔP and amount 
of time spent with ΔP > 14 cmH2O were significantly correlated with 
mortality at 28  day post discharge from ICU: OR = 1.13, 95%CI (1.02-
1.26), p = 0.021; and, OR = 1.02, 95% CI (1.003-1.03), p = 0.015 respec-
tively. At 90 day, the time spent with DP > 14 cmH2O (more than 50% 
of measurements) was associated with increased mortality OR = 2.58 
95%CI (1.2- 5.4), p = 0.012, but the mean ΔP was not. An increase in 
the frequency of elevated ΔP (quartiles) was associated with increased 
mortality (figure). No correlation was found between either Vt or end 
inspiratory pressure and mortality.
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Conclusion: LPV was not always implemented, it is especially shown 
with the high frequency of elevated ΔP values. ΔP was significantly 
associated with mortality regardless of whether the patient had ARDS 
or not. To validate these results, further studies are needed.
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Introduction: The COVID-19 pandemic has seen a surge of patients 
with acute respiratory distress syndrome (ARDS) in intensive care units. 
Although early reports suggested that COVID-19-associated ARDS has 
distinctive features that set it apart from historical ARDS, emerging 
evidence indicates that the respiratory system mechanics of patients 
with ARDS, with or without COVID-19, are broadly similar.1 Prevalence 
of ARDS among COVID-19 patients has been reported to be up to 
17%.2 Among the introduced treatment methods for management of 
ARDS patients, prone position can be used as an adjuvant therapy for 
improving ventilation in these patients.3.
Objectives: The aim of this study was to describe our experience with 
prone position in SARS-CoV2 positive patients. We also compared the 
patients who survived with those who died to understand if there 
were any 28-day mortality predictors.
Methods: We retrospectively studied the patients who tested posi-
tive for SARS-CoV2 admitted in Hospital Beatriz Ângelo (HBA) ICU from 
April to June of 2020. Demographic data, comorbidities, severity scor-
ing scales, PaO2/FiO2, days on mechanical ventilation, number and 
hours of prone position, complications, days at Intensive Care Unit and 
deaths were extracted from medical records and were submitted to 
statistic description and analysis.
Results: There were 62 patients positive for SARS-CoV2 admitted in 
HBA ICU from April to June of 2020, and 39 were mechanically venti-
lated. Twenty patients (32%) were placed in prone position, 65% were 
males. The mean age was 63  years old (minimum 31 and maximum 
83). In relation to the severity criteria, the medium APACHE II score was 
13 points and SAPS II was 37 points.
Half of the patients (10) registered a severe ARDS (P/F ≤ 100) when 
admitted in the ICU and had had symptoms for 8 days before IOT. In six 
patients there was a HNFC trial, without success.
These 20 patients fulfilled on average 5 periods of prone ventilation 
and the mean of prone ventilation hours were 94. The patients were 
ventilated for 32 hours on average before prone position. The first 
prone position lasted a mean of 20 hours.
These patients were intubated on average 15 days. Fifty percent were 
extubated for NIV and in 5 patients was performed a tracheostomy. 
There were complications like accidental extubation (2), exterioriza-
tion of a central venous catheter (1), facial edema (1) and pressure 
ulcers (5).
These patients have been in the ICU for 20 days on average, with a 20 
percent mortality rate in the ICU plus 5% in the hospital  < 28 days.
When we compare the patients that survived with those who died, 
the latter were older (60 years vs 71), had worse SAPS II (34 vs 46) and 
APACHE II (12 vs 16), more days of symptoms until intubated (7 vs 12) 
and hours of ventilation until prone position (25 vs 53). On the other 
hand, we found that patients that survived had an inferior initial p/f 
ratio (118 vs 170).
Conclusion: Even before SARS-CoV2 pandemic we knew ARDS is an 
inflammatory process, with long hospitalization and significant mor-
tality. From our experience, this study seems to show that the sooner 
the patients are intubated and placed in prone position, the best the 
outcome. Further research is needed.
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Introduction: The main respiratory dynamics of invasively ventilated 
COVID-19 patients are still not well known.
Objectives: In this prospective cohort we aimed to observe the 
characteristics of the respiratory system of COVID-19 patients under 
invasive mechanical ventilation and evaluate their relationship with 
mortality.
Methods: Patients admitted to our ICU with COVID-19 (confirmed 
SARS-CoV-2 infection in nasal or pharyngeal swab specimens) and 
invasively ventilated for more than 24 hours were enrolled. Demo-
graphics and laboratory values were recorded at baseline. Respiratory 
variables such as tidal volume, plateau pressure, PEEP, static compli-
ance, driving pressure were recorded daily under passive conditions 
and median values were analyzed. Data are expressed as median (IQR) 
of numbers (%).
Results: 48 patients (33 male) were enrolled between 01 March 2020 
and 01 July 2020. All patients had ARDS. Median age was 64 years (58-
72). Mortality was 60% at day 28. Survivors were significantly younger 
than nonsurvivors. Plateau pressure, driving pressure and static com-
pliance significantly differ between survivors and nonsurvivors. Other 
laboratory values were comparable. (Table 1).
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Characteristics of patients 
Variable Nonsurvivors Survivors p value 
Age, years 66 (62-73) 61 (46-67) 0.021
APACHE II 21 (15-33) 19 (11-21) 0.06 
SAPS 53 (38-79) 47 (40-56) 0.26 
PaO2/FiO2 140 (96-190) 136 (92-229) 0.84 
Vt/kg, ml 8 (7-8) 7 (6-9) 1 
Pplateau, cmH2O 31 (28-33) 28 (24-30) 0.01
PEEP, cmH2O 11 (8-14) 10 (9-12) 0.73 
Pdriving. cmH2O 20 (14-23) 15 (12-18) 0.008
Cst, ml/cmH2O 29 (21-36) 37 (30-50) 0.008
Conclusion: COVID 19 related ARDS seems to have similar character-
istics as other forms of ARDS. Lung protective ventilation with low pla-
teau and driving pressures may be related with lower mortality.
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Introduction: Patients admitted to the ICU with severe COVID-19 
pneumonia present clinical complications during their admission, 
such as endotracheal obstruction due to accumulation of secretions. 
This problem often requires urgent endotracheal tube change and 
manual ventilation, both of which are health risk procedures for the 
generation of aerosols and constitute a potential life-threatening risk 
for the patient.
The model based on Machine Learning (ML) techniques and intelli-
gent computing, using the signals produced by the respirators, consti-
tute fundamental tools for the extraction of common patterns related 
to obstruction, and for the creation of prognostic and therapeutic pre-
diction systems.
Objectives: To study the possibility of predicting the appearance of 
endotracheal obstruction in patients with COVID-19 pneumonia, using 
neuronal computing techniques, integrating the different respiratory 
variables during hospital admission into a model.
Generate a predictive model that follows the time course of patients 
with COVID-19 pneumonia undergoing mechanical ventilation and 
predict the appearance of endotracheal obstruction well in advance.
Methods: Descriptive, observational study using data mining in 22 
patients with Pneumonia due to COVID-19, where 16 of them pre-
sented an episode of endotracheal obstruction during their admission 
to the IMU. Compilation of the respiratory variables Peak Pressure, Pla-
teau Pressure, Medium Pressure, Resistance and Compliance, collected 
at least every 15 minutes during the entire intensive care admission. 
The recording of signals during the hours prior to the development of 
the obstruction is studied, representing the signals collected synchro-
nously and in parallel. To develop a neural computing model, using 
data mining techniques, to analyze the existence of specific temporal 
patterns that help early detection of endotracheal obstruction, hours 
before it occurs.
Results: Based on the designed predictive model, changes in the res-
piratory mechanical signals collected by the system during admission 
to the ICU that precede the development of endotracheal obstruction 
are detected, with an average anticipation of 47 hours.
The model’s output (black line) provides information about lung 
mechanics, from patient admission to endotracheal obstruction 
(green line). Image  1 shows common patterns of changes in lung 
mechanics prior to obstruction. The blue line indicates the start of 
abnormal changes in the registry, thus indicating the start time of the 
alert against possible obstruction. In the studied patients, changes 
in the pulmonary mechanics are observed with an average 47 hours 
before the episode of endotracheal obstruction.
Conclusion: We demonstrate that the application of computational 
intelligence techniques and data mining on lung mechanical signals 
studied, show promising results in the early detection of endotracheal 
obstruction.
This is of great value for the prevention of this complication during 
ICU admission, being useful in reducing the mortality of COVID-19 
patients and reducing biosanitary risk.
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Introduction: The current COVID-19 pandemic has caused a high 
percentage of patients who require critical management due to acute 
hypoxemic respiratory failure with the need for mechanical ventila-
tion. This situation implies a high vital risk in addition to possible res-
piratory complications such as obstruction of the endotracheal tube.
This complication occurs suddenly from the first week of admission, it 
is a medical emergency due to the impossibility of ventilation of the 
patient and implies a high risk of contagion for the health workers due 
to exposure to aerosols.
Data mining and Artificial Intelligence (AI) techniques are a fundamen-
tal tool to create patient profiles, study their common characteristics 
and help predict the evolutionary development of this disease.
Objectives: Design and develop a computational predictive model 
to study the evolution of patients with COVID-19 pneumonia with 
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mechanical ventilation. Analyzing the clinical variables that help pre-
dict the development of endotracheal obstruction over time.
Methods: We recorded the clinical variables (heart rate, systolic blood 
pressure, diastolic pressure, mean pressure, oxygen saturation, and 
temperature) of all patients at least every 15 minutes during the entire 
intensive care admission. The variables were The set of variables were 
studied, represented in graphs synchronously and in parallel.
Through data mining and the development of neural networks, a com-
putational model was generated that helps early detection of endotra-
cheal obstruction.
Results: In our unit, of the 22 patients with COVID-19 Pneumonia 
who required mechanical ventilation, 72.7% had at least one episode 
of endotracheal obstruction. 100% of these events took place after 
7 days of admission.
The predictive model detects changes in the clinical variables studied 
that precede the endotracheal obstruction with an average advance 
of 42 hours.
In the Image  1, the changes observed in the clinical variables pre-
cede the development of endotracheal obstruction (green line). It 
shows common patterns of disturbances in the studied signals prior 
to obstruction. The blue line shows the start of abnormal registry 
changes indicating the time.
In the studied patients, clinical changes are observed with an average 
42 hours before the endotracheal obstruction.
Conclusion: The use of signal recording of clinical variables, studied 
techniques using data mining and RNN techniques, show promising 
results in the early detection of endotracheal obstruction, being of 
great value for the prevention of this complication during ICU admis-
sion, reducing mortality of the Covid-19 patients as well as the risk for 
the health workers.
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Introduction: Continuous Positive Air Pressure (CPAP) treatment is 
used when approaching patients with dyspnoea in the prehospital 
(PH) setting1. Despite being one of the best treatment strategies for 
this clinical condition, CPAP is an aerosol generating procedure. There-
fore brought insecurity to the emergency PH teams and challenges to 
maintain its application. In order to promote its safe use the Depart-
ment of Emergency Medicine (DEM) of the National Institute for Medi-
cal Emergency (INEM), modified the procedure promoting security.
Objectives: To analyse prehospital CPAP use in two homologous peri-
ods, before and during the COVID-19 pandemic.
Methods: A case series of CPAP used by Lisbon Immediate Life Sup-
port ambulance (SIV- ambulance staffed nurse), before and during 
COVID-19 pandemic will be compared. For this purpose, patients 
records between 1st of March and 30th July 2019 and the same period 
in 2020 were extracted from the ITEAMS clinical record (INEM Tool for 
Emergency Alert System), concerning the application of dyspnoea 
protocol3,4 where CPAP is recommended.
Results: Between 1st of March and 30th July 2019, dyspnoea protocol 
was applied in 121 patients, resulting in 11 uses of CPAP (9%). For the 
same period in 2020 (COVID-19 pandemic period), dyspnoea protocol 
was applied in 80 patients, resulting in 4 CPAP applications (5%). How-
ever, it should be considered that at the beginning of the pandemic 
in Portugal the use of CPAP was discouraged. Only after 28th of April 
2020, when a safer method of CPAP was suggested, nurses felt com-
fortable and secure to use this treatment.
Between 1st of May and 30th July 2020, dyspnoea protocol was 
applied to 39 patients, resulting in 3 CPAP uses (7.7%), compared to 
the same period in 2019 when dyspnoea protocol was applied in 66 
patients, resulting in 4 CPAP uses (6%).
Conclusion: The use of CPAP in PH is essential to maintain quality of 
care for patients with dyspnoea. Its use was decreased at the begin-
ning of the pandemic in Portugal but measures were implemented 
promoting the safe use of CPAP. The results demonstrate the mainte-
nance and even an increase in the use of CPAP compared to the same 
period in 2019 (7.7% in 2020 vs 6% in 2019). Until now, no staff mem-
ber of the SIV Lisboa ambulance had COVID-19. This analysis refers to 
one out of the 40 SIV ambulances with nurses in Portugal, which is not 
sufficient to national extrapolation of data.
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Introduction: Experience from the use of high-flow nasal oxygen 
(HFO) in acute hypoxemic respiratory failure (AHRF) (1), indicates that 
this method of respiratory support may reduce the invasive mechani-
cal ventilation requirement of patients with COVID-19, depending on 
the degree of V/Q matching, and may be an appropriate therapy when 
conventional oxygen therapy does not provide sufficient respiratory 
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support. However, its application is controversial, particularly for the 
risk of aerosolization.
Objectives: To describe the characteristics and identify prognostic 
factors in response to the application of HFO as first line of respiratory 
support of patients Covid-19 with AHFR.
Methods: Analysis of prospectively collected data of 41 patients with 
pneumonia Covid-19, confirmed by RT-PCR assay, admitted to our 
polyvalent ICU of terciary hospital (34 bed), from 22 March to 5 May 
2020. Patients with moderate AHRF (PaO2/FiO2 100-200 at admission) 
were included. Excluded patients were  <  18, immediate mechanical 
ventilation (MV) criteria, hypercapnia or given HFO as a tool to wean-
ing from MV. The HFO was applied using Philips  V60® ventilator and 
Fisher &  Paykel® MR850 device, flow 40-60 L/min, FiO2 for SpO2 ≥ 
92%. We compared baseline characteristics, physiological, prognosis 
parameters, and Rox index in the first 12  h, as ratio of SpO2/FiO2 to 
respiratory rate (2), according to success or failure HFO. For statistical 
analysis we used U-Mann-Whitney or Fisher test as appropriate. Prog-
nosis of success of HFO was calculated as sensitivity and specificity, 
relative risk (RR) (95% CI) and ROC curves for ROX index. The literature 
determines the cut-off point at 12 h at 4,88.
Results: Among 41 patients with AHRF Covid-19 admitted to the ICU, 
20 (48.78%) were intubated on admission. Altogether 21 (51.22%) 
patients were eligible for HFO, 15 (71.43%), were defined as success 
which was regarded as no escalation to non-invasive ventilation, MV, 
ECMO or death within 28  days after commencement of HFO. Char-
acteristics patients are shown in Table  1, the two group were well 
matched, only SOFA scores shown significant difference in failure HFO. 
Overall ICU mortality: 11 (26.83%), MV vs HFO: 8 (19.5%) vs 3 (7.3%) 
(p  = 0.015). Parameters related to outcome see Table 2. ROC analysis 
for ROX index showed an AUC of 0.889 (95% CI 0.697 – 0.988). A cut-
off ≥ 5.57 was associated with the best index for success, sensivity of 
0.93 (95% CI 0.75-0.91), and specificity of 0.83 (95% CI 0.41-0.98), PPV 
of 0.94 and NPV 0.83. RR 6 (95% CI 1.47-24.42).
Conclusion: In our sample of Covid-19 patients, the Rox index at 
12 h allowed us to predict with accuracy the response to HFO with a 
cut value of 5.57, similar to the cut value describe in the literature for 
other causes of moderate AHRF. SOFA index value could be helpful in 
selecting the patients who could benefit from HFO. Careful selection 
of patients to whom HFO is applied as first-line treatment is neces-
sary, since those who fail and delay intubation have high mortality and 
higher stay in ICU. Data need to be confirmed in wider population.
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Introduction: COVID-19 pandemic is an international health problem. 
Declared a worldwide pandemic by World Health Organization (WHO) 
in February 2020, the main complication causes severe acute respira-
tory syndrome (SARS-CoV-2) progressing to hypoxemia, requiring high 
oxygen fractions and invasive ventilation. The growing number of 
patients requiring invasive ventilatory support and the limited num-
ber of mechanical ventilator overload of the health systems. Alterna-
tive ventilatory support strategies are need for these individuals with 
COVID-19.
High-flow nasal cannula (HFNC) get attention as an alternative 
resource of ventilatory support for patients with severe hypoxemia.
Objectives: The primary outcome this study was to evaluate the pro-
portion of patients that HFNC avoided tracheal intubation.
Methods: We realized a retrospective observational study of the 
patients that received HFNC as ventilatory support for treatment of 
acute respiratory failure because COVID-19.
Results: This study analyzed a total of 16 patients who used high flow 
nasal cannula (HFNC) for treatment of hypoxemic acute respiratory 
failure on patients with COVID-19, between the patients, we analyzed 
a subgroup of 5 patients who received combined therapy. For the pur-
poses of this we classified combined therapy as HFNC and noninvasive 
ventilation (NIV). The rate of success for avoid tracheal intubation was 
69% on HFNC group and 100% on combined therapy group, the aver-
age time of use of therapy was 4 days versus 6 days respectively, we 
also analyzed the time of duration on hours that was 92,8 (SD  ± 64,7) 
hours versus 134,4 (SD  ± 84,2) hours respectively. This study verified 
that the most of patients presented the worst radiologic pattern but 
doesn’t seem influenced on outcome.
Conclusion: High-flow nasal cannula was feasible, and it seems to be 
an efficient in avoid tracheal intubation in patients with COVID-19. The 
effect of HFNC in COVID-19 survival should be further investigated in a 
large prospective study.
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Introduction: Acute hypoxemic respiratory failure and ARDS are com-
mon in COVID-19. The benefit of continuous positive airway pressure 
(CPAP), and associated risks of viral transmission through aerosoliza-
tion, are unclear. Discouraging noninvasive ventilation (NIV) in the 
COVID-19 patient may increase the need for intubation and induce 
increased morbidity and mortality and led to rapidly saturation of 
resources and the availability of ICU bed. Some studies suggest that 
helmet CPAP can represent an effective alternative to improve the 
hypoxemia and decrease the risk of droplets’ air-dispersion.
Objectives: To evaluate, the safety and efficacy of face mask CPAP in 
COVID-19 patients with acute hypoxemic respiratory failure.
Methods: Retrospective descriptive observational cohort study 
was conducted, from Mars 25, 2020, to July 28, 2020, in King Fahad 
armed forces hospital, Kingdom of Saudi Arabia. We included all 
adult patients with confirmed COVID-19 pneumonia and developed 
acute hypoxemic respiratory failure defined by PaO2/FiO2 less than 
300 mmHg and required CPAP. We collected baseline data on demo-
graphics, clinical presentation, laboratory, arterial blood gas, ventila-
tion setting, and the outcomes, mainly the rate of tracheal intubation, 
the rate of Health care workers (HCWs) contaminated by SARS-CoV2, 
the length of stay and the rate of mortality. The failure of CPAP was 
defined by the requirement of tracheal intubation. We determined 
by multivariate analysis, the independent predictive factors of CPAP 
failure.
Results: Of the 86 patients included in the study, the median (IQR) age 
was 62 (54-70) years and 58 (67.3%) were male. 78 patients (90.7%) 
had at least one comorbidity. The median (IQR) of SOFA score and 
APACHE II score were 4 (3-5) and 9 (7-13) respectively. The median 
time from first symptom to CPAP was 7.0  days. The median level of 
CPAP and FiO2 were 10 cmH2O and 0.5, respectively. The median 
(IQR) PaO2/FiO2 was 143 (120-169) and 13 patients (15.1%) had severe 
acute respiratory distress syndrome. The prone position with CPAP was 
performed in 31 patients (36%). The methylprednisolone was admin-
istered to 70 patients (81.4%) and empiric antibiotics to 83 patients 
(96.5%). The rate of failure of CPAP was 17.4% (15 patients) among 
them 3 patients was intubated within the first 24 hours of admission. 
The SOFA score at admission more than 4 [OR, 4.63; 95% CI, 1.11–
19.33; P  =  0.035) and PaO2/FiO2 at admission less than 140  mmHg 
(OR, 11.22; 95% CI, 2.44–51.61; P  =  0.002), were independent risk fac-
tors of CPAP failure whereas the proning during CPAP (OR, 0.067; 95% 
CI, 0.01–0.41; P  =  0.004) was a protective factor. One nurse caring for a 
patient was infected with SARS-CoV2. The median (IQR) length of stay 
was 9 (7-12) days and 6 patients (7%) had died.
Conclusion: The face mask CPAP as respiratory support for COVID-19 
pneumonia with acute hypoxemic respiratory failure, is effective and 
safe. The rate of CPAP failure is less than 18% and the 3 predictive fac-
tors of failure were, SOFA score at admission, PaO2/FiO2 at admission 
and the use of prone position during CPAP.
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Introduction: The recent COVID-19 pandemic has been dramatically 
aggressive in the region of Lombardy: the overwhelming number of 
patients who needed intensive care during the peak of the health 
emergency, exceeded the available resources. This crisis led to a revi-
sion of the usual admission criteria to the ICU: patients with a higher 
expectation of survival had priority access to ICU. Outside the ICU, 
the highest ventilatory care was CPAP helmet (up to 12 cmH20 PEEP 
and FiO2 0.8). Looking backward to those daunting weeks, we noticed 
some anecdotal cases who survived in medical wards despite severe 
COVID acute distress respiratory syndrome (C-ARDS) without mechani-
cal ventilation (MV).
Objectives: Hence, we retrospectively compared mortality rates 
between elder C-ARDS patients treated with MV vs CPAP helmet.
Methods: We retrospectively analyzed the outcomes of patients with 
severe C-ARDS. Two groups were made: first, CPAP group with elder 
patients (age 70-79) treated with CPAP helmet (with no access to ICU) 
with a refractory hypoxemia (P/F  <  150 for more than 48  h regard-
less the administration of CPAP helmet); second MV groups, made of 
patients assisted with an endotracheal tube (ETT) and ventilated with 
positive pressures, aged 55-69, and elder ones, aged 70 -78. Addition-
ally, we collected the maximal d-dimer values per each patient before 
and after the placement of the ETT.
Results: We hospitalized 493 patients with covid respiratory distress 
syndrome. CPAP group (n = 22) had a lethality rate of 50%. The lethal-
ity of the MV group aged 55-69 (n = 31) was 52%, while about the 
elder CMV group (n = 13) 77% died. We found a significant increase (p 
value  <  0.05) in plasmatic d-dimer after CMV begun: mean values pre 
- ETT (n = 15) 8362 μg/dl (CI  ±  5987); mean values post - EET (n = 30) 
21846 μg/dl (CI  ±  10781).
Conclusion: Among patients with C-ARDS, we found only a slight dif-
ference in mortality between the population admitted to ICU (receiv-
ing MV) and the population not admitted (receiving CPAP helmet). 
Considering the thrombophilic condition caused by SARS COV2 
infection, we raise the question if an aggressive invasive respiratory 
approach is advisable compared to a more gradual approach. How-
ever, we can not exclude that, in spite of similar hypoxemia, the ICU 
patients had a more severe clinical picture liable for the worse out-
come. We acknowledge the limitations of our sample, but our results 
are interesting in light of a “less is more” strategy.
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Introduction: Non-invasive ventilation (NIV) consists of respira-
tory support without the need for intubation. NIV has been used in a 
plethora of clinical situations such as acute pulmonary oedema, acute 
respiratory failure in patients with chronic pulmonary disease and 
obstructive sleep apnoea (1).
The application of positive pressure in the thoracic cavity has both 
positive and negative hemodynamic effects. It impairs the venous 
return to the right heart and the blood flow to the pulmonary arteries 
(reduced RV preload, increased afterload) but aids the flow of blood to 
and from the left ventricle (increased LV preload, decreased afterload) 
(2).
Objectives: The aim of this pilot trial is to investigate the impact of dif-
ferent levels of NIV on hemodynamics in a group of 5 healthy subjects.
Methods: The study protocol was approved by the ethical committee 
of UZ Brussel (B.U.N. 143201940980) and registered at clinicaltrials.gov 
(NCT04178694).
NIV (V60, Philips) was administered with an oro-nasal mask at an 
expiratory positive airway pressure (EPAP) of 4 cmH2O and a pressure 
support (PS) of 0 cmH2O. The subjects were allowed to adapt to the 
treatment for 5 minutes. Then, PS was gradually increased by 2 cmH2O 
every 2 minutes until an inspiratory positive airway pressure (IPAP) of 
12 cmH2O had been reached and held for another 2 minutes.
Non-invasive hemodynamic monitoring  (Nexfin®) was used to moni-
tor a range of hemodynamic parameters.
We analysed our data by simple linear regression with Graphpad 
 Prism®.
Results: Although the IPAP increased, the heart rate (HR) of the test 
subjects did not significantly rise (slope 0.189;  R2 0.57; p 0.085). How-
ever, the diastolic blood pressure (DBP) significantly rose (slope 0.507; 
 R2 0.68; p 0.043), the systolic (SBP) and mean arterial blood pressure 
(MAP) also went up but not significantly (slope 0.832;  R2 0.60; p 0.070 
and slope 0.536;  R2 0.65; p 0.054).
The stroke volume index (SVI) dropped significantly at higher IPAP 
levels (slope -0.164;  R2 0.82; p 0.014), the cardiac index (CI) diminished 
slightly but the change was not significant (slope -0.005;  R2 0.52; p 
0.108).
Both the systemic vascular resistance index (SVRI), a surrogate for 
afterload, and the dP/dt, which is a measure for LV contractility as it 
represents the ratio of pressure change in the LV during the isovolu-
metric contraction period, increased but not by a statistically signifi-
cant amount (slope 20.42;  R2 0.65; p 0.053 and slope 13.44;  R2 0.65; p 
0.051).
Conclusion: This pilot trial suggests that NIV induces hemodynamic 
changes in healthy volunteers. These changes appear to be related to 
the amount of IPAP applied.
Following a decline in venous return, a decreased stroke volume and 
cardiac output may trigger baroreceptors in the cardiovascular sys-
tem. The activation of these receptors could augment sympathetic 
tone, resulting in a blood pressure rise, an increase in HR, SVR and 
contractility.
A follow-up trial on a larger population is needed to confirm and vali-
date these results.
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Introduction: The optimal management strategy for respiratory sup-
port in covid-19 remains unclear. A low threshold for invasive ventila-
tion in patients with moderate to severe respiratory failure has been 
advocated by some. The use of NIV in MERS, a similar coronavirus, had 
a high risk of failure. In addition, the hypothetical risk of patient self-
inflicted lung injury (PILI) raised concerns that CPAP may be detrimen-
tal in Covid-19. However, use of CPAP avoids associated morbidity of 
invasive ventilation and is less burdensome on healthcare resources.
Objectives: Primary: To establish the success of CPAP for respiratory 
failure secondary to covid-19; defined as avoidance of invasive ventila-
tion, liberation from CPAP and discharge from hospital in those appro-
priate for escalation of care.
Secondary: 1. To establish incidence of intubation and ventilation fol-
lowing CPAP and compare mortality rates for patients for those that 
were invasively ventilated on admission to ICU compared to those 
that had a period of CPAP prior to invasive ventilation. 2. To identify 
associated factors of those patients on CPAP that required intubation 
and ventilation.
Methods: A single centre retrospective observational study of all 
patients managed with CPAP for respiratory failure secondary to 
Covid-19 from 10th March to 21st May 2020. Patients positive for SARS 
CoV2 RNA and those with a clinical diagnosis of covid requiring res-
piratory support were included. Further respiratory parameters were 
collected from a subset of 45 patients admitted between 16th March 
to the 3rd April 2020.
Results: 37 of 61 patients (60%) who received CPAP and were appro-
priate for escalation of care were managed successfully on CPAP alone. 
No patients that were appropriate for escalation died without escala-
tion of care. Of those that required invasive ventilation (n = 24) mortal-
ity rates in those that had prolonged CPAP prior to invasive ventilation 
was not increased compared to those intubated immediately. In those 
where CPAP was the ceiling of care, outcome was poor; mortality rate 
58% (19 of 33).
Table 1: Outcome of patients suitable for escalation who received CPAP 
Outcome Survival n (%)
CPAP only, n=37 37 (100%) 
Invasive ventilation following <48 hr 
CPAP, n=8
3 (38%) 
Invasive ventilation following >48hr 
but <7 days of CPAP, n=11
5 (45%) 
Invasive ventilation following >7 
days of CPAP, n=5
4 (80%)  
Immediate invasive ventilation 
without CPAP, n=8
5 (63%) 
All patients managed initially with 
CPAP who were appropriate for 
escalation, n=61
54 (89%) 
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Table 2: Respiratory parameters of those who progressed to invasive ventilation compared 
to those that were managed successfully on CPAP alone. 
SF = oxygen saturations / fraction inspired oxygen. ROX = ratio of pulse oximetry/FIO2 to 









SF pre CPAP 120 [116-152] 153 [120-160] 0.08 
ROX index pre CPAP 5.28 [3.54-6.22] 5.94 [5.32-7.15] 0.12 






Change in ROX during 
CPAP
1.2 [-0.16-1.83] 1.8 [0.35-4.16] 0.23 
Days on CPAP 1.5 [1-3.5] 3 [1.25-5.75] 0.23 
S:F ratios and ROX index were significantly lower in patients trialled on 
CPAP that went on to require invasive ventilation.
Conclusion: Patients with Covid-19 that present with respiratory fail-
ure could be managed with an initial trial of CPAP in a well controlled 
and monitored area. It is likely that a third of these will progress to 
needing invasive ventilation, but two thirds are likely to escape the 
need for intubation and ventilation. This has a tremendous impact 
on resource allocation, ICU bed days, length of stay, and complica-
tions associated with intubation and ventilation. SF ratio and ROX 
index may play a role in differentiating between patients that are 
likely to improve with CPAP alone and those that will require invasive 
ventilation.
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Introduction: Available data suggests that 5–20% of patients with 
Coronavirus Disease-2019 (COVID-19) develop acute hypoxemic 
respiratory failure (AHRF) (1). Guidelines have given a weak recom-
mendation for non-invasive positive pressure ventilation (NIPPV) as 
a preventive strategy for avoiding intubation in this scenario (2). As 
such, the procedure should only be considered in selected COVID-19 
patients with AHRF and without major organ dysfunction.
Objectives: To assess the effect of NIPPV on the rates of invasive 
mechanical ventilation (IMV) and in-hospital mortality in a series of 
patients with COVID-19 and AHRF.
Methods: Consecutive patients from a single center with confirmed 
COVID-19 admitted between March 1st and July 20th, 2020 were ret-
rospectively analyzed. Patients were stratified according to an 8-point 
ordinal scale recommended by the World Health Organization for use 
in clinical research among hospitalized patients with COVID-19, and 
only those with severe disease (score ≥ 5) were included (3). Clini-
cal variables and the respiratory support strategy were correlated to 
IMV requirement and in-hospital mortality. Categorical data were 
expressed by percentages and continuous variables were repre-
sented by the median with the 25th to 75th percentile interquartile 
range (IQR). Multivariate logistic regression models were performed to 
determine independent associations. A p value  < 0.05 was considered 
significant.
Results: Nine two patients were included, of which 61.9% were male, 
with a median age of 72 years (IQR 60.5-84). Significant comorbidities 
were hypertension (48.9%), diabetes (25%), cardiovascular disease 
(CVD) (10%) and obesity (10%). Sixty nine (75%) patients received 
NIPPV for a median of 5 days (IQR 1-13.5), of which 44 (63.8%) did not 
require IMV. NIPPV was significantly associated with a lower frequency 
of IMV (36.2% vs 87%, p < 0.001), even when adjusted for age, sex, 
hypertension, diabetes, obesity and underlying cardiovascular dis-
ease (OR 0.08 [95% CI 0.02–0.3], p < 0.001). The overall mortality rate 
was 32.6% (n = 30), and was lower in those treated with NIPPV (26.1% 
vs 52.2%, p = 0.02). In the multivariate analysis, NIPPV remained asso-
ciated with lower mortality (OR 0.25 [95% CI 0.08–0.84], p < 0.001), 
whereas age ≥75 years was predictive of death (OR 12.2 [95% CI 3.4–
43.1], p < 0.001).
Conclusion: In a series of patients with COVID-19 and AHRF, NIPPV 
was significantly associated with a lower frequency of IMV and in-hos-
pital mortality. Identifying patients who may benefit from NIPPV and 
determining predictors of failure from the intervention are key factors 
to adequately allocate resources and improve clinical outcomes.
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Introduction: High-flow oxygen therapy via nasal canula (HFNC) is 
a technique that delivers heated and humidified oxygen through 
short nasal prongs at high flow rates. Its great tolerability and positive 
results of its use in pneumonia, immunocompromised patients and 
ventilatory weaning have highlighted it as a first-line option for some 
of these conditions. Recent data show that it’s the only non-invasive 
ventilatory technique that doesn’t increase death space during ven-
tilatory support, allowing for continuous air renewal, minimizing the 
risk of hypercapnia. HNFC allows to oxygenate critical patients with 
isolated hypoxemia, preventing intubation alllowing the lung to heal. 
It is the only device that oxygenates critical patients without compro-
mising communication or feeding. It’s benefical effect on the epithe-
lial lining makes it an option even in chronic obstructive respiratory 
disease.
Our study illustrates a 14  months experience in a secondary care 
center, since HNFC acquisition. The team based their strategies on the 
local protocol that relied on starting with maximum temperature, O2 
Flow and FiO2, and decrease support after 2 hours.
Methods: We performed a retrospective study with a descriptive 
analysis of HFNC’s application in our Secoundary Care Center Intensive 
Care Unit (ICU), from February 2019 through June 2020.
Results: In 14 months a total of 33 patients were treated with HNFC. 
The mean age was 63.5  years and 63.6% of the patients were male. 
The average duration of HNFC was 2 days. The major condition for its 
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use was acute respiratory failure (72.7%). In 18.2% it was used for ven-
tilatory weaning. In 3 cases it was applied in patients with a do-not-
intubate order. The most common diagnosis was community acquired 
pneumonia (54.2%). HNFC was successful in 51.5% of the cases, with 
pneumonia being the most common successful condition (58.8% of 
the successful cases). In the cases of failure, 25% had COVID-19 pneu-
monia, and 31.3% presented with associated multiorgan disfunction. 
50% needed invasive mechanical ventilation, while 25% proceeded 
successfully with non-invasive ventilation (NIV) with positive pressure. 
When HNFC was used for ventilatory weaning, 66.7% had a successful 
outcome.
Conclusion: Literature on HFNC includes an heterogenous group of 
patients with diverse clinical diagnosis. It is increasingly applied in 
adults with hypoxemic respiratory failure with diverse etiologies. As 
observed in our report, diverse studies present pneumonia as the most 
common cause of respiratory failure in patients selected for HFNC. 
Some studies assessed the need of intubation after a HFNC trial and 
found that only 30% required intubation after failure of HFNC. In our 
study the “failure rate” was approximately 48.5%. HNFC delayed use 
in patients with advanced stage disease and multiorgan disfunction 
might explain these results. The development of studies to determine 
which group of patients benefit the most from HFNC is imperative. The 
25% patients with HFNC failure that progressed successfully to NIV 
raise the question whether they had a limitation for the technique that 
was not initially identified by the physician. The possibility of avoiding 
intubation in patients with severe hypoxemia worths the trial, even in 
cases with uncertain predicted responsiveness. It is fundamental to 
watch closely the evolution of these patients because, besides its ben-
efits, HNFC shall not delay intubation when it is needed.
03. AIDS, hematologic-oncologic issues in the ICU > AIDS, hemato-
logic-oncologic issues in the ICU.
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Introduction: Patients with cancer are at risk of being admitted to 
the intensive care unit (ICU) with a mortality rate similar to that of the 
general ICU population (30-65%) (1). Prognosis factors are described 
for general ICU patients, while there is scarce information about such 
factors in critically ill patients with hematological malignancies. Hence, 
to provide better care for our patients, more information is needed.
Objectives: To describe the characteristics of patients with hemato-
logic malignancies (HM) admitted to the ICU, and to determine the 
association between already known prognostic factors and mortality 
in our population.
Methods: A descriptive-analytical, cross-sectional study was done. 
Adult patients with HM admitted to the ICU from Jan 2008 – Dec 2018 
at Hospital Universitario Fundación Santa Fe de Bogotá, Colombia, 
were enrolled. Demographics, disease stage, disease-specific param-
eters, laboratory results, hospital course, and outcomes were gathered 
from medical charts and analyzed using SPSS ver. 25.
Results: From the 185 patients enrolled, most were men (56.8%), 
the mean age was 63  years, and ICU admission was mostly due to 
cardiovascular causes (17.9%). Lymphoma (43.2%) and multiple 
myeloma(MM) (28.1%) were the most frequent hematologic diag-
nosis, and the majority were diagnosed recently (49.7%). More than 
half (~65%) were receiving acute treatment, either induction therapy 
(45%) or rescue therapy (18.3%). Around 29,1% of patients required 
vasopressors and 25,4% required mechanical ventilation, with a mean 
duration of 3.34 (1-21), and 5.45 (1-26) days respectively. Overall mor-
tality was 31.3%, divided into ICU mortality of 21,6% and in hospital 
mortality of 9,7%.
Subgroup analysis for HM type showed a difference in mortality 
rates. Lymphoma patients had greater mortality (41.3%), followed by 
acute leukemias (29.3%), and MM (24.1%). Nevertheless, this differ-
ence was not statistically significant. On the other hand, mortality was 
more common in patients undergoing induction (24.48%) and rescue 
(22.41%) chemotherapy.
The bivariate analysis showed that male sex (OR:2.18,p:.022), previ-
ous diagnosis of non-hematological malignancy (OR:2.17,p:.043), 
neutropenia on admission (OR:2.11,p:.038), disseminated intravas-
cular coagulation (OR:4.49,p:.012), alveolar bleeding, (OR:9,86,p:.03), 
requirement of mechanical ventilation (OR:5.99,p: < .001) and transfu-
sion (OR:3.39,p: < .001) were associated with general mortality.
Binomial logistic regression showed that diabetic patients (B:1,638;OR 
2,68;p = ,034), vasopressor requirement (B:2,83; OR 8,31;p =  < ,001) 
and dialysis requirement (B:2,93; OR 8,602;p = ,001) were strongly 
associated with ICU mortality.
Conclusion: Mortality rates in our patients were similar to those 
already described, albeit on the lower end. Lymphoma patients and 
those in induction therapy had greater mortality compared to others. 
Also, hematological causes were the most common cause of admis-
sion for deceased patients. Lastly, in our population, the main predic-
tors of mortality were diabetes, use of vasopressors and hemodialysis 
requirement.
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Introduction: The prognosis of malignant hematological diseases 
has changed in the past few years, making it increasingly frequent 
the admission of these patients to the ICU; but controversy continues 
regarding the real benefit of ICU admission in the long term.
Objectives:
– To describe the baseline characteristics of hematological patients 
admitted to our ICU.
– Identify factors likely associated with higher mortality in these 
patients.
– Description of mortality according to the main causes of ICU 
admission and comparison between them.
Methods: Observational, retrospective and analytical study that 
includes oncohematological patients admitted to the ICU between 
April 2018 and 2020. A database was created in SPSS with the baseline 
characteristics of the patients (demographic, comorbidities, underly-
ing disease, transplantation of hematopoietic precursors, neutrope-
nia), cause of ICU admission, cause of death, respiratory support and 
decision to limit life support treatment. They were then evaluated in 
terms of descriptive statistics with frequencies for qualitative vari-
ables and median, interquartile range for quantitative; Comparisons 
between groups were made using the Student’s t test and chi square 
respectively.
Results: Of the 60 patients included, 25% were admitted in 2018, 
46.7% in 2019 and 28.3% in 2020 so far, of which 28 (46.7%) are women 
and 32 (53.3%) men. Base disease: lymphomas 18 (30%), leukemias 
36 (60%), myelomas 3 (5%), others 3 (5%), relationship with mortality 
(p  =  0.54). Prior to admission, 3 (5%) had received autoHSCT, 24 (40%) 
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alloHSCT and 32 (53.3%) had not yet been transplanted; association 
with mortality (p  =  0.59). 39 (65%) developed neutropenia, with no 
direct relationship to mortality (p  =  0.63). The causes of ICU admission 
were: respiratory failure (56.67%), septic shock (26.67%) and loss of 
consciousness (11.6%), with no difference in mortality between them 
(p  =  0.6). Regarding respiratory support, 45 (75%) required NIMV/
HNFO and 33 (55%) IMV, the latter with higher mortality (p  =  0.003). 
Total mortality in ICU 38 (63.3%), significantly higher than overall unit 
mortality (18.3%), p = 0.001. LTE was decided in 24 patients (40%).
Conclusion: 
– The admissions of oncohematological patients in the ICU are 
increasing in the last years.
– The characteristics that were significantly related to a higher mor-
tality were: age, invasive mechanical ventilation and SOFA score.
– The underlying disease, the cause for admission to the ICU, the 
HSCT, the presence of neutropenia and the requirement for NIMV 
did not present a statistically significant relationship with the mor-
tality of these patients.
– ICU mortality in oncohematological patients, regardless of the 
cause of admission, is higher than the overall mortality in the ICU.
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Introduction: Outcome prediction after Out of Hospital Cardiac Arrest 
(OOHCA) remains challenging with high cost and resource burden. 
Multimodal approach has been adapted in most hospitals as advised 
by the ESICM and ERC (1). Carbon Monoxide (CO) has recently gained 
interest as a molecule with wide ranging physiological properties (2). 
The potential for novel pharmacological intervention is vast and excit-
ing (3,4). Most notably, CO plays an important role in apoptosis related 
cell death with ischaemic-reperfusion brain injury (5–7). We proposed 
that early CO measurment, using COHb as a surrogate marker, corre-
lates with outcome in our OOHCA patient population.
Objectives: We retrospectively analysed Arterial Blood Gas (ABG) data 
to measure COHb blood concentrations in patients admitted from 
OOHCA for an initial 72-hr period. We evaluated COHb with regard to 
our long term follow up outcomes.
Methods: Retrospective data for 94 patients who were admitted 
to our Cardiothoracic Intensive Care Unit (CTICU) after OOHCA dur-
ing 2016. Data collected included: ABG measurements for the 72hr 
period, demographic, and prognostic scores (Intensive Care National 
Audit & Research Centre (INARC) and Acute Physiology and Chronic 
Health Evaluation (APACHE II) and outcome measures (Death and cer-
ebral performance score (CPC) in hospital and at 3-, 6- and 12-month 
intervals).
Univariate analyses of categorical and continuous data were per-
formed to determine differences between Patients who died or 
remained alive following OOHCA. Tabulations of dichotomous or 
categorical variables for comparisons using Chi-square Test. The dis-
tribution of continuous variables was assessed for normality with 
Shapiro-Wilk Test, and Independent Samples Test or Mann-Whitney 
U Tests were used to compare both groups. The Receiver Operating 
Characteristic Curve analysis was required for survival, along with Mul-
tiple Logistic Regression analyses and graphical methods. Friedman 
Repeated Measures Analysis of Variance on Ranks was needed and 
Pairwise Multiple Comparison Procedures (Tukey Test) was used to 
isolate the group of samples that differ from the others.
Results: 94 patients were analysed, and the overall survival was 56%. 
73% of the patients were male and median age was 65 years. Median 
age (p: < 0.001), mean ICNARC score (p: < 0.001), median APACHE II 
score (p: < 0.001), median lowest pH (p: < 0.001), and median lowest 
COHb concentrations in the first 5 hours (p: 0.032) were significantly 
different in the surviving population. Initial 5 Hour Median COHb ≥ 
0.975% had a sensitivity of 0.77 and specificity of 0.49 to predict sur-
vival in our OOHCA patient population with the AUC of 63%.
Conclusion: Initial COHb blood concentration measurements are 
predictive of overall survival in patients presenting to hospital with 
OOHCA. This may be explained by the cytoprotective effects of CO in 
ischaemic-reperfusion brain injury, but further larger scale evaluation 
of the association is planned and required.
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Introduction: OHCA is a common disease with a high mortality with 
the commonest cause being ischaemic heart disease(1). Survival 
ranges from around 1-3% to 20-25%, suggesting that high quality care 
can have significant impact on survival(2). One small study reported 
a survival of 8.1% for Qatar(3). The COVID-19 pandemic caused by 
SARS-CoV-2, initially reported in China in December, 2019, and sub-
sequently announced as a global pandemic by WHO on March 11, 
2020. The first case of SARS-CoV-2 reported in Qatar was on 29th of 
February. More than 90000 cases of COVID-19 have been reported in 
Qatar since February 2020, with more than 145 deaths as of mid-July, 
2020. The risk of viral transmission from patients in OHCA to health 
care workers saw changes in practice recommended in international 
guidelines. Cardiopulmonary resuscitation (CPR) and endotracheal 
intubation according to the centers for disease control and preven-
tion (CDC) are aerosolizing procedures and should be performed using 
full personal protective equipment (PPE), moreover few hospitals told 
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their healthcare worker not to perform CPR or ventilation in patient 
suspected to have Covid-19 diagnosis unless they are wearing full PPE 
(5, 6). Public behavior also changed due to either the restrictions on 
public movement to reduce viral transmission or the fear from coming 
to hospital with COVID-19 cases with many countries reporting falling 
in ED attendances (7). In Qatar all outpatient clinics moved on line with 
possible difficulties for the patients to obtain medications and inves-
tigations, arguably reducing the quality of care provided. Our ED saw 
only small falls in public attendance and the cardiac catheterization 
rate remained stable. All these previously listed factors and changes 
have unknown consequences on the incidence and survival of OHCA 
with possible direct or indirect impact on the quality of care. Previous 
publications have highlighted an increased incidence of OHCA and 
reduced survival during the Covid-19 pandemic. Given these differ-
ences, we collected data on the incidence and survival of OHCA in our 
population.
Methods: Date collection: We developed a dedicated Covid-19 OHCA 
guideline and set up a dedicated team to teach this in our ED. In order 
to ensure rapidly emerging knowledge and to be translated into clini-
cal care we set up a dedicated team to collect data on non-traumatic 
OHCA management and outcomes. We met weekly and adjusted 
our care according to local data, international guidelines and emerg-
ing knowledge on both transmission risk and treatment. The data in 
this report was collected using PAROS (Pan Asian Resuscitation Out-
comes Study) which relay on Ustein complaint data. The Ustein crite-
ria are a standardized data set used internationally to collect data on 
OHCA(4). Data was collected prospectively during Covid-19 outbreak 
from mid-March till mid-June 2020 (12  weeks period). Retrospec-
tive data was collected from the electronic medical records in the 
same period extending from mid-March till mid-June 2019 (12 weeks 
period) using the same template. Both periods data (2019 and 2020) 
was analyzed for the following: incidence, location of arrest, gender, 
age, first assessed rhythm, survival to hospital admission, survival to 
hospital discharge. Comparison graphs were established to show the 
deference between 2019 and 2020 of the same yearly periods. Set-
ting: Qatar has a population of 2.8 million with around 90% being 
non-nationals and a median age of 32.3 years. Hamad General hospi-
tal emergency department (ED) is the largest ED in Doha, Qatar, with 
average ED visit > 1000 patients per day. It is co-located with a dedi-
cated cardiac hospital and receives > 90% of cardiac arrests in Qatar. 
There is 24/7 PCI and an active ECMO service. eCPR was ceased during 
the pandemic to preserve the resource for Covid-19 related respira-
tory failure. Local policy sees around two thirds of OHCA transported 
to hospital. The project was registered along departmental guidelines 
with corporation level approval.
Results: The total number of non-traumatic OHCA during COVID-19 
outbreak period in 2020 was 92 cases compared to 69 cases in non-
outbreak period in 2019. The average weekly incidence of OHCA for 
outbreak period and the non-outbreak period were 7 and 5.3 respec-
tively. survival to hospital admission (SHA) and Survival to hospital dis-
charge (SHD) were in outbreak period (28.3%) and (11%) respectively, 
compared to the non-outbreak period where SHA (43.5%) and SHD 
(22%).
Conclusion: Two reports from Europe showed an increase the OHCA 
incidence during COVID outbreak. The first one in Lombardy, Italy (8) 
and the second one in Paris, France (9). There is an increase in OHCA 
incidence during COVID-19 outbreak in Qatar. This result might be 
partly related to the effect of COVID-19 outbreak. Unusual unexpected 
situation like Outbreak or a crisis might have an impact on health care 
system by direct or indirect ways. healthcare provider training and 
population education might mitigate that effect.
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Introduction: Weaning and tracheal extubation of post-operative ICU 
patients is a stressful procedure which triggers the sympathetic nerv-
ous system leading to potential deterioration of cardiac performance 
in patients with left ventricular dysfunction. This study was conducted 
to compare the efficacy and safety of Landiolol, a novel ultra-short-
acting-beta-1 blocker with those of Esmolol in cardiovascular response 
during the extubation of patients with heart failure.
Methods: Thirty-nine patients with heart failure [LVEF (%): 36.6 ± 7.6, 
NYHA Class III/IV (n): 32/9] 　were randomly divided into two groups: 
Landiolol group of 19 patients and Esmolol group of 20 patients. Lan-
diolol infusion at the rate of 4 μg/Kg/min and Esmolol infusion at the 
rate of 100/Kg/min was started as soon as the procedure of weaning 
began. Heart rate (HR) systolic arterial pressure (SAP) diastolic arterial 
pressure (DAP) mean arterial pressure (MAP) and cardiac rhythm were 
recorded every minute up to 30 min after the extubation of trachea.
Results: Mean age, LVEF, NYHA Class, Acute Physiology and Chronic 
Health Evaluation II and Sequential Organ Failure Assessment score 
were similar between the two groups. Landiolol produced a more 
rapid and substantial decrease in HR than Esmolol (-40 ± 20 vs 
-30 ± 16 bpm) without any deterioration of hemodynamics. Significant 
reduction of MAP was recorded in the Esmolol group.
Conclusion: Landiolol more rapidly and more potent reduced the HR 
than Esmolol. Significant reduction of MAP was recorded only in the 
Esmolol group.
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Introduction: Massive pulmonary embolism is a life-threatening com-
plication of the patient admitted in intensive care unit (ICU) and the 
consecutive hemodynamic instability or cardiogenic shock is some-
times accompanied by unusual blood gas alterations. If hypoxemia 
and hypocapnia are usual, hypercapnia in embolic disease is rarely 
reported in the literature and is the result of increased dead space ven-
tilation due to extensive embolic vascular obstruction.
Objectives: So the aim of this study was to hypothesize that the pres-
ence and persistence of hypercapnia during pulmonary embolism 
would be a marker of severity and of poor prognosis.
Methods: we retrospectively collected data from a group of 15 ICU 
patients (group 1) who presented hypercapnic pulmonary embolisms 
from 2017 to 2019 and compared them with those of a group of 15 
patients (group 2) presenting pulmonary embolisms with normocap-
nia or hypocapnia, between 2012 and 2015. The number of patients 
with hypercapnic pulmonary embolisms being rare, we compared 
them with an identical number of patients presenting pulmonary 
embolisms with normocapnia or hypocapnia. The patients of the 2 
groups were aged 68- + 7  years, weighing 75 + -6  kg, without pre-
vious cardiac or pulmonary pathology. The patients of the 2 groups 
were in spontaneous ventilation and breathed oxygen between 6 to 
10  l/min. On admission to ICU, we monitored and recorded systolic 
arterial pressure (SAP) with a catheter inserted in radial left artery and 
evaluated with echocardiography, cardiac index (CI) and systolic pul-
monary arterial pressure.(SPAP).We measured blood gases, lactate,BNP 
from the arterial wave line and finally we evaluated ICU mortality in 
each group.
Results: .Statistical analysis was performed using Student ‘s t test. 
Results were expressed as mean +- standard deviation.
We observed that Pco2 (mmHg) in the group of patients presenting 
hypercapnic pulmonary embolism (group 1) was obviously different 
than in the group of embolism with hypocapnia (group 2), respectively 
51.41+-4.10 vs 28.86+-1.18. P < 0.0001.However, Po2 (mmHg) was 
not different between group 1 and group 2,respectively 74.33+- 4.8 
vs76.33+-1.87 P < 0.14. SAP (mmHg) was in the group 1 significantly 
different of SAP of the group 2, respectively 79.2+-8.3 vs 102.06+-5.73 
P < 0.0001. Similarly, SPAP (mmHg) was different between group 1 and 
group 2 respectively 55.46+-2.50 vs 44.8+-1.78. P < 0.0001. CI was dif-
ferent between group1 and group2, respectively 1.85+-0.09 vs2.28+-
0.14 P < 0.0001 . The value of BNP(Pg/ml) was more elevated in group 
1 than in group 2 respectively 2888.33+-827 vs 1722+-291 P < 0.0001. 
Similarly, Blood lactate concentration(mmol/l) was higher in group 1 
than in group2,respectively 4.78+-1.14 vs 3.69+-0.77.P < 0.005.ICU 
mortality,despite any therapeutic, was higher in the group 1 than in 
the group 2 respectively 50% vs 40%.
Conclusion: We can observe that massive pulmonary embolisms 
with hypercapnia seem to have a worse prognosis than those which 
are,accompanied by hypocapnia or normocapnia.
The persistence of hypercapnia in a patient with previously healthy 
lungs indicates that 50% or more of the lung is underperfused 
and prompts the use of either thrombolytic therapy or surgical 
intervention.
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Introduction: Upper gastrointestinal bleeding (UGIB) is an emergency 
requiring prompt management to achieve favorable outcomes(1). It 
presents with hematemesis and/or melena (1), and may be followed 
by hemodynamic instability. Hemorrhagic gastritis and peptic ulcer 
disease make up for 75% of UGIB etiologies, while esophageal varices, 
esophagitis, duodenitis, andMallory-Weiss syndrome represent the 
remaining causes (2).
However, in our population, knowledge about the epidemiologi-
cal characteristics is scarce. Therefore, to correctly utilize our limited 
health resources, information regarding patients in our territory is 
needed.
Objectives: The objective is to characterize UGIB patients admitted 
into the intensive Care Unit (ICU) in a Latin American hospital and 
to determine the presence of prognostic factors associated with ICU 
mortality, in-hospital mortality and rebleeding.
Methods: An analytical, cross-sectional study, was carried out. UGIB 
patients admitted to the ICU between Jun/2013-Jun/2018 in a hos-
pital in Bogotá, Colombia were enrolled. Demographics, comorbidi-
ties, clinical presentation, laboratory results, management, predictive 
scores, clinical course, complications and outcomes were retrieved 
and analyzed using SPSS ver.25. Descriptive analysis was done along-
side a correlation matrix and binomial regression using outcomes such 
as rebleeding, ICU mortality and in hospital mortality, with a statisti-
cal significance of p < 0.05. Rebleeding risk was according to Forrest 
classification.
Results: The study enrolled 321 patients, 62% were male and average 
age was 66.11 years. At admission, 75.7% were diagnosed with UGIB, 
black stools were present in 67% of patients, hematemesis in 31.8%, 
hematochezia in 17.1%, and ground-like vomit in 16.8%. Also, a sig-
nificant number presented hypovolemic shock on admission (20.5%). 
Notably, 26.2% patients received chronic antiplatelet therapy, and 
17.8% were anticoagulated.
For management, 99.1% received proton pump inhibitors and endos-
copy was performed in 94.1% of patients. The main findings were pep-
tic ulcer (44.9%), gastroduodenal erosions (17.4%), and esophagitis 
(10%). During endoscopy, 32.1% of patients underwent sclerotherapy, 
and 19.6% varicose veins clip ligation. Around 62.9% required red 
blood cell transfusion and 10% had intrahospital re-bleeding. Antico-
agulation/anti-aggregation was restarted 6.34 days on average. Lastly, 
ICU mortality was 8% and average ICU stay was 4.93 days.
Logistic regression concluded that ICU mortality increases 7.39 times 
for males, 26 times if there are dementia, lung and/or liver comorbidi-
ties, 8.5 times if the person is anticoagulated and 5 times with each 
point of the AIMS65 (all of the above with a p =  < 0,05).
Conclusion: The demographic characteristics of UGIB patients in 
our hospital were similar to those reported on global literature. Also, 
rebleeding affects 10% of patients, a value lower than those reported 
(3). Lastly, this is the first study in south American literature that shows 
the usefulness of AIMS65 predicting ICU mortality of UGIB patients.
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Introduction: Patients admitted to the Intensive Care Unit (ICU) for 
coronavirus disease 2019 (COVID-19) present an inflammatory state 
that conditions a high thrombotic risk. There are several studies about 
thrombotics events in patients with COVID-19 in ICU but they are lim-
ited in size and without report all thrombotic events.
Objectives: To determine the incidence of venous thromboembolic 
disease (VTE) in critically ill patients with COVID-19 and the correlation 
with D-dimer levels.
Methods: A prospective study of critically ill patients with severe 
SARS-CoV-2 pneumonia. Inclusion criteria: severe SARS-CoV-2 pneu-
monia confirmed by PCR and admission to the ICU. Exclusion crite-
ria: ECMO, pregnant woman, puerperium, age  < 18  years. The study 
included all patients admitted to the ICU who met the inclusion 
criteria and none of the exclusion on 15-16 April 2020. Ultrasound 
screening with venous compression bilateral in lower extremities 
was performed. Asymptomatic and symptomatic VTE was recorded 
[pulmonary thromboembolism (PD), deep vein thrombosis (DVT)] 
throughout the ICU stay, patient characteristics, blood test results, 
and results with 30 days follow-up. Categorical data are expressed as 
frequency (%). The quantitative data are expressed as mean (standard 
deviation) or as median (interquartile range 25-75). Categorical vari-
ables were compared using the chi-square test and Fisher’s exact test. 
Continuous variables were compared with the T Student test or the 
Mann-Whitney U test. The association between D-Dimers and VTE has 
been calculated using the area below the curve (AUROC). Approved by 
the Ethics Committee of Clinical Research (PR (AG) 213/2020).
Results: On 15-16 April 2020, 118 patients [77% male, age mean 59.37 
(10.20) years, BMI 30.5 (4.74), 100 (84.74%) with invasive mechani-
cal ventilation] were studied. D-Dimer on the day of the ultrasound 
screening was 1575 (703.5-2963) ng/mL. VTE was prevalence of 30.5% 
(36/118). At 30 days of follow-up, the cumulative incidence of VTE was 
35% (41/118): 31 DVT, 5 PD, 5 DVT + PD. There were 17 (14%) hemor-
rhages (4 major and 14 minor). The VTE was not more frequent in ven-
tilated patients. Mortality was 13.6% (16 patients) without difference 
depending on the existence of thrombosis (5 patients in patients with 
VTE and 11 in patients without VTE, p ns). Elevation of the D-Dimer 
above 1500 ng/ml is related to thromboembolic phenomena (AUROC 
0.77, p  < 0.0001, 95% CI 0.62-0.82), sensitivity 73% and specificity 60%.
Conclusion: Patients admitted to the ICU for severe SARS-CoV-2 pneu-
monia are at high risk of VTE. The elevation of D-Dimers is related to 
VTE.
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Introduction: The availability of different mechanical circulatory sup-
port devices (MCSDs) allows physicians to provide the most appropri-
ate support to a wide range of clinical conditions.
Objectives: To analyze the different types of MCSDs used in our Inten-
sive Care Unit (ICU). Analyze the clinical characteristics of the patients 
who had removed their first device support and required a second 
device course.
Methods: Retrospective observational study from 2013 to 2019 in 
a third level ICU with heart transplantation program. We included all 
patients who required more than one device implantation. We exam-
ined demographic data, cause for VAD implantation, type of first 
(VAD1) and second (VAD2) device used, days of VAD support, ICU 
length of stay, in-hospital and ICU mortality. Absolute number and fre-
quency described qualitative variables and median and interquartile 
range (IR) described quantitative variables.
Results: A total of 22 patients were included, 16 were male (72.7%), 
with a median age of 53.50 (34.25-60.50). The main reason for more 
than one device placement was post myocardial infarction cardio-
genic shock 10 (45.5%) follow by descompensated chronic cardio-
myopathy 6 (27.3%), postcardiotomy shock 1 (4.5%), non-ischemic 
cardiogenic shock 1 (4.5%), acute myocarditis 1 (4.5%), electrical storm 
1 (4.5%), right ventricular disfunction 1 (4.5%) and ischemic cardio-
myopathy 1 (4.5%). VAD1 as bridge to transplant was performed in 
11 patients (50%), bridge to decision in 8 (36.4%) and to recovery in 
3 (13.6%). Different types of VAD implanted are shown in table 1. An 
average of 7 days of VAD1 support was reported (4.50 - 11.50[1]) and 
7.5 days for VAD2 support (4.75 - 13.25). A second device placement 
was needed due to clinical deterioration as bridge to recovery 17 
(77.3%), decision 3 (13.6%) and transplant 2 (9.1%). Median ICU stay of 
32.50 days (16.50 – 44.75). ICU and hospital mortality of 36.4%.
Table 1. Types of VAD implanted.
VAD1 
(n = 22) 
VAD2 
(n = 22) 
)7.22(5)1.9(2OMCE-AVlartneC
Peripheral femoro-femoral VA-ECMO 8 (36.4) 5 (22.7) 





Biventricular Centrimag 1 (4.5)   
)1.9(2OMCEVV
.
Conclusion: In our cohort, post myocardial infarction cardiogenic 
shock was the main cause for placing more than one VAD. Femoro-
femoral VA-ECMO was the most frequent device used. A second device 
placement increased to 59.1% the percentage of patients recovered.
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Introduction: Veno-arterial extracorporeal membrane oxygena-
tion (VA-ECMO) is a temporary mechanical circulatory support (MCS) 
used as rescue therapy in patients with acute refractory cardiogenic 
shock. Its use as a bridge to recovery has been increasing over the last 
decade.
Objectives: To describe epidemiological and clinical features of 
patients with acute heart failure (AHF) admitted to our ICU that 
required VA-ECMO implantation as a bridge to recovery.
Methods: A retrospective study was performed from January 2011 to 
December 2019 in a third-level cardiovascular ICU. All patients with 
AHF that required VA-ECMO as a bridge to recovery were included. We 
collected demographic data, cardiovascular risk factors such as smok-
ing, alcoholism, hypertension and diabetes mellitus, AHF etiology, ICU 
length of stay, ECMO cannulation techniques, days on ECMO, clinical 
outcomes and complications after ECMO implantation. Qualitative 
variables were described by absolute number and frequency; quanti-
tative variables by median and interquartile range.
Results: A total of 40 patients were included, median age was 51.50 
(40.25-60.75), 24 were males (60%). Smoking habits 21 (52.5%), alco-
holism 6 (15%), hypertension 19 (47.5%) and diabetes mellitus 8 (20%). 
Past medical history of heart disease was detected in 26 (65%) patients 
being heart valve disease the most frequent in 8 patients (20%), fol-
lowed by ischemic 5 (12.5%), congenital 4 (10%), idiopathic dilated 3 
(7.5%), hypertrophic 2 (5%) and restrictive cardiomyopathy 1 (2.25%). 
Peripheral femoro-femoral cannulation was the most common tech-
nique in 22 (55%) patients, central ECMO in 10 (25%) and peripheral 
femoro-axilar in 8 (20%). Median time on ECMO was 6 days (3-11.25).
Main causes of acute heart failure are shown in Table  1. The most 
frequent complications were pericannula bleeding 11 (27.5%) and 
mediastinal bleeding 14 (35%). Ventilator-associated pneumonia was 
reported in 15 patients (37.5%) under ECMO support and bacteriemia 
in 13 (30%). Clinical outcomes are shown in Table 2. Median length of 
stay in ICU and in Hospital was 18 (7-38) and 51 (25-76) days respec-









Non-ischemic chronic cardiomyopathy 2 (5) 
)5.2(1yhtapoymoidracyhcaT






Conclusion: ECMO is widely used in refractory cardiogenic shock as 
a bridge to recovery. Although the indications of implantation have 
increased in the last years, ECMO is not free of risk, being infections 
and bleeding the most frequent complications.
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Introduction: Despite the differential characteristic of older patients, 
the results are not worse than in younger patients, so clinical decisions 
in these cases should be individualized.
Objectives: To assess the clinical, evolutive and prognostic character-
istics of patients older than 70 years who underwent cardiac surgery 
for infective endocarditis.
Methods: We evaluated endocarditis patients from two hospital cent-
ers (Fundación Jimenez Diaz and Hospital Rey Juan Carlos in Madrid) 
operated by the same surgical team between 2010 and 2019.
Patients were divided in two groups according to age: GROUP 1 
≤70 years and GROUP 2> 70 years. Any value of p  < 0.05 is considered 
significant.
Results: We evaluated 103 patients, 50 of them older than 70  years 
(48.5%). Comparing the two groups (≤70  years vs> 70  years) we 
obtained:.
Demographic data: Male sex (83% vs 50%; p  < 0.001) and age (58.77  ± 
9.36 vs 77.16  ±  4.49; p> 0.001).
Personal history: smoking (26.4% vs. 10.2%; p  =  0.036), alcohol/
drugs (7.5% vs. 0%; p  =  0.05),arterial hypertension (45.3% vs. 71.4%; 
p  =  0.008), COPD (17% vs. 10.2%; p  =  0.320), Stroke (18.9% vs. 38%; 
p  =  0.031), hypothyroidism (5.7% vs. 16.3%; p  =  0.083), very reduced 
mobility (Barthel index  < 50) (17% vs 30%; p  =  0.118), non invasive 
mechanical ventilation (28.3% vs 12.2%; p  =  0.045), previous cardiac 
surgery (18, 9% vs 55.1%; p  < 0.001), coronary artery disease (7.5% vs 
12.2%; p  =  0.425).
Disease data: pre-surgery inotropic (34% vs. 14.3%; p  =  0.021), moder-
ate or severe LV dysfunction (20.8% vs. 10.2%; p  =  0.143), arrhythmias 
(22.6% vs 40.8%; p  =  0.048), cardiogenic shock (20.8% vs 6.1%; p  = 
0.032), prosthetic dysfunction (20.8% vs 51%; p  =  0.001), emergency 
surgery (18, 9% vs 2%; p  =  0.01), pre-intervention antibiotic (7.45  ± 
7.15 vs 12.45  ±  10.99 days; p  =  0.007) and days between diagnosis 
and surgery (5.05  ±  5.89 vs. 7.91  ±  8.05; p  =  0.44), type of surgery 
(mitral valve 30.2% vs. 44.9%; aortic valve 39.6% vs. 28.6%; mitral valve 
and aortic 18.9% vs 20.4%; p  =  0.362) and logistical EUROSCORE II 
(25.37  ±  21.23 vs 37.04  ±  20.50; p  =  0.006).
Complications: atrial fibrilation (17% vs. 6.1%; p  =  0.089), renal fail-
ure requiring temporary hemodialisis (18.9% vs. 8.2%; p  =  0.116), 
mechanical ventilation> 96 hours (17% vs. 2%; p  =  0.011), ICU admis-
sion days (13.22  ±  19.44 vs. 7.75  ±  9.88; p  =  0.08), hospytal dis-
charge mortality (13.2% vs. 16%; p  =  0.688).
Conclusion: There is a great number of elderly patients in our serie, 
predominantly male, smokers, alcoholic, with arterial hypertension, 
previous Stroke, and non invasive mechanical ventilation compared 
to younger ones. The orders present more pre-intervention complica-
tions with need os vasoactives and cardiogenic shock, arrhythmias, 
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prosthetic dysfunction, EUROSCORE II log and longer mechanical ven-
tilation times.
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Introduction: To asses in those patients admitted on the ICU for coro-
navirus the relationbetween mortality and some prognostic ratings 
evaluated at the admission and on the thirdday.
Methods: Prospective cohort study of patients with coronavirus 
admitted to the ICU at the HospitalUniversitario de Jaén, Hospital San 
Agustín de Linares and the Hospital Infanta Margarita deCabra.Contin-
uous variables are expressed as median (25th percentile, 75th percen-
tile) andqualitative variables with absolute and relative frequencies. U 
Mann Whitney was used forcomparison of continuous variables and 
X2 for qualitative variables. Discrimination wasassessed with the area 
under RO curve P &lt;0.05 was considered as statistically significant 
(s.s).A specifically “R” program “randomForestSRC” was used to impute 
missing values.
Results: We have studied 52 admitted patients at ICU by coronavirus 
infection, 41 of them at Jaénhospital ICU, 11 at Cabra hospital.51 of the 
52 patients were alive on the third day and they were evaluated. The 
average agewas 62 (58,71) years old. APACHE II at the admission was 
12 (8.5, 16) points and SOFA 6 (3.8)points. SOFA on the third day was 7 
(3.5, 9) points and the SOFA difference between the firstand third day 
was 0 (-2.0) points.
There weren’t the value of troponin in 10 of the patients (less than 
20% of the sample)and it was input by statistics methods. Ultrasensi-
tive troponin at the admission was 20 (10,42)and on the third day was 
19 (9,49). In 23 patients (46%) the determinations carried out on days1 
and 3 were elevated. In 23 patients (45.09%) the determinations on 
the first and third dayswere elevated.
Patients who deceased (n = 19) showed higher number of troponin at 
the admission butthe differences weren’t s.s. 26 (14,42) vs 17 (10,42), 
(p = 0.47) and on the third day 35 (19,54)vs 13 (8,31), (p =  0.029). 
31.58% of the 28 patients without troponin increment on the first 
andthird day, died, and 68.42% of the 23 patients in whom it was 
increased in the three days (p  = 0.009).
Those patients who died (n = 19) had more SOFA at the admission 7 
(4,8) vs 6 (3,7) points(p = 0.20) but without being significant the differ-
ences. However, differences were statisticallysignificant on the third 
day in regard to SOFA 8 (7,9) vs 6 (3,8) points (p = 0.003) and thedif-
ferences between the first and the third day of SOFA –1 (-3.0) vs 0 
(-1.25,1) points(p = 0.007). Diifferences regarding APACHE II were also 
significant 14 (12,18) vs 10 (8,15) points(p = 0.011).
For a better display of prognostic capacity of SOFA on the third day, 
patients wereclassified according to SOFA, if was less than 7 points 
(n = 22) with a 9% of mortality or if was 7points or more (n = 29) with 
59% of mortality (p < 0.0029).
Multivariate analysis with logistic regression shows that hospital mor-
tality is relatedwith SOFA higher than or equal to 7 points OR on the 
third day: 12.78 (2.81,94.14) with anincrease of troponin on the first 
day. On the first day, OR: 4.09 (1.05, 17.79). Thediscrimination of the 
exemplar, evaluated with the area under ROC curve was 0.82 (0.72, 
0.93).From the 22 patients studied (43% of the sample) with SOFA 
lower than 7 points and withoutan increase of troponin, just 2 of them 
died (9%).
Conclusion: In ICU patients, admitted for coronavirus, on the third day 
afteradmission to the ICU, most are alive and the increase of troponins 
on the first and third day isassociated with higher mortality. And if we 
add, to the said before, high SOFA on the third day,it allows us to select 
a group of patients with low mortality.
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Introduction: Despite appearance of other less invasive therapeu-
tic alternatives for the treatment of coronary artery disease, surgery 
continues to be a safe technique with very good results in selected 
patients.
Objectives: Describe clinical and evolutive characteristics of the coro-
nary artery bypass surgery.
Methods: Retrospective and descriptive study of the patients oper-
ated of coronary artery disease from January 2012 to June 2020, in two 
centers by the same surgical and Intensive Care Unit (ICU) team (Hos-
pitales Fundación Jiménez Díaz y Rey Juan Carlos from Madrid).We col-
lected demographics parameters (age, sex), EUROSCORE II, personal 
history of coronary artery intervention (interventional or surgery), 
type of surgery (urgent or not), surgical times, post-operative compli-
cations, length of stay on ICU and hospital, ICU re-entry and mortality.
We made a quartile analysis according to the stay in ICU by hours 
and got four homogeneous groups on number, sex and age of the 
patients: GROUP 1 =  < 24H; GROUP 2 =  24-48H; GROUP 3 = 48-72H; 
GROUP 4 = >72H.
Results: 724 patients. 84% males. Medium age of 65,5 ± 10  years. 
Medium EUROSCORE 2 was 4.31 ± 5.50. 19.75% had previous coronary 
artery intervention. Medium length of stay in ICU was 66 ± 82 hours, 
10 ± 8  days on hospitalization floor and global hospital time was 
14 ± 9 days. The total mortality was 1.5%. Comparing the groups:
GROUP 1 GROUP 2 GROUP 3 GROUP 4 p
ICU stay 
(hours)
<24 24-48 48-72 >72   
N 183 270 118 153   
Males (%) 87 83 86 82 0.502 
Previous CI 
(%)
23 17 28.8 13.7 0.0007 
Urgent Surgery 0 0.3 0.8 9.8 <0.001 
Surgery with 
EC




















60 (48-80) 61 (49-75) 62 (50-80) 64 (46-84) 0.949 
MV time(hours) 4(3-5) 5(3-7) 6(4-11) 14(6-61) <0.001 
Complications 
(%)
16.39 20 31.4 67 <0.001 
Cardiogenic 
shock(%)
0.5 1.1 0.8 6.5 0.002 
IABP need (%) 0 0.4 2.5 13.7 <0.001 
PMI (%) 0.5 1.1 1.6 5.8 0.002 
ARF (%) 0.5 1.9 4.2 20.9 <0.001 
ERRT need 
(%)
0 0.4 2.5 7.1 <0.001 
Bleeding (%) 0.5 0 5.1 7.8 <0.001 




10(8-14 10(8-14) 11(8-16 18(13-23) 
<0.001 
Mortality (%) 0.5 1.1 0 4.5 0.005  
.
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Conclusion: Coronary artery bypass surgery in our series has few com-
plications, short ICU and hospital stay times and low mortality, consid-
ering that we have not a specific cardiologic ICU. Patients who require 
urgent surgery and spend in ICU >72 h, have worse results.
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Introduction: Since Covid19 was described, almost 17 million cases 
and more than 665000 deaths have been reported. Different theories 
regarding the increased mortality in patients diagnosed with high 
blood pressure that IECAs/ARAII as antihypertensive treatment have 
been postulated, the evidence of which has changed.
Objectives:
– To describe the general characteristics of the patients with Covid19 
admitted in the ICU of the Virgen de las Nieves Hospital.
– To describe the association between mortality and the history of 
hypertension.
– To describe the relationship between the use of antihypertensives 
acting on the renin-angiotensin-aldosterone system and the mor-
tality of patients with Covid19.
Methods: Observational, retrospective and analytical study that 
includes the 58 patients admitted to ICU by Covid19 between March 
and July 2020. A database was created in SPSS with the demographic 
characteristics of patients, comorbidities, antihypertensive treat-
ment, SOFA at admission, APACHEII in the first 24 hours and type of 
respiratory support. They were subsequently evaluated in terms of 
descriptive statistics with frequencies, means, and standard deviation; 
Mortality-based comparisons were made using Student’s T-test for 
quantitative variables and chi squared for qualitative variables.
Results: Of the 58 patients included, 79% were men and 21% women. 
Their mean age was 60 years (+/- 11), their main comorbidities were: 
hypertension (54%) 23 (39.66%) of whom were treated with ACEi/
ARB, diabetes mellitus (35%), obesity (56%), COPD (28%), renal failure 
(9%). SOFA at admission 6.79 (+/- 2.68) with significant association 
with mortality p  =  0.006. APACHE II in the first 24 h was 15.9 (+/- 6.68) 
association with significant mortality p  =  0.002. IMV since admission 
32 (55%) and combination of HFNO and then IMV 17 (29%), unrelated 
to mortality. ICU mortality 33%, hospital mortality 39%. Mortality of 
hypertensive patients 24.13% (p  =  0.23) and of those taking ACEI/ARB 
is 13.79% (p  =  1).
Conclusion: 
– More than half of the patients admitted to the ICU for Covid19 are 
hypertensive, however this risk factor does not represent a signifi-
cant increase in their mortality. Most of them also associate other 
cardiovascular risk factors.
– In accordance with what is described in the medical literature, 
hypertensive patients treated with drugs that act on RAAS do not 
present a higher mortality compared to those who take other types 
of antihypertensive medication.
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Introduction: Sepsis is frequently associated with new-onset 
supraventricular arrhythmias (NOSVA). The identified predictors of SVA 
in sepsis include advanced age, renal failure, preexisting cardiomyo-
pathy, history of hypertension, high SOFA score, and previous calcium 
channel blocker treatment.
Objectives: The aim of this study is to prospectively assess the preva-
lence of NOSVA during septic shock, identify the associated factors, 
and to evaluate its impact on hemodynamics and outcome of patients.
Methods: This prospective observational study enrolled 60 critically 
ill and mechanically-ventilated patients admitted to the critical care 
medicine department at Alexandria University Hospitals, screened 
with continuous 12-lead ECG for the occurrence of NOSVA, and 
assessed for hemodynamic tolerance and prognosis.
Results: The first group (SVA Group) included 24 patients who devel-
oped NOSVA. The second group (SR Group) consisted of 36 patients 
who didn’t develop NOSVA. The deterioration in mean arterial pressure 
increased the prevalence of inotrope indication in SVA group. Serum 
creatinine was significantly higher in SVA group. Also serum calcium 
and magnesium were significantly lower in SVA group. Patients with 
SVA group had higher rate of mortality within 7 days from admission 
and higher duration on mechanical ventilation but the difference from 
SR group didn’t reach the level of statistical significance.
Conclusion: New onset SVA is frequent and poorly tolerated dur-
ing septic shock, and is associated with higher rates of inotrope use. 
Hypomagnesemia, hypocalcemia and elevated serum creatinine are 
considered as potential co-factors or causes for the development of 
NOSVA in septic shock patients.
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Introduction: Emergency anaesthesia is frequently performed in ICU 
and Emergency Departments for critically ill patients. However, it has 
been demonstrated that there is a higher incidence of complications 
when performing emergency anaesthesia in these environments com-
pared to the operating theatre. In our department we anecdotally 
noted that documentation of emergency anaesthesia was frequently 
of poor quality or had missing information. During the course of an 
ICU admission patients may require reintubation and details (such as 
grade of intubation, equipment and drugs used) regarding the initial 
procedure are essential for safe planning.
Objectives: The aim of our quality improvement project was to 
improve the documentation of emergency anaesthesia in the ICU and 
Emergency Department by implementation of a sticker.
Methods: A retrospective audit was performed of 40 consecutive 
patients who were intubated and ventilated in the emergency depart-
ment or ICU. 17 key points for documentation were identified and data 
was collected as to whether or not these were documented: indica-
tion, intubator, airway assistant, monitoring, laryngoscope, airway, 
grade, tied at lips, manoeuvres, pre-oxygenation, apnoeic ventilation, 
adjuncts, opiate, anaesthetic agent, neuromuscular blocker, emer-
gency drugs and critical incidents.
Following the audit an emergency anaesthesia sticker was introduced 
to act as an aide memoire and to improve efficiency of documenta-
tion. These were located in the ICU and emergency department. A 
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further prospective audit of 40 consecutive patients was performed to 
determine whether or not there was an improvement.
Results: Prior to the introduction of the sticker, the audit confirmed 
that documentation was inadequate. Use of monitoring was docu-
mented in 23% of cases and pre-oxygenation in 18%. Choice of laryn-
goscope was documented in 80% of cases, airway used in 78% and 
adjuncts in 23%. Of note in 13% of cases there was no documentation 
of drugs used either in the notes or on the kardex and 44% made no 
reference to whether or not any critical incidents occurred.
Following the implementation of the sticker uptake on use was 68% 
(27/40 cases). Where the sticker was used, documentation was noted 
to be improved. 100% documented monitoring, pre-oxygenation, 
laryngoscope, airway and drugs. 70% documented use of adjuncts 
and 93% documented whether or not a critical incident occurred.
Conclusion: Accurate and thorough documentation of emergency 
anaesthesia is not only important for medico-legal purposes but 
is also crucial to ensure that any future intubations are prepared for 
and managed as safely as possible. Implementation of an emergency 
anaesthesia sticker is a simple and cost effective intervention and 
this quality improvement project demonstrated that it delivers a sig-
nificant improvement in the documentation of emergency anaesthe-
sia in the ICU and emergency department. Further education within 
the department will be aimed at improving the uptake of use of the 
sticker.
Reference(s) and grant ackowledgment(s)
1. 1. Cook TM et al. Major complications of airway management in the UK: 
results of the 4th national audit project of the Royal College of Anaes‑
thetists and the Difficult Airway Society. Part 2 Intensive care and the 
emergency department. British Journal of Anaesthetics 2011.
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Introduction: COVID-19 is considered an airborne pathogen by the 
WHO and Public Health England in the context of aerosol generating 
procedures. During the 2002 to 2004 SARS epidemic, healthcare work-
ers were shown to be at a significantly increased risk of infection(1), 
with tracheal intubation posing the highest risk for transmission(2). 
Therefore, amid the current pandemic additional precautions have 
been introduced to minimise the risk of SARS-CoV-2 transmission.
Medical record keeping plays an integral role in delivering safe patient 
care (3,4). Despite this, documentation is often given a low priority 
when additional demands are placed on doctors.
In an effort to improve patient and staff safety, and to promote a con-
sistent procedural approach and good quality documentation among 
doctors, we implemented a modified COVID-19 percutaneous trache-
ostomy checklist and procedure note.
Objectives: This project aimed to assess the improvement in quality 
of documentation of percutaneous tracheostomy procedures per-
formed by the ICU team after the implementation of the checklist.
Methods: We undertook retrospective audits of the documentation 
of percutaneous tracheostomy procedures on ICU during the whole 
of 2019 (n = 14) and during the COVID-19 period up to June 2020 
(n = 11).
Following the first audit, we formulated and introduced a modified 
COVID-19 percutaneous tracheostomy checklist. The checklist not only 
includes ‘Sign In’, ‘Time Out’ and ‘Sign Out’ but also highlights key steps 
in the updated procedure guidelines, which were created through 
repeated simulation sessions. This formed part of a COVID-19 Trache-
ostomy Local Safety Standards for Invasive Procedures (LocSSIPs) to 
promote a more consistent technical approach amongst operating 
doctors.
Results: The initial audit from 2019 in our Trust demonstrated a poor 
quality of documentation. This issue was successfully addressed with 
implementation of the COVID-19 percutaneous tracheostomy check-
list and procedure note. The second audit reported a significant 
improvement: 100% of percutaneous tracheostomy procedures were 
documented using the designated form, versus 50% in the first audit; 
100% of equipment used were also recorded, up from 57.14% in 2019. 
A consistent improvement was also observed in the documentation 
of patient consent, post-operative instructions, and overall quality 
of documentation. Furthermore, doctors and theatre staff reported a 
reduction in concern when remembering the additional steps made 
necessary for personal protection.
Conclusion: The implementation of a checklist and procedure note 
not only helped to provide a consistent structured approach to the 
procedure and to documentation but also reduced anxiety among the 
healthcare workers. We strongly feel that the quality of documentation 
is a consistently overlooked element of good quality patient care and 
we find the improvement observed, even in the face of increased tech-
nical and human factors complexity, very encouraging.
Reference(s) and grant ackowledgment(s)
1. 1. Kamming, D., Gardam, M. and Chung, F., 2003. I. Anaesthesia and SARS. 
British Journal of Anaesthesia, 90(6), pp.715‑718.
2. 2. Tran, K., Cimon, K., Severn, M., Pessoa‑Silva, C. and Conly, J., 2012. Aerosol 
Generating Procedures and Risk of Transmission of Acute Respiratory Infec‑
tions to Healthcare Workers: A Systematic Review. PLoS ONE, 7(4), p.e35797.
3. 3. Care Quality Commission. Guidance for Providers. Regulation 17: Good 
Governance. [Internet]. Cqc.org.uk. 2020 [cited 27 July 2020]. Available from: 
https ://www.cqc.org.uk/guida nce‑provi ders/regul ation s‑enfor cemen t/
regul ation ‑17‑good‑gover nance #guida nce.
4. 4. Good Medical Practice [Internet]. General Medical Council; 2013 [cited 30 
July 2020]. Available from: https ://www.gmc‑uk.org/‑/media /docum ents/
good‑medic al‑pract ice—engli sh‑20200 128_pdf‑51527 435.pdf.
001237 
Scaling a UK District General Hospital (DGH) Critical Care Unit 
by 400% during the COVID 19 Pandemic
R.  Loveless1; A.  Falek1; T.  Samuels1; A.  Myers1
1Intensive care unit, East Surrey Hospital, Redhill, United Kingdom 
Correspondence: R. Loveless
Intensive Care Medicine Experimental 2020, 8(2): 001237
Introduction: East Surrey Hospital is a DGH in South East England that 
serves a population of 535,000 and has 700 acute beds(1). The Critical 
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Care Unit has 8 level 3 beds and 8 level 2 beds. The unit is staffed by 
10 consultants, 16 junior doctors (50% airway trained), and 84 nurses 
(1/3 have less than 2 years ICU experience). The trust has 17 ICU ven-
tilators (including 4 transfer ventilators) and 29 anaesthetic machines 
offering only basic mandatory ventilation. COVID 19 required planning 
to accommodate an increase in patients with severe respiratory failure 
requiring mechanical ventilation.
Objectives: We aimed to increase level 3 bed capacity safely by 400%.
Methods: We identified 6 elements of our organisation requiring 
attention in order to facilitate rapid escalation in ICU capacity.
1. Footprint.
A 22 bed medical ward was converted into an additional ICU. At peak 
this unit had 17 ventilated patients. Theatre recovery was used for 
non-COVID patients.
2. Equipment.
17 ICU ventilators were supplemented by 21 anaesthetic machines. 
Anaesthetic machine gas analysers were used as EtCO2 monitors ran 
out. Haemofiltration units were rotated between patients in 12 hour 
sessions. Midazolam sedation was used as supplies of propofol were 
compromised.
3. Infection Control.
Full PPE was used in all critical care zones during the pandemic. A 
patient gym became a donning area and temporary partitions created 
a one way system for doffing. Acquiring PPE was challenging nation-
wide, but the procurement department was proactive ensuring ade-
quate supply.
4. Staffing.
An emergency rota was created that provided 24/7 consultants on site, 
with 9 ICU doctors at all times. 10 consultants and 24 trainees worked 
a 1 in 4 pattern, with 6 anaesthetic consultants joining critical care. 
Doctors with previous experience were redeployed to ICU. Anaesthetic 
consultants staffed 2 MERIT teams 24/7 for emergency intubations 
and transfers. 151 nurses were redeployed from Theatres and surgical 
wards. Patients were divided into “zones” of 3-4 patients, with 1 ICU 
nurse leading 3-4 non-ICU trained nurses. Physiotherapists, consultant 
and trainee surgeons formed proning teams.
5. Communication.
Two way radios allowed communication between units, doc-
tors, charge nurses and the emergency department. A temporary 
bespoke electronic patient record (COVID SitRep) was designed using 
FileMaker(TM) and was used for patient tracking, handover and audit. 
A family liaison team updated each patient’s family daily.
6. Clinical Management Protocols.
Protocols for airway management, CT transfers, admission investiga-
tions and proning ensured patients received the highest level of care.
Results: We had a maximum of 33 ventilated patients at any one time, 
across 3 geographically distant critical care units. Over the pandemic 
we treated 59 confirmed and 34 suspected COVID-19 patients in criti-
cal care, and performed 10 non-clinical transfers of ventilated patients. 
Our mortality for ventilated COVID 19 patients was 29%.
Conclusion: During the COVID 19 pandemic we delivered safe, effec-
tive care at 400% capacity. Using a robust education and management 
structure for new nurses, redesigning rotas to increase staffing and 
creating protocols using national guidance(2) ensured safe expan-
sion. Our outcomes compare favourably with other institutions in 
the UK (ICNARC mortality of ventilated COVID 19 patients is 48%(3)). 
Feedback from patients, staff and families was positive. Structures are 
in place for psychological support for staff and patients, which aim to 
mitigate the effects of an unprecedented time.
Reference(s) and grant ackowledgment(s)
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Introduction: The importance of good communication in an Intensive 
Care Unit (ICU) is being increasingly recognised.[1] Effective communi-
cations improves families’ trust in the medical team clinical ability and 
decision making, as well as their own psychological well being.[2].
The COVID19 pandemic is an unprecedented health crisis which has 
reshaped our way of practicing medicine and communicating with 
our patients and families. The growth rate of the COVID19 virus led to 
restrictions and subsequently banning of all visitors to hospital wards 
and ICU. At the height of the pandemic, communication between 
medical staff and families could only be through phone or video calls.
Objectives: To assess communication with families at the height of 
the pandemic in a UK based intensive care unit. This was measured 
against standards set by senior nursing staff and our consultant body 
prior to the pandemic. Standards set were for patient families to be 
contacted by nursing staff daily, and medical staff every 48 hours.
Methods: We conducted a retrospective case note review of all 
patients admitted to the Adult Intensive Care Unit (AICU) or Recovery 
Intensive Care Unit (RICU) between the 16th and 31st of March 2020 at 
St Mary’s hospital. Only COVID19 positive, or clinically suspected cases 
were included in this study.
Family Communication notes, Nursing documentation as well as Daily 
Documentation notes were reviewed on the critical care software sys-
tem IntelliSpace Critical Care and Anaesthesia (ICCA).
Key clinical characteristics of patients were recorded including age, 
length of ICU admission, if mechanical ventilation was used, level of 
care on admission, and whether any End of Life (EoL) care was in place.
Documented family discussions were reviewed and classified as either: 
First meeting within 48 hours, Update or Follow-up, Clinical deterio-
ration or DNACPR discussion. The date and clinical staff leading each 
communication was recorded.
Results: A total of 32 patients were admitted with positive or clini-
cally suspected COVID19, and 331 communications were recorded. 
The mean length of stay in ICU was 17.3  days, and the mean age 
was 54 years old. Mechanical ventilation was used in 29 (91%) of our 
cohort. 12 (38%) patients died in the unit, 15 (47%) were discharged 
to a ward. Among our cohort, 16 (50%) had a DNACPR in place, and 10 
(31%) had an EoL care pathway in place.
Nursing staff met our standard of contacting families daily in 1 (3%) 
patient, and doctors of contacting families every 48 hours in 6 (18%) 
patients. 5 (18%) patients had no documented family discussions 
with a doctor, 3 (9%) had no documented conversation with a nurse 
and 2 (6%) had no documented discussions with any healthcare 
professional.
Family discussions within 48 hours of admission were made in 25 
(78%) of our cohort, with nursing staff initiating 18 (72%) of these 
conversations. The median time to a first documented discussion with 
family for nurses was 1 day, and 4 days for doctors.
Junior Doctors led 8/10 (80%) of documented DNACPR discussions, 
and 25/58 (43%) Clinical Deterioration discussions. Consultant discus-
sions were held with families in 2/10 (20%) patients on an End Of Life 
care pathway.
Conclusion: At the height of the pandemic, nurses and doctors did 
not meet the standards set for family communication. Nursing staff 
initiated family discussions within 48 hours of admission, and Junior 
Doctors were leading difficult discussions with families. Agreed guide-
lines on the regularity of family communication during a pandemic, 
and the level of Nurse/Doctor expected to communicate needs to be 
developed. Further training is needed to support Junior Doctors in 
conducting difficult discussions if a further spike is to occur.
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Introduction: Tracheostomy is usually performed for patients with 
prolonged stays on mechanical ventilation and/or embarking upon a 
slow wean from mechanical ventilation.
Objectives: The aims of this audit were to;identify the length of, and 
reasons for, delays in performing tracheostomy once a decision made 
to proceed and to determine the adequacy of documentation of 
delays.If a delay in carrying out tracheostomy is encountered, whether 
planned or unforeseen, the reason for delay should be documented 
for each day tracheostomy is delayed beyond 2  days after a deci-
sion. The two standards employed in this audit are therefore; 75% of 
patients should receive a tracheostomy within 2  days of decision to 
proceed and if tracheostomy is delayed beyond 2  days, 100% of the 
days in question should have a documented reason for the delay.
Methods: Retrospective review of patients undergoing either percu-
taneous or surgical tracheostomy during ICU stay between September 
2015 and September 2016. We recorded 1)technique of tracheostomy 
2) number of days between decision to perform tracheostomy (classed 
as Day 0) and the procedure itself, where there were more than 2 days 
between decision and procedure, the number of days for which a rea-
son for the delay was documented.
Results: A total of 21 tracheostomy episodes were recorded dur-
ing the audit period, of which 12 were percutaneous and 9 surgical. 
2 patients had unsuccessful percutaneous attempts followed by suc-
cessful surgical tracheostomies.Overall, 12/21 patients (57%) had their 
tracheostomies performed within 2  days of the decision to proceed. 
Only 1 additional patient had procedure within 3 days of decision; the 
remaining 8 patients waited 4 or more days.
There was no significant difference between the delays in the percu-
taneous and surgical groups, although both patients with a delay of 
8 days required surgical tracheostomies.
Mean Median
Overall 3.0 2 
Percutaneous 2.3 2 
Table 1 - Days Delay (by type of procedure)
Surgical 4.1 4.5 
The reasons documented were:
Liver USS 
ENT review required (x 2)
ENT not available (x 2)
Atrial fibrillation causing compromise 
Coagulopathy requiring reversal 
Anaesthetist not available 
Family discussion 
Table 2 – Documented reasons for delays in tracheostomy
.
Conclusion: The unit did not meet the standards for either timely 
performance or documentation of reasons for delays, with rates of 
57% (standard 75%) and 18% (standard 100%) respectively. Possible 
reasons for this were availability of experienced anaesthetic and ENT 
.Clinical limitations e.g. coagulopathies or anti-coagulant treatment, 
or a general instability and low reserve to tolerate procedure. It was 
difficult to comment on the appropriateness of delays by a sizeable 
minority of patients because of the poor standard of documentation. 
Possible reasons for incomplete documentation include insufficient 
time on ward round or at the end of shifts, lack of or misunderstand-
ing of reasons for delays and attributing little importance to such 
documentation.
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Introduction: Limited evidence indicates that mortality rates of 
elderly patients treated in the intensive care unit (ICU) vary widely 
across Europe.
Objectives: The aim of this study was to evaluate the variation in 
short-term mortality among patients ≥ 80 years old admitted to Euro-
pean ICUs.
Methods: We used data from two multicenter prospective cohort 
studies which enrolled very old intensive care unit patients (VIPs) 
between the years 2016 and 2019 in 20 European countries. The pri-
mary outcome was mortality within 30-days from admission to the 
ICU. Nine clinical variables were adjusted for in multilevel logistic 
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regression models. Country was included in the model as a random 
effect and categorized healthcare expenditure per capita ( < 2500$, 
2500-5000$, >5000$) was a country-level variable.
Results: The median age in the sample of 8257 consecutive patients 
was 84  years (IQR: 81-86) and the median Sequential Organ Failure 
Assessment score was equal to 6 points (IQR: 4-10). Crude mortal-
ity in participating countries ranged from 10.6% to 50.0% in the ICU 
and from 21.9% to 54.4% in 30-day follow-up. After adjusting for 
patient-level variables, the proportion of individual variation in mor-
tality attributable to systematic differences between countries was 
equal to 3% at discharge from the ICU and 2% in 30-day follow-up. 
Lower healthcare expenditure per capita was associated with higher 
ICU mortality, but we did not find evidence that a similar relationship 
exists in 30-day follow-up.
Conclusion: Systematic differences between patients, not countries, 
largely explain the variation in short-term mortality among European 
countries. Lower healthcare expenditure is associated with higher 
mortality in the ICU, but the direction and magnitude of this relation-
ship is less certain in 30-day follow-up.
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Introduction: Invasive fungal disease is a common cause of morbid-
ity and mortality in Intensive Care Units (ICU) worldwide [1]. A Beta-
D-glucan (BDG) test has a high negative predictive value and can be 
used to exclude invasive fungal disease in appropriate populations 
[1,2].
Objectives: To describe the prevalence and clinical outcomes of 
patients treated with empirical antifungals and to identify how BDG 
testing is utilised in the ICU at the Royal Liverpool University Hospital, 
a tertiary academic teaching hospital.
Methods: We performed a retrospective observational study of all 
patients treated with anti-fungal medication between December 
2018-December 2019 utilising medical notes, microbiological data 
and prescription charts. Patients treated for oral or genital candidiasis 
or with prophylactic antifungals were excluded.
Financial estimates were made by analysing the prescriptions of 
patients with no positive fungal culture, excluding those with haema-
tological malignancy or oesophageal perforation, for whom empirical 
anti-fungal use is appropriate, and assuming an eight-day turnaround 
time for testing.
Results: One-hundred-and-six patients received anti-fungal medi-
cation over 107 admissions to ICU during the specified time period. 
Sixty-two (58%) admissions were male, the mean age was 56 and 63% 
were admitted from surgical specialties, most commonly Upper Gas-
trointestinal or Hepato-pancreato-biliary. The inpatient mortality was 
28.9%.
Fifty-seven (53%) patients had a positive fungal culture, 3.9% of the 
1480 admissions in the study period. The most common species cul-
tured was Candida albicans (n = 25), followed by Candida glabrata 
(n = 15). The most commonly infected sites were: intra-abdominal 
fluid (n = 25); blood culture (n = 11); and urine (n = 6). There were four 
blood stream infections due to central venous catheters. The median 
number of days patients were treated with antifungals was 16 [IQR 
11-28].
Of the 49 patients with no positive fungal culture, only 6 (12%) had a 
BDG test sent, which were all negative. The mean number of days for a 
BDG result to be available was 8.3 ± 3.3 days. We estimate that apply-
ing BDG testing to appropriate patient cohorts would save 142 days of 
anti-fungal use and approximately €12,300 per year.
Conclusion: It is common for no fungal species to be identified in 
patients who are started on empirical antifungals. BDG testing is 
under-utilised in our ICU and improving its uptake and speed are 
important measures for both antifungal stewardship and fiscal 
management.
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Introduction: The COVID-19 pandemic has seen a unique response 
arise in hospitals, one feature of which has been the rapid redeploy-
ment of healthcare workers of all stratifications to intensive care units 
(ICUs) across the country. This posed a sudden and unfamiliar chal-
lenge of a high-acuity environment to many staff, who have had lit-
tle or no prior ICU experience. In the Whittington Hospital ICU, staff 
expressed uncertainty about assessing and managing patients, but 
opportunities for bedside teaching were limited due to workload, 
staffing ratios and communication challenges due to personal pro-
tective equipment (PPE). This teaching programme was designed to 
deliver high quality, relevant information for navigating ICU, appro-
priate to different healthcare backgrounds of staff recruited at short 
notice. The aim was to provide basic but thorough cross-skilling 
swiftly, in a structured and standardized way, to enhance confidence 
amongst newly deployed staff and to improve patient safety in an 
unprecedented  situation1.
Objectives: The overall objective was to increase the competence 
of as many staff as possible – both medical and auxiliary – who were 
redeployed to the Whittington ICU. Further aims were to improve staff 
confidence in assessing and managing an intensive care patient by 
25% following delivery of ‘Training for ICU Crash Course’ (‘TICC’) pro-
gramme, and provide with the relevant learning supplementation 
appropriate to level. Lastly, to provide bedside checklist resources for 
basic management as an aide-memoir, for improved communication 
under difficult circumstances and amongst unfamiliar teams.
Methods: TICC comprised of a standalone session delivered as a tuto-
rial with accompanying slides away from the bedside so staff did not 
have responsibility for clinical care and were not hindered by wear-
ing PPE. It consisted of a set of slides using a standardised systems 
(ABCDE) approach which was tailored to the audience background, 
and augmented by practical demonstration of simple equipment such 
as arterial lines, three way taps and giving sets. Participants were all 
healthcare workers with 6  months or less experience in Intensive 
Care, or any current ICU recruit who felt that they would benefit from 
attending.
The learning supplement consisted of two stratified checklists appro-
priate to level (one targeted at doctors, one at auxiliary staff), given 
as handouts at the end, in the format corresponding to the course. 
The bedside resource was a further corresponding laminated check-
list, with a wipe-clean tick box function, for use in PPE on the unit. It 
was designed to improve coordination, efficiency and safety in the 
patient’s multi-person team by keeping track of jobs and assessments, 
again according to the system taught.
Feedback including confidence levels by system, usefulness of con-
tent and format was collected immediately before and after teach-
ing by an anonymous questionnaire. Further feedback was obtained 
several weeks later by an online questionnaire to assess retention and 
confidence.
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Results: The course was delivered to 47 members of staff who were 
working in the Whittington Hospital ICU including doctors (foundation 
doctor level to medical registrars), registered nurses, physiotherapists, 
healthcare assistants, medical and nursing students, other healthcare 
workers (e.g. speech and language therapists, podiatrists). Of the stu-
dents, 74% (35/47) had no previous ICU experience. The topics that 
people identified as being the most anxious about were airway and 
breathing. Immediately after the course, confidence levels in assess-
ing an ICU patient were improved by 39%, increasing from a mean 
score of 2.5/5 to 3.5/5. 2  months following the course, participants 
confidence levels were 36% greater than prior to the course. Students 
reported feeling most confident in assessing breathing, and the most 
useful topics were determined to be either airway, or the whole ses-
sion A-I. Qualitative feedback on the usefulness of the learning mate-
rials distributed post-tutorial was highly positive, with a constructive 
influence on team coordination.
Conclusion: The teaching session was designed to be both achiev-
able and rapid to implement, while still being fully modifiable as to 
be appropriate for a variety of audiences. It was successful in this aim 
and in providing a basic standardised structure for novice workers on 
ICU. Increased confidence levels of healthcare staff were reported in 
high risk areas (e.g breathing assessment) which is a vital skill for safely 
managing patients with COVID-19 pneumonitis. In particular, qualita-
tive feedback suggested it helped to maintain safety standards and 
team co-ordination when ICU nursing ratios were low. This course has 
the potential to rapidly cross-skill staff from a variety of backgrounds 
to improve staff confidence and wellbeing, team co-ordination and 
efficiency. Ultimately improving patient safety in rapid response to a 
novel, chaotic and highly challenging situation.
Reference(s) and grant ackowledgment(s)
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Introduction: The COVID 19 pandemic brought a significant increase 
in workload for healthcare workers (HCW) around the world (1). This 
fact was especially relevant in the ICU where adverse events could be 
caused by this burden. The Safety Huddle (SH) is a strategy designed 
to mitigate this risk (2), mostly focusing on increase in situation aware-
ness, communication skills and psychological safety for HCW. It has 
not been tested in the current COVID-19 scenario.
Hospital Sao Lucas is a 210-bed general private hospital in the city of 
Rio de Janeiro – Brazil. Before the pandemic, the hospital had 75 ICU 
beds. After the beginning of COVID-19 in the city of Rio de Janeiro, 
the number of ICU beds was increased to 100 beds, of which 79 beds 
dedicated exclusively to COVID-19 patients. As part of the Quality and 
Safety department improvement initiatives, two-tier safety huddle 
was implemented in a 60 bed ICU.
Objectives: The aim of the present study is to test if the feasibility, 
HCW impact and clinical outcomes associated with SH implementa-
tion in the context of COVID-19 pandemic.
Methods: The first level SH was leaded by the shift nurse and involved 
the bedside team of the corresponding shift. The second level was 
conducted with representants of each ICU (senior doctor or nurse), 
heads of nurse, respiratory therapy, medical director and quality and 
safety. Most of participants were in remote contact with each other, 
including the leader of the 2nd tier.
An anonymous electronic survey consisting of perceptions was 
launched for HCW, 5 weeks after the beginning of the safety huddle.
A before and after analysis was performed for the critically ill patients. 
Outcome for COVID 19 was retrieved from the EMR, using current 
definitions.
Results: Safety huddles were performed daily, including weekends, 
from 7thMay, until now. The duration was approximately 10 min in the 
fist level and 60 minutes in the second level.
Three hundred and twenty (35%) two out of 906 HCW answered the 
survey of whom 181 (56%) RN and nurse assistants, 87 (27%) respira-
tory therapists and 54 (17%) other professionals (including 4 physi-




Do you believe that Safety Huddle brings positive results? 97% 
Do you believe that Safety Huddle has a positive effect in 
your daily routine? 
92% 
Do you feel comfortable in sharing your perceptions and 
doubts during the Safety Huddle? 
89% 
Do you believe that structural improvements were 
implemented because of the Safety Huddle? 
91% 
Table 1. Proportion of respondents in a HCW survey concerning the perceptions of Safety Huddle
From 16th March 2020 to 15th July, HSL discharged 452 patients, 
of whom 255 (56%) stayed in the ICU for some time. The main clini-




Before SH (n = 
91 patients) 
After SH (n = 164 
patients) 
P value
Age - years (±SD) 69.0 70.2 0.59 
SAPS3  - points (±SD) 58.4 57.7 0.70 
Use of MV -  n (%) 55 (60) 96 (58) 0.76 
Hospital LOS -  days 14.6 26.0 0.03 
Hospital death n (%) 46 (50) 49 (30) <0.01 
SMR (±SD) 1.51 1.00 <0.01 
Conclusion: Safety Huddle is feasible during COVID-19 pandemic cri-
sis and is associated with positive perception among healthcare work-
ers and better clinical outcomes for critically ill patients.
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Introduction: Prioritising staff wellbeing improves the health of 
staff and patients1. In the latest GMC survey almost 25% of trainees 
reported burnout2. This can be particularly prevalent for trainees 
working in critical care3. A key contributor to anxiety is uncertainty4, 
which renders core anaesthetic trainees vulnerable as they transition 
into intensive care. In contrast to anaesthetic practice – which sets a 
standard using the initial assessment of competence5 – there is no 
benchmark for trainees starting in ICU. Trainees may assume high lev-
els of responsibility with little experience and distant senior support 
out of hours.
Objectives: To identify the anxieties experienced by trainees prior 
to starting on the ICU on-call rota, to gain their perspective on what 
could have reduced these anxieties, and to use this information to 
deliver targeted training to alleviate these concerns for future trainees. 
To assess the impact of our intervention.
Methods: A survey was sent to all trainees who had completed core 
anaesthetic training within our hospital over the past two years, detail-
ing their experiences of transitioning onto the on-call ICU rota in CT2. 
The results were assessed and a targeted one-day ICU boot-camp was 
developed to address the areas in which trainees had felt vulnerable. 
This was delivered to two trainee cohorts over two years prior to them 
going on-call. Surveys were distributed before and after the boot-
camp to assess changes in anxiety and perceived preparedness. A pre 
and post-course quiz was included to provide objective information 
on improvements in knowledge. Further information was collected on 
the on-going concerns of trainees and how they felt these could be 
addressed.
Results: Our initial survey highlighted that trainees had not felt ade-
quately prepared for transitioning onto the on-call rota, with prepar-
edness being scored as 3.8/10 (0-6.5; n = 7). Specific issues highlighted 
were variation in length of shadowing in ICU (0-4  weeks; mean 1.1); 
and inconsistencies in experience during shadowing. 86% of trainees 
stated that they would have liked a standardised introduction to ICU. 
After implementation of our boot-camp, 100% of trainees reported 
reduction in anxiety and increase in preparedness for transitioning 
onto the ICU on-call rota (n = 7). Test scores improved from 51% to 
87.5%. Feedback has highlighted a need for additional simulated criti-
cal incidents and more real-life exposure to ICU referrals.
Conclusion: Understanding the anxieties of trainees is invaluable 
in improving their experience. A simple survey can be a useful way 
to gain insight and to design relevant interventions. From our ini-
tial work, we designed a simple yet effective ICU training day that 
improved trainee performance and confidence. Based on our on-
going feedback we plan to design a database of simulation scenarios 
to facilitate teaching, and to implement a CT1 bleep for trainees to 
carry prior to their ICU block alerting them to ICU referrals so they can 
attend in a supernumerary capacity.
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Introduction: The COVID-19 pandemic brought unprecedented chal-
lenges to critical care units across the world. Significant restrictions 
on hospital visiting hugely impacted the way in which we commu-
nicate and interact with families. Effective communication, usually in 
the form of family meetings and bedside updates, improves family 
understanding, clinical decision making and the psychological well-
being of family members.1 We found that the absence of face-to-face 
communication heightened anxiety and distress for families and the 
critical care team. A lack of physical presence resulted in many families 
struggling to comprehend the severity of their relatives’ condition. In 
particular, end of life discussions was extremely difficult to cope with. 
In order to improve communication and patient care we implemented 
a new secure method of asynchronous video communication called 
 vCreate® (Windsor, Berkshire).
Methods: This study was conducted in two critical care units in Edin-
burgh, during and slightly after the acute phase of the COVID-19 peak 
in the UK. vCreate has been used in the UK neonatal critical care set-
ting but was an entirely new concept for adult critical care. It provides 
a means to send regular visual updates via pre-recorded videos and 
photos to document patient progress, both positive and negative. This 
virtual connection has enabled us to record and share key moments 
in a patient’s journey: videos prior to intubation, treatments such as 
proning and has been used by our physiotherapy and rehabilita-
tion team. In addition, we have developed vCreate to allow relatives 
to send personal videos and photos to be shared with the patient. To 
evaluate the impact of vCreate and its acceptability as a new commu-
nication tool, a family survey was conducted.
Results: 36 patients and their families have benefitted from the ser-
vice with 163 videos and 111 photos being sent. The initial responses 
from 10 families who used the service is illustrated in Figure 1. Of these 
10 families, 9 strongly agreed that using vCreate improved their con-
nection with their relative, 7 strongly agreed that vCreate improved 
communication and 8 strongly agreed that vCreate helped them to 
understand their relatives’ situation.
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All 10 families responded that they would recommend the use of 
vCreate to other families.
Conclusion: Initial feedback has been overwhelmingly positive and 
has shown vCreate to be an effective additional communication tool, 
improving family and patient connection, communication and under-
standing of the patient’s condition and prognosis. A full evaluation is 
underway to determine the overall impact of video communication 
with families, using vCreate. Based on this initial success we will con-
tinue to use this technology. Both hospitals are tertiary referral centres, 
and so vCreate could provide an invaluable communication link for 
many patient groups whose families live remotely, even once hospital 
visiting returns to normal.
Reference(s) and grant ackowledgment(s)
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Introduction: Prone positioning has been used since the 1970’s and 
is well recognised to provide benefit in patients with acute respiratory 
distress. 1, 2 The PROSEVA trial demonstrated the significant mortality 
benefits of prone positioning when used within 36 hours of ICU admis-
sion with severe ARDS. 3 Robust evidence for proning in COVID-19 
infection is not yet published. However, it has been observed as a use-
ful therapeutic tool.
Protocols can optimise and standardise clinical practice, during the 
COVID-19 pandemic period protocols may help maintain good clinical 
practice. 4,5 In our District General Hospital we have developed a pro-
tocol specific to proning and supinating intubated COVID-19 patients.
Objectives: Ascertain how frequently proning was utilised during a 
four-month period across our trust. We also aimed to identify any com-
plications related to proning that occurred during this time period.
Methods: We reviewed all electronic and paper records of any patient 
admitted to our ICUs between 01/03/20 - 30/06/20. We also reviewed 
incident report forms for this time period.
Results: Seventy-Two patients tested positive for COVID-19 during 
this period. Patient demographics include mean age of 60.6 years old, 
range 21 to 86 years, 49 (68%) of all patients were male. Twenty-eight 
(39%) patients with COVID-19 died. Twenty-six patients (36%) were 
proned during their admission. Fifty-five proning attempts were made, 
ranging from one to six times per patient, 50% of these patients were 
only proned once. For those that were proned, the average length of 
ICU admission was 26.4 days vs 8 days for non-proned patients. Forty-
two percent of the patients that were proned did not survive, com-
pared to 37% of the patients that were never proned.
There were five complications attributed to proning - this was 19.2% of 
proned patients, and 9.1% of all proning attempts. This included one 
shoulder subluxation and one brachial plexus injury. Optic neuropa-
thy/retinal haemorrhage were identified in two further patients. One 
patient developed pressure sores on their ear and clavicle.
Conclusion: Patients that were proned were more likely to die from 
COVID-19, this likely indicates the disease severity. Fewer patients 
experienced complications than those identified in previous studies. 
2, 6, 7 Meticulous use of our proning protocol helped to minimise the 
risk of the most common complications and is in line with national 
guidance and standards 6. A clear protocol also facilitated teams cross-
skilling from other specialties into an unfamiliar environment.
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Introduction: ICU bed capacity is relatively low in Ireland (255 beds at 
baseline, 5.2 ICU beds/100,000 population). The COVID-19 pandemic 
had the potential to overwhelm ICU capacity leading to a high mor-
tality rate. We documented (i) ICU bed occupancy in Ireland during 
the surge in COVID activity in March – May 2020 and (ii) mortality for 
COVID-19 patients in ICU in Ireland up to July 6th 2020. We referenced 
this to mortality in ICU in the UK in the same period as documented by 
the Intensive Care National Audit and Research Centre, UK (ICNARC)1.
Methods: The National Office of Clinical Audit (NOCA) collected data 
on ICU bed occupancy during March-May 2020. Data were entered on 
a web portal by all ICU’s twice daily, with support and validation by 
NOCA. A Census documented ICU bed capacity (i) on March 13th, at 
baseline and (ii) on May 1st, after the expansion of capacity to cope 
with COVID-19.
The Health Protection Surveillance Centre (HPSC) published weekly 
data on outcomes in COVID patients admitted to ICU in Ireland.
ICNARC publish data for the United Kingdom (UK) (except Scotland) 
weekly (1).
Results: ICU bed capacity in Ireland increased by 39% from 255 
at baseline to 354 beds at peak surge capacity. The peak number of 
patients in ICU during this period was 255 and the peak number 
of COVID patients in ICU was 176. Numbers of non-COVID patients 
decreased significantly, to a low point of just 62 patients.
Thus total numbers of patients in ICU in Ireland remained less than 
the baseline number of ICU beds. This was due to (i) a smaller num-
ber of COVID patients admitted to ICU than expected and (ii) a major 
decrease in non-COVID patients in ICU. Numbers of patients in ICU 
nationally remained significantly below the total number of beds 
available after the expansion of capacity for COVID.
ICU mortality for COVID patients in Ireland was lower than that 
reported in other countries, including the UK (Table 1). This was noted 
for (i) all ICU admissions with COVID and (ii) for ICU patients undergo-
ing invasive ventilation.
Ireland                         UK(1) 
COVID-19 ICU admissions / 100,000 
population                8.9                               16.0 
Age on admission (yrs, median)                                       60                               60 
 % of ICU admissions invasively 
ventilated                        66%                             72% 
ICU mortality – all COVID admissions to ICU                     17 
%                             40%  
Hospital mortality – all COVID admissions to 
ICU               20%                             47% 
ICU mortality in COVID patients invasively 
ventilated         26%                             49%  
Table 1. Outcomes of (i) all COVID admissions to ICU and (ii) COVID patients who
underwent invasive ventilation 
.
Conclusion: The demand for ICU beds remained within the available 
capacity because of (i) fewer COVID admissions to ICU, relative to the 
UK and (ii) decreased numbers of non-COVID patients in ICU. This was 
associated with a lower ICU mortality rate than the rate reported for 
the UK which has a comparable healthcare system.
Reference(s) and grant ackowledgment(s)
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Introduction: Organization and Rebuild intensive care unit (ICU) dur-
ing pandemic case surge such as COVID-19 is essential for preventing 
the collapse of healthcare system and excessive damage.
Objectives: We developed new ICU for COVID-19 in the secondary-
level, non-teaching, public provincial hospital.
Methods: The administration of Gyeonggi province in the Republic 
of Korea raised the fund for reconstructing ICU and equipping medi-
cal resources for COVID-19, such as high flow nasal cannula (HFNC), 
mechanical ventilator (MV), critical care ultrasound system, continu-
ous renal replacement machines, etc. Collaborating the tertiary-level, 
teaching, public central hospital, one intensivist, and ICU nurse master 
prepared the educational plan including simulation workshop, device 
demonstration.
Results: After two weeks of preparedness, the confirmed COVID-19 
critically ill patients from the long term care facilities were admitted to 
the new ICU due to respiratory failure enough requiring HFNC or MV 
support. Invasive monitoring via arterial lines and maintaining criti-
cal care medication via central venous lines were done by collabora-
tion dispatched one intensivist with local house staffs. Currently, five 
COVID-19 critically ill patients were admitted, two discharged with sur-
vival, one transported to the tertiary hospital, remained still admitted 
in the new ICU.
.
Conclusion: We reported the first experience of the organization 
and rebuild the new ICU for COVID-19 via collaboration in one public 
sector.
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Introduction: Show the results for the year 2019; from the ICUWW 
team; which is a reactive and proactive team that performs assess-
ment, assistance, monitoring and procedures activities for critical/
semi-critical patients outside the scope of the Intensive Care Unit 
(ICU). Responsible for the early detection and treatment of those who 
are admitted and present clinical deterioration regardless of where 
they are, the ICUWW is also in charge of monitoring the patients 
assessed in the previous 24 hours by the ICU on-call team and it also 
follow fragile patients after discharge from the ICU. We the results we 
want to evaluate if it is justified the implementation of this team.
Methods: Descriptive study from January to December 2019; that 
shows the results of the evaluations made by the ICUWW. Variables are 
described as means,  ±  standard deviation or percentage. Chi square 
(X2) and Mann-Whitney test for continuous variables were used to 
compare categorical variables.
Results: In 2019, a total of 1,289 patients were treated by the ICUWW 
team, who underwent 2,059 interventions, 798 were men (61.9%) 
and 491 (38.1%) women, with an average age of 61.7 years. The aver-
age attention time was 158 minutes, with a follow-up of 1 to 12 days 
(average 1.26). 553 patients (42.9%) had medical pathology, 624 
(48.4%) surgical and 112 (8.7%) trauma. 25.21% of the patients were 
evaluated in the Emergency Department, 15.4% in the Digestive Sur-
gery service, and the rest in other services. In 54.4% of the occasions 
the attention was in response to a direct call; 6.9% follow-up was of 
patients assessed in the previous on-call team and who had not been 
admitted to the ICU; 17.1% of the evaluations were for CVC placement; 
3.8% follow-up of fragile patients after ICU discharge. 30.2% of the 
care resulted in admission to the ICU, 24.7% were attended for man-
agement and 33.5% did not require admission, due to lack of criteria 
or due to proper management of patients at risk. 5.35% underwent 
limitation of the therapeutic effort (LTE) after evaluation. Of the fragile 
patients who were followed-up at discharge, 8,8% required readmis-
sion to the ICU.
Conclusion: With the number of patients evaluated and the number 
of interventions made (active and reactive); continuing with ICUWW 
team for our hospital or a similar hospital is justified.
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Introduction: This survey aims to evaluate whether communication 
with families was affected by the coronavirus (COVID-19) pandemic 
and whether video call software mitigated these difficulties.
In 2011 the NHS Outcome Framework recognised “ensuring people 
have a positive experience of care” as a key domain of quality. In criti-
cal care, family members play a crucial role in the care and decision 
making process. Meeting the emotional and practical needs of family 
members is essential to delivering good quality care. Family Satisfac-
tion in the Intensive Care Unit FS-ICU has been developed and vali-
dated for assessing families’ satisfaction with care and communication.
The coronavirus pandemic has placed unforeseen constraints on all 
aspects of critical care including communication with patients’ family 
members. Due to the need to limit coronavirus spread, family visita-
tions have been limited if not absent across the country. In order to 
allow families to communicate with their inpatient relatives, we 
acquired tablet computers with the TouchAway application. Further-
more, doctors on our ICU made a daily phone call to each family.
Methods: An anonymous, retrospective survey was sent to all families 
affected by the visitor restrictions during the coronavirus period from 
early March until the present. The questionnaire utilized was based 
on the FS-ICU questionnaire, and was modified to focus on commu-
nication with doctors and include questions regarding video call use 
between families and patients.
Results: 24 responses were received. Half of the cohort who 
responded to the survey had access to video calling. The answers to 
each domain have been categorised into satisfied and not satisfied 
and presented in the table below.
deifsitaSniamoD Not satisfied 
Frequency of communication 83 (20/24) 17 (4/24) 
Ease of getting information and adequate 
explanations 
88% (21/24) 12 (3/24) 
Honesty of information 96% (23/24) 4% (1/24) 
Consistency of information 79% (19/24) 21% (5/24) 
Ease of video calling 91% (10/11) 9% (1/11) 
Frequency of video calls 67% (8/12) 33% (4/12) 




Table 1: Results by selected domain, divided by satisfaction 
We also included an opportunity in the survey for free text comments 
regarding improving our communication and the use of video calls. 
Many families were very positive; “daily phone call from ICU for update 
was a lifeline for my family” and that doctors were thorough and 
honest with them regarding their relative’s condition. There was also 
feedback that some families did not receive consistent phone calls 
particularly around time of admission.
Families were very grateful for the opportunity to video call, which 
helped them appreciate how unwell their relative was and helped 
them feel connected with their relative and the staff. They commented 
the application was easy to set up. Families who were not able to use 
video calls, also said that they would have liked to use this service and 
all agreed that even outside of pandemic restrictions, it would be a 
useful addition.
Conclusion: This survey has shown that during a pandemic, we can 
effectively communicate with patients’ relatives. The utilisation of 
video calls in critical care has been a welcome addition to our services 
while families are unable to visit their loved ones. The future benefits 
of using this technology remain enormous; particularly during further 
COVID-waves.
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Introduction: The COVID-19 pandemic poses massive strains on 
healthcare systems worldwide. In a recent report from the UK, approxi-
mately 17% of hospitalised patients required intensive care unit (ICU) 
admission. Efficient triage of patients with COVID-19 at the time of 
hospital admission will support local resource planning. There is an 
urgent need for prediction models that use commonly available clini-
cal measurements to estimate the risk of patients requiring respiratory 
support and ICU admission.
We aimed to compare physiological observations between patients 
who require invasive mechanical ventilation and those who do not 
using the first available data after presentation of patients to our Acci-
dent and Emergency Department to allow rapid triaging.
Methods: We retrospectively reviewed case notes of all patients 
admitted to the Royal Liverpool University Hospital between March 
23rd and April 23rd 2020 with a positive COVID-19 RT-PCR result. The 
chosen time period reflects the peak of the pandemic in North West 
England. Routine clinical data including demographic data and initial 
admission physiological data were extracted. We assessed the pre-
dictive value of admission physiological parameters including heart 
rate, oxygen saturations, required fraction of inspired oxygen (FiO2), 
mean arterial pressure, temperature and National Early Warning Score 
(NEWS) by generating Receiver Operator Characteristics.
Results: 455 RT-PCR positive COVID patients were included in our 
analysis. In univariate analysis, patients requiring mechanical ventila-
tion had lower admission oxygen saturation (87% vs 93%, p < 0.001), 
higher respiratory rate (27 vs 22 bpm, p < 0.001), lower estimated P/F 
ratio (46 vs 35, p < 0.001) and were more tachycardic (102 vs 93 bpm, 
p < 0.001). Mean arterial blood pressure was not significantly differ-
ent (93 vs 90  mmHg, p:0.44). Temperature was comparable between 
groups (37 vs 37.5oC, p = 0.55). When physiological parameters were 
combined into the NEW score, patients requiring mechanical ventila-
tion had a significantly higher NEWS (6 vs 4 p < 0.001). Following logis-
tic regression, oxygen saturations and estimated P/F ratio predicted 
need for mechanical ventilation with an area under the curve of 77% 
and 73% respectively.
Conclusion: Our study identifies a number of physiological param-
eters which predict the need for invasive mechanical ventilation. 
Physiological markers associated with hypoxia, including lower admis-
sion oxygen saturations, higher respiratory rate and lower estimated 
P/F ratio show potential to predict the need for invasive ventilation. 
Patients with COVID-19 were relatively haemodynamically stable 
with comparable mean arterial pressures between patients requiring 
mechanical ventilation and those who do not. In the UK it is common 
practice to combine physiological parameters into the NEWS, how-
ever, for patients with COVID-19 the NEWS was not superior in predict-
ing those patients requiring mechanical ventilation.
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Introduction: Invasive ventilation to treat respiratory failure may 
become a scarce resource during pandemics, necessitating critical 
review to allocate ventilators and intensive care beds to patients likely 
to benefit most from this intervention.
Demographic characteristics and differences in functional state 
between patients who were declined escalation to invasive mechani-
cal ventilation compared to those who were admitted to critical care 
for this intervention during the COVID-19 pandemic have not been 
well described so far.
In this retrospective cohort study we analysed data from 83 patients 
who were referred to critical care specialists with the question as to 
whether they should be admitted to critical care for invasive ventila-
tion in case of clinical deterioration.
Methods: Data for all patients admitted to Royal Liverpool Univer-
sity Hospital between March 23rd and April 23rd 2020 with a positive 
COVID-19 RT-PCR result who were referred to and reviewed by a con-
sultant intensivist were analysed. Outcome of the critical care review 
was documented as “suitable for escalation to invasive ventilation if 
required” or “ward level care only”. Frailty scores, comorbidities, demo-
graphic data and laboratory results were reviewed for the day of hos-
pital admission. Univariate statistics were performed using  X2 tests for 
categorical and Mann-Whitney-U test or T-test for independent sam-
ples for metric data.
Results: 83 patients were included in the analysis. 53 patients were 
assessed as suitable for escalation to invasive ventilation, while treat-
ment was limited to ward level care in 31 patients. Patients in whom 
escalation was deemed appropriate had lower Rockwood frailty 
scores (2.5 ± 1.3) compared to patients declined for escalation of care 
(4.3 ± 1.4, p < 0.001). Patients offered escalation were significantly 
younger (63.8 ± 11.5  years) than patient who were not offered esca-
lation (54.0 ± 12.2 years, p < 0.001). Markers of infection on admission 
to hospital did not differ between patient groups, indicating that the 
severity of infection did not influence decision making. Ischemic heart 
disease, COPD, malignancies, liver disease and chronic kidney dis-
ease were documented significantly more often for patients deemed 
unsuitable for escalation of care (p < 0.001). In contrast, comorbidities 
that showed no significantly different distribution between groups 
included diabetes, asthma and hypertension.
Conclusion: Patient factors that influenced decision making of critical 
care specialists as to whether treatment offered should include inva-
sive ventilation included frailty, comorbidities such as heart, kidney or 
liver disease and patient age. Although not directly investigated in this 
study, age correlated with the occurrence of these comorbidities and 
with frailty. Mortality of COVID-19 increased with age. Further research 
is required to fully understand the decision-making process for offer-
ing escalation of care in pandemic situations with limited critical care 
capacity.
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Introduction: The ICUWW team is conformed by intensivist doctors 
who carry out activities from 8 am to 8 pm, accompanied by a nurse 
with training in critical patients from 10 am to 5 pm, Monday through 
Friday. Its activity has 2 components. The first is that of the ICU, which 
is reactive to any need of the hospital (care of critically ill patients, 
assistance in CPR, assessment of multiple trauma patients, etc..) and 
other that is proactive; which focuses on the follow-up of fragile 
patients after discharge from the ICU or who have previously been 
evaluated by on-call doctors or by the ICUWW team.
Objectives: Show some comparative data about the care provided by 
the ICUWW team for the years 2018 and 2019, in a hospital of 400 beds 
in Lleida, Catalunya, Spain.
Methods: Descriptive study from January 2018 to December 2019; 
that shows the results of the evaluations made by the ICUWW. Vari-
ables are described as means,  ±  standard deviation or percentage. 
Chi square (X2) and Mann-Whitney test for continuous variables were 
used to compare categorical variables.
Results: In 2018 the ICUWW attended 932 patients, with a total of 
1496 interventions. 63% were men and 37% women, with an average 
age of 61 years. The average time of attention was 81 minutes with one 
average follow-up of 1.36 days. 52% had medical pathologies, 38.2% 
surgical, and 9.8% traumatic. The 29.7% were assessed at the emer-
gency department, 13.2% at the digestive surgery unit, and the rest in 
other areas. 49.3% of the attention was made by a direct call; 5.6% was 
a follow-up of patients assessed in the previous ICU night shift, 11,4% 
required central venous catheter placement, 5.7% were the follow-up 
of fragile patients after the ICU discharge. The 17.2% required admis-
sion to ICU, 13.5% did not require admission. 8.5%. underwent limita-
tion therapeutic effort (LTE). Of the patients that required follow-up 
(N = 193), 20.7% needed more than 2 days; 14% admission to ICU, and 
the rest avoided the admission. Only (N = 53) 24.5% of the patients 
with a follow-up after the discharge from ICU required re-entry.
In 2019, a total of 826 patients were treated by the ICUWW team, who 
underwent 2,060 interventions; 289 patients with scheduled admis-
sions were also evaluated and 174 CVC insertions were performed. 
61.9% were men and 38.1% women; with a mean age of 61.7 years old. 
The average attention time was 158 minutes, with an average follow-
up of 1.26 days. 42.9% had medical, 48.4% surgical, and 8.7% trauma 
pathology. 25.2% of the patients were evaluated in the emergency 
department, 15.4% in the digestive surgery unit, and the rest in other 
services. 30.2% required admission to the ICU, 24.7% were attended 
for management and support and 33.5% did not require admission. 
5.35% underwent therapeutic effort limitation (LTSV) after evaluation. 
Of the frail patients who underwent follow-up at ICU discharge (N: 45), 
8.9% required readmission to the ICU.
Conclusion: With these data, we show the evolution of the ICUWW. 
Our goal is to improve the team. Try to make better monitoring of frag-
ile patients, and identify critically ill patients earlier. Those are the task 
for the next years.
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Introduction: This audit retrospectively repeats a closed loop on an 
audit assessing adherence to the GPICS standards of 100% patients 
receiving twice-daily consultant review (1). An initial audit was carried 
out before trust wide implementation of a daily management pro-
forma, which contains a pre-printed section for evening ward rounds. 
The loop was closed after implementation, showing a modest. As staff 
have become more used to the proforma, the audit was repeated to 
re-assess documentation.
Methods: A retrospective case notes review was carried out using 
‘Evolve’, an electronic record of scanned handwritten notes. All patients 
across both sites (site A and site B) were audited over pre-selected 
days. The days were chosen such that a selection of consultants would 
be reviewed; 1 day a week, 8 days apart between 2nd December 2018 
and 7th January 2019. This allowed for approximately 2 years since the 
previous data collection, during which, the proforma had been used 
exclusively. A patient was deemed to have been reviewed by a con-
sultant if the consultant themselves had documented an assessment 
or if a doctor had documented the consultant name into the notes. 
Data were recorded using a simple spreadsheet. Slightly differently to 
the previous audit, we reviewed whether a specific bed space in the 
ICU had been reviewed as opposed to a particular patient.
Results: During the assessment period, a total of 87 patient episodes 
were assessed. An episode was either a morning or an afternoon 
review. Notes were not available for 14 of those episodes on Evolve. 
These were included for the data analysis as ‘consultant review not 
documented’. Where a bedspace was empty or a patient was stepped 
down, no episode was recorded.
Prior to implementation of the proforma, trust-wide 24% patients had 
a twice daily consultant review documented, immediately post intro-
duction, 35% patients had a twice daily review and two years later, 
33% patients had a twice daily review.
1. 29 patients had two documented consultant reviews daily (25 site A 4 site 
B).
2. 25 patients had documented morning reviews only (21 site A 4 site B).
3. 7 patients had documented evening reviews only (6 site A 1 site B).
4. 26 patients had no documented reviews (16 site A 10 site B).
This table compares % patients with documented consultant reviews 
at both sites for morning and afternoon episodes pre and post intro-
duction of the proforma and the repeat audit.
SITE A Pre Post 1 Post 2
Twice 21% 45% 37% 
None 17% 20% 24% 
AM 57% 33% 31% 
PM  5% 2% 8% 
SITE B Pre Post 1 Post 2
Twice 31% 11% 21% 
None 4% 21% 53% 
AM 65% 68% 21% 
PM 0% 0% 5% 
Overall Pre Post 1 Post 2
Twice 24% 35% 33% 
None 14% 21% 30% 
AM 59% 43% 29% 
PM 3% 1% 8%  
Conclusion: The GPICS standards of 100% of patients having twice 
daily documented consultant reviews has not been met long after 
introduction of the ward round proforma. Trust wide, the number of 
twice-daily reviews have decreased from 35-33%. There has been an 
improvement across both sites for evening reviews.
The reason for the drop may be as simple as the consultant presence 
on the ward round not being documented.
Recommended actions:
• departmental presentation of audit findings to encourage more 
meticulous documentation.
• to further encourage use of the daily management sheet on ward 
rounds.
• inclusion of the proforma as part of the paperwork pack when a 
patient is admitted to the unit.
• interviewing staff using the proforma regarding potential difficul-
ties in its use.
Reference(s) and grant ackowledgment(s)
1. 1. Guidelines for Provision of Intensive Care Services (GPICS) 3.1.1.5 https ://
www.ficm.ac.uk/sites /defau lt/files /GPICS %20‑%20Ed.1%20%28201 5%29_0.
pdf.
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Introduction: The rapidly increasing burden of sepsis in India and 
also the availability of advanced care options have profound impacts 
on health care costs for patients and their families. High out-of-pocket 
expenditure, lack of insurance, and low government expenditure cre-
ate a vicious cycle, leading to household impoverishment.
Objectives: We aim to address the financial implications of sepsis 
and septic shock management in a tertiary care ICU. We also plan to 
study the factors influencing financial toxicity and catastrophic health 
expenditure.
Methods: Prospective data from 23 patients who underwent ICU 
admission for sepsis and septic shock between January 2019 and 
July 2019 were collected and analyzed. The time frame for considera-
tion of expenses, including all preoperative investigations, was from 
the first hospital visit to the day of discharge. Socioeconomic status 
was assessed using Kuppaswamy Scale [1] and financial burden was 
assessed using the Comprehensive Score for Financial Toxicity(COST) 
[2].
Results: Overall mortality in the study was 40% consistent with 
APACHE II mortality (adjusted for 6 patients who required emergency 
surgery). The proportion of patients who had partial or full insurance 
coverage was 50%. The average Kuppuswamy score for the study 
population is 2.5 (consistent with the middle-income group). Finan-
cial toxicity was noted in all irrespective of socioeconomic class. It was 
significantly higher in lower and middle-income groups than the high-
income groups(Table 1).









Class 1 and 2 (High and upper-
middle) 
11 20.9±4.79  0.003 
Class 3 and 4 (Lower middle 
and Low) 
12 20.9±4.79   
Conclusion: Thus to conclude, a major financial burden was seen in 
most patients treated for severe sepsis and was highest in low and 
middle-income groups. Recoverable illness like sepsis needs financial 
support programs/insurance schemes like the ones seen with cancer 
care.
Reference(s) and grant ackowledgment(s)
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D. Measuring financial toxicity as a clinically relevant patient‑reported 
outcome: The validation of the Comprehensive Score for financial Toxicity 
(COST). Cancer. 2017 Feb 1;123(3):476‑484.
2. 1. Wani RT. Socioeconomic status scales‑modified Kuppuswamy and 
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Introduction: The Basic Life Support (BLS) course run by Resuscita-
tion for Medical Disciplines (RMD) Birmingham at the University of Bir-
mingham uses a peer to peer teaching model, teaching approximately 
1000 healthcare students each year (1). The importance of face-to-face 
training needs to be balanced with limiting the risk to educators and 
students and maintaining an environment in which the risk of trans-
mission of SARS-CoV 2 is as low as possible. We therefore describe the 
modifications that have been introduced to our BLS course; the larg-
est European Resuscitation Council (ERC) certified course in the United 
Kingdom.
Objectives: This project aimed to investigate the adaptations made to 
the ongoing academic course (2020-2021) to ensure high quality BLS 
education is delivered in a safe environment.
Methods: Our course’s faculty and student committee produced a 
COVID-19 strategy using a modified Delphi approach. Amendments 
to our course’s usual running were authored iteratively and shared 
electronically. Modifications were added at each stage until the group 
achieved consensus.
Strategic planning utilised guidelines from the ERC and World Health 
Organisation (WHO) to develop an adapted BLS course for the COVID-
19 era (2, 3).
Results: Broadly, our group’s strategy was to reduce face-to-face con-
tact where possible, and where impractical, to take steps to minimise 
risks to trainers and participants.
Data from our prior work (publication under review) suggests that 
face-to-face teaching outperforms distance learning methods to 
reteach BLS in healthcare students from their second year of study 
onwards. Some aspects of our curriculum can be delivered remotely 
– including all lectures and seminars where no practical training is 
delivered.
The WHO clearly encourages strict hand hygiene and limited social 
contact (by reducing group sizes), and the ERC suggests remote train-
ing may be effective for professionals requiring BLS training (2,3). 
Process management and crowd flow through buildings was also 
analysed and systems were introduced to enable large numbers of 
peoples to pass through the educational environment for training and 
testing without reduction in social distancing and maintaining a low 
total number of participants in the building at any time.
Conclusion: BLS education at this large-scale ERC BLS course in the UK 
has been adapted to reduce the risk of COVID-19 transmission, main-
taining the use of face to face teaching as the most effective teach-
ing method in our cohort. Such teaching will incorporate additional 
safety measures with the view to reduce transmission risk of COVID-19, 
whilst maintaining a high standard of BLS education.
Reference(s) and grant ackowledgment(s)
1. 3. European Resuscitation Council. European Resuscitation Council COVID‑
19 Guidelines. 2020 [Cited July 2020]. [internet’. Available from: https ://
www.erc.edu/sites /5714e 77d5e 61586 1f00f 7d18/conte nt_entry 5ea88 4fa4c 
84867 335e4 d1ff/5ea88 6ae4c 84867 421e4 d1f8/files /ERC_covid 19_pages 
_secti on6.pdf?15882 57412 .
2. 2. World Health Organisation. Coronavirus disease (COVID‑19) advice for the 
public. 2020 [Cited April 2020]. [internet]. Available from: https ://www.who.
int/emerg encie s/disea ses/novel ‑coron aviru s‑2019/advic e‑for‑publi c.
3. 1. Harvey P, Higenbottam CV, Owen A, Hulme J, Bion JF. Peer‑led training 
and assessment in basic life support for healthcare students: Synthesis 
of literature review and fifteen years practical experience. Resuscitation. 
2012;83(7): 894‑899.
4. NA.
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Introduction: Critical care telemedicine (CCT) has long been used 
to expand the delivery of best care to critically ill patients located in 
geographically distant areas[1]. During the COVID-19 pandemic, those 
health systems with CCT appeared better prepared to respond to the 
pandemic [2]. However, several challenges remain for CCT to be suc-
cessfully implemented [3].
Objectives: To undertake a qualitative evidence synthesis of health-
care stakeholders’ perceptions and experiences of factors affecting the 
implementation of CCT, with a view hypothesising about factors more 
likely to foster implementation.
Methods: To undertake a qualitative evidence synthesis of healthcare 
stakeholders’ perceptions and experiences of factors affecting imple-
mentation of CCT, with a view hypothesising about factors more likely 
to foster implementation.Included studies were imported into Nvivo 
(QSR International Ltd) for coding. Data synthesis followed the Best-
Fit framework approach, guided by the Consolidated Framework for 
Implementation Research (CFIR) [4]. Additional themes not captured 
by CFIR were classified under a separate theme. The GRADE-CERQual 
[5] approach was used to summarise confidence in the review find-
ings. Conflicts throughout the process were resolved through team 
discussion.
Results: Thirteen studies were identified, published between 2008 
and 2019, and conducted in North America. Most studies (n = 12) 
included bedside and hub staff, directors and hospital administrators; 
one study (n = 1) included family members. Most studies collected 
data through interviews and observations (n = 10), while three pro-
vided qualitative data through open-ended survey questions.
Analysis and synthesis of evidence identified twenty review findings. 
Most mapped under CFIR’s domains of intervention characteristics, 
inner setting and individual characteristics. The most prominent find-
ings related to networks and communication, knowledge and beliefs 
about the intervention, and interactions between hub and bedside 
teams.
ICU stakeholders, including patients and family members, acknowl-
edged CCT’s potential for improving patient safety and quality of care 
regarding standardisation of practice, early recognition of patient 
deterioration and continuous data collection; and valued the potential 
of allowing patients to remain in their community. Hospital staff also 
highlighted the mentoring role of CCT for junior staff at the bedside.
Barriers to implementation stemmed from CCT’s disruptiveness within 
the everyday workflow, and additional work imposed on bedside staff, 
such as relaying patient information to the hub team. The presence 
of a camera was reported as a risk to patient confidentiality and staff 
autonomy. The absence of ongoing dialogue and engagement by 
leadership were perceived as major barriers.
Hospital staff suggested adequate training and rehearsing of the pro-
cesses relating to the use of CCT prior to its implementation as impor-
tant facilitators. Both bedside and hub clinicians reported that they 
wanted their needs to be heard throughout the process, allowing time 
for them to accept and normalize CCT in their daily workflow.
While bedside clinicians valued prompt access to critical care exper-
tise enabled by the CCT, they were concerned about the hub team 
interfering with their decisions over patient treatment. The conflict 
between bedside and hub clinicians was reported, in some instances, 
raising issues of disrespect and animosity. Effective communication 
featured by trust, teamness, and a sense of professional community 
were important enablers to the implementation of CCT.
Conclusion: We concluded with high or moderate confidence in 
the evidence contributing to several of these review findings. Fur-
ther research, especially in contexts other than North- America, with 
different cultures, norms and practices will strengthen the evidence 
base for the implementation of CCT internationally.
Reference(s) and grant ackowledgment(s)
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Introduction: The first patient admitted to our intensive care unit 
(ICU) with COVID-19 at the Royal Gwent Hospital (RGH), Newport, 
Wales was on the 9th March 2020. RGH ICU went into surge capac-
ity on the 28th March, remaining well beyond normal occupancy for 
40 days. During this time additional doctors were redeployed from the 
anaesthetic and surgical departments to cover an emergency ICU rota.
Objectives: A quality improvement project was undertaken to intro-
duce a “COVID-19 ICU Daily Review Sheet” that could be completed 
during daily consultant-led ward-rounds for each patient. The aim was 
to promote standardisation of care and completion of comprehensive 
daily assessments, in a time-effective manner, during a chaotic and 
stressful pandemic environment. A further aim was to assist junior 
doctors with minimal ICU experience, such as those being redeployed, 
with structuring reviews of patients.
Methods: Between the 13th and 14th April, pre-intervention meas-
urements were taken of daily ward-rounds (n = 32) from the hospital 
notes regarding junior preparatory review prior to senior review; full 
systematic patient review; and an “ICU-bundle” review: antibiotics, 
lines, drug chart, gastroprotection, venous-thromboembolism (VTE). 
The “COVID-19 ICU Daily Review Sheet” was introduced on the 15th 
April after emailing staff and making sheets available on the ICU. 
Post-intervention, between the 25th April and 1st May (7 days), ward-
rounds (n = 119) were re-assessed.
Results: Following its introduction, the “COVID-19 ICU Daily Review 
Sheet” was used on 69% (82 of 119) of ward rounds overall between 
the 25th April and the 1st May. Pre-intervention 31% (10/32) of 
patients had a pre-emptive junior doctor review and 56% (18/32) 
received a full systematic review. Post-intervention this had risen 
to 65% (77/119) and 68% (81/119) respectively. “ICU-bundle” docu-
mentation before/after the intervention was as follows: antibiotics 
(34%/45%), lines (28%/30%), drug chart (0%/28%), gastroprotection 
(3%/48%), VTE (13%/27%).
Conclusion: The “COVID-19 ICU Daily Review Sheet” had high uptake, 
appearing to encourage more comprehensive ward-rounds and docu-
mentation. The sheets appeared to promote a culture of ‘near to nor-
mal levels of care’ despite being in surge capacity. The wide-spread 
uptake suggests that the sheets were equally, if not more, time-effi-
cient than free-hand documentation. We would reintroduce the sheet 
Page 516 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
in the event of a second wave as a useful aid in this complex cohort of 
patients.
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Introduction: Antibiotic stewardship programmes (ASPs) aim to 
improve antibiotic use and patient outcomes and to lower anti-
microbial resistance (AMR) rates. Despite growing international 
commitment and the availability of antibiotic stewardship (AS) imple-
mentation guidelines, differences in local practices still may exist.
Objectives: This study aimed to (1) assess current AS practices in 
intensive care units (ICU) worldwide, and (2) to explore characteristics 
of AS-focused centers vs. others.
Methods: Data of the DIANA study (DetermInants of Antimicrobial use 
aNd de-escalAtion in critical care), a multicentre international prospec-
tive observational cohort study, were used. Details of ICU and hospital 
characteristics, background AMR levels, as well as different aspects of 
AS practices, including the use of antibiotic de-escalation (ADE), were 
collected from participating centers. AS-focused centers were defined 
as centers where (1) local guidelines on antibiotic therapy were avail-
able, (2) ASP team members were easily accessible for consultation 
and/or multidisciplinary AS meetings were held on a regular basis 
with presence of at least 2 out of 3 of the following team members 
other than the intensivist: infectious diseases (ID) specialist, medical 
microbiologist and pharmacologist, and (3) microbiology samples 
were processed daily. Descriptive statistics were used to compare ICUs 
in AS-focused centers vs. other centers and a 2-proportion two-sided 
Z-test was used to explore for differences in ADE proportions between 
both groups.
Results: Data from 144 ICUs were analyzed. Local guidelines on antibi-
otic treatment were available in 94 ICUs (65%). A scheduled multidis-
ciplinary AS meeting with the intensivist plus at least an ID specialist, 
a medical microbiologist or a pharmacologist, was organized in 28%, 
23% and 22% of the ICUs respectively. In 69% of the ICUs, microbiol-
ogy samples were processed on a daily basis. Consequently, forty-
nine ICUs (34%) were categorized as AS-focused centers. AS-focused 
centers were located more often in the Americas and Oceania, com-
pared to Asia and Europe (64%, 67%, 18% and 38% respectively). 
Country economy status (high income vs. low and middle income) 
and hospital status (teaching and non-teaching hospitals) were com-
parable. Median bed capacity in AS-focused centers and other cent-
ers was 17 vs. 11 beds. A closed ICU setting was present in 37% of 
AS-focused centers, vs. 26% of the other centers. Hospital AMR levels 
were lower in AS-focused centers compared to other centers. A statisti-
cally higher proportion of patients underwent ADE in ICUs located in 
an AS-focused center, compared to those admitted in other centres 
(p < 0.001).
Conclusion: This study showed that only 1 out of 3 ICUs fulfilled the 
set criteria of AS-focused center, but these did not have a typical geo-
graphical or organisational profile. The observed AMR levels were 
lower and the ADE rates higher in AS-focused centers.
Reference(s) and grant ackowledgment(s)
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Introduction: The COVID-19 pandemic has placed enormous strain on 
healthcare systems worldwide requiring rapid reorganisation of ser-
vices. Necessary expansion of Intensive Care (ICU) capacity mandated 
mass redeployment to support existing ICU staf.
Objectives: The primary end point of this study was the impact of the 
pandemic on career aspirations, specifically likelihood of pursuing fur-
ther experience or training in ICM. Other outcomes explored include 
qualitative data on experiences during the pandemic surge and per-
ceived learning outcomes during this challenging period.
Methods: The study was conducted as a single centre, observational 
cross-sectional analysis of survey data. Data were collected at Guy’s 
and St Thomas’s NHS Foundation Trust, a 1100 bed hospital, regional 
High Consequences Infectious Diseases (HCID) and ECMO centre. An 
online questionnaire was offered to all doctors via electronic mailing 
lists at the end of the ‘redeployment’ period. Data were analysed using 
R (version 4.0.0, http://www.r-proje ct.org).
Results: 115 doctors completed the survey; 17 already worked on 
ICU, 41 were redeployed to ICU and 57 worked in other departments 
during the pandemic. Most respondents (44.8%, 26/58) worked on 
ICU for 2-3 months. Roughly half of those working on ICU during the 
pandemic had at least 1 month post-graduate ICU experience (48.3%, 
28/58). We found no difference in our primary endpoint of likelihood 
to pursue further employment in ICU in any of the groups surveyed. 
That being said as shown in Figure 1, whilst as a cohort there is no con-
sistent shift, on an individual level there is flux in both directions in all 
groups. Follow up phone calls are ongoing and we hope to present 
further data on the experiences underlying these individual changes 
in career aspiration. Our secondary findings showed the majority of 
trainees deployed to ICU (72.5%) felt they had learnt new skills dur-
ing their redeployment useful to their parent specialty compared to 
those not deployed to ICU (29.9%). Canvassing the three words to best 
describe their experience on ICU the top four words selected were 
teamwork (67.2%), difficult (44.8%), supportive (44.8%) and camarade-
rie (36.2%).
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Conclusion: The COVID-19 pandemic was an unprecedented national 
healthcare crisis that rapidly evolved over a short period of time, 
requiring the mass redeployment of junior doctors under difficult 
circumstances. However it also presented a unique opportunity for 
doctors from many specialties to work together towards a collective 
goal. Despite not resulting in a consistent shift towards or against 
pursuing further training in ICU, our results support the assertion that 
those deployed to ICU in particular felt they had learned new skills and 
become part of a cohesive team rising to the challenges faced.
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Introduction Burnout (BO) is reaching epidemic levels in the medical 
population with prevalence reported around or over 50%1. Its pres-
ence is associated with poor patient safety outcomes2. Burnout is a 
threat to the profession of critical care medicine, with high prevalence 
rates across critical care provider disciplines3. In Ukraine, specifically, 
the concept of BO in ICM remains poorly understood and is largely 
under recognized, or dismissed. We decided to continue investigating 
the reality of BO experience in our country.
Objectives To assess the BO experience and identify associated risk 
factors in the ICU of City Clinical Hospitals in Ukraine.
Methods The focus of the study was the frontline ICU staff of two dif-
ferent city clinical hospitals. The final sample size was nurses (n = 99) 
and doctors (n = 113). Data collection was performed with the help of 
the Maslach Burnout Inventory (MBI) survey. The BO rate was assessed 
across various ICU types, seniority, gender and age groups.
Results The response rate was 72%. The overall prevalence of BO in 
ICUs was 69% (nurses 71.2%, doctors 66.4%). There was no difference 
on BO subscales between doctors and nurses (95% CI, P > 0.05) We 
also found no statistically significant difference in the incidence of BO 
between doctors and nurses (P > 0.05). Our study showed no differ-
ence (P > 0.05) in the incidence of BO in doctors across ICU type, sen-
iority level, gender or age group. In contrast, there was a difference in 
the incidence of BO in nurses across the ICU type (P < 0.05).
Conclusions BO prevalence was notably high in both ICU nurses and 
doctors. Our findings indicate that doctors and nurses are equally 
at risk of a BO experience. The study showed no clear association 
between any of the risks and the incidence of BO in doctors. With 
regard to nurses, the ICU type proved to be a factor in the incidence 
of burnout. The nurses of neurosurgery and burn ICUs were most 
affected possibly due to demanding workload and severity of the 
patients in these units. Limitations of our study include a relatively 
small number of respondents that prevents from drawing conclu-
sions in the context of a country/healthcare system. Further research 
is warranted in hospitals across the country to determine BO rates 
and risk factors. We expect our study raise awareness about the real-
ity of BO in Ukraine. We hope obtained data will contribute to better 
understanding of BO experience and will help us explore the existing 
opportunities to mitigate its impact and restore fulfillment among ICM 
professionals.
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Introduction: In our study we describe the effect of Ventilator Associ-
ated Pneumonia (VAP) on the on the length of stay (LOS) in patients 
with traumatic brain injury (TBI) in the Intensive Care Unit (ICU).
Methods: From December 2016 until January 2020, 156 patients, 96 
males and 60 females with TBI requiring mechanical ventilation more 
than 48 hours GCS ≤ 8 were studied. The mean age was 43 years. On 
admission to the ICU they had body mass index 27 ± 6  kg/m2 and 
APACHE II score 20 ± 2. Out of 156 patients the 54 had co morbid med-
ical illness.
Results: VAP occurred in 69 out of 156 TBI patients There was no dif-
ference in predominance as far as gender was concerned. VAP was 
significantly associated to patients requiring longer mechanical ven-
tilation 18 days ±  2 and longer sedation 14 days ± 2. Patients with co 
morbid medical illness and VAP were associated with a significantly 
greater degree of non neurological organ system dysfunction, though 
there was no difference in frequency of VAP development compared 
to the patients without co morbid medical illness. Although VAP was 
not associated with increased hospital mortality, patients who devel-
oped VAP had a longer duration of mechanical ventilation (28 versus 
10 days, p  <  0.0001) and longer ICU lengths of stay (31 versus 12 days, 
p  <  0.0001.
Conclusion: The effect of VAP in patients with TBI is high; increasing 
the mechanical ventilation duration and the ICU length of stay; how-
ever, does not affect the prognosis and does not seem to be associ-
ated with a significantly increased risk of mortality though increases 
the mechanical ventilation duration.
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Introduction: Several reports have suggested that the incidence of 
aneurysmal subarchnoid haemorrhage (SAH) varies seasonally with 
peaks in autumn and/or winter (1) and recently have suggested that 
weather effects may be related (2).
Objectives: To see if admissions to critical care (CC) with SAH were 
seasonal and if weather factors were related over a twenty year period.
Methods: Our patient record database was searched for patients with 
an admission diagnosis of SAH between January 2000 and December 
2019. Data for age, sex, Glasgow coma score (GCS) at presentation, 
length of unit and hospital stay, unit and hospital outcome and ulti-
mate discharge destination were retrieved. Weather data for the local 
health board region were obtained from online weather sources. Vari-
ables of monthly maximum, minimum and average monthly tempera-
ture and maximum, minimum and average atmospheric pressure were 
obtained.
Results: 357 patients were identified. 63% were female. Median age 
56  years (range18-86, IQR 17). Median time to CC admission 0  days 
(range 0-46, IQR 1). Median length of stay 1.8 days (range 0.1-30.5, IQR 
3.7). 61% died before hospital discharge, 37.5% died in critical care. 
15.9% were discharged to home or normal residence. Median APACHE 
II score 18 (range 4-40).
There was a seasonal variation of admissions to critical care with a 
peak occurring in October (figure  1.). There was no correlation with 
maximum, minimum, average monthly or monthly changes in temper-
ature (r = - 0.10783, -0.07064, -0.11881, -0.02244 respectively), or with 
maximum, minimum, average monthly or monthly change in atmos-
pheric pressure (r =  0.088, 0.449, 0.009, 0.002 respectively). There was 
no significance difference in number of deaths according to month of 
admission (p = 0.9)
Conclusion: We have shown that there is a seasonal variation in the 
incidence of SAH being admitted to critical care in the North of Scot-
land. We have not been able to explain this in relation to changes in 
temperature or atmospheric pressure.
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Introduction: To investigate the demographic, clinic and laboratory 
features of the critically ill patients with gastrointestinal bleeding (GIB) 
in Intensive Care Unit (ICU).
Methods: This study was performed prospectively in ICU. Patients 
aged 18  years and older, who had hospitalized for at least 24 hours, 
with gastrointestinal bleeding, were included the study.
Results: A total of 86 patients were enrolled the study. The mean age 
was 65 ± 14 years. The APACHE II score was 13 (2-41). Glasgow Coma 
Scale (GCS) was 13 ± 4 and SOFA score was 3 (0-16). Glasgow-Blatch-
ford risk score was 12 (2-18) and Rockall risk score was 6 (1-10). The 
most common co-morbid diseases were hypertension (44%), diabetes 
mellitus (27%), and chronic liver disease (27%). The most frequent pre-
disposing factor for GIB were chronic liver disease (22%) and throm-
bocytopenia (21%). The anatomic location of bleeding was mostly in 
the esophagus (35%) and stomach (24%). Endoscopic intervention 
was performed 42% of patients during ICU follow-up. The length of 
ICU stay was 5 days (min: 2-max: 28). The ICU mortality rate was 19%. 
APACHE II, SOFA and Glasgow-Blatchford scores were higher in the 
patients who died, compared to survivor patients (p  < 0.05).
Conclusion: As a result of this study, chronical liver disease and throm-
bocytopenia were found the most common predisposing factor of 
GIB. The most common localization of bleeding was the stomach and 
esophagus regions. Approximately half of the patients were treated 
endoscopically. APACHE II, SOFA and Glasgow-Blatchford scores were 
higher in patients who died compared to the survivors.
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Introduction: During the 2020 COVID-19 pandemic, critical care 
departments across the United Kingdom expanded capacity to care 
for unprecedented numbers of critically ill patients. The Queen Eliza-
beth University Hospital in Glasgow (QEUH) is relatively unusual in 
its separation of high dependency (level 2) and intensive care (level 
3) patients within the critical care cohort. Therefore the opportunity 
was taken to investigate the demographics of the COVID-19 positive 
patients presenting to high dependency (HDU) during the pandemic 
and to explore whether these demographics were associated with 
either HDU or hospital outcome.
Methods: All patients with COVID-19 presenting to HDU at QEUH 
were identified. Data on age, gender, comorbidities, length of HDU 
stay, augmented care period (ACP), discharge destination, unit out-
come and hospital outcome were collected. Deprivation quintile was 
calculated using the Scottish Index of Multiple Deprivation (SIMD) 
according to the patient’s home postcode.
The comorbidities that were assessed were diabetes (1,2), cardio-
vascular disease (excluding hypertension) (1-3), hypertension (1-3), 
chronic respiratory disease (1,3), renal disease (4) and obesity (5). 
These comorbidities were chosen as early studies had identified them 
as comorbidities that might affect infection rate and/or outcome in 
patients with COVID-19.
Data were analysed to determine whether age, gender, deprivation 
status or the presence of certain comorbidities were associated with 
HDU outcome (improved or deteriorated) and hospital outcome (sur-
vived to discharge or died in hospital).
Page 519 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Results: Between 24/03/20 and 25/05/20, there were 74 admissions of 
69 patients to HDU at the QEUH. Together they amassed 307 patient 
days in HDU: 13 days at ACP level 3; 230 at level 2; 54 at level 1; and 10 
at level 0. Age ranged from 27-76 years (mean 57, IQR 50-65) and 51 
patients were male (74%). The majority of patients admitted lived in 
areas of high deprivation. Length of HDU stay ranged from 1-16 days 
(median 3, IQR 2-5).
Of the 69 patients, 23 had none of the pre-determined comorbidities 
(33%); 16 had diabetes mellitus (23%); 8 had cardiovascular disease 
(12%); 11 had hypertension (16%), 13 had chronic respiratory disease 
(19%); 4 had renal disease (6%); and 31 were obese (55%). Twenty-four 
patients were multimorbid (35%), as described as having two or more 
of the aforementioned diagnoses.
Of the 74 admissions, 42 patients improved and were discharged to 
the ward (57%); 29 patients deteriorated and were admitted to inten-
sive care (39%); and three patients deteriorated but were not esca-
lated (4%). Of the 69 patients who were admitted to HDU, 51 survived 
hospital and were discharged home (74%).
In analysis, none of the demographic or comorbidity variables were 
associated with HDU or hospital outcome.
Conclusion: During the covid pandemic an unusually sick cohort of 
patients were admitted to HDU at the QEUH, the majority of whom 
survived to hospital discharge. However, none of the prior identified 
risk factors for poor outcome were found to be reliable in our cohort. 
This should be borne in mind in the event of a second wave of the 
pandemic when making decisions regarding critical care escalation.
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Introduction: Since the last week of December, 2019, a massive public 
health crisis has been rapidly spreading from China to the rest of the 
world, caused by a newly identified coronavirus named SARS-CoV-2. 
This rapidly evolving infection affected mainly the respiratory system 
and can lead to fatal morbidity and mortality.
Objectives: The aim of this study was to describe clinical character-
istics and to identify the factors associated with ICU mortality in criti-
cally ill COVID-19 patients.
Methods: A retrospective cohort study was performed in the medi-
cal ICU of Jean Bernard hospital in Valenciennes, France, including 
all consecutive critically ill patient with confirmed COVID-19 infec-
tion between Mars 11 and Mai 15, 2020. A confirmed case of COVID-
19 was defined by a positive RT-PCR (upper or lower respiratory tract 
specimens). Data were collected by reviewing the electronic medical 
charts. Were collected: clinical features at admission, severity of illness 
and ICU course. Univariate and multivariate analysis regression analy-
ses were performed to identify factors independently associated to 
mortality. Statistical seizure and analyses were performed using the 
statistical software package SPSS 24.0.
Results: Among 685 COVID-19 patients hospitalized in Valenciennes 
regional hospital during the study period, 77(11.2%) were admitted 
to the ICU. Their general characteristics were: age, 64.67 ± 11  years 
with ages ranging from 24 to 89  years; male, 52(67.5%); mean BMI, 
31.27 ± 9.05  kg/m2; Charlson comorbidity index, 3.03 ± 1.99; dura-
tion of symptoms before ICU admission, 9 ± 4.1 days; the mean SAP-
SII score, 36.11 ±  10.33; the mean SOFA score, 4.56 ±  2.46; invasive 
mechanical ventilation (IMV), 57(74%) with median duration, 17[9-
26.25] days; the median of peep and compliance during first 3  days 
were respectively 12[12-16] cmh2O and 36[30-45] ml/cmH2O; the 
most CT- lung opacification percentage at admission [50%-75%], 
23(29.9%); Vasopressors, 45(72.7%); hydrocortisone, 23(29.9%); 
hydroxychloroquine, 29(37.7%); ECMO, 4(5.1%); tracheostomy, 
10(13%); thromboembolism complications, 19(24.6%); acute kidney 
injury (AKI), 34(44.2%); renal replacement therapy, 20(26%); median 
length of ICU stay, 17[6-26] days; mortality rate, 3.8%.
Univariate analysis showed significant association between mortal-
ity and the following factors: age>65 years (p =  0.03), Charlson index 
(p = 0.032), IMV at admission (p = 0.032), AKI (p =  0.000), and ventila-
tor free days (p = 0.000).
Multivariate logistic regression analysis has identified only 3 vari-
ables as independently associated with ICU mortality: Age(OR, 1.06; 
95%CI[1.00-1.13], p 0.048), AKI(OR, 17.74; 95%CI[4.22-74.52], p 0.000), 
and length of ICU stay(OR, 0.94; 95%CI[0.91-0.98], p 0.011).
Conclusion: In this non selected consecutive COVID-19 population in 
a medical ICU, the age, acute kidney injury and the length of ICU stay, 
demonstrated acceptable predictive values for the in‐hospital mortal-
ity of critically ill patients with COVID‐19.
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Introduction: In December 2019, cases of COVID-19 infection were 
reported and this novel virus spread rapidly to touch every corner of 
the world within weeks. COVID-19 affects mainly the respiratory sys-
tem and would result in acute respiratory distress syndrome, requir-
ing ICU admission and prolonged mechanical ventilation. For ICU 
survivors, recovery may be characterized by a marked compromise 
between physical and psychological health after ICU discharge which 
may decrease quality of life.
Objectives: The objective of our study was to evaluate the incidence 
and risk factors of post ICU physical impairment of COVID-19 patients.
Methods: A retrospective study was performed in the medical ICU of 
Jean Bernard hospital in Valenciennes, France, included all consecutive 
critically ill patients with confirmed COVID-19 infection between Mars 
11 and Mai 15, 2020. The study collected clinical features at admission, 
severity of illness, ICU course, and acute management procedures. 
Univariate and multivariate regression analyses were performed to 
identify factors independently associated with physical declines. The 
statistical analyses were performed using the SPSS 24.0.
Results: A total of 77 patients were included: 52 male (67.5%), mean 
age, 64.67 ± 11  years; mean BMI, 31.27 ± 9.05  kg/m2; mean Charl-
son index, 3.03 ± 1.99; mean SAPSII score, 36.11 ±  10.33; mean SOFA 
score, 4.56 ±  2.46; invasive mechanical ventilation (IMV), 57(74%) with 
median duration, 17[9-26.25] days; vasopressors, 45(72.7%); hydro-
cortisone, 23(29.9%); neuromuscular blockers agents, 46 (59.7%); 
ECMO, 4(5.1%); tracheostomy, 10(13%); median length of ICU stay, 
17[6-26] days; mortality rate, 33.8%. Twenty-one (42%) of ICU survi-
vors were transferred to rehabilitation ward with mean length of stay, 
19.35 ± 9.45 days. On the day of hospital discharge, 14(28%) patients 
kept persistent physical impairment.
Univariate analysis identified several factors associated to rehabili-
tation needs after ICU stay: age, p 0.006; use of corticosteroids and 
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neuromuscular blockers agents with p value respectively 0.000 and 
0.006; duration of IMV, p 0.006 and duration of ICU stay, p 0.000. In 
multivariate analysis two predictors were independently associated to 
rehabilitation needs: the age (OR, 1.104; 95%CI[1.00-1.22], p 0.051) and 
duration of ICU stay (OR, 1.11; 95%CI[1.01-1.22], p 0.023).
Univariate analysis identified the age (p = 0.038), neuromuscular 
blockers agents (p =  0.009) and medical history of diabetes (p  = 
0.026) as factors associated with prolonged stay (>14 days) in rehabili-
tation ward.
Conclusion: Critically ill patients who survive COVID-19 infection fre-
quently experience important and long-lasting physical impairments. 
In fact, identified factors associated with persistent physical disabilities 
after ICU discharge may offer physicians the opportunity to facilitate 
adequate screening and to develop preventive measures to improve 
health-related quality of life of critical illness survivors.
001299 
Descriptive analysis of critically ill patients admitted 
to a third‑level hospital in covid‑19 pandemic
P. García  Olivares1; A.  Garrido1; J. Cedeño  Mora1; C.  Mata1; J.  Cui1; P.  Oliver1; 
G. Castañeda1; C.  Alvarez1; N.  Cango1; JM.  Gomez1
1Intensive Care Unit, H.G.U Gregorio Marañón, Madrid, Spain 
Correspondence: P. García Olivares
Intensive Care Medicine Experimental 2020, 8(2): 001299
Introduction: COVID-19 is a potentially fatal disease, with high conta-
giousness, that has become a global public health problem.
Objectives: The aim of this study was to describe the characteristics of 
patients admitted to the critical care units of a third level hospital dur-
ing the COVID-19 pandemic.
Methods: Prospective, observational study performed in critically 
ill Covid-19 patients admitted to H.G.U Gregorio Marañón during 
March-April 2020. We collected epidemiological data, comorbidities, 
presentation symptoms, relevant clinical data, organic support meas-
ures used, complications during stay, administered treatments and 
outcome.
Descriptive analysis was express as means (SD) for normally distrib-
uted quantitative variables, medians (IQR) for non-normally distrib-
uted variables, and as percentages for categorical data.
Results: One hundred and fifty patients were included, 70% were 
male, mean age was 61  years (49-70). Charlson Comorbidity Index 1 
pts (0-3) and the most frequent comorbidities observed were: Obe-
sity (MCI ≥ 30) 53%, hypertension 53%, diabetes 18%, dyslipidemia 
47%, cardiovascular disease 56%, chronic respiratory disease 26% 
and immunodeficiency 10%. The elapsed time from the onset of the 
clinical picture to hospital admission was 6 ± 4  days, being the most 
common symptoms: fever 90%, cough 70%, shortness of breath 60%, 
myalgia 46% and headache 7%. The delay until ICU admission was 
2 ± 1  days and the main clinical characteristics at admission were: 
APACHE II 17 ± 5, SOFA 6 ± 3, PaO2/FiO2 ratio 102 ± 45, mechanical 
ventilation 70%, High-flow oxygen therapy 27% and requiring imme-
diate prone-position ventilation 57% of patients. During ICU stay, 88% 
of patients needed mechanical ventilation, with an average time of 
15 days (8-25), 74% prone-position ventilation, with a median of 2 ses-
sions (0-5), 64% neuromuscular blockers and 37% of patients under-
went tracheostomy for respiratory support removal. Vasopressor 
therapy was required by 63% of patients, 30% developed acute renal 
failure and 10% needed renal replacement therapy. During ICU stay, 
infectious complications (ventilator-related pneumonia 28% and cath-
eter-related bacteraemia 24%) were the most frequent, followed by 
delirium 30%, pneumothorax 10% and clinical thromboembolism 7%. 
Regarding the treatment administered: 99% of patients received anti-
biotics, 99% Ritonavir/Lopinavir, 97% Hidroxichloroquine, 76% Tocili-
zumab, 60% Beta-Interferon and 22% Remdesivir. Of all the patients, 
76% received corticosteroids at some time during hospital stay.
The ICU mortality was 38%, with mean stay of 24 days (10-32). In-hos-
pital mortality was 40%, with mean stay of 36 days (17-53). The main 
causes of mortality were multiple organ dysfunction syndrome 47%, 
and refractory hypoxemia 40%.
Conclusion: There was a significant mortality and a large number of 
complications in critically ill Covid-19 patients. A high percentage of 
patients needed respiratory support and prone-position ventilation. 
Prolonged ICU and hospital stay was required.
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Introduction: Critically ill patients in intensive care units (ICUs) are 
exposed to stressful conditions and experience discomfort from multi-
ple sources, such as the environment or related to care provided in the 
ICU, depending on the care organizations and patient health status. 
This discomfort may have short-term and long-term consequences 
for ICU survivors, such as various degrees of anxiety and/or depression 
or post-traumatic stress disorder (PTSD) (1) which may affect patient’s 
quality of life. Reducing discomfort in the ICU has therefore become a 
major issue. IT has already been demonstrated that the implementa-
tion of a tailored multicomponent program for discomfort prevention 
in adult ICUs (named the IPREA3 program): 1) may decrease the self-
perceived discomfort in general adult ICU survivors of at the end of 
their ICU stay, according the results of the IPREA3 study, a cluster-ran-
domized controlled study (2); 2) may reduce substantial PTSD symp-
toms assessed 1 year after ICU discharge, according the results of the 
AQVAR study, a prospective cohort study inluding patients who were 
exposed and unexposed to the IPREA3 program (3). These promising 
results justify the need for a confirmatory study using a randomized 
design, the PTSD-REA study.
Methods: The PTSD-REA study is a stepped wedge cluster-rand-
omized interventional study involving 18 French ICUs. The cluster level 
comprises the ICUs, which are the units of randomization. Patients 
hospitalized in the ICUs comprise the individual level.
The intervention is the implementation of the IPREA3 program, a 
tailored multicomponent program consisting of assessment of ICU-
related self-perceived discomforts, immediate and monthly feedback 
to the healthcare team, and site-specific tailored interventions. The 
whole duration of the inclusion period will be 15 months and patients 
will be followed-up 1 year after ICU discharge. During the first month 
of the inclusion period, no ICU is exposed to the IPREA3 program. 
Every following month, 2 new ICUS of the 18 participating ICUs are 
randomized to the application of IPREA3 until the end of the inclusion 
period, leading to 9 steps. We considered 3 periods, a control period, 
an unvariable 5-month learning period for each ICU, and an interven-
tional period during which the IPREA3 program will be applied during 
more than 5  months until the end of the inclusion period. Patients 
will be included only during the control period and the interventional 
period. For each participating ICU, the durations of the control period 
and the interventional period range from 1 to 9 months, according the 
randomization date for crossing over to the IPREA3 program.
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The eligible patients are patients who survived an ICU stay of at least 3 
calendar days with an affiliation to a social security scheme. The exclu-
sion criteria include death prior to the 1-year follow-up after the index 
ICU hospitalization, patients under trusteeship, patients with cognitive 
incapacity, and patients who did not understand French sufficiently to 
complete the questionnaires exploring psychiatric morbidity. All par-
ticipants provided written informed consent. We planned to include 
4500 patients during the study, 2250 patients in each group.
The primary outcome measure is the presence of substantial PTSD 
symptoms at one year after ICU discharge assessed from the post-
traumatic stress-disorder checklist (PCL-5) which is a 20-item self-
report measure for PTSD symptoms according the DSM-5 (Diagnostic 
and Statistical Manual of Mental Disorders). The secondary outcomes 
are the following : the ICU stay’s duration, the number of days with 
mechanical ventilation, the overall score of discomfort assessed from 
the IPREA3 questionnaire, the duration of hospital stay after ICU dis-
charge. The other secondary outcomes will be asseseed at 1 year after 
ICU discharge: the number of symptoms in categories A,B,C, D and E, 
respectively, assessed from the PCL-5, the scores of the sub-scales A 
and D, respectively, of the questionnaire HAD-S (Hospital and Anxiety 
Depression Scale), the score obtained from the World Health Organi-
zation Quality of Life (WHOQOL-BREF), the number of emergency 
room visits, hospitalizations, and consulations with a psychologist or 
psychiatrist during the past year since ICU discharge, return to own 
home, and occupational status.
Results: The inclusion period started on November 1, 2020, but was 
interrupted on March 19, 2020 due to the consequences of the global 
COVID-19 pandemic on the functionning of French ICUs, when 1252 
patients had already been included. It is planned to resume the inclu-
sions in the ICUs on September 1, 2020. The provisional date for end-
ing the inclusions without further interruption due to the COVID-19 
pandemic is now July 31, 2021.
Conclusion: Despite the interruption of the PTSD-REA study due to 
the COVID-19 pandemic, more than a thousand patients in the control 
group could be already included. The results of the PTSD-REA study 
are eagerly expected to confirm that applying the IPREA3 program 
during the ICU stay may reduce substantial PTSD symptoms at 1 year 
after ICU discharge in general adult ICU survivors.
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Introduction: Veno-arterial Extracorporeal Membrane 
Oxygenation(VA ECMO) is used in cases of cardiogenic shock or refrac-
tory cardiac arrest. Upper gastrointestinal bleeding (UGIB) is a com-
mon complication in intensive care patients. Few data are available for 
patients on VA ECMO.
Objectives: The objective of our study was to assess the incidence, 
risk factors and attributable morbidity and mortality of UGIB in this 
population.
Methods: We conducted a retrospective cohort study in our medical 
intensive care unit (ICU) at Bichat Hospital (APHP-Paris). All patients 
admitted between 2014 and 2017 who had a VA ECMO were included. 
A survival model with death as a competitive risk was used to deter-
mine the risk factors for UGIB.
Results: 257 patients were included, 48 patients (18.7%) presented 
UGIB. These patients had a lower SAPS II score and a lower lactate level 
at the setting up of ECMO (respectively 51 [41; 67.5] vs 60 [44; 80] p  = 
0.05; 4 mmol/L [2.4; 8.1 ] vs 5.6 mmol/L [2.7; 10.3], p  =  0.04) a longer 
length of stay in ICU and mechanical ventilation duration (respectively 
40.5 days [19; 82] vs 15 days [6; 26]; p  < 0.01 and 32 days [17.5; 45] vs 
9 days [5; 18]; p  < 0.01). UGIB occurred in median at 18 days [7; 43]. The 
most frequently found lesions on endoscopy were peptic ulcers. In 
multivariate analysis a BMI (body mass index) > 30 (HR 2.46 [1.22; 4.97], 
p  =  0.01), diabetes (HR 2.91 [1.48; 5.72]; p  < 0.01) and a history of cer-
ebrovascular disease (HR 3.18 [1.19; 8.47]; p  =  0.02) were associated 
with a risk of developing UGIB. UGIB was associated with a reduced 
risk of mortality (HR 0.53 [0.34; 0.83]; p  =  0.01).
Conclusion: The incidence of UGIB is high in the population of 
patients on ECMO VA (18.7%). The decrease in the risk of mortality in 
this population could be explained by a lower severity of patients on 
admission, allowing survival long enough to develop UGIB. Obesity, 
diabetes, and a history of cerebrovascular disease appear to be linked 
to the risk of developing UGIB and could be witnesses to damage to 
pre-existing splanchnic microcirculation.
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Introduction: Many prognostic scoring models have been devised 
to predict mortality risk in burn patients. Ryan mortality prediction 
model is a system that predicts mortality taking into account three 
major risk factors: age 60 years or over, the burned surface area (BSA) 
of at least 40%, and the presence of an inhalation injury. An increasing 
number of risk factors (0-3) is associated with an increasing mortality 
rate. This formula predicts 0.3%, 3%, 33%, and approx. 90% mortality 
when, respectively, zero, one, two, or three risk factors are present [1].
Objectives: The aim of this presentation is to apply this prediction 
model in two cohort burn patients hospitalized in ICU and to evaluate 
the observed deaths with the predicted ones.
Methods: The study retrospectively analyzes the data of all burn 
patients admitted in the ICU of the Service of Burns and Plastic Sur-
gery of the UHC in Tirana, Albania in 1998 to 2008 and 2009 to 2019.
Results: Overall mortality during 2009 to 2019 was improved : 6.89% 
(116 deaths in 1684 patients) compared with 1998 to 2008 which 
was 10.5% (255 deaths in 2337 patients). The observed mortality was 
0.09%, 5.61%, 35.23% and 81.4% when, respectively, zero, one, two, 
or three risk factors were present and there is statistical significance 
for the difference between two decades(table  1). We performed the 
comparison of the full model (Age, BSA and presence of Inhalation 
Injury) against a null through Nominal Regression. [χ2(3)  = 488.808, 
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p < 0.001]. The Goodness of Fit test was used to affirm that the data 
gathered fit the distribution form the population [χ2(694)  = 617.914, 
p = .982]. The likelihood Ratios confirmed all the predictors of the 
model to be significant (p < 0.001).
Conclusion: Observed mortality in patients with one and two risk fac-
tors is improved but when are present the three risk factors mortality 
is higher. The data derived from this study confirm the strength of the 
Ryan model.
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Introduction: Medical yoga, a form of Kundalini Yoga with move-
ments, breathing exercises and meditation has been found to be 
associated with improved regulation of the sympathetic nervous sys-
tem and hypothalamic-pituitary-adrenal system. Yoga may improve a 
number of biological measure (cortisol, systolic blood pressure, resting 
heart rate, high frequency heart rate variability, fasting blood glucose, 
cholesterol and low density lipoprotein) (1) as well as patient reported 
outcome measures e.g. health-related quality of life in various patient 
populations (e.g. anxiety, depression, stress-related disorders, cardio-
vascular disease, neurological conditions and cancer). (2-4). This indi-
cates that Medical yoga can be used as an instrument for patients with 
prolonged disorders after critical illness such as post-intensive care 
syndrome (PICS) or heart failure. However, for severely ill persons it can 
be difficult to leave the home and attend regular yoga classes.
Objectives: To develop a feasibility- and pilot tested home-based 
tele-yoga intervention.
Methods: The tele-yoga includes live yoga sessions twice a week led 
by a certified instructor and individual daily yoga practice supported 
by an app. The mHealth tool used is a tablet with Internet connection 
that contains a video communication ability for the yoga sessions and 
an app with instructions (text, pictures, and sound files) on how to self-
perform medical yoga daily. The video communication app (ZOOM) 
and yoga app, installed on a tablet with a sim card and 4G surf, were 
tested for feasibility together with nine persons from a local cardiac 
patient organization. Further, a pilot study with 10 participants with 
heart failure (five intervention and five controls) were conducted to 
test the design of a planned RCT study.
Results: The feasibility testing resulted in minor modifications, and 
most technical problems were related to sound. Therefore, the yoga 
instructor changed to a more advanced microphone in the pilot study 
and a more detailed checklist for using the technology was developed. 
In the pilot study the design and technology worked sufficiently. The 
RCT study is now ongoing aiming to recruit 200 participants with post 
intensive care or heart failure randomized to receive medical yoga 
remotely at home (teleyoga) for 12  weeks or individualized training 
to the same extent. The primary hypothesis is that medical tele-yoga 
significantly increases physical function, health-related quality of life 
and mental well-being in people after a period of critical illness com-
pared to a control group receiving individualized exercise advice. The 
secondary hypothesis is that medical yoga improves sleep, heart rate, 
blood pressure, biomarkers for stress and inflammation and cognition 
in people after a period of critical illness compared to a control group 
receiving individualized exercise advice.
Conclusion: The tele-yoga intervention was feasible after minor 
adjustments and the RCT design was successfully tested in the pilot 
study. The ongoing RCT study will evaluate efficacy of tele-yoga on 
multiple outcomes after critical illness.
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Introduction: Acute renal failure is very common in the critically ill 
patients and it is associated with increased mortality.
Objectives: To determine the prognostic impact of the early acute 
renal failure (ARF) in critically ill patients.
Methods: Prospective, observational study conducted during the 
months of November and December 2019. Epidemiological data, 
reason for admission, severity scores, organic support and renal func-
tion data, were collected in all patients admitted to ICU. The ARF was 
defined according to AKIN, RIFLE and KDIGO scores in the first 24 
hours of admission.
In descriptive analysis, qualitative variables were expressed in percent-
ages and quantitative variables in means (SD) or medians (IQR). The 
univariate analysis was performed using Chi-square (RR) for qualitative 
variables and simple logistic regression (OR) for quantitative variables. 
The prognostic impact of ARF was determined by means of a multi-
ple logistic regression analysis (OR), adjusted for different confounding 
factors.
Results: We included 95 patients. Epidemiological profile: males 56%, 
age 60 ± 17 years, some comorbidity 52%. Reason of admission: neu-
rological pathology 30%, respiratory 26% and infectious 20%. Severity 
scores: APACHE II 18 (13-25), SOFA 6 (4-8). Mechanical ventilation was 
required in 52% of patients and 51% needed vasoactive therapy. The 
three scores used determined ARF in 34% of patients (14% stage I/risk, 
8% stage II/damage, 12% stage III/failure), 33% of them required renal 
replacement therapy. Mortality was 29% and average stay was 11 days 
(6-29).
In the univariate analysis, the patients with early ARF had higher mor-
tality (50% vs 17.5%, p = 0,001). For each stage of ARF there was an 
increase in mortality (stage I/risk 23%, stage II/damage 50%, stage III/
failure 82%, p = 0.001).
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In the multivariate analysis (adjusted for age, comorbidities, reason of 
admission, severity scores, mechanical ventilation and vasoactive ther-
apy), early ARF was an independent prognostic factor for mortality (OR 
6.28; 95% CI 1.28-30.99). Each stage of ARF increased the risk of death: 
stage I/risk (OR 1.39; 95% CI 0.33-5.90), stage II/damage (OR 4.64; 95% 
CI 1.01-21.44), stage III/failure (OR 20.86; 95% CI 3.95-110.27).
Conclusion: Early acute renal failure was an independent prognostic 
factor for mortality. The risk of death increased with each stage pro-
posed in the scores used.
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Introduction: Glasgow Coma Scale which predicts ICU mortality is 
being criticized due to difficulty in verbal assessment in tracheally 
intubated patients. FOUR Score (Full Outline of Unresponsiveness 
Full Outline of Unresponsiveness) includes eye movements, motor 
response, brainstem reflexes and breathing pattern and it is specu-
lated as a more reliable score. BIS (Bispectral index score) gives numer-
ical data to monitor neurological status. We aimed to compare the 
FOUR score with GCS and BIS to predict mortality.
Methods: Between August 2015 and April 2016, all unconcious adult 
patients were monitored by BIS in the first 24-h of admission after 
hemodynamic and metabolic stabilisation. GCS and FOUR scores were 
assessed by the same physician. Patients younger than 18, concious, 
paralyzed or sedated patients were excluded. Demographics, ICU and 
hospital stay and mortality were recorded.
Results: 65 patients included (32 males). Mortality was 83% (54/65 
patients). Average age, BMI, mean arterial pressure, APACHE II score, 
duration of ICU and hospital stay differed between the survivors and 
non-survivors. In predicting mortality, the sensitivity and spesific-
ity of GCS, FOUR and BIS scores were 83.3%/63.6%, 83.3%/54.5% and 
90.7%/63.6% respectively. The cut-off values of GCS, FOUR and BIS 
for predicting mortality were 6, 8 and 60, respectively. The correlation 
between BIS/FOUR and between BIS/GCS score was similar (0.797 vs 
0.764).
Conclusion: In this patient population with advanced age and high 
APACHE II score, GCS ≤6, FOUR score ≤8 and BIS value ≤ 60 were 
related with poor prognosis. When compared with BIS score, the prog-
nostic values of GCS and FOUR score were similar and can be used 
interchangeably.
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Introduction: Existing studies have looked at the risk factors for death 
among COVID-19 patients admitted to the intensive care unit (ICU). 
However, few is known about the actual process of death such as the 
precise role of secondary bacterial infections, cardiac or kidney failure.
Objectives: The present study aimed to describe specific causes of 
death among COVID-19 patients at our ICU to better understand phys-
iopathological pathway of the disease and to guide diagnostic and 
therapeutic decision.
Methods: Medical charts of all COVID-19 patients died at the ICU of 
Rimini Hospital between 20/02/2020 and 30/06/2020 were retrieved. 
Information regarding laboratory test, imaging findings, microbial 
culture and daily not in the medical records were reviewed to define 
the final process that lead to death (according to WHO guidelines). 
Severity of organ failure was estimated by the SOFA score. Finally, we 
classified patients according to the clinical conditions that contributed 
to the dying process including the proportionality of care and unex-
pected deaths.
Results: Among 71 patients admitted to ICU in the study period, 28 
(39.4%) died during the ICU admission (median ICU stay: 15  days 
(range: 0-88)). Respiratory failure was the leading cause of death in 
16 (57.1%) patients. Pneumonia-COVID related was identified in 10 
(35.7%) deceased patients with a bacterial superinfection present in 4 
of those. Six (21.4%) patients developed ventilator associated bacterial 
pneumonia prior to death and in 3 of those COVID-related pneumonia 
was not improving while in 1 case severe lung fibrosis had developed 
leading to impossible weaning from the ventilators (ICU length of stay: 
88 days). Bacterial infections were the main cause of death in 7 (25%) 
patients and in 6 of them COVID-related pneumonia was improving. 
Finally, 5 (17.9%) patients death was related to other causes: 1 fulmi-
nant myocarditis, 1 cerebral hemorrhage, 1 hemorrhagic shock, 1 myo-
cardial infarction, and one disseminated neoplasm. In 3 cases deaths 
was unexpected while in 5 patients withdrawal of treatment was 
decided. The median SOFA score increased from 6.5 (3-11) the day of 
ICU admission to 8 (4-18) 3 days before death, and to 11 (3-18) the day 
of death.
Conclusion: The course of critically ill COVID-19 patients is hetero-
geneous. Bacterial infections played an important role in the dying 
process and a systematic approach to infection vigilance could help 
to prevent some deaths especially in a contest where inflammatory 
markers might have been masked by use of steroids or immunosup-
pressive therapies.
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Introduction: The increased risk of dysphagia and laryngeal injury in 
patients following intubation is widely described in the literature [2]. 
Patients diagnosed with COVID-19 were intubated and ventilated for 
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prolonged periods and subsequently presented with profound weak-
ness and confusion, all of which contribute to increased risk of post-
extubation dysphagia [1, 3]. The presence of Speech and Language 
Therapy (SLT) within the MDT, to provide early dysphagia assessment 
[1, 4], is essential.
Objectives: To review the impact on SLT dysphagia intervention using 
a validated outcome measure with all COVID-19 patients referred to 
SLT at the Royal Brompton Hospital.
Methods: During the period between March to June 2020 (inclusive), 
SLT were referred and treated 42 of 136 COVID-19 patients admitted 
to the Royal Brompton Hospital (RBH). One patient solely received 
voice intervention and six were repatriated prior to completing their 
dysphagia treatment; and so these patients were excluded from data 
analysis.
Impact was measured using ‘The Royal Brisbane Hospital Outcome 
Measures (RBHOM)’. This is a validated numerical scale, which shows 
progress from Nil-by-Mouth (NBM) to full oral intake [5]. This outcome 
measure was scored following initial assessment and repeated on 
discharge.
Results: A total of 35 patients, including 23 with tracheostomy with 
and without mechanical ventilation, received SLT dysphagia inter-
vention. These are interim findings and data collection is still being 
collated.
Interim data analysis has shown that an average of eight days of SLT 
dysphagia intervention resulted in patients having an average five 
point increase on the RBHOM. Only one patient remained NBM with a 
gastrostomy on discharge whilst all others returned to full oral intake.
From the data collected thus far, 97% of patients went from NBM to 
safely returning to oral intake.
Conclusion: Whilst this is a small sample of patients and data col-
lection is ongoing, results are strongly showing that SLT dysphagia 
intervention has a direct impact on improving outcome measures for 
COVID-19 patients.
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Introduction: Critically-ill patients with COVID-19 have a prolonged 
intensive care unit (ICU) course and their short- and long-term health 
outcome are unknown.
Objectives: To report short-term physical, nutritional, cognitive, psy-
chological impairment, and quality-of-life in ICU survivors with COVID-
19, 1 month after ICU discharge.
Methods: Patients who stayed in ICU for > 7 days between March 21, 
2020 and May 1, 2020 were included. Patients were evaluated in the 
follow-up visit within 1st month after ICU discharge, where general 
performance, nutritional status, 6-minute-walking test (6MWT), mus-
cle function, cognitive, psychological and quality-of-life assessments 
were performed. Related samples were compared by Wilcoxon-
Signed-Rank test and results are presented as median (IQR).
Results: Out of 30 patients with COVID-19 who were admitted to ICU, 
11 patients (7 males, 4 females) with a median age of 60 (52-75) were 
evaluated. Their admission APACHE II score was 15 (12-18). ICU length 
of stay was 13 (9-23) and hospital length of stay was 23 (17-33) days. 
PaO2/FiO2 improved at ICU discharge as compared to admission val-
ues (260 (217-300) vs 158 (146-227); p = 0.03). Five patients received 
invasive mechanical ventilation. ECOG performance and Clinical Frailty 
Scale © scores were worse during the follow-up visit than their base-
line (0 (0-1) vs 0 (0-0), p = 0.03 and 2 (1-3) vs 1 (1-2), p = 0.008, respec-
tively). Compared to baseline they lost 7.9% (5.8-11.8) of their weight 
at ICU discharge and weight loss at follow-up visit was 6.5% (2.4-12.4) 
kg. Predicted distance walked during 6MWT in 10 patients was 82.2% 
(72.4-88.8) and 6 patients reported dyspnea at rest. The handgrip 
strength test was below normal in 4 patients. ICU-acquired weakness 
according to Medical Research Council was present in 5 patients at 
ICU discharge, whereas it improved in the follow-up visit compared to 
baseline (54 (51-58) vs 48 (42-52), p = 0.005). The Mini-mental test was 
abnormal in 2 patients. Three patients had anxiety, 1 had borderline 
depression and 1 had post-traumatic stress disorder. Six patients had 
moderate-severe pain and 6 patients reported sleep problems. The 
physical-component score of Short Form-36 was low in 8, the mental-
component score was low in 4 patients.
Conclusion: Short-term outcome of critically-ill COVID-19 patients 
1 month after ICU discharge was poor. Long-term outcome should be 
evaluated in more number of patients.
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Introduction: The Covid-19 pandemic has put the need for ICU reha-
bilitation in bright light due to extreme strain on ICU capacity. During 
the pandemic, the Sormland region became one of the heaviest tar-
geted areas in Sweden with 57 patients/100.000 inhabitants needing 
intensive care. To meet the anticipated need for ICU rehabilitation, a 
multi professional taskforce was formed to design and institute a reha-
bilitation program encompassing all phases of the clinical course from 
the ICU to hospital discharge and the following time in outpatient 
care.
ICU patients frequently develop sequel after their ICU stay with long-
standing reduction in HRQoL. These impairments, described as PICS 
(Post Intensive Care Syndrome), involves both cognitive and neuro-
muscular dysfunction. Early ICU adapted rehabilitation and use of PICS 
preventive bundles have shown favourable effects on long time out-
come and individually tailored aftercare in ICU step down and rehabili-
tation units has been advocated. Compared to the normal ICU setting, 
Covid -19 patients are cared for in a most unfavourable ICU milieu 
which expose them extensively to virtually all known risk factors for 
PICS including separation from relatives, use of heavy sedation and 
neuromuscular blockers in addition to the severe respiratory injury 
and biomedical stress.
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In this paper we describe the development of the rehab program. Col-
lection of outcome data are in progress and are not presented at this 
stage.
Objectives:
• To design and implement a follow up and rehabilitation program 
for COVID-19 patients.
• Within the program collect data on clinical outcome, PREM and 
PROM, later to be used to describe longitudinal outcome trajec-
tories.
Methods: During multiple interprofessional workshops, a patient/
family centred rehabilitation program was developed and instituted 
in clinical practice. ICU follow up clinics were used for program coor-
dination and for data collection. The program was organized in in-
hospital and outpatient components. A multi professional rehab team 
was formed and evaluation was done using pre set clinimetrics . A 
“stepdown unit“ was formed were extubated ICU patients could de-
escalate respiratory and residual organ support parallel with escalat-
ing physio and occupational therapy. At discharge from the stepdown 
unit, all patients were triaged by a specialist in rehab medicine to indi-
vidual trajectories.
Results: Between 200311- 200719 a total of 143 patients were treated 
in the ICU. At the start of the pandemic, an already developed ICU 
early rehab program was expediently initiated. Thus, an early in-ICU 
rehab program was available at ICU admission.
The complete Rehab-program was developed during the first three 
weeks of the pandemic and was operational in April from when all 
ICU patients were discharged to the stepdown facility. The individual 
course of the patients is currently monitored by the rehab team at 2, 6 
and 12 months scheduled Post ICU clinics. Currently, the 2-month clin-
ics and data collection are in progress.
Conclusion: The urgent demand for post ICU rehabilitation resulting 
from the COVID-19 pandemic could be rapidly met by the expedient 
institution of a complete rehab program. This was possible due to the 
work of an interprofessional response team, endorsed by the hospital 
board, were ICU and rehab competencies collaborated. This program, 
catalysed by the pandemic, satisfies a long-experienced need for an 
organised rehab program for ICU patients.
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Introduction: Post Intensive Care Syndrome (PICS) is an entity that 
affects patients cognitively, physically and emotionally after being 
managed in the Intensive Care Unit (ICU) (1). These sequalae impact 
the quality of life (QOL) of ICU survivor patients and can persist after 
5  years (2). The diagnosis of PICS, same as other pathologies such 
as Delirium, can be challenging and make it difficult to determine 
its exact prevalence (Rawal 2017). Given its impact on the QOL of 
patients, it is necessary to stablish its prevalence in order to generate 
awareness of it and the strategies available to prevent it.
Objectives: The objective is to determine the prevalence of PICS 
5  years after admission to the ICU of a Latin American Hospital in 
Bogotá, Colombia. Also, to characterize the patients that were admit-
ted during that same year.
Methods: A cross-sectional, descriptive study was done. Patients 
18 years old or older admitted into the ICU during 2015 were enrolled. 
Demographics, comorbidities, diagnostics, severity scores, ICU stay, 
Hospital stay, days of vasopressor and invasive mechanical ventila-
tion, complications and contact information were gathered. To evalu-
ate PICS, the Post Intensive Care Syndrome Questionnaire (PICSq) 
was used (3). This tool is a Likert style questionnaire consisting of 18 
questions that evaluate the cognitive, physical and emotional spheres 
(6 questions per sphere). The answers can be graded as “never-
0”,”sometimes-1”,”often-2” and “always-3”, thus, giving it a range of 
0-54 points. A score of 23 or more is indicative of the development 
of PICS. Furthermore, A value equal to or superior to 6, 9 and 7 in the 
cognitive, physical and mental spheres respectively, indicate severe 
compromise. This tool was previously validated for Spanish language 
in our institution. Data gathered was analyzed using SPSS ver. 25.
Results: A total of 1434 patients were admitted to the ICU on 2015. 
At this moment, 119 medical charts have been reviewed. Same event 
mortality was 21,8%, (26/119), making our available population 93 
patients. Most (63,8%) were male and mean age was 64,5 years. Aver-
age ICU stay and Hospital stay were 5,7  days and 22,2  days respec-
tively. Vasopressors were used on 38,7% of patients with an mean 
duration of 2 days. Invasive mechanical ventilation was used on 25,8% 
of patients with a mean duration of 1,9  days. A total of 23 patients 
(24,7%) died along the course of the 5 years after ICU admission, 18,2% 
died the first year, 3,2% on the second year, 1,07% on the third year, 
3,2% on the fourth year and none died on the fifth year. This left us 
with 70 eligible patients for applying the PICSq.
Out of the 70 eligible patients, 47 (67%) had changed contact infor-
mation or were not available. The PICSq was applied to 23 patients 
(32,8%) and the results were as following: The average score was 10,2. 
Only 3 patients had scores above the cut off value of 23, giving PICS 
a prevalence of 13,04%. The mean score for the cognitive compo-
nent was 2,56, for the physical component was 5,3 and for the men-
tal component was 2,3. According to the cut off values, out of the 23 
patients evaluated, 13,04% had severe cognitive impairment, 26% had 
severe physical impairment and 8,6% had severe mental compromise. 
Lastly, for those that did not meet the criteria for PICS, around 20% of 
patients suffered from severe physical compromise.
Conclusion: The partial results of this study show that PICS affects around 
13% of our population, with severe physical compromise being the most 
common affection for both those diagnosed with PICS and those that 
did not meet the criteria. The process of gathering information needs to 
continue in order to stablish the real prevalence of PICS in our population. 
Lastly, a better strategy to follow up patients is needed in the ICU.
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Introduction: Hepatobilier injury (HBI) is very frequent in ICU patients 
and associated with poor outcome. Pulmonary ICU patients are vul-
narable to HBI reasons like hypoxemia, pulmonary hypertension, 
right heart failure and frequent ICU infections and antibiotic usage. 
But there is limited data about HBI’s prevalance, type, risk factors and 
impact on mortality in Pulmonary ICU patients.
Objectives: The aim of this study was to assess frequency, risk factors, 
types, severity and effect on outcome of HBI in critically ill patients.
Methods: A retrospective observational cohort study was performed 
in an University hospital pulmonary ICU and all patients who admit-
ted last 5 years were included in the study. All potential risk factors for 
HBI like sepsis, hypoxia, congestion, medications and nutrition routes, 
were recorded from the patient files. Hepatobilier injury and severity 
are defined according to the classification of the European and Ameri-
can guidelines for 2017 and 2019. The value of R for HBI and the type 
of damage (hepatocellular, cholestatic and mix) calculated accord-
ing to RUCAM system. All potential risk factors were compared with 
univariate analysis (t test, Chi square test, Mann Whitney U test). Risk 
factors for HBI, mortality, length of stay in ICU were investigated with 
logistic regression analysis.
Results: 478 patients were included in the study and there were HBI 
in the 207 (43%) of them. Most frequent ICU admission reasons were, 
community-acquired pneumonia (21%), respiratory failure (18%) and 
COPD (18%). The mean age of the patients was 70 ± 15, 55% of them 
were male, mean APACHE II score was 20 ± 8, and mean SOFA score 
was 4 ± 3.
HBI developed median 5  days before ICU admission in the 71% of 
patients and 7 days after ICU admission in the 29% of patients, during 
the worst period of HBI, 39% of the patients were at stage 1, 33% at 
stage 2, 15% at stage 3, and 14% at stage 4 HBI was reversible in 77% 
of the patients. According to R coefficient HBI was considered as chole-
static (54%), mixed (29%) and hepatocellular (16%) patterns. DILI was 
thought to be present in 42% (86) of the patients with HBI. Mortality 
was higher in HBI group also (39% vs 6%).
Risk factors for HBI as (OR (95% CI), p) were TPN: 2.3 (1.3-4), p: 0.004, 
enteral nutrition: 2.3 (1.5-3.7), p: 0.0001, APACHE II score on admission: 
1.1 (1.06-1.14), p: 0.001, use of clarithromycin: 2.3 (1.2-4.4), p: 0.01, and 
immunosuppression: 2.6 (1.1-6.3), p: 0.032. HBI increased mortality risk 
four-fold in this study population(3.9(2-8), p:o.oo1). and was not risk 
factor for the increased length of ICU stay more than ten days. Liver 
function results of patients with hepatobiliary injuries are given in the 
table.
.
Conclusion: In this study population, 43% of the patients developed 
mostly cholestatic type HBI, despite many of them had mild-modarete 
stage and reversible disease it was an independent risk factor for ICU 
mortality.
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Introduction: Acute mesenteric ischemia (AMI) is a life-threatening 
disease. In 2016, the first French national intestinal stroke center 
was set up (SURVI, Beaujon and Bichat Hospitals, AP-HP, France); it is 
based on a multidisciplinary and multimodal management of life- and 
gut-saving strategy, focusing on intestinal viability that is achieved 
through (1) early AMI recognition, (2) urgent medical protocol, and (3) 
digestive revascularization and necrotic bowel resection if required.
Objectives: Our objectives were to describe the prognosis in the 
intensive care unit (ICU) of patients with AMI admitted in the intestinal 
stroke center, and to analyze factors associated with ICU mortality.
Methods: An observational retrospective analysis of a prospective 
database was conducted from February 2016 to December 2018, 
which consecutively included all patients with AMI admitted in ICU 
in the intestinal stroke center. Collected data were patients’ demo-
graphic characteristics, past medical history, mechanisms of AMI, 
intra-operative findings and ICU hospitalization. Data are presented 
as median [IQR] or number (percentage). Univariate analyses of factors 
associated with ICU mortality were performed using Chi-squared tests 
and Mann-Whitney U tests. Multivariate exact logistic regression was 
performed on clinical relevant factors that were significantly associ-
ated with ICU mortality in univariate analyses (p < 0.05). Statistical sig-
nificance was considered for p-value  <  0.05.
Results: Seventy patients (age 65 [54-76] years, 61% of male, SOFA 4 
[2-6], SAPS II 42 [30-53]) were admitted to ICU with AMI, mainly due 
to superior mesenteric artery occlusion (87%). Sixty patients (91%) 
underwent initial urgent laparotomy. Bowel resection was performed 
in 32 patients (50%), and 7 patients (10%) had extensive bowel necro-
sis beyond therapeutic possibilities. Forty-one patients (64%) had 
endovascular (n = 17) or open (n = 24) initial revascularization of the 
ischemic gut. Thirty patients (43%) required one or more revision 
surgeries.
Median ICU length of stay and duration of mechanical ventilation were 
6 [2-14] days and 2 [0-5] days respectively. Forty-seven patients (67%) 
had acute kidney injury. On ICU discharge, 20 patients (29%) had short 
bowel syndrome and 44 patients (63%) required exclusive parenteral 
nutrition.
Seventeen patients (24%) died in ICU. Factors associated with ICU mor-
tality in univariate analysis were age ≥ 80 years old, chronic hyperten-
sion, signs of hepatic infarction on CT scan, SAPS II on admission, delta 
SOFA score between admission and day 1 > 0, duration of mechanical 
ventilation and acute kidney injury.
Delta SOFA score > 0 (OR 9.0, 95%CI [1.8-69.5]) and chronic hyperten-
sion (OR 7.7, 95%CI [1.8-42.4]) were independently associated with ICU 
mortality in multivariate analysis.
Conclusion: We describe for the first time the prognosis of critically ill 
patients with AMI in an intestinal stroke center in France. The 24% ICU 
mortality rate suggests that intestinal stroke center might improve the 
outcomes of ICU patients with AMI.
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Introduction: Critically-ill patients with COVID-19 have been pro-
posed to have poor prognosis.
Objectives: To evaluate baseline characteristics and outcomes of 
patients with COVID-19 requiring ICU admission in Turkish ICUs.
Methods: Critically-ill patients admitted to 26 ICUs from 23 Hospi-
tals in Turkey from 10 March to 11 June 2020 were evaluated in this 
descriptive observational study. Results are presented as median (IQR) 
and counts (%).
Results: A total of 426 confirmed COVID-19 patients were included. 
The median age of the population was 67 (57-76) years. There were 
254 (59.6%) male and 172 (40.4%) female patients. The most frequent 
comorbidity was hypertension 217 (50.9%), followed by diabetes mel-
litus 131 (30.8%), cardiac diseases 107 (25.1%), chronic respiratory 
diseases 82 (19.2%), cancer 46 (10.8%) and chronic renal failure 16 
(3.8%). Duration from start of symptoms till ICU admission was 6 (4-10) 
days. Admission APACHE II score was 17 (12-25) and SOFA score was 
4 (3-7). Admission PaO2/FiO2 was 148 (102-206) and SpO2/FiO2 196 
(147-240). Admission lymphocyte count was 860 (560-1240) per mm3, 
CRP was 109.3 (57.7-188.5) mg/L, D-Dimer was 1120 (547-2970) ng/mL 
and ferritin was 491 (197-958) ng/mL. Invasive mechanical ventilation 
was applied in 231 (54.2%) patients and vasopressors in 163 (37.3%) 
patients. Hydroxychloroquine was used in 304 (71.4%), antibacterial 
treatment in 205 (48.1%), azitromycin in 196 (46.0%), favipiravir in 162 
(38.0%), oseltamivir in 158 (37.1%), convalescent plasma in 51 (12.0%), 
tocilizumab in 41 (9.6%), corticosteroids in 30 (7.0%), intravenous 
immunoglobulin in 10 (3.3%), lopinavir/ritonavir 9 (2.1%), cytokine/
endotoxin removal 9 (2.1%), plasma exchange in 5 (1.2%) patients. ICU 
length of stay was 7 (3-14) and ICU mortality was 215 (50.5%).
Conclusion: Multi-center study from Turkish ICUs revealed that more 
than half of critically-ill COVID-19 patients were older than 65 years of 
age, invasive mechanical ventilation was applied in more than half of 
patients and ICU mortality rate was high.
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Introduction: Cancer is the second global cause of death and inci-
dence is increasing. Mortality of ICU cancer patients has dropped, 
yet prognostication and patient selection remain to be adjusted. The 
severity of acute illness could be more important to predict short-term 
survival than the underlying type or stage of cancer.
Objectives: To determine the outcome of patients with solid tumors 
in ICU, the usefulness of SAPS 2 and APACHE II as prognostic tools and 
identify poor outcome factors in the oncologic population.
Methods: We enrolled patients with solid malignancies in active sys-
temic treatment admitted in an oncologic intensive care unit due to 
medical complications in a 3-year period. Clinical data were collected 
retrospectively.
Results: In our sample (n = 57), gastrointestinal cancers were the 
most frequent (14, 25%) followed by lung and breast (9 each, 16%). 
The cancer was stage IV in 36 patients (64%), 78% received chemo-
therapy in the 30 days prior and half was of palliative intent; 6 patients 
had received immunotherapy. Infection, acute respiratory failure 
and hematological disturbances were the most common problems 
at admission (75%, 77% and 82%), 39% of cases were classified as 
multi-organic disfunction. Major ICU interventions included invasive 
mechanical ventilation (53%) and vasopressor support (40%). ICU and 
hospital mortality were 25% and 44%. Six month mortality was 60%. 
Stage IV cancer, ECOG performance status, hematologic disturbances 
and infection were not independently related to higher mortality. 
APACHE II and SAPS2 scores showed a positive correlation with mor-
tality in the ICU. APACHE II and SAPS2 score distributions showed sta-
tistically significant relation to mortality (p = 0.017).
Conclusion: Stage IV cancer was not an independent risk factor for 
acute mortality, confirming the results of other published works. Most 
of the patients that survived the hospital stay were alive in 6 months. 
APACHE II and SAPS2 are often used in cancer patients, although they 
were never validated in this population. In our work, these scores rea-
sonably predict ICU mortality, but were far from perfect tests.
Conclusion: Patients receiving systemic treatment for cancer should 
be considered for ICU admission like other severely ill patients without 
cancer. Larger prospective studies are needed to understand prognos-
tic factors and refine predictive scores in this special population. Indi-
vidual evaluation of patient characteristics, oncological disease and 
treatment response are essential. Dialogue between oncologists and 
intensive care specialists is paramount in the decision making process 
of this population.
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Introduction: With the ongoing Coronavirus disease 2019 (COVID-19) 
pandemic, increased numbers of patients are being admitted to inten-
sive care units (ICU) worldwide. Many guidelines recommend early 
utilisation of the prone position (‘proning’) following intubation in this 
patient population, owing to the evidence that this position improves 
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lung mechanics and gas exchange.1 The increased utilisation of pron-
ing in patients where sedation and muscle relaxants have been used 
creates the hypothetical risk of precipitating brachial plexus injuries, 
for which the terms ‘Prone Position Plexopathy’ has been coined.2 The 
objective of this paper is to report a case and a review of the relevant 
literature.
A 36  year old gentleman presented to the emergency department 
with an 8 day history of progressive shortness of breath. His past medi-
cal history was limited to a high body mass index (BMI) and a previous 
traumatic brain injury (TBI) in 2002. He was found to be significantly 
hypoxic despite maximal oxygen therapy, and was brought to the crit-
ical care unit for ventilation and proning directly. He initially improved 
with airway pressure release ventilation (APRV) and frequent proning; 
however, he developed a ventilator-associated pneumonia (VAP) and 
deteriorated, and was transferred for veno-venous ECMO (VV-ECMO). 
On his return, he was noted to have new right upper limb weakness 
despite a computed tomography (CT) scan of his head showing no 
new signs; on examination he was unable to abduct his right shoulder 
and he had MRC grade 2 of the right Bicep, with generalised bilateral 
weakness. On nerve conduction studies and electromyography of his 
right upper limb several weeks after a successful discharge, he was 
found to have an underlying moderately severe lesion of the upper 
trunk of the right brachial plexus from which the large majority of 
nerve fibres to the right suprascapular, musculocutaneous and axillary 
nerves are derived, with relative sparing of the right middle and lower 
trunks, and posterior and medial cords, confirming the neurological 
findings.
Methods: A systematic literature search was conducted on PubMed 
using the search strategy: (“prone position*”) AND (“brachial plexus 
injur*” OR “brachial plexopathy” OR “nerve injury”), which identified 34 
articles that were subsequently screened. The resulting seven full-text 
articles were assessed for eligibility. Five studies, of which three were 
case reports and two were case series, were included.3-7.
Results: Twenty-one cases of brachial plexopathy, or impending bra-
chial plexopathy, secondary to proning were identified. The most 
common reason for proning was for spinal surgery (n = 18). This was 
followed by thoracoscopic oesophagectomy (n = 1), debridement of 
necrotising fasciitis (n = 1) and, indeed, the use of prone positioning in 
a patient with ARDS in an intensive care unit setting (n = 1). Only one 
case within the dataset underwent proning as it is described in the 
use for patients with ARDS secondary to COVID-19, and this was the 
patient who was proned for up to 12 hours a day in ICU as part of the 
management of ARDS. All of the plexopathies identified had almost 
entirely resolved within ten months, with two patients experiencing 
residual sensory deficits.3-7.
Conclusion: injury secondary to proning during the COVID-19 pan-
demic, and the second case in an ICU patient proned for the man-
agement of ARDS. Brachial plexopathy is a pathology to consider in 
patients who have undergone proning in an ICU environment as part 
of their treatment of ARDS secondary to COVID-19 who show signs of 
focal neurological deficits of the upper limb upon removal of paralysis 
and sedation; and as the COVID-19 pandemic continues, adaptations 
such as modifying SSKIN (a five step model for pressure ulcer preven-
tion) during proning and using scoring systems in critical care follow 
up will be needed to improve outcomes.
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Introduction: Novel Coronavirus (SARS-Coronavirus-2: SARS-CoV-2) 
or Coronavirus Disease 19 (COVID-19) emerged in Wuhan, China in 
December 2019 and it was declared a global pandemic in March 2020.
Objectives: To describe the epidemiological characteristics and clini-
cal manifestations of patients with COVID-19 in South-East London 
Region.
Methods: A single centre retrospective observational study was 
completed comprising patients with laboratory confirmed diagnosis 
of Covid-19 in a period between 12th March and 3rd April. Data was 
collected on patient characteristics, clinical manifestations, laboratory 
results, radiology findings and management in Intensive Care Unit 
(ICU). Moreover, described some of the complications that were noted 
in the COVID-19 cohort.
Results: 57 patients (68% male) were followed up for 23  days. The 
most common co-morbidities were hypertension (54%), obesity (53%) 
and type2diabetes (32%). The most common clinical manifestations 
were shortness of breath (88%), fever (%88) and cough (84%), which 
was initially noted 8 days prior to ICU admission. The typical radiology 
findings seen in COVID-19 patients were bilateral infiltrates on chest 
X-ray. Laboratory findings that were common in majority of patients 
were lymphopenia with raised white cell count, raised C-reactive pro-
tein and raised ferritin. 21% of the patients required renal replacement 
therapy due to acute kidney injury. Invasive mechanical ventilation 
(IMV) was required by 93% of the cohort; however, initially the unit 
did not try non-invasive ventilation for COVID-19 patients. PaO2/FiO2 
ratio illustrated appropriately the biochemical picture of acute res-
piratory distress syndrome. At the end of the follow-up period for this 
study, 35% had died, 28% had been discharged from hospital, 9% was 
stepped down to the ward from ICU and 28% remained in ICU. The 
average ICU stays in this cohort was 15 days. Mortality was correlated 
with age, PaO2/FiO2 ratio, ventilator settings, peak ferritin and neutro-
phil count over the first 72hours of IMV.
Some of the complications that were seen in this cohort: eight 
patients developed pneumomediastinum, surgical emphysema and 
pneumothoraces, one patient had a ST-elevation myocardial infarc-
tion requiring PCI and one had a micro-haemorrhage/subarachnoid 
haemorrhage (8 mm) and one patient developed posterior reversible 
encephalopathy syndrome (PRES).
Conclusion: This retrospective observational study described the 
clinical characteristics and outcomes of a South-East London cohort. 
It described few of the complications that were seen in this cohort, 
which could be co-related to COVID-19. Moreover, it reports factors 
that are correlated with mortality for patients with COVID-19.
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Introduction: In severly burnt patients, it is important to focus on 
fluid resuscitation, not just pain relief, because a burnt patient loses a 
big amount of fluid.
Objectives: Our study’s purpose is to find out how much fluid did 
these patients get during the prehospital care.
Methods: We included those patients who suffered an at least 20% 
second, third degree burn, and their fluid resuscitation started in 
the prehospital phase. We did our study with document analysis. We 
checked the documents from 2008.01.01. to 2018.12.31. With the 
hepl of including and exluding criterias we could include 104 people 
(n = 104). For data analysis we used Microsoft Word and Excel 2016 
and SPSS version 25,0. For statistical tests, we used correlation, Chi-
square test and independent T-test.
Results: In this study there were 70 male (67,3%) and 34 female 
(32,7%) patients. The average age was 56,59  years. Patients suffered 
an average 31,90% burn. In the prehospital care these people got 
averagely 1315,84 ml fluid. The 32,7% of the patients died during hos-
pital care. We found that TBSA (total burn surface area) correlate sig-
nificantly with surviving (p < 0,01). Surviving also correlate with almost 
every complications significantly (p < 0,001). We also found that Evans 
formula is more sensitive than Parkland formula, and there is a sig-
nificant difference between real fluid resuscitation and recommended 
fluid resuscitation by the formulas (p < 0,001). We confirmed that Park-
land formula decreases occurence of complications. It was also clear 
that patients got more than twice as many fluid prehospitaly than 
Parkland formula would provided.
Conclusion: Evans formula is more sensitive and it would drive 
patients fluid management better, but in prehospital care it is imprac-
ticable due to lack of equipment. There is more chance of compli-
cations if the patients got not the right amount fluid what they’re 
needed. Finally patients got more than twice as many fluid as it was 
recomended by Parkland formula in the guidline, so it is clear the 
prehospital medical providers didn’t work as the guidline would 
recommend.
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Introduction: APACHE (Acute Physiology and Chronic Health Evalua-
tion) II and SAPS (Simplified Acute Physiology Score) II have become 
a necessary tool to describe ICU (intensive care unit) populations and 
to predict differences in mortality. Both are calculated in the first 24 
hours of hospitalization, in which higher levels correspond to more 
serious diseases and a higher risk of death. Sepsis is a major cause of 
morbidity in ICU, it is estimated that about half of the patients have a 
nosocomial infection and are, therefore, at a higher risk of death.
Objectives: The aim of this study was to determine the comparative 
efficacy of different scoring system (APACHE II and SAPS II scores) 
in assessing the prognosis of critically ill patients that were admit-
ted to the ICU by sepsis in a tertiary hospital and compare them for 
prediction of the outcome in these patients in early mortality (up to 
3 months).
Methods: We performed a retrospective review of five hundred and 
thirty three patients that were admitted to the ICU from January 
2018 to December 2019. We included all patients (medical or surgi-
cal patients) over the age 16 years old, and we selected those with the 
first diagnosis of “sepsis”. Patient selection and information collection 
were obtained through medical records. It was calculated the predic-
tive mortality by APACHE II and SAPS II and also the early mortality.
Group comparisons between survivors and non-survivors from sepsis 
were performed using the Student-T test for continuous variables and 
Pearson chi-square test for categorical variables. A p-value less than 
0.05 was considered significant. Statistical analysis was performed 
using SPSS software version 25.0 (IBM, Armonk, NY, USA).
Results: Out of 533 patients, 71 had sepsis (13%). Of these 71 patients, 
36 (50,7%) died up to 3 months. Average APACHE II and SAPS II scores 
in all patients were 23,5  ±  8,1 (p = 0,02) and 52,9  ±  17,7 (p < 0,01) 
respectively, and they were significantly different between survivors 
and non-survivors. A statistically significant positive correlation was 
established between the values of SAPS II and APACHE II (r = 0.76; 
p < 0.01). By the examination of validity and classification accuracy by 
ROC curve, we conclude that: SAPS II had AUC > 0,662 and APACHE 
II had AUC > 0,639. Both can predict the risk of mortality in these 
patients, but SAPS II seems to be slightly more accurate. We also 
observed that elderly patients were expected to have a worse prog-
nosis. The average age of survivors was 64,5  ±  13,8 years and for non-
survivors 75,2  ±  8,8 years (p < 0,01).
Conclusion: Both APACHE and SAPS II were accurate tools to describe 
and predicted mortality caused by sepsis. There was no significant dif-
ference in the clinical values of SAPS II and APACHE II and taking in 
consideration the high correlation between both, only one, could be 
enough to make a mortality prediction.
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Introduction: APACHE (Acute Physiology and Chronic Health Evalu-
ation) II and SAPS (Simplified Acute Physiology Score) II are the two 
Page 530 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
main tools to evaluate patients in an intensive care unit (ICU), 24 hours 
after admission, regarding the predictable intrahospital rate of death. 
In multi-trauma patients, previous reviews showed that SAPS II was 
valid to predict intrahospital death in these patients when compared 
to APACHE II. However, the correlation of these scores with the hospi-
tal length of stay was not demonstrated.
Objectives: The aim of this study was to verify if there is a correlation 
between the main score systems used in a Portuguese tertiary hospital 
ICU and the hospital length of stay (LOS) in multi-trauma patients.
Methods: This retrospective review evaluated the admitted patients 
in an ICU during two years, from January 2018 to December 2019, 
through the consultation of clinical records, calculated predictive 
mortality by APACHE II and SAPS II, as well as the hospital length of 
stay, including the time spent in ICU. We obtained a population of 
533 patients from which we selected the ones admitted with “multi-
trauma” as first diagnosis.
Group comparisons between both scores and LOS were performed 
using the Pearson correlation. A linear regression model was applied. 
A p-value less than 0.05 was considered statistically significant. Statis-
tical analysis was performed using SPSS software version 25.0 (IBM, 
Armonk, NY, USA).
Results: Out of 533 patients, 27 had multi-trauma (5.06%). These 27 
patients were 53.6  ±  18.1 years old, from which 6 (22.2%) were female 
and 21 (77.8%) were male. The hospital LOS was 47.2  ±  24.3  days. 
Average APACHE II and SAPS II scores were 13.9  ±  6.0 and 33.0  ± 
12.7, respectively. Pearson correlation showed us that there is a cor-
relation between SAPS II and LOS (p = 0.021) that was not verified 
to APACHE II (p = 0.188). Therefore, it was possible to apply a simple 
linear regression model correlating the SAPS II and the hospital LOS 
which concluded that each unity added to SAPS II represented an 
increase of 0.42 days to the LOS. This linear regression model explains 
the LOS variation by 6% (p = 0.028).
Conclusion: A correlation between SAPS II and the hospital length of 
stay was verified with a statistic significance that was not verified with 
APACHE II. It is possible to assume that the calculation of SAPS II in 
multi-trauma patients could predict the approximated hospital length 
of stay, which is a remarkable predictor to clinicians to established 
the plan for these patients. Further studies on this topic are needed 
to confirm the association between SAPS II and the hospital length of 
stay.
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Introduction: APACHE (Acute Physiology and Chronic Health Evalua-
tion) II and SAPS (Simplified Acute Physiology Score) II are commonly 
used scoring systems to calculate the severity of illness in intensive 
care patients. Both are calculated in the first 24 hours of hospitaliza-
tion and can predict the risk of intrahospital mortality. Acute Kidney 
Injury (AKI) is frequent and has high morbidity and mortality rates, 
which determines an enormous importance in the context of ICU 
(Intensive Care Unit).
Objectives: The aim of this study is to investigate the capacity of main 
score systems to predict intrahospital mortality of patients with AKI, in 
a portuguese tertiary hospital ICU.
Methods: We performed a retrospective review that evaluated the 
admitted patients in an ICU during two years, from January 2018 to 
December 2019, through the consultation of clinical records and cal-
culated predictive mortality by APACHE II and SAPS II. From the 535 
patients included, those with AKI at admission were selected, regard-
less of the main diagnosis, according to Acute Kidney Injury classifica-
tion (AKIN).
Group comparisons between survivors and non-survivors from AKI 
were performed using the Student-T test for continuous variables and 
Pearson chi-square test for categorical variables. A p-value less than 
0.05 was considered significant. Statistical analysis was performed 
using SPSS software version 25.0 (IBM, Armonk, NY, USA).
Results: Out of 535 patients, 272 patients (50.8%) had AKI and 263 
patients (49.4%) had not. The mortality rate was 37.9% and 21.7%, 
respectively, with significant difference between them (p < 0.01). 
Patients with AKI were mainly males (57%). There is no difference 
between the mortality rate and gender (p = 0,06). Out of 272 patients 
with AKI, 169 survived (62.1%) and 103 died (37.9%). The average age 
of survivors was 68.93  ±  14.59 years and of non-survivors group was 
74.14  ±  11.82  years. The mean SAPS II score in the survivors group 
was 53.60  ±  19.24 while in the non-survivors group was 68.08  ± 
19.83 (p < 0,01). The mean APACHE II score was 25.11  ±  9.36 and 
30.98  ±  8.84, respectively (p < 0,01). Conserning creatinine and urea 
levels in both groups of patients, there was no difference neither in 
mean creatinine levels (p = 0.72) neither in mean urea levels (p = 0.34).
APACHE II and SAPS II are valid predictors of intrahospital mortality in 
critical patients with Acute Kidney Injury at admission. Furthermore, 
non-survivor patients showed a higher age mean than survivors, as 
expected. Despite our assumptions, the main renal function analytical 
parameters showed no influence in the outcome of the patients with 
Acute Renal Injury.
Conclusion: APACHE II and SAPS II are valid predictors of intrahospi-
tal mortality in critical patients with Acute Kidney Injury at admission. 
Furthermore, non-survivor patients showed a higher age mean than 
survivors, as expected. Despite our assumptions, the main renal func-
tion analytical parameters showed no influence in the outcome of the 
patients with Acute Renal Injury.
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Introduction: As the Covid-19 pandemic has spread around the 
world, several new scores have been released to predict risk of criti-
cal illness or mortality among Covid-19 patients. None of these scores 
have been validated in the UK population.
Objectives: We attempted to compare 3 scores – COVID-GRAM [1], 
HNC-LL [2] and CURB-65 scoring systems in assessing accuracy for pre-
dicting critical illness or in-patient mortality among Covid-19 patients 
at our institution.
Methods: We collected data on 429 patients with RT-PCR confirmed 
Covid-19 infection identified from the local ISARIC CCP and hospital 
databases, admitted during March and April 2020. Our endpoints were 
1). Critical illness defined as Deaths and/or ICU admission 2). In-patient 
mortality.
Results: The incidence of inpatient mortality and progression to 
critical illness in our cohort was 32.1% and 38.7% respectively. COVID-
GRAM tool showed the highest accuracy in predicting critical illness 
(AUC 0.647; 95% CI 0.600 to 0.692) and inpatient mortality (AUC 0.695; 
95% CI 0.649 to 0.739). There was no significant difference in accuracy 
of AUC between CURB-65 and COVID-GRAM (p-0.9074) for inpatient 
mortality but both were better than HNCLL. (p - 0.0415 and 0.0112). 
HNCLL showed lowest accuracy in predicting both the endpoints of 
interest .
Conclusion: While COVID-GRAM was most accurate in predicting criti-
cal illness and inpatient mortality from COVID 19, it was only margin-
ally higher than CURB65. We recommend the continued use of CURB 
65 as convenient and easy to use tool in predicting complications and 
mortality from COVID 19.
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Introduction: Eye tracking has a long history in diagnosis of neu-
ropsychiatric and neurodevelopmental disorders, specifically in schiz-
ophrenia and autism [1]–[4]. It has recently been advocated for as a 
method for inferring attention as a surrogate marker of delirium but 
has been hampered due to lack of technological solutions available 
for the Intensive Care Unit (ICU) environment [5]. To that extent, we 
have developed a non-invasive, end of the bed, eye tracker that auto-
matically tracks the eye movements and the gaze of a patient without 
instrumentation or calibration.We sought to understand the accept-
ability of this new monitoring method from the multidisciplinary team 
across a single centre prior to deployment in a clinical feasibility trial.
Objectives: To ascertain the:
1. Practical issue with current delirium assessment methods.
2. Acceptability of automating delirium detection.
3. Acceptability of non‑invasive eye tracking in intensive care.
Methods: A Google Form of qualitative and quantitative questions 
was made ascertaining the views of delirium assessment and the 
views on the automation of delirium detection. A picture of the system 
as setup in an ICU bed-space was then shown with an explanation of 
its function (Figure 1). Open questions were asked about their opinion 
prior to closed questions of specific interest.
R version 4.0.1 was used for analysis.
Results: A wide range of MDT roles were gathered (n = 29, 65% nurses, 
21% doctor, 3% dietician, 3% pharmacist, 3% critical care technolo-
gist, 3% patient care coordinator).Nurses found that current delirium 
assessment methods were laborious, often confusing to perform and 
are only formalising their intuition but welcomed automation (82%). 
The majority (92%) of responders welcomed the use of eye tracking 
as a method of delirium detection. The majority thought that the 
setup would not interfere with their day to day clinical activities with 
the patient (75%), their families (80%), and other members of the MDT 
(98%).Qualitatively, a theme of avoiding “clutter” around the bed-
space was highlighted. The end of the bed camera marker (a 10x10cm 
plastic code) was highlighted as a potential point of delirium ‘genera-
tion’.Of interest, the theme of privacy and was not highlighted.
Conclusion: Non-invasive eye tracking as a method of delirium assess-
ment is generally well accepted in AICU across the MDT. Specific care 
is to be taken to avoid adding further clutter around an already busy 
AICU bed-space.
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Introduction: Intensive Care Unit (ICU) delivers care through a mul-
tidisciplinary approach. In order to predict the probability of death 
we have some severity indices to use, such as Acute Physiology and 
Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiol-
ogy Score (SAPS II). They were initially designed for sepsis patients, but 
nowadays they are used as mortality predictors in ICU patients of all 
etiologies.
Objectives: The aim of the study was to analyze if APACHE II and SAPS 
II are feasible scores to predict mortality in surgical patients admitted 
to ICU, given that both were not originally designed for these kind of 
patients.
Methods: The authors designed a retrospective study, considering all 
the patients admitted to the ICU during a two year period (from Janu-
ary 2018 until December 2019). The APACHE II and SAPS II scores were 
analyzed in order to understand in which cases these scores are more 
accurate. All the patients over 16 years old were included. The patients 
admitted for a period inferior to 24 hours were excluded.
The statistical analysis was made using SPSS software version 205.0. 
T-student test was used to compare survivals and non survivals 
patients in different time-lines and ROC curve to understand the valid-
ity of the scores in surgical patients.
Results: We analyzed 533 patients, 155 of them admitted in ICU as 
surgical patients. 74 women and 81 men, with median age of 68.6 
( ± 17.1). With an APACHE II mean of 18.9 ( ± 9.3) and SAPS II mean 
45.6( ± 20.1). 113 were survivors and 42 were non-survivors, (mortal-
ity rate of 27%). The survivors presented APACHE II score mean of 16 
and a SAPS II mean score of 40 (p < 0.01). The non-survivors presented 
a mean APACHE II score of 25 and a mean SAPS II score of 61 (p <  0.01). 
ROC curves showed that both scores were good predictors of mor-
tality in ICU, showing a AUC 0.782 for APACHE II (p < 0.01) and 0.782 
(p < 0.01) for SAPS II. Between the non-survivors (n = 42), 69% (n = 29) 
died at the ICU admission and 12% (n = 5) during hospital admission 
after ICU discharge. 19% (n = 8) died at home before 3  months after 
ICU discharge.
For predicting mortality during hospital admission after ICU discharge, 
mean APACHE II score of 21.4 ( ± 12) (p = 0.14) and mean SAPS II of 
57.6 ( ± 17.5) (p>0.01) for APACHE II and SAPS II did not show feasible 
results to predict mortality at home during 3  months after ICU dis-
charge (p = 0.64 for APACHE II and p = 0.16 for SAPS II).
The patients were divided on scheduled surgical ones (n = 40) and 
non-scheduled surgical patients (n = 115). In scheduled surgical 
patients the mortality rate was 12.5% (n = 5), with APACHE II and SAPS 
II scores predicting death in these patients showing no accuracy at 
all (p = 0.07 and p = 0.54, respectively). In the non-scheduled surgi-
cal patients the mortality rate was 32% (n = 37); in this patients both 
scores showed to be good mortality predictors in this group (APACHE 
II with p < 0.01, SAPS II with p < 0.01).
Conclusion: The results showed that APACHE II and SAPS II are both 
good mortality predictors scores in surgical patients admitted in ICU. 
SAPS II was better in predicting mortality during hospital admission 
after ICU discharge than APACHE II.
Both showed valid results to predict death during ICU admission and 
early death ( < 3 months).
Both showed accurate results to predict mortality in non-scheduled 
surgical patients but not on scheduled surgical ones.
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Introduction: Young trauma patients undergo repeat radiologic 
imaging during initial trauma evaluation and ICU stay trough high 
radiation exposure of these patients is suspected studies are scarce. In 
this regard we retrospectively calculated ionizing radiation exposure 
of young ICU trauma patients due to medical imaging.
Methods: We reviewed records of  < 40 year old ICU trauma patients 
with lengths of stay (LOS)>20 days treated within the past 18 months. 
All imaging studies involving ionizing radiation were recorded. A 
Typical Effective Dose (TED) per type of study was assumed based 
on the literature. TED’s incurred by plain radiographs (XR), computed 
tomographic (CT) scans and fluoroscopic studies (FL) were added 
to calculate a Cumulative Effective Dose (CED) per patient. CED’s 
were compared to established limits of annual radiation exposure. 
The total medical radiation detriment was calculated using the for-
mula 0.073XCED/Sv. Numbers given represent mean  ±  sem.
Results: 36 patients (male:34 mean age 26.8 ± 1.1  years; mean los 
48.6 ± 7.7  days; mean Injury Severity Score ISS:32.7 ± 1.7) underwent 
1311XRs (36.4 ± 2.7/patient), 248 CT-scans (6.9 ± 0.5/patient), and 25 
FL’s (0.8 ± 0.2/patient; 1 limb angiography, 23 fluoroscopy guided bone 
fixation procedures, 1 diaphragm fluoroscopy). The mean CED/patient 
was 40.5 ± 2.8  mSv. Partial CED’s attributable to XR, CT and FL were 
2.5 ± 0.3, 37.3 ± 2.8 and 0.81 ± 0.15  mSv/patient or 8 ± 2%, 89 ± 3% 
and 3% of total CED respectively. The mean detriment due to medical 
exposure to ionizing radiation in our study was 0.00296 ± 0.0002.
Conclusion: The mean CED exceeded international and national (envi-
ronmental:1  mSv occupational:20  mSv) annual radiation exposure 
limits. CT scans accounted for the bulk of CED . Studies designed to 
investigate the short-term benefits vs long-term sequellae of X-ray 
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imaging studies performed in ICU patient are needed especially indi-
viduals at child-bearing ages with long life-expectancies.
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Introduction: During the COVID 19 pandemic, the anaesthetic team 
was often involved in the transfer of patients from intensive care (ICU) 
to computerized tomography (CT). With the associated thromboem-
bolic events in COVID patients, often these scans were CT pulmonary 
angiograms (CTPAs) and therefore required higher intravenous (IV) 
contrast flows. Often these patients had been on ICU for a long period 
of time, had no peripheral access and only a central venous catheter 
(CVC) line in situ. We came across a huge variation in clinical practice 
with CVC lines being used for power injecting contrast. Some radi-
ographers would not allow the CVC line to be used and asked for a 
peripheral cannula to be inserted. Others were happy for the CVC line 
to be used, as long as the accompanying doctor connected the power 
injector to the CVC line took responsibility for it. This variety in practice 
led us to research current understanding and experience with inject-
ing IV contrast down a CVC line via a power injector and to review the 
literature and guidance surrounding it. We then ran a teaching session 
for the anaesthetic department and reassessed these views after this 
session.
Objectives: 1. To find out current understanding and experience in 
the radiology and anaesthetic department surrounding power inject-
ing IV contrast down a CVC line.
2. If required, to run a teaching session to help develop an understand-
ing of the issues and guidance surrounding administering IV contrast 
in patients with CVC lines but no peripheral access.
3. To find out whether further education has changed understanding 
or practice.
Methods: We sent out a short questionnaire via SurveyMonkey to 
both the anaesthetists (n = 28) and to the radiographers (n = 27). This 
was to find out the current understanding, experiences and practices 
of both anaesthetists and radiographers. We then offered a teaching 
session to the anaesthetic department on the equipment used in CT, 
the CVC lines used at the hospital, the flows of IV contrast required for 
certain CT scans and how Poiseuille’s Law links pressure in the lines to 
its length, gauge, and viscosity of the contrast. We also reviewed the 
current literature looking at CVC lines used with power injectors. We 
then did a second questionnaire for the anaesthetists (n = 11) which 
looked at whether their views and practice had changed.
Results: Results showed that 85% of radiographers were not comfort-
able with IV contrast being given via the CVC line. Despite this, around 
half anaesthetists who answered the questionnaire have been asked 
by the radiographer to connect the power injector to the CVC line. 
100% anaesthetists found the teaching useful with 91% anaesthetists 
feeling informed about the issues surrounding giving IV contrast via a 
CVC line compared to 9% prior to teaching.
100% anaesthetists said that this teaching would change their prac-
tice, with 36% anaesthetists likely to give IV contrast via through a CVC 
line compared to 64% prior to teaching.
Conclusion: There is currently no UK national guidance on injection 
of IV contrast via a CVC line. In the United States, the American Com-
mittee or Radiology has recently released guidance suggesting that 
for power injection of IV contrast via CVC lines the radiologist should 
consult the manufacturers guidance (American College of Radiology, 
2020). Some hospitals have local policies (UCSF, 2020; Royal Marsden 
NHS Foundation Trust Policy, 2017) but this is not something that we 
currently have implemented at our hospital.
Seeing as there is no formal guidance nationally, and few hospitals 
have formal policies implemented, often it comes down to individual 
risk analysis as to whether IV contrast can be injected via a CVC line. 
Our data showed that few anaesthetists were well informed on these 
issues prior to teaching.
Anaesthetists and intensivists are often involved in the transfer of 
unwell patients. As a result, they are often are involved in decision 
making such as whether or not IV contrast can be injected down a 
central line. Interestingly, following teaching, the number of anaesthe-
tists who would power inject IV contrast via a CVC line nearly halved. 
This quality improvement project shows that with education on this 
subject, anaesthetists may change their practice. 100% of anaesthe-
tists said that they would like a formal policy in place in order to help 
with the decision-making process. This is something we hope to cre-
ate and implement in the future in concordance with the radiology 
department.
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Introduction: Point-of-care ultrasound (POCUS) has a major role in 
the management of patients with acute hypoxic respiratory and circu-
latory failure and guides hemodynamic management. There is scarce 
literature on POCUS assessment characteristics in COVID-19 pneumo-
nia with hypoxic respiratory failure.
Methods: The study is an observational, prospective, single-center 
study conducted in the intensive care unit of Adan General Hospital 
from May 1st, 2020, to June 25, 2020. The study included adults sus-
pected to have COVID-19 transferred to the intensive care unit (ICU) 
with fever or suspected respiratory infection. Patients were transferred 
to the ICU after reverse transcriptase-polymerase chain reaction (RT-
PCR) testing. A certified intensivist in critical care ultrasound who was 
blinded to the RT-PCR results, performed the lung ultrasound and 
echocardiology within 12 hours of the patient’s admission to the ICU. 
We calculated the E/e’, E/A ratio, left ventricular ejection fraction EF, IVC 
diameter, RV size and systolic function. We performed ultrasound in 12 
chest areas.
Results: Of 92 patients with suspected COVID-19 pneumonia, 77 
(84%) cases were confirmed.
In the group of patients with confirmed COVID-19 pneumonia, echo-
cardiographic findings showed normal E/e’, deceleration time (DT), 
and transmittal E/A ratio in comparison to the non-COVID19 patients 
(P .001 for both). The IVC diameter was  < 2  cm with > 50% collaps-
ibility in 62 (81%) patients with COVID-19 pneumonia; a diameter of 
> 2 cm and  <  50% collapsibility in all patients, with a P value of 0.001, 
was detected among those with non-COVID-19 pneumonia. There 
were 3 cases of myocarditis with poor EF (5.5%), severe RV dysfunction 
was seen in 9 cases (11.6%), and 3 cases showed RV thrombus.
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.
Conclusion: POCUS plays an important role in bedside diagnosis, 
hemodynamic assessment and management of patients with acute 
hypoxic respiratory and circulatory failure in patients with COVID-19 
pneumonia.
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Introduction: Cardiac tamponade is a severe complication after 
cardiac surgery. Echocardiography, both transthoracic (TTE) and 
transesophageal (TEE), may help to identify cardiac tamponade in 
postoperative period, but its diagnostic value is still questioned and 
has not been studied in large cohorts.
Methods: From January 2011 to March 2017, 8.974 adult patients 
underwent cardiac surgery in the Catharina hospital Eindhoven, a 
tertiary referral cardiothoracic center. A retrospective study was con-
ducted in which patients with suspected cardiac tamponade were 
included. Sensitivity and specificity were calculated by comparing 
echocardiographic findings with surgical confirmation of tamponade. 
Patients in whom a re-exploration was not performed and recovered 
without intervention were considered not having tamponade.
Results: 511 patients (male  =  65%, median age 66  years) were 
included in whom 427 echocardiograms were performed. The follow-
ing patient characteristics differed between patients who underwent a 
TTE or TEE: percentage of emergency surgery (13 vs 35%), EuroSCORE 
(mean (SD) 9 (11) vs 18 (22)), and duration extracorporeal circulation 
(mean (SD) 115 (69) vs 171 (101) minutes). Cardiac tamponade was 
confirmed at re-exploration in 189 patients, while 278 patients were 
considered to be negative. In-hospital mortality of the re-intervention 
group was 14%. The diagnostic value for TTE comprises a sensitivity 
of 64% (95% CI 53 - 75), a specificity of 96% (95% CI 92-98), a positive 
predictive value (PPV) of 81% (95% CI 69 – 89), and a negative predic-
tive value (NPV) of 90% (95% CI 86 – 93). Regarding TEE, the diagnostic 
value a sensitivity of 50% (30 – 70), a specificity of 79% (59 – 91), a PPV 
of 68% (44 – 86), and a NPV of 63% (45 -78). The area under the ROC 
curve for TTE was 0,80 (p < 0.001), and for TEE 0.64 (p = 0.072).
Conclusion: In patients within 4 weeks after cardiac surgery, TTE has 
a high specificity and negative predicting value to detect cardiac tam-
ponade. These diagnostic values were lower for TEE, which might be 
caused by a selection bias based on severity of disease.
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Introduction: The long-term sequelae after Covid-19 severe disease 
are largely unknown. In particular, late radiological and clinical evolu-
tion have not investigated yet.
Objectives: The aims of this study is to describe morphological abnor-
malities of “late” lung CT scan in relationship to disease severity and 
clinical evolution in a small cohort of Covid-19 critically ill patients 
with severe interstitial pneumonia.
Methods: We retrospectively analyzed the data of 24 Sars-Cov-2 
positive patients with severe interstitial pneumonia admitted to the 
intensive Care Unit in a large regional hospital in Northern Italy, in 
March-April 2020, with a “late” lung CT scan performed for clinical rea-
son not earlier than 2 weeks after hospital admission. CT scans were 
analyzed by two experienced radiologists and classified according to 
morphological abnormalities previously described in ARDS subjects 
based on the Fleischner Society Glossary, including 1) ground glass 
opacities 2) consolidation 3) fibrotic pattern with interlobular and 
intralobular thickening or cyst walls and 4) decreased attenuation, 
which includes emphysema and small airways disease. Six patients 
had two CT scan (i.e. admission and follow up CT scan) for longitudinal 
analysis. Clinal data were electronically recorded and retrospectively 
collected in an electronical data base.
Results: Patients were 22 M and 2 F, the median age was 66 (min 39, 
max 79). The median time from symptom onset to ICU admission was 
5  days (range 4-8). 9 patients (37.5%) underwent immediate intuba-
tion and mechanical ventilation (MV) and were directly admitted to 
ICU, whereas the majority (62,5%) received prior non invasive ventila-
tion (NIV). The median duration of MV was 24 days (range 18-34). One 
patient was treated with NIV and never MV. Patients were ventilated 
according to protective strategies with TV of 6-8  ml/kg, plateau  < 
20  mmHg. Hypoxemia was extremely severe as indicated by median 
PaO2/FiO2 (PF) before intubation of 99 (range 81-143), which amelio-
rated by day 1 (134; range 101-178), to day 5 (146; range 137-180), day 
10 (183; range 147-211) and day 15 (191; 147-251); Kruskal-Wallis test, 
p = 0.015. PEEP levels decreased significantly over time, from day 1 
(mean PEEP = 12, range 12-14), to day 5 (mean PEEP = 12; range 10-14) 
day 10 (men PEEP = 10, range 9-12) and day 15 (mean 9.5, range 7-10); 
Kruskal-Wallis test, p < 0.001. Rescue therapies were frequently used: 
prone position in 16 (66%) and NO in 3 (12%). 7 patients (25%) died in 
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ICU. The median length of ICU stay was 27 days (range 19-34). Surviv-
ing patients were discharged home (n = 13) or to a rehabilitation facil-
ity (n = 4). Length of hospital stay (LOS) was 51 days (range 34-68). CT 
scan were performed at a median time of 36 days (range 19-55) after 
hospital admission. Ground glass opacities (n = 20), classical morpho-
logical abnormalities of the early phase, and reticular pattern (22), a 
typical late abnormality, were both the most frequent pattern. Paren-
chymal consolidation (n = 19), bronchiectasis (n = 17) and emphy-
sema (n = 13) were also frequent. Longitudinal analysis (n = 6) shows 
reticular pattern in all subjects, both in early and late scans (resem-
bling early fibrosis in these latter). Notably, decrease attenuation pat-
tern could only be observed in late scans, except in one patient with 
few bronchiectasis on admission.
Conclusion: In a selected cohort of patients with severe Covid-19 dis-
ease requiring prolonged ventilation and hospital stay, follow up CT 
scans show severe lung damage with predominant reticular pattern, 
resembling early fibrosis, emphysema and small airways disease (i.e. 
bronchiectasis). These abnormalities are likely the consequences of 
the disease and not related to previous lung pathology. Long-term fol-
low up studies will be necessary to determine the clinical and morpho-
logical evolution of criticall pulmonary Covid-19 disease, to provide 
new preventive and therapeutic strategies.
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Introduction: Weaning failure from mechanical ventilation is associ-
ated with an increased risk of morbidity and mortality. Different dia-
phragmatic ultrasound parameters have been studied. However, there 
are many gaps in our understanding of the discriminatory capacity to 
predict weaning failure.
Methods: A prospective study in a heterogeneous cohort of patients 
in intensive care units. The diaphragmatic ultrasound was used to 
determine the diaphragmatic inspiratory excursion (DE), time to peak 
inspiratory amplitude of the diaphragm (TPIAdia,), diaphragmatic 
excursion velocity (DE/TPIAdia, cm/sec), and diaphragm thickening 
fraction (Δtdi %). The measures were performed at the end of a spon-
taneous breathing trial (SBT) and compared with the extubation out-
come. Also, the rapid shallow breathing index (RSBI) was calculated. 
Weaning failure was defined as the inability to maintain spontaneous 
breathing for at least 72 h, without any form of ventilatory support.
Results: The study included 43 patients. Median age was 72  years 
[58.0-77.5], APACHE II score was 18.0 [9.0-23.0], and RSBI previous to 
the SBT was 37 [24.0-48.5]. Patients who failed the SBT (30%) had a 
lower median vital capacity (12.4 [11.5-14.1(mL/Kg)] vs. 21.3 [15.6-
23.6]; p = 0.05), DE (cm)(1.8 [1.6-2.1] vs. 1.50 [1.3-1.8];p = 0.03), and 
Δtdi% (29.0% [21.0%-35.0%] vs. 39.0% [28.2% - 47.5%;p = 0.02). [E1] 
RSBI had the highest discriminatory capability (AUC-ROC 0.76). Among 
DUS measures, Δtdi% had the highest AUC-ROC (0.71), followed by DE 
(0.70), and DE/TPIAdia (0.54). Using both, the DE/TPIAdia and RSCI the 
discriminatory capacity was improved and associated with a success-
ful weaning trial (AUC-ROC 0.77). DE/TPIAdia (cm/sec) alone was not 
able to discriminate patients who failed the SBT (1.40 [1.10-1.80] vs. 
1.55 [1.22- 1.80]; p = 0.69).
Conclusion: Combining the used of DE/TPIAdia and RSBI leads to a 
discriminatory capability improventfor detecting patients at high risk 
of extubation. This combined measure was similar to RSBI alone.
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Introduction: Patients with severe respiratory diseases usually use 
accessory respiratory muscles. In that specific patients sternocleido-
mastoid and trapezius muscle may be hypertrophic than in control 
intensive care unit (ICU) population. That specific muscles may have 
different ratio as compared to the quadriceps femoris muscle, which 
is usually an indicator of nutritional status and overall skeletal muscle 
status.
Objectives: The aim of this study is to compare the diameter of acces-
sory respiratory muscles in patients with respiratory diseases and 
patients without such diseases and compare these muscles with the 
quadriceps femoris muscle in the patients with and without chronic 
respiratory diseases. We aimed to determine whether there is a cor-
relation between the ultrasound-measured thickness of accessory 
respiratory muscles and patients age, hemoglobin, body mass index 
(BMI), duration of mechanical ventilation (MV) in the ICU, and patients’ 
outcome in the ICU.
Methods: Ethics committee approval was obtained for this study and 
patients or their legal representatives gave written informed con-
sent. A total of 50 subsequent patients admitted into the ICU were 
examined. Patients of both genders were included, with and without 
chronic respiratory diseases, including patients using mechanical 
ventilation. The study was performed using a Mindray TE7 ultrasound 
machine with the depth of the linear probe at 70 – mm and gain of 
90 – dB; settings remained unchanged during the study. The probe 
was set at the musculoskeletal ultrasound mode. Measurements of 
the right m. sternocleidomastoideus (SCM), the right trapezius muscle, 
and the right quadriceps femoris muscle (vastus lateralis, vastus inter-
medius, vastus medialis, and rectus femoris; MQF) were taken at the 
admission into ICU, three times in each patient. The final value was the 
average of three measurements. Laboratory measurements, a duration 
of MV, and survival were registered.
Results: Out of 50 patients examined, there were 15 patients with pre-
viously recognized chronic pulmonary diseases, and 48 patients were 
mechanically ventilated. Patients with chronic pulmonary diseases 
have a significantly thinner SCM than patients without chronic pul-
monary diseases (79 ± 13 vs. 92 ± 17 mm; Student’s t test P  =  0.007), 
and it was it was thinner in relation to SCM than in patients without 
chronic lung disease(SCM/MQF 16,9 ± 3.5% vs. 19.8 ± 5.3%; P = 0.03). 
No differences in other muscles was observed. A significant negative 
correlation was observed between patients age and MQF (r = -0.359, 
P = 0.01), BMI and MQF (r = 0.338; P = 0.02) and MQF and patients’ 
hemoglobin (r = 0.458, P = 0.001). Treatment outcomes were not 
affected by the thickness of accessory respiratory muscles.
Conclusion: The thickness of the SCM was lower in the patients with 
chronic pulmonary diseases than in patients without such diseases. 
The importance of accessory respiratory muscle thickness for the res-
piratory function in the ICU may be better evaluated after subsequent 
measurements and whether elasticity of the muscles was evaluated.
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Introduction: A high incidence of pulmonary embolus (PE) has been 
reported in patients infected with Covid-19 [1]. When computed 
tomography (CT) is not available, transthoracic echocardiography 
(TTE) has a high specificity for the diagnosis of PE [2]. However, raised 
pulmonary pressures associated with Covid-19 can create similar 
echocardiographic changes to a PE [3]. Lung ultrasound (LUS) can 
identify PE associated wedge infarcts and may have a place in diagno-
sis when other investigations fail [4].
Objectives: To evaluate the role of focused echocardiography and 
lung ultrasound in the diagnosis of PE in patients with COVID-19 
pneumonitis.
Methods: We performed a prospective observational study of Covid-
19 patients admitted into intensive care during a 3-week period. 
Patients received focused echocardiography (looking at RV dilatation, 
TRVMax, TAPSE and RVS’) and 6-point lung ultrasound (giving each 
region a score of 0 to 3 [5]). On day 1 and 5 of admission, cumulative 
lung score was also calculated using ROC curve analysis for the best 
cut-off threshold for PE. Individual lung regions were reviewed to 
determine if a score 3 (wedge infarct) was associated with PE. Covid-19 
was confirmed by viral PCR swabs. Fisher exact test or and odds ratio 
(OR) were used to determine association between variables. P values 
less than 0.05 is considered statistically significant.
Results: 49 Covid-19 positive patients were admitted to our intensive 
care units during the study period. 16/49 (37.2%) patients had con-
firmed PE. We did not find any statistical difference in focused echo-
cardiography between the two groups. RV dilatation was seen in 15/38 
(60.5%) patients with PE and absent in 9/11 (81.8%) non-PE patients 
(p = .19). TAPSE of 26 mm or more was seen in 5/20 (25%) PE patients 
and  < 26 mm in 15/26 (57.7%) non-PE patients (p = .22). RVS’ > 16 mm 
was seen in 10/30 (33.3%) patients with PE and absent in 8/14 (57.1%) 
patients without PE (p = .54). TRV Max of 30 mmHg or more was seen 
in 12/28 (42.9%) patients with a PE and  <  30 mmHg in 10/13 (76.9%) 
patients without PE (p = .22).
43/49 had complete 6-point lung ultrasound scores. At day 1 of 
admission, average cumulative lung scores did not differ significantly 
between patients with or without PE (9.3 (SD 2.8) vs 8.7 (SD 3.4); p = .6). 
At day 5 of admission, a cumulative lung score of ≥7 was shown to be 
significantly associated with presence of PE (p = .03, OR 5.83, 95%CI 
1.06-32.02). Individually, left upper lobe score of 3 (p = .012) and left 
lateral and score of 3 (p = .038) were significantly associated with pres-
ence of PE.
Conclusion: Focused echocardiography is not useful in the diagnosis 
of PE in COVID-19. Under these circumstances lung ultrasound has 
diagnostic value.
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Introduction: In March, 2020 – June 2020 Central and East Europe 
had a period of the response to COVID-19 pandemic. Disease sever-
ity of pneumonia on admission can be assessed by various scales, 
including PORT, PSI, CURB-65, CRB-65 and SMRT-CO. Some of them 
include laboratory findings but none of them include the amount of 
lung lesion on CT, which is important to assess COVD-19 pneumonia. 
The most frequent types of lesions on CT for COVID-19 pneumonia are 
ground-glass opacity (GGO) and consolidation. Lesion volumes can be 
determined by quantitative CT. Therefore, it is important to analyze 
the relationship between quantitative CT parameters and clinical and 
laboratory findings.
Objectives: To evaluate the sensitivity of COVID-Multivox program in 
estimation of severity of lung injury in COVID-19 patients and to assess 
the correlation between quantity of involved lung parenchyma, types 
of CT-findings and laboratory findings.
Methods: 76 patients with COVID-19 were retrospectively reviewed 
from March 15, 2020 to March 31, 2020. Laboratory data and CT 
findings on admission were analyzed. CT quantitative parameters, 
including GGO volume, consolidation volume, total lesion volume, 
percentage of GGO, and consolidation) were calculated. Relationships 
between the CT findings and laboratory data were statistically esti-
mated (Spearman rank correlation coefficient was used).
Results: There were 56.6% men of the 76 people examined. The most 
common laboratory markers of COVID-19 were an increase in the level 
of C-reactive protein, observed in 72 (94.7%) patients, an increase in 
LDH, noted in 62 (81.6%) patients, and lymphopenia, which was noted 
in 40 patients (52.6%). CT-findings revealed total lesion volume 11,2%-
54,2% (mean 29,4%), with a GGO volume 9,4%-49,2% (mean 28,5%) 
and a consolidation volume 0,3-1,8% (mean 0,7%).
A correlation was revealed between LDH and the total volume of the 
affected lung tissue, the total percentage of lesions by the type of 
ground glass, the percentage of consolidation (rs  =  0.610, rs  =  0.628, 
rs  =  0.316; p  < 0.01, respectively), slightly less correlation of the level 
of C-reactive protein with similar volumes (rs  =  0.497, rs  =  0.468, rs  = 
0.410; p  < 0.01), as well as a inverse correlation between the total vol-
ume of the lesion and the level of lymphocytes (rs  =  -0.251, p  < 0.05).
Conclusion: There is a strong correlation of the percentage of lung 
tissue lesion, detected by quantitative computed tomography, with 
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the level of LDH and C-reactive protein. Quantitative lungs CT may be 
used not only to estimate the degree of the lung damage, but also to 
assess the severity of the systemic inflammatory response for patients 
with COVID-19.
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Introduction Ultrasound (US) is increasingly recognized as an essen-
tial tool in the ICU setting. The safety and utility of bedside ultrasonog-
raphy by an appropriately trained ICU physician has now been well 
demonstrated1. Despite the worldwide routine use of ultrasound in 
ICUs, a large number of ICU physicians remain unacquainted with US 
techniques. Following the 2011 international expert statement, the 
training of every ICU physician should incorporate basic level of critical 
care ultrasonography (CCUS)2. We decided to continue investigating 
the evolving CCUS paradigm of ICU physician skills and competencies 
in our country.
Objectives To summarize knowledge on the current use of CCUS and 
attitudes towards its utilization in the ICUs of two city hospitals.
Methods Our study focused on the ICU physicians (n=113) of two city 
hospitals. Data collection was performed with the help of an electronic 
survey.
Results The response rate of the survey was 78%. 64% of the respond-
ents were young specialists. The majority (56%) had no previous expe-
rience in CCUS and only 45.5% were aware of the locally organized 
training programs. The most useful CCUS modalities reported were 
TTE and TEE, pleural/ lung US, vascular US for access, nerve block, FAST 
and vascular US-DVT. All of the respondents recognized the existence 
of barriers to CCUS training, citing lack of formal training and finan-
cial costs as the most significant ones. Although In Ukraine CCUS still 
remains the prerogative of the on-call radiologists, it was not per-
ceived as a training barrier.
Conclusions While Ukraine is lacking a formal CCUS training program, 
there is an unmet demand for it in the ICU. Our survey has demon-
strated a prevailing lack of US skills among the young ICU physicians. 
At the same time there was a general consensus on list of core US 
modalities that should be incorporated in such training as well as on 
the barriers that prevent ICU physicians from mastering them. The 
young demographics of the study has also highlighted the potential 
for international training programs and initiatives. Due to the limited 
number of respondents in our survey, further study across hospitals is 
required to fill in the knowledge gap on the country-specific state of 
CCUS training. We expect our ongoing study to be the call for action 
among the ICU physicians to stimulate the activity of the locally organ-
ized training programs. In future we hope to start a cross-country con-
versation on the challenges of CCUS standards implementation and 
the possible ways forward.
001637 
The value of radiological features as a screening tool in Covid‑19 
infection
JM.  Low1; JK.  Rane1; A.  Bhide1; D.  Padman1; HD.  Aya1; S.  Leaver1; A. 
 Rhodes1; M.  Hamilton1
1General intensive care unit, St George’s Hospital, London, United King‑
dom 
Correspondence: J.M. Low
Intensive Care Medicine Experimental 2020, 8(2): 001637
Introduction: SARS-CoV-2 has spread rapidly from first recognition 
in December 2019. Radiological findings on chest radiograph (CXR) 
and computerised tomography (CT) are often non-specific, most 
commonly consistent with atypical pneumonia, with predominant 
bilateral, peripheral and basal involvement [1,2]. Current recommen-
dations advise that CT imaging should be reserved for the evaluation 
of complications and should not be employed as a diagnostic tool for 
Covid-19 [3,4,]. As an alternative, CXRs are often the first-line imaging 
modality employed, and there is paucity in the literature regarding 
how this correlates with definitive reverse transcriptase polymerase 
chain reaction (RT-PCR) testing.
Objectives: To describe radiological findings on CXR and CT imaging 
in patients with acute respiratory failure caused by SARS-Cov-2 infec-
tion and to investigate whether classical radiological features of SARS-
Cov-2 infection on CXR are reliable as a diagnostic tool.
Methods: This was a single centre retrospective observational study. 
Patients admitted to Intensive Care Units (ICUs) in a tertiary teaching 
hospital from March to May 2020 with a CXR and a RT-PCR test were 
included. Baseline and serial CXRs and, where available, CT scans 
were reviewed and findings categorised under pre-specified head-
ings. Reports of radiological features as classic Covid-19 were noted, 
according to the British Society of Thoracic Imaging (BSTI) grading 
templates[5]. These CXRs were deemed to fulfil the criteria of lower 
lobe and peripheral predominant multiple opacities that are bilateral, 
and given the BSTI code CVCX1. A chi-square statistic was used for the 
univariate analysis, and estimation of predictive values. A p- value less 
than 0.05 was considered statistically significant.
Results: 134 patients were included in the study. 109 (79%) had a 
positive PCR for Covid-19. On review of the CXRs[sL1] of the Covid-
19 positive cohort, 42.4% (45) of patients had alveolar consolidation 
(26.6% lobar, 73.3% bilateral), and 89.6% (95) had hazy increased 
opacity (90.5% bilateral, 9.5% Lobar) which was associated with a posi-
tive PCR (p  =  0.02). Of the 44 patients who had a CT scan, 35 had a 
positive PCR. Within these 35 CT reports, 10 had ground-glass opacity 
(2 central, 8 peripheral), 4 had enlarged lymph nodes, 3 had pulmo-
nary embolisms or pleural effusions, 2 had architectural distortion and 
there was 1 example each of air bronchogram, vascular thickening and 
fibrous stripes (figure 1). Classic radiological features of Covid-19 were 
associated with a positive PCR (c2 (1) 7.9, p  =  0.005), with a sensitivity 
of 65.1%, specificity of 64.3%, positive predictive value of 87.3% and 
negative predictive value of 32.7%.
Conclusion: Covid-19 infection typically presents with bilateral hazy 
increased opacity on CXR, and less frequently bilateral alveolar con-
solidation. Classic radiological features of Covid-19 infection can be 
useful as a screening tool.
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Introduction: Point of care ultrasound (POCUS) is an important diag-
nostic and monitoring tool in ICU. The ICU at Addenbrooke’s Hospital 
in Cambridge, UK is running a successful educational POCUS program 
for the last 6  years. Focused ultrasound is widely used also by the 
emergency medicine and acute medicine physicians in our institution 
with a separate certification body and educational program.
Objectives: In 2019 an innovative collaborative project for training in 
POCUS was established by the ICU, emergency medicine and acute 
medicine focused ultrasound leads. The aim of the project was to pro-
vide equal quality of training and governance of the POCUS amongst 
the acute specialities.
Methods: A two day course Point of care ultrasound for acute spe-
cialities (POCAS) was launched covering the requirements for certi-
fication of the three acute specialities. The certification bodies were 
approached for course approval and CPD points. The course was 
aimed for acute specialty physicians ST3 to consultant level. The 
administration of the course and the venue were provided by the 
Postgraduate Medical Centre. The course consisted of lectures and 
practical sessions covering focused lung, heart, abdominal, and vas-
cular ultrasound. The faculty was represented by the POCUS mentors 
in the acute specialities and consultant cardiologist, respiratory physi-
cian and radiologist experts in the ultrasound field. The learners were 
offered POCUS educational mentorship program run by the same fac-
ulty at Addenbrooke’s Hospital.
Results: Two courses were run in 2019- April and December edition. 
The April edition was attended by 23 learners and the December one 
by 24. The spring edition had more equal attendance spread amongst 
the three specialities while the winter one had minimal attend-
ance from the emergency medicine. It can be explained by deanery 
required parallel course running for this speciality just before our 
course. Most of the attendees were doctors in training. The consultant 
attendance was 2 for the first edition and 3 for the second one. The 
courses received detailed feedback evaluating the course as a valid 
method to acquire theoretical knowledge and basic practical skills in 
POCUS. Interestingly the lectures run by the acute specialities ultra-
sound leads were valued more than the ones delivered by the experts 
appraising the simplicity of explanation and focused approach. The 
acute medicine attendees rated the vascular access practical session 
very high which can represent less experience in their field in place-
ment of lines under US guidance. The most valued session was the one 
with video cases of ultrasound imaging of real patients, their interpre-
tation and application to the clinical management of the patients. The 
mentorship educational program was established and we are training 
12 learners of which 5 got already certified in POCUS.
Conclusion: Point of care ultrasound is a powerful tool in the diagno-
sis and management of the acutely unwell patients. We have estab-
lished a training system in POCUS amongst the acute specialities that 
guarantee high quality of training offered to all the learners regardless 
of their primary speciality and adequate governance of the educa-
tional process.
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Introduction: COVID related severe respiratory syndrome (SARS-
CoV-2) is associated to a high mortality. Several risk factors have 
been identified, such as hypertension, obesity, advanced age or male 
gender.
Objectives: We wanted to study the presence of such factors in our 
population, and assess if there existed a relation with the mortality in 
patients admitted in our Intensive Care Unit as pneumonia caused by 
SARS-CoV-2.
Methods: Retrospective, observational and analytical study, on 
patients diagnosed with SARS-CoV-2 pneumonia admitted to the ICU 
of a tertiary hospital, between March and June 2020.
We collected demographic, clinical and therapeutical variables 
including: age, gender, ethnicity, previous medical conditions and 
treatment, presenting symptoms, need of mechanical ventilation, 
treatment received, complications (neurological, musculoskeletal, 
cardiac, abdominal, renal, nosocomial infection, haemorrhagic throm-
botic) and mortality.
We used χ2 test and Fisher’s exact test, regression study, considering 
statistical significance when p < 0.05.
Results: A total of 101 patients were included in the analysis, with 
a global mortality of 26.7%. 69 were men, with a mortality of 24.6% 
among them, and 32 were women, with a mortality of 31.2%.
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Subgroup analysis identified female gender and Hispanic ethnicity as 
risk factor for increased mortality. 13 women were Hispanic (40.6%), 
mortality within that subgroup 53.8%, p = 0.049.
In studied cohort most of the previously identified risk factors weren’t 
associated to an increased mortality, not even obesity, in 36.6% of our 
patients, regression study: OR -2.4, p = 0.017, CI [(-5.4)-(-0.5)].
Presenting symptoms were dyspnoea and hypoxemia in 82.2% and 
83.2%, respectively. Within the first 24 hours, 69 patients (68.3%) 
needed invasive mechanical ventilation, and 29 (28.7%) non-invasive, 
without relation with their mortality. Of those 29 patients, during 
admission 7 (24.1%) required intubation.
Regarding treatment received, prolonged neuromuscular blockade 
(43 patients, 42.6%, p = 0.03) was the only therapeutical interven-
tion related to mortality. A persistently positive PCR test on 30th day 
occurred in 7 patients (6.9%) and was significantly related to mortality 
(p = 0.01).
Regarding complications, only renal failure (23 patients (22.8%) pre-
sented impaired renal function, with or without needing renal replace-
ment therapy) had a significative relation with mortality (p = 0.04).
In the regression study, there was also a relation with mortality in use 
of kidney replacement therapy (4% of cohort), p = 0.03, OR 2.17, CI 
[0.04-0.9], and prolonged neuromuscular blockade (42.6%), p = 0.02, 
OR 2.29, CI [0.06-0.8]).
Conclusion: In our cohort, Hispanic female patients were more prone 
to die. The extended use of neuromuscular blockade, possibly due to 
the presence of a more severe respiratory failure, and the persistence 
of Coronavirus detection on the 30th day of admission, indicating con-
tinued viremia, were related with mortality. Among complications, the 
one most associated with mortality and worse prognosis was renal 
failure.
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Introduction: Although Brazil is the second country in the world in 
number of cases and deaths by COVID-19 there are limited informa-
tion describing clinical characteristics and outcomes of the patients 
requiring treatment in Brazilian intensive care units.
Objectives: To describe the clinical characteristics and outcomes of 
patients with COVID-19 requiring treatment in an intensive care unit 
in northeastern Brazil.
Methods: Retrospective observational study of 187 consecutive 
patients with confirmed diagnosis of COVID-19 admitted to a 35-bed 
ICU at a tertiary hospital in the state of Maranhão, Brazil, from March 
27 to June 15, 2020. We collected demographic and clinical-laboratory 
data, therapeutic interventions including management of respiratory 
failure, complications and mortality.
Results: Of the 187 patients included in the study, the median age was 
64 years (IIQ 51–75), 122 (65,2%) were male and 163 patients (87,1%) 
had at least one chronic disease, the most common being arterial 
hypertension (100 patients, 53,4%) and diabetes melitus (86 patients, 
45,9%). Upon arrival to the ICU, patients had a median PaO2/FIO2 of 
195 (IIQ 136-300). Thirty-seven patients (19.8%) were treated with 
non-invasive respiratory support while 150 (80.2%) underwent inva-
sive mechanical ventilation. Seventy-four patients (39.6%) underwent 
hemodialysis and one patient was treated with ECMO. Seventy-nine 
patients (42,2%) died during the ICU stay. Mortality among the 150 
patients undergoing invasive mechanical ventilation (77 patients, 
51.3%) was significantly higher than that of the 37 patients undergo-
ing non-invasive respiratory support (5,4%), p  < 0.0001. Among the 74 
patients (39.6%) who had a bacterial infectious complication, mortal-
ity (38 patients, 51.3%) was significantly higher compared to the 110 
patients who did not have a secondary infection (38 patients, 34.5%); 
p  =  0.001.
Conclusion: This case series describes the clinical characteristics and 
outcomes of 187 critically ill patients with COVID-19 treated in a ter-
tiary hospital in northeastern Brazil.
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Introduction: It has been known about possibility of microorganisms 
to create specific multi-layered structures called biofilms. Non-cellular 
deoxyribonucleic acid actively participates in regulation of properties 
of biofilms. Thus, in biofilms transfer of genetic information including 
genes responsible for sensitivity to antibacterial drugs occurs much 
more often than in single-living bacterial cells. However, despite 
the involvement of extracellular deoxyribonucleic acid in adhesive 
processes and intercellular interactions, its role has not been fully 
understood.
Methods: 238 isolates isolated from sputum and pharynx of 175 
patients during 2016-2019 were studied. Patients were divided into 
two groups: the 1st group of 139 people (79,4%) had severe respira-
tory infections, the 2nd of 36 people (20,6%) - respiratory infections of 
moderate severity.
Results: A method was developed for determining percentage of 
deoxyribonucleic acid in microbial community using 4’6-diamidino-
2-phenylindole dihydrochloride. Average age of the 1st group was 
higher than the second (p < 0,05). Pseudomonas aeruginosa had the 
largest mass of biofilm and percentage of deoxyribonucleic acid in 
group 1, 48,25 [30,5-70,1] mcg/ml and 5,21 [2,17-7,67] %, p  =  0,04. 
A strong relationship was found between percentage of deoxyribo-
nucleic acid in Pseudomonas aeruginosa and severity of disease, r  = 
0,73, p < 0,05. The incidence of adverse outcomes in isolating antibiotic 
resistant isolates was higher than in antibiotic sensitive (p < 0,05). Anal-
ysis of results made it possible to propose fatal outcome when mass of 
microbial biofilm is > 47,5 mcg/well and percentage of deoxyribonu-
cleic acid is >2,33% (p < 0,01).
Conclusion: Method for determining percentage of deoxyribonu-
cleic acid in biofilm has been proposed. With age there is a decrease 
in immune system which contributes to adherence of more patho-
genic, antibiotic resistant microflora which has high biofilm weight 
and deoxyribonucleic acid percentage leading to disease progression 
and death.
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Introduction: In modern concepts of pathogenesis of inflammatory 
diseases, much attention is paid to nonspecific humoral factors of 
immune system, including lysozyme.
Objectives: To create a simpler and a cheaper way of evaluating 
lysozyme activity in biological fluids and analyse its level in patients 
with severe bacterial pneumonia.
Methods: A complex examination of 56 patients with severe bacterial 
pneumonia and 50 practically healthy people was performed. Blood 
was taken from the ulnar vein before meals into sterile test tubes.
Results: We have created a simpler and a cheaper way of evaluating 
lysozyme activity in biological fluids, which demands little time and 
has clear evaluation criteria. The invention relates to medicine, namely 
to laboratory diagnosis. From cell walls of Micrococcus lysodeikticus 
culture ATCC 4698 peptidoglycan substrate was prepared, and the 
activity of lysozyme was calculated by the formula obtained after con-
structing calibration curve for lysozyme, which showed the depend-
ence of the concentration of lysozyme and the optical density of the 
solution of Congo red. The positive effect of the proposed method was 
that the substrate for the production of reaction was prepared once 
and could be used for a long time. The way was easy and simple in 
play. The sensitivity of this method to lysozyme was 0.06 mg/ml. This is 
enough to determine immunodeficiency states, because the content 
of lysozyme in biological fluids varies according to various data in a 
wide range from 0.2 to 28 mg/ml in normal.
It was found that the lysozyme activity in the serum was lower in 
patients with severe bacterial pneumonia (116.0; 56.5-160.1 mcg/
ml) in comparison with practically healthy people (246,0; 183,6-305,7 
mcg/ml).
Conclusion: There was a statistically significant decrease of nonspe-
cific humoral resistance in patients with severe bacterial pneumonia.
Reference(s) and grant ackowledgment(s)
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Introduction: The ongoing emergence of antimicrobial resist-
ance is considered a major threat for public health. Mainly due to its 
extremely vulnerable population of critically ill patients, the unique 
nature of the intensive care unit (ICU) environment makes this a focus 
for the emergence and spread of many antimicrobial resistant patho-
gens. However, and despite the total burden of multi-drug resistant 
(MDR) bacteria in the broader community remains a blind spot, it now 
seems that a growing number of patients are already colonised or 
infected with MDR microorganisms on arrival in the ICU.
Objectives: To investigate the relationship between MDR bacterial 
infections, patient provenience and mean hospital stay before ICU 
admission.
Methods: This was a retrospective study performed in a mixed medi-
cal and surgical ICU at Faro Hospital, Portugal, between January and 
December 2019. During the study period, 464 patients were admitted 
to the ICU. Data from a total of 104 patients were collected after apply-
ing exclusion criteria. Patient demographics, clinical details and micro-
biological data were recorded and analysed.
Results: One hundred and four patients were included in this study. 
They were predominantly male (n = 67, 64.4%), with a mean age 
of 61.4  years, a mean APACHE II of 21, and mainly admitted due to 
urgent surgical causes (n = 50, 48.1%). Overall, 171 organisms were 
isolated from this patients. The most frequent infection sites were 
urinary (26.7%), respiratory (25.3%), bloodstream (18.8%) and intra-
abdominal (16.3%). Most bacterial isolates were Gram-negative 
(59.1%). Escherichia coli was the main genus identified, of which 
27.3% were MDR. Staphylococcus aureus represented 40.4% of all 
Gram-positive isolates, with 33.3% methicillin-resistance. Preva-
lence of MDR bacteria was 24.2%, of which the most frequent were 
Escherichia coli (16.2%), Staphylococcus aureus (13.5%), Pseudomonas 
aeruginosa (13.5%), Enterobacter aerogenes (13.5%) and Klebsiella 
pneumoniae (10.8%). Interestingly, MDR bacteria were isolated in 
patients coming predominantly from the Emergency Department 
(ED) (n = 62, 59.6%), with a mean hospital stay before ICU admission 
of 3,3 days. Infections by MDR bacteria were also associated with an 
increased hospital length of stay.
Conclusion: In this study we noted that critically ill patients infected 
with MDR bacteria were admitted predominantly from the ED, with a 
mean hospital stay before ICU admission of 3,3  days. These findings 
suggest they could be already colonised or infected with MDR patho-
gens on arrival to the ICU, and make us think about having to recon-
sider the usual empiric coverage strategies used in several patients. 
Future studies are required to prove this changing pattern of antimi-
crobial resistance and its growing tendency of occurrence in the com-
munity. Additional efforts to increase the effectiveness of infection 
control programs, knowledge of local epidemiologies of resistance 
and antimicrobial stewardship strategies are essential to make pro-
gress in this problematic matter.
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Introduction: Since the start of the COVID-19 pandemic, age and 
chronic diseases have been described as important risk factors related 
to patient prognosis.
Objectives: To assess whether the age and comorbidity of COVID-19 
critical patients are independent risk factors related to mortality.
Methods: Prospective, observational study carried out in patients 
admitted to HGU Gregorio Marañón critical care units during the 
COVID-19 pandemic. Demographic and clinical data, comorbidities, 
severity risk scores, complications during stay, administered treat-
ments and outcome, were collected.
Descriptive analysis was expressed as mean (SD) or median (RIC) for 
quantitative variables and as percentages for qualitative variables. 
Univariate analysis was performed using Chi-square (RR) for qualita-
tive variables and a simple logistic regression analysis (OR) for quan-
titative variables. Multiple logistic regression analysis, adjusted for 
severity, was carried out to determine if the age and comorbidity were 
independently factors related to mortality.
Results: We included 150 patients, 71% were male, mean age was 
58 ± 14  years. Charlson comorbidity Index was 1(0-3), 53% present-
ing obesity and 53% hypertension (comorbidities not included in that 
index). Severity risk scores: APACHE II 16 (12-20), SOFA 6 (4-8). 88% 
of patients required mechanical ventilation and 74% prone-position. 
63% of patient required vasoactive drugs, 30% developed renal failure 
and 10% required continuous renal replacement therapy. Mortality 
in ICU was 38%, with the following age distribution:  <  40 years 10%, 
41-50  years 30%, 51-60  years 32%, 61-70  years 52% and 71-80  years 
48%. The univariate analysis showed that age (range) OR 1.54; 95% 
CI 1.17-2.02, Charlson index 1.44; 95% CI 1.17-1.78 and hypertension 
RR 2.07; 95% CI 1.05-4.05, were related to an unfavourable prognosis, 
but not obesity (BMI >30) RR 1.17; 95% CI 0.60-2.25. When the age was 
analysed by ranges, after the sixth decade the risk of death increased 
significantly: 61-70 years RR 9.44; 95% CI 1.91-46.66 and 71-80 years RR 
8.05; 95% CI 1.62-39.91.
In the multivariate analysis, adjusted for severity (APACHE II, SOFA and 
mechanical ventilation), obesity and hypertension, both age OR 1.46; 
95% CI 1.04‑2.04 and Charlson Comorbidity Index OR 1.24; 95% CI 
1.02‑1.56 remained as independent risk factors for mortality.
Conclusion: In our experience, both age and comorbidity, expressed 
as the Charlson index, were independent risk factors associated with 
mortality in critically ill COVID-19 patients.
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Introduction: Unit acquired blood infections are commonly used as 
a quality indicator. Intensive care units report such data quarterly and 
this is collected by ICNARC(1).
West Middlesex University Hospital (WMUH) has a high turnover AICU, 
with 199 and 167 admissions for quarters 1 and 2 respectively in 2019. 
From April to December 2019, WMUH had reported 0 unit acquired 
infections. Nationally, an increase in secondary bacterial infections in 
COVID ICU patients has been reported(2). Studies have reported 50% 
of COVID patients who died had secondary bacterial infections(3).
Objectives: To compare the incidence of unit acquired infections dur-
ing the COVID-19 pandemic with a typical pre-pandemic period.
Methods: We included 74 patients over a 55-day period. Patients were 
confirmed COVID positive from throat or tracheal aspirate swab PCR. 
Data was extracted from the ICE reporting system. Unit acquired infec-
tions were deemed to be positive blood cultures greater than 48 hours 
after admission.
Results: Thirteen patients had a unit acquired infection. There were 
16 positive blood cultures in total, as some had more than one posi-
tive culture during admission. Cases are broken down by organism, 
see Figure 1. Average length of time from admission to positive blood 
culture was 14.4 days. The length of stay for all 74 COVID positive ICU 
patients was 12.6  days compared to 25.8  days for those who devel-
oped unit acquired infection. 32 out of 74 COVID patients died (43.2%). 
7 of the 13 patients with a positive blood culture died (53.8%).
Conclusion: We have demonstrated an unexpected increase in unit 
acquired infections during the COVID pandemic. 17.5% of patients 
developed a unit acquired infection, compared to 0% over a similar 
time period in 2019.
This is almost certainly multifactorial, with the average length of stay 
and exposure to invasive procedures a significant risk factor in devel-
oping infection (1). During the height of the pandemic, WMUH AICU 
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was expanded from an 11-bed unit with a maximum of 6 level 3 beds 
to 35 level 3 beds.
We can speculate that increasing the nursing ratio from standard 1:1 
to 1:4.5 patients, as seen on an international level (3), along with multi-
ple proned patients, made it challenging to maintain usual strict infec-
tion control measures.
In particular, proned patients with CVCs sited in the internal jugular 
vein may have been at a greater risk of contamination from organism 
containing oro-pharygeal secretions.
Additionally, lines were inserted in closed spaces whilst wearing heavy 
PPE, making sterility challenging. Once in  situ lines could be con-
taminated when disconnecting during patient turning, as reported 
at other ICUs (2). These patients were also physiologically unstable, 
receiving multiple courses of antibiotics and iatrogenic immuno-sup-
pression with steroids. It is therefore not unreasonable that this group 
of patients developed secondary infection.
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Introduction: Obesity appears to be an independent risk factor for 
ICU admission and a severe disease course in COVID-19 patients (1). 
An aberrant inflammatory response and impaired respiratory function 
have been suggested as underlying mechanisms (2, 3). Today, it is not 
known whether obesity is only a risk factor for COVID-19 susceptibil-
ity and for the need of intensive care, or whether it also influences the 
outcome of the patients once admitted on intensive care units.
Objectives: We investigated whether obesity is associated with differ-
ences in inflammatory, respiratory, and clinical outcome parameters in 
critically ill COVID-19 patients.
Methods: Sixty-seven COVID-19 ICU patients were divided into obese 
(BMI ≥30  kg/m2, n = 18) and non-obese (BMI  < 30  kg/m2, n = 49) 
groups. Plasma concentrations of interleukin (IL)-6, interferon gamma-
induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, 
and granulocyte colony-stimulating factor (G-CSF) were determined 
from ICU admission until 10  days afterwards, and routine laboratory 
and clinical parameters were collected.
Results: BMI was 32.6 [31.2-34.5] and 26.0 [24.4-27.7] kg/m2 in the 
obese and non-obese group, respectively. Apart from temperature, 
which was significantly lower in obese patients (38.1 [36.9-38.9] vs. 
38.7 [38.0 -39.5] °C, p = 0.02), there were no between-group differ-
ences on ICU admission. Plasma cytokine concentrations declined 
over time (p < 0.001 for all), but no differences between obese and 
non-obese patients were observed. The kinetics of clinical inflamma-
tory parameters and respiratory mechanics were also similar in both 
groups. Finally, no differences in time on ventilator (22 [16-40] vs. 27 
[14-40] days, p = 0.34), ICU length of stay (25 [17-40] vs. 29 [15-40] 
days, p = 0.49), or 40-day mortality (17% vs. 24%, p = 0.76) between 
obese and non-obese patients were apparent (Fig. 1).
Conclusion: In COVID-19 patients requiring mechanical ventilation in 
the ICU, obesity is not related to a different immunological response, 
unfavourable respiratory mechanics, or impaired outcome.
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Introduction: The clinical spectrum of SARS-CoV-2 infection ranges 
from asymptomatic cases to severe pneumonia and viral sepsis lead-
ing to organ dysfunction and high mortality (1). A subset of critically 
ill COVID-19 patients develop a hyperinflammatory state. Anakinra, a 
recombinant interleukin-1 receptor antagonist, is known to be effec-
tive in several hyperinflammatory diseases. Recently, small studies 
suggest that anakinra improve respiratory function and clinical out-
come in COVID-19 patients (2-4).
Objectives: We investigated the effects of anakinra on inflammatory 
parameters and clinical outcomes in critically ill, mechanically venti-
lated COVID-19 patients with clinical features of hyperinflammation.
Methods: In this prospective cohort study, 21 critically ill COVID-
19 patients treated with anakinra were compared to a group of 39 
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critically ill COVID-19 patients receiving standard care. Serial data of 
clinical inflammatory parameters and concentrations of several circu-
lating cytokines were aligned on start day of anakinra in the treatment 
group, and median start day of anakinra in the control group. Analysis 
were performed from day -10 to +10 relative to alignment day. Clini-
cal outcomes were analyzed during 28 days. Additionally, a sensitivity 
analysis was performed in propensity score matched groups.
Results: Patient characteristics and clinical parameters on ICU admis-
sion were similar between groups. Due to bias by indication, plasma 
levels of ASAT (p = 0.0002), ferritin (p = 0.009), and temperature 
(p = 0.001) were significantly higher in the anakinra group on align-
ment day. Following treatment, no differences in the kinetics of cir-
culating cytokines were observed between both groups. Decrease of 
temperature (p = 0.03), white blood cell counts (p = 0.02), and plasma 
levels of ferritin (p = 0·003), procalcitonin (p = 0.001), creatinine 
(p = 0.01), and bilirubin (p = 0.007) was more pronounced in the anak-
inra group (Fig. 1 a-f respectively). No differences in clinical outcomes 
were observed between groups. The propensity-matched analysis 
confirmed these results.
Conclusion: Anakinra is effective in treating clinical signs of hyperin-
flammation that may promote organ dysfunction in critically ill COVID-
19 patients.
Reference(s) and grant ackowledgment(s)
1. 4. Dimopoulos G et al. Favorable anakinra responses in severe COVID‑19 
patients with secondary hemophagocytic lymphohistocytosis. Cell Host 
Microbe. 2020.
2. 3. Huet et al. Anakinra for severe forms of COVID‑19: a cohort study. The 
Lancet Rheumatology. 2020.
3. 2. Cavalli et al. Interleukin‑1 blockade with high‑dose anakinra in patients 
with COVID‑19, acute respiratory distress syndrome, and hyperinflamma‑
tion: a retrospective cohort study. Lancet Rheumatol. 2020;2(6):e325‑e31.
4. 1. Zhou F et al. Clinical course and risk factors for mortality of adult inpa‑
tients with COVID‑19 in Wuhan, China: a retrospective cohort study. Lancet. 
2020;395(10229):1054‑62.
5. Funded by the participating departments.
001349 
Comparison of procalcitonin levels according to pathogen type 
and gram staining in bloodstream infection in ICU
O.  Kaynarca1; M.  Uyar2; C.  Bor3; K.  Demirag2
1Anesthesiology and intensive care, Ege University Medical Faculty Hospi‑
tal, İzmir, Turkey; 2Anesthesiology and intensive care, Ege University Hos‑
pital, Izmir, Turkey; 3Anesthesiology and intensive care, Ege Üniversitesi Tıp 
Fakültesi, İzmir, Turkey 
Correspondence: O. Kaynarca
Intensive Care Medicine Experimental 2020, 8(2): 001349
Introduction: Procalcitonin (PCT) is a biochemical marker that can 
increase in hours in the presence of bacterial infection, which may 
assist in the early recognition of bacteremia and sepsis with a high 
specificity and sensitivity. Studies conducted in recent years reveal 
that the PCT level in plasma varies according to the type of pathogen 
causing the infection and the gram staining feature. In our study, the 
relationship between the type of causative pathogen and PCT level in 
patients diagnosed with bloodstream infection was investigated with 
a retrospective observational study design.
Methods: 208 infection epizode from 137 ICU patients who were 
diagnosed as bloodstream infection between January 2016 and Feb-
ruary 2018 were included in the study. The highest fever, leukocyte, 
CRP and procalcitonin values in 24-h before and 24-h after the blood 
culture, infectious agent, APACHE II score, use of antibiotic when 
blood culture was taken, duration of ICU stay and 30-day survival was 
recorded using the data in the electronic patient file.
Results: Patients were divided into four groups as gram positive, gram 
negative, fungus and multiple agents according to the culture results. 
No significant difference was observed between the groups for fever, 
leukocyte and CRP levels, while procalcitonin level was found higher 
in gram negative infections (p  < 0.0001). Procalcitonin cut-off value 
for gram negative infection was 5.95 ng/ml (sensitivity 54%, specific-
ity 81%). It has been shown that procalcitonin and CRP levels correlate 
with APACHE II score, but the correlation coefficient of procalcitonin 
value is higher. The relationship between PCT and CRP levels with 30-d 
mortality was found significant, with a procalcitonin cut-off value was 
4.99 ng/ml (sensitivity 66.7% specificity 75%), while CRP cut-off value 
19.01 mg/L (sensitivity 62.4% and specificity 67%). No significant dif-
ference in PCT levels was found between the patients who used anti-
biotics and those who did not when culture was taken. There was also 
no significant relationship between the duration of ICU stay and the 
PCT level.
Conclusion: In conclusion, we think that procalcitonin is a marker to 
help predict the causative agent of infection and determine the prob-
ability of mortality in patients with bloodstream infection.
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Introduction: Despite most common SARS-CoV-2 infection clini-
cal findings are related to respiratory apparatus, Covid-19 may affect 
other organs than lungs such as liver, bowel and kidneys [1]. Com-
monly, in fact, patients suffer for abdominal and gastro-enteric symp-
toms[2]. We report the first case, to our knowledge, of a Covid-19 
patient affected by ascending colon perforation due to a Pseudomem-
branous Colitis (PC) in absence of Clostridium Difficile (CD) toxins, but 
with SARS-CoV-2 identification in gastric fluid.
Methods: In April 2020, a 73-years-old man came in our ED with fever 
and dyspnea for 24  h. His remote medical history revealed ischemic 
heart disease, hypertension and NIDDM. Chest X-ray showed right 
basal consolidation and bilateral congestion. A RT-PCR test for Covid-
19 was negative. The patient was admitted with the diagnosis of 
CAP and heart failure and treated with antibiotics and diuretics. Ten 
days later, respiratory symptoms and radiological findings worsen-
ing leaded to perform a new nasopharyngeal swab for Covid-19 that 
resulted positive. The patient needed CPAP ventilation and hydroxy-
chloroquine, azithromycin and LMWH administration were started. 
Five days later, he developed fever and diarrhea: on physical exami-
nation abdomen is quite manageable. Piperacillin/tazobactam was 
started empirically. An abdominal CT scan showed a parietal ascend-
ing colon thickening and intra-peritoneal air collection. Right hemi-
colectomy with ileostomy for perforation has been performed. After 
surgery, he was admitted to our ICU. The anatomopathological exami-
nation revealed a PC. Diffuse tissue edema, acute inflammation and 
necrotizing vasculitis with fibrin thrombi and intravascular neutrophils 
infiltration were identified (Fig.1). Samples from ileostomy and stool 
in rectal ampoule were negative for CD toxins. A PCR test for SARS-
CoV-2 performed on gastric fluid was positive. After improvement, the 
patient was discharged from ICU to a low intensity ward.
Results: Necrotizing vasculitis is commonly found in Covid-19 patients 
in several organs [3]. Some authors suggest enteric involvement in up 
to 50% of Covid-19 patients, but it’s not yet completely understood. 
ACE-2 receptor is expressed by intestinal epithelium: mouse models 
suggested that ACE-2 receptor modification due to infection can cause 
bowel inflammation and colitis [4]. In this case, clinical findings were 
typical and patient had several predisposing factors for CD colitis. 
Since CD tests were always negative and the patient improved without 
CD specific therapies, we supposed viral infection related necrotizing 
vasculitis as pseudomembranous colitis and perforation cause. Anato-
mopathological findings and viral RNA detection in gastric fluid sup-
port our hypothesis.
Conclusion: Many COVID 19 patients present GI symptoms together 
with respiratory ones. Gastro-enteric involvement may be due to 
enteric viral replication. CD negative PC due to a necrotizing vasculitis, 
in our case, may be a SARS-CoV-2 infection complication too.
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Introduction: Healthcare workers are at high risk of contracting 
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) 
pneumonia from either infected patients or staff [1]. Whilst effective 
use of personal protective equipment (PPE) is essential, sourcing ade-
quate supplies has been a global challenge. [2].
Objectives: To perform a cross-sectional study at two time points dur-
ing the COVID-19 pandemic to estimate the type and quantity of PPE 
being used in the intensive care unit.
Methods: This was a single-centre, prospective study at the Queen 
Elizabeth Hospital Birmingham. PPE use was in line with Public Health 
England guidance for ICUs [3] and all staff entering the COVID-19 ICU 
wore Level-3 PPE. Redeployed non-clinical military and outpatient 
hospital staff were trained as donning and doffing officers to ensure 
staff followed the PPE protocols. Donning officers recorded the type 
of PPE used every time a staff member entered the ICU. This was docu-
mented for each day, over two sampling periods (19th-30th March and 
18th-28th April) on one of our three dedicated COVID-19 ICUs. Con-
tinuous data is presented as mean ( ± SEM) and compared using a Stu-
dent’s t-test. Categorical data is presented as % and analysed using a 
chi squared test. A p value of  < 0.05 determined statistical significance.
Results: Over the total period of data collection, 5,066 donning epi-
sodes were recorded. The daily mean number of patients was 22 ( ± 2) 
and staff working on the area was 101 ( ± 6). The daily mean number 
of donning episodes was 300 ( ± 26), equating to approximately 3 
episodes per healthcare worker or 14 episodes per patient each day. 
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86% of donning episodes were with an FFP3 face mask and 14% used 
a powered respirator.
In the second study period, the number of staff and patients increased, 
as did the number of donning episodes (see Table  1). A greater fre-
quency of donning episodes relative to the number of staff on the unit 
was also observed (3.4 vs 2.4 episodes per staff member per day) and 
a higher proportion of staff wore FFP3 masks rather than powered res-
pirators (FFP3 mask use: 89.3% in 2nd period vs 77.4% in 1st period; 
p < 0.0001).
Eleven percent of nursing staff were on leave due to illness each week. 
Staff sickness rates were equivalent between the two periods of data 
collection (10.6% vs 10.5%). Non-clinical nursing staff (working in 
administrative roles) had a sickness rate of 5.4% over the same study 
period.
Conclusion: Vast quantities of PPE were used on a daily basis dur-
ing the UK-peak of the COVID-19 pandemic to maintain the safety of 
staff and patients. Whilst the number of healthcare workers increased 
between the two periods, PPE use relative to the number of staff was 
also greater. This may be explained by the introduction of additional 
support teams to deliver interventions as patient numbers grew (pron-
ing, line insertion et cetera). FFP3 masks were more frequently used 
compared to powered respirators.
Compared to prior reports [1] a lower rate of illness in healthcare work-
ers was observed in our study, and sickness rates in clinical nursing 
staff were only slightly higher than their non-clinical colleagues. This 
indicates a lower rate of healthcare worker infection - which could in 
part be explained by the PPE strategy used in our ICU.
In conclusion, PPE use and preference changed over two time periods 
in one area of a single ICU during the COVID-19 pandemic. As equip-
ment is scarce but in high demand, healthcare departments should be 
encouraged to regularly audit PPE use to better estimate clinical need.
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Introduction: SARS-CoV-2 infection, originating from Wuhan, China is 
the underlying cause of COVID-19 disease [1]. The first known patient 
with COVID-19 disease was admitted to our intensive care unit (ICU) 
at the Royal Gwent Hospital (RGH), Newport, Wales on the 9th March.
Objectives: In this case-series analysis we describe the epidemiology 
of the first wave of COVID-19, focusing on the interplay between eth-
nicity and social deprivation, by using data from the first 60 days at the 
RGH ICU.
Methods: Our prospective service evaluation recorded anonymised 
data on patient age; sex; BMI; postcode; ethnicity; Welsh Index of Mul-
tiple Deprivation (WIMD) score [2]; need for any assistance with daily 
activities; APACHE II score; time from hospital admission to ICU, and 
ICU mortality. Background data on ethnicity for the hospital catch-
ment area was obtained from the UK Census data 2011 (Office for 
National Statistics).
Results: The Black, Asian and Minority Ethnic (BAME) population, while 
being only 5% of the background population, represented 35% of ICU 
COVID-19 admissions (18 of 52) and 35% of deaths (6 of 17). Within the 
BAME group, 72% (13 of 18) of patients were from geographical areas 
representing the 20% most deprived (lowest quintile) in Wales, versus 
27% of Caucasians (9 of 33). When looking at deaths by ethnicity, more 
occurred within the lowest deprivation quintile in the BAME group (4 
of 6 deaths) compared to the Caucasian group (3 of 11).
Conclusion: We found that patients from the BAME group are at sig-
nificantly higher risk of ICU admission and death from COVID-19, 
despite an overwhelming Caucasian background population (95%). 
We observed a striking interaction between deprivation and ethnic-
ity, which may be multifactorial, including greater prevalence of co-
morbidities; increased community spread; genetic polymorphisms; or 
other unidentified factors [3-5]. These factors need further investiga-
tion and evaluation.
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Introduction: Convalescent plasma containing virus specific anti-
bodies has been used before and was associated with reduced mor-
tality during Spanish flu, SARS, and H1N1 influenza A pandemics. 
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Therapeutic plasma exchange (TPE) has shown some benefits for 
cytokine clearance in sepsis with multiorgan failure in the past and 
in 2009 H1N1 influenza A pandemic. We combined both therapies 
together for COVID-19 treatment.
Objectives: To evaluate safety and efficacy of therapeutic plasma 
exchange followed by convalescent plasma therapy in critically ill 
patients with severe acute respiratory syndrome corona virus 2 (SARS-
COV-2) infections.
Methods: 6 patients with laboratory-confirmed COVID-19 and acute 
respiratory distress syndrome (ARDS) were treated with one session 
TPE followed by 500 ml convalescent plasma transfusion in addition to 
standard treatment who met the following criteria: severe pneumonia 
with rapid progression and life threatening illness (PAO2/FIO2  < 300 
and mechanical ventilation, shock, organ failure). The study was con-
ducted at Mediclinic City Hospital, Dubai, UAE from April 20, 2020 to 
June 20, 2020. Outcomes measured were death from any cause, time 
to negative SARS-COV-2 PCR, time to removal of mechanical ventila-
tion after intervention, clinical (body temperature, Sequential Organ 
Failure Assessment (SOFA) score, PAO2/FIO2), biochemical (ferritin, 
D-dimer, CRP, LDH, procalcitonin) and radiological parameters before 
and after therapy. Mechanical ventilation days, ICU length of stay, hos-
pital length of stay were also measured.
Results: Patients were in the age range of 36-65  years, 4 males and 
two females. All patients were receiving mechanical ventilation, Meth-
ylprednisone and therapeutic anticoagulation. All the patients sur-
vived and were discharged home. Time to negative SARS-COV-2 RT 
PCR was 1-18 days and time to removal of mechanical ventilation was 
2 -41 days after intervention. Out of six, 4 patients were off mechani-
cal ventilation within 7  days of therapy. 3 out of 6 patients had nor-
mal body temperature, 5 had improved PAO2/FIO2 within 48hrs. SOFA 
score improved by 2 points within 48 hrs in 3 patients and within 
5 days in another 2 patients. All the biochemical parameters improved 
within 48 hrs except D- dimer which worsened in 3 patients after ther-
apy. Chest X ray showed improvement in pulmonary lesions within 
48 hrs and significant improvement by day 7. Mechanical ventilation 
days, ICU and hospital length of stay was 8-42, 10-42 and 20-60 days 
respectively.
Conclusion: Critically ill Covid-19 patients with ARDS treated with 
therapeutic plasma exchange followed by convalescent plasma in 
addition to standard therapy showed improvements in clinical, labo-
ratory, and virological parameters. Although this uncontrolled limited 
case series had very good success rate, further evaluation in clinical tri-
als is necessary in order to corroborate the findings.
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Introduction: On March 2020, World Health Organization (WHO) 
declared COVID-19, a disease caused by the SARS-COV2 virus, as a 
pandemic. Some studies have highlighted advanced age, male sex, 
and other comorbidities as cardiovascular diseases, diabetes, and pul-
monary diseases, increase the risk and severity of the COVID-19.
There have been few molecular level hypotheses raised for the vari-
able susceptibility to disease and vulnerability to severe disease. Land-
steiner’s ABO carbohydrate moieties are genetically inherited. Some 
reports suggest a correlation between ABO blood group, cardiovascu-
lar diseases, and cancers, as well as typing and susceptibility to certain 
infections, including COVID-19 infection.
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Only few clinical studies demonstrated that there exists a relationship 
between infection risk and the blood groups, and how blood group O 
had a negative predictive effect, associated with a lower risk of infec-
tion and mortality, and the blood group A was correlated with a severe 
pulmonary damage.
Objectives: Main: To analize a group of COVID-19 patients admitted to 
our Intensive Care Unit (ICU) between March-2020 and June-2020 by 
their blood group and Rh factor.
Secundary: To determine the frequency of main comorbidities, analyti-
cal results, ICU evolution, treatment needed, ventilation characteris-
tics, and score on risk scales.
Methods: Observational, descriptive, retrospective study in COVID-
19 patients admitted to our ICU in 3 months, using a database of 14 
patients, with previous defined blood group and Rh factor, and medi-
cal history, analytical results (at the admission, 2 days, 4 days, 6 days 
and 8 days later), ICU evolution, treatment needed (vasoactive drugs 
and COVID-19 drugs), ventilation characteristics and scores on the risk 
scales (APACHE, SOFA and SAPS II).
Results: The clinical characteristics of 14 patients included according 
to their blood group, were: main age of patients 63 (44–78) and the 
percentage of female patients was 57%. The most frequently detected 
blood group was type O with 57% amongst the COVID-19 patients. 
This was followed by group type A with 43%. Rh factor more detected 
was positive with 93%, being statistically significant the relation 
between female gender and positive Rh factor 54% (p 0.011).
An important history of cardiovascular diseases was determined 
among these patients, highlighting high blood pressure 50% type O 
and 50% type A; obesity 50% type O and 37,5% type A, dyslipidemia 
66% type O and 12,5% type, without statistically significant.
No important difference was found in the analytical results at the 
admission, 2  days, 4  days, 6  days and 8  days later; just highlight the 
main D-Dimer levels at the admission in ICU was substantially more 
elevated in type A (4342 ng/ml) than O (1429 ng/ml).
Group type A had highest needs of vasoactive drugs: Noradrenaline 
100% (62% Group type 0), Dobutamine 50% and Adrenaline 16% 
(both 0% in Group type 0), and also a 100% needed glucocorticoid 
treatment (62% Group type 0).
The use of renal replacement therapy was prescribed for 50% of 
patients in Group type A, compared to. 12,5% in Group type 0, as well 
as the need of percutaneous tracheostomy (same percentages).
The ICU evolution was fateful in Group type A, with 50% of death, 
compared to 37,5% in Group type 0, without statistically significant 
differences. Likewise, the ICU evolution was worse in negative Rh fac-
tor patient.
Fibrinolytic therapies such as rtPA, or bronchodilator therapies with 
nitric oxide, were used for the treatment of refractory cases, in 33% of 
Group typ A, and in the negative Rh factor patient, unlike 7% positive 
Rh factor patients, being statistically significant (p 0,017).
No differences in mechanical ventilation was found between both 
groups.
Finally, in relation to the score on risk scales, SAPS- II after the admis-
sion of patients with positive Rh factor, had a mean of 34,63, statisti-
cally significant (p 0,012); we did not detect differences in SOFA or 
APACHE scales after the admission.
Conclusion: Group type O and positive Rh factor were the most fre-
quent in our COVID-19 patients, being statistically significant the rela-
tion between female gender and SAPS-II score after admission with 
positive Rh factor. Although Group type A patients were less numer-
ous, they needed more vasoactive drugs, refractory treatments and 
had worse ICU evolution.
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Introduction: Providing an efficient care to the patients of the most 
severely affected category – ICU patients - has become one of the 
serious problems appearing in the COVID-19 pandemics [1]. A typical 
patient’s clinical portrait in ICUs of COVID centers is very similar in dif-
ferent countries, however, the key to improve the treatment results for 
critically ill patients has not yet been found [2].
Objectives: The aim of the study is to identify predictors of the severe 
pneumonia caused by the SARS-CoV-2 virus in patients admitted to an 
intensive care unit (ICU) of the COVID-center of the Federal Research 
Clinical Center.
Methods: In this report, we describe the clinical, laboratory and instru-
mental data of 70 patients admitted to the ICU, and discuss the found 
predictors of the severe COVID-19 pneumonia course.
Results: The mortality in the ICU was 48.9%, the mortality among the 
patients required mechanical ventilation was 57.9%. The following fac-
tors have been determined which contribute to the development of 
the severe course of the disease and to the risk of the mortality: male 
gender (p = 0.021), age older than 70.5  years (p = 0.014), initial lym-
phocytopenia of lower than 0.98×109/l(p = 0.014), neutrophil to lym-
phocyte ratio of higher than 7.75 (p = 0.004), D-dimer level of higher 
than 0.85 µg/ml (p = 0.001), IL-6 of higher than 184.7 pg/ml (p = 0.011), 
procalcitonin of higher than 0.22 ng/ml (p = 0.009), hyperglycemia of 
higher than 9 mmol/l, signs of myocardial damage (high-sensitive tro-
ponin T of higher than 22 pg/ml (p = 0.005), echocardiography data), 
and a severe vitamin D deficiency (lower than 9.9 ng/ml, p = 0.044).
Conclusion: Clinical features of the patients change in course of pan-
demia. These are influenced by changes in treatment approaches and 
new discoveries in disease pathophysiology. Above mentioned pre-
dictors of severe course of disease is partly modifiable and we are able 
to influence them and perhaps achieve better results in treatment of 
severe patients with COVID-19.
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Introduction: The COVID-19 is considered as the major pandemic that 
we have experienced in the last century. Therefore, the management 
of the critically ill patients with COVID-19 is extremely important. The 
need for intensive care might differ according to institutions or even 
countries, depending on the demand and supply ranging from 5% to 
32%. ICU mortality due to COVID-19 varies from 16% to 78% accord-
ing to different studies. As of July 28th, 2020, a total of over 270000 
COVID-19 cases and 2800 deaths have been reported in Saudi Arabia. 
No data available concerning the characteristics and outcomes of 
severe COVID-19 patients in the Kingdom.
Objectives: To describe the demographic and clinical characteristics 
and report our management and the outcomes of patients admitted 
for severe COVID-19.
Methods: Retrospective descriptive observational cohort study 
was conducted, from Mars 25, 2020, to July 28, 2020, in King Fahad 
armed forces hospital, Kingdom of Saudi Arabia. We included all adult 
patients with confirmed severe COVID-19 and required ICU admission 
or ICU management outside ICU. We collected baseline data on demo-
graphics, clinical presentation, laboratory, arterial blood gas, ventila-
tion setting, the management, and the outcomes.
Results: Of the 110 patients included in the study, 52 (47.3%) were 
admitted in ICU and the remaining patients were followed by ICU 
team in the ward. The median (IQR) age was 62 (54-70) years and 74 
(67.3%) were male. 97 patients (88.2%) had at least one comorbid-
ity, mainly diabetes mellitus (70%) and hypertension (65.5%). The 
median (IQR) of SOFA score and APACHE II score were 4 (3-5) and 9 
(7-13) respectively. The median time from first symptom to ICU team 
management was 7.0  days. All patients had acute respiratory failure 
and 34 patients (30.9%) had combined others organ damage. The 
lymphopenia less than 1.0 x 109/L, D-dimer more than 1 mcg/mL and 
high ferritin occurred in 49%, 54.5% and 85.5% respectively. The res-
piratory support was needed for 90 patients (81.8%), among them 86 
patients (78.2%) received continuous positive airway pressure (CPAP). 
Invasive mechanical ventilation within the first 24 hours of admission 
occurred for 8 patients (7.3%). Moderate to severe acute respiratory 
distress syndrome (ARDS) was observed in 71.8% of the patients and 
the median (IQR) PaO2/FIO2 was 152 (123-191). The median FIO2 was 
45% (IQR, 35%-60%). Awake proning with CPAP was performed for 
31 patients (28.2%). All patients had negative fluid balance during at 
least the first 3  days of ICU team management. Methylprednisolone 
was administered to 78 patients (71%) and empiric antibiotics to 106 
patients (96.4%). During hospital stay, 20 patients (18.2%) required tra-
cheal intubation and the median (IQR) length of stay was 8 (5-11) days. 
Among the 110 patients, three were still in the ICU, and 8 (7.5%) had 
died.
Conclusion: In this single center case series of severe COVID-19, all 
patients had acute respiratory failure and the majority needed respira-
tory support mainly by CPAP and the rate of mortality was low, less 
than 8%.
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Introduction: Catheter-related bloodstream infection (CRBSI) and 
other infections have beenfrequent in patients admitted in ICU for 
Covid -19. However, many cultures collected withsuspected infection-
have been negative or contaminated.
Objectives: We aim to analyze the microbiological isolates from blood 
cultures in patients admitted for Covid-19 and Catheter-related blood-
stream infection (CRBSI) in our Unit during the months of the Covid-19 
pandemic.
Methods: Retrospective, descriptive, observational study of the 
microbiological isolates in blood cultures and catheter tips in patients 
admitted for Covid-19 from March to May 2020 in the ICU of a third-
level hospital. The data we used was obtained from the ENVIN-HELICS 
registry. The following were analyzed: demographic data, number of 
blood cultures extracted, number of positive blood cultures, percent-
age of Gram positive, Gram negative and fungal organisms, number 
and incidence density of CRBSI, hospital mortality and ICU mortality.
Results: 60 patients were included, 48 (80%) were men and 12 women 
(20%), median APACHE II score 14.1 points, median age 60.47  years. 
Some blood culture was extracted from 51 patients (90%), 31 of them 
(53.4%) had the blood culture positive. In total, 163 blood cultures 
were performed: 73 were positive (45%) and 90 negative (55%). Of the 
positive results, 80% correspond to Gram positive microorganisms, 9% 
to Gram negative and 9% to fungi. The most frequent microorganism 
was coagulase- negative Staphilococcus (34%).
69 catheter tips were removed. In 21 (30.4%) microorganisms were 
isolated: gram positive 60%, gram negative 17% and fungi 23%. The 
remaining 69.6% were negative. There were 12 CRBSI in a total of 
1285  days of central venous catheter (9.34 bacteremia/1000  days of 
central venous catheter). Utilization ratio =  1.02.
ICU mortality was 33% and hospital mortality 38.98%.
Conclusion: Our study reported a high number of blood cultures 
sent and catheters removed with suspected infection. Although most 
blood cultures were negative, there is a high rate of Gram-positive iso-
lated and catheter-related infections, probably due to the high num-
ber of devices used and the severity of the disease. Despite these data, 
mortality in our ICU is similar to that described in the literature.
This study makes us think that in an unknown Scenario and with 
exceptional protection measures, we cannot forget “zero projects” as a 
measure to lower infection rates and to establish improvement points 
in ICUs.
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Introduction: SARS-CoV 2 (COVID-19) critical ill patients with pneu-
monia requiring mechanical ventilation (MV) frequently present 
endotracheal tube (ET) obstruction episodes. ET obstruction and ET 
emergent change procedure may increase the risk of Intensive Care 
Unit (ICU) complications with prognostic implications.
Methods: Retrospective observational trial. Patients with confirmed 
SARS-CoV-2 (COVID-19) pneumonia requiring mechanical ventila-
tion longer than 48 hours between March 6th and May 6th 2020 were 
included. In patients with ET obstruction and ET emergent change, 
the following events were recorded: new onset ventilator associated 
pneumonia (VAP), pneumothorax and mortality related to ET change. 
Intubation days, ICU-stay and mortality were compared between 
both groups (patients with ET obstruction vs patients without ET 
obstruction).
Results: 49 COVID-19 patients with pneumonia required MV. Two 
patients died in the next 48 hours and were excluded. 47 patients 
were included. Mean age was 61,7 (+/- 1,6) years old, 35 (74,4%) male. 
Mean APACHE 2 was 14,4 (+/- 0,8), mean SAPS 2 34,1 (+/- 1,3). Global 
mortality was 29,7%. Mean ICU-stay was 29 (+/- 2,6) days and mean 
intubation days 24 (+/- 2,4). In 28 patients (59,5%) ET was changed at 
least once. Mean ET change day was 11,1 (+/- 1,3) . Among ET change 
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group, 14,3% had pneumothorax; 60,7% developed VAP in the follow 
72 hours, 58,8% of which had new germ isolation. After comparing 
both groups, patients who needed ET change stayed longer intubated 
(28,4 vs 17,7, p < 0,05) and admitted in ICU (34,5 vs 21 days, p < 0,05). 
There were not significant differences in mortality. One patient died 
(3,6%) secondary to a ET change.
Conclusion: More than half SARS-CoV 2 intubated critical ill patients 
presented ET obstructions. These episodes may increase the risk of 
developing complications such as VAP and pneumothorax, which 
determine longer intubation period and ICU-stay. Strategies headed 
for limiting and preventing ET obstruction episodes may decrease 
morbidity during MV, having an impact in ICU-stay.
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Introduction: The recent SARS-CoV-2 pandemic has motivated the 
evaluation of several therapeutic agents as treatment for the corona-
virus disease 19 (Covid-19). Remdesivir has been shown to be superior 
to placebo in shortening the time to recovery in adults hospitalized 
with Covid-19(1).
Objectives: After the early access program implementation in Por-
tugal, we began to treat Covid-19 patients with remdesivir according 
to the published criteria. We aimed to determine the impact of rem-
desivir in the outcomes (ICU length of stay, SOFA score improvement 
and adapted clinical eight-category ordinary WHO scale (ACECOWS) 
improvement, at ICU discharge date) of patients admitted to ICU with 
SARS-CoV-2 pneumonia, as compared to supportive care (SC) (with 
no use of off-label drugs). Secondary objective was to determine 
the impact of remdesivir in the duration of mechanical ventilation of 
Covid-19 patients and ICU-mortality and hospital mortality of both 
groups.
Methods: We performed a single center retrospective cohort study. All 
adult patients admitted in ICU with SARS-CoV-2 pneumonia were eli-
gible for the study. SARS-CoV-2 pneumonia was diagnosed using clini-
cal and radiologic and microbiological criteria. Statistical assessment 
of the outcomes was made between remdesivir-treated group vs SC 
group.
Results: 43 patients (mean age 61  years, 65% males) were included 
in the analysis (36 in SC group and 7 in the remdesivir group). The 
ICU length of stay (8.8  days vs 12.1  days, p = 0.408) and duration of 
mechanical ventilation (4.9  days vs 8.1  days, p = 0.41) were lower in 
the remdesivir-treated group. In addition, remdisivir-treated group 
was associated with greater SOFA score improvement (p = 0.036) and 
greater ACECOWS improvement (p = 0.030) at ICU discharge. Till now, 
no deaths were registered in the remdesivir-treated group, either dur-
ing ICU or hospital stay in our cohort.
Conclusion: Despite our small cohort, remdesivir seems to be supe-
rior to SC in the treatment of Covid-19 patients, with a faster and more 
marked clinical improvement at ICU discharge.
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Introduction: During the UK peak of the COVID-19 pandemic, many 
intensive care units expanded bed capacity rapidly. In our own unit, 
our bed capacity peaked at 258%, with 37  days spent above 100% 
capacity. Combined with this; redeployment of staff from other areas 
and use of personal protective equipment understandably leads to 
concerns about increased rates of hospital acquired infection, or cross-
contamination between patients. We sought to examine our own 
experience through analysis of blood stream infections.
Methods: We identified all patients admitted to our intensive care 
between March and May 2020 with COVID-19 pneumonia. Data was 
collected on demographics and outcome from our local critical care 
database Wardwatcher, and positive microbiology from blood cul-
tures obtained peripherally or from invasive lines.
We categorised positive results into pathogenic organisms, likely con-
taminants, and low pathogenicity organisms associated with nosoco-
mial infection. To review results over time, we categorised into first 48 
hours, 3 to 7 days, 7 to 21 days, and after 22 days of ICU stay. Analysis 
was performed in Excel.
Results: From March to May 2020, we admitted 52 patients with 
COVID-19 pneumonia of whom 96% were invasively ventilated. 71% of 
patients were male, median age 57, median length of stay 16 days and 
overall ICU mortality was 27%. All ventilated patients had arterial and 
central venous catheters (CVC) placed, with those experiencing longer 
stays having lines replaced if concerns about possible line infection.
Overall we documented 61 positive blood culture results of which 
16% were pathogenic (Klebsiella pneumoniae, and Candida albicans), 
the majority of these grew from samples from CVCs and represent 3 
separate patient episodes (6%). 31% were nosocomial associated 
organisms (Enterobacter species, one vancomycin resistant enterococ-
cus faecium), again the majority from CVC samples.
Over time, we saw the majority of positive blood cultures occurring 
after 7 days, with both pathogenic and nosocomial organisms peaking 
between 7 to 22 days (see Fig 1).
Conclusion: Our results demonstrate similar rates of pathogenic 
blood stream infections compared to published literature of 8%(1), 
the majority of which occurred after 7 days in ICU, similar to a recently 
published cohort from UK(2). This concurs with other published evi-
dence on the need for focus on infection control measures to reduce 
morbidity in this patient cohort when faced with the unique chal-
lenges associated with a pandemic.
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Introduction: Respiratory infection is a frequent reason for ICU admis-
sions or complications. It is a condition associated with substantial 
morbidity and mortality. Multiple organ failure is often observed in 
this setting. Timely management and appropriate antibiotic selection 
are of paramount importance in order to achieve favorable outcomes. 
Βiofire®  FilmArray® Pneumonia Panel Plus is a multiplex PCR platform 
that may rapidly identify the pathogen. It may detect 18 bacterial and 
8 viral pathogens commonly associated with CAP, as well as 7 antibi-
otic resistance genes.
Objectives: We examine the impact of the use ofΒiofire®  FilmArray® 
in the management of ICU patients with severe respiratory infections 
requiring mechanical ventilation in a six bed general ICU of a provin-
cial hospital in Northern Greece.
Methods: It is a retrospective observational study of the impact of the 
use of Βiofire®  FilmArray® in the treatment of patients with severe res-
piratory infections and respiratory insufficiency requiring mechanical 
ventilation during one year. The parameters analyzed included: demo-
graphics, microbiological and routine laboratory data, use of antibi-
otics, clinical outcome. Also, we defined two groups, depending on 
whether Βiofire®  FilmArray® was tested within 48 hours from admis-
sion or not.
Results: A total of 19 patients were included in the study. In 13 of 
them, Βiofire®  FilmArray® was positive. Ten tests revealed the pres-
ence of multiple pathogens; in 5 tests, 9 “fastidious” (i.e. difficult to 
grow without specific conditions) microbes were detected, (Haemo-
philous inf, Streptococcus pne), 6 were positive for viruses (Influenza 
A, Rhinovirus, Parainfluenza), 8 tests identified 12 common ICU patho-
gens (Acinetobacter, Klebsiella, Pseudomonas), in two cases Legionella 
was diagnosed and in one case Moraxella. Routine cultures yielded 
negative results in most of these cases (84,6% bronchial secretions, 
76,9% pharyngeal). The test results led to antibiotic treatment modi-
fication in 76,9%. In 4 samples the presence of antibiotic resistance 
genes was noted and appropriate antibiotics were selected.
Conclusion: The introduction and integration of Βiofire®  FilmArray® 
in the clinical practice, had a decisive impact in the treatment of the 
patients. This was demonstrated not only in minimizing the time to 
obtain the results, but also when considering that the routine cul-
tures collected on admission to the ICU often yielded negative results. 
Thus, Βiofire®  FilmArray® provided a valid identification of the patho-
gen and, at the same time, allowed for a prompt de-escalation of the 
broad-spectrum antibiotics initially administered. In conjunction with 
the economic implications of this practice, sparing unnecessary anti-
biotic usage may be beneficial for both the patients and the antibiotic 
resistance patterns of the nosocomial flora.
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Introduction: Despite the widespread use of contact isolation crite-
ria (CIC) in critically ill patients, their ability to predict the carrier state 
of multidrug-resistant microorganisms (MDRO) has not been well 
defined.
Objectives: To determine the ability of commonly used CIC to predict 
the carrier state of MDRO in critically ill patients.
Methods: Patients admitted consecutively to the Intensive Care Unit 
(ICU) were studied. Inclusion criteria were all patients admitted from 
July 2018 to December 2019. Exclusion criterion was previous ICU 
admission.
Pharyngeal and rectal swabs were collected at admission and weekly 
for epidemiological surveillance cultures. The presence of any of the 
following CIC was registered: (1) hospital admission for longer than 
6  days over the previos 3  months; (2) admission in a chronic health 
care facility; (3) known MDRO carrier; (4) antibiotic treatment for more 
than 6 days in the previous month; (5) receiving hemodialysis or peri-
toneal dialysis; (6) diagnosis of a chronic condition associated with 
colonization by MDRO; (7) transferred from another institution.
Sensitivity (Sn), specificity (Sp), positive predictive value (PPV) and 
negative predictive value (NPV) to predict the carrier state by MDRO 
were calculated for each of the criteria. Values  are percentage and 
median (p25, p75). WASPSS (Wise Antimicrobial Stewardship Support 
System) and SPSS V25.0 were used for the analysis. The local Ethics 
Committee approved the study.
Results: We studied 1,156 patients (age 70 [61-78] years, SAPS III 55.5 
[47-66] points, ICU non survivors 42 [26.6%], women 50 [31.6%]) of 
whom 158 (13.7%) were isolated for having at least one of the CIC. Car-
rier state was confirmed by culture of the first surveillance sample in 
40 patients. The 7 criteria were present, respectively, in 123 (12%), 11 
(1%), 21 (2%), 76 (7%), 6 (1%), 15 (1%) and 24 (2%). For each criteria 
considered individually, Sn was  < 50% (except for criterion 1: Sn 67%) 
and PPV  < 30% (except criterion 3, PPV 52%). Each criteria considered 
individually had Es and NPV> 90%. At least one of the CIC was found in 
158 (15%) patients (Sn 80%, Es 88%, PPV 20%, NPV 99%).
Conclusion: Individual CIC, in general, have a very low Sn and a high 
Sp for the detection of MDRO carrier state. None of the CIC is useful 
enough to determine the carrier state, since Se and PPV (which should 
be interpreted with caution as it depends on the prevalence) are low. 
The use of a set of 7 CIC presents a moderate Se for the detection of 
MDRO carrier state.
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Introduction: De-escalation consists in the reappraisal of anti-microbial 
therapy as soon as antimicrobial susceptibility testing results are available, 
and may be achieved through replacing broad-spectrum antibiotics by 
narrow-spectrum drugs, or stopping components of an antibiotic com-
bination. No study has been performed so far to explore this strategy on 
animal models, and its effect on microbial diversity and resistance genes 
in the microbiota and on the immune system remains unknown.
Objectives: Here, we aimed to study the effect of antibiotic de-
escalation versus non de-escalation on a microbiota exposed to 
environmental anti-microbial resistance pressure, both on micro-
bial diversity and resistance genes in the microbiota, but also on the 
immune system.
Methods: Mice were divided in three groups, whether they received 
amoxicillin, imipenem, or imipenem followed by amoxicllin. The ICU 
environment was recreated by co-housing antibiotic-treated mice with 
mice previously contaminated with carbapenemase-carrying E.coli. 
Stools were cultured in selective media supplemented with cefotaxime, 
ertapenem and colistin, and the stool DNA was extracted for PCR and 
whole metagenomics analysis. Blood cytokines were measured by ELISA.
Results: Stool culture revealed the carriage of carbapenemase-posi-
tive E.coli, confirmed by PCR in 7/8 mice in the imipenem group, 5/10 
mice in the de-escalation group and 7/9mice in the amoxicillin group 
(p>0.05). Metagenomics analysis showed no difference in diversity 
and in antimicrobial resistance genes between groups. ELISA tests are 
still ongoing.
Conclusion: There were no difference between groups in terms of 
antimicrobial resistance emergence, as confirmed by culture, PCR and 
metagenomics techniques. Antibiotic de-escalation does not prevent 
the acquisition of resistance genes compared to narrow or broad-
spectrum antibiotic regimen.
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Introduction: Genetic similarities with SARS-CoV-1, and subsequent 
biophysical data, suggested a role for Angiotensin Converting Enzyme 
2 (ACE2) in the SARS-CoV-2 invasion of pneumonocytes1,2,3. Subse-
quently, other proteins constituting the Renin-Angiotensin-Aldoster-
one System (RAAS) have been scrutinised for their relevance to the 
COVID-19 pathology. Such proteins may be pharmacological targets 
benefitting outcomes, or biomarkers of disease severity.
Angiotensin Converting Enzyme (ACE) performs a key role within the 
RAAS, cleaving angiotensin 1 to angiotensin 2 (ANG-2). ACE is preva-
lent in the pulmonary epithelium, and thus equally ANG-2. ANG-2 is a 
potent vasoconstrictor, and associated with inflammation, fibrosis and 
oxidative stress4. It has been implicated in COVID-19 disease severity, 
raised ANG-2 has been reported in cases of COVID-195 and in mice 
studies of ARDS is associated with severe lung injury6.
While much literature focusses on the regulatory functions of ACE2 
on ANG-2, we considered a potential role for measuring serum ACE to 
monitor disease severity. We hypothesised that unknown pathologi-
cal mechanisms would modify serum ACE levels, given an increase in 
ANG-2. We were unclear whether this may be through a negative or 
positive feedback mechanism.
Objectives: To perform opportunistic isolated serum ACE levels on 
COVID-19 patients admitted to our Intensive Care Unit (ICU), during a 
1-month period, to determine whether it was objectively altered dur-
ing the disease state. This pilot study would justify future, systematic 
investigation.
Methods: Within the analysis period we tested 28 patients admitted 
to our District General Hospital ICU, London. Severe Acute Respiratory 
Syndrome Coronavirus 2 infection had been diagnosed by reverse-
transcriptase polymerase-chain-reaction for 26 patients and 2 with 
compelling radiographic evidence. Data on ACE-inhibitor use was 
not available, though it is likely no patient used them within 7 days of 
testing.
Results: Of the patients tested, 26 had a normal serum ACE level 
(8-52  IU/L) representing 93% of the sample. One patient’s level was 
objectively low ( < 5  IU/L), and another high (78  IU/L). The overall 
cohort mortality was 32%. Of note, both objectively abnormal patients 
died.
Conclusion: ANG-2 is regulated in its production by ACE, and removal 
by ACE-2. Any increase in ANG-2 activity may be resultant from an 
excess of the former, and/or a deficiency in the latter. Given the largely 
normal serum ACE amongst the population, it further implicates a 
downregulation of ACE-2 in the pathophysiology of severe COVID-19. 
Murine and in vitro studies of SARS-CoV-1 observed decreased ACE-2 
expression following its interaction with the viral spike protein7, 8.
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ACE does not appear to be reliably modified during the COVID-19 dis-
ease process for use as a biomarker, or to justify future biochemical 
analysis; an important negative finding for ongoing investigations into 
the relevance of the RAAS pathway to COVID-19. Robust investigation 
of the changes to ANG-2 regulation, particularly relating to ACE-2, is 
required.
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Introduction: The implementation of isolation measures in critically ill 
patients with multidrug-resistant microorganisms (MDRO) is resource 
consuming. However, whether patients who are carriers of MDRO 
have a higher mortality is not well established.
Objectives: To determine whether the carrier state (CS) of MDRO in 
critically ill patients is associated with mortality.
Methods: Patients admitted consecutively to Intensive Care Unit (ICU) 
from July 2018 to December 2019 were studied. Inclusion criteria were 
patients who met any of the following contact isolation criteria: (1) 
hospital admission for longer than 6 days over the previos 3 months; 
(2) admission in a chronic health care facility; (3) known MDRO carrier; 
(4) antibiotic treatment for more than 6  days in the previous month; 
(5) receiving hemodialysis or peritoneal dialysis; (6) diagnosis of a 
chronic condition associated colonization by MDRO; (7) transferred 
from another institution. Exclusion criterion was previous ICU admis-
sion. Demographic variables and SAPS III were recorded. Survivors 
(SUR) and non survivors (NONSUR) were compared using a univariate 
analysis (Chi-square test) and a multivariate logistic regression analy-
sis, adjusting for SAPS III score. Values  are percentage and median 
(p25, p75). The strength of the association was measured by the odds 
ratio (OR) and its 95% confidence interval (CI). The WASPSS (Wise Anti-
microbial Stewardship Support System) and SPSS V25.0 were used. 
The local Ethics Committee approved the study.
Results: We studied 192 patients, NONSUR 52 (27.1%), CS 66 (34.4%). 
NONSUR, as compared to SUR were older (75.5 [65.0-79.0] vs. 69.0 
[58.3-77.8] years, p  =  0.074), had a higher SAPS III score (64, 5 [51.5-
75.8] vs. 54.0 [45.0-62.0], p  =  0.001), had a lower proportion of women 
(17.5% vs. 82.5%, p  =  0.037), and a similar proportion of patients with 
CS (18 [34.6%] vs. 48 [34.3%], p  =  0.548. In univariate analysis, the 
mortality of CS versus non CS was not different (18 of 66 [27.3%] vs. 34 
of 126 [27.0%], p  =  0.548). In multivariate analysis, after adjusting for 
SAPS III score, CS was not significantly associated with mortality (OR 
1,171; 95% CI 0.574-2.388, p  =  0.665).
Conclusion: MDRO carrier state is not associated with increased mor-
tality in critically ill patients.
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Introduction: A more detailed knowledge of infectious complications 
in critically ill patients with COVID-19 may help the implementation of 
preventive measures and improve survival.
Objectives: To determine the prevalence of infections and the most 
frequent pathogens involved, and its impact on mortality, in patients 
with COVID-19 and acute respiratory failure requiring invasive 
mechanical ventilation.
Methods: We studied all patients admitted to our Intensive Care 
Unit (ICU) with the diagnosis of viral pneumonia due to SARS-CoV-2 
and requiring invasive mechanical ventilation from March 8 to May 1, 
2020. Patients transferred to another facility were excluded. The end 
point was survival status on day 60 after ICU admission. All patients 
were treated with selective digestive decontamination (oral and 
enteral neomycin, tobramycin and nystatin). Data are median (p25-
p75) or n and percentage. Data were compared by the Chi square 
test or the Fisher exact test, as appropriate, or by the Mann- Whitney 
U test. Association between independent variables and survival status 
was analyzed by multivariate regression analysis adjusted by the SPAS 
III score, and measured by the odds ratio (OR) and its 95% confidence 
interval (CI). A p value  <  0.05 was considered statistically significant. 
The local Ethics Committee approved the study.
Results: We admitted 118 patients during the study period, of whom 
6 were transferred to another facility. Of 112 patients, age was 67 (59-
62) years, 79 (70.5%) were male, SAPS III score was 50 (46-55), 53 (47%) 
had had at least one infection, and 41 (37%) had died by day 60. The 
prevalence of any infection was (48%, 46%), primary bacteremia (11%, 
10%), secondary bacteremia (8%, 7%), catheter-related bacteremia 
(18%, 27%), urinary tract infection (UTI) (21%, 12%), for survivors and 
non survivors, respectively (p>0.3 for all comparisons). Only ventilator 
associated pneumonia (VAP) differed in survivors and non survivors (4 
of 71 [6%] versus 8 of 41 [20%], respectively, p = 0.029; adjusted odds 
ratio 4.47, 95% CI 1.11;18.02).
The most common pathogens in all isolates were: for primary bacte-
remia (n = 12 isolates), S. faecalis 6 (50%), other grampositive cocci 6 
(50%); for secondary bacteremia (n = 8 isolates), gramnegative bacilli 
4 (50%), S. faecalis 3 (38%); for catheter-related bacteremia (n = 24 
isolates), S. epidermidis 12 (50%), S. faecalis 7 (29%); for VAP (n = 21 
isolates), S. aureus 5 (24%), gramnegative bacilli 5 (24%), S. faecalis 2 
(10%); for UTI (23 isolates), S. faecalis 9 (39%), gramnegative bacilli 8 
(25%).
Conclusion: Infections are very prevalent in patients with COVID-19 
and acute respiratory failure. VAP is strongly associated with survival. 
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S. faecalis and a variety gramnegative bacilli, along with S. aureus in 
the case of VAP, are the most prevalent microorganisms isolated 
in these patients. Measures aimed at pneumonia prevention could 
improve survival of critically ill patients with COVID-19.
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Introduction: Since Covid19 was first described, almost 17 million 
cases and more than 665,000 deaths have been reported; therefore it 
is considered an emergency situation in public health of international 
interest. It is postulated that many characteristics of the most affected 
population have direct relationship with mortality.
Objectives: - To describe the main aspects related to the increased 
mortality of patients admitted with Covid19 in the ICU of the Virgen 
de las Nieves Hospital.
- Describe the differences between the characteristics and evolution of 
the patients admitted in our ICU and those published by other centers.
Methods: Observational, retrospective and analytical study that 
includes the patients admitted to the ICU with Covid19 between 
March and July 2020. A database was created in SPSS with the demo-
graphic characteristics of the patients, comorbidities, APACHE II in 
the first 24  h, laboratory tests related to inflammation and coagula-
tion and type of respiratory support. Data was evaluated in terms of 
descriptive statistics with frequencies, means and standard deviation 
for variables with normal distribution and median with interquartile 
range for non-parametric distributions; Comparisons between groups 
according to mortality were made using the Student’s T test for quan-
titative variables and chi-square for qualitative variables.
Results: Of the 58 patients included, 79% were men and 21% women. 
Their mean age was 60 years (+/- 11), their main comorbidities were: 
hypertension (54%), diabetes mellitus (35%), obesity (56%), COPD 
(28%), kidney failure (9%). ICU mortality 33%, hospital mortality 
39%. SCID score mean was 1.94 (+/- 1.3). Analytically, the difference 
between the ferritin on the first and seventh day (delta ferritin) stands 
out with an average of 306 (+/- 2190), the comparison of delta ferri-
tin between the living and the dead had a p 0.029. Patients exclusively 
with IMV were 32 (54%) and combination of HFNO+IMV 17 (29%), 
average hours of HFNO prior to IMV was 6 (2-23), days of IMV 19 (10-
26), APACHE II in patients with combined MV 12 (+/- 4) and exclusive 
IMV 15 (+/- 4) with a p  =  0.007, pO2/FiO2 in patients with combined 
VM 148 (+/- 54), exclusive IMV 120 (+/- 45) p  =  0.04, mortality of 
patients with combined VM 25% and exclusive VM 30% (p  =  0.16).
Conclusion: -Delta ferritin and not the ferritin peak is independently 
associated with mortality. The lower the ferritin clearance capacity is, 
the higher the mortality.
-Patients who received HFNO prior to IMV had similar mortality to 
those with IMV since the admission, contrary to what was postulated 
regarding self-inflicted lung injury. We believe that these findings are 
related to the fact that patients with the combined approach had sig-
nificantly lower APACHE II and higher pO2/FiO2.
-Despite what has been published regarding the importance of coagu-
lopathy, according to the diagnostic scale for sepsis induced coagu-
lopathy, our patients did not present coagulation disorders.
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Introduction: Carbapenemase-producing Enterobacteriaceae (CPE) 
can cause healthcare-associated infections with high mortality rates.
Objectives: We analised an outbreak of NDM carbapenemase in an 
increased capacity (35 beds) usual 12-bed ICU during the COVID-19 
pandemic peak in Madrid.
Methods: Retrospective cohort study of patients suffering from SARS 
CoV-2 infection admitted to the ICU and other areas reconverted 
into ICU in Hospital de Mostoles in Madrid, Spain, during the peak of 
COVID-19 pandemic from March to June 2020. We collected data from 
electronic medical records on demographics, Simplified Acute Physiol-
ogy Score III (SAPS III),comorbidities, type of ICU where the patient was 
admitted, treatments received prior to the carbapenemase outbreak, 
length of ICU admission and mortality in ICU.
Results: 13 (15.85%) patients over 82 critically-ill patients with SARS 
CoV-2 infection admitted to ICU suffered from carbapenemase infec-
tion (69%) or colonisation (31%). Mean age was 61 and 84.6% were 
men. All patients except one had been admitted first to an ICU-con-
verted area (92%), including operating theatre, before moving, even-
tually, to our ICU.
COVID 19-specific treatment, administered according to our Hospital 
protocol, included Ceftriaxone and Azithromicin in 92.3% of the 13 
patients, only one received Ceftriaxone alone; 100% received Lopi-
navir/Ritonavir, Hidroxychloroquine and steroids (Metilprenisolone 
or Dexametasone), 53% Tocilizumab and Baricitinib and 15% Anak-
inra and Beta-Interferon. All 13 patients had received, during ICU 
admission, broad-spectrum antibiotics. Mean length of stay in ICU 
was 24,2 days. Carbapenemase infection included 38.5% pneumonia, 
15.4% tracheobronchitis and one UTI. All patients were treated with 
Ceftazidime-Avibactam plus Aztreonam as in vitro synergy was proven 
in the Hospital Lab. Mean SAPS III score 60.1 and mortality 38.5%.
Conclusion: A significant number of our critically ill SARS CoV-2 
patients suffered from different multidrug resistant bacterial infec-
tions. 13 (15.85%) patients of the entire cohort of 82 developed NDM-1 
carbapenemase. They had a high mortality rate despite directed anti-
biotic therapy. Several factors may have contributed to the appear-
ance of this outbreak in our Unit: high antibiotic selection pressure 
and extensive use of immunosuppressant therapy, workload burden, 
deficient implementation of infection control protocols generally in 
place in Spanish ICUs most possibly associated to working areas not 
usually used as ICUs (open wards and operating theatres, health pro-
fessionals unfamiliar with protocols) and lack of active surveillance 
cultures.
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Introduction: Secondary infection in critically ill patients with COVID-
19 is poorly understood. It is challenging to discriminate between 
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isolated COVID-19 viral and extra bacterial or fungal infection and 
there is paucity of data, mainly in critically ill patients (1). We investi-
gated the secondary infection rate in COVID-19 critically ill patients, 
risk factors for infection and mortality.
Methods: We performed a retrospective analysis of critically ill COVID-
19 patients admitted to the Critical Care Unit (CCU) of the Hospital 
Universitario La Paz (Madrid, Spain), a 1300- bed teaching hospital, 
between 16 March 2020 and 17 May 2020. In that period a total of 
3002 patients with COVID-19 were admitted to hospital, and our unit 
had a total of 83 beds during the pandemic period. All patients that 
needed invasive mechanical ventilation were included. We recorded 
patient demographic data, microbiology data and incidence of sec-
ondary infection during CCU stay, including ventilator associated 
pneumonia (VAP) and nosocomial bacteremia (primary and second-
ary), according to Center for Disease Control (CDC) criteria.
A total of 107 patients with a mean age 62.210.6 years were included. 
Incidence of secondary infection during CCU stay was 43.0% (46 
patients), including nosocomial bacteremia (32.1%, 34 patients) and 
VAP (32.7%, 35 patients).
Results: In univariate analysis, age and coronary arterial disease were 
related to development of secondary infection. Age remained as an 
independent predictor of secondary infection in multivariate analysis 
(OR 1.053, 95% CI 1.010-1.098, p = 0.015). Nor the use of systemic corti-
costeroids and tocilizumab was related to secondary infection.
Overall hospital mortality by 30 June 2020 was 68.2%. Mortality 
was higher in older patients (mean age 65.0 8.1 vs. 56.112.8  years, 
p = 0.001), in patients infected by antimicrobial resistant pathogens 
(94.1% vs. 63.3%, p = 0.012) and in case of secondary infection (82.6% 
vs. 57.3%, p = 0.006). Corticosteroids and tocilizumab administra-
tion was not related to mortality. Age and infection by antimicrobial 
resistant pathogens were independent predictors of mortality in 
multivariate analyses (OR = 1.091, 95% CI 1.039-1.145, p < 0.001; and 
OR = 8.742, 95% CI 1.069-71.485, p = 0.043, respectively).
The incidence of secondary infection in critically ill COVID-19 patients 
in our study is high (43.9%), higher than reported by Ferrando et  al 
(4), with and incidence of respiratory bacterial infection and bactere-
mia of 27.15% and 26.24%, respectively, and Yang et al (5) (incidence 
of pneumonia and bacteremia of 11.5% and 2%, respectively). Feng 
et  al declared an incidence of secondary infection of 34.4% in the 
more severe subgroup of COVID-19 patients (6). Our cohort includes 
only patients under invasive mechanical ventilation, what may explain 
partially these differences. An important finding of our study is the 
lack of relationship of corticosteroids and tocilizumab use and devel-
opment of infections and mortality, in contrast to findings published 
by Sommers et  al, with a lower mortality rate but a higher infection 
occurrence with tocilizumab use (10). Ferrando et  al also showed no 
association between corticoids and tocilizumab use and mortality (4).
To our knowledge, this is the first study that focus on secondary noso-
comial infections in mechanically ventilated, critically ill patients with 
COVID-19. Our study has several limitations: the retrospective nature 
of the analysis; the lack of invasive modalities to help diagnose VAP 
(bronchoalveolar lavage) due to infection control measures; and the 
absence of data regarding antibiotic treatment since appropriate 
empiric antibiotic treatment affects mortality.
Conclusion: In conclusion, our data suggest that the incidence of sec-
ondary infection is very high in critically-ill patients with COVID-19. 
Infections by antimicrobial resistant pathogens may have a significant 
impact in prognosis. We cannot rule out that infections by resistant 
pathogens was simply a marker of severity. Further studies on larger 
populations are needed to investigate secondary infection in critically 
ill COVID-19 patients.
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Introduction: Rapid identification of pneumonia-causing organ-
isms is challenging in the emergency department setting. Delayed 
identification of organisms results in improper antibiotic selection 
and administration. A point-of-care, nebulized urea breath test for 
pneumonia caused by urease-producing bacteria could aid in proper 
antibiotic selection, but the safety of nebulized urea has not yet been 
established. We report initial safety outcomes and study feasibility in 
an ongoing investigation of this test. We further combine sputum and 
oropharengeal microbiome data to assess the potential utility of the 
inhaled urea breath testing.
Methods: We enrolled a pre-defined safety cohort of 15 emergency 
department subjects with radiographic and clinical evidence of 
pneumonia, and who were planned for outpatient treatment. Sub-
jects in this cohort completed inhalation of a nebulized preparation 
of 50 mg 13C-urea dissolved in 3 mL of sterile water. Breath samples 
were collected before and after inhalation of 13C-urea and analyzed 
for exhaled 13CO2. Adverse events (AEs) were recorded from time of 
enrollment until completion of telephone follow-up at 48-96 hours 
post nebulization. Exhaled 13CO2 was measured before and after 
13C-urea nebulization to calculate a normalized change from baseline. 
Student’s T-test was used to determine significance of change over 
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baseline. We further enrolled 54 subjects admitted for inpatient treat-
ment of pneumonia in a broader safety and feasibility cohort. Forty-six 
patients completed telephone follow up. Tracheal aspirate and saliva 
samples were isolated from these patients for microbiome analysis.
Results: Initially, we screened 257 subjects for the study and excluded 
242 for clinical signs of severe disease (Mild, self-limited cough 
was noted in 3 cases and nausea in one case after administration of 
13C-urea. One episode of syncope was noted but was determined to 
be an exacerbation of a pre-existing condition and not related to the 
study product. From both cohorts, eight patients were determined to 
have significantly elevated exhaled 13CO2 and were found in post-hoc 
chart review to have high suspicion for bacterial pneumonia including 
elevated procalcitonin levels or bilateral pneumonia on imaging.
Conclusion: Mild cough was common after urea administration, 
though all subjects were able to complete nebulization. There were 
no reports of clinical deterioration related to the study drug. This study 
establishes a preliminary safety profile of inhaled 13C-urea in subjects 
with pneumonia. We noted significantly elevated exhaled13CO2 in 
eight subjects and are currently analyzing sputum microbiome data to 
ascertain the potential utility of the inhaled urea breath test.
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Introduction: Introduction: Tracheostomy is a common procedure 
performed for the management of upper and lower airway conditions. 
There is evidence that secretions draining from the upper airways can 
collect on the top of the tracheostomy tube cuff and become a risk for 
tracheal aspiration resulting in infections [1]. Reports in the literature 
describes posterior tracheal wall injury from the subglottic suction 
port [2,3]. A new tracheostomy product (Voyager, Medtronic Boulder 
USA) has a suction port just above the cuff intended for evacuation of 
secretions collecting on top of the cuff. The new tracheostomy can-
nula has the suction port located in the lateral wall of the tube body. 
The purpose of this study was to characterize the suction performance 
and tracheal wall injuries in an animal model during mechanical 
ventilation.
Methods: Methods: 16 porcine underwent tracheostomy and 
received the Voyager tracheostomy tube. Eight animals (Group 1) had 
normal secretion viscosity (500centiPoise) liquid and 8 animals (Group 
2) had thick simulated mucous (5000centiPoise) liquid infused at 3 ml/
hour on top of the cuff. The subglottic space was suctioned every 15 
minutes for the 4 hour duration of the study using the subglottic suc-
tion port. The suction method was 3 cycles of 15 seconds on and 10 
seconds off at 100 cmH2O negative pressure (Ohio Medical Push-To-
Set™ Vacuum Regulator, OHIO Medical, Gurnee, USA)[4]. Fluoroscopic 
images and data collection were performed through 4 hours following 
placement of the device. At the completion, the trachea was removed 
with the Voyager tracheostomy tube in situ and the site of the suction 
lumen exposed. Changes in the tracheal wall was assessed through 
macroscopic observations and given scores of 0-4 where 0 is no injury 
and 4 is necrosis[5].
Results: Results: Both groups had equal amounts of secretions infused 
on top of the cuff, Group1 12.1 ml and Group 2 11.9 ml (p < 0.29) and in 
both groups secretion was recovered, Group1 10 ml and Group 2 8 ml 
(p < 0.33). Damage to the trachea from the suction port, Group 1 had 1 
animal scored as 2 and 3 as 1 and Group 2 had 3 animals scored as 1. 
No secretions were seen below the cuff in any Group.
Conclusion: Conclusion: There were no technical issues with the sub-
glottic suction system and the suction lumen was patent during the 
experiment. The suction performance was similar between the groups 
with slightly less recovery of the 5000centiPoise fluid as could be 
expected. Most animals in both Groups had no tracheal injury (0) or 
mild erythema (1) at the site of the suction port. One animal in Group 
1 had edema (2) at the site of the suction port. The Voyager tracheos-
tomy tube design with the suction port in the lateral wall allows for 
adequate removal of subglottic secretions. Only clinical studies will 
completely elucidate the long-term effect of the new design.
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Introduction: The city of Mulhouse, situated in the Alsace region, has 
been one of the largest European clusters of SARS-CoV-2 infection 
after a gathering of more than 2000 people during several days. The 
Groupe Hospitalier de la Région de Mulhouse Sud-Alsace (GHRMSA) 
is a hospital complex with a total capacity of 2612 beds including 20 
medical ICU beds and 16 surgical ICU beds respectively, covering the 
needs of about 480,000 people.
Objectives: The first patient was admitted in our medical ICU on 
March 2nd for severe acute respiratory syndrome and during the fol-
lowing first week 18 patients was admitted for the same reason. Our 
bed capacity was rapidly saturated. According to the occurring trend, 
quick interventions and innovations appeared to be more than essen-
tial so as to handle the expected coming tsunami.
Methods: During the first week Non - COVID -19 patients were trans-
ferred to the surgical ICU so as to admit only COVID -19 patients in our 
unit but by the end of the first week our medical ICU bed capacity was 
saturated. During the coming weeks, scheduled surgical and medical 
activities have had to be cancelled. The cardiac surgery ICU(4 beds) 
was transformed to a COVID-19 ICU, 16 additional beds were added in 
five operative and post-operative rooms and the surgical ICU was con-
verted in a sole COVID-19 ICU too. During the third week a national as 
well as an international cooperation was set up in order to transfer ICU 
patients to other cities, regions and countries by air or by train so as to 
cope with the massive influx of critical patients. Finally on the fourth 
week patients were transferred to a 30-bed field military intensive care 
hospital deployed on the hospital car park by the French military med-
ical service: l’Élément Militaire de Réanimation du Service de Santé 
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des Armées (EMRSSA). This stood as an unprecedented experience in 
France.
Results: More than 340 critically ill patients have been admitted in our 
general hospital where more than 1500 patients have been hospital-
ized up to now. More than 140 critically ill patients have been admit-
ted in our medical ICU and about 50% of them have been transferred 
to another hospital. 47 patients have been admitted in the field mili-
tary intensive care hospital deployed on the hospital car park.
Conclusion: The organization set up so as to cope with the massive 
influx of critically ill patient will stand as an unprecedented experience 
in this setting. ICU medical and non-medical staffs working hand in 
hand with other colleagues and hospital administrators so as to take 
quick decision leaving behind frontiers and barriers provided a way to 
our will.
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Introduction: A significant number of patients admitted in ICU for 
Covid-19 have had bacterial isolatesin respiratory samples. Many of 
these isolates correspond to colonizations, but other patients have-
developed bacterial superinfections during their evolution in the ICU, 
such as ventilator-associatedpneumonia (VAP). Data extracted from 
the ENVIN-HELICS registry.
Objectives: Our objective was to analyze the number of positive bron-
chial aspirates performed,the number of bronchial aspirates with a 
positive result, the rate of VAP and the most frequentmicroorganisms.
Methods: Descriptive, observational, and retrospective study of bron-
chial aspirates that wereperformed in patients admitted with Covid-
19 during the months of March to May 2020 in the ICU of athird-level 
hospital.
Results: 49 patients on mechanical ventilation were included, of 
which 36 (62%) had a bronchialaspirate culture withdrawn during 
their ICU stay. In 28 of them (77%) it was positive. In total, 90bronchial 
aspirates were performed. 74 microorganisms were isolated: 11 (15%) 
were Gram positivemicroorganisms, 35 (57%) Gram negative and 28 
(38%) fungi.
Conclusion: In patients admitted for coronavirus, the bacterial super-
infection rates have been high, probably due to the severity of the 
patients and a high rate of use of MV. Most are caused by Gramnega-
tive and fungi.
The data from our study, show us that even though we are facing a 
new virus and we are working indifferent conditions than usual, we 
should not forget the project &quot;Zero pneumonia&quot; as pre-
vention ofVAP.
001592 
Cardiovascular events after community‑acquired pneumonia: 
a systematic review and meta‑analysis of observational studies
A. Tralhão1; P.  Povoa2
1Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, CHLO, 
Lisbon, Portugal; 2Polyvalent intensive care unit, Hospital de São Francisco 
Xavier, CHLO, Lisbon, Portugal, Lisboa, Portugal 
Correspondence: A. Tralhão
Intensive Care Medicine Experimental 2020, 8(2): 001592
Introduction: Acute cardiovascular disease after community-acquired 
pneumonia (CAP) is a well-accepted complication for which defini-
tive treatment strategies are lacking. These complications share 
some common features but have distinct diagnostic and treatment 
approaches.
Objectives: To determine the incidence of overall and individual car-
diac complications after CAP and its impact on short-term mortality ( < 
90 days).
Methods: Systematic review of published studies (Medline) of adult 
non-immunocompromised patients with clinical and radiological evi-
dence of CAP for whom outcomes were explicitly reported, followed 
by a meta-analysis of proportions, using the double-arcsine transfor-
mation and a random-effects model. Meta-regression analysis by year 
of publication was further performed.
Results: From 1984 to November 2019, thirty-nine studies were 
accrued, involving 92,188 patients, divided by setting (inpatients ver-
sus outpatients) and clinical severity (low risk versus high risk). Over-
all cardiac complications occurred in 14% (95% confidence interval 
(CI) 9.6–19), acute coronary syndromes in 4.5% (95% CI 2.9–6.5), heart 
failure in 9.2% (95% CI 6.7–12), arrhythmias in 7.2% (95% CI 5.6–9.0) 
and stroke in 0.71% (95% CI 0.1–3.9) of pooled inpatients. During this 
period, meta-regression analysis suggests that the incidence of overall 
and individual cardiac complications is decreasing. After adjusting for 
confounders, cardiovascular events taking place after CAP indepen-
dently increase the risk for short-term mortality (range of odds-ratio: 
1.4–5.5).
Conclusion: Despite a reduction in the last decades, the incidence of 
cardiac complications after CAP remains high. Our findings highlight 
the need for efective, large trial based, preventive and therapeutic 
interventions in this important patient population.
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Introduction: Bacterial superinfections have been a very frequent 
finding in patients admitted to theICU diagnosed with COVID-19, 
some of them associated with devices, highlighting thecatheter asso-
ciated urinary tract infection (CA-UTI).
Objectives: Our objective with this abstract is to analyze the results 
of urine cultures in patientsdiagnosed with COVID-19 admitted in UCI.
Methods: Descriptive, observational, and retrospective study of 
urine cultures that werewithdrawn in patients admitted with COVID-
19, between March and May 2020 in theUCI of a third-level hospital. 
We analyze : demographic data, number of urine cultureswithdrawn, 
number of positive urine cultures, percentage of gram positive, gram-
negative and fungi and incidence density of CA-UTI.
Results: We included 60 patients, 48 (80%) were men and 12 women 
(20%), median APACHEII score 14.1 points, median age 60.47 years. In 
40 patients (68.9%) a urine culturewas withdrawn, with a total number 
of urine cultures of 77 samples. The number ofpatients with a positive 
results were 18 (31%), and the number of positives urineculture were 
22 (28.5%); negative results were 55 (71.4%). Regarding themicrobio-
logical isolates, in 5 urine cultures (22.7%) gram positives were iso-
lated, beingall of them E. faecalis. In 4 positive urine cultures (18.1%), 
gram negatives wereisolated, being all of them E. coli, 2 of wich were 
ESBL. Also striking is the highpercentage of fungal isolates, in a total of 
13 urine cultures (59%). 11 of them were C.albicans, and the remaining 
2 were C. glabrata.Of the 22 urine cultures with positive results, 14 of 
them were considered colonizationsor contaminants, while 8 of them 
were considered bacterial superinfections. The totalnumber of urinary 
catheterization days were 1118, with a total of 7.16 urinary infections-
for every 1000 days of urinary catheterization.
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Conclusion: Our study shows a high percentage of urine cultures with 
negative results. Amongpositive results, the majority of isolates have 
been considered colonization orcontamination, and not superinfec-
tion. These data can be explained by the presence ofdifferent con-
founding factors in these patients, since they are complex patients 
withhigh severity and extensive use of devicesAlthough most cultures 
are negative or contaminated, the urinary infection rate isabove the 
results obtained in other series of patients not admitted for COVID-19 
in ourunit. This reminds us that although we work in different condi-
tions than usual and witha new disease, we must not forget the pre-
vention measures of CA-UTI Zero project.
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Introduction: The coronavirus disease 2019 (COVID-19) is an emerg-
ing health threat.(1).
Sepsis, respiratory failure, acute respiratory distress syndrome, 
heart failure, and shock are commonly observed in these critically ill 
patients.(2).
Bloodstream infections (BSI) in recent pre-COVID19 studies has a 
reported rate between 3,5 and 5% (3)(4). However Xiaochen Li et al 
found a rate of BSI of 14,1% in severe COVID-19 committed patients 
from Tongji Hospital. (5).
Objectives: To describe the rate and the pathogens involved in BSI 
in critically-ill COVID-19 patients, and to explore its impact in ICU 
outcomes.
Methods: Retrospective study of all critically-ill COVID-19 patients 
admitted in the ICU in a tertiary hospital in Northern Portugal.
Primary end-points: incidence of BSI, agent identification and primary 
infection site.
Secondary end-points: association with co-morbidities and admission 
scores of organ dysfunction. Evaluation of impact of BSI on ICU length 
of stay(LOS), organ-support requirements and mortality.
Results: Between March 17th and May 10th, 36 COVID-19 patients 
were admitted to our ICU, with median APACHE II 18,0 (IQR 10,75) and 
median SAPSII 42,0 (IQR 20,5). Median LOS was 16 days (IQR 16,5). 12 
(33.3%) patients developed a BSI during ICU stay, with Klebsiella pneu-
moniae being the most frequently isolated pathogen (8,4%), followed 
by Pseudomonas aeruginosa (5,6%) and MSSA (5,6%). As for primary 
source, respiratory infection was the most frequent, accounting for 
19,4% of all cases. Overall mortality was 25% (n = 9).
Severity of comorbidities, as measured by the Charlson Comorbidity 
Index, age and gender were not associated with the occurrence of BSI. 
Higher SAPS II score at admission was significantly associated with the 
occurrence of BSI (45 vs 34; p = 0,03). Patients who developed BSI dur-
ing ICU stay had more severe respiratory insufficiency, as measured by 
the PO2/FiO2 ratio at admission (136 VS 171.5; p = 0,049).
There was no correlation in need for invasive mechanical ventilation 
or pronning maneuvers; however there was an association with longer 
duration of mechanical ventilation (p = 0,002), need for traqueostomy 
and duration of vasopressor requirement (p = 0,029). Patients with BSI 
also had longer ICU LOS (27 VS 14  days; p < 0,001). Regarding treat-
ment options, there was an association between corticoid use and BSI, 
even with low doses used for shock management.(OR 9,8; CI 95%).
There was no impact on mortality.
Conclusion: In this sample, COVID-19 patients were more susceptible 
to BSI, which resulted in greater ICU LOS and greater length of invasive 
mechanical ventilation.
Main study limitations are the sample size and retrospective nature.
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Introduction: COVID-19 infection has been characterized by respira-
tory manifestations. After the experience of the current pandemic, it 
has been shown that the profile of manifestations of this infection is 
not limited exclusively to the respiratory system.
Objectives: To analyze the gastrointestinal manifestations of COVID-
19 infection in patients.
Methods: A retrospective observational study was conducted in a 
ICU of a second level hospital. We collected demographic variables, 
severity scales on admission, comorbidities, analytical data, treat-
ment received, and mortality. Statistical analysis was performed with 
IBMâSPSS Statistics 25.
Results: 101 patients were admitted requiring transfer 26 due to the 
absence of beds in our Unit, so the sample of the present study is 
made up of 75 patients. Demographic variables, comorbidities, sever-
ity scales on admission to the ICU and treatment received are shown 
in Table 1. All were admitted with the diagnosis of severe respiratory 
failure secondary to atypical pneumonia due to SARS-CoV-2 without 
any clear digestive manifestation. The most frequent digestive compli-
cations are shown in Table 2. In the analysis by their group we found 
that age and obesity are associated with an increase risk of Ogilvie 
syndrome; those with a history of hypertension and cardiovascular 
disease more frequently developed diarrhea, lower gastrointesti-
nal bleeding (LGB) and cholestasis; and dyslipidemic patients more 
frequently developed ischemic hepatitis. Regarding the treatment 
received, the use of lopinavir/ritonavir and tocilizumab was associated 
with an increase in cases of cytolysis; corticotherapy with the develop-
ment of cytolysis and cholestasis; and interferon with constipation. It 
should be noted that in patients who developed AKI during their ICU 
admission had a higher incidence of mesenteric ischemia, ischemic 
hepatitis, LGB and cytolysis. When analyzing the inflammatory 
parameters, the determination of D-Dimer was significantly higher in 
patients with mesenteric ischemia, ischemic hepatitis and diarrhea; 
levels of IL-6 were higher in those with cytolysis, diarrhea, ischemic 
hepatitis, mesenteric ischemia, and adinamic ileus; ferritin levels in 
patients with cholestasis, LGB and ischemic hepatitis; CRP in patients 
with diarrhea and ischemic hepatitis; and finally patients with choles-
tasis and cytolysis presented more severe lymphopenia. It is relevant 
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in our sample that the patients who suffered mesenteric ischemia, 
diarrhea, cholestasis and cytolysis had a higher mortality than those 
who did not present these gastrointestinal complications.
Conclusion: Despite the fact that the reason for admission was pul-
monary involvement by SARS-CoV-2, the development of various gas-
trointestinal disorders was observed in our cohort, with an increase in 
mortality in certain cases. The development of ARF increases the risk of 
GI complications as well as the use of lopinavir/ritonavir, tocilizubam 
and corticosteroids. Inflammatory parameters can be useful to identify 
patients at risk of GI manifestations.
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Introduction: The COVID-19 pandemic continues to threaten popu-
lations across the world [1]. Delay in the diagnosis of COVID-19 can 
cause exponential harm. Lung ultrasound can quickly identify a 
COVID-19 phenotype as interstitial syndrome of the lung [2]. Com-
bined with focused echocardiogram to rule out left ventricular (LV) 
impairment as a cause, it can be used to quickly identify patients 
highly likely to have COVID-19.
Objectives: We aimed to assess a describe a system for the diagnosis 
of COVID-19 by focused heart and lung ultrasound.
Methods: We performed a prospective observational study on all 
patients admitted to a tertiary hospital Intensive Care Unit over a 
three-week period. Each patient received a point of care ultrasound 
(POCUS) scan consisting of focused echocardiogram and 6-point lung 
ultrasound (using FUSIC guided scoring system [3]). Patients were 
diagnosed with COVID-19 using two swab positive PCR. The primary 
outcome was the association between COVID-19 diagnosis and phe-
notype of COVID-19 defined by two category 2 regions on Lung ultra-
sound (interstitial syndrome) in the absence of LV impairment. We 
used fisher’s-exact test for comparison of the two groups. A p-value of 
less than 0.05 was considered significant.
Results: Of 69 patients admitted to ICU, 61 patients were eligible for 
inclusion in our study with adequate POCUS. 43 patients (70%) were 
swab positive for COVID-19, 18 were negative. 33 out of 43 (76.7%) 
swab positive patients had a positive COVID-19 phenotype on focused 
ultrasound, 10 /43 (23.3%) did not. 16 /18 (88.9%) swab negative 
patients had a negative COVID 19 phenotype on focused ultrasound, 
2/18 (11.1%) had a positive phenotype. P-value  =  0.000002. Area 
under the Curve 0.83 (CI 0.71 – 0.94). Accuracy 0.8 (0.71 – 0.91). Posi-
tive Predictive value 0.94 (0.81 – 0.98). Negative Predictive Value 0.62 
(0.43 – 0.78). Likelihood ratio of 6.91 (CI 1.85 – 25.8).
Conclusion: Focused lung ultrasound is highly predictive of COVID-
19 when looking for Interstitial syndrome of the lung and excluding 
patients with LV failure.
Reference(s) and grant ackowledgment(s)
1. European Centre for Disease Prevention and Control.
2. Focused Ultrasound in Intensive Care (FUSIC): FUSIC COVID info [internet]. 
London: Intensive Care Society Available from: https ://www.ics.ac.uk/ICS/
Pdfs/FUSIC _DOCS/FUSIC _COVID 19_info.aspx.
3. S. Kulkarni ‘Point‑of‑care lung ultrasound in intensive care during 
the COVID‑19 pandemic’ Clinical Radiology 13 May 2020. https ://doi.
org/10.1016/j.crad.2020.05.001.
001627 
Thrombocytosis in COVID‑19 patients admitted to the ICU
M.  Fazzi1; M.  Nijsten1
1Department of critical care, University Medical Center Groningen, Gron‑
ingen, Netherlands 
Correspondence: M. Nijsten
Intensive Care Medicine Experimental 2020, 8(2): 001627
Introduction: Some of the most severe aspects of COVID-19 may 
be related to expression of interleukin-6 (IL-6). IL-6 is a key media-
tor of thrombopoiesis and thrombocytosis in acute and chronic 
inflammation [1]. COVID-19 patients may thus manifest IL-6 induced 
thrombocytosis.
Objectives: Examine the time course of platelet counts (PLC) in a 
cohort of COVID-19 patients admitted to our ICU and compare this 
time course with that of non-COVID ICU-survivors and non-survivors 
from a large published cohort [2]. Since COVID-19 patients have rela-
tively long ICU-stays we used only non-COVID patients with an ICU-
stay of ≥14 days.
Methods: Over the first 30 ICU days median daily PLC in COVID-19 
patients were compared with non-COVID hospital survivors and non-
COVID hospital non-survivors.
Results: A total of 90 COVID-19 patients were compared with 2682 
non-COVID-19 ICU-survivors (S) and 1149 non-COVID-19 non-survi-
vors (NS) who had an ICU-stay of ≥14 days. A total of 89,000 PLC were 
analyzed. Median PLC in COVID-19 patients followed a markedly dif-
ferent time course from both S and NS non-COVID patients. COVID-19 
patients had a higher PLC at admission: 295  109/L vs 175  109/L and 172 
 109/L in S and NS respectively (P < 0.001). Subsequently the nadir in 
PLC observed between ICU day 1 and 5 in S and NS alike was absent 
in COVID-19 patients. The rise in PLC observed in non-COVID-19 dur-
ing the second ICU week was also observed in COVID-19 patients, 
although the maximal PLC in COVID-19 patients was higher: 486 
 109/Lcompared to 366  109/Land 249  109/L in S and NS respectively 
(P < 0.001). In contrast to S and NS non-COVID patients, even after 
30  days median PLC was still above the reference range (150 to 350 
 109/L) in COVID-19 patients.
Conclusion: COVID-19 patients display a pronounced thrombocytosis 
during the first ICU month compatible with the thrombopoietic action 
of IL-6. Ongoing trials with IL-6 receptor inhibitors in may establish the 
causality of IL-6 in thrombocytosis in COVID-19 patients.
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Introduction: COVID-19 patients display several responses related to 
severe and sustained inflammation. Interleukin-6 (IL-6) is considered 
to be a key mediator among the cytokines released during COVID-19. 
One of the actions of IL-6 is the stimulation of polyclonal immunoglob-
ulin production by B-cells [1].
Objectives: Analyze the secondary components of the acute phase 
response as can be derived from routine laboratory measurements. 
Over a 1 month period we compared the time course of albumin, total 
protein and fibrinogen in COVID-19 patients with that observed in 
non-COVID ICU patients. We also specifically looked at the difference 
between total protein and albumin as a reflection of the (immuno-)
globulin fraction.
Methods: From a large database of ICU-patients and laboratory data 
built in our center for the ICU-Labome study [2], we selected only 
patients with a prolonged ICU-stay (i.e. ≥14  days). This was done for 
better comparison with the COVID-19 patients who tend to have rela-
tively long ICU stays. We compared COVID-19 patients (C) with non-
COVID hospital survivors (nC-S) and non-COVID non-survivors (nC-NS). 
All available fibrinogen, albumin and total protein levels were ana-
lyzed. To estimate the non-albumin proteins, albumin was subtracted 
from total protein. Median levels are reported and comparisons were 
performed with non-parametric tests.
Results: The nC-S and nC-NS groups consisted of 2682 and 1149 
patients respectively. These were compared with 90 COVID-19 ICU 
patients treated till May 2020. 3400 and 129,000 laboratory measure-
ments were used. At ICU-admission, fibrinogen levels were already 
considerably higher (P < 0.001) in COVID-19 patients: 7.6  g/L com-
pared with 2.5 and 2.9  g/L in nC-S and nC-NS. Only after 2  weeks of 
ICU admission fibrinogen in COVID had decreased to levels similar to 
S and NS. The time course of albumin in COVID-19 patients was simi-
lar to that nC-S. Total protein levels were much higher at admission 
in COVID-19 than either nC-S and nC-NS (P < 0.001), with admission 
levels of 61  g/L vs 50 and 50  g/L respectively, with only limited sub-
sequent changes. The estimated non-albumin fraction at admission in 
COVID-19 was 34 g/L compared to 23 and 25 g/L in nC-S and nC-NS 
(P < 0.001). The estimated non-albumin fraction stayed 9 to 10  g/L 
higher than nC-S and nC-NS over the observation period (P < 0.001) 
and rose to 40 g/L at day 30.
Conclusion: In addition to the well-described components of the 
acute phase response in COVID-19 such as elevated CRP and fibrino-
gen, there is a pronounced and sustained rise in total protein that 
points to the production of other acute phase proteins or gamma-
globulins. This response is markedly different from that seen in other 
critically ill patients. Ongoing trials with IL-6 receptor inhibitors may 
indicate if IL-6 responsible for these peculiar reactions.
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Introduction: In December 2019, the first cases of respiratory pathol-
ogy (COVID-19) caused by the new coronavirus (SARS-CoV-2) were 
reported in Wuhan. Since then, COVID-19 has spread exponentially 
throughout the world, having been recognized by the World Health 
Organization (WHO) as an international public health emergency on 
January 30, 2020. On March 11, 2020, the WHO has officially declared 
the COVID-19 pandemic.
In our country the first case of COVID-19 was confirmed on March 2, 
with causalities starting on March 18.
The differences between countries or different Intensive Care Units 
(ICU) are still under investigation for the disparities in regional admis-
sions and the severity of illness. This illustrates how natural evolution 
of COVID-19 and its prognosis are still not fully understood.
Conscient that there is an important impact of public health restric-
tion and confinement in local evolution and transmission, there is rel-
evancy in mentioning that National Emergency State was declared on 
March 18, and a national calamity on May 3, resulting in closure of not 
essential public stores.
There was an adjustment of our ICU organization, with the creation of 
a separate cohort, named COVID ICU exclusively dedicated to these 
patients.
Objectives: Characterization of the population of patients infected 
with SARS-Cov-2 admitted to Intensive Care Unit at a university affili-
ated hospital, during the COVID-19 pandemic. Analysis of a district 
hospital experience during an outbreak (from preparation to the 
results).
Methods: This is a retrospective and descriptive study that includes 
only data from the usual clinical practice. All positive COVID-19 
patients admitted to the ICU from March 2, 2020 to June 26 were 
included. Patients were followed from admission to discharge from the 
ICU.
Results: Over the last 3 months, coincidentally with the national spike 
and the so-called ”first wave” of cases, there was an adjustment of the 
ICU organization, with the creation of a separate cohort exclusively 
dedicated to this patients.
With a total of 169 patients admitted to our hospital, we had 13 admis-
sions (12 patients, but one readmitted).
The mean age of the patients was 74 years, and 66.6% were men. Of 
the 12 patients, 2 had no symptoms but had known risk contact and 
presented with silent hypoxemia. Length of stay varied from 1 to 
25 days.
Laboratory results showed the usual highly elevated c- reactive Pro-
tein levels and lactate dehydrogenase.
At admission, patients had a mean PaO2/FiO2 ratio of 169, with a mini-
mum of 52. Five had mechanical ventilation since the admission with 
an average of 14 days of ventilation.
Patients who developed an ARDS (5 patients) were treated according 
to the recommendations.
All patients were treated with hydroxychloroquine following the rec-
ommendations in force until the hospitalization.
Four of the 12 patients didn’t survive (33.3%).
Conclusion: The pandemic has tested public health measures as the 
functioning and responsiveness of health services worldwide. The 
ICUs, in the role of manager of the critical patient, have a particularly 
important role in the approach of these patients considering the risk 
of flooding ICU during outbursts, and the consciousness that inten-
sive care support is crucial for the surviving of severe cases. The lack of 
knowledge and the limit of resources are factors of added difficulty in 
the approach of patients with COVID -19. The variability between cent-
ers is still not understood. The lack of evidence has originated different 
strategies around the world.
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Introduction: Fluid bolus therapy (FBT) is our most common ICU 
intervention [1], however there is little agreement on when and how 
this therapy should be used. FBT is often needed to maintain organ 
perfusion, but excess fluid has been associated with increased long-
term morbidity [2-5]. Also, there are indications that the response to 
fluid is usually smaller than anticipated [6, 7]. What triggers are used 
and what would constitute a significant response vary. Therefore, 
we conducted a prospective clinical trial in Sweden and Australia to 
describe accuracy and precision of clinical expectation compared to 
actual response to FBT.
Objectives: To describe the accuracy and precision of clinicians’ 
expectations of the hemodynamic effect of fluid boluses (FB) on physi-
ological variables at completion of a FB and after one hour. . To inves-
tigate triggers for FBT and to what extent clinicians’ expectations are 
met.
Methods: We evaluated 77 ICU patients at Austin Hospital, Melbourne 
Australia and Södersjukhuset, Stockholm Sweden. Patients were 
included if they were planned to receive a FB of ≥250 ml of resuscita-
tion fluid over ≤30 minutes. The treating physician then completed a 
questionnaire asking for primary and secondary triggers for FBT from a 
list. Also, they were asked what physiological responses to the FB they 
expected at the end of the FB and one hour later.
Clinicians’ responses were then compared to the measured values 
at these time-points. Data was collected directly from the electroni-
cal monitoring systems and the electronic medical records regarding 
physiological variables, lab values etc. Levels of vasopressors and seda-
tion was collected to statically correct for these.
Results: 18 patients were recruited in Australia and 59 in Sweden. 46 
were males and 31 females. Mean SOFA score was 8.2. Mean bolus 
size (SD) was 352.0 ml (107.6) over 22 minutes (11.8). 57.1% of boluses 
were Ringer´s Acetate and 42.9% Albumin 40-50 g/L. 54.5% of patients 
had infusions of noradrenaline and 37.7% had infusions of propofol.
Hypotension was the most common trigger for a FB (46.8%), followed 
by poor urine output (20.8%). The most common secondary triggers 
for a FB were tachycardia and poor urine output (each 16.9%).
At the end of the FB, 25% of expectations were within 10% of meas-
ured mean arterial pressure (MAP), and 52.1% within 10% of measured 
heart rate (HR).
One hour later, 37.5% of expectations were within 10% of measured 
MAP, and 39.2% within 10% of measured HR, and 8% of expectations 
were within 10% of measured urine output.
The mean difference between expected and measured MAP (SD) was 
9.1 mmHg (8.7), the difference in HR (SD) 7.1 bpm (8.9), the difference 
in urine output (SD) 44 ml (52.6) and the difference in cardiac index (CI) 
(SD) 0.32 (0.30) at the end of the bolus.
33% of patients had an increase in MAP>10% at the end of a fluid 
bolus, and 29.3% at 1 h, whereas only 13% had an increase in CI> 10% 
at end of bolus but 45.5% after 1  h and 6.6% had a decrease in HR 
>10% at end of bolus and 10.4% after 1 h.
Correction for levels of sedation or pressors led to no significant 
change of these values.
Conclusion: The most common reasons for administering a FB was to 
improve MAP and urine output, followed by resolving tachycardia. Cli-
nicians’ expectations were only accurate in 25-51% of cases and were 
often not met, with a mean difference of 9 mmHg between expected 
and measured MAP. Further research might be needed into how FBs 
are used in the ICU and what expectations we have of them, so that we 
might choose to use them more judiciously.
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Introduction: Severe Acute Respiratory Syndrome Coronavi-
rus 2 (SARS-CoV-2) has spread across the globe. Among infected 
patients,causes mild respiratory disease in most have a mild disease 
course, however a significant minority require hospitalisation. with 
Of those hospitalised, between 5-15% of those in hospital requiringe 
admission to the intensive care unit (ICU)1.
Secondary infection is well described in ICU patients with other viral 
respiratory illnesses such as influenza2, Severe Acute Respiratory Syn-
drome (SARS)3 and Middle East Respiratory Syndrome (MERS) 4, and 
may lead to increased mortality. Although data is limited, it is likely 
that SARS-CoV-2 predisposes to co-infection. ICU admission and organ 
support such as mechanical ventilation are risk factors for infection, 
independent of COVID-19. Furthermore, many established pre-morbid 
conditions such as diabetes mellitus and obesity which pre-dispose to 
co-infection in ICU have also been described as risk factors for severe 
SARS-CoV-2 disease1. Finally, patients with severe COVID-19 appear to 
have significant immune dysregulation, with lymphopaenia, abnor-
mal levels of inflammatory cytokines and features of T cell immune 
“exhaustion”5. This abnormal immune response and associated lung 
damage can may leave patients vulnerable to bacterial proliferation.
Objectives: 1. Characterisation of the co-infections in SARS-CoV-2 
patients admitted to Tallaght Hospital ICU.
2. Description of the effect of co-infection on patient outcomes.
Methods: This is a single centre retrospective observational study of 
patients admitted to a single ICU with COVID-19 from January to June 
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2020. Patients were followed until discharge from ICU. Patient demo-
graphics, microbiology, clinical/pharmacological treatment were 
recorded until discharge from ICU. The primary analysis compared 
patients with bacterial co-infection to those without. recorded from 
paper and electronic chartCo-infection was defined as any positive 
bacterial culture during ICU admission requiring antimicrobial treat-
ment. Proportions and continuous variables were compared using 
Fisher’s exact test and independent samples t testing respectively.
Results: Twenty-five patients were admitted during the study period. 
Thirteen (52%) developed co-infection. Baseline demographics and 
co-morbidities were similar between patientsgroups. Organism’s iden-
tified as co-infections are detailed in Table  1. A highly resistant ESBL 
producing Klebsiella pneumoniae was isolated in 3 patients. Staphylo-
coccus aureus pneumonia was identified in the respiratory tract of 3 
patients. Two patients who underwent prolonged mechanical venti-
lation developed Stenotrophomonas maltophila. MRSA and VRE were 
identified in 3 and 2 patients respectively. There were no cases of C. 
difficile colitis, despite extensive use of empiric cephalosporins (68%)
amongst the patients. Patients who developed co-infection spent a 
significantly longer time mechanically ventilated and on vasopressor 
therapy than those who did not. ICU length of stay was also prolonged 
in co-infected patients (Table 2).
Conclusion: Co-infection increases duration of mechanical ventilation, 
ICU stay and vasopressor dependence in ICU patients with COVID-19.
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Introduction: Septic cardiomyopathy is a serious complication in 
the course of sepsis. A prognostic association between patients who, 
in the context of impaired cardiac contractility, maintain increased 
diastolic volumes has been described by different authors. Further-
more, the emergence of various minimally invasive technologies has 
allowed access to different indicators of hemodynamic status that 
have become relevant in recent years.
Objectives: The objective of our work was to determine if the global 
final diastolic volume (VDFG) and the global ejection fraction (FEG) 
could be associated with a worse prognosis in septic patients with 
hemodynamic failure, and if the association between systolic dysfunc-
tion due to septic cardiomyopathy and dilatation of cardiac chambers 
had a better prognosis in that population.
Methods: Aperture measurement was included retrospectively for all 
patients requiring minimally invasive hemodynamic monitoring using 
the transpulmonary thermodilution technique with the Ed 1000 EV 
equipment.
Age, sex, height, weight, Apache II, SOFA, diagnosis, cardiac index, 
indexed global final diastolic volume, indexed systolic volume, 
extravascular pulmonary water index, pulmonary vascular permeabil-
ity index, central venous pressure, variability of systolic volume were 
measured, index of indexed systemic vascular resistance, mean arte-
rial pressure, heart rate. The patients were subsequently classified into 
patients with impaired contractility and increased or decreased dias-
tolic volumes.
A univariate analysis was performed with the student t test for con-
tinuous variables and  chi2 for categorical variables. Subsequently, the 
variables were included in a multivariate analysis to test their associa-
tion with mortality.
Results: After multivariate analysis, the only factor that was indepen-
dently associated with mortality was overall final diastolic volume. 
Those patients had no associated contractility disorders.
Conclusion: In this cohort of critically ill patients with shock and multi-
organ failure, the only independent predictor associated with mortal-
ity was the index global final diastolic volume. Patients with high end 
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diastolic volumes were more likely to survive, although this was not 
related to disorders of cardiac contractility.
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Introduction: The use of intravenous immunoglobulins (IVIG) as 
adjunctive therapy for the treatment of infections, and particularly 
pneumonia, is controversial but there is less controversy for intrave-
nous vitamin C (IVvit-C) associated with antibiotics to treat sepsis since 
the study of Fowler et al. published in JAMA 2019. However, we never 
observed in the literature the combination of IVIG and IVvit-C for treat-
ment of severe sepsis or community acquired pneumonia.
Objectives: So the objective of our study was to assess the admin-
istration of IVIG and IVvit-C in patients with severe community 
acquired pneumonia and to evaluate the effectiveness of this asso-
ciation in terms of outcome including morbidity and mortality. So, we 
hypothesized that the combination of IVIG and IVvit-C would be more 
effective than IVIG alone or placebo.
Methods: We conducted a prospective observational study from 
march 2018 to march 2020 and enrolled a total of 45 patients suffer-
ing of severe hypoxemic community acquired pneumonia and under 
invasive mechanical ventilation(IMV) . They were 60+-13 years old and 
presented the same apache II score .All the patients received the first 
of dose of antibiotics in the emergency room and were infused with 
norepinephrine .We randomized the patients in 3 groups.
A first group of 15 patients receiving IVIG 1 g /kg the first day, 0.5 g/kg 
the next two days and IV-vitC 50 mg/kg/6 h during 96 h, administered 
2 hours after the first dose of IVIG.
A second group of 15 patients receiving immunoglobulins alone at the 
same dose as previously described.
And finally a third group receiving placebo alone .We performed a 
blood level of vit-C and immunoglobulins(IG) at 96  h in each group. 
We recorded for each group: SOFA score day1 and day4, duration of 
vasopressors, duration of invasive mechanical ventilation (IMV), ICU 
stay, dosage of immunoglobulins and vit-C and finally ICU mortality.
Results: Statistical analysis was performed using Student ‘s t test. 
Results were expressed as mean +- standard deviation.
SOFA score day1 was not different between the 3 groups and calcu-
lated at 4 but SOFA score day4 was, respectively,in the IVIG-vitC group 
significantly lower than in the IVIG group and placebo group(4.53-
+0.74 vs 7.33+-0.72 vs 12.13+-0.74)p < 0.0001. Similarly, duration of 
IMV was respectively shorter in IVIG-vitC group than in IVIG and pla-
cebo groups. (6.76+-0.71vs9.86+-0.29vs12.73+-0.59) p < 0.0001. Dura-
tion of vasopressors(days) was shorter respectively in IVIG-vitC group 
than IVIG and placebo group (1.96+-0.12vs 3.03+-0.22vs5.06+-0.17) 
p < 0.001. ICU length of stay was also shorter in IVIG-vit-C group than 
in IVIG and placebo groups. (11.93+-0.45vs15.86+-0.51vs19.73+-0.7) 
p < 0.0001. Blood levels of immunoglobulins at 96  h were obviously 
and respectively lower in the placebo group than in the IVIG-vitC 
and IVIG group(4.99  g/l+-0.63 vs14.66  g/l +-0.89 vs 14,8  g/l+-0.86) 
P < 0.0001.Blood levels of vit C were low in the 3 groups before admin-
istration (99 µmol/l+-2.2) and reach at 96 h a value of 703 µmol/l+-3.2 
in the IVIG-vitC-group. ICU mortality was significantly lower in the 
IVIG-vit-C group than in the IVIG group and placebo group, respec-
tively 26%, 40% and 66%.
Conclusion: The administration of high dose of IVIG combined with IV 
vit-C improved SOFA score day4 increases the ventilator free days, ICU 
free days, and decreases ICU mortality compared with immunoglobu-
lins alone or placebo. Early infusion of this therapeutic associated with 
antibiotics for the treatment of severe community acquired pneumo-
nia improves outcome. A large Randomized Controlled Trial is needed 
to confirm these preliminary results.
Reference(s) and grant ackowledgment(s)
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Introduction: To study the evolution and mortality of postsurgical 
bacteremia due to Acinetobacter baumannii resistant to carbapenems 
and sensitive to colistin in the critically ill patient.
Methods: Retrospective, multicenter cohort study. We analyze post-
surgical patients (previous surgery 30  days) who had monomicrobial 
bacteremia due to Acinetobacter baumannii carbapenemas resistant 
and sensitive-colistin. We use logistic regression for multivariate analy-
sis. The main variable was mortality on day 14 and 30 after the diagno-
sis of bacteremia.
Results: Of the total of patients, 41 (35%) presented postoperative 
bacteremia detected during the study time, 61% men with a mean 
age of 61  ±  11, APACHE II at admission 23  ±  9 and Charlson index 
3  ±  2. This type of Bacteremia was more frequent in patients under-
going abdominal surgery: 18 patients (44%). Bacteremia appeared 
on day +12 after initial surgery (8 vs. 26). Most frequent comorbidi-
ties: diabetes mellitus 15 (36%) and chronic kidney failure 8 (20%). The 
most frequent type of bacteremia was secondary (33/41): pneumonia 
associated with mechanical ventilation 49% (20/41) and peritonitis 
32% (13/41). 71% of the patients presented septic shock. In this group 
of patients, 29 required renal replacement therapy. The treatment 
administered was: monotherapy with colistin 73% (30/41) and com-
bination therapy with tigecycline-colistin in 27% (11/41). Mortality at 
14 days was 32% (13/41) and at 30 days it was 63% (26/41). There is no 
statistically significant difference between mortality in postoperative 
bacteremia and non-postoperative bacteremia.
Conclusion: Post-surgical bacteremia in our patients is similar with 
that of non-postoperative bacteremia. Empirical treatment with 
colistin did not reduce 30-day mortality after this type of bacteremia. 
Mortality at day 14 and day 30 is similar to that which occurs in non-
postoperative bacteremia.
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Introduction: Ventilator-associated pneumonia (VAP) is a serious 
complication in critically ill patients. The usual etiology of these pneu-
monias is usually similar in the same complexity units.
Objectives: To determine whether the isolates in pneumonia that 
were observed in the following 72  h after an episode of orotracheal 
tube (OTT) obstruction directly compared to those common in VAP.
Methods: Single-center retrospective study. Patients with con-
firmed SARS-COV 2 pneumonia (COVID-19) who required mechani-
cal ventilation (VM) for more than 48 hours from March 6 to May 6 in 
the Intensive Care Unit (ICU) in a medium complexity hospital. The 
microbiological isolates of those patients who required one or more 
changes of OTT and developed a VAP in the following 72  h were 
recognized.
Results: 47 patients were included. Two patients who died in the 
first 36 hours of admission with bacterial pneumonia associated with 
SARS-VOC 2 were excluded. The mean age was 61.7 years, 35 (74.4%) 
men and 12 (25.5%) women. The average APACHE 2 was 15, the aver-
age SAPS 2 was 35.6. 60% of patients affected a VAP in the following 
72 hours. The isolates found were Enterobacter 5 (29.4%), E. faecalis 3 
(17.6%), methicillin sensitive S. aureus 3 (17.6%), methicillin resistant S. 
aureus (MRSA) 2 (11.8%), Pseudomonas aeruginosa 2 (11.8%), Candida 
spp 1 (5.9%), Others 1 (5.9%).
Conclusion: The development of VAP in the first 72 hours after OTT 
obstruction has been a frequent finding in COVID patients. The most 
frequently isolated microorganism was Enterobacter with a higher 
percentage than that found in published series, followed by E. fae-
calis, which also has a higher than expected presence. Germs more 
commonly related to VAP, such as Pseudomonas and SAMR, have pre-
sented in the usual proportions for patients intubated in the ICU.
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Introduction: Positive culture of the heart valve could be associated 
with severity and condition worse prognosis of the disease.
Objectives: To assess if surgical patients with endocarditis and micro-
biological isolation in the infected valve, present any clinical or evolu-
tive differences from the others patients.
Methods: We evaluated endocarditis patients from two hospital cent-
ers (Fundación Jimenez Diaz and Hospital Rey Juan Carlos in Madrid) 
operated by the same surgical team between 2010 and 2019.
Patients were divided in two groups according to the microbiological 
findings in the infected valve: GROUP 1 with a negative culture (NC) 
and GROUP 2 with a positive culture (PC). Any value of p  < 0.05 is con-
sidered significant.
Results: 103 patients were included, 30 with PC (29.4%).
Comparing the groups (NC vs PC) we observe:
Personal history: alcohol-drugs (2.8% vs. 6.7%; p  =  0.357), mellitus 
diabetes (27.8% vs. 43.3%; p  =  0.126), arterial hypertension (54.2% vs. 
66.7%; p  =  0.244), dyslipidemia (43.1% vs. 63.3%; p  =  0.062), COPD 
(9.7% vs. 23.3%; p  =  0.069), renal failure (26.4% vs. 56, 7%; p  =  0.004), 
previous cardiac surgery (31.9% vs 46.7%; p  =  0.159), paroxistic atrial 
fibrillation (4.2% vs 13.3%, p  =  0.095) permanent Atrial fibrillation (23, 
6% vs. 13.3%; p  =  0.242), coronary artery disease (8.3% vs. 13.3%; p  = 
0.439), cardiogenic shock (12.5%  vs. 16.7%; p  =  0.577), recent uro-
logical handling (2.8% vs. 13.3%; p  =  0.039), cancer (0 vs. 6.7%; p  = 
0.027), bicuspid valve (12.5%  vs. 3.3%; p  =  0.156).
Disease data: vegetations> 15  mm (19.4% vs 31%; p  =  0.213), pre-
intervention antibiotic time (10.36  ±  9.90 vs 8.56  ±  8.38  days; p  = 
0.386), Logistic EUROSCORE II (29.20  ±  22.45 vs 35.56  ±  19.38; p  = 
0.178) and type of surgery (mitral valve 38.9% vs 33.3%, aortic valve 
30.6% vs 43.3%, mitral and aortic valve (22.2% vs. 13.3%); p  =  0.551).
Evolutive data: intubation time (189.86  ±  1047.94 vs 187.40  ±  365.55 
(hours); p  =   < 0.001), ICU stay time (6.61  ±  10.59 vs 12.76  ±  16, 
26  days; p  =  0.026), tracheostomy (8.3% vs. 16.7%), pleural effusion 
(4.2% vs. 10%; p  =  0.254), reoperation because bleeding (5.6% vs. 
13.3%; p  =  0.183), postcardiotomy shock (0 vs 6.7%; p  =  0.027), renal 
failure (26.4% vs 40%; p  =  0.173), lower gastrointestinal bleeding (0 vs 
10%; p  =  0.006), liver failure (1.4% vs. 10%; p  =  0.041), polyneuropa-
thy (1.4% vs. 16.7%; p  =  0.003), pericarditis (0 vs. 6.7%; p  =  0.027) and 
state of death at hospital discharge (13.9% vs. 16.7%; p  =  0.718).
Conclusion: Patients with positive culture in infected valve have 
higher incidence of Renal failure, recent urological handling and pre-
vious cancer. They present longer intubation and ICU stay times and 
more complications: cardiogenic shock, upper gastrointestinal bleed-
ing, liver failure, severe polyneuropathy, and postoperative pericardi-
tis. However, we did not find significant differences before surgery or 
in mortality at hospital discharge.
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Introduction: To evaluate the influence of the age and multiorganic 
fail of patients at themoment of being admitted at the ICU for corona-
virus on the mortality.
Methods: Prospective cohort study of patients with coronavirus 
admitted to the ICU at theHospital Universitario de Jaén, Hospital San 
Agustín de Linares and the HospitalInfanta Margarita de Cabra.Contin-
uous variables are expressed as median (25th percentile, 75th percen-
tile) andqualitative variables with absolute and relative frequencies. U 
Mann Whitney was usedfor comparison of continuous variables and 
X2 for qualitative variables. P &lt;0.05 wasconsidered as statistically 
significant (s.s.).
Results: We have studied 63 admitted patients AT ICU by coronavirus 
INFECTION, 44 of them to theJaén hospital ICU, 11 at Cabra hospital 
and 8 at Linares hospital. The average age was 58 (37,62). The evalu-
ated severity with APACHE II was 12 (9,17) pointsand the same evalu-
ation but using SOFA was 6 (4,8) points at the first day. 63,5% (n = 40)
required tracheal intubation on their first day and 82,5% (n = 52) dur-
ing the entire ICU stay.Mortality in the ICU was a percent of 38 mean-
while in the hospital was 39,7Those patients who deceased were older 
than the survivors, 64 (60,72) vs 60 (52,70) years old,but the differences 
weren’t statistically significant (s.s) (p = 0.16.). These ones also showed 
mostacutely according to Apache II, 18 (14,23) vs 14 (12,18) points (p < 
0,005), and a higher SOFA atthe admission 7 (4,8) vs 6 (3,8) points, but 
without being statistically significant (p = 0.09).
Later, we classified the severity evaluated with the SOFA and age in 
intervals for a betterevaluation of the relation of both variables with 
age and in suspicion that the relation was notlinear.Patients were 
classified according to the SOFA upon admission as 7 or more points 
(n  =  32,51.6%) and another group if it was less than 7 points (n  =  30, 
48.4%). In the 32 patients withSOFA at admission of less than 7 points, 
9 died (28.1%) and in the 30 with SOFA of 7 or morepoints, 16 died 
(53.3%) (p  =  0.043).
The patients were classified according to the age, over 60 years (n  = 
40, 64.5%) or less or equalto 60  years (n  =  22, 35.5%). Mortality in 
those over 60 years old was higher, 47.5% vs. 27.3%but the differences 
were not s.s. (p  =  0.12). Then, the influence of the age on mortality 
was analyzed according to the severity evaluatedwith the SOFA at 
admission. And it was observed that the mortality of patients with 
SOFA of 7or more points was high in the two age groups, 55.6% of 
9 patients aged 60  years or youngerand 52.4% of 21 with ages over 
60 years, without s.s. differencesThen the influence of the age to the 
mortality.
Nevertheless, in patients with less severity (SOFA lower than 7 
points) mortality was high inthose who were older than 60 years old 
(42.18% of 119 patients) but in youth people wasmuch lower (7.7% 
of 13 patients) (p = 0.033).SOFA of the 13 patients with SOFA less 
than 7 points and age less than or equal to 60  yearswas (2 points: 
15.4%, 3 points:30.8%, 4 points:30.8% and 6 points:23.1%) and 69.2% 
requiredintubation.
Conclusion: In ICU patients admitted for coronavirus infection, the 
ICU evaluation of SOFAand age allows identification of a group of 
patients with lower mortality than the rest. They arealso those with 
low SOFA (less than 7 points) and age less than or equal to 60 years. 
Mortalityin this group was less than 10% in our series. In the rest of 
the patient groups, with high SOFAregardless of age and low SOFA but 
with age over 60 years, mortality is much higher than theaforemen-
tioned group.
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Introduction: Albumin is known to be associated with outcomes 
in critically ill patients, but the use of human albumin solution (HAS) 
has a less clear role. As a mortality benefit has not been demonstrated 
in large clinical trials, HAS is currently reserved for particular patient 
cohorts and otherwise its use remains clinician dependent.
We have previously described 7-day trends of serum albumin in septic 
and non-septic critically ill patients [1]. In this study we aimed to evalu-
ate the use of human albumin solution (HAS) in the same population, 
and to assess the effect of HAS administration on outcomes.
Methods: We retrospectively assessed the records of 755 patients 
admitted to the Royal Liverpool University Hospital Intensive Care Unit 
(ICU) between 2008 and 2014, who had seven days of albumin data 
available. Sepsis was identified in 513 patients (67.9%) of patients. The 
overall mortality rate at day 28 was 20.3%. We collected demographic 
data, including age, sex and APACHE II scores, 28 day mortality rates. 
We also noted the degree of hypoalbuminaemia during the first 7 days 
of ICU admission, and the first day patients received HAS. IBM SPSS 
25.0 was used for statistical analysis; X2 tests or Fisher’s Exact test were 
used for categorical data, and Student’s t-test or Mann-Whitney U test 
were used for continuous variables.
Results: Data for HAS administration was available for 719 of the 755 
patients. 64 patients received HAS (8.9%). 4.4% (10/226) of non-septic 
patients and 11% (54/493) of septic patients received HAS. Amongst 
septic patients, HAS was more commonly administered to patients 
with albumin levels  < 20 g/L (47 patients, 87.0% vs 7 patients, 13.0% of 
patients with serum albumin 20-34 g/L, p = 0.001); and most patients 
were given HAS during the first 4 days of their admission (43 patients, 
79.6%). There was no significant difference in APACHE II score or age 
between septic patients who did or did not receive HAS, but there 
was a difference in the minimum albumin level, which was lower in 
patients who received HAS (p < 0.01). We found higher mortality rates 
amongst septic patients who received HAS compared to those who 
did not (p = 0.006).
Conclusion: We found that septic patients were more likely to receive 
HAS than non-septic patients; and the majority of septic patients 
received HAS during the first 4  days of their ICU admission. Higher 
mortality rates were noted amongst septic patients receiving HAS in 
our study, though they also had lower minimum levels of albumin. 
More research is required for the development of evidence-based 
recommendations to guide HAS administration to septic critically ill 
patients during the resuscitative and de-resuscitative phases of their 
ICU admission.
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Introduction: Septic shock is a well-known clinical condition associ-
ated to high mortality rate and impaired quality of life. Some stud-
ies showed that age, comorbidities, functional status and the type 
of pathogen may affect the prognosis of septic patients1. Although 
many studies have examined short-term outcomes in septic shock, 
long-term outcomes in this field have been poorly investigated in the 
literature.
Objectives: We hypothesized that septic shock patients show poor 
long-term outcomes such as high rates of mortality, hospital readmis-
sion and condition of frailty at the discharge.
Methods: We performed a retrospective analysis, reviewing all 
patients admitted for septic shock in our Intermediate Care Unit 
(IMCU) from January 1st 2016 to December 31th 2019. The inclusion 
criteria were age ≥ 18 years old; diagnosis at IMCU admission of sep-
tic shock (according to SEPSIS-3 criteria) requiring norepinephrine (or 
other vasopressors) for 24 hours at least. We collected demographic 
Page 565 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
characteristics and we evaluated long-term outcomes such as rates of 
mortality at 28 days, 6 months and 1 year; rate of hospital readmission 
in the first year and condition of frailty at the first discharge from the 
hospital (i.e. rate of bedridden patients; pressure ulcers; percutaneous 
endoscopic gastrostomy/nasogastric tube; urinary catheter).
Results: We reviewed 113 patients and 79/113 respected the inclusion 
criteria. Demographic characteristics are shown in the Table  1. 39/79 
(49,4%) patients died at 28  days from the hospital admission; other 
18/79 (22,8%) patients died at 6 month while a single patient died at 
1 year (see Figure 1). Total mortality rate at 1 year was 59/79 (73,4%) 
patients. We found a total of 17 hospital readmissions (8/17 in Inten-
sive Care Unit; 4/17 in IMCU; 5/17 in general wards). About condition 
of frailty, 3/79 (3,8%) patients showed percutaneous endoscopic gas-
trostomy/nasogastric tube; 29/79 (36,7%) showed urinary catheter; 
10/79 (12,7%) showed pressure ulcers; 27/79 (34,1%) patients were 
bedridden.
Conclusion: In our observational study, septic shock patients showed 
poor long-term outcomes with high rates of mortality, hospital read-
mission and condition of frailty at the discharge.
Reference(s) and grant ackowledgment(s)
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in patients admitted with severe infection. BMC Infect Dis . 2018 Apr 
5;18(1):161.
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Introduction: COVID-19 infection can range from asymptomatic 
infection to life-threatening illness. Severe disease commonly mani-
fests as Adult Respiratory Distress syndrome (ARDS) (1) but may also 
cause immune dysregulation (2), which may be difficult to distinguish 
from superimposed bacterial infection. Procalcitonin (PCT) is a bio-
marker that is released in response to bacterial infection and strongly 
correlates with severity (3). COVID-19 itself does not appear to increase 
PCT levels (4). Therefore, a raised PCT in these patients could identify a 
superimposed bacterial infection (5,6) and guide appropriate initiation 
and cessation of antimicrobial therapy (7).
Methods: We included adult ICU patients with proven or highly sus-
pected COVID-19 infection who had a PCT sent as part of clinical care. 
Demographic, clinical and laboratory data were obtained from medi-
cal records. The Median and Interquartile Range (IQR) were calculated 
for White Cell Count (WCC), neutrophils, C-reactive protein (CRP) and 
PCT. Mann-Whitney-U test was performed to compare patients who 
died with those who survived. Spearman correlation coefficient was 
used to demonstrate correlation of PCT results with the other inflam-
matory markers.
Results: Forty PCT tests were performed on 26 patients, of which 
eight died. Mean age was 57.8 ± 12.5 years with a mean length of stay 
of 26.8 ± 19.0 days. PCT testing was performed for a variety of reasons: 
“fever” for 14 tests; “clinical deterioration” in eight tests; “comparison 
with previous test” for six tests; “difficult wean” for three tests; and “to 
stop antibiotics” for one test. There was no documentation for eight 
requests.
PCT levels correlated with WCC (r = 0.515, p = 0.007), lymphocyte 
count and CRP levels (r = 0.423, p = 0.044). Survivors had significantly 
lower PCT results (0.57  ng/mL, IQR: 3.95) than patients who died 
(2.82 ng/mL, IQR: 7.35, p = 0.047). Similarly, CRP was lower in survivors 
(109 mg/L, IQR: 3.62 versus 270 mg/L, IQR: 186.5 p = 0.003). A change 
in treatment was made following 9 of 40 (22.5%) test results. On three 
occasions, antibiotics were commenced, antibiotics were stopped on 
one occasion and a change in antibiotics occurred on five occasions. 
High-dose steroids were started in six patients after PCT results had 
become available.
Conclusion: Our results, albeit in a small population, confirm the 
previously described correlation between PCT and traditional inflam-
matory markers, WCC and CRP. PCT levels were significantly higher in 
non-survivors from COVID-19.
Although treatment was changed after nearly a quarter of PCT tests, 
it remains unclear on how many occasions treatment would have 
been changed based on WCC and CRP alone. Further research is war-
ranted to fully elucidate the usefulness of procalcitonin in patients 
with COVID-19 for initiation of immunomodulatory therapy, high-dose 
steroids, diagnosis of superimposed bacterial infection or change in 
antibiotic regimen.
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Introduction: Evaluation of the relation between APACHE II and mor-
tality on patients admitted tothe ICU for Coronavirus.
Methods: Prospective cohort study of patients with coronavirus 
admitted to the ICU at theHospital Universitario de Jaén, Hospital San 
Agustín de Linares and the Hospital InfantaMargarita de Cabra.Contin-
uous variables are expressed as median (25th percentile, 75th percen-
tile) andqualitative variables with absolute and relative frequencies. U 
Mann Whitney was usedfor comparison of continuous variables and 
X2 for qualitative variables. Discriminationwas evaluated with the area 
under the RO curve. P &lt;0.05 was considered asstatistically significant 
(e.s).
Results: We have studied 52 admitted patients AT ICU by coronavirus 
INFECTION, 41 of themAT Jaén hospital ICU, 11 at Cabra hospital. The 
average age was 63 (58,71). The evaluated severity with APACHE II was 
12 (9,16) pointsand the same evaluation but using SOFA on the first 
day was 6 (3,8) points. 62,5% (n = 32)required tracheal intubation on 
their first day and 78,8% (n = 41) during the entire ICU stay. 9(17,3%) of 
them didn’t manifest any of the evaluated records (cirrhosis, cardiac, 
renal,respiratory, neurological, oncological, hematological or surgical 
pathology) and 43 patients(82.7%) showed 1 or more records.Mortal-
ity in the ICU was a percent of 38,5 and (meanwhile) at the hospital 
was 38,5%.Deceased patientes had higher APACHE II 14 (12,18) vs 10 
(8,15 points, (p = 0.007)), and biggersofa on the day of the admission, 
but without statistically significant differences 7 (4,8) poinstvs 6 (3,7) 
points (p = 0.227).Predicted mortality by APACHE II according to the 
original equation was 16% and thatobserved was less than expected, 
specifically 38.5%.
Conclusion: On ICU patienes admitted for coronavirus, the severity 
assessed by APACHE IIis bigger in those who die than in those whos 
survive. Anyway, APACHE II statistics of these illpeople are not very 
high, being the observed mortality higher than predicted for patients 
withthe same APACHE II score and admitted to the ICU for acute res-
piratory distress.
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Introduction: Biological evaluation of septic shock.
Objectives: To describe and analyse the biological profile, risk of 
development of multiorgan dysfunction (MODS), and mortality of criti-
cally ill patients with septic shock and a previous state of immunosup-
pression (IS).
Methods: We performed a retrospective analysis of prospectively 
collected data of patients with respiratory, abdominal and urinary 
septic shock, according to their immunocompetent (IC) or immuno-
suppressive (IS) state (1). We include patients identidied through the 
in-hospital activation of Sepsis Code (SC) and admitted in the ICU in 
septic shock. Samples were stored in the Sepsis Bank between 2017 
and 2018.
We analysed the demographic variables, acute severity scores 
(APACHE II), development of multiorgan dysfunction (MODS) defined 
by a Sequential Organ Failure Assessment (SOFA) score > 9, in-hospital 
and ICU mortality, the vital status at day 28 and the biological profile 
through the measurement of cytokine levels (IL-1, IL-2 RA, IL-6, IL8 
IL-10, IL-12, INF, TNFa), and inflammatory biomarkers (PCT, CRP, MR-
proADM).Categorical data were expressed as proportions, and quan-
titative data were expressed as mean (SD) or median (interquartile 
range), according to data distribution. The comparison of qualitative 
data was performed using the Chi-square test. The comparison of 
quantitative was performed using the Mann Whitney U test or the Stu-
dent t test. The Institutional Ethical Committee approved the present 
study (CEIC (PR (AG) 11/2016, PR (AG) 336/2016)), and the patients or 
their representatives signed the informed consent.
Results: During the study period, 758 SC activations were registered; 
a total of 76 patients fulfilled the inclusion criteria. Fifty-one patients 
(67.1%) were men, age 62 (14.5) years, the mean of SOFA 9.2 (2.5) 
and the APACHE 23.5 (6.9). 41 of patients (53.9%), were considered IS, 
mainly by solid organ transplant under immunosuppressive treatment 
(26.9%). The most frequent focus of infection was respiratory (39.5%). 
In-hospital mortality was 28.9%, and ICU mortality was 18.4%. 63.2% 
developed MODS during the index episode of ICU admission. The ICU 
mortality, 28-day mortality and in-hospital mortality of IS vs. IC groups 
were 31.7% vs .2.8% (p  =  0.01), 29.3% vs. 0% p <  0.01, 41.4% vs 14.2% 
(p  =  0.08), respectively.In-hospital mortality was 41.4% vs 14.2% 
(p  =  0.08) in the IC group and IS group, respectively. ICU Mortality 
was 31.7% vs .2.8% (p  =  0.01). 28-day mortality was (29.3% vs. 0% 
p  < 0.01), in the IC group and the IS group, respectively. There were no 
significant differences in the development of MODS (56.3%vs. 43.8% 
p  =  0.38) between both groups. There were not significant differences 
in the biological profiles between IC and IS patients. We obtained the 
following plasma levels of cytokines in both groups: IL1β (11.8 [6] vs. 
[12.1 [3.8] pg/mL p =  0.67), IL2RA (2610[91] vs. 3310.3 [461] pg/mL p = 
0.21), IL6 (2618 [45.4] vs. 2399.2 [11] pg/mL p =  0.78), IL8 (165.9 [77] 
vs. 158 [22] pg/mL p =  0.84), IL10 (291.1 [12] vs. 199.5 [13] pg/mL p = 
0.20), IL12 (24[3.8] vs. 31.6 [1.8] pg/mL p =  0.11), INF (41.6 [9.5] vs. 47.2 
[5.7] pg/mL p =  0.97), TNFa (153.7 [4.8] vs. 200.3 [3.8] pg/mL p =  0.85); 
inflammatory reactants: PCT (7.6 [3.9] vs.16[9] ng/mL p =  0.83), CRP 
(19.9 [3] vs.28 [1.9] ng/mL p =  0.16), MR-proADM (5.3 [3.1] vs. 6.6 [4.1] 
nmol/L p =  0.84).
Conclusion: We found an association between the IS state of criti-
cally ill patients with septic shock and mortality; however, it was not 
associated with increased risk for the development of MODS. Besides 
it seems that IS state was not associated with a different inflammatory 
response (cytokine levels and biomarkers). There may be other factors 
related to the prognosis in these patients.
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Introduction: Biological evaluation of septic shock.
Objectives: To describe the impact of the Neutropenia (NT) in the bio-
logical profile, development of Multiorgan Failure (MOF), and mortal-
ity in critically ill patients with septic shock (SS).
Methods: We performed a retrospective analysis of prospectively col-
lected data of patients with respiratory, abdominal,and urinary SS and 
evaluated the presence of NT at the admission and the first 48 h. We 
include patients identified through the in-hospital activation of Sep-
sis Code (SC) and admitted in the ICU in septic shock. We analysed the 
demographic variables, acute severity scores (APACHE II), develop-
ment of MOF defined by a (SOFA score) > 9, day 28 mortality, the pres-
ence of NT (1.0 × 109 /litre)1 and the biological profile through the 
measurement of cytokine levels (IL-1, IL-2 RA, IL-6, IL8 IL-10, IL-12, INF, 
TNFa), and inflammatory biomarkers (PCT, CRP, MR-proADM).
Results: 758 SC activations were registered with a total of 76 septic 
shock patients. Fifty-one patients (67.1%) were men, age 62 (14.5) 
years, the mean of SOFA 9.2 (2.5) and APACHE 23.5 (6.9). Respiratory 
was more frequent focus (39.5%) of infection. 41 patients (53.9%), 
presented a state of immunosuppression, mainly by solid organ trans-
plant (26.9%). 18 patients (23.7%) presented NT, at 48 h, 4 (22.2%) have 
recovered and 12 (75%) have persisted. 28 days mortality was 19.7% 
and 63.2% developed MOF during the index episode of ICU admis-
sion. There were no significant differences in the development of MOF 
(27.1%vs. 17.9% p  =  0.26), and 28  days mortality [68.2% vs .31.8% 
(p  =  0.21)], between Non-Neutropenic (NN) and Neutropenic (NT) 
group respectively. The assessment of the biologic profile showed no 
significant differences between NN and NT group: IL1β (13.8 [6] vs. 
[13.1 [2.8] pg/mL p =  0.63), IL2RA (2691.5[93] vs. 3311.3 [467] pg/mL 
p =  0.24), IL6 (2818.3 [35.4] vs. 2344.2 [12] pg/mL p =  0.78), IL8 (165.9 
[77] vs. 158.4 [21] pg/mL p =  0.84), IL10 (251.1 [11] vs. 199.5 [13] pg/
mL p =  0.19), IL12 (23.9 [3.8] vs. 31.6 [1.9] pg/mL p =  0.13), INF (42.6 
[9.5] vs. 47.8 [5.7] pg/mL p =  0.95), TNFa (173.7 [4.8] vs. 190.5 [3.8] pg/
mL p =  0.84); inflammatory biomarkers: PCT (7.5 [3.9] vs.14.5 [10] ng/
mL p =  0.84), CRP (19.9 [3] vs.25.7 [1.9] ng/mL p =  0.19), MR-proADM 
(5.3 [3.2] vs. 6.6 [4.7] nmol/L p =  0.84). There were no significant differ-
ences in the persistent NT in the inflammatory profile.
Conclusion: Septic shock patients with neutropenia and persistent 
neutropenia, not presented a significantly difference in the mortality, 
developing of MOF. In addition, the degree of neutropenia does not 
influence the levels of cytokines and biomarkers.
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Introduction: Release of cardiac troponins (cT) can occur when myo-
cytes are damaged by a variety of conditions, such as exposure to tox-
ins, inflammation and necrosis. Sepsis is frequently associated with 
release of cT and the levels of cTs are independently associated with 
in-hospital and short-term mortality after sepsis [1].
Objectives: The objective of the work was to investigate associa-
tions between circulating high-sensitive cardiac troponin T (hs-cTnT) 
and quantitative mass spectrometry-based metabolomics profile of 
plasma and cardiac tissues in an animal model of septic shock. This is 
an ancillary study, the data from the animal experiments were previ-
ously published [2,3].
Methods: Septic shock (SS) was induced in anesthetized, instru-
mented and ventilated adult swines by polymicrobial peritonitis (6 SS 
and 3 sham pigs). Metabolites were quantified in the myocardium and 
in plasma with quantitative targeted metabolomics. Circulating hs-
cTnT was measured using the  Elecsys® assay. Fold-change in hs-cTnT 
from baseline and after full resuscitation (fluids and vasopressors) was 
used to stratify the animals. Univariate and multivariate analyses were 
performed.
Results: No sign of myocardial infarction or contractility reduction was 
detected in this animal model. Hs-cTnT wasn’t significantly different 
between SS and sham animals at each time point, but hs-cTnT fold-
change was higher in septic versus sham animals. In harvested heart 
tissues, proline and glycine levels were significantly higher in the high 
hs-cTnT fold-change group, i.e. in those animals with a more severe 
degree of myocardial injury. By stratifying animals on the basis of hs-
cTnT fold-change, proline and hydroxyproline were among the first 
ranked circulating metabolites in multivariate models to explain the 
severity of myocardial injury.
Conclusion: Evidence of myocardial injury occurs in the early phase 
of shock, as indicated by the hs-cTnT fold-changes in the animal study. 
As collagen is an abundant reservoir for proline and hydroxyproline, 
we may infer that sepsis-associated myocardial injury could be associ-
ated with collagen destruction and/or dysregulated metabolism. In a 
longitudinal study [4] markers of collagen metabolism were increased 
in patients with sepsis. The authors showed that serum increasing col-
lagen propeptide levels were associated with the development of mul-
tiple organ failure and death. Our results reinforce the concept that 
collagen degradation could be one of the important mechanisms that 
contributes to myocardial injury secondary to septic shock.
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Introduction: In sepsis, enteral feeding is avoided or trophic enteral 
feeding is recommended especially in the early period when hemo-
dynamics is impaired. There are no clear recommendations in the 
international nutritional guidelines for parenteral nutrition and lipid 
content in sepsis, largely due to lack of evidence.
Objectives: Multiple organ injury due to free radicals and decreased 
mesenteric blood flow are the consequences of septic shock. We 
investigated and compared whether different Parenteral Lipid Emul-
sions could attenuate the deleterious effects of endotoxin, such as 
mesenteric hypoperfusion, inflammatory oxidative damage and mul-
tiple organ damage in a mouse model of sepsis.
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Methods: Swiss-albino mice (20-40 g) were administered subcutane-
ously sterile saline (NaCl 0.9%, w/v), fish oil (Omegaven), soybean oil 
(Kabiven) or olive oil (Oliclinomel) in 50 ml kg-1 dosage 10 min after 
they have received E.coli endotoxin (LPS, O55:B5, 10 mg kg-1) or its sol-
vent sterile saline. Four hours later, mice were anaesthetized, mesen-
teric blood flow values were measured, spleen and liver weight/body 
weight ratios were determined and the organs were examined histo-
pathologically. Oxidative stress index was also calculated according to 
total antioxidant status (TAS) and total oxidant status (TOS) measure-
ments which were done from tissue homogenates and serum by ELISA 
assay (Oxidative stress index (OSI)  =  TOS/TAS). Results are expressed 
as mean ± SE. Statistical analysis was performed with one-way ANOVA 
or Kruskal-Wallis.
Results: Endotoxin decreased mesenteric blood flow (ml min-1, saline: 
3.02 ± 0.10; endotoxin: 1.44 ± 0.10; n = 12, P < 0.05), increased the 
weight of liver (g per kg body weight, saline: 47.51 ± 1.05; endotoxin: 
56.46 ± 1.46; n = 12, P < 0.05) and spleen (g per kg body weight, saline: 
4.41 ± 0.17; endotoxin: 8.92 ± 0.80; n = 12, P < 0.01) while it inflicted 
significant histopathological injury to both organs. Although fish oil 
emulsion treatment abrogated the decrease in mesenteric artery 
blood flow, none of the parenteral lipid emulsions reversed the wet 
weight gain in liver and spleen. Histopathological examination of the 
liver revealed portal inflammatory reaction, intrasinusoidal conges-
tion, intrasinusoidal lymphoreticular reaction, hepatocellular injury, 
ballooning degeneration and congestion was observed in spleen in 
endotoxin-treated mice. Lipid emulsions, at the doses used, lead to 
histopathologically harmful effects in the liver and spleen of the con-
trol group (saline-saline). Fish oil emulsion treatment has abolished 
some of the deleterious effects of endotoxin only in liver. OSI was 
increased in liver, kidney, lung, spleen and serum after endotoxin chal-
lenge. The protective effects of some emulsions were observed only in 
kidney and spleen.
Conclusion: The main finding of this study is that fish oil emulsions 
containing high omega-3 fatty acids abrogate the decrease in mesen-
teric blood flow and prevent liver damage in the experimental sepsis 
model. All of the lipid emulsions, including fish oil, may cause organ 
damage in healthy animals, even in protective doses.
Reference(s) and grant ackowledgment(s)
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Introduction: Citrulline and intestinal fatty acid binding protein 
(iFABP) are proposed as biomarkers to detect acute gastrointestinal 
injury which is commonly unrecognized in critically ill.
Objectives: To evaluate role of citrulline and iFABP to predict acute 
gastrointestinal dysfunction (AGD) in critically ill septic patients admit-
ted to a medical ICU.
Methods: Critically ill patients admitted to a medical ICU with sepsis 
were evaluated for AGD in accordance with ESICM recommendations. 
Patients with chronic renal disease were excluded. Blood samples for 
citrulline and iFABP were collected between 48-72 hours of admission. 
Patients were grouped as with or without AGD. Healthy controls were 
included from outpatient clinics.
Results: A total of 51 patients and 51 controls were included in the 
study. Mean age of patients was 70.1  years. There were 19 males 
(37.3%). All were medical admissions. Mean APACHEII score was 24.8. 
Mean SOFA score was 8.2. Acute renal injury developed in 41 (80.4%) 
of patients. Citrulline levels in septic patients were significantly lower 
than the controls (11.6 vs 13.0; p = 0.004). There was a moderate, 
positive correlation between citrulline and iFABP in septic patients 
(r:0.567, p < 0.001). AGD score was higher in patients with hypocal-
cemia (p = 0.016) and hyperthermia (p = 0.049). Patients with higher 
AGD score were less likely to attain nutritional goals (p < 0.001). When 
patients with and without AGD were compared, no significant differ-
ence was found for citrulline and iFABP. Citrulline and iFABP levels were 
not associated with mortality.
Conclusion: This study with critically ill medical patients have shown 
that citrulline and iFABP levels alone may not be adequate to detect 
acute gastrointestinal injury presenting as a component of multiorgan 
dsyfunction syndrome.
Reference(s) and grant ackowledgment(s)
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Introduction: Vitamin D deficiency has been associated with an 
increased risk of respiratory infections such as respiratory syncytial 
virus infection, tuberculosis and influenza [1, 2]. Sufficient vitamin D 
level may decrease the risk of death from COVID-19 [3]. However, the 
vitamin D level in patients with COVID-19, its optimal cut-off value to 
predict mortality has not been evaluated yet.
Objectives: The aim of the present study was to evaluate vitamin D 
level in patients on admission to intensive care unit (ICU) as a predic-
tor of mortality in COVID-19 infection.
Methods: The retrospective study was conducted in Federal Research 
and Clinical Centre. 40 adult patients were enrolled from April 06, 
2020 to April 27, 2020. Blood samples were collected within 24 hours 
after admission to ICU to perform routine laboratory tests and level of 
25-hydroxyvitamin D (25(OH)D). Continuous and categorical variables 
were presented as mean  ±  standard deviation or median (Inter-quar-
tile range), as appropriate. The optimal vitamin D cut-off point was 
evaluated by receiver operator characteristic (ROC) curve.
Results: In present study 40 patients of 67 ± 16.5 years were enrolled, 
13 (32.5%) of them were males. The average 25(OH)D level on admis-
sion was 12 (9; 15) ng/ml.
A significant difference in vitamin D level between the dead patients 
(n = 13) and the survivors (n = 27) was revealed 9 [7.35; 11.5] and 14 
[10; 16], respectively, p  =  0.004 (the Mann–Whitney test). The area 
under the ROC curve was 0.79 (95% confidence interval (CI) [0.62; 
0.95]), p = 0.004. The optimum cut-off value for vitamin D was 9.45 ng/
ml. The predictive accuracy of mortality in patients with 25 (OH) D of 
less than 9.45 ng/ml had a sensitivity of 85% and a specificity of 62%, 
figure 1.
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Patients with vitamin D deficiency (25(OH)D of ≤ 9.45  ng/ml) had a 
7-fold higher risk of death compared with 25(OH)D levels > 9.45 ng/ml 
(Odds Ratio 7.04, 95% CI [1.6-30.9]).
Conclusion: ICU COVID patients had deficiency of vitamin D. 25(OH)D 
level on admission less than 9.45 ng/mL could predict in-hospital mor-
tality in patients with COVID-19. Interventional study is warranted to 
elucidate whether vitamin D supplementation is useful for treatment 
of COVID-19.
Reference(s) and grant ackowledgment(s)
1. 1. Berry D.J., Hesketh K., Power C. Vitamin D status has a linear associa‑
tion with seasonal infections and lung function in British adults. Br J Nutr. 
2011;106:1433–1440.
2. 2. Cannell J.J., Vieth R., Umhau J.C. Epidemic influenza and vitamin D. Epide‑
miol Infect. 2006;134:1129–1140.
3. 3. Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D sup‑
plementation could reduce risk of influenza and COVID‐19 infections and 
deaths. Nutrients. 2020;12(4):988.
001384 
Nutricional characteristics of Covid‑19 mechanical ventilated 
patients in Virgen de las Nieves hospital´s ICU
T. Rodríguez Fernández De Simón1; L. Hidalgo  Manchado1; D. García 
 Huertas1; A. Fuentes  Calatayud2; AB. Garcia  Ruano3; F. Manzano  Manzano1
1Intensive care unit, University Hospital Complex of Granada, Granada, 
Spain; 2Intensive care, University Hospital Complex of Granada, Granada, 
Spain; 3Clinical analyses, University Hospital Complex of Granada, Granada, 
Spain 
Correspondence: L. Hidalgo
Intensive Care Medicine Experimental 2020, 8(2): 00384
Introduction: Covid 19 infection is an emerging disease that has 
become a worldwide pandemic. Some patients develop a severe 
pneumonia that evolves in acute respiratory distress syndrome and 
therefore in a long stay in ICU.
Objectives: To describe the main nutritional characteristics of 
mechanical ventilated patients with covid 19 pneumonia admitted to 
Virgen de Las Nieves Hospital’s ICU.
Methods: We perform a retrospective observational study with 50 
patientes that required mechanical ventilation (MV) in ICU.
Results: Among the 50 patients, 76% were men, the mean age was 
60 +/- 10 years, APACHE at the admission in ICU was 14.7 +/- 6, and 
the mean of MV were 22 +/- 17 days. Mortality rate in ICU was 36%, 
without significant differences between men and women when they 
required MV (p < 0.26, CI 0.11-1.79).
Enteral nutrition was given to 97% of patinets, while only 12.2% 
received parenteral nutrition. Protein intake was 44% of daily rec-
ommended (0.57  g/kg/day) and caloric intake was 59.9% (1198 +/- 
355 kcal/day). Mean IMC was 30.4.
MRC (muscle power assestment scale) at ICU exit was > 48 in 78% 
of the patients, which implies a lack of intensive care unit-adquired 
weakness.
Caloric intake was a protective factor against mortality (p < 0.99, CI 
0.994-0.999). Meanwhile, poor glycemic control was an independent 
risk factor for mortality (p < 0.03, CI 1.00-1.03).
Conclusion: An aproppiate nutrition in ICU allowed better results in 
patients with covid 19 infection.
– Mortality rate was higher in patients with hyperglucemia and lower 
in patients with higher caloric intake.
– Hypertriglyceridemia is frequent in patients with covid 19 pneumo-
nia in MV (18% of patients with TG > 500 mg/dL).
– The incidence of intensive care unit-adquired weakness in patients 
with covid 19 infection was 22% (MRC  <  48).
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Introduction: Relate nutritional status with the presence of complica-
tions and mortality in patients undergoing pancreatic oncological sur-
gery admitted to our Intensive Care Unit (ICU).
Methods: Retrospective cohort study of patients undergoing pan-
creatic oncological surgery at the University Hospital of Jaén, admit-
ted to the ICU for postoperative management from December 
2017 to December 2019. Nutritional risk was evaluated using the 
NUTRIC(NUTrition RIsk in Critically ill) score. A descriptive analysis was 
performed and multivariate analysis.
Results: 47 patients, 29 were male. The median age was 69 (43-86) 
years, APACHE II 12 (5-29), SOFA score 6 (1-15), Charlson index 3 (2-9) 
and Nutric score 4 (2-9). Median days of ICU admission was 2  days 
(1-37). Comorbidities: 55% arterial hypertension, 36% diabetes melli-
tus, 11% atrial fibrillation, 8% ischemic heart disease, 6% COPD and 4% 
chronic kidney disease.
32 patients had pancreatic neoplasia. In 87% (36/41) the type of sur-
gery performed was cephalic duodenopancreatectomy. Complications 
intraoperative: 36% (17/47) hemodynamic instability, 23% (11/47) 
bleeding intraoperative and of these 5 required polytransfusion. Sur-
gical complications: 7 Suture dehiscence and 6 pancreatic fistula. 16 
patients had a NUTRIC of high risk and in 13 of them early parenteral 
nutrition was started.
Six patients re-admitted in the ICU and 4 of them died on re-admis-
sion, median of re-entry days was 6 (2-15) from ICU discharge. ICU 
mortality was 12% and hospital mortality of 23%.
In the multivariate analysis we observed a statistically significant 
relationship between the high nutritional risk (NUTRIC score 5-9): his-
tory of chronic kidney disease (p.044; OR 0.31 (0.20- 0.48)), ICU read-
mission (p.044; OR 0.31 (0.20-0.48) and ICU Mortality (p.001; OR 0.26 
(0.16-0.44).
Conclusion: We have observed that a high-risk nutritional status 
can relate to the mortality of our sample, in addition readmissions of 
these patients were more frequent. A multidisciplinary team has been 
created management of these patients with the aim of improving 
the state nutritional and consequently prognosis and morbidity and 
mortality.
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Introduction: Many critically ill patients experience a long rehabilita-
tion course due to prolonged ventilatory support and inflammatory 
state. Creatine has a pivotal role in ATP formation and increasing mus-
cular performance, when combined with resistance training (1). Sup-
plementation might enhance the recovery of the critically ill patient.
Objectives: A review of the literature assessing the possible roles of 
creatine supplementation in rehabilitation in critical illness.
Methods: A PubMed search was conducted, only articles in English, on 
adult humans were withheld. Case reports were excluded. Cochrane 
database was searched. Ongoing trials in the ICU were assessed. (clini-
caltrials.gov, controlled-trials.com).
Results: 42 articles were withheld: no trials in the ICU were found. 
Only 18 of these were clinical trials. Cochrane reviews were found on 
creatine in cardiovascular disease and (neuro)muscular disorders.
Conclusion: The muscular performance-enhancing effect of creatine 
supplementation is preserved in age related sarcopenia(2), disuse 
muscle wasting(3), cachexia(4) and muscular disorders(5), but only 
when combined with resistance training. No clear benefit was found 
in neuromuscular(6), mitochondrial(7) or motor neuron disease(8). 
Creatine’s effect on ICU acquires weakness will depend on whether 
myopathy or polyneuropathy predominate. Creatine’s free-radical 
scavenging and post-ischemic protein synthesis enhancing proper-
ties might attenuate the muscular effects of systemic inflammatory 
conditions(9).
Both pulmonary and cardiac dysfunction might impair rehabili-
tation tolerance. Creatine supplementation does not ameliorate 
COPD patient’s quality of life or exertional performance(10)., yet the 
underlying pathophysiology of COPD is different than that of res-
piratory weakness after prolonged ventilation. A reduction of dysp-
nea and orthopnea in heart failure have been noted after months 
of creatine intake(11). Cognitive performance, neuroprotection and 
post-traumatic stress disorder have been improved after creatine 
administration(12).
Meta-analysis confirms the safety and low incidence of side effects(13). 
Meta-analysis could not show any changes in plasma creatinine(14), 
nor urea excretion. The effect on urinary output is unclear, but kidney 
function can be tested by biomarker or urinary albumin excretion. A 
decreased endogenous creatine synthesis in chronic kidney disease 
might require supplementation(15).
There are no studies into creatine supplementation in the ICU, only 
two reviews advocate its further study(16,17). Other creatine supple-
mentation studies in specific populations are often lacking in patients 
and are relatively few in number. Dosing regimens vary amongst stud-
ies making comparison harder. Creatine supplementation might have 
multiple positive effects on rehabilitation of critically ill patients when 
combined with resistance training. Studies establishing its applica-
tions and safety in the ICU are needed.
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Introduction: Physiology textbooks consider albumin to be an impor-
tant buffer in human plasma and blood. (1) According to traditional 
definition buffers are substances which by their presence in solution 
increase the amount of acid or alkali that must be added to cause unit 
change in pH. (2) Contrarily, Stewart’s quantitative physicochemical 
theory predicts that weak acids such as albumin actually cause H+ 
to change more rapidly with addition of acid (defined as change in 
strong ion difference or pCO2). (3) However, this theory has not yet 
been experimentally verified.
Objectives: Our aim was to prepare an experiment to assess which of 
the aforementioned theories better describes the effect of albumin on 
pH in human plasma.
Methods: We used lyophylized albumin from human serum, sodium 
chloride, sodium bicarbonate and water to prepare 5 solutions of arti-
ficial plasma with varying concentrations of albumin (10, 30, 50, 70 
and 90 g/L). Strong ion difference of all samples was 39-41 mEq/L and 
osmolarity was 252-284 mOsmol/l. Using CO2 tonometer, we exposed 
the samples to varying levels of pCO2 (2-16  kPa) at 37°C. The pCO2 
and corresponding pH were immediately measured using standard 
blood gas analyser. At least 15 measurements were performed on 
each sample. In physiological pH range the dependency of H+ on 
pCO2 in plasma is linear, therefore the buffer power of each solution 
was estimated according to slope of the H+/pCO2 line. To increase 
biological plausibility of the model the whole process was than repro-
duced with addition of red blood cells (RBC) of a healthy volunteer 
thus creating solutions resembling whole blood.
Results: As shown in the figure, increasing the concentration of albu-
min caused the solution to be more acidic (observed as shift to higher 
H+ concentrations). At the same time, increasing concentration of 
albumin caused the H+ to change more rapidly (observed as steeper 
H+/pCO2 line). The same phenomenon was observed in presence of 
RBC.
.
Conclusion: The results of our experiment confirm Stewart’s predic-
tions that albumin, as a weak non-volatile acid, does not make the 
solution more resistant to pH changes, but rather sets a baseline 
value from which the pH changes of the solution are derived. Despite 
being recognized by Stewart’s approach enthusiasts, this fact is not 
well known by majority of physiologists and clinicians. Consequently, 
patients with hypoalbuminaemia and respiratory failure might be less 
prone to acidifying effects of CO2 accumulation, but clinical relevance 
of this phenomenon needs further investigation.
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Introduction: Hypernatraemia in COVID-19 patients is multi-factorial. 
Known reasons include increased insensible losses due to pyrexia, 
tachypnoea, and use of diuretics to achieve negative fluid balance. 
However, it is possible that COVID-19 independently causes hyper-
natraemia through an undetermined pathway.
Objectives: To determine the prevalence and potential associations 
of hypernatraemia in COVID-19 patients admitted to acute medical 
wards compared to intensive care (ICU).
Methods: Data including sodium (Na), base excess (BE), haematocrit, 
use of diuretics and renal replacement therapy were extracted for 
230 COVID-19 patients admitted to a ward and 70 COVID-19 patients 
admitted to a single ICU. COVID-19 status was confirmed by PCR.
Results: The mean Na for ICU patients was 143, for ward patients 139 
(p < 0.001) (Fig.1a). Very severe dysnatraemia (Na >160/ Na < 120) was 
seen in 10.0%/ 2.9% of ICU patients and 1.3%/ 0.9% of ward patients, 
whilst severe dysnatraemia (Na>150/ Na < 130) was seen in 48.6%/ 
25.7% of ICU patients and 5.7%/ 10.9% of ward patients respectively. 
This effect was largely independent of diuretic use (Fig.1b). There was 
a weak positive correlation firstly between base excess and sodium 
(adjusted R2 0.14), and secondly between urea-creatinine elevation 
ratio (UCR) and sodium (adjusted R2 0.14) (Fig.1c).
Conclusion: Dysnatraemia was common, especially amongst criti-
cally ill patients, and this was more likely to be hyper- rather than 
hyponatraemia. Although there is a correlation between elevated 
sodium and markers of dehydration, which was mostly seen in criti-
cally ill patients, these did not completely explain the degree of 
hypernatraemia seen. We hypothesise that dysnatraemia may be a 
consequence of COVID-19 specific sodium retention, and that this is 
more pronounced with increasing severity of illness.
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Introduction: Up until today, the acute patient affected by COVID 19 
disease presents with a severe acute inflammatory disease, mainly 
affecting the respiratory system. The severely acute patients need 
admission to Intensive Care Units (ICU), in order to receive respira-
tory support, for at least 48 hours. Due to this complications, COVID 
19 is related to high nutritional requirements and at the same time the 
need to avoid volume overload. Moreover, patients affected by COVID 
19, need muscular relaxation and prone positions maneuvers as 
part of the treatment, as well as the administration of rather unusual 
medication via nasogastric tube. Additionally, this unusual medica-
tion, is rarely used in ITU and has higher risk of interaction with other 
medication. On the basis of the above, the acute patient affected by 
SARS-CoV-2 infection has higher risk of malnutrition, with all the con-
sequences associated with it. This patients might benefit from a nutri-
tional protocol specific for ITU patients.
Objectives: To describe and analyse if patients affected by SARS-
CoV-2 admitted in the ICU of the Consorcio Hospital General Uni-
versitario from Valencia (CHGUV) during the pandemic period from 
February to May 2020 reached the 80% of the nutritional require-
ments obtained by weight.
Methods: Observational, descriptive, retrospective and longitudinal 
design to evaluate the accomplish of estimated nutritional require-
ments in positive COVID-19 patients admitted to the ICU of the 
CHGUV.
Results: A sample of 29 patients was obtained. 24.1% started enteral 
nutrition early. 28.6% of the patients reached the nutritional require-
ments before day 10, while 35.7% did not reach the nutritional require-
ments at any time. 6.9% reached nutritional requirements before day 
15 and 17.2% before day 20. 12.6% was not evaluable because oral tol-
erance was not possible. Furthermore, 10.34% received complemen-
tary parenteral nutrition, 33.3% for failing to meet the requirements.
Conclusion: In our study, data collection such as height and weight 
was not accurate enough, so the exact BMI was unknown. Besides, the 
pandemic situation provoked a different behaviour and more difficul-
ties to accomplish the nutritional standards. That means, our patients 
were no table to get the nutritional requirements. Finally, it is very 
important to create new protocols to help us to understand our con-
text and improve it.
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Introduction: COVID-19 respiratory failure frequently causes severe 
pulmonary gas exchange disturbances. Neuromuscular blockade 
(NMB) can be employed to improve ventilatory mechanics. However, it 
may also be benificial to reduce oxygen consumption although there 
are conflicting reports [1,2].
Objectives: To assess the shortterm effect of NMB on metabolism 
reflected by carbon dioxide minute production  (VCO2) as measured by 
mechanical ICU ventilators.
Methods: Most of our ICU ventilators report  VCO2 measurements 
(Evita Drager V500, Evital Drager XL, Maquet Servo-I, Maquet Servo-
U). Our electronic health record records device measurements at one 
minute intervals. From all (n = 94) initial ICU admissions to our ICU 
during the first wave of the COVID-19 pandemic in the Netherlands 
(March 19th, 2020 until May 1st, 2020) we analyzed  VCO2 measure-
ments in the 3 hour time window ending 30 minutes before the start 
of the first administration of continuous NMB and compared those 
with  VCO2 measurements in the 3 hour time window starting 30 min-
utes after the start of continous NMB. We excluded all patients venti-
lated less than 12 hours before or 4 hours after initiation of NMB, or 
patients who received any dose of NMB in the 12 hours before start 
of continuous NMB. Before and after  VCO2 difference were compared 
using paired samples Student t-test. Rocuroniumbromide was used 
exclusively for NMB.
Results: Our selection criteria identified 17 patients out of 94 
tested for inclusion. 12(70%) were male with a mean   ±   SD age 
of 62.8 ± 8.8  years. Mean weight and BMI were 94.1 ± 16.3  kg and 
30.1 ± 4.7 kg/m2. 12(70%) patients survived until hospital discharge.
Mean  VCO2 was 260 ± 65 mL/min (2.79 ± 0.68 mL/kg/min) before ini-
tiation of NMB and 264 ± 66  mL/min (2.82 ± 0.65  mL/kg/min) after 
(p = 0.413).
Conclusion: In this cohort of mechanically ventilated COVID-19 
patients the initiation of continuous NMB using rocuronium did 
not significantly change  VCO2. Therefore, it is unlikely that initia-
tion of NMB has significant effects on  O2-consumption and energy 
expenditure.
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Introduction: The aim of this study is to prospectively evaluate demo-
graphic and clinical parameters of patients with critical chronic liver 
disease (CLD) followed in the intensive care unit (ICU).
Methods: Patients with CLD who were admitted to the ICU and older 
than 18  years old were included in this study. The demographic and 
clinical information of the patients, the etiology of CLD, the indications 
for hospitalization, and the mortality status were investigated.
Results: A total of 75 patients were included in the study. The mean 
age was 66  ±  13  years. The most common reason for ICU admis-
sion was gastrointestinal (GIS) bleeding (34%) and hepatic encepha-
lopathy (32%). The most frequent causes of CLD were hepatitis C 
(24%) and hepatitis B (20%). Mean APACHE II score was 15  ±  7. The 
median SOFA score of the patients was 5 (min: 0 max: 16).Mean MELD 
score of all patients was 18  ±  8. Mechanical ventilation was needed 
27% of patients during ICU period. A total of 24% patients received 
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vasopressor treatment. Acute kidney injury (AKI) was developed in 
33% of patients. We determined new site infections in 23 patients 
(31%). Cancer as additional co-morbidity (β (SE): 0.711, OR (low, up): 
9.874 (2.451-39.783), p  =  0.001) and increased age (β (SE): 0.032 OR 
(low, up): 1.096 (1.029-1.167), p  =  0.004) was determined as an inde-
pendent risk factor for ICU mortality. ICU mortality was 27%.
Conclusion: As a result of this study, the most common cause of CLD 
was hepatitis C and the most frequent reason for hospitalization was 
GI bleeding. Cancer and older age were determined independent risk 
factor for mortality with critical chronic liver disease patients in ICU.
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Introduction: Patients with severely head-injured have worst out-
comes. Moderate and severe disability occurred around a sixth of 
these patients. Moreover, about 33% of them do not survive and 
the remaining patients usually end up with persistent vegetative 
state. Decompressive craniectomy (DC) is recommended as a second 
level treatment of Traumatic Brain Injured (TBI) patients with refrac-
tory intracranial hypertension (ICH). The outcome of DC still remains 
controversial.
Objectives: TTo analyze factors related to disability and mortality at 
6 months after ICU discharge, in TBI patients with refractory ICH with DC.
Methods: A retrospective study was performed in TBI patients admit-
ted to the ICU from May 1, 2009 to December 31, 2018, who had DC 
after a TBI with refractory ICH. Demographic variables and risk factors 
associated with mortality were analyzed. demographic data; neu-
rological data (clinical examination and Glasgow Coma Score: GCS); 
hypotension type of craniectomy and DC complications; Rankin scale, 
and Glasgow outcome scale (GOS at ICU discharge and 6 months after 
ICU discharge and 30 days after it; hypo and hyperglycemia; applica-
tion of mannitol or hypertonic saline solution before and after DC and 
other related factors. The percentages were compared with the X2 test 
or Fisher’s exact test, the means with the t-test and the medians with 
the Wilcoxon test for independent data. A multidimensional logistic 
analysis of mortality was performed 6 months after ICU discharge.
Results: Twenty eight out of 230 TBI and 105 polytrauma patients, 
with associated severe TBI, were included. Hospital mortality was 
28.6% and ICU mortality was 10.7%. Factors associated with mortality 
that showed statistically significant differences (p  < 0.05) were among 
others (Table  1a and 1b): age (p  =  0.002), APACHE II (p  =  0.006), 
Higher GCS at ICU admission (p =  0.013), midline displacement on cra-
nial CT, GOS and Rankin Scale, both at ICU discharge (p  =  0.005 and 
p  =  0.001, respectively) and 30 days after ICU discharge (p  =  0.004 
and p  =  0.005, respectively). GOS values were 3 at ICU discharge 
and 30 days after it Rankin was 5 at ICU discharge and 30 days after it 
was 3. Factors that were independently associated with mortality, at 
6  months after ICU discharge, were diabetes mellitus, hypertension, 
orotracheal intubation in the prehospital setting, no reactive pupils 
before and reactive after DC (Table  2). The most common observed 
complications were nosocomial pneumonia (67.9%), extraaxial hema-
toma at the surgical site (57.1%) and hydrocephalus (39.3%).
Conclusion: Patients with TBI and ICH refractory to medical treatment 
and undergoing DC, had a low mortality rate at ICU discharge, but 
with severe disability.Factors independently associated with mortality 
at 6 months after ICU discharge were diabetes mellitus, arterial hyper-
tension, orotracheal intubation in the prehospital setting, none reac-
tive pupils before DC and both reactive pupils after DC.
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Introduction: Significant variability exists among physicians, in the 
prophylactic use of anticonvulsants in severe Traumatic Brain Injury 
(TBI).
Objectives: The purpose of this study was to evaluate the degree of 
compliance to the Brain Trauma Foundation guidelines in the admin-
istration of anti-epileptic prophylaxis and to determine the incidence 
of post traumatic seizures (PTS) in a cohort of critically ill patients with 
TBI.
Methods: A retrospective analysis of adult patients with traumatic 
brain injury, admitted to a level III Intensive Care Unit (ICU) over a 
period of 4  years, was carried out. Details on the demographic data, 
severity of injury, CT severity grades, use of EEG monitoring and the 
administration of anti epileptic prophylaxis were determined. The inci-
dence of post-traumatic seizures was compared between the groups 
of patients who received anti-epileptic prophylaxis and those who did 
not.
Results: 562 patients were included in the study. Anti-seizure prophy-
laxis was given to 77% of the patients with severe TBI. Serum pheny-
toin levels were measured in only a minority of patients (13.1%) and 
34% of them were at a sub-therapeutic level. Standard EEG monitoring 
was performed in 26% of patients and epileptiform activity was found 
in only 3% of them. Continuous EEG monitoring was employed in only 
0.5% of the study population. 13.3% of the study population devel-
oped post traumatic seizures (PTS). The incidence of early PTS was 
7.3% and that of late PTS was 3.6%. Post-traumatic seizures occurred at 
a significantly higher rate in the group of patients who received anti-
epileptic prophylaxis (20.2% vs 3.1%, p  =  0.000).
Conclusion: Post-traumatic seizures occur despite the prophylaxis 
with anti-epileptics. Administration of phenytoin should be guided 
with serial measurements of serum phenytoin levels and continuous 
EEG monitoring.
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Introduction: Spontaneus intracraneal hemorrage (SICH) is the sec-
ond most frequent type of cerebrovascular accident with an incidence 
of 10-15% and a high morbidity and mortality worldwide. To differenti-
ate patients at higher risk of mortality may improve its management 
and result in better outcomes.
Objectives: To describe the characteristics of patients with SICH as 
well as treatment strategies and mortality.
Methods: Observational, descriptive and prospective study of 1321 
patients who were admitted to a neurocritical ICU between March 
1996 and March 2020. We analyzed demographic and clinical char-
acteristics (Glasgow Coma Scale (GSC), Intracraneal Hemorrage Score 
(ICH), hydrocephalus and pupils). The volume and location of the 
hematoma, intraventricular extension, treatment strategy and mortal-
ity were analyzed too.
Results: Mean age was 58,8  years (SD 15,1) and 62,6% were males 
with a mean ICU stay of 7,2  ±  9,3  days and hospital stay of 25,7  ± 
35,1 days. Mean GSC score at ICU admissión was 6 (SD 3) with 8 points 
or less in a 66,3% of patients and mean ICH score was 2,37 (SD 1,38). 
Only 1 patient (0,1%) was admitted with an ICH score of 6. Most of 
patients (73%) presented with normal pupillary reflex and only 11% 
were admitted with nonreactive bilateral mydriasis. Mean hematoma 
volume was 54,6  cc (SD 51,1) and the most frequent location was 
supratentorial (78,3%), being basal ganglia specifically the most preva-
lent (40,8%). Intraventricular hemorrage developed in 70,7% but less 
than half (45,1%) suffered from hydrocephalus. 22,8% of patients were 
under surgical treatment and an external ventricular drainage was 
placed in 14,8% of patients. ICU mortality was 45,4% and hospital mor-
tality was higher (50,5%).
Conclusion: Patient with SICH who is admitted at our neurocritical ICU 
is usually a male in his sixties with high risk of mortality (high bleeding 
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volume with low GSC score). Major mortality rate happened at ICU 
during the acute phase and this results are consistent with that pub-
lished in the literature.
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Introduction: Non-traumatic subarachnoid hemorrhage (SAH) is a dis-
ease with high mortality and disability rates.1 Identification of risk fac-
tors and initial management decisions may affect outcome.2.
Objectives: To investigate the association of clinical characteristics 
and early interventions with outcome in patients with severe non-
traumatic SAH.
Methods: This study is an observational, retrospective, single-center 
study conducted in a level III intensive care unit (ICU) of a tertiary 
referral hospital in Greece. Population of the study was comprised 
of 29 patients that were admitted in the ICU between July 2018 and 
February 2020 with the diagnosis of non-traumatic SAH. Outcome 
was assessed with the Glasgow Outcome Scale Extended (GOS-E) at 
28 days, 3 months and 6 months after admission. A favorable outcome 
was defined as a GOS-E score of 5 or higher at last available assess-
ment. The clinical parameters that were evaluated as potential pre-
dictors of outcome were age, gender, Acute Physiology And Chronic 
Health Evaluation (APACHE) II score and Glascow Coma Scale (GCS) on 
admission. Initial treatment and monitoring options under investiga-
tion were external ventricular drainage (EVD) catheter, surgery before 
ICU admission and intracranial pressure (ICP) monitoring. Fisher’s 
exact test was used for comparison and univariate logistic regression 
models were fitted to the data.
Results: We present our results as preliminary because of limited 
sample size. Mean age of participants was 62.3 ( ± 8.5) years and the 
majority (72.4%) were females. Median GCS on admission was 6 (IQR 
5) indicating severity and mean APACHE II score was 20.34 ( ± 5.38). 
A trend of age being negatively associated with favorable outcome 
was observed (p = 0.126, p>0.05, OR 0.87, 95%CI 0.73, 1.04). Likewise, 
increased APACHE II score on admission exhibited a negative impact 
on favorable outcome (p = 0.224, p>0.05, OR 0.86, 95%CI 0.67-1.1). 
Increased GCS on admission had a significant positive relationship 
with favorable outcome (p = 0.02, p < 0.05, OR 1.74, 95%CI 1.09, 2.27). 
In our population male gender was related with unfavorable outcome 
but that was not significant (p = 0.9, p>0.05, OR 0.86, 95%CI 0.08, 9.69). 
Regarding interventions, surgery for SAH during admission was asso-
ciated with a trend towards favorable outcome (p = 0.483, p>0.05, 
OR 2.36, 95%CI 0.21, 25.91). In the majority of our patients (86.2%) 
EVD was placed so EVD was not related with type of outcome (p = 1, 
p>0.05). ICP monitoring was beneficial regarding outcome (p = 0.55, 
p>0.05).
Conclusion: In our population of patients with non-traumatic 
SAH, severe clinical presentation assessed with decreased GCS and 
increased APACHE II score were associated with unfavorable outcome. 
Younger patients and females showed a trend toward more favora-
ble outcome. EVD was not related with outcome and ICP monitoring 
exhibited a positive effect on outcome of patients with SAH. Early sur-
gery was beneficial in our population but that was not significant. As 
our cohort of patients increases, we aim to clarify our results and study 
more specific subgroups of patients.
Reference(s) and grant ackowledgment(s)
1. Daou BJ, Koduri S, Thompson BG, Chaudhary N, Pandey AS. Clinical and 
experimental aspects of aneurysmal subarachnoid hemorrhage. CNS Neu‑
rosci Ther. 2019;25(10):1096‑1112. https ://doi.org/10.1111/cns.13222 .
2. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors 
for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 
2007;38(8):2315‑2321. https ://doi.org/10.1161/strok eaha.107.48436 0.
3. None.
001348 
Characteristics and results of two cohorts of patients 
with spontaneus intracraneal hemorrage
MJL.  Serrano1; S. Ramiro González2; R. Prieto  Jurado3; A. Iglesias  Santiago4; 
LF.  Guerrero5
1Intensive care, Hospital Virgen de las Nieves, Granada, Spain; 2Intensive 
Care Unit, Virgen de las Nieves Hospital, Granada, Spain; 3Intensive Care, 
Hospital Virgen de las Nieves, granada, Spain; 4Critical care department, 
Hospital Virgen de las Nieves, Granada, Spain; 5Neurocritical and trauma 
intensive care unit, University Hospital Complex of Granada, Granada, 
Spain 
Correspondence: R. Prieto Jurado
Intensive Care Medicine Experimental 2020, 8(2): 001348
Introduction: Stroke`s incidence has decreased by 42% in developed 
countries in the last 4decades due to improvements in health preven-
tion. Conversely, morbidity andmortality have not suffered possitive 
changes despite the efforts.
Objectives: To compare the characteristics and results of 2 series 
of patients withspontaneus intracraneal hemorrage (SICH) and to 
analyze the differences interms of severity, treatment strategies and 
mortality.
Methods: Observational and prospective study which compares 2 
temporal cohorts of patients with SICH. The first one consists in 1208 
patients recruited between March 1996 and June 2016 and the second 
one consists in 113 patients recruited between March 2018 and March 
2020. Both groups were admitted to a neurocritical ICU. Variables ana-
lyzed were clinicial variables, SICH chracteristics, treatment strategy 
and mortality. Statistic analysis with Chi-squared test for cualitative 
variables and Student’s T-distribution for cuantitative variables.
Results: Age was significantly higher in the second cohort of patients 
(61,8  ±  11,4  years) with respect to the first one (58,6  ±  15,3  years) 
p  = 0.007 without differences in sex between them. Regarding sever-
ity scores; APACHE-II and APACHE-III were significantly lower in the 
second cohort (p = 0.003 for APACHE-II, p = 0.001 for APACHE-III) 
but for SAPS-II score difference was not significant (44  ±  22 cohort 
1, 42  ±  19 cohort 2, p = 0.229). Mean ICU stay in the first cohort was 
7,2  ±  9,5  days and 7,3  ±  7,4  days in the second one (p =  0.108). 
Mean hospital stay was 25,6  ±  35,6 days in the first cohort and 26,9  ± 
29,9 days in the second one (p = 0.096). Both groups had similar SICH 
characteristics in terms of volume (p = 0.096), location (p = 0.169), 
intraventricular hemorrage (p = 0.354) and hidrocephalus (p = 0.189). 
No differences were found as well in treatment strategy. Surgical 
intervention was 21,9% in the first cohort and 32,7% in the second 
one (p = 0.08). Ventricular drainage was placed in 14,4% of the first 
and 18,6% of the second cohort (p = 0.231). Regarding mortality there 
were not statistically significant differences in ICU mortality (46,1% 
first cohort, 38,1% second cohort, p = 0.102) or hospital mortality 
(51,2% first cohort, 42,5% second cohort, p =  0.075).
Conclusion: We can conclude that the characteristics of the patients 
with SICH have been similar over time except age that is higher in 
the most recent cohort. Results are similar in both groups in terms of 
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ICU/Hospital stay, treatment strategy and mortality. Despite failing to 
achive statistically significant differences, there is a statistical trend in 
the second cohort of patients to lower ICU/Hospital mortality as well 
as to higher surgical intervention and ventricular drainage placement 
as treatment options.
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Introduction: Deep Venous Thrombosis (DVT) is common in patients 
with TBI and correlates with poor outcome, increased number of days 
of mechanical ventilation and length of admission [1,2]. An increased 
number of VAEs has been described in these patients. The TARDIS 
(Traumatic Brain Injury Associated Radiological Deep Vein Thrombosis 
Incidence and Significance) study has been designed to investigate 
incidence (via compression ultrasound) of DVT in patients with moder-
ate/severe TBI who require ventilation. The association between DVT 
and acute lung injury (ALI), VAEs, ICU length of stay and short or long-
term survival and disability outcomes are secondary objectives.
Severe trauma patients, including TBI, present coagulation abnormali-
ties with increased morbidity and mortality [3]. Conventional coagula-
tion tests have many limits while TEG displayed a potential diagnostic 
and prognostic role [4].
Methods: Following consent, ventilatory associated events (new x-ray 
infiltrates, worsening of oxygenation or increased secretions, signs 
of inflammation, need to commence patients on antibiotics with or 
without microbiological confirmation) were recorded to 10 days post 
injury in ventilated patients with brain trauma admitted to intensive 
care unit, as part of the TARDIS study protocol. A compression ultra-
sound scan (USS) of both legs was performed and repeated on alter-
nate days up to Day 10 from injury; clinical, ventilatory and laboratory 
variables were collected daily. TEG was performed at admission, as per 
the manufacturers’ instructions. Clinical and viscoelastic variables were 
correlated with the incidence of VAE. Data is described as mean (stand-
ard error of the mean) and median (interquartile range) as appropriate. 
Proportions were analysed by t-student and Chi square test, p < 0.05 
are considered significant.
Results: Preliminary data from a single Institution are included. Six out 
of 15 (40%) patients developed VAE during the first 10 days of admis-
sion. No significant correlation was observed between gender, age, 
GCS and Marshall scores at admission and VAEs.
TEG displayed increased K and reduced Alpha angle values (see 
Table). Mean values were altered in both groups, but contingency 
test showed a high percentage of patients with VAEs with prolonged 
K (66%) and reduced a (83%). Four out of 6 patients (66%) had both 
values altered.
Conclusion: VAEs are frequent in our cohort of patients with TBI 
requiring mechanical ventilation. Despite no statistical significance, 
our data suggest that a hypocoagulable profile recorded via TEG 
seems associated with increased risk of developing VAEs. This work 
requires further confirmation and is continuing in the TARDIS study.
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Introduction: In the neurocritical care setting catheter associated 
ventriculitis (CAV) is a frequent complication associated with increased 
morbidity and mortality. Precipitating risk factors are still under 
discussion.
Objectives: To investigate potential CAV “triggers” and secondary to 
record for microbial etiology and incidence in our cohort.
Methods: Single center study on adult neurocritical care patients 
requiring urgent EVD insertion (January 2018 - April 2020). Exclusion 
criteria were: prior hospitalization, CNS infection or hydrocephalus 
and CSF leakage. All catheters were antibiotic impregnated connected 
to a drainage system placed in the operating theatre. Periprocedural 
antibiotics were given in all. Dressing change performed every 2 days. 
CSF samples were obtained from the EVD as clinically indicated. CAV 
defined as CSF: positive culture  ±  pleocytosis  ±  hypoglycorrhachia 
(IDSA guidelines 2017). Patients were divided into two groups (non 
CAV/CAV). Demographics, Charlson comorbidity index (CCI) score, 
GCS, APACHE II, neurosurgical intervention, EVD related data, CSF 
sampling count, CAV incidence, bacteria cultured, intraventricular anti-
biotic use and concurrent infection were recorded. Student t-test or 
Mann Whitney U test used for quantitative data and the Pearson chi-
squared test for qualitative data as necessary. The level of significance 
was set at P < 0.05.
Results: We retrieved 52 medical records with 76 EVD insertion pro-
cedures for a total of 804 EVD days (mean age 61.65  ±  11.51 years). 
The indication was TBI (5.7%), aSAH (63.5%) and ICH/IVH (30.8%). CAV 
confirmed in 9 patients (17.3%). Each of them experienced only one 
episode of EVD infection while 3 (33.33%) had a co-infection. CAV rate 
estimated as 11.2/1000  days. Gram stain had findings in 3 of them 
(33.3%). Major CSF pathogens were: Acinetobacter baumannii (n = 5, 
55.6%), coagulase-negative staphylococci (n = 2, 22.2%), Enterococcus 
species (n = 1, 11.1%) and Klebsiella oxytoca (n = 1, 11.1%). Intraven-
tricular antibiotics used as an adjunct in 5 (55.6%).
Baseline characteristics (gender, age, CCI, GCS) and indication of EVD 
insertion were similar in both groups (p>0.05). Univariate analysis 
showed that CAV patients received more EVD catheters (p < 0.001) 
and had longer total drainage duration (13.93vs22.77; p = 0.016) but 
retention of the drainage system >10  days was not correlated with 
increased risk of infection (p = 0.81). Indeed in most CAV patients 
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(6/9; 66.6%) infection documented during the time period of the first 
inserted EVD. Among other tested variables potential “triggers” were 
neurosurgical intervention (p = 0.01), CSF sampling >1 time (p < 0.001) 
and the simultaneous presence of intraparenchymal ICP monitoring 
devices (p = 0.021).
Conclusion: Neurosurgical operation and recurrent sampling, but not 
shunting duration, were factors associated with EVD infections. Inter-
estingly enough, concurrent existence of intraparenchymal ICP moni-
toring devices seems to have a correlation with the presence of CAV in 
our cohort. These results are in agreement with previous studies and 
confirm the need to focus on minimizing potential “triggers” in order 
to overcome the CAV obstacle in neurointensive care patients.
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Introduction: Positive CSF culture is the cornerstone of EVD related 
infections (ERI) diagnosis. However it is time consuming while prompt 
antimicrobial therapy is crucial. Several conventional CSF parameters 
have supplementarily used but their diagnostic accuracy especially 
in case of hemorrhagic CSF is uncertain. Under these limitations the 
cell index, a formula to correct for blood contamination, and the CSF/
serum glucose ratio have been proposed as alternatives.
Objectives: To evaluate and compare the utility of cell index over the 
CSF/ serum glucose ratio in early diagnosis of ERI in patients with hem-
orrhagic CSF.
Methods: We reviewed data of consecutive adult neurocritical 
patients who received an EVD in an emergency setting from Janu-
ary 2018 to April 2020. We enrolled patients with raised clinical sus-
picion for ERI in whom at least one CSF sample and complete blood 
count send for analysis at the same day. Samples were obtained from 
the EVD system. Patients who excluded were those who had prior 
hospitalization or CNS infection. All included patients received anti-
microbial impregnated EVD catheters at the operating theatre and 
protocol based antimicrobial prophylaxis as well with no further anti-
biotic exposure until CSF sampling. ERI was defined based on CSF 
positive cultures. We assigned patients into two groups according to 
presence or absence of ERI. Data concerning demographics, indication 
of EVD insertion, GCS, Charlson Comorbidity Index (CCI) and APACHE II 
were collected. Peripheral blood (WBC, RBC, glucose) and CSF (WBC, 
RBC, glucose, culture) cytobiochemical/microbiological analyses at 
the time of clinical suspicion of ERI were retrieved. We calculated for 
each sample the cell index [(CSF leukocytes/CSF erythrocytes)/(blood 
leukocytes/blood erythrocytes)] and the CSF/serum glucose ratio. Cat-
egorical variables were tested using a chi-square test and continuous 
variables using the Student t test or Mann Whitney U test. The level of 
significance was set at P < 0.05. The predictive ability of the CSF tests 
of interest was estimated using an area under the receiver operating 
characteristic curve (AUC-ROC) analysis.
Results: 28 patients met study criteria (mean age 62.21  ±  11.59; 
females 60.71%). 19 of them were classified as non ERI whereas 9 
as ERI (32.14%). Indications for drain placement were TBI (1vs0), 
aSAH (11vs7) and ICH/IVH (7vs2). No differences were observed in 
baseline characteristics (gender, age, GCS, CCI, APACHE II) or in indi-
cation of EVD insertion between the groups (p>0.05). In patients with 
ERI the median cell index was 15.14 vs 0.61 for the rest of patients 
(p < 0.001). No statistical difference was noted in CSF/serum glucose 
ratio when comparing ERI and non ERI patients (0.53 vs 0.76 respec-
tively; p = 0.058). Discriminatory power of cell index was excellent 
(AUC:0,927; 95%CI:0,763-0,991; p < 0001) in confirming ERI at the time 
of clinical suspicion whereas that of the CSF/serum glucose ratio was 
fair (AUC:0,722; 95%CI: 0,522-0,874; p = 0.069).
Conclusion: In the context of hemorrhagic CSF, cell index calculation 
had an excellent diagnostic accuracy in confirming ERI in our cohort 
as compared to the widely used CSF/serum glucose ratio. Our results 
extend knowledge from previous studies. Further research should be 
carried out in order to incorporate this costless index in every day clini-
cal practice.
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Introduction: One-third of the patients that present to the emer-
gency room with stroke symptoms are stroke mimics (SM) (1), leading 
to stroke code activation, several diagnostic tests required, unneces-
sary treatment, and high costs to the health system before the diagno-
sis of a stroke mimic can be confirmed (2).
Objectives: This study aimed to describe the patient’s characteristics, 
risk factors, diagnostic tests, and types of mimic presenting to a uni-
versity hospital at Bogota, Colombia.
Methods: This was a single-center cross-sectional study of patients 
admitted to the emergency room with stroke symptoms and further 
diagnosis of SM. Data were obtained from January 2017 to March 2020 
from a clinical database. Patients excluded if the stroke code was not 
activated or the admission at the emergency room (ER) was not due 
to stroke symptoms. FABS and Telestroke score for SM prediction were 
calculated.
Results: The study included 111 patients, being women 54.1% of 
them. The clinical characteristics on admission to the ER were simi-
lar between men and women. The mean time between the onset of 
symptoms and admission at ER was 4.7 +/- 8.5 hours, and the mean-
time of stroke code activated was 2.1 +/- 2 hours. The most common 
disease in medical history was hypertension (49.5%), followed by 
dyslipidemia (19.8%) and cancer (15.3%). In most patients, the diag-
nosis of mimic was made between 1 and 4 hours from the ER admis-
sion (64.9%), MRI was the most frequent first neuroimage that allows 
the identification of SM (57.7%). Only 4.5% of cases did not require a 
neuroimage at ER because the diagnosis of SM was predominant over 
stroke. The mean score of Telestroke and FABS score was 15.8 +/- 6.2 
and 2.1 +/- 0.6, respectively, with a high probability of being a mimic 
according to both scores in 84.7% and 99.1% of cases, respectively. 
The most common etiology of mimic among women were migraine 
(18.3%) followed by a transient ischemic attack (16.7%) and conversion 
disorder (11.7%) with no cases of conversion disorder among men. 
The most common cause of SM among both sexes was also migraine 
(15.3%). Administration of tissue plasminogen activator was done in 
0.9% of patients, being only men.
Conclusion: Both FABS and Telestroke seem to easily stratify patients 
with a high probability of having an SM at the ER. This pathology is 
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most common in women and predominantly confused with migraine 
symptoms. It is crucial to identify the population at risk of SM to 
reduce the unnecessary administration of stroke treatments.
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Introduction: The diagnosis of meningitis is a clinical challenge in 
intensive care, even more in neurocritical patients. This population has 
an increased risk of meningitis, related to cerebral damage, surgical 
intervention and use of intracranial devices.
However, the classical clinical diagnosis of meningitis is compromised 
in neurocritical patients, due to impaired neurological status, and dif-
ficult valuation of cerebrospinal fluid (CSF).
Objectives: To describe and analyse the determinant factors to diag-
nose meningitis in neurocritical patients: risk factors, interventions/
intracranial devices, clinical signs and CSF analysis.
Methods: Retrospective analysis of adult neurocritical patients admit-
ted in an intensive care unit (ICU) from a 3-year period in which menin-
geal infection was suspected and CSF analysis was done.
Results: Twenty-seven surgical patients were included, with a mean 
age of 49  years old. Seventy percent of the patients were male. The 
ICU mortality was 11%. Meningitis was diagnosed in more than 65% 
of the sample. There were no significant association between any risk 
factor, intervention/intracranial device or clinical sign and the diagno-
sis of meningitis. When analysing the CSF, there was a significant asso-
ciation between cell counting and the diagnosis of meningitis, with a 
mean cell counting of 122/mL vs 923/mL (p < 0.05).
Conclusion: Classical signs of meningitis are of little use in neurocriti-
cal intensive care patients. Risk factors and interventions or the use of 
intracranial devices may be an alert to doctors but were not signifi-
cantly associated with the diagnosis. The most crucial parameter to 
better diagnosis of meningitis is the cell number of CSF analysis.
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Introduction: TBI (Traumatic Brain Injury:traumatic brain injury) is 
associated with one of the highest rate of deaths and setbacks in the 
recovery and return to life in society. The latest reports of the medical 
literature emphasized the need for further research in terms of meth-
ods for treatment of patients with TBI. One of the drugs with positive 
impact on prognosis in this group of patients is cerebrolysin. This drug 
is a component produced from a homogeneous, purified pig brain, 
containing different protein molecules of low molecular weight, which 
have neuroprotective and neurotrophic effects in  vitro and in  vivo. 
In the existing literature there are no reports describing the effect of 
early cerebrolysin administration in patients with TBI, in correlation 
with neuropsychological tests and neuroimaging results.
Objectives: Evaluation of the impact of early administration of neuro-
protective drug (cerebrolysin) on outcome of patients after a TBI, who 
were treated neurosurgically and under the conditions of the ICU .
Methods: 10 patients were included in the study according to inclu-
sion criteria: TBI diagnosis (subarachnoid, epidural, or subdural hem-
orrhage) in patients, who were qualified for neurosurgical treatment 
(decompressive craniectomy,implantation of ventricular drainage), 
age 40-65y, GCS  < 8, time from the injury less than 6  h. After ran-
domisation patients were assigned to two groups (Group 1early drug 
adminstration, Group 2 control group). After the qualification the 
neuroprotective drug was administrated in Group 1 (Cerebrolysin - 
intravenous infusion 50 ml for 21 days, first dose in first 6 hours after 
the injury). After the neurosurgical treatment the patients of both 
groups were hospitalized in the ICU where standard intensive care 
was provided in both groups. The condition of the patients was moni-
tored by neuroimaging (Computed Tomography), and neuropsycho-
logical tests (Barthel scale: evaluation of the efficiency of the patient, 
Mini -Mental State Examination :the scale of assessment of cognitive 
disorders).
Results: The results of the study contain the results of general out-
come of the patients, GOC, the neuroimaging and psychological tests 
results.
Conclusion: The effects of early administration of neuroprotective 
drug (cerebrolysin) in correlation with neuroimaging results and neu-
ropsychological test results of patients after TBI need further research 
on larger group.
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Introduction: To study in patients admitted to the ICU with trau-
matic brain injury (TBI), the long-term functional situation (3-4 years) 
and analyze whether the evaluation one year after admission in ICU 
reflects what your situation will be in the future.
Methods: Prospective cohort study of patients with TBI admitted to the 
ICU of the Regional Hospital of Malaga during the years 2004 to 2008, 
collection of data at hospital admission and subsequent follow-up with 
telephone call to evaluate functional situation. GOS (Glasgow Outcome 
Scale) was used to assess the functional situation. X 2 was used for pro-
portion comparison and p < 0.05 was considered statistically significant.
Results: A total of 531 patients, age 35 (22.56) years, APACHE II 17 
(13.23) points, Glasgow 7 (4.10) points, were included in the study. 
Mortality in the ICU was 25% and in hospital mortality was 28.6%.
Of the 379 patients admitted to the hospital, follow-up could be per-
formed at one year in 363 patients and their functional situation was 
as follows: GOS 1 (deceased): 38 (10.5%), GOS 2: 15 (4.1%), GOS 3: 98 
(27%), GOS 4: 99 (27.3%) and GOS 5: 113 (31.1%).
At 3-4  years, a new follow-up of patients was performed and 445 
patients (86 missing) could be evaluated. The classification accord-
ing to the Glasgow Outcome Scale shows that 181 patients (171 per 
year and 10 thereafter) had died (GOS 1). At 1 year, 40.2% of the 445 
patients evaluated had good functional status (Normal (GOS 5) or Dis-
function but Self-sufficient (GOS 4)). At 3-4  years, 45% (N = 200) had 
good functional status (GOS-4-GOS 5) and 64 (14.38%) of the patients 
followed and who had not died had a poor functional status (Vegeta-
tive (GOS 2) or Disfunction and not Self-Sufficer (GOS 3)). Among the 
patients who had no died, only 1 patient had worsened their func-
tional status between the year and 3-4  years and 65 patients had 
improved their functional status (14.6% of the total 445 patients evalu-
ated per year and 23.7% of the patients who had not died per year and 
who were followed at 3-4 years).
.
Conclusion: In patients admitted to the ICU with TBI, the year-end 
evaluation of the functional situation does not reflect what their 
functional situation will be in the future. And these patients show 
an improvement in their functional situation between the periods of 
1 year and 3-4 years in a fairly high group of patients.
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Introduction: Gastrointestinal motility (GI) disorders were frequently 
observed in the patients with neurodegenerative diseases and in the 
critically ill patients. The incidence of both gastroparesis and constipa-
tion in the neurosurgical patients in the intensive care units (ICU) was 
rarely reported and was not correlated with brain swelling in the area 
of the vagal nuclei.
Objectives: The aim of this cross-sectional study was to evaluate the 
incidence of gastroparesis, constipation and stress ulcers in neurosur-
gical patients, and the correlation between acute brain injury in the 
area of the vagal nerve and GI motility disorders.
Methods: An institutional ethics committee approval was obtained 
prior to the study. Electronic database and medical records of 207 
neurosurgical patients hospitalized at ICU of the University Hospital 
Centre Osijek from November 2018 to November 2019 were analyzed. 
Demographic data, total opioid consumption per patient, drugs used 
for GI stimulation, and brain CT images were correlated with gastropa-
resis and constipation. A subgroup of 69 mechanically ventilated (MV) 
patients who stayed in the ICU for ≥4 days was investigated up to the 
day 15. Total opioids were calculated as morphine equivalents (ME). 
Brain lesions involving the vagal nuclei area was graded by neuroradi-
ologist as follows: 1 no edema, 2 edema present, 3 edema with midline 
shift. Gastroparesis and constipation were considered if delayed emp-
tying without evidence of mechanical obstruction was present.
Results: A total of 113 emergency and 94 elective patients were 
admitted in the ICU. In the subgroup of 69 MV patients (63 emer-
gency and 6 elective) who stayed ≥4  days in the ICU brain edema 
was registered in 57 (82.6%) patients. Gastroparesis was observed 
in 48 (69.6%), constipation in 67 (97.1%) and stress ulcers in 4 (5.8%) 
of MV patients. During their ICU stay patients had GI stimulation for 
463 days (39%), and had stool in 306 days (25%) out of 1183 ICU days. 
The first stool, despite stimulation was registered later in patients with 
brain edema compared to those who did not have edema (7.0 ± 3.1 
vs 3.5 ± 2.6 days; P  =  0.012). Patients with swelling in the vagal nuclei 
area had common paroxysmal hypertensive episodes and needed 
more opioids for sedation as compared to patients without edema 
(12.7 ± 12.1 vs. 46.2 ± 35.9 ME; P < 0.001).
Conclusion: Patients with brain edema had more GI dysmotility dis-
orders than patients without edeam. Randomized controlled studies 
comparing different sedation protocols, opioid vs. nonopioid may 
more accurately confirm an occurrence of GI dysmotility disorders, 
and their correlation with brain edema, and opioid and non-opioid 
sedation in the ICU.
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Introduction: Stroke is the most important medical and social prob-
lem. One of the primary prevention methods is transluminal balloon 
angioplasty with stenting of the internal carotid arteries (ICA TBA) 
for stenosing atherosclerosis as the most common cause of ischemic 
stroke. A significant risk of surgery is carotid sinus syndrome (SCS).
Objectives: To determine of the frequency and timing of the devel-
opment of SCS to ensure its personalized prevention and treatment 
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in patients with atherosclerotic stenosis of the internal carotid arteries 
when performing TBA.
Methods: The prospective study included 120 patients with ath-
erosclerotic carotid stenosis, who underwent TBA. The indications for 
surgical treatment were “symptomatic” stenoses of 50% or more and 
“asymptomatic” stenoses of 70% or more. All patients underwent inva-
sive (Blood Preassure [BP]) and non-invasive monitoring (BP, heart-
beat [HB], sPO2, respiratoty rate [RR]) during and after surgery. The 
diagnosis of SCS was established according to the generally accepted 
classification.
Results: SCS developed in 70% of cases of ICA TBA (n = 84), sig-
nificantly more often in men - 71.4% (n = 60) than in women - 28.6% 
(n = 24), (p < 0.05). The median age was 68 (44:91). The predomi-
nant type of SCS was mixed than cardio-inhibitory or vasodepressor 
(p < 0.05).It took place in 63% of cases and was characterized by the 
almost simultaneous occurrence of sinus bradycardia (or asystole) 
and hypotension. In a little more than half of cases, 54.7% (n = 29) SDS 
developed in response to balloon dilatation, in 11.3% (n = 6) patients 
within 1 hour after dilatation, and in 34% (n = 18) - in more distant 
terms, on average after 6 hours (from 2 to 11 hours). The cardio-inhib-
itory type was observed in 20% of cases (n = 17) and in the majority 
of patients 82% (n = 14) manifested sinus bradycardia both during 
balloon dilatation and within the first hour after it. Atrioventricular 
[AV] block of I and II degrees took place in 2 patients (11.7%). Asys-
tole for more than 3 seconds without loss of consciousness was noted 
in 1 patient for balloon dilatation (6.3%). The vasodepressor type was 
observed in 17% of cases (n = 14). In half of cases - 50% (n = 7) arterial 
hypotension occurred immediately on balloon dilatation, in 5 patients 
- within the first hour after dilatation, and in 2 patients - at more dis-
tant periods (after 2 and 5 hours).
Conclusion: The work performed showed that three out of four 
patients with elective surgical endovascular intervention on the inter-
nal carotid arteries develop SCS, which is most often manifested by 
the almost simultaneous development of arterial hypotension and 
sinus bradycardia. In some cases, surgery is accompanied by cardiac 
arrest. These symptoms can occur not only during balloon dilatation, 
but also hours after surgery. This requires maximum awareness and 
preparedness of the anesthesiologist-resuscitator to provide the nec-
essary assistance to patients, including the correct maintenance of 
blood pressure and heart function in order to prevent stroke and myo-
cardial infarction.
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Introduction: Encephalitis is a severe pathology of the nervous sys-
tem that is difficult to diagnose and treat. Currently, there are a num-
ber of limitations for verifying the etiology of encephalitis. The most 
common symptom is a change in behavior, a decrease in the level of 
consciousness up to coma, epileptic seizures, and focal neurological 
pathology. Often, with viral encephalitis, there is a hemorrhagic trans-
formation of the inflammation focus, interstitial edema in the area of 
the focus, often with a displacement of the mid-stem structures, which 
may require decompression craniotomy.
Objectives: To investigate the peculiarities of diagnosis and treat-
ment of encephalitis of various etiologies.
Methods: We observed 5 patients with encephalitis of various etiol-
ogy. All patients underwent MRI of the brain at admission and in the 
medical examination. To exclude myelitis, MRI of the cervical spinal 
cord was performed. Also, all patients underwent a general study of 
cerebrospinal fluid, PCR of cerebrospinal fluid (CSF) for the presence 
of DNA viruses and intrathecal synthesis of oligoclonal antibodies. 
Also, taking into account the volume and level of lesion of the foci, all 
patients underwent EEG, and a number of patients underwent blood 
tests for the presence of antibodies to NMDA receptors.
Results: In the neurological status, all patients had behavioral 
changes, and later a decrease in the level of consciousness to coma 
in 4 patients and 1 patient developed mutism. Upon further exami-
nation, the following etiology of encephalitis was established: in 2 
cases, herpetic encephalitis (PCR for Herpes simplex virus types 1 and 
2 was positive), in 1 case, bacterial ventriculomeningoencephalitis 
(PCR for Listeria monocytogenes was positive), in 1 patient, necrotizing 
encephalitis associated with Influenza virus, and 1 case - multiple scle-
rosis (intrathecal synthesis of oligoclonal antibodies was determined 
in the CSF). In the general analysis of CSF, all patients had an increase 
in protein and cytosis. EEG in 3 patients out of 5 revealed epileptiform 
activity, which required the appointment of anticonvulsant therapy. 
All patients received glucocorticosteroid therapy and antiviral therapy 
3 out of 5, antibiotic therapy in 1 patient. IVL was performed in 4 out of 
5 patients. 1 patient with herpetic encephalitis underwent decompres-
sion trepanation, 1 patient received external ventricular drainage. The 
outcome in all patients is favorable. (fig MRI).
Conclusion: Thus, MRI and CSF exsamination are necessary diagnos-
tic methods for detecting encephalitis and verifying its etiology. Also, 
neurosurgical treatment can improve the outcome of patients with 
progressive ventriculitis or laterally displaced encephalitis.
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Introduction: Study in patients who are discharged from the Inten-
sive Care Unit (ICU) with a diagnosis of traumatic brain injury (TBI), if 
the situation neurological evaluated with the Glasgow coma Scale at 
discharge from ICU and other variables known at admission and dur-
ing their stay at ICU are related to the situation functional at one year 
evaluated with the Glasgow Outcome Scale (GOS).
Methods: Prospective cohort study of patients with TBI admitted to 
the ICU of the Regional Hospital of Malaga during the years 2004 to 
2008, data collection at hospital admission and monitoring of the 
functional situation with a phone call. Descriptive analysis using pro-
gramme R.
Results: A total of 531 patients, age 35 (22.56) years, APACHE II 17 
(13.23) points, Glasgow on admission 7 (4.10) points were included 
in the study. 398 patients from the total of those admitted were dis-
charged to the ward (6 of them to other hospitals). Follow-up at one 
year was made of 491 patients, 34 were lost to follow-up. 177 patients 
died from hospital admission (133 in the ICU, 19 in the hospital ward 
and 19 in the following year). Using the “R” program, through the 
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“randomForestSRC” program and the function “Vimp” we have stud-
ied the variables with the highest relationship with the dependent 
variable “Functional situation at one year”, classified as good or bad 
situation. The most related variables in order of importance were: 
Glasgow Coma Scale score at discharge from ICU, Age, APACHE II, 
Glasgow Coma Scale Score at ICU a mission. The following table shows 
the relationship with these variables categorized in intervals.
With these variables it was possible to create a predictive model with 
“randomForestSRC” with a discrimination evaluated with the Area 
under the ROC curve 0.818 (0.73-0.90).
Conclusion: The patients with the best functional situation at one 
year are patients who have a Glasgow score on admission to the ICU 
greater than or equal to 6 points, with an age of less than 66  years, 
an APACHE II score of less than 18 points and a Glasgow discharge at 
discharge of ICU greater than or equal to 11 points. We can observe 
that in those patients who are discharged from the ICU with a Glas-
gow score of less than 11 in 92%, the functional situation is poor at 
one year (death, vegetative state or severe disability).
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Introduction: Neuropsychological dysfunction is reported in Covid-19 
patients (C-19 P) (1).
This could be explained by CBF alterations.
TDC was performed in C-19 P to explore CBF and was compared to 
healthy control subjects (C).
Methods: 29 C-19 P and 50 C were included during a two months 
period (March to May 2020). Doppler samples were set at the middle 
cerebral artery (M1 segment of MCA). Transthoracic echocardiography 
was used to record Velocity Time Integral at the left ventricular out-
flow tract (VTIAo).
Demographic data, reasons for admission in ICU, SAPS, sedative, vaso-
pressor use and ventilator support were recorded as well as Mean 
Arterial Pressure (MAP), Systolic (Vs), diastolic (Vd) and mean veloci-
ties, (Vm), Pulsatility (PI) and Resistivity Indexes (RI). Velocity Time 
Integral MCA (VTIMCA) was sampled using TCD. Data were shown as 
median (interquartile: 25-75). T test or non-parametric test (if appropri-
ate) were use. P < 0,05 was considered as significant.
Results: Reason for admission in C-19 P was ARDS. The main comor-
bidities were HTA, diabetes and obesity.
Sex ratio(M/F): 20/9 in C-19 P with SAPS II  = 47(38-62) and 26/24 in C. 
Age: 62 years (53-67) in C-19 P vs 40 years (30-52) in C. All patients but 
2 had invasive respiratory and vasopressor support and sedative drugs.
All TCD classical parameters were altered.
The low values of VTIMCA/VTIAo ratio and HF*VTIMCA/BSA (might 
be a surrogate of the CBF for the later) showed an alteration of the 
CBF. For 15 C-19P, VTIMCA/VTIAo ratio was  < 1,5 and suggested a 
depressed CBF autoregulation independently of CO. (Spearman: 
R2:0,62 p < 0,001).
13 C-19 P had delirium during the weaning and two had a fatal 
ischemic stroke.
Conclusion: CBF autoregulation in Covid -19 patients was markedly 
altered. Alteration of the vasomotor tone thought to be linked to 
endothelium dysfunction. The persistence of CBF abnormalities must 
be evaluated as well as the neuro-psychological and cognitive impact 
on the following.
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Introduction: One of the promising methods of non-invasive ICP 
assessment in the acute period of traumatic brain injury is the ONSD 
assessment based on CT data [1, 2, 3]. The advantages of the method 
are simplicity, relative availability, speed and reproducibility of ONSD 
assessment [5, 6, 7].
Objectives: The aim of the study was to assess the correlation 
between ONSD measured according to CT data, and invasive ICP value 
in patients in the acute period of severe TBI.
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Methods: A retrospective analysis of 49 patients with severe TBI was 
made. Among them 38 were males and 11 females. Average age was 
34 +/- 12 years, GCS (Glasgow coma scale) score - 5.7 +/- 1.8. Twenty-
nine (59%) patients were operated, 17 of them underwent decom-
pressive craniectomy. All victims were admitted to the ICU in the acute 
period of TBI: 2 +/- 1  days from the moment of injury. Upon admis-
sion, all patients underwent brain CT scan and invasive monitoring of 
ICP. ONSD was assessed at a distance of 3 mm from the posterior pole 
of the eyeball [3, 7, 8]. Statistical processing was performed using the 
StatSoft STATICTICA 7.0 package.
Results: A significant correlation was obtained between ONSD and 
the ICP value at the time of ICP sensor (r  =  0.39; r2  =  0.15; p  < 0.01) 
implantation. The correlation between the maximum, average ICP 
value for the entire monitoring period and ONSD did not reach a 
significant level (p> 0.05), what can be explained by the influence 
of therapeutic and neurosurgical methods on the ICP value used for 
intracranial hypertension correction. There was a significant differ-
ence in ONSD in the groups of patients with normal and high ICP (Z  = 
-2.366; p  =  0.017).
Conclusion: In our research significant correlation between ONSD and 
ICP in the acute period of severe TBI was established. There is a further 
need for a more deeper analysisof the relationship between ONSD 
and intracranial hypertension duration, the role of aggressive meth-
ods for ICP correction [1, 4], as well as the prognostic value of ONSD in 
patients with various types of acute cerebral injury [4, 9, 10].
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Introduction: Anemia incidence in neurocritical pathologies like 
subarachnoid hemorrhage (SAH) and traumatic brain injury (TBI) is 
around 30 and 46% respectively (1,2). Anemia is an important cause 
of secondary neurologic injury due to hypoxia(3). Despite its impact, 
the thresholds for red blood cell (RBC) transfusion in clinical practice 
guidelines are only based on hemoglobin values, with no clear recom-
mendation in many cases (4-7).
Objectives: To identify the paraclinical parameters used by health 
care personal to decide the best moment to transfuse critical care 
patients with SAH or TBI.
Methods: Data were obtained from December 2017 to December 
2019 through a google forms survey distributed by email and pub-
lished at the “Asociación Colombiana de Medicina Crítica y Cuidado 
Intensivo (AMCI)” and Latin American Brain Injury Consortium (LABIC) 
web pages. The questionnaire used a format of multiple-choice and 
open-ended questions to assess socio-demographic information, lit-
erature support in which the contestants based their decisions, safe 
number of RBC units to transfuse in less than 24 hours, and optimal 
range of paraclinical tests variables appraising hemoglobin (Hb), 
brain tissue oxygen tension (PbtO2), jugular venous oxygen satura-
tion (SjvO2) and arterio-jugular differences of CO2 (A-VYCO2). The 
entire dataset was stored in a spreadsheet (xlsx) gathering a total of 
90 responses.
Results: The majority of responses came from intensivists (59%) with 
ages between 25-40 years old (55.4%). The countries involved in this 
study were Colombia (22%) and Mexico (11.1%). The type of intensive 
care unit where the responders work, was predominantly a mixed unit 
in 88.2%, with disponibility of blood bank in 85.1% of cases. The major-
ity of the participants (72 and 76.6%) agree with less than 2 RBC units 
as a secure limit for blood transfusion in less than 24 hours for patients 
with TBI and SAH, respectively. Predominantly, there is no perception 
of medical literature guidance to conceal blood cell transfusion in 
patients with TBI (66.6%) or SAH (78.8%). The most common response 
at the moment to determine the optimal range of Hb for TBI and SAH 
was 9.1-10.0  g/dL (31.1%, 34.44%) (Fig.1), being this parameter used 
alone the most common referent to start RBC transfusion (57% for 
TBI and 60% for SAH). The prevailing values to start a RBC transfusion 
in patients for TBI and SAH were  < 7 g/dL for Hb (38.8% and 33.3%); 
16-20 mmHg for PbtO2 (14.4% and 14.4%); < 55% for SjvO2 (33.3% and 
32.2%) and >8 for A-VYCO2 (22.2% and 16.6%) respectively. The major-
ity of respondents use Hb alone for transfusion of RBC (Table 1).
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Conclusion: It is important to promote the assessment of other para-
clinical tests instead of just Hb to achieve a multimodal neuromoni-
toring for RBC transfusion in neurocritical care patients. This will allow 
us to understand more precisely the brain’s metabolic and perfusion 
status and therefore to improve patients’ outcomes.
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Introduction: At the beginning of the 21st century, proning had 
become unpopular in ICU’s across the United Kingdom. This was felt 
to be due to the additional need for resources to carryout, and risk 
of adverse events (1). However, the ARDSNET trial in 2000 and PRO-
SEVA trial in 2013, both showed mortality benefit for patients without 
serious adverse outcomes (2,3). The lack of harm was also confirmed 
by a recent Cochrane review in 2015 (4). In 2019, our remote district 
general ICU felt that proning should be used more frequently, and an 
education session was set up to try and improve the multidisciplinary 
teams’ knowledge and ability to carry it out.
Objectives: Improve the knowledge of respiratory failure and acute 
respiratory distress syndrome (ARDS) amongst the ICU multidiscipli-
nary team.
Teach all members of the multidisciplinary team how to prone and 
deprone a patient safely.
Empower the team to highlight when they feel a patient is deteriorat-
ing and requires proning.
Methods: The teaching sessions were commenced in October 2019. 
A pre attendance questionnaire was given to the attendees to test 
their knowledge of respiratory failure, ARDS and proning. They then 
attended a proning education session where they were given a short 
lecture followed by a teaching session on how to prone and deprone 
a patient safely.
After the session the same knowledge questionnaire was given out. 
This allowed us to directly compare their knowledge and see if our 
intervention was successful.
Results: On average each staff member had proned around one 
patient in the past 12 months.
They also felt before the session that it would take around 30 minutes 
to prone someone and their main concerns were tube displacement, 
patient position, risk of injury to patient, line displacement and patient 
stability.
There were ten knowledge questions. All showed an improvement 
after the session. When the ten questions were averaged, the percent-
age of correct answers improved from 55.6% to 85.5%.
The staff’s confidence to prone a patient, using a scale out of 10, 
improved from 4.0 to 8.9.
The staff’s knowledge of the local protocol, using a scale out of 10, 
improved from 3.2 to 10.
Conclusion: Staff knowledge of respiratory failure, ARDS and proning 
was greatly increased following the session.
Staff confidence to perform the procedure was also greatly improved.
After the success of these education sessions. We are looking to run 
further sessions on proning and other important aspects of ICU care.
The timing of this study was very fortuitus seeing as proning has 
become such an essential part of managing COVID-19 patients. Hav-
ing done and taught the staff in our ICU before the pandemic started, 
it allowed the busy team to focus on other important and vital aspects 
of ICU care.
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Introduction: The Royal London Hospital is a major teaching hospital 
in East London (UK). The Adult Critical Care Unit (ACCU) comprises 44 
beds, staffed by 210 nurses. During the Covid-19 pandemic, critical 
care services doubled in capacity. Critical care nurse to patient ratios 
were dramatically altered. At the same time, over 300 non-critical care 
nurses were redeployed into the department to accommodate this 
increased demand for critical care beds.
Objectives: The primary aim of this project was to offer nurses a col-
lective reflection and processing space to enhance post pandemic 
wellbeing support. The secondary aim was to capture learning about 
processes that supported effective care delivery. Factors contributing 
to positive and effective working practices would inform prepared-
ness for a potential second surge.
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Methods: An Appreciative Inquiry model was used to guide small 
group reflective conversations (1). Critical care and redeployed nurses 
were invited to take part. Groups were distributed according to their 
clinical role. All the sessions were facilitated by an external coach, a 
clinical psychologist and senior staff from the ACCU. A thematic analy-
sis approach was used to identify emerging themes.
Results: The sessions allowed staff the opportunity to discuss difficult 
experiences from working in the Covid19 pandemic. Fifty nurses from 
each staff group participated in these discussions,which generated 
clear descriptions of what promoted effective working and patient 
safety. The views from the two different nursing groups about what 
they valued were complementary. Nurses reported an increased emo-
tional load during Covid-19 with anxiety levels often higher at the 
beginning of the shift. These resulted from feeling overwhelmed and 
fearful of not being able to cope.
The staff huddle at the start of the shift emerged as a key event to 
enable effective working and promote nurses’ psychological safety, 
although this was not consistently used. Redeployed nurses lacked 
the supportive structures of their familiar workplaces and therefore 
valued the welcoming and team working environment created by the 
ITU nurses.
Outcomes from these results include the development of a huddle 
template and education strategies for promoting staff wellbeing.
Conclusion: Appreciative Inquiry proved a valuable and accessi-
ble intervention for nursing staff to acknowledge the achievements 
and contributions during the Covid19 pandemic. The staff huddle 
emerged as a vital part of staff wellbeing. It promoted effective work-
ing relationships, which in turn, are likely to impact positively on care 
delivery and patient experience. Ongoing work will focus on how to 
deliver further sessions more widely to other staff and training.
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Introduction: In the ICU, nursing notes represent the patient’s nar-
rative at the extremes of illness and are used to support decisions 
regarding the escalation or withdrawal of treatment. Their importance 
has recently been dramatically highlighted in a seminal paper that 
revealed that nursing notes can and do predict patients’ probability of 
survival on ICU1.
Objectives: This is a multi-centre service evaluation investigating the 
nursing and medical attitudes towards nursing notes. We wanted to 
investigate how nurses perceived the attitudes of, and frequency with 
which doctor colleagues read their entries into the patients notes and 
if there were differences in attitudes across the different training hier-
archies of nurses and doctors. In addition we wanted to characterise 
the perceived reasons that nurses attributed to this lack of attention.
Methods: This project used an anonymous web-based question-
naire that was sent to nurses and doctors in four ICUs in the East of 
England. Nurses reported their grade, how frequently they believed 
that doctors read their entries into the patients notes (Always/often/
sometimes/rarely/never) and aspects of their notes they thought were 
important to the doctors. For the purpose of analysis, the frequency of 
note reviewing was divided into generally positive responses (always/
often/sometimes) and generally negative responses (rarely/never). 
Doctors reported their grade, the frequency with which they read 
nursing notes and their views on nursing note contents and their util-
ity. Responses were collected from 47 doctors and 120 nurses. Nurses 
were stratified by grade into five groups; Group 1 ( < 5  years nursing 
experience), Group 2 (>5  years experience), Group 3 (Sisters), Group 
4 (CCOT and nurse specialists) and Group 5 (Ward managers and 
Matrons). Doctors were stratified by staff hierarchical grade into four 
groups (Foundation, SHO, Registrars and Consultants).
Results: Analysis of 121 nursing staff responses revealed differences 
in the perceived frequency that nurses reported that their doctor 
colleagues reviewed their notes. The frequency with which nurses 
believed doctors reviewed nurses entries appeared to vary with the 
grade of the nurse, with 66% of Group 4 nurses reporting positively. 
The most negative responses were that of the most senior nurses in 
Group 5 with 100% of responses falling into the negative response cat-
egory. Analysis of the 47 doctors also revealed hierarchical differences, 
with doctors in training having more ‘generally positive’ results than 
consultants.
80% of nurses thought this was due to doctors not having enough 
time/not being interested in the content/not finding them useful. 49% 
of doctors made similar reports.
Conclusion: Nursing notes appear not to be perceived as serving their 
function to facilitate effective communication between allied health-
care professionals. Writing notes reduces the time spent on direct clini-
cal tasks, consideration for how to improve this needs to be made.
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Introduction: Functional electrical stimulation-assisted cycle ergom-
etry (FESCE) enables in-bed leg exercise independently of patients’ 
volition. We hypothesised that early use of FESCE-based intensified 
rehabilitation improves physical function in survivors of critical care 
after 6 months.
Methods: We enrolled mechanically ventilated adults estimated to 
need >7  days of ICU stay into an assessor-blinded single centre ran-
domised controlled trial to receive either FESCE-based protocolised or 
standard rehabilitation that continued up to day 28 or ICU discharge.
Results: We randomised in 1:1 ratio 150 patients (Age 61 ± 15  years, 
APACHE II 21 ± 7) at a median of 21 (IQR 19-43) hours after admis-
sion to ICU. Mean rehabilitation dose delivered to intervention vs. 
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control group was 80 ± 35 vs. 56 ± 15 mins per day, p < 0.01. At six 
months 42 (56%) and 46 (61%) were alive in interventional vs. con-
trol groups (p = 0.51) and their physical component summary of SF36 
(primary outcome) was not different [50 (IQR 21-69) vs. 49 (IQR 49-76); 
p  = 0.26]. At ICU discharge, there were no differences in the ICU 
length of stay, functional performance, rectus femoris cross-sectional 
area or muscle power despite daily nitrogen balance 0.6 (95%CI 0.2-
1.0) g less negative in intervention group. There were more ICP eleva-
tions in intervention group (1.5 vs. 0 ICP elevations/day, p = 0.018) and 
significantly worse mental component summary score of SF-36 after 
6 months [53 (95%CI 45;61) vs. 64 (95%CI 57;72), p = 0.018].
Conclusion: Early delivery of FESCE-based protocolised rehabilitation 
to ICU patients does not improve physical functioning at 6 months in 
survivors and may cause harm.
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Introduction: Coronavirus disease (COVID-19) is a pandemic of inter-
national concern, cause severe respiratory failure and require invasive 
mechanical ventilation.
Early mobilization (EM) in the ICU is safe, feasible, and reduces the 
frequency and severity of complications in critical illness patients. 
Weakness is a frequent problem in ICU, even more evident in patients 
undergoing mechanical ventilation, patients with COVID-19 usually 
needs mechanical ventilation.
We purpose evaluate early mobilization as a facilitator of successful 
weaning from mechanical ventilation and post-extubation outcome in 
patients with SARS-CoV-2 pneumonia.
Objectives: We purpose evaluate early mobilization as a facilitator of 
successful weaning from mechanical ventilation and post-extubation 
outcome in patients with SARS-CoV-2 pneumonia.
Methods: This was a observational retrospective analysis performed 
form medical records of patients with SARS-CoV-2 pneumonia who 
required invasive mechanical ventilation (IMV) for more than 24 hours, 
and, after that, having passed the spontaneous breathing trial. They 
were divided into two groups: the first group that underwent early 
mobilization during the IMV period and the second group receive 
only passive range of motion (PROM). We defined as early mobilization 
the following conducts: sitting on the edge of bed, sitting out of bed, 
active standing, passive standing with a tilt table, and walking during 
IMV.
Results: We analyzed a total of 40 patients who were submitted tra-
cheal extubation. Patients were divided in two groups, EM group 21 
patients and PROM group 19 patients, with average mean age 56,1 
(SD  ± 16,03) and 66,3 (SD  ±  12,91) respectively, the SOFA score mean 
was 4,52 (SD  ±  2,60) versus 6,32 (SD  ±  2,71), and the SAPS III was 
53,29 (SD  ±  9,76) versus 57,11 (SD  ±  9,24), the duration of mechani-
cal ventilation was 10,38 (SD  ±  4,48) versus 10,42 (SD  ±  6,02) 
respectively.
The primary outcome was rate of failed extubation that was in the EM 
group 2/21 (10%) and PROM group 7/19 (35%) (OR 0,18 [IC 0,03-1,01]), 
the rate of mortality was the second outcome, the EM group pre-
sented (0/21) 0% versus (4/19) 20% respectively.
Conclusion: Early mobilization was feasible, safe and maybe associ-
ated with a better outcome for extubated critical patients. Early mobi-
lizations can be associated with lower mortality in COVID-19 patients, 
probably due the improve muscle strength that these patients 
develop.
The relation between early mobilization and successful weaning of 
mechanical ventilation in patients with COVID-19 should be further 
investigated in a large prospective study, that can measure objectively 
the force at the time of extubation.
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Introduction: Subglottic devices, i.e. endotracheal tube (ETT) and 
tracheostomic cannula (CT) are used in critical care both to provide 
mechanical ventilation and to isolate airways from the gastrointestinal 
tract. A correct cuff pressure management is required while caring for 
critical care patients, in order to avoid ischemic damages coming from 
an excessive pressure, and to prevent the inhalation risk related to 
insufficient cuffing. Several studies investigated the influence of mobi-
lization procedures on the cuff pressure, whilst the effects of other 
procedures (such as endotracheal suctioning) were rarely.
Objectives: The aim of this study was to determine the cuff pressure 
variations determined by caring interventions, in order to define an 
ideal cuff pressure monitoring interval and to highlight the procedures 
most frequently involved in generating cuff pressure out of recom-
mended ranges (20-30 cmH2O).
Methods: Study design and setting. A prospective observational 
study was conducted within the three ICU of the Anesthesia and Inten-
sive Care Department at the University Hospital of Udine, Italy.
Population. Patients carrying ETT or CT, aged ≥18 admitted to ICU 
between December 2019 and February 2020.
Variables. Cuff pressure was checked before and after caring pro-
cedures (changes in position, general hygiene care, oral care, tra-
cheal suctioning, fibre-optic bronchoscopy, device’s dressing). Other 
patients and devices variables were recorded.
Statistical analysis. Data were analyzed using the software GraphPad 
Prism 8.0 (GraphPad Software, San Diego, CA, USA). Descriptive meas-
ures were used to describe sample charachteristics. Moreover, pressure 
variation after the procedures was calculated, and the percentage of 
inadequate (i.e. exceeding the range 20-30 mmHg, as recommended 
from the available literature) values was determined. Two-tailed rank 
Wilcoxon test was used to describe periprocedural pressure variation. 
Fisher exact test was used to determine associations between the 
independent variables “need for pressure adjustment prior to the pro-
cedure”, “lenght of intubation ≥ 5 days”, “body temperature ≥37.5°C”, 
and the dependent variable “inadequate cuff pressure”. Kruskal-Wallis 
test was used to describe cuff pressure variations during the days after 
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patients enrollment in the study. Statistical significance was consid-
ered when p < 0.05.
Results: 81 patients (58 males, 72%) were enrolled for observation. 
Globally, 601 paired observations (i.e. before and after the procedure) 
were conducted. Median number of observations per patient was 
4 (range 1-35). Cuff pressure was out of recommended range in 351 
(58%) observations prior procedure performance and in 178 (30%) 
after procedures. Median cuff pressure variation when pre-procedural 
adjustment was not required was -4  cm H2O (range -20; 8  cm H2O). 
Median cuff pressure variation when pre-procedural adjustment was 
required was -6 cm H2O (range -23; 10 cm H2O). Post-procedural cuff 
pressure was out of recommended range after postural change in 58% 
(7/12) of observations, after body hygiene in 31% (50/163) of observa-
tions, in 27% (33/123) of observations after oral care hygiene, in 28% 
(37/132) of observations after tracheal suctioning, in 33% (6/18) of 
observations after fibre-optic bronchoscopy, in 23% (45/193) of obser-
vations after ETT/CT dressing. Post-procedural cuff pressure reduction 
occurred in 510 (85%) of observations; particularly, in 62 observations 
cuff pressure values were ≤15  cm H2O, and in 3 observatons values 
were 5 cm H2O. Median pressure decrease was 6 cmH2O (range -23;-1 
cmH2O). In 65 (11%) observations cuff pressure had no variations and 
in 26 (4%) it increased. Median pressure increase was 6 cmH2O (range 
1-10 cmH2O). Paired two tail Wilcoxon test revealed a statistically 
significant decrease for all paired observations (median difference -5 
cmH2O; p < 0.0001) and for single procedures. Fisher test highlighted 
that the risk for inadequate cuff pressure significantly decreased when 
pre-procedural adjustment was required (RR 0.58, 95% IC 0.45-0.74; 
p < 0.0001). Duration of intubation ≥ 5 days resulted in a lower risk for 
inadequate post-procedural cuff pressure, although the association 
was not statistically significant (RR 0.78, 95% IC 0.60-1.00; p  =  0.595), 
whilst body temperature ≥ 37.5°C slightly increased the risk for post-
procedural inadequate cuff pressure (RR = 1.104, 95% IC 0.81-1.49; p  = 
0.58).
Conclusion: In most observations, a pressure reduction was observed 
after a procedure was performed, and the amount of procedures gen-
erating significant out-of-range pressures was not negligible. There-
fore, cuff pressure should always be checked before and after each 
procedure generating potential cariations. Further studies with larger 
samples might highight the role of rarely investigated procedures 
(such as fibre-optic bronchoscopy and body hygiene) and other risk 
factors related to patient in generating inadequate cuff pressures.
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Introduction: Patients and relatives have an increased need for infor-
mation about what happens before, during and after a critical illness 
and the time at ICU. The knowledge can bring a sense of security and 
safety and also an opportunity to be more involved in the patient care, 
and also to be able to get back to the information and read it again 
during the care The most common form to inform is an information 
booklet, but there are limitations as i.e. updating and availability. 
Today’s technology gives an increased possibility for accessibility of 
information which can help the patients and relatives during the criti-
cal illness and recovery.
Objectives: to create an easily accessible, interactive web-application 
(IVAPP) with information that covers the time of care, before-during-
and after ICU.
Methods: An interprofessional group with a physiotherapist, intensive 
care nurses, assistant nurses, physicians and management staff was 
formed. To collect and create content in the IVAPP, a search for current 
data, as existing information, research and web-sites was done. Con-
tact was also made with various support functions and organizations 
for their input. Photographs from the ICU and equipment were taken 
to supplement the written text. Former ICU patients and relatives were 
invited at two times to review the draft and give feedback on what 
information they would appreciated to get during their ICU care. The 
final version was qualitative reviewed by the ICU director and nursing 
manager before publishing.
The IVAPP was implemented in October 2019 and the information 
about the release was spread in Swedish national broadcasting, news-
papers, in Karolinska Hospital ICUs and at open meetings for staff and 
patients. Also, all the care units that the ICU patients often stays before 
and/or after their ICU care was informed about the app.
Results: The feedback was positive both from staff, patients and rela-
tives. The information obtained in the cellphone filled the needs, it 
was accessible for all, even to those that could not be in the ICU and it 
could be accessed on demand. The information could reduce anxiety, 
aid preparing for discharge from the ICU and hospital and individual-
ize patient care. Statistics showed that “general information about 
the ICU”,” to come home”, “what happened during a day in the ICU”, 
“working in ICU” and “”, were the most visited sides.
Conclusion: IVAPP has been developed in an interprofessional collab-
oration together with patients and relatives. IVAPP is easily accessible 
and can give relatives and patients the opportunity to easily find infor-
mation about intensive care before, during and after the care period.
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Introduction: The International Pediatric Sepsis Consensus defined 
septic shock as sepsis syndrome complicated with cardiovascular 
organ dysfunction, with myocardial and/or circulatory failure being 
leading causes of death. Indeed, septic shock is often characterized 
also by myocardial depression. The evaluation of cardiac function is 
important to detect early deterioration that can have important impli-
cations for treatment and prognostication. Critical Care Echocardi-
ography (CCE) is an established noninvasive tool for the assessment 
of hemodynamic changes in adult patients with shock, and its use is 
increasing in the pediatric critically ill patient too. Several parameters 
describing left and right ventricular (LV and RV, respectively) function 
in septic newborns or children have been studied, from the most con-
ventional ones to the use of Tissue Doppler Imaging (TDI) and strain 
echocardiography (STE). Therefore, we conducted a systematic-review 
in order to describe the echocardiography parameters most stud-
ied so far, and subsequently we performed a meta-analysis aiming at 
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investigating the prognostic value of echocardiography parameters 
and mortality in pediatric patients with sepsis.
Objectives: We conducted a systematic review and meta-analysis to 
investigate the prognostic value of echocardiographic parameters and 
mortality in pediatric septic patients.
Methods: Data Sources: MEDLINE, PubMed and EMBASE (last update 
April 5th, 2020). Study Selection: observational studies conducted on 
pediatric sepsis providing echocardiographic parameters according 
to mortality. Data Extraction: Echocardiography data were divided in 
those describing left ventricular (LV) systolic or diastolic function, right 
ventricle (RV) function and strain echocardiography parameters. Data 
were entered dividing studies in two subgroups: newborns and chil-
dren. Analysis is reported as standardized mean difference (SMD) and 
95%confidence interval (CI).
Results: We included data from 14 articles (n = 5 newborns, n = 98 
children). The Fractional Shortening was the most commonly reported 
variables (11 studies, n = 555 patients) and was not associated with 
mortality (SMD 0.22, 95%CI[-0.02, 0.47];p = 0.097, I2 = 28%). No asso-
ciation with mortality was seen also for LV ejection fraction (9 studies, 
n = 417; SMD 0.06, 95%CI[-0.27, 0.40];p = 0.72, I2 = 51%), s’ (4 studies, 
n = 178; SMD -0.01, 95%CI[-0.34, 0.33];p = 0.97, I2 = 0%), and myocar-
dial performance index (4 studies, n = 199; SMD -0.37, 95%CI[-1.01, 
0.26];p = 0.25, I2 = 65%). Regarding LV diastolic function, we found a 
significant association of mortality with E/e’ ratio (4 studies, n = 189, 
SMD -0.45, 95%CI[-0.80, - 0.10]; p = 0.01, I2 = 0%) or e’ wave (3 studies, 
n = 159; SMD 0.49, 95%CI[0.13, 0.85];p = 0.008, I2 = 0%). No association 
was found between E/A ratio (6 studies, n = 273; SMD 0.28, 95%CI[-
0.42, 0.99];p = 0.43, I2 = 81%) and s’ measured at tricuspid annulus (3 
studies, n = 148; SMD -0.18, 95%CI[-0.53, 0.17]; p = 0.32, I2 = 0%). Only 
few studies were conducted with strain echocardiography.
Conclusion: We found no association between mortality of septic 
pediatric patients and parameters evaluating LV systolic function and 
RV function. A significant association was found between mortality 
and higher E/e’ or lower e’, indicating a possible influence of worsened 
LV diastolic function. These findings are preliminary due to the high 
clinical heterogeneity of the studies included.
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Introduction: Elective intensive care unit (ICU) admission represents 
an important part of all ICU admissions. Critical care admission may 
be necessary for surgical patients requiring organ support or inva-
sive monitoring in the perioperative period. Planed postoperative 
admissions aim to prevent complications arising in the postopera-
tive period, reducing the risk of a poor outcome. Several prognostic 
indices have been used to predict the outcome of surgical critically ill 
patients. Among them, acute physiology and chronic health evalua-
tion II (APACHE II) and simplified acute physiology score 2 (SAPS 2) are 
broadly used. Moreover, biological markers such as C-reactive protein 
(CRP), albumin, and blood lactate levels correlate with the degree of 
inflammation during the immediate postoperative phase and could be 
used as independent predictors.
Objectives: The purpose of this study is to demographically and 
clinically analyze all the elective surgical admissions between January 
2018 and June 2020 and also to evaluate patients outcomes compar-
ing the different predictive values of prognostic indices and biological 
markers in the outcome of 62 surgical patients admitted to the ICU in 
the postoperative phase.
Methods: A retrospective cohort study of all elective surgical admis-
sions in a ten-bedded combined medical-surgical intensive care unit 
of a Portuguese hospital between January 2018 to June 2020. Com-
paration between albumin levels were performed using Man-Whitney 
U-test.
Results: In the period from January 2018 to June 2020, 62 patients 
were elective admitted to our ICU. The mean patient’s age was 67.9 
(19-88), being 50% of them men (31). Among the elective admissions 
the majority were after whipple procedure, representing 67.7% of all 
admissions. The median Charlson score was 5 points [0-11 points]. 
The median ICU length of stay was 3 days [2-4 days] and the median 
time with mechanical ventilation was 2 days [1-3 days], being that 34 
patients needed less than 24 hours of mechanical ventilation. Regard-
ing the prognostic indices the median SAPS 2 was 30 [23-43.3] and 
the median APACHE II was 13 [8.8-19]. As to biological markers the 
median admission C-reactive protein was 58  mg/dL [17.3-101.7] and 
the median admission lactate was 2,6 [2.1-3.3]. When analyzing albu-
min, the patients submitted to whipple procedure demonstrate a 
significant lower ICU admission albumin levels with a median of 26 g/
dL than the patients undergone to other types of procedures with a 
median of 30 g/dL (P 0.004). As for the evaluation of sepsis during the 
length of ICU stay, 5 patients (8,1%) develop sepsis. According to the 
acute kidney injury classification (AKIN) 11,3% had a stage 1 acute kid-
ney injury, 6,5% a stage 2, and 1,6% a stage 3. None of the patients 
analyzed needed renal replacement therapy. The overall ICU mortality 
was 3,2%, the hospital mortality was 6,5% and 49 patients were still 
alive after a 6 month follow up, representing 79% of patients.
Conclusion: This retrospective study conducted in a 10-bed inten-
sive care unit shows that critical care admitted patients after elective 
surgery were mainly submitted to a whipple procedure and have a 
median charlson score of 5. The median length of stay in the ICU was 
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less than 4  days and the median mechanical ventilation time was 
4 days. Regarding the prognostic indices we found low APACHE II and 
SAPS 2 values reflecting the fact that those patients were electively 
admitted and that most of them didn’t develop any complication dur-
ing the perioperative phase or during the hospital stay. We also found 
that postoperative albumin levels were low mainly in the group of 
patients submitted to a whipple procedure, probably reflecting the 
magnitude of surgery and the associated stress response. In addition, 
overall mortality was low in this patient population.
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Introduction: Acute surgical patients account for a significant per-
centage of admissions in an Intensive Care Unit (ICU). Outcomes of 
these surgical patients must be assessed and several clinical scores 
are available to guide clinicians. Acute Physiology And Chronic Health 
Evaluation II (APACHE II) and Simplified Acute Physiology Score 2 
(SAPS 2) have been used to predict the outcome of surgical critically 
ill patients. However, none of these scores have a 100% sensitivity or 
100% specificity. Most of these patients are septic and serum lactate 
level is considered a sensitive marker for sepsis or septic shock reflect-
ing a cell-based metabolism. C-reactive protein (CRP), albumin, CRP/
Albumin ratio and blood lactate levels correlate with the degree of 
inflammation during postoperative care. These and potentially oth-
ers biological parameters could be used as independent predictors of 
poor outcomes.
Objectives: The aim of this study is to compare prognostic value of 
two indices (APACHE II and SAPS 2 scores) and biological markers in 
the outcome of acute surgical patients admitted in ICU in the immedi-
ate postoperative care.
Methods: An observational retrospective study of all acute surgical 
admissions into our ICU in the immediate postoperative care from 
January, 1st to December, 31st 2018 and had a ICU length of stay 
longer than 24 hours. Data concerning the diagnosis, comorbidities 
and demographics were documented in medical records. The bio-
logical markers CRP, albumin, serum blood lactate, N-terminal pro-B 
type natriuretic peptide (NT Pro-BNP), leukocytes, platelets and Glo-
merular Filtration Rate were collected during the first 24 hours after 
patient’s admission and prognosis indices (APACHE II and SAPS 2) 
were recorded. Patients were divided into survivors and non-survivors. 
Comparations between survivors and non-survivors were performed 
using the Student-T test or Man-Whitney U-test for quantitative vari-
ables (parametric and non-parametric variables, respectively) and 
Pearson Chi-square test for qualitative variables.
Results: Sixty surgical patients admitted into our ten-bed ICU in the 
immediate postoperative care were retrospectively studied. Patients 
were divided into survivors (n = 33) and non survivors (n = 27) as 
decribed. The ICU and overall in-hospital mortality were 30% and 
15%, respectively. Non-survivors were older than survivors (76 vs 69 
yeats old, p = 0.024) and males died more than females (males 63% vs 
36,4%, p = 0.042). Comorbidities were performed by Charlson’s score 
and non-survivors had a statistically higher Charlson’s score (score 
5 vs 3, p = 0.001). There were no statistic differences in ICU length of 
stay between groups. APACHE II (27 vs 19, p < 0.001), SAPS (61 vs 46, 
p < 0.001), serum lactate (4,8 vs 3,2; p = 0.015) were significantly higher 
in the non-survivors group. Glomerular Filtration Rate in ICU admis-
sion was lower in non-survivors (17,4 vs 56,3; p = 0.001) and the need 
of Renal Replacement Therapy was higher in this group (29,6 vs 9,1%; 
p = 0,043). No differences were found between groups in days of 
mechanical ventilation, ratio CRP/Albumin, CRP, Albumin, NT-proBNP, 
leukocytes count, hemoglobin or blood transfusions. No differences 
were found between two groups regarding sepsis in admission.
Conclusion: Mortality rates in acute surgical patients are still very 
high in Intensive Care Unit and several scores of severity of critically 
ill patients can predict their mortality like APACHE II and SAPS 2. In 
our study these scores are higher in non-survivors patients and can 
be associated with greater severity of the disease and their higher 
in-hospital mortality. Serum lactate levels are related with mortality 
and can be associated with tissue hypoxia and elevated inflamma-
tion during postoperative care. Glomerular Filtration Rate is lower in 
non-survivors, reflecting acute kidney injury and renal failure with the 
need of Renal Replacement Therapy. Studies have showned that sepsis 
is frequently complicated by acute kidney injury which increases the 
mortality risk.
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Introduction: Despite the fact that laparoscopic surgery seems to 
be safe in high-risk surgical patients, it is associated with significant 
hemodynamic changes. Patients with colorectal malignances often 
have a number of cardiovascular and other comorbidities, and severe 
hemodynamic fluctuations could be a risk factor for postoperative 
morbidity. Thus, we hypothesis that hemodynamic changes during 
elective laparoscopic colorectal surgery might be associated with 
postoperative complications development.
Objectives: The aim of the study is to analyze potentially modifiable 
risk factors related to hemodynamic changes during laparoscopic sur-
gery in patients with colorectal malignances.
Methods: A single-center retrospective study was performed in a 
university clinic in Saint-Petersburg, Russia. We analyzed 100 medical 
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recordings of patients undergoing elective colorectal surgery in 2017-
2019. The analysis considered systolic blood pressure (SBP) changes, 
changes of mean arterial pressure (MAP), intraabdominal perfusion 
pressure (IPP), incidence of tachy- or bradycardia during operation 
time, and complications Clavien-Dindo Grade III-V. Univariate and mul-
tivariate analyses were performed in SPSS Statistics 20.0 to identify risk 
factors for postoperative complications.
Results: Postoperative complications occurred in 16 patients (16%). 
These patients had significantly more episodes of SBP drop from base-
line, MAP  <  65 mm Hg, IPP  <  65 mm Hg during pneumoperitoneum. 
SBP lowering, MAP, IPP were significant risk factors for postoperative 
complications (p  <  0,001). In multivariate analysis, SBP lowering (OR 
1,535, 95% CI 1,095-2,152, p  =  0,013) and IPP (OR 0,75, 95% CI 0,611-
0,932, p  =  0,009) were independent risk factors for postoperative 
complications.
Conclusion: Our results may suggest that severe hemodynamic fluc-
tuations could be related to postoperative complications in patients 
undergoing elective laparoscopic colorectal surgery.
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Introduction: Vascular surgeries are associated with a particularly 
high risk of postoperative complications due to a high number of 
comorbidities in this population as well as increased risk of periopera-
tive bleeding and hypotension associated with these procedures.
Objectives: To assess the incidence of major cardiovascular complica-
tions in 1-year follow-up after vascular surgeries.
Methods: This is a substudy of the Vascular Events In Noncardiac Sur-
gery Patients Cohort Evaluation Study (VISION), in which patients aged 
≥ 45 years undergoing non-cardiac surgeries and hospitalized at least 
overnight were enrolled. In this large, international prospective cohort 
study, each patient had postoperative troponin measurement to 
assess the association between troponin level and postoperative out-
comes. Additionally, patients or their relatives were contacted 30 days 
and 1  year after the procedure to assess the incidence of complica-
tions in short- and long-term observation.
Results: Study group consisted of 2641 patients undergoing vas-
cular surgeries. There were 2047 (77.5%) males and the mean age 
accounted to 68.2 (SD 9.8) years. The most common comorbidities 
were hypertension (75.5%), peripheral artery disease (67.5%) and cor-
onary artery disease (38.0%). During the 1-year follow-up 223 patients 
died (8.4%), 243 patients had myocardial infarction (9.2%), 35 patients 
suffered a stroke (1.3%), 192 patients underwent amputation (7.3%), 
68 patients developed congestive heart failure (2.6%) and 18 patients 
had non-fatal cardiac arrest (0.7%).
Conclusion: Major cardiovascular complications were common 
among patients undergoing vascular surgeries in the long-term obser-
vation. The most common complications were myocardial infarction, 
death and amputation.
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Introduction: Diabetes insipidus (DI) is a clinical disorder of water 
metabolism in the human haemostasis, commonly resulting from 
the deficiency of antidiuretic hormone (ADH) or from renal insen-
sivity to ADH. DI manifests by the patient passing diluted copious 
amount of urine.1 DI is classified as central or nephrogenic and preg-
nancy induced, in central DI, posterior pituitary gland fails to secret 
ADH. Nephrogenic DI is when the renal receptors do not respond to 
ADH. Pregnancy induced DI is when placenta consumes most of the 
secreted ADH, leading to ADH deficency.2 DI is common after the pitu-
itary gland surgeries.3 There are a few case reports of DI after general 
surgical procedures. 4 Although polyuria is common in the post-oper-
ative period, it is important to diagnose DI to prevent severe dehydra-
tion and life-threatening electrolyte imbalance. We report two unusual 
cases of DI during the perioperative period requiring hydration and 
intravenous desmopressin.
Methods: Case Reports.
Results: Case1: A 49 years old healthy male was diagnosed with cer-
vical vertebral disc prolapse (C5-6), planned for cervical discectomy 
and cage fusion. General anaesthesia was induced with etomidate 
and fentanyl, trachea was intubated under the effect of rocuronium, 
in addition patient received ketamine and cefazolin during induction. 
Anesthesia was maintained by propofol and remifentanil target con-
trolled infusion (TCI). Foley’s catheter was in place and he was pour-
ing 50 and 70  ml of urine per hour. His hemodynamics were stable. 
In the 2nd hour of surgery he became polyuric and passed 700 to 
800 ml diluted urine in next 2 hours until the surgical procedure was 
over. He was started on 50 ml/hour of 0.45%saline and shifted to post 
anaesthesia care unit. He remained polyuric and keep passing 400 and 
300  ml of diluted urine next 2 hours. He developed hypernatremia, 
renal functions were with in normal range and urine specific gravity 
was  < 1005, diagnosed to have central diabetes insipidus and given 
intravenous (IV) 2 micrograms (µgrams) of desmopressin. For the next 
hours his urine became concentrated and urine output dropped to 
50, 60 and 70  ml/hour. He was transferred to high dependency unit 
(HDU), remained stable, from there discharged home and followed up 
in neurosurgical outpatient clinics.
Case 2: A 36-year-old healthy male presented with on and off head-
ache. Computer tomography (CT) and MRI (magnetic resonance 
tomography) diagnosed to have 3rd ventricular cyst. He underwent 
right frontal craniotomy and excision of ventricular cyst. Anesthesia 
was induced with propofol and remifentanil, trachea was intubated 
under the effect of rocuronium. He received cefazolin during the 
induction of anaesthesia. Anesthesia was maintained with remifen-
tanil and propofol infusion. Patient remained hemodynamically sta-
ble. His urine output remained 50 to 70  ml/hour during the surgical 
period. Patient was transferred to the surgical intensive care unit 
(SICU) for further monitoring. In the SICU during the 1st and 2nd hour 
he passed 600 ml and 700 ml of diluted urine respectively. His serum 
sodium jumped to 148  mmol/litre, renal functions were normal and 
urinary specific gravity was  < 1005. Patient was started on 100  ml/
hour of 0.45% saline and desmopressin 2 µgram was administrated 
intravenously. From the next hour his urine became concentrated 
and urine output dropped to 50 to 100  ml/hours. Patient remained 
hemodynamically stable and serum sodium became normal. He was 
transferred to the ward the next day and from there discharged home. 
Followed up in the neurosurgical outpatient clinic without any issues.
Conclusion: : The occurrence of DI in above mentioned surgeries is 
very rare. Both surgical procedure and anaesthesia medications can 
cause perioperative DI.
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Introduction: Dynamic indices of fluid responsiveness (e.g. pulse 
pressure variation – PPV and stroke volume variation – SVV) differ 
between hemodynamic monitors, which use proprietary algorithms, 
and vary even over a short period of time.
Objectives: The aim is to compare the stability and predictive value 
for fluid responsiveness of PPV and SVV measured by various mini-
mally invasive devices in high-risk patients undergoing general 
surgery.
Methods: In this prospective study, clinically indicated fluid chal-
lenges (FC; 500  ml of balanced crystalloid administered over 10 
minutes) in patients ventilated with tidal volume of 8 ml/kg were mon-
itored. Increase in cardiac output (CO) ≥ 15% defined fluid responders. 
Two minutes of arterial pressure waveform was recorded with simul-
taneous video recording of hemodynamic monitors – GE Carescape 
B650 (measuring PPV), FloTrac/Vigileo (SVV) and LidCO Rapid (PPV 
and SVV) before and after the FC. All devices used the same arterial 
line and waveform; arterial line flushing was used for synchronization 
with the video. Analysis was limited to intervals with regular rhythm 
and good waveform quality. Up to 17 values were read from the video 
in 5 s intervals and reference PPV was calculated from the stored arte-
rial pressure waveform at the same timepoints offline. Stability of 
the parameter was assessed by calculating the range and standard 
deviation (SD) of the index over observed period up to 80  s before 
FC. Receiver operating characteristic (ROC) analysis and a correlation 
of the index with change in CO were used to evaluate the predictive 
value of the indices.
Results: Twenty three patients were analysed; 14 of 60 fluid chal-
lenges were excluded due to changes in vasoactive drugs, patient‘s 
position change, arrhythmia or artefacts during the FC. Stability was 
assessed by variation of parameters – mean values of range (and SD) 
were 3.8 (1.0) % for reference PPV, 1.8 (0.5) % for GE PPV, 10.8 (3.0) 
% for LiDCO PPV, 8.3% (2.4) for LiDCO SVV and 2.3 (0.9) % for Vigileo 
SVV. Mean value of the indexes during 80-second interval before FC 
was used to calculate the area under the ROC curve (AUROC), opti-
mal threshold, correlation with ΔCO (r) and specificity/sensitivity for 
threshold values of 10% and 13%, which are presented in the table. 
Mostly, an average value of the index had better AUROC than minimal 
or maximal observed values within the observed period.
Conclusion: LiDCO displayed higher fluctuation of indices than the 
other monitors. Although a significant span of threshold values was 
observed, the predictive value of PPV and SVV from all the monitors 
was comparable. Despite ideal conditions, the diagnostic ability of all 
parameters was only moderate and lower than expected.
16. Poisoning/Toxicology /Pharmacology > Poisoning/Toxicology /
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Introduction: Metformin associated lactic acidosis (MALA) has been 
reported as from 1977, but full understanding of this entity has yet to 
be achieved. It is the major toxicity of metformin with high attributed 
mortality rate. In the most severe cases intensive care admission and 
renal replacement therapy (RRT) are required.
Objectives: To report on our experience with the MALA patient’s 
characteristics, severity scores, supportive measures required in the 
last 5 years.
Methods: Retrospective analysis of the clinical information of patients 
admitted in intensive care level 2 and 3 with main or additional diag-
nosis of MALA from 2015 to 2019.
Results: We obtained 20 patients of which 13 (65,0%) had principal 
diagnosis of MALA. Most of the patients were female (n = 11), mean 
age 75,9  ±  5,9. 14 patients (70,0%) were admitted on level 3 care. 
Antibiotics were administered to 60,0% (n = 12) of patients with only 
41,6% of those (n = 5) having clinically confirmed infection. Initial 
lactate levels were 12,6  ±  3,5 and 24 h lactate levels were 3,2  ±  3,3. 
60,0% of patients required renal replacement therapy (n = 12). The 
RRT modalities were: continuous veno-venous hemodiafiltration in 
33,3% (n = 4), continuous veno-venous hemofiltration in 33,3% (n = 4) 
and conventional haemodialysis in 33,3% (n = 4). Invasive mechanical 
ventilation was necessary in 25,0% of patients. Severity scores were: 
APACHE II 25,5  ±  7,3; SAPS II 50,9  ±  11,5; SAPS 3 69,2  ±  16,2; SOFA at 
admission 9,0  ±  3,8. Mean length of stay in intensive care was 3,5  ± 
4,2 days and in hospital was 16,0  ±  9,1 days. Hospital mortality was 
the same of net mortality: 2 patients (10,0%).
Conclusion: Although with limitations due to its retrospective nature, 
known under-report of the condition in matter, and varied concur-
rent pathologies of patients reported, this study presents our reality 
while treating MALA. We confirmed high use of antibiotics compared 
to clinically confirmed infection, something referred in the literature. 
Continuous veno-venous renal replacement was used in the majority 
of the patients requiring renal replacement. Patients with diagnosis of 
MALA present with high severity scores but have low mortality in our 
experience.
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Introduction: Studies on characteristics, outcome and clinical burden 
of Intensive Care Unit (ICU) admissions following drug overdose are 
scarce despite the significant health and social impact caused.
Methods: A retrospective observational study was carried out from 
2015 to 2019 in an ICU of a district general hospital in Essex, UK with 
the aim of identifying the demographic and clinical characteristics and 
factors affecting delay in discharge of the patients admitted to ICU fol-
lowing drug overdose.
Results: Total number of admissions with illicit or prescription drug 
overdose over the last 5  years were 202 (4.3% of total admissions). 
56% were females. Mean age was 38.7  years and patients in the age 
range of 30-39  years had the highest number of admissions (n = 51, 
25.2%). 74.2% were known patients with mental health disorders and 
49.5% had a previous history of self-harm. 25 were readmissions which 
comprised 12.43% of total admissions. Psychoactive medications were 
the commonest drugs used. Average ICU stay was 2.85 days (Median - 
1.8 days). 93.7% were discharged and mortality was 4.4%. The majority 
were home discharges (43.5%). All home discharges were reviewed by 
the mental health team (MHT) except 11 self-discharges. All ward dis-
charges (30.7%) were referred to MHT to be reviewed in ward. Delay 
in discharge from ICU for more than 6 hours since being declared 
‘Medically Fit for Discharge’ was identified as a late discharge. 40.5% 
of admissions got a delay in discharge. Average delay in discharge was 
1.05 days and it ranged from 8 - 96 hours. 72% of the delays occurred 
due to late assessment by MHT to ensure mental fitness for safe home 
discharge or in arranging a mental health ward bed if not fit for dis-
charge. Reasons for delay and the frequency are shown in the follow-
ing table.
Notably the duration of ICU stay had a rising trend over the years 
along with a proportional increase in delay in discharge as shown 
below.
Conclusion: Drug overdose continues to be a growing public health 
concern worldwide. Importantly, younger generation is mainly 
affected, most are preventable and many require ICU care. A striking 
proportion of our study; 75% had mental health issues and 50% had 
a previous history of self-harm. Readmission rate was high, highlight-
ing the importance of psychological support these patients contin-
ues to require more. Hence review by MHT is essential before a safe 
discharge. However, a significant percentage (40.5%) had a late dis-
charge, longest being 96 hours. The main reason was a delay in MHT’s 
review and arranging further psychological care. Patients who faced 
delays awaiting MHT were otherwise medically fit for direct discharge 
to home and did not require inward care.
Drug overdose admissions accounted for an average of 115.1 ICU bed 
days per year. Out of this, 42.42 ICU beds days (36.8%) were occupied 
due to the delay in discharge. Since the estimated daily cost of a level 
2 ICU bed at our institute is 800 pounds, 33,936 pounds/year can be 
saved by optimising the barriers to prompt discharge from ICU. These 
may include increasing MHT staff and their availability in ICU and pri-
oritizing ward bed allocation to patients stepping down from ICU.
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Introduction: Renal function changes in COVID-19 patients admitted 
to the ICU are still poorly delineated. Sole use of plasma creatinine only 
allows for determination of estimated glomerular filtration rate (eGFR), 
whereas combined with 24 h urinary creatinine excretion, direct deter-
mination of measured creatinine clearance (mCC) is possible.
Objectives: Our goal was to assess renal function with mCC in criti-
cally ill COVID-19 patients and also assess its relationship with vanco-
mycin dosing.
Methods: Consecutive COVID-19 patients admitted to our ICU until 
May 2020 were analyzed over the first 30 ICU days. Vancomycin was 
administered as a loading dose followed by continuous infusion with 
dose adjustments based on therapeutic drug monitoring (TDM) with 
a target vancomycin plasma concentration between 20 and 25 mg/L. 
Plasma creatinine, eGFR, mCC as well as vancomycin concentrations 
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were regularly obtained. We defined augmented renal clearance as 
an mCC >130 mL/min/1.73 m2 [1]. Our current vancomycin TDM algo-
rithms do not use mCC but are based on weight and eGFR.
Results: We evaluated 90 patients (73% male), with a mean ( ± SD) 
age of 62  ± 10  years. Unadjusted hospital mortality was 21%. 
Mean weight, BMI and BSA were 90  ± 16  kg, 28.5  ± 4.6  kg/m2 and 
2.07  ± 0.20 m2. In total 1063 mCC measurements were available. In 31 
(34%) patients an mCC < 30 ml/min was observed at any time and 11 
of these patients required renal replacement therapy (RRT). In patients 
not requiring RRT the mean mCC was 112  ± 48  ml/min. Augmented 
renal clearance was observed in 39 patients (43%) for a total of 194 
(18%) mCC measurements.
Vancomycin was prescribed for 35 episodes in 30 (33%) patients 
with a mean loading dose of 1724  ± 574 mg (19.0  ± 4.9 mg/kg), and 
a mean maintenance dose of 2268  ± 886  mg (25.3  ± 10.8  mg/kg). 
181 vancomycin levels were determined with a mean concentration 
of 22.7  ± 6.7 mg/L with 17 (57%) patients having at least 2 measure-
ments below 20  mg/L. Daily vancomycin dose was more correlated 
(P < 0.01) with mCC (R2 = 0.66) compared to eGFR (R2 = 0.43).
Conclusion: Although we observed renal failure in our cohort of 
COVID-19 patients treated in the ICU, a considerable subgroup 
showed augmented renal clearance when mCC was employed, likely 
explaining the failure to reach therapeutic vancomycin levels. Deter-
mining mCC in COVID-19 patients has therefore clear benefits over the 
use of eGFR.
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Introduction: A systemic inflammation may affect tramadol metabo-
lism within first 24 postoperative hours.
Objectives: The aim of this study was to examine concentrations 
of tramadol, O-demethyltramadol (ODT) and N-demethyltramadol 
(NDT) in patients admitted to the intensive care unit (ICU) after major 
abdominal surgery in the patients with and without criteria for sys-
temic inflammation.
Methods: For this study Ethics committee approval was obtained and 
all the patients wrote informed consent. In between of 50 postsurgi-
cal patients, a group of 47 patients who had both CYP2D6 gene poly-
morphism analyses and tramadol and it’s metabolites measured were 
analyzed. The development of a systemic inflammation was assessed 
based on preoperative levels of CRP, PCT, leukocyte count, plasma 
cholinesterase activity (ChE), arterial blood gas, and postoperative 
clinical indicators. Postoperatively, patients received 100 mg of trama-
dol IV. every 6 hours for the next 24 hours. Tramadol, ODT and NDT 
levels were determined 1, 2 and 4 hours after the first dose, and before 
the second, third and fifth doses of tramadol by high-performance liq-
uid chromatography. Pain was assessed before and 30 minutes after 
tramadol administrations.
Results: According to CYP2D6 polymorphism there were 2 poor 
(PM), 22 intermediate (IM), 22 extensive (EM) and 1 ultrafast metabo-
lizer (UM). Tramadol effectively reduced pain in all patients except 
PM. The highest levels of ODT were measured in the EM and IM, 97.4 
(52.5–139) and 51.7 (25.7–93.5) µg/L, respectively (P = 0.03). ODT lev-
els in all measurements were higher in EM compared to IM and PM, 
P < 0.05. ChE activity of £4244 U/L was a cut-off value in prediction of 
systemic inflammation. There was a statistically significant increase in 
NDT levels in IM and EM patients with low ChE activity (LChE group, 
n = 18) compared to patients with normal ChE activity (NChE group, 
n = 25). The ranges were from 11.58 (4.2–21.9) to 59.31 (18.5–92.6) 
µg/L vs. 3.93 (3.5–5.6) to 26.31 (17.4–48.9) µg/L in LChE and NChE, 
respectively. Genetically determined difference in ODT levels between 
IM and EM no longer existed in states of systemic inflammation in all 
measurements. Despite these differences, tramadol was effective in 
patients who were EM and IM in reducing pain at all measurement 
points (P < 0.001), but not in 2 patients who were categorized as poor 
metabolizers (P>0.05).
Conclusion: The results of this study confirm that CYP2D6 poly-
morphism is a major factor in O-demethylation of tramadol. In the 
systemic inflammation characterized by low ChE activity there is a 
significant shift in the tramadol metabolism towards N-demethyla-
tion. Further studies should evaluate whether tramadol dose may be 
reduced in the patients with systemic inflammation.
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Introduction: Sedation is an integral practice in intensive care units 
(ICU). Higher sedation requirements were observed in patients with 
COVID 19 [1]. However, the negative impact of oversedation in the 
intensive care setting is well established. Patients are at risk of a higher 
morbidity, increased length of stay, longer time on mechanical venti-
lation, increased nosocomial infections, haemodynamic compromise 
and neurological complications such as delirium to name a few [2-5].
Objectives: This is a retrospective analysis of sedation practice pre- 
and during the COVID 19 pandemic at the Royal Cornwall Hospital, 
a district general hospital in the United Kingdom. IV sedation agents 
were reviewed for rapid escalation or for exceeding maximum recom-
mended doses.
Methods: All patients receiving continuous IV sedation in January 
2020 (pre-COVID 19) and April 2020 (during the COVID 19 pandemic) 
were screened. Those who had >24 hour sedation were included. Their 
charts were reviewed for breaching the maximum doses according to 
local protocol or the British National Formulary (Table 1) or increasing 
> = 50% in 4 hours. A notes review was carried out around the time of 
a breach for any documented rationale. The number of adjuvant seda-
tive medications a patient received in the duration of their ICU admis-
sion was also recorded. This included oral clonidine, intermittent doses 
of benzodiazepines (IV and oral), haloperidol and quetiapine.
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Results: Prior to the COVID-19 pandemic 6/16 (37.5%) of patients had 
a sedation breach. This is compared to 9/12 (75%) of patients during 
the pandemic of which half (6) were patients who did not have COVID 
19. Of these, 4/6 (66.7%) of the non COVID 19 and 5/6 (83.3%) of the 
COVID 19 patients had sedation breaches. Breaches recorded were 
predominantly in exceeding maximum infusion rates. Pre-COVID 19, 
there were only 2 patients breached for rate increases > = 50% ver-
sus 5 patients who exceeded maximum rate infusions. During- COVID 
19 5 patients recorded rate increases > = 50% compared to 7 who 
exceeded maximum infusion rates.
Propofol was the main agent for which sedation breaches occurred in 
both cohorts -before COVID 19 5/15 (33.3%) and 8/10 (80%) during the 
panedemic. The main reason for edation breaches was difficult ventila-
tion in both cohorts (37.5% pre CVOID 19 and 42.5% during). Adjuvant 
sedative medications were used in 9/16 patients pre- COVID 19 and 
9/12 patients during COVID 19. During COVID 19 the patients received 
3 or more adjuvant agents 6/9 compared to pre-COVID 19 2/9.
Conclusion: The sedation of patients at this ICU was less compliant 
to guidance and experienced more sedation infusion rate increases 
> = 50% during the COVID 19 pandemic in keeping with experience 
elsewhere that they had a higher sedation need. However, these 
patients also received a larger number of adjuvant sedative medica-
tions. This could also relate to a change in sedation practices by pre-
emptive concerns about difficult to sedate patients or other factors 
such as routine ICU medication stock levels.
Although there were fewer sedation breaches pre-COVID 19, over a 
third of patients still received high doses of sedation in normal times. 
This suggests more can be done to optimise sedation administration 
through a multimodal approach which addresses education and ergo-
nomic clinical environments. Recommendations implemented at this 
centre include: training for staff new to the ICU environment, an eas-
ily accessible “sedation user guide” which to highlight common clini-
cal considerations for sedative choice and encourages staff to review 
why sedation requirement may have changed, a standardised white-
board to record sedation targets and infusion rates, and once per 
shift reminders to check sedative infusion rates A review is due in the 
autumn of 2020 subsequent to the adoption of these practices.
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Introduction: Management of pain in critical patients is one of the 
most important part of the treatment and it is necessary to improve it 
in order to get better prognosis.
Objectives: To describe prevalence of pain detection and analgesic 
prescriptions in patients admitted to an ICU of a terciary hospital.
Methods: Weekly registration for 1  month in 2 consecutive years 
(2018-2019) of: type of admission, treatment phase, analgesic regimen 
and assessment of pain through Visual Analogue Scale (VAS), Behav-
iour Indicators of Pain and Richmond Agitation Sedation Scale (RASS), 
as appropriate; as well as pharmacological non-pharmacological 
interventions.
Results: In a total of 184 patients, of which 56.5% of them were males; 
respiratory failure (45.7%), followed by neurological deterioration 
(32.6%) and shock (17.4%) were main causes for admission. 58.7% 
of the patients were awake and able to self-report pain, and the rest 
were under sedation or non-collaborative. Of all of them, 69% required 
mecanical ventilation (MV) (invasive MV 54.9% and non invasive MV 
14.1%) and 20.7% had tracheostomy.
Attending to analgesic regimen, 99.5% of the patients had established 
analgesic regimen: 29.3% of them had a fixed regimen without adju-
vant therapy, 13.6% were only prescribed in case of pain, and 56.5% 
had a fixed regimen plus adjuvant therapy during pain episodes. and 
rescues. 66.8% of the patients had up to 2 medications for pain and 
the rest of them, had more than 3 medicationes.
Attending to registration of pain episodes: In every patient it was 
recorded at least once per day. In 1.6% it was only registered once a 
day, in 20.7% twice a day; in 54.3% three times per day, and 13.4% four 
or more times per day. There was also a explicit reference of that in 
in 79.3% of nursery registration during mornings, 78.3% during after-
noon, and 72.3% during night, as well as in 80% of medical comments. 
According to the degree of pain, 44% of the patients did no show pain, 
36% of them showed mild pain (VAS 1-3), 13.5% showed moderate 
pain (VAS 4-6) and 6.5% had episodes of severe pain (VAS> 7). Over 
20% of episodes of moderate or severe pain (VAS> 4), 97% of them 
were treated and solved.
Regarding non-pharmacological measures, calm environment was 
detected in 86% of the records, adequate light in 97.8%, proper sound 
in 77.2% and pleasant temperature in 90.2% of them. Every patient 
had postural changes. 81% of them were movilized to chair, and only 
25% of the patients who required physical therapy, received it. In com-
parison between the 2  years, differences were only observed in the 
highest registration of pain episodes by nursing staff (68% vs. 85% 
p0.03). Attending analgesic regime, the one prescribed just in case of 
pain, was related to more pain episodes.
Conclusion: We consider pain awareness and registration are well 
established in our Unit; although it is still needed to minimice epi-
sodes of moderate or severe pain and to improve physical therapy in 
our patients.
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Introduction: Agitation is a common behavior in intensive care 
patients following acute traumatic brain injury (TBI), which can pro-
long recovery of TBI patients due to delayed mechanically ventilation 
weaning and/or mobilization. Actigraphy, which measures rest-wake 
rhythms using movements with an accelerometer, has been used as 
an alternative to polysomnography to estimate sleep and to measure 
physical activity in outpatient settings. In the ICU setting, actigraphy 
has been used for the same purposes, but more studies are needed as 
it has only been studied in patients in whom analgosedation has been 
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discontinued. Our hypothesis is that actigraphy could be a useful tool 
to monitor agitation and sleep-wake cycles in TBI patients.
Objectives: The primary study objective was to evaluate the feasibility 
of using wrist actigraphs in critically ill TBI patients who were receiving 
analgosedation. The feasibility aims were to measure recruitment rate, 
to describe actigraphy recording duration, to assess missing activity 
count per day, and to identify impediments to its use.
Methods: We prospectively recruited adult patients admitted to 
the ICU of Hôpital du Sacré-Coeur de Montréal with acute TBI and 
abnormal CT scan within 48 hours of ICU admission. Exclusions crite-
ria included: spinal cord injury, prior history of TBI, major neurologi-
cal or psychiatric disease, high risk of short-term mortality, expected 
stay  < 48 hours. Actiwatch-Spectrum actigraphs (Philips/Respironics, 
Murrysville, PA) were placed in patients’ non-paralyzed wrists after ICU 
admission and study inclusion. Reasons for not using actigraph were 
documented. Actigraphy data such as the amount of missing data and 
total recording time were analysed.
Results: Between September 2018 and July 2019, 47 patients were 
considered eligible and 30 patients were recruited. Median age was 
64.5  years (IQR 41.3) and 73% were males. TBIs were severe, moder-
ate and mild complex in 30%, 43% and 27% of cases, respectively. One 
patient was discharged before actigraph was placed and four patients 
had less than 24 h of recorded data. These 5 patients were excluded 
from analyses. A total of 214 completed days of actigraphy data were 
recorded. The mean number of completed days per patient was 6.5 
(SD 5.1), with a minimum of 1 completed day and a maximum of 27. 
The mean missing activity count per day was 20.3 minutes (SD 81.7) 
and 89% of the days had less than 30 minutes of missing data per day. 
Actigraphs were removed for surgery or exams outside the ICU, as 
well as to download recorded data. Electronic interferences between 
ICU equipment, tissue oedema and neuromuscular blocker use were 
found as barriers on the use of actigraphy.
Conclusion: This study supports the feasibility of actigraphy use 
to monitor agitation and sleep-wake cycles in TBI patients during 
their stay in the ICU. However, specific aspects of analgosedated TBI-
patients should be considered when monitoring patients.
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Introduction: Patients in need for sedation during mechanical ventila-
tion are at risk for adverse effects of currently used intravenous seda-
tives, such as long and unpredictable wake-up times, development of 
delirium, propofol infusion syndrome or life-threatening bradycardia. 
A number of publications and increasing clinical use indicate that 
inhaled isoflurane for sedation may be a good option. This study was 
performed with the aim to evaluate the efficacy and safety of isoflu-
rane via the AnaConDa (SEDACONDA).
Objectives: To compare the efficacy and safety of SEDACONDA with 
propofol as the sole sedative regimen for up to 48 hours in invasively 
ventilated patients in a phase III randomized controlled registration 
trial.
Methods: After ethical approval (Ärztekammer des Saarlandes, 11/17), 
German and Slovenian competent authority approval and trial regis-
tration (Eudra CT#: 2016-004551-67), 300 adult invasively ventilated 
patients with clinical need for sedation were recruited in 23 study sites 
in Germany and Slovenia. Written informed consent was obtained 
from the patient or legal representative according to national laws and 
regulations. Patients were randomized to either SEDACONDA (Sedana 
Medical, Danderyd, Sweden) or intravenous propofol, until extubation 
or for up to 48+/-6 hours, whichever was first. Sedation efficacy was 
assessed as the proportion of time within RASS-1 to RASS -4 without 
rescue sedation (primary outcome measure). Wake-up times after stop 
of sedation, opioid dosing over time, percentage of time with sponta-
neous breathing, ventilator-free and ICU-free days in the first 30 days, 
adverse events and 30  day mortality were also monitored. For the 
primary outcome, the non-inferiority margin for isoflurane was pre-
defined to 15% relative the mean proportion of time in target RASS for 
propofol.
Results: Between July 2017 and January 2020, 301 patients were 
included. The percentage of time patients were sedated in the target 
RASS range without rescue sedation was similar for the SEDACONDA 
and propofol groups (mean percentage of time [CI] 90.7 [86.8-94.6%] 
vs 91.1 [87.2, 95.0]). Thus, the lower CI of SEDACONDA was above the 
non-inferiority margin (77.5%). Secondary outcome measures are 
under statistical evaluation and will be presented during the congress.
Conclusion: The preliminary results indicate that SEDACONDA is effi-
cacious as a primary sole sedative, in the same efficacy range as propo-
fol. Further evaluation of study data and future studies will answer 
clinically important questions regarding other effects of isoflurane for 
long-term sedation of critically ill patients.
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Introduction: Delirium is under-recognized, misdiagnosed and 
undertreated. Research focusing on associations, prevention and 
treatment of delirium has increased tremendously in the last decade, 
but still little is known about patient’s experience of delirium. Up to 
80% of intensive care unit (ICU) survivors remember their delirium. 
Delirium has been described as highly unpleasant and distressing with 
vivid hallucinations and scary delusions. Delirium has been linked to 
subsequent cognitive dysfunction, psychological sequelae and post-
traumatic stress disorder. Knowledge on how delirium is perceived by 
patients has the potential to improve recognition, management and 
treatment of delirium.
Objectives: This study investigates how ICU patients recall and 
experience delirium. We aim to identify predictors of delirium recall 
and interventions that might reduce distress and symptom severity 
related to delirium. We aim to understand recollections of delirium 
and thereby highlight the importance of early recognition and guide 
future management to relieve patient distress related to delirium.
Methods: This study has a mixed-methods design involving both 
quantitative measurements and qualitative assessment. Subjects 
were adult critically ill patients that were CAM-ICU positive during 
ICU stay. We conducted interviews after ICU discharge when patients 
were delirium-free assessed by ‘rapid clinical test for delirium’ (4AT). 
The interviews where semi-structured and took place at the general 
ward or patient home. Interviewees used an interview-guide to gather 
detailed information on recall, experiences and various symptoms 
related to ICU delirium. The interviews were transcribed and themati-
cally analysed by the research team.
Results: To date sixteen of twenty-five patients have been inter-
viewed. A univariate analysis comparing patients with and without 
memory of delirium using background characteristics as co-variates 
(age, admission type, SMS-ICU and delirium motor subtype) will be 
performed. At present, an 81% of participants remember some part 
of their delirium during their ICU stay. Fourteen out of sixteen partici-
pants found their delirium experience to be very distressing, including 
two patients who did not remember their ICU stay at all. Twelve partic-
ipants remembered being confused/disoriented, eleven remembered 
sleep disturbance and nine had one or more clear memories of hallu-
cinations and/or delusions. Patients tend to experience delirium as a 
mix of fact and fiction where realistic events merge with delusions and 
frightening hallucinations. Final results of the thematic and statistical 
analysis will be presented at the congress.
Conclusion: The conclusion will be presented at the congress.
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Introduction: Administration of opioids to patients during hospitali-
zation can induce its chronic consumption. Analgo-sedation strategies 
based on 1st analgesia, 2nd sedation, can cause the administration of 
high doses of opioids.
Objectives: Assess the impact of opioid use during ICU admission in 
patients mechanically ventilated for ARDS secondary to SARS-CoV-2, 
as well as factors modifiable in their discharge treatment in this sub-
group of patients.
Methods: Prospective study approved by the Hospital’s Ethics and 
Research Committee. This includes all patients admitted to the ICU 
between March and May 2020 for ARDS secondary to SARS-CoV-2 
who were discharged from the ICU and subsequently from the hospi-
tal. Demographic factors and clinical data related to admission to the 
ICU and hospitalization were analyzed. The cumulative dose of opi-
ates is expressed in mg of iv morphine (10 mg morphine iv  =  100 μg 
fentanyl iv  =  100  μg remifentanil  =  20  mg oral methadone). Data 
expressed in mean ( ±  standard deviation), median (IQ25-IQ75) or 
with frequency and percentage. To compare means, the Mann-Whit-
ney U test was used.
Results: 54 patients are included, 41 males, with mean age 62  years 
( ±  12), stay included median ICU of 13 days (8–25) and 14 days (8-20) 
in the hospitalization. APACHE II 16.9 ( ±  4.6), SOFA at income 6.6 ( ± 
2.1). No patient received opioids prior to admission. In ICU, patients 
received continuous infusion opioids for a median of 216 hours (133-
348), and a cumulative median dose of 2910  mg (969-7892). At dis-
charge from the ICU, in 16 patients (30%), they prescribed opiates (6 iv 
morphine if needed, 5 IV prescribed morphine and 5 transdermal fen-
tanyl). Four patients were discharged from the hospital with opiates, 
all with fentanyl transdermal already prescribed for discharge from 
the ICU. The average cumulative dose of opiates administered in ICU 
in patients discharged from the hospital with opiates was 12,450 mg, 
and 4,883  mg in those without opiate prescribed at discharge (U of 
Mann-Whitney 45.00, p  =  0.07).
Conclusion: 7% of survivors were discharged from the hospital with 
opiates, all with transdermal fentanyl. In 80% of patients discharged 
from the ICU with fentanyl transdermal, this was maintained at hospi-
tal discharge. A study with a larger number of patients is necessary to 
assess whether the total dose of opiates during ICU admission influ-
ences their maintenance at hospital discharge.
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Introduction: Administration of opioids to patients during hospitali-
zation can induce its chronicconsumption. Analgo-sedation strategies 
based on 1st analgesia, 2nd sedation,can cause the administration of 
high doses of opioids.
Objectives: Assess the impact of opioid use during ICU admission 
in mechanically ventilated patients with ARDS secondary to SARS-
CoV-2. In addition, we studied the presence of chronic analgesic 
Page 597 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
consumption, the quality of life perceived three months after hospital 
discharge, and its possible relationship with the administration of opi-
oids during admission to the ICU.
Methods: Prospective study approved by the Hospital’s Ethics and 
Research Committee. This includes all patients admitted to the ICU 
between March and May 2020 for ARDS secondary to SARS-CoV-2 
who were discharged from the ICU and subsequently from the hospi-
tal. Demographic factors and clinical data related to admission to the 
ICU and hospital ward are analyzed. The cumulative dose of opioids is 
expressed in mg of iv morphine (10 mg iv morphine  =  100 μg iv fen-
tanyl  =  100 μg remifentanil  =  20 mg oral methadone). Three months 
after hospital discharge, a phone call is made to assess the chronic 
consumption of analgesics drugs, assess the perceived quality of life 
and the existence or not of chronic pain. Information is collected on 
the usual analgesic treatment and will be verified by reviewing the 
electronic medical record and MUP (single prescription module in the 
Community of Madrid). For the evaluation of quality of life, the Euroqol 
EQ-5D questionnaire will be used. In patients who answer >1 to item 
number 4 of this questionnaire (existence of pain), the evaluation of 
pain will be complemented with the Latineen index. Data expressed as 
mean ( ±  standard deviation), median (IQ25-IQ75) or with frequency 
and%. The Mann-Whitney U test was used to compare means.
Results: 32 patients are included, 69% male, with a mean age of 
62 years ( ±  11), median ICU stay of 9 days (7–16) and 11 days (7-14) 
in hospitalization. APACHE II 16.8 ( ±  4), SOFA at income 6.8 ( ±  2.1). 
No patient received opioids prior to admission. In the ICU, patients 
received continuous infusion opiates for a median of 170 hours (116-
223), and a median cumulative dose of 1447  mg (672-4960). At dis-
charge from the ICU, opiates were prescribed in 6 patients (19%) (3 
prescribed iv morphine and 3 iv morphine if needed). No patient was 
discharged from the hospital with opioid treatment. At 3  months 
(phone call made 93  ±  2 days after hospital discharge), only 1 patient 
received opioid treatment with tramadol, while 14 (44%) received 
non-opioid analgesics (paracetamol, metamizole and/or NSAIDs). 
The mean cumulative dose of opioids administered in the ICU in 
patients who received analgesics 3  months after hospital discharge 
was 4141 mg, and 2416 mg in those who had no chronic use (Mann-
Whitney U 94.00, p  =  0.22). The results of the EQ-5D questionnaire 
are shown in Table 1, as well as the relationship between the average 
doses of opiads consumed depending on the scores on quality of life. 
50% of patients reported some pain or discomfort 3 months after hos-
pital discharge (EQ-5D pain >1); in them, the mean Latineen index was 
5.9 ( ±  4), 56% consumed analgesics but only 1 patient consumed opi-
oid analgesia.
Conclusion: There is no relationship between the doses of opioids 
administered in the ICU and their maintenance at hospital discharge 
or chronic consumption. Neither is there a relationship with different 
aspects of perceived quality of life at 3 months or with the existence 
of chronic pain. However, a study with a larger number of patients is 
necessary to adequately assess these findings.
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Introduction: Large numbers of Covid-19 patients simultaneously 
needed invasive mechanical ventilation in many countries, leading to 
shortages of ICU beds and intravenous sedatives [1,2]. Some report 
that ventilated CoV19 patients need high doses of sedatives and neu-
romuscular blocking agents (NMBA) [3]. For those patients, inhaled 
sedation with isoflurane (ISO) applied with the AnaConDa system 
(Sedana Medical, Danderyd, Sweden) may be beneficial [4,5].
Objectives: We investigated dosing of propofol (PRO) and ISO, in 
Covid-19 patients in need for deep sedation with and without extra-
corporeal membrane oxygenation (ECMO) treatment.
Methods: In a chart review, we analysed the patients’ needs of PRO, 
ISO, use of co-sedatives, NMBAs, opioids, documented sedation scores 
(Richmond Agitation Sedation Scale, RASS), minute ventilation (MV) 
and ECMO treatment during the first 30 days of treatment in our ICU 
as long as the patients were in need for deep sedation. Sedation days 
were classified according to the sedative used (PRO, ISO, or both). All 
parameters were averaged on a daily basis, and compared between 
PRO and ISO days with Student’s t-Tests for parametric data, or 
 Chi2-tests for frequencies.
Results: 19 consecutive Covid-19 patients, aged 64 ± 10  years, 
admitted to the ICU with acute respiratory failure in need for inva-
sive mechanical ventilation and deep sedation were evaluated. Eight 
patients had been sedated with isoflurane during 7.1 ± 7.7 days, all but 
one had received propofol on 9.1 ± 8.2 days. 9 patients received ECMO 
treatment for 14 ± 4 days during this time.
In total, 305 sedation days were recorded, of which PRO had been 
used on 164 days, and ISO on 100 days. On 41 days, both drugs had 
been used. These days were excluded from further analysis.
During PRO days, high doses of PRO were recorded. PRO infusion 
rates (IR) were 8.9 ± 2.8  ml/h corresponding to 214 ± 67  ml/24  h. On 
24% of PRO days, mean doses higher than 3.5  mg/h/kg predicted 
body weight (PBW, 22*height  [m]2) were used, and on 12%, the rec-
ommended maximum dose of 4 mg/h/kg PBW was exceeded. Under 
PRO compared to ISO, NMBAs (PRO vs ISO: 24% vs 11%, P = 0.010) as 
well as co-sedatives (32% vs 9%, P = 0.001, mainly clonidine: 26% vs 
7%, P = 0.001) were used more frequently and sufentanil doses were 
higher (5.7 ± 1.2 vs 4.0 ± 1.2 mL/h, P = 0.029). RASS scores, as judged 
by nursing staff, indicated deeper sedation under ISO (-2.9 ± 1.4 vs 
-3.5 ± 0.9, P = 0.001).
ISO-IR were 4.8 ± 2.2 ml/h corresponding to 115  ±  53 ml/24 h with a 
mean end-tidal concentration (ET) of 1.07 ± 0.37 Vol%. ET correlated 
poorly with the IR, negatively with the MV, and best with the ratio IR 
divided by MV. As the MV during ECMO is reduced, IR were signifi-
cantly lower during ECMO days (3.5 ± 1.4 vs 7.1 ± 3.1 ml/h, P = 0.001).
Conclusion: Inhaled sedation with isoflurane is an interesting alter-
native to propofol in invasively ventilated CoV19 patients in need for 
deep sedation. High doses of both drugs are needed. Propofol use was 
associated with polypharmacy, and higher doses of opioids. Isoflurane 
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Conclusion: WAT-1 has been demonstrated to have a very good sen-
sitivity and specificity to detect WS at the bedside in adult critically-ill 
patients who received prolonged sedo-analgesics. Age  < 50 years was 
the only independent variable predicting WS.
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Introduction: Acute pancreatitis (AP) is an inflammatory condition, 
the worldwide incidence is 13 to 45/100,000. Severe acute pancreati-
tis (SAP) is associated with serious morbidity and mortality and these 
patients require intensive care unit (ICU) admission. Factors predicting 
mortality and morbidity need to be identified for improving outcome.
Objectives: The aim of our study was evaluation of demographic and 
outcome of patients with SAP admitted to our ICU from June 2018 to 
June 2020. The secondary objective was to identify the factors respon-
sible for adverse outcome.
Methods: Retrospective analysis of patients with SAP admitted to the 
ICU between june 2018 and june 2020.
Results: Eleven SAP patients were admitted to ICU (54.5% female, 
mean age 64.3).
consumption is reduced under ECMO treatment. These data may 
guide stockpiling of sedatives in the future.
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Introduction: Withdrawal Syndrome (WS) is a common problem in 
the intensive care unit (ICU). Recognizing WS could be difficult due to 
lack of a sensitive tool avaliable at the bedside in adult ICUs. Neuro-
psychiatric disorders accompanying patients being weaned from 
sedo-analgesia is another crucial point challenging WS diagnosis.
Objectives: We aimed to validate Withdrawal Assessment Tool-1 
(WAT-1) in terms of detecting WS in adult ICU.
Methods: Patients >18  years old admitted to Hacettepe University 
Medical ICU between March 2019 and March 2020, who were intu-
bated and received sedo-analgesics for >72 hours, were prospectively 
evaluated. Patients with neuro-psychiatric disorders were excluded. 
WS was defined according to DSM-5 criteria. Both WAT-1 and DSM-5 
assessments were performed by a neurologist. Primary outcome was 
to define the correlation between WAT-1 and DSM-5 with respect to 
WS diagnosis whereas secondary outcome was to compare patients 
with WS with those without WS.
Results: WS occured in 28 (70%) out a total of 40 patients included 
in the study. Patient characteristics are seen in Table. All patients sur-
vived. Sensitivity and specificity (95% CI) of WAT-1 were found to be 
0.78 (0.59-0.91) and 1.00 (0.70-1.00), respectively. Age ( < 50 years) was 
the only independent variable predicting WS when adjusted for ARDS, 
pulmonary edema, and midazolam dose (Odd Ratio [95% CI]: 8.97 
[1.03-77.50], p = 0.04).
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All patients received anticoagulation during their admission. Treat-
ment dose anticoagulation was given to 22 (23.9%), whilst 70 (76.1%) 
received only prophylactic anticoagulation. The median duration of 
COVID-19 symptom onset to thromboprophylaxis initiation was 8 days 
(IQR 6 - 10).
Macrovascular thrombi were detected in 22 (23.9%) of the popula-
tion. Of these, 7 (33.3%) were pulmonary emboli, and 7 (33.3%) were 
venous thrombi. There were 2 strokes, 2 arterial occlusions, 1 myo-
cardial infarction, 1 renal vein thrombus and 1 ventricular thrombus 
(fig 1). During the same period, 8 (8.7%) patients developed significant 
haemorrhages; 4 had an upper gastrointestinal bleed, 2 an intracranial 
haemorrhage, and there was one pulmonary and one urinary tract 
haemorrhage.
On univariate analysis, there was a non-statistically significant reduc-
tion in the incidence of major thrombi in Black (OR 0.336, 95% CI 
0.085 - 1.111, p = 0.090) and Asian patients (OR 0.231, 95% CI 0.033 - 
0.986, p = 0.076) compared to Caucasian patients. APTT ratio prolon-
gation >1.8x was more frequent in patients not developing thrombi 
(p = 0.032), whilst Fibrinogen levels  < 1.8  g/L occurred more often 
with thrombosis (p = 0.015).
Conclusion: Critically ill patients with COVID-19 face high incidence 
of thrombotic complications despite anticoagulation. Low levels of 
fibrinogen are associated with thrombi. Clinicians must remain vigilant 
to the development of thrombi even in anticoagulated patients.
Reference(s) and grant ackowledgment(s)
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Introduction: Blood transfusions are common in critically ill patients; 
30 to 45% patients receive red cell transfusions of, 10-30% plasma 
transfusions and 10-20% platelet transfusions during their ICU stay. 
The most common aetiologie were gallstones (72.7%) and hypertri-
glyceridemia (18.2%).
The severity of AP as depicted by Ranson’s score showed mean score 
of 3.2 at admission, and 3.5 after 48 hours. On admission to ICU, the 
median Acute Physiology and Chronic Health Evaluation (APACHE) II 
score was 22.3 and the median Computed Tomography Severity Index 
(CTSI) was 3 (range 2-4).
During the ICU stay, 72% of patients required mechanical ventilatory 
support, ranging in duration from 1 to 35 days; 90.9% developed acute 
kidney injury (AKI) and 18.2% required continuous renal replacement 
(CRR); 72.7% needed vasopressor support.
A significant number of patients (54.5%) tolerated early enteral nutri-
tion via either a nasogastric tube or a nasojejunal tube, while total par-
enteral nutrition (TPN) was used in 18.2% of patients.
The disease course was complicated with pancreatic abscess (45.5%), 
abdominal compartment syndrome (18.2%) and pseudo cyst forma-
tion (9%). Surgical intervention was required in 50% of these patients.
The median length of stay in ICU and hospital were 13 (ranged from 1 
to 74) and 25 (ranged from 1 to 110) days, respectively.
ICU mortality and hospital mortality were 45% and 9%, respectively. 
Mean APACHE II score of these patients was 28.7. All these patients 
had AKI and two patients who needed RRT died.
Conclusion: Acute pancreatitis remains a challenging disease for 
intensive care medicine and this retrospective data showed high mor-
tality of AP requiring ICU admission.
Predicting the outcome of ICU patients with AP remains a difficult task 
despite the availability of scoring systems. In our study, the APACHE II 
score was higher between non-survivors. The mean of Ranson score in 
our study population was 3.2 and 3.5 at and after 48 hours of admis-
sion, which has a predicted mortality of 11 to 15%, so the predictive 
value of this scoring system is questionable in our study. Although AKI 
itself was not an independent risk factor of adverse outcome in our 
study, patients who need CRR died.
The authors wish to highlight the need to early severity assessment 
and management for those patients at risk of SAP.
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Introduction: Macrovascular thrombi are a common complication of 
COVID-19. Risk factors for COVID-related thrombi are not well under-
stood (1).
Objectives: To examine the incidence of macrovascular thrombi in 
patients admitted to the intensive care unit (ICU) with COVID-19, and 
to explore factors associated with thrombi in COVID-19.
Methods: We retrospectively enrolled all patients aged >18 admitted 
to ICU between 1/3/2020 and 30/4/2020 with a laboratory-confirmed 
diagnosis of COVID-19 (n  =  93). 1 patient was excluded as an inciden-
tal diagnosis of COVID-19 admitted to ICU for post-operative monitor-
ing. Data was extracted from health records using a standardised data 
collection tool. Patients were followed up to 24/5/20.
Results: The median age was 57 (IQR 48 - 62), 70 (76.1%) were male. 
The population was diverse; 37 (44.6%) were Caucasian, 26 (31.3%) 
were Black, 18 (21.7%) were Asian, 2 (2.4%) were of mixed ethnicity 
and in 9 cases ethnicity was not recorded. Median duration of illness 
prior to hospital admission was 7 (IQR 4 - 9) days.
Cardiovascular risk factors were common; 44 (47.8%) were hyper-
tensive, 30 (32.6%) were obese and 30 (32.6%) were diabetic. Four-
teen (15.2%) patients had a cardiovascular condition, 10 (10.9%) had 
chronic respiratory disease, 13 (14.1%) had a baseline eGFR  < 60  ml/
min, and 5 (5.4%) had known cancers. Several patients used coagula-
tion-modifying drugs; 9 (9.8%) took antiplatelet agents, and one was 
anticoagulated with warfarin.
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Each of the studies that have reported on plasma and platelet use and 
outcomes in ICU has reported separately for each blood product type. 
There are limited studies that have reported on the transfusion of red 
cells, plasma, platelets and cryoprecipitate concurrently in ICU.
Objectives: The primary outcomes of the study were to examine the 
prevalence of red cells and multicomponent transfusion during ICU 
stay.
Methods: A retrospective study of 5783 patients enrolled in the 
INFORM trial including 2332 patients that were admitted at the Flin-
ders Medical Centre ICU between April 2012 and October 2015 was 
performed. Total red cells (RC) and blood products transfused at any 
point between ICU admission and discharge were analysed leading 
to three specific categories - RC only transfusion (RC-only), MCT and 
non-transfusion (NT). Multicomponent transfusion included RC-MT 
[RC co-transfusion with plasma (FFP), platelets (PLT) and cryoprecipi-
tate (CRYO) or combination of components without RC (MT). The com-
mon types of RC-MCT included RC+FFP, RC+ PLT, RC+FFP+PLT and 
RC+FFP+ PLT+CRYO.
Results: Of the 2726 ICU admissions analysed, 1323 (48.5%, 95% CI 
46.6-50.4) received no transfusion (NT), 660 (24.2%, 95% CI 22.6-25.9) 
received MCT and 743 (27.7%, 95% CI 25.6-28.9) received RC-only 
during ICU stay. Besides trauma (33.7%) and haematology admis-
sions (31.8%), half or more than half of the admissions in each clini-
cal groups did not receive a transfusion during ICU stay. RC-MT ranged 
from 9.2% to 45.6% across all clinical groups, highest being in hae-
matology (41.5%) and gastroenterology (GIT, 32.1%) admissions (Fig-
ure  1). Amongst all types of RC-MT, RC +FFP+PLT (36.1%) was the 
commonest type, followed by RC+FFP (27.3%), RC +PLT (16.5%) and 
RC +FFP+PLT +CRYO (16.5%). RC-MCT varied across clinical groups, 
with 61.5% of metabolic admissions received RC+FFP, 30.8% of sep-
sis admissions received RC +PLT and 26.3% of GIT admissions received 
RC+FFP+PLT+CRYO (Figure 2).
Fig.  1 & 2 ‑ Percentage of non‑transfused and transfused admis‑
sions including transfusedadmissions with types of multi‑compo‑
nent transfusion for various admitting ICU diagnoses
Conclusion: Almost half of ICU admissions were transfused. Fifty per-
cent of those transfused received red cells and the other half received 
multicomponent transfusion. Multicomponent transfusion including 
the various types of multicomponent transfusion varied between clini-
cal groups. Further studies are required to study outcomes in patients 
receiving multicomponent transfusion in ICU.
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Introduction: Coronavirus disease 2019 (COVID-19), caused by SARS-
CoV-2, has recently emerged in Wuhan, China, and rapidly spread 
worldwide [1]. Apart from respiratory failure, coagulopathy is a com-
mon abnormality in COVID-19 patients and is associated with poor 
prognosis [2, 3]. Regardless of increasing evidence of coagulation dys-
function, the data available for the most severe patients is still scarce.
Objectives: To describe the coagulation parameters of critically ill 
COVID-19 patients and evaluate its association with mortality.
Methods: Observational retrospective study of coagulation param-
eters and outcomes of all COVID-19 patients admitted to a polyvalent 
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intensive care unit (ICU) of a Portuguese tertiary hospital between 
March 15th and May 10th 2020.
Results: Thirty-six patients required ICU admission from a total of 264 
COVID-19 patients admitted to our hospital. Median age was 62 [58.3; 
65.8] years, 23 (63.9%) were men and median APACHE II score and 
SAPS II were 18 [13.0; 23.7] and 42 [31.0; 51.5], respectively. Twenty-
nine (80.6%) patients had chronic diseases, mainly arterial hyperten-
sion (n = 21, 58.3%), diabetes (n = 11, 30.6%), respiratory disease 
(n = 7, 19.4%) and coronary heart disease (n = 5, 13.9%). Median ICU 
length of stay was 16 [6.8; 22.3] days and the overall mortality was 25% 
(n = 9). All patients received at least prophylactic doses of low molecu-
lar weight heparin. The coagulation parameters were analyzed from 
admission to day 14 of ICU stay. No difference in ICU stay was found 
between survivors and non-survivors (17 vs 14  days, p = 0.494) and 
none of the coagulation parameters at admission were correlated with 
ICU length of stay. Non-survivors had significantly higher D-dimer lev-
els at admission (2.89 vs 1.47 mg/mL, p = 0.04), and longer prothrom-
bin time (PT) and activated partial thromboplastin time (APTT) at day 
10 (17.67 vs 16.43 sec, p = 0.016 and 38.07 vs 33.30 sec, p = 0.046, 
respectively). Despite high fibrinogen levels at admission (mean 
675  ±  156 mg/dL) and during ICU stay, no statistical significance was 
found between the two groups. Sepsis-Induced Coagulopathy (SIC) 
and International Society on Thrombosis and Haemostasis Dissemi-
nated Intravascular Coagulation (DIC) scores were significantly higher 
in non-survivors at day 10 (3 vs 2, p = 0.006 and 4 vs 2, p = 0.001). Fur-
thermore, 44.4% (n = 4) of non-survivors and 16.6% (n = 4) of survivors 
met the SIC criteria, but only one (11.1%) non-survivor and 2 (7.4%) 
survivors matched the ISTH DIC score. From these, only one patient 
actually developed clinical DIC.
Conclusion: At admission D-dimer was positively correlated with 
mortality. By the late ICU stay, non-survivors revealed significantly 
prolonged PT and APTT. The occurrence of DIC was rare. It seems 
that COVID-19 coagulopathy might not be equal to the known sepsis 
coagulopathy, so DIC diagnostic criteria applied to this specific disease 
should be reviewed. Further studies are needed to clarify the effective 
prognosis value of coagulation parameters in critically ill COVID-19 
patients.
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Introduction: Coronavirus Infectious Disease 2019 (COVID-19) is 
reported to be associated with a high rate of venous thromboembo-
lism (VTE). Most published reports to date (1-3) are retrospective, do 
not systematically screen for deep venous thrombosis (DVT) and sug-
gest a higher frequency of pulmonary embolism (PE) than DVT.
Objectives: To determine the rate of DVT in critically ill patients with 
COVID-19. The study is ongoing and the results of the first 15 patients 
are reported here.
Methods: We conducted a prospective, observational trial to examine 
rates of DVT in patients COVID-19 admitted to the critical care unit of 
a large tertiary hospital. We enrolled consecutive patients with COVID-
19 confirmed by polymerase chain reaction (PCR) testing. The screen-
ing test was compression ultrasound (CUS) of the proximal veins of 
both legs performed by any of 3 advanced intensive care medicine 
trainees all of whom had prior experience in CUS for DVT. The leg 
veins were compressed every 2  cm from the common femoral vein 
at the inguinal ligament until the trifurcation in the popliteal fossa. A 
non-compressible vein was considered positive for DVT. Any positive 
scans were reviewed by several investigators. Positive results were 
communicated to the treating physician. Scans were performed every 
72 hrs up until 30 days or until the patient left critical care.
The primary outcome was the rate of DVT by CUS.
Results: We enrolled 15 patients with confirmed COVID-19 between 
2nd April and 10th May 2020. Baseline characteristics are shown in 
Table 1.
No patient had a clinical suspicion for DVT prior to enrolment. All 
patients were on either therapeutic or prophylactic anticoagulation. At 
the time of study, COVID-19 patients were being treated with a higher 
dose of or prophylactic enoxaparin than typical critical care patients at 
a dose of 0.5 mg/kg twice daily.
We found a single DVT in the popliteal vein of a ventilated patient at 
time of enrolment to the study. 4 other patients were diagnosed with 
VTE during the study, 3 with PE and one with an upper limb DVT.
Further enrollment is currently halted due to significant drop off in 
COVID-19 prevalence in Ireland at the time of writing.
Conclusion: In this ongoing study the rate of DVT in critically ill 
patients was low with only 1 of the 15 patients having a lower limb 
DVT throughout their critical care stay, though it is notable this 
occurred in the setting of higher dose prophylaxis.
However, the observed 20% rate of PE despite this prophylaxis may 
represent thrombosis in situ or immunothrombosis rather than embo-
lism from a distal venous site.
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Introduction: Novel oral anticoagulants (NOACs) represent first-line 
treatment for venous thromboembolism and prevention of stroke 
in nonvalvular atrial fibrillation. Bleeding complications have been 
reported in NOACS users during the postoperative period.
Objectives: Aim of the study is to identify if there is any correlation 
between postoperative hemorrhagic complications and pre-operative 
use of novel oral anticoagulants (ΝΟΑCS) in cardiac surgical patients.
Methods: All patients who underwent elective cardiac surgical 
procedures with the use of cardiopulmonary bypass from January 
2019 to March 2020 were evaluated. Patients were divided in 3 cat-
egories: Group Α consisted of patients with preop use of ΝΟΑCS : 
Αpixaban(Eliquis), Dabigadran(Pradaxa) and Rivaroxaban (Xarelto). 
Group B consisted of patients with preop use of vitamin K antagonists 
and Group C consisted of patients without preop use of any anticoag-
ulant. NOACS were discontinued 3-5 days before surgery. The follow-
ing perioperative factors were compared: sternal reopening because 
of hemorrhage, transfusion with at least 1 unit of platelets, transfusion 
with at least 1 unit of Fresh Frosen Plasma, transfusion with more than 
3 units of red blood cells and no transfusion at all. Decisions for trans-
fusion was based on lab results and rotational thromboelastometry –
ROTEM. Chi square test was used for statistical analysis.
Results: A total of 581 patients were evaluated. First we compared 
Group A (n = 41 - 7 Αpixaban,24 Rivaroxaban and 13 Dabigadran) with 
Group C. Results are shown in table 1
Comparison between drugs revealed statistical significant correlation 
between use of Dabigadran with resternotomy (20/559 -3,6% versus 
3/13-23,1% p < 0,005).
We also compared Groups A and B. Results are shown in table 2.
Conclusion: Preoperative use of NOACS correlates significantly with 
higher incidence of transfusions with FFP after elective cardiac surgi-
cal procedures. Dabigadran use correlates with higher incidence of 
resternotomy because of hemorrhage. No difference in hemorrhagic 
complications were found between use of NOACS and use of Vitamin 
K antagonists.
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Introduction: Between the ages of 1 and 4 years and the ages of 15 
and 34  years, trauma is the single most common cause of death in 
Europe1. Major uncontrolled hemorrhage after trauma remains the 
leading cause of preventable death after severe traumatic injury2. Any 
improvement in the quality of care provided to these patients could 
have a great impact on healthcare systems, reducing associated medi-
cal and social costs.
Objectives: The aim of this study was to determine the epidemiology 
of trauma-related mayor hemorrhage at our institution and to identify 
modifiable factors associated with mortality.
Methods: A retrospective analysis of prospectively collected data 
of adult trauma patients who activated the “Massive Hemorrhage 
Protocol” (MHP) at Cruces University Hospital (HUC) and received at 
least one unit of Red Blood Cells (RBC) from 15th February 2017 to 
4th September 2019, was conducted. HUC is a trauma regional refer-
ral Hospital in the Basque Country (Northern Spain), for an estimated 
population of 1 million.
Results: A total of 32 patients met the inclusion criteria. All patients 
were critically injured, with median Injury Severity Score of 34 (IQR 
25-43) and with median admission systolic blood pressure of 95 (IQR 
70-117) mmHg. Median age was 47 (IQR 38-74) years, and 28% of the 
patients were 65 years or older. The proportion of male patients was 
59%. Regarding the trauma mechanism, most of our patients pre-
sented blunt trauma (up to 84%).
Patients received a median of 2 (IQR 0-4) units of Fresh Frozen Plasma 
(FFP), 5 (IQR 4-9) units of RBC, 0 (IQR 0-1) units of platelets (1:2.5:0 
median ratio), and a median of 2 (IQR 0-4) grams of Fibrinogen con-
centrate. In 41% of patients resuscitation was TEG-guided.
We observed an overall mortality of 44%, with 64% of the deaths 
within the first 24  h after admission. Exsanguination due to uncon-
trolled hemorrhage below the diaphragm was the cause 100% of the 
early deaths in our study population.
The median lactate level and base excess (BE) on admission were 5.2 
(IQR 3.0-11.8) mmol/L and -9 (IQR -13.98 - -6.45) mmol/L, respectively. 
Median International Normalized Ratio (INR) and fibrinogen level on 
admission were 1.5 (IQR 1.3-1.85) and 189 (IQR 146-264) mg/dl. In 
the group of patients that survived > 24 h after admission and dam-
age control resuscitation was completed; lactate, BE, INR and fibrino-
gen values were corrected (median Lactate 1.2  mmol/L, median BE 
-0.5 mmol/L, median INR 1.2, median Fibrinogen 331 mg/dl).
No statistically significant differences were found between mortal-
ity and gender, age, blood product consumption or ISS; however, 
increased lactate or INR on admission, and the need of damage con-
trol surgery where associated to higher mortality rates.
Conclusion: Although a damage control resuscitation strategy probed 
to be highly effective for critically injured patients (median ISS 34) with 
adequate hemorrhage control, exsanguination due to uncontrolled 
hemorrhage below the diaphragm was the cause of 100% of the early 
deaths in our series.
According to a recent joint statement from the American College of 
Surgeons Committee on Trauma, the American College of Emergency 
Physicians, the National Association of Emergency Medical Services 
Physicians and the National Association of Emergency Medical Tech-
nicians regarding the clinical use of Resuscitative Endovascular Bal-
loon Occlusion of the Aorta (REBOA) in civilian trauma systems; this 
device may be used for traumatic life-threatening hemorrhage below 
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the diaphragm in patients in hemorrhagic shock who are refractory to 
resuscitation. This indication resemble the main cause of preventable 
death identified in our study.
The development of a local REBOA protocol and a quality assurance 
program could be recommended to reduce early trauma-related 
mayor hemorrhage mortality of in our setting.
Reference(s) and grant ackowledgment(s)
1. Bulger E, Perina D, Qasim Z, Beldowicz B, Brenner M, Guyette F et al. Clinical 
use of resuscitative endovascular balloon occlusion of the aorta (REBOA) in 
civilian trauma systems in the USA, 2019: a joint statement from the Ameri‑
can College of Surgeons Committee on Trauma, the American College of 
Emergency Physicians, the National Association of Emergency Medical 
Services Physicians and the National Association of Emergency Medical 
Technicians. Trauma Surgery & Acute Care Open. 2019;4(1):e000376.
2. Spahn D, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt B et al. The 
European guideline on management of major bleeding and coagulopathy 
following trauma: fifth edition. Critical Care. 2019;23(1).
3. Ec.europa.eu. (2019). Accidents and injuries statistics ‑ Statistics Explained. 
[online] Available at https ://ec.europ a.eu/euros tat/stati stics expla ined/
index .php?title = Accid ents_and_injur ies_stati stics &oldid = 45201 7#Death 
s_from_accid ents.2C_injur ies_and_assau lt [Accessed 22 Nov. 2019].
001520 
Experience of thromboprophylaxis of patients with COVID‑19 
disease across two Intensive Care Units in the West of Scotland
A.  Taylor1; F.  Mcmorrow2; A.  Allison3; R.  Hart4; E.  Black5; J.  Allan2
1intensive care, Queen Elizabeth University Hospital, Glasgow, UK, United 
Kingdom; 2Intensive care, University Hospital Crosshouse, Crosshouse, 
United Kingdom; 3Intensive care, Queen Elizabeth University Hospital, 
Glasgow, United Kingdom; 4Critical care, Queen Elizabeth University Hos‑
pital, Glasgow, United Kingdom; 5Department of critical care, Queen Eliza‑
beth University Hospital, Glasgow, United Kingdom 
Correspondence: A. Taylor
Intensive Care Medicine Experimental 2020, 8(2): 001520
Introduction: The incidence of venous thrombo-embolism (VTE) in 
intensive care patients is between 5-15% (1). Fixed dosing of once 
daily low molecular weight heparin (LMWH) is routinely used to miti-
gate this when appropriate. Target dosing is of 0.5  mg/kg but this 
is often not achievable at extremes of body weight. It is not routine 
practice currently to measure anti-xa levels for assessing attainment of 
therapeutic levels.
Objectives: During the COVID 19 pandemic it became quickly appar-
ent these patients were presenting profoundly pro-thrombotic and 
hyper-inflammatory, often with d-dimers in tens of thousands and 
with a high incidence of VTE. After consultation with haematology 
colleagues we changed our practice of once daily (OD) to twice daily 
(BD) dosing of LMWH in response, and sought to ensure no increase in 
patient harm or significant bleeding complications.
Methods: Data was collected for two hospital sites in the West of 
Scotland: Queen Elizabeth University Hospital and University Hospi-
tal Crosshouse. A total of 84 patients admitted over a 9 weight period 
from March 2020 requiring ventilation were reviewed. The regime and 
dose of LMWH, incidence of VTE and outcome were recorded. Dose 
adjustment was made for those with renal impairment and extremes 
of body weight. Anti-xa levels were not routinely measured but were 
noted when taken. We recorded patients actual weight which allowed 
calculation of mg/kg dosing. An excel document was used for record-
ing patient data. Patients admitted on treatment dose anti-coagula-
tion and those who were on renal replacement therapy and heparin 
only throughout their admission were excluded.
Results: During the weeks 1-3 prior to practice change 100% of 
patients admitted were commenced on OD LMWH. Practice change 
was introduced in week 4, and from week 5-9 there is a 95% compli-
ance rate with either changing from OD to BD dosing, or commencing 
on BD dosing. Our sample size is too small to show statistical signifi-
cance but we see a fall in mortality in the weeks following change and 
trend to lower incidence of confirmed VTE.
Actual dose was calculated for each of our patients with an accurately 
recorded weight. We found 63% (N = 30) of those who died in the 
QEUH were on an equivocal dose of  < 0.5 mg/kg daily.
Anti-xa levels were not routinely measured in patients on OD LMWH 
however when checked in patients moved to BD dosing levels were 
between 0.12-0.39.
We did not find any increase in significant bleeding complications or 
evidence of patient harm from this change.
Conclusion: We have shown the ability to rapidly induce a change 
in practice across two Intensive Care Units in the West of Scotland. 
We have not shown any evidence of increase in harm. We have high-
lighted a variable patient specific dose in this pro-thrombotic patient 
cohort already at increased risk of significant VTE. It may be in the 
future we should consider altering our practice further. Dose adjust-
ment for underlying condition, renal function, weight and specific 
drug half-life with routine measurement of anti-xa levels may allow 
a more patient specific, targeted approach. This could further help 
reduce VTE incidence, not just in COVID 19 patients but in all critically 
ill patients receiving VTE prophylaxis.
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Introduction: Many studies are beginning to study the relationship 
between COVID-19 infected patients and an increased risk of pro-
thrombotics. So far, all clinical guidelines suggest starting prophylac-
tic anticoagulation in this type of patient, but we do not really know 
what is the optimal dose to avoid bleeding complications and at the 
same time decrease the risk of thrombosis. We hypothesize that moni-
toring of the antiXa factor may serve to guide anticoagulant therapy, 
either at prophylactic or therapeutic doses in patients infected with 
SARS-CoV-2.
Methods: This is a prospective descriptive study in which we included 
11 patients infected with COVID19 admitted to the Intensive Care Unit 
at a tertiary hospital in southern Spain. Variables such as comorbidity, 
renal function, BMI, initial and final dose of low molecular weight hep-
arin, and laboratory parameters such as factor VIII coagulant activity, 
Von Willebrand antigen (VW Ag), ristocetin cofactor Von Willebrand’s 
(VWRCo), antithrombin, fibrinogen, D-dimer were collected, as well as 
bleeding and thrombotic complications.
The following data were collected for each patient: demographics, 
previous conditions: comorbidities, obesity, Charlson comorbidity 
index, clinical characteristics, severity of illness (APACHE II and SOFA 
score), renal clearance, the need for renal replacement therapy (RRT), 
and cardiovascular risk factors (hyperlipidemia, hypertension, diabe-
tes, ischemic cardiopathy). In addition, initial enoxaparin dose and 
subsequent goal dose, renal function, and all anti-factor Xa levels 
were collected. Major and minor bleeding events, Heparine-Induced 
Thrombocytopenia (HIT) and thrombotics events rule out by CT, 
were analysed. All patients received at least standard doses thrombo-
prophylaxis (enoxaparine 40 mgr/24 h).
Results: 54% of our patients needed to increase the dose of enoxa-
parin to reach levels of AntiXa in the prophylactic range (AntiXa 
0.3-0.7  IU/ml). Only 2 were maintained with the same initial dose 
(enoxaparine 40mgr/24  h and 100 mgr/24  h respectively).We per-
formed computed tomography (CT) to rule out thrombosis, and only 
one of our patients presented jugular thrombosis. 3 of our patients 
presented bleeding events that required blood product transfusion.
Conclusion: We found that conventional prophylactic dose might not 
be enough for prophylactic anticoagulation in patients with severe 
pneumonia and ARDS COVID-19 in the Intensive Care Unit. Most of the 
time (54%), we needed increasingly higher doses os enoxaparine (up 
to 100 mg per day) to range prophylactic dose. The study concludes 
with the need to determine the AntiXa factor in all patients infected 
with COVID 19 as a guide for anticoagulant therapy or prophylaxis, 
probably due to the proinflammatory state. Although the sample of 
our observation is small, we consider a highly relevant topic that has 
not yet been reported in patients with COVID-19. The importance of 
the findings will serve as a basis for studies with a larger sample. To 
further investigate the significance of these findings, we suggest stud-
ying these data in depth in future controlled clinical trails.
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Introduction: Early after the beginning of the Covid-19 pandemic, 
reports of fatal pro-thrombotic complications of the disease led 
some experts to advocate the use of systemic anticoagulation in criti-
cally ill SARS-CoV-2 patients. As a consequence, an institutional algo-
rithm, stratified on severity, was implemented at the Liege University 
Hospital.
Objectives: The objective of this retrospective study is to highlight 
the incidence of thromboembolic or hemorrhagic events in critically ill 
mechanically ventilated patients with SARS-CoV2 who were all treated 
with systemic anticoagulation, either prophylactic or therapeutic. The 
primary endpoint was to compare all-cause mortality between the 2 
regimens of anticoagulation. The secondary endpoint was to compare 
the incidence of thrombotic events (deep venous thrombosis, pulmo-
nary embolism, myocardial infarction, mesenteric ischemia, hepatic 
ischemia, stroke) and hemorrhagic events between the 2 groups of 
patients.
Methods: Between March 14th and June 1st, 2020, all consecutive 
patients with SARS-CoV-2 hospitalized in the 7 ICUs at the Liege Uni-
versity Hospital were included in this study. The Institutional Review 
Board waived the need for consent to use prospectively collected 
clinical data and the study was appointed the serial number 2020-214.
The exclusion criteria included: the lack of use of mechanical ventila-
tion and of anticoagulation. All patients received either prophylactic 
(enoxaparin 0.5 mg/kg/day) or therapeutic (enoxaparin 1 mg/kg, twice 
a day) anticoagulation. All patients were sampled for D-dimers, plate-
lets, Fibrinogen upon admission. Calculation of DIC score (ISTH crite-
ria) and severity scores (SOFA, SAPS2) was acquired upon admission 
for all patients. Arterial and venous thrombotic events led to a diag-
nostic workup upon clinical suspicion.
Results: Seventy-three patients were included in the final analyses. 
Demographic and clinical data are shown in Table  1. Mortality was 
not different between the 2 groups: 19/49 (38.8%) in the prophylactic 
group versus 7/24 (29.2%) in the therapeutic group. Moreover, there 
was no difference in the incidence of thrombotic or hemorrhagic 
events between the 2 groups. Median platelet counts were normal 
and DIC was predominantly non-overt. However, fibrin monomers 
taken from 49% of patients and D-Dimers, which should consolidate 
DIC scoring, were statistically higher in the prophylactic group in 
which three thrombotic events occurred (3/73, 4.1%). Of note, the lat-
ter incidence is substantially lower than in recent reports thus validat-
ing a systemic anticoagulation in Covid-19 patients(1, 2).
Finally, while not conferring a mortality benefit as suggested by a 
recent study, the therapeutic regimen appeared safe.
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Conclusion: Taken together, these findings are concordant with pre-
vious reports in emphasizing the fact that Covid-19 coagulopathy, 
while overlapping with many well characterized coagulopathies does 
not perfectly match any of them(3). They also confirm that systemic 
anticoagulation is mandatory in critically ill mechanically ventilated 
patients.
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Introduction: In COVID-19 patients hyperinflamation, immobilisation, 
hypoxia and vascular dysfunction may predispose to both venous and 
arterial thromboembolism. Describing these complications is neces-
sary in order to adjust the intensity of thromboprophylaxis specially in 
critically ill patients who are at increased thrombotic risk.
Objectives: To identify predictive factors and determine the fre-
quency of thrombotic complications in ICU COVID-19 patients receiv-
ing pharmacological thromboprophylaxis.
Methods: Descriptive retrospective study. Statistical analysis was per-
formed with IBMâSPSS Statistics 25.
Results: 77 patients with confirmed COVID-19 hospitalized in the ICU 
of our second level hospital were screened between March 6, 2020 
and May 6, 2020. All patients were adults diagnosed with respiratory 
failure and undergoing mechanical ventilation. Demographics, comor-
bidities, severity score,inflammatory markers, medical and antithrom-
botic treatment were collected. All these data were analyzed between 
patients with thrombotic episodes and those who did not, establish-
ing the incidence of thrombosis, the type, the diagnosis used, and 
analyzed the significance of the risk factors.
Of the 77 patients included in the study, 64.9% were male. The average 
age is 58 ± 11 years. At admission, the mean APACHE II was 17 ± 17.32. 
40.3% had a history of HT, 70% chronic lung disease, 67.5% DM, 45.5% 
DL and 74% obesity, with CKD being present in one of the patients 
and 7.8% previous thrombotic events. 15.5% were oncologic patients. 
Regarding anti-thrombotic treatment with LMWH, 55.8% received 
thromboprophylaxis, 16.9% adjusted the dose to weight/renal func-
tion,15.6% received intermediate doses of prophylaxis (1 mg/kg/day) 
and 10.4% anticoagulant doses. The incidence of venous thrombo-
embolism was 32.5% of the total with DVT being 32% (3 with distal; 
2 with distal and proximal; 1 with bilateral; 1 other type) and pulmo-
nar thromboembolism in 76% (6 bilateral; 8 with segmental; 2 with 
lobar; 3 with massive). Note that, the means of the inflammation 
parameters were significantly higher in the patients with thrombotic 
complications compared to those who did not suffer them (D-dimer 
63,3 ± 124vs16 ± 21 ng/ml, p =  0,001; Il-6 2311 ± 2767 vs 924 ± 1175, 
P = 0,001;PCR 246 ± 122 vs 215 ± 117, p =  0,016; Ferritina 6012 ± 2014 
vs 1827 ± 1560 ng/ml, p =  0,012;LDH 708 ± 388 vs 1344 ± 1552 ng/ml, 
p <  0,01). Paradoxically, mortality among thrombosed patients is not 
significantly higher.
Conclusion: In conclusion, despite systematic thrombosis prophylaxis, 
the 32,5% incidence of thrombotic complications in these patients is 
remarkably high and well comparable to the VTE incidence in other 
patient categories, but mortality mong these patients is not signifi-
cantly higher. D-dimer, IL-6, Ferritina, LDH and PCR level-guided more 
aggressive thromboprophylaxis regimens using higher doses of hepa-
rin seem to be a good instrument in critically ill patients but more pro-
spective studies are needed in this regard.
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Introduction: Recently published data show that COVID-19 is charac-
terized by a hypercoagulable ROTEM profile and decreased fibrinoly-
sis[1]. Multiple reports suggest that severe COVID-19 infection is 
associated with an increased thromboembolic risk[2,3]. There are lim-
ited data associating a hypercoagulable ROTEM profile and outcomes 
in the literature. A hypercoagulable ROTEM profile could help identify 
patients at risk of worse outcome and help target a study population 
for enhanced anticoagulation therapy or other COVID-19 therapy.
Objectives: To determine if early hypercoagulability on ROTEM is 
associated with a higher risk of thromboembolic complications or 
worse outcome, in a population of mechanically ventilated COVID-19 
patients transferred to a tertiary ARDS/ECMO referral center.
Methods: All COVID-19 patients receiving mechanical ventilation 
at our center between April 3 and June 15, 2020 were assessed with 
ROTEM. Testing performed included at least ExTEM and FibTEM. 
Patients were classified as hypercoagulable (HC) or not (nHC) using the 
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following criteria from ROTEM: EXTEM clot formation time (E_CFT)  < 
40 sec, alpha (α) angle >79° and, either ExTEM or FibTEM maximum 
clot firmness (E_MCF or F_MCF) >70  mm or >24  mm, respectively. 
Outcomes, assessed at discharge from our ICU, included thrombo-
embolic events (TE: composite of deep vein thrombosis, pulmonary 
embolism and ischemic stroke), acute kidney injury (AKI: AKIN 4 stage 
>2 with or without dialysis[4]), duration of mechanical ventilation, 
requirement for ECMO, and death. Difference between groups was 
determined using the chi-square or Fisher-exact test for categorical 
data and a t-test for continuous variables respectively, using p < 0.05 
as significant.
Results: Of 59 patients included, 31 were hypercoagulable (HC) on 
admission. Mean (SD) age was 52(14), and SOFA score on admission 
was high 15(2). The severity of disease was similar in both groups 
especially for the cardiac and respiratory SOFA components (Table 1). 
The composite outcome of TE was not different between the groups 
(HC 9/31, nHC 6/28, p = 0.7). The composite renal outcome was not 
different (HC 18/31 vs nHC 16/28). Mortality rate (29%, HC 9 vs nHC 
8), and the duration of ventilation in survivors (HC 22 vs nHC 22 days) 
were similar in both groups. Requirement for ECMO support was 
similar (HC 8 vs nHC 12, p =  0.27). Patients were tested with daily vis-
coelastic tests and, neither fibrinolysis nor DIC were documented. All 
patients received TE prophylaxis and 34 received therapeutic intrave-
nous heparin for ECMO (n = 20) or TE treatment (n = 14). Initial ROTEM 
were conducted on therapeutic heparin in 22 cases (12 HC, 10 nHC)
Conclusion: Our data suggest that in a population of mechanically 
ventilated patients with severe COVID-19, an early hypercoagulable 
profile on ROTEM is not associated with an increased risk of throm-
boembolic events, AKI, prolonged ventilation, ECMO or death during 
their ICU stay.
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Introduction: In COVID-19 patients,coagulopathy is frequently 
reported and is a significant poor prognosis factor. There is particularly 
high frequency of thromboembolic events,so the use of heparin was 
associated with reduced mortality in COVID-19.
Objectives: In order to optimize the treatment in these patients, the 
objective of our study was to analyze the incidence of bleeding com-
plications and what factors were most associated with them.
Methods: We made a descriptive retrospective study with adult 
patients with confirmed COVID-19 hospitalized in the ICU of our sec-
ond level hospital between March 6, 2020 and May 6, 2020. Statistical 
analysis was performed with IBMâSPSS Statistics 25.
Results: All were diagnosed with respiratory failure and required inva-
sive mechanical ventilation.We collect demographics, comorbidities, 
severity score (APACHE, SOFA, SAPS II),medical and antithrombotic 
treatment,an extensive study of coagulation, mortality and average 
ICU stay. We try to establish the incidence and importance of bleed-
ing complications analyzing the importance of risk factors associated 
with them.Our sample included 77 patients. Most of them (64.9%) 
were male. The average age was 58 ± 11 years. At admission, the mean 
APACHE II was 17 ± 17.32. 40.3% had a history of HT, 70% chronic 
lung disease, 67.5% DM, 45.5% DL and 74% obesity, with CKD being 
present in one of the patients and 7.8% previous thrombotic events. 
15.5% were oncologic patients. Regarding anti-thrombotic treatment 
with LMWH, 55.8% received thromboprophylaxis, 16.9% adjusted the 
dose to weight/renal function,15.6% received intermediate doses of 
prophylaxis (1  mg/kg/day) and 10.4% anticoagulant doses. The inci-
dence of bleeding complications (11,68%, 8 patients) compared with 
that of thrombosis (32,5%) was low. However thrombotic complica-
tions were not significantly associated with higher mortality, while 
hemorrhagic complications were. There were,three patients with cer-
ebral hemorrhage, 2 with digestive hemorrhage, 1 with hemoptysis, 1 
with peritracheostomy bleeding and one with muscular hematoma. Of 
these, 2 patients had LMWH at anticoagulant doses, 2 with intermedi-
ate doses (1  mg/kg), 3 with prophylactic doses and one with a dose 
adjusted for renal function. Only 1 received antifibrinolytic treatment.
Comparing the data between patients with hemorrhages and those 
without SOFA on admission (6,84 ± 18vs6,5 ± 3,6 p = 0,003) was the 
only risk factor that was significantly associated. Clarify, that 3 of them 
had had concomitant major whirlwind events.
Conclusion: Therefore we can conclude that although hemorrhagic 
complications have a lower incidence than thrombotic, their mortal-
ity is much higher and that it is difficult to establish possible risk fac-
tors that help us predict them. It is important to emphasize in order 
to optimize thrombotic event prophylaxis that heparin doses were not 
significantly associated with bleeding complications, but we require 
further studies with a larger sample to try to establish more risk factors 
that are associated.
001191 
CABARET: Clinical implicAtions of Bromelain Application in buRn 
patiEnTs
S.  Provinciael1; K.  Colpaert1; S.  Monstrey2
1Critical care, Ghent University Hospital, Ghent, Belgium; 2Plastic surgery, 
Ghent University Hospital, Ghent, Belgium 
Correspondence: S. Provinciael
Intensive Care Medicine Experimental 2020, 8(2): 001191
Page 607 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Introduction: Bromelain-based enzymatic debridement of burns is 
a relatively new technique, though it has already shown promising 
results on wound healing, with limiting blood loss and a lower prob-
ability of skin transplantation.
However, a higher degree of inflammation was clinically suspected in 
patients receiving bromelain. This study examines the association of 
using bromelain and the initiation of an inflammatory reaction.
Methods: A retrospective survey was performed on the database of 
burn patients in the universitary hospital of Ghent (Belgium), during 
the period of 05/2016-06/2019, with a total of 52 included patients. 
Inflammatory parameters were studied before and after the applica-
tion of bromelain. The parameters include vital signs (blood pressure, 
heart rate, temperature), laboratory findings (such as WBC (white 
blood cell count), CRP (C-reactive protein), coagulation, renal function, 
fibrinogen, hematocrit, lactate and blood glucose) and therapeutic 
measurements (such as use of oxygen, inotropic agents and vasopres-
sion). Sequential Organ Failure Assessment (SOFA) Score was addition-
ally determined.
Results: A statistical difference (p < 0.05) was seen in temperature, 
tension, heart rate, WBC, CRP and coagulation. We observed a higher 
temperature, hypotension, tachycardia, a higher CRP, a prolonged 
coagulation and a lower hematocrit. The white blood cell count was 
significantly lower after application of bromelain. No significant differ-
ence was seen in the other variables, neither in SOFA score.
Conclusion: Significant differences of augmented temperature, hypo-
tension, tachycardia, elevated CRP and prolonged coagulation were 
noticed after the application of bromelain, which suggest that bro-
melain may induce inflammation. Further research is needed in order 
to determine a clear causal relationship between the application of 
bromelain and the induced inflammatory response with the applica-
tion of standardised prospective study protocol.
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Introduction: Different acute critical illnesses such as sepsis or severe 
traumatic injury share some kind of inflammatory response (1), in 
which monocytes play an active role (2). Changes in cell volume 
parameters are related to cell activation, and one of these parameters 
is the monocyte distribution width (MDW), which is the standard devi-
ation of monocyte volume.
Recently, an elevated monocyte distribution width (MDW) has been 
found to differentiate patients with sepsis from those with a less 
severe infection (3-4).
We hypothesized that an elevated MDW would also occur in some 
trauma patients, especially in those with increased severity and a 
worse prognosis.
Objectives: The aim of this study was to evaluate the association 
between MDW value on admission of politraumatized patients, with 
trauma severity and prognosis.
Methods: This study took place in a trauma ICU in Madrid. Patients 
admitted with traumatic injury between August and November 2019 
were included, in which the MDW was measured in the first whole 
blood sample on the  UniCel® DxH 800  Coulter® Cellular Analysis Sys-
tem. No patients were excluded. They were classified according to 
MDW values (greater or less than 20 U). We compared for each group: 
injury severity score (ISS), hemodynamic instability, organ failures, 
length of stay and mortality. For statistical analysis we used SPSS soft-
ware, version 20.
Results: We included 87 patients with a median age of 43 years (inter-
quartile range IQR 27-52), 77% were men. Half of the patients pre-
sented with severe trauma, with a median ISS of 17 (IQR 11-25). Severe 
traumatic brain injury occurred in 18% of patients, 20% had severe 
thoracic trauma, 17% moderate-to-severe orthopedic trauma, and 
15% moderate-to-severe abdominal trauma. Demographic variables 
were well balanced between MDW defined groups: those with a MDW 
≥ 20 U represented 43% of patients, median age was 45  years (IQR 
31-61), and median ISS was 17 (IQR 13-27). High MDW patients were 
more likely to present hemodynamic instability on admission (77% vs 
23%, p = 0,013), as well as acute renal failure during ICU stay (80% vs 
20%, p = 0,017). These results were still observed after adjusting for 
age, ISS and metabolic acidosis on admission (base deficit of 4 mmol/L 
or more). A MDW ≥ 20 U was associated with hemodynamic instability 
on admission with an OR of 3,8 (IC 95% 1,09-12; p =  0,03), with failure 
of two organs or more with an OR of 12 (IC 95% 1,2-123; p = 0,034), 
and with acute kidney injury (AKI) with an OR of 17 (IC 95% 1,5 – 202; 
p =  0,023). We found no association between an elevated MDW and 
mortality of length of stay.
Conclusion: In trauma patients, a MDW ≥ 20 U on admission was 
independently associated with greater hemodynamic instability and a 
greater risk of multiorgan failure, especially AKI.
The monocyte distribution width is a parameter available from the 
complete blood count. It could be useful in predicting severity in the 
initial evaluation of trauma patients.
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Introduction: Veno-arterial carbon dioxide tension difference (ΔPCO2) 
is inversely related to cardiac output. No study has ever assessed 
ΔPCO2 as a marker of hemodynamic status following severe trauma.
Objectives: The aim of this study was to assess femoral ΔPCO2 (ΔPCO2 
fem) ability to predict the need of emergency erythrocyte transfusion 
following severe trauma.
Methods: This is a prospective, observational study, conducted in a 
French level I trauma center. Patients admitted to the trauma resus-
citation room following severe trauma with an Injury Severity Score 
(ISS) >15, who had arterial and venous femoral catheters inserted were 
included. ΔPCO2 fem and arterial lactatemia were measured over the 
first 48 hours of admission. ΔPCO2 fem and lactate abilities to predict 
erythrocyte transfusion during the first six hours of admission and 
emergency hemostatic procedure have been assessed using receiver 
operating characteristics curve.
Results: 42 trauma patients were included in the study. Median ISS 
was 27 (22-32). 22 patients (48%) received at least one red blood cell 
unit and 17 patients (40%) had a hemostatic procedure performed 
during the first six hours of admission. Mean overall ΔPCO2 fem at 
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admission was 9.5  ±  6.3 mmHg and median lactatemia was 2.2 (1.5-
4) mmol/l. ΔPCO2 fem was significantly higher in patients who were 
transfused than in those who were not transfused (12  ±  7  mmHg 
vs 7 ± 3  mmHg, p = 0.018). The best threshold to predict red blood 
cell transfusion in the first six hours of admission was 8.1 mmHg and 
the best threshold to predict emergency hemostatic procedure was 
5.8 mmHg. Lactatemia was not predictive of red blood cell transfusion 
or hemostatic procedure in the first six hours of admission.
Conclusion: After severe trauma, ΔPCO2 fem at hospital admission 
predicts the need for red blood cell transfusion and emergency hemo-
static procedure. ΔPCO2 fem on admission has the potential to stratify 
patients at risk of severe bleeding following trauma.
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Introduction: Queen’s Medical Centre (QMC) is a regional major 
trauma centre in East Midlands of England, serving the population of 
4.8 million people. A significant proportion of patients admitted to 
Major Trauma Ward (MTW) have chest wall injuries.
A trust-wide guideline on management of blunt chest trauma and 
rib fractures was published in July 2018 to help identify patients with 
multiple rib fractures who would benefit from an early administration 
of a thoracic epidural, which is the gold standard of analgesia in those 
with rib fractures in QMC.
Objectives: This study aims to look at the incidence of escalation to 
Critical Care (Level 2 & 3 care) from Major Trauma Ward (Level 1 care) in 
patients with ≥ 3 rib fractures since the introduction of the blunt chest 
trauma and rib fractures guideline.
Methods: List of patients who were admitted to MTW directly from 
Emergency Department with ≥ 3 rib fractures between July 2018 and 
June 2019 was obtained from Trauma Audit and Research Network 
(TARN) database. Data such as patient demographics, number of rib 
fractures, whether it was isolated chest injury, a form of analgesia 
including rib open reduction and internal fixation (ORIF), reason for 
delay in administration of an appropriate analgesia (including antico-
agulant use), escalation to Critical Care, total length of hospital stay 
were collected and analysed.
Results: A total of 176 patients were admitted to MTW with ≥ 3 rib 
fractures over one year period. 2 patients were excluded due to insuf-
ficient data.
The mean age was 64.5. 44 (25.3%) had an isolated chest wall injury. 
The mean number of ribs fractured was 5.7. The mean length of hospi-
tal stay was 9.9 days.
89 (51.1%) received an oral analgesia and 85 (48.9%) received a 
regional block. 7 (4%) had a rib ORIF.
Out of 85 with a regional block, 81 (91.0%) received a thoracic epi-
dural, 3 (3.5%) received a morphine PCA and 1 (1.2%) received a para-
vertebral block.
In terms of escalation, 10 out of 174 (5.7%) were escalated from MTW 
to Critical Care. 7 were on oral analgesia (for non-respiratory reasons) 
and 3 on thoracic epidural. All of these 3 epidural patients were esca-
lated for respiratory deterioration. 2 patients had a delay in epidural 
insertion; one due to deranged clotting due to liver cirrhosis and the 
other due to being on DOAC.
Conclusion: Early administration of a thoracic epidural in rib fracture 
patients enhances respiratory function and minimises the risk of res-
piratory complications. The result showed that only 3 (1.7%) patients 
were escalated to Critical Care due to respiratory deterioration over 
one year period. Having a definite rib fracture pathway for analge-
sia minimises the incidence of admission to Level 2 and 3 care. This 
potentially increases the cost effectiveness and allows appropriate uti-
lisation of resources in the critical care environment.
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Introduction: Cardiac mimicry have been described in patients with 
subarachnoid hemorrhage(1), which presumably is caused by an 
elevated sympathetic tone with excessive catecholamine release. 
This phenomenon has not been extensively studied in patients with 
traumatic brain injury (TBI). Recently we observed a high incidence of 
electrocardiographic (ECG) abnormalities in patients with severe TBI.
(2) However, primary cardiac injury as cause of ECG abnormalities was 
not determined systematically by echocardiography.
Objectives: In this study we evaluated brain-heart interactions in 
TBI patients admitted to the intensive care unit (ICU) with echocar-
diographic images systematically obtained within 24  h after ICU 
admission. We aimed to determine the incidence of right ventricle 
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dysfunction, since it is most at risk due its anatomical position during 
thoracic injury(3), and their association with brain injury severity in 
comparison to a trauma-control group.
Methods: Prospective observational study of trauma patients 
(≥18 years) admitted to the ICU of the University Medical Center Gro-
ningen between April 2015-July 2019 (SICS-I and SICS-II study(4)). Pri-
mary outcome was the incidence of right ventricular dysfunction; right 
ventricular systolic excursion (RV S’) (abnormal ≤9.5 cm/s) and tricus-
pid annular peak systolic excursion (TAPSE) (abnormal  < 17 mm). Sec-
ondary outcome was the association with brain injury severity scored 
according to the Glasgow Coma Scale.
Results: In total, 109 patients were included, median (IQR; interquar-
tile range) age was 57 years (38-68), and 69% were male. The 30-day 
mortality rate was 14%. Brain injury severity groups were as follows: 
trauma-control (20%), mild- (35%), moderate- (11%), and severe TBI 
(34%). Overall RV S’ was abnormal in 5% of patients with a median 
(IQR) of 14.0  cm/s (11-16) and TAPSE was abnormal in 10% with a 
median IQR of 22.2  mm (18.2-25.0). No differences were observed 
between RV S’ and TAPSE with brain injury severity groups (p  =  0.866 
and p  =  0.589, respectively).
Conclusion: Right ventricular cardiac function remains adequate in 
patients with traumatic brain injury admitted to the ICU and is not 
associated with brain injury severity. Despite often observed ECG 
abnormalities in patients with severe TBI, our data underscores that 
ECG abnormalities more likely reflect the secondary effect of brain 
injury (i.e. cardiac mimicry) rather than primary cardiac dysfunction.
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Introduction: Major trauma is the leading cause of death among chil-
dren and young adults with more than 16000 annual deaths in the UK. 
Following advances in trauma care from armed conflicts and excessive 
mortality and morbidity from inadequacies in delivery of trauma care 
in the UK, a centralised trauma network system was introduced.
University Hospitals Plymouth was designated as a major trauma cen-
tre in 2012 with 4 district general satellite trauma units in the South 
West of England. We analysed various RSI methods used during the 
transition and incidence of complications and vasopressor use in 
trauma RSI.
Objectives: 
– Evaluate the change in practice of trauma RSI during transition to a 
major trauma centre between 2012 and 2019.
– Compare clinical practice to existing RSI standard operating proce-
dure (SOP) during the transition period 2012-2019.
– Review complications associated with different induction agents 
and vasopressor use in trauma RSI.
Methods: Patients were identified from UK’s Trauma Audit & Research 
Network (TARN) database. We selected trauma cases across three 
years encompassing the transition period (2012, 2015 and 2019). Data 
was collected retrospectively based on TARN data base and hospital 
records. Patients intubated pre-hospitally and transfers from trauma 
units were included.
Results: We analysed 120 patients in total, only those with complete 
set of data were included in the final analysis (n = 68). In our study 
group, blunt trauma was the main mechanism of injury (95.5%) and 
85% of RSIs were performed in patients with an injury severity score 
>15. Only 11% of RSIs were done by non-anaesthtists and ketamine/
midazolam was used for those. Table 1 details induction agents used.
Rocuronium largely replaced suxamethonium for muscle relaxation. It 
was used for half RSIs in 2015, with suxamethonium only being used 
once in 2019.
Hypotension (systolic blood pressure <  90) was the main complication 
(24.5%), and has largely occurred with propofol (87%) but also seen 
with ketamine (13%). 40% of propofol inductions in patients with trau-
matic brain injury (TBI) required vasopressor use.
Conclusion: The incorporation of major trauma centre RSI protocols 
required a transition from individual anaesthetist-centred practice 
to a multidisciplinary trauma team based approach.Whilst adapta-
tion of rocuronium as the preferred muscle-relaxant occurred ahead 
of updating the trauma RSI SOP in 2018, propofol remained as the 
induction agent of choice despite SOP suggesting ketamine use. This 
might be due to most RSIs being delivered by anaesthetists who use 
propofol more regularly. This may not necessarily worsen outcomes 
for non-TBI; however, it may do so in traumatic brain injuries where 
hypotension commonly occurred with propofol.Overall incidence of 
hypotension was similar to other published data, and the selection of 
RSI drugs is comparable to RSI practice in the UK.
Reference(s) and grant ackowledgment(s)
1. 1. Trauma Audit and Research Network, www.tarn.ac.uk .
2. 2. Findlay G, Martin I, Carter S., et al. Trauma: Who Cares?; A report of the 
National Confi dential Enquiry into Patient Outcome and Death.NCEPOD 
2007.
3. 3. Hylands M, Toma A, Beaudoin N, et al. Vasopressor use following trau‑
matic injury: protocol for a systematic review. BMJ Open 2017.
4. 4. Heffner A, Swords D, Kline J, Jones A. The frequency and significance of 
postintubation hypotension during emergency airway management. J Crit 
Care. 2012.
5. 5. Sajayan A, Wicker J, Ungureanu N, et al. Current practice of rapid 
sequence induction of anaesthesia in the UK ‑ a national survey. Br J 
Anaesth. 2016.
001650 
Thoracic Trauma: first steps into a new score
M.  Romano1; R.  Passos2; F.  Cardoso2; D.  Alves2; J.  Braga2; R.  Corga2; J. 
 Caldeiro2
1Internal medicine, Hospital Santa Luzia ‑ Ulsam, Viana do Castelo, Viana 
do Castelo, Portugal; 2Intensive medicine, Hospital Santa Luzia ‑ Ulsam, 
Viana do Castelo, Viana do Castelo, Portugal 
Correspondence: F. Cardoso
Intensive Care Medicine Experimental 2020, 8(2): 001650
Page 610 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
Introduction: Thoracic trauma is a common admission problem to the 
emergency department, with a wide variety of presentations. Trauma 
patients may be difficult to access, especially with blunt lesions, con-
sidering that the extent of the visible lesions may underestimate its 
severity. Several scoring systems are commonly used to evaluate 
severity in these patients, and have been proposed to predict the 
development of acute respiratory distress syndrome (ARDS), however 
there is no global acceptance for a single scoring system. Our goal is 
to design a new score. Combining the Lung Ultrasound Score secto-
rial points, we hope to enhance sensitivity for severe (more diffuse) 
lesions. While preparing this new scoring system to be ultrasound 
based, we decided first to retrospectively evaluate its usefulness 
reviewing our patient data and their Computarized Tomography (CT) 
scan, knowing beforehand which have developed such complication.
Methods: We conduct a retrospective, consecutive review of the med-
ical records of patients who were admitted to the ICU with thoracic 
trauma who were managed at our institution between september 
2019 and june 2020. Inclusion criteria were: thoracic trauma, admis-
sion in ICU, arterial blood gasometry at admission, and thoracic CT 
scan within the first 12hours. The score used accessed each patient by 
gasometry, presence of pneumothorax and hemothorax, and contu-
sion/consolidation extent, ranging from 0 to 20. Then we analyzed the 
association between the proposed score and evolution to ARDS, need 
for mechanical ventilation and in-hospital mortality.
Results: 19 patients met the final inclusion criteria. The minimum 
score was 4 and the maximum 12. In this study we noticed that all 
patients that didn’t evolved to ARDS (from mild to severe) had a score 
equal or inferior to 7. The same cut-off was noticed to the need of 
mechanical ventilation. From the 19 patients enrolled, only one died 
and was one of the 3 patients with the highest score (12).
Conclusion: The present study aims to evaluate all thoracic trauma 
patients admitted to an ICU for a period of 10 months and evaluate the 
validity of a new score as a predictor of in-hospitality mortality and/
or evolution to ARDS, trying to find cut-off above or under which one 
could decide ICU admission. The authors have in mind the handicaps 
of these study: 1) the few patients enrolled, 2) the retrospective evalu-
ation, 3) the use of CT. Nevertheless, it was important to notice a clear 
cut-off for the less ill patients, in spite of their admission in ICU. This 
emphasizes the need for further research in this area, with a greater 
number of patients for a longer time. The authors of the study aim 
for future testing the score using thoracic ultrasonography at admis-
sion. This point of care exam would be faster, safer (innocuous to the 
patient) and cheaper. We add that the operator dependency is easily 
resolved with basic training and experience.
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Introduction: The rapid COVID-19 pandemic spreading, associated 
with insufficient resources, changed the focus of health care profes-
sionals (HCP) from caring with the best quality to preserving as many 
lives as possible. End-of-life (EOL) procedures (1) implemented in the 
ICU were changed to minimize the use of scarce personal protec-
tive equipments (PPE) and the risk to disseminate SARS-CoV-2 infec-
tion among HCP and families of ICU patients. Portuguese authorities 
implemented restrictions following state of emergency declaration (2): 
visits were forbidden, EOL decision meetings with families were can-
celled, communication was restricted to a physician in charge call to 
one family member once or twice daily. In addition, institutional reli-
gious support was withheld. As many patients admitted to the ICU 
were previously in a good medical condition they had not a living 
will and, though they were awake, conversations with them about 
EOL issues were short or nonexistent due to severe hypoxia: there-
fore their will was mostly unknown. Communication of EOL decisions 
is traditionally variable (3): however, in such conditions, the extent of 
the impact of these measures on communication and humanization is 
unpredictable.
Objectives: To describe decision making, communication practices 
and palliative measures in EOL COVID-19 patients at an university hos-
pital intensive care department.
Methods: Data from all COVID-19 patients admitted to the ICU from 
11-3 to 29-4-2020 were studied. No interventions were given to 
patients. Institutional approval was obtained [2020.084(067-DEFI/068-
CE) – TRILIPA 19(TRiage, LImitation of therapy and PAlliative care in 
COVID 19 patients)].
Results: 51 patients were enrolled (67% male, mean age 65 yo) with a 
median SOFA score on ICU admission of 7, a median Charlson Comor-
bidity Index of 4 and median Frailty Score of 3; median LOS in ICU was 
8 days. 42 (82%) patients were awake on ICU admission.
21 (41%) patients died in the ICU, 27 had decisions to limit life sustain-
ing treatments (LST); none patient had a living will; no information 
about patient’s wishes was asked. Although only 2 patients had limita-
tion of LST on admission, neither the patient or the family participated 
on its discussion. Decisions to either withholding or to withdrawing 
therapy were communicated to the family before death in 22% of 
the cases. Nurses participated in 8% of EOL decisions. Palliative care 
measures included sedoanalgesia (100%) to guarantee that patients 
died gently and tranquilly. There were no visits (100%) for the dying 
patients.
Conclusion: Procedures related to EOL care of the dying patient in 
the ICU were changed during COVID 19 pandemic, consequently 
humanization in EOL was not protected and these patients were not 
equally treated in rights and dignity. The psychological and sociologi-
cal effects of the civil liberties and human rights restrictions on both 
the families and caregivers of the dead and HCP are to be determined.
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Introduction: Though End-of-life pratices (EOLP) are variable [1] and 
change over time [2]. The COVID-19 pandemic brought new dilemmas 
to ICU physicians concerning triage, limitation of life-sustaining ther-
apy (LLST) and humanization. Many decisions were left to the ICU staff 
alone (sometimes to the physician in charge alone), being the patient 
or the family unable to participate in the decision making process. 
Documentation, which is frequently poor [3], may be even more chal-
lenging under these circunstances.
Objectives: To describe EOLP in COVID-19 patients at an university 
hospital intensive care department.
Methods: All COVID-19 patients admitted to the ICU from 11-3-2020 
to 29-4-2020 were enrolled in a retrospective observational study. 
Institutional approval was obtained [2020.084(067-DEFI/068-CE) 
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- TRILIPA 19 (TRiage, LImitation of therapy and PAlliative care in 
COVID-19 patients)] with a waiver of informed consent. LLST definitons 
used were: “Do-not-resuscitate (DNR) order” when the order to DNR 
was prescribed and documented; “failed CPR” when death occurred 
despite cardiopulmonary resuscitation (CPR) efforts, “withholding life 
support” (WH) when a decision was made not to start or increase a life-
sustaining intervention like cardiopulmonary resuscitation (WH_CPR), 
vasopressors and/or inotropes (WH_Vas), invasive mechanical ventila-
tion (WH_IMV), renal replacement therapy (WH_RRT) or extracorporeal 
membrane oxygenation (WH_ECMO); “withdrawing life support” (WD) 
when a decision was made to actively stop a life-sustaining interven-
tion presently being given, maintaining only closed circuit ventilation 
to protect health care workers from the risk of contamination.
Results: 51 patients were enrolled (67% male, mean age 65 yo, median 
LOS in ICU 8  days): on ICU admission, the median SOFA score was 7, 
the median Charlson Comorbidity Index (CCI) was 4 and the median 
Frailty Score was 3. The ICU mortality was 41% (n = 21) and the hos-
pital mortality was 49% (n = 25). At admission a decision to WH was 
made in 2 patients (WH_IMV). During ICU stay, 25 decisions of LLST in 
20 patients were taken: DNR in 1 patient, WH_RRT in 1 patient, WH_
ECMO in 2 patients, WH_CPR in 6 patients and WD in 15 patients. Only 
1 patient who had LLST survived to the hospital stay. Death occured 
after WH treatment in 8 patients (38%) and after WD treatment in 13 
(62%). Reasons for a LLST were multi-organ failure or devastating brain 
injury. 74% of the LLST decisions were partially documented.
Conclusion: All COVID-19 patients died after a LLST due to multi-
organ failure or devastating brain injury. Though these patients had 
low prevalence of comorbidities and low level of functional disabil-
ity, none was considered for CPR. LLST decisions were insufficiently 
documented.
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Introduction: Spain has developed a succesful transplant activity, 
fundamentally thanks to deceased organ donation, reaching 46.9 mil-
lion per million inhabitants in 2017. Since 2017, the General Consor-
tium University Hospital of Valencia (GCUHV), a tertiary hospital, has 
collaborated in the increase and development of such activity and has 
included in its protocols for patients that meet the criteria for poten-
tial donors the option to donate when the responsible medical team 
changes its therapeutic objetective towards donation-centered com-
fort measures and end-of-life care.
Objectives: To describe the number and characteristics of patients 
who deceased in our hospital and were candidates for organ donation 
in asystole from December 2017 to May 2019.
Methods: Descriptive and retrospective study including patients who 
deceased in our hospital and were candidates for organ donation in 
asystole. Variables such as age, intensive care stay in days, cause of 
death and removed organs were retrieved.
Results: A total of 13 asystolic donors were collected from December 
2017 to May 2019 at this tertiary hospital. Of these, 11 were neuro-
critical patients and 2 were patients recovered from cardiac arrest. The 
average age was 60.3 years (40-69) and mean intensive care stay was 
7.38 days (3-17). Among the removed organs, it is worth mentioning 
that kidneys from all 13 patients, livers from 9 of them and a total of 3 
pancreas were successfully implanted.
Conclusion: Despite a significant increase in the availability of organs 
for transplantation in recent years, a gap between supply and demand 
still persists. The development of new alternative means of organ 
donation is necessary in order to assure the availability of organs for 
transplantation. The program was initially very cautious, but its easily 
improvable. We expect a significant increase in the number of dona-
tions for the coming years.
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Introduction: Early intervention in sepsis have been shown to be cru-
cial in preventing the transition into septic shock and reducing mortal-
ity in this population. Early recognition can be challenging, and many 
scores have been created to help physicians anticipate clinical dete-
rioration (e.g. qSOFA or NEWS). Main limitations are lack in external 
validity and inclusion of few parameters only. We propose to predict 
clinical deterioration by considering all the variables systematically 
recorded by electronic health records (EHR). With the advent of new 
techniques in healthcare settings like machine learning, we aim to 
build tailored-to-patients scores that will improve the ability to antici-
pate and prevent intensive care admission.
Objectives: Predicting ICU admission in septic patients using machine 
learning models.
Methods: Our cohort included all the patients with ICD-9 codes for 
sepsis (995.92) and septic shock (785.52) that were admitted from 
standard ward to in intensive care units (ICU), among all patients 
hospitalized in 2018 in Humanitas Research Hospital. Data were 
anonymized at extraction from repository. Demographics and vital 
signs available in general wards were extracted from EHR, including 
heart rate, respiratory rate, peripheral oxygen saturation, tempera-
ture and peripheral blood pressure. We divided the features in data 
windows and the mean of each vital sign was calculated and retained 
for each block. We began the iterative process of building machine 
learning models (Logistic Regression and Random Forest Classifier) to 
Page 612 of 612Intensive Care Medicine Experimental 2020, 8(Suppl 2):73
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
predict the admission in ICU, using a train-test set division and k-fold 
cross validation. We trained the models with the 72  h hours data 
before ICU admission for cases and 72 h prior the worst mean arterial 
pressure for controls (as it was considered the most critical moment in 
those who were not admitted to ICU), considering age, gender, heart 
rate, respiratory rate, peripheral oxygen saturation, temperature and 
the trend of systolic, diastolic and mean arterial pressures.
Results: The cohort comprehends 105 patients of which 15 were 
admitted to ICU (14%). The median age for those admitted in ICU was 
statistically significantly lower (69.5[68-79] vs 77 [69-85], p-value  < 
0.01]) and most patients admitted in ICU were males (12 vs 3, 
p-value  =  0.20). The best cross-validated logistic regression model 
had an AUROC of 0.77, while for random forest the AUROC was 0.74. 
In logistic regression, male gender, heart rate and respiratory rate were 
positively correlated, while age, diastolic blood pressure and oxygen 
saturation were reversely correlated.
Conclusion: In this first preliminary study, we demonstrated that 
machine learning models might be an innovative solution to predict 
intensive care admission in septic patients before clinical deteriora-
tion using data derived from EHR Further studies on larger cohorts and 
wider types of data, like laboratory values, should be performed to 
assess the real potential of machine learning models.
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